SeqName	Description	Length	#Hits	e-Value	sim mean	#GO	GO IDs list	GO Names list	Enzyme Codes list	InterPro IDs	
tr|H9GZV1|H9GZV1_HORSE	immunoglobulin alpha heavy chain constant partial	330	20	0E0	71.3%					
tr|H9GZU8|H9GZU8_HORSE	immunoglobulin gamma 1 heavy chain constant partial	324	20	0E0	80.55%					
tr|H9GZT5|H9GZT5_HORSE	heavy chain precursor	335	20	0E0	83.5%					
tr|H9GZR2|H9GZR2_HORSE	immunoglobulin gamma 1 heavy chain constant partial	338	20	0E0	77.35%					
tr|H9GZS6|H9GZS6_HORSE	immunoglobulin gamma 1 heavy chain constant partial	338	20	0E0	76.65%					
tr|H9GZU9|H9GZU9_HORSE	immunoglobulin gamma 1 heavy chain constant partial	325	20	0E0	79.8%					
tr|F6QAU5|F6QAU5_HORSE	immunoglobulin lambda light chain constant partial	107	20	9.12E-71	97.35%					
tr|F7CAC5|F7CAC5_HORSE	immmunoglobulin lambda light chain variable partial	117	20	6.67E-78	99.65%					
tr|F6SQD7|F6SQD7_HORSE	immunoglobulin lambda light chain constant partial	107	20	3.31E-64	90.7%					
tr|F6SP11|F6SP11_HORSE	immmunoglobulin lambda light chain variable partial	106	20	1.5E-67	98.5%					
tr|F7AU56|F7AU56_HORSE	complement factor I isoform X2	560	20	0E0	88.5%					
tr|F6UPN4|F6UPN4_HORSE	spectrin alpha non-erythrocytic 1 isoform X2	2476	20	0E0	99%					
tr|F7BV56|F7BV56_HORSE		1884								
tr|F6PNY0|F6PNY0_HORSE	immunoglobulin lambda light chain variable partial	97	20	1.14E-56	87.55%					
tr|F6WF42|F6WF42_HORSE	mammaglobin-A-like	93	20	7.25E-62	79.35%					
tr|F7A559|F7A559_HORSE		610								
tr|F6VIZ0|F6VIZ0_HORSE		2115								
tr|H9GZQ2|H9GZQ2_HORSE	immunoglobulin heavy chain variable partial	98	20	6.08E-63	98.3%					
tr|F7BNQ2|F7BNQ2_HORSE	C4b-binding alpha chain	602	20	0E0	80.9%					
tr|H9GZQ3|H9GZQ3_HORSE	immunoglobulin heavy chain variable partial	100	20	1.53E-64	92.9%					
tr|F6QBE4|F6QBE4_HORSE	immunoglobulin lambda light chain variable partial	100	20	6.42E-64	96.95%					
tr|F6PP62|F6PP62_HORSE	immunoglobulin lambda light chain variable partial	99	20	3.12E-63	98.5%					
tr|H9GZN8|H9GZN8_HORSE	immunoglobulin heavy partial	97	20	2.11E-62	99.9%					
tr|F7AJE4|F7AJE4_HORSE	immunoglobulin lambda light chain variable partial	93	20	2.39E-58	97.6%					
tr|F7AIT9|F7AIT9_HORSE	immunoglobulin lambda light chain variable partial	107	20	1.51E-69	98.85%					
tr|F7DS76|F7DS76_HORSE	immunoglobulin lambda light chain variable partial	128	20	4.88E-76	96.3%					
tr|F6ZMW3|F6ZMW3_HORSE	immunoglobulin lambda light chain variable partial	115	20	1.37E-76	93.15%					
tr|F6VC90|F6VC90_HORSE	immunoglobulin kappa light chain V-J partial	100	20	4.54E-53	89.1%					
tr|F6Q448|F6Q448_HORSE	immunoglobulin lambda light chain V-J partial	77	20	6.7E-47	94.2%					
tr|F6ZLH3|F6ZLH3_HORSE	immunoglobulin kappa light chain V-J partial	115	20	1.89E-72	92.7%					
tr|F6R3Z7|F6R3Z7_HORSE	immunoglobulin lambda light chain variable partial	97	20	1.34E-62	84.9%					
tr|F7A3F7|F7A3F7_HORSE		1455								
tr|F7BQW2|F7BQW2_HORSE	immunoglobulin kappa light chain V-J partial	124	20	4.3E-69	92.6%					
tr|F6T4S3|F6T4S3_HORSE	nmrA-like family domain-containing 1	286	20	0E0	92.9%					
tr|F6VG02|F6VG02_HORSE		35233								
tr|F7CCI0|F7CCI0_HORSE	immunoglobulin lambda light chain variable partial	121	20	2.65E-58	83.6%					
tr|F6R2K0|F6R2K0_HORSE		1222								
tr|F7A103|F7A103_HORSE	nesprin-1 isoform X1	7677	20	0E0	96.1%					
tr|F6RHE9|F6RHE9_HORSE	nesprin-1 isoform X1	8800	20	0E0	96.25%					
tr|F7BM69|F7BM69_HORSE	immunoglobulin kappa light chain V-J partial	115	20	5.29E-76	95.9%					
tr|F6X6N8|F6X6N8_HORSE	zymogen granule 16 homolog B	174	20	1.25E-106	81.4%					
tr|F6XNR9|F6XNR9_HORSE		1704								
tr|F6WIY8|F6WIY8_HORSE	PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein C6orf132 homolog	119	20	6.96E-71	93.65%					
tr|F7D1U4|F7D1U4_HORSE	immmunoglobulin lambda light chain variable partial	42	20	4.21E-20	98.95%					
tr|F7BYK3|F7BYK3_HORSE		776								
tr|F6XGG1|F6XGG1_HORSE	immunoglobulin lambda light chain variable partial	116	20	9.49E-78	89.75%					
tr|F6XWU0|F6XWU0_HORSE	glutamate-rich 5	381	20	0E0	76.55%					
tr|F6R2W0|F6R2W0_HORSE	immunoglobulin lambda light chain variable partial	89	20	5.67E-48	87.05%					
tr|F6Z4A7|F6Z4A7_HORSE	immunoglobulin lambda light chain V-J partial	106	20	2.63E-58	84.15%					
tr|F7DBG6|F7DBG6_HORSE	Ig kappa light chain variable partial	119	20	1.44E-53	80.4%					
tr|F6YG97|F6YG97_HORSE	collagen alpha-1(XXVII) chain	665	20	0E0	78.4%					
tr|F6ZPZ2|F6ZPZ2_HORSE	A-kinase anchor 13	1890	20	0E0	94.6%					
tr|F6W6H9|F6W6H9_HORSE		3651								
tr|F6Y1Y3|F6Y1Y3_HORSE	msx2-interacting isoform X1	3626	20	0E0	93.45%					
tr|F7DHH2|F7DHH2_HORSE	GON-4 isoform X1	2232	20	0E0	95.3%					
gi|71842631|gb|AAZ43316.1|	immunoglobulin heavy chain variable partial	123	20	2.11E-83	81.75%					
gi|71842641|gb|AAZ43321.1|	immunoglobulin heavy chain variable partial	115	20	4.73E-77	80.3%					
gi|71842653|gb|AAZ43327.1|	immunoglobulin heavy chain variable partial	119	20	1.25E-79	81.45%					
gi|71842677|gb|AAZ43339.1|	immunoglobulin heavy chain variable partial	124	20	5.33E-85	81.25%					
gi|149719418|ref|XP_001504761.1|	olfactomedin 1	402	20	0E0	93.5%					IPR003112 (SMART); IPR003112 (PFAM); PTHR23192 (PANTHER); IPR031229 (PTHR23192:PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR003112 (PROSITE_PROFILES)
gi|194215152|ref|XP_001917082.1|	lymphocyte antigen 6H-like	137	20	4.2E-95	65.05%					IPR016054 (PFAM); G3DSA:2.10.60.10 (GENE3D); PTHR32217 (PANTHER); PTHR32217:SF3 (PANTHER); IPR018363 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SSF57302 (SUPERFAMILY)
gi|194228216|ref|XP_001915811.1|	leucine-rich repeat and calponin homology domain-containing 2 isoform X1	764	20	0E0	97.05%					
gi|300386601|gb|ADK09331.1|	immunoglobulin heavy chain V-D-J partial	176	20	3.42E-125	86%					
gi|300386855|gb|ADK09452.1|	immunoglobulin heavy chain V-D-J partial	173	20	1.63E-122	87.2%					
gi|300386859|gb|ADK09454.1|	immunoglobulin heavy chain V-D-J partial	174	20	9.72E-124	88.25%					
gi|300386873|gb|ADK09461.1|	immunoglobulin heavy chain V-D-J partial	176	20	1.58E-125	86.25%					
gi|300387416|gb|ADK09725.1|	immunoglobulin lambda light chain V-J partial	214	20	3.03E-150	88.6%					
gi|300387424|gb|ADK09729.1|	immmunoglobulin lambda light chain variable partial	214	20	1.44E-150	90.9%					
gi|300387430|gb|ADK09732.1|	immunoglobulin lambda light chain V-J partial	212	20	4.55E-150	87%					
gi|300387461|gb|ADK09747.1|	immunoglobulin lambda light chain V-J partial	204	20	7.79E-143	90.1%					
gi|300387601|gb|ADK09814.1|	immunoglobulin lambda light chain V-J partial	199	20	6.47E-143	88.35%					
gi|300387684|gb|ADK09854.1|	immmunoglobulin lambda light chain variable partial	217	20	3.11E-155	93.55%					
gi|300387716|gb|ADK09870.1|	immunoglobulin lambda light chain V-J partial	218	20	9.03E-154	89.6%					
gi|335772576|gb|AEH58112.1|	UPF0553 C9orf64 homolog	262	20	0E0	97.55%					IPR019438 (PFAM); PTHR21314:SF0 (PANTHER); IPR019438 (PANTHER)
gi|338712970|ref|XP_001497747.3|	pentraxin-4	475	20	0E0	87%					
gi|338725360|ref|XP_001918162.2|	PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein C1orf87 homolog	588	20	0E0	85.4%					IPR011992 (G3DSA:1.10.238.GENE3D); PTHR34830:SF1 (PANTHER); PTHR34830 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR011992 (SUPERFAMILY)
gi|338726081|ref|XP_003365253.1|		1925								
gi|347825942|gb|AEP27052.1|	immunoglobulin heavy chain variable partial	128	20	9.91E-88	78.15%					
gi|379991136|ref|NP_001244009.1|	coiled-coil domain-containing 87	858	20	0E0	86.9%					PF03999 (PFAM)
gi|478683743|gb|AGJ50427.1|	immunoglobulin heavy chain variable partial	134	20	2.87E-92	88.6%					
gi|478683745|gb|AGJ50428.1|	immunoglobulin heavy chain variable partial	136	20	3.06E-95	89.7%					
gi|478683773|gb|AGJ50442.1|	immunoglobulin heavy partial	135	20	6.14E-94	88.75%					
gi|545180600|ref|XP_005597999.1|	peripheral-type benzodiazepine receptor-associated 1	1872	20	0E0	90.05%					
gi|545180867|ref|XP_005598090.1|	COMM domain-containing 9	198	20	1.48E-140	96.9%					IPR017920 (PFAM); PTHR15663 (PANTHER); IPR017920 (PROSITE_PROFILES)
gi|545182084|ref|XP_005598503.1|		1160								
gi|545182421|ref|XP_005615180.1|	PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein C7orf26 homolog	650	20	0E0	92.05%					
gi|545184180|ref|XP_005599231.1|	UPF0544 C5orf45 homolog	313	20	0E0	77.45%					IPR032739 (PFAM); PTHR15863:SF2 (PANTHER); IPR032739 (PANTHER)
gi|545184780|ref|XP_005599418.1|	proline-rich basic 1	1019	20	0E0	87.75%					IPR027838 (PFAM); PTHR33775 (PANTHER)
gi|545185480|ref|XP_005599654.1|		4238								
gi|545188986|ref|XP_005600846.1|	FAM198A isoform X1	578	20	0E0	89.4%					IPR029207 (PFAM); PTHR15905 (PANTHER); PTHR15905:SF5 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS)
gi|545203026|ref|XP_005605590.1|	pleckstrin homology domain-containing family D member 1	554	20	0E0	96.3%					IPR001849 (SMART); IPR001849 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); PTHR14383 (PANTHER); IPR001849 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY)
gi|545205054|ref|XP_005606277.1|	flocculation FLO11 isoform X1	729	20	0E0	76.15%					PTHR35825 (PANTHER)
gi|545209010|ref|XP_005607555.1|	msx2-interacting isoform X1	3664	20	0E0	94.7%					
gi|545212207|ref|XP_005615188.1|	spermatogenesis-associated 2	407	20	0E0	85.55%					
gi|545212209|ref|XP_005608625.1|	VPS9 domain-containing 1	665	20	0E0	88.4%					IPR003123 (SMART); IPR003123 (PFAM); PTHR23101:SF78 (PANTHER); PTHR23101 (PANTHER); IPR003123 (PROSITE_PROFILES); SSF109993 (SUPERFAMILY)
gi|545213989|ref|XP_005609243.1|	sterile alpha motif domain-containing 9-like	1584	20	0E0	91.65%					
gi|545214660|ref|XP_005609438.1|	glucocorticoid-induced transcript 1	547	20	0E0	95.2%					IPR026642 (PFAM); IPR026642 (PANTHER); IPR026639 (PTHR14972:PANTHER)
gi|545217741|ref|XP_005610470.1|	coiled-coil domain-containing 18 isoform X1	1458	20	0E0	95.65%					PTHR18875 (PANTHER); IPR029613 (PTHR18875:PANTHER)
gi|545224909|ref|XP_005612907.1|	hinderin isoform X1	700	20	0E0	88.5%					IPR032736 (PFAM); PTHR28375:SF1 (PANTHER); PTHR28375 (PANTHER)
gi|545226003|ref|XP_005613285.1|	vacuolar sorting-associated 13B isoform X2	3991	20	0E0	96.3%					IPR031645 (PFAM); IPR026854 (PFAM); IPR009543 (PFAM); PTHR12517:SF0 (PANTHER); PTHR12517 (PANTHER)
gi|545226766|ref|XP_005613537.1|		1441								IPR027970 (PFAM); PF14650 (PFAM); PTHR21859 (PANTHER); PTHR21859:SF1 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|545229190|ref|XP_005614377.1|	PREDICTED: uncharacterized protein CXorf49 homolog	672	20	0E0	66.45%					IPR027822 (PFAM); IPR027822 (PANTHER)
gi|545229878|ref|XP_005614620.1|	MAGE domain-containing MAGEA13P	350	20	0E0	84.45%					IPR021072 (SMART); IPR002190 (SMART); IPR002190 (PFAM); IPR021072 (PFAM); PTHR11736 (PANTHER); PTHR11736:SF85 (PANTHER); IPR002190 (PROSITE_PROFILES)
gi|677285139|gb|AIM46368.1|	immunoglobulin lambda light chain variable partial	127	20	1.31E-86	82.35%					
gi|723943377|gb|AIY24854.1|	immmunoglobulin lambda light chain variable partial	224	20	1.73E-160	92.45%					
gi|815891334|ref|NP_001295212.1|	HEAT repeat-containing 5A isoform X1	2046	20	0E0	98.1%					
gi|953841277|ref|XP_014588541.1|	probable domain-containing histone demethylation 2C isoform X1	2505	20	0E0	97.55%					IPR003347 (SMART); IPR003347 (PFAM); PTHR12549 (PANTHER); PTHR12549:SF6 (PANTHER); IPR003347 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY)
gi|953842823|ref|XP_005603226.2|	NUT family member 1	1180	20	0E0	87%					IPR024309 (PFAM); IPR024310 (PANTHER); PTHR22879:SF13 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|953844251|ref|XP_014589457.1|	PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein C10orf71 homolog	1425	20	0E0	84.9%					IPR027838 (PFAM); PTHR33775 (PANTHER)
gi|953844439|ref|XP_014589519.1|	CASC5	2351	20	0E0	92.1%					PTHR16520 (PANTHER); PTHR16520:SF3 (PANTHER)
gi|953848926|ref|XP_005608953.2|		1455								G3DSA:1.20.5.170 (GENE3D); IPR032771 (PFAM); PTHR36866 (PANTHER)
gi|953849429|ref|XP_014594216.1|		1308								IPR028030 (PFAM)
gi|953858600|ref|XP_014597023.1|		3451								IPR000082 (G3DSA:3.30.70.GENE3D); IPR000082 (PFAM); IPR028850 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000082 (PROSITE_PROFILES); IPR000082 (SUPERFAMILY); IPR000082 (SUPERFAMILY); IPR000082 (SUPERFAMILY); IPR000082 (SUPERFAMILY); IPR000082 (SUPERFAMILY); IPR000082 (SUPERFAMILY); IPR000082 (SUPERFAMILY); IPR000082 (SUPERFAMILY); IPR000082 (SUPERFAMILY); IPR000082 (SUPERFAMILY); IPR000082 (SUPERFAMILY); IPR000082 (SUPERFAMILY); IPR000082 (SUPERFAMILY)
gi|953864609|ref|XP_014587677.1|		1492								IPR025451 (PFAM); PTHR14709 (PANTHER); PTHR14709:SF1 (PANTHER)
gi|953865539|ref|XP_014590306.1|	PREDICTED: uncharacterized protein KIAA0408 homolog	696	20	0E0	88.7%					
gi|953865748|ref|XP_014590967.1|	NHS 1	1467	20	0E0	85.1%					IPR024845 (PFAM); PTHR23039 (PANTHER); PTHR23039:SF3 (PANTHER)
gi|953866142|ref|XP_005597677.2|	KIAA0100 homolog	2211	20	0E0	95.3%					IPR019441 (SMART); IPR019443 (PFAM); IPR019441 (PFAM); IPR019439 (PFAM); PTHR15678 (PANTHER)
gi|953869266|ref|XP_014585011.1|	FAM111B	732	20	0E0	83.85%					PF13365 (PFAM); G3DSA:2.40.10.10 (GENE3D); G3DSA:2.40.10.10 (GENE3D); PTHR14389:SF4 (PANTHER); PTHR14389 (PANTHER); IPR009003 (SUPERFAMILY)
gi|953873317|ref|XP_014586222.1|	transmembrane 232 isoform X1	657	20	0E0	88.6%					
gi|953875997|ref|XP_014587025.1|	glutamate-rich 6	531	20	0E0	88.95%					IPR029281 (PFAM); PTHR23093 (PANTHER); PTHR23093:SF11 (PANTHER)
gi|953877695|ref|XP_014587531.1|		5706								IPR031624 (PFAM); PTHR35542:SF1 (PANTHER); PTHR35542 (PANTHER)
gi|953879513|ref|XP_014588131.1|	leucine- glutamate- and lysine-rich 1	492	20	0E0	93.75%					PTHR34251 (PANTHER)
gi|953880274|ref|XP_014588354.1|	MAATS1	773	20	0E0	93.1%					IPR032840 (PFAM); IPR026720 (PTHR22455:PANTHER); PTHR22455 (PANTHER)
gi|953880542|ref|XP_014588422.1|	very large A-kinase anchor	2950	20	0E0	85.95%					IPR001064 (PRINTS); IPR000772 (SMART); IPR001064 (SMART); G3DSA:2.60.20.10 (GENE3D); G3DSA:2.60.20.10 (GENE3D); IPR001064 (PFAM); IPR000772 (PFAM); G3DSA:2.60.20.10 (GENE3D); G3DSA:2.80.10.50 (GENE3D); PTHR11818:SF38 (PANTHER); PTHR11818 (PANTHER); IPR000772 (PROSITE_PROFILES); IPR001064 (PROSITE_PROFILES); IPR011024 (SUPERFAMILY); IPR011024 (SUPERFAMILY); IPR011024 (SUPERFAMILY); IPR000772 (SUPERFAMILY)
gi|953883471|ref|XP_014590538.1|	heat shock 70 kDa 12B	686	20	0E0	97.2%					G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); PTHR14187 (PANTHER); IPR029509 (PTHR14187:PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY)
gi|953886466|ref|XP_014591345.1|		3306								
gi|953887597|ref|XP_014591671.1|		1616								IPR027914 (PFAM); IPR028089 (PFAM); IPR026701 (PTHR21444:PANTHER); PTHR21444 (PANTHER)
gi|953888484|ref|XP_014591967.1|		3130								IPR019528 (PFAM); PTHR18937 (PANTHER); IPR024151 (PTHR18937:PANTHER)
gi|953888806|ref|XP_014592071.1|	Werner syndrome ATP-dependent helicase isoform X1	1449	20	0E0	94.75%					
gi|953892081|ref|XP_005614226.2|	melanoma-associated antigen B10-like	743	20	0E0	77.7%					IPR021072 (SMART); IPR002190 (SMART); IPR021072 (PFAM); IPR002190 (PFAM); PTHR11736:SF73 (PANTHER); PTHR11736 (PANTHER); IPR002190 (PROSITE_PROFILES)
gi|953892923|ref|XP_014584616.1|	PREDICTED: uncharacterized protein KIAA1210 homolog isoform X1	1529	20	0E0	74.65%					
gi|953893185|ref|XP_014584703.1|		6679								IPR031554 (PFAM); PTHR21856 (PANTHER); PTHR21856:SF4 (PANTHER)
gi|953894578|ref|XP_005613646.2|	maestro heat-like repeat family member 5	231	20	4.43E-169	91.85%					PTHR23120:SF10 (PANTHER); PTHR23120 (PANTHER)
gi|1008836024|gb|AMR08117.1|	immunoglobulin lambda light chain variable partial	120	20	1.9E-80	91.45%					
gi|1008836112|gb|AMR08161.1|	immunoglobulin lambda light chain variable partial	123	20	1.33E-83	88.3%					
gi|1008836138|gb|AMR08174.1|	immunoglobulin lambda light chain variable partial	123	20	5.45E-82	92.15%					
gi|1008836164|gb|AMR08187.1|	immunoglobulin lambda light chain variable partial	117	20	3.09E-78	87.75%					
gi|1008836222|gb|AMR08216.1|	immunoglobulin lambda light chain variable partial	118	20	3.56E-81	86.3%					
F6WF42	mammaglobin-A-like	93	20	7.25E-62	79.35%					IPR016126 (PFAM); G3DSA:1.10.210.10 (GENE3D); PTHR14037 (PANTHER); PTHR14037:SF4 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR016126 (PROSITE_PROFILES); PS51257 (PROSITE_PROFILES); IPR016126 (SUPERFAMILY)
F7BNQ2	C4b-binding alpha chain	602	20	0E0	80.9%					IPR000436 (SMART); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); IPR000436 (PFAM); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); PTHR19325 (PANTHER); PTHR19325:SF341 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000436 (PROSITE_PROFILES); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY)
F6T4S3	nmrA-like family domain-containing 1	286	20	0E0	92.9%					IPR016040 (G3DSA:3.40.50.GENE3D); IPR008030 (PFAM); PTHR14194:SF51 (PANTHER); PTHR14194 (PANTHER); IPR016040 (SUPERFAMILY)
F6X6N8	zymogen granule 16 homolog B	174	20	1.25E-106	81.4%					IPR001229 (SMART); IPR001229 (PFAM); IPR001229 (G3DSA:2.100.10.GENE3D); PTHR33589:SF1 (PANTHER); PTHR33589 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR001229 (PROSITE_PROFILES); IPR001229 (SUPERFAMILY)
F6WIY8	PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein C6orf132 homolog	119	20	6.96E-71	93.65%					PTHR35077 (PANTHER); PTHR35077:SF2 (PANTHER)
F7BYK3		776								PTHR32093:SF9 (PANTHER); PTHR32093 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS)
F6XWU0	glutamate-rich 5	381	20	0E0	76.55%					IPR027856 (PFAM); PTHR23006 (PANTHER); PTHR23006:SF0 (PANTHER)
F6YG97	collagen alpha-1(XXVII) chain	665	20	0E0	78.4%					PR01217 (PRINTS); IPR001791 (SMART); IPR013320 (G3DSA:2.60.120.GENE3D); IPR008160 (PFAM); PTHR24023:SF549 (PANTHER); PTHR24023 (PANTHER); IPR013320 (SUPERFAMILY)
tr|F6W1N4|F6W1N4_HORSE	polymeric immunoglobulin receptor	762	20	0E0	82%	13	C:GO:0019814; P:GO:0007173; C:GO:0043235; P:GO:0001580; P:GO:0043113; F:GO:0001792; C:GO:0005886; P:GO:0038093; P:GO:0001895; C:GO:0005615; C:GO:0070062; P:GO:0002415; C:GO:0016021	C:immunoglobulin complex; P:epidermal growth factor receptor signaling pathway; C:receptor complex; P:detection of chemical stimulus involved in sensory perception of bitter taste; P:receptor clustering; F:polymeric immunoglobulin receptor activity; C:plasma membrane; P:Fc receptor signaling pathway; P:retina homeostasis; C:extracellular space; C:extracellular exosome; P:immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor; C:integral component of membrane		
tr|F7CT65|F7CT65_HORSE	major allergen Equ c 1-like	188	20	6.87E-134	87.95%	5	F:GO:0005550; F:GO:0036094; C:GO:0005576; P:GO:0006810; F:GO:0005215	F:pheromone binding; F:small molecule binding; C:extracellular region; P:transport; F:transporter activity		
tr|F7CPJ5|F7CPJ5_HORSE	major allergen Equ c 1-like	188	20	3.48E-134	88.45%	6	F:GO:0005550; F:GO:0036094; C:GO:0005576; P:GO:0006810; F:GO:0005215; P:GO:0007610	F:pheromone binding; F:small molecule binding; C:extracellular region; P:transport; F:transporter activity; P:behavior		
tr|F6RI47|F6RI47_HORSE	alpha-2-macroglobulin-like	1477	20	0E0	90.95%	13	F:GO:0019959; P:GO:0007165; F:GO:0048306; F:GO:0002020; F:GO:0005102; F:GO:0004867; C:GO:0070062; P:GO:0048863; C:GO:0072562; F:GO:0043120; P:GO:0001869; P:GO:0010951; F:GO:0019966	F:interleukin-8 binding; P:signal transduction; F:calcium-dependent protein binding; F:protease binding; F:receptor binding; F:serine-type endopeptidase inhibitor activity; C:extracellular exosome; P:stem cell differentiation; C:blood microparticle; F:tumor necrosis factor binding; P:negative regulation of complement activation, lectin pathway; P:negative regulation of endopeptidase activity; F:interleukin-1 binding		
tr|F6Z2L5|F6Z2L5_HORSE	apolipo A-I	266	20	0E0	90.4%	64	P:GO:0019915; P:GO:0050919; P:GO:0006644; F:GO:0034191; P:GO:0055091; P:GO:0045723; P:GO:0018158; P:GO:0050713; P:GO:0010898; P:GO:0070328; P:GO:0030300; P:GO:0032489; P:GO:0051006; P:GO:0060354; C:GO:0042627; P:GO:0034380; F:GO:0015485; P:GO:0007186; P:GO:0050728; P:GO:0006695; F:GO:0008035; F:GO:0045499; P:GO:1900026; P:GO:0006656; P:GO:0051180; C:GO:0030139; P:GO:0051496; P:GO:0010903; P:GO:0031102; P:GO:0019433; P:GO:0034372; P:GO:0070508; P:GO:0035025; P:GO:0034375; F:GO:0060228; P:GO:0042158; P:GO:0042632; P:GO:0002740; P:GO:0051346; P:GO:0007229; C:GO:0070062; P:GO:0043691; C:GO:0072562; C:GO:0034366; F:GO:0031210; F:GO:0017127; P:GO:0010873; P:GO:0030325; C:GO:0034361; F:GO:0042802; P:GO:0008211; F:GO:0005543; P:GO:0043534; F:GO:0001540; P:GO:0001932; P:GO:0010804; P:GO:0001935; P:GO:0034115; P:GO:0033344; F:GO:0070653; P:GO:0050821; P:GO:0018206; P:GO:0033700; F:GO:0019899	P:lipid storage; P:negative chemotaxis; P:phospholipid metabolic process; F:apolipoprotein A-I receptor binding; P:phospholipid homeostasis; P:positive regulation of fatty acid biosynthetic process; P:protein oxidation; P:negative regulation of interleukin-1 beta secretion; P:positive regulation of triglyceride catabolic process; P:triglyceride homeostasis; P:regulation of intestinal cholesterol absorption; P:regulation of Cdc42 protein signal transduction; P:positive regulation of lipoprotein lipase activity; P:negative regulation of cell adhesion molecule production; C:chylomicron; P:high-density lipoprotein particle assembly; F:cholesterol binding; P:G-protein coupled receptor signaling pathway; P:negative regulation of inflammatory response; P:cholesterol biosynthetic process; F:high-density lipoprotein particle binding; F:chemorepellent activity; P:positive regulation of substrate adhesion-dependent cell spreading; P:phosphatidylcholine biosynthetic process; P:vitamin transport; C:endocytic vesicle; P:positive regulation of stress fiber assembly; P:negative regulation of very-low-density lipoprotein particle remodeling; P:neuron projection regeneration; P:triglyceride catabolic process; P:very-low-density lipoprotein particle remodeling; P:cholesterol import; P:positive regulation of Rho protein signal transduction; P:high-density lipoprotein particle remodeling; F:phosphatidylcholine-sterol O-acyltransferase activator activity; P:lipoprotein biosynthetic process; P:cholesterol homeostasis; P:negative regulation of cytokine secretion involved in immune response; P:negative regulation of hydrolase activity; P:integrin-mediated signaling pathway; C:extracellular exosome; P:reverse cholesterol transport; C:blood microparticle; C:spherical high-density lipoprotein particle; F:phosphatidylcholine binding; F:cholesterol transporter activity; P:positive regulation of cholesterol esterification; P:adrenal gland development; C:very-low-density lipoprotein particle; F:identical protein binding; P:glucocorticoid metabolic process; F:phospholipid binding; P:blood vessel endothelial cell migration; F:beta-amyloid binding; P:regulation of protein phosphorylation; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:endothelial cell proliferation; P:negative regulation of heterotypic cell-cell adhesion; P:cholesterol efflux; F:high-density lipoprotein particle receptor binding; P:protein stabilization; P:peptidyl-methionine modification; P:phospholipid efflux; F:enzyme binding		
sp|P27425|TRFE_HORSE	serotransferrin	706	20	0E0	88.55%	6	P:GO:0006879; C:GO:0005623; C:GO:0005615; F:GO:0008199; P:GO:0015682; F:GO:0015091	P:cellular iron ion homeostasis; C:cell; C:extracellular space; F:ferric iron binding; P:ferric iron transport; F:ferric iron transmembrane transporter activity		
tr|H9GZN9|H9GZN9_HORSE	immunoglobulin M heavy partial	450	20	0E0	81.5%	20	F:GO:0042834; P:GO:0050829; C:GO:0009274; C:GO:0009897; F:GO:0003697; P:GO:0006910; C:GO:0070062; P:GO:0006911; P:GO:0050871; F:GO:0003823; P:GO:0006958; P:GO:0045087; C:GO:0072562; C:GO:0016021; P:GO:0019731; F:GO:0031210; C:GO:0071756; F:GO:0034987; C:GO:0071757; P:GO:0050853	F:peptidoglycan binding; P:defense response to Gram-negative bacterium; C:peptidoglycan-based cell wall; C:external side of plasma membrane; F:single-stranded DNA binding; P:phagocytosis, recognition; C:extracellular exosome; P:phagocytosis, engulfment; P:positive regulation of B cell activation; F:antigen binding; P:complement activation, classical pathway; P:innate immune response; C:blood microparticle; C:integral component of membrane; P:antibacterial humoral response; F:phosphatidylcholine binding; C:pentameric IgM immunoglobulin complex; F:immunoglobulin receptor binding; C:hexameric IgM immunoglobulin complex; P:B cell receptor signaling pathway		
tr|F6ZEH8|F6ZEH8_HORSE	serotransferrin-like	990	20	0E0	84.55%	10	C:GO:0005789; F:GO:0005525; P:GO:0006879; C:GO:0005615; F:GO:0008199; P:GO:0007264; P:GO:0015682; C:GO:0016021; C:GO:0005881; F:GO:0015091	C:endoplasmic reticulum membrane; F:GTP binding; P:cellular iron ion homeostasis; C:extracellular space; F:ferric iron binding; P:small GTPase mediated signal transduction; P:ferric iron transport; C:integral component of membrane; C:cytoplasmic microtubule; F:ferric iron transmembrane transporter activity		
tr|F6UDZ6|F6UDZ6_HORSE	ovostatin homolog 2-like	1404	20	0E0	90.75%	3	C:GO:0005615; F:GO:0004866; P:GO:0010951	C:extracellular space; F:endopeptidase inhibitor activity; P:negative regulation of endopeptidase activity		
tr|F7E454|F7E454_HORSE	complement C3	1640	20	0E0	90.75%	20	P:GO:0006631; P:GO:0045766; P:GO:0001970; P:GO:0045745; P:GO:0010828; F:GO:0031715; P:GO:0006935; P:GO:0006957; P:GO:0006954; P:GO:2000427; C:GO:0070062; F:GO:0004866; P:GO:0001798; P:GO:0006958; C:GO:0072562; P:GO:0001934; P:GO:0010951; P:GO:0010866; P:GO:0010884; P:GO:0010575	P:fatty acid metabolic process; P:positive regulation of angiogenesis; P:positive regulation of activation of membrane attack complex; P:positive regulation of G-protein coupled receptor protein signaling pathway; P:positive regulation of glucose transport; F:C5L2 anaphylatoxin chemotactic receptor binding; P:chemotaxis; P:complement activation, alternative pathway; P:inflammatory response; P:positive regulation of apoptotic cell clearance; C:extracellular exosome; F:endopeptidase inhibitor activity; P:positive regulation of type IIa hypersensitivity; P:complement activation, classical pathway; C:blood microparticle; P:positive regulation of protein phosphorylation; P:negative regulation of endopeptidase activity; P:regulation of triglyceride biosynthetic process; P:positive regulation of lipid storage; P:positive regulation of vascular endothelial growth factor production		
tr|F7CJG3|F7CJG3_HORSE	complement C3	1661	20	0E0	90.55%	20	P:GO:0006631; P:GO:0045766; P:GO:0001970; P:GO:0045745; P:GO:0010828; F:GO:0031715; P:GO:0006935; P:GO:0006957; P:GO:0006954; P:GO:2000427; C:GO:0070062; F:GO:0004866; P:GO:0001798; P:GO:0006958; C:GO:0072562; P:GO:0001934; P:GO:0010951; P:GO:0010866; P:GO:0010884; P:GO:0010575	P:fatty acid metabolic process; P:positive regulation of angiogenesis; P:positive regulation of activation of membrane attack complex; P:positive regulation of G-protein coupled receptor protein signaling pathway; P:positive regulation of glucose transport; F:C5L2 anaphylatoxin chemotactic receptor binding; P:chemotaxis; P:complement activation, alternative pathway; P:inflammatory response; P:positive regulation of apoptotic cell clearance; C:extracellular exosome; F:endopeptidase inhibitor activity; P:positive regulation of type IIa hypersensitivity; P:complement activation, classical pathway; C:blood microparticle; P:positive regulation of protein phosphorylation; P:negative regulation of endopeptidase activity; P:regulation of triglyceride biosynthetic process; P:positive regulation of lipid storage; P:positive regulation of vascular endothelial growth factor production		
tr|F7BTW7|F7BTW7_HORSE	complement C3	1664	20	0E0	91.15%	20	P:GO:0006631; P:GO:0045766; P:GO:0001970; P:GO:0045745; P:GO:0010828; F:GO:0031715; P:GO:0006935; P:GO:0006957; P:GO:0006954; P:GO:2000427; C:GO:0070062; F:GO:0004866; P:GO:0001798; P:GO:0006958; C:GO:0072562; P:GO:0001934; P:GO:0010951; P:GO:0010866; P:GO:0010884; P:GO:0010575	P:fatty acid metabolic process; P:positive regulation of angiogenesis; P:positive regulation of activation of membrane attack complex; P:positive regulation of G-protein coupled receptor protein signaling pathway; P:positive regulation of glucose transport; F:C5L2 anaphylatoxin chemotactic receptor binding; P:chemotaxis; P:complement activation, alternative pathway; P:inflammatory response; P:positive regulation of apoptotic cell clearance; C:extracellular exosome; F:endopeptidase inhibitor activity; P:positive regulation of type IIa hypersensitivity; P:complement activation, classical pathway; C:blood microparticle; P:positive regulation of protein phosphorylation; P:negative regulation of endopeptidase activity; P:regulation of triglyceride biosynthetic process; P:positive regulation of lipid storage; P:positive regulation of vascular endothelial growth factor production		
tr|F7BAY6|F7BAY6_HORSE	serum albumin	607	20	0E0	92.05%	22	F:GO:0015643; F:GO:0019825; P:GO:0019836; C:GO:0019814; F:GO:0030170; C:GO:0043209; F:GO:0008144; C:GO:0005783; C:GO:0005794; P:GO:0009267; P:GO:0006810; C:GO:0005634; F:GO:0003677; P:GO:0001895; C:GO:0070062; F:GO:0005504; P:GO:0006955; F:GO:0046872; P:GO:0043066; C:GO:0072562; F:GO:0051087; P:GO:0051659	F:toxic substance binding; F:oxygen binding; P:hemolysis by symbiont of host erythrocytes; C:immunoglobulin complex; F:pyridoxal phosphate binding; C:myelin sheath; F:drug binding; C:endoplasmic reticulum; C:Golgi apparatus; P:cellular response to starvation; P:transport; C:nucleus; F:DNA binding; P:retina homeostasis; C:extracellular exosome; F:fatty acid binding; P:immune response; F:metal ion binding; P:negative regulation of apoptotic process; C:blood microparticle; F:chaperone binding; P:maintenance of mitochondrion location		
sp|P35747|ALBU_HORSE	serum albumin	607	20	0E0	91.95%	22	F:GO:0015643; F:GO:0019825; P:GO:0019836; C:GO:0019814; F:GO:0030170; C:GO:0043209; F:GO:0008144; C:GO:0005783; C:GO:0005794; P:GO:0009267; P:GO:0006810; C:GO:0005634; F:GO:0003677; P:GO:0001895; C:GO:0070062; F:GO:0005504; P:GO:0006955; F:GO:0046872; P:GO:0043066; C:GO:0072562; F:GO:0051087; P:GO:0051659	F:toxic substance binding; F:oxygen binding; P:hemolysis by symbiont of host erythrocytes; C:immunoglobulin complex; F:pyridoxal phosphate binding; C:myelin sheath; F:drug binding; C:endoplasmic reticulum; C:Golgi apparatus; P:cellular response to starvation; P:transport; C:nucleus; F:DNA binding; P:retina homeostasis; C:extracellular exosome; F:fatty acid binding; P:immune response; F:metal ion binding; P:negative regulation of apoptotic process; C:blood microparticle; F:chaperone binding; P:maintenance of mitochondrion location		
tr|F6ZXW9|F6ZXW9_HORSE	c-binding	1908	20	0E0	89.7%	7	C:GO:0070062; F:GO:0003723; F:GO:0005515; P:GO:0008033; F:GO:0008168; P:GO:0006364; P:GO:0032259	C:extracellular exosome; F:RNA binding; F:protein binding; P:tRNA processing; F:methyltransferase activity; P:rRNA processing; P:methylation		
sp|P60708|ACTB_HORSE	cytoplasmic 1	375	20	0E0	100%	44	C:GO:0014069; C:GO:0035267; C:GO:0043209; F:GO:0000978; C:GO:0005871; P:GO:0038096; F:GO:0000980; F:GO:0005524; C:GO:0005667; C:GO:0070062; C:GO:0005925; P:GO:0007409; P:GO:0051086; C:GO:0072562; C:GO:0005829; C:GO:0070688; P:GO:0071257; P:GO:0034329; F:GO:0050998; P:GO:0070527; C:GO:0030424; C:GO:0030027; C:GO:0030863; C:GO:0036464; F:GO:0019901; F:GO:0042802; P:GO:0045815; F:GO:0031492; P:GO:0045214; F:GO:0005200; C:GO:0005886; P:GO:0021762; P:GO:0001895; P:GO:0048010; C:GO:0000790; F:GO:0031625; C:GO:0097433; F:GO:0030957; P:GO:0006928; P:GO:0043044; P:GO:0048013; F:GO:0019894; C:GO:0031941; C:GO:0030016	C:postsynaptic density; C:NuA4 histone acetyltransferase complex; C:myelin sheath; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; C:kinesin complex; P:Fc-gamma receptor signaling pathway involved in phagocytosis; F:RNA polymerase II distal enhancer sequence-specific DNA binding; F:ATP binding; C:transcription factor complex; C:extracellular exosome; C:focal adhesion; P:axonogenesis; P:chaperone mediated protein folding independent of cofactor; C:blood microparticle; C:cytosol; C:MLL5-L complex; P:cellular response to electrical stimulus; P:cell junction assembly; F:nitric-oxide synthase binding; P:platelet aggregation; C:axon; C:lamellipodium; C:cortical cytoskeleton; C:cytoplasmic ribonucleoprotein granule; F:protein kinase binding; F:identical protein binding; P:positive regulation of gene expression, epigenetic; F:nucleosomal DNA binding; P:sarcomere organization; F:structural constituent of cytoskeleton; C:plasma membrane; P:substantia nigra development; P:retina homeostasis; P:vascular endothelial growth factor receptor signaling pathway; C:nuclear chromatin; F:ubiquitin protein ligase binding; C:dense body; F:Tat protein binding; P:movement of cell or subcellular component; P:ATP-dependent chromatin remodeling; P:ephrin receptor signaling pathway; F:kinesin binding; C:filamentous actin; C:myofibril		
tr|F7AAK7|F7AAK7_HORSE	cytoplasmic 2	375	20	0E0	99.85%	24	F:GO:0042802; C:GO:0043209; P:GO:0034332; P:GO:0045214; C:GO:0043034; F:GO:0005200; P:GO:0038096; C:GO:0005886; C:GO:0005634; F:GO:0005524; P:GO:0001895; P:GO:0048010; C:GO:0070062; F:GO:0031625; C:GO:0005925; C:GO:0097433; P:GO:0006928; C:GO:0072562; P:GO:0048013; C:GO:0005829; C:GO:0031012; C:GO:0031941; P:GO:0034329; P:GO:0070527	F:identical protein binding; C:myelin sheath; P:adherens junction organization; P:sarcomere organization; C:costamere; F:structural constituent of cytoskeleton; P:Fc-gamma receptor signaling pathway involved in phagocytosis; C:plasma membrane; C:nucleus; F:ATP binding; P:retina homeostasis; P:vascular endothelial growth factor receptor signaling pathway; C:extracellular exosome; F:ubiquitin protein ligase binding; C:focal adhesion; C:dense body; P:movement of cell or subcellular component; C:blood microparticle; P:ephrin receptor signaling pathway; C:cytosol; C:extracellular matrix; C:filamentous actin; P:cell junction assembly; P:platelet aggregation		
tr|F6SMC6|F6SMC6_HORSE	aldehyde dimeric NADP-preferring	444	20	0E0	93.45%	21	P:GO:0006094; P:GO:0006081; P:GO:0006570; F:GO:0004030; P:GO:0006096; C:GO:0005783; P:GO:0042203; C:GO:0005886; F:GO:0008106; C:GO:0005654; F:GO:0004028; C:GO:0005615; P:GO:0006547; P:GO:0006558; P:GO:0019384; P:GO:0046486; P:GO:0042184; C:GO:0016021; P:GO:0055114; F:GO:0018479; P:GO:0018874	P:gluconeogenesis; P:cellular aldehyde metabolic process; P:tyrosine metabolic process; F:aldehyde dehydrogenase [NAD(P)+] activity; P:glycolytic process; C:endoplasmic reticulum; P:toluene catabolic process; C:plasma membrane; F:alcohol dehydrogenase (NADP+) activity; C:nucleoplasm; F:3-chloroallyl aldehyde dehydrogenase activity; C:extracellular space; P:histidine metabolic process; P:L-phenylalanine metabolic process; P:caprolactam catabolic process; P:glycerolipid metabolic process; P:xylene catabolic process; C:integral component of membrane; P:oxidation-reduction process; F:benzaldehyde dehydrogenase (NAD+) activity; P:benzoate metabolic process	EC:1.1.1; EC:1.2.1.5; EC:1.1.1.2; EC:1.2.1.3; EC:1.2.1; EC:1.2.1.28	
tr|F6PJ64|F6PJ64_HORSE	major allergen Equ c 1-like	182	20	2.07E-129	88.3%	5	F:GO:0005550; F:GO:0036094; C:GO:0005576; P:GO:0006810; F:GO:0005215	F:pheromone binding; F:small molecule binding; C:extracellular region; P:transport; F:transporter activity		
tr|F6XLB1|F6XLB1_HORSE	lactotransferrin	708	20	0E0	91.3%	36	P:GO:0055072; P:GO:0043123; P:GO:0060349; P:GO:1902732; F:GO:0008201; P:GO:1900159; P:GO:0045669; P:GO:0051092; P:GO:0006811; C:GO:0070062; F:GO:0005506; P:GO:0001503; C:GO:0042581; P:GO:2001205; P:GO:0045071; P:GO:0033690; F:GO:0043539; P:GO:0032780; P:GO:0034145; P:GO:0032680; F:GO:0004252; C:GO:0043234; P:GO:1900229; C:GO:0009986; P:GO:2000308; C:GO:0005634; P:GO:0001895; C:GO:0005615; P:GO:0002227; P:GO:0043066; P:GO:0044793; P:GO:0006508; P:GO:0019731; P:GO:0019732; P:GO:0071902; P:GO:0031665	P:iron ion homeostasis; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:bone morphogenesis; P:positive regulation of chondrocyte proliferation; F:heparin binding; P:positive regulation of bone mineralization involved in bone maturation; P:positive regulation of osteoblast differentiation; P:positive regulation of NF-kappaB transcription factor activity; P:ion transport; C:extracellular exosome; F:iron ion binding; P:ossification; C:specific granule; P:negative regulation of osteoclast development; P:negative regulation of viral genome replication; P:positive regulation of osteoblast proliferation; F:protein serine/threonine kinase activator activity; P:negative regulation of ATPase activity; P:positive regulation of toll-like receptor 4 signaling pathway; P:regulation of tumor necrosis factor production; F:serine-type endopeptidase activity; C:protein complex; P:negative regulation of single-species biofilm formation in or on host organism; C:cell surface; P:negative regulation of tumor necrosis factor (ligand) superfamily member 11 production; C:nucleus; P:retina homeostasis; C:extracellular space; P:innate immune response in mucosa; P:negative regulation of apoptotic process; P:negative regulation by host of viral process; P:proteolysis; P:antibacterial humoral response; P:antifungal humoral response; P:positive regulation of protein serine/threonine kinase activity; P:negative regulation of lipopolysaccharide-mediated signaling pathway	EC:3.4.21	
tr|F6XSF7|F6XSF7_HORSE	complement C4-A	1750	20	0E0	91.85%	6	P:GO:0006956; C:GO:0005615; P:GO:0006954; F:GO:0004866; P:GO:0016064; P:GO:0010951	P:complement activation; C:extracellular space; P:inflammatory response; F:endopeptidase inhibitor activity; P:immunoglobulin mediated immune response; P:negative regulation of endopeptidase activity		
tr|F6QC83|F6QC83_HORSE	mucin-5AC	4492	20	0E0	82.5%	9	C:GO:0005615; C:GO:0070062; P:GO:0048015; P:GO:0036438; P:GO:0016266; C:GO:0005796; F:GO:0005201; P:GO:0043206; C:GO:0043205	C:extracellular space; C:extracellular exosome; P:phosphatidylinositol-mediated signaling; P:maintenance of lens transparency; P:O-glycan processing; C:Golgi lumen; F:extracellular matrix structural constituent; P:extracellular fibril organization; C:fibril		
tr|F7BLE3|F7BLE3_HORSE	complement C3	1215	20	0E0	88.9%	13	P:GO:0006631; P:GO:0045745; P:GO:0010828; F:GO:0031715; P:GO:0006957; C:GO:0005615; P:GO:0006954; F:GO:0004866; P:GO:0006958; P:GO:0001934; P:GO:0010951; P:GO:0010866; P:GO:0010884	P:fatty acid metabolic process; P:positive regulation of G-protein coupled receptor protein signaling pathway; P:positive regulation of glucose transport; F:C5L2 anaphylatoxin chemotactic receptor binding; P:complement activation, alternative pathway; C:extracellular space; P:inflammatory response; F:endopeptidase inhibitor activity; P:complement activation, classical pathway; P:positive regulation of protein phosphorylation; P:negative regulation of endopeptidase activity; P:regulation of triglyceride biosynthetic process; P:positive regulation of lipid storage		
tr|F6YR34|F6YR34_HORSE	thrombospondin-1	1170	20	0E0	99.05%	73	P:GO:0007050; P:GO:0016525; P:GO:0040037; P:GO:0045727; C:GO:0016529; P:GO:0032570; P:GO:0002040; C:GO:0008305; P:GO:0045766; P:GO:0042535; F:GO:0050431; C:GO:0005788; P:GO:0000187; F:GO:0001786; P:GO:0009749; P:GO:0001666; P:GO:0006955; P:GO:0030823; F:GO:0043394; F:GO:0005509; P:GO:0043154; P:GO:0043032; P:GO:2000353; P:GO:1902043; F:GO:0043236; P:GO:0051895; P:GO:0032914; P:GO:0002605; P:GO:0010748; F:GO:0017134; P:GO:0018149; P:GO:0034976; P:GO:0051897; C:GO:0009897; F:GO:0005178; F:GO:0008201; P:GO:0002581; P:GO:0007155; P:GO:0006986; C:GO:0005577; P:GO:0002576; C:GO:0070062; P:GO:0034605; P:GO:0010757; P:GO:0010759; P:GO:0048266; F:GO:0001968; P:GO:0010754; P:GO:2001027; P:GO:0032026; C:GO:0031012; F:GO:0030169; P:GO:0016477; P:GO:2000379; P:GO:0010751; C:GO:0031093; P:GO:0043537; F:GO:0042802; P:GO:0051918; P:GO:0036066; P:GO:0043652; P:GO:0043536; F:GO:0070052; P:GO:0002544; F:GO:0070051; P:GO:0042493; P:GO:0051592; P:GO:0030198; P:GO:2001237; P:GO:0001937; P:GO:0032695; P:GO:0010763; P:GO:0030511	P:cell cycle arrest; P:negative regulation of angiogenesis; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of translation; C:sarcoplasmic reticulum; P:response to progesterone; P:sprouting angiogenesis; C:integrin complex; P:positive regulation of angiogenesis; P:positive regulation of tumor necrosis factor biosynthetic process; F:transforming growth factor beta binding; C:endoplasmic reticulum lumen; P:activation of MAPK activity; F:phosphatidylserine binding; P:response to glucose; P:response to hypoxia; P:immune response; P:regulation of cGMP metabolic process; F:proteoglycan binding; F:calcium ion binding; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of macrophage activation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; F:laminin binding; P:negative regulation of focal adhesion assembly; P:positive regulation of transforming growth factor beta1 production; P:negative regulation of dendritic cell antigen processing and presentation; P:negative regulation of plasma membrane long-chain fatty acid transport; F:fibroblast growth factor binding; P:peptide cross-linking; P:response to endoplasmic reticulum stress; P:positive regulation of protein kinase B signaling; C:external side of plasma membrane; F:integrin binding; F:heparin binding; P:negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; P:cell adhesion; P:response to unfolded protein; C:fibrinogen complex; P:platelet degranulation; C:extracellular exosome; P:cellular response to heat; P:negative regulation of plasminogen activation; P:positive regulation of macrophage chemotaxis; P:behavioral response to pain; F:fibronectin binding; P:negative regulation of cGMP-mediated signaling; P:negative regulation of endothelial cell chemotaxis; P:response to magnesium ion; C:extracellular matrix; F:low-density lipoprotein particle binding; P:cell migration; P:positive regulation of reactive oxygen species metabolic process; P:negative regulation of nitric oxide mediated signal transduction; C:platelet alpha granule lumen; P:negative regulation of blood vessel endothelial cell migration; F:identical protein binding; P:negative regulation of fibrinolysis; P:protein O-linked fucosylation; P:engulfment of apoptotic cell; P:positive regulation of blood vessel endothelial cell migration; F:collagen V binding; P:chronic inflammatory response; F:fibrinogen binding; P:response to drug; P:response to calcium ion; P:extracellular matrix organization; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of endothelial cell proliferation; P:negative regulation of interleukin-12 production; P:positive regulation of fibroblast migration; P:positive regulation of transforming growth factor beta receptor signaling pathway		
tr|F7CS60|F7CS60_HORSE	fibronectin isoform X1	2476	20	0E0	97.7%	24	P:GO:0007161; F:GO:0016504; P:GO:0007044; F:GO:0002020; F:GO:0005178; P:GO:0045773; C:GO:0005793; P:GO:1904237; C:GO:0008305; C:GO:0005577; P:GO:0070372; P:GO:0042060; C:GO:0070062; C:GO:0005605; P:GO:0010628; P:GO:0048146; C:GO:0072562; P:GO:0010952; P:GO:0034446; P:GO:0035987; P:GO:0018149; C:GO:0016324; P:GO:0033622; P:GO:2001202	P:calcium-independent cell-matrix adhesion; F:peptidase activator activity; P:cell-substrate junction assembly; F:protease binding; F:integrin binding; P:positive regulation of axon extension; C:endoplasmic reticulum-Golgi intermediate compartment; P:positive regulation of substrate-dependent cell migration, cell attachment to substrate; C:integrin complex; C:fibrinogen complex; P:regulation of ERK1 and ERK2 cascade; P:wound healing; C:extracellular exosome; C:basal lamina; P:positive regulation of gene expression; P:positive regulation of fibroblast proliferation; C:blood microparticle; P:positive regulation of peptidase activity; P:substrate adhesion-dependent cell spreading; P:endodermal cell differentiation; P:peptide cross-linking; C:apical plasma membrane; P:integrin activation; P:negative regulation of transforming growth factor-beta secretion		
sp|A2Q0Z1|HSP7C_HORSE	Heat shock cognate 71 kDa	646	20	0E0	99.75%	84	C:GO:0014069; F:GO:0055131; C:GO:0008021; P:GO:0046777; C:GO:0000974; P:GO:0061738; C:GO:0005874; C:GO:0098575; C:GO:0005667; C:GO:1990124; F:GO:0001786; P:GO:1902904; P:GO:0045892; C:GO:0043195; C:GO:0043198; C:GO:0043197; C:GO:0005829; P:GO:0051726; F:GO:0031072; C:GO:0061202; C:GO:0005681; C:GO:0005882; P:GO:1904589; P:GO:0042026; C:GO:0005886; P:GO:0007269; F:GO:0031625; C:GO:0000151; P:GO:0097214; C:GO:0005913; C:GO:0042470; P:GO:0043085; P:GO:0006606; P:GO:0046034; C:GO:0032279; P:GO:0001916; P:GO:0010667; C:GO:0001917; P:GO:0050766; F:GO:1904593; C:GO:0043209; P:GO:1904592; P:GO:1900034; C:GO:0005770; F:GO:0042277; P:GO:0043488; P:GO:0045862; C:GO:0005730; C:GO:0043204; P:GO:0006986; C:GO:0005776; C:GO:0005654; P:GO:0000398; P:GO:0061635; F:GO:0005524; C:GO:0070062; C:GO:0005925; P:GO:0048026; C:GO:0072562; P:GO:0016032; C:GO:0031012; P:GO:0061740; P:GO:0061741; P:GO:0044829; P:GO:1904764; P:GO:0006351; P:GO:0043254; P:GO:0051085; F:GO:0051082; F:GO:0008134; F:GO:0043531; P:GO:0009267; F:GO:0023026; C:GO:0009986; F:GO:0044822; F:GO:0098641; C:GO:0048471; P:GO:0031647; C:GO:0045121; F:GO:1990833; C:GO:0016021; C:GO:1990836; F:GO:0031686; P:GO:0072318	C:postsynaptic density; F:C3HC4-type RING finger domain binding; C:synaptic vesicle; P:protein autophosphorylation; C:Prp19 complex; P:late endosomal microautophagy; C:microtubule; C:lumenal side of lysosomal membrane; C:transcription factor complex; C:messenger ribonucleoprotein complex; F:phosphatidylserine binding; P:negative regulation of fibril organization; P:negative regulation of transcription, DNA-templated; C:terminal bouton; C:dendritic shaft; C:dendritic spine; C:cytosol; P:regulation of cell cycle; F:heat shock protein binding; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; C:spliceosomal complex; C:intermediate filament; P:regulation of protein import; P:protein refolding; C:plasma membrane; P:neurotransmitter secretion; F:ubiquitin protein ligase binding; C:ubiquitin ligase complex; P:positive regulation of lysosomal membrane permeability; C:cell-cell adherens junction; C:melanosome; P:positive regulation of catalytic activity; P:protein import into nucleus; P:ATP metabolic process; C:asymmetric synapse; P:positive regulation of T cell mediated cytotoxicity; P:negative regulation of cardiac muscle cell apoptotic process; C:photoreceptor inner segment; P:positive regulation of phagocytosis; F:prostaglandin binding; C:myelin sheath; P:positive regulation of protein refolding; P:regulation of cellular response to heat; C:late endosome; F:peptide binding; P:regulation of mRNA stability; P:positive regulation of proteolysis; C:nucleolus; C:perikaryon; P:response to unfolded protein; C:autophagosome; C:nucleoplasm; P:mRNA splicing, via spliceosome; P:regulation of protein complex stability; F:ATP binding; C:extracellular exosome; C:focal adhesion; P:positive regulation of mRNA splicing, via spliceosome; C:blood microparticle; P:viral process; C:extracellular matrix; P:protein targeting to lysosome involved in chaperone-mediated autophagy; P:chaperone-mediated protein transport involved in chaperone-mediated autophagy; P:positive regulation by host of viral genome replication; P:chaperone-mediated autophagy translocation complex disassembly; P:transcription, DNA-templated; P:regulation of protein complex assembly; P:chaperone mediated protein folding requiring cofactor; F:unfolded protein binding; F:transcription factor binding; F:ADP binding; P:cellular response to starvation; F:MHC class II protein complex binding; C:cell surface; F:poly(A) RNA binding; F:cadherin binding involved in cell-cell adhesion; C:perinuclear region of cytoplasm; P:regulation of protein stability; C:membrane raft; F:clathrin-uncoating ATPase activity; C:integral component of membrane; C:lysosomal matrix; F:A1 adenosine receptor binding; P:clathrin coat disassembly	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	
tr|F7AUW2|F7AUW2_HORSE	Heat shock cognate 71 kDa	647	20	0E0	99.85%	84	C:GO:0014069; F:GO:0055131; C:GO:0008021; P:GO:0046777; C:GO:0000974; P:GO:0061738; C:GO:0005874; C:GO:0098575; C:GO:0005667; C:GO:1990124; F:GO:0001786; P:GO:1902904; P:GO:0045892; C:GO:0043195; C:GO:0043198; C:GO:0043197; C:GO:0005829; P:GO:0051726; F:GO:0031072; C:GO:0061202; C:GO:0005681; C:GO:0005882; P:GO:1904589; P:GO:0042026; C:GO:0005886; P:GO:0007269; F:GO:0031625; C:GO:0000151; P:GO:0097214; C:GO:0005913; C:GO:0042470; P:GO:0043085; P:GO:0006606; P:GO:0046034; C:GO:0032279; P:GO:0001916; P:GO:0010667; C:GO:0001917; P:GO:0050766; F:GO:1904593; C:GO:0043209; P:GO:1904592; P:GO:1900034; C:GO:0005770; F:GO:0042277; P:GO:0043488; P:GO:0045862; C:GO:0005730; C:GO:0043204; P:GO:0006986; C:GO:0005776; C:GO:0005654; P:GO:0000398; P:GO:0061635; F:GO:0005524; C:GO:0070062; C:GO:0005925; P:GO:0048026; C:GO:0072562; P:GO:0016032; C:GO:0031012; P:GO:0061740; P:GO:0061741; P:GO:0044829; P:GO:1904764; P:GO:0006351; P:GO:0043254; P:GO:0051085; F:GO:0051082; F:GO:0008134; F:GO:0043531; P:GO:0009267; F:GO:0023026; C:GO:0009986; F:GO:0044822; F:GO:0098641; C:GO:0048471; P:GO:0031647; C:GO:0045121; F:GO:1990833; C:GO:0016021; C:GO:1990836; F:GO:0031686; P:GO:0072318	C:postsynaptic density; F:C3HC4-type RING finger domain binding; C:synaptic vesicle; P:protein autophosphorylation; C:Prp19 complex; P:late endosomal microautophagy; C:microtubule; C:lumenal side of lysosomal membrane; C:transcription factor complex; C:messenger ribonucleoprotein complex; F:phosphatidylserine binding; P:negative regulation of fibril organization; P:negative regulation of transcription, DNA-templated; C:terminal bouton; C:dendritic shaft; C:dendritic spine; C:cytosol; P:regulation of cell cycle; F:heat shock protein binding; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; C:spliceosomal complex; C:intermediate filament; P:regulation of protein import; P:protein refolding; C:plasma membrane; P:neurotransmitter secretion; F:ubiquitin protein ligase binding; C:ubiquitin ligase complex; P:positive regulation of lysosomal membrane permeability; C:cell-cell adherens junction; C:melanosome; P:positive regulation of catalytic activity; P:protein import into nucleus; P:ATP metabolic process; C:asymmetric synapse; P:positive regulation of T cell mediated cytotoxicity; P:negative regulation of cardiac muscle cell apoptotic process; C:photoreceptor inner segment; P:positive regulation of phagocytosis; F:prostaglandin binding; C:myelin sheath; P:positive regulation of protein refolding; P:regulation of cellular response to heat; C:late endosome; F:peptide binding; P:regulation of mRNA stability; P:positive regulation of proteolysis; C:nucleolus; C:perikaryon; P:response to unfolded protein; C:autophagosome; C:nucleoplasm; P:mRNA splicing, via spliceosome; P:regulation of protein complex stability; F:ATP binding; C:extracellular exosome; C:focal adhesion; P:positive regulation of mRNA splicing, via spliceosome; C:blood microparticle; P:viral process; C:extracellular matrix; P:protein targeting to lysosome involved in chaperone-mediated autophagy; P:chaperone-mediated protein transport involved in chaperone-mediated autophagy; P:positive regulation by host of viral genome replication; P:chaperone-mediated autophagy translocation complex disassembly; P:transcription, DNA-templated; P:regulation of protein complex assembly; P:chaperone mediated protein folding requiring cofactor; F:unfolded protein binding; F:transcription factor binding; F:ADP binding; P:cellular response to starvation; F:MHC class II protein complex binding; C:cell surface; F:poly(A) RNA binding; F:cadherin binding involved in cell-cell adhesion; C:perinuclear region of cytoplasm; P:regulation of protein stability; C:membrane raft; F:clathrin-uncoating ATPase activity; C:integral component of membrane; C:lysosomal matrix; F:A1 adenosine receptor binding; P:clathrin coat disassembly	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	
tr|F7CKH3|F7CKH3_HORSE	retinal dehydrogenase 1	500	20	0E0	96.4%	14	P:GO:0042572; P:GO:0009851; F:GO:0047434; P:GO:0042203; P:GO:0006568; F:GO:0000287; F:GO:0030976; C:GO:0070062; C:GO:0005737; P:GO:0042184; F:GO:0001758; P:GO:0055114; F:GO:0018479; P:GO:0018874	P:retinol metabolic process; P:auxin biosynthetic process; F:indolepyruvate decarboxylase activity; P:toluene catabolic process; P:tryptophan metabolic process; F:magnesium ion binding; F:thiamine pyrophosphate binding; C:extracellular exosome; C:cytoplasm; P:xylene catabolic process; F:retinal dehydrogenase activity; P:oxidation-reduction process; F:benzaldehyde dehydrogenase (NAD+) activity; P:benzoate metabolic process	EC:1.2.1.36; EC:4.1.1.74; EC:1.2.1.3; EC:1.2.1.28	
tr|F6USP9|F6USP9_HORSE	plasminogen isoform X1	817	20	0E0	87.6%	13	P:GO:0046716; F:GO:0004252; P:GO:0045445; P:GO:0007596; C:GO:0005576; P:GO:0042246; P:GO:0042730; P:GO:0048771; P:GO:0060716; P:GO:0071674; P:GO:0060707; P:GO:0006508; C:GO:0019897	P:muscle cell cellular homeostasis; F:serine-type endopeptidase activity; P:myoblast differentiation; P:blood coagulation; C:extracellular region; P:tissue regeneration; P:fibrinolysis; P:tissue remodeling; P:labyrinthine layer blood vessel development; P:mononuclear cell migration; P:trophoblast giant cell differentiation; P:proteolysis; C:extrinsic component of plasma membrane	EC:3.4.21	
tr|F6RMD0|F6RMD0_HORSE	complement factor B	768	20	0E0	93%	8	P:GO:0006957; C:GO:0070062; P:GO:0030449; C:GO:0072562; P:GO:0006508; F:GO:0004252; F:GO:0001848; C:GO:0005886	P:complement activation, alternative pathway; C:extracellular exosome; P:regulation of complement activation; C:blood microparticle; P:proteolysis; F:serine-type endopeptidase activity; F:complement binding; C:plasma membrane	EC:3.4.21	
tr|F7CAB8|F7CAB8_HORSE	zinc-alpha-2-glyco	285	20	0E0	90.35%	12	C:GO:0019814; C:GO:0005634; P:GO:0001895; C:GO:0005615; C:GO:0070062; F:GO:0042605; P:GO:0006955; F:GO:0001948; P:GO:0001580; P:GO:0007155; P:GO:0002474; C:GO:0042612	C:immunoglobulin complex; C:nucleus; P:retina homeostasis; C:extracellular space; C:extracellular exosome; F:peptide antigen binding; P:immune response; F:glycoprotein binding; P:detection of chemical stimulus involved in sensory perception of bitter taste; P:cell adhesion; P:antigen processing and presentation of peptide antigen via MHC class I; C:MHC class I protein complex		
sp|Q8HZM6|ANXA1_HORSE	annexin A1	346	20	0E0	95.3%	54	C:GO:0016328; P:GO:2000483; F:GO:0005198; P:GO:0045920; P:GO:0002685; C:GO:0031514; P:GO:0006954; C:GO:0042383; F:GO:0005509; C:GO:0005829; C:GO:0031232; C:GO:0031313; P:GO:0090303; P:GO:0007187; P:GO:0002250; P:GO:0042102; C:GO:0031901; P:GO:0030216; C:GO:0030659; P:GO:0043086; P:GO:0050482; P:GO:0050727; P:GO:0018149; C:GO:0016323; C:GO:0016324; F:GO:0019834; P:GO:0008360; P:GO:0045629; P:GO:0045627; P:GO:0031340; P:GO:0046632; C:GO:0001891; C:GO:0005654; P:GO:0097350; C:GO:0070062; C:GO:0005925; P:GO:0046883; P:GO:0014839; P:GO:0070588; P:GO:0031532; P:GO:0032743; P:GO:1900087; P:GO:0033031; F:GO:0048306; F:GO:0005544; C:GO:0001533; C:GO:0005615; P:GO:0002548; P:GO:0045087; P:GO:0071385; P:GO:0006909; P:GO:0032652; P:GO:0071621; F:GO:0030674	C:lateral plasma membrane; P:negative regulation of interleukin-8 secretion; F:structural molecule activity; P:negative regulation of exocytosis; P:regulation of leukocyte migration; C:motile cilium; P:inflammatory response; C:sarcolemma; F:calcium ion binding; C:cytosol; C:extrinsic component of external side of plasma membrane; C:extrinsic component of endosome membrane; P:positive regulation of wound healing; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:adaptive immune response; P:positive regulation of T cell proliferation; C:early endosome membrane; P:keratinocyte differentiation; C:cytoplasmic vesicle membrane; P:negative regulation of catalytic activity; P:arachidonic acid secretion; P:regulation of inflammatory response; P:peptide cross-linking; C:basolateral plasma membrane; C:apical plasma membrane; F:phospholipase A2 inhibitor activity; P:regulation of cell shape; P:negative regulation of T-helper 2 cell differentiation; P:positive regulation of T-helper 1 cell differentiation; P:positive regulation of vesicle fusion; P:alpha-beta T cell differentiation; C:phagocytic cup; C:nucleoplasm; P:neutrophil clearance; C:extracellular exosome; C:focal adhesion; P:regulation of hormone secretion; P:myoblast migration involved in skeletal muscle regeneration; P:calcium ion transmembrane transport; P:actin cytoskeleton reorganization; P:positive regulation of interleukin-2 production; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of neutrophil apoptotic process; F:calcium-dependent protein binding; F:calcium-dependent phospholipid binding; C:cornified envelope; C:extracellular space; P:monocyte chemotaxis; P:innate immune response; P:cellular response to glucocorticoid stimulus; P:phagocytosis; P:regulation of interleukin-1 production; P:granulocyte chemotaxis; F:protein binding, bridging		
tr|F6YA47|F6YA47_HORSE	alpha-2-macroglobulin 1 isoform X1	1185	20	0E0	94.2%	6	C:GO:0005634; C:GO:0005615; F:GO:0004867; F:GO:0008270; C:GO:0070062; P:GO:0010951	C:nucleus; C:extracellular space; F:serine-type endopeptidase inhibitor activity; F:zinc ion binding; C:extracellular exosome; P:negative regulation of endopeptidase activity		
tr|F6PQ46|F6PQ46_HORSE	ceruloplasmin isoform X2	1068	20	0E0	93.2%	16	P:GO:0015994; P:GO:0046688; P:GO:0007584; F:GO:0004322; P:GO:0007568; C:GO:0005765; C:GO:0046658; P:GO:0006879; P:GO:0006825; C:GO:0070062; F:GO:0005507; P:GO:0001889; C:GO:0072562; F:GO:0051087; P:GO:0055114; P:GO:0030324	P:chlorophyll metabolic process; P:response to copper ion; P:response to nutrient; F:ferroxidase activity; P:aging; C:lysosomal membrane; C:anchored component of plasma membrane; P:cellular iron ion homeostasis; P:copper ion transport; C:extracellular exosome; F:copper ion binding; P:liver development; C:blood microparticle; F:chaperone binding; P:oxidation-reduction process; P:lung development	EC:1.16.3.1; EC:1.16.3	
tr|F6W3M5|F6W3M5_HORSE	pyruvate kinase PKM isoform X2	541	20	0E0	97.65%	18	P:GO:0006094; C:GO:0043209; P:GO:0006096; P:GO:0006144; F:GO:0023026; C:GO:0005886; F:GO:0044822; F:GO:0000287; C:GO:0005634; F:GO:0004743; C:GO:0070062; F:GO:0030955; C:GO:0005739; C:GO:0005929; C:GO:0031012; F:GO:0016301; P:GO:0012501; P:GO:0015976	P:gluconeogenesis; C:myelin sheath; P:glycolytic process; P:purine nucleobase metabolic process; F:MHC class II protein complex binding; C:plasma membrane; F:poly(A) RNA binding; F:magnesium ion binding; C:nucleus; F:pyruvate kinase activity; C:extracellular exosome; F:potassium ion binding; C:mitochondrion; C:cilium; C:extracellular matrix; F:kinase activity; P:programmed cell death; P:carbon utilization	EC:2.7.1.40	
sp|Q28372|GELS_HORSE	gelsolin isoform X2	731	20	0E0	97.7%	38	P:GO:1902174; C:GO:0016528; P:GO:1903689; P:GO:1903903; C:GO:0002102; P:GO:1903923; C:GO:0070062; P:GO:0006911; C:GO:0005925; F:GO:0005509; P:GO:0045010; C:GO:0072562; P:GO:2001269; C:GO:0005829; P:GO:0051127; C:GO:0030027; F:GO:0019904; P:GO:0042989; P:GO:0014891; P:GO:0060271; P:GO:0030041; F:GO:0045159; C:GO:0005886; P:GO:0097284; P:GO:1990000; P:GO:0031648; P:GO:1903906; C:GO:0005634; P:GO:0051016; P:GO:0051014; F:GO:0003779; P:GO:0046597; P:GO:0097017; P:GO:1903909; C:GO:0016460; C:GO:0030478; P:GO:0071801; P:GO:0090527	P:positive regulation of keratinocyte apoptotic process; C:sarcoplasm; P:regulation of wound healing, spreading of epidermal cells; P:regulation of establishment of T cell polarity; C:podosome; P:positive regulation of protein processing in phagocytic vesicle; C:extracellular exosome; P:phagocytosis, engulfment; C:focal adhesion; F:calcium ion binding; P:actin nucleation; C:blood microparticle; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; C:cytosol; P:positive regulation of actin nucleation; C:lamellipodium; F:protein domain specific binding; P:sequestering of actin monomers; P:striated muscle atrophy; P:cilium morphogenesis; P:actin filament polymerization; F:myosin II binding; C:plasma membrane; P:hepatocyte apoptotic process; P:amyloid fibril formation; P:protein destabilization; P:regulation of plasma membrane raft polarization; C:nucleus; P:barbed-end actin filament capping; P:actin filament severing; F:actin binding; P:negative regulation of viral entry into host cell; P:renal protein absorption; P:regulation of receptor clustering; C:myosin II complex; C:actin cap; P:regulation of podosome assembly; P:actin filament reorganization		
tr|F6V7C1|F6V7C1_HORSE	alpha-enolase	434	20	0E0	98.9%	21	P:GO:0006094; C:GO:0043209; P:GO:0009094; P:GO:0006571; P:GO:0006096; P:GO:0009615; C:GO:0000015; F:GO:0044822; F:GO:0000287; F:GO:0004634; C:GO:0005634; C:GO:0005615; C:GO:0070062; P:GO:0045892; P:GO:0051099; P:GO:0000162; F:GO:0046982; P:GO:0001701; P:GO:0030308; F:GO:0051020; C:GO:0019897	P:gluconeogenesis; C:myelin sheath; P:L-phenylalanine biosynthetic process; P:tyrosine biosynthetic process; P:glycolytic process; P:response to virus; C:phosphopyruvate hydratase complex; F:poly(A) RNA binding; F:magnesium ion binding; F:phosphopyruvate hydratase activity; C:nucleus; C:extracellular space; C:extracellular exosome; P:negative regulation of transcription, DNA-templated; P:positive regulation of binding; P:tryptophan biosynthetic process; F:protein heterodimerization activity; P:in utero embryonic development; P:negative regulation of cell growth; F:GTPase binding; C:extrinsic component of plasma membrane	EC:4.2.1.11	
sp|P02062|HBB_HORSE	hemoglobin subunit beta	146	20	6.54E-102	93.4%	6	C:GO:0005833; F:GO:0019825; F:GO:0005506; P:GO:0015671; F:GO:0005344; F:GO:0020037	C:hemoglobin complex; F:oxygen binding; F:iron ion binding; P:oxygen transport; F:oxygen transporter activity; F:heme binding		
tr|F6YE73|F6YE73_HORSE	apolipo B-100	4540	20	0E0	89.6%	23	C:GO:0034361; F:GO:0035473; P:GO:0034383; P:GO:0007165; C:GO:0034363; P:GO:0034374; C:GO:0034362; P:GO:0008203; C:GO:0005794; F:GO:0008201; C:GO:0043025; F:GO:0005543; P:GO:0009615; P:GO:0042632; C:GO:0005886; C:GO:0070062; F:GO:0050750; C:GO:0015629; P:GO:0010886; P:GO:0010744; P:GO:0030301; F:GO:0017127; C:GO:0034359	C:very-low-density lipoprotein particle; F:lipase binding; P:low-density lipoprotein particle clearance; P:signal transduction; C:intermediate-density lipoprotein particle; P:low-density lipoprotein particle remodeling; C:low-density lipoprotein particle; P:cholesterol metabolic process; C:Golgi apparatus; F:heparin binding; C:neuronal cell body; F:phospholipid binding; P:response to virus; P:cholesterol homeostasis; C:plasma membrane; C:extracellular exosome; F:low-density lipoprotein particle receptor binding; C:actin cytoskeleton; P:positive regulation of cholesterol storage; P:positive regulation of macrophage derived foam cell differentiation; P:cholesterol transport; F:cholesterol transporter activity; C:mature chylomicron		
tr|F6X485|F6X485_HORSE	myosin-9	1781	20	0E0	98.55%	51	P:GO:0015031; C:GO:0008305; P:GO:0000212; P:GO:1903923; P:GO:0006911; C:GO:0005826; C:GO:0005903; P:GO:0001701; P:GO:1903919; P:GO:0030220; C:GO:0005829; C:GO:0031594; C:GO:0008180; P:GO:0030224; P:GO:0070527; F:GO:0019904; P:GO:0031032; C:GO:0005884; F:GO:0000146; F:GO:0051015; F:GO:0030898; F:GO:0005516; C:GO:0005913; P:GO:0051295; P:GO:0032796; P:GO:0008360; C:GO:0032154; P:GO:0000910; C:GO:0001772; F:GO:0005524; P:GO:0007229; C:GO:0070062; C:GO:0005925; P:GO:0001525; F:GO:0043495; P:GO:0001768; C:GO:0001725; C:GO:0001726; P:GO:0030048; P:GO:0031532; F:GO:0042803; P:GO:0007520; F:GO:0043531; P:GO:0043534; F:GO:0044822; C:GO:0001931; P:GO:0006509; C:GO:0097513; C:GO:0016460; C:GO:0005819; P:GO:0050900	P:protein transport; C:integrin complex; P:meiotic spindle organization; P:positive regulation of protein processing in phagocytic vesicle; P:phagocytosis, engulfment; C:actomyosin contractile ring; C:brush border; P:in utero embryonic development; P:negative regulation of actin filament severing; P:platelet formation; C:cytosol; C:neuromuscular junction; C:COP9 signalosome; P:monocyte differentiation; P:platelet aggregation; F:protein domain specific binding; P:actomyosin structure organization; C:actin filament; F:microfilament motor activity; F:actin filament binding; F:actin-dependent ATPase activity; F:calmodulin binding; C:cell-cell adherens junction; P:establishment of meiotic spindle localization; P:uropod organization; P:regulation of cell shape; C:cleavage furrow; P:cytokinesis; C:immunological synapse; F:ATP binding; P:integrin-mediated signaling pathway; C:extracellular exosome; C:focal adhesion; P:angiogenesis; F:protein anchor; P:establishment of T cell polarity; C:stress fiber; C:ruffle; P:actin filament-based movement; P:actin cytoskeleton reorganization; F:protein homodimerization activity; P:myoblast fusion; F:ADP binding; P:blood vessel endothelial cell migration; F:poly(A) RNA binding; C:uropod; P:membrane protein ectodomain proteolysis; C:myosin II filament; C:myosin II complex; C:spindle; P:leukocyte migration	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	
tr|F6PH38|F6PH38_HORSE	fibrinogen beta chain	490	20	0E0	91.95%	35	F:GO:0050839; P:GO:0045907; P:GO:0090277; C:GO:0009897; F:GO:0005198; P:GO:0042730; C:GO:0005577; P:GO:0045921; P:GO:0002576; C:GO:0070062; P:GO:0043152; P:GO:0031639; P:GO:0044320; C:GO:0072562; F:GO:0051087; P:GO:0050714; P:GO:2000352; P:GO:0070527; C:GO:0031093; P:GO:0007160; P:GO:1902042; P:GO:0007165; P:GO:0002250; P:GO:1900026; F:GO:0005102; P:GO:0051258; P:GO:0072378; C:GO:0005938; P:GO:0045087; P:GO:0051592; P:GO:0070374; P:GO:0030198; P:GO:0034116; P:GO:0071347; F:GO:0030674	F:cell adhesion molecule binding; P:positive regulation of vasoconstriction; P:positive regulation of peptide hormone secretion; C:external side of plasma membrane; F:structural molecule activity; P:fibrinolysis; C:fibrinogen complex; P:positive regulation of exocytosis; P:platelet degranulation; C:extracellular exosome; P:induction of bacterial agglutination; P:plasminogen activation; P:cellular response to leptin stimulus; C:blood microparticle; F:chaperone binding; P:positive regulation of protein secretion; P:negative regulation of endothelial cell apoptotic process; P:platelet aggregation; C:platelet alpha granule lumen; P:cell-matrix adhesion; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:signal transduction; P:adaptive immune response; P:positive regulation of substrate adhesion-dependent cell spreading; F:receptor binding; P:protein polymerization; P:blood coagulation, fibrin clot formation; C:cell cortex; P:innate immune response; P:response to calcium ion; P:positive regulation of ERK1 and ERK2 cascade; P:extracellular matrix organization; P:positive regulation of heterotypic cell-cell adhesion; P:cellular response to interleukin-1; F:protein binding, bridging		
tr|F7CYP1|F7CYP1_HORSE	alpha-1-antitrypsin	423	20	0E0	88.85%	10	C:GO:0005615; F:GO:0004867; F:GO:0042802; C:GO:0070062; P:GO:0010951; C:GO:0005783; C:GO:0005794; F:GO:0001948; F:GO:0002020; P:GO:0006953	C:extracellular space; F:serine-type endopeptidase inhibitor activity; F:identical protein binding; C:extracellular exosome; P:negative regulation of endopeptidase activity; C:endoplasmic reticulum; C:Golgi apparatus; F:glycoprotein binding; F:protease binding; P:acute-phase response		
tr|F7CU94|F7CU94_HORSE	lysozyme C	148	20	2.38E-105	93.2%	9	P:GO:0001895; P:GO:0019835; P:GO:0005975; C:GO:0005615; F:GO:0042802; C:GO:0070062; F:GO:0046872; P:GO:0042742; F:GO:0003796	P:retina homeostasis; P:cytolysis; P:carbohydrate metabolic process; C:extracellular space; F:identical protein binding; C:extracellular exosome; F:metal ion binding; P:defense response to bacterium; F:lysozyme activity	EC:3.2.1.17	
tr|F6W2Y1|F6W2Y1_HORSE	fibrinogen gamma chain	437	20	0E0	93.25%	31	F:GO:0050839; P:GO:0045907; P:GO:0090277; C:GO:0009897; F:GO:0005198; P:GO:0042730; C:GO:0005577; P:GO:0045921; P:GO:0002576; C:GO:0070062; P:GO:0031639; C:GO:0072562; P:GO:0050714; P:GO:2000352; P:GO:0070527; C:GO:0031093; P:GO:0007160; P:GO:1902042; P:GO:0007165; P:GO:1900026; F:GO:0005102; P:GO:0009306; P:GO:0051258; P:GO:0072378; F:GO:0046872; C:GO:0005938; P:GO:0051592; P:GO:0070374; P:GO:0030198; P:GO:0034116; F:GO:0030674	F:cell adhesion molecule binding; P:positive regulation of vasoconstriction; P:positive regulation of peptide hormone secretion; C:external side of plasma membrane; F:structural molecule activity; P:fibrinolysis; C:fibrinogen complex; P:positive regulation of exocytosis; P:platelet degranulation; C:extracellular exosome; P:plasminogen activation; C:blood microparticle; P:positive regulation of protein secretion; P:negative regulation of endothelial cell apoptotic process; P:platelet aggregation; C:platelet alpha granule lumen; P:cell-matrix adhesion; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:signal transduction; P:positive regulation of substrate adhesion-dependent cell spreading; F:receptor binding; P:protein secretion; P:protein polymerization; P:blood coagulation, fibrin clot formation; F:metal ion binding; C:cell cortex; P:response to calcium ion; P:positive regulation of ERK1 and ERK2 cascade; P:extracellular matrix organization; P:positive regulation of heterotypic cell-cell adhesion; F:protein binding, bridging		
tr|F6QAD8|F6QAD8_HORSE	alpha-2-macroglobulin isoform X1	1468	20	0E0	87.05%	13	F:GO:0019959; P:GO:0007165; F:GO:0048306; F:GO:0002020; F:GO:0005102; F:GO:0004867; C:GO:0070062; P:GO:0048863; C:GO:0072562; F:GO:0043120; P:GO:0001869; P:GO:0010951; F:GO:0019966	F:interleukin-8 binding; P:signal transduction; F:calcium-dependent protein binding; F:protease binding; F:receptor binding; F:serine-type endopeptidase inhibitor activity; C:extracellular exosome; P:stem cell differentiation; C:blood microparticle; F:tumor necrosis factor binding; P:negative regulation of complement activation, lectin pathway; P:negative regulation of endopeptidase activity; F:interleukin-1 binding		
tr|F7AQX6|F7AQX6_HORSE	major allergen Equ c 1-like	174	20	1.02E-122	87.05%	5	F:GO:0005550; F:GO:0036094; C:GO:0005576; P:GO:0006810; F:GO:0005215	F:pheromone binding; F:small molecule binding; C:extracellular region; P:transport; F:transporter activity		
tr|F7DZ01|F7DZ01_HORSE	coagulation factor V	1476	20	0E0	79.65%	7	C:GO:1903561; C:GO:0005615; C:GO:0031091; F:GO:0005507; C:GO:0016020; P:GO:0008015; P:GO:0030168	C:extracellular vesicle; C:extracellular space; C:platelet alpha granule; F:copper ion binding; C:membrane; P:blood circulation; P:platelet activation		
tr|F6T0P6|F6T0P6_HORSE	vitamin D-binding	474	20	0E0	93.15%	7	C:GO:0070062; F:GO:0003779; C:GO:0072562; F:GO:0051183; P:GO:0051180; F:GO:1902118; P:GO:0042359	C:extracellular exosome; F:actin binding; C:blood microparticle; F:vitamin transporter activity; P:vitamin transport; F:calcidiol binding; P:vitamin D metabolic process		
tr|F6T7K7|F6T7K7_HORSE	transcobalamin-1	429	20	0E0	83.65%	5	P:GO:0006824; C:GO:0005615; F:GO:0031419; P:GO:0009235; P:GO:0015889	P:cobalt ion transport; C:extracellular space; F:cobalamin binding; P:cobalamin metabolic process; P:cobalamin transport		
tr|H9GZQ9|H9GZQ9_HORSE	immunoglobulin gamma 1 heavy chain constant partial	337	20	0E0	84%	16	C:GO:0009897; F:GO:0004252; P:GO:0038096; P:GO:0042742; P:GO:0006910; C:GO:0070062; P:GO:0006911; P:GO:0050871; F:GO:0003823; P:GO:0006958; P:GO:0045087; C:GO:0042571; C:GO:0072562; P:GO:0006508; F:GO:0034987; P:GO:0050853	C:external side of plasma membrane; F:serine-type endopeptidase activity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:defense response to bacterium; P:phagocytosis, recognition; C:extracellular exosome; P:phagocytosis, engulfment; P:positive regulation of B cell activation; F:antigen binding; P:complement activation, classical pathway; P:innate immune response; C:immunoglobulin complex, circulating; C:blood microparticle; P:proteolysis; F:immunoglobulin receptor binding; P:B cell receptor signaling pathway	EC:3.4.21	
sp|Q2TU62|CLCA1_HORSE	calcium-activated chloride channel regulator 1	913	20	0E0	92.45%	11	C:GO:0005615; F:GO:0005229; C:GO:0005902; F:GO:0046872; P:GO:1902476; C:GO:0030141; P:GO:0006508; P:GO:0006816; C:GO:0016021; C:GO:0031226; F:GO:0008237	C:extracellular space; F:intracellular calcium activated chloride channel activity; C:microvillus; F:metal ion binding; P:chloride transmembrane transport; C:secretory granule; P:proteolysis; P:calcium ion transport; C:integral component of membrane; C:intrinsic component of plasma membrane; F:metallopeptidase activity		
tr|F7CYR1|F7CYR1_HORSE	antithrombin-III	463	20	0E0	95%	11	F:GO:0004867; C:GO:0070062; P:GO:0050728; C:GO:0072562; P:GO:0010951; P:GO:2000266; F:GO:0002020; F:GO:0008201; P:GO:0007584; P:GO:0007596; C:GO:0005886	F:serine-type endopeptidase inhibitor activity; C:extracellular exosome; P:negative regulation of inflammatory response; C:blood microparticle; P:negative regulation of endopeptidase activity; P:regulation of blood coagulation, intrinsic pathway; F:protease binding; F:heparin binding; P:response to nutrient; P:blood coagulation; C:plasma membrane		
tr|H9GZS9|H9GZS9_HORSE	immunoglobulin gamma 3 heavy chain constant partial	354	20	0E0	78.6%	21	F:GO:0042834; P:GO:0050829; C:GO:0009274; C:GO:0009897; F:GO:0004252; P:GO:0038096; F:GO:0003697; P:GO:0006910; C:GO:0070062; P:GO:0006911; P:GO:0050871; F:GO:0003823; P:GO:0006958; P:GO:0045087; C:GO:0072562; P:GO:0019731; F:GO:0031210; C:GO:0071756; F:GO:0034987; C:GO:0071757; P:GO:0050853	F:peptidoglycan binding; P:defense response to Gram-negative bacterium; C:peptidoglycan-based cell wall; C:external side of plasma membrane; F:serine-type endopeptidase activity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; F:single-stranded DNA binding; P:phagocytosis, recognition; C:extracellular exosome; P:phagocytosis, engulfment; P:positive regulation of B cell activation; F:antigen binding; P:complement activation, classical pathway; P:innate immune response; C:blood microparticle; P:antibacterial humoral response; F:phosphatidylcholine binding; C:pentameric IgM immunoglobulin complex; F:immunoglobulin receptor binding; C:hexameric IgM immunoglobulin complex; P:B cell receptor signaling pathway	EC:3.4.21	
sp|Q29482|CLUS_HORSE	clusterin	449	20	0E0	90.9%	45	F:GO:0016887; P:GO:1902230; P:GO:2000060; P:GO:0045429; P:GO:0061077; P:GO:1902430; C:GO:0005794; P:GO:0097193; P:GO:0061518; P:GO:0009615; P:GO:0051092; P:GO:1902998; P:GO:1902949; C:GO:0005788; C:GO:0097440; C:GO:0070062; C:GO:0072562; F:GO:0051087; C:GO:0005829; P:GO:0032463; P:GO:0032760; C:GO:0031012; C:GO:0034366; P:GO:2001244; F:GO:0051787; P:GO:0051788; P:GO:0032286; P:GO:0000902; P:GO:1900221; C:GO:0042583; P:GO:1902004; C:GO:0043234; P:GO:1901216; P:GO:1902847; C:GO:0009986; C:GO:0005634; P:GO:0001774; C:GO:0031966; C:GO:0048471; F:GO:0031625; P:GO:0051131; C:GO:0097418; P:GO:0032436; P:GO:0050821; P:GO:0017038	F:ATPase activity; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; P:positive regulation of nitric oxide biosynthetic process; P:chaperone-mediated protein folding; P:negative regulation of beta-amyloid formation; C:Golgi apparatus; P:intrinsic apoptotic signaling pathway; P:microglial cell proliferation; P:response to virus; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of neurofibrillary tangle assembly; P:positive regulation of tau-protein kinase activity; C:endoplasmic reticulum lumen; C:apical dendrite; C:extracellular exosome; C:blood microparticle; F:chaperone binding; C:cytosol; P:negative regulation of protein homooligomerization; P:positive regulation of tumor necrosis factor production; C:extracellular matrix; C:spherical high-density lipoprotein particle; P:positive regulation of intrinsic apoptotic signaling pathway; F:misfolded protein binding; P:response to misfolded protein; P:central nervous system myelin maintenance; P:cell morphogenesis; P:regulation of beta-amyloid clearance; C:chromaffin granule; P:positive regulation of beta-amyloid formation; C:protein complex; P:positive regulation of neuron death; P:regulation of neuronal signal transduction; C:cell surface; C:nucleus; P:microglial cell activation; C:mitochondrial membrane; C:perinuclear region of cytoplasm; F:ubiquitin protein ligase binding; P:chaperone-mediated protein complex assembly; C:neurofibrillary tangle; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein stabilization; P:protein import	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	
tr|F7APU2|F7APU2_HORSE	complement factor I	559	20	0E0	89.25%	8	C:GO:0005615; C:GO:0070062; P:GO:0007165; C:GO:0016020; P:GO:0006508; F:GO:0004252; F:GO:0005044; P:GO:0006898	C:extracellular space; C:extracellular exosome; P:signal transduction; C:membrane; P:proteolysis; F:serine-type endopeptidase activity; F:scavenger receptor activity; P:receptor-mediated endocytosis	EC:3.4.21	
tr|F6QX36|F6QX36_HORSE	inter-alpha-trypsin inhibitor heavy chain H1 isoform X1	909	20	0E0	95.2%	5	F:GO:0004867; C:GO:0070062; C:GO:0072562; P:GO:0010951; P:GO:0030212	F:serine-type endopeptidase inhibitor activity; C:extracellular exosome; C:blood microparticle; P:negative regulation of endopeptidase activity; P:hyaluronan metabolic process		
tr|F6VJR6|F6VJR6_HORSE	alpha-1B-glyco	500	20	0E0	68.95%	4	C:GO:0031093; P:GO:0002576; C:GO:0070062; C:GO:0072562	C:platelet alpha granule lumen; P:platelet degranulation; C:extracellular exosome; C:blood microparticle		
tr|F6RZ27|F6RZ27_HORSE	apolipo A-IV	381	20	0E0	92.7%	46	P:GO:0034372; P:GO:0034371; F:GO:0016209; P:GO:0034375; F:GO:0060228; P:GO:0006982; P:GO:0042158; P:GO:0042632; P:GO:0007159; P:GO:0045723; C:GO:0005788; C:GO:0005769; C:GO:0070062; P:GO:0001523; F:GO:0005507; P:GO:0043691; P:GO:0044240; C:GO:0072562; C:GO:0005829; P:GO:0034445; F:GO:0031210; P:GO:0010898; P:GO:0070328; P:GO:0030300; F:GO:0017127; P:GO:0010873; P:GO:0051006; P:GO:0035634; C:GO:0034361; C:GO:0042627; F:GO:0042803; P:GO:0034380; F:GO:0015485; C:GO:0034364; P:GO:0006695; P:GO:0044267; C:GO:0009986; P:GO:0042744; P:GO:0002227; P:GO:0046470; P:GO:0019430; P:GO:0031102; P:GO:0033344; P:GO:0034378; P:GO:0019433; P:GO:0033700	P:very-low-density lipoprotein particle remodeling; P:chylomicron remodeling; F:antioxidant activity; P:high-density lipoprotein particle remodeling; F:phosphatidylcholine-sterol O-acyltransferase activator activity; P:response to lipid hydroperoxide; P:lipoprotein biosynthetic process; P:cholesterol homeostasis; P:leukocyte cell-cell adhesion; P:positive regulation of fatty acid biosynthetic process; C:endoplasmic reticulum lumen; C:early endosome; C:extracellular exosome; P:retinoid metabolic process; F:copper ion binding; P:reverse cholesterol transport; P:multicellular organism lipid catabolic process; C:blood microparticle; C:cytosol; P:negative regulation of plasma lipoprotein particle oxidation; F:phosphatidylcholine binding; P:positive regulation of triglyceride catabolic process; P:triglyceride homeostasis; P:regulation of intestinal cholesterol absorption; F:cholesterol transporter activity; P:positive regulation of cholesterol esterification; P:positive regulation of lipoprotein lipase activity; P:response to stilbenoid; C:very-low-density lipoprotein particle; C:chylomicron; F:protein homodimerization activity; P:high-density lipoprotein particle assembly; F:cholesterol binding; C:high-density lipoprotein particle; P:cholesterol biosynthetic process; P:cellular protein metabolic process; C:cell surface; P:hydrogen peroxide catabolic process; P:innate immune response in mucosa; P:phosphatidylcholine metabolic process; P:removal of superoxide radicals; P:neuron projection regeneration; P:cholesterol efflux; P:chylomicron assembly; P:triglyceride catabolic process; P:phospholipid efflux		
tr|F6YV53|F6YV53_HORSE	alpha-actinin-4 isoform X1	747	20	0E0	96.3%	36	P:GO:0030050; P:GO:1902396; P:GO:0015031; F:GO:0000977; P:GO:0051271; P:GO:1901224; P:GO:0045893; F:GO:0042974; C:GO:0005667; P:GO:0048384; C:GO:0070062; C:GO:0005903; C:GO:0005925; C:GO:0030529; F:GO:0005509; C:GO:0001725; P:GO:0035357; C:GO:0030863; F:GO:0031490; F:GO:0042803; P:GO:1900025; F:GO:0044325; F:GO:0001882; F:GO:0044822; P:GO:0048549; F:GO:0051015; C:GO:0005634; C:GO:0030018; C:GO:0005615; C:GO:0005911; C:GO:0048471; F:GO:0030374; P:GO:0070830; C:GO:0031143; P:GO:0051017; P:GO:0030335	P:vesicle transport along actin filament; P:protein localization to bicellular tight junction; P:protein transport; F:RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of cellular component movement; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of transcription, DNA-templated; F:retinoic acid receptor binding; C:transcription factor complex; P:retinoic acid receptor signaling pathway; C:extracellular exosome; C:brush border; C:focal adhesion; C:intracellular ribonucleoprotein complex; F:calcium ion binding; C:stress fiber; P:peroxisome proliferator activated receptor signaling pathway; C:cortical cytoskeleton; F:chromatin DNA binding; F:protein homodimerization activity; P:negative regulation of substrate adhesion-dependent cell spreading; F:ion channel binding; F:nucleoside binding; F:poly(A) RNA binding; P:positive regulation of pinocytosis; F:actin filament binding; C:nucleus; C:Z disc; C:extracellular space; C:cell-cell junction; C:perinuclear region of cytoplasm; F:ligand-dependent nuclear receptor transcription coactivator activity; P:bicellular tight junction assembly; C:pseudopodium; P:actin filament bundle assembly; P:positive regulation of cell migration		
tr|F6SRP7|F6SRP7_HORSE	adenylyl cyclase-associated 1 isoform X1	475	20	0E0	97.75%	9	C:GO:0070062; C:GO:0005925; F:GO:0003779; P:GO:0001667; P:GO:0000902; P:GO:0006898; P:GO:0030036; C:GO:0005886; C:GO:0030864	C:extracellular exosome; C:focal adhesion; F:actin binding; P:ameboidal-type cell migration; P:cell morphogenesis; P:receptor-mediated endocytosis; P:actin cytoskeleton organization; C:plasma membrane; C:cortical actin cytoskeleton		
tr|F7DA17|F7DA17_HORSE	-glutamine gamma-glutamyltransferase 2	697	20	0E0	94.2%	16	P:GO:0060662; P:GO:0032471; P:GO:0043277; C:GO:0005783; P:GO:0045785; P:GO:0060445; F:GO:0003810; C:GO:0070062; C:GO:0005925; P:GO:0051561; F:GO:0046872; C:GO:0005739; P:GO:0043065; C:GO:0005829; C:GO:0031226; P:GO:0018149	P:salivary gland cavitation; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:apoptotic cell clearance; C:endoplasmic reticulum; P:positive regulation of cell adhesion; P:branching involved in salivary gland morphogenesis; F:protein-glutamine gamma-glutamyltransferase activity; C:extracellular exosome; C:focal adhesion; P:positive regulation of mitochondrial calcium ion concentration; F:metal ion binding; C:mitochondrion; P:positive regulation of apoptotic process; C:cytosol; C:intrinsic component of plasma membrane; P:peptide cross-linking	EC:2.3.2.13	
tr|F7CIM1|F7CIM1_HORSE	14-3-3 sigma	248	20	0E0	99.05%	18	P:GO:0010482; F:GO:0019901; F:GO:0019904; P:GO:0045606; P:GO:0046827; P:GO:0008630; P:GO:0061436; P:GO:0000079; P:GO:0003334; P:GO:0010839; C:GO:0005634; P:GO:0030307; C:GO:0070062; C:GO:0005737; P:GO:0043154; P:GO:0001836; F:GO:0051219; P:GO:0031424	P:regulation of epidermal cell division; F:protein kinase binding; F:protein domain specific binding; P:positive regulation of epidermal cell differentiation; P:positive regulation of protein export from nucleus; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:establishment of skin barrier; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:keratinocyte development; P:negative regulation of keratinocyte proliferation; C:nucleus; P:positive regulation of cell growth; C:extracellular exosome; C:cytoplasm; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:release of cytochrome c from mitochondria; F:phosphoprotein binding; P:keratinization		
tr|F7BFJ1|F7BFJ1_HORSE	prothrombin	623	20	0E0	90.7%	34	P:GO:0008360; P:GO:0014068; P:GO:0030194; P:GO:0008284; P:GO:0009611; P:GO:0048712; P:GO:0045861; P:GO:0007596; P:GO:0042730; C:GO:0005576; P:GO:0007599; P:GO:0030307; P:GO:0032967; C:GO:0070062; F:GO:0005509; C:GO:0072562; C:GO:0005829; P:GO:0030168; P:GO:2000379; F:GO:0004252; F:GO:0008236; P:GO:0051480; P:GO:0007166; F:GO:0008233; P:GO:0051281; F:GO:0005102; P:GO:0006953; F:GO:0070053; C:GO:0005615; P:GO:1900738; P:GO:0006508; P:GO:0001934; P:GO:0010468; F:GO:0016787	P:regulation of cell shape; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of blood coagulation; P:positive regulation of cell proliferation; P:response to wounding; P:negative regulation of astrocyte differentiation; P:negative regulation of proteolysis; P:blood coagulation; P:fibrinolysis; C:extracellular region; P:hemostasis; P:positive regulation of cell growth; P:positive regulation of collagen biosynthetic process; C:extracellular exosome; F:calcium ion binding; C:blood microparticle; C:cytosol; P:platelet activation; P:positive regulation of reactive oxygen species metabolic process; F:serine-type endopeptidase activity; F:serine-type peptidase activity; P:regulation of cytosolic calcium ion concentration; P:cell surface receptor signaling pathway; F:peptidase activity; P:positive regulation of release of sequestered calcium ion into cytosol; F:receptor binding; P:acute-phase response; F:thrombospondin receptor activity; C:extracellular space; P:positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway; P:proteolysis; P:positive regulation of protein phosphorylation; P:regulation of gene expression; F:hydrolase activity		
tr|F7B7X0|F7B7X0_HORSE	type II cytoskeletal 1	639	20	0E0	91.9%	14	P:GO:0050728; F:GO:0005198; C:GO:0005882; P:GO:0061436; P:GO:0001895; C:GO:0005634; C:GO:0005615; C:GO:0070062; C:GO:0045095; P:GO:0001867; C:GO:0072562; C:GO:0016020; C:GO:0031012; F:GO:0030246	P:negative regulation of inflammatory response; F:structural molecule activity; C:intermediate filament; P:establishment of skin barrier; P:retina homeostasis; C:nucleus; C:extracellular space; C:extracellular exosome; C:keratin filament; P:complement activation, lectin pathway; C:blood microparticle; C:membrane; C:extracellular matrix; F:carbohydrate binding		
tr|F6XWM5|F6XWM5_HORSE	haptoglobin	346	20	0E0	90.75%	10	P:GO:0007219; F:GO:0016209; F:GO:0030492; P:GO:0006508; F:GO:0004252; P:GO:0098869; C:GO:0005576; P:GO:0042742; P:GO:0006953; P:GO:0002376	P:Notch signaling pathway; F:antioxidant activity; F:hemoglobin binding; P:proteolysis; F:serine-type endopeptidase activity; P:cellular oxidant detoxification; C:extracellular region; P:defense response to bacterium; P:acute-phase response; P:immune system process		
tr|F6RUZ6|F6RUZ6_HORSE	fibrinogen alpha chain	795	20	0E0	78.55%	61	C:GO:1903561; F:GO:0050839; F:GO:0005198; P:GO:0046898; C:GO:0005791; P:GO:0042730; P:GO:0043623; P:GO:0045921; P:GO:1990643; P:GO:0043152; P:GO:0031639; P:GO:0050714; P:GO:2000352; P:GO:0070527; P:GO:1902042; P:GO:0002250; P:GO:0043278; P:GO:1900026; P:GO:0002376; C:GO:0005886; P:GO:0051258; F:GO:0005515; P:GO:0072378; P:GO:0072377; F:GO:0046872; P:GO:0032355; P:GO:0071407; P:GO:0006461; P:GO:2000261; P:GO:0090277; P:GO:0045907; C:GO:0009897; P:GO:0007596; C:GO:0005576; P:GO:0007599; C:GO:0005577; P:GO:0002576; P:GO:0097421; C:GO:0070062; P:GO:0071354; C:GO:0072562; P:GO:0030168; P:GO:0007160; C:GO:0031093; C:GO:0031091; P:GO:0033595; P:GO:0007165; P:GO:0044267; F:GO:0005102; P:GO:0006953; C:GO:0009986; C:GO:0005615; C:GO:0005737; P:GO:0045087; C:GO:0005938; P:GO:0051592; P:GO:0070374; P:GO:0034116; P:GO:0030198; P:GO:0071345; F:GO:0030674	C:extracellular vesicle; F:cell adhesion molecule binding; F:structural molecule activity; P:response to cycloheximide; C:rough endoplasmic reticulum; P:fibrinolysis; P:cellular protein complex assembly; P:positive regulation of exocytosis; P:cellular response to granulocyte colony-stimulating factor; P:induction of bacterial agglutination; P:plasminogen activation; P:positive regulation of protein secretion; P:negative regulation of endothelial cell apoptotic process; P:platelet aggregation; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:adaptive immune response; P:response to morphine; P:positive regulation of substrate adhesion-dependent cell spreading; P:immune system process; C:plasma membrane; P:protein polymerization; F:protein binding; P:blood coagulation, fibrin clot formation; P:blood coagulation, common pathway; F:metal ion binding; P:response to estradiol; P:cellular response to organic cyclic compound; P:protein complex assembly; P:negative regulation of blood coagulation, common pathway; P:positive regulation of peptide hormone secretion; P:positive regulation of vasoconstriction; C:external side of plasma membrane; P:blood coagulation; C:extracellular region; P:hemostasis; C:fibrinogen complex; P:platelet degranulation; P:liver regeneration; C:extracellular exosome; P:cellular response to interleukin-6; C:blood microparticle; P:platelet activation; P:cell-matrix adhesion; C:platelet alpha granule lumen; C:platelet alpha granule; P:response to genistein; P:signal transduction; P:cellular protein metabolic process; F:receptor binding; P:acute-phase response; C:cell surface; C:extracellular space; C:cytoplasm; P:innate immune response; C:cell cortex; P:response to calcium ion; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of heterotypic cell-cell adhesion; P:extracellular matrix organization; P:cellular response to cytokine stimulus; F:protein binding, bridging		
tr|F7D9J2|F7D9J2_HORSE	transketolase	595	20	0E0	98.15%	20	P:GO:0009052; C:GO:0043209; F:GO:0042803; P:GO:0006098; P:GO:0008152; P:GO:0040008; C:GO:0005654; C:GO:0005777; C:GO:0005634; P:GO:0005999; F:GO:0005515; C:GO:0070062; F:GO:0004802; F:GO:0046872; F:GO:0003824; F:GO:0048037; P:GO:0046166; C:GO:0005829; C:GO:0031982; F:GO:0016740	P:pentose-phosphate shunt, non-oxidative branch; C:myelin sheath; F:protein homodimerization activity; P:pentose-phosphate shunt; P:metabolic process; P:regulation of growth; C:nucleoplasm; C:peroxisome; C:nucleus; P:xylulose biosynthetic process; F:protein binding; C:extracellular exosome; F:transketolase activity; F:metal ion binding; F:catalytic activity; F:cofactor binding; P:glyceraldehyde-3-phosphate biosynthetic process; C:cytosol; C:vesicle; F:transferase activity		
tr|F7D7M0|F7D7M0_HORSE	galectin-3-binding isoform X1	567	20	0E0	87.4%	13	P:GO:0007165; F:GO:0005044; P:GO:0043123; F:GO:0004871; P:GO:0006898; C:GO:0005615; C:GO:0070062; F:GO:0005509; C:GO:0072562; C:GO:0016020; F:GO:0016462; P:GO:0030166; C:GO:0031012	P:signal transduction; F:scavenger receptor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; F:signal transducer activity; P:receptor-mediated endocytosis; C:extracellular space; C:extracellular exosome; F:calcium ion binding; C:blood microparticle; C:membrane; F:pyrophosphatase activity; P:proteoglycan biosynthetic process; C:extracellular matrix		
tr|F6SJK9|F6SJK9_HORSE	type I cytoskeletal 10	346	20	0E0	97.55%	8	C:GO:0005634; P:GO:0030216; C:GO:0005615; C:GO:0070062; C:GO:0005737; C:GO:0016020; F:GO:0005198; C:GO:0005882	C:nucleus; P:keratinocyte differentiation; C:extracellular space; C:extracellular exosome; C:cytoplasm; C:membrane; F:structural molecule activity; C:intermediate filament		
tr|F6SQQ0|F6SQQ0_HORSE	type I cytoskeletal 10	381	20	0E0	97.6%	8	C:GO:0005634; P:GO:0030216; C:GO:0005615; C:GO:0070062; C:GO:0005737; C:GO:0016020; F:GO:0005198; C:GO:0005882	C:nucleus; P:keratinocyte differentiation; C:extracellular space; C:extracellular exosome; C:cytoplasm; C:membrane; F:structural molecule activity; C:intermediate filament		
tr|F6WDW3|F6WDW3_HORSE	type I cytoskeletal 10 isoform X1	393	20	0E0	98.45%	8	C:GO:0005634; P:GO:0030216; C:GO:0005615; C:GO:0070062; C:GO:0005737; C:GO:0016020; F:GO:0005198; C:GO:0005882	C:nucleus; P:keratinocyte differentiation; C:extracellular space; C:extracellular exosome; C:cytoplasm; C:membrane; F:structural molecule activity; C:intermediate filament		
tr|F6SS14|F6SS14_HORSE	type I cytoskeletal 10 isoform X1	471	20	0E0	98.15%	8	C:GO:0005634; P:GO:0030216; C:GO:0005615; C:GO:0070062; C:GO:0005737; C:GO:0016020; F:GO:0005198; C:GO:0005882	C:nucleus; P:keratinocyte differentiation; C:extracellular space; C:extracellular exosome; C:cytoplasm; C:membrane; F:structural molecule activity; C:intermediate filament		
tr|F6UZH0|F6UZH0_HORSE	AMBP	352	20	0E0	89.8%	11	F:GO:0004867; C:GO:0005615; C:GO:0070062; F:GO:0042803; C:GO:0072562; P:GO:0010951; F:GO:0036094; F:GO:0019862; C:GO:0005576; C:GO:0005886; F:GO:0020037	F:serine-type endopeptidase inhibitor activity; C:extracellular space; C:extracellular exosome; F:protein homodimerization activity; C:blood microparticle; P:negative regulation of endopeptidase activity; F:small molecule binding; F:IgA binding; C:extracellular region; C:plasma membrane; F:heme binding		
tr|F7DXM5|F7DXM5_HORSE	alpha-1-antitrypsin	422	20	0E0	96.05%	13	F:GO:0042802; F:GO:0002020; C:GO:0005794; C:GO:0005783; C:GO:0005576; P:GO:0006953; F:GO:0030414; C:GO:0005615; F:GO:0004867; C:GO:0070062; P:GO:0010951; F:GO:0001948; P:GO:0010466	F:identical protein binding; F:protease binding; C:Golgi apparatus; C:endoplasmic reticulum; C:extracellular region; P:acute-phase response; F:peptidase inhibitor activity; C:extracellular space; F:serine-type endopeptidase inhibitor activity; C:extracellular exosome; P:negative regulation of endopeptidase activity; F:glycoprotein binding; P:negative regulation of peptidase activity		
tr|A0A0B4J1C4|A0A0B4J1C4_HORSE	immunoglobulin J chain	158	20	1.12E-113	93.4%	22	F:GO:0042834; P:GO:0060267; F:GO:0042803; P:GO:0032461; P:GO:0003094; P:GO:0002250; F:GO:0003697; P:GO:0001895; C:GO:0005615; C:GO:0070062; C:GO:0071750; C:GO:0071751; P:GO:0045087; C:GO:0072562; P:GO:0006959; C:GO:0071752; P:GO:0019731; F:GO:0019862; F:GO:0031210; C:GO:0071748; C:GO:0071756; F:GO:0034987	F:peptidoglycan binding; P:positive regulation of respiratory burst; F:protein homodimerization activity; P:positive regulation of protein oligomerization; P:glomerular filtration; P:adaptive immune response; F:single-stranded DNA binding; P:retina homeostasis; C:extracellular space; C:extracellular exosome; C:dimeric IgA immunoglobulin complex; C:secretory IgA immunoglobulin complex; P:innate immune response; C:blood microparticle; P:humoral immune response; C:secretory dimeric IgA immunoglobulin complex; P:antibacterial humoral response; F:IgA binding; F:phosphatidylcholine binding; C:monomeric IgA immunoglobulin complex; C:pentameric IgM immunoglobulin complex; F:immunoglobulin receptor binding		
tr|F6X1X3|F6X1X3_HORSE	vitelline membrane outer layer 1 homolog	200	20	4.6E-144	89.65%	1	C:GO:0070062	C:extracellular exosome		
tr|F6Z041|F6Z041_HORSE	beta-2-glyco 1	345	20	0E0	93.25%	27	P:GO:0016525; P:GO:0034392; P:GO:0030193; P:GO:0030195; P:GO:0007597; P:GO:0006641; F:GO:0008289; F:GO:0008201; C:GO:0005576; C:GO:0070062; P:GO:0031639; F:GO:0001948; C:GO:0031012; P:GO:0010596; P:GO:0051006; C:GO:0034361; F:GO:0042802; C:GO:0042627; P:GO:0051918; C:GO:0034364; P:GO:0033033; P:GO:0051917; F:GO:0060230; F:GO:0005543; C:GO:0009986; C:GO:0005615; P:GO:0001937	P:negative regulation of angiogenesis; P:negative regulation of smooth muscle cell apoptotic process; P:regulation of blood coagulation; P:negative regulation of blood coagulation; P:blood coagulation, intrinsic pathway; P:triglyceride metabolic process; F:lipid binding; F:heparin binding; C:extracellular region; C:extracellular exosome; P:plasminogen activation; F:glycoprotein binding; C:extracellular matrix; P:negative regulation of endothelial cell migration; P:positive regulation of lipoprotein lipase activity; C:very-low-density lipoprotein particle; F:identical protein binding; C:chylomicron; P:negative regulation of fibrinolysis; C:high-density lipoprotein particle; P:negative regulation of myeloid cell apoptotic process; P:regulation of fibrinolysis; F:lipoprotein lipase activator activity; F:phospholipid binding; C:cell surface; C:extracellular space; P:negative regulation of endothelial cell proliferation		
tr|F6UPQ8|F6UPQ8_HORSE	spectrin alpha non-erythrocytic 1 isoform X1	2481	20	0E0	99%	6	F:GO:0005516; C:GO:0005856; F:GO:0003779; P:GO:0051693; C:GO:0005737; C:GO:0005938	F:calmodulin binding; C:cytoskeleton; F:actin binding; P:actin filament capping; C:cytoplasm; C:cell cortex		
tr|F6UQC4|F6UQC4_HORSE	spectrin alpha non-erythrocytic 1 isoform X1	2484	20	0E0	99%	5	C:GO:1903561; C:GO:0015630; C:GO:0070062; F:GO:0005509; C:GO:0043231	C:extracellular vesicle; C:microtubule cytoskeleton; C:extracellular exosome; F:calcium ion binding; C:intracellular membrane-bounded organelle		
tr|F6UPM7|F6UPM7_HORSE	spectrin alpha non-erythrocytic 1 isoform X5	2461	20	0E0	98.6%	5	C:GO:1903561; C:GO:0015630; C:GO:0070062; F:GO:0005509; C:GO:0043231	C:extracellular vesicle; C:microtubule cytoskeleton; C:extracellular exosome; F:calcium ion binding; C:intracellular membrane-bounded organelle		
tr|F6WFZ5|F6WFZ5_HORSE	serpin B3-like	374	20	0E0	87.3%	3	F:GO:0004867; C:GO:0005615; P:GO:0010951	F:serine-type endopeptidase inhibitor activity; C:extracellular space; P:negative regulation of endopeptidase activity		
tr|F7DU87|F7DU87_HORSE	BPI fold-containing family A member 2	249	20	1.51E-174	76.15%	6	F:GO:0005515; C:GO:0070062; F:GO:0008289; C:GO:0005576; P:GO:0042742; F:GO:0001530	F:protein binding; C:extracellular exosome; F:lipid binding; C:extracellular region; P:defense response to bacterium; F:lipopolysaccharide binding		
tr|F6RGN2|F6RGN2_HORSE	fatty acid-binding epidermal	135	20	7.97E-95	97.7%	16	P:GO:0008544; P:GO:0009611; F:GO:0008289; P:GO:0006006; P:GO:0006656; P:GO:0006810; F:GO:0005215; C:GO:0005654; F:GO:0005504; F:GO:0005515; C:GO:0070062; C:GO:0005737; P:GO:0006629; C:GO:0005829; P:GO:0019433; P:GO:0015758	P:epidermis development; P:response to wounding; F:lipid binding; P:glucose metabolic process; P:phosphatidylcholine biosynthetic process; P:transport; F:transporter activity; C:nucleoplasm; F:fatty acid binding; F:protein binding; C:extracellular exosome; C:cytoplasm; P:lipid metabolic process; C:cytosol; P:triglyceride catabolic process; P:glucose transport		
tr|F6YG82|F6YG82_HORSE	78 kDa glucose-regulated	652	20	0E0	99%	39	F:GO:0016887; C:GO:0043209; C:GO:0005793; P:GO:0006983; C:GO:0005789; F:GO:0000166; F:GO:0005524; C:GO:0005788; P:GO:0021680; C:GO:0070062; C:GO:0005925; P:GO:0071353; P:GO:0031398; P:GO:0035437; F:GO:0001948; C:GO:0034663; C:GO:0008180; P:GO:0051603; F:GO:0051787; F:GO:0019904; P:GO:0021589; C:GO:0005783; F:GO:0051082; P:GO:1901998; C:GO:0005886; P:GO:0042149; P:GO:0021762; C:GO:0009986; C:GO:0005634; P:GO:0006987; F:GO:0031625; P:GO:0043066; F:GO:0043022; C:GO:0016020; C:GO:0030176; C:GO:0030496; P:GO:0030512; F:GO:0019899; P:GO:0030335	F:ATPase activity; C:myelin sheath; C:endoplasmic reticulum-Golgi intermediate compartment; P:ER overload response; C:endoplasmic reticulum membrane; F:nucleotide binding; F:ATP binding; C:endoplasmic reticulum lumen; P:cerebellar Purkinje cell layer development; C:extracellular exosome; C:focal adhesion; P:cellular response to interleukin-4; P:positive regulation of protein ubiquitination; P:maintenance of protein localization in endoplasmic reticulum; F:glycoprotein binding; C:endoplasmic reticulum chaperone complex; C:COP9 signalosome; P:proteolysis involved in cellular protein catabolic process; F:misfolded protein binding; F:protein domain specific binding; P:cerebellum structural organization; C:endoplasmic reticulum; F:unfolded protein binding; P:toxin transport; C:plasma membrane; P:cellular response to glucose starvation; P:substantia nigra development; C:cell surface; C:nucleus; P:activation of signaling protein activity involved in unfolded protein response; F:ubiquitin protein ligase binding; P:negative regulation of apoptotic process; F:ribosome binding; C:membrane; C:integral component of endoplasmic reticulum membrane; C:midbody; P:negative regulation of transforming growth factor beta receptor signaling pathway; F:enzyme binding; P:positive regulation of cell migration		
tr|F6QIZ4|F6QIZ4_HORSE	talin-1 isoform X2	2540	20	0E0	99%	18	P:GO:0007044; P:GO:0007155; F:GO:0005200; F:GO:0005178; P:GO:0007016; C:GO:0005886; P:GO:0030866; F:GO:0051015; C:GO:0005856; C:GO:0070062; F:GO:0003779; C:GO:0005925; C:GO:0005815; C:GO:0005737; C:GO:0001726; F:GO:0017166; F:GO:0030274; P:GO:0070527	P:cell-substrate junction assembly; P:cell adhesion; F:structural constituent of cytoskeleton; F:integrin binding; P:cytoskeletal anchoring at plasma membrane; C:plasma membrane; P:cortical actin cytoskeleton organization; F:actin filament binding; C:cytoskeleton; C:extracellular exosome; F:actin binding; C:focal adhesion; C:microtubule organizing center; C:cytoplasm; C:ruffle; F:vinculin binding; F:LIM domain binding; P:platelet aggregation		
tr|F6RZP8|F6RZP8_HORSE	talin-1 isoform X4	2543	20	0E0	98.8%	18	P:GO:0007044; P:GO:0007155; F:GO:0005200; F:GO:0005178; P:GO:0007016; C:GO:0005886; P:GO:0030866; F:GO:0051015; C:GO:0005856; C:GO:0070062; F:GO:0003779; C:GO:0005925; C:GO:0005815; C:GO:0005737; C:GO:0001726; F:GO:0017166; F:GO:0030274; P:GO:0070527	P:cell-substrate junction assembly; P:cell adhesion; F:structural constituent of cytoskeleton; F:integrin binding; P:cytoskeletal anchoring at plasma membrane; C:plasma membrane; P:cortical actin cytoskeleton organization; F:actin filament binding; C:cytoskeleton; C:extracellular exosome; F:actin binding; C:focal adhesion; C:microtubule organizing center; C:cytoplasm; C:ruffle; F:vinculin binding; F:LIM domain binding; P:platelet aggregation		
tr|F6PN89|F6PN89_HORSE	talin-1 isoform X2	2562	20	0E0	98.75%	26	P:GO:0007155; F:GO:0005178; C:GO:0042995; P:GO:0007016; P:GO:0030866; C:GO:0070062; C:GO:0005925; C:GO:0001726; F:GO:0017166; F:GO:0032403; P:GO:0070527; P:GO:0007044; F:GO:0005200; C:GO:0005886; F:GO:0051015; F:GO:0098641; C:GO:0005856; F:GO:0005515; F:GO:0003779; C:GO:0005815; C:GO:0005737; C:GO:0005913; C:GO:0016020; F:GO:0030274; C:GO:0030054; P:GO:0098609	P:cell adhesion; F:integrin binding; C:cell projection; P:cytoskeletal anchoring at plasma membrane; P:cortical actin cytoskeleton organization; C:extracellular exosome; C:focal adhesion; C:ruffle; F:vinculin binding; F:protein complex binding; P:platelet aggregation; P:cell-substrate junction assembly; F:structural constituent of cytoskeleton; C:plasma membrane; F:actin filament binding; F:cadherin binding involved in cell-cell adhesion; C:cytoskeleton; F:protein binding; F:actin binding; C:microtubule organizing center; C:cytoplasm; C:cell-cell adherens junction; C:membrane; F:LIM domain binding; C:cell junction; P:cell-cell adhesion		
sp|Q9GKX7|HS90A_HORSE	heat shock HSP 90-alpha	733	20	0E0	99.15%	35	F:GO:0016887; P:GO:0045429; C:GO:0043209; P:GO:0046677; C:GO:0005576; C:GO:0005654; F:GO:0000166; P:GO:0009409; F:GO:0005524; P:GO:0009408; C:GO:0070062; F:GO:0051020; P:GO:0050790; C:GO:0005829; C:GO:0032587; P:GO:0031396; F:GO:0042802; F:GO:0042803; F:GO:0042826; F:GO:0051082; P:GO:0006457; F:GO:0023026; P:GO:0006950; C:GO:0005622; C:GO:0005886; F:GO:0044822; C:GO:0005634; P:GO:0045040; F:GO:0030911; F:GO:0005515; C:GO:0042470; C:GO:0005737; C:GO:0016020; P:GO:0051131; F:GO:0030235	F:ATPase activity; P:positive regulation of nitric oxide biosynthetic process; C:myelin sheath; P:response to antibiotic; C:extracellular region; C:nucleoplasm; F:nucleotide binding; P:response to cold; F:ATP binding; P:response to heat; C:extracellular exosome; F:GTPase binding; P:regulation of catalytic activity; C:cytosol; C:ruffle membrane; P:regulation of protein ubiquitination; F:identical protein binding; F:protein homodimerization activity; F:histone deacetylase binding; F:unfolded protein binding; P:protein folding; F:MHC class II protein complex binding; P:response to stress; C:intracellular; C:plasma membrane; F:poly(A) RNA binding; C:nucleus; P:protein import into mitochondrial outer membrane; F:TPR domain binding; F:protein binding; C:melanosome; C:cytoplasm; C:membrane; P:chaperone-mediated protein complex assembly; F:nitric-oxide synthase regulator activity		
tr|F7B762|F7B762_HORSE	pro-epidermal growth factor isoform X1	1211	20	0E0	88.25%	42	P:GO:0043406; P:GO:0018108; P:GO:2000060; F:GO:0042813; F:GO:0008083; P:GO:0090279; P:GO:0007173; P:GO:0008284; F:GO:0005154; P:GO:0044332; P:GO:0048754; P:GO:0043388; P:GO:0045840; P:GO:0045741; P:GO:0090370; P:GO:0051048; P:GO:0050730; P:GO:0000187; P:GO:0000186; C:GO:0070062; P:GO:0060749; P:GO:0001525; P:GO:0045893; F:GO:0005509; P:GO:0060070; F:GO:0017147; P:GO:0050731; P:GO:0035413; P:GO:0042327; P:GO:0007262; P:GO:0021940; C:GO:0043235; P:GO:1900127; C:GO:0005765; C:GO:0005886; C:GO:0005622; P:GO:0070371; C:GO:0005615; P:GO:2000008; C:GO:0016020; C:GO:0016021; P:GO:0010800	P:positive regulation of MAP kinase activity; P:peptidyl-tyrosine phosphorylation; P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; F:Wnt-activated receptor activity; F:growth factor activity; P:regulation of calcium ion import; P:epidermal growth factor receptor signaling pathway; P:positive regulation of cell proliferation; F:epidermal growth factor receptor binding; P:Wnt signaling pathway involved in dorsal/ventral axis specification; P:branching morphogenesis of an epithelial tube; P:positive regulation of DNA binding; P:positive regulation of mitotic nuclear division; P:positive regulation of epidermal growth factor-activated receptor activity; P:negative regulation of cholesterol efflux; P:negative regulation of secretion; P:regulation of peptidyl-tyrosine phosphorylation; P:activation of MAPK activity; P:activation of MAPKK activity; C:extracellular exosome; P:mammary gland alveolus development; P:angiogenesis; P:positive regulation of transcription, DNA-templated; F:calcium ion binding; P:canonical Wnt signaling pathway; F:Wnt-protein binding; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of catenin import into nucleus; P:positive regulation of phosphorylation; P:STAT protein import into nucleus; P:positive regulation of cerebellar granule cell precursor proliferation; C:receptor complex; P:positive regulation of hyaluronan biosynthetic process; C:lysosomal membrane; C:plasma membrane; C:intracellular; P:ERK1 and ERK2 cascade; C:extracellular space; P:regulation of protein localization to cell surface; C:membrane; C:integral component of membrane; P:positive regulation of peptidyl-threonine phosphorylation		
tr|F7B726|F7B726_HORSE	pro-epidermal growth factor isoform X1	1210	20	0E0	88.2%	42	P:GO:0043406; P:GO:0018108; P:GO:2000060; F:GO:0042813; F:GO:0008083; P:GO:0090279; P:GO:0007173; P:GO:0008284; F:GO:0005154; P:GO:0044332; P:GO:0048754; P:GO:0043388; P:GO:0045741; P:GO:0045840; P:GO:0090370; P:GO:0051048; P:GO:0050730; P:GO:0000187; P:GO:0000186; C:GO:0070062; P:GO:0060749; P:GO:0001525; P:GO:0045893; F:GO:0005509; P:GO:0060070; F:GO:0017147; P:GO:0050731; P:GO:0035413; P:GO:0042327; P:GO:0007262; P:GO:0021940; C:GO:0043235; P:GO:1900127; C:GO:0005886; C:GO:0005622; C:GO:0005765; P:GO:0070371; C:GO:0005615; P:GO:2000008; C:GO:0016020; C:GO:0016021; P:GO:0010800	P:positive regulation of MAP kinase activity; P:peptidyl-tyrosine phosphorylation; P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; F:Wnt-activated receptor activity; F:growth factor activity; P:regulation of calcium ion import; P:epidermal growth factor receptor signaling pathway; P:positive regulation of cell proliferation; F:epidermal growth factor receptor binding; P:Wnt signaling pathway involved in dorsal/ventral axis specification; P:branching morphogenesis of an epithelial tube; P:positive regulation of DNA binding; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of mitotic nuclear division; P:negative regulation of cholesterol efflux; P:negative regulation of secretion; P:regulation of peptidyl-tyrosine phosphorylation; P:activation of MAPK activity; P:activation of MAPKK activity; C:extracellular exosome; P:mammary gland alveolus development; P:angiogenesis; P:positive regulation of transcription, DNA-templated; F:calcium ion binding; P:canonical Wnt signaling pathway; F:Wnt-protein binding; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of catenin import into nucleus; P:positive regulation of phosphorylation; P:STAT protein import into nucleus; P:positive regulation of cerebellar granule cell precursor proliferation; C:receptor complex; P:positive regulation of hyaluronan biosynthetic process; C:plasma membrane; C:intracellular; C:lysosomal membrane; P:ERK1 and ERK2 cascade; C:extracellular space; P:regulation of protein localization to cell surface; C:membrane; C:integral component of membrane; P:positive regulation of peptidyl-threonine phosphorylation		
tr|F7C0D9|F7C0D9_HORSE	kininogen-1 isoform X1	645	20	0E0	84.05%	13	P:GO:0007162; P:GO:0030195; P:GO:0045861; F:GO:0005102; P:GO:0007204; F:GO:0030414; C:GO:0005615; C:GO:0070062; F:GO:0004869; C:GO:0072562; C:GO:0005829; P:GO:0010951; P:GO:0010466	P:negative regulation of cell adhesion; P:negative regulation of blood coagulation; P:negative regulation of proteolysis; F:receptor binding; P:positive regulation of cytosolic calcium ion concentration; F:peptidase inhibitor activity; C:extracellular space; C:extracellular exosome; F:cysteine-type endopeptidase inhibitor activity; C:blood microparticle; C:cytosol; P:negative regulation of endopeptidase activity; P:negative regulation of peptidase activity		
tr|F7D917|F7D917_HORSE	6-phosphogluconate decarboxylating	483	20	0E0	97.95%	11	C:GO:0005634; P:GO:0009051; C:GO:0070062; F:GO:0004616; C:GO:0005737; F:GO:0016491; P:GO:0006098; P:GO:0019322; C:GO:0005829; P:GO:0055114; P:GO:0019521	C:nucleus; P:pentose-phosphate shunt, oxidative branch; C:extracellular exosome; F:phosphogluconate dehydrogenase (decarboxylating) activity; C:cytoplasm; F:oxidoreductase activity; P:pentose-phosphate shunt; P:pentose biosynthetic process; C:cytosol; P:oxidation-reduction process; P:D-gluconate metabolic process		
tr|F6X1I8|F6X1I8_HORSE	hemopexin	462	20	0E0	89.1%	18	P:GO:0060332; F:GO:0015232; P:GO:0042168; C:GO:0005576; P:GO:0006810; P:GO:0042511; P:GO:0060335; P:GO:0020027; P:GO:0006879; P:GO:0051246; C:GO:0005623; C:GO:0005615; C:GO:0070062; F:GO:0046872; C:GO:0072562; P:GO:0002925; P:GO:0002639; P:GO:0015886	P:positive regulation of response to interferon-gamma; F:heme transporter activity; P:heme metabolic process; C:extracellular region; P:transport; P:positive regulation of tyrosine phosphorylation of Stat1 protein; P:positive regulation of interferon-gamma-mediated signaling pathway; P:hemoglobin metabolic process; P:cellular iron ion homeostasis; P:regulation of protein metabolic process; C:cell; C:extracellular space; C:extracellular exosome; F:metal ion binding; C:blood microparticle; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; P:positive regulation of immunoglobulin production; P:heme transport		
tr|F6QXN5|F6QXN5_HORSE	transgelin-2	204	20	1.39E-146	97.9%	4	P:GO:0030855; F:GO:0005515; C:GO:0070062; C:GO:0031982	P:epithelial cell differentiation; F:protein binding; C:extracellular exosome; C:vesicle		
tr|F6WA57|F6WA57_HORSE	plastin-2	628	20	0E0	99.05%	26	P:GO:0002286; C:GO:0001891; C:GO:0002102; C:GO:0070062; C:GO:0005925; F:GO:0005509; F:GO:0051020; P:GO:0010737; C:GO:0001725; C:GO:0001726; C:GO:0015629; C:GO:0005829; P:GO:0033157; P:GO:0016477; F:GO:0042802; P:GO:0022617; C:GO:0005884; C:GO:0005886; F:GO:0051015; C:GO:0005615; F:GO:0003779; C:GO:0005737; C:GO:0032432; C:GO:0030175; P:GO:0071803; P:GO:0051017	P:T cell activation involved in immune response; C:phagocytic cup; C:podosome; C:extracellular exosome; C:focal adhesion; F:calcium ion binding; F:GTPase binding; P:protein kinase A signaling; C:stress fiber; C:ruffle; C:actin cytoskeleton; C:cytosol; P:regulation of intracellular protein transport; P:cell migration; F:identical protein binding; P:extracellular matrix disassembly; C:actin filament; C:plasma membrane; F:actin filament binding; C:extracellular space; F:actin binding; C:cytoplasm; C:actin filament bundle; C:filopodium; P:positive regulation of podosome assembly; P:actin filament bundle assembly		
tr|F7D1R1|F7D1R1_HORSE	phosphoglycerate kinase 1	396	20	0E0	98.95%	16	P:GO:0006094; P:GO:0006096; P:GO:0061621; F:GO:0000166; P:GO:0030855; F:GO:0005524; F:GO:0005515; C:GO:0070062; C:GO:0005737; F:GO:0004618; C:GO:0045121; C:GO:0016020; C:GO:0005829; P:GO:0016310; F:GO:0016740; F:GO:0016301	P:gluconeogenesis; P:glycolytic process; P:canonical glycolysis; F:nucleotide binding; P:epithelial cell differentiation; F:ATP binding; F:protein binding; C:extracellular exosome; C:cytoplasm; F:phosphoglycerate kinase activity; C:membrane raft; C:membrane; C:cytosol; P:phosphorylation; F:transferase activity; F:kinase activity		
sp|P00559|PGK1_HORSE	phosphoglycerate kinase 1	417	20	0E0	98.25%	16	P:GO:0006094; P:GO:0006096; P:GO:0061621; F:GO:0000166; P:GO:0030855; F:GO:0005524; F:GO:0005515; C:GO:0070062; C:GO:0005737; F:GO:0004618; C:GO:0045121; C:GO:0016020; C:GO:0005829; P:GO:0016310; F:GO:0016740; F:GO:0016301	P:gluconeogenesis; P:glycolytic process; P:canonical glycolysis; F:nucleotide binding; P:epithelial cell differentiation; F:ATP binding; F:protein binding; C:extracellular exosome; C:cytoplasm; F:phosphoglycerate kinase activity; C:membrane raft; C:membrane; C:cytosol; P:phosphorylation; F:transferase activity; F:kinase activity		
tr|F6WIP4|F6WIP4_HORSE	major allergen Can f 1-like	176	20	3.18E-127	79.9%	5	P:GO:0001895; C:GO:0005615; C:GO:0070062; C:GO:0005576; P:GO:0006810	P:retina homeostasis; C:extracellular space; C:extracellular exosome; C:extracellular region; P:transport		
tr|F6SX98|F6SX98_HORSE	Fructose-bisphosphate aldolase A	381	20	0E0	96.95%	34	P:GO:0008360; F:GO:0015631; P:GO:0046716; F:GO:0016829; P:GO:0007015; P:GO:0006000; C:GO:0005576; P:GO:0006941; P:GO:0002576; F:GO:0070061; C:GO:0070062; P:GO:0051289; F:GO:0003824; C:GO:0015629; C:GO:0005829; C:GO:0031674; C:GO:0031430; P:GO:0030388; C:GO:0031093; P:GO:0006094; F:GO:0042802; P:GO:0006096; P:GO:0006754; P:GO:0061621; F:GO:0004332; F:GO:0044822; C:GO:0005634; C:GO:0005615; F:GO:0005515; F:GO:0003779; C:GO:0005737; C:GO:0016020; C:GO:0016021; F:GO:0008092	P:regulation of cell shape; F:tubulin binding; P:muscle cell cellular homeostasis; F:lyase activity; P:actin filament organization; P:fructose metabolic process; C:extracellular region; P:striated muscle contraction; P:platelet degranulation; F:fructose binding; C:extracellular exosome; P:protein homotetramerization; F:catalytic activity; C:actin cytoskeleton; C:cytosol; C:I band; C:M band; P:fructose 1,6-bisphosphate metabolic process; C:platelet alpha granule lumen; P:gluconeogenesis; F:identical protein binding; P:glycolytic process; P:ATP biosynthetic process; P:canonical glycolysis; F:fructose-bisphosphate aldolase activity; F:poly(A) RNA binding; C:nucleus; C:extracellular space; F:protein binding; F:actin binding; C:cytoplasm; C:membrane; C:integral component of membrane; F:cytoskeletal protein binding		
tr|F6R1X9|F6R1X9_HORSE	alpha cardiac muscle 1	377	20	0E0	99.75%	37	F:GO:0016887; P:GO:0060047; P:GO:0090131; P:GO:0060048; F:GO:0000166; F:GO:0005524; P:GO:0045471; C:GO:0070062; C:GO:0005925; C:GO:0072562; P:GO:0006915; F:GO:0017022; C:GO:0005829; P:GO:0055003; C:GO:0031674; P:GO:0030048; P:GO:0055008; P:GO:0030049; C:GO:0030027; P:GO:0031032; P:GO:0033275; P:GO:0030240; P:GO:0035050; C:GO:0005884; C:GO:0042643; C:GO:0005615; C:GO:0005856; F:GO:0005515; C:GO:0005737; P:GO:0042493; P:GO:0043066; P:GO:0070252; P:GO:0010628; C:GO:0044297; C:GO:0016020; C:GO:0030175; C:GO:0030017	F:ATPase activity; P:heart contraction; P:mesenchyme migration; P:cardiac muscle contraction; F:nucleotide binding; F:ATP binding; P:response to ethanol; C:extracellular exosome; C:focal adhesion; C:blood microparticle; P:apoptotic process; F:myosin binding; C:cytosol; P:cardiac myofibril assembly; C:I band; P:actin filament-based movement; P:cardiac muscle tissue morphogenesis; P:muscle filament sliding; C:lamellipodium; P:actomyosin structure organization; P:actin-myosin filament sliding; P:skeletal muscle thin filament assembly; P:embryonic heart tube development; C:actin filament; C:actomyosin, actin portion; C:extracellular space; C:cytoskeleton; F:protein binding; C:cytoplasm; P:response to drug; P:negative regulation of apoptotic process; P:actin-mediated cell contraction; P:positive regulation of gene expression; C:cell body; C:membrane; C:filopodium; C:sarcomere		
tr|F7CW82|F7CW82_HORSE	aortic smooth muscle	377	20	0E0	99.55%	29	P:GO:0090131; P:GO:0009615; F:GO:0000166; F:GO:0005524; C:GO:0005865; C:GO:0070062; P:GO:0048741; P:GO:0006936; P:GO:0072144; C:GO:0001725; C:GO:0015629; C:GO:0032982; C:GO:0005829; C:GO:0030485; C:GO:0030027; F:GO:0019901; P:GO:0030240; F:GO:0005200; C:GO:0043234; C:GO:0005884; P:GO:0008217; C:GO:0005615; C:GO:0005856; F:GO:0005515; C:GO:0005737; P:GO:0014829; P:GO:0010628; C:GO:0044297; C:GO:0030175	P:mesenchyme migration; P:response to virus; F:nucleotide binding; F:ATP binding; C:striated muscle thin filament; C:extracellular exosome; P:skeletal muscle fiber development; P:muscle contraction; P:glomerular mesangial cell development; C:stress fiber; C:actin cytoskeleton; C:myosin filament; C:cytosol; C:smooth muscle contractile fiber; C:lamellipodium; F:protein kinase binding; P:skeletal muscle thin filament assembly; F:structural constituent of cytoskeleton; C:protein complex; C:actin filament; P:regulation of blood pressure; C:extracellular space; C:cytoskeleton; F:protein binding; C:cytoplasm; P:vascular smooth muscle contraction; P:positive regulation of gene expression; C:cell body; C:filopodium		
tr|F6Z8K0|F6Z8K0_HORSE	gamma-enteric smooth muscle	376	20	0E0	99.8%	23	P:GO:0030240; P:GO:0090131; C:GO:0005884; F:GO:0000166; F:GO:0005524; C:GO:0005865; C:GO:0005615; C:GO:0005856; C:GO:0070062; C:GO:0005737; P:GO:0048741; P:GO:0006936; P:GO:0010628; C:GO:0072562; C:GO:0044297; C:GO:0001725; C:GO:0015629; C:GO:0032982; C:GO:0005829; C:GO:0030175; C:GO:0030017; C:GO:0030027; C:GO:0071944	P:skeletal muscle thin filament assembly; P:mesenchyme migration; C:actin filament; F:nucleotide binding; F:ATP binding; C:striated muscle thin filament; C:extracellular space; C:cytoskeleton; C:extracellular exosome; C:cytoplasm; P:skeletal muscle fiber development; P:muscle contraction; P:positive regulation of gene expression; C:blood microparticle; C:cell body; C:stress fiber; C:actin cytoskeleton; C:myosin filament; C:cytosol; C:filopodium; C:sarcomere; C:lamellipodium; C:cell periphery		
sp|P38029|A1AT2_HORSE	alpha-1-antitrypsin	421	20	0E0	96%	13	F:GO:0042802; F:GO:0002020; C:GO:0005794; C:GO:0005783; C:GO:0005576; P:GO:0006953; F:GO:0030414; C:GO:0005615; F:GO:0004867; C:GO:0070062; P:GO:0010951; F:GO:0001948; P:GO:0010466	F:identical protein binding; F:protease binding; C:Golgi apparatus; C:endoplasmic reticulum; C:extracellular region; P:acute-phase response; F:peptidase inhibitor activity; C:extracellular space; F:serine-type endopeptidase inhibitor activity; C:extracellular exosome; P:negative regulation of endopeptidase activity; F:glycoprotein binding; P:negative regulation of peptidase activity		
tr|F7DW69|F7DW69_HORSE	heat shock 70 kDa 1B-like	642	20	0E0	99.25%	11	F:GO:0000166; F:GO:0005524; P:GO:0009408; P:GO:0007339; C:GO:0005737; P:GO:0043066; P:GO:0043154; C:GO:0044297; C:GO:0005739; C:GO:0002199; C:GO:0005622	F:nucleotide binding; F:ATP binding; P:response to heat; P:binding of sperm to zona pellucida; C:cytoplasm; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; C:cell body; C:mitochondrion; C:zona pellucida receptor complex; C:intracellular		
sp|Q9GKX8|HS90B_HORSE	heat shock HSP 90-beta	724	20	0E0	99.2%	72	P:GO:0032092; F:GO:0008144; F:GO:0003725; P:GO:0050790; F:GO:0032564; C:GO:0005829; F:GO:0001948; P:GO:0031396; C:GO:0008180; F:GO:0019887; F:GO:0019901; P:GO:0061684; P:GO:0010033; P:GO:0045859; F:GO:0042826; P:GO:0006457; F:GO:0044325; F:GO:0002134; C:GO:0005765; F:GO:0002135; F:GO:0005515; P:GO:0032516; C:GO:0005913; C:GO:0042470; F:GO:0017098; C:GO:0016323; P:GO:0071407; C:GO:0016324; P:GO:0032435; P:GO:1903660; P:GO:0033160; P:GO:0045429; P:GO:0009651; P:GO:1900034; P:GO:0038096; P:GO:0001890; P:GO:0006986; P:GO:0043524; P:GO:0061635; C:GO:0005654; F:GO:0005525; F:GO:0000166; F:GO:0005524; P:GO:0019062; C:GO:0070062; P:GO:0045793; P:GO:0071353; P:GO:0033554; C:GO:0016234; F:GO:0019900; P:GO:0061741; P:GO:0060338; F:GO:0051082; P:GO:0060334; F:GO:0023026; P:GO:0006950; C:GO:0005622; C:GO:0009986; F:GO:0044822; F:GO:0098641; F:GO:0030911; C:GO:0031526; C:GO:0005737; P:GO:0043066; C:GO:0016020; P:GO:0097435; C:GO:0005739; C:GO:1990913; F:GO:0030235; P:GO:0050821; P:GO:0071902; C:GO:1990917	P:positive regulation of protein binding; F:drug binding; F:double-stranded RNA binding; P:regulation of catalytic activity; F:dATP binding; C:cytosol; F:glycoprotein binding; P:regulation of protein ubiquitination; C:COP9 signalosome; F:protein kinase regulator activity; F:protein kinase binding; P:chaperone-mediated autophagy; P:response to organic substance; P:regulation of protein kinase activity; F:histone deacetylase binding; P:protein folding; F:ion channel binding; F:UTP binding; C:lysosomal membrane; F:CTP binding; F:protein binding; P:positive regulation of phosphoprotein phosphatase activity; C:cell-cell adherens junction; C:melanosome; F:sulfonylurea receptor binding; C:basolateral plasma membrane; P:cellular response to organic cyclic compound; C:apical plasma membrane; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of complement-dependent cytotoxicity; P:positive regulation of protein import into nucleus, translocation; P:positive regulation of nitric oxide biosynthetic process; P:response to salt stress; P:regulation of cellular response to heat; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:placenta development; P:response to unfolded protein; P:negative regulation of neuron apoptotic process; P:regulation of protein complex stability; C:nucleoplasm; F:GTP binding; F:nucleotide binding; F:ATP binding; P:virion attachment to host cell; C:extracellular exosome; P:positive regulation of cell size; P:cellular response to interleukin-4; P:cellular response to stress; C:inclusion body; F:kinase binding; P:chaperone-mediated protein transport involved in chaperone-mediated autophagy; P:regulation of type I interferon-mediated signaling pathway; F:unfolded protein binding; P:regulation of interferon-gamma-mediated signaling pathway; F:MHC class II protein complex binding; P:response to stress; C:intracellular; C:cell surface; F:poly(A) RNA binding; F:cadherin binding involved in cell-cell adhesion; F:TPR domain binding; C:brush border membrane; C:cytoplasm; P:negative regulation of apoptotic process; C:membrane; P:fibril organization; C:mitochondrion; C:sperm head plasma membrane; F:nitric-oxide synthase regulator activity; P:protein stabilization; P:positive regulation of protein serine/threonine kinase activity; C:ooplasm		
tr|F7AGA5|F7AGA5_HORSE	plastin-3	630	20	0E0	99.6%	7	F:GO:0003779; P:GO:0042491; C:GO:0005737; F:GO:0046872; F:GO:0005509; C:GO:0032420; P:GO:0060348	F:actin binding; P:auditory receptor cell differentiation; C:cytoplasm; F:metal ion binding; F:calcium ion binding; C:stereocilium; P:bone development		
tr|F6S6J4|F6S6J4_HORSE	peroxiredoxin-1	199	20	1.71E-145	99.9%	29	P:GO:0008283; C:GO:0043209; F:GO:0016209; P:GO:0006979; C:GO:0070062; P:GO:0001501; F:GO:0016491; C:GO:0005829; F:GO:0051920; F:GO:0042802; P:GO:0034101; F:GO:0008379; P:GO:0042267; P:GO:0042345; P:GO:0000302; F:GO:0044822; P:GO:0042744; F:GO:0004601; P:GO:0001895; C:GO:0005634; C:GO:0005615; F:GO:0005515; C:GO:0042470; C:GO:0005737; P:GO:0019430; C:GO:0005739; P:GO:0098869; P:GO:0032872; P:GO:0055114	P:cell proliferation; C:myelin sheath; F:antioxidant activity; P:response to oxidative stress; C:extracellular exosome; P:skeletal system development; F:oxidoreductase activity; C:cytosol; F:peroxiredoxin activity; F:identical protein binding; P:erythrocyte homeostasis; F:thioredoxin peroxidase activity; P:natural killer cell mediated cytotoxicity; P:regulation of NF-kappaB import into nucleus; P:response to reactive oxygen species; F:poly(A) RNA binding; P:hydrogen peroxide catabolic process; F:peroxidase activity; P:retina homeostasis; C:nucleus; C:extracellular space; F:protein binding; C:melanosome; C:cytoplasm; P:removal of superoxide radicals; C:mitochondrion; P:cellular oxidant detoxification; P:regulation of stress-activated MAPK cascade; P:oxidation-reduction process		
tr|F7C450|F7C450_HORSE	alpha-2-HS-glyco	358	20	0E0	83.45%	13	P:GO:0006953; P:GO:0030502; C:GO:0005615; F:GO:0004866; C:GO:0070062; F:GO:0004869; P:GO:0001503; C:GO:0072562; P:GO:0050727; P:GO:0010951; P:GO:0070168; C:GO:0031012; P:GO:0050766	P:acute-phase response; P:negative regulation of bone mineralization; C:extracellular space; F:endopeptidase inhibitor activity; C:extracellular exosome; F:cysteine-type endopeptidase inhibitor activity; P:ossification; C:blood microparticle; P:regulation of inflammatory response; P:negative regulation of endopeptidase activity; P:negative regulation of biomineral tissue development; C:extracellular matrix; P:positive regulation of phagocytosis		
tr|F6RVM2|F6RVM2_HORSE	cornulin isoform X1	596	20	0E0	76.35%	6	P:GO:0016337; P:GO:0009408; C:GO:0070062; F:GO:0046872; F:GO:0005509; C:GO:0016020	P:single organismal cell-cell adhesion; P:response to heat; C:extracellular exosome; F:metal ion binding; F:calcium ion binding; C:membrane		
tr|F7BTD2|F7BTD2_HORSE	serpin B3-like	378	20	0E0	88%	3	F:GO:0004867; C:GO:0005615; P:GO:0010951	F:serine-type endopeptidase inhibitor activity; C:extracellular space; P:negative regulation of endopeptidase activity		
tr|F7C6T2|F7C6T2_HORSE	adenosylhomocysteinase	431	20	0E0	93.35%	8	C:GO:0070062; P:GO:0033353; C:GO:0005737; C:GO:0042470; C:GO:0005829; F:GO:0004013; P:GO:0006730; F:GO:0016787	C:extracellular exosome; P:S-adenosylmethionine cycle; C:cytoplasm; C:melanosome; C:cytosol; F:adenosylhomocysteinase activity; P:one-carbon metabolic process; F:hydrolase activity		
tr|F6VIG9|F6VIG9_HORSE	adenosylhomocysteinase	432	20	0E0	98.4%	8	C:GO:0070062; P:GO:0033353; C:GO:0005737; C:GO:0042470; C:GO:0005829; F:GO:0004013; P:GO:0006730; F:GO:0016787	C:extracellular exosome; P:S-adenosylmethionine cycle; C:cytoplasm; C:melanosome; C:cytosol; F:adenosylhomocysteinase activity; P:one-carbon metabolic process; F:hydrolase activity		
tr|F6ZXQ2|F6ZXQ2_HORSE	type I cytoskeletal 19	394	20	0E0	94.55%	14	P:GO:0043627; F:GO:0005198; P:GO:0045214; C:GO:0043034; C:GO:0005882; C:GO:0005886; C:GO:0030018; P:GO:0007219; C:GO:0070062; F:GO:0008307; C:GO:1990357; P:GO:0060706; C:GO:0042383; C:GO:0071944	P:response to estrogen; F:structural molecule activity; P:sarcomere organization; C:costamere; C:intermediate filament; C:plasma membrane; C:Z disc; P:Notch signaling pathway; C:extracellular exosome; F:structural constituent of muscle; C:terminal web; P:cell differentiation involved in embryonic placenta development; C:sarcolemma; C:cell periphery		
tr|F6YU15|F6YU15_HORSE	sweat gland latherin partial	228	20	2.59E-155	77.95%	4	P:GO:0001659; P:GO:0050828; F:GO:0008289; C:GO:0005576	P:temperature homeostasis; P:regulation of liquid surface tension; F:lipid binding; C:extracellular region		
tr|F6TIR2|F6TIR2_HORSE	neutrophil gelatinase-associated lipocalin	199	20	3.99E-147	90.2%	12	C:GO:0005623; C:GO:0005615; C:GO:0070062; F:GO:0005506; P:GO:0015891; P:GO:0045087; F:GO:0036094; P:GO:0097192; C:GO:0005576; P:GO:0009615; P:GO:0006810; F:GO:0005215	C:cell; C:extracellular space; C:extracellular exosome; F:iron ion binding; P:siderophore transport; P:innate immune response; F:small molecule binding; P:extrinsic apoptotic signaling pathway in absence of ligand; C:extracellular region; P:response to virus; P:transport; F:transporter activity		
tr|F7E0H3|F7E0H3_HORSE	tubulin beta chain	444	20	0E0	99.3%	31	F:GO:0005198; C:GO:0005576; C:GO:0005874; P:GO:0007017; F:GO:0005525; P:GO:0051301; F:GO:0000166; P:GO:0051225; C:GO:0070062; P:GO:0000086; P:GO:0030705; C:GO:0045298; F:GO:0003924; C:GO:0031012; F:GO:0032403; C:GO:0036464; F:GO:0019904; F:GO:0005200; F:GO:0042288; C:GO:0043234; P:GO:0042267; C:GO:0005641; P:GO:0009987; C:GO:0005634; F:GO:0005515; C:GO:0005856; F:GO:0031625; C:GO:0005737; P:GO:0006928; C:GO:0044297; F:GO:0032794	F:structural molecule activity; C:extracellular region; C:microtubule; P:microtubule-based process; F:GTP binding; P:cell division; F:nucleotide binding; P:spindle assembly; C:extracellular exosome; P:G2/M transition of mitotic cell cycle; P:cytoskeleton-dependent intracellular transport; C:tubulin complex; F:GTPase activity; C:extracellular matrix; F:protein complex binding; C:cytoplasmic ribonucleoprotein granule; F:protein domain specific binding; F:structural constituent of cytoskeleton; F:MHC class I protein binding; C:protein complex; P:natural killer cell mediated cytotoxicity; C:nuclear envelope lumen; P:cellular process; C:nucleus; F:protein binding; C:cytoskeleton; F:ubiquitin protein ligase binding; C:cytoplasm; P:movement of cell or subcellular component; C:cell body; F:GTPase activating protein binding		
tr|F6W3T1|F6W3T1_HORSE	L-lactate dehydrogenase A chain	336	20	0E0	98.55%	12	P:GO:0005975; C:GO:0005634; F:GO:0004459; C:GO:0070062; F:GO:0016616; C:GO:0005737; F:GO:0016491; F:GO:0003824; C:GO:0016020; P:GO:0055114; P:GO:0019752; P:GO:0021762	P:carbohydrate metabolic process; C:nucleus; F:L-lactate dehydrogenase activity; C:extracellular exosome; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; C:cytoplasm; F:oxidoreductase activity; F:catalytic activity; C:membrane; P:oxidation-reduction process; P:carboxylic acid metabolic process; P:substantia nigra development		
tr|F6V6R7|F6V6R7_HORSE	prolactin-inducible	146	20	6.09E-104	84.6%	15	F:GO:0004190; F:GO:0046983; P:GO:0001580; P:GO:0002682; C:GO:0005576; P:GO:0001895; C:GO:0005634; C:GO:0005615; C:GO:0070062; P:GO:0070233; P:GO:0010628; P:GO:0006508; F:GO:0001948; F:GO:0019864; C:GO:0016324	F:aspartic-type endopeptidase activity; F:protein dimerization activity; P:detection of chemical stimulus involved in sensory perception of bitter taste; P:regulation of immune system process; C:extracellular region; P:retina homeostasis; C:nucleus; C:extracellular space; C:extracellular exosome; P:negative regulation of T cell apoptotic process; P:positive regulation of gene expression; P:proteolysis; F:glycoprotein binding; F:IgG binding; C:apical plasma membrane		
tr|F7E3Y7|F7E3Y7_HORSE	heat shock beta-1	209	20	2.52E-150	93.2%	46	P:GO:0038033; P:GO:1903202; P:GO:1902176; P:GO:0043122; C:GO:0045202; C:GO:0043204; P:GO:0009615; P:GO:0006469; P:GO:0006986; F:GO:0008426; P:GO:0045766; P:GO:0042535; C:GO:0030425; C:GO:0070062; C:GO:0043292; C:GO:0005925; F:GO:0043130; P:GO:2001028; C:GO:0031674; P:GO:0010976; C:GO:0031012; C:GO:0031430; P:GO:0070527; P:GO:0035556; C:GO:0030424; C:GO:0098839; F:GO:0005080; F:GO:0019901; F:GO:0042802; C:GO:0000502; C:GO:0005886; C:GO:0005622; P:GO:0043536; F:GO:0044822; P:GO:0001895; C:GO:0030018; C:GO:0005634; C:GO:0005615; C:GO:0005856; C:GO:0005737; C:GO:0097512; C:GO:0005819; P:GO:0035924; P:GO:0071901; P:GO:0032731; P:GO:2001234	P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; P:negative regulation of oxidative stress-induced cell death; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:regulation of I-kappaB kinase/NF-kappaB signaling; C:synapse; C:perikaryon; P:response to virus; P:negative regulation of protein kinase activity; P:response to unfolded protein; F:protein kinase C inhibitor activity; P:positive regulation of angiogenesis; P:positive regulation of tumor necrosis factor biosynthetic process; C:dendrite; C:extracellular exosome; C:contractile fiber; C:focal adhesion; F:ubiquitin binding; P:positive regulation of endothelial cell chemotaxis; C:I band; P:positive regulation of neuron projection development; C:extracellular matrix; C:M band; P:platelet aggregation; P:intracellular signal transduction; C:axon; C:postsynaptic density membrane; F:protein kinase C binding; F:protein kinase binding; F:identical protein binding; C:proteasome complex; C:plasma membrane; C:intracellular; P:positive regulation of blood vessel endothelial cell migration; F:poly(A) RNA binding; P:retina homeostasis; C:Z disc; C:nucleus; C:extracellular space; C:cytoskeleton; C:cytoplasm; C:cardiac myofibril; C:spindle; P:cellular response to vascular endothelial growth factor stimulus; P:negative regulation of protein serine/threonine kinase activity; P:positive regulation of interleukin-1 beta production; P:negative regulation of apoptotic signaling pathway		
tr|F7BV85|F7BV85_HORSE	clathrin heavy chain 1 isoform X2	1685	20	0E0	99.3%	54	C:GO:1903561; F:GO:0032051; F:GO:0008022; F:GO:0005198; F:GO:0004386; P:GO:0006886; C:GO:0030669; F:GO:0030506; F:GO:0003725; C:GO:0043195; C:GO:0005905; C:GO:0042383; C:GO:0043231; C:GO:0005829; P:GO:0019886; F:GO:0031072; F:GO:0019901; P:GO:0033572; P:GO:0007067; C:GO:0043234; P:GO:0042147; P:GO:0006898; C:GO:0005886; C:GO:0030659; F:GO:0005515; C:GO:0042470; C:GO:0030132; C:GO:0030136; P:GO:0031623; P:GO:0090307; C:GO:0043209; C:GO:0030130; P:GO:0007030; F:GO:0042277; P:GO:0016192; C:GO:0070062; C:GO:0005925; P:GO:0001649; C:GO:0031410; P:GO:0060071; C:GO:0031012; C:GO:0071439; C:GO:0032588; P:GO:1903077; C:GO:0036020; P:GO:1900126; F:GO:0044822; C:GO:0030118; C:GO:0030117; C:GO:0030315; C:GO:0016020; C:GO:0005739; C:GO:0005819; C:GO:0031523	C:extracellular vesicle; F:clathrin light chain binding; F:protein C-terminus binding; F:structural molecule activity; F:helicase activity; P:intracellular protein transport; C:clathrin-coated endocytic vesicle membrane; F:ankyrin binding; F:double-stranded RNA binding; C:terminal bouton; C:clathrin-coated pit; C:sarcolemma; C:intracellular membrane-bounded organelle; C:cytosol; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; F:heat shock protein binding; F:protein kinase binding; P:transferrin transport; P:mitotic nuclear division; C:protein complex; P:retrograde transport, endosome to Golgi; P:receptor-mediated endocytosis; C:plasma membrane; C:cytoplasmic vesicle membrane; F:protein binding; C:melanosome; C:clathrin coat of coated pit; C:clathrin-coated vesicle; P:receptor internalization; P:mitotic spindle assembly; C:myelin sheath; C:clathrin coat of trans-Golgi network vesicle; P:Golgi organization; F:peptide binding; P:vesicle-mediated transport; C:extracellular exosome; C:focal adhesion; P:osteoblast differentiation; C:cytoplasmic vesicle; P:Wnt signaling pathway, planar cell polarity pathway; C:extracellular matrix; C:clathrin complex; C:trans-Golgi network membrane; P:negative regulation of protein localization to plasma membrane; C:endolysosome membrane; P:negative regulation of hyaluronan biosynthetic process; F:poly(A) RNA binding; C:clathrin coat; C:membrane coat; C:T-tubule; C:membrane; C:mitochondrion; C:spindle; C:Myb complex		
tr|F6YV40|F6YV40_HORSE	glyceraldehyde-3-phosphate dehydrogenase	333	20	0E0	99.05%	35	C:GO:0015630; P:GO:0006006; F:GO:0004365; P:GO:0006417; C:GO:0070062; C:GO:0030529; F:GO:0051287; F:GO:0016491; C:GO:0043231; P:GO:0006915; C:GO:0005829; P:GO:0017148; P:GO:0051402; F:GO:0042802; P:GO:0006096; P:GO:0000226; C:GO:0005886; F:GO:0008017; C:GO:0097452; C:GO:0005811; C:GO:0005634; F:GO:0050661; C:GO:0031965; C:GO:0005856; F:GO:0005515; P:GO:0035606; C:GO:0005737; C:GO:0016020; C:GO:0031982; P:GO:0055114; F:GO:0035605; P:GO:0071346; F:GO:0016740; P:GO:0050821; F:GO:0016620	C:microtubule cytoskeleton; P:glucose metabolic process; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity; P:regulation of translation; C:extracellular exosome; C:intracellular ribonucleoprotein complex; F:NAD binding; F:oxidoreductase activity; C:intracellular membrane-bounded organelle; P:apoptotic process; C:cytosol; P:negative regulation of translation; P:neuron apoptotic process; F:identical protein binding; P:glycolytic process; P:microtubule cytoskeleton organization; C:plasma membrane; F:microtubule binding; C:GAIT complex; C:lipid particle; C:nucleus; F:NADP binding; C:nuclear membrane; C:cytoskeleton; F:protein binding; P:peptidyl-cysteine S-trans-nitrosylation; C:cytoplasm; C:membrane; C:vesicle; P:oxidation-reduction process; F:peptidyl-cysteine S-nitrosylase activity; P:cellular response to interferon-gamma; F:transferase activity; P:protein stabilization; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor		
tr|F6UUS3|F6UUS3_HORSE	elongation factor 2	856	20	0E0	99%	42	P:GO:0045727; P:GO:0002244; F:GO:0005525; C:GO:0005844; F:GO:0000166; P:GO:0045471; F:GO:0002039; C:GO:0070062; F:GO:0003723; P:GO:0002931; F:GO:0003746; P:GO:0003009; C:GO:0030529; P:GO:0035914; P:GO:0017183; F:GO:0003924; C:GO:0005829; C:GO:0016235; F:GO:0019901; P:GO:0014076; F:GO:0008097; P:GO:0042542; P:GO:0007568; P:GO:0006414; C:GO:0005886; C:GO:0005622; P:GO:0006412; F:GO:0044822; C:GO:0042788; F:GO:0051015; C:GO:0005634; F:GO:0005515; P:GO:2000767; C:GO:0005737; F:GO:0043022; C:GO:0045121; C:GO:0016020; P:GO:0051593; P:GO:1990416; P:GO:0032355; P:GO:0014009; P:GO:0034976	P:positive regulation of translation; P:hematopoietic progenitor cell differentiation; F:GTP binding; C:polysome; F:nucleotide binding; P:response to ethanol; F:p53 binding; C:extracellular exosome; F:RNA binding; P:response to ischemia; F:translation elongation factor activity; P:skeletal muscle contraction; C:intracellular ribonucleoprotein complex; P:skeletal muscle cell differentiation; P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine; F:GTPase activity; C:cytosol; C:aggresome; F:protein kinase binding; P:response to fluoxetine; F:5S rRNA binding; P:response to hydrogen peroxide; P:aging; P:translational elongation; C:plasma membrane; C:intracellular; P:translation; F:poly(A) RNA binding; C:polysomal ribosome; F:actin filament binding; C:nucleus; F:protein binding; P:positive regulation of cytoplasmic translation; C:cytoplasm; F:ribosome binding; C:membrane raft; C:membrane; P:response to folic acid; P:cellular response to brain-derived neurotrophic factor stimulus; P:response to estradiol; P:glial cell proliferation; P:response to endoplasmic reticulum stress		
tr|F6Z129|F6Z129_HORSE	pantetheinase isoform X1	516	20	0E0	89.15%	15	F:GO:0016810; P:GO:0016337; F:GO:0016811; P:GO:0033089; P:GO:1902176; P:GO:0002544; P:GO:0006954; C:GO:0070062; P:GO:0006807; P:GO:0002526; P:GO:0045087; P:GO:0015939; C:GO:0016020; C:GO:0016021; F:GO:0017159	F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; P:single organismal cell-cell adhesion; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; P:positive regulation of T cell differentiation in thymus; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:chronic inflammatory response; P:inflammatory response; C:extracellular exosome; P:nitrogen compound metabolic process; P:acute inflammatory response; P:innate immune response; P:pantothenate metabolic process; C:membrane; C:integral component of membrane; F:pantetheine hydrolase activity		
tr|F6ZR63|F6ZR63_HORSE	complement factor H	1242	20	0E0	82.85%	12	P:GO:0006956; P:GO:0006957; C:GO:0005615; F:GO:0005515; P:GO:0030449; C:GO:0070062; P:GO:0045087; C:GO:0072562; F:GO:0043395; F:GO:0008201; C:GO:0005576; P:GO:0002376	P:complement activation; P:complement activation, alternative pathway; C:extracellular space; F:protein binding; P:regulation of complement activation; C:extracellular exosome; P:innate immune response; C:blood microparticle; F:heparan sulfate proteoglycan binding; F:heparin binding; C:extracellular region; P:immune system process		
tr|F6Z8W0|F6Z8W0_HORSE	WD repeat-containing 1	601	20	0E0	96.85%	7	C:GO:0043209; C:GO:0070062; P:GO:0030836; C:GO:0005737; P:GO:0045214; P:GO:0060307; P:GO:0030036	C:myelin sheath; C:extracellular exosome; P:positive regulation of actin filament depolymerization; C:cytoplasm; P:sarcomere organization; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:actin cytoskeleton organization		
tr|F6SU04|F6SU04_HORSE	calpain-1 catalytic subunit	713	20	0E0	96.9%	17	P:GO:0060056; F:GO:0008234; F:GO:0008233; F:GO:0004198; C:GO:0005622; C:GO:0005886; C:GO:0005764; P:GO:0032801; C:GO:0070062; C:GO:0005925; C:GO:0005737; F:GO:0005509; C:GO:0005739; C:GO:0016020; P:GO:0006508; C:GO:0005829; F:GO:0016787	P:mammary gland involution; F:cysteine-type peptidase activity; F:peptidase activity; F:calcium-dependent cysteine-type endopeptidase activity; C:intracellular; C:plasma membrane; C:lysosome; P:receptor catabolic process; C:extracellular exosome; C:focal adhesion; C:cytoplasm; F:calcium ion binding; C:mitochondrion; C:membrane; P:proteolysis; C:cytosol; F:hydrolase activity		
tr|F6XEB4|F6XEB4_HORSE	14-3-3 zeta delta	245	20	2.07E-180	99.85%	30	P:GO:0043488; C:GO:0005654; C:GO:0070062; C:GO:0005925; P:GO:0051683; C:GO:0072562; C:GO:0005829; P:GO:0030168; F:GO:0019901; P:GO:0061024; F:GO:0042802; F:GO:0019904; P:GO:0090168; P:GO:0007165; P:GO:1900740; F:GO:0008134; F:GO:0004497; F:GO:0044822; P:GO:0006605; C:GO:0005634; C:GO:0030659; C:GO:0005615; F:GO:0005515; F:GO:0031625; C:GO:0042470; C:GO:0005737; P:GO:0043066; C:GO:0005739; P:GO:0010941; P:GO:0055114	P:regulation of mRNA stability; C:nucleoplasm; C:extracellular exosome; C:focal adhesion; P:establishment of Golgi localization; C:blood microparticle; C:cytosol; P:platelet activation; F:protein kinase binding; P:membrane organization; F:identical protein binding; F:protein domain specific binding; P:Golgi reassembly; P:signal transduction; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; F:transcription factor binding; F:monooxygenase activity; F:poly(A) RNA binding; P:protein targeting; C:nucleus; C:cytoplasmic vesicle membrane; C:extracellular space; F:protein binding; F:ubiquitin protein ligase binding; C:melanosome; C:cytoplasm; P:negative regulation of apoptotic process; C:mitochondrion; P:regulation of cell death; P:oxidation-reduction process		
tr|F6PKE1|F6PKE1_HORSE	inhibitor of carbonic anhydrase-like isoform X2	340	20	0E0	85.9%	4	C:GO:0005615; P:GO:0043086; F:GO:0004857; C:GO:0005576	C:extracellular space; P:negative regulation of catalytic activity; F:enzyme inhibitor activity; C:extracellular region		
tr|F7DXG8|F7DXG8_HORSE	cofilin-1	166	20	1.17E-116	99.45%	46	P:GO:0022604; P:GO:0007010; P:GO:0030030; P:GO:0043200; P:GO:0044794; P:GO:0007015; P:GO:0009615; P:GO:0006468; C:GO:0042995; C:GO:0070062; P:GO:0001842; C:GO:0005925; P:GO:0000281; P:GO:0045792; C:GO:0015629; C:GO:0032587; P:GO:0030043; C:GO:0031012; C:GO:0030864; C:GO:0030027; C:GO:0031258; P:GO:0061001; C:GO:0031252; P:GO:0030042; P:GO:0007266; C:GO:0005886; C:GO:0005622; F:GO:0051015; C:GO:0005634; C:GO:0005615; F:GO:1902936; C:GO:0005856; F:GO:0005515; C:GO:0005911; F:GO:0003779; P:GO:0001755; C:GO:0005737; P:GO:0030836; P:GO:0006928; P:GO:0043066; P:GO:0006606; C:GO:0016020; C:GO:0016363; C:GO:0031982; P:GO:0030010; P:GO:0030036	P:regulation of cell morphogenesis; P:cytoskeleton organization; P:cell projection organization; P:response to amino acid; P:positive regulation by host of viral process; P:actin filament organization; P:response to virus; P:protein phosphorylation; C:cell projection; C:extracellular exosome; P:neural fold formation; C:focal adhesion; P:mitotic cytokinesis; P:negative regulation of cell size; C:actin cytoskeleton; C:ruffle membrane; P:actin filament fragmentation; C:extracellular matrix; C:cortical actin cytoskeleton; C:lamellipodium; C:lamellipodium membrane; P:regulation of dendritic spine morphogenesis; C:cell leading edge; P:actin filament depolymerization; P:Rho protein signal transduction; C:plasma membrane; C:intracellular; F:actin filament binding; C:nucleus; C:extracellular space; F:phosphatidylinositol bisphosphate binding; C:cytoskeleton; F:protein binding; C:cell-cell junction; F:actin binding; P:neural crest cell migration; C:cytoplasm; P:positive regulation of actin filament depolymerization; P:movement of cell or subcellular component; P:negative regulation of apoptotic process; P:protein import into nucleus; C:membrane; C:nuclear matrix; C:vesicle; P:establishment of cell polarity; P:actin cytoskeleton organization		
tr|F7AY97|F7AY97_HORSE	involucrin	276	20	2.57E-169	78.85%	9	P:GO:0030216; C:GO:0001533; C:GO:0070062; C:GO:0005737; F:GO:0005198; P:GO:0018149; P:GO:0031424; F:GO:0030674; P:GO:0010224	P:keratinocyte differentiation; C:cornified envelope; C:extracellular exosome; C:cytoplasm; F:structural molecule activity; P:peptide cross-linking; P:keratinization; F:protein binding, bridging; P:response to UV-B		
tr|F7BPT4|F7BPT4_HORSE	ezrin isoform X1	586	20	0E0	98.15%	100	P:GO:1903364; P:GO:1901222; F:GO:0050839; P:GO:0007411; P:GO:0043622; P:GO:0007016; P:GO:0034629; C:GO:0005903; C:GO:0005902; P:GO:0050714; F:GO:0019904; C:GO:0005884; C:GO:0005886; P:GO:1902966; C:GO:0098592; F:GO:0051015; P:GO:0001951; F:GO:0005515; P:GO:0032956; P:GO:0072697; P:GO:0048015; C:GO:0044297; C:GO:0031982; P:GO:2000643; P:GO:0031623; P:GO:0051017; C:GO:0005730; C:GO:0044853; P:GO:0040018; C:GO:0001772; C:GO:0070062; P:GO:0051660; P:GO:1900041; C:GO:0036064; P:GO:0022612; P:GO:0022614; C:GO:0005622; C:GO:0005615; C:GO:0005856; P:GO:0050860; C:GO:0001931; C:GO:0005737; P:GO:0032532; C:GO:0071944; P:GO:0035088; P:GO:1902115; P:GO:0003376; C:GO:0051286; C:GO:0045177; P:GO:0010737; C:GO:0015629; C:GO:0097449; C:GO:0005829; F:GO:0032403; C:GO:0030863; P:GO:0030855; C:GO:0097454; F:GO:0003779; P:GO:0010628; P:GO:0071320; C:GO:0030175; C:GO:0016323; C:GO:0016324; P:GO:0008360; C:GO:0036398; C:GO:0043209; P:GO:0008361; P:GO:1902896; C:GO:0042995; P:GO:0007159; P:GO:0000122; C:GO:0005768; C:GO:0005925; P:GO:0045198; C:GO:0001726; C:GO:0032587; P:GO:0031532; P:GO:0090004; P:GO:0090002; P:GO:1903753; P:GO:0061028; P:GO:0046847; F:GO:0044548; F:GO:0008017; F:GO:0044822; C:GO:0031528; C:GO:0030315; P:GO:0030953; C:GO:0044393; C:GO:0048471; P:GO:0070373; C:GO:0005938; C:GO:0045121; C:GO:0016020; F:GO:0034237; P:GO:0030033; F:GO:0034236; C:GO:0019898; F:GO:0008092; F:GO:0051117	P:positive regulation of cellular protein catabolic process; P:regulation of NIK/NF-kappaB signaling; F:cell adhesion molecule binding; P:axon guidance; P:cortical microtubule organization; P:cytoskeletal anchoring at plasma membrane; P:cellular protein complex localization; C:brush border; C:microvillus; P:positive regulation of protein secretion; F:protein domain specific binding; C:actin filament; C:plasma membrane; P:positive regulation of protein localization to early endosome; C:cytoplasmic side of apical plasma membrane; F:actin filament binding; P:intestinal D-glucose absorption; F:protein binding; P:regulation of actin cytoskeleton organization; P:protein localization to cell cortex; P:phosphatidylinositol-mediated signaling; C:cell body; C:vesicle; P:positive regulation of early endosome to late endosome transport; P:receptor internalization; P:actin filament bundle assembly; C:nucleolus; C:plasma membrane raft; P:positive regulation of multicellular organism growth; C:immunological synapse; C:extracellular exosome; P:establishment of centrosome localization; P:negative regulation of interleukin-2 secretion; C:ciliary basal body; P:gland morphogenesis; P:membrane to membrane docking; C:intracellular; C:extracellular space; C:cytoskeleton; P:negative regulation of T cell receptor signaling pathway; C:uropod; C:cytoplasm; P:regulation of microvillus length; C:cell periphery; P:establishment or maintenance of apical/basal cell polarity; P:regulation of organelle assembly; P:sphingosine-1-phosphate signaling pathway; C:cell tip; C:apical part of cell; P:protein kinase A signaling; C:actin cytoskeleton; C:astrocyte projection; C:cytosol; F:protein complex binding; C:cortical cytoskeleton; P:epithelial cell differentiation; C:Schwann cell microvillus; F:actin binding; P:positive regulation of gene expression; P:cellular response to cAMP; C:filopodium; C:basolateral plasma membrane; C:apical plasma membrane; P:regulation of cell shape; C:TCR signalosome; C:myelin sheath; P:regulation of cell size; P:terminal web assembly; C:cell projection; P:leukocyte cell-cell adhesion; P:negative regulation of transcription from RNA polymerase II promoter; C:endosome; C:focal adhesion; P:establishment of epithelial cell apical/basal polarity; C:ruffle; C:ruffle membrane; P:actin cytoskeleton reorganization; P:positive regulation of establishment of protein localization to plasma membrane; P:establishment of protein localization to plasma membrane; P:negative regulation of p38MAPK cascade; P:establishment of endothelial barrier; P:filopodium assembly; F:S100 protein binding; F:microtubule binding; F:poly(A) RNA binding; C:microvillus membrane; C:T-tubule; P:astral microtubule organization; C:microspike; C:perinuclear region of cytoplasm; P:negative regulation of ERK1 and ERK2 cascade; C:cell cortex; C:membrane raft; C:membrane; F:protein kinase A regulatory subunit binding; P:microvillus assembly; F:protein kinase A catalytic subunit binding; C:extrinsic component of membrane; F:cytoskeletal protein binding; F:ATPase binding		
tr|F7BPX8|F7BPX8_HORSE	cathepsin L2	334	20	0E0	95.15%	20	F:GO:0016807; F:GO:0004197; P:GO:0046697; F:GO:0008234; F:GO:0008233; C:GO:0005730; C:GO:0005764; P:GO:0010839; C:GO:0005634; C:GO:0005615; C:GO:0070062; F:GO:0042393; P:GO:0006508; P:GO:0031069; C:GO:0031410; P:GO:0016485; P:GO:0016540; P:GO:2000249; P:GO:0051603; F:GO:0016787	F:cysteine-type carboxypeptidase activity; F:cysteine-type endopeptidase activity; P:decidualization; F:cysteine-type peptidase activity; F:peptidase activity; C:nucleolus; C:lysosome; P:negative regulation of keratinocyte proliferation; C:nucleus; C:extracellular space; C:extracellular exosome; F:histone binding; P:proteolysis; P:hair follicle morphogenesis; C:cytoplasmic vesicle; P:protein processing; P:protein autoprocessing; P:regulation of actin cytoskeleton reorganization; P:proteolysis involved in cellular protein catabolic process; F:hydrolase activity		
tr|F6VSN2|F6VSN2_HORSE	glutathione S-transferase P	210	20	6.27E-155	96.05%	25	P:GO:0043407; P:GO:0043508; P:GO:0009890; P:GO:0032691; F:GO:0004364; P:GO:0006469; C:GO:0070062; F:GO:0035730; F:GO:0035731; P:GO:0071638; P:GO:0032720; P:GO:0008152; C:GO:0005622; C:GO:0005634; C:GO:0005615; C:GO:0097057; C:GO:0005737; P:GO:0051771; P:GO:0070373; P:GO:0006749; C:GO:0005739; P:GO:0006805; P:GO:2001237; C:GO:0031982; F:GO:0016740	P:negative regulation of MAP kinase activity; P:negative regulation of JUN kinase activity; P:negative regulation of biosynthetic process; P:negative regulation of interleukin-1 beta production; F:glutathione transferase activity; P:negative regulation of protein kinase activity; C:extracellular exosome; F:S-nitrosoglutathione binding; F:dinitrosyl-iron complex binding; P:negative regulation of monocyte chemotactic protein-1 production; P:negative regulation of tumor necrosis factor production; P:metabolic process; C:intracellular; C:nucleus; C:extracellular space; C:TRAF2-GSTP1 complex; C:cytoplasm; P:negative regulation of nitric-oxide synthase biosynthetic process; P:negative regulation of ERK1 and ERK2 cascade; P:glutathione metabolic process; C:mitochondrion; P:xenobiotic metabolic process; P:negative regulation of extrinsic apoptotic signaling pathway; C:vesicle; F:transferase activity		
tr|F6RRV1|F6RRV1_HORSE	fetuin-B	374	20	0E0	78.05%	8	C:GO:0005615; P:GO:0007339; C:GO:0070062; F:GO:0004869; P:GO:0010951; F:GO:0008191; C:GO:0005576; P:GO:0007338	C:extracellular space; P:binding of sperm to zona pellucida; C:extracellular exosome; F:cysteine-type endopeptidase inhibitor activity; P:negative regulation of endopeptidase activity; F:metalloendopeptidase inhibitor activity; C:extracellular region; P:single fertilization		
tr|F7ATS5|F7ATS5_HORSE	Golgi membrane 1	368	20	0E0	87.2%	7	C:GO:0005615; C:GO:0070062; C:GO:0016020; C:GO:0016021; C:GO:0005794; P:GO:0019216; P:GO:0006997	C:extracellular space; C:extracellular exosome; C:membrane; C:integral component of membrane; C:Golgi apparatus; P:regulation of lipid metabolic process; P:nucleus organization		
sp|P05619|ILEU_HORSE	leukocyte elastase inhibitor	379	20	0E0	93.2%	8	F:GO:0030414; C:GO:0005615; F:GO:0004867; C:GO:0070062; C:GO:0005737; C:GO:0016020; P:GO:0010951; P:GO:0010466	F:peptidase inhibitor activity; C:extracellular space; F:serine-type endopeptidase inhibitor activity; C:extracellular exosome; C:cytoplasm; C:membrane; P:negative regulation of endopeptidase activity; P:negative regulation of peptidase activity		
tr|F6YCC0|F6YCC0_HORSE	cystatin-A	102	20	1.92E-69	92.4%	18	P:GO:0016337; F:GO:0005198; P:GO:0045861; F:GO:0002020; C:GO:0005622; P:GO:0030216; F:GO:0030414; C:GO:0005634; C:GO:0001533; C:GO:0005615; F:GO:0004866; C:GO:0070062; F:GO:0004869; C:GO:0005737; P:GO:0010951; P:GO:0018149; F:GO:0030674; P:GO:0010466	P:single organismal cell-cell adhesion; F:structural molecule activity; P:negative regulation of proteolysis; F:protease binding; C:intracellular; P:keratinocyte differentiation; F:peptidase inhibitor activity; C:nucleus; C:cornified envelope; C:extracellular space; F:endopeptidase inhibitor activity; C:extracellular exosome; F:cysteine-type endopeptidase inhibitor activity; C:cytoplasm; P:negative regulation of endopeptidase activity; P:peptide cross-linking; F:protein binding, bridging; P:negative regulation of peptidase activity		
tr|F6XAH7|F6XAH7_HORSE	deoxynucleoside triphosphate triphosphohydrolase SAMHD1	670	20	0E0	92.65%	13	F:GO:0008270; F:GO:0008832; C:GO:0005886; C:GO:0005654; P:GO:0006203; F:GO:0003676; C:GO:0005634; P:GO:0051289; F:GO:0003723; P:GO:0045088; P:GO:0051607; P:GO:0046061; F:GO:0032567	F:zinc ion binding; F:dGTPase activity; C:plasma membrane; C:nucleoplasm; P:dGTP catabolic process; F:nucleic acid binding; C:nucleus; P:protein homotetramerization; F:RNA binding; P:regulation of innate immune response; P:defense response to virus; P:dATP catabolic process; F:dGTP binding		
tr|F6ZI35|F6ZI35_HORSE	histidine-rich glyco	236	20	1.16E-171	84.1%	36	P:GO:0016525; P:GO:0030193; P:GO:0008285; F:GO:0008201; C:GO:0005576; P:GO:0050730; P:GO:1900747; C:GO:0070062; P:GO:0030308; C:GO:0072562; F:GO:0043395; P:GO:2001027; P:GO:0010951; P:GO:0002839; P:GO:0050832; F:GO:0019865; P:GO:0030168; P:GO:0015886; F:GO:0008270; P:GO:0010593; P:GO:0051918; P:GO:0007162; P:GO:0043254; F:GO:0005102; F:GO:0020037; P:GO:0033629; F:GO:0004867; P:GO:0051894; P:GO:0032956; F:GO:0004869; F:GO:0046872; P:GO:2000504; P:GO:0043065; P:GO:0010468; P:GO:0010543; C:GO:0036019	P:negative regulation of angiogenesis; P:regulation of blood coagulation; P:negative regulation of cell proliferation; F:heparin binding; C:extracellular region; P:regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of vascular endothelial growth factor signaling pathway; C:extracellular exosome; P:negative regulation of cell growth; C:blood microparticle; F:heparan sulfate proteoglycan binding; P:negative regulation of endothelial cell chemotaxis; P:negative regulation of endopeptidase activity; P:positive regulation of immune response to tumor cell; P:defense response to fungus; F:immunoglobulin binding; P:platelet activation; P:heme transport; F:zinc ion binding; P:negative regulation of lamellipodium assembly; P:negative regulation of fibrinolysis; P:negative regulation of cell adhesion; P:regulation of protein complex assembly; F:receptor binding; F:heme binding; P:negative regulation of cell adhesion mediated by integrin; F:serine-type endopeptidase inhibitor activity; P:positive regulation of focal adhesion assembly; P:regulation of actin cytoskeleton organization; F:cysteine-type endopeptidase inhibitor activity; F:metal ion binding; P:positive regulation of blood vessel remodeling; P:positive regulation of apoptotic process; P:regulation of gene expression; P:regulation of platelet activation; C:endolysosome		
tr|F7E419|F7E419_HORSE	annexin A8	327	20	0E0	96.8%	17	P:GO:0007032; P:GO:1900004; P:GO:0007596; F:GO:0043325; P:GO:1900138; P:GO:0007599; C:GO:0005886; F:GO:0005544; F:GO:0005547; F:GO:0051015; C:GO:0031902; F:GO:0005546; C:GO:0070062; F:GO:0046872; F:GO:0005509; P:GO:0016197; C:GO:0005829	P:endosome organization; P:negative regulation of serine-type endopeptidase activity; P:blood coagulation; F:phosphatidylinositol-3,4-bisphosphate binding; P:negative regulation of phospholipase A2 activity; P:hemostasis; C:plasma membrane; F:calcium-dependent phospholipid binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:actin filament binding; C:late endosome membrane; F:phosphatidylinositol-4,5-bisphosphate binding; C:extracellular exosome; F:metal ion binding; F:calcium ion binding; P:endosomal transport; C:cytosol		
tr|F7DL17|F7DL17_HORSE	inter-alpha-trypsin inhibitor heavy chain H2	946	20	0E0	95%	5	F:GO:0004867; C:GO:0070062; C:GO:0072562; P:GO:0010951; P:GO:0030212	F:serine-type endopeptidase inhibitor activity; C:extracellular exosome; C:blood microparticle; P:negative regulation of endopeptidase activity; P:hyaluronan metabolic process		
tr|F7CTJ3|F7CTJ3_HORSE	inter-alpha-trypsin inhibitor heavy chain H2	947	20	0E0	94.7%	5	F:GO:0004867; C:GO:0070062; C:GO:0072562; P:GO:0010951; P:GO:0030212	F:serine-type endopeptidase inhibitor activity; C:extracellular exosome; C:blood microparticle; P:negative regulation of endopeptidase activity; P:hyaluronan metabolic process		
tr|F7DAF6|F7DAF6_HORSE	inter-alpha-trypsin inhibitor heavy chain H2	949	20	0E0	94.8%	5	F:GO:0004867; C:GO:0070062; C:GO:0072562; P:GO:0010951; P:GO:0030212	F:serine-type endopeptidase inhibitor activity; C:extracellular exosome; C:blood microparticle; P:negative regulation of endopeptidase activity; P:hyaluronan metabolic process		
tr|F7BSX5|F7BSX5_HORSE	MHC class I partial	387	20	0E0	85.9%	10	P:GO:0006955; F:GO:0042605; F:GO:0003823; C:GO:0016020; C:GO:0016021; P:GO:0019882; P:GO:0002474; P:GO:0002376; C:GO:0005886; C:GO:0042612	P:immune response; F:peptide antigen binding; F:antigen binding; C:membrane; C:integral component of membrane; P:antigen processing and presentation; P:antigen processing and presentation of peptide antigen via MHC class I; P:immune system process; C:plasma membrane; C:MHC class I protein complex		
tr|F7CY85|F7CY85_HORSE	tubulin beta-2B chain	445	20	0E0	99.4%	14	C:GO:1903561; P:GO:0007010; F:GO:0005200; C:GO:0005874; P:GO:0007017; F:GO:0000166; F:GO:0005525; C:GO:0005634; P:GO:0001764; C:GO:0005856; F:GO:0005515; C:GO:0070062; C:GO:0005737; F:GO:0003924	C:extracellular vesicle; P:cytoskeleton organization; F:structural constituent of cytoskeleton; C:microtubule; P:microtubule-based process; F:nucleotide binding; F:GTP binding; C:nucleus; P:neuron migration; C:cytoskeleton; F:protein binding; C:extracellular exosome; C:cytoplasm; F:GTPase activity		
tr|F7C3Z3|F7C3Z3_HORSE	lactoperoxidase	710	20	0E0	93.15%	17	P:GO:0018969; F:GO:0036393; P:GO:0001580; C:GO:0005576; P:GO:0042742; F:GO:0020037; P:GO:0042744; F:GO:0004601; P:GO:0006979; C:GO:0005615; C:GO:0070062; C:GO:0005737; F:GO:0046872; F:GO:0016491; P:GO:0098869; P:GO:0055114; C:GO:0016323	P:thiocyanate metabolic process; F:thiocyanate peroxidase activity; P:detection of chemical stimulus involved in sensory perception of bitter taste; C:extracellular region; P:defense response to bacterium; F:heme binding; P:hydrogen peroxide catabolic process; F:peroxidase activity; P:response to oxidative stress; C:extracellular space; C:extracellular exosome; C:cytoplasm; F:metal ion binding; F:oxidoreductase activity; P:cellular oxidant detoxification; P:oxidation-reduction process; C:basolateral plasma membrane		
tr|F6Y014|F6Y014_HORSE	F-actin-capping subunit beta isoform X2	272	20	0E0	100%	41	P:GO:0090036; P:GO:0022604; P:GO:0007010; P:GO:0030030; C:GO:0043025; P:GO:0051490; P:GO:0007596; C:GO:0070062; C:GO:0005903; C:GO:0001669; F:GO:0048487; C:GO:0043197; C:GO:0015629; C:GO:0005829; C:GO:0030863; C:GO:0030027; P:GO:0031115; P:GO:0010591; P:GO:0031175; P:GO:0000902; C:GO:0005884; P:GO:0048747; F:GO:0051015; F:GO:0098641; P:GO:0051016; C:GO:0030018; F:GO:0005515; C:GO:0005856; F:GO:0003779; P:GO:0051693; C:GO:0005737; C:GO:0005913; P:GO:0006928; C:GO:0016020; C:GO:0014704; P:GO:0030032; C:GO:0071203; C:GO:0008290; P:GO:0098609; P:GO:0030036; C:GO:0030017	P:regulation of protein kinase C signaling; P:regulation of cell morphogenesis; P:cytoskeleton organization; P:cell projection organization; C:neuronal cell body; P:negative regulation of filopodium assembly; P:blood coagulation; C:extracellular exosome; C:brush border; C:acrosomal vesicle; F:beta-tubulin binding; C:dendritic spine; C:actin cytoskeleton; C:cytosol; C:cortical cytoskeleton; C:lamellipodium; P:negative regulation of microtubule polymerization; P:regulation of lamellipodium assembly; P:neuron projection development; P:cell morphogenesis; C:actin filament; P:muscle fiber development; F:actin filament binding; F:cadherin binding involved in cell-cell adhesion; P:barbed-end actin filament capping; C:Z disc; F:protein binding; C:cytoskeleton; F:actin binding; P:actin filament capping; C:cytoplasm; C:cell-cell adherens junction; P:movement of cell or subcellular component; C:membrane; C:intercalated disc; P:lamellipodium assembly; C:WASH complex; C:F-actin capping protein complex; P:cell-cell adhesion; P:actin cytoskeleton organization; C:sarcomere		
tr|F7ATL5|F7ATL5_HORSE	type I cytoskeletal 14	354	20	0E0	98.4%	13	F:GO:0005198; C:GO:0005882; P:GO:0007568; P:GO:0042633; C:GO:0005622; P:GO:0030855; F:GO:1990254; C:GO:0005634; C:GO:0045095; C:GO:0070062; C:GO:0005737; P:GO:0045110; C:GO:0071944	F:structural molecule activity; C:intermediate filament; P:aging; P:hair cycle; C:intracellular; P:epithelial cell differentiation; F:keratin filament binding; C:nucleus; C:keratin filament; C:extracellular exosome; C:cytoplasm; P:intermediate filament bundle assembly; C:cell periphery		
tr|F6ZEQ3|F6ZEQ3_HORSE	type I cytoskeletal 16	466	20	0E0	88.4%	21	P:GO:0008283; P:GO:0007010; P:GO:0008544; F:GO:0005198; P:GO:0045104; C:GO:0005882; F:GO:0005200; P:GO:0007568; P:GO:0061436; P:GO:0042633; P:GO:0030216; C:GO:0005634; P:GO:0006954; C:GO:0005856; F:GO:0005515; C:GO:0070062; P:GO:0002009; P:GO:0045087; P:GO:0031424; P:GO:0030336; P:GO:0051546	P:cell proliferation; P:cytoskeleton organization; P:epidermis development; F:structural molecule activity; P:intermediate filament cytoskeleton organization; C:intermediate filament; F:structural constituent of cytoskeleton; P:aging; P:establishment of skin barrier; P:hair cycle; P:keratinocyte differentiation; C:nucleus; P:inflammatory response; C:cytoskeleton; F:protein binding; C:extracellular exosome; P:morphogenesis of an epithelium; P:innate immune response; P:keratinization; P:negative regulation of cell migration; P:keratinocyte migration		
sp|P30441|B2MG_HORSE	beta-2-microglobulin precursor	118	20	3.05E-82	91.8%	40	P:GO:0055072; P:GO:0032092; P:GO:1904434; C:GO:0009897; P:GO:0002481; P:GO:1904437; C:GO:0005794; P:GO:0003254; C:GO:0005576; P:GO:0071281; C:GO:0042612; P:GO:0002237; C:GO:0070062; P:GO:0006955; C:GO:0005925; P:GO:0010977; F:GO:0001948; P:GO:0019885; P:GO:0048260; P:GO:0050830; F:GO:0042802; P:GO:0050829; P:GO:0033077; P:GO:1903991; P:GO:1900122; P:GO:1900121; P:GO:0042026; P:GO:0002474; P:GO:0002376; C:GO:0005886; P:GO:0001895; C:GO:0005615; P:GO:0071222; C:GO:0005737; P:GO:0045087; C:GO:0016020; C:GO:1990712; P:GO:0002726; P:GO:0019731; P:GO:0001916	P:iron ion homeostasis; P:positive regulation of protein binding; P:positive regulation of ferrous iron binding; C:external side of plasma membrane; P:antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent; P:positive regulation of transferrin receptor binding; C:Golgi apparatus; P:regulation of membrane depolarization; C:extracellular region; P:cellular response to iron ion; C:MHC class I protein complex; P:response to molecule of bacterial origin; C:extracellular exosome; P:immune response; C:focal adhesion; P:negative regulation of neuron projection development; F:glycoprotein binding; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; P:positive regulation of receptor-mediated endocytosis; P:defense response to Gram-positive bacterium; F:identical protein binding; P:defense response to Gram-negative bacterium; P:T cell differentiation in thymus; P:positive regulation of ferrous iron import into cell; P:positive regulation of receptor binding; P:negative regulation of receptor binding; P:protein refolding; P:antigen processing and presentation of peptide antigen via MHC class I; P:immune system process; C:plasma membrane; P:retina homeostasis; C:extracellular space; P:cellular response to lipopolysaccharide; C:cytoplasm; P:innate immune response; C:membrane; C:HFE-transferrin receptor complex; P:positive regulation of T cell cytokine production; P:antibacterial humoral response; P:positive regulation of T cell mediated cytotoxicity		
sp|A2Q0Z0|EF1A1_HORSE	elongation factor 1-alpha 1	462	20	0E0	99.05%	35	C:GO:0043209; F:GO:0008144; C:GO:0005730; P:GO:1903427; C:GO:0005853; P:GO:1904714; F:GO:0005525; F:GO:0000166; C:GO:0070062; C:GO:0098574; F:GO:0003746; F:GO:0003924; F:GO:0019001; C:GO:0005829; C:GO:0032587; F:GO:0003729; P:GO:0010976; C:GO:0030864; F:GO:0019901; P:GO:0006351; P:GO:0051260; P:GO:0006355; F:GO:0000049; P:GO:0006414; C:GO:0005886; C:GO:0005622; P:GO:0006412; F:GO:0044822; C:GO:0005634; C:GO:0005615; F:GO:0005515; C:GO:0005737; C:GO:0016020; P:GO:0071364; P:GO:0010942	C:myelin sheath; F:drug binding; C:nucleolus; P:negative regulation of reactive oxygen species biosynthetic process; C:eukaryotic translation elongation factor 1 complex; P:regulation of chaperone-mediated autophagy; F:GTP binding; F:nucleotide binding; C:extracellular exosome; C:cytoplasmic side of lysosomal membrane; F:translation elongation factor activity; F:GTPase activity; F:guanyl nucleotide binding; C:cytosol; C:ruffle membrane; F:mRNA binding; P:positive regulation of neuron projection development; C:cortical actin cytoskeleton; F:protein kinase binding; P:transcription, DNA-templated; P:protein homooligomerization; P:regulation of transcription, DNA-templated; F:tRNA binding; P:translational elongation; C:plasma membrane; C:intracellular; P:translation; F:poly(A) RNA binding; C:nucleus; C:extracellular space; F:protein binding; C:cytoplasm; C:membrane; P:cellular response to epidermal growth factor stimulus; P:positive regulation of cell death		
tr|F6UME7|F6UME7_HORSE	elongation factor 1-alpha 1	462	20	0E0	99.7%	35	C:GO:0043209; F:GO:0008144; C:GO:0005730; P:GO:1903427; C:GO:0005853; P:GO:1904714; F:GO:0005525; F:GO:0000166; C:GO:0070062; C:GO:0098574; F:GO:0003746; F:GO:0003924; F:GO:0019001; C:GO:0005829; C:GO:0032587; F:GO:0003729; P:GO:0010976; C:GO:0030864; F:GO:0019901; P:GO:0006351; P:GO:0051260; P:GO:0006355; F:GO:0000049; P:GO:0006414; C:GO:0005886; C:GO:0005622; P:GO:0006412; F:GO:0044822; C:GO:0005634; C:GO:0005615; F:GO:0005515; C:GO:0005737; C:GO:0016020; P:GO:0071364; P:GO:0010942	C:myelin sheath; F:drug binding; C:nucleolus; P:negative regulation of reactive oxygen species biosynthetic process; C:eukaryotic translation elongation factor 1 complex; P:regulation of chaperone-mediated autophagy; F:GTP binding; F:nucleotide binding; C:extracellular exosome; C:cytoplasmic side of lysosomal membrane; F:translation elongation factor activity; F:GTPase activity; F:guanyl nucleotide binding; C:cytosol; C:ruffle membrane; F:mRNA binding; P:positive regulation of neuron projection development; C:cortical actin cytoskeleton; F:protein kinase binding; P:transcription, DNA-templated; P:protein homooligomerization; P:regulation of transcription, DNA-templated; F:tRNA binding; P:translational elongation; C:plasma membrane; C:intracellular; P:translation; F:poly(A) RNA binding; C:nucleus; C:extracellular space; F:protein binding; C:cytoplasm; C:membrane; P:cellular response to epidermal growth factor stimulus; P:positive regulation of cell death		
tr|F6RRD0|F6RRD0_HORSE	elongation factor 1-alpha 1	462	20	0E0	99%	35	C:GO:0043209; F:GO:0008144; C:GO:0005730; P:GO:1903427; C:GO:0005853; P:GO:1904714; F:GO:0005525; F:GO:0000166; C:GO:0070062; C:GO:0098574; F:GO:0003746; F:GO:0003924; F:GO:0019001; C:GO:0005829; C:GO:0032587; F:GO:0003729; P:GO:0010976; C:GO:0030864; F:GO:0019901; P:GO:0006351; P:GO:0051260; P:GO:0006355; F:GO:0000049; P:GO:0006414; C:GO:0005886; C:GO:0005622; P:GO:0006412; F:GO:0044822; C:GO:0005634; C:GO:0005615; F:GO:0005515; C:GO:0005737; C:GO:0016020; P:GO:0071364; P:GO:0010942	C:myelin sheath; F:drug binding; C:nucleolus; P:negative regulation of reactive oxygen species biosynthetic process; C:eukaryotic translation elongation factor 1 complex; P:regulation of chaperone-mediated autophagy; F:GTP binding; F:nucleotide binding; C:extracellular exosome; C:cytoplasmic side of lysosomal membrane; F:translation elongation factor activity; F:GTPase activity; F:guanyl nucleotide binding; C:cytosol; C:ruffle membrane; F:mRNA binding; P:positive regulation of neuron projection development; C:cortical actin cytoskeleton; F:protein kinase binding; P:transcription, DNA-templated; P:protein homooligomerization; P:regulation of transcription, DNA-templated; F:tRNA binding; P:translational elongation; C:plasma membrane; C:intracellular; P:translation; F:poly(A) RNA binding; C:nucleus; C:extracellular space; F:protein binding; C:cytoplasm; C:membrane; P:cellular response to epidermal growth factor stimulus; P:positive regulation of cell death		
tr|F6REX3|F6REX3_HORSE	alpha-2-macroglobulin-like	1475	20	0E0	90.75%	5	C:GO:0005615; F:GO:0004866; P:GO:0010951; C:GO:0005576; P:GO:0007566	C:extracellular space; F:endopeptidase inhibitor activity; P:negative regulation of endopeptidase activity; C:extracellular region; P:embryo implantation		
tr|F6SHJ8|F6SHJ8_HORSE	type II cytoskeletal 2 epidermal	594	20	0E0	90.55%	14	P:GO:0043616; F:GO:0005198; C:GO:0005882; C:GO:0005794; C:GO:0005634; C:GO:0005615; C:GO:0045095; C:GO:0070062; C:GO:0045111; C:GO:0005737; C:GO:0016020; P:GO:0032980; P:GO:0031424; P:GO:0051546	P:keratinocyte proliferation; F:structural molecule activity; C:intermediate filament; C:Golgi apparatus; C:nucleus; C:extracellular space; C:keratin filament; C:extracellular exosome; C:intermediate filament cytoskeleton; C:cytoplasm; C:membrane; P:keratinocyte activation; P:keratinization; P:keratinocyte migration		
tr|F6VP61|F6VP61_HORSE	serpin B10	397	20	0E0	91.7%	10	C:GO:0005634; F:GO:0030414; C:GO:0005615; F:GO:0004867; C:GO:0005737; P:GO:0010951; P:GO:0098779; P:GO:0002230; P:GO:0098792; P:GO:0010466	C:nucleus; F:peptidase inhibitor activity; C:extracellular space; F:serine-type endopeptidase inhibitor activity; C:cytoplasm; P:negative regulation of endopeptidase activity; P:mitophagy in response to mitochondrial depolarization; P:positive regulation of defense response to virus by host; P:xenophagy; P:negative regulation of peptidase activity		
tr|F6TJS5|F6TJS5_HORSE	deleted in malignant brain tumors 1 - partial	233	20	2.17E-138	81.35%	25	P:GO:0007275; P:GO:0015031; C:GO:0005576; P:GO:0002221; C:GO:0070062; P:GO:0043152; P:GO:0016032; P:GO:0051607; F:GO:0035375; F:GO:0005044; F:GO:0048306; P:GO:0044267; P:GO:0006810; P:GO:0006898; C:GO:0042589; P:GO:0030855; C:GO:0005615; F:GO:0005515; F:GO:0008329; C:GO:0005737; P:GO:0045087; C:GO:0016020; P:GO:0030154; C:GO:0030670; C:GO:0019898	P:multicellular organism development; P:protein transport; C:extracellular region; P:pattern recognition receptor signaling pathway; C:extracellular exosome; P:induction of bacterial agglutination; P:viral process; P:defense response to virus; F:zymogen binding; F:scavenger receptor activity; F:calcium-dependent protein binding; P:cellular protein metabolic process; P:transport; P:receptor-mediated endocytosis; C:zymogen granule membrane; P:epithelial cell differentiation; C:extracellular space; F:protein binding; F:signaling pattern recognition receptor activity; C:cytoplasm; P:innate immune response; C:membrane; P:cell differentiation; C:phagocytic vesicle membrane; C:extrinsic component of membrane		
tr|F6QMA1|F6QMA1_HORSE	serpin B3-like	388	20	0E0	91.95%	3	F:GO:0004867; C:GO:0005615; P:GO:0010951	F:serine-type endopeptidase inhibitor activity; C:extracellular space; P:negative regulation of endopeptidase activity		
tr|F7D2D9|F7D2D9_HORSE	flavin reductase (NADPH)	208	20	1.03E-144	93.55%	9	F:GO:0042602; C:GO:0070062; C:GO:0005737; F:GO:0004074; C:GO:0005829; P:GO:0042167; P:GO:0055114; C:GO:0005886; C:GO:0005654	F:riboflavin reductase (NADPH) activity; C:extracellular exosome; C:cytoplasm; F:biliverdin reductase activity; C:cytosol; P:heme catabolic process; P:oxidation-reduction process; C:plasma membrane; C:nucleoplasm		
tr|F6WQ44|F6WQ44_HORSE	sulfhydryl oxidase 1	710	20	0E0	83.7%	17	C:GO:0030173; P:GO:0045454; C:GO:0005794; P:GO:0006457; C:GO:0005623; C:GO:0005615; C:GO:0045171; F:GO:0003756; C:GO:0070062; F:GO:0016491; C:GO:0043231; C:GO:0016020; C:GO:0016021; P:GO:0016242; P:GO:0055114; F:GO:0016971; F:GO:0016972	C:integral component of Golgi membrane; P:cell redox homeostasis; C:Golgi apparatus; P:protein folding; C:cell; C:extracellular space; C:intercellular bridge; F:protein disulfide isomerase activity; C:extracellular exosome; F:oxidoreductase activity; C:intracellular membrane-bounded organelle; C:membrane; C:integral component of membrane; P:negative regulation of macroautophagy; P:oxidation-reduction process; F:flavin-linked sulfhydryl oxidase activity; F:thiol oxidase activity		
tr|F6WR95|F6WR95_HORSE	sulfhydryl oxidase 1	742	20	0E0	84.2%	17	C:GO:0030173; P:GO:0045454; C:GO:0005794; P:GO:0006457; C:GO:0005623; C:GO:0005615; C:GO:0045171; F:GO:0003756; C:GO:0070062; F:GO:0016491; C:GO:0043231; C:GO:0016020; C:GO:0016021; P:GO:0016242; P:GO:0055114; F:GO:0016971; F:GO:0016972	C:integral component of Golgi membrane; P:cell redox homeostasis; C:Golgi apparatus; P:protein folding; C:cell; C:extracellular space; C:intercellular bridge; F:protein disulfide isomerase activity; C:extracellular exosome; F:oxidoreductase activity; C:intracellular membrane-bounded organelle; C:membrane; C:integral component of membrane; P:negative regulation of macroautophagy; P:oxidation-reduction process; F:flavin-linked sulfhydryl oxidase activity; F:thiol oxidase activity		
tr|F6SYI2|F6SYI2_HORSE	alpha-crystallin B chain	174	20	1.24E-122	98.35%	28	P:GO:0060561; C:GO:0043209; P:GO:0002088; F:GO:0005212; C:GO:0070062; P:GO:0001666; C:GO:0043292; P:GO:0043154; P:GO:0043010; C:GO:0005829; P:GO:0032387; F:GO:0042802; F:GO:0042803; P:GO:0007021; P:GO:0051260; F:GO:0051082; P:GO:0042542; C:GO:0005886; P:GO:0007517; P:GO:0010629; C:GO:0030018; C:GO:0005634; P:GO:0071480; F:GO:0046872; C:GO:0005737; P:GO:0043066; C:GO:0005739; P:GO:0010941	P:apoptotic process involved in morphogenesis; C:myelin sheath; P:lens development in camera-type eye; F:structural constituent of eye lens; C:extracellular exosome; P:response to hypoxia; C:contractile fiber; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:camera-type eye development; C:cytosol; P:negative regulation of intracellular transport; F:identical protein binding; F:protein homodimerization activity; P:tubulin complex assembly; P:protein homooligomerization; F:unfolded protein binding; P:response to hydrogen peroxide; C:plasma membrane; P:muscle organ development; P:negative regulation of gene expression; C:Z disc; C:nucleus; P:cellular response to gamma radiation; F:metal ion binding; C:cytoplasm; P:negative regulation of apoptotic process; C:mitochondrion; P:regulation of cell death		
tr|F6RCA8|F6RCA8_HORSE	peroxiredoxin- mitochondrial	161	20	8.63E-111	96.6%	38	F:GO:0016209; P:GO:0060785; F:GO:0043027; P:GO:0006979; P:GO:0006954; C:GO:0070062; P:GO:0032967; F:GO:0016491; F:GO:0072541; C:GO:0043231; P:GO:0043154; P:GO:0006915; C:GO:0005829; C:GO:0031410; F:GO:0051920; F:GO:0008379; F:GO:0046983; C:GO:0005782; P:GO:0000302; F:GO:0005102; F:GO:0001016; P:GO:0042744; F:GO:0004601; C:GO:0005777; C:GO:0005634; C:GO:0005615; P:GO:0051354; C:GO:0048471; P:GO:0016480; C:GO:0005759; C:GO:0005737; P:GO:0043066; C:GO:0005739; P:GO:0098869; P:GO:0070995; P:GO:0055114; P:GO:2001057; P:GO:0034614	F:antioxidant activity; P:regulation of apoptosis involved in tissue homeostasis; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; P:response to oxidative stress; P:inflammatory response; C:extracellular exosome; P:positive regulation of collagen biosynthetic process; F:oxidoreductase activity; F:peroxynitrite reductase activity; C:intracellular membrane-bounded organelle; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; C:cytosol; C:cytoplasmic vesicle; F:peroxiredoxin activity; F:thioredoxin peroxidase activity; F:protein dimerization activity; C:peroxisomal matrix; P:response to reactive oxygen species; F:receptor binding; F:RNA polymerase III regulatory region DNA binding; P:hydrogen peroxide catabolic process; F:peroxidase activity; C:peroxisome; C:nucleus; C:extracellular space; P:negative regulation of oxidoreductase activity; C:perinuclear region of cytoplasm; P:negative regulation of transcription from RNA polymerase III promoter; C:mitochondrial matrix; C:cytoplasm; P:negative regulation of apoptotic process; C:mitochondrion; P:cellular oxidant detoxification; P:NADPH oxidation; P:oxidation-reduction process; P:reactive nitrogen species metabolic process; P:cellular response to reactive oxygen species		
tr|F6YRC5|F6YRC5_HORSE	ras GTPase-activating IQGAP1	1639	20	0E0	98.35%	47	C:GO:0036057; C:GO:0016328; C:GO:0015630; P:GO:0007173; F:GO:0005096; P:GO:0008543; C:GO:0043005; P:GO:0043547; C:GO:0005874; F:GO:0005547; C:GO:0030426; C:GO:0070062; C:GO:0030529; C:GO:0005925; P:GO:0071277; F:GO:0048365; C:GO:0001726; C:GO:0015629; C:GO:0031234; F:GO:0017048; C:GO:0030424; C:GO:0036464; F:GO:0019901; F:GO:0019904; F:GO:0043539; F:GO:0019903; P:GO:0007165; P:GO:0007264; C:GO:0031252; P:GO:0036120; P:GO:0044344; P:GO:0048008; C:GO:0005622; F:GO:0044548; F:GO:0005516; C:GO:0005911; P:GO:0072015; P:GO:0045860; C:GO:0005737; P:GO:1990138; P:GO:0043087; C:GO:0016020; P:GO:0071364; P:GO:0035305; C:GO:0030496; P:GO:0001817; P:GO:0071902	C:slit diaphragm; C:lateral plasma membrane; C:microtubule cytoskeleton; P:epidermal growth factor receptor signaling pathway; F:GTPase activator activity; P:fibroblast growth factor receptor signaling pathway; C:neuron projection; P:positive regulation of GTPase activity; C:microtubule; F:phosphatidylinositol-3,4,5-trisphosphate binding; C:growth cone; C:extracellular exosome; C:intracellular ribonucleoprotein complex; C:focal adhesion; P:cellular response to calcium ion; F:Rac GTPase binding; C:ruffle; C:actin cytoskeleton; C:extrinsic component of cytoplasmic side of plasma membrane; F:Rho GTPase binding; C:axon; C:cytoplasmic ribonucleoprotein granule; F:protein kinase binding; F:protein domain specific binding; F:protein serine/threonine kinase activator activity; F:protein phosphatase binding; P:signal transduction; P:small GTPase mediated signal transduction; C:cell leading edge; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:platelet-derived growth factor receptor signaling pathway; C:intracellular; F:S100 protein binding; F:calmodulin binding; C:cell-cell junction; P:glomerular visceral epithelial cell development; P:positive regulation of protein kinase activity; C:cytoplasm; P:neuron projection extension; P:regulation of GTPase activity; C:membrane; P:cellular response to epidermal growth factor stimulus; P:negative regulation of dephosphorylation; C:midbody; P:regulation of cytokine production; P:positive regulation of protein serine/threonine kinase activity		
tr|F6QYS3|F6QYS3_HORSE	extracellular matrix 1	544	20	0E0	89.55%	21	P:GO:0007165; F:GO:0008022; P:GO:0043123; F:GO:0002020; F:GO:0005134; C:GO:0005576; F:GO:0004871; F:GO:0043236; P:GO:0045766; P:GO:0006357; P:GO:0001960; P:GO:0030502; C:GO:0005615; P:GO:0006954; C:GO:0070062; P:GO:2000404; P:GO:0002828; P:GO:0001938; C:GO:0031012; P:GO:0010466; F:GO:0019899	P:signal transduction; F:protein C-terminus binding; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; F:protease binding; F:interleukin-2 receptor binding; C:extracellular region; F:signal transducer activity; F:laminin binding; P:positive regulation of angiogenesis; P:regulation of transcription from RNA polymerase II promoter; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of bone mineralization; C:extracellular space; P:inflammatory response; C:extracellular exosome; P:regulation of T cell migration; P:regulation of type 2 immune response; P:positive regulation of endothelial cell proliferation; C:extracellular matrix; P:negative regulation of peptidase activity; F:enzyme binding		
tr|F7BBJ0|F7BBJ0_HORSE	rho GDP-dissociation inhibitor 2	200	20	1.1E-144	98.95%	12	P:GO:0035023; C:GO:0070062; F:GO:0005094; C:GO:0005737; P:GO:1901164; F:GO:0003924; F:GO:0048365; F:GO:0005096; P:GO:0050790; C:GO:0005829; P:GO:2000249; P:GO:0043547	P:regulation of Rho protein signal transduction; C:extracellular exosome; F:Rho GDP-dissociation inhibitor activity; C:cytoplasm; P:negative regulation of trophoblast cell migration; F:GTPase activity; F:Rac GTPase binding; F:GTPase activator activity; P:regulation of catalytic activity; C:cytosol; P:regulation of actin cytoskeleton reorganization; P:positive regulation of GTPase activity		
tr|F7DIB3|F7DIB3_HORSE	SEC14 3	391	20	0E0	93%	5	C:GO:0016021; F:GO:0008289; P:GO:0006810; C:GO:0005622; F:GO:0005215	C:integral component of membrane; F:lipid binding; P:transport; C:intracellular; F:transporter activity		
tr|F7CZS6|F7CZS6_HORSE	malate cytoplasmic	334	20	0E0	99.4%	20	F:GO:0030060; C:GO:0043209; F:GO:0016615; F:GO:0016616; P:GO:0006099; P:GO:0002230; P:GO:0098792; P:GO:0005975; C:GO:0005615; C:GO:0005813; C:GO:0070062; P:GO:0006108; C:GO:0005737; F:GO:0016491; F:GO:0003824; C:GO:0005739; C:GO:0005829; P:GO:0098779; P:GO:0055114; P:GO:0019752	F:L-malate dehydrogenase activity; C:myelin sheath; F:malate dehydrogenase activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; P:tricarboxylic acid cycle; P:positive regulation of defense response to virus by host; P:xenophagy; P:carbohydrate metabolic process; C:extracellular space; C:centrosome; C:extracellular exosome; P:malate metabolic process; C:cytoplasm; F:oxidoreductase activity; F:catalytic activity; C:mitochondrion; C:cytosol; P:mitophagy in response to mitochondrial depolarization; P:oxidation-reduction process; P:carboxylic acid metabolic process		
tr|F7B821|F7B821_HORSE	disulfide-isomerase	459	20	0E0	98.5%	32	P:GO:1902175; C:GO:0009897; P:GO:0046598; F:GO:0005178; C:GO:0005793; P:GO:0042158; C:GO:0005576; F:GO:0004656; C:GO:0005788; C:GO:0070062; C:GO:0005925; F:GO:0046982; P:GO:0071456; C:GO:0034663; F:GO:0016853; C:GO:0005783; P:GO:0045454; P:GO:0006457; P:GO:0000302; C:GO:0005886; F:GO:0044822; F:GO:0051213; F:GO:0005515; F:GO:0003756; C:GO:0042470; C:GO:0016020; P:GO:0055114; C:GO:0016222; F:GO:0031545; P:GO:0018401; P:GO:0034976; F:GO:0019899	P:regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; C:external side of plasma membrane; P:positive regulation of viral entry into host cell; F:integrin binding; C:endoplasmic reticulum-Golgi intermediate compartment; P:lipoprotein biosynthetic process; C:extracellular region; F:procollagen-proline 4-dioxygenase activity; C:endoplasmic reticulum lumen; C:extracellular exosome; C:focal adhesion; F:protein heterodimerization activity; P:cellular response to hypoxia; C:endoplasmic reticulum chaperone complex; F:isomerase activity; C:endoplasmic reticulum; P:cell redox homeostasis; P:protein folding; P:response to reactive oxygen species; C:plasma membrane; F:poly(A) RNA binding; F:dioxygenase activity; F:protein binding; F:protein disulfide isomerase activity; C:melanosome; C:membrane; P:oxidation-reduction process; C:procollagen-proline 4-dioxygenase complex; F:peptidyl-proline 4-dioxygenase activity; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:response to endoplasmic reticulum stress; F:enzyme binding		
tr|F6V5H1|F6V5H1_HORSE	LChain Crystal Structures In An Anti-hiv Antibody Lineage From Immunization Of Rhesus Macaques	104	20	2.53E-67	78.7%	25	C:GO:0009897; P:GO:0038095; P:GO:0038096; C:GO:0005576; P:GO:0006956; P:GO:0006910; P:GO:0006955; P:GO:0006911; P:GO:0050871; C:GO:0070062; F:GO:0003823; P:GO:0006958; C:GO:0072562; F:GO:0034987; P:GO:0050853; P:GO:0050776; F:GO:0004252; P:GO:0006898; P:GO:0042742; C:GO:0005886; P:GO:0001895; C:GO:0005615; P:GO:0045087; C:GO:0042571; P:GO:0006508	C:external side of plasma membrane; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; C:extracellular region; P:complement activation; P:phagocytosis, recognition; P:immune response; P:phagocytosis, engulfment; P:positive regulation of B cell activation; C:extracellular exosome; F:antigen binding; P:complement activation, classical pathway; C:blood microparticle; F:immunoglobulin receptor binding; P:B cell receptor signaling pathway; P:regulation of immune response; F:serine-type endopeptidase activity; P:receptor-mediated endocytosis; P:defense response to bacterium; C:plasma membrane; P:retina homeostasis; C:extracellular space; P:innate immune response; C:immunoglobulin complex, circulating; P:proteolysis		
tr|F6Y0Q6|F6Y0Q6_HORSE	aldehyde dehydrogenase family 1 member A3	512	20	0E0	98.35%	25	P:GO:0060166; P:GO:0042573; P:GO:0042574; P:GO:0060324; P:GO:0002138; C:GO:0070062; P:GO:0007626; F:GO:0016491; P:GO:0048048; F:GO:0070324; F:GO:0070403; P:GO:0060013; F:GO:0042803; P:GO:0021768; P:GO:0031076; F:GO:0004030; P:GO:0008152; P:GO:0002072; F:GO:0004029; C:GO:0005737; P:GO:0043065; P:GO:0042472; P:GO:0055114; F:GO:0016620; P:GO:0050885	P:olfactory pit development; P:retinoic acid metabolic process; P:retinal metabolic process; P:face development; P:retinoic acid biosynthetic process; C:extracellular exosome; P:locomotory behavior; F:oxidoreductase activity; P:embryonic eye morphogenesis; F:thyroid hormone binding; F:NAD+ binding; P:righting reflex; F:protein homodimerization activity; P:nucleus accumbens development; P:embryonic camera-type eye development; F:aldehyde dehydrogenase [NAD(P)+] activity; P:metabolic process; P:optic cup morphogenesis involved in camera-type eye development; F:aldehyde dehydrogenase (NAD) activity; C:cytoplasm; P:positive regulation of apoptotic process; P:inner ear morphogenesis; P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; P:neuromuscular process controlling balance		
tr|F6UL68|F6UL68_HORSE	transthyretin	147	20	8.18E-104	93.35%	18	F:GO:0042802; P:GO:0042572; P:GO:0044267; F:GO:0042562; F:GO:0036094; C:GO:0043234; C:GO:0005576; F:GO:0005179; P:GO:0006810; C:GO:0005615; F:GO:0005515; C:GO:0070062; P:GO:0001523; C:GO:0005737; F:GO:0046982; P:GO:0030198; F:GO:0070324; P:GO:0070327	F:identical protein binding; P:retinol metabolic process; P:cellular protein metabolic process; F:hormone binding; F:small molecule binding; C:protein complex; C:extracellular region; F:hormone activity; P:transport; C:extracellular space; F:protein binding; C:extracellular exosome; P:retinoid metabolic process; C:cytoplasm; F:protein heterodimerization activity; P:extracellular matrix organization; F:thyroid hormone binding; P:thyroid hormone transport		
tr|F7AX54|F7AX54_HORSE	myosin light polypeptide 6 isoform X2	151	20	1.2E-108	98.65%	17	C:GO:0016459; F:GO:0000146; F:GO:0003774; F:GO:0030898; F:GO:0005515; C:GO:0070062; F:GO:0008307; C:GO:0005903; P:GO:0006936; P:GO:0007519; F:GO:0005509; C:GO:0016020; C:GO:0016461; C:GO:0005829; C:GO:0031982; C:GO:0031012; P:GO:0030049	C:myosin complex; F:microfilament motor activity; F:motor activity; F:actin-dependent ATPase activity; F:protein binding; C:extracellular exosome; F:structural constituent of muscle; C:brush border; P:muscle contraction; P:skeletal muscle tissue development; F:calcium ion binding; C:membrane; C:unconventional myosin complex; C:cytosol; C:vesicle; C:extracellular matrix; P:muscle filament sliding		
tr|F7BA40|F7BA40_HORSE	transaldolase	305	20	0E0	98.6%	17	P:GO:0009052; P:GO:0006098; P:GO:0006002; F:GO:0048029; C:GO:0005634; P:GO:0005975; F:GO:0004801; F:GO:0005515; P:GO:0005999; C:GO:0070062; C:GO:0005737; F:GO:0003824; C:GO:0043231; P:GO:0019682; C:GO:0005829; F:GO:0016740; F:GO:0030246	P:pentose-phosphate shunt, non-oxidative branch; P:pentose-phosphate shunt; P:fructose 6-phosphate metabolic process; F:monosaccharide binding; C:nucleus; P:carbohydrate metabolic process; F:sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity; F:protein binding; P:xylulose biosynthetic process; C:extracellular exosome; C:cytoplasm; F:catalytic activity; C:intracellular membrane-bounded organelle; P:glyceraldehyde-3-phosphate metabolic process; C:cytosol; F:transferase activity; F:carbohydrate binding		
tr|F6YDZ0|F6YDZ0_HORSE	serpin B5	375	20	0E0	97.05%	9	F:GO:0004867; C:GO:0005615; C:GO:0070062; C:GO:0005737; P:GO:0002009; P:GO:0030198; P:GO:0010951; P:GO:0050678; P:GO:0060512	F:serine-type endopeptidase inhibitor activity; C:extracellular space; C:extracellular exosome; C:cytoplasm; P:morphogenesis of an epithelium; P:extracellular matrix organization; P:negative regulation of endopeptidase activity; P:regulation of epithelial cell proliferation; P:prostate gland morphogenesis		
tr|F6UJ33|F6UJ33_HORSE	profilin-1	140	20	1.62E-100	99.45%	40	P:GO:0008064; C:GO:0045202; P:GO:0045944; C:GO:0043005; F:GO:0000774; F:GO:0070064; F:GO:0005546; C:GO:0070062; P:GO:0001843; C:GO:0005925; C:GO:0072562; P:GO:0010634; F:GO:0017048; P:GO:0050434; P:GO:0042989; P:GO:0032781; P:GO:1900029; F:GO:0005102; F:GO:0003785; P:GO:0006357; F:GO:0044822; P:GO:0030833; F:GO:0098641; C:GO:0005634; P:GO:0051497; C:GO:0005856; F:GO:0005515; F:GO:0003779; P:GO:0030837; C:GO:0005737; C:GO:0005913; P:GO:0051496; C:GO:0005938; C:GO:0016020; P:GO:0030838; P:GO:0051054; P:GO:0032232; P:GO:0032233; P:GO:0050821; P:GO:0030036	P:regulation of actin polymerization or depolymerization; C:synapse; P:positive regulation of transcription from RNA polymerase II promoter; C:neuron projection; F:adenyl-nucleotide exchange factor activity; F:proline-rich region binding; F:phosphatidylinositol-4,5-bisphosphate binding; C:extracellular exosome; P:neural tube closure; C:focal adhesion; C:blood microparticle; P:positive regulation of epithelial cell migration; F:Rho GTPase binding; P:positive regulation of viral transcription; P:sequestering of actin monomers; P:positive regulation of ATPase activity; P:positive regulation of ruffle assembly; F:receptor binding; F:actin monomer binding; P:regulation of transcription from RNA polymerase II promoter; F:poly(A) RNA binding; P:regulation of actin filament polymerization; F:cadherin binding involved in cell-cell adhesion; C:nucleus; P:negative regulation of stress fiber assembly; C:cytoskeleton; F:protein binding; F:actin binding; P:negative regulation of actin filament polymerization; C:cytoplasm; C:cell-cell adherens junction; P:positive regulation of stress fiber assembly; C:cell cortex; C:membrane; P:positive regulation of actin filament polymerization; P:positive regulation of DNA metabolic process; P:negative regulation of actin filament bundle assembly; P:positive regulation of actin filament bundle assembly; P:protein stabilization; P:actin cytoskeleton organization		
tr|F6ZND8|F6ZND8_HORSE	Keratin 6A	562	20	0E0	94.25%	15	P:GO:0008284; F:GO:0005198; C:GO:0005882; F:GO:0005200; P:GO:0002230; P:GO:0098792; C:GO:0005634; P:GO:0042060; F:GO:0005515; C:GO:0070062; C:GO:0045095; P:GO:0002009; C:GO:0016020; P:GO:0030154; P:GO:0098779	P:positive regulation of cell proliferation; F:structural molecule activity; C:intermediate filament; F:structural constituent of cytoskeleton; P:positive regulation of defense response to virus by host; P:xenophagy; C:nucleus; P:wound healing; F:protein binding; C:extracellular exosome; C:keratin filament; P:morphogenesis of an epithelium; C:membrane; P:cell differentiation; P:mitophagy in response to mitochondrial depolarization		
tr|F7AGY4|F7AGY4_HORSE	Keratin 6A	565	20	0E0	94.75%	15	P:GO:0008284; F:GO:0005198; C:GO:0005882; F:GO:0005200; P:GO:0002230; P:GO:0098792; C:GO:0005634; P:GO:0042060; F:GO:0005515; C:GO:0070062; C:GO:0045095; P:GO:0002009; C:GO:0016020; P:GO:0030154; P:GO:0098779	P:positive regulation of cell proliferation; F:structural molecule activity; C:intermediate filament; F:structural constituent of cytoskeleton; P:positive regulation of defense response to virus by host; P:xenophagy; C:nucleus; P:wound healing; F:protein binding; C:extracellular exosome; C:keratin filament; P:morphogenesis of an epithelium; C:membrane; P:cell differentiation; P:mitophagy in response to mitochondrial depolarization		
tr|F6WBP0|F6WBP0_HORSE	glutathione S-transferase A2-like	221	20	4.61E-161	92.1%	3	P:GO:0008152; F:GO:0004364; F:GO:0016740	P:metabolic process; F:glutathione transferase activity; F:transferase activity		
tr|F6Z4J4|F6Z4J4_HORSE	rab GDP dissociation inhibitor beta	431	20	0E0	93.7%	24	F:GO:0005093; F:GO:0005092; C:GO:0043209; P:GO:0007264; P:GO:0007165; F:GO:0005096; P:GO:0015031; C:GO:0005794; P:GO:0043547; C:GO:0005622; F:GO:0044822; F:GO:0005515; P:GO:0016192; C:GO:0070062; C:GO:0005925; C:GO:0005737; F:GO:0016491; P:GO:0051056; C:GO:0016020; P:GO:0050790; C:GO:0005829; F:GO:0031267; C:GO:0031982; P:GO:0055114	F:Rab GDP-dissociation inhibitor activity; F:GDP-dissociation inhibitor activity; C:myelin sheath; P:small GTPase mediated signal transduction; P:signal transduction; F:GTPase activator activity; P:protein transport; C:Golgi apparatus; P:positive regulation of GTPase activity; C:intracellular; F:poly(A) RNA binding; F:protein binding; P:vesicle-mediated transport; C:extracellular exosome; C:focal adhesion; C:cytoplasm; F:oxidoreductase activity; P:regulation of small GTPase mediated signal transduction; C:membrane; P:regulation of catalytic activity; C:cytosol; F:small GTPase binding; C:vesicle; P:oxidation-reduction process		
tr|F6Q6X3|F6Q6X3_HORSE	coronin-1A	461	20	0E0	97.9%	64	F:GO:0043548; P:GO:0050918; F:GO:0008022; P:GO:0008064; P:GO:0007015; P:GO:0043029; P:GO:0051126; P:GO:0050870; C:GO:0015629; C:GO:0005829; C:GO:0030424; C:GO:0030864; C:GO:0030027; C:GO:0045335; C:GO:0043234; P:GO:0042102; C:GO:0005884; C:GO:0005886; P:GO:0038180; F:GO:0003785; F:GO:0051015; C:GO:0005634; C:GO:0005911; F:GO:0005515; P:GO:0032956; F:GO:0003779; P:GO:0006928; F:GO:0032036; P:GO:0032796; P:GO:0031589; P:GO:0030335; P:GO:0034097; P:GO:0008360; P:GO:0043320; C:GO:0001891; P:GO:0001771; P:GO:0043524; C:GO:0001772; C:GO:0005769; C:GO:0070062; P:GO:0031339; P:GO:0001845; P:GO:0006816; P:GO:0071353; C:GO:0031410; P:GO:0016477; F:GO:0042802; F:GO:0042803; C:GO:0031252; P:GO:0061502; F:GO:0044822; P:GO:0030833; P:GO:0051279; C:GO:0005856; P:GO:0048873; C:GO:0005737; P:GO:0045087; C:GO:0005938; C:GO:0016020; P:GO:0006909; C:GO:0030670; P:GO:0030595; F:GO:0008092; P:GO:0030036	F:phosphatidylinositol 3-kinase binding; P:positive chemotaxis; F:protein C-terminus binding; P:regulation of actin polymerization or depolymerization; P:actin filament organization; P:T cell homeostasis; P:negative regulation of actin nucleation; P:positive regulation of T cell activation; C:actin cytoskeleton; C:cytosol; C:axon; C:cortical actin cytoskeleton; C:lamellipodium; C:phagocytic vesicle; C:protein complex; P:positive regulation of T cell proliferation; C:actin filament; C:plasma membrane; P:nerve growth factor signaling pathway; F:actin monomer binding; F:actin filament binding; C:nucleus; C:cell-cell junction; F:protein binding; P:regulation of actin cytoskeleton organization; F:actin binding; P:movement of cell or subcellular component; F:myosin heavy chain binding; P:uropod organization; P:cell-substrate adhesion; P:positive regulation of cell migration; P:response to cytokine; P:regulation of cell shape; P:natural killer cell degranulation; C:phagocytic cup; P:immunological synapse formation; P:negative regulation of neuron apoptotic process; C:immunological synapse; C:early endosome; C:extracellular exosome; P:negative regulation of vesicle fusion; P:phagolysosome assembly; P:calcium ion transport; P:cellular response to interleukin-4; C:cytoplasmic vesicle; P:cell migration; F:identical protein binding; F:protein homodimerization activity; C:cell leading edge; P:early endosome to recycling endosome transport; F:poly(A) RNA binding; P:regulation of actin filament polymerization; P:regulation of release of sequestered calcium ion into cytosol; C:cytoskeleton; P:homeostasis of number of cells within a tissue; C:cytoplasm; P:innate immune response; C:cell cortex; C:membrane; P:phagocytosis; C:phagocytic vesicle membrane; P:leukocyte chemotaxis; F:cytoskeletal protein binding; P:actin cytoskeleton organization		
tr|F6VAS5|F6VAS5_HORSE	vascular non-inflammatory molecule 2	517	20	0E0	91.2%	7	F:GO:0016810; F:GO:0016811; P:GO:0007417; P:GO:0006768; P:GO:0006807; P:GO:0015939; F:GO:0017159	F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; P:central nervous system development; P:biotin metabolic process; P:nitrogen compound metabolic process; P:pantothenate metabolic process; F:pantetheine hydrolase activity		
tr|F7DZ82|F7DZ82_HORSE	alpha-actinin-1 isoform X2	857	20	0E0	99%	65	C:GO:0016328; P:GO:0007015; P:GO:0051764; C:GO:0005903; F:GO:0003725; F:GO:0005509; C:GO:0042383; P:GO:0030220; C:GO:0005829; P:GO:0048041; P:GO:0070527; C:GO:0030027; P:GO:0045214; P:GO:0042981; C:GO:0005884; F:GO:0044325; F:GO:0005523; C:GO:0005886; F:GO:0051015; C:GO:0030018; C:GO:0005911; F:GO:0005515; F:GO:0003779; F:GO:0046872; C:GO:0005916; C:GO:0005915; F:GO:0030374; C:GO:0030054; C:GO:0031143; P:GO:0051017; P:GO:0051271; F:GO:0051393; F:GO:0005178; C:GO:0005576; P:GO:1903506; C:GO:0042995; P:GO:0002576; C:GO:0005923; C:GO:0070062; C:GO:0005925; P:GO:0048741; F:GO:0043495; C:GO:0001725; C:GO:0001726; F:GO:0017166; C:GO:0030486; P:GO:0030168; C:GO:0090636; C:GO:0090637; C:GO:0031093; P:GO:0046928; P:GO:0036344; F:GO:0042803; C:GO:0031252; C:GO:0005622; C:GO:0005615; C:GO:0005856; P:GO:0051234; C:GO:1990357; C:GO:0097433; C:GO:0005737; P:GO:0043462; C:GO:0012506; C:GO:0016020; P:GO:0051639	C:lateral plasma membrane; P:actin filament organization; P:actin crosslink formation; C:brush border; F:double-stranded RNA binding; F:calcium ion binding; C:sarcolemma; P:platelet formation; C:cytosol; P:focal adhesion assembly; P:platelet aggregation; C:lamellipodium; P:sarcomere organization; P:regulation of apoptotic process; C:actin filament; F:ion channel binding; F:tropomyosin binding; C:plasma membrane; F:actin filament binding; C:Z disc; C:cell-cell junction; F:protein binding; F:actin binding; F:metal ion binding; C:fascia adherens; C:zonula adherens; F:ligand-dependent nuclear receptor transcription coactivator activity; C:cell junction; C:pseudopodium; P:actin filament bundle assembly; P:negative regulation of cellular component movement; F:alpha-actinin binding; F:integrin binding; C:extracellular region; P:regulation of nucleic acid-templated transcription; C:cell projection; P:platelet degranulation; C:bicellular tight junction; C:extracellular exosome; C:focal adhesion; P:skeletal muscle fiber development; F:protein anchor; C:stress fiber; C:ruffle; F:vinculin binding; C:smooth muscle dense body; P:platelet activation; C:outer dense plaque of desmosome; C:inner dense plaque of desmosome; C:platelet alpha granule lumen; P:regulation of neurotransmitter secretion; P:platelet morphogenesis; F:protein homodimerization activity; C:cell leading edge; C:intracellular; C:extracellular space; C:cytoskeleton; P:establishment of localization; C:terminal web; C:dense body; C:cytoplasm; P:regulation of ATPase activity; C:vesicle membrane; C:membrane; P:actin filament network formation		
tr|F7DZI2|F7DZI2_HORSE	alpha-actinin-1 isoform X1	879	20	0E0	99%	59	C:GO:0016328; P:GO:0007015; P:GO:0051764; C:GO:0005903; F:GO:0003725; F:GO:0005509; C:GO:0042383; P:GO:0030220; C:GO:0005829; P:GO:0048041; P:GO:0070527; C:GO:0030027; P:GO:0045214; P:GO:0042981; C:GO:0005884; F:GO:0044325; C:GO:0005886; F:GO:0051015; C:GO:0030018; F:GO:0005515; C:GO:0005911; F:GO:0003779; F:GO:0046872; C:GO:0005916; C:GO:0005915; F:GO:0030374; C:GO:0030054; C:GO:0031143; P:GO:0051017; P:GO:0051271; F:GO:0051393; F:GO:0005178; C:GO:0005576; P:GO:1903506; C:GO:0042995; P:GO:0002576; C:GO:0005923; C:GO:0070062; C:GO:0005925; P:GO:0048741; C:GO:0001725; C:GO:0001726; F:GO:0017166; C:GO:0030486; P:GO:0030168; C:GO:0090636; C:GO:0090637; C:GO:0031093; P:GO:0036344; F:GO:0042803; C:GO:0031252; C:GO:0005622; C:GO:0005615; C:GO:0005856; C:GO:1990357; C:GO:0005737; C:GO:0097433; C:GO:0016020; P:GO:0051639	C:lateral plasma membrane; P:actin filament organization; P:actin crosslink formation; C:brush border; F:double-stranded RNA binding; F:calcium ion binding; C:sarcolemma; P:platelet formation; C:cytosol; P:focal adhesion assembly; P:platelet aggregation; C:lamellipodium; P:sarcomere organization; P:regulation of apoptotic process; C:actin filament; F:ion channel binding; C:plasma membrane; F:actin filament binding; C:Z disc; F:protein binding; C:cell-cell junction; F:actin binding; F:metal ion binding; C:fascia adherens; C:zonula adherens; F:ligand-dependent nuclear receptor transcription coactivator activity; C:cell junction; C:pseudopodium; P:actin filament bundle assembly; P:negative regulation of cellular component movement; F:alpha-actinin binding; F:integrin binding; C:extracellular region; P:regulation of nucleic acid-templated transcription; C:cell projection; P:platelet degranulation; C:bicellular tight junction; C:extracellular exosome; C:focal adhesion; P:skeletal muscle fiber development; C:stress fiber; C:ruffle; F:vinculin binding; C:smooth muscle dense body; P:platelet activation; C:outer dense plaque of desmosome; C:inner dense plaque of desmosome; C:platelet alpha granule lumen; P:platelet morphogenesis; F:protein homodimerization activity; C:cell leading edge; C:intracellular; C:extracellular space; C:cytoskeleton; C:terminal web; C:cytoplasm; C:dense body; C:membrane; P:actin filament network formation		
tr|F6YRE7|F6YRE7_HORSE	leukotriene A-4 hydrolase isoform X1	612	20	0E0	98.1%	26	P:GO:0010043; F:GO:0042277; F:GO:0004463; C:GO:0005654; F:GO:0004301; P:GO:0006954; C:GO:0070062; P:GO:0043171; P:GO:0060509; C:GO:0005829; F:GO:0070006; F:GO:0008270; P:GO:0006691; F:GO:0004177; F:GO:0008233; P:GO:0043434; C:GO:0005886; F:GO:0008237; F:GO:0044822; C:GO:0005634; P:GO:0019370; F:GO:0005515; F:GO:0046872; C:GO:0005737; P:GO:0006508; F:GO:0016787	P:response to zinc ion; F:peptide binding; F:leukotriene-A4 hydrolase activity; C:nucleoplasm; F:epoxide hydrolase activity; P:inflammatory response; C:extracellular exosome; P:peptide catabolic process; P:Type I pneumocyte differentiation; C:cytosol; F:metalloaminopeptidase activity; F:zinc ion binding; P:leukotriene metabolic process; F:aminopeptidase activity; F:peptidase activity; P:response to peptide hormone; C:plasma membrane; F:metallopeptidase activity; F:poly(A) RNA binding; C:nucleus; P:leukotriene biosynthetic process; F:protein binding; F:metal ion binding; C:cytoplasm; P:proteolysis; F:hydrolase activity		
tr|F6PUX2|F6PUX2_HORSE	moesin	577	20	0E0	99.7%	48	P:GO:0008360; C:GO:0043209; P:GO:1903364; P:GO:0008361; F:GO:0050839; P:GO:1902115; C:GO:0042995; P:GO:0007159; P:GO:0071394; C:GO:0070062; C:GO:0005925; C:GO:0045177; C:GO:0005902; F:GO:0003725; C:GO:0072562; P:GO:0045198; F:GO:0019901; P:GO:0022612; F:GO:0005200; P:GO:0022614; F:GO:0005102; P:GO:0061028; C:GO:0005886; P:GO:1902966; C:GO:0031528; C:GO:0005634; C:GO:0005615; C:GO:0048471; C:GO:0005856; F:GO:0005515; C:GO:0001931; F:GO:0003779; C:GO:0005737; P:GO:0006928; P:GO:0010628; C:GO:0016020; P:GO:2000643; C:GO:0031982; C:GO:0030175; P:GO:0050900; C:GO:0031143; C:GO:0019898; F:GO:0008092; C:GO:0016323; P:GO:0071803; C:GO:0016324; P:GO:2000401; C:GO:0071944	P:regulation of cell shape; C:myelin sheath; P:positive regulation of cellular protein catabolic process; P:regulation of cell size; F:cell adhesion molecule binding; P:regulation of organelle assembly; C:cell projection; P:leukocyte cell-cell adhesion; P:cellular response to testosterone stimulus; C:extracellular exosome; C:focal adhesion; C:apical part of cell; C:microvillus; F:double-stranded RNA binding; C:blood microparticle; P:establishment of epithelial cell apical/basal polarity; F:protein kinase binding; P:gland morphogenesis; F:structural constituent of cytoskeleton; P:membrane to membrane docking; F:receptor binding; P:establishment of endothelial barrier; C:plasma membrane; P:positive regulation of protein localization to early endosome; C:microvillus membrane; C:nucleus; C:extracellular space; C:perinuclear region of cytoplasm; C:cytoskeleton; F:protein binding; C:uropod; F:actin binding; C:cytoplasm; P:movement of cell or subcellular component; P:positive regulation of gene expression; C:membrane; P:positive regulation of early endosome to late endosome transport; C:vesicle; C:filopodium; P:leukocyte migration; C:pseudopodium; C:extrinsic component of membrane; F:cytoskeletal protein binding; C:basolateral plasma membrane; P:positive regulation of podosome assembly; C:apical plasma membrane; P:regulation of lymphocyte migration; C:cell periphery		
tr|F6WGX6|F6WGX6_HORSE	type II cytoskeletal 1b isoform X1	586	20	0E0	88.55%	5	C:GO:0005856; C:GO:0070062; C:GO:0045095; F:GO:0005198; C:GO:0005882	C:cytoskeleton; C:extracellular exosome; C:keratin filament; F:structural molecule activity; C:intermediate filament		
tr|F7DK11|F7DK11_HORSE	periplakin	1737	20	0E0	96.5%	2	C:GO:0005856; C:GO:0070062	C:cytoskeleton; C:extracellular exosome		
tr|F6YXD8|F6YXD8_HORSE	nucleobindin-2	420	20	0E0	96.8%	7	F:GO:0003677; C:GO:0005634; C:GO:0005737; F:GO:0005509; C:GO:0005783; C:GO:0005640; C:GO:0005794	F:DNA binding; C:nucleus; C:cytoplasm; F:calcium ion binding; C:endoplasmic reticulum; C:nuclear outer membrane; C:Golgi apparatus		
tr|F6Y426|F6Y426_HORSE	nucleobindin-2	421	20	0E0	96.75%	31	P:GO:1901142; P:GO:0032099; P:GO:0042594; C:GO:0005794; P:GO:0044752; C:GO:0005793; C:GO:0005576; P:GO:0070093; C:GO:0005797; P:GO:0009749; C:GO:0070062; P:GO:0046321; F:GO:0005509; C:GO:0005829; P:GO:0045599; F:GO:0005164; P:GO:0030818; C:GO:0005783; C:GO:0005640; P:GO:1990680; P:GO:0046627; C:GO:0005886; C:GO:0005635; F:GO:0003677; C:GO:0005634; C:GO:0005615; F:GO:0005515; F:GO:0046872; C:GO:0005737; P:GO:2000845; C:GO:0016020	P:insulin metabolic process; P:negative regulation of appetite; P:response to starvation; C:Golgi apparatus; P:response to human chorionic gonadotropin; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular region; P:negative regulation of glucagon secretion; C:Golgi medial cisterna; P:response to glucose; C:extracellular exosome; P:positive regulation of fatty acid oxidation; F:calcium ion binding; C:cytosol; P:negative regulation of fat cell differentiation; F:tumor necrosis factor receptor binding; P:negative regulation of cAMP biosynthetic process; C:endoplasmic reticulum; C:nuclear outer membrane; P:response to melanocyte-stimulating hormone; P:negative regulation of insulin receptor signaling pathway; C:plasma membrane; C:nuclear envelope; F:DNA binding; C:nucleus; C:extracellular space; F:protein binding; F:metal ion binding; C:cytoplasm; P:positive regulation of testosterone secretion; C:membrane		
tr|F6V3D5|F6V3D5_HORSE	T-complex 1 subunit gamma	545	20	0E0	98.75%	16	C:GO:0043209; P:GO:0046931; F:GO:0051082; P:GO:1901998; P:GO:0006457; C:GO:0002199; C:GO:0005886; C:GO:0005874; F:GO:0044822; F:GO:0000166; C:GO:0005832; F:GO:0005524; P:GO:0007339; C:GO:0070062; C:GO:0005737; C:GO:0044297	C:myelin sheath; P:pore complex assembly; F:unfolded protein binding; P:toxin transport; P:protein folding; C:zona pellucida receptor complex; C:plasma membrane; C:microtubule; F:poly(A) RNA binding; F:nucleotide binding; C:chaperonin-containing T-complex; F:ATP binding; P:binding of sperm to zona pellucida; C:extracellular exosome; C:cytoplasm; C:cell body		
tr|F6VFV9|F6VFV9_HORSE	Histone partial	103	20	1.92E-65	100%	7	F:GO:0003677; C:GO:0005634; F:GO:0046982; P:GO:0006352; C:GO:0005694; C:GO:0000786; P:GO:0006334	F:DNA binding; C:nucleus; F:protein heterodimerization activity; P:DNA-templated transcription, initiation; C:chromosome; C:nucleosome; P:nucleosome assembly		
tr|F7CVJ0|F7CVJ0_HORSE	2-5A-dependent ribonuclease	722	20	0E0	88.1%	32	P:GO:2001275; P:GO:0043488; F:GO:0004540; P:GO:0045444; P:GO:0006364; P:GO:0045944; P:GO:0006468; C:GO:0005575; F:GO:0004521; F:GO:0000166; F:GO:0005524; F:GO:0003723; F:GO:0004519; F:GO:0004518; C:GO:0005829; P:GO:0051607; F:GO:0019843; P:GO:0045071; P:GO:0090502; P:GO:0055085; P:GO:0090501; F:GO:0004672; P:GO:0006397; P:GO:0060337; F:GO:0005515; F:GO:0046872; C:GO:0005759; C:GO:0005737; F:GO:0043021; C:GO:0005739; C:GO:0016363; F:GO:0016787	P:positive regulation of glucose import in response to insulin stimulus; P:regulation of mRNA stability; F:ribonuclease activity; P:fat cell differentiation; P:rRNA processing; P:positive regulation of transcription from RNA polymerase II promoter; P:protein phosphorylation; C:cellular_component; F:endoribonuclease activity; F:nucleotide binding; F:ATP binding; F:RNA binding; F:endonuclease activity; F:nuclease activity; C:cytosol; P:defense response to virus; F:rRNA binding; P:negative regulation of viral genome replication; P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:transmembrane transport; P:RNA phosphodiester bond hydrolysis; F:protein kinase activity; P:mRNA processing; P:type I interferon signaling pathway; F:protein binding; F:metal ion binding; C:mitochondrial matrix; C:cytoplasm; F:ribonucleoprotein complex binding; C:mitochondrion; C:nuclear matrix; F:hydrolase activity		
tr|F6TZS9|F6TZS9_HORSE	triosephosphate isomerase	249	20	0E0	98.35%	19	P:GO:0006094; P:GO:0006098; P:GO:0007275; P:GO:0008152; P:GO:0006096; P:GO:0061621; P:GO:0006006; C:GO:0005634; C:GO:0005615; F:GO:0005515; F:GO:0031625; C:GO:0070062; F:GO:0003824; P:GO:0019682; P:GO:0046166; F:GO:0004807; C:GO:0005829; P:GO:0019563; F:GO:0016853	P:gluconeogenesis; P:pentose-phosphate shunt; P:multicellular organism development; P:metabolic process; P:glycolytic process; P:canonical glycolysis; P:glucose metabolic process; C:nucleus; C:extracellular space; F:protein binding; F:ubiquitin protein ligase binding; C:extracellular exosome; F:catalytic activity; P:glyceraldehyde-3-phosphate metabolic process; P:glyceraldehyde-3-phosphate biosynthetic process; F:triose-phosphate isomerase activity; C:cytosol; P:glycerol catabolic process; F:isomerase activity		
tr|F6R7J2|F6R7J2_HORSE	Isocitrate dehydrogenase [NADP] cytoplasmic	420	20	0E0	98.65%	22	P:GO:0060696; F:GO:0042803; F:GO:0016616; F:GO:0004450; P:GO:0006102; P:GO:0006099; P:GO:0071071; F:GO:0005102; P:GO:0006103; F:GO:0000287; P:GO:0006979; C:GO:0005777; F:GO:0004448; C:GO:0070062; C:GO:0005737; F:GO:0051287; F:GO:0046872; F:GO:0016491; P:GO:0006749; C:GO:0005739; C:GO:0005829; P:GO:0055114	P:regulation of phospholipid catabolic process; F:protein homodimerization activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:isocitrate dehydrogenase (NADP+) activity; P:isocitrate metabolic process; P:tricarboxylic acid cycle; P:regulation of phospholipid biosynthetic process; F:receptor binding; P:2-oxoglutarate metabolic process; F:magnesium ion binding; P:response to oxidative stress; C:peroxisome; F:isocitrate dehydrogenase activity; C:extracellular exosome; C:cytoplasm; F:NAD binding; F:metal ion binding; F:oxidoreductase activity; P:glutathione metabolic process; C:mitochondrion; C:cytosol; P:oxidation-reduction process		
sp|Q14ST5|S10A7_HORSE	S100-A7	101	20	7.51E-69	87.8%	18	P:GO:0050829; P:GO:0090026; C:GO:0005783; C:GO:0005576; P:GO:0000302; F:GO:0043621; C:GO:0005634; C:GO:0070062; C:GO:0005737; F:GO:0046872; F:GO:0005509; P:GO:0070374; P:GO:0010820; C:GO:0005829; P:GO:0032496; F:GO:0050786; P:GO:0071624; P:GO:0051238	P:defense response to Gram-negative bacterium; P:positive regulation of monocyte chemotaxis; C:endoplasmic reticulum; C:extracellular region; P:response to reactive oxygen species; F:protein self-association; C:nucleus; C:extracellular exosome; C:cytoplasm; F:metal ion binding; F:calcium ion binding; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of T cell chemotaxis; C:cytosol; P:response to lipopolysaccharide; F:RAGE receptor binding; P:positive regulation of granulocyte chemotaxis; P:sequestering of metal ion		
tr|F6R6Z6|F6R6Z6_HORSE	epithelial cell adhesion molecule	289	20	0E0	95.25%	20	C:GO:0016328; P:GO:0008284; P:GO:0023019; P:GO:0045944; C:GO:0005886; C:GO:0009986; F:GO:0098641; C:GO:0005887; C:GO:0005923; C:GO:0070062; P:GO:0048863; P:GO:0001657; P:GO:2000648; C:GO:0016020; C:GO:0016021; F:GO:0032403; P:GO:0098609; C:GO:0016323; C:GO:0016324; P:GO:2000048	C:lateral plasma membrane; P:positive regulation of cell proliferation; P:signal transduction involved in regulation of gene expression; P:positive regulation of transcription from RNA polymerase II promoter; C:plasma membrane; C:cell surface; F:cadherin binding involved in cell-cell adhesion; C:integral component of plasma membrane; C:bicellular tight junction; C:extracellular exosome; P:stem cell differentiation; P:ureteric bud development; P:positive regulation of stem cell proliferation; C:membrane; C:integral component of membrane; F:protein complex binding; P:cell-cell adhesion; C:basolateral plasma membrane; C:apical plasma membrane; P:negative regulation of cell-cell adhesion mediated by cadherin		
tr|F6SK75|F6SK75_HORSE	desmoglein-1	1035	20	0E0	89.9%	14	P:GO:0007155; P:GO:0007156; C:GO:0005886; C:GO:0009898; F:GO:0045295; C:GO:0005911; C:GO:0070062; F:GO:0046872; F:GO:0005509; C:GO:0016020; C:GO:0016021; C:GO:0030054; C:GO:0030057; P:GO:0050821	P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; C:plasma membrane; C:cytoplasmic side of plasma membrane; F:gamma-catenin binding; C:cell-cell junction; C:extracellular exosome; F:metal ion binding; F:calcium ion binding; C:membrane; C:integral component of membrane; C:cell junction; C:desmosome; P:protein stabilization		
tr|F7BU09|F7BU09_HORSE	glutathione S-transferase P-like	210	20	1.88E-153	95.05%	3	P:GO:0008152; F:GO:0004364; F:GO:0016740	P:metabolic process; F:glutathione transferase activity; F:transferase activity		
tr|F6WDY8|F6WDY8_HORSE	glucosylceramidase	536	20	0E0	95.1%	25	P:GO:0043407; P:GO:0006680; P:GO:0046512; P:GO:0046513; C:GO:0043202; P:GO:0006665; P:GO:0023021; C:GO:0070062; P:GO:0071356; F:GO:0016798; P:GO:0016239; P:GO:1903052; P:GO:0008152; P:GO:0009267; F:GO:0005102; C:GO:0005765; C:GO:0005764; F:GO:0004348; P:GO:0032715; P:GO:0005975; C:GO:0016020; P:GO:0006629; P:GO:0035307; P:GO:0032434; F:GO:0016787	P:negative regulation of MAP kinase activity; P:glucosylceramide catabolic process; P:sphingosine biosynthetic process; P:ceramide biosynthetic process; C:lysosomal lumen; P:sphingolipid metabolic process; P:termination of signal transduction; C:extracellular exosome; P:cellular response to tumor necrosis factor; F:hydrolase activity, acting on glycosyl bonds; P:positive regulation of macroautophagy; P:positive regulation of proteolysis involved in cellular protein catabolic process; P:metabolic process; P:cellular response to starvation; F:receptor binding; C:lysosomal membrane; C:lysosome; F:glucosylceramidase activity; P:negative regulation of interleukin-6 production; P:carbohydrate metabolic process; C:membrane; P:lipid metabolic process; P:positive regulation of protein dephosphorylation; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; F:hydrolase activity		
tr|F7D144|F7D144_HORSE	macrophage-capping	349	20	0E0	98.4%	12	P:GO:0051016; C:GO:0005634; F:GO:0019904; C:GO:0070062; F:GO:0003779; C:GO:0072686; C:GO:0005737; C:GO:0005814; C:GO:0090543; C:GO:0005730; F:GO:0032403; C:GO:0005654	P:barbed-end actin filament capping; C:nucleus; F:protein domain specific binding; C:extracellular exosome; F:actin binding; C:mitotic spindle; C:cytoplasm; C:centriole; C:Flemming body; C:nucleolus; F:protein complex binding; C:nucleoplasm		
tr|F6ZTR4|F6ZTR4_HORSE	tropomyosin alpha-3 chain isoform X1	285	20	0E0	100%	12	F:GO:0005515; C:GO:0005856; C:GO:0070062; F:GO:0003779; C:GO:0005737; P:GO:0006928; P:GO:0006936; C:GO:0001725; C:GO:0005829; C:GO:0005862; F:GO:0003674; P:GO:0030049	F:protein binding; C:cytoskeleton; C:extracellular exosome; F:actin binding; C:cytoplasm; P:movement of cell or subcellular component; P:muscle contraction; C:stress fiber; C:cytosol; C:muscle thin filament tropomyosin; F:molecular_function; P:muscle filament sliding		
tr|F6ZW10|F6ZW10_HORSE	ladinin-1 isoform X1	509	20	0E0	81.95%	2	C:GO:0070062; F:GO:0005198	C:extracellular exosome; F:structural molecule activity		
tr|F6T1M5|F6T1M5_HORSE	ladinin-1 isoform X1	509	20	0E0	82.45%	2	C:GO:0070062; F:GO:0005198	C:extracellular exosome; F:structural molecule activity		
tr|F6YYI3|F6YYI3_HORSE	S100-A8	89	20	1.12E-57	94.7%	33	F:GO:0035662; P:GO:0014002; F:GO:0016209; C:GO:0005576; P:GO:0006935; P:GO:0006954; C:GO:0070062; P:GO:0006914; F:GO:0005509; P:GO:0006915; P:GO:0070488; P:GO:0006919; P:GO:2001244; P:GO:0018119; F:GO:0008270; P:GO:0050729; P:GO:0002793; P:GO:0002376; C:GO:0005886; F:GO:0008017; C:GO:0005634; P:GO:0002523; C:GO:0005615; C:GO:0005856; F:GO:0046872; C:GO:0005737; P:GO:0045087; C:GO:0016020; P:GO:0098869; P:GO:0050727; P:GO:0030593; F:GO:0050544; F:GO:0050786	F:Toll-like receptor 4 binding; P:astrocyte development; F:antioxidant activity; C:extracellular region; P:chemotaxis; P:inflammatory response; C:extracellular exosome; P:autophagy; F:calcium ion binding; P:apoptotic process; P:neutrophil aggregation; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:peptidyl-cysteine S-nitrosylation; F:zinc ion binding; P:positive regulation of inflammatory response; P:positive regulation of peptide secretion; P:immune system process; C:plasma membrane; F:microtubule binding; C:nucleus; P:leukocyte migration involved in inflammatory response; C:extracellular space; C:cytoskeleton; F:metal ion binding; C:cytoplasm; P:innate immune response; C:membrane; P:cellular oxidant detoxification; P:regulation of inflammatory response; P:neutrophil chemotaxis; F:arachidonic acid binding; F:RAGE receptor binding		
tr|F6SSG3|F6SSG3_HORSE	collagen alpha-1(I) chain	1424	20	0E0	94.6%	38	P:GO:0015031; P:GO:0043589; C:GO:0005576; P:GO:0043588; P:GO:0060346; P:GO:0060325; C:GO:0005578; P:GO:0010718; P:GO:0007605; P:GO:0071230; P:GO:0001501; P:GO:0001568; P:GO:0010812; P:GO:0045893; P:GO:0001649; C:GO:0031012; P:GO:0034505; P:GO:0032964; P:GO:0070208; P:GO:0034504; F:GO:0042802; C:GO:0005581; P:GO:0060351; P:GO:0090263; C:GO:0005584; P:GO:0007601; P:GO:0048706; F:GO:0005201; P:GO:0048705; F:GO:0048407; C:GO:0005615; P:GO:0071260; F:GO:0046872; C:GO:0005737; P:GO:0001957; P:GO:0001958; P:GO:0030199; P:GO:0030335	P:protein transport; P:skin morphogenesis; C:extracellular region; P:skin development; P:bone trabecula formation; P:face morphogenesis; C:proteinaceous extracellular matrix; P:positive regulation of epithelial to mesenchymal transition; P:sensory perception of sound; P:cellular response to amino acid stimulus; P:skeletal system development; P:blood vessel development; P:negative regulation of cell-substrate adhesion; P:positive regulation of transcription, DNA-templated; P:osteoblast differentiation; C:extracellular matrix; P:tooth mineralization; P:collagen biosynthetic process; P:protein heterotrimerization; P:protein localization to nucleus; F:identical protein binding; C:collagen trimer; P:cartilage development involved in endochondral bone morphogenesis; P:positive regulation of canonical Wnt signaling pathway; C:collagen type I trimer; P:visual perception; P:embryonic skeletal system development; F:extracellular matrix structural constituent; P:skeletal system morphogenesis; F:platelet-derived growth factor binding; C:extracellular space; P:cellular response to mechanical stimulus; F:metal ion binding; C:cytoplasm; P:intramembranous ossification; P:endochondral ossification; P:collagen fibril organization; P:positive regulation of cell migration		
tr|F6RVX8|F6RVX8_HORSE	collagen alpha-1(I) chain	1432	20	0E0	94.85%	38	P:GO:0015031; P:GO:0043589; C:GO:0005576; P:GO:0043588; P:GO:0060346; P:GO:0060325; C:GO:0005578; P:GO:0010718; P:GO:0007605; P:GO:0071230; P:GO:0001501; P:GO:0001568; P:GO:0010812; P:GO:0045893; P:GO:0001649; C:GO:0031012; P:GO:0034505; P:GO:0032964; P:GO:0070208; P:GO:0034504; F:GO:0042802; C:GO:0005581; P:GO:0060351; P:GO:0090263; C:GO:0005584; P:GO:0007601; P:GO:0048706; F:GO:0005201; P:GO:0048705; F:GO:0048407; C:GO:0005615; P:GO:0071260; F:GO:0046872; C:GO:0005737; P:GO:0001957; P:GO:0001958; P:GO:0030199; P:GO:0030335	P:protein transport; P:skin morphogenesis; C:extracellular region; P:skin development; P:bone trabecula formation; P:face morphogenesis; C:proteinaceous extracellular matrix; P:positive regulation of epithelial to mesenchymal transition; P:sensory perception of sound; P:cellular response to amino acid stimulus; P:skeletal system development; P:blood vessel development; P:negative regulation of cell-substrate adhesion; P:positive regulation of transcription, DNA-templated; P:osteoblast differentiation; C:extracellular matrix; P:tooth mineralization; P:collagen biosynthetic process; P:protein heterotrimerization; P:protein localization to nucleus; F:identical protein binding; C:collagen trimer; P:cartilage development involved in endochondral bone morphogenesis; P:positive regulation of canonical Wnt signaling pathway; C:collagen type I trimer; P:visual perception; P:embryonic skeletal system development; F:extracellular matrix structural constituent; P:skeletal system morphogenesis; F:platelet-derived growth factor binding; C:extracellular space; P:cellular response to mechanical stimulus; F:metal ion binding; C:cytoplasm; P:intramembranous ossification; P:endochondral ossification; P:collagen fibril organization; P:positive regulation of cell migration		
tr|F7D939|F7D939_HORSE	collagen alpha-1(I) chain	1448	20	0E0	97.65%	71	P:GO:0055093; P:GO:0015031; C:GO:0005794; P:GO:0043589; P:GO:0043588; P:GO:0060325; P:GO:0007605; C:GO:0005788; P:GO:0042060; P:GO:0001501; P:GO:0001503; P:GO:0010812; P:GO:0045893; P:GO:0034505; P:GO:0032964; P:GO:0070208; P:GO:0034504; C:GO:0030141; P:GO:0060351; P:GO:0090263; P:GO:0007584; P:GO:0042542; P:GO:0043434; F:GO:0005201; F:GO:0048407; P:GO:0071560; F:GO:0005515; P:GO:0044691; F:GO:0046872; P:GO:0071364; P:GO:0001957; P:GO:0032355; P:GO:0001958; P:GO:0030574; P:GO:0031667; P:GO:0030335; P:GO:0051591; P:GO:0007596; C:GO:0005576; P:GO:0060346; C:GO:0005578; P:GO:0009612; P:GO:0010718; P:GO:0071230; P:GO:0001568; P:GO:0001649; P:GO:0071356; C:GO:0031012; P:GO:0030168; P:GO:0050776; F:GO:0042802; C:GO:0005581; P:GO:0044344; C:GO:0005783; C:GO:0005584; P:GO:0048545; P:GO:0007601; P:GO:0048706; P:GO:0048705; C:GO:0005615; P:GO:0071260; P:GO:1902617; P:GO:1902618; C:GO:0005737; P:GO:0071300; P:GO:0042493; P:GO:0030198; P:GO:0031960; P:GO:0050900; P:GO:0030199; P:GO:0071306	P:response to hyperoxia; P:protein transport; C:Golgi apparatus; P:skin morphogenesis; P:skin development; P:face morphogenesis; P:sensory perception of sound; C:endoplasmic reticulum lumen; P:wound healing; P:skeletal system development; P:ossification; P:negative regulation of cell-substrate adhesion; P:positive regulation of transcription, DNA-templated; P:tooth mineralization; P:collagen biosynthetic process; P:protein heterotrimerization; P:protein localization to nucleus; C:secretory granule; P:cartilage development involved in endochondral bone morphogenesis; P:positive regulation of canonical Wnt signaling pathway; P:response to nutrient; P:response to hydrogen peroxide; P:response to peptide hormone; F:extracellular matrix structural constituent; F:platelet-derived growth factor binding; P:cellular response to transforming growth factor beta stimulus; F:protein binding; P:tooth eruption; F:metal ion binding; P:cellular response to epidermal growth factor stimulus; P:intramembranous ossification; P:response to estradiol; P:endochondral ossification; P:collagen catabolic process; P:response to nutrient levels; P:positive regulation of cell migration; P:response to cAMP; P:blood coagulation; C:extracellular region; P:bone trabecula formation; C:proteinaceous extracellular matrix; P:response to mechanical stimulus; P:positive regulation of epithelial to mesenchymal transition; P:cellular response to amino acid stimulus; P:blood vessel development; P:osteoblast differentiation; P:cellular response to tumor necrosis factor; C:extracellular matrix; P:platelet activation; P:regulation of immune response; F:identical protein binding; C:collagen trimer; P:cellular response to fibroblast growth factor stimulus; C:endoplasmic reticulum; C:collagen type I trimer; P:response to steroid hormone; P:visual perception; P:embryonic skeletal system development; P:skeletal system morphogenesis; C:extracellular space; P:cellular response to mechanical stimulus; P:response to fluoride; P:cellular response to fluoride; C:cytoplasm; P:cellular response to retinoic acid; P:response to drug; P:extracellular matrix organization; P:response to corticosteroid; P:leukocyte migration; P:collagen fibril organization; P:cellular response to vitamin E		
tr|F7D9C7|F7D9C7_HORSE	collagen alpha-1(I) chain	1448	20	0E0	97.8%	71	P:GO:0055093; P:GO:0015031; C:GO:0005794; P:GO:0043589; P:GO:0043588; P:GO:0060325; P:GO:0007605; C:GO:0005788; P:GO:0042060; P:GO:0001501; P:GO:0001503; P:GO:0010812; P:GO:0045893; P:GO:0034505; P:GO:0032964; P:GO:0070208; P:GO:0034504; C:GO:0030141; P:GO:0060351; P:GO:0090263; P:GO:0007584; P:GO:0042542; P:GO:0043434; F:GO:0005201; F:GO:0048407; P:GO:0071560; F:GO:0005515; P:GO:0044691; F:GO:0046872; P:GO:0071364; P:GO:0001957; P:GO:0032355; P:GO:0001958; P:GO:0030574; P:GO:0031667; P:GO:0030335; P:GO:0051591; P:GO:0007596; C:GO:0005576; P:GO:0060346; C:GO:0005578; P:GO:0009612; P:GO:0010718; P:GO:0071230; P:GO:0001568; P:GO:0001649; P:GO:0071356; C:GO:0031012; P:GO:0030168; P:GO:0050776; F:GO:0042802; C:GO:0005581; P:GO:0044344; C:GO:0005783; C:GO:0005584; P:GO:0048545; P:GO:0007601; P:GO:0048706; P:GO:0048705; C:GO:0005615; P:GO:0071260; P:GO:1902617; P:GO:1902618; C:GO:0005737; P:GO:0071300; P:GO:0042493; P:GO:0030198; P:GO:0031960; P:GO:0050900; P:GO:0030199; P:GO:0071306	P:response to hyperoxia; P:protein transport; C:Golgi apparatus; P:skin morphogenesis; P:skin development; P:face morphogenesis; P:sensory perception of sound; C:endoplasmic reticulum lumen; P:wound healing; P:skeletal system development; P:ossification; P:negative regulation of cell-substrate adhesion; P:positive regulation of transcription, DNA-templated; P:tooth mineralization; P:collagen biosynthetic process; P:protein heterotrimerization; P:protein localization to nucleus; C:secretory granule; P:cartilage development involved in endochondral bone morphogenesis; P:positive regulation of canonical Wnt signaling pathway; P:response to nutrient; P:response to hydrogen peroxide; P:response to peptide hormone; F:extracellular matrix structural constituent; F:platelet-derived growth factor binding; P:cellular response to transforming growth factor beta stimulus; F:protein binding; P:tooth eruption; F:metal ion binding; P:cellular response to epidermal growth factor stimulus; P:intramembranous ossification; P:response to estradiol; P:endochondral ossification; P:collagen catabolic process; P:response to nutrient levels; P:positive regulation of cell migration; P:response to cAMP; P:blood coagulation; C:extracellular region; P:bone trabecula formation; C:proteinaceous extracellular matrix; P:response to mechanical stimulus; P:positive regulation of epithelial to mesenchymal transition; P:cellular response to amino acid stimulus; P:blood vessel development; P:osteoblast differentiation; P:cellular response to tumor necrosis factor; C:extracellular matrix; P:platelet activation; P:regulation of immune response; F:identical protein binding; C:collagen trimer; P:cellular response to fibroblast growth factor stimulus; C:endoplasmic reticulum; C:collagen type I trimer; P:response to steroid hormone; P:visual perception; P:embryonic skeletal system development; P:skeletal system morphogenesis; C:extracellular space; P:cellular response to mechanical stimulus; P:response to fluoride; P:cellular response to fluoride; C:cytoplasm; P:cellular response to retinoic acid; P:response to drug; P:extracellular matrix organization; P:response to corticosteroid; P:leukocyte migration; P:collagen fibril organization; P:cellular response to vitamin E		
tr|F6VUP8|F6VUP8_HORSE	collagen alpha-1(I) chain	1449	20	0E0	97.15%	36	P:GO:0015031; P:GO:0043589; P:GO:0043588; P:GO:0060346; P:GO:0060325; C:GO:0005578; P:GO:0010718; P:GO:0007605; P:GO:0071230; P:GO:0001501; P:GO:0001568; P:GO:0010812; P:GO:0045893; P:GO:0001649; C:GO:0031012; P:GO:0034505; P:GO:0032964; P:GO:0070208; P:GO:0034504; F:GO:0042802; C:GO:0005581; P:GO:0060351; P:GO:0090263; C:GO:0005584; P:GO:0007601; P:GO:0048706; F:GO:0005201; P:GO:0048705; F:GO:0048407; C:GO:0005615; P:GO:0071260; C:GO:0005737; P:GO:0001957; P:GO:0001958; P:GO:0030199; P:GO:0030335	P:protein transport; P:skin morphogenesis; P:skin development; P:bone trabecula formation; P:face morphogenesis; C:proteinaceous extracellular matrix; P:positive regulation of epithelial to mesenchymal transition; P:sensory perception of sound; P:cellular response to amino acid stimulus; P:skeletal system development; P:blood vessel development; P:negative regulation of cell-substrate adhesion; P:positive regulation of transcription, DNA-templated; P:osteoblast differentiation; C:extracellular matrix; P:tooth mineralization; P:collagen biosynthetic process; P:protein heterotrimerization; P:protein localization to nucleus; F:identical protein binding; C:collagen trimer; P:cartilage development involved in endochondral bone morphogenesis; P:positive regulation of canonical Wnt signaling pathway; C:collagen type I trimer; P:visual perception; P:embryonic skeletal system development; F:extracellular matrix structural constituent; P:skeletal system morphogenesis; F:platelet-derived growth factor binding; C:extracellular space; P:cellular response to mechanical stimulus; C:cytoplasm; P:intramembranous ossification; P:endochondral ossification; P:collagen fibril organization; P:positive regulation of cell migration		
tr|F7AW05|F7AW05_HORSE	tetranectin	202	20	2.69E-148	94.7%	17	P:GO:0030282; F:GO:0036143; F:GO:0008201; C:GO:0005576; C:GO:0001652; P:GO:0002576; P:GO:0071560; C:GO:0005615; C:GO:0070062; P:GO:0071310; C:GO:0005737; P:GO:0001503; F:GO:0005509; P:GO:0010756; C:GO:0031012; C:GO:0031089; F:GO:0030246	P:bone mineralization; F:kringle domain binding; F:heparin binding; C:extracellular region; C:granular component; P:platelet degranulation; P:cellular response to transforming growth factor beta stimulus; C:extracellular space; C:extracellular exosome; P:cellular response to organic substance; C:cytoplasm; P:ossification; F:calcium ion binding; P:positive regulation of plasminogen activation; C:extracellular matrix; C:platelet dense granule lumen; F:carbohydrate binding		
tr|F6YY66|F6YY66_HORSE	nucleoside diphosphate kinase B	227	20	7.35E-163	94.35%	40	P:GO:0006163; P:GO:0006241; P:GO:0006183; P:GO:0006165; P:GO:0006220; P:GO:0007155; P:GO:0045944; C:GO:0042995; P:GO:0009117; F:GO:0000166; F:GO:0005524; F:GO:0003700; P:GO:0007229; C:GO:0070062; C:GO:0005925; P:GO:0015949; C:GO:0001726; C:GO:0005829; P:GO:0098779; P:GO:0016310; P:GO:0050679; C:GO:0030027; P:GO:0045618; P:GO:0006351; P:GO:0009142; P:GO:0006355; F:GO:0004550; F:GO:0004673; F:GO:0003677; C:GO:0005634; P:GO:0006228; F:GO:0005515; F:GO:0046872; C:GO:0005737; P:GO:0043066; P:GO:0045682; F:GO:0016740; F:GO:0016301; P:GO:0018106; C:GO:0071944	P:purine nucleotide metabolic process; P:CTP biosynthetic process; P:GTP biosynthetic process; P:nucleoside diphosphate phosphorylation; P:pyrimidine nucleotide metabolic process; P:cell adhesion; P:positive regulation of transcription from RNA polymerase II promoter; C:cell projection; P:nucleotide metabolic process; F:nucleotide binding; F:ATP binding; F:transcription factor activity, sequence-specific DNA binding; P:integrin-mediated signaling pathway; C:extracellular exosome; C:focal adhesion; P:nucleobase-containing small molecule interconversion; C:ruffle; C:cytosol; P:mitophagy in response to mitochondrial depolarization; P:phosphorylation; P:positive regulation of epithelial cell proliferation; C:lamellipodium; P:positive regulation of keratinocyte differentiation; P:transcription, DNA-templated; P:nucleoside triphosphate biosynthetic process; P:regulation of transcription, DNA-templated; F:nucleoside diphosphate kinase activity; F:protein histidine kinase activity; F:DNA binding; C:nucleus; P:UTP biosynthetic process; F:protein binding; F:metal ion binding; C:cytoplasm; P:negative regulation of apoptotic process; P:regulation of epidermis development; F:transferase activity; F:kinase activity; P:peptidyl-histidine phosphorylation; C:cell periphery		
tr|F6R3F4|F6R3F4_HORSE	inter-alpha-trypsin inhibitor heavy chain H4 isoform X1	941	20	0E0	80.7%	16	P:GO:0034097; C:GO:0005576; P:GO:0006953; C:GO:0005886; P:GO:0002576; F:GO:0030414; F:GO:0004867; F:GO:0005515; F:GO:0004866; C:GO:0070062; C:GO:0005737; C:GO:0072562; P:GO:0010951; C:GO:0031089; P:GO:0030212; P:GO:0010466	P:response to cytokine; C:extracellular region; P:acute-phase response; C:plasma membrane; P:platelet degranulation; F:peptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity; F:protein binding; F:endopeptidase inhibitor activity; C:extracellular exosome; C:cytoplasm; C:blood microparticle; P:negative regulation of endopeptidase activity; C:platelet dense granule lumen; P:hyaluronan metabolic process; P:negative regulation of peptidase activity		
tr|F7BXA6|F7BXA6_HORSE	puromycin-sensitive aminopeptidase	806	20	0E0	99.15%	11	F:GO:0008270; P:GO:0043171; C:GO:0070062; C:GO:0005737; P:GO:0006508; F:GO:0070006; F:GO:0042277; P:GO:0071456; P:GO:1903955; C:GO:0005886; F:GO:0008237	F:zinc ion binding; P:peptide catabolic process; C:extracellular exosome; C:cytoplasm; P:proteolysis; F:metalloaminopeptidase activity; F:peptide binding; P:cellular response to hypoxia; P:positive regulation of protein targeting to mitochondrion; C:plasma membrane; F:metallopeptidase activity		
tr|F6XA04|F6XA04_HORSE	14-3-3 epsilon isoform X1	233	20	3.32E-172	99.7%	49	C:GO:0005871; P:GO:1902309; F:GO:0046982; P:GO:0043154; C:GO:0005829; F:GO:0032403; P:GO:0035556; C:GO:0030424; F:GO:0019904; F:GO:0019903; F:GO:0042826; P:GO:1900740; P:GO:0003064; P:GO:0021987; F:GO:0044325; P:GO:0006605; C:GO:0030659; F:GO:0005515; F:GO:0031625; C:GO:0005913; C:GO:0042470; F:GO:0051219; P:GO:0086091; P:GO:0035308; P:GO:0086013; P:GO:1900034; P:GO:0060306; P:GO:0001764; C:GO:0070062; P:GO:0000086; C:GO:0005925; P:GO:0016032; F:GO:0050815; P:GO:0061024; P:GO:0021766; P:GO:1901016; F:GO:0023026; F:GO:0004497; P:GO:0021762; F:GO:0044822; F:GO:0098641; C:GO:0005737; C:GO:0016020; C:GO:0005739; P:GO:0035329; P:GO:0055114; P:GO:0071901; F:GO:0015459; F:GO:0019899	C:kinesin complex; P:negative regulation of peptidyl-serine dephosphorylation; F:protein heterodimerization activity; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; C:cytosol; F:protein complex binding; P:intracellular signal transduction; C:axon; F:protein domain specific binding; F:protein phosphatase binding; F:histone deacetylase binding; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of heart rate by hormone; P:cerebral cortex development; F:ion channel binding; P:protein targeting; C:cytoplasmic vesicle membrane; F:protein binding; F:ubiquitin protein ligase binding; C:cell-cell adherens junction; C:melanosome; F:phosphoprotein binding; P:regulation of heart rate by cardiac conduction; P:negative regulation of protein dephosphorylation; P:membrane repolarization during cardiac muscle cell action potential; P:regulation of cellular response to heat; P:regulation of membrane repolarization; P:neuron migration; C:extracellular exosome; P:G2/M transition of mitotic cell cycle; C:focal adhesion; P:viral process; F:phosphoserine binding; P:membrane organization; P:hippocampus development; P:regulation of potassium ion transmembrane transporter activity; F:MHC class II protein complex binding; F:monooxygenase activity; P:substantia nigra development; F:poly(A) RNA binding; F:cadherin binding involved in cell-cell adhesion; C:cytoplasm; C:membrane; C:mitochondrion; P:hippo signaling; P:oxidation-reduction process; P:negative regulation of protein serine/threonine kinase activity; F:potassium channel regulator activity; F:enzyme binding		
tr|F7DZV9|F7DZV9_HORSE	14-3-3 beta alpha	246	20	0E0	99.75%	36	F:GO:0008022; P:GO:0043488; P:GO:0051291; P:GO:0045744; P:GO:0000165; C:GO:0070062; C:GO:0005925; P:GO:0051220; P:GO:0045892; P:GO:0016032; C:GO:0005829; F:GO:0050815; P:GO:0016310; F:GO:0032403; P:GO:0061024; F:GO:0019904; F:GO:0042826; P:GO:1900740; C:GO:0043234; P:GO:0006605; C:GO:0005634; C:GO:0030659; C:GO:0048471; F:GO:0005515; P:GO:0043085; C:GO:0042470; C:GO:0005737; F:GO:0003714; C:GO:0017053; C:GO:0016020; C:GO:0005739; P:GO:0035329; F:GO:0051219; P:GO:0035308; F:GO:0016301; F:GO:0019899	F:protein C-terminus binding; P:regulation of mRNA stability; P:protein heterooligomerization; P:negative regulation of G-protein coupled receptor protein signaling pathway; P:MAPK cascade; C:extracellular exosome; C:focal adhesion; P:cytoplasmic sequestering of protein; P:negative regulation of transcription, DNA-templated; P:viral process; C:cytosol; F:phosphoserine binding; P:phosphorylation; F:protein complex binding; P:membrane organization; F:protein domain specific binding; F:histone deacetylase binding; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; C:protein complex; P:protein targeting; C:nucleus; C:cytoplasmic vesicle membrane; C:perinuclear region of cytoplasm; F:protein binding; P:positive regulation of catalytic activity; C:melanosome; C:cytoplasm; F:transcription corepressor activity; C:transcriptional repressor complex; C:membrane; C:mitochondrion; P:hippo signaling; F:phosphoprotein binding; P:negative regulation of protein dephosphorylation; F:kinase activity; F:enzyme binding		
tr|F6XQQ9|F6XQQ9_HORSE	glutathione S-transferase A1	222	20	9.44E-161	93.25%	3	P:GO:0008152; F:GO:0004364; F:GO:0016740	P:metabolic process; F:glutathione transferase activity; F:transferase activity		
tr|F6ZUT4|F6ZUT4_HORSE	anterior gradient 2 homolog	175	20	6.96E-126	97.9%	17	F:GO:0042803; P:GO:0060480; P:GO:0090004; F:GO:0005154; P:GO:0045742; P:GO:0060548; F:GO:0002162; P:GO:1903899; P:GO:1903896; C:GO:0005783; P:GO:0048546; P:GO:0048639; C:GO:0005615; P:GO:0070254; P:GO:0010628; C:GO:0005739; P:GO:0010811	F:protein homodimerization activity; P:lung goblet cell differentiation; P:positive regulation of establishment of protein localization to plasma membrane; F:epidermal growth factor receptor binding; P:positive regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of cell death; F:dystroglycan binding; P:positive regulation of PERK-mediated unfolded protein response; P:positive regulation of IRE1-mediated unfolded protein response; C:endoplasmic reticulum; P:digestive tract morphogenesis; P:positive regulation of developmental growth; C:extracellular space; P:mucus secretion; P:positive regulation of gene expression; C:mitochondrion; P:positive regulation of cell-substrate adhesion		
tr|F7D5X8|F7D5X8_HORSE	type II cytoskeletal 4	604	20	0E0	90.75%	10	P:GO:0030855; C:GO:0005634; F:GO:0005515; C:GO:0045095; P:GO:0007010; C:GO:0045111; P:GO:0050680; F:GO:0005198; C:GO:0005882; C:GO:0009986	P:epithelial cell differentiation; C:nucleus; F:protein binding; C:keratin filament; P:cytoskeleton organization; C:intermediate filament cytoskeleton; P:negative regulation of epithelial cell proliferation; F:structural molecule activity; C:intermediate filament; C:cell surface		
sp|P02561|TPM4_HORSE	tropomyosin alpha-4 chain isoform X3	248	20	7.49E-166	99.5%	21	C:GO:0005862; F:GO:0003674; C:GO:0002102; C:GO:0005856; F:GO:0005515; C:GO:0070062; F:GO:0008307; F:GO:0003779; C:GO:0005925; C:GO:0005737; F:GO:0046872; P:GO:0006928; P:GO:0006936; F:GO:0005509; C:GO:0016020; C:GO:0001725; P:GO:0001649; C:GO:0005829; C:GO:0031941; C:GO:0030863; P:GO:0030049	C:muscle thin filament tropomyosin; F:molecular_function; C:podosome; C:cytoskeleton; F:protein binding; C:extracellular exosome; F:structural constituent of muscle; F:actin binding; C:focal adhesion; C:cytoplasm; F:metal ion binding; P:movement of cell or subcellular component; P:muscle contraction; F:calcium ion binding; C:membrane; C:stress fiber; P:osteoblast differentiation; C:cytosol; C:filamentous actin; C:cortical cytoskeleton; P:muscle filament sliding		
tr|F7BXD8|F7BXD8_HORSE	CD5 antigen-like	330	20	0E0	82.45%	5	C:GO:0070062; C:GO:0072562; C:GO:0016020; F:GO:0005044; P:GO:0006898	C:extracellular exosome; C:blood microparticle; C:membrane; F:scavenger receptor activity; P:receptor-mediated endocytosis		
sp|P01958|HBA_HORSE	hemoglobin subunit alpha	142	20	1.23E-97	98.65%	8	F:GO:0019825; C:GO:0005833; F:GO:0005506; F:GO:0046872; P:GO:0015671; F:GO:0005344; P:GO:0006810; F:GO:0020037	F:oxygen binding; C:hemoglobin complex; F:iron ion binding; F:metal ion binding; P:oxygen transport; F:oxygen transporter activity; P:transport; F:heme binding		
tr|C6L1J5|C6L1J5_HORSE	lactate dehydrogenase B	333	20	0E0	99.1%	22	F:GO:0042802; C:GO:0043209; F:GO:0016616; P:GO:0006089; P:GO:0005975; F:GO:0004457; F:GO:0004459; F:GO:0005515; C:GO:0070062; C:GO:0005737; F:GO:0003824; F:GO:0051287; F:GO:0016491; C:GO:0005739; C:GO:0016020; C:GO:0045121; P:GO:0019674; C:GO:0005829; P:GO:0055114; P:GO:0019752; P:GO:0006090; F:GO:0019900	F:identical protein binding; C:myelin sheath; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; P:lactate metabolic process; P:carbohydrate metabolic process; F:lactate dehydrogenase activity; F:L-lactate dehydrogenase activity; F:protein binding; C:extracellular exosome; C:cytoplasm; F:catalytic activity; F:NAD binding; F:oxidoreductase activity; C:mitochondrion; C:membrane; C:membrane raft; P:NAD metabolic process; C:cytosol; P:oxidation-reduction process; P:carboxylic acid metabolic process; P:pyruvate metabolic process; F:kinase binding		
tr|F7BWJ9|F7BWJ9_HORSE	cysteine-rich secretory 2	245	20	0E0	90.7%	6	P:GO:0016337; P:GO:0007283; C:GO:0042581; P:GO:0009566; C:GO:0005576; F:GO:0003674	P:single organismal cell-cell adhesion; P:spermatogenesis; C:specific granule; P:fertilization; C:extracellular region; F:molecular_function		
tr|F6VE52|F6VE52_HORSE	type II cytoskeletal 3	624	20	0E0	95.55%	5	C:GO:0045095; C:GO:0070062; F:GO:0005198; P:GO:0045104; C:GO:0005882	C:keratin filament; C:extracellular exosome; F:structural molecule activity; P:intermediate filament cytoskeleton organization; C:intermediate filament		
tr|F6W7V0|F6W7V0_HORSE	type II cytoskeletal 5	593	20	0E0	97.1%	10	F:GO:0097110; C:GO:0005634; C:GO:0070062; C:GO:0045095; C:GO:0005737; C:GO:0005739; C:GO:0016020; F:GO:0005198; C:GO:0005882; C:GO:0005886	F:scaffold protein binding; C:nucleus; C:extracellular exosome; C:keratin filament; C:cytoplasm; C:mitochondrion; C:membrane; F:structural molecule activity; C:intermediate filament; C:plasma membrane		
tr|F6W8W3|F6W8W3_HORSE	type I cytoskeletal 24	506	20	0E0	94.3%	5	C:GO:0070062; C:GO:0045111; C:GO:0005737; F:GO:0005198; C:GO:0005882	C:extracellular exosome; C:intermediate filament cytoskeleton; C:cytoplasm; F:structural molecule activity; C:intermediate filament		
tr|F7CAB1|F7CAB1_HORSE	epithelial chloride channel -like	904	20	0E0	92.4%	15	P:GO:1902476; F:GO:0005262; F:GO:0005244; F:GO:0005254; P:GO:0006821; P:GO:0006810; C:GO:0034707; P:GO:0006811; F:GO:0005229; C:GO:0016020; P:GO:0006816; C:GO:0016021; P:GO:0034765; P:GO:0070588; C:GO:0031226	P:chloride transmembrane transport; F:calcium channel activity; F:voltage-gated ion channel activity; F:chloride channel activity; P:chloride transport; P:transport; C:chloride channel complex; P:ion transport; F:intracellular calcium activated chloride channel activity; C:membrane; P:calcium ion transport; C:integral component of membrane; P:regulation of ion transmembrane transport; P:calcium ion transmembrane transport; C:intrinsic component of plasma membrane		
tr|F6YKZ7|F6YKZ7_HORSE	type II cytoskeletal 8	485	20	0E0	81.95%	21	P:GO:0051707; F:GO:0005198; P:GO:0097191; P:GO:0045214; C:GO:0005882; P:GO:0097284; C:GO:0005654; C:GO:0030018; F:GO:0097110; C:GO:0005634; P:GO:0033209; C:GO:0005911; F:GO:0005515; C:GO:0070062; C:GO:0045095; C:GO:0005737; P:GO:0060706; C:GO:0042383; C:GO:0016010; C:GO:0016363; C:GO:0071944	P:response to other organism; F:structural molecule activity; P:extrinsic apoptotic signaling pathway; P:sarcomere organization; C:intermediate filament; P:hepatocyte apoptotic process; C:nucleoplasm; C:Z disc; F:scaffold protein binding; C:nucleus; P:tumor necrosis factor-mediated signaling pathway; C:cell-cell junction; F:protein binding; C:extracellular exosome; C:keratin filament; C:cytoplasm; P:cell differentiation involved in embryonic placenta development; C:sarcolemma; C:dystrophin-associated glycoprotein complex; C:nuclear matrix; C:cell periphery		
tr|F6WKL7|F6WKL7_HORSE	type II cytoskeletal 8	492	20	0E0	82.65%	18	P:GO:0051707; P:GO:0097191; F:GO:0005198; C:GO:0005882; P:GO:0097284; C:GO:0005654; C:GO:0030018; F:GO:0097110; C:GO:0005634; P:GO:0033209; C:GO:0005911; C:GO:0045095; C:GO:0070062; C:GO:0005737; P:GO:0060706; C:GO:0042383; C:GO:0016363; C:GO:0071944	P:response to other organism; P:extrinsic apoptotic signaling pathway; F:structural molecule activity; C:intermediate filament; P:hepatocyte apoptotic process; C:nucleoplasm; C:Z disc; F:scaffold protein binding; C:nucleus; P:tumor necrosis factor-mediated signaling pathway; C:cell-cell junction; C:keratin filament; C:extracellular exosome; C:cytoplasm; P:cell differentiation involved in embryonic placenta development; C:sarcolemma; C:nuclear matrix; C:cell periphery		
tr|F6ZSB4|F6ZSB4_HORSE	tubulin alpha-1A chain	451	20	0E0	99.85%	28	C:GO:0043209; P:GO:0007010; F:GO:0005198; P:GO:0021634; C:GO:0005874; P:GO:0007017; F:GO:0005525; P:GO:0051301; F:GO:0000166; C:GO:0070062; P:GO:0000086; P:GO:0030705; F:GO:0003725; F:GO:0003924; P:GO:0071353; C:GO:0005829; C:GO:0036464; F:GO:0019904; F:GO:0005200; C:GO:0005881; P:GO:0000226; C:GO:0005634; C:GO:0005856; F:GO:0005515; F:GO:0031625; C:GO:0005737; P:GO:0043066; C:GO:0055037	C:myelin sheath; P:cytoskeleton organization; F:structural molecule activity; P:optic nerve formation; C:microtubule; P:microtubule-based process; F:GTP binding; P:cell division; F:nucleotide binding; C:extracellular exosome; P:G2/M transition of mitotic cell cycle; P:cytoskeleton-dependent intracellular transport; F:double-stranded RNA binding; F:GTPase activity; P:cellular response to interleukin-4; C:cytosol; C:cytoplasmic ribonucleoprotein granule; F:protein domain specific binding; F:structural constituent of cytoskeleton; C:cytoplasmic microtubule; P:microtubule cytoskeleton organization; C:nucleus; C:cytoskeleton; F:protein binding; F:ubiquitin protein ligase binding; C:cytoplasm; P:negative regulation of apoptotic process; C:recycling endosome		
tr|F7ANC9|F7ANC9_HORSE	tubulin alpha-1A chain	454	20	0E0	99.7%	29	C:GO:0043209; P:GO:0007010; F:GO:0005198; P:GO:0021634; C:GO:0005874; P:GO:0007017; F:GO:0005525; P:GO:0051301; F:GO:0000166; C:GO:0070062; P:GO:0000086; P:GO:0030705; F:GO:0003725; F:GO:0003924; P:GO:0071353; C:GO:0005829; C:GO:0036464; F:GO:0019904; F:GO:0005200; C:GO:0005881; P:GO:0000226; C:GO:0005634; C:GO:0005856; F:GO:0005515; F:GO:0031625; C:GO:0005737; P:GO:0043066; C:GO:0055037; C:GO:0030496	C:myelin sheath; P:cytoskeleton organization; F:structural molecule activity; P:optic nerve formation; C:microtubule; P:microtubule-based process; F:GTP binding; P:cell division; F:nucleotide binding; C:extracellular exosome; P:G2/M transition of mitotic cell cycle; P:cytoskeleton-dependent intracellular transport; F:double-stranded RNA binding; F:GTPase activity; P:cellular response to interleukin-4; C:cytosol; C:cytoplasmic ribonucleoprotein granule; F:protein domain specific binding; F:structural constituent of cytoskeleton; C:cytoplasmic microtubule; P:microtubule cytoskeleton organization; C:nucleus; C:cytoskeleton; F:protein binding; F:ubiquitin protein ligase binding; C:cytoplasm; P:negative regulation of apoptotic process; C:recycling endosome; C:midbody		
tr|F6SAV5|F6SAV5_HORSE	Tubulin alpha-1D chain	455	20	0E0	99%	8	F:GO:0000166; F:GO:0005525; C:GO:0005856; C:GO:0005737; F:GO:0003924; F:GO:0005200; C:GO:0005874; P:GO:0007017	F:nucleotide binding; F:GTP binding; C:cytoskeleton; C:cytoplasm; F:GTPase activity; F:structural constituent of cytoskeleton; C:microtubule; P:microtubule-based process		
tr|F6YRE0|F6YRE0_HORSE	tubulin alpha-1C chain	449	20	0E0	99.15%	17	P:GO:0008150; F:GO:0005198; F:GO:0005200; C:GO:0005881; F:GO:0003674; C:GO:0005874; P:GO:0007017; F:GO:0000166; F:GO:0005525; P:GO:0051301; C:GO:0005634; C:GO:0005856; F:GO:0005515; P:GO:0030705; C:GO:0005737; F:GO:0003924; C:GO:0031982	P:biological_process; F:structural molecule activity; F:structural constituent of cytoskeleton; C:cytoplasmic microtubule; F:molecular_function; C:microtubule; P:microtubule-based process; F:nucleotide binding; F:GTP binding; P:cell division; C:nucleus; C:cytoskeleton; F:protein binding; P:cytoskeleton-dependent intracellular transport; C:cytoplasm; F:GTPase activity; C:vesicle		
tr|F7B3I5|F7B3I5_HORSE	afamin	593	20	0E0	92.7%	6	C:GO:0005615; C:GO:0070062; C:GO:0072562; F:GO:0008431; P:GO:0006810; P:GO:0051180	C:extracellular space; C:extracellular exosome; C:blood microparticle; F:vitamin E binding; P:transport; P:vitamin transport		
tr|F6VS95|F6VS95_HORSE	disulfide-isomerase A6	440	20	0E0	98.6%	18	P:GO:0036498; P:GO:0043277; P:GO:0045454; C:GO:0005783; C:GO:0005793; P:GO:0006457; C:GO:0005886; C:GO:0005789; C:GO:0005788; C:GO:0005623; F:GO:0005515; F:GO:0003756; C:GO:0070062; C:GO:0042470; C:GO:0016020; C:GO:0034663; P:GO:0034976; F:GO:0016853	P:IRE1-mediated unfolded protein response; P:apoptotic cell clearance; P:cell redox homeostasis; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; P:protein folding; C:plasma membrane; C:endoplasmic reticulum membrane; C:endoplasmic reticulum lumen; C:cell; F:protein binding; F:protein disulfide isomerase activity; C:extracellular exosome; C:melanosome; C:membrane; C:endoplasmic reticulum chaperone complex; P:response to endoplasmic reticulum stress; F:isomerase activity		
tr|F6RVI6|F6RVI6_HORSE	mammaglobin-B-like	93	20	2.83E-61	81.7%	3	C:GO:0005615; F:GO:0046982; P:GO:0030521	C:extracellular space; F:protein heterodimerization activity; P:androgen receptor signaling pathway		
tr|F6RLT8|F6RLT8_HORSE	calpain small subunit 1	265	20	0E0	97%	13	P:GO:0022617; P:GO:0008284; F:GO:0004198; C:GO:0005886; F:GO:0005515; C:GO:0070062; C:GO:0005737; F:GO:0046872; F:GO:0005509; P:GO:0006508; C:GO:0016020; P:GO:0016241; C:GO:0005829	P:extracellular matrix disassembly; P:positive regulation of cell proliferation; F:calcium-dependent cysteine-type endopeptidase activity; C:plasma membrane; F:protein binding; C:extracellular exosome; C:cytoplasm; F:metal ion binding; F:calcium ion binding; P:proteolysis; C:membrane; P:regulation of macroautophagy; C:cytosol		
tr|F7CQT0|F7CQT0_HORSE	fatty acid synthase	2508	20	0E0	94.25%	31	F:GO:0016788; C:GO:0005794; F:GO:0004320; P:GO:0009058; F:GO:0004315; F:GO:0004314; F:GO:0004317; F:GO:0004316; C:GO:0070062; F:GO:0004319; F:GO:0003824; F:GO:0016491; P:GO:0071353; F:GO:0016295; P:GO:0001649; F:GO:0016296; F:GO:0016297; F:GO:0031177; P:GO:0008152; P:GO:0006633; C:GO:0042587; C:GO:0005886; F:GO:0004313; F:GO:0004312; F:GO:0044822; P:GO:0030879; C:GO:0005737; C:GO:0016020; C:GO:0005739; P:GO:0055114; F:GO:0016740	F:hydrolase activity, acting on ester bonds; C:Golgi apparatus; F:oleoyl-[acyl-carrier-protein] hydrolase activity; P:biosynthetic process; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; F:[acyl-carrier-protein] S-malonyltransferase activity; F:3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity; F:3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; C:extracellular exosome; F:enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity; F:catalytic activity; F:oxidoreductase activity; P:cellular response to interleukin-4; F:myristoyl-[acyl-carrier-protein] hydrolase activity; P:osteoblast differentiation; F:palmitoyl-[acyl-carrier-protein] hydrolase activity; F:acyl-[acyl-carrier-protein] hydrolase activity; F:phosphopantetheine binding; P:metabolic process; P:fatty acid biosynthetic process; C:glycogen granule; C:plasma membrane; F:[acyl-carrier-protein] S-acetyltransferase activity; F:fatty acid synthase activity; F:poly(A) RNA binding; P:mammary gland development; C:cytoplasm; C:membrane; C:mitochondrion; P:oxidation-reduction process; F:transferase activity		
tr|F7DDN1|F7DDN1_HORSE	fatty acid synthase	2519	20	0E0	94.35%	31	F:GO:0016788; C:GO:0005794; F:GO:0004320; P:GO:0009058; F:GO:0004315; F:GO:0004314; F:GO:0004317; F:GO:0004316; C:GO:0070062; F:GO:0004319; F:GO:0003824; F:GO:0016491; P:GO:0071353; F:GO:0016295; P:GO:0001649; F:GO:0016296; F:GO:0016297; F:GO:0031177; P:GO:0008152; P:GO:0006633; C:GO:0042587; C:GO:0005886; F:GO:0004313; F:GO:0004312; F:GO:0044822; P:GO:0030879; C:GO:0005737; C:GO:0016020; C:GO:0005739; P:GO:0055114; F:GO:0016740	F:hydrolase activity, acting on ester bonds; C:Golgi apparatus; F:oleoyl-[acyl-carrier-protein] hydrolase activity; P:biosynthetic process; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; F:[acyl-carrier-protein] S-malonyltransferase activity; F:3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity; F:3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; C:extracellular exosome; F:enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity; F:catalytic activity; F:oxidoreductase activity; P:cellular response to interleukin-4; F:myristoyl-[acyl-carrier-protein] hydrolase activity; P:osteoblast differentiation; F:palmitoyl-[acyl-carrier-protein] hydrolase activity; F:acyl-[acyl-carrier-protein] hydrolase activity; F:phosphopantetheine binding; P:metabolic process; P:fatty acid biosynthetic process; C:glycogen granule; C:plasma membrane; F:[acyl-carrier-protein] S-acetyltransferase activity; F:fatty acid synthase activity; F:poly(A) RNA binding; P:mammary gland development; C:cytoplasm; C:membrane; C:mitochondrion; P:oxidation-reduction process; F:transferase activity		
tr|F6Q3P2|F6Q3P2_HORSE	trefoil factor 1	83	20	5.75E-52	80%	12	P:GO:0005975; F:GO:0008083; C:GO:0005615; F:GO:0005515; P:GO:0008285; P:GO:0030154; P:GO:0010039; P:GO:0007586; P:GO:0030277; P:GO:0035902; C:GO:0005576; P:GO:0043434	P:carbohydrate metabolic process; F:growth factor activity; C:extracellular space; F:protein binding; P:negative regulation of cell proliferation; P:cell differentiation; P:response to iron ion; P:digestion; P:maintenance of gastrointestinal epithelium; P:response to immobilization stress; C:extracellular region; P:response to peptide hormone		
tr|F6ZBH0|F6ZBH0_HORSE	signal transducer and activator of transcription 1-alpha beta	749	20	0E0	98.55%	47	P:GO:0034097; P:GO:0016525; F:GO:0000979; F:GO:0000978; P:GO:0008284; F:GO:0003690; P:GO:0051591; P:GO:0043124; P:GO:0045944; C:GO:0005730; C:GO:0005654; P:GO:0007259; P:GO:0032869; P:GO:0048661; F:GO:0003700; P:GO:0072162; P:GO:0045893; P:GO:0006915; P:GO:0006919; P:GO:0035456; P:GO:0072308; P:GO:0035458; F:GO:0042802; P:GO:0060333; F:GO:0042803; P:GO:0006351; P:GO:0007165; F:GO:0005164; P:GO:0006355; P:GO:0008015; P:GO:0007584; P:GO:0046725; F:GO:0004871; P:GO:0043434; F:GO:0000983; P:GO:0061326; P:GO:0006357; P:GO:0060337; F:GO:0003677; C:GO:0005634; P:GO:0033209; C:GO:0000790; C:GO:0048471; P:GO:0072136; C:GO:0005737; P:GO:0001937; F:GO:0019899	P:response to cytokine; P:negative regulation of angiogenesis; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; P:positive regulation of cell proliferation; F:double-stranded DNA binding; P:response to cAMP; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of transcription from RNA polymerase II promoter; C:nucleolus; C:nucleoplasm; P:JAK-STAT cascade; P:cellular response to insulin stimulus; P:positive regulation of smooth muscle cell proliferation; F:transcription factor activity, sequence-specific DNA binding; P:metanephric mesenchymal cell differentiation; P:positive regulation of transcription, DNA-templated; P:apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:response to interferon-beta; P:negative regulation of metanephric nephron tubule epithelial cell differentiation; P:cellular response to interferon-beta; F:identical protein binding; P:interferon-gamma-mediated signaling pathway; F:protein homodimerization activity; P:transcription, DNA-templated; P:signal transduction; F:tumor necrosis factor receptor binding; P:regulation of transcription, DNA-templated; P:blood circulation; P:response to nutrient; P:negative regulation by virus of viral protein levels in host cell; F:signal transducer activity; P:response to peptide hormone; F:transcription factor activity, RNA polymerase II core promoter sequence-specific; P:renal tubule development; P:regulation of transcription from RNA polymerase II promoter; P:type I interferon signaling pathway; F:DNA binding; C:nucleus; P:tumor necrosis factor-mediated signaling pathway; C:nuclear chromatin; C:perinuclear region of cytoplasm; P:metanephric mesenchymal cell proliferation involved in metanephros development; C:cytoplasm; P:negative regulation of endothelial cell proliferation; F:enzyme binding		
tr|F6VUW2|F6VUW2_HORSE	cathepsin S isoform X1	330	20	0E0	94.8%	23	F:GO:0004197; P:GO:0002250; F:GO:0008234; F:GO:0008233; F:GO:0043236; C:GO:0005764; P:GO:0097067; C:GO:0005615; P:GO:0006955; F:GO:0005518; F:GO:0043394; C:GO:0043231; P:GO:0048002; P:GO:0006508; F:GO:0001968; P:GO:0019882; P:GO:2001259; P:GO:0016485; P:GO:0030574; P:GO:0010447; P:GO:0034769; P:GO:0051603; F:GO:0016787	F:cysteine-type endopeptidase activity; P:adaptive immune response; F:cysteine-type peptidase activity; F:peptidase activity; F:laminin binding; C:lysosome; P:cellular response to thyroid hormone stimulus; C:extracellular space; P:immune response; F:collagen binding; F:proteoglycan binding; C:intracellular membrane-bounded organelle; P:antigen processing and presentation of peptide antigen; P:proteolysis; F:fibronectin binding; P:antigen processing and presentation; P:positive regulation of cation channel activity; P:protein processing; P:collagen catabolic process; P:response to acidic pH; P:basement membrane disassembly; P:proteolysis involved in cellular protein catabolic process; F:hydrolase activity		
tr|F6SG30|F6SG30_HORSE	S100-A9-like isoform X2	155	20	9.76E-104	91.7%	9	F:GO:0035662; F:GO:0008270; F:GO:0046872; P:GO:0045087; F:GO:0005509; P:GO:0050727; F:GO:0050786; F:GO:0050544; F:GO:0008017	F:Toll-like receptor 4 binding; F:zinc ion binding; F:metal ion binding; P:innate immune response; F:calcium ion binding; P:regulation of inflammatory response; F:RAGE receptor binding; F:arachidonic acid binding; F:microtubule binding		
tr|F6Q7J3|F6Q7J3_HORSE	complement component C7	842	20	0E0	93.6%	3	C:GO:0005579; C:GO:0070062; P:GO:0006955	C:membrane attack complex; C:extracellular exosome; P:immune response		
sp|P83704|APOA2_HORSE	apolipo A-II	76	20	5.46E-48	88.45%	55	P:GO:0009395; F:GO:0034190; P:GO:0046340; P:GO:0009749; F:GO:0046982; P:GO:0018158; P:GO:0030301; P:GO:0030300; P:GO:0050995; P:GO:0050996; P:GO:0034380; C:GO:0042627; F:GO:0015485; P:GO:0034384; F:GO:0008035; P:GO:0045416; P:GO:0006457; P:GO:0006656; P:GO:0006810; F:GO:0005319; P:GO:0043085; P:GO:0010903; P:GO:0034370; P:GO:0034375; P:GO:0034374; F:GO:0060228; P:GO:0008203; F:GO:0008289; P:GO:0042157; C:GO:0005576; P:GO:0042632; P:GO:0060621; P:GO:0002740; C:GO:0070062; P:GO:0043691; C:GO:0072562; F:GO:0055102; P:GO:0060192; F:GO:0031210; C:GO:0034366; F:GO:0017127; P:GO:0010873; C:GO:0034361; P:GO:0060695; F:GO:0042803; C:GO:0034364; F:GO:0005543; P:GO:0006869; C:GO:0005615; P:GO:0031647; P:GO:0033344; P:GO:0032375; F:GO:0070653; P:GO:0018206; P:GO:0033700	P:phospholipid catabolic process; F:apolipoprotein receptor binding; P:diacylglycerol catabolic process; P:response to glucose; F:protein heterodimerization activity; P:protein oxidation; P:cholesterol transport; P:regulation of intestinal cholesterol absorption; P:negative regulation of lipid catabolic process; P:positive regulation of lipid catabolic process; P:high-density lipoprotein particle assembly; C:chylomicron; F:cholesterol binding; P:high-density lipoprotein particle clearance; F:high-density lipoprotein particle binding; P:positive regulation of interleukin-8 biosynthetic process; P:protein folding; P:phosphatidylcholine biosynthetic process; P:transport; F:lipid transporter activity; P:positive regulation of catalytic activity; P:negative regulation of very-low-density lipoprotein particle remodeling; P:triglyceride-rich lipoprotein particle remodeling; P:high-density lipoprotein particle remodeling; P:low-density lipoprotein particle remodeling; F:phosphatidylcholine-sterol O-acyltransferase activator activity; P:cholesterol metabolic process; F:lipid binding; P:lipoprotein metabolic process; C:extracellular region; P:cholesterol homeostasis; P:negative regulation of cholesterol import; P:negative regulation of cytokine secretion involved in immune response; C:extracellular exosome; P:reverse cholesterol transport; C:blood microparticle; F:lipase inhibitor activity; P:negative regulation of lipase activity; F:phosphatidylcholine binding; C:spherical high-density lipoprotein particle; F:cholesterol transporter activity; P:positive regulation of cholesterol esterification; C:very-low-density lipoprotein particle; P:negative regulation of cholesterol transporter activity; F:protein homodimerization activity; C:high-density lipoprotein particle; F:phospholipid binding; P:lipid transport; C:extracellular space; P:regulation of protein stability; P:cholesterol efflux; P:negative regulation of cholesterol transport; F:high-density lipoprotein particle receptor binding; P:peptidyl-methionine modification; P:phospholipid efflux		
tr|F7BBP1|F7BBP1_HORSE	phospholipase membrane associated	144	20	2.42E-101	89.65%	29	P:GO:0036151; P:GO:0036152; P:GO:0034374; P:GO:0036150; C:GO:0005576; P:GO:0006644; C:GO:0005789; C:GO:0070062; F:GO:0047498; F:GO:0005509; P:GO:0036148; P:GO:0036149; P:GO:0050830; C:GO:0030141; P:GO:0050729; C:GO:0005783; F:GO:0005543; P:GO:0006654; F:GO:0004623; C:GO:0005615; C:GO:0048471; F:GO:0046872; P:GO:0046473; P:GO:0016042; C:GO:0016020; P:GO:0006629; P:GO:0070374; P:GO:0010744; F:GO:0016787	P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylethanolamine acyl-chain remodeling; P:low-density lipoprotein particle remodeling; P:phosphatidylserine acyl-chain remodeling; C:extracellular region; P:phospholipid metabolic process; C:endoplasmic reticulum membrane; C:extracellular exosome; F:calcium-dependent phospholipase A2 activity; F:calcium ion binding; P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylinositol acyl-chain remodeling; P:defense response to Gram-positive bacterium; C:secretory granule; P:positive regulation of inflammatory response; C:endoplasmic reticulum; F:phospholipid binding; P:phosphatidic acid biosynthetic process; F:phospholipase A2 activity; C:extracellular space; C:perinuclear region of cytoplasm; F:metal ion binding; P:phosphatidic acid metabolic process; P:lipid catabolic process; C:membrane; P:lipid metabolic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of macrophage derived foam cell differentiation; F:hydrolase activity		
tr|F7BKK5|F7BKK5_HORSE	glutathione S-transferase Mu 3	227	20	5.47E-169	96.55%	16	F:GO:0042802; P:GO:0043627; F:GO:0042803; P:GO:0018916; P:GO:0008152; P:GO:0042178; F:GO:0004364; C:GO:0005634; C:GO:0070062; F:GO:0043295; C:GO:0005737; P:GO:0006749; F:GO:0016740; C:GO:0035686; P:GO:0070458; F:GO:0019899	F:identical protein binding; P:response to estrogen; F:protein homodimerization activity; P:nitrobenzene metabolic process; P:metabolic process; P:xenobiotic catabolic process; F:glutathione transferase activity; C:nucleus; C:extracellular exosome; F:glutathione binding; C:cytoplasm; P:glutathione metabolic process; F:transferase activity; C:sperm fibrous sheath; P:cellular detoxification of nitrogen compound; F:enzyme binding		
tr|F6ZF46|F6ZF46_HORSE	calmodulin 5	149	20	2.48E-101	88.4%	2	C:GO:0070062; F:GO:0005509	C:extracellular exosome; F:calcium ion binding		
tr|F6S8H1|F6S8H1_HORSE	S100-A8	89	20	4.27E-58	91.15%	47	F:GO:0035662; P:GO:0014002; P:GO:0010043; C:GO:0005576; P:GO:0051092; P:GO:0006935; P:GO:0045471; P:GO:0030307; P:GO:0006954; P:GO:0042060; C:GO:0070062; P:GO:0006914; F:GO:0005509; P:GO:0006915; C:GO:0005829; P:GO:0070488; P:GO:0006919; P:GO:0050832; P:GO:2001244; P:GO:0032602; P:GO:0018119; F:GO:0008270; P:GO:0050729; P:GO:0002793; P:GO:0042742; P:GO:0002376; C:GO:0005886; F:GO:0008017; P:GO:0002544; C:GO:0005634; P:GO:0002523; C:GO:0005615; P:GO:0032119; C:GO:0005856; F:GO:0005515; F:GO:0046872; C:GO:0005737; P:GO:0002526; P:GO:0045087; P:GO:0051493; C:GO:0016020; P:GO:0050727; P:GO:0030593; P:GO:0001816; P:GO:0032496; F:GO:0050544; F:GO:0050786	F:Toll-like receptor 4 binding; P:astrocyte development; P:response to zinc ion; C:extracellular region; P:positive regulation of NF-kappaB transcription factor activity; P:chemotaxis; P:response to ethanol; P:positive regulation of cell growth; P:inflammatory response; P:wound healing; C:extracellular exosome; P:autophagy; F:calcium ion binding; P:apoptotic process; C:cytosol; P:neutrophil aggregation; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:defense response to fungus; P:positive regulation of intrinsic apoptotic signaling pathway; P:chemokine production; P:peptidyl-cysteine S-nitrosylation; F:zinc ion binding; P:positive regulation of inflammatory response; P:positive regulation of peptide secretion; P:defense response to bacterium; P:immune system process; C:plasma membrane; F:microtubule binding; P:chronic inflammatory response; C:nucleus; P:leukocyte migration involved in inflammatory response; C:extracellular space; P:sequestering of zinc ion; C:cytoskeleton; F:protein binding; F:metal ion binding; C:cytoplasm; P:acute inflammatory response; P:innate immune response; P:regulation of cytoskeleton organization; C:membrane; P:regulation of inflammatory response; P:neutrophil chemotaxis; P:cytokine production; P:response to lipopolysaccharide; F:arachidonic acid binding; F:RAGE receptor binding		
tr|F6W039|F6W039_HORSE	rho GDP-dissociation inhibitor 1	204	20	3.69E-150	99.1%	24	P:GO:0008360; F:GO:0019901; P:GO:0035023; F:GO:0005094; P:GO:0032880; F:GO:0005096; P:GO:0007266; P:GO:0043547; C:GO:0001772; C:GO:0005634; C:GO:0005615; P:GO:0071260; F:GO:0005515; F:GO:0005504; C:GO:0070062; C:GO:0005737; P:GO:0050790; C:GO:0016020; C:GO:0005829; F:GO:0051879; F:GO:0017048; P:GO:2000249; P:GO:0030336; P:GO:0071526	P:regulation of cell shape; F:protein kinase binding; P:regulation of Rho protein signal transduction; F:Rho GDP-dissociation inhibitor activity; P:regulation of protein localization; F:GTPase activator activity; P:Rho protein signal transduction; P:positive regulation of GTPase activity; C:immunological synapse; C:nucleus; C:extracellular space; P:cellular response to mechanical stimulus; F:protein binding; F:fatty acid binding; C:extracellular exosome; C:cytoplasm; P:regulation of catalytic activity; C:membrane; C:cytosol; F:Hsp90 protein binding; F:Rho GTPase binding; P:regulation of actin cytoskeleton reorganization; P:negative regulation of cell migration; P:semaphorin-plexin signaling pathway		
tr|F6RV94|F6RV94_HORSE	glycogen liver form	830	20	0E0	97.7%	22	F:GO:0008184; F:GO:0016757; F:GO:0030170; F:GO:0016208; F:GO:0008144; F:GO:0032052; F:GO:0002060; P:GO:0008152; P:GO:0005980; C:GO:0005886; F:GO:0004645; F:GO:0000166; P:GO:0005975; F:GO:0005524; P:GO:0005977; C:GO:0070062; C:GO:0005737; F:GO:0003824; P:GO:0070266; P:GO:0042593; F:GO:0016740; F:GO:0019842	F:glycogen phosphorylase activity; F:transferase activity, transferring glycosyl groups; F:pyridoxal phosphate binding; F:AMP binding; F:drug binding; F:bile acid binding; F:purine nucleobase binding; P:metabolic process; P:glycogen catabolic process; C:plasma membrane; F:phosphorylase activity; F:nucleotide binding; P:carbohydrate metabolic process; F:ATP binding; P:glycogen metabolic process; C:extracellular exosome; C:cytoplasm; F:catalytic activity; P:necroptotic process; P:glucose homeostasis; F:transferase activity; F:vitamin binding		
tr|F6Z2I7|F6Z2I7_HORSE	glutathione S-transferase Mu 1	228	20	4.59E-160	95.65%	10	F:GO:0042803; F:GO:0043295; P:GO:0018916; C:GO:0005737; P:GO:0006749; P:GO:0008152; P:GO:0042178; F:GO:0004364; F:GO:0016740; F:GO:0019899	F:protein homodimerization activity; F:glutathione binding; P:nitrobenzene metabolic process; C:cytoplasm; P:glutathione metabolic process; P:metabolic process; P:xenobiotic catabolic process; F:glutathione transferase activity; F:transferase activity; F:enzyme binding		
sp|O77691|S10A6_HORSE	S100-A6	92	20	6.79E-60	94.1%	18	F:GO:0008270; F:GO:0042803; F:GO:0048306; F:GO:0005523; C:GO:0005886; F:GO:0044548; C:GO:0005635; P:GO:0098586; C:GO:0005634; C:GO:0070062; C:GO:0048471; C:GO:0005737; F:GO:0046872; F:GO:0005509; C:GO:0016020; C:GO:0001726; C:GO:0005829; C:GO:0031234	F:zinc ion binding; F:protein homodimerization activity; F:calcium-dependent protein binding; F:tropomyosin binding; C:plasma membrane; F:S100 protein binding; C:nuclear envelope; P:cellular response to virus; C:nucleus; C:extracellular exosome; C:perinuclear region of cytoplasm; C:cytoplasm; F:metal ion binding; F:calcium ion binding; C:membrane; C:ruffle; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane		
tr|F6SKV7|F6SKV7_HORSE	latent-transforming growth factor beta-binding 4 isoform X2	1560	20	0E0	70.05%	2	C:GO:0031012; F:GO:0005488	C:extracellular matrix; F:binding		
tr|F6QP34|F6QP34_HORSE	WAP four-disulfide core domain 2	123	20	8.02E-81	84%	12	F:GO:0030414; F:GO:0004867; C:GO:0005615; F:GO:0004866; C:GO:0070062; F:GO:0004869; F:GO:0019828; P:GO:0007283; P:GO:0006508; P:GO:0010951; C:GO:0005576; P:GO:0010466	F:peptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity; C:extracellular space; F:endopeptidase inhibitor activity; C:extracellular exosome; F:cysteine-type endopeptidase inhibitor activity; F:aspartic-type endopeptidase inhibitor activity; P:spermatogenesis; P:proteolysis; P:negative regulation of endopeptidase activity; C:extracellular region; P:negative regulation of peptidase activity		
sp|P00443|SODC_HORSE	superoxide dismutase [Cu-Zn]	154	20	2.21E-106	90.8%	102	P:GO:0060088; P:GO:0060087; F:GO:0004784; P:GO:0000187; F:GO:0005507; P:GO:0051881; F:GO:0016491; F:GO:0051087; F:GO:0048365; P:GO:0032287; P:GO:0034465; P:GO:0010033; C:GO:0030141; P:GO:0046620; C:GO:0043234; P:GO:0042542; C:GO:0005886; C:GO:0005764; C:GO:0005634; C:GO:0005758; F:GO:0005515; C:GO:0005759; P:GO:0043085; F:GO:0046872; P:GO:0045541; C:GO:0032839; P:GO:0043087; P:GO:0040014; C:GO:1904115; P:GO:1902177; P:GO:0033081; P:GO:0042554; P:GO:0001890; C:GO:0005576; C:GO:0043005; P:GO:0048538; P:GO:0043524; P:GO:0006302; P:GO:0002576; P:GO:0009408; P:GO:0007626; C:GO:0070062; P:GO:0071276; P:GO:0071318; P:GO:0019226; P:GO:0008217; P:GO:0001541; P:GO:0001895; P:GO:0072593; C:GO:0005615; C:GO:0005737; P:GO:0006309; C:GO:0005739; P:GO:0055114; C:GO:0031045; P:GO:0001819; P:GO:0032930; P:GO:0060047; F:GO:0016209; P:GO:0048678; C:GO:0043025; P:GO:0006879; P:GO:0007605; C:GO:0005829; F:GO:0030346; F:GO:0008270; P:GO:0045859; P:GO:0000303; P:GO:0000302; P:GO:0097332; P:GO:0006801; P:GO:0019430; P:GO:0031667; P:GO:0035865; P:GO:0046716; C:GO:0043209; P:GO:0008089; P:GO:0046677; P:GO:0002262; C:GO:0005654; P:GO:0006979; P:GO:0045471; C:GO:0031410; C:GO:0031012; F:GO:0042802; F:GO:0042803; P:GO:0060052; P:GO:0007283; P:GO:0046688; P:GO:0007568; P:GO:0007569; P:GO:0007566; C:GO:0005777; P:GO:0001975; P:GO:0042493; P:GO:0043066; P:GO:0006749; P:GO:0043065; P:GO:0034599; P:GO:0050665; P:GO:0008090; F:GO:0019899	P:auditory receptor cell stereocilium organization; P:relaxation of vascular smooth muscle; F:superoxide dismutase activity; P:activation of MAPK activity; F:copper ion binding; P:regulation of mitochondrial membrane potential; F:oxidoreductase activity; F:chaperone binding; F:Rac GTPase binding; P:peripheral nervous system myelin maintenance; P:response to carbon monoxide; P:response to organic substance; C:secretory granule; P:regulation of organ growth; C:protein complex; P:response to hydrogen peroxide; C:plasma membrane; C:lysosome; C:nucleus; C:mitochondrial intermembrane space; F:protein binding; C:mitochondrial matrix; P:positive regulation of catalytic activity; F:metal ion binding; P:negative regulation of cholesterol biosynthetic process; C:dendrite cytoplasm; P:regulation of GTPase activity; P:regulation of multicellular organism growth; C:axon cytoplasm; P:positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:regulation of T cell differentiation in thymus; P:superoxide anion generation; P:placenta development; C:extracellular region; C:neuron projection; P:thymus development; P:negative regulation of neuron apoptotic process; P:double-strand break repair; P:platelet degranulation; P:response to heat; P:locomotory behavior; C:extracellular exosome; P:cellular response to cadmium ion; P:cellular response to ATP; P:transmission of nerve impulse; P:regulation of blood pressure; P:ovarian follicle development; P:retina homeostasis; P:reactive oxygen species metabolic process; C:extracellular space; C:cytoplasm; P:apoptotic DNA fragmentation; C:mitochondrion; P:oxidation-reduction process; C:dense core granule; P:positive regulation of cytokine production; P:positive regulation of superoxide anion generation; P:heart contraction; F:antioxidant activity; P:response to axon injury; C:neuronal cell body; P:cellular iron ion homeostasis; P:sensory perception of sound; C:cytosol; F:protein phosphatase 2B binding; F:zinc ion binding; P:regulation of protein kinase activity; P:response to superoxide; P:response to reactive oxygen species; P:response to antipsychotic drug; P:superoxide metabolic process; P:removal of superoxide radicals; P:response to nutrient levels; P:cellular response to potassium ion; P:muscle cell cellular homeostasis; C:myelin sheath; P:anterograde axonal transport; P:response to antibiotic; P:myeloid cell homeostasis; C:nucleoplasm; P:response to oxidative stress; P:response to ethanol; C:cytoplasmic vesicle; C:extracellular matrix; F:identical protein binding; F:protein homodimerization activity; P:neurofilament cytoskeleton organization; P:spermatogenesis; P:response to copper ion; P:aging; P:cell aging; P:embryo implantation; C:peroxisome; P:response to amphetamine; P:response to drug; P:negative regulation of apoptotic process; P:glutathione metabolic process; P:positive regulation of apoptotic process; P:cellular response to oxidative stress; P:hydrogen peroxide biosynthetic process; P:retrograde axonal transport; F:enzyme binding		
tr|F7A7E0|F7A7E0_HORSE	beta-microsemino	113	20	1.42E-78	84.55%	1	C:GO:0005576	C:extracellular region		
tr|F6ZI51|F6ZI51_HORSE	annexin A2	339	20	0E0	99.1%	60	P:GO:0042730; P:GO:0051290; P:GO:0032804; F:GO:0030546; F:GO:0005546; F:GO:0001786; F:GO:0005509; C:GO:0042383; C:GO:0043231; F:GO:0004859; C:GO:0005829; F:GO:0001948; P:GO:0002091; C:GO:0005886; C:GO:0005765; C:GO:0031902; C:GO:0005634; C:GO:0031988; P:GO:0051099; C:GO:0035749; P:GO:0043086; C:GO:0042470; C:GO:0065010; C:GO:0031982; C:GO:0030496; C:GO:0016323; F:GO:0019834; P:GO:0070509; P:GO:0036035; P:GO:0031340; F:GO:0002020; C:GO:0005576; C:GO:0005578; C:GO:0005604; C:GO:0005769; C:GO:0005768; P:GO:0001765; C:GO:0070062; P:GO:0001525; C:GO:1990667; P:GO:0070588; P:GO:0031214; P:GO:2000273; F:GO:0005262; P:GO:1900121; F:GO:0048306; F:GO:0044548; C:GO:0009986; F:GO:0005544; F:GO:0044822; C:GO:0005811; C:GO:0005615; P:GO:0006900; C:GO:0005737; C:GO:0043220; C:GO:0045121; C:GO:0016020; P:GO:0030199; F:GO:0008092; C:GO:0019897	P:fibrinolysis; P:protein heterotetramerization; P:negative regulation of low-density lipoprotein particle receptor catabolic process; F:receptor activator activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:calcium ion binding; C:sarcolemma; C:intracellular membrane-bounded organelle; F:phospholipase inhibitor activity; C:cytosol; F:glycoprotein binding; P:negative regulation of receptor internalization; C:plasma membrane; C:lysosomal membrane; C:late endosome membrane; C:nucleus; C:membrane-bounded vesicle; P:positive regulation of binding; C:myelin sheath adaxonal region; P:negative regulation of catalytic activity; C:melanosome; C:extracellular membrane-bounded organelle; C:vesicle; C:midbody; C:basolateral plasma membrane; F:phospholipase A2 inhibitor activity; P:calcium ion import; P:osteoclast development; P:positive regulation of vesicle fusion; F:protease binding; C:extracellular region; C:proteinaceous extracellular matrix; C:basement membrane; C:early endosome; C:endosome; P:membrane raft assembly; C:extracellular exosome; P:angiogenesis; C:PCSK9-AnxA2 complex; P:calcium ion transmembrane transport; P:biomineral tissue development; P:positive regulation of receptor activity; F:calcium channel activity; P:negative regulation of receptor binding; F:calcium-dependent protein binding; F:S100 protein binding; C:cell surface; F:calcium-dependent phospholipid binding; F:poly(A) RNA binding; C:lipid particle; C:extracellular space; P:membrane budding; C:cytoplasm; C:Schmidt-Lanterman incisure; C:membrane raft; C:membrane; P:collagen fibril organization; F:cytoskeletal protein binding; C:extrinsic component of plasma membrane		
tr|F7APS1|F7APS1_HORSE	cystatin-B	98	20	1.68E-67	94.75%	15	P:GO:0045861; F:GO:0002020; P:GO:0008344; C:GO:0005730; C:GO:0005622; F:GO:0044822; F:GO:0030414; C:GO:0005634; C:GO:0005615; F:GO:0004866; C:GO:0070062; F:GO:0004869; C:GO:0005737; P:GO:0010951; P:GO:0010466	P:negative regulation of proteolysis; F:protease binding; P:adult locomotory behavior; C:nucleolus; C:intracellular; F:poly(A) RNA binding; F:peptidase inhibitor activity; C:nucleus; C:extracellular space; F:endopeptidase inhibitor activity; C:extracellular exosome; F:cysteine-type endopeptidase inhibitor activity; C:cytoplasm; P:negative regulation of endopeptidase activity; P:negative regulation of peptidase activity		
tr|F7BGS8|F7BGS8_HORSE	filamin-A isoform X2	2638	20	0E0	98.85%	40	P:GO:0034394; P:GO:0007195; P:GO:0043123; P:GO:0042177; P:GO:0042993; C:GO:0005730; P:GO:0051764; C:GO:0070062; F:GO:0017160; C:GO:0005925; P:GO:0051220; F:GO:0048365; P:GO:0042384; C:GO:0015629; F:GO:0001948; F:GO:0017048; P:GO:2001046; P:GO:0070527; F:GO:0034988; P:GO:0031532; P:GO:0016479; F:GO:0042803; P:GO:0043433; F:GO:0008134; P:GO:1900026; P:GO:0043113; F:GO:0004871; C:GO:0005886; F:GO:0044822; P:GO:0045184; F:GO:0051015; C:GO:0005634; F:GO:0003779; C:GO:0005737; P:GO:0043066; C:GO:0016020; F:GO:0031267; P:GO:0050821; C:GO:0031523; P:GO:0090307	P:protein localization to cell surface; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of protein catabolic process; P:positive regulation of transcription factor import into nucleus; C:nucleolus; P:actin crosslink formation; C:extracellular exosome; F:Ral GTPase binding; C:focal adhesion; P:cytoplasmic sequestering of protein; F:Rac GTPase binding; P:cilium assembly; C:actin cytoskeleton; F:glycoprotein binding; F:Rho GTPase binding; P:positive regulation of integrin-mediated signaling pathway; P:platelet aggregation; F:Fc-gamma receptor I complex binding; P:actin cytoskeleton reorganization; P:negative regulation of transcription from RNA polymerase I promoter; F:protein homodimerization activity; P:negative regulation of sequence-specific DNA binding transcription factor activity; F:transcription factor binding; P:positive regulation of substrate adhesion-dependent cell spreading; P:receptor clustering; F:signal transducer activity; C:plasma membrane; F:poly(A) RNA binding; P:establishment of protein localization; F:actin filament binding; C:nucleus; F:actin binding; C:cytoplasm; P:negative regulation of apoptotic process; C:membrane; F:small GTPase binding; P:protein stabilization; C:Myb complex; P:mitotic spindle assembly		
tr|F7BH02|F7BH02_HORSE	filamin-A isoform X1	2646	20	0E0	98.9%	40	P:GO:0034394; P:GO:0007195; P:GO:0043123; P:GO:0042177; P:GO:0042993; C:GO:0005730; P:GO:0051764; C:GO:0070062; F:GO:0017160; C:GO:0005925; P:GO:0051220; F:GO:0048365; P:GO:0042384; C:GO:0015629; F:GO:0001948; F:GO:0017048; P:GO:2001046; P:GO:0070527; F:GO:0034988; P:GO:0031532; P:GO:0016479; F:GO:0042803; P:GO:0043433; F:GO:0008134; P:GO:1900026; P:GO:0043113; F:GO:0004871; C:GO:0005886; F:GO:0044822; P:GO:0045184; F:GO:0051015; C:GO:0005634; F:GO:0003779; C:GO:0005737; P:GO:0043066; C:GO:0016020; F:GO:0031267; P:GO:0050821; C:GO:0031523; P:GO:0090307	P:protein localization to cell surface; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of protein catabolic process; P:positive regulation of transcription factor import into nucleus; C:nucleolus; P:actin crosslink formation; C:extracellular exosome; F:Ral GTPase binding; C:focal adhesion; P:cytoplasmic sequestering of protein; F:Rac GTPase binding; P:cilium assembly; C:actin cytoskeleton; F:glycoprotein binding; F:Rho GTPase binding; P:positive regulation of integrin-mediated signaling pathway; P:platelet aggregation; F:Fc-gamma receptor I complex binding; P:actin cytoskeleton reorganization; P:negative regulation of transcription from RNA polymerase I promoter; F:protein homodimerization activity; P:negative regulation of sequence-specific DNA binding transcription factor activity; F:transcription factor binding; P:positive regulation of substrate adhesion-dependent cell spreading; P:receptor clustering; F:signal transducer activity; C:plasma membrane; F:poly(A) RNA binding; P:establishment of protein localization; F:actin filament binding; C:nucleus; F:actin binding; C:cytoplasm; P:negative regulation of apoptotic process; C:membrane; F:small GTPase binding; P:protein stabilization; C:Myb complex; P:mitotic spindle assembly		
tr|F6VE62|F6VE62_HORSE	beta-hexosaminidase subunit beta	486	20	0E0	89.65%	42	P:GO:0008360; P:GO:0019915; P:GO:0008049; P:GO:0009313; P:GO:0042552; C:GO:0043202; P:GO:0045944; F:GO:0004563; P:GO:0006689; P:GO:0007338; P:GO:0006687; P:GO:0007605; P:GO:0030207; P:GO:0007626; C:GO:0070062; P:GO:0001501; F:GO:0046982; C:GO:0001669; P:GO:0042340; C:GO:0042582; P:GO:0030203; F:GO:0016798; P:GO:0043615; P:GO:0007040; F:GO:0042803; F:GO:0008375; P:GO:0007341; P:GO:0008152; P:GO:0050905; P:GO:0008654; P:GO:0044267; F:GO:0004553; C:GO:0005764; P:GO:0006874; P:GO:0005975; P:GO:0048477; C:GO:0016020; P:GO:0019953; P:GO:0050885; P:GO:0031323; F:GO:0016787; P:GO:0030214	P:regulation of cell shape; P:lipid storage; P:male courtship behavior; P:oligosaccharide catabolic process; P:myelination; C:lysosomal lumen; P:positive regulation of transcription from RNA polymerase II promoter; F:beta-N-acetylhexosaminidase activity; P:ganglioside catabolic process; P:single fertilization; P:glycosphingolipid metabolic process; P:sensory perception of sound; P:chondroitin sulfate catabolic process; P:locomotory behavior; C:extracellular exosome; P:skeletal system development; F:protein heterodimerization activity; C:acrosomal vesicle; P:keratan sulfate catabolic process; C:azurophil granule; P:glycosaminoglycan metabolic process; F:hydrolase activity, acting on glycosyl bonds; P:astrocyte cell migration; P:lysosome organization; F:protein homodimerization activity; F:acetylglucosaminyltransferase activity; P:penetration of zona pellucida; P:metabolic process; P:neuromuscular process; P:phospholipid biosynthetic process; P:cellular protein metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds; C:lysosome; P:cellular calcium ion homeostasis; P:carbohydrate metabolic process; P:oogenesis; C:membrane; P:sexual reproduction; P:neuromuscular process controlling balance; P:regulation of cellular metabolic process; F:hydrolase activity; P:hyaluronan catabolic process		
tr|F6ZJE4|F6ZJE4_HORSE	ras-related Rab-8A	207	20	3.31E-151	99.7%	57	C:GO:0014069; C:GO:0008021; P:GO:0015031; P:GO:0030030; C:GO:0000139; C:GO:0005794; C:GO:0043025; C:GO:0030425; P:GO:0048169; P:GO:0007409; F:GO:0003924; P:GO:0042384; F:GO:0019003; C:GO:0005829; C:GO:0031513; F:GO:0019901; P:GO:0032880; P:GO:0007264; C:GO:0030140; C:GO:0045335; P:GO:0006810; C:GO:0005886; P:GO:0048210; C:GO:0005634; C:GO:0072372; C:GO:0030659; F:GO:0005515; F:GO:0017137; P:GO:0072659; C:GO:0005730; C:GO:0042995; F:GO:0005525; P:GO:0032869; F:GO:0000166; C:GO:0005768; C:GO:0070062; P:GO:0051223; P:GO:0000086; C:GO:0097546; C:GO:0005929; C:GO:0031410; P:GO:0061024; C:GO:0036064; P:GO:0009306; C:GO:0005622; C:GO:0005813; C:GO:0005856; C:GO:0005814; C:GO:0005737; C:GO:0016020; P:GO:0006904; C:GO:0030670; C:GO:0016023; C:GO:0055037; C:GO:0055038; P:GO:0032456; F:GO:0031489	C:postsynaptic density; C:synaptic vesicle; P:protein transport; P:cell projection organization; C:Golgi membrane; C:Golgi apparatus; C:neuronal cell body; C:dendrite; P:regulation of long-term neuronal synaptic plasticity; P:axonogenesis; F:GTPase activity; P:cilium assembly; F:GDP binding; C:cytosol; C:nonmotile primary cilium; F:protein kinase binding; P:regulation of protein localization; P:small GTPase mediated signal transduction; C:trans-Golgi network transport vesicle; C:phagocytic vesicle; P:transport; C:plasma membrane; P:Golgi vesicle fusion to target membrane; C:nucleus; C:primary cilium; C:cytoplasmic vesicle membrane; F:protein binding; F:Rab GTPase binding; P:protein localization to plasma membrane; C:nucleolus; C:cell projection; F:GTP binding; P:cellular response to insulin stimulus; F:nucleotide binding; C:endosome; C:extracellular exosome; P:regulation of protein transport; P:G2/M transition of mitotic cell cycle; C:ciliary base; C:cilium; C:cytoplasmic vesicle; P:membrane organization; C:ciliary basal body; P:protein secretion; C:intracellular; C:centrosome; C:cytoskeleton; C:centriole; C:cytoplasm; C:membrane; P:vesicle docking involved in exocytosis; C:phagocytic vesicle membrane; C:cytoplasmic, membrane-bounded vesicle; C:recycling endosome; C:recycling endosome membrane; P:endocytic recycling; F:myosin V binding		
tr|F7BFF5|F7BFF5_HORSE	ras-related Rab-8B	207	20	3.46E-150	99.05%	29	P:GO:0034332; P:GO:0015031; F:GO:0005525; F:GO:0000166; C:GO:0070062; C:GO:0051286; F:GO:0003924; P:GO:0051461; P:GO:0042384; F:GO:0019003; C:GO:0031410; P:GO:0019882; P:GO:0007264; C:GO:0045335; F:GO:0005102; P:GO:0006810; P:GO:0009306; C:GO:0005886; C:GO:0005622; C:GO:0005778; C:GO:0048471; F:GO:0005515; F:GO:0030911; P:GO:0045046; C:GO:0016020; C:GO:0005739; P:GO:0006904; C:GO:0030670; P:GO:0031346	P:adherens junction organization; P:protein transport; F:GTP binding; F:nucleotide binding; C:extracellular exosome; C:cell tip; F:GTPase activity; P:positive regulation of corticotropin secretion; P:cilium assembly; F:GDP binding; C:cytoplasmic vesicle; P:antigen processing and presentation; P:small GTPase mediated signal transduction; C:phagocytic vesicle; F:receptor binding; P:transport; P:protein secretion; C:plasma membrane; C:intracellular; C:peroxisomal membrane; C:perinuclear region of cytoplasm; F:protein binding; F:TPR domain binding; P:protein import into peroxisome membrane; C:membrane; C:mitochondrion; P:vesicle docking involved in exocytosis; C:phagocytic vesicle membrane; P:positive regulation of cell projection organization		
tr|F6VQF0|F6VQF0_HORSE	ras-related Rab-10	200	20	5.46E-146	99.45%	54	P:GO:0015031; C:GO:0000139; C:GO:0005794; P:GO:0006886; P:GO:0097051; C:GO:0005789; P:GO:0007409; F:GO:0003924; F:GO:0019003; P:GO:0019882; P:GO:0007264; P:GO:0006893; P:GO:0006810; C:GO:0005886; C:GO:0000145; C:GO:0030659; C:GO:0072372; C:GO:0005911; F:GO:0005515; P:GO:0030859; C:GO:0005913; P:GO:0072659; C:GO:0032593; P:GO:0043001; P:GO:0090150; C:GO:0042995; F:GO:0005525; P:GO:0032869; F:GO:0000166; C:GO:0005802; P:GO:0016192; C:GO:0005768; C:GO:0070062; C:GO:0005925; P:GO:0016197; C:GO:0005929; C:GO:0031410; P:GO:0071236; P:GO:0061024; C:GO:0005783; P:GO:0061467; C:GO:0005622; F:GO:0098641; C:GO:0048471; P:GO:0045200; C:GO:0016020; C:GO:0071782; C:GO:0030670; C:GO:0055037; C:GO:0010008; P:GO:0071786; C:GO:0055038; P:GO:0098609; F:GO:0031489	P:protein transport; C:Golgi membrane; C:Golgi apparatus; P:intracellular protein transport; P:establishment of protein localization to endoplasmic reticulum membrane; C:endoplasmic reticulum membrane; P:axonogenesis; F:GTPase activity; F:GDP binding; P:antigen processing and presentation; P:small GTPase mediated signal transduction; P:Golgi to plasma membrane transport; P:transport; C:plasma membrane; C:exocyst; C:cytoplasmic vesicle membrane; C:primary cilium; C:cell-cell junction; F:protein binding; P:polarized epithelial cell differentiation; C:cell-cell adherens junction; P:protein localization to plasma membrane; C:insulin-responsive compartment; P:Golgi to plasma membrane protein transport; P:establishment of protein localization to membrane; C:cell projection; F:GTP binding; P:cellular response to insulin stimulus; F:nucleotide binding; C:trans-Golgi network; P:vesicle-mediated transport; C:endosome; C:extracellular exosome; C:focal adhesion; P:endosomal transport; C:cilium; C:cytoplasmic vesicle; P:cellular response to antibiotic; P:membrane organization; C:endoplasmic reticulum; P:basolateral protein localization; C:intracellular; F:cadherin binding involved in cell-cell adhesion; C:perinuclear region of cytoplasm; P:establishment of neuroblast polarity; C:membrane; C:endoplasmic reticulum tubular network; C:phagocytic vesicle membrane; C:recycling endosome; C:endosome membrane; P:endoplasmic reticulum tubular network organization; C:recycling endosome membrane; P:cell-cell adhesion; F:myosin V binding		
tr|F6ZPC6|F6ZPC6_HORSE	ras-related Rab-1A	202	20	1.22E-148	99.3%	43	P:GO:0090557; P:GO:1903020; P:GO:0007030; P:GO:0015031; P:GO:0090110; C:GO:0000139; C:GO:0005794; C:GO:0043025; P:GO:0006886; F:GO:0005525; C:GO:0005789; P:GO:0000045; F:GO:0000166; C:GO:0005769; C:GO:0005768; C:GO:0070062; P:GO:0016192; P:GO:0006914; F:GO:0003924; P:GO:0047496; P:GO:0042384; P:GO:0034446; C:GO:0005829; P:GO:0019068; P:GO:0072606; P:GO:0016477; P:GO:0032402; P:GO:0007264; P:GO:0006890; C:GO:0005783; P:GO:0006897; P:GO:0006810; P:GO:0042742; C:GO:0005622; P:GO:0048208; F:GO:0098641; P:GO:0006888; F:GO:0005515; C:GO:0042470; C:GO:0005737; C:GO:0005913; C:GO:0016020; P:GO:0030252	P:establishment of endothelial intestinal barrier; P:positive regulation of glycoprotein metabolic process; P:Golgi organization; P:protein transport; P:cargo loading into COPII-coated vesicle; C:Golgi membrane; C:Golgi apparatus; C:neuronal cell body; P:intracellular protein transport; F:GTP binding; C:endoplasmic reticulum membrane; P:autophagosome assembly; F:nucleotide binding; C:early endosome; C:endosome; C:extracellular exosome; P:vesicle-mediated transport; P:autophagy; F:GTPase activity; P:vesicle transport along microtubule; P:cilium assembly; P:substrate adhesion-dependent cell spreading; C:cytosol; P:virion assembly; P:interleukin-8 secretion; P:cell migration; P:melanosome transport; P:small GTPase mediated signal transduction; P:retrograde vesicle-mediated transport, Golgi to ER; C:endoplasmic reticulum; P:endocytosis; P:transport; P:defense response to bacterium; C:intracellular; P:COPII vesicle coating; F:cadherin binding involved in cell-cell adhesion; P:ER to Golgi vesicle-mediated transport; F:protein binding; C:melanosome; C:cytoplasm; C:cell-cell adherens junction; C:membrane; P:growth hormone secretion		
tr|F6TGA5|F6TGA5_HORSE	ras-related Rab-1B	201	20	1.06E-147	99.55%	26	P:GO:0090557; P:GO:1903020; P:GO:0015031; C:GO:0000139; C:GO:0005794; C:GO:0005793; F:GO:0005525; C:GO:0005789; F:GO:0000166; C:GO:0070062; P:GO:0006914; P:GO:0019068; C:GO:0033116; P:GO:0007264; P:GO:0006890; C:GO:0034045; P:GO:0006810; C:GO:0005622; P:GO:0048208; P:GO:0006888; F:GO:0005515; C:GO:0005737; C:GO:0016020; C:GO:0005739; P:GO:2000785; C:GO:0030133	P:establishment of endothelial intestinal barrier; P:positive regulation of glycoprotein metabolic process; P:protein transport; C:Golgi membrane; C:Golgi apparatus; C:endoplasmic reticulum-Golgi intermediate compartment; F:GTP binding; C:endoplasmic reticulum membrane; F:nucleotide binding; C:extracellular exosome; P:autophagy; P:virion assembly; C:endoplasmic reticulum-Golgi intermediate compartment membrane; P:small GTPase mediated signal transduction; P:retrograde vesicle-mediated transport, Golgi to ER; C:pre-autophagosomal structure membrane; P:transport; C:intracellular; P:COPII vesicle coating; P:ER to Golgi vesicle-mediated transport; F:protein binding; C:cytoplasm; C:membrane; C:mitochondrion; P:regulation of autophagosome assembly; C:transport vesicle		
tr|F6YHD4|F6YHD4_HORSE	ras-related Rab-15	212	20	1.26E-157	99.4%	15	P:GO:0007264; P:GO:0015031; P:GO:0006810; C:GO:0005886; C:GO:0005622; P:GO:1903307; F:GO:0005525; F:GO:0000166; C:GO:0072372; F:GO:0005515; C:GO:0070062; C:GO:0048471; C:GO:0005737; C:GO:0016020; C:GO:0010008	P:small GTPase mediated signal transduction; P:protein transport; P:transport; C:plasma membrane; C:intracellular; P:positive regulation of regulated secretory pathway; F:GTP binding; F:nucleotide binding; C:primary cilium; F:protein binding; C:extracellular exosome; C:perinuclear region of cytoplasm; C:cytoplasm; C:membrane; C:endosome membrane		
tr|F6RM82|F6RM82_HORSE	S100-A9-like isoform X2	131	20	2.13E-89	93.25%	9	F:GO:0035662; F:GO:0008270; F:GO:0046872; P:GO:0045087; F:GO:0005509; P:GO:0050727; F:GO:0050786; F:GO:0050544; F:GO:0008017	F:Toll-like receptor 4 binding; F:zinc ion binding; F:metal ion binding; P:innate immune response; F:calcium ion binding; P:regulation of inflammatory response; F:RAGE receptor binding; F:arachidonic acid binding; F:microtubule binding		
tr|F6SX07|F6SX07_HORSE	galectin-7	136	20	2.45E-93	88.55%	6	C:GO:0005634; C:GO:0005615; C:GO:0005737; P:GO:0006915; P:GO:0007157; F:GO:0030246	C:nucleus; C:extracellular space; C:cytoplasm; P:apoptotic process; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; F:carbohydrate binding		
tr|F6PNM1|F6PNM1_HORSE	45 kDa calcium-binding	361	20	0E0	94.9%	7	C:GO:0070062; F:GO:0005509; C:GO:0016020; C:GO:0005770; C:GO:0005794; P:GO:0045444; C:GO:0005796	C:extracellular exosome; F:calcium ion binding; C:membrane; C:late endosome; C:Golgi apparatus; P:fat cell differentiation; C:Golgi lumen		
tr|F6Z5C4|F6Z5C4_HORSE	calmodulin	148	20	2.12E-102	100%	89	F:GO:0043548; F:GO:0015276; P:GO:0043388; P:GO:0022400; P:GO:0043547; C:GO:0030426; P:GO:0031954; C:GO:0034704; P:GO:0051000; F:GO:0072542; F:GO:0005509; F:GO:0043274; F:GO:0017022; C:GO:0005829; F:GO:0031432; P:GO:0050999; F:GO:0031996; P:GO:0019722; F:GO:0031997; F:GO:0050998; F:GO:0019901; F:GO:0019904; P:GO:0007186; P:GO:0034220; C:GO:0008076; P:GO:0060316; F:GO:0005088; P:GO:0007223; F:GO:0044325; P:GO:0060314; C:GO:0005886; P:GO:0060315; P:GO:0051412; C:GO:0005876; P:GO:0005513; C:GO:0005634; F:GO:0005515; P:GO:0032516; F:GO:0046872; F:GO:0047485; C:GO:0031982; P:GO:0035307; C:GO:0030017; P:GO:0043647; P:GO:0010880; F:GO:0008440; P:GO:0038095; P:GO:1901841; P:GO:1901844; C:GO:0005576; P:GO:0006468; C:GO:0043005; C:GO:0005654; P:GO:0002576; P:GO:0000165; P:GO:0051343; P:GO:0030801; C:GO:0070062; P:GO:0000086; P:GO:0006936; P:GO:0032465; P:GO:0016310; P:GO:0007190; F:GO:0043539; C:GO:0000922; F:GO:0048306; F:GO:0008179; P:GO:0005980; F:GO:0005102; P:GO:0021762; P:GO:1901339; F:GO:0004689; P:GO:0002027; C:GO:0005813; F:GO:0031800; C:GO:0005856; P:GO:0001975; C:GO:0005737; P:GO:0010801; P:GO:0051592; C:GO:0005819; P:GO:0010800; F:GO:0016740; F:GO:0030235; F:GO:0016301; F:GO:0030234; P:GO:0055117; P:GO:0071902; P:GO:0010881	F:phosphatidylinositol 3-kinase binding; F:ligand-gated ion channel activity; P:positive regulation of DNA binding; P:regulation of rhodopsin mediated signaling pathway; P:positive regulation of GTPase activity; C:growth cone; P:positive regulation of protein autophosphorylation; C:calcium channel complex; P:positive regulation of nitric-oxide synthase activity; F:protein phosphatase activator activity; F:calcium ion binding; F:phospholipase binding; F:myosin binding; C:cytosol; F:titin binding; P:regulation of nitric-oxide synthase activity; F:thioesterase binding; P:calcium-mediated signaling; F:N-terminal myristoylation domain binding; F:nitric-oxide synthase binding; F:protein kinase binding; F:protein domain specific binding; P:G-protein coupled receptor signaling pathway; P:ion transmembrane transport; C:voltage-gated potassium channel complex; P:positive regulation of ryanodine-sensitive calcium-release channel activity; F:Ras guanyl-nucleotide exchange factor activity; P:Wnt signaling pathway, calcium modulating pathway; F:ion channel binding; P:regulation of ryanodine-sensitive calcium-release channel activity; C:plasma membrane; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:response to corticosterone; C:spindle microtubule; P:detection of calcium ion; C:nucleus; F:protein binding; P:positive regulation of phosphoprotein phosphatase activity; F:metal ion binding; F:protein N-terminus binding; C:vesicle; P:positive regulation of protein dephosphorylation; C:sarcomere; P:inositol phosphate metabolic process; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; F:inositol-1,4,5-trisphosphate 3-kinase activity; P:Fc-epsilon receptor signaling pathway; P:regulation of high voltage-gated calcium channel activity; P:regulation of cell communication by electrical coupling involved in cardiac conduction; C:extracellular region; P:protein phosphorylation; C:neuron projection; C:nucleoplasm; P:platelet degranulation; P:MAPK cascade; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of cyclic nucleotide metabolic process; C:extracellular exosome; P:G2/M transition of mitotic cell cycle; P:muscle contraction; P:regulation of cytokinesis; P:phosphorylation; P:activation of adenylate cyclase activity; F:protein serine/threonine kinase activator activity; C:spindle pole; F:calcium-dependent protein binding; F:adenylate cyclase binding; P:glycogen catabolic process; F:receptor binding; P:substantia nigra development; P:regulation of store-operated calcium channel activity; F:phosphorylase kinase activity; P:regulation of heart rate; C:centrosome; F:type 3 metabotropic glutamate receptor binding; C:cytoskeleton; P:response to amphetamine; C:cytoplasm; P:negative regulation of peptidyl-threonine phosphorylation; P:response to calcium ion; C:spindle; P:positive regulation of peptidyl-threonine phosphorylation; F:transferase activity; F:nitric-oxide synthase regulator activity; F:kinase activity; F:enzyme regulator activity; P:regulation of cardiac muscle contraction; P:positive regulation of protein serine/threonine kinase activity; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion		
tr|F7B812|F7B812_HORSE	serine protease HTRA1	323	20	0E0	99.1%	24	F:GO:0019838; P:GO:0022617; F:GO:0004252; F:GO:0008236; F:GO:0008233; P:GO:0001890; C:GO:0005576; F:GO:0005520; C:GO:0005886; P:GO:0030514; P:GO:0097187; C:GO:0005615; C:GO:0070062; C:GO:0005737; P:GO:0001558; P:GO:0060718; C:GO:0016020; P:GO:0006508; C:GO:0005829; C:GO:0031012; P:GO:0050679; P:GO:0050687; P:GO:0030512; F:GO:0016787	F:growth factor binding; P:extracellular matrix disassembly; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:peptidase activity; P:placenta development; C:extracellular region; F:insulin-like growth factor binding; C:plasma membrane; P:negative regulation of BMP signaling pathway; P:dentinogenesis; C:extracellular space; C:extracellular exosome; C:cytoplasm; P:regulation of cell growth; P:chorionic trophoblast cell differentiation; C:membrane; P:proteolysis; C:cytosol; C:extracellular matrix; P:positive regulation of epithelial cell proliferation; P:negative regulation of defense response to virus; P:negative regulation of transforming growth factor beta receptor signaling pathway; F:hydrolase activity		
tr|F6W683|F6W683_HORSE	GDP-mannose 4,6 dehydratase	343	20	0E0	98.6%	11	F:GO:0005515; P:GO:0007219; C:GO:0070062; C:GO:0005737; P:GO:0042351; F:GO:0016829; F:GO:0070401; P:GO:0019673; C:GO:0005829; C:GO:0005575; F:GO:0008446	F:protein binding; P:Notch signaling pathway; C:extracellular exosome; C:cytoplasm; P:'de novo' GDP-L-fucose biosynthetic process; F:lyase activity; F:NADP+ binding; P:GDP-mannose metabolic process; C:cytosol; C:cellular_component; F:GDP-mannose 4,6-dehydratase activity		
tr|F6T0M8|F6T0M8_HORSE	EGF-containing fibulin-like extracellular matrix 1	490	20	0E0	95.95%	16	P:GO:0018108; F:GO:0008083; P:GO:0007173; F:GO:0005154; P:GO:0006355; C:GO:0005576; C:GO:0005578; F:GO:0005006; C:GO:0005615; C:GO:0070062; P:GO:0048048; F:GO:0005509; P:GO:0043010; P:GO:0032331; C:GO:0031012; P:GO:0048050	P:peptidyl-tyrosine phosphorylation; F:growth factor activity; P:epidermal growth factor receptor signaling pathway; F:epidermal growth factor receptor binding; P:regulation of transcription, DNA-templated; C:extracellular region; C:proteinaceous extracellular matrix; F:epidermal growth factor-activated receptor activity; C:extracellular space; C:extracellular exosome; P:embryonic eye morphogenesis; F:calcium ion binding; P:camera-type eye development; P:negative regulation of chondrocyte differentiation; C:extracellular matrix; P:post-embryonic eye morphogenesis		
tr|F6PVG3|F6PVG3_HORSE	EGF-containing fibulin-like extracellular matrix 1	498	20	0E0	97%	13	P:GO:0018108; P:GO:0007173; F:GO:0005154; P:GO:0006355; F:GO:0005006; C:GO:0005615; C:GO:0070062; P:GO:0048048; F:GO:0005509; P:GO:0043010; P:GO:0032331; C:GO:0031012; P:GO:0048050	P:peptidyl-tyrosine phosphorylation; P:epidermal growth factor receptor signaling pathway; F:epidermal growth factor receptor binding; P:regulation of transcription, DNA-templated; F:epidermal growth factor-activated receptor activity; C:extracellular space; C:extracellular exosome; P:embryonic eye morphogenesis; F:calcium ion binding; P:camera-type eye development; P:negative regulation of chondrocyte differentiation; C:extracellular matrix; P:post-embryonic eye morphogenesis		
tr|F6XLG0|F6XLG0_HORSE	purine nucleoside phosphorylase	289	20	0E0	96.15%	9	F:GO:0016757; C:GO:0005737; F:GO:0003824; P:GO:0009116; P:GO:0043101; F:GO:0016740; F:GO:0016763; P:GO:0006139; F:GO:0004731	F:transferase activity, transferring glycosyl groups; C:cytoplasm; F:catalytic activity; P:nucleoside metabolic process; P:purine-containing compound salvage; F:transferase activity; F:transferase activity, transferring pentosyl groups; P:nucleobase-containing compound metabolic process; F:purine-nucleoside phosphorylase activity		
tr|F6QME0|F6QME0_HORSE	purine nucleoside phosphorylase	230	20	1.98E-170	96.4%	24	F:GO:0016757; F:GO:0008144; F:GO:0002060; P:GO:0009116; P:GO:0043101; P:GO:0042102; F:GO:0042301; P:GO:0046638; P:GO:0006139; C:GO:0005622; F:GO:0004731; F:GO:0001882; P:GO:0006148; C:GO:0070062; P:GO:0006955; P:GO:0034418; C:GO:0005737; F:GO:0003824; P:GO:0070970; P:GO:0006738; P:GO:0042493; P:GO:0034356; F:GO:0016740; F:GO:0016763	F:transferase activity, transferring glycosyl groups; F:drug binding; F:purine nucleobase binding; P:nucleoside metabolic process; P:purine-containing compound salvage; P:positive regulation of T cell proliferation; F:phosphate ion binding; P:positive regulation of alpha-beta T cell differentiation; P:nucleobase-containing compound metabolic process; C:intracellular; F:purine-nucleoside phosphorylase activity; F:nucleoside binding; P:inosine catabolic process; C:extracellular exosome; P:immune response; P:urate biosynthetic process; C:cytoplasm; F:catalytic activity; P:interleukin-2 secretion; P:nicotinamide riboside catabolic process; P:response to drug; P:NAD biosynthesis via nicotinamide riboside salvage pathway; F:transferase activity; F:transferase activity, transferring pentosyl groups		
tr|F7DY67|F7DY67_HORSE	purine nucleoside phosphorylase-like isoform X1	274	20	0E0	96.1%	30	F:GO:0008144; F:GO:0002060; P:GO:0043101; P:GO:0009116; P:GO:0042278; C:GO:0005576; P:GO:0046638; P:GO:0006148; P:GO:0006955; C:GO:0070062; F:GO:0003824; P:GO:0006738; C:GO:0005829; F:GO:0016757; P:GO:0006195; P:GO:0042102; F:GO:0042301; P:GO:0006139; F:GO:0004731; C:GO:0005622; F:GO:0001882; C:GO:0005634; C:GO:0005856; P:GO:0034418; C:GO:0005737; P:GO:0070970; P:GO:0042493; P:GO:0034356; F:GO:0016740; F:GO:0016763	F:drug binding; F:purine nucleobase binding; P:purine-containing compound salvage; P:nucleoside metabolic process; P:purine nucleoside metabolic process; C:extracellular region; P:positive regulation of alpha-beta T cell differentiation; P:inosine catabolic process; P:immune response; C:extracellular exosome; F:catalytic activity; P:nicotinamide riboside catabolic process; C:cytosol; F:transferase activity, transferring glycosyl groups; P:purine nucleotide catabolic process; P:positive regulation of T cell proliferation; F:phosphate ion binding; P:nucleobase-containing compound metabolic process; F:purine-nucleoside phosphorylase activity; C:intracellular; F:nucleoside binding; C:nucleus; C:cytoskeleton; P:urate biosynthetic process; C:cytoplasm; P:interleukin-2 secretion; P:response to drug; P:NAD biosynthesis via nicotinamide riboside salvage pathway; F:transferase activity; F:transferase activity, transferring pentosyl groups		
tr|F6PRI5|F6PRI5_HORSE	liver carboxylesterase-like isoform X1	565	20	0E0	92.35%	4	P:GO:0030855; C:GO:0005615; F:GO:0052689; F:GO:0016787	P:epithelial cell differentiation; C:extracellular space; F:carboxylic ester hydrolase activity; F:hydrolase activity		
tr|F6U592|F6U592_HORSE	PDZ and LIM domain 1	329	20	0E0	97.65%	7	C:GO:0005667; F:GO:0008270; C:GO:0005856; F:GO:0003713; C:GO:0005925; F:GO:0046872; P:GO:0006355	C:transcription factor complex; F:zinc ion binding; C:cytoskeleton; F:transcription coactivator activity; C:focal adhesion; F:metal ion binding; P:regulation of transcription, DNA-templated		
tr|F6UFH2|F6UFH2_HORSE	carboxypeptidase D	1250	20	0E0	95.9%	13	F:GO:0008270; F:GO:0004180; F:GO:0004181; F:GO:0004185; C:GO:0005634; C:GO:0005615; C:GO:0005802; C:GO:0070062; P:GO:0006518; C:GO:0016020; P:GO:0006508; C:GO:0016021; P:GO:0016485	F:zinc ion binding; F:carboxypeptidase activity; F:metallocarboxypeptidase activity; F:serine-type carboxypeptidase activity; C:nucleus; C:extracellular space; C:trans-Golgi network; C:extracellular exosome; P:peptide metabolic process; C:membrane; P:proteolysis; C:integral component of membrane; P:protein processing		
tr|F6PWL9|F6PWL9_HORSE	rab GDP dissociation inhibitor alpha	446	20	0E0	99.05%	21	P:GO:0090315; F:GO:0005093; F:GO:0005092; C:GO:0043209; P:GO:0007264; F:GO:0005096; P:GO:0032482; P:GO:0015031; C:GO:0005794; C:GO:0043234; C:GO:0043005; C:GO:0005622; P:GO:0043547; P:GO:0050771; C:GO:0005737; F:GO:0016491; P:GO:0051592; P:GO:0050790; P:GO:0055114; C:GO:0030496; F:GO:0017137	P:negative regulation of protein targeting to membrane; F:Rab GDP-dissociation inhibitor activity; F:GDP-dissociation inhibitor activity; C:myelin sheath; P:small GTPase mediated signal transduction; F:GTPase activator activity; P:Rab protein signal transduction; P:protein transport; C:Golgi apparatus; C:protein complex; C:neuron projection; C:intracellular; P:positive regulation of GTPase activity; P:negative regulation of axonogenesis; C:cytoplasm; F:oxidoreductase activity; P:response to calcium ion; P:regulation of catalytic activity; P:oxidation-reduction process; C:midbody; F:Rab GTPase binding		
tr|F7BR00|F7BR00_HORSE	peptidyl-glycine alpha-amidating monooxygenase isoform X1	974	20	0E0	95.85%	8	F:GO:0016715; F:GO:0005507; F:GO:0003824; P:GO:0006518; C:GO:0016020; C:GO:0016021; P:GO:0055114; F:GO:0004497	F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen; F:copper ion binding; F:catalytic activity; P:peptide metabolic process; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity		
tr|F6ZCC8|F6ZCC8_HORSE	peptidyl-glycine alpha-amidating monooxygenase isoform X1	976	20	0E0	95.4%	8	F:GO:0016715; F:GO:0005507; F:GO:0003824; P:GO:0006518; C:GO:0016020; C:GO:0016021; P:GO:0055114; F:GO:0004497	F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen; F:copper ion binding; F:catalytic activity; P:peptide metabolic process; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity		
tr|F6V822|F6V822_HORSE	antileuko ase	131	20	2.36E-90	81.85%	19	C:GO:0005576; P:GO:0042742; P:GO:0032091; P:GO:0002376; F:GO:0030414; C:GO:0005615; F:GO:0004867; F:GO:0004866; F:GO:0005515; C:GO:0070062; P:GO:0006955; P:GO:0045087; P:GO:0010951; P:GO:0019731; P:GO:0032496; C:GO:0031012; P:GO:0045071; P:GO:0010466; F:GO:0019899	C:extracellular region; P:defense response to bacterium; P:negative regulation of protein binding; P:immune system process; F:peptidase inhibitor activity; C:extracellular space; F:serine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:protein binding; C:extracellular exosome; P:immune response; P:innate immune response; P:negative regulation of endopeptidase activity; P:antibacterial humoral response; P:response to lipopolysaccharide; C:extracellular matrix; P:negative regulation of viral genome replication; P:negative regulation of peptidase activity; F:enzyme binding		
tr|F7BHV8|F7BHV8_HORSE	tubulin beta-4A chain	425	20	0E0	99.7%	23	C:GO:0043209; P:GO:0007010; P:GO:0030030; F:GO:0005164; F:GO:0005200; C:GO:0043025; C:GO:0042995; C:GO:0005874; P:GO:0007017; F:GO:0000166; F:GO:0005525; C:GO:0005634; C:GO:0005856; F:GO:0005515; C:GO:0070062; P:GO:0006955; P:GO:0000086; C:GO:0005737; F:GO:0003924; C:GO:0016020; C:GO:0005929; C:GO:0033269; C:GO:0005829	C:myelin sheath; P:cytoskeleton organization; P:cell projection organization; F:tumor necrosis factor receptor binding; F:structural constituent of cytoskeleton; C:neuronal cell body; C:cell projection; C:microtubule; P:microtubule-based process; F:nucleotide binding; F:GTP binding; C:nucleus; C:cytoskeleton; F:protein binding; C:extracellular exosome; P:immune response; P:G2/M transition of mitotic cell cycle; C:cytoplasm; F:GTPase activity; C:membrane; C:cilium; C:internode region of axon; C:cytosol		
tr|F6UF75|F6UF75_HORSE	S100-A4	101	20	3.36E-68	99.35%	15	F:GO:0042802; P:GO:0043123; F:GO:0048306; C:GO:0043005; F:GO:0044822; C:GO:0005634; C:GO:0005615; F:GO:0005515; C:GO:0070062; C:GO:0048471; F:GO:0003779; F:GO:0046872; F:GO:0005509; P:GO:0001837; F:GO:0050786	F:identical protein binding; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; F:calcium-dependent protein binding; C:neuron projection; F:poly(A) RNA binding; C:nucleus; C:extracellular space; F:protein binding; C:extracellular exosome; C:perinuclear region of cytoplasm; F:actin binding; F:metal ion binding; F:calcium ion binding; P:epithelial to mesenchymal transition; F:RAGE receptor binding		
tr|F7APR4|F7APR4_HORSE	actin-related 2 3 complex subunit 2	298	20	0E0	99%	33	C:GO:0036195; C:GO:0005794; C:GO:0045202; P:GO:0038096; C:GO:0043005; C:GO:0042995; C:GO:0030426; C:GO:0005768; C:GO:0070062; C:GO:0005925; C:GO:0015629; C:GO:0005829; P:GO:0014911; F:GO:0071933; P:GO:0010592; F:GO:0035650; C:GO:0031252; F:GO:0005200; P:GO:1900026; C:GO:0005886; C:GO:0005885; P:GO:0030833; F:GO:0051015; C:GO:0005856; F:GO:0005515; F:GO:0003779; C:GO:0005737; P:GO:0006928; P:GO:0048013; P:GO:0030838; F:GO:0019894; P:GO:0034314; C:GO:0030054	C:muscle cell projection membrane; C:Golgi apparatus; C:synapse; P:Fc-gamma receptor signaling pathway involved in phagocytosis; C:neuron projection; C:cell projection; C:growth cone; C:endosome; C:extracellular exosome; C:focal adhesion; C:actin cytoskeleton; C:cytosol; P:positive regulation of smooth muscle cell migration; F:Arp2/3 complex binding; P:positive regulation of lamellipodium assembly; F:AP-1 adaptor complex binding; C:cell leading edge; F:structural constituent of cytoskeleton; P:positive regulation of substrate adhesion-dependent cell spreading; C:plasma membrane; C:Arp2/3 protein complex; P:regulation of actin filament polymerization; F:actin filament binding; C:cytoskeleton; F:protein binding; F:actin binding; C:cytoplasm; P:movement of cell or subcellular component; P:ephrin receptor signaling pathway; P:positive regulation of actin filament polymerization; F:kinesin binding; P:Arp2/3 complex-mediated actin nucleation; C:cell junction		
tr|F6Z0A9|F6Z0A9_HORSE	ras-related C3 botulinum toxin substrate 1 isoform X1	199	20	1.89E-145	99.85%	111	P:GO:0007010; P:GO:0021831; P:GO:0007411; P:GO:0007015; P:GO:0021799; P:GO:0006954; P:GO:0010811; F:GO:0031996; P:GO:0035556; C:GO:0030027; F:GO:0019901; F:GO:0042826; P:GO:0090103; P:GO:0007264; P:GO:0002093; P:GO:1900026; C:GO:0005884; P:GO:0006972; C:GO:0005886; C:GO:0031901; C:GO:0005634; P:GO:0048010; F:GO:0005515; P:GO:0051894; P:GO:0051496; P:GO:0048532; P:GO:0048013; P:GO:0051932; P:GO:0071526; P:GO:0008283; P:GO:0035025; P:GO:0060263; P:GO:0014041; P:GO:0038095; P:GO:0048812; P:GO:0009653; P:GO:0038096; P:GO:0007596; C:GO:0001891; P:GO:0021894; P:GO:0048813; F:GO:0000166; P:GO:0006935; C:GO:0070062; F:GO:0051022; P:GO:0050690; P:GO:0032707; P:GO:0034446; P:GO:0051668; P:GO:0048261; P:GO:0016477; P:GO:0016358; C:GO:0036464; P:GO:0031295; P:GO:0043652; C:GO:0005622; P:GO:0071260; C:GO:0005737; P:GO:0071542; P:GO:0001934; P:GO:0010762; P:GO:0022604; C:GO:0000139; C:GO:0005789; P:GO:0006911; P:GO:0045453; F:GO:0003924; C:GO:0005829; F:GO:0030742; P:GO:0010592; P:GO:0007186; P:GO:0090023; P:GO:0003382; P:GO:0043552; P:GO:0006897; P:GO:0045216; P:GO:0097178; P:GO:0051056; P:GO:0006928; C:GO:0042470; P:GO:0030334; F:GO:0017137; P:GO:0072659; P:GO:0008361; P:GO:0009611; P:GO:0045740; P:GO:0007155; C:GO:0042995; F:GO:0005525; C:GO:0005802; C:GO:0005925; C:GO:0032587; C:GO:0031410; P:GO:0060071; P:GO:0010310; P:GO:0030168; P:GO:0007160; P:GO:0030041; P:GO:0002551; P:GO:0048870; P:GO:0048873; P:GO:0031529; P:GO:0043065; C:GO:0016020; P:GO:0030838; P:GO:0030032; C:GO:0016023; C:GO:0019897; P:GO:0030036; P:GO:0035567; F:GO:0019899	P:cytoskeleton organization; P:embryonic olfactory bulb interneuron precursor migration; P:axon guidance; P:actin filament organization; P:cerebral cortex radially oriented cell migration; P:inflammatory response; P:positive regulation of cell-substrate adhesion; F:thioesterase binding; P:intracellular signal transduction; C:lamellipodium; F:protein kinase binding; F:histone deacetylase binding; P:cochlea morphogenesis; P:small GTPase mediated signal transduction; P:auditory receptor cell morphogenesis; P:positive regulation of substrate adhesion-dependent cell spreading; C:actin filament; P:hyperosmotic response; C:plasma membrane; C:early endosome membrane; C:nucleus; P:vascular endothelial growth factor receptor signaling pathway; F:protein binding; P:positive regulation of focal adhesion assembly; P:positive regulation of stress fiber assembly; P:anatomical structure arrangement; P:ephrin receptor signaling pathway; P:synaptic transmission, GABAergic; P:semaphorin-plexin signaling pathway; P:cell proliferation; P:positive regulation of Rho protein signal transduction; P:regulation of respiratory burst; P:regulation of neuron maturation; P:Fc-epsilon receptor signaling pathway; P:neuron projection morphogenesis; P:anatomical structure morphogenesis; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:blood coagulation; C:phagocytic cup; P:cerebral cortex GABAergic interneuron development; P:dendrite morphogenesis; F:nucleotide binding; P:chemotaxis; C:extracellular exosome; F:Rho GDP-dissociation inhibitor binding; P:regulation of defense response to virus by virus; P:negative regulation of interleukin-23 production; P:substrate adhesion-dependent cell spreading; P:localization within membrane; P:negative regulation of receptor-mediated endocytosis; P:cell migration; P:dendrite development; C:cytoplasmic ribonucleoprotein granule; P:T cell costimulation; P:engulfment of apoptotic cell; C:intracellular; P:cellular response to mechanical stimulus; C:cytoplasm; P:dopaminergic neuron differentiation; P:positive regulation of protein phosphorylation; P:regulation of fibroblast migration; P:regulation of cell morphogenesis; C:Golgi membrane; C:endoplasmic reticulum membrane; P:phagocytosis, engulfment; P:bone resorption; F:GTPase activity; C:cytosol; F:GTP-dependent protein binding; P:positive regulation of lamellipodium assembly; P:G-protein coupled receptor signaling pathway; P:positive regulation of neutrophil chemotaxis; P:epithelial cell morphogenesis; P:positive regulation of phosphatidylinositol 3-kinase activity; P:endocytosis; P:cell-cell junction organization; P:ruffle assembly; P:regulation of small GTPase mediated signal transduction; P:movement of cell or subcellular component; C:melanosome; P:regulation of cell migration; F:Rab GTPase binding; P:protein localization to plasma membrane; P:regulation of cell size; P:response to wounding; P:positive regulation of DNA replication; P:cell adhesion; C:cell projection; F:GTP binding; C:trans-Golgi network; C:focal adhesion; C:ruffle membrane; C:cytoplasmic vesicle; P:Wnt signaling pathway, planar cell polarity pathway; P:regulation of hydrogen peroxide metabolic process; P:platelet activation; P:cell-matrix adhesion; P:actin filament polymerization; P:mast cell chemotaxis; P:cell motility; P:homeostasis of number of cells within a tissue; P:ruffle organization; P:positive regulation of apoptotic process; C:membrane; P:positive regulation of actin filament polymerization; P:lamellipodium assembly; C:cytoplasmic, membrane-bounded vesicle; C:extrinsic component of plasma membrane; P:actin cytoskeleton organization; P:non-canonical Wnt signaling pathway; F:enzyme binding		
tr|F7AX30|F7AX30_HORSE	ras-related C3 botulinum toxin substrate 2	192	20	4.11E-140	98.75%	32	P:GO:0030031; P:GO:0060263; P:GO:0008284; P:GO:0007015; P:GO:0043304; F:GO:0005525; F:GO:0000166; P:GO:0006935; P:GO:0071593; C:GO:0070062; C:GO:0005925; P:GO:0045453; F:GO:0003924; C:GO:0005829; P:GO:0010810; F:GO:0019887; C:GO:0030027; P:GO:0010592; P:GO:0042129; P:GO:0045859; P:GO:0007186; P:GO:0007264; P:GO:0090023; P:GO:1902622; C:GO:0005884; P:GO:0060753; P:GO:1903955; C:GO:0005622; C:GO:0005635; C:GO:0005737; C:GO:0016020; P:GO:0030036	P:cell projection assembly; P:regulation of respiratory burst; P:positive regulation of cell proliferation; P:actin filament organization; P:regulation of mast cell degranulation; F:GTP binding; F:nucleotide binding; P:chemotaxis; P:lymphocyte aggregation; C:extracellular exosome; C:focal adhesion; P:bone resorption; F:GTPase activity; C:cytosol; P:regulation of cell-substrate adhesion; F:protein kinase regulator activity; C:lamellipodium; P:positive regulation of lamellipodium assembly; P:regulation of T cell proliferation; P:regulation of protein kinase activity; P:G-protein coupled receptor signaling pathway; P:small GTPase mediated signal transduction; P:positive regulation of neutrophil chemotaxis; P:regulation of neutrophil migration; C:actin filament; P:regulation of mast cell chemotaxis; P:positive regulation of protein targeting to mitochondrion; C:intracellular; C:nuclear envelope; C:cytoplasm; C:membrane; P:actin cytoskeleton organization		
tr|F7AJD4|F7AJD4_HORSE	neuroblast differentiation-associated AHNAK isoform X1	3838	20	0E0	86.9%	23	P:GO:1901385; C:GO:0043034; C:GO:0005886; F:GO:0044548; C:GO:0005765; F:GO:0097493; F:GO:0044822; C:GO:0044291; C:GO:0030315; C:GO:0005634; F:GO:0005515; C:GO:0070062; C:GO:0005925; C:GO:0005737; C:GO:0042383; P:GO:0043484; C:GO:0016020; C:GO:0045121; C:GO:0015629; C:GO:0005829; C:GO:0019013; C:GO:0031982; P:GO:0051259	P:regulation of voltage-gated calcium channel activity; C:costamere; C:plasma membrane; F:S100 protein binding; C:lysosomal membrane; F:structural molecule activity conferring elasticity; F:poly(A) RNA binding; C:cell-cell contact zone; C:T-tubule; C:nucleus; F:protein binding; C:extracellular exosome; C:focal adhesion; C:cytoplasm; C:sarcolemma; P:regulation of RNA splicing; C:membrane; C:membrane raft; C:actin cytoskeleton; C:cytosol; C:viral nucleocapsid; C:vesicle; P:protein oligomerization		
tr|F6R9A3|F6R9A3_HORSE	lipopolysaccharide-responsive and beige-like anchor isoform X1	2866	20	0E0	95.4%	1	C:GO:0016020	C:membrane		
tr|F6YQM5|F6YQM5_HORSE	prosaposin isoform X2	513	20	0E0	95.95%	20	P:GO:0007193; P:GO:0043408; P:GO:1903206; P:GO:0060736; F:GO:0008047; P:GO:0048589; P:GO:0043410; P:GO:0060742; C:GO:0005764; P:GO:0006687; P:GO:0006665; F:GO:0001664; C:GO:0005615; C:GO:0070062; P:GO:0071310; C:GO:0005737; P:GO:0043085; C:GO:0005739; P:GO:0006629; P:GO:0019216	P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; P:regulation of MAPK cascade; P:negative regulation of hydrogen peroxide-induced cell death; P:prostate gland growth; F:enzyme activator activity; P:developmental growth; P:positive regulation of MAPK cascade; P:epithelial cell differentiation involved in prostate gland development; C:lysosome; P:glycosphingolipid metabolic process; P:sphingolipid metabolic process; F:G-protein coupled receptor binding; C:extracellular space; C:extracellular exosome; P:cellular response to organic substance; C:cytoplasm; P:positive regulation of catalytic activity; C:mitochondrion; P:lipid metabolic process; P:regulation of lipid metabolic process		
tr|F6ZHQ5|F6ZHQ5_HORSE	chloride intracellular channel 1	241	20	5.29E-178	99.2%	30	P:GO:1902476; F:GO:0004364; F:GO:0005254; P:GO:0045669; P:GO:0006821; C:GO:0034707; P:GO:0006811; C:GO:0070062; C:GO:0005903; P:GO:0051881; C:GO:0072562; P:GO:0034765; P:GO:0051726; P:GO:0070527; P:GO:0007165; F:GO:0005244; P:GO:0006810; C:GO:0005886; C:GO:0005635; C:GO:0005634; C:GO:0005615; C:GO:0031965; C:GO:0048471; F:GO:0005515; C:GO:0005737; P:GO:0006749; C:GO:0016020; C:GO:0005739; C:GO:0016021; C:GO:0031982	P:chloride transmembrane transport; F:glutathione transferase activity; F:chloride channel activity; P:positive regulation of osteoblast differentiation; P:chloride transport; C:chloride channel complex; P:ion transport; C:extracellular exosome; C:brush border; P:regulation of mitochondrial membrane potential; C:blood microparticle; P:regulation of ion transmembrane transport; P:regulation of cell cycle; P:platelet aggregation; P:signal transduction; F:voltage-gated ion channel activity; P:transport; C:plasma membrane; C:nuclear envelope; C:nucleus; C:extracellular space; C:nuclear membrane; C:perinuclear region of cytoplasm; F:protein binding; C:cytoplasm; P:glutathione metabolic process; C:membrane; C:mitochondrion; C:integral component of membrane; C:vesicle		
sp|P62327|TYB4_HORSE	TMSB4X partial	44	20	4.11E-22	100%	8	C:GO:0005634; F:GO:0005515; C:GO:0005856; C:GO:0005829; P:GO:0007015; P:GO:0030334; F:GO:0044822; F:GO:0003785	C:nucleus; F:protein binding; C:cytoskeleton; C:cytosol; P:actin filament organization; P:regulation of cell migration; F:poly(A) RNA binding; F:actin monomer binding		
tr|F6VSN9|F6VSN9_HORSE	disulfide-isomerase A3	504	20	0E0	98.25%	26	F:GO:0015036; C:GO:0043209; P:GO:0006621; C:GO:0005788; C:GO:0070062; C:GO:0005925; F:GO:0016853; P:GO:0007165; F:GO:0004197; C:GO:0005783; P:GO:0045454; P:GO:0006457; P:GO:0002474; C:GO:0009986; F:GO:0044822; C:GO:0005634; F:GO:0005515; F:GO:0003756; C:GO:0042470; P:GO:0006606; F:GO:0004629; P:GO:0006508; P:GO:2001238; P:GO:0055114; P:GO:0034976; P:GO:0034975	F:disulfide oxidoreductase activity; C:myelin sheath; P:protein retention in ER lumen; C:endoplasmic reticulum lumen; C:extracellular exosome; C:focal adhesion; F:isomerase activity; P:signal transduction; F:cysteine-type endopeptidase activity; C:endoplasmic reticulum; P:cell redox homeostasis; P:protein folding; P:antigen processing and presentation of peptide antigen via MHC class I; C:cell surface; F:poly(A) RNA binding; C:nucleus; F:protein binding; F:protein disulfide isomerase activity; C:melanosome; P:protein import into nucleus; F:phospholipase C activity; P:proteolysis; P:positive regulation of extrinsic apoptotic signaling pathway; P:oxidation-reduction process; P:response to endoplasmic reticulum stress; P:protein folding in endoplasmic reticulum		
tr|F6WPZ3|F6WPZ3_HORSE	plectin isoform X9	4428	20	0E0	91.85%	15	P:GO:0031581; F:GO:0044822; C:GO:0005856; C:GO:0043292; C:GO:0070062; F:GO:0008307; F:GO:0003779; C:GO:0005903; C:GO:0005925; C:GO:0045111; C:GO:0005737; F:GO:0030506; C:GO:0042383; C:GO:0030056; F:GO:0008092	P:hemidesmosome assembly; F:poly(A) RNA binding; C:cytoskeleton; C:contractile fiber; C:extracellular exosome; F:structural constituent of muscle; F:actin binding; C:brush border; C:focal adhesion; C:intermediate filament cytoskeleton; C:cytoplasm; F:ankyrin binding; C:sarcolemma; C:hemidesmosome; F:cytoskeletal protein binding		
tr|F6WQF0|F6WQF0_HORSE	plectin isoform X11	4428	20	0E0	91.8%	15	P:GO:0031581; F:GO:0044822; C:GO:0005856; C:GO:0043292; C:GO:0070062; F:GO:0008307; F:GO:0003779; C:GO:0005903; C:GO:0005925; C:GO:0045111; C:GO:0005737; F:GO:0030506; C:GO:0042383; C:GO:0030056; F:GO:0008092	P:hemidesmosome assembly; F:poly(A) RNA binding; C:cytoskeleton; C:contractile fiber; C:extracellular exosome; F:structural constituent of muscle; F:actin binding; C:brush border; C:focal adhesion; C:intermediate filament cytoskeleton; C:cytoplasm; F:ankyrin binding; C:sarcolemma; C:hemidesmosome; F:cytoskeletal protein binding		
tr|F6WQ73|F6WQ73_HORSE	plectin isoform X10	4434	20	0E0	91.85%	15	P:GO:0031581; F:GO:0044822; C:GO:0005856; C:GO:0043292; C:GO:0070062; F:GO:0008307; F:GO:0003779; C:GO:0005903; C:GO:0005925; C:GO:0045111; C:GO:0005737; F:GO:0030506; C:GO:0042383; C:GO:0030056; F:GO:0008092	P:hemidesmosome assembly; F:poly(A) RNA binding; C:cytoskeleton; C:contractile fiber; C:extracellular exosome; F:structural constituent of muscle; F:actin binding; C:brush border; C:focal adhesion; C:intermediate filament cytoskeleton; C:cytoplasm; F:ankyrin binding; C:sarcolemma; C:hemidesmosome; F:cytoskeletal protein binding		
tr|F6WXR4|F6WXR4_HORSE	plectin isoform X6	4455	20	0E0	91.7%	15	P:GO:0031581; F:GO:0044822; C:GO:0005856; C:GO:0043292; C:GO:0070062; F:GO:0008307; F:GO:0003779; C:GO:0005903; C:GO:0005925; C:GO:0045111; C:GO:0005737; F:GO:0030506; C:GO:0042383; C:GO:0030056; F:GO:0008092	P:hemidesmosome assembly; F:poly(A) RNA binding; C:cytoskeleton; C:contractile fiber; C:extracellular exosome; F:structural constituent of muscle; F:actin binding; C:brush border; C:focal adhesion; C:intermediate filament cytoskeleton; C:cytoplasm; F:ankyrin binding; C:sarcolemma; C:hemidesmosome; F:cytoskeletal protein binding		
tr|F6WQW5|F6WQW5_HORSE	plectin isoform X1	4570	20	0E0	91.45%	15	P:GO:0031581; F:GO:0044822; C:GO:0005856; C:GO:0043292; C:GO:0070062; F:GO:0008307; F:GO:0003779; C:GO:0005903; C:GO:0005925; C:GO:0045111; C:GO:0005737; F:GO:0030506; C:GO:0042383; C:GO:0030056; F:GO:0008092	P:hemidesmosome assembly; F:poly(A) RNA binding; C:cytoskeleton; C:contractile fiber; C:extracellular exosome; F:structural constituent of muscle; F:actin binding; C:brush border; C:focal adhesion; C:intermediate filament cytoskeleton; C:cytoplasm; F:ankyrin binding; C:sarcolemma; C:hemidesmosome; F:cytoskeletal protein binding		
tr|F6WRA4|F6WRA4_HORSE	plectin isoform X1	4574	20	0E0	91.45%	15	P:GO:0031581; F:GO:0044822; C:GO:0005856; C:GO:0043292; C:GO:0070062; F:GO:0008307; F:GO:0003779; C:GO:0005903; C:GO:0005925; C:GO:0045111; C:GO:0005737; F:GO:0030506; C:GO:0042383; C:GO:0030056; F:GO:0008092	P:hemidesmosome assembly; F:poly(A) RNA binding; C:cytoskeleton; C:contractile fiber; C:extracellular exosome; F:structural constituent of muscle; F:actin binding; C:brush border; C:focal adhesion; C:intermediate filament cytoskeleton; C:cytoplasm; F:ankyrin binding; C:sarcolemma; C:hemidesmosome; F:cytoskeletal protein binding		
tr|F6UIC2|F6UIC2_HORSE	3 (2 ),5 -bisphosphate nucleotidase 1 isoform X1	308	20	0E0	97.85%	7	F:GO:0000287; C:GO:0070062; F:GO:0008441; C:GO:0005737; P:GO:0046854; P:GO:0016311; P:GO:0006139	F:magnesium ion binding; C:extracellular exosome; F:3'(2'),5'-bisphosphate nucleotidase activity; C:cytoplasm; P:phosphatidylinositol phosphorylation; P:dephosphorylation; P:nucleobase-containing compound metabolic process		
tr|F6U5V3|F6U5V3_HORSE	transcobalamin-2	429	20	0E0	87.65%	3	C:GO:0070062; F:GO:0031419; P:GO:0015889	C:extracellular exosome; F:cobalamin binding; P:cobalamin transport		
tr|F6X8Q2|F6X8Q2_HORSE	phosphoglucomutase-1 isoform X2	644	20	0E0	93.2%	11	F:GO:0000287; P:GO:0005975; F:GO:0004614; P:GO:0005978; F:GO:0016868; F:GO:0046872; F:GO:0005509; P:GO:0019388; C:GO:0005829; P:GO:0006006; P:GO:0071704	F:magnesium ion binding; P:carbohydrate metabolic process; F:phosphoglucomutase activity; P:glycogen biosynthetic process; F:intramolecular transferase activity, phosphotransferases; F:metal ion binding; F:calcium ion binding; P:galactose catabolic process; C:cytosol; P:glucose metabolic process; P:organic substance metabolic process		
tr|F7DVQ8|F7DVQ8_HORSE	trefoil factor 3	80	20	4.87E-52	88.85%	5	P:GO:0010906; C:GO:0005737; C:GO:0030141; C:GO:0005576; C:GO:0005578	P:regulation of glucose metabolic process; C:cytoplasm; C:secretory granule; C:extracellular region; C:proteinaceous extracellular matrix		
tr|F7BRA4|F7BRA4_HORSE	proteasome subunit alpha type-6	246	20	0E0	99.55%	45	P:GO:0038095; C:GO:0000932; P:GO:0043488; P:GO:0051092; P:GO:0006521; C:GO:0005654; P:GO:0002223; C:GO:0005844; P:GO:0000165; P:GO:0002479; F:GO:0003723; C:GO:0070062; F:GO:0035639; C:GO:0005829; P:GO:0060071; P:GO:0051603; P:GO:0050852; P:GO:0000209; F:GO:0004175; P:GO:0090263; P:GO:0038061; F:GO:0004298; C:GO:0000502; F:GO:0008233; P:GO:0006511; P:GO:0090090; F:GO:0051059; C:GO:0005634; P:GO:0043161; P:GO:0033209; F:GO:0005515; C:GO:0005737; P:GO:0007519; C:GO:0005839; P:GO:0006508; C:GO:0019773; P:GO:0031145; C:GO:0016363; P:GO:0050727; P:GO:0000090; P:GO:0051437; C:GO:0030017; F:GO:0016787; C:GO:0030016; P:GO:0051436	P:Fc-epsilon receptor signaling pathway; C:cytoplasmic mRNA processing body; P:regulation of mRNA stability; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of cellular amino acid metabolic process; C:nucleoplasm; P:stimulatory C-type lectin receptor signaling pathway; C:polysome; P:MAPK cascade; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; F:RNA binding; C:extracellular exosome; F:purine ribonucleoside triphosphate binding; C:cytosol; P:Wnt signaling pathway, planar cell polarity pathway; P:proteolysis involved in cellular protein catabolic process; P:T cell receptor signaling pathway; P:protein polyubiquitination; F:endopeptidase activity; P:positive regulation of canonical Wnt signaling pathway; P:NIK/NF-kappaB signaling; F:threonine-type endopeptidase activity; C:proteasome complex; F:peptidase activity; P:ubiquitin-dependent protein catabolic process; P:negative regulation of canonical Wnt signaling pathway; F:NF-kappaB binding; C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:tumor necrosis factor-mediated signaling pathway; F:protein binding; C:cytoplasm; P:skeletal muscle tissue development; C:proteasome core complex; P:proteolysis; C:proteasome core complex, alpha-subunit complex; P:anaphase-promoting complex-dependent catabolic process; C:nuclear matrix; P:regulation of inflammatory response; P:mitotic anaphase; P:positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition; C:sarcomere; F:hydrolase activity; C:myofibril; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle		
tr|F7C6F2|F7C6F2_HORSE	ubiquitin-like modifier-activating enzyme 1 isoform X2	1058	20	0E0	99.05%	21	P:GO:0006464; F:GO:0008641; P:GO:0006974; C:GO:0005765; F:GO:0044822; F:GO:0000166; C:GO:0000792; C:GO:0005634; F:GO:0005524; F:GO:0004842; C:GO:0030867; C:GO:0070062; C:GO:0005737; C:GO:0005739; F:GO:0004839; C:GO:0005829; C:GO:0010008; C:GO:0030057; P:GO:0019941; F:GO:0016874; P:GO:0016567	P:cellular protein modification process; F:small protein activating enzyme activity; P:cellular response to DNA damage stimulus; C:lysosomal membrane; F:poly(A) RNA binding; F:nucleotide binding; C:heterochromatin; C:nucleus; F:ATP binding; F:ubiquitin-protein transferase activity; C:rough endoplasmic reticulum membrane; C:extracellular exosome; C:cytoplasm; C:mitochondrion; F:ubiquitin activating enzyme activity; C:cytosol; C:endosome membrane; C:desmosome; P:modification-dependent protein catabolic process; F:ligase activity; P:protein ubiquitination		
tr|F6X9U4|F6X9U4_HORSE	dystroglycan	894	20	0E0	97.4%	67	P:GO:0060441; F:GO:0015631; F:GO:0002162; C:GO:0009279; C:GO:0045202; P:GO:0060445; P:GO:0007016; P:GO:0022011; P:GO:0021682; C:GO:0045211; F:GO:0005509; C:GO:0042383; C:GO:0016010; C:GO:0005829; C:GO:0016011; P:GO:0019048; F:GO:0032403; C:GO:0030027; P:GO:0010470; P:GO:0006493; C:GO:0043034; F:GO:0043237; P:GO:0002011; P:GO:0043434; C:GO:0005886; C:GO:0005634; F:GO:0005515; C:GO:0005911; F:GO:0008307; F:GO:0003779; C:GO:0005913; P:GO:0006607; C:GO:0030054; C:GO:0030175; P:GO:1904261; C:GO:0016323; P:GO:0030336; P:GO:0051898; P:GO:0046718; P:GO:0034453; P:GO:0014044; P:GO:0043409; F:GO:0051393; C:GO:0005576; C:GO:0005654; P:GO:0010717; C:GO:0005604; C:GO:0070062; C:GO:0005925; P:GO:0016032; F:GO:0017166; P:GO:0071711; P:GO:0016476; P:GO:0071679; C:GO:0070938; F:GO:0042169; C:GO:0005615; C:GO:0005856; P:GO:0006509; C:GO:0005737; C:GO:0045121; C:GO:0016020; C:GO:0016021; P:GO:0016340; P:GO:0030198; C:GO:0033268; F:GO:0001618	P:epithelial tube branching involved in lung morphogenesis; F:tubulin binding; F:dystroglycan binding; C:cell outer membrane; C:synapse; P:branching involved in salivary gland morphogenesis; P:cytoskeletal anchoring at plasma membrane; P:myelination in peripheral nervous system; P:nerve maturation; C:postsynaptic membrane; F:calcium ion binding; C:sarcolemma; C:dystrophin-associated glycoprotein complex; C:cytosol; C:dystroglycan complex; P:modulation by virus of host morphology or physiology; F:protein complex binding; C:lamellipodium; P:regulation of gastrulation; P:protein O-linked glycosylation; C:costamere; F:laminin-1 binding; P:morphogenesis of an epithelial sheet; P:response to peptide hormone; C:plasma membrane; C:nucleus; F:protein binding; C:cell-cell junction; F:structural constituent of muscle; F:actin binding; C:cell-cell adherens junction; P:NLS-bearing protein import into nucleus; C:cell junction; C:filopodium; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; C:basolateral plasma membrane; P:negative regulation of cell migration; P:negative regulation of protein kinase B signaling; P:viral entry into host cell; P:microtubule anchoring; P:Schwann cell development; P:negative regulation of MAPK cascade; F:alpha-actinin binding; C:extracellular region; C:nucleoplasm; P:regulation of epithelial to mesenchymal transition; C:basement membrane; C:extracellular exosome; C:focal adhesion; P:viral process; F:vinculin binding; P:basement membrane organization; P:regulation of embryonic cell shape; P:commissural neuron axon guidance; C:contractile ring; F:SH2 domain binding; C:extracellular space; C:cytoskeleton; P:membrane protein ectodomain proteolysis; C:cytoplasm; C:membrane raft; C:membrane; C:integral component of membrane; P:calcium-dependent cell-matrix adhesion; P:extracellular matrix organization; C:node of Ranvier; F:virus receptor activity		
tr|F6ZNS0|F6ZNS0_HORSE	pleckstrin homology domain-containing family S member 1 isoform X2	461	20	0E0	86.6%	1	F:GO:0005515	F:protein binding		
tr|F6ZSZ5|F6ZSZ5_HORSE	vinculin isoform X1	1066	20	0E0	99.65%	49	P:GO:0034394; C:GO:1903561; P:GO:0090136; F:GO:0005198; F:GO:0002162; F:GO:0045294; C:GO:0005623; C:GO:0005903; F:GO:0045296; C:GO:0015629; C:GO:0005829; P:GO:0070527; C:GO:0043034; C:GO:0043234; C:GO:0005886; F:GO:0051015; C:GO:0005912; C:GO:0005911; F:GO:0005515; F:GO:0031625; F:GO:0003779; C:GO:0005913; P:GO:0006928; P:GO:0002009; C:GO:0005916; C:GO:0005915; C:GO:0030055; C:GO:0030054; P:GO:0034333; P:GO:0030334; P:GO:0030336; P:GO:0007155; C:GO:0005576; P:GO:0002576; C:GO:0070062; C:GO:0005925; P:GO:0006936; P:GO:0043297; C:GO:0090636; C:GO:0090637; P:GO:0007160; F:GO:0008013; C:GO:0005856; C:GO:1990357; P:GO:0048675; C:GO:0005737; C:GO:0045121; C:GO:0016020; P:GO:0030032	P:protein localization to cell surface; C:extracellular vesicle; P:epithelial cell-cell adhesion; F:structural molecule activity; F:dystroglycan binding; F:alpha-catenin binding; C:cell; C:brush border; F:cadherin binding; C:actin cytoskeleton; C:cytosol; P:platelet aggregation; C:costamere; C:protein complex; C:plasma membrane; F:actin filament binding; C:adherens junction; C:cell-cell junction; F:protein binding; F:ubiquitin protein ligase binding; F:actin binding; C:cell-cell adherens junction; P:movement of cell or subcellular component; P:morphogenesis of an epithelium; C:fascia adherens; C:zonula adherens; C:cell-substrate junction; C:cell junction; P:adherens junction assembly; P:regulation of cell migration; P:negative regulation of cell migration; P:cell adhesion; C:extracellular region; P:platelet degranulation; C:extracellular exosome; C:focal adhesion; P:muscle contraction; P:apical junction assembly; C:outer dense plaque of desmosome; C:inner dense plaque of desmosome; P:cell-matrix adhesion; F:beta-catenin binding; C:cytoskeleton; C:terminal web; P:axon extension; C:cytoplasm; C:membrane raft; C:membrane; P:lamellipodium assembly		
tr|F6ZT22|F6ZT22_HORSE	vinculin isoform X1	1134	20	0E0	99.1%	49	P:GO:0034394; C:GO:1903561; P:GO:0090136; F:GO:0005198; F:GO:0002162; F:GO:0045294; C:GO:0005623; C:GO:0005903; F:GO:0045296; C:GO:0015629; C:GO:0005829; P:GO:0070527; C:GO:0043034; C:GO:0043234; C:GO:0005886; F:GO:0051015; C:GO:0005912; C:GO:0005911; F:GO:0005515; F:GO:0031625; F:GO:0003779; C:GO:0005913; P:GO:0002009; P:GO:0006928; C:GO:0005916; C:GO:0005915; C:GO:0030055; C:GO:0030054; P:GO:0034333; P:GO:0030334; P:GO:0030336; P:GO:0007155; C:GO:0005576; P:GO:0002576; C:GO:0070062; C:GO:0005925; P:GO:0006936; P:GO:0043297; C:GO:0090636; C:GO:0090637; P:GO:0007160; F:GO:0008013; C:GO:0005856; C:GO:1990357; P:GO:0048675; C:GO:0005737; C:GO:0045121; C:GO:0016020; P:GO:0030032	P:protein localization to cell surface; C:extracellular vesicle; P:epithelial cell-cell adhesion; F:structural molecule activity; F:dystroglycan binding; F:alpha-catenin binding; C:cell; C:brush border; F:cadherin binding; C:actin cytoskeleton; C:cytosol; P:platelet aggregation; C:costamere; C:protein complex; C:plasma membrane; F:actin filament binding; C:adherens junction; C:cell-cell junction; F:protein binding; F:ubiquitin protein ligase binding; F:actin binding; C:cell-cell adherens junction; P:morphogenesis of an epithelium; P:movement of cell or subcellular component; C:fascia adherens; C:zonula adherens; C:cell-substrate junction; C:cell junction; P:adherens junction assembly; P:regulation of cell migration; P:negative regulation of cell migration; P:cell adhesion; C:extracellular region; P:platelet degranulation; C:extracellular exosome; C:focal adhesion; P:muscle contraction; P:apical junction assembly; C:outer dense plaque of desmosome; C:inner dense plaque of desmosome; P:cell-matrix adhesion; F:beta-catenin binding; C:cytoskeleton; C:terminal web; P:axon extension; C:cytoplasm; C:membrane raft; C:membrane; P:lamellipodium assembly		
tr|F6ZT60|F6ZT60_HORSE	vinculin isoform X1	1137	20	0E0	99%	49	P:GO:0034394; C:GO:1903561; P:GO:0090136; F:GO:0005198; F:GO:0002162; F:GO:0045294; C:GO:0005623; C:GO:0005903; F:GO:0045296; C:GO:0015629; C:GO:0005829; P:GO:0070527; C:GO:0043034; C:GO:0043234; C:GO:0005886; F:GO:0051015; C:GO:0005912; C:GO:0005911; F:GO:0005515; F:GO:0031625; F:GO:0003779; C:GO:0005913; P:GO:0002009; P:GO:0006928; C:GO:0005916; C:GO:0005915; C:GO:0030055; C:GO:0030054; P:GO:0034333; P:GO:0030334; P:GO:0030336; P:GO:0007155; C:GO:0005576; P:GO:0002576; C:GO:0070062; C:GO:0005925; P:GO:0006936; P:GO:0043297; C:GO:0090636; C:GO:0090637; P:GO:0007160; F:GO:0008013; C:GO:0005856; C:GO:1990357; P:GO:0048675; C:GO:0005737; C:GO:0045121; C:GO:0016020; P:GO:0030032	P:protein localization to cell surface; C:extracellular vesicle; P:epithelial cell-cell adhesion; F:structural molecule activity; F:dystroglycan binding; F:alpha-catenin binding; C:cell; C:brush border; F:cadherin binding; C:actin cytoskeleton; C:cytosol; P:platelet aggregation; C:costamere; C:protein complex; C:plasma membrane; F:actin filament binding; C:adherens junction; C:cell-cell junction; F:protein binding; F:ubiquitin protein ligase binding; F:actin binding; C:cell-cell adherens junction; P:morphogenesis of an epithelium; P:movement of cell or subcellular component; C:fascia adherens; C:zonula adherens; C:cell-substrate junction; C:cell junction; P:adherens junction assembly; P:regulation of cell migration; P:negative regulation of cell migration; P:cell adhesion; C:extracellular region; P:platelet degranulation; C:extracellular exosome; C:focal adhesion; P:muscle contraction; P:apical junction assembly; C:outer dense plaque of desmosome; C:inner dense plaque of desmosome; P:cell-matrix adhesion; F:beta-catenin binding; C:cytoskeleton; C:terminal web; P:axon extension; C:cytoplasm; C:membrane raft; C:membrane; P:lamellipodium assembly		
tr|F7CZH3|F7CZH3_HORSE	thioredoxin domain-containing 5	324	20	0E0	95.5%	16	C:GO:0031083; P:GO:0043277; P:GO:0045454; C:GO:0005783; C:GO:0043202; P:GO:0006457; C:GO:0005788; C:GO:0005623; F:GO:0005515; C:GO:0070062; F:GO:0003756; P:GO:0043066; P:GO:0016197; C:GO:0030133; P:GO:0034976; F:GO:0016853	C:BLOC-1 complex; P:apoptotic cell clearance; P:cell redox homeostasis; C:endoplasmic reticulum; C:lysosomal lumen; P:protein folding; C:endoplasmic reticulum lumen; C:cell; F:protein binding; C:extracellular exosome; F:protein disulfide isomerase activity; P:negative regulation of apoptotic process; P:endosomal transport; C:transport vesicle; P:response to endoplasmic reticulum stress; F:isomerase activity		
tr|F7DIE1|F7DIE1_HORSE	cornifin-A	73	20	3.22E-36	72.1%	9	P:GO:0030216; C:GO:0001533; C:GO:0070062; C:GO:0005737; F:GO:0005198; P:GO:0008544; P:GO:0018149; P:GO:0031424; F:GO:0030674	P:keratinocyte differentiation; C:cornified envelope; C:extracellular exosome; C:cytoplasm; F:structural molecule activity; P:epidermis development; P:peptide cross-linking; P:keratinization; F:protein binding, bridging		
tr|F7BWW6|F7BWW6_HORSE	transitional endoplasmic reticulum ATPase	803	20	0E0	98.95%	75	F:GO:0016887; P:GO:0006281; P:GO:2001171; P:GO:1903007; P:GO:1903006; C:GO:0005789; P:GO:0072389; P:GO:0006914; C:GO:0043231; C:GO:0005829; P:GO:0070842; P:GO:0018279; P:GO:0006919; F:GO:0032403; F:GO:0019904; F:GO:0019903; F:GO:0031593; P:GO:0008152; P:GO:0051260; P:GO:0045732; C:GO:0000502; C:GO:0043234; F:GO:1990381; P:GO:0006974; P:GO:0006810; C:GO:0005634; P:GO:0006888; P:GO:0043161; F:GO:0005515; C:GO:1990730; F:GO:0031625; P:GO:0046034; P:GO:0019079; P:GO:0034214; P:GO:0030970; P:GO:0032436; F:GO:0036435; C:GO:0036513; P:GO:0016567; C:GO:0035861; C:GO:0043209; P:GO:1903862; C:GO:0034098; F:GO:0008289; C:GO:0005654; P:GO:0006302; F:GO:0000166; F:GO:0005524; P:GO:0010918; P:GO:0006734; C:GO:0070062; F:GO:0003824; P:GO:0019985; P:GO:0031334; P:GO:0071712; P:GO:0036503; F:GO:0042802; F:GO:1904288; C:GO:0005783; F:GO:0042288; F:GO:0044389; F:GO:0043531; P:GO:1903715; F:GO:0005102; P:GO:0006511; F:GO:0044822; C:GO:0005811; P:GO:0097352; C:GO:0048471; C:GO:0005737; C:GO:0016020; C:GO:0016021; F:GO:0035800; P:GO:0030433; F:GO:0016787	F:ATPase activity; P:DNA repair; P:positive regulation of ATP biosynthetic process; P:positive regulation of Lys63-specific deubiquitinase activity; P:positive regulation of protein K63-linked deubiquitination; C:endoplasmic reticulum membrane; P:flavin adenine dinucleotide catabolic process; P:autophagy; C:intracellular membrane-bounded organelle; C:cytosol; P:aggresome assembly; P:protein N-linked glycosylation via asparagine; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; F:protein complex binding; F:protein domain specific binding; F:protein phosphatase binding; F:polyubiquitin binding; P:metabolic process; P:protein homooligomerization; P:positive regulation of protein catabolic process; C:proteasome complex; C:protein complex; F:ubiquitin-specific protease binding; P:cellular response to DNA damage stimulus; P:transport; C:nucleus; P:ER to Golgi vesicle-mediated transport; P:proteasome-mediated ubiquitin-dependent protein catabolic process; F:protein binding; C:VCP-NSFL1C complex; F:ubiquitin protein ligase binding; P:ATP metabolic process; P:viral genome replication; P:protein hexamerization; P:retrograde protein transport, ER to cytosol; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; F:K48-linked polyubiquitin binding; C:Derlin-1 retrotranslocation complex; P:protein ubiquitination; C:site of double-strand break; C:myelin sheath; P:positive regulation of oxidative phosphorylation; C:VCP-NPL4-UFD1 AAA ATPase complex; F:lipid binding; C:nucleoplasm; P:double-strand break repair; F:nucleotide binding; F:ATP binding; P:positive regulation of mitochondrial membrane potential; P:NADH metabolic process; C:extracellular exosome; F:catalytic activity; P:translesion synthesis; P:positive regulation of protein complex assembly; P:ER-associated misfolded protein catabolic process; P:ERAD pathway; F:identical protein binding; F:BAT3 complex binding; C:endoplasmic reticulum; F:MHC class I protein binding; F:ubiquitin-like protein ligase binding; F:ADP binding; P:regulation of aerobic respiration; F:receptor binding; P:ubiquitin-dependent protein catabolic process; F:poly(A) RNA binding; C:lipid particle; P:autophagosome maturation; C:perinuclear region of cytoplasm; C:cytoplasm; C:membrane; C:integral component of membrane; F:deubiquitinase activator activity; P:ER-associated ubiquitin-dependent protein catabolic process; F:hydrolase activity		
tr|F6YXX3|F6YXX3_HORSE	PDZ and LIM domain 5 isoform X1	596	20	0E0	95.3%	3	F:GO:0008270; F:GO:0046872; C:GO:0015629	F:zinc ion binding; F:metal ion binding; C:actin cytoskeleton		
sp|Q8MIP0|FRIH_HORSE	ferritin heavy chain	182	20	4.16E-134	97.45%	18	F:GO:0008199; P:GO:0008285; P:GO:0006880; F:GO:0004322; C:GO:0044754; P:GO:0006879; C:GO:0005623; C:GO:0005634; P:GO:0097286; P:GO:0006955; C:GO:0070062; F:GO:0005506; F:GO:0016491; F:GO:0046872; P:GO:0048147; P:GO:0006826; C:GO:0005739; P:GO:0055114	F:ferric iron binding; P:negative regulation of cell proliferation; P:intracellular sequestering of iron ion; F:ferroxidase activity; C:autolysosome; P:cellular iron ion homeostasis; C:cell; C:nucleus; P:iron ion import; P:immune response; C:extracellular exosome; F:iron ion binding; F:oxidoreductase activity; F:metal ion binding; P:negative regulation of fibroblast proliferation; P:iron ion transport; C:mitochondrion; P:oxidation-reduction process		
tr|F6WXH5|F6WXH5_HORSE	ferritin heavy chain	186	20	3.9E-134	97.25%	12	P:GO:0006879; C:GO:0005623; P:GO:0006955; F:GO:0008199; F:GO:0046872; F:GO:0016491; P:GO:0048147; P:GO:0006826; P:GO:0008285; C:GO:0005739; P:GO:0055114; F:GO:0004322	P:cellular iron ion homeostasis; C:cell; P:immune response; F:ferric iron binding; F:metal ion binding; F:oxidoreductase activity; P:negative regulation of fibroblast proliferation; P:iron ion transport; P:negative regulation of cell proliferation; C:mitochondrion; P:oxidation-reduction process; F:ferroxidase activity		
tr|F7CBN0|F7CBN0_HORSE	alcohol dehydrogenase [NADP(+)]	324	20	0E0	98.55%	11	P:GO:0046185; F:GO:0047939; C:GO:0005615; C:GO:0070062; F:GO:0016491; F:GO:0004032; C:GO:0005829; P:GO:0055114; P:GO:0042840; P:GO:0019853; C:GO:0016324	P:aldehyde catabolic process; F:L-glucuronate reductase activity; C:extracellular space; C:extracellular exosome; F:oxidoreductase activity; F:alditol:NADP+ 1-oxidoreductase activity; C:cytosol; P:oxidation-reduction process; P:D-glucuronate catabolic process; P:L-ascorbic acid biosynthetic process; C:apical plasma membrane		
tr|F6WWW7|F6WWW7_HORSE	F-actin-capping subunit alpha-1	273	20	0E0	94.4%	8	P:GO:0051016; C:GO:0005856; C:GO:0070062; F:GO:0003779; P:GO:0051693; C:GO:0005737; C:GO:0071203; C:GO:0008290	P:barbed-end actin filament capping; C:cytoskeleton; C:extracellular exosome; F:actin binding; P:actin filament capping; C:cytoplasm; C:WASH complex; C:F-actin capping protein complex		
tr|F6ZFH9|F6ZFH9_HORSE	14-3-3 gamma	218	20	7.7E-161	100%	27	C:GO:0043209; P:GO:0045664; P:GO:0006469; F:GO:0008426; F:GO:0005159; P:GO:0032869; C:GO:0070062; P:GO:0000086; C:GO:0005925; P:GO:0048167; C:GO:0005829; F:GO:0005080; P:GO:0061024; F:GO:0019904; P:GO:1900740; P:GO:0009966; C:GO:0005622; F:GO:0044822; P:GO:0006605; C:GO:0030659; F:GO:0005515; C:GO:0031988; C:GO:0005737; C:GO:0016020; C:GO:0005739; P:GO:0071901; F:GO:0030971	C:myelin sheath; P:regulation of neuron differentiation; P:negative regulation of protein kinase activity; F:protein kinase C inhibitor activity; F:insulin-like growth factor receptor binding; P:cellular response to insulin stimulus; C:extracellular exosome; P:G2/M transition of mitotic cell cycle; C:focal adhesion; P:regulation of synaptic plasticity; C:cytosol; F:protein kinase C binding; P:membrane organization; F:protein domain specific binding; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of signal transduction; C:intracellular; F:poly(A) RNA binding; P:protein targeting; C:cytoplasmic vesicle membrane; F:protein binding; C:membrane-bounded vesicle; C:cytoplasm; C:membrane; C:mitochondrion; P:negative regulation of protein serine/threonine kinase activity; F:receptor tyrosine kinase binding		
tr|F6ZE54|F6ZE54_HORSE	glucose-6-phosphate isomerase	558	20	0E0	97.35%	20	P:GO:0006094; C:GO:0043209; P:GO:0034101; P:GO:0006096; C:GO:0005576; F:GO:0005125; C:GO:0005886; C:GO:0005654; F:GO:0004347; C:GO:0005615; C:GO:0070062; F:GO:0031625; C:GO:0005737; P:GO:0001701; P:GO:0001525; C:GO:0016020; P:GO:0042593; C:GO:0060170; P:GO:0001707; F:GO:0016853	P:gluconeogenesis; C:myelin sheath; P:erythrocyte homeostasis; P:glycolytic process; C:extracellular region; F:cytokine activity; C:plasma membrane; C:nucleoplasm; F:glucose-6-phosphate isomerase activity; C:extracellular space; C:extracellular exosome; F:ubiquitin protein ligase binding; C:cytoplasm; P:in utero embryonic development; P:angiogenesis; C:membrane; P:glucose homeostasis; C:ciliary membrane; P:mesoderm formation; F:isomerase activity		
tr|F6Q4Q1|F6Q4Q1_HORSE	heterogeneous nuclear ribonucleo K isoform X2	463	20	0E0	99.15%	97	C:GO:0014069; P:GO:0016925; F:GO:0000978; F:GO:0003690; F:GO:0003730; F:GO:0003697; F:GO:0003723; C:GO:0071013; P:GO:0001822; C:GO:0043197; F:GO:0031072; F:GO:0019904; P:GO:2000010; P:GO:0021549; P:GO:1902165; P:GO:0060999; P:GO:0007422; F:GO:0005521; F:GO:0001159; C:GO:0005634; F:GO:0005515; P:GO:0007417; C:GO:0005913; P:GO:1900273; P:GO:0033120; P:GO:0045944; P:GO:0000398; P:GO:0048538; C:GO:0002102; C:GO:0070062; C:GO:0030529; P:GO:0001889; P:GO:0048025; P:GO:0043010; P:GO:0072369; P:GO:0048260; F:GO:1990829; P:GO:0045716; P:GO:0006396; P:GO:0021766; P:GO:0006397; P:GO:0006953; P:GO:0001541; F:GO:0003676; F:GO:0003677; P:GO:0072752; C:GO:0005737; C:GO:0005739; F:GO:0043021; F:GO:1990715; P:GO:0008380; P:GO:1902074; P:GO:0006366; P:GO:0032091; F:GO:0001077; F:GO:0030628; P:GO:0071333; C:GO:0005829; P:GO:0010976; P:GO:2000173; P:GO:0050806; C:GO:0005681; P:GO:0021987; C:GO:0043679; P:GO:0010629; C:GO:0000790; P:GO:0010988; C:GO:0032993; P:GO:0010467; C:GO:0030054; P:GO:0014823; P:GO:1903861; C:GO:0042995; C:GO:0005654; P:GO:0032869; P:GO:0000122; P:GO:0071230; C:GO:0005925; P:GO:0016032; C:GO:0031012; P:GO:0030324; P:GO:0090129; P:GO:0006351; P:GO:0007165; F:GO:0042805; P:GO:1904322; P:GO:0006355; F:GO:0008134; P:GO:0007568; P:GO:0006357; F:GO:0044822; F:GO:0098641; P:GO:0043066; C:GO:0005938; C:GO:0016020; C:GO:0019013; F:GO:0051117	C:postsynaptic density; P:protein sumoylation; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; F:double-stranded DNA binding; F:mRNA 3'-UTR binding; F:single-stranded DNA binding; F:RNA binding; C:catalytic step 2 spliceosome; P:kidney development; C:dendritic spine; F:heat shock protein binding; F:protein domain specific binding; P:positive regulation of protein localization to cell surface; P:cerebellum development; P:regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:positive regulation of dendritic spine development; P:peripheral nervous system development; F:lamin binding; F:core promoter proximal region DNA binding; C:nucleus; F:protein binding; P:central nervous system development; C:cell-cell adherens junction; P:positive regulation of long-term synaptic potentiation; P:positive regulation of RNA splicing; P:positive regulation of transcription from RNA polymerase II promoter; P:mRNA splicing, via spliceosome; P:thymus development; C:podosome; C:extracellular exosome; C:intracellular ribonucleoprotein complex; P:liver development; P:negative regulation of mRNA splicing, via spliceosome; P:camera-type eye development; P:regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter; P:positive regulation of receptor-mediated endocytosis; F:C-rich single-stranded DNA binding; P:positive regulation of low-density lipoprotein particle receptor biosynthetic process; P:RNA processing; P:hippocampus development; P:mRNA processing; P:acute-phase response; P:ovarian follicle development; F:nucleic acid binding; F:DNA binding; P:cellular response to rapamycin; C:cytoplasm; C:mitochondrion; F:ribonucleoprotein complex binding; F:mRNA CDS binding; P:RNA splicing; P:response to salt; P:transcription from RNA polymerase II promoter; P:negative regulation of protein binding; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; F:pre-mRNA 3'-splice site binding; P:cellular response to glucose stimulus; C:cytosol; P:positive regulation of neuron projection development; P:negative regulation of branching morphogenesis of a nerve; P:positive regulation of synaptic transmission; C:spliceosomal complex; P:cerebral cortex development; C:axon terminus; P:negative regulation of gene expression; C:nuclear chromatin; P:regulation of low-density lipoprotein particle clearance; C:protein-DNA complex; P:gene expression; C:cell junction; P:response to activity; P:positive regulation of dendrite extension; C:cell projection; C:nucleoplasm; P:cellular response to insulin stimulus; P:negative regulation of transcription from RNA polymerase II promoter; P:cellular response to amino acid stimulus; C:focal adhesion; P:viral process; C:extracellular matrix; P:lung development; P:positive regulation of synapse maturation; P:transcription, DNA-templated; P:signal transduction; F:actinin binding; P:cellular response to forskolin; P:regulation of transcription, DNA-templated; F:transcription factor binding; P:aging; P:regulation of transcription from RNA polymerase II promoter; F:poly(A) RNA binding; F:cadherin binding involved in cell-cell adhesion; P:negative regulation of apoptotic process; C:cell cortex; C:membrane; C:viral nucleocapsid; F:ATPase binding		
tr|F6XT77|F6XT77_HORSE	filamin-B isoform X1	2508	20	0E0	98.95%	14	F:GO:0042802; P:GO:0003382; C:GO:0005886; F:GO:0044822; P:GO:0003334; C:GO:0070062; F:GO:0003779; C:GO:0005903; C:GO:0005925; C:GO:0005737; P:GO:0007519; C:GO:0001725; P:GO:0030154; P:GO:0030036	F:identical protein binding; P:epithelial cell morphogenesis; C:plasma membrane; F:poly(A) RNA binding; P:keratinocyte development; C:extracellular exosome; F:actin binding; C:brush border; C:focal adhesion; C:cytoplasm; P:skeletal muscle tissue development; C:stress fiber; P:cell differentiation; P:actin cytoskeleton organization		
tr|F6W4R2|F6W4R2_HORSE	angiotensinogen	485	20	0E0	88.8%	33	P:GO:0032270; P:GO:0014068; P:GO:0061098; F:GO:0008483; P:GO:0045742; P:GO:1901201; P:GO:1902632; P:GO:0003014; F:GO:0017080; P:GO:0051387; C:GO:0070062; P:GO:0001822; F:GO:0003824; P:GO:0045893; C:GO:0072562; P:GO:0010951; P:GO:0010535; P:GO:0010595; P:GO:0050731; P:GO:0010873; P:GO:0003081; P:GO:0007186; P:GO:1903598; F:GO:0008453; P:GO:0008217; P:GO:1903779; F:GO:0031703; P:GO:0090190; C:GO:0005615; F:GO:0004867; F:GO:0031702; P:GO:2001238; F:GO:0016740	P:positive regulation of cellular protein metabolic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein tyrosine kinase activity; F:transaminase activity; P:positive regulation of epidermal growth factor receptor signaling pathway; P:regulation of extracellular matrix assembly; P:positive regulation of membrane hyperpolarization; P:renal system process; F:sodium channel regulator activity; P:negative regulation of neurotrophin TRK receptor signaling pathway; C:extracellular exosome; P:kidney development; F:catalytic activity; P:positive regulation of transcription, DNA-templated; C:blood microparticle; P:negative regulation of endopeptidase activity; P:positive regulation of activation of JAK2 kinase activity; P:positive regulation of endothelial cell migration; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of cholesterol esterification; P:regulation of systemic arterial blood pressure by renin-angiotensin; P:G-protein coupled receptor signaling pathway; P:positive regulation of gap junction assembly; F:alanine-glyoxylate transaminase activity; P:regulation of blood pressure; P:regulation of cardiac conduction; F:type 2 angiotensin receptor binding; P:positive regulation of branching involved in ureteric bud morphogenesis; C:extracellular space; F:serine-type endopeptidase inhibitor activity; F:type 1 angiotensin receptor binding; P:positive regulation of extrinsic apoptotic signaling pathway; F:transferase activity		
tr|F6V625|F6V625_HORSE	ubiquitin	77	20	2.12E-48	99.8%	7	C:GO:0043209; F:GO:0003735; C:GO:0016020; C:GO:0016021; C:GO:0005840; C:GO:0005622; P:GO:0006412	C:myelin sheath; F:structural constituent of ribosome; C:membrane; C:integral component of membrane; C:ribosome; C:intracellular; P:translation		
tr|A0A0B4J1C5|A0A0B4J1C5_HORSE	Ubiquitin-60S ribosomal L40	128	20	9.68E-90	100%	99	P:GO:0006283; P:GO:0007254; P:GO:0051092; P:GO:0019083; P:GO:0000187; P:GO:0010939; P:GO:0075733; P:GO:0002755; P:GO:0002756; P:GO:0000184; C:GO:0030666; P:GO:0051403; P:GO:0006296; P:GO:0034220; P:GO:0006294; P:GO:0006297; P:GO:0042787; C:GO:0005765; C:GO:0005886; C:GO:0005634; F:GO:0005515; F:GO:0003735; P:GO:0035666; P:GO:0000717; P:GO:0000715; P:GO:0038095; P:GO:0043123; P:GO:0042276; P:GO:0043488; C:GO:0022625; P:GO:0045944; C:GO:0005575; F:GO:0003674; P:GO:0002223; P:GO:0000165; C:GO:0070062; C:GO:0030529; P:GO:0016197; P:GO:0019068; P:GO:0019985; P:GO:0038128; P:GO:0016236; P:GO:0050852; P:GO:0070987; P:GO:0000209; P:GO:0002230; P:GO:0007249; C:GO:0005622; C:GO:0005615; P:GO:0005978; C:GO:0005737; P:GO:0010803; P:GO:0019058; C:GO:0010008; P:GO:0051437; P:GO:0030512; P:GO:0051436; P:GO:0036297; P:GO:0007179; P:GO:0008543; P:GO:0061418; P:GO:0006364; P:GO:0042059; P:GO:0016055; C:GO:0005829; P:GO:0008150; P:GO:0032480; P:GO:0090263; P:GO:1901796; P:GO:0038061; C:GO:0005840; P:GO:0006413; P:GO:0098792; P:GO:0006412; P:GO:0033209; P:GO:0043161; P:GO:0007219; P:GO:0031145; P:GO:0070911; P:GO:0032479; C:GO:0043209; P:GO:0033683; P:GO:0045742; P:GO:0006464; C:GO:0005654; P:GO:0000122; P:GO:0006614; P:GO:0006977; P:GO:0000086; P:GO:0070423; P:GO:0000080; P:GO:0060071; P:GO:0042769; P:GO:0044267; P:GO:0090090; P:GO:0045087; P:GO:0043066; P:GO:0043065; P:GO:0000090	P:transcription-coupled nucleotide-excision repair; P:JNK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:viral transcription; P:activation of MAPK activity; P:regulation of necrotic cell death; P:intracellular transport of virus; P:MyD88-dependent toll-like receptor signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; C:endocytic vesicle membrane; P:stress-activated MAPK cascade; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:ion transmembrane transport; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, DNA gap filling; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; C:lysosomal membrane; C:plasma membrane; C:nucleus; F:protein binding; F:structural constituent of ribosome; P:TRIF-dependent toll-like receptor signaling pathway; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA damage recognition; P:Fc-epsilon receptor signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:error-prone translesion synthesis; P:regulation of mRNA stability; C:cytosolic large ribosomal subunit; P:positive regulation of transcription from RNA polymerase II promoter; C:cellular_component; F:molecular_function; P:stimulatory C-type lectin receptor signaling pathway; P:MAPK cascade; C:extracellular exosome; C:intracellular ribonucleoprotein complex; P:endosomal transport; P:virion assembly; P:translesion synthesis; P:ERBB2 signaling pathway; P:macroautophagy; P:T cell receptor signaling pathway; P:error-free translesion synthesis; P:protein polyubiquitination; P:positive regulation of defense response to virus by host; P:I-kappaB kinase/NF-kappaB signaling; C:intracellular; C:extracellular space; P:glycogen biosynthetic process; C:cytoplasm; P:regulation of tumor necrosis factor-mediated signaling pathway; P:viral life cycle; C:endosome membrane; P:positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; P:interstrand cross-link repair; P:transforming growth factor beta receptor signaling pathway; P:fibroblast growth factor receptor signaling pathway; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:rRNA processing; P:negative regulation of epidermal growth factor receptor signaling pathway; P:Wnt signaling pathway; C:cytosol; P:biological_process; P:negative regulation of type I interferon production; P:positive regulation of canonical Wnt signaling pathway; P:regulation of signal transduction by p53 class mediator; P:NIK/NF-kappaB signaling; C:ribosome; P:translational initiation; P:xenophagy; P:translation; P:tumor necrosis factor-mediated signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:Notch signaling pathway; P:anaphase-promoting complex-dependent catabolic process; P:global genome nucleotide-excision repair; P:regulation of type I interferon production; C:myelin sheath; P:nucleotide-excision repair, DNA incision; P:positive regulation of epidermal growth factor receptor signaling pathway; P:cellular protein modification process; C:nucleoplasm; P:negative regulation of transcription from RNA polymerase II promoter; P:SRP-dependent cotranslational protein targeting to membrane; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:G2/M transition of mitotic cell cycle; P:nucleotide-binding oligomerization domain containing signaling pathway; P:mitotic G1 phase; P:Wnt signaling pathway, planar cell polarity pathway; P:DNA damage response, detection of DNA damage; P:cellular protein metabolic process; P:negative regulation of canonical Wnt signaling pathway; P:innate immune response; P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; P:mitotic anaphase		
tr|F7AUY9|F7AUY9_HORSE	ubiquitin-40S ribosomal S27a	172	20	2.53E-120	99.15%	98	P:GO:0006281; P:GO:0006283; P:GO:0007254; P:GO:0051092; P:GO:0019083; P:GO:0000187; P:GO:0010939; P:GO:0075733; P:GO:0002755; P:GO:0002756; P:GO:0000184; C:GO:0030666; P:GO:0051403; P:GO:0006296; P:GO:0034220; P:GO:0006294; P:GO:0006297; P:GO:0042787; C:GO:0005886; C:GO:0005634; F:GO:0005515; F:GO:0003735; F:GO:0046872; P:GO:0035666; P:GO:0000717; C:GO:0022627; P:GO:0000715; P:GO:0038095; P:GO:0043123; P:GO:0042276; P:GO:0043488; P:GO:0045944; C:GO:0005730; P:GO:0002223; P:GO:0000165; C:GO:0070062; C:GO:0030529; P:GO:0016197; P:GO:0019068; P:GO:0019985; P:GO:0038128; P:GO:0016236; P:GO:0050852; P:GO:0070987; P:GO:0000209; P:GO:0007249; C:GO:0005615; P:GO:0005978; C:GO:0005737; P:GO:0010803; P:GO:0019058; C:GO:0015935; C:GO:0010008; P:GO:0051437; P:GO:0030512; P:GO:0051436; P:GO:0036297; P:GO:0007179; P:GO:0008543; P:GO:0061418; P:GO:0006364; P:GO:0042059; P:GO:0016055; C:GO:0005829; P:GO:0008150; P:GO:0032480; P:GO:0090263; P:GO:1901796; P:GO:0038061; C:GO:0005840; P:GO:0006413; P:GO:0006412; P:GO:0033209; P:GO:0043161; P:GO:0007219; P:GO:0031145; P:GO:0070911; P:GO:0032479; C:GO:0043209; P:GO:0033683; P:GO:0045742; C:GO:0005654; P:GO:0000122; P:GO:0006977; P:GO:0006614; P:GO:0000086; P:GO:0070423; P:GO:0000080; P:GO:0060071; P:GO:0042769; P:GO:0044267; F:GO:0044822; P:GO:0090090; P:GO:0045087; P:GO:0043066; P:GO:0043065; C:GO:0016020; P:GO:0000090	P:DNA repair; P:transcription-coupled nucleotide-excision repair; P:JNK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:viral transcription; P:activation of MAPK activity; P:regulation of necrotic cell death; P:intracellular transport of virus; P:MyD88-dependent toll-like receptor signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; C:endocytic vesicle membrane; P:stress-activated MAPK cascade; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:ion transmembrane transport; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, DNA gap filling; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; C:plasma membrane; C:nucleus; F:protein binding; F:structural constituent of ribosome; F:metal ion binding; P:TRIF-dependent toll-like receptor signaling pathway; P:nucleotide-excision repair, DNA duplex unwinding; C:cytosolic small ribosomal subunit; P:nucleotide-excision repair, DNA damage recognition; P:Fc-epsilon receptor signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:error-prone translesion synthesis; P:regulation of mRNA stability; P:positive regulation of transcription from RNA polymerase II promoter; C:nucleolus; P:stimulatory C-type lectin receptor signaling pathway; P:MAPK cascade; C:extracellular exosome; C:intracellular ribonucleoprotein complex; P:endosomal transport; P:virion assembly; P:translesion synthesis; P:ERBB2 signaling pathway; P:macroautophagy; P:T cell receptor signaling pathway; P:error-free translesion synthesis; P:protein polyubiquitination; P:I-kappaB kinase/NF-kappaB signaling; C:extracellular space; P:glycogen biosynthetic process; C:cytoplasm; P:regulation of tumor necrosis factor-mediated signaling pathway; P:viral life cycle; C:small ribosomal subunit; C:endosome membrane; P:positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; P:interstrand cross-link repair; P:transforming growth factor beta receptor signaling pathway; P:fibroblast growth factor receptor signaling pathway; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:rRNA processing; P:negative regulation of epidermal growth factor receptor signaling pathway; P:Wnt signaling pathway; C:cytosol; P:biological_process; P:negative regulation of type I interferon production; P:positive regulation of canonical Wnt signaling pathway; P:regulation of signal transduction by p53 class mediator; P:NIK/NF-kappaB signaling; C:ribosome; P:translational initiation; P:translation; P:tumor necrosis factor-mediated signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:Notch signaling pathway; P:anaphase-promoting complex-dependent catabolic process; P:global genome nucleotide-excision repair; P:regulation of type I interferon production; C:myelin sheath; P:nucleotide-excision repair, DNA incision; P:positive regulation of epidermal growth factor receptor signaling pathway; C:nucleoplasm; P:negative regulation of transcription from RNA polymerase II promoter; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:SRP-dependent cotranslational protein targeting to membrane; P:G2/M transition of mitotic cell cycle; P:nucleotide-binding oligomerization domain containing signaling pathway; P:mitotic G1 phase; P:Wnt signaling pathway, planar cell polarity pathway; P:DNA damage response, detection of DNA damage; P:cellular protein metabolic process; F:poly(A) RNA binding; P:negative regulation of canonical Wnt signaling pathway; P:innate immune response; P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; C:membrane; P:mitotic anaphase		
tr|F6YM88|F6YM88_HORSE	polyubiquitin-B	229	20	1.49E-162	99.75%	91	P:GO:0061136; P:GO:0006283; P:GO:0036297; P:GO:0007179; P:GO:0008543; P:GO:0061418; P:GO:0007254; C:GO:0043025; P:GO:0042059; P:GO:0051092; P:GO:0000187; P:GO:0010939; P:GO:0075733; P:GO:0002755; P:GO:0002756; P:GO:0051881; P:GO:0031398; C:GO:0005829; P:GO:0016055; C:GO:0030666; P:GO:0051403; P:GO:0032480; P:GO:0006296; P:GO:0034220; P:GO:0006294; P:GO:0090263; P:GO:1901796; P:GO:0038061; P:GO:0006297; P:GO:1902527; P:GO:0042787; C:GO:0005886; C:GO:0005634; P:GO:0033209; P:GO:0043161; F:GO:0005515; P:GO:0007219; P:GO:0031145; P:GO:0070911; P:GO:0035666; P:GO:0032479; P:GO:0033683; P:GO:0000717; P:GO:1902255; P:GO:0000715; P:GO:0038095; P:GO:0043123; P:GO:0048812; P:GO:0045742; P:GO:0042276; P:GO:0043488; P:GO:0045944; C:GO:0043005; C:GO:0005654; P:GO:0002223; P:GO:0000122; P:GO:0000165; C:GO:0070062; P:GO:0006977; P:GO:0000086; P:GO:0047497; P:GO:0016197; P:GO:0070423; P:GO:0019068; P:GO:0000080; P:GO:0060071; P:GO:0019985; P:GO:0038128; P:GO:0016236; P:GO:0050852; P:GO:0070987; P:GO:0042769; P:GO:0000209; P:GO:0044267; P:GO:1901214; P:GO:0007249; P:GO:0090090; C:GO:0005615; P:GO:0005978; C:GO:0005737; P:GO:0045087; P:GO:0043066; P:GO:0043065; C:GO:0005739; P:GO:0010803; P:GO:0019058; P:GO:0000090; C:GO:0010008; P:GO:0051437; P:GO:0030512; P:GO:0051436	P:regulation of proteasomal protein catabolic process; P:transcription-coupled nucleotide-excision repair; P:interstrand cross-link repair; P:transforming growth factor beta receptor signaling pathway; P:fibroblast growth factor receptor signaling pathway; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:JNK cascade; C:neuronal cell body; P:negative regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of NF-kappaB transcription factor activity; P:activation of MAPK activity; P:regulation of necrotic cell death; P:intracellular transport of virus; P:MyD88-dependent toll-like receptor signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:regulation of mitochondrial membrane potential; P:positive regulation of protein ubiquitination; C:cytosol; P:Wnt signaling pathway; C:endocytic vesicle membrane; P:stress-activated MAPK cascade; P:negative regulation of type I interferon production; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:ion transmembrane transport; P:nucleotide-excision repair, preincision complex assembly; P:positive regulation of canonical Wnt signaling pathway; P:regulation of signal transduction by p53 class mediator; P:NIK/NF-kappaB signaling; P:nucleotide-excision repair, DNA gap filling; P:positive regulation of protein monoubiquitination; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; C:plasma membrane; C:nucleus; P:tumor necrosis factor-mediated signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; F:protein binding; P:Notch signaling pathway; P:anaphase-promoting complex-dependent catabolic process; P:global genome nucleotide-excision repair; P:TRIF-dependent toll-like receptor signaling pathway; P:regulation of type I interferon production; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA duplex unwinding; P:positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator; P:nucleotide-excision repair, DNA damage recognition; P:Fc-epsilon receptor signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:neuron projection morphogenesis; P:positive regulation of epidermal growth factor receptor signaling pathway; P:error-prone translesion synthesis; P:regulation of mRNA stability; P:positive regulation of transcription from RNA polymerase II promoter; C:neuron projection; C:nucleoplasm; P:stimulatory C-type lectin receptor signaling pathway; P:negative regulation of transcription from RNA polymerase II promoter; P:MAPK cascade; C:extracellular exosome; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:G2/M transition of mitotic cell cycle; P:mitochondrion transport along microtubule; P:endosomal transport; P:nucleotide-binding oligomerization domain containing signaling pathway; P:virion assembly; P:mitotic G1 phase; P:Wnt signaling pathway, planar cell polarity pathway; P:translesion synthesis; P:ERBB2 signaling pathway; P:macroautophagy; P:T cell receptor signaling pathway; P:error-free translesion synthesis; P:DNA damage response, detection of DNA damage; P:protein polyubiquitination; P:cellular protein metabolic process; P:regulation of neuron death; P:I-kappaB kinase/NF-kappaB signaling; P:negative regulation of canonical Wnt signaling pathway; C:extracellular space; P:glycogen biosynthetic process; C:cytoplasm; P:innate immune response; P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; C:mitochondrion; P:regulation of tumor necrosis factor-mediated signaling pathway; P:viral life cycle; P:mitotic anaphase; C:endosome membrane; P:positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle		
sp|Q8MKD1|UBB_HORSE	polyubiquitin-B	305	20	0E0	99.05%	16	P:GO:0061136; P:GO:1902255; P:GO:0048812; P:GO:1901214; C:GO:0043025; P:GO:1902527; C:GO:0043005; C:GO:0005634; C:GO:0005615; F:GO:0005515; C:GO:0070062; C:GO:0005737; P:GO:0051881; P:GO:0047497; C:GO:0005739; P:GO:0031398	P:regulation of proteasomal protein catabolic process; P:positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator; P:neuron projection morphogenesis; P:regulation of neuron death; C:neuronal cell body; P:positive regulation of protein monoubiquitination; C:neuron projection; C:nucleus; C:extracellular space; F:protein binding; C:extracellular exosome; C:cytoplasm; P:regulation of mitochondrial membrane potential; P:mitochondrion transport along microtubule; C:mitochondrion; P:positive regulation of protein ubiquitination		
tr|F6S2F8|F6S2F8_HORSE	histone	213	20	5.3E-124	96.05%	15	F:GO:0031490; P:GO:0080182; C:GO:0005694; C:GO:0000786; P:GO:0006334; F:GO:0044822; P:GO:0006357; P:GO:0000122; F:GO:0003677; P:GO:0098532; C:GO:0005634; F:GO:0005515; C:GO:0035327; C:GO:0005719; P:GO:0016584	F:chromatin DNA binding; P:histone H3-K4 trimethylation; C:chromosome; C:nucleosome; P:nucleosome assembly; F:poly(A) RNA binding; P:regulation of transcription from RNA polymerase II promoter; P:negative regulation of transcription from RNA polymerase II promoter; F:DNA binding; P:histone H3-K27 trimethylation; C:nucleus; F:protein binding; C:transcriptionally active chromatin; C:nuclear euchromatin; P:nucleosome positioning		
tr|F6ZVN2|F6ZVN2_HORSE	nucleobindin-1 isoform X1	262	20	0E0	100%	7	C:GO:0015630; C:GO:0005615; C:GO:0070062; F:GO:0005509; C:GO:0016020; C:GO:0005794; C:GO:0005793	C:microtubule cytoskeleton; C:extracellular space; C:extracellular exosome; F:calcium ion binding; C:membrane; C:Golgi apparatus; C:endoplasmic reticulum-Golgi intermediate compartment		
tr|F6QXW2|F6QXW2_HORSE	phosphatidylethanolamine-binding 1	190	20	6.13E-133	95.75%	13	F:GO:0019901; F:GO:0008289; F:GO:0044822; F:GO:0000166; F:GO:0030414; C:GO:0005634; F:GO:0005524; F:GO:0004867; C:GO:0070062; C:GO:0005737; P:GO:0010951; P:GO:0010466; F:GO:0019899	F:protein kinase binding; F:lipid binding; F:poly(A) RNA binding; F:nucleotide binding; F:peptidase inhibitor activity; C:nucleus; F:ATP binding; F:serine-type endopeptidase inhibitor activity; C:extracellular exosome; C:cytoplasm; P:negative regulation of endopeptidase activity; P:negative regulation of peptidase activity; F:enzyme binding		
tr|F7BXI0|F7BXI0_HORSE	retinol-binding 1	135	20	4.21E-97	99.5%	10	P:GO:0002138; P:GO:0042572; C:GO:0005829; P:GO:0042573; F:GO:0008289; P:GO:0033189; P:GO:0006776; P:GO:0006810; F:GO:0005215; P:GO:0030852	P:retinoic acid biosynthetic process; P:retinol metabolic process; C:cytosol; P:retinoic acid metabolic process; F:lipid binding; P:response to vitamin A; P:vitamin A metabolic process; P:transport; F:transporter activity; P:regulation of granulocyte differentiation		
tr|F6YZJ4|F6YZJ4_HORSE	heat shock 70 kDa 4	840	20	0E0	98.2%	9	F:GO:0000166; F:GO:0005524; F:GO:0005515; P:GO:0045040; C:GO:0070062; C:GO:0005737; P:GO:0051131; C:GO:0005829; P:GO:0006986	F:nucleotide binding; F:ATP binding; F:protein binding; P:protein import into mitochondrial outer membrane; C:extracellular exosome; C:cytoplasm; P:chaperone-mediated protein complex assembly; C:cytosol; P:response to unfolded protein		
tr|F7DTP2|F7DTP2_HORSE	glutathione mitochondrial isoform X1	469	20	0E0	96.9%	19	F:GO:0016668; F:GO:0009055; C:GO:0009897; F:GO:0004362; P:GO:0045454; P:GO:0000302; C:GO:0005623; F:GO:0050661; C:GO:0070062; C:GO:0005759; C:GO:0005737; F:GO:0050660; F:GO:0016491; P:GO:0006749; C:GO:0005739; P:GO:0015949; P:GO:0098869; C:GO:0005829; P:GO:0055114	F:oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor; F:electron carrier activity; C:external side of plasma membrane; F:glutathione-disulfide reductase activity; P:cell redox homeostasis; P:response to reactive oxygen species; C:cell; F:NADP binding; C:extracellular exosome; C:mitochondrial matrix; C:cytoplasm; F:flavin adenine dinucleotide binding; F:oxidoreductase activity; P:glutathione metabolic process; C:mitochondrion; P:nucleobase-containing small molecule interconversion; P:cellular oxidant detoxification; C:cytosol; P:oxidation-reduction process		
tr|F7B9G0|F7B9G0_HORSE	programmed cell death 6-interacting isoform X2	870	20	0E0	98.25%	20	C:GO:1903561; C:GO:0043209; F:GO:0042803; P:GO:0090611; P:GO:1903553; P:GO:1903543; P:GO:1903551; F:GO:0048306; F:GO:0046983; P:GO:0000920; C:GO:0001772; C:GO:0070062; P:GO:0010824; C:GO:0005925; C:GO:0005737; C:GO:0016020; F:GO:0031871; C:GO:0005829; C:GO:0070971; P:GO:0039702	C:extracellular vesicle; C:myelin sheath; F:protein homodimerization activity; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:positive regulation of extracellular exosome assembly; P:positive regulation of exosomal secretion; P:regulation of extracellular exosome assembly; F:calcium-dependent protein binding; F:protein dimerization activity; P:cell separation after cytokinesis; C:immunological synapse; C:extracellular exosome; P:regulation of centrosome duplication; C:focal adhesion; C:cytoplasm; C:membrane; F:proteinase activated receptor binding; C:cytosol; C:endoplasmic reticulum exit site; P:viral budding via host ESCRT complex		
tr|F6XTN1|F6XTN1_HORSE	eukaryotic initiation factor 4A-I	406	20	0E0	99.5%	30	F:GO:0016887; F:GO:0000339; F:GO:0004386; P:GO:0006446; F:GO:0004004; F:GO:0000166; F:GO:0003743; F:GO:0005524; C:GO:0070062; F:GO:0003723; F:GO:0003725; P:GO:0016032; C:GO:0005829; F:GO:0003729; C:GO:0031012; F:GO:0008135; P:GO:0006413; P:GO:0000289; P:GO:0006412; F:GO:0044822; F:GO:0003676; C:GO:0005634; F:GO:0005515; C:GO:0016281; C:GO:0005737; C:GO:0016020; P:GO:0010501; P:GO:0010468; P:GO:0031100; F:GO:0016787	F:ATPase activity; F:RNA cap binding; F:helicase activity; P:regulation of translational initiation; F:ATP-dependent RNA helicase activity; F:nucleotide binding; F:translation initiation factor activity; F:ATP binding; C:extracellular exosome; F:RNA binding; F:double-stranded RNA binding; P:viral process; C:cytosol; F:mRNA binding; C:extracellular matrix; F:translation factor activity, RNA binding; P:translational initiation; P:nuclear-transcribed mRNA poly(A) tail shortening; P:translation; F:poly(A) RNA binding; F:nucleic acid binding; C:nucleus; F:protein binding; C:eukaryotic translation initiation factor 4F complex; C:cytoplasm; C:membrane; P:RNA secondary structure unwinding; P:regulation of gene expression; P:animal organ regeneration; F:hydrolase activity		
tr|F6YYS2|F6YYS2_HORSE	eukaryotic initiation factor 4A-II isoform X1	407	20	0E0	99.05%	22	F:GO:0016887; P:GO:1900260; F:GO:0004386; P:GO:0006446; P:GO:0006413; P:GO:0000289; F:GO:0004004; F:GO:0044822; P:GO:0006412; F:GO:0000166; F:GO:0003676; F:GO:0003743; F:GO:0005524; F:GO:0005515; F:GO:0003723; C:GO:0048471; C:GO:0016281; P:GO:0016032; P:GO:0010468; P:GO:0010501; C:GO:0005829; F:GO:0016787	F:ATPase activity; P:negative regulation of RNA-directed RNA polymerase activity; F:helicase activity; P:regulation of translational initiation; P:translational initiation; P:nuclear-transcribed mRNA poly(A) tail shortening; F:ATP-dependent RNA helicase activity; F:poly(A) RNA binding; P:translation; F:nucleotide binding; F:nucleic acid binding; F:translation initiation factor activity; F:ATP binding; F:protein binding; F:RNA binding; C:perinuclear region of cytoplasm; C:eukaryotic translation initiation factor 4F complex; P:viral process; P:regulation of gene expression; P:RNA secondary structure unwinding; C:cytosol; F:hydrolase activity		
tr|F7D3D1|F7D3D1_HORSE	epidermal growth factor receptor kinase substrate 8 1	576	20	0E0	89.5%	12	P:GO:0035023; C:GO:0070062; F:GO:0003779; C:GO:0005737; F:GO:0042608; C:GO:0032587; C:GO:0043234; F:GO:0005089; P:GO:0007266; P:GO:1900029; P:GO:0043547; F:GO:0030676	P:regulation of Rho protein signal transduction; C:extracellular exosome; F:actin binding; C:cytoplasm; F:T cell receptor binding; C:ruffle membrane; C:protein complex; F:Rho guanyl-nucleotide exchange factor activity; P:Rho protein signal transduction; P:positive regulation of ruffle assembly; P:positive regulation of GTPase activity; F:Rac guanyl-nucleotide exchange factor activity		
tr|F6ZQX6|F6ZQX6_HORSE	proteasome subunit alpha type-7	216	20	4.87E-157	100%	14	F:GO:0042802; F:GO:0004175; C:GO:0000502; F:GO:0004298; F:GO:0008233; P:GO:0006511; C:GO:0005634; C:GO:0070062; C:GO:0005737; C:GO:0005839; P:GO:0006508; C:GO:0019773; P:GO:0051603; F:GO:0016787	F:identical protein binding; F:endopeptidase activity; C:proteasome complex; F:threonine-type endopeptidase activity; F:peptidase activity; P:ubiquitin-dependent protein catabolic process; C:nucleus; C:extracellular exosome; C:cytoplasm; C:proteasome core complex; P:proteolysis; C:proteasome core complex, alpha-subunit complex; P:proteolysis involved in cellular protein catabolic process; F:hydrolase activity		
tr|F7AMX0|F7AMX0_HORSE	glycerol-3-phosphate dehydrogenase 1	335	20	0E0	98.2%	29	P:GO:0090038; C:GO:0009331; F:GO:0004367; F:GO:0017080; P:GO:0006734; C:GO:0070062; F:GO:0051287; F:GO:0016491; P:GO:0046168; P:GO:0033137; C:GO:0005829; P:GO:0006072; F:GO:0042803; P:GO:2000010; F:GO:0016616; P:GO:0060373; P:GO:0086005; F:GO:0044325; C:GO:0005886; P:GO:0006654; P:GO:0002027; P:GO:0005975; C:GO:0005737; C:GO:0016020; P:GO:2000649; P:GO:0019432; P:GO:0019674; P:GO:0010765; P:GO:0055114	P:negative regulation of protein kinase C signaling; C:glycerol-3-phosphate dehydrogenase complex; F:glycerol-3-phosphate dehydrogenase [NAD+] activity; F:sodium channel regulator activity; P:NADH metabolic process; C:extracellular exosome; F:NAD binding; F:oxidoreductase activity; P:glycerol-3-phosphate catabolic process; P:negative regulation of peptidyl-serine phosphorylation; C:cytosol; P:glycerol-3-phosphate metabolic process; F:protein homodimerization activity; P:positive regulation of protein localization to cell surface; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; P:regulation of ventricular cardiac muscle cell membrane depolarization; P:ventricular cardiac muscle cell action potential; F:ion channel binding; C:plasma membrane; P:phosphatidic acid biosynthetic process; P:regulation of heart rate; P:carbohydrate metabolic process; C:cytoplasm; C:membrane; P:regulation of sodium ion transmembrane transporter activity; P:triglyceride biosynthetic process; P:NAD metabolic process; P:positive regulation of sodium ion transport; P:oxidation-reduction process		
tr|F6XLZ5|F6XLZ5_HORSE	ADP-ribosylation factor 2	181	20	1.68E-131	99.45%	8	F:GO:0000166; F:GO:0005525; P:GO:0016192; P:GO:0007264; P:GO:0015031; C:GO:0005794; P:GO:0006810; C:GO:0005622	F:nucleotide binding; F:GTP binding; P:vesicle-mediated transport; P:small GTPase mediated signal transduction; P:protein transport; C:Golgi apparatus; P:transport; C:intracellular		
tr|F6TD06|F6TD06_HORSE	ADP-ribosylation factor 3	181	20	5.41E-132	100%	15	P:GO:0007264; P:GO:0006890; P:GO:0015031; C:GO:0005794; C:GO:0000139; P:GO:0006661; P:GO:0006810; C:GO:0005622; F:GO:0000166; F:GO:0005525; C:GO:0070062; P:GO:0016192; C:GO:0048471; C:GO:0005737; F:GO:0003924	P:small GTPase mediated signal transduction; P:retrograde vesicle-mediated transport, Golgi to ER; P:protein transport; C:Golgi apparatus; C:Golgi membrane; P:phosphatidylinositol biosynthetic process; P:transport; C:intracellular; F:nucleotide binding; F:GTP binding; C:extracellular exosome; P:vesicle-mediated transport; C:perinuclear region of cytoplasm; C:cytoplasm; F:GTPase activity		
tr|F6YYB1|F6YYB1_HORSE	proteasome subunit beta type-1	241	20	7.76E-179	96.5%	11	C:GO:0005634; C:GO:0070062; C:GO:0005737; C:GO:0005839; P:GO:0006508; F:GO:0004175; F:GO:0004298; C:GO:0000502; F:GO:0008233; P:GO:0051603; F:GO:0016787	C:nucleus; C:extracellular exosome; C:cytoplasm; C:proteasome core complex; P:proteolysis; F:endopeptidase activity; F:threonine-type endopeptidase activity; C:proteasome complex; F:peptidase activity; P:proteolysis involved in cellular protein catabolic process; F:hydrolase activity		
tr|F7D854|F7D854_HORSE	catalase	505	20	0E0	96.35%	40	P:GO:0014068; F:GO:0016209; P:GO:0009650; P:GO:0008203; P:GO:0006641; F:GO:0004046; P:GO:0051092; P:GO:0020027; P:GO:0006979; C:GO:0070062; P:GO:0051289; C:GO:0005925; P:GO:0051781; F:GO:0016491; P:GO:0051262; C:GO:0043231; P:GO:0001649; F:GO:0008080; F:GO:0042803; P:GO:0032088; F:GO:0004096; P:GO:0042542; P:GO:0000302; F:GO:0005102; F:GO:0020037; P:GO:0042744; C:GO:0005778; F:GO:0004601; C:GO:0005777; F:GO:0050661; F:GO:0046872; P:GO:0043066; C:GO:0016020; C:GO:0005739; P:GO:0098869; P:GO:0055114; F:GO:0016684; F:GO:0016740; P:GO:0009060; F:GO:0019899	P:positive regulation of phosphatidylinositol 3-kinase signaling; F:antioxidant activity; P:UV protection; P:cholesterol metabolic process; P:triglyceride metabolic process; F:aminoacylase activity; P:positive regulation of NF-kappaB transcription factor activity; P:hemoglobin metabolic process; P:response to oxidative stress; C:extracellular exosome; P:protein homotetramerization; C:focal adhesion; P:positive regulation of cell division; F:oxidoreductase activity; P:protein tetramerization; C:intracellular membrane-bounded organelle; P:osteoblast differentiation; F:N-acetyltransferase activity; F:protein homodimerization activity; P:negative regulation of NF-kappaB transcription factor activity; F:catalase activity; P:response to hydrogen peroxide; P:response to reactive oxygen species; F:receptor binding; F:heme binding; P:hydrogen peroxide catabolic process; C:peroxisomal membrane; F:peroxidase activity; C:peroxisome; F:NADP binding; F:metal ion binding; P:negative regulation of apoptotic process; C:membrane; C:mitochondrion; P:cellular oxidant detoxification; P:oxidation-reduction process; F:oxidoreductase activity, acting on peroxide as acceptor; F:transferase activity; P:aerobic respiration; F:enzyme binding		
tr|F6UNR3|F6UNR3_HORSE	elongation factor 1-delta isoform X1	642	20	0E0	92.8%	18	F:GO:0031072; P:GO:0009299; P:GO:0007165; P:GO:0043123; P:GO:0006355; C:GO:0005783; C:GO:0005730; F:GO:0004871; P:GO:0006414; C:GO:0005853; P:GO:0006412; F:GO:0003677; C:GO:0005634; F:GO:0003746; C:GO:0005737; P:GO:0010941; P:GO:0071479; F:GO:0033613	F:heat shock protein binding; P:mRNA transcription; P:signal transduction; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of transcription, DNA-templated; C:endoplasmic reticulum; C:nucleolus; F:signal transducer activity; P:translational elongation; C:eukaryotic translation elongation factor 1 complex; P:translation; F:DNA binding; C:nucleus; F:translation elongation factor activity; C:cytoplasm; P:regulation of cell death; P:cellular response to ionizing radiation; F:activating transcription factor binding		
tr|F6YGC8|F6YGC8_HORSE	Proteasome activator complex subunit 1	120	20	2.8E-83	98.95%	29	F:GO:0061133; P:GO:0061136; P:GO:0038095; P:GO:0043488; P:GO:0006521; C:GO:0005654; P:GO:0002223; P:GO:0000165; P:GO:0002479; C:GO:0070062; C:GO:0005829; P:GO:0060071; P:GO:0019884; P:GO:0050852; P:GO:0010950; P:GO:0000209; P:GO:0090263; P:GO:0038061; C:GO:0000502; C:GO:0008537; P:GO:0090090; P:GO:0043161; P:GO:0033209; C:GO:0005737; P:GO:0031145; P:GO:0000090; P:GO:2000045; P:GO:0051437; P:GO:0051436	F:endopeptidase activator activity; P:regulation of proteasomal protein catabolic process; P:Fc-epsilon receptor signaling pathway; P:regulation of mRNA stability; P:regulation of cellular amino acid metabolic process; C:nucleoplasm; P:stimulatory C-type lectin receptor signaling pathway; P:MAPK cascade; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; C:extracellular exosome; C:cytosol; P:Wnt signaling pathway, planar cell polarity pathway; P:antigen processing and presentation of exogenous antigen; P:T cell receptor signaling pathway; P:positive regulation of endopeptidase activity; P:protein polyubiquitination; P:positive regulation of canonical Wnt signaling pathway; P:NIK/NF-kappaB signaling; C:proteasome complex; C:proteasome activator complex; P:negative regulation of canonical Wnt signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:tumor necrosis factor-mediated signaling pathway; C:cytoplasm; P:anaphase-promoting complex-dependent catabolic process; P:mitotic anaphase; P:regulation of G1/S transition of mitotic cell cycle; P:positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle		
tr|F7A3N5|F7A3N5_HORSE	carbohydrate-binding AQN-1-like	138	20	1.13E-83	76.45%	3	F:GO:0008201; C:GO:0005576; P:GO:0007338	F:heparin binding; C:extracellular region; P:single fertilization		
tr|F7DQG1|F7DQG1_HORSE	peptidoglycan recognition 1	193	20	2.7E-142	83.5%	18	F:GO:0042834; F:GO:0016019; F:GO:0008270; P:GO:0050728; P:GO:0009253; P:GO:0044117; C:GO:0005576; P:GO:0002221; P:GO:0042742; F:GO:0008745; P:GO:0002376; C:GO:0070062; P:GO:0045087; P:GO:0032827; P:GO:0016045; P:GO:0001818; P:GO:0032689; P:GO:0050830	F:peptidoglycan binding; F:peptidoglycan receptor activity; F:zinc ion binding; P:negative regulation of inflammatory response; P:peptidoglycan catabolic process; P:growth of symbiont in host; C:extracellular region; P:pattern recognition receptor signaling pathway; P:defense response to bacterium; F:N-acetylmuramoyl-L-alanine amidase activity; P:immune system process; C:extracellular exosome; P:innate immune response; P:negative regulation of natural killer cell differentiation involved in immune response; P:detection of bacterium; P:negative regulation of cytokine production; P:negative regulation of interferon-gamma production; P:defense response to Gram-positive bacterium		
tr|F7DMG5|F7DMG5_HORSE	glucose-6-phosphate 1-dehydrogenase	515	20	0E0	98.7%	30	P:GO:0009051; P:GO:0006740; P:GO:0006006; P:GO:0043249; C:GO:0009898; F:GO:0004345; C:GO:0070062; F:GO:0016491; C:GO:0043231; P:GO:0006739; P:GO:0019322; C:GO:0005829; P:GO:0010734; F:GO:0042802; F:GO:0042803; P:GO:0006098; P:GO:0006695; P:GO:0021762; F:GO:0005536; P:GO:0005975; C:GO:0005813; F:GO:0050661; P:GO:0051156; C:GO:0005815; C:GO:0005737; P:GO:0006749; C:GO:0016020; P:GO:0034599; P:GO:0055114; P:GO:0046390	P:pentose-phosphate shunt, oxidative branch; P:NADPH regeneration; P:glucose metabolic process; P:erythrocyte maturation; C:cytoplasmic side of plasma membrane; F:glucose-6-phosphate dehydrogenase activity; C:extracellular exosome; F:oxidoreductase activity; C:intracellular membrane-bounded organelle; P:NADP metabolic process; P:pentose biosynthetic process; C:cytosol; P:negative regulation of protein glutathionylation; F:identical protein binding; F:protein homodimerization activity; P:pentose-phosphate shunt; P:cholesterol biosynthetic process; P:substantia nigra development; F:glucose binding; P:carbohydrate metabolic process; C:centrosome; F:NADP binding; P:glucose 6-phosphate metabolic process; C:microtubule organizing center; C:cytoplasm; P:glutathione metabolic process; C:membrane; P:cellular response to oxidative stress; P:oxidation-reduction process; P:ribose phosphate biosynthetic process		
tr|F6PH57|F6PH57_HORSE	actin-related 2 3 complex subunit 4	168	20	6.23E-119	99.9%	18	P:GO:0030041; F:GO:0005200; P:GO:0038096; C:GO:0042995; C:GO:0005885; F:GO:0051015; C:GO:0005856; F:GO:0005515; C:GO:0070062; F:GO:0003779; C:GO:0005737; P:GO:0045010; P:GO:0048013; C:GO:0015629; P:GO:0034314; C:GO:0005829; F:GO:0030674; F:GO:0019899	P:actin filament polymerization; F:structural constituent of cytoskeleton; P:Fc-gamma receptor signaling pathway involved in phagocytosis; C:cell projection; C:Arp2/3 protein complex; F:actin filament binding; C:cytoskeleton; F:protein binding; C:extracellular exosome; F:actin binding; C:cytoplasm; P:actin nucleation; P:ephrin receptor signaling pathway; C:actin cytoskeleton; P:Arp2/3 complex-mediated actin nucleation; C:cytosol; F:protein binding, bridging; F:enzyme binding		
tr|F7ASE9|F7ASE9_HORSE	histone H2B type 1	126	20	1.06E-85	100%	18	C:GO:0000788; C:GO:0005694; C:GO:0000786; P:GO:0042742; P:GO:0006334; F:GO:0003674; P:GO:0021762; C:GO:0005654; F:GO:0003677; C:GO:0005634; C:GO:0005615; F:GO:0005515; C:GO:0070062; P:GO:0002227; C:GO:0005737; F:GO:0046982; P:GO:0019731; P:GO:0050830	C:nuclear nucleosome; C:chromosome; C:nucleosome; P:defense response to bacterium; P:nucleosome assembly; F:molecular_function; P:substantia nigra development; C:nucleoplasm; F:DNA binding; C:nucleus; C:extracellular space; F:protein binding; C:extracellular exosome; P:innate immune response in mucosa; C:cytoplasm; F:protein heterodimerization activity; P:antibacterial humoral response; P:defense response to Gram-positive bacterium		
tr|F6VUX0|F6VUX0_HORSE	histone H2B type 1	126	20	1.69E-85	99.05%	18	C:GO:0000788; C:GO:0005694; C:GO:0000786; P:GO:0042742; P:GO:0006334; F:GO:0003674; P:GO:0021762; C:GO:0005654; F:GO:0003677; C:GO:0005634; C:GO:0005615; F:GO:0005515; C:GO:0070062; P:GO:0002227; C:GO:0005737; F:GO:0046982; P:GO:0019731; P:GO:0050830	C:nuclear nucleosome; C:chromosome; C:nucleosome; P:defense response to bacterium; P:nucleosome assembly; F:molecular_function; P:substantia nigra development; C:nucleoplasm; F:DNA binding; C:nucleus; C:extracellular space; F:protein binding; C:extracellular exosome; P:innate immune response in mucosa; C:cytoplasm; F:protein heterodimerization activity; P:antibacterial humoral response; P:defense response to Gram-positive bacterium		
tr|F6TWM4|F6TWM4_HORSE	histone H2B type 1	126	20	8.58E-86	100%	18	C:GO:0000788; C:GO:0005694; C:GO:0000786; P:GO:0042742; P:GO:0006334; F:GO:0003674; P:GO:0021762; C:GO:0005654; F:GO:0003677; C:GO:0005634; C:GO:0005615; F:GO:0005515; P:GO:0002227; C:GO:0070062; C:GO:0005737; F:GO:0046982; P:GO:0019731; P:GO:0050830	C:nuclear nucleosome; C:chromosome; C:nucleosome; P:defense response to bacterium; P:nucleosome assembly; F:molecular_function; P:substantia nigra development; C:nucleoplasm; F:DNA binding; C:nucleus; C:extracellular space; F:protein binding; P:innate immune response in mucosa; C:extracellular exosome; C:cytoplasm; F:protein heterodimerization activity; P:antibacterial humoral response; P:defense response to Gram-positive bacterium		
tr|F6VYH8|F6VYH8_HORSE	histone H2B type 2-F	126	20	5.33E-86	100%	11	F:GO:0003677; C:GO:0005634; C:GO:0070062; C:GO:0005737; F:GO:0046982; C:GO:0000788; C:GO:0005694; C:GO:0000786; P:GO:0006334; F:GO:0003674; C:GO:0005654	F:DNA binding; C:nucleus; C:extracellular exosome; C:cytoplasm; F:protein heterodimerization activity; C:nuclear nucleosome; C:chromosome; C:nucleosome; P:nucleosome assembly; F:molecular_function; C:nucleoplasm		
tr|F7DLL0|F7DLL0_HORSE	histone H2B type 1	126	20	8.77E-86	98.45%	17	C:GO:0000788; C:GO:0005694; C:GO:0000786; P:GO:0042742; P:GO:0006334; P:GO:0021762; C:GO:0005654; F:GO:0003677; C:GO:0005634; C:GO:0005615; F:GO:0005515; C:GO:0070062; P:GO:0002227; C:GO:0005737; F:GO:0046982; P:GO:0019731; P:GO:0050830	C:nuclear nucleosome; C:chromosome; C:nucleosome; P:defense response to bacterium; P:nucleosome assembly; P:substantia nigra development; C:nucleoplasm; F:DNA binding; C:nucleus; C:extracellular space; F:protein binding; C:extracellular exosome; P:innate immune response in mucosa; C:cytoplasm; F:protein heterodimerization activity; P:antibacterial humoral response; P:defense response to Gram-positive bacterium		
tr|F7E1X9|F7E1X9_HORSE	histone H2B type 1-M	126	20	5.87E-86	99.85%	18	C:GO:0000788; C:GO:0005694; C:GO:0000786; P:GO:0042742; P:GO:0006334; F:GO:0003674; C:GO:0000784; C:GO:0005654; F:GO:0003677; C:GO:0005634; C:GO:0005615; F:GO:0005515; C:GO:0070062; P:GO:0002227; C:GO:0005737; F:GO:0046982; P:GO:0019731; P:GO:0050830	C:nuclear nucleosome; C:chromosome; C:nucleosome; P:defense response to bacterium; P:nucleosome assembly; F:molecular_function; C:nuclear chromosome, telomeric region; C:nucleoplasm; F:DNA binding; C:nucleus; C:extracellular space; F:protein binding; C:extracellular exosome; P:innate immune response in mucosa; C:cytoplasm; F:protein heterodimerization activity; P:antibacterial humoral response; P:defense response to Gram-positive bacterium		
tr|F6PWV1|F6PWV1_HORSE	histone H2B type 1	126	20	1.26E-85	100%	19	C:GO:0000788; C:GO:0005694; C:GO:0000786; P:GO:0042742; P:GO:0006334; F:GO:0003674; P:GO:0021762; C:GO:0000784; C:GO:0005654; F:GO:0003677; C:GO:0005634; C:GO:0005615; F:GO:0005515; C:GO:0070062; P:GO:0002227; C:GO:0005737; F:GO:0046982; P:GO:0019731; P:GO:0050830	C:nuclear nucleosome; C:chromosome; C:nucleosome; P:defense response to bacterium; P:nucleosome assembly; F:molecular_function; P:substantia nigra development; C:nuclear chromosome, telomeric region; C:nucleoplasm; F:DNA binding; C:nucleus; C:extracellular space; F:protein binding; C:extracellular exosome; P:innate immune response in mucosa; C:cytoplasm; F:protein heterodimerization activity; P:antibacterial humoral response; P:defense response to Gram-positive bacterium		
tr|F7CJ51|F7CJ51_HORSE	histone H2B type 1	126	20	1.18E-85	99.2%	18	C:GO:0000788; C:GO:0005694; C:GO:0000786; P:GO:0042742; P:GO:0006334; F:GO:0003674; P:GO:0021762; C:GO:0005654; F:GO:0003677; C:GO:0005634; C:GO:0005615; F:GO:0005515; C:GO:0070062; P:GO:0002227; C:GO:0005737; F:GO:0046982; P:GO:0019731; P:GO:0050830	C:nuclear nucleosome; C:chromosome; C:nucleosome; P:defense response to bacterium; P:nucleosome assembly; F:molecular_function; P:substantia nigra development; C:nucleoplasm; F:DNA binding; C:nucleus; C:extracellular space; F:protein binding; C:extracellular exosome; P:innate immune response in mucosa; C:cytoplasm; F:protein heterodimerization activity; P:antibacterial humoral response; P:defense response to Gram-positive bacterium		
tr|F6SP02|F6SP02_HORSE	14-3-3 theta	245	20	1.21E-180	99.65%	24	P:GO:0061024; F:GO:0019904; P:GO:0007264; P:GO:0007165; F:GO:0008022; P:GO:1900740; C:GO:0043234; F:GO:0044325; F:GO:0004497; P:GO:0021762; P:GO:0006605; C:GO:0030659; F:GO:0005515; C:GO:0070062; C:GO:0005925; P:GO:0045892; C:GO:0005737; F:GO:0047485; C:GO:0005739; C:GO:0016020; C:GO:0005829; P:GO:0055114; P:GO:0034766; F:GO:0071889	P:membrane organization; F:protein domain specific binding; P:small GTPase mediated signal transduction; P:signal transduction; F:protein C-terminus binding; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; C:protein complex; F:ion channel binding; F:monooxygenase activity; P:substantia nigra development; P:protein targeting; C:cytoplasmic vesicle membrane; F:protein binding; C:extracellular exosome; C:focal adhesion; P:negative regulation of transcription, DNA-templated; C:cytoplasm; F:protein N-terminus binding; C:mitochondrion; C:membrane; C:cytosol; P:oxidation-reduction process; P:negative regulation of ion transmembrane transport; F:14-3-3 protein binding		
tr|F6WSA6|F6WSA6_HORSE	glutathione synthetase	474	20	0E0	97.2%	11	F:GO:0000166; F:GO:0000287; F:GO:0005524; F:GO:0042803; C:GO:0070062; F:GO:0043295; F:GO:0046872; P:GO:0006750; P:GO:0046686; F:GO:0004363; F:GO:0016874	F:nucleotide binding; F:magnesium ion binding; F:ATP binding; F:protein homodimerization activity; C:extracellular exosome; F:glutathione binding; F:metal ion binding; P:glutathione biosynthetic process; P:response to cadmium ion; F:glutathione synthase activity; F:ligase activity		
tr|F6QB61|F6QB61_HORSE	peptidoglycan recognition 1	193	20	2.01E-141	84.1%	18	F:GO:0042834; F:GO:0016019; F:GO:0008270; P:GO:0050728; P:GO:0009253; C:GO:0005576; P:GO:0044117; P:GO:0002221; P:GO:0042742; F:GO:0008745; P:GO:0002376; C:GO:0070062; P:GO:0045087; P:GO:0032827; P:GO:0016045; P:GO:0001818; P:GO:0032689; P:GO:0050830	F:peptidoglycan binding; F:peptidoglycan receptor activity; F:zinc ion binding; P:negative regulation of inflammatory response; P:peptidoglycan catabolic process; C:extracellular region; P:growth of symbiont in host; P:pattern recognition receptor signaling pathway; P:defense response to bacterium; F:N-acetylmuramoyl-L-alanine amidase activity; P:immune system process; C:extracellular exosome; P:innate immune response; P:negative regulation of natural killer cell differentiation involved in immune response; P:detection of bacterium; P:negative regulation of cytokine production; P:negative regulation of interferon-gamma production; P:defense response to Gram-positive bacterium		
tr|F6RMM1|F6RMM1_HORSE	SH3 domain-binding glutamic acid-rich	114	20	3.75E-78	99.4%	7	C:GO:0005634; C:GO:0005615; F:GO:0005070; C:GO:0070062; C:GO:0005737; F:GO:0017124; P:GO:0009967	C:nucleus; C:extracellular space; F:SH3/SH2 adaptor activity; C:extracellular exosome; C:cytoplasm; F:SH3 domain binding; P:positive regulation of signal transduction		
tr|F6V0B8|F6V0B8_HORSE	cornifin-B	89	20	2.02E-45	83.2%	9	P:GO:0030216; C:GO:0001533; C:GO:0070062; C:GO:0005737; F:GO:0005198; P:GO:0008544; P:GO:0018149; P:GO:0031424; F:GO:0030674	P:keratinocyte differentiation; C:cornified envelope; C:extracellular exosome; C:cytoplasm; F:structural molecule activity; P:epidermis development; P:peptide cross-linking; P:keratinization; F:protein binding, bridging		
tr|F6XEJ7|F6XEJ7_HORSE	unconventional myosin-VI isoform X2	1276	20	0E0	97.9%	18	C:GO:0016459; C:GO:0005794; C:GO:0045334; P:GO:0045944; C:GO:0005654; F:GO:0003774; F:GO:0000166; C:GO:0005634; F:GO:0005524; P:GO:0051046; C:GO:0031965; C:GO:0070062; C:GO:0016591; C:GO:0016020; C:GO:0001726; P:GO:0030330; C:GO:0016023; C:GO:0031941	C:myosin complex; C:Golgi apparatus; C:clathrin-coated endocytic vesicle; P:positive regulation of transcription from RNA polymerase II promoter; C:nucleoplasm; F:motor activity; F:nucleotide binding; C:nucleus; F:ATP binding; P:regulation of secretion; C:nuclear membrane; C:extracellular exosome; C:DNA-directed RNA polymerase II, holoenzyme; C:membrane; C:ruffle; P:DNA damage response, signal transduction by p53 class mediator; C:cytoplasmic, membrane-bounded vesicle; C:filamentous actin		
tr|F6XF24|F6XF24_HORSE	unconventional myosin-VI isoform X1	1285	20	0E0	98.25%	18	C:GO:0016459; C:GO:0005794; C:GO:0045334; P:GO:0045944; C:GO:0005654; F:GO:0003774; F:GO:0000166; F:GO:0005524; C:GO:0005634; P:GO:0051046; C:GO:0031965; C:GO:0070062; C:GO:0016591; C:GO:0016020; C:GO:0001726; P:GO:0030330; C:GO:0016023; C:GO:0031941	C:myosin complex; C:Golgi apparatus; C:clathrin-coated endocytic vesicle; P:positive regulation of transcription from RNA polymerase II promoter; C:nucleoplasm; F:motor activity; F:nucleotide binding; F:ATP binding; C:nucleus; P:regulation of secretion; C:nuclear membrane; C:extracellular exosome; C:DNA-directed RNA polymerase II, holoenzyme; C:membrane; C:ruffle; P:DNA damage response, signal transduction by p53 class mediator; C:cytoplasmic, membrane-bounded vesicle; C:filamentous actin		
tr|F6XF44|F6XF44_HORSE	unconventional myosin-VI isoform X1	1294	20	0E0	98.45%	18	C:GO:0016459; C:GO:0005794; C:GO:0045334; P:GO:0045944; C:GO:0005654; F:GO:0003774; F:GO:0000166; C:GO:0005634; F:GO:0005524; P:GO:0051046; C:GO:0031965; C:GO:0070062; C:GO:0016591; C:GO:0016020; C:GO:0001726; P:GO:0030330; C:GO:0016023; C:GO:0031941	C:myosin complex; C:Golgi apparatus; C:clathrin-coated endocytic vesicle; P:positive regulation of transcription from RNA polymerase II promoter; C:nucleoplasm; F:motor activity; F:nucleotide binding; C:nucleus; F:ATP binding; P:regulation of secretion; C:nuclear membrane; C:extracellular exosome; C:DNA-directed RNA polymerase II, holoenzyme; C:membrane; C:ruffle; P:DNA damage response, signal transduction by p53 class mediator; C:cytoplasmic, membrane-bounded vesicle; C:filamentous actin		
tr|F6RP73|F6RP73_HORSE	15 kDa B-like	167	20	2.04E-104	74.1%	8	P:GO:1901491; P:GO:0016525; C:GO:0005615; F:GO:0004869; C:GO:0031410; P:GO:0010951; C:GO:0005576; P:GO:0006952	P:negative regulation of lymphangiogenesis; P:negative regulation of angiogenesis; C:extracellular space; F:cysteine-type endopeptidase inhibitor activity; C:cytoplasmic vesicle; P:negative regulation of endopeptidase activity; C:extracellular region; P:defense response		
tr|F6ZMG7|F6ZMG7_HORSE	liver carboxylesterase-like isoform X1	567	20	0E0	91.85%	3	C:GO:0005615; F:GO:0052689; F:GO:0016787	C:extracellular space; F:carboxylic ester hydrolase activity; F:hydrolase activity		
tr|F6XNT7|F6XNT7_HORSE	ribonuclease T2	175	20	2.83E-126	92%	3	P:GO:0090502; F:GO:0003723; F:GO:0033897	P:RNA phosphodiester bond hydrolysis, endonucleolytic; F:RNA binding; F:ribonuclease T2 activity		
tr|F6T8J7|F6T8J7_HORSE	ly6 PLAUR domain-containing 3	351	20	0E0	86.9%	6	P:GO:0007160; C:GO:0005615; C:GO:0016020; C:GO:0016021; F:GO:0043236; C:GO:0005886	P:cell-matrix adhesion; C:extracellular space; C:membrane; C:integral component of membrane; F:laminin binding; C:plasma membrane		
tr|F7BAB4|F7BAB4_HORSE	tumor D52 isoform X4	221	20	1E-153	95.85%	10	P:GO:0046903; F:GO:0005515; F:GO:0042803; C:GO:0048471; P:GO:0030183; C:GO:0005737; F:GO:0046982; F:GO:0005509; P:GO:0009653; C:GO:0005783	P:secretion; F:protein binding; F:protein homodimerization activity; C:perinuclear region of cytoplasm; P:B cell differentiation; C:cytoplasm; F:protein heterodimerization activity; F:calcium ion binding; P:anatomical structure morphogenesis; C:endoplasmic reticulum		
tr|F7CAG8|F7CAG8_HORSE	Ig kappa light chain variable partial	106	20	2.4E-53	84.45%	10	P:GO:0006956; P:GO:0006958; P:GO:0006508; P:GO:0038095; F:GO:0004252; P:GO:0038096; C:GO:0005576; P:GO:0006898; C:GO:0005886; P:GO:0050776	P:complement activation; P:complement activation, classical pathway; P:proteolysis; P:Fc-epsilon receptor signaling pathway; F:serine-type endopeptidase activity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; C:extracellular region; P:receptor-mediated endocytosis; C:plasma membrane; P:regulation of immune response		
tr|F7A1W7|F7A1W7_HORSE	apolipo C-II	101	20	3.3E-65	84.25%	15	C:GO:0034361; C:GO:0042627; C:GO:0034364; C:GO:0034362; F:GO:0060230; F:GO:0008047; C:GO:0005576; P:GO:0006810; P:GO:0045723; P:GO:0006869; P:GO:0043085; P:GO:0006629; P:GO:0016042; P:GO:0010898; P:GO:0051006	C:very-low-density lipoprotein particle; C:chylomicron; C:high-density lipoprotein particle; C:low-density lipoprotein particle; F:lipoprotein lipase activator activity; F:enzyme activator activity; C:extracellular region; P:transport; P:positive regulation of fatty acid biosynthetic process; P:lipid transport; P:positive regulation of catalytic activity; P:lipid metabolic process; P:lipid catabolic process; P:positive regulation of triglyceride catabolic process; P:positive regulation of lipoprotein lipase activity		
tr|F6ZPY1|F6ZPY1_HORSE	EF-hand domain-containing D2	138	20	1.96E-92	98.8%	4	F:GO:0046872; F:GO:0005509; C:GO:0016020; C:GO:0045121	F:metal ion binding; F:calcium ion binding; C:membrane; C:membrane raft		
tr|F7ALV0|F7ALV0_HORSE	thioredoxin	97	20	1.04E-64	95.9%	26	F:GO:0015037; F:GO:0015035; P:GO:0009314; P:GO:0006662; P:GO:1903206; P:GO:0043388; C:GO:0005576; P:GO:0000122; C:GO:0005623; C:GO:0070062; C:GO:0005829; P:GO:0033158; F:GO:0016671; P:GO:0033138; P:GO:0046826; P:GO:0006351; P:GO:0006355; P:GO:0045454; P:GO:0006457; P:GO:0000103; F:GO:0044822; C:GO:0005634; C:GO:0005737; C:GO:0005739; P:GO:0034599; P:GO:0055114	F:peptide disulfide oxidoreductase activity; F:protein disulfide oxidoreductase activity; P:response to radiation; P:glycerol ether metabolic process; P:negative regulation of hydrogen peroxide-induced cell death; P:positive regulation of DNA binding; C:extracellular region; P:negative regulation of transcription from RNA polymerase II promoter; C:cell; C:extracellular exosome; C:cytosol; P:regulation of protein import into nucleus, translocation; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; P:positive regulation of peptidyl-serine phosphorylation; P:negative regulation of protein export from nucleus; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:cell redox homeostasis; P:protein folding; P:sulfate assimilation; F:poly(A) RNA binding; C:nucleus; C:cytoplasm; C:mitochondrion; P:cellular response to oxidative stress; P:oxidation-reduction process		
sp|O97508|THIO_HORSE	thioredoxin	105	20	2.46E-70	96.05%	37	P:GO:0008283; P:GO:0030091; F:GO:0015037; F:GO:0015035; P:GO:0009314; P:GO:0006662; P:GO:1903206; P:GO:0043388; C:GO:0005576; C:GO:0005654; P:GO:0000122; C:GO:0005623; C:GO:0070062; P:GO:0015949; C:GO:0005829; P:GO:0033158; F:GO:0016671; P:GO:0032148; P:GO:0033138; P:GO:0046826; P:GO:0006351; P:GO:0007165; P:GO:0007267; P:GO:0006355; P:GO:0045454; P:GO:0006457; P:GO:0000302; P:GO:0000103; F:GO:0044822; C:GO:0005634; F:GO:0005515; C:GO:0005737; P:GO:0006928; C:GO:0005739; P:GO:0034599; P:GO:0055114; P:GO:0051897	P:cell proliferation; P:protein repair; F:peptide disulfide oxidoreductase activity; F:protein disulfide oxidoreductase activity; P:response to radiation; P:glycerol ether metabolic process; P:negative regulation of hydrogen peroxide-induced cell death; P:positive regulation of DNA binding; C:extracellular region; C:nucleoplasm; P:negative regulation of transcription from RNA polymerase II promoter; C:cell; C:extracellular exosome; P:nucleobase-containing small molecule interconversion; C:cytosol; P:regulation of protein import into nucleus, translocation; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; P:activation of protein kinase B activity; P:positive regulation of peptidyl-serine phosphorylation; P:negative regulation of protein export from nucleus; P:transcription, DNA-templated; P:signal transduction; P:cell-cell signaling; P:regulation of transcription, DNA-templated; P:cell redox homeostasis; P:protein folding; P:response to reactive oxygen species; P:sulfate assimilation; F:poly(A) RNA binding; C:nucleus; F:protein binding; C:cytoplasm; P:movement of cell or subcellular component; C:mitochondrion; P:cellular response to oxidative stress; P:oxidation-reduction process; P:positive regulation of protein kinase B signaling		
tr|F7CL92|F7CL92_HORSE	glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 isoform X1	699	20	0E0	98.3%	23	P:GO:0036498; P:GO:0006042; P:GO:0045719; F:GO:0008483; F:GO:0004360; P:GO:0006112; P:GO:0006002; P:GO:0006541; P:GO:0006047; P:GO:1901137; P:GO:0006048; P:GO:0009744; P:GO:0032869; P:GO:0005975; P:GO:0032922; P:GO:0032868; P:GO:0051289; C:GO:0070062; P:GO:0048511; C:GO:0005829; F:GO:0016740; F:GO:0016597; F:GO:0030246	P:IRE1-mediated unfolded protein response; P:glucosamine biosynthetic process; P:negative regulation of glycogen biosynthetic process; F:transaminase activity; F:glutamine-fructose-6-phosphate transaminase (isomerizing) activity; P:energy reserve metabolic process; P:fructose 6-phosphate metabolic process; P:glutamine metabolic process; P:UDP-N-acetylglucosamine metabolic process; P:carbohydrate derivative biosynthetic process; P:UDP-N-acetylglucosamine biosynthetic process; P:response to sucrose; P:cellular response to insulin stimulus; P:carbohydrate metabolic process; P:circadian regulation of gene expression; P:response to insulin; P:protein homotetramerization; C:extracellular exosome; P:rhythmic process; C:cytosol; F:transferase activity; F:amino acid binding; F:carbohydrate binding		
tr|F7CQ86|F7CQ86_HORSE	alpha-1-acid glyco 2-like	201	20	7.53E-150	81.65%	4	C:GO:0005615; P:GO:0002682; C:GO:0005576; P:GO:0006810	C:extracellular space; P:regulation of immune system process; C:extracellular region; P:transport		
tr|F6RTH0|F6RTH0_HORSE	thioredoxin domain-containing 17	123	20	8.22E-88	96.6%	9	F:GO:0004601; P:GO:0033209; F:GO:0005515; C:GO:0070062; C:GO:0005737; F:GO:0047134; P:GO:0098869; C:GO:0005829; P:GO:0055114	F:peroxidase activity; P:tumor necrosis factor-mediated signaling pathway; F:protein binding; C:extracellular exosome; C:cytoplasm; F:protein-disulfide reductase activity; P:cellular oxidant detoxification; C:cytosol; P:oxidation-reduction process		
tr|F7A4B1|F7A4B1_HORSE	F-box only 50	183	20	6.24E-132	92.25%	3	C:GO:0070062; C:GO:0005737; P:GO:0008284	C:extracellular exosome; C:cytoplasm; P:positive regulation of cell proliferation		
tr|F6YMD9|F6YMD9_HORSE	microtubule-actin cross-linking factor isoforms 1 2 3 5 isoform X7	7280	20	0E0	94%	25	F:GO:0016887; P:GO:0007050; P:GO:0043001; C:GO:0005794; C:GO:0042995; C:GO:0005874; P:GO:0042060; F:GO:0005509; C:GO:0032587; P:GO:0010632; P:GO:0016055; P:GO:0032886; P:GO:0045773; C:GO:0005886; F:GO:0008017; F:GO:0044822; F:GO:0051015; P:GO:0051893; F:GO:0005515; C:GO:0005856; F:GO:0003779; F:GO:0046872; C:GO:0005737; C:GO:0016020; P:GO:0030177	F:ATPase activity; P:cell cycle arrest; P:Golgi to plasma membrane protein transport; C:Golgi apparatus; C:cell projection; C:microtubule; P:wound healing; F:calcium ion binding; C:ruffle membrane; P:regulation of epithelial cell migration; P:Wnt signaling pathway; P:regulation of microtubule-based process; P:positive regulation of axon extension; C:plasma membrane; F:microtubule binding; F:poly(A) RNA binding; F:actin filament binding; P:regulation of focal adhesion assembly; F:protein binding; C:cytoskeleton; F:actin binding; F:metal ion binding; C:cytoplasm; C:membrane; P:positive regulation of Wnt signaling pathway		
tr|F6Z3G9|F6Z3G9_HORSE	hexokinase-3 isoform X1	924	20	0E0	95.3%	19	P:GO:0006096; F:GO:0004340; F:GO:0004396; P:GO:0046835; F:GO:0008865; F:GO:0005536; F:GO:0000166; F:GO:0005524; C:GO:0005623; P:GO:0005975; P:GO:0051156; P:GO:0001678; C:GO:0005739; C:GO:0005829; F:GO:0019158; P:GO:0016310; F:GO:0016773; F:GO:0016740; F:GO:0016301	P:glycolytic process; F:glucokinase activity; F:hexokinase activity; P:carbohydrate phosphorylation; F:fructokinase activity; F:glucose binding; F:nucleotide binding; F:ATP binding; C:cell; P:carbohydrate metabolic process; P:glucose 6-phosphate metabolic process; P:cellular glucose homeostasis; C:mitochondrion; C:cytosol; F:mannokinase activity; P:phosphorylation; F:phosphotransferase activity, alcohol group as acceptor; F:transferase activity; F:kinase activity		
tr|F7BRS8|F7BRS8_HORSE	S100-A2	97	20	1.16E-64	97.45%	4	F:GO:0042802; F:GO:0046872; F:GO:0005509; P:GO:0043542	F:identical protein binding; F:metal ion binding; F:calcium ion binding; P:endothelial cell migration		
tr|F6X449|F6X449_HORSE	alpha-2-antiplasmin isoform X1	491	20	0E0	91.7%	33	P:GO:0048514; F:GO:0002020; P:GO:0042730; P:GO:0045944; C:GO:0005576; C:GO:0005577; P:GO:0002576; P:GO:0048661; P:GO:0032967; C:GO:0070062; P:GO:0010757; C:GO:0072562; P:GO:0010951; P:GO:0071636; C:GO:0031093; P:GO:0010033; F:GO:0042803; P:GO:0051918; P:GO:0045597; P:GO:0002034; P:GO:0006953; C:GO:0009986; F:GO:0030414; F:GO:0004867; C:GO:0005615; F:GO:0004866; F:GO:0005515; P:GO:0051496; P:GO:0046330; P:GO:0070374; P:GO:0030199; P:GO:2000049; P:GO:0010466	P:blood vessel morphogenesis; F:protease binding; P:fibrinolysis; P:positive regulation of transcription from RNA polymerase II promoter; C:extracellular region; C:fibrinogen complex; P:platelet degranulation; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of collagen biosynthetic process; C:extracellular exosome; P:negative regulation of plasminogen activation; C:blood microparticle; P:negative regulation of endopeptidase activity; P:positive regulation of transforming growth factor beta production; C:platelet alpha granule lumen; P:response to organic substance; F:protein homodimerization activity; P:negative regulation of fibrinolysis; P:positive regulation of cell differentiation; P:regulation of blood vessel size by renin-angiotensin; P:acute-phase response; C:cell surface; F:peptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity; C:extracellular space; F:endopeptidase inhibitor activity; F:protein binding; P:positive regulation of stress fiber assembly; P:positive regulation of JNK cascade; P:positive regulation of ERK1 and ERK2 cascade; P:collagen fibril organization; P:positive regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of peptidase activity		
tr|F7B5C4|F7B5C4_HORSE	vimentin	361	20	0E0	96.95%	34	P:GO:0014002; P:GO:0007010; F:GO:0008022; P:GO:0060020; F:GO:0005198; P:GO:0045103; C:GO:0043005; C:GO:0042995; P:GO:0045109; F:GO:0005212; C:GO:0070062; C:GO:0005925; C:GO:0045111; F:GO:0003725; P:GO:0010977; C:GO:0005829; F:GO:0001948; P:GO:0070307; P:GO:0008150; F:GO:0042802; C:GO:0031252; P:GO:0060395; C:GO:0005882; F:GO:0005200; C:GO:0005886; F:GO:1990254; C:GO:0005777; F:GO:0097110; F:GO:0005515; C:GO:0005856; C:GO:0005737; P:GO:0010628; C:GO:0016363; C:GO:0030496	P:astrocyte development; P:cytoskeleton organization; F:protein C-terminus binding; P:Bergmann glial cell differentiation; F:structural molecule activity; P:intermediate filament-based process; C:neuron projection; C:cell projection; P:intermediate filament organization; F:structural constituent of eye lens; C:extracellular exosome; C:focal adhesion; C:intermediate filament cytoskeleton; F:double-stranded RNA binding; P:negative regulation of neuron projection development; C:cytosol; F:glycoprotein binding; P:lens fiber cell development; P:biological_process; F:identical protein binding; C:cell leading edge; P:SMAD protein signal transduction; C:intermediate filament; F:structural constituent of cytoskeleton; C:plasma membrane; F:keratin filament binding; C:peroxisome; F:scaffold protein binding; F:protein binding; C:cytoskeleton; C:cytoplasm; P:positive regulation of gene expression; C:nuclear matrix; C:midbody		
tr|F7DQ79|F7DQ79_HORSE	peripherin isoform X2	467	20	0E0	98.25%	5	C:GO:0070062; C:GO:0045098; C:GO:0016020; F:GO:0005198; C:GO:0005882	C:extracellular exosome; C:type III intermediate filament; C:membrane; F:structural molecule activity; C:intermediate filament		
tr|F7CVC4|F7CVC4_HORSE	AP-2 complex subunit alpha-2 isoform X1	912	20	0E0	98.2%	11	F:GO:0019901; C:GO:0030117; P:GO:0016192; C:GO:0005737; C:GO:0016020; P:GO:0015031; C:GO:0030131; F:GO:0008565; C:GO:0016023; P:GO:0006886; P:GO:0006810	F:protein kinase binding; C:membrane coat; P:vesicle-mediated transport; C:cytoplasm; C:membrane; P:protein transport; C:clathrin adaptor complex; F:protein transporter activity; C:cytoplasmic, membrane-bounded vesicle; P:intracellular protein transport; P:transport		
tr|F7CZP0|F7CZP0_HORSE	odorant-binding -like	174	20	9.06E-122	69.25%	6	F:GO:0005549; P:GO:0007608; C:GO:0005576; P:GO:0006810; P:GO:0050896; F:GO:0005215	F:odorant binding; P:sensory perception of smell; C:extracellular region; P:transport; P:response to stimulus; F:transporter activity		
tr|F6UH83|F6UH83_HORSE	T-complex 1 subunit epsilon	541	20	0E0	99.1%	27	C:GO:0043209; P:GO:1904874; F:GO:0031681; P:GO:1904851; P:GO:1904871; C:GO:0005730; P:GO:0009615; C:GO:0005874; F:GO:0000166; F:GO:0005524; C:GO:0070062; F:GO:0048487; C:GO:0005829; F:GO:0051082; P:GO:1901998; P:GO:0006457; C:GO:0002199; C:GO:0005832; C:GO:0005813; P:GO:0007339; C:GO:0005856; F:GO:0005515; C:GO:0005815; C:GO:0005737; C:GO:0044297; P:GO:0032212; P:GO:0050821	C:myelin sheath; P:positive regulation of telomerase RNA localization to Cajal body; F:G-protein beta-subunit binding; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; C:nucleolus; P:response to virus; C:microtubule; F:nucleotide binding; F:ATP binding; C:extracellular exosome; F:beta-tubulin binding; C:cytosol; F:unfolded protein binding; P:toxin transport; P:protein folding; C:zona pellucida receptor complex; C:chaperonin-containing T-complex; C:centrosome; P:binding of sperm to zona pellucida; C:cytoskeleton; F:protein binding; C:microtubule organizing center; C:cytoplasm; C:cell body; P:positive regulation of telomere maintenance via telomerase; P:protein stabilization		
tr|F7BC94|F7BC94_HORSE	hypoxia up-regulated 1 isoform X1	980	20	0E0	97.65%	12	F:GO:0000166; F:GO:0005524; P:GO:1903382; P:GO:0002931; C:GO:0070062; C:GO:0005925; P:GO:1903298; P:GO:0043066; C:GO:0016020; C:GO:0034663; P:GO:0071456; P:GO:0034976	F:nucleotide binding; F:ATP binding; P:negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway; P:response to ischemia; C:extracellular exosome; C:focal adhesion; P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway; P:negative regulation of apoptotic process; C:membrane; C:endoplasmic reticulum chaperone complex; P:cellular response to hypoxia; P:response to endoplasmic reticulum stress		
tr|F7D3E3|F7D3E3_HORSE	UMP-CMP kinase	172	20	1.33E-122	99.9%	18	P:GO:0046939; F:GO:0009041; P:GO:0009142; P:GO:0006165; F:GO:0004550; P:GO:0006221; P:GO:0006139; F:GO:0000166; C:GO:0005634; F:GO:0005524; F:GO:0004127; P:GO:0006207; C:GO:0070062; C:GO:0005737; P:GO:0016310; F:GO:0016740; F:GO:0019205; F:GO:0016301	P:nucleotide phosphorylation; F:uridylate kinase activity; P:nucleoside triphosphate biosynthetic process; P:nucleoside diphosphate phosphorylation; F:nucleoside diphosphate kinase activity; P:pyrimidine nucleotide biosynthetic process; P:nucleobase-containing compound metabolic process; F:nucleotide binding; C:nucleus; F:ATP binding; F:cytidylate kinase activity; P:'de novo' pyrimidine nucleobase biosynthetic process; C:extracellular exosome; C:cytoplasm; P:phosphorylation; F:transferase activity; F:nucleobase-containing compound kinase activity; F:kinase activity		
tr|F7CCF5|F7CCF5_HORSE	latexin	222	20	1.73E-166	95.4%	4	C:GO:0070062; P:GO:0010951; F:GO:0008191; P:GO:0050965	C:extracellular exosome; P:negative regulation of endopeptidase activity; F:metalloendopeptidase inhibitor activity; P:detection of temperature stimulus involved in sensory perception of pain		
tr|F7C3F9|F7C3F9_HORSE	hemicentin-2	4300	20	0E0	78.55%	5	C:GO:0005604; F:GO:0005509; C:GO:0005938; C:GO:0030054; C:GO:0005576	C:basement membrane; F:calcium ion binding; C:cell cortex; C:cell junction; C:extracellular region		
tr|F7E481|F7E481_HORSE	Ig kappa chain V-II region RPMI 6410	122	20	1.1E-68	88.2%	14	F:GO:0004252; P:GO:0038095; P:GO:0038096; C:GO:0005576; P:GO:0006898; C:GO:0005886; P:GO:0006956; C:GO:0070062; P:GO:0006955; F:GO:0003823; P:GO:0006958; C:GO:0072562; P:GO:0006508; P:GO:0050776	F:serine-type endopeptidase activity; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; C:extracellular region; P:receptor-mediated endocytosis; C:plasma membrane; P:complement activation; C:extracellular exosome; P:immune response; F:antigen binding; P:complement activation, classical pathway; C:blood microparticle; P:proteolysis; P:regulation of immune response		
tr|F6Z563|F6Z563_HORSE	S100-P	98	20	6.64E-65	92.6%	15	P:GO:0010033; F:GO:0048306; P:GO:0043542; C:GO:0042995; C:GO:0005886; F:GO:0000287; C:GO:0031528; C:GO:0005634; F:GO:0005515; C:GO:0070062; C:GO:0005737; F:GO:0046872; F:GO:0005509; C:GO:0016020; F:GO:0050786	P:response to organic substance; F:calcium-dependent protein binding; P:endothelial cell migration; C:cell projection; C:plasma membrane; F:magnesium ion binding; C:microvillus membrane; C:nucleus; F:protein binding; C:extracellular exosome; C:cytoplasm; F:metal ion binding; F:calcium ion binding; C:membrane; F:RAGE receptor binding		
tr|F7AS83|F7AS83_HORSE	granulins	605	20	0E0	89.55%	3	C:GO:0070062; C:GO:0043231; F:GO:0044822	C:extracellular exosome; C:intracellular membrane-bounded organelle; F:poly(A) RNA binding		
tr|F7AB03|F7AB03_HORSE	granulins	592	20	0E0	89.65%	17	F:GO:0008083; P:GO:0060179; P:GO:0007165; P:GO:0061351; P:GO:0060999; C:GO:0005576; F:GO:0005125; F:GO:0044822; C:GO:0005615; F:GO:0005515; C:GO:0070062; P:GO:0048488; C:GO:0043231; P:GO:0032355; C:GO:0005829; P:GO:0035988; P:GO:0010976	F:growth factor activity; P:male mating behavior; P:signal transduction; P:neural precursor cell proliferation; P:positive regulation of dendritic spine development; C:extracellular region; F:cytokine activity; F:poly(A) RNA binding; C:extracellular space; F:protein binding; C:extracellular exosome; P:synaptic vesicle endocytosis; C:intracellular membrane-bounded organelle; P:response to estradiol; C:cytosol; P:chondrocyte proliferation; P:positive regulation of neuron projection development		
tr|F7DZZ9|F7DZZ9_HORSE	vasodilator-stimulated phospho	381	20	0E0	88.75%	22	P:GO:0008154; P:GO:0007411; C:GO:0042995; C:GO:0005886; F:GO:0005522; C:GO:0031527; C:GO:0005923; C:GO:0005856; P:GO:0051289; C:GO:0070062; P:GO:0001843; F:GO:0003779; C:GO:0005925; C:GO:0005737; P:GO:0030838; C:GO:0016020; C:GO:0030054; C:GO:0030175; F:GO:0017124; P:GO:0030036; C:GO:0030027; C:GO:0031258	P:actin polymerization or depolymerization; P:axon guidance; C:cell projection; C:plasma membrane; F:profilin binding; C:filopodium membrane; C:bicellular tight junction; C:cytoskeleton; P:protein homotetramerization; C:extracellular exosome; P:neural tube closure; F:actin binding; C:focal adhesion; C:cytoplasm; P:positive regulation of actin filament polymerization; C:membrane; C:cell junction; C:filopodium; F:SH3 domain binding; P:actin cytoskeleton organization; C:lamellipodium; C:lamellipodium membrane		
tr|F6VZY5|F6VZY5_HORSE	vasodilator-stimulated phospho	213	20	2.94E-101	94.95%	22	P:GO:0008154; P:GO:0007411; C:GO:0042995; C:GO:0005886; F:GO:0005522; C:GO:0031527; C:GO:0005923; C:GO:0005856; P:GO:0051289; C:GO:0070062; P:GO:0001843; F:GO:0003779; C:GO:0005925; C:GO:0005737; P:GO:0030838; C:GO:0016020; C:GO:0030054; C:GO:0030175; F:GO:0017124; P:GO:0030036; C:GO:0030027; C:GO:0031258	P:actin polymerization or depolymerization; P:axon guidance; C:cell projection; C:plasma membrane; F:profilin binding; C:filopodium membrane; C:bicellular tight junction; C:cytoskeleton; P:protein homotetramerization; C:extracellular exosome; P:neural tube closure; F:actin binding; C:focal adhesion; C:cytoplasm; P:positive regulation of actin filament polymerization; C:membrane; C:cell junction; C:filopodium; F:SH3 domain binding; P:actin cytoskeleton organization; C:lamellipodium; C:lamellipodium membrane		
tr|F7ALH5|F7ALH5_HORSE	tryptophan--tRNA cytoplasmic	466	20	0E0	94.05%	12	F:GO:0000166; P:GO:0006418; F:GO:0005524; C:GO:0005634; F:GO:0004812; C:GO:0070062; C:GO:0005737; P:GO:0045765; P:GO:0006436; F:GO:0016874; F:GO:0004830; P:GO:0006412	F:nucleotide binding; P:tRNA aminoacylation for protein translation; F:ATP binding; C:nucleus; F:aminoacyl-tRNA ligase activity; C:extracellular exosome; C:cytoplasm; P:regulation of angiogenesis; P:tryptophanyl-tRNA aminoacylation; F:ligase activity; F:tryptophan-tRNA ligase activity; P:translation		
tr|Q3S4D6|Q3S4D6_HORSE	ganglioside GM2 activator	193	20	1.32E-137	86.4%	11	P:GO:0019915; C:GO:0070062; P:GO:0043085; C:GO:0005739; P:GO:0009313; F:GO:0008047; F:GO:0004563; P:GO:0050877; P:GO:0006689; P:GO:0050885; P:GO:0007611	P:lipid storage; C:extracellular exosome; P:positive regulation of catalytic activity; C:mitochondrion; P:oligosaccharide catabolic process; F:enzyme activator activity; F:beta-N-acetylhexosaminidase activity; P:neurological system process; P:ganglioside catabolic process; P:neuromuscular process controlling balance; P:learning or memory		
tr|F6Y4I1|F6Y4I1_HORSE	UTP--glucose-1-phosphate uridylyltransferase isoform X1	502	20	0E0	99.2%	11	C:GO:0005634; F:GO:0042802; F:GO:0016779; C:GO:0070062; C:GO:0005737; F:GO:0046872; P:GO:0008152; P:GO:0006011; F:GO:0016740; F:GO:0003983; F:GO:0070569	C:nucleus; F:identical protein binding; F:nucleotidyltransferase activity; C:extracellular exosome; C:cytoplasm; F:metal ion binding; P:metabolic process; P:UDP-glucose metabolic process; F:transferase activity; F:UTP:glucose-1-phosphate uridylyltransferase activity; F:uridylyltransferase activity		
tr|F7A676|F7A676_HORSE	cytosol aminopeptidase	519	20	0E0	95.45%	13	P:GO:0019538; F:GO:0008235; F:GO:0004177; F:GO:0008233; C:GO:0005622; C:GO:0005654; C:GO:0005634; C:GO:0070062; C:GO:0005925; C:GO:0005737; C:GO:0005739; P:GO:0006508; F:GO:0030145	P:protein metabolic process; F:metalloexopeptidase activity; F:aminopeptidase activity; F:peptidase activity; C:intracellular; C:nucleoplasm; C:nucleus; C:extracellular exosome; C:focal adhesion; C:cytoplasm; C:mitochondrion; P:proteolysis; F:manganese ion binding		
tr|F6Z6Q7|F6Z6Q7_HORSE	T-complex 1 subunit delta	497	20	0E0	99.15%	20	F:GO:0051082; P:GO:1901998; P:GO:0006457; C:GO:0002199; C:GO:0042995; F:GO:0044822; C:GO:0005874; C:GO:0005654; F:GO:0000166; F:GO:0005524; C:GO:0005832; C:GO:0005813; P:GO:0007339; C:GO:0005856; C:GO:0070062; C:GO:0005815; C:GO:0005737; C:GO:0042470; C:GO:0044297; C:GO:0005929	F:unfolded protein binding; P:toxin transport; P:protein folding; C:zona pellucida receptor complex; C:cell projection; F:poly(A) RNA binding; C:microtubule; C:nucleoplasm; F:nucleotide binding; F:ATP binding; C:chaperonin-containing T-complex; C:centrosome; P:binding of sperm to zona pellucida; C:cytoskeleton; C:extracellular exosome; C:microtubule organizing center; C:cytoplasm; C:melanosome; C:cell body; C:cilium		
tr|F7BMU5|F7BMU5_HORSE	cytidine deaminase	145	20	6.3E-104	94.65%	13	F:GO:0042802; F:GO:0008270; F:GO:0042803; P:GO:0009972; F:GO:0004126; F:GO:0001882; P:GO:0051289; P:GO:0045980; P:GO:0030308; F:GO:0003824; F:GO:0046872; C:GO:0005829; F:GO:0016787	F:identical protein binding; F:zinc ion binding; F:protein homodimerization activity; P:cytidine deamination; F:cytidine deaminase activity; F:nucleoside binding; P:protein homotetramerization; P:negative regulation of nucleotide metabolic process; P:negative regulation of cell growth; F:catalytic activity; F:metal ion binding; C:cytosol; F:hydrolase activity		
tr|F6X0P8|F6X0P8_HORSE	kinesin-1 heavy chain	924	20	0E0	98.95%	27	P:GO:0032230; P:GO:0008104; P:GO:0007411; P:GO:0043268; C:GO:0005871; P:GO:0007018; C:GO:0043005; C:GO:0043227; C:GO:0005874; F:GO:0000166; F:GO:0005524; P:GO:0072383; P:GO:0030705; P:GO:0035617; P:GO:0047496; C:GO:0035253; P:GO:0090004; F:GO:0008574; F:GO:0008017; P:GO:0007028; C:GO:0030139; F:GO:0003777; P:GO:0042391; C:GO:0005815; C:GO:0005737; C:GO:0016020; C:GO:0031982	P:positive regulation of synaptic transmission, GABAergic; P:protein localization; P:axon guidance; P:positive regulation of potassium ion transport; C:kinesin complex; P:microtubule-based movement; C:neuron projection; C:membrane-bounded organelle; C:microtubule; F:nucleotide binding; F:ATP binding; P:plus-end-directed vesicle transport along microtubule; P:cytoskeleton-dependent intracellular transport; P:stress granule disassembly; P:vesicle transport along microtubule; C:ciliary rootlet; P:positive regulation of establishment of protein localization to plasma membrane; F:ATP-dependent microtubule motor activity, plus-end-directed; F:microtubule binding; P:cytoplasm organization; C:endocytic vesicle; F:microtubule motor activity; P:regulation of membrane potential; C:microtubule organizing center; C:cytoplasm; C:membrane; C:vesicle		
tr|F6SYQ8|F6SYQ8_HORSE	secretoglobin family 1D member-like	90	20	3.45E-53	70.05%	3	C:GO:0005615; P:GO:0007165; C:GO:0005576	C:extracellular space; P:signal transduction; C:extracellular region		
sp|P48770|CO9_HORSE	complement component C9	547	20	0E0	89.95%	14	P:GO:0019835; C:GO:0005576; P:GO:0002376; C:GO:0005886; P:GO:0006957; C:GO:0005579; P:GO:0006955; C:GO:0070062; C:GO:0005737; P:GO:0006958; P:GO:0045087; C:GO:0072562; C:GO:0016020; C:GO:0016021	P:cytolysis; C:extracellular region; P:immune system process; C:plasma membrane; P:complement activation, alternative pathway; C:membrane attack complex; P:immune response; C:extracellular exosome; C:cytoplasm; P:complement activation, classical pathway; P:innate immune response; C:blood microparticle; C:membrane; C:integral component of membrane		
tr|F6UFT2|F6UFT2_HORSE	complement component C9	547	20	0E0	90%	14	P:GO:0019835; C:GO:0005576; P:GO:0002376; C:GO:0005886; P:GO:0006957; C:GO:0005579; P:GO:0006955; C:GO:0070062; C:GO:0005737; P:GO:0006958; P:GO:0045087; C:GO:0072562; C:GO:0016020; C:GO:0016021	P:cytolysis; C:extracellular region; P:immune system process; C:plasma membrane; P:complement activation, alternative pathway; C:membrane attack complex; P:immune response; C:extracellular exosome; C:cytoplasm; P:complement activation, classical pathway; P:innate immune response; C:blood microparticle; C:membrane; C:integral component of membrane		
tr|F7C0S3|F7C0S3_HORSE	ninein isoform X1	1347	20	0E0	97.25%	6	C:GO:0000242; C:GO:0005813; F:GO:0005509; C:GO:0000922; P:GO:0034454; C:GO:0005730	C:pericentriolar material; C:centrosome; F:calcium ion binding; C:spindle pole; P:microtubule anchoring at centrosome; C:nucleolus		
tr|F6WG98|F6WG98_HORSE	sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)	639	20	0E0	96.3%	17	P:GO:0055085; P:GO:0006520; F:GO:0015293; F:GO:0015171; P:GO:0006810; P:GO:0006865; P:GO:0009636; P:GO:0003333; C:GO:0005886; P:GO:0006836; C:GO:0005887; F:GO:0005328; C:GO:0070062; C:GO:0031526; C:GO:0016020; C:GO:0016021; C:GO:0031982	P:transmembrane transport; P:cellular amino acid metabolic process; F:symporter activity; F:amino acid transmembrane transporter activity; P:transport; P:amino acid transport; P:response to toxic substance; P:amino acid transmembrane transport; C:plasma membrane; P:neurotransmitter transport; C:integral component of plasma membrane; F:neurotransmitter:sodium symporter activity; C:extracellular exosome; C:brush border membrane; C:membrane; C:integral component of membrane; C:vesicle		
tr|H9H007|H9H007_HORSE	cytosolic 10-formyltetrahydrofolate dehydrogenase isoform X1	896	20	0E0	95.4%	15	P:GO:0008152; P:GO:0009258; F:GO:0047105; P:GO:0009058; P:GO:0006730; C:GO:0070062; C:GO:0005737; F:GO:0003824; F:GO:0016491; C:GO:0005739; F:GO:0019145; F:GO:0016155; P:GO:0055114; F:GO:0016620; F:GO:0016742	P:metabolic process; P:10-formyltetrahydrofolate catabolic process; F:4-trimethylammoniobutyraldehyde dehydrogenase activity; P:biosynthetic process; P:one-carbon metabolic process; C:extracellular exosome; C:cytoplasm; F:catalytic activity; F:oxidoreductase activity; C:mitochondrion; F:aminobutyraldehyde dehydrogenase activity; F:formyltetrahydrofolate dehydrogenase activity; P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; F:hydroxymethyl-, formyl- and related transferase activity		
tr|F6XW20|F6XW20_HORSE	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 isoform X1	776	20	0E0	96.65%	21	P:GO:0007165; F:GO:1901981; F:GO:0004871; P:GO:0042127; C:GO:0005622; F:GO:0004435; F:GO:0001786; C:GO:0070062; P:GO:0060716; C:GO:0005737; P:GO:0001525; F:GO:0005509; F:GO:0004629; P:GO:0006629; P:GO:0016042; C:GO:0005829; F:GO:0070300; F:GO:0032794; F:GO:0008081; P:GO:0035556; F:GO:0016787	P:signal transduction; F:phosphatidylinositol phosphate binding; F:signal transducer activity; P:regulation of cell proliferation; C:intracellular; F:phosphatidylinositol phospholipase C activity; F:phosphatidylserine binding; C:extracellular exosome; P:labyrinthine layer blood vessel development; C:cytoplasm; P:angiogenesis; F:calcium ion binding; F:phospholipase C activity; P:lipid metabolic process; P:lipid catabolic process; C:cytosol; F:phosphatidic acid binding; F:GTPase activating protein binding; F:phosphoric diester hydrolase activity; P:intracellular signal transduction; F:hydrolase activity		
tr|F7C5G3|F7C5G3_HORSE	26S proteasome non-ATPase regulatory subunit 11	421	20	0E0	99%	33	P:GO:0038095; F:GO:0005198; C:GO:0022624; P:GO:0043488; C:GO:0008541; P:GO:0043248; P:GO:0006521; C:GO:0005654; P:GO:0002223; P:GO:0000165; P:GO:0002479; C:GO:0070062; P:GO:0048863; C:GO:0005829; P:GO:0060071; P:GO:0050852; P:GO:0000209; P:GO:0090263; P:GO:0038061; C:GO:0000502; P:GO:0006511; P:GO:0090090; C:GO:0005634; P:GO:0043161; P:GO:0033209; F:GO:0005515; C:GO:0005737; C:GO:0016020; C:GO:0005838; P:GO:0031145; P:GO:0000090; P:GO:0051437; P:GO:0051436	P:Fc-epsilon receptor signaling pathway; F:structural molecule activity; C:proteasome accessory complex; P:regulation of mRNA stability; C:proteasome regulatory particle, lid subcomplex; P:proteasome assembly; P:regulation of cellular amino acid metabolic process; C:nucleoplasm; P:stimulatory C-type lectin receptor signaling pathway; P:MAPK cascade; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; C:extracellular exosome; P:stem cell differentiation; C:cytosol; P:Wnt signaling pathway, planar cell polarity pathway; P:T cell receptor signaling pathway; P:protein polyubiquitination; P:positive regulation of canonical Wnt signaling pathway; P:NIK/NF-kappaB signaling; C:proteasome complex; P:ubiquitin-dependent protein catabolic process; P:negative regulation of canonical Wnt signaling pathway; C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:tumor necrosis factor-mediated signaling pathway; F:protein binding; C:cytoplasm; C:membrane; C:proteasome regulatory particle; P:anaphase-promoting complex-dependent catabolic process; P:mitotic anaphase; P:positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle		
tr|F6PGW8|F6PGW8_HORSE	calpain-2 catalytic subunit	589	20	0E0	94.05%	35	C:GO:0005794; P:GO:0071230; C:GO:0030425; C:GO:0070062; P:GO:0001666; C:GO:0005925; F:GO:0046982; F:GO:0005509; P:GO:0001824; C:GO:0005829; P:GO:0051603; C:GO:0030864; P:GO:0022617; P:GO:0007520; F:GO:0008234; C:GO:0005783; F:GO:0008233; F:GO:0004198; C:GO:0000785; C:GO:0005622; C:GO:0005886; C:GO:0005764; C:GO:0005634; F:GO:0005515; C:GO:0097038; F:GO:0046872; C:GO:0005737; P:GO:0051493; C:GO:0016020; C:GO:0045121; P:GO:0006508; P:GO:0016540; C:GO:0031143; F:GO:0008092; F:GO:0016787	C:Golgi apparatus; P:cellular response to amino acid stimulus; C:dendrite; C:extracellular exosome; P:response to hypoxia; C:focal adhesion; F:protein heterodimerization activity; F:calcium ion binding; P:blastocyst development; C:cytosol; P:proteolysis involved in cellular protein catabolic process; C:cortical actin cytoskeleton; P:extracellular matrix disassembly; P:myoblast fusion; F:cysteine-type peptidase activity; C:endoplasmic reticulum; F:peptidase activity; F:calcium-dependent cysteine-type endopeptidase activity; C:chromatin; C:intracellular; C:plasma membrane; C:lysosome; C:nucleus; F:protein binding; C:perinuclear endoplasmic reticulum; F:metal ion binding; C:cytoplasm; P:regulation of cytoskeleton organization; C:membrane; C:membrane raft; P:proteolysis; P:protein autoprocessing; C:pseudopodium; F:cytoskeletal protein binding; F:hydrolase activity		
tr|F7AAW3|F7AAW3_HORSE	condensin-2 complex subunit D3	1478	20	0E0	90.5%	18	P:GO:0010032; P:GO:0007076; F:GO:0035064; P:GO:0030261; C:GO:0000779; P:GO:0007067; C:GO:0000799; F:GO:0003682; P:GO:0007049; C:GO:0005654; P:GO:0051301; P:GO:0000088; C:GO:0005634; F:GO:0005515; F:GO:0042393; C:GO:0016020; C:GO:0031618; P:GO:0051304	P:meiotic chromosome condensation; P:mitotic chromosome condensation; F:methylated histone binding; P:chromosome condensation; C:condensed chromosome, centromeric region; P:mitotic nuclear division; C:nuclear condensin complex; F:chromatin binding; P:cell cycle; C:nucleoplasm; P:cell division; P:mitotic prophase; C:nucleus; F:protein binding; F:histone binding; C:membrane; C:nuclear pericentric heterochromatin; P:chromosome separation		
tr|F7BQE2|F7BQE2_HORSE	acyl-coenzyme A thioesterase 1	408	20	0E0	84.25%	14	P:GO:0000038; F:GO:0047617; F:GO:0005102; P:GO:0006637; P:GO:0001676; F:GO:0016290; C:GO:0070062; C:GO:0005759; C:GO:0005739; F:GO:0016790; P:GO:0035338; C:GO:0005829; F:GO:0052689; F:GO:0016787	P:very long-chain fatty acid metabolic process; F:acyl-CoA hydrolase activity; F:receptor binding; P:acyl-CoA metabolic process; P:long-chain fatty acid metabolic process; F:palmitoyl-CoA hydrolase activity; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; F:thiolester hydrolase activity; P:long-chain fatty-acyl-CoA biosynthetic process; C:cytosol; F:carboxylic ester hydrolase activity; F:hydrolase activity		
tr|F6ULK6|F6ULK6_HORSE	acyl-coenzyme A thioesterase 4	423	20	0E0	86.35%	14	P:GO:0043648; P:GO:0043649; F:GO:0047617; P:GO:0000038; F:GO:0005102; P:GO:0046459; P:GO:0006104; P:GO:0006637; C:GO:0005777; P:GO:0001676; F:GO:0004778; F:GO:0016790; P:GO:0032788; P:GO:0032789	P:dicarboxylic acid metabolic process; P:dicarboxylic acid catabolic process; F:acyl-CoA hydrolase activity; P:very long-chain fatty acid metabolic process; F:receptor binding; P:short-chain fatty acid metabolic process; P:succinyl-CoA metabolic process; P:acyl-CoA metabolic process; C:peroxisome; P:long-chain fatty acid metabolic process; F:succinyl-CoA hydrolase activity; F:thiolester hydrolase activity; P:saturated monocarboxylic acid metabolic process; P:unsaturated monocarboxylic acid metabolic process		
tr|F7DUG2|F7DUG2_HORSE	acyl-coenzyme A thioesterase 6-like	423	20	0E0	92.6%	3	P:GO:0006637; F:GO:0016790; C:GO:0005829	P:acyl-CoA metabolic process; F:thiolester hydrolase activity; C:cytosol		
tr|H9GZM1|H9GZM1_HORSE	growth arrest-specific 6	485	20	0E0	93.1%	73	P:GO:0061098; P:GO:0085029; P:GO:0046813; F:GO:0043027; F:GO:0001786; P:GO:0010934; P:GO:0045892; P:GO:0071333; F:GO:0005509; P:GO:0043154; P:GO:0072661; P:GO:2000510; P:GO:0070168; P:GO:2000352; P:GO:0050711; P:GO:0032689; P:GO:0032008; P:GO:0032720; P:GO:0035754; P:GO:0033138; F:GO:0060090; P:GO:0046827; P:GO:1900142; P:GO:0043277; P:GO:0043433; F:GO:0005245; P:GO:0032715; P:GO:0045860; P:GO:0071363; P:GO:0010628; P:GO:0019079; F:GO:0030296; P:GO:0018105; P:GO:0050766; P:GO:0031589; F:GO:0030971; P:GO:0051897; P:GO:0046718; F:GO:0048018; P:GO:0007596; C:GO:0005576; P:GO:0006468; P:GO:0032825; P:GO:0003104; P:GO:0001961; P:GO:0001764; P:GO:0043491; C:GO:0070062; P:GO:0019064; P:GO:0048146; P:GO:0097028; P:GO:0033159; P:GO:0070588; P:GO:2000533; P:GO:0032148; P:GO:0035457; P:GO:2000270; P:GO:0007165; P:GO:0035690; P:GO:1900165; P:GO:0009267; P:GO:0007167; F:GO:0005102; P:GO:0097241; C:GO:0005615; C:GO:0005737; P:GO:2000669; P:GO:0043066; P:GO:0010804; P:GO:0070374; P:GO:0001934; P:GO:0006909; P:GO:0071307	P:positive regulation of protein tyrosine kinase activity; P:extracellular matrix assembly; P:receptor-mediated virion attachment to host cell; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:phosphatidylserine binding; P:macrophage cytokine production; P:negative regulation of transcription, DNA-templated; P:cellular response to glucose stimulus; F:calcium ion binding; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:protein targeting to plasma membrane; P:positive regulation of dendritic cell chemotaxis; P:negative regulation of biomineral tissue development; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of interleukin-1 secretion; P:negative regulation of interferon-gamma production; P:positive regulation of TOR signaling; P:negative regulation of tumor necrosis factor production; P:B cell chemotaxis; P:positive regulation of peptidyl-serine phosphorylation; F:binding, bridging; P:positive regulation of protein export from nucleus; P:negative regulation of oligodendrocyte apoptotic process; P:apoptotic cell clearance; P:negative regulation of sequence-specific DNA binding transcription factor activity; F:voltage-gated calcium channel activity; P:negative regulation of interleukin-6 production; P:positive regulation of protein kinase activity; P:cellular response to growth factor stimulus; P:positive regulation of gene expression; P:viral genome replication; F:protein tyrosine kinase activator activity; P:peptidyl-serine phosphorylation; P:positive regulation of phagocytosis; P:cell-substrate adhesion; F:receptor tyrosine kinase binding; P:positive regulation of protein kinase B signaling; P:viral entry into host cell; F:receptor agonist activity; P:blood coagulation; C:extracellular region; P:protein phosphorylation; P:positive regulation of natural killer cell differentiation; P:positive regulation of glomerular filtration; P:positive regulation of cytokine-mediated signaling pathway; P:neuron migration; P:protein kinase B signaling; C:extracellular exosome; P:fusion of virus membrane with host plasma membrane; P:positive regulation of fibroblast proliferation; P:dendritic cell differentiation; P:negative regulation of protein import into nucleus, translocation; P:calcium ion transmembrane transport; P:negative regulation of renal albumin absorption; P:activation of protein kinase B activity; P:cellular response to interferon-alpha; P:negative regulation of fibroblast apoptotic process; P:signal transduction; P:cellular response to drug; P:negative regulation of interleukin-6 secretion; P:cellular response to starvation; P:enzyme linked receptor protein signaling pathway; F:receptor binding; P:hematopoietic stem cell migration to bone marrow; C:extracellular space; C:cytoplasm; P:negative regulation of dendritic cell apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of protein phosphorylation; P:phagocytosis; P:cellular response to vitamin K		
tr|F6XHX6|F6XHX6_HORSE	collagen alpha-1(XVIII) chain	1110	20	0E0	91.1%	5	C:GO:0005581; F:GO:0005198; P:GO:0007155; C:GO:0031012; C:GO:0005578	C:collagen trimer; F:structural molecule activity; P:cell adhesion; C:extracellular matrix; C:proteinaceous extracellular matrix		
tr|F6XGY6|F6XGY6_HORSE	cytoplasmic dynein 1 heavy chain 1	4461	20	0E0	99%	27	F:GO:0016887; P:GO:0007052; P:GO:0051293; P:GO:0007018; C:GO:0005874; F:GO:0003774; F:GO:0000166; F:GO:0005524; C:GO:0005868; C:GO:0070062; P:GO:0000086; C:GO:0030286; C:GO:0005829; P:GO:0019886; P:GO:0034063; P:GO:0006810; F:GO:0044822; F:GO:0003777; C:GO:0005813; P:GO:0006888; C:GO:0005856; F:GO:0005515; C:GO:0005737; C:GO:0016020; P:GO:0033962; F:GO:0051959; C:GO:0030175	F:ATPase activity; P:mitotic spindle organization; P:establishment of spindle localization; P:microtubule-based movement; C:microtubule; F:motor activity; F:nucleotide binding; F:ATP binding; C:cytoplasmic dynein complex; C:extracellular exosome; P:G2/M transition of mitotic cell cycle; C:dynein complex; C:cytosol; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:stress granule assembly; P:transport; F:poly(A) RNA binding; F:microtubule motor activity; C:centrosome; P:ER to Golgi vesicle-mediated transport; C:cytoskeleton; F:protein binding; C:cytoplasm; C:membrane; P:cytoplasmic mRNA processing body assembly; F:dynein light intermediate chain binding; C:filopodium		
tr|F6RHB3|F6RHB3_HORSE	cytoplasmic dynein 1 heavy chain 1	4646	20	0E0	99.05%	27	F:GO:0016887; P:GO:0007052; P:GO:0051293; P:GO:0007018; C:GO:0005874; F:GO:0003774; F:GO:0000166; F:GO:0005524; C:GO:0005868; C:GO:0070062; P:GO:0000086; C:GO:0030286; C:GO:0005829; P:GO:0019886; P:GO:0034063; P:GO:0006810; F:GO:0044822; F:GO:0003777; C:GO:0005813; P:GO:0006888; C:GO:0005856; F:GO:0005515; C:GO:0005737; C:GO:0016020; P:GO:0033962; F:GO:0051959; C:GO:0030175	F:ATPase activity; P:mitotic spindle organization; P:establishment of spindle localization; P:microtubule-based movement; C:microtubule; F:motor activity; F:nucleotide binding; F:ATP binding; C:cytoplasmic dynein complex; C:extracellular exosome; P:G2/M transition of mitotic cell cycle; C:dynein complex; C:cytosol; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:stress granule assembly; P:transport; F:poly(A) RNA binding; F:microtubule motor activity; C:centrosome; P:ER to Golgi vesicle-mediated transport; C:cytoskeleton; F:protein binding; C:cytoplasm; C:membrane; P:cytoplasmic mRNA processing body assembly; F:dynein light intermediate chain binding; C:filopodium		
tr|F7BAA0|F7BAA0_HORSE	glutathione S-transferase omega-1	241	20	2.06E-179	90.95%	29	P:GO:0010880; C:GO:0043209; P:GO:0042178; F:GO:0004364; P:GO:1901687; F:GO:0045174; C:GO:0005604; C:GO:0070062; F:GO:0016491; C:GO:0005829; P:GO:0014810; F:GO:0050610; C:GO:0030424; P:GO:0008152; P:GO:0060316; P:GO:0060315; C:GO:0031965; F:GO:0005515; C:GO:0005737; P:GO:0006749; C:GO:0044297; P:GO:0071243; P:GO:0098869; P:GO:0019852; P:GO:0055114; F:GO:0016740; P:GO:0019853; P:GO:0010881; P:GO:0032259	P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; C:myelin sheath; P:xenobiotic catabolic process; F:glutathione transferase activity; P:glutathione derivative biosynthetic process; F:glutathione dehydrogenase (ascorbate) activity; C:basement membrane; C:extracellular exosome; F:oxidoreductase activity; C:cytosol; P:positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; F:methylarsonate reductase activity; C:axon; P:metabolic process; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:negative regulation of ryanodine-sensitive calcium-release channel activity; C:nuclear membrane; F:protein binding; C:cytoplasm; P:glutathione metabolic process; C:cell body; P:cellular response to arsenic-containing substance; P:cellular oxidant detoxification; P:L-ascorbic acid metabolic process; P:oxidation-reduction process; F:transferase activity; P:L-ascorbic acid biosynthetic process; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:methylation		
tr|F6RLD7|F6RLD7_HORSE	glutathione S-transferase omega-2	216	20	4.46E-161	97.25%	13	P:GO:0008152; F:GO:0004364; F:GO:0045174; C:GO:0070062; C:GO:0005737; F:GO:0016491; P:GO:0006749; P:GO:0071243; P:GO:0006805; P:GO:0098869; P:GO:0055114; P:GO:0019852; F:GO:0016740	P:metabolic process; F:glutathione transferase activity; F:glutathione dehydrogenase (ascorbate) activity; C:extracellular exosome; C:cytoplasm; F:oxidoreductase activity; P:glutathione metabolic process; P:cellular response to arsenic-containing substance; P:xenobiotic metabolic process; P:cellular oxidant detoxification; P:oxidation-reduction process; P:L-ascorbic acid metabolic process; F:transferase activity		
tr|F6TZF2|F6TZF2_HORSE	pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16	1226	20	0E0	99.05%	13	C:GO:0005681; F:GO:0008026; F:GO:0004386; P:GO:0000398; F:GO:0044822; F:GO:0004004; F:GO:0000166; F:GO:0003676; F:GO:0005524; C:GO:0071013; C:GO:0005737; C:GO:0016020; F:GO:0016787	C:spliceosomal complex; F:ATP-dependent helicase activity; F:helicase activity; P:mRNA splicing, via spliceosome; F:poly(A) RNA binding; F:ATP-dependent RNA helicase activity; F:nucleotide binding; F:nucleic acid binding; F:ATP binding; C:catalytic step 2 spliceosome; C:cytoplasm; C:membrane; F:hydrolase activity		
tr|F7BH96|F7BH96_HORSE	cullin-associated NEDD8-dissociated 1	1229	20	0E0	99%	16	C:GO:0031461; C:GO:0005794; C:GO:0005654; P:GO:0045899; C:GO:0005634; F:GO:0005515; C:GO:0070062; P:GO:0043086; C:GO:0000151; C:GO:0005737; P:GO:0045893; C:GO:0016020; P:GO:0030154; F:GO:0017025; P:GO:0010265; P:GO:0016567	C:cullin-RING ubiquitin ligase complex; C:Golgi apparatus; C:nucleoplasm; P:positive regulation of RNA polymerase II transcriptional preinitiation complex assembly; C:nucleus; F:protein binding; C:extracellular exosome; P:negative regulation of catalytic activity; C:ubiquitin ligase complex; C:cytoplasm; P:positive regulation of transcription, DNA-templated; C:membrane; P:cell differentiation; F:TBP-class protein binding; P:SCF complex assembly; P:protein ubiquitination		
tr|F6WU92|F6WU92_HORSE	arf-GAP with Rho-GAP ANK repeat and PH domain-containing 1 isoform X1	1214	20	0E0	93.55%	23	P:GO:0008360; P:GO:0007165; C:GO:0032580; F:GO:0005096; P:GO:0051491; P:GO:0045742; C:GO:0005794; P:GO:0051270; P:GO:0043547; C:GO:0005886; F:GO:0005547; C:GO:0005802; P:GO:0051497; F:GO:0005515; F:GO:0031702; C:GO:0005737; P:GO:0001921; P:GO:0051056; F:GO:0046872; C:GO:0016020; C:GO:0005829; C:GO:0031410; P:GO:0030037	P:regulation of cell shape; P:signal transduction; C:Golgi cisterna membrane; F:GTPase activator activity; P:positive regulation of filopodium assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; C:Golgi apparatus; P:regulation of cellular component movement; P:positive regulation of GTPase activity; C:plasma membrane; F:phosphatidylinositol-3,4,5-trisphosphate binding; C:trans-Golgi network; P:negative regulation of stress fiber assembly; F:protein binding; F:type 1 angiotensin receptor binding; C:cytoplasm; P:positive regulation of receptor recycling; P:regulation of small GTPase mediated signal transduction; F:metal ion binding; C:membrane; C:cytosol; C:cytoplasmic vesicle; P:actin filament reorganization involved in cell cycle		
tr|F6WUK1|F6WUK1_HORSE	arf-GAP with Rho-GAP ANK repeat and PH domain-containing 1 isoform X1	1455	20	0E0	92.55%	9	F:GO:0005547; P:GO:0008360; P:GO:0051497; P:GO:0007165; F:GO:0005096; P:GO:0051491; C:GO:0005794; P:GO:0051270; P:GO:0043547	F:phosphatidylinositol-3,4,5-trisphosphate binding; P:regulation of cell shape; P:negative regulation of stress fiber assembly; P:signal transduction; F:GTPase activator activity; P:positive regulation of filopodium assembly; C:Golgi apparatus; P:regulation of cellular component movement; P:positive regulation of GTPase activity		
tr|F7DMQ3|F7DMQ3_HORSE	aldose reductase	316	20	0E0	95.45%	9	C:GO:0070062; C:GO:0005737; F:GO:0016491; P:GO:0044597; F:GO:0004032; P:GO:0055114; P:GO:0044598; F:GO:0043795; C:GO:0005654	C:extracellular exosome; C:cytoplasm; F:oxidoreductase activity; P:daunorubicin metabolic process; F:alditol:NADP+ 1-oxidoreductase activity; P:oxidation-reduction process; P:doxorubicin metabolic process; F:glyceraldehyde oxidoreductase activity; C:nucleoplasm		
tr|F6VET1|F6VET1_HORSE	3-oxo-5-beta-steroid 4-dehydrogenase	326	20	0E0	95.35%	17	P:GO:0007586; P:GO:0008202; F:GO:0047787; F:GO:0005496; F:GO:0004033; P:GO:0008207; P:GO:0006699; P:GO:0008209; C:GO:0070062; P:GO:0006707; C:GO:0005737; F:GO:0016491; P:GO:0006629; P:GO:0016042; C:GO:0005829; P:GO:0055114; P:GO:0030573	P:digestion; P:steroid metabolic process; F:delta4-3-oxosteroid 5beta-reductase activity; F:steroid binding; F:aldo-keto reductase (NADP) activity; P:C21-steroid hormone metabolic process; P:bile acid biosynthetic process; P:androgen metabolic process; C:extracellular exosome; P:cholesterol catabolic process; C:cytoplasm; F:oxidoreductase activity; P:lipid metabolic process; P:lipid catabolic process; C:cytosol; P:oxidation-reduction process; P:bile acid catabolic process		
tr|F6TXZ9|F6TXZ9_HORSE	40S ribosomal S25	137	20	3.06E-82	98.75%	24	C:GO:0022627; P:GO:0034198; P:GO:0006364; P:GO:0000028; C:GO:0005730; C:GO:0005840; P:GO:0006413; C:GO:0005654; F:GO:0044822; P:GO:0006412; C:GO:0005844; P:GO:0019083; C:GO:0005634; F:GO:0005515; C:GO:0070062; F:GO:0003723; P:GO:0006614; F:GO:0003735; C:GO:0030529; P:GO:0000184; C:GO:0005737; C:GO:0005829; C:GO:0015935; C:GO:0031012	C:cytosolic small ribosomal subunit; P:cellular response to amino acid starvation; P:rRNA processing; P:ribosomal small subunit assembly; C:nucleolus; C:ribosome; P:translational initiation; C:nucleoplasm; F:poly(A) RNA binding; P:translation; C:polysome; P:viral transcription; C:nucleus; F:protein binding; C:extracellular exosome; F:RNA binding; P:SRP-dependent cotranslational protein targeting to membrane; F:structural constituent of ribosome; C:intracellular ribonucleoprotein complex; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; C:cytoplasm; C:cytosol; C:small ribosomal subunit; C:extracellular matrix		
tr|F6YLA3|F6YLA3_HORSE	thioredoxin reductase cytoplasmic isoform X1	513	20	0E0	96.8%	18	P:GO:0008283; F:GO:0016668; F:GO:0015035; F:GO:0009055; F:GO:0004791; P:GO:0045454; P:GO:0007369; C:GO:0005634; C:GO:0005623; C:GO:0070062; C:GO:0005737; F:GO:0050660; F:GO:0016491; C:GO:0005739; P:GO:0098869; C:GO:0005829; P:GO:0055114; P:GO:0001707	P:cell proliferation; F:oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor; F:protein disulfide oxidoreductase activity; F:electron carrier activity; F:thioredoxin-disulfide reductase activity; P:cell redox homeostasis; P:gastrulation; C:nucleus; C:cell; C:extracellular exosome; C:cytoplasm; F:flavin adenine dinucleotide binding; F:oxidoreductase activity; C:mitochondrion; P:cellular oxidant detoxification; C:cytosol; P:oxidation-reduction process; P:mesoderm formation		
tr|F7DNJ9|F7DNJ9_HORSE	A disintegrin and metallo ase with thrombospondin motifs 17	1088	20	0E0	91.55%	10	F:GO:0008270; F:GO:0046872; P:GO:0006508; F:GO:0008233; C:GO:0031012; C:GO:0005576; F:GO:0004222; C:GO:0005578; F:GO:0008237; F:GO:0016787	F:zinc ion binding; F:metal ion binding; P:proteolysis; F:peptidase activity; C:extracellular matrix; C:extracellular region; F:metalloendopeptidase activity; C:proteinaceous extracellular matrix; F:metallopeptidase activity; F:hydrolase activity		
tr|F7D7K7|F7D7K7_HORSE	A disintegrin and metallo ase with thrombospondin motifs 17	1093	20	0E0	91.25%	10	F:GO:0008270; F:GO:0046872; P:GO:0006508; F:GO:0008233; C:GO:0031012; C:GO:0005576; F:GO:0004222; C:GO:0005578; F:GO:0008237; F:GO:0016787	F:zinc ion binding; F:metal ion binding; P:proteolysis; F:peptidase activity; C:extracellular matrix; C:extracellular region; F:metalloendopeptidase activity; C:proteinaceous extracellular matrix; F:metallopeptidase activity; F:hydrolase activity		
tr|F6Z1U4|F6Z1U4_HORSE	glyoxalase domain-containing 4	298	20	0E0	97.4%	2	C:GO:0070062; C:GO:0005739	C:extracellular exosome; C:mitochondrion		
tr|F7DEB1|F7DEB1_HORSE	insulin-like growth factor-binding 6	237	20	1.82E-166	93.3%	8	C:GO:0005615; C:GO:0070062; P:GO:0001558; P:GO:0043567; C:GO:0005576; F:GO:0005520; F:GO:0031994; F:GO:0031995	C:extracellular space; C:extracellular exosome; P:regulation of cell growth; P:regulation of insulin-like growth factor receptor signaling pathway; C:extracellular region; F:insulin-like growth factor binding; F:insulin-like growth factor I binding; F:insulin-like growth factor II binding		
tr|F7ABF0|F7ABF0_HORSE	ATPase family AAA domain-containing 5	1857	20	0E0	91.2%	2	F:GO:0000166; F:GO:0005524	F:nucleotide binding; F:ATP binding		
tr|F7CPM7|F7CPM7_HORSE	DIS3-like exonuclease 1 isoform X2	971	20	0E0	97.65%	11	C:GO:0000177; P:GO:0090503; C:GO:0000176; C:GO:0005813; F:GO:0000175; C:GO:0005737; P:GO:0016075; P:GO:0006364; P:GO:0006402; C:GO:0005886; F:GO:0019899	C:cytoplasmic exosome (RNase complex); P:RNA phosphodiester bond hydrolysis, exonucleolytic; C:nuclear exosome (RNase complex); C:centrosome; F:3'-5'-exoribonuclease activity; C:cytoplasm; P:rRNA catabolic process; P:rRNA processing; P:mRNA catabolic process; C:plasma membrane; F:enzyme binding		
tr|F6UCT9|F6UCT9_HORSE	centrosomal of 83 kDa	304	20	0E0	96.9%	4	P:GO:0051660; C:GO:0005814; P:GO:0048278; P:GO:0042384	P:establishment of centrosome localization; C:centriole; P:vesicle docking; P:cilium assembly		
tr|F7AGH6|F7AGH6_HORSE	N-acetyl-D-glucosamine kinase	344	20	0E0	99.05%	7	C:GO:0070062; F:GO:0009384; F:GO:0045127; P:GO:0006044; P:GO:0016310; P:GO:0046835; F:GO:0016301	C:extracellular exosome; F:N-acylmannosamine kinase activity; F:N-acetylglucosamine kinase activity; P:N-acetylglucosamine metabolic process; P:phosphorylation; P:carbohydrate phosphorylation; F:kinase activity		
tr|F7E1H4|F7E1H4_HORSE	5 -nucleotidase domain-containing 1	450	20	0E0	94.5%	2	F:GO:0008253; P:GO:0016311	F:5'-nucleotidase activity; P:dephosphorylation		
tr|F6ZBL0|F6ZBL0_HORSE	centrosomal of 83 kDa	701	20	0E0	96.85%	4	P:GO:0051660; C:GO:0005814; P:GO:0048278; P:GO:0042384	P:establishment of centrosome localization; C:centriole; P:vesicle docking; P:cilium assembly		
tr|F6WHM4|F6WHM4_HORSE	sal 2 isoform X1	1018	20	0E0	96.25%	14	P:GO:0021915; P:GO:0007165; P:GO:0007275; F:GO:0044212; P:GO:0006366; F:GO:0043565; P:GO:0000122; F:GO:0003676; C:GO:0005634; P:GO:0001654; F:GO:0003700; P:GO:0045892; F:GO:0046872; C:GO:0016581	P:neural tube development; P:signal transduction; P:multicellular organism development; F:transcription regulatory region DNA binding; P:transcription from RNA polymerase II promoter; F:sequence-specific DNA binding; P:negative regulation of transcription from RNA polymerase II promoter; F:nucleic acid binding; C:nucleus; P:eye development; F:transcription factor activity, sequence-specific DNA binding; P:negative regulation of transcription, DNA-templated; F:metal ion binding; C:NuRD complex		
tr|F7CFS8|F7CFS8_HORSE	ubiquitin-like modifier-activating enzyme 7 isoform X1	1011	20	0E0	91.35%	13	P:GO:0032020; P:GO:0006464; F:GO:0008641; F:GO:0000166; F:GO:0005524; F:GO:0004842; C:GO:0005634; F:GO:0019782; C:GO:0005829; F:GO:0004839; P:GO:0019941; F:GO:0016874; P:GO:0016567	P:ISG15-protein conjugation; P:cellular protein modification process; F:small protein activating enzyme activity; F:nucleotide binding; F:ATP binding; F:ubiquitin-protein transferase activity; C:nucleus; F:ISG15 activating enzyme activity; C:cytosol; F:ubiquitin activating enzyme activity; P:modification-dependent protein catabolic process; F:ligase activity; P:protein ubiquitination		
tr|F6ZT82|F6ZT82_HORSE	desmoglein-3	983	20	0E0	90.65%	10	C:GO:0070062; F:GO:0046872; F:GO:0005509; C:GO:0016020; C:GO:0016021; C:GO:0030054; P:GO:0007155; C:GO:0030057; P:GO:0007156; C:GO:0005886	C:extracellular exosome; F:metal ion binding; F:calcium ion binding; C:membrane; C:integral component of membrane; C:cell junction; P:cell adhesion; C:desmosome; P:homophilic cell adhesion via plasma membrane adhesion molecules; C:plasma membrane		
tr|F6PYX5|F6PYX5_HORSE	CAP-Gly domain-containing linker 1 isoform X1	1429	20	0E0	96.3%	16	F:GO:0015631; C:GO:0015630; F:GO:0008270; C:GO:0035371; P:GO:0044861; C:GO:0044354; C:GO:0005881; F:GO:0008017; C:GO:0005874; C:GO:0005813; P:GO:0001578; C:GO:1990752; C:GO:0005737; C:GO:0016020; F:GO:0051010; P:GO:0031116	F:tubulin binding; C:microtubule cytoskeleton; F:zinc ion binding; C:microtubule plus-end; P:protein transport into plasma membrane raft; C:macropinosome; C:cytoplasmic microtubule; F:microtubule binding; C:microtubule; C:centrosome; P:microtubule bundle formation; C:microtubule end; C:cytoplasm; C:membrane; F:microtubule plus-end binding; P:positive regulation of microtubule polymerization		
tr|F6PYZ4|F6PYZ4_HORSE	CAP-Gly domain-containing linker 1 isoform X1	1440	20	0E0	96.25%	16	F:GO:0015631; C:GO:0015630; F:GO:0008270; C:GO:0035371; P:GO:0044861; C:GO:0044354; C:GO:0005881; F:GO:0008017; C:GO:0005874; C:GO:0005813; P:GO:0001578; C:GO:1990752; C:GO:0005737; C:GO:0016020; F:GO:0051010; P:GO:0031116	F:tubulin binding; C:microtubule cytoskeleton; F:zinc ion binding; C:microtubule plus-end; P:protein transport into plasma membrane raft; C:macropinosome; C:cytoplasmic microtubule; F:microtubule binding; C:microtubule; C:centrosome; P:microtubule bundle formation; C:microtubule end; C:cytoplasm; C:membrane; F:microtubule plus-end binding; P:positive regulation of microtubule polymerization		
tr|F7AX81|F7AX81_HORSE	T-complex 1 subunit alpha	558	20	0E0	99.1%	24	C:GO:0043209; C:GO:0005794; F:GO:0051082; P:GO:1901998; P:GO:0006457; C:GO:0002199; C:GO:0005720; F:GO:0044822; C:GO:0005874; F:GO:0000166; P:GO:2000109; C:GO:0000242; F:GO:0005524; C:GO:0005832; C:GO:0005813; P:GO:0007339; C:GO:0005856; F:GO:0031625; C:GO:0070062; C:GO:0005815; C:GO:0005737; P:GO:0044053; C:GO:0001669; C:GO:0044297	C:myelin sheath; C:Golgi apparatus; F:unfolded protein binding; P:toxin transport; P:protein folding; C:zona pellucida receptor complex; C:nuclear heterochromatin; F:poly(A) RNA binding; C:microtubule; F:nucleotide binding; P:regulation of macrophage apoptotic process; C:pericentriolar material; F:ATP binding; C:chaperonin-containing T-complex; C:centrosome; P:binding of sperm to zona pellucida; C:cytoskeleton; F:ubiquitin protein ligase binding; C:extracellular exosome; C:microtubule organizing center; C:cytoplasm; P:translocation of peptides or proteins into host cell cytoplasm; C:acrosomal vesicle; C:cell body		
tr|F7C555|F7C555_HORSE	bifunctional purine biosynthesis PURH	591	20	0E0	96.85%	24	F:GO:0042803; P:GO:0006164; P:GO:0021549; P:GO:0008152; P:GO:0003360; P:GO:0009259; P:GO:0009116; P:GO:0006189; P:GO:0009168; P:GO:0021987; P:GO:0046654; P:GO:0006139; F:GO:0004643; C:GO:0070062; F:GO:0003824; C:GO:0005739; C:GO:0016020; P:GO:0046452; F:GO:0003937; C:GO:0005829; P:GO:0031100; F:GO:0016740; P:GO:0010035; F:GO:0016787	F:protein homodimerization activity; P:purine nucleotide biosynthetic process; P:cerebellum development; P:metabolic process; P:brainstem development; P:ribonucleotide metabolic process; P:nucleoside metabolic process; P:'de novo' IMP biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process; P:cerebral cortex development; P:tetrahydrofolate biosynthetic process; P:nucleobase-containing compound metabolic process; F:phosphoribosylaminoimidazolecarboxamide formyltransferase activity; C:extracellular exosome; F:catalytic activity; C:mitochondrion; C:membrane; P:dihydrofolate metabolic process; F:IMP cyclohydrolase activity; C:cytosol; P:animal organ regeneration; F:transferase activity; P:response to inorganic substance; F:hydrolase activity		
tr|F6UES9|F6UES9_HORSE	sciellin isoform X1	687	20	0E0	89.9%	7	P:GO:0009790; P:GO:0030216; F:GO:0008270; C:GO:0070062; C:GO:0005737; F:GO:0046872; P:GO:0008544	P:embryo development; P:keratinocyte differentiation; F:zinc ion binding; C:extracellular exosome; C:cytoplasm; F:metal ion binding; P:epidermis development		
tr|F6U8R0|F6U8R0_HORSE	sciellin isoform X1	667	20	0E0	87.85%	10	P:GO:0009790; P:GO:0030216; C:GO:0001533; F:GO:0008270; F:GO:0005515; C:GO:0070062; C:GO:0005737; F:GO:0046872; C:GO:0016020; P:GO:0008544	P:embryo development; P:keratinocyte differentiation; C:cornified envelope; F:zinc ion binding; F:protein binding; C:extracellular exosome; C:cytoplasm; F:metal ion binding; C:membrane; P:epidermis development		
tr|F6QDP0|F6QDP0_HORSE	ATP-citrate synthase isoform X1	1110	20	0E0	99.05%	26	P:GO:0006084; P:GO:0006085; P:GO:0006101; F:GO:0046912; C:GO:0005654; F:GO:0000166; F:GO:0005524; C:GO:0070062; F:GO:0003824; P:GO:0035338; C:GO:0005829; P:GO:0008152; P:GO:0008610; P:GO:0006695; P:GO:0006633; C:GO:0005886; P:GO:0006107; F:GO:0005515; F:GO:0003878; F:GO:0046872; F:GO:0048037; C:GO:0005737; C:GO:0016020; P:GO:0006629; F:GO:0016740; P:GO:0031325	P:acetyl-CoA metabolic process; P:acetyl-CoA biosynthetic process; P:citrate metabolic process; F:transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer; C:nucleoplasm; F:nucleotide binding; F:ATP binding; C:extracellular exosome; F:catalytic activity; P:long-chain fatty-acyl-CoA biosynthetic process; C:cytosol; P:metabolic process; P:lipid biosynthetic process; P:cholesterol biosynthetic process; P:fatty acid biosynthetic process; C:plasma membrane; P:oxaloacetate metabolic process; F:protein binding; F:ATP citrate synthase activity; F:metal ion binding; F:cofactor binding; C:cytoplasm; C:membrane; P:lipid metabolic process; F:transferase activity; P:positive regulation of cellular metabolic process		
tr|F6U3I9|F6U3I9_HORSE	interferon-induced very large GTPase 1-like	2428	20	0E0	91.15%	1	F:GO:0005525	F:GTP binding		
tr|F7DRS2|F7DRS2_HORSE	corticosteroid-binding globulin	404	20	0E0	81.7%	9	C:GO:0005615; F:GO:0004867; C:GO:0070062; P:GO:0010951; F:GO:0008289; P:GO:0008211; F:GO:0005496; C:GO:0005576; P:GO:0006810	C:extracellular space; F:serine-type endopeptidase inhibitor activity; C:extracellular exosome; P:negative regulation of endopeptidase activity; F:lipid binding; P:glucocorticoid metabolic process; F:steroid binding; C:extracellular region; P:transport		
tr|F6WKM3|F6WKM3_HORSE	src substrate cortactin isoform X2	511	20	0E0	95.15%	40	P:GO:1903146; P:GO:0048812; C:GO:0005794; P:GO:0006886; C:GO:0042995; P:GO:0045987; C:GO:0002102; C:GO:0030426; C:GO:1990023; C:GO:0030425; C:GO:0070062; C:GO:0005925; C:GO:0005905; C:GO:0043231; C:GO:0043197; C:GO:0001726; P:GO:0048041; P:GO:0031532; C:GO:0030027; C:GO:0030863; C:GO:0008076; P:GO:0030041; C:GO:0005884; P:GO:0006930; P:GO:0006897; P:GO:0097062; P:GO:0006898; C:GO:0005886; F:GO:0005522; P:GO:0097581; P:GO:0048870; P:GO:0030516; F:GO:0005515; C:GO:0005856; C:GO:0005737; C:GO:0005938; C:GO:0016020; P:GO:0030838; P:GO:2001237; C:GO:0030054	P:regulation of mitophagy; P:neuron projection morphogenesis; C:Golgi apparatus; P:intracellular protein transport; C:cell projection; P:positive regulation of smooth muscle contraction; C:podosome; C:growth cone; C:mitotic spindle midzone; C:dendrite; C:extracellular exosome; C:focal adhesion; C:clathrin-coated pit; C:intracellular membrane-bounded organelle; C:dendritic spine; C:ruffle; P:focal adhesion assembly; P:actin cytoskeleton reorganization; C:lamellipodium; C:cortical cytoskeleton; C:voltage-gated potassium channel complex; P:actin filament polymerization; C:actin filament; P:substrate-dependent cell migration, cell extension; P:endocytosis; P:dendritic spine maintenance; P:receptor-mediated endocytosis; C:plasma membrane; F:profilin binding; P:lamellipodium organization; P:cell motility; P:regulation of axon extension; F:protein binding; C:cytoskeleton; C:cytoplasm; C:cell cortex; C:membrane; P:positive regulation of actin filament polymerization; P:negative regulation of extrinsic apoptotic signaling pathway; C:cell junction		
tr|F6X4S0|F6X4S0_HORSE	src substrate cortactin isoform X1	551	20	0E0	95.15%	40	P:GO:1903146; P:GO:0048812; C:GO:0005794; P:GO:0006886; C:GO:0042995; P:GO:0045987; C:GO:0002102; C:GO:0030426; C:GO:1990023; C:GO:0030425; C:GO:0070062; C:GO:0005925; C:GO:0005905; C:GO:0043231; C:GO:0043197; C:GO:0001726; P:GO:0048041; P:GO:0031532; C:GO:0030027; C:GO:0030863; C:GO:0008076; P:GO:0030041; C:GO:0005884; P:GO:0006897; P:GO:0006930; P:GO:0097062; P:GO:0006898; C:GO:0005886; F:GO:0005522; P:GO:0097581; P:GO:0048870; P:GO:0030516; F:GO:0005515; C:GO:0005856; C:GO:0005737; C:GO:0005938; C:GO:0016020; P:GO:0030838; P:GO:2001237; C:GO:0030054	P:regulation of mitophagy; P:neuron projection morphogenesis; C:Golgi apparatus; P:intracellular protein transport; C:cell projection; P:positive regulation of smooth muscle contraction; C:podosome; C:growth cone; C:mitotic spindle midzone; C:dendrite; C:extracellular exosome; C:focal adhesion; C:clathrin-coated pit; C:intracellular membrane-bounded organelle; C:dendritic spine; C:ruffle; P:focal adhesion assembly; P:actin cytoskeleton reorganization; C:lamellipodium; C:cortical cytoskeleton; C:voltage-gated potassium channel complex; P:actin filament polymerization; C:actin filament; P:endocytosis; P:substrate-dependent cell migration, cell extension; P:dendritic spine maintenance; P:receptor-mediated endocytosis; C:plasma membrane; F:profilin binding; P:lamellipodium organization; P:cell motility; P:regulation of axon extension; F:protein binding; C:cytoskeleton; C:cytoplasm; C:cell cortex; C:membrane; P:positive regulation of actin filament polymerization; P:negative regulation of extrinsic apoptotic signaling pathway; C:cell junction		
tr|F6QXE4|F6QXE4_HORSE	neural cell adhesion molecule L1 isoform X2	1209	20	0E0	96.65%	13	P:GO:0035640; P:GO:0031175; P:GO:0007411; F:GO:0002020; P:GO:0008344; P:GO:0043524; C:GO:0030425; P:GO:0001764; C:GO:0070062; P:GO:0050890; C:GO:0045177; C:GO:0016020; C:GO:0016021	P:exploration behavior; P:neuron projection development; P:axon guidance; F:protease binding; P:adult locomotory behavior; P:negative regulation of neuron apoptotic process; C:dendrite; P:neuron migration; C:extracellular exosome; P:cognition; C:apical part of cell; C:membrane; C:integral component of membrane		
tr|F7CSM4|F7CSM4_HORSE	calpastatin isoform X5	728	20	0E0	97.85%	6	C:GO:0005737; C:GO:0016020; P:GO:2000675; C:GO:0005829; C:GO:0005783; F:GO:0044822	C:cytoplasm; C:membrane; P:negative regulation of type B pancreatic cell apoptotic process; C:cytosol; C:endoplasmic reticulum; F:poly(A) RNA binding		
tr|F7C625|F7C625_HORSE	calpastatin isoform X4	771	20	0E0	95.35%	6	C:GO:0005737; C:GO:0016020; P:GO:2000675; C:GO:0005829; C:GO:0005783; F:GO:0044822	C:cytoplasm; C:membrane; P:negative regulation of type B pancreatic cell apoptotic process; C:cytosol; C:endoplasmic reticulum; F:poly(A) RNA binding		
tr|F7C6E3|F7C6E3_HORSE	calpastatin isoform X5	699	20	0E0	97.85%	6	C:GO:0005737; C:GO:0016020; P:GO:2000675; C:GO:0005829; C:GO:0005783; F:GO:0044822	C:cytoplasm; C:membrane; P:negative regulation of type B pancreatic cell apoptotic process; C:cytosol; C:endoplasmic reticulum; F:poly(A) RNA binding		
tr|F6PZP5|F6PZP5_HORSE	carcinoembryonic antigen-related cell adhesion molecule 1-like isoform X1	521	20	0E0	88%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		
tr|F6T1X0|F6T1X0_HORSE	carcinoembryonic antigen-related cell adhesion molecule 1-like isoform X1	370	20	0E0	90.4%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		
tr|F6V278|F6V278_HORSE	ubiquitin carboxyl-terminal hydrolase 14 isoform X1	494	20	0E0	99%	33	P:GO:0061136; F:GO:0070628; P:GO:0051492; C:GO:0045202; P:GO:0006468; F:GO:0000166; F:GO:0005524; C:GO:0070062; P:GO:0010951; P:GO:0016310; F:GO:0017048; F:GO:0017049; P:GO:0035556; P:GO:2000114; P:GO:0016579; P:GO:0007268; F:GO:0004672; P:GO:0007266; F:GO:0004674; C:GO:0005622; C:GO:0009986; P:GO:0006511; F:GO:0004843; F:GO:0004866; F:GO:0046872; C:GO:0005737; P:GO:0051493; C:GO:0016023; F:GO:0016740; P:GO:0050920; F:GO:0016301; P:GO:1903070; F:GO:0036459	P:regulation of proteasomal protein catabolic process; F:proteasome binding; P:regulation of stress fiber assembly; C:synapse; P:protein phosphorylation; F:nucleotide binding; F:ATP binding; C:extracellular exosome; P:negative regulation of endopeptidase activity; P:phosphorylation; F:Rho GTPase binding; F:GTP-Rho binding; P:intracellular signal transduction; P:regulation of establishment of cell polarity; P:protein deubiquitination; P:chemical synaptic transmission; F:protein kinase activity; P:Rho protein signal transduction; F:protein serine/threonine kinase activity; C:intracellular; C:cell surface; P:ubiquitin-dependent protein catabolic process; F:thiol-dependent ubiquitin-specific protease activity; F:endopeptidase inhibitor activity; F:metal ion binding; C:cytoplasm; P:regulation of cytoskeleton organization; C:cytoplasmic, membrane-bounded vesicle; F:transferase activity; P:regulation of chemotaxis; F:kinase activity; P:negative regulation of ER-associated ubiquitin-dependent protein catabolic process; F:thiol-dependent ubiquitinyl hydrolase activity		
tr|F6ZI08|F6ZI08_HORSE	tetraspanin-1	176	20	9.34E-122	85.5%	13	P:GO:0008283; P:GO:0045807; P:GO:0007166; C:GO:0005886; C:GO:0005887; C:GO:0070062; C:GO:0048471; C:GO:0005737; C:GO:0016020; C:GO:0016021; C:GO:0031982; P:GO:0050821; P:GO:0016477	P:cell proliferation; P:positive regulation of endocytosis; P:cell surface receptor signaling pathway; C:plasma membrane; C:integral component of plasma membrane; C:extracellular exosome; C:perinuclear region of cytoplasm; C:cytoplasm; C:membrane; C:integral component of membrane; C:vesicle; P:protein stabilization; P:cell migration		
tr|F6V9C9|F6V9C9_HORSE	caspase-7	302	20	0E0	93.7%	15	F:GO:0004190; F:GO:0004197; F:GO:0008234; P:GO:0009411; F:GO:0008233; P:GO:0097194; F:GO:0097153; P:GO:0007507; F:GO:0097200; C:GO:0005737; P:GO:0006508; P:GO:0006915; P:GO:0016485; P:GO:0051402; F:GO:0016787	F:aspartic-type endopeptidase activity; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; P:response to UV; F:peptidase activity; P:execution phase of apoptosis; F:cysteine-type endopeptidase activity involved in apoptotic process; P:heart development; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; C:cytoplasm; P:proteolysis; P:apoptotic process; P:protein processing; P:neuron apoptotic process; F:hydrolase activity		
tr|F7CFN5|F7CFN5_HORSE	complement component C8 alpha chain	548	20	0E0	90.95%	5	P:GO:0006956; C:GO:0005579; P:GO:0006955; C:GO:0070062; C:GO:0072562	P:complement activation; C:membrane attack complex; P:immune response; C:extracellular exosome; C:blood microparticle		
tr|F6X756|F6X756_HORSE	elongation factor 1-beta	159	20	3.87E-109	100%	9	C:GO:0005634; F:GO:0005515; F:GO:0003746; C:GO:0005737; C:GO:0005829; C:GO:0005783; P:GO:0006414; C:GO:0005853; P:GO:0006412	C:nucleus; F:protein binding; F:translation elongation factor activity; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; P:translational elongation; C:eukaryotic translation elongation factor 1 complex; P:translation		
tr|F6ZPS6|F6ZPS6_HORSE	breast carcinoma-amplified sequence 1 isoform X1	569	20	0E0	88.45%	1	C:GO:0070062	C:extracellular exosome		
tr|F7D7Q9|F7D7Q9_HORSE	interferon-induced transmembrane 1-like	126	20	2.16E-89	90.45%	3	P:GO:0009607; C:GO:0016020; C:GO:0016021	P:response to biotic stimulus; C:membrane; C:integral component of membrane		
tr|F6RQE8|F6RQE8_HORSE	interferon-induced transmembrane 3-like	121	20	1.25E-73	89.45%	3	P:GO:0009607; C:GO:0016020; C:GO:0016021	P:response to biotic stimulus; C:membrane; C:integral component of membrane		
tr|F6WCY9|F6WCY9_HORSE	ribonuclease inhibitor isoform X2	456	20	0E0	92.1%	7	C:GO:0070062; F:GO:0008428; P:GO:0043086; C:GO:0005737; C:GO:0032311; P:GO:0045765; C:GO:0005654	C:extracellular exosome; F:ribonuclease inhibitor activity; P:negative regulation of catalytic activity; C:cytoplasm; C:angiogenin-PRI complex; P:regulation of angiogenesis; C:nucleoplasm		
tr|F7AJP3|F7AJP3_HORSE	chitotriosidase-1 isoform X3	600	20	0E0	92.1%	24	F:GO:0008061; P:GO:0006032; P:GO:0007250; P:GO:0006030; C:GO:0005783; F:GO:0004553; C:GO:0005576; P:GO:0045766; F:GO:0008843; P:GO:0009612; F:GO:0004568; P:GO:0005975; C:GO:0005615; P:GO:0006954; C:GO:0005737; P:GO:0070374; P:GO:0070555; P:GO:0071356; P:GO:0010800; P:GO:0070741; P:GO:0072606; P:GO:0051897; P:GO:0034612; P:GO:0030324	F:chitin binding; P:chitin catabolic process; P:activation of NF-kappaB-inducing kinase activity; P:chitin metabolic process; C:endoplasmic reticulum; F:hydrolase activity, hydrolyzing O-glycosyl compounds; C:extracellular region; P:positive regulation of angiogenesis; F:endochitinase activity; P:response to mechanical stimulus; F:chitinase activity; P:carbohydrate metabolic process; C:extracellular space; P:inflammatory response; C:cytoplasm; P:positive regulation of ERK1 and ERK2 cascade; P:response to interleukin-1; P:cellular response to tumor necrosis factor; P:positive regulation of peptidyl-threonine phosphorylation; P:response to interleukin-6; P:interleukin-8 secretion; P:positive regulation of protein kinase B signaling; P:response to tumor necrosis factor; P:lung development		
tr|F6SUP2|F6SUP2_HORSE	secretoglobin family 1D member-like	82	20	5.97E-51	74.8%	2	P:GO:0007165; C:GO:0005576	P:signal transduction; C:extracellular region		
tr|F7ALC9|F7ALC9_HORSE	annexin A7 isoform X2	466	20	0E0	96%	24	P:GO:0008283; P:GO:0008360; P:GO:0035176; P:GO:0009651; P:GO:0009992; F:GO:0048306; C:GO:0042584; F:GO:0005178; P:GO:0007599; C:GO:0005886; F:GO:0044822; F:GO:0005544; P:GO:0006874; C:GO:0005789; C:GO:0005635; P:GO:0030855; P:GO:0010629; C:GO:0005634; C:GO:0070062; P:GO:0006914; F:GO:0005509; C:GO:0016020; C:GO:0005829; C:GO:0031982	P:cell proliferation; P:regulation of cell shape; P:social behavior; P:response to salt stress; P:cellular water homeostasis; F:calcium-dependent protein binding; C:chromaffin granule membrane; F:integrin binding; P:hemostasis; C:plasma membrane; F:poly(A) RNA binding; F:calcium-dependent phospholipid binding; P:cellular calcium ion homeostasis; C:endoplasmic reticulum membrane; C:nuclear envelope; P:epithelial cell differentiation; P:negative regulation of gene expression; C:nucleus; C:extracellular exosome; P:autophagy; F:calcium ion binding; C:membrane; C:cytosol; C:vesicle		
tr|F6VSH5|F6VSH5_HORSE	WAP four-disulfide core domain 18-like	46	20	1.67E-21	75.6%	22	P:GO:0007186; P:GO:0050729; C:GO:0005576; F:GO:0008009; F:GO:0005125; P:GO:0042742; P:GO:0043547; P:GO:0006935; F:GO:0030414; C:GO:0005615; P:GO:0006954; P:GO:0006955; F:GO:0048020; P:GO:0048247; P:GO:0002548; P:GO:0070098; P:GO:0070374; P:GO:0071347; P:GO:0030593; P:GO:0071356; P:GO:0071346; P:GO:0010466	P:G-protein coupled receptor signaling pathway; P:positive regulation of inflammatory response; C:extracellular region; F:chemokine activity; F:cytokine activity; P:defense response to bacterium; P:positive regulation of GTPase activity; P:chemotaxis; F:peptidase inhibitor activity; C:extracellular space; P:inflammatory response; P:immune response; F:CCR chemokine receptor binding; P:lymphocyte chemotaxis; P:monocyte chemotaxis; P:chemokine-mediated signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:cellular response to interleukin-1; P:neutrophil chemotaxis; P:cellular response to tumor necrosis factor; P:cellular response to interferon-gamma; P:negative regulation of peptidase activity		
tr|F6PR72|F6PR72_HORSE	secretoglobin family 1D member-like	82	20	3.52E-52	80.85%	2	P:GO:0007165; C:GO:0005576	P:signal transduction; C:extracellular region		
tr|F6YF95|F6YF95_HORSE	cellular nucleic acid-binding isoform X3	170	20	1.35E-120	99.15%	19	F:GO:0008270; P:GO:0006351; P:GO:0008284; P:GO:0006695; P:GO:0006355; C:GO:0005783; P:GO:0045944; F:GO:0044822; F:GO:0003697; F:GO:0003676; F:GO:0003677; C:GO:0005634; F:GO:0003700; F:GO:0005515; C:GO:0005737; F:GO:0046872; P:GO:0045893; F:GO:0003727; C:GO:0005829	F:zinc ion binding; P:transcription, DNA-templated; P:positive regulation of cell proliferation; P:cholesterol biosynthetic process; P:regulation of transcription, DNA-templated; C:endoplasmic reticulum; P:positive regulation of transcription from RNA polymerase II promoter; F:poly(A) RNA binding; F:single-stranded DNA binding; F:nucleic acid binding; F:DNA binding; C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:protein binding; C:cytoplasm; F:metal ion binding; P:positive regulation of transcription, DNA-templated; F:single-stranded RNA binding; C:cytosol		
sp|P0DN28|APOC3_HORSE	apolipo C-III	97	20	8.48E-63	79.9%	38	P:GO:0034375; P:GO:0006641; F:GO:0008289; P:GO:0042157; C:GO:0005576; P:GO:0042632; P:GO:0060621; P:GO:0010916; P:GO:0051005; C:GO:0070062; P:GO:0010897; F:GO:0055102; C:GO:0034366; P:GO:0070328; P:GO:0048261; P:GO:0050995; P:GO:0032489; C:GO:0034361; P:GO:0045717; P:GO:0034382; C:GO:0042627; P:GO:0007186; C:GO:0034363; F:GO:0005543; P:GO:0006810; P:GO:0045833; P:GO:0006869; C:GO:0005615; P:GO:0010989; P:GO:0010903; P:GO:0016042; P:GO:0006629; P:GO:0033344; P:GO:0010987; P:GO:0019433; F:GO:0070653; F:GO:0030234; P:GO:0033700	P:high-density lipoprotein particle remodeling; P:triglyceride metabolic process; F:lipid binding; P:lipoprotein metabolic process; C:extracellular region; P:cholesterol homeostasis; P:negative regulation of cholesterol import; P:negative regulation of very-low-density lipoprotein particle clearance; P:negative regulation of lipoprotein lipase activity; C:extracellular exosome; P:negative regulation of triglyceride catabolic process; F:lipase inhibitor activity; C:spherical high-density lipoprotein particle; P:triglyceride homeostasis; P:negative regulation of receptor-mediated endocytosis; P:negative regulation of lipid catabolic process; P:regulation of Cdc42 protein signal transduction; C:very-low-density lipoprotein particle; P:negative regulation of fatty acid biosynthetic process; P:chylomicron remnant clearance; C:chylomicron; P:G-protein coupled receptor signaling pathway; C:intermediate-density lipoprotein particle; F:phospholipid binding; P:transport; P:negative regulation of lipid metabolic process; P:lipid transport; C:extracellular space; P:negative regulation of low-density lipoprotein particle clearance; P:negative regulation of very-low-density lipoprotein particle remodeling; P:lipid catabolic process; P:lipid metabolic process; P:cholesterol efflux; P:negative regulation of high-density lipoprotein particle clearance; P:triglyceride catabolic process; F:high-density lipoprotein particle receptor binding; F:enzyme regulator activity; P:phospholipid efflux		
sp|O18999|IL1RA_HORSE	interleukin-1 receptor antagonist isoform X1	177	20	1.16E-130	93.75%	19	F:GO:0005150; P:GO:0030073; F:GO:0005152; F:GO:0005151; C:GO:0005576; F:GO:0005125; P:GO:0006953; F:GO:0005149; P:GO:0001960; C:GO:0005615; C:GO:0070062; F:GO:0045353; P:GO:0019221; F:GO:0045352; P:GO:0006629; P:GO:0051384; C:GO:0031982; P:GO:0034115; P:GO:2000660	F:interleukin-1, Type I receptor binding; P:insulin secretion; F:interleukin-1 receptor antagonist activity; F:interleukin-1, Type II receptor binding; C:extracellular region; F:cytokine activity; P:acute-phase response; F:interleukin-1 receptor binding; P:negative regulation of cytokine-mediated signaling pathway; C:extracellular space; C:extracellular exosome; F:interleukin-1 Type II receptor antagonist activity; P:cytokine-mediated signaling pathway; F:interleukin-1 Type I receptor antagonist activity; P:lipid metabolic process; P:response to glucocorticoid; C:vesicle; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of interleukin-1-mediated signaling pathway		
tr|A0A140TAU8|A0A140TAU8_HORSE	interleukin-1 receptor antagonist isoform X1	177	20	1.37E-130	93.55%	19	F:GO:0005150; P:GO:0030073; F:GO:0005152; F:GO:0005151; C:GO:0005576; F:GO:0005125; P:GO:0006953; F:GO:0005149; P:GO:0001960; C:GO:0005615; C:GO:0070062; F:GO:0045353; P:GO:0019221; F:GO:0045352; P:GO:0006629; P:GO:0051384; C:GO:0031982; P:GO:0034115; P:GO:2000660	F:interleukin-1, Type I receptor binding; P:insulin secretion; F:interleukin-1 receptor antagonist activity; F:interleukin-1, Type II receptor binding; C:extracellular region; F:cytokine activity; P:acute-phase response; F:interleukin-1 receptor binding; P:negative regulation of cytokine-mediated signaling pathway; C:extracellular space; C:extracellular exosome; F:interleukin-1 Type II receptor antagonist activity; P:cytokine-mediated signaling pathway; F:interleukin-1 Type I receptor antagonist activity; P:lipid metabolic process; P:response to glucocorticoid; C:vesicle; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of interleukin-1-mediated signaling pathway		
tr|F7CIW5|F7CIW5_HORSE	epididymal secretory E1	149	20	7.45E-105	91.65%	16	F:GO:0015485; P:GO:0008203; P:GO:0008202; C:GO:0005783; C:GO:0005576; P:GO:0009615; P:GO:0042632; C:GO:0005764; F:GO:0005515; C:GO:0070062; P:GO:0006629; P:GO:0032366; P:GO:0032367; P:GO:0033344; P:GO:0030301; F:GO:0019899	F:cholesterol binding; P:cholesterol metabolic process; P:steroid metabolic process; C:endoplasmic reticulum; C:extracellular region; P:response to virus; P:cholesterol homeostasis; C:lysosome; F:protein binding; C:extracellular exosome; P:lipid metabolic process; P:intracellular sterol transport; P:intracellular cholesterol transport; P:cholesterol efflux; P:cholesterol transport; F:enzyme binding		
tr|F6S4R4|F6S4R4_HORSE	S-phase kinase-associated 1	163	20	3.48E-115	99.95%	31	F:GO:0061630; P:GO:0038095; C:GO:0005654; P:GO:0002223; C:GO:0070062; P:GO:0000086; P:GO:0035518; C:GO:0031519; F:GO:0097602; C:GO:0005829; P:GO:0016055; P:GO:0000080; C:GO:0019005; P:GO:0016310; P:GO:0050852; P:GO:0051403; P:GO:0000209; P:GO:0038061; F:GO:0008013; P:GO:0006511; F:GO:0004842; C:GO:0005634; P:GO:0043161; C:GO:0005813; F:GO:0005515; C:GO:0005737; P:GO:0031146; P:GO:0051437; F:GO:0016301; P:GO:0016567; C:GO:0031467	F:ubiquitin protein ligase activity; P:Fc-epsilon receptor signaling pathway; C:nucleoplasm; P:stimulatory C-type lectin receptor signaling pathway; C:extracellular exosome; P:G2/M transition of mitotic cell cycle; P:histone H2A monoubiquitination; C:PcG protein complex; F:cullin family protein binding; C:cytosol; P:Wnt signaling pathway; P:mitotic G1 phase; C:SCF ubiquitin ligase complex; P:phosphorylation; P:T cell receptor signaling pathway; P:stress-activated MAPK cascade; P:protein polyubiquitination; P:NIK/NF-kappaB signaling; F:beta-catenin binding; P:ubiquitin-dependent protein catabolic process; F:ubiquitin-protein transferase activity; C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:centrosome; F:protein binding; C:cytoplasm; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition; F:kinase activity; P:protein ubiquitination; C:Cul7-RING ubiquitin ligase complex		
tr|F6UY34|F6UY34_HORSE	-glutamate O-methyltransferase	441	20	0E0	94.3%	9	P:GO:2001020; F:GO:0008168; F:GO:0016740; F:GO:0008757; P:GO:0006479; P:GO:0006974; F:GO:0051998; F:GO:0019899; P:GO:0032259	P:regulation of response to DNA damage stimulus; F:methyltransferase activity; F:transferase activity; F:S-adenosylmethionine-dependent methyltransferase activity; P:protein methylation; P:cellular response to DNA damage stimulus; F:protein carboxyl O-methyltransferase activity; F:enzyme binding; P:methylation		
sp|Q9N0T3|CALCB_HORSE	calcitonin gene-related peptide 2 isoform X2	129	20	1.36E-87	92.3%	2	C:GO:0005576; F:GO:0005179	C:extracellular region; F:hormone activity		
tr|F6X3S7|F6X3S7_HORSE	UV excision repair RAD23 homolog B	386	20	0E0	97.45%	12	C:GO:0005634; P:GO:0043161; C:GO:0005737; F:GO:0031593; P:GO:0007283; P:GO:0000715; C:GO:0071942; P:GO:0006289; P:GO:0006974; F:GO:0003684; P:GO:0032434; C:GO:0005654	C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:cytoplasm; F:polyubiquitin binding; P:spermatogenesis; P:nucleotide-excision repair, DNA damage recognition; C:XPC complex; P:nucleotide-excision repair; P:cellular response to DNA damage stimulus; F:damaged DNA binding; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; C:nucleoplasm		
tr|F6Q2E5|F6Q2E5_HORSE	STE20-like serine threonine- kinase isoform X1	1242	20	0E0	95.4%	12	F:GO:0000166; F:GO:0005524; F:GO:0042802; F:GO:0004702; F:GO:0042803; C:GO:0070062; C:GO:0005737; P:GO:0046777; F:GO:0004672; F:GO:0004674; P:GO:0006468; P:GO:0023014	F:nucleotide binding; F:ATP binding; F:identical protein binding; F:receptor signaling protein serine/threonine kinase activity; F:protein homodimerization activity; C:extracellular exosome; C:cytoplasm; P:protein autophosphorylation; F:protein kinase activity; F:protein serine/threonine kinase activity; P:protein phosphorylation; P:signal transduction by protein phosphorylation		
tr|F6VTV5|F6VTV5_HORSE	mannose-1-phosphate guanyltransferase beta	291	20	0E0	99.05%	11	F:GO:0000166; F:GO:0005525; F:GO:0016779; F:GO:0005515; C:GO:0070062; C:GO:0005737; P:GO:0009298; C:GO:0005739; P:GO:0009058; F:GO:0016740; F:GO:0004475	F:nucleotide binding; F:GTP binding; F:nucleotidyltransferase activity; F:protein binding; C:extracellular exosome; C:cytoplasm; P:GDP-mannose biosynthetic process; C:mitochondrion; P:biosynthetic process; F:transferase activity; F:mannose-1-phosphate guanylyltransferase activity		
tr|F6ZY40|F6ZY40_HORSE	lamin	663	20	0E0	99.05%	35	P:GO:0036498; P:GO:0007077; C:GO:0016607; P:GO:1904178; F:GO:0005198; P:GO:0045669; C:GO:0005652; P:GO:0009612; C:GO:0005654; P:GO:0006998; C:GO:0005829; P:GO:0071456; P:GO:0034504; P:GO:0007084; P:GO:0090201; P:GO:0007283; P:GO:0090343; C:GO:0005882; F:GO:0008157; P:GO:0006997; C:GO:0005635; P:GO:0007517; C:GO:0005634; C:GO:0031965; C:GO:0048471; F:GO:0005515; C:GO:0005737; C:GO:0005638; C:GO:0016363; P:GO:2001237; P:GO:0055015; P:GO:0030334; P:GO:0035105; P:GO:1900180; P:GO:0030951	P:IRE1-mediated unfolded protein response; P:mitotic nuclear envelope disassembly; C:nuclear speck; P:negative regulation of adipose tissue development; F:structural molecule activity; P:positive regulation of osteoblast differentiation; C:nuclear lamina; P:response to mechanical stimulus; C:nucleoplasm; P:nuclear envelope organization; C:cytosol; P:cellular response to hypoxia; P:protein localization to nucleus; P:mitotic nuclear envelope reassembly; P:negative regulation of release of cytochrome c from mitochondria; P:spermatogenesis; P:positive regulation of cell aging; C:intermediate filament; F:protein phosphatase 1 binding; P:nucleus organization; C:nuclear envelope; P:muscle organ development; C:nucleus; C:nuclear membrane; C:perinuclear region of cytoplasm; F:protein binding; C:cytoplasm; C:lamin filament; C:nuclear matrix; P:negative regulation of extrinsic apoptotic signaling pathway; P:ventricular cardiac muscle cell development; P:regulation of cell migration; P:sterol regulatory element binding protein import into nucleus; P:regulation of protein localization to nucleus; P:establishment or maintenance of microtubule cytoskeleton polarity		
tr|F6SGS9|F6SGS9_HORSE	chymotrypsin-like elastase family member 1	266	20	0E0	94.1%	22	P:GO:0035264; P:GO:0061113; P:GO:0009791; F:GO:0004252; F:GO:0008236; F:GO:0008233; C:GO:0005576; P:GO:0045944; P:GO:0045766; P:GO:0042127; P:GO:0048771; P:GO:0000122; C:GO:0005615; P:GO:0006954; P:GO:0045595; P:GO:0060309; F:GO:0046872; P:GO:0006508; P:GO:0055123; P:GO:0016055; P:GO:0031017; F:GO:0016787	P:multicellular organism growth; P:pancreas morphogenesis; P:post-embryonic development; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:peptidase activity; C:extracellular region; P:positive regulation of transcription from RNA polymerase II promoter; P:positive regulation of angiogenesis; P:regulation of cell proliferation; P:tissue remodeling; P:negative regulation of transcription from RNA polymerase II promoter; C:extracellular space; P:inflammatory response; P:regulation of cell differentiation; P:elastin catabolic process; F:metal ion binding; P:proteolysis; P:digestive system development; P:Wnt signaling pathway; P:exocrine pancreas development; F:hydrolase activity		
tr|F6YKL4|F6YKL4_HORSE	myotrophin	118	20	4.02E-81	99.25%	25	F:GO:0043565; P:GO:0006584; C:GO:0005575; P:GO:0051092; P:GO:0043403; P:GO:0006417; P:GO:0051247; P:GO:0030307; C:GO:0070062; P:GO:0051146; P:GO:2000812; C:GO:0005829; P:GO:0010613; P:GO:0010557; C:GO:0030424; P:GO:0021707; P:GO:0030182; C:GO:0005634; P:GO:0071260; C:GO:0048471; F:GO:0005515; C:GO:0005737; C:GO:0008290; P:GO:0016202; P:GO:0016049	F:sequence-specific DNA binding; P:catecholamine metabolic process; C:cellular_component; P:positive regulation of NF-kappaB transcription factor activity; P:skeletal muscle tissue regeneration; P:regulation of translation; P:positive regulation of protein metabolic process; P:positive regulation of cell growth; C:extracellular exosome; P:striated muscle cell differentiation; P:regulation of barbed-end actin filament capping; C:cytosol; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of macromolecule biosynthetic process; C:axon; P:cerebellar granule cell differentiation; P:neuron differentiation; C:nucleus; P:cellular response to mechanical stimulus; C:perinuclear region of cytoplasm; F:protein binding; C:cytoplasm; C:F-actin capping protein complex; P:regulation of striated muscle tissue development; P:cell growth		
tr|F6XWJ6|F6XWJ6_HORSE	RUN and FYVE domain-containing 1	600	20	0E0	97.15%	15	F:GO:0008270; P:GO:0015031; F:GO:0008565; F:GO:0008289; P:GO:0006897; P:GO:0006810; C:GO:0031901; C:GO:0005634; C:GO:0005768; F:GO:0005515; C:GO:0005737; F:GO:0046872; C:GO:0043231; C:GO:0016020; P:GO:0030100	F:zinc ion binding; P:protein transport; F:protein transporter activity; F:lipid binding; P:endocytosis; P:transport; C:early endosome membrane; C:nucleus; C:endosome; F:protein binding; C:cytoplasm; F:metal ion binding; C:intracellular membrane-bounded organelle; C:membrane; P:regulation of endocytosis		
tr|F6W1S0|F6W1S0_HORSE	resistin	68	20	8.83E-42	92.4%	16	P:GO:0008150; P:GO:2000252; P:GO:0050806; P:GO:0045444; C:GO:0005576; P:GO:0007568; F:GO:0005179; P:GO:0009612; P:GO:0048661; C:GO:0005634; C:GO:0005615; P:GO:0032868; C:GO:0070062; P:GO:0010714; P:GO:0014911; P:GO:2000872	P:biological_process; P:negative regulation of feeding behavior; P:positive regulation of synaptic transmission; P:fat cell differentiation; C:extracellular region; P:aging; F:hormone activity; P:response to mechanical stimulus; P:positive regulation of smooth muscle cell proliferation; C:nucleus; C:extracellular space; P:response to insulin; C:extracellular exosome; P:positive regulation of collagen metabolic process; P:positive regulation of smooth muscle cell migration; P:positive regulation of progesterone secretion		
tr|F6R3X8|F6R3X8_HORSE	brain acid soluble 1	233	20	5.54E-144	89.45%	14	F:GO:0019904; C:GO:0016607; F:GO:0044212; P:GO:0021762; C:GO:0005886; C:GO:0005634; C:GO:0070062; P:GO:0045892; C:GO:0005737; F:GO:0003714; P:GO:0072112; C:GO:0031982; C:GO:0030054; C:GO:0008180	F:protein domain specific binding; C:nuclear speck; F:transcription regulatory region DNA binding; P:substantia nigra development; C:plasma membrane; C:nucleus; C:extracellular exosome; P:negative regulation of transcription, DNA-templated; C:cytoplasm; F:transcription corepressor activity; P:glomerular visceral epithelial cell differentiation; C:vesicle; C:cell junction; C:COP9 signalosome		
tr|F6XX28|F6XX28_HORSE	alanine--tRNA cytoplasmic	970	20	0E0	98.05%	28	P:GO:0043200; F:GO:0002161; P:GO:0043588; P:GO:0006400; P:GO:0043524; F:GO:0000166; F:GO:0005524; P:GO:0021680; C:GO:0070062; P:GO:0001942; F:GO:0004813; P:GO:0030968; P:GO:0006419; C:GO:0005829; P:GO:0034620; F:GO:0016597; F:GO:0016876; F:GO:0008270; P:GO:0006450; P:GO:0050905; P:GO:0006457; P:GO:0043039; F:GO:0000049; F:GO:0003676; C:GO:0005737; C:GO:0016020; C:GO:0005739; P:GO:0050885	P:response to amino acid; F:aminoacyl-tRNA editing activity; P:skin development; P:tRNA modification; P:negative regulation of neuron apoptotic process; F:nucleotide binding; F:ATP binding; P:cerebellar Purkinje cell layer development; C:extracellular exosome; P:hair follicle development; F:alanine-tRNA ligase activity; P:endoplasmic reticulum unfolded protein response; P:alanyl-tRNA aminoacylation; C:cytosol; P:cellular response to unfolded protein; F:amino acid binding; F:ligase activity, forming aminoacyl-tRNA and related compounds; F:zinc ion binding; P:regulation of translational fidelity; P:neuromuscular process; P:protein folding; P:tRNA aminoacylation; F:tRNA binding; F:nucleic acid binding; C:cytoplasm; C:membrane; C:mitochondrion; P:neuromuscular process controlling balance		
tr|F6Y4Z6|F6Y4Z6_HORSE	proteasome subunit beta type-9	219	20	7.35E-159	98.5%	47	F:GO:0070628; P:GO:0038095; P:GO:0048536; P:GO:0043488; P:GO:1901423; P:GO:0006521; P:GO:0048538; C:GO:0005654; P:GO:0002223; P:GO:0000165; P:GO:0002479; C:GO:0070062; P:GO:0001889; P:GO:0016032; C:GO:0005829; P:GO:0071257; P:GO:0060071; P:GO:0051603; P:GO:2000116; P:GO:0050852; P:GO:0000209; F:GO:0004175; P:GO:0090263; P:GO:0038061; F:GO:0004298; C:GO:0000502; P:GO:0043279; F:GO:0008233; P:GO:0002376; P:GO:0090090; P:GO:0098586; C:GO:1990111; C:GO:0005634; P:GO:0043161; P:GO:0033209; F:GO:0005515; C:GO:0005737; P:GO:0042493; C:GO:0005839; P:GO:0006508; P:GO:0071347; P:GO:0031145; P:GO:0000090; P:GO:0014889; P:GO:0051437; F:GO:0016787; P:GO:0051436	F:proteasome binding; P:Fc-epsilon receptor signaling pathway; P:spleen development; P:regulation of mRNA stability; P:response to benzene; P:regulation of cellular amino acid metabolic process; P:thymus development; C:nucleoplasm; P:stimulatory C-type lectin receptor signaling pathway; P:MAPK cascade; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; C:extracellular exosome; P:liver development; P:viral process; C:cytosol; P:cellular response to electrical stimulus; P:Wnt signaling pathway, planar cell polarity pathway; P:proteolysis involved in cellular protein catabolic process; P:regulation of cysteine-type endopeptidase activity; P:T cell receptor signaling pathway; P:protein polyubiquitination; F:endopeptidase activity; P:positive regulation of canonical Wnt signaling pathway; P:NIK/NF-kappaB signaling; F:threonine-type endopeptidase activity; C:proteasome complex; P:response to alkaloid; F:peptidase activity; P:immune system process; P:negative regulation of canonical Wnt signaling pathway; P:cellular response to virus; C:spermatoproteasome complex; C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:tumor necrosis factor-mediated signaling pathway; F:protein binding; C:cytoplasm; P:response to drug; C:proteasome core complex; P:proteolysis; P:cellular response to interleukin-1; P:anaphase-promoting complex-dependent catabolic process; P:mitotic anaphase; P:muscle atrophy; P:positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition; F:hydrolase activity; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle		
tr|F6UD63|F6UD63_HORSE	cathelicidin antimicrobial peptide	157	20	5.74E-110	85.5%	3	C:GO:0005576; P:GO:0006952; P:GO:0042742	C:extracellular region; P:defense response; P:defense response to bacterium		
tr|Q95LJ1|Q95LJ1_HORSE	insulin-like growth factor-binding 7	117	20	5.05E-81	100%	10	F:GO:0019838; C:GO:0005615; F:GO:0005515; C:GO:0070062; P:GO:0001558; P:GO:0008285; P:GO:0007155; C:GO:0031012; C:GO:0005576; F:GO:0005520	F:growth factor binding; C:extracellular space; F:protein binding; C:extracellular exosome; P:regulation of cell growth; P:negative regulation of cell proliferation; P:cell adhesion; C:extracellular matrix; C:extracellular region; F:insulin-like growth factor binding		
tr|F6TIL8|F6TIL8_HORSE	AP-1 complex subunit mu-2 isoform X2	423	20	0E0	99.05%	6	P:GO:0016192; C:GO:0043231; P:GO:0015031; C:GO:0030131; P:GO:0006886; P:GO:0006810	P:vesicle-mediated transport; C:intracellular membrane-bounded organelle; P:protein transport; C:clathrin adaptor complex; P:intracellular protein transport; P:transport		
tr|F6SZ35|F6SZ35_HORSE	proteasome subunit beta type-10	273	20	0E0	94.55%	36	P:GO:0038095; P:GO:0043488; P:GO:0006521; C:GO:0005654; P:GO:0002223; P:GO:0000165; P:GO:0002479; P:GO:0006959; P:GO:0016032; C:GO:0005829; P:GO:0060071; P:GO:0051603; P:GO:0050852; P:GO:0000209; P:GO:0000902; F:GO:0004175; P:GO:0090263; P:GO:0038061; F:GO:0004298; C:GO:0000502; F:GO:0008233; P:GO:0090090; C:GO:1990111; C:GO:0005634; P:GO:0043161; P:GO:0033209; F:GO:0005515; C:GO:0005737; C:GO:0005839; P:GO:0042098; P:GO:0006508; P:GO:0031145; P:GO:0000090; P:GO:0051437; F:GO:0016787; P:GO:0051436	P:Fc-epsilon receptor signaling pathway; P:regulation of mRNA stability; P:regulation of cellular amino acid metabolic process; C:nucleoplasm; P:stimulatory C-type lectin receptor signaling pathway; P:MAPK cascade; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:humoral immune response; P:viral process; C:cytosol; P:Wnt signaling pathway, planar cell polarity pathway; P:proteolysis involved in cellular protein catabolic process; P:T cell receptor signaling pathway; P:protein polyubiquitination; P:cell morphogenesis; F:endopeptidase activity; P:positive regulation of canonical Wnt signaling pathway; P:NIK/NF-kappaB signaling; F:threonine-type endopeptidase activity; C:proteasome complex; F:peptidase activity; P:negative regulation of canonical Wnt signaling pathway; C:spermatoproteasome complex; C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:tumor necrosis factor-mediated signaling pathway; F:protein binding; C:cytoplasm; C:proteasome core complex; P:T cell proliferation; P:proteolysis; P:anaphase-promoting complex-dependent catabolic process; P:mitotic anaphase; P:positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition; F:hydrolase activity; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle		
tr|F6QYQ4|F6QYQ4_HORSE	15 kDa seleno	95	20	1.55E-61	94.55%	5	C:GO:0005788; C:GO:0070062; F:GO:0008430; P:GO:0051084; C:GO:0005783	C:endoplasmic reticulum lumen; C:extracellular exosome; F:selenium binding; P:'de novo' posttranslational protein folding; C:endoplasmic reticulum		
tr|F6XS05|F6XS05_HORSE	S-formylglutathione hydrolase isoform X1	282	20	0E0	98.3%	14	F:GO:0016788; P:GO:0008150; F:GO:0018738; P:GO:1901687; F:GO:0047374; C:GO:0005788; F:GO:0005515; P:GO:0046294; C:GO:0070062; C:GO:0005737; C:GO:0031410; C:GO:0016023; F:GO:0052689; F:GO:0016787	F:hydrolase activity, acting on ester bonds; P:biological_process; F:S-formylglutathione hydrolase activity; P:glutathione derivative biosynthetic process; F:methylumbelliferyl-acetate deacetylase activity; C:endoplasmic reticulum lumen; F:protein binding; P:formaldehyde catabolic process; C:extracellular exosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic, membrane-bounded vesicle; F:carboxylic ester hydrolase activity; F:hydrolase activity		
tr|F6RW00|F6RW00_HORSE	myosin regulatory light chain skeletal muscle isoform	170	20	6.66E-122	99.6%	6	C:GO:0016459; F:GO:0008307; F:GO:0046872; P:GO:0007519; F:GO:0005509; C:GO:0005765	C:myosin complex; F:structural constituent of muscle; F:metal ion binding; P:skeletal muscle tissue development; F:calcium ion binding; C:lysosomal membrane		
tr|F7DMY7|F7DMY7_HORSE	basement membrane-specific heparan sulfate proteoglycan core	4357	20	0E0	94.25%	6	C:GO:0005615; C:GO:0070062; C:GO:0005925; F:GO:0008022; F:GO:0005509; C:GO:0031012	C:extracellular space; C:extracellular exosome; C:focal adhesion; F:protein C-terminus binding; F:calcium ion binding; C:extracellular matrix		
tr|F7C0I7|F7C0I7_HORSE	basement membrane-specific heparan sulfate proteoglycan core	4370	20	0E0	94.35%	6	C:GO:0005615; C:GO:0070062; C:GO:0005925; F:GO:0008022; F:GO:0005509; C:GO:0031012	C:extracellular space; C:extracellular exosome; C:focal adhesion; F:protein C-terminus binding; F:calcium ion binding; C:extracellular matrix		
tr|F6QPI5|F6QPI5_HORSE	transportin-1 isoform X2	856	20	0E0	96%	22	P:GO:0015031; F:GO:0008565; P:GO:0043488; P:GO:0006886; P:GO:0006810; F:GO:0008536; P:GO:0000059; C:GO:0005622; F:GO:0008139; F:GO:0044822; P:GO:0006610; C:GO:0005634; C:GO:0072372; C:GO:0031965; F:GO:0005515; C:GO:0070062; C:GO:0005737; P:GO:0006607; P:GO:0000060; P:GO:0016032; C:GO:0005829; C:GO:0034399	P:protein transport; F:protein transporter activity; P:regulation of mRNA stability; P:intracellular protein transport; P:transport; F:Ran GTPase binding; P:protein import into nucleus, docking; C:intracellular; F:nuclear localization sequence binding; F:poly(A) RNA binding; P:ribosomal protein import into nucleus; C:nucleus; C:primary cilium; C:nuclear membrane; F:protein binding; C:extracellular exosome; C:cytoplasm; P:NLS-bearing protein import into nucleus; P:protein import into nucleus, translocation; P:viral process; C:cytosol; C:nuclear periphery		
tr|F7DCH4|F7DCH4_HORSE	calponin-3	329	20	0E0	99.25%	13	C:GO:0014069; P:GO:0032780; P:GO:0031032; C:GO:0043025; F:GO:0008017; P:GO:0030855; C:GO:0030425; F:GO:0005516; F:GO:0003779; C:GO:0005925; C:GO:0005737; C:GO:0043197; C:GO:0015629	C:postsynaptic density; P:negative regulation of ATPase activity; P:actomyosin structure organization; C:neuronal cell body; F:microtubule binding; P:epithelial cell differentiation; C:dendrite; F:calmodulin binding; F:actin binding; C:focal adhesion; C:cytoplasm; C:dendritic spine; C:actin cytoskeleton		
tr|F7DGE2|F7DGE2_HORSE	vesicle-fusing ATPase	738	20	0E0	99.05%	39	F:GO:0016887; C:GO:0014069; C:GO:0043209; P:GO:0015031; P:GO:0043001; C:GO:0000139; P:GO:0045026; P:GO:0006886; C:GO:0005795; P:GO:0006887; P:GO:0006813; F:GO:0000166; F:GO:0005524; C:GO:0070062; P:GO:0016192; P:GO:0001921; C:GO:0043198; F:GO:0030165; C:GO:0005829; F:GO:0032403; F:GO:0019901; P:GO:0006890; F:GO:0019905; P:GO:0045732; P:GO:0006891; P:GO:0006810; C:GO:0005765; C:GO:0005886; P:GO:0048208; F:GO:0042623; P:GO:0006888; F:GO:0005515; F:GO:0046872; C:GO:0005737; F:GO:0017075; P:GO:0048211; P:GO:0017157; F:GO:0017137; F:GO:0016787	F:ATPase activity; C:postsynaptic density; C:myelin sheath; P:protein transport; P:Golgi to plasma membrane protein transport; C:Golgi membrane; P:plasma membrane fusion; P:intracellular protein transport; C:Golgi stack; P:exocytosis; P:potassium ion transport; F:nucleotide binding; F:ATP binding; C:extracellular exosome; P:vesicle-mediated transport; P:positive regulation of receptor recycling; C:dendritic shaft; F:PDZ domain binding; C:cytosol; F:protein complex binding; F:protein kinase binding; P:retrograde vesicle-mediated transport, Golgi to ER; F:syntaxin binding; P:positive regulation of protein catabolic process; P:intra-Golgi vesicle-mediated transport; P:transport; C:lysosomal membrane; C:plasma membrane; P:COPII vesicle coating; F:ATPase activity, coupled; P:ER to Golgi vesicle-mediated transport; F:protein binding; F:metal ion binding; C:cytoplasm; F:syntaxin-1 binding; P:Golgi vesicle docking; P:regulation of exocytosis; F:Rab GTPase binding; F:hydrolase activity		
tr|F7BYZ1|F7BYZ1_HORSE	Niban	916	20	0E0	88.3%	8	C:GO:0070062; P:GO:0045727; C:GO:0005737; P:GO:0001933; C:GO:0016020; P:GO:0001934; C:GO:0005886; P:GO:0034976	C:extracellular exosome; P:positive regulation of translation; C:cytoplasm; P:negative regulation of protein phosphorylation; C:membrane; P:positive regulation of protein phosphorylation; C:plasma membrane; P:response to endoplasmic reticulum stress		
tr|F7BC37|F7BC37_HORSE	prostasin	300	20	0E0	93.9%	10	C:GO:0005615; C:GO:0070062; P:GO:0006508; C:GO:0016020; C:GO:0016021; F:GO:0004252; F:GO:0008236; F:GO:0008233; C:GO:0005886; F:GO:0016787	C:extracellular space; C:extracellular exosome; P:proteolysis; C:membrane; C:integral component of membrane; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:peptidase activity; C:plasma membrane; F:hydrolase activity		
tr|F6UPK3|F6UPK3_HORSE	carbonic anhydrase 4	311	20	0E0	86.2%	22	F:GO:0008270; C:GO:0031362; C:GO:0005791; C:GO:0005794; F:GO:0004089; C:GO:0005793; P:GO:0006730; C:GO:0005886; C:GO:0009986; C:GO:0046658; C:GO:0030667; C:GO:0005802; C:GO:0030658; C:GO:0031526; C:GO:0070062; C:GO:0048471; F:GO:0046872; C:GO:0016020; C:GO:0016021; P:GO:0015701; C:GO:0016324; C:GO:0031225	F:zinc ion binding; C:anchored component of external side of plasma membrane; C:rough endoplasmic reticulum; C:Golgi apparatus; F:carbonate dehydratase activity; C:endoplasmic reticulum-Golgi intermediate compartment; P:one-carbon metabolic process; C:plasma membrane; C:cell surface; C:anchored component of plasma membrane; C:secretory granule membrane; C:trans-Golgi network; C:transport vesicle membrane; C:brush border membrane; C:extracellular exosome; C:perinuclear region of cytoplasm; F:metal ion binding; C:membrane; C:integral component of membrane; P:bicarbonate transport; C:apical plasma membrane; C:anchored component of membrane		
tr|F6S193|F6S193_HORSE	zinc finger 185 isoform X1	486	20	0E0	74.65%	8	F:GO:0008270; C:GO:0005856; C:GO:0005925; C:GO:0005737; F:GO:0046872; C:GO:0015629; C:GO:0030054; C:GO:0005886	F:zinc ion binding; C:cytoskeleton; C:focal adhesion; C:cytoplasm; F:metal ion binding; C:actin cytoskeleton; C:cell junction; C:plasma membrane		
tr|F7A0N8|F7A0N8_HORSE	serine threonine- phosphatase 2A 65 kDa regulatory subunit A alpha isoform	589	20	0E0	99.8%	43	C:GO:0015630; P:GO:0008380; P:GO:0042518; P:GO:0006461; P:GO:0007059; C:GO:0005694; C:GO:0000159; C:GO:0000775; F:GO:0008601; P:GO:0000188; P:GO:0070262; C:GO:0070062; P:GO:0000086; F:GO:0003823; P:GO:0000184; P:GO:0045595; P:GO:0030308; F:GO:0046982; P:GO:0006915; C:GO:0005829; P:GO:0034047; P:GO:0051306; P:GO:0007084; P:GO:2001241; P:GO:0010033; P:GO:0007143; P:GO:0006470; P:GO:0006355; P:GO:0006275; P:GO:0006672; P:GO:0040008; P:GO:1903538; F:GO:0004722; C:GO:0005634; F:GO:0005515; C:GO:0005737; P:GO:0051232; C:GO:0016020; C:GO:0005739; P:GO:0030155; P:GO:0030111; P:GO:0051754; P:GO:0019932	C:microtubule cytoskeleton; P:RNA splicing; P:negative regulation of tyrosine phosphorylation of Stat3 protein; P:protein complex assembly; P:chromosome segregation; C:chromosome; C:protein phosphatase type 2A complex; C:chromosome, centromeric region; F:protein phosphatase type 2A regulator activity; P:inactivation of MAPK activity; P:peptidyl-serine dephosphorylation; C:extracellular exosome; P:G2/M transition of mitotic cell cycle; F:antigen binding; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of cell differentiation; P:negative regulation of cell growth; F:protein heterodimerization activity; P:apoptotic process; C:cytosol; P:regulation of protein phosphatase type 2A activity; P:mitotic sister chromatid separation; P:mitotic nuclear envelope reassembly; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:response to organic substance; P:female meiotic division; P:protein dephosphorylation; P:regulation of transcription, DNA-templated; P:regulation of DNA replication; P:ceramide metabolic process; P:regulation of growth; P:regulation of meiotic cell cycle process involved in oocyte maturation; F:protein serine/threonine phosphatase activity; C:nucleus; F:protein binding; C:cytoplasm; P:meiotic spindle elongation; C:membrane; C:mitochondrion; P:regulation of cell adhesion; P:regulation of Wnt signaling pathway; P:meiotic sister chromatid cohesion, centromeric; P:second-messenger-mediated signaling		
tr|F7AS57|F7AS57_HORSE	proteasome activator complex subunit 2	239	20	7.53E-176	98.85%	29	F:GO:0061133; P:GO:0061136; P:GO:0038095; P:GO:0043488; P:GO:0006521; C:GO:0005654; P:GO:0002223; P:GO:0000165; P:GO:0002479; C:GO:0070062; C:GO:0005829; P:GO:0060071; P:GO:0050852; P:GO:0010950; P:GO:0000209; P:GO:0090263; P:GO:0038061; C:GO:0000502; C:GO:0008537; P:GO:0090090; P:GO:0043161; P:GO:0033209; C:GO:0005737; C:GO:0016020; P:GO:0031145; P:GO:0000090; P:GO:2000045; P:GO:0051437; P:GO:0051436	F:endopeptidase activator activity; P:regulation of proteasomal protein catabolic process; P:Fc-epsilon receptor signaling pathway; P:regulation of mRNA stability; P:regulation of cellular amino acid metabolic process; C:nucleoplasm; P:stimulatory C-type lectin receptor signaling pathway; P:MAPK cascade; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; C:extracellular exosome; C:cytosol; P:Wnt signaling pathway, planar cell polarity pathway; P:T cell receptor signaling pathway; P:positive regulation of endopeptidase activity; P:protein polyubiquitination; P:positive regulation of canonical Wnt signaling pathway; P:NIK/NF-kappaB signaling; C:proteasome complex; C:proteasome activator complex; P:negative regulation of canonical Wnt signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:tumor necrosis factor-mediated signaling pathway; C:cytoplasm; C:membrane; P:anaphase-promoting complex-dependent catabolic process; P:mitotic anaphase; P:regulation of G1/S transition of mitotic cell cycle; P:positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle		
tr|F7BSK7|F7BSK7_HORSE	dynactin subunit 2 isoform X2	403	20	0E0	97.55%	14	P:GO:0008283; P:GO:0007052; P:GO:0007067; C:GO:0000776; P:GO:0007017; C:GO:0030426; C:GO:0005813; C:GO:0070062; F:GO:0030507; C:GO:0005737; C:GO:0005869; C:GO:0031982; P:GO:0071539; P:GO:0032402	P:cell proliferation; P:mitotic spindle organization; P:mitotic nuclear division; C:kinetochore; P:microtubule-based process; C:growth cone; C:centrosome; C:extracellular exosome; F:spectrin binding; C:cytoplasm; C:dynactin complex; C:vesicle; P:protein localization to centrosome; P:melanosome transport		
tr|F6Z352|F6Z352_HORSE	vitamin K-dependent S	649	20	0E0	94%	9	C:GO:0005615; C:GO:0070062; F:GO:0005509; C:GO:0072562; P:GO:0030195; P:GO:0007596; P:GO:0042730; C:GO:0005576; P:GO:0007599	C:extracellular space; C:extracellular exosome; F:calcium ion binding; C:blood microparticle; P:negative regulation of blood coagulation; P:blood coagulation; P:fibrinolysis; C:extracellular region; P:hemostasis		
tr|F7DCZ5|F7DCZ5_HORSE	60S ribosomal L29	161	20	5.3E-109	92.1%	9	F:GO:0003735; C:GO:0030529; P:GO:0002181; C:GO:0016020; C:GO:0022625; C:GO:0005840; C:GO:0005622; F:GO:0044822; P:GO:0006412	F:structural constituent of ribosome; C:intracellular ribonucleoprotein complex; P:cytoplasmic translation; C:membrane; C:cytosolic large ribosomal subunit; C:ribosome; C:intracellular; F:poly(A) RNA binding; P:translation		
tr|F6VB94|F6VB94_HORSE	transforming growth factor-beta-induced ig-h3	666	20	0E0	98.25%	14	P:GO:0008283; F:GO:0050839; P:GO:0007155; F:GO:0005178; C:GO:0005576; C:GO:0005578; F:GO:0050840; C:GO:0005615; C:GO:0005802; C:GO:0070062; F:GO:0005518; P:GO:0001525; P:GO:0030198; C:GO:0031012	P:cell proliferation; F:cell adhesion molecule binding; P:cell adhesion; F:integrin binding; C:extracellular region; C:proteinaceous extracellular matrix; F:extracellular matrix binding; C:extracellular space; C:trans-Golgi network; C:extracellular exosome; F:collagen binding; P:angiogenesis; P:extracellular matrix organization; C:extracellular matrix		
tr|F6RRL9|F6RRL9_HORSE	insulin-like growth factor-binding 3	194	20	1.42E-138	90.75%	28	F:GO:0019838; F:GO:0008160; P:GO:0008285; P:GO:0045663; P:GO:0043567; C:GO:0005576; P:GO:0006468; P:GO:0043568; P:GO:0032868; C:GO:0070062; P:GO:0044342; P:GO:0048662; F:GO:0001968; P:GO:0001649; P:GO:0014912; F:GO:0031994; F:GO:0031995; P:GO:0043410; F:GO:0005520; P:GO:0040008; C:GO:0042567; C:GO:0005634; C:GO:0005615; P:GO:0010906; P:GO:0043085; P:GO:0001558; P:GO:0001933; P:GO:0043065	F:growth factor binding; F:protein tyrosine phosphatase activator activity; P:negative regulation of cell proliferation; P:positive regulation of myoblast differentiation; P:regulation of insulin-like growth factor receptor signaling pathway; C:extracellular region; P:protein phosphorylation; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:response to insulin; C:extracellular exosome; P:type B pancreatic cell proliferation; P:negative regulation of smooth muscle cell proliferation; F:fibronectin binding; P:osteoblast differentiation; P:negative regulation of smooth muscle cell migration; F:insulin-like growth factor I binding; F:insulin-like growth factor II binding; P:positive regulation of MAPK cascade; F:insulin-like growth factor binding; P:regulation of growth; C:insulin-like growth factor ternary complex; C:nucleus; C:extracellular space; P:regulation of glucose metabolic process; P:positive regulation of catalytic activity; P:regulation of cell growth; P:negative regulation of protein phosphorylation; P:positive regulation of apoptotic process		
tr|F7DW15|F7DW15_HORSE	40S ribosomal S8	191	20	1.41E-136	99.7%	21	C:GO:0022627; P:GO:0006364; C:GO:0005840; P:GO:0006413; C:GO:0005622; F:GO:0044822; C:GO:0005654; P:GO:0006412; P:GO:0019083; P:GO:0000462; C:GO:0005634; F:GO:0005515; P:GO:0006614; C:GO:0070062; F:GO:0003735; C:GO:0005925; C:GO:0030529; P:GO:0000184; C:GO:0005737; C:GO:0016020; C:GO:0005829	C:cytosolic small ribosomal subunit; P:rRNA processing; C:ribosome; P:translational initiation; C:intracellular; F:poly(A) RNA binding; C:nucleoplasm; P:translation; P:viral transcription; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:nucleus; F:protein binding; P:SRP-dependent cotranslational protein targeting to membrane; C:extracellular exosome; F:structural constituent of ribosome; C:focal adhesion; C:intracellular ribonucleoprotein complex; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; C:cytoplasm; C:membrane; C:cytosol		
tr|F6T7J1|F6T7J1_HORSE	beta-hexosaminidase subunit alpha	529	20	0E0	93.15%	23	P:GO:0007040; P:GO:0019915; P:GO:0008152; P:GO:0060395; P:GO:0042552; P:GO:0048667; F:GO:0004553; F:GO:0004563; P:GO:0006689; C:GO:0005764; P:GO:0007605; P:GO:0050884; P:GO:0007628; P:GO:0005975; P:GO:0007626; P:GO:0001501; C:GO:0016020; C:GO:0016021; P:GO:0019953; P:GO:0050885; P:GO:0030203; F:GO:0016787; F:GO:0016798	P:lysosome organization; P:lipid storage; P:metabolic process; P:SMAD protein signal transduction; P:myelination; P:cell morphogenesis involved in neuron differentiation; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:beta-N-acetylhexosaminidase activity; P:ganglioside catabolic process; C:lysosome; P:sensory perception of sound; P:neuromuscular process controlling posture; P:adult walking behavior; P:carbohydrate metabolic process; P:locomotory behavior; P:skeletal system development; C:membrane; C:integral component of membrane; P:sexual reproduction; P:neuromuscular process controlling balance; P:glycosaminoglycan metabolic process; F:hydrolase activity; F:hydrolase activity, acting on glycosyl bonds		
tr|A5YBL8|A5YBL8_HORSE	peptidyl-prolyl cis-trans isomerase B	216	20	2.34E-153	98.55%	24	P:GO:0044829; P:GO:0061077; P:GO:0044794; F:GO:0042277; C:GO:0005783; P:GO:0000413; P:GO:0006457; P:GO:0040018; F:GO:0044822; P:GO:0060348; F:GO:0070063; C:GO:0005634; C:GO:0005788; F:GO:0003755; C:GO:0070062; C:GO:0048471; C:GO:0005925; C:GO:0042470; C:GO:0016020; C:GO:0032991; C:GO:0034663; F:GO:0032403; P:GO:0050821; F:GO:0016853	P:positive regulation by host of viral genome replication; P:chaperone-mediated protein folding; P:positive regulation by host of viral process; F:peptide binding; C:endoplasmic reticulum; P:protein peptidyl-prolyl isomerization; P:protein folding; P:positive regulation of multicellular organism growth; F:poly(A) RNA binding; P:bone development; F:RNA polymerase binding; C:nucleus; C:endoplasmic reticulum lumen; F:peptidyl-prolyl cis-trans isomerase activity; C:extracellular exosome; C:perinuclear region of cytoplasm; C:focal adhesion; C:melanosome; C:membrane; C:macromolecular complex; C:endoplasmic reticulum chaperone complex; F:protein complex binding; P:protein stabilization; F:isomerase activity		
tr|F7CH72|F7CH72_HORSE	sortilin-related receptor	2120	20	0E0	96.85%	52	P:GO:1902430; P:GO:1902997; P:GO:1902953; C:GO:0005794; P:GO:0032091; P:GO:1902955; P:GO:0045053; F:GO:0030306; P:GO:1902948; P:GO:0051604; P:GO:1902960; P:GO:1902963; P:GO:0045732; P:GO:0006892; P:GO:0006897; C:GO:0005641; P:GO:0006810; P:GO:0006898; P:GO:1902966; P:GO:0006605; F:GO:0005515; P:GO:2001137; P:GO:0050768; C:GO:0031985; P:GO:0043407; P:GO:1902771; P:GO:0008203; P:GO:0008202; C:GO:0005576; P:GO:0006622; C:GO:0005887; C:GO:0005802; C:GO:0005769; C:GO:0005768; C:GO:0070062; P:GO:0000042; P:GO:0070863; F:GO:0030169; P:GO:0014910; P:GO:0007165; C:GO:0034362; P:GO:0032460; P:GO:1901215; C:GO:0005783; F:GO:0001540; P:GO:0006869; C:GO:0005615; F:GO:0004888; C:GO:0016020; P:GO:0006629; C:GO:0016021; C:GO:0055037	P:negative regulation of beta-amyloid formation; P:negative regulation of neurofibrillary tangle assembly; P:positive regulation of ER to Golgi vesicle-mediated transport; C:Golgi apparatus; P:negative regulation of protein binding; P:positive regulation of early endosome to recycling endosome transport; P:protein retention in Golgi apparatus; F:ADP-ribosylation factor binding; P:negative regulation of tau-protein kinase activity; P:protein maturation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of protein catabolic process; P:post-Golgi vesicle-mediated transport; P:endocytosis; C:nuclear envelope lumen; P:transport; P:receptor-mediated endocytosis; P:positive regulation of protein localization to early endosome; P:protein targeting; F:protein binding; P:positive regulation of endocytic recycling; P:negative regulation of neurogenesis; C:Golgi cisterna; P:negative regulation of MAP kinase activity; P:positive regulation of choline O-acetyltransferase activity; P:cholesterol metabolic process; P:steroid metabolic process; C:extracellular region; P:protein targeting to lysosome; C:integral component of plasma membrane; C:trans-Golgi network; C:early endosome; C:endosome; C:extracellular exosome; P:protein targeting to Golgi; P:positive regulation of protein exit from endoplasmic reticulum; F:low-density lipoprotein particle binding; P:regulation of smooth muscle cell migration; P:signal transduction; C:low-density lipoprotein particle; P:negative regulation of protein oligomerization; P:negative regulation of neuron death; C:endoplasmic reticulum; F:beta-amyloid binding; P:lipid transport; C:extracellular space; F:transmembrane signaling receptor activity; C:membrane; P:lipid metabolic process; C:integral component of membrane; C:recycling endosome		
tr|F7CG82|F7CG82_HORSE	sortilin-related receptor	2120	20	0E0	96.8%	52	P:GO:1902430; P:GO:1902997; P:GO:1902953; C:GO:0005794; P:GO:0032091; P:GO:1902955; P:GO:0045053; F:GO:0030306; P:GO:1902948; P:GO:0051604; P:GO:1902960; P:GO:1902963; P:GO:0045732; P:GO:0006892; P:GO:0006897; C:GO:0005641; P:GO:0006810; P:GO:0006898; P:GO:1902966; P:GO:0006605; F:GO:0005515; P:GO:2001137; P:GO:0050768; C:GO:0031985; P:GO:0043407; P:GO:1902771; P:GO:0008203; P:GO:0008202; C:GO:0005576; P:GO:0006622; C:GO:0005887; C:GO:0005802; C:GO:0005769; C:GO:0005768; C:GO:0070062; P:GO:0000042; P:GO:0070863; F:GO:0030169; P:GO:0014910; P:GO:0007165; C:GO:0034362; P:GO:0032460; P:GO:1901215; C:GO:0005783; F:GO:0001540; P:GO:0006869; C:GO:0005615; F:GO:0004888; C:GO:0016020; P:GO:0006629; C:GO:0016021; C:GO:0055037	P:negative regulation of beta-amyloid formation; P:negative regulation of neurofibrillary tangle assembly; P:positive regulation of ER to Golgi vesicle-mediated transport; C:Golgi apparatus; P:negative regulation of protein binding; P:positive regulation of early endosome to recycling endosome transport; P:protein retention in Golgi apparatus; F:ADP-ribosylation factor binding; P:negative regulation of tau-protein kinase activity; P:protein maturation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of protein catabolic process; P:post-Golgi vesicle-mediated transport; P:endocytosis; C:nuclear envelope lumen; P:transport; P:receptor-mediated endocytosis; P:positive regulation of protein localization to early endosome; P:protein targeting; F:protein binding; P:positive regulation of endocytic recycling; P:negative regulation of neurogenesis; C:Golgi cisterna; P:negative regulation of MAP kinase activity; P:positive regulation of choline O-acetyltransferase activity; P:cholesterol metabolic process; P:steroid metabolic process; C:extracellular region; P:protein targeting to lysosome; C:integral component of plasma membrane; C:trans-Golgi network; C:early endosome; C:endosome; C:extracellular exosome; P:protein targeting to Golgi; P:positive regulation of protein exit from endoplasmic reticulum; F:low-density lipoprotein particle binding; P:regulation of smooth muscle cell migration; P:signal transduction; C:low-density lipoprotein particle; P:negative regulation of protein oligomerization; P:negative regulation of neuron death; C:endoplasmic reticulum; F:beta-amyloid binding; P:lipid transport; C:extracellular space; F:transmembrane signaling receptor activity; C:membrane; P:lipid metabolic process; C:integral component of membrane; C:recycling endosome		
tr|F6WB51|F6WB51_HORSE	quinone oxidoreductase	328	20	0E0	93.3%	14	F:GO:0008270; P:GO:0042178; P:GO:0007601; F:GO:0003960; F:GO:0003730; C:GO:0070062; F:GO:0003723; P:GO:0051289; C:GO:0005737; F:GO:0016491; C:GO:0005829; F:GO:0070402; P:GO:0055114; F:GO:0070404	F:zinc ion binding; P:xenobiotic catabolic process; P:visual perception; F:NADPH:quinone reductase activity; F:mRNA 3'-UTR binding; C:extracellular exosome; F:RNA binding; P:protein homotetramerization; C:cytoplasm; F:oxidoreductase activity; C:cytosol; F:NADPH binding; P:oxidation-reduction process; F:NADH binding		
tr|F7ABC9|F7ABC9_HORSE	fibulin-1 isoform X1	684	20	0E0	97.1%	31	F:GO:0016504; F:GO:0008022; F:GO:0005178; P:GO:1904237; C:GO:0005576; C:GO:0005578; C:GO:0005577; C:GO:0005604; C:GO:0070062; F:GO:0005509; P:GO:0048146; F:GO:0001968; P:GO:0010952; C:GO:0071953; C:GO:0031012; F:GO:0032403; P:GO:2001202; P:GO:1904188; F:GO:0042802; P:GO:0007162; P:GO:1900025; F:GO:0005201; C:GO:0005615; F:GO:0070051; P:GO:0072378; P:GO:2000647; P:GO:0070373; P:GO:0001933; P:GO:0010628; P:GO:0030198; P:GO:2000146	F:peptidase activator activity; F:protein C-terminus binding; F:integrin binding; P:positive regulation of substrate-dependent cell migration, cell attachment to substrate; C:extracellular region; C:proteinaceous extracellular matrix; C:fibrinogen complex; C:basement membrane; C:extracellular exosome; F:calcium ion binding; P:positive regulation of fibroblast proliferation; F:fibronectin binding; P:positive regulation of peptidase activity; C:elastic fiber; C:extracellular matrix; F:protein complex binding; P:negative regulation of transforming growth factor-beta secretion; P:negative regulation of transformation of host cell by virus; F:identical protein binding; P:negative regulation of cell adhesion; P:negative regulation of substrate adhesion-dependent cell spreading; F:extracellular matrix structural constituent; C:extracellular space; F:fibrinogen binding; P:blood coagulation, fibrin clot formation; P:negative regulation of stem cell proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of protein phosphorylation; P:positive regulation of gene expression; P:extracellular matrix organization; P:negative regulation of cell motility		
tr|F7A860|F7A860_HORSE	galectin-3	238	20	2.86E-171	86.15%	40	P:GO:0045806; P:GO:0008380; P:GO:0050918; F:GO:0042056; C:GO:0005576; C:GO:0001772; C:GO:0070062; P:GO:0071674; P:GO:0048246; P:GO:0048245; P:GO:0071677; F:GO:0019863; C:GO:0031012; F:GO:0030246; P:GO:2001189; P:GO:2001200; P:GO:0042129; P:GO:1902041; C:GO:0005681; P:GO:0006397; F:GO:0043236; P:GO:0002376; C:GO:0005743; C:GO:0005886; F:GO:0044822; P:GO:0090280; P:GO:0030855; C:GO:0005634; C:GO:0005615; F:GO:0005515; P:GO:0050860; P:GO:0070232; C:GO:0005737; P:GO:0002548; P:GO:0045087; C:GO:0016020; P:GO:0030154; P:GO:2000521; P:GO:2001237; P:GO:0030593	P:negative regulation of endocytosis; P:RNA splicing; P:positive chemotaxis; F:chemoattractant activity; C:extracellular region; C:immunological synapse; C:extracellular exosome; P:mononuclear cell migration; P:macrophage chemotaxis; P:eosinophil chemotaxis; P:positive regulation of mononuclear cell migration; F:IgE binding; C:extracellular matrix; F:carbohydrate binding; P:negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; P:positive regulation of dendritic cell differentiation; P:regulation of T cell proliferation; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; C:spliceosomal complex; P:mRNA processing; F:laminin binding; P:immune system process; C:mitochondrial inner membrane; C:plasma membrane; F:poly(A) RNA binding; P:positive regulation of calcium ion import; P:epithelial cell differentiation; C:nucleus; C:extracellular space; F:protein binding; P:negative regulation of T cell receptor signaling pathway; P:regulation of T cell apoptotic process; C:cytoplasm; P:monocyte chemotaxis; P:innate immune response; C:membrane; P:cell differentiation; P:negative regulation of immunological synapse formation; P:negative regulation of extrinsic apoptotic signaling pathway; P:neutrophil chemotaxis		
tr|F6V8I5|F6V8I5_HORSE	poly(rC)-binding 1	356	20	0E0	99.15%	24	P:GO:0039694; F:GO:0008494; P:GO:0006397; P:GO:0045944; F:GO:0000981; P:GO:0000398; C:GO:0005654; F:GO:0044822; F:GO:0003697; F:GO:0098641; F:GO:0003676; F:GO:0003677; C:GO:0005634; F:GO:0005515; F:GO:0003723; C:GO:0070062; C:GO:0030529; C:GO:0005737; C:GO:0005913; C:GO:0043231; C:GO:0016020; F:GO:0098847; F:GO:0003729; P:GO:0010467	P:viral RNA genome replication; F:translation activator activity; P:mRNA processing; P:positive regulation of transcription from RNA polymerase II promoter; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:mRNA splicing, via spliceosome; C:nucleoplasm; F:poly(A) RNA binding; F:single-stranded DNA binding; F:cadherin binding involved in cell-cell adhesion; F:nucleic acid binding; F:DNA binding; C:nucleus; F:protein binding; F:RNA binding; C:extracellular exosome; C:intracellular ribonucleoprotein complex; C:cytoplasm; C:cell-cell adherens junction; C:intracellular membrane-bounded organelle; C:membrane; F:sequence-specific single stranded DNA binding; F:mRNA binding; P:gene expression		
tr|F6RKM7|F6RKM7_HORSE	60S ribosomal L22	128	20	1.44E-89	99.3%	23	P:GO:0002181; F:GO:0008201; P:GO:0046632; P:GO:0006364; C:GO:0022625; C:GO:0005840; P:GO:0006413; C:GO:0005622; F:GO:0044822; P:GO:0006412; P:GO:0019083; C:GO:0005634; F:GO:0005515; F:GO:0003723; C:GO:0070062; P:GO:0006614; F:GO:0003735; P:GO:0000184; C:GO:0030529; C:GO:0005925; C:GO:0005737; C:GO:0005829; C:GO:0031012	P:cytoplasmic translation; F:heparin binding; P:alpha-beta T cell differentiation; P:rRNA processing; C:cytosolic large ribosomal subunit; C:ribosome; P:translational initiation; C:intracellular; F:poly(A) RNA binding; P:translation; P:viral transcription; C:nucleus; F:protein binding; F:RNA binding; C:extracellular exosome; P:SRP-dependent cotranslational protein targeting to membrane; F:structural constituent of ribosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; C:intracellular ribonucleoprotein complex; C:focal adhesion; C:cytoplasm; C:cytosol; C:extracellular matrix		
tr|F6S0D9|F6S0D9_HORSE	catenin delta-1 isoform X1	932	20	0E0	99%	11	P:GO:0090090; P:GO:0016337; C:GO:0005634; C:GO:0005911; C:GO:0070062; C:GO:0005737; F:GO:0045296; C:GO:0005829; C:GO:0030496; F:GO:0005102; C:GO:0005886	P:negative regulation of canonical Wnt signaling pathway; P:single organismal cell-cell adhesion; C:nucleus; C:cell-cell junction; C:extracellular exosome; C:cytoplasm; F:cadherin binding; C:cytosol; C:midbody; F:receptor binding; C:plasma membrane		
tr|F6ZRN7|F6ZRN7_HORSE	elafin	117	20	4.86E-77	76.3%	9	F:GO:0030414; F:GO:0004867; F:GO:0004866; C:GO:0070062; P:GO:0007620; P:GO:0010951; C:GO:0005576; C:GO:0005578; P:GO:0010466	F:peptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; C:extracellular exosome; P:copulation; P:negative regulation of endopeptidase activity; C:extracellular region; C:proteinaceous extracellular matrix; P:negative regulation of peptidase activity		
tr|F6Z230|F6Z230_HORSE	S100-A12	94	20	4.4E-60	92.9%	19	F:GO:0008144; C:GO:0042629; P:GO:0043123; C:GO:0005576; P:GO:0043303; P:GO:0002376; C:GO:0005886; C:GO:0005634; P:GO:0006954; F:GO:0005515; C:GO:0005856; C:GO:0005737; F:GO:0046872; P:GO:0045087; F:GO:0005509; C:GO:0016020; P:GO:0006805; P:GO:0050832; F:GO:0050786	F:drug binding; C:mast cell granule; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; C:extracellular region; P:mast cell degranulation; P:immune system process; C:plasma membrane; C:nucleus; P:inflammatory response; F:protein binding; C:cytoskeleton; C:cytoplasm; F:metal ion binding; P:innate immune response; F:calcium ion binding; C:membrane; P:xenobiotic metabolic process; P:defense response to fungus; F:RAGE receptor binding		
tr|F6U783|F6U783_HORSE	coatomer subunit beta	904	20	0E0	97.05%	10	C:GO:0030117; P:GO:0006888; P:GO:0016192; P:GO:0006890; F:GO:0005198; P:GO:0006891; C:GO:0005794; P:GO:1901998; P:GO:0006886; C:GO:0030126	C:membrane coat; P:ER to Golgi vesicle-mediated transport; P:vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to ER; F:structural molecule activity; P:intra-Golgi vesicle-mediated transport; C:Golgi apparatus; P:toxin transport; P:intracellular protein transport; C:COPI vesicle coat		
tr|F7B274|F7B274_HORSE	Fanconi anemia group M	1985	20	0E0	94.45%	12	F:GO:0003677; P:GO:0090305; F:GO:0005524; C:GO:0043240; F:GO:0004518; C:GO:0071821; P:GO:0000712; P:GO:0031297; F:GO:0003682; P:GO:0006259; C:GO:0005654; F:GO:0016787	F:DNA binding; P:nucleic acid phosphodiester bond hydrolysis; F:ATP binding; C:Fanconi anaemia nuclear complex; F:nuclease activity; C:FANCM-MHF complex; P:resolution of meiotic recombination intermediates; P:replication fork processing; F:chromatin binding; P:DNA metabolic process; C:nucleoplasm; F:hydrolase activity		
tr|F6ZRU5|F6ZRU5_HORSE	phospholipase D3	490	20	0E0	98.35%	11	C:GO:0005789; C:GO:0070062; F:GO:0003824; C:GO:0016020; P:GO:0006629; P:GO:0016042; C:GO:0016021; C:GO:0005783; F:GO:0004630; F:GO:0070290; F:GO:0016787	C:endoplasmic reticulum membrane; C:extracellular exosome; F:catalytic activity; C:membrane; P:lipid metabolic process; P:lipid catabolic process; C:integral component of membrane; C:endoplasmic reticulum; F:phospholipase D activity; F:N-acylphosphatidylethanolamine-specific phospholipase D activity; F:hydrolase activity		
tr|F7E0R1|F7E0R1_HORSE	AP-3 complex subunit beta-2	1047	20	0E0	96.45%	18	C:GO:1904115; P:GO:0008089; P:GO:0015031; C:GO:0005794; P:GO:0006892; P:GO:0006886; P:GO:0006810; F:GO:0005215; C:GO:0005654; C:GO:0030117; P:GO:0016192; C:GO:0005737; C:GO:0016020; C:GO:0031410; C:GO:0030123; P:GO:0048490; C:GO:0030137; C:GO:0030665	C:axon cytoplasm; P:anterograde axonal transport; P:protein transport; C:Golgi apparatus; P:post-Golgi vesicle-mediated transport; P:intracellular protein transport; P:transport; F:transporter activity; C:nucleoplasm; C:membrane coat; P:vesicle-mediated transport; C:cytoplasm; C:membrane; C:cytoplasmic vesicle; C:AP-3 adaptor complex; P:anterograde synaptic vesicle transport; C:COPI-coated vesicle; C:clathrin-coated vesicle membrane		
tr|F7BL38|F7BL38_HORSE	mucin-1 isoform X5	174	20	1.49E-125	88.95%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		
tr|F6YGW2|F6YGW2_HORSE	apoptosis regulator BAX	173	20	2.5E-96	86.4%	127	P:GO:0008584; P:GO:0009791; P:GO:0048515; P:GO:0008625; P:GO:0006687; P:GO:0002358; P:GO:0048087; P:GO:0051881; P:GO:0001822; F:GO:0046982; P:GO:1990009; P:GO:0033137; P:GO:0051402; P:GO:0051260; P:GO:0009566; P:GO:0008630; P:GO:0045136; P:GO:1902445; P:GO:0006974; P:GO:0008635; C:GO:0005635; C:GO:0005634; C:GO:0005757; C:GO:0097136; P:GO:0072332; P:GO:0001836; P:GO:0051259; P:GO:0008283; P:GO:0009651; P:GO:0008285; P:GO:0097191; P:GO:0097190; F:GO:0008289; P:GO:0097193; P:GO:0097192; P:GO:0043523; P:GO:0043525; P:GO:0043524; P:GO:0001764; C:GO:0070062; P:GO:0070584; P:GO:0071310; P:GO:0048147; P:GO:0033599; P:GO:0060011; F:GO:0015267; P:GO:2001241; P:GO:0008053; P:GO:0090200; P:GO:0043497; P:GO:0043496; P:GO:0043653; P:GO:0051281; P:GO:0002352; C:GO:0005741; P:GO:0001782; C:GO:0005622; P:GO:0001783; P:GO:0001541; P:GO:1902108; F:GO:0051434; P:GO:0001776; C:GO:0031966; P:GO:0001777; C:GO:0005737; C:GO:0005739; P:GO:0010248; P:GO:0002904; P:GO:0010524; P:GO:0070059; P:GO:2001234; P:GO:0060041; P:GO:1902110; C:GO:0046930; P:GO:1902512; P:GO:0048678; P:GO:0032091; P:GO:0009636; P:GO:0097296; C:GO:0005789; P:GO:0070242; P:GO:0006915; C:GO:0005829; P:GO:0006919; P:GO:0051726; P:GO:0010332; P:GO:2001244; P:GO:0010212; P:GO:0035234; P:GO:0046666; P:GO:0042981; P:GO:0021987; P:GO:1900103; P:GO:0043281; P:GO:0006927; P:GO:0035108; P:GO:0006808; P:GO:0060068; P:GO:0032471; P:GO:0009611; P:GO:0007399; P:GO:0021854; P:GO:0042475; P:GO:0002262; C:GO:0097144; P:GO:0007548; P:GO:0008637; P:GO:0001844; P:GO:0034644; P:GO:1902262; P:GO:0007281; P:GO:1902263; F:GO:0042802; P:GO:0060058; F:GO:0042803; P:GO:0032461; P:GO:0007283; C:GO:0005783; P:GO:0001974; P:GO:0048873; P:GO:0048872; P:GO:0048597; P:GO:1990117; P:GO:0043065; C:GO:0016020; C:GO:0016021; P:GO:0032976	P:male gonad development; P:post-embryonic development; P:spermatid differentiation; P:extrinsic apoptotic signaling pathway via death domain receptors; P:glycosphingolipid metabolic process; P:B cell homeostatic proliferation; P:positive regulation of developmental pigmentation; P:regulation of mitochondrial membrane potential; P:kidney development; F:protein heterodimerization activity; P:retinal cell apoptotic process; P:negative regulation of peptidyl-serine phosphorylation; P:neuron apoptotic process; P:protein homooligomerization; P:fertilization; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:development of secondary sexual characteristics; P:regulation of mitochondrial membrane permeability involved in programmed necrotic cell death; P:cellular response to DNA damage stimulus; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; C:nuclear envelope; C:nucleus; C:mitochondrial permeability transition pore complex; C:Bcl-2 family protein complex; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:release of cytochrome c from mitochondria; P:protein oligomerization; P:cell proliferation; P:response to salt stress; P:negative regulation of cell proliferation; P:extrinsic apoptotic signaling pathway; P:apoptotic signaling pathway; F:lipid binding; P:intrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:regulation of neuron apoptotic process; P:positive regulation of neuron apoptotic process; P:negative regulation of neuron apoptotic process; P:neuron migration; C:extracellular exosome; P:mitochondrion morphogenesis; P:cellular response to organic substance; P:negative regulation of fibroblast proliferation; P:regulation of mammary gland epithelial cell proliferation; P:Sertoli cell proliferation; F:channel activity; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:mitochondrial fusion; P:positive regulation of release of cytochrome c from mitochondria; P:regulation of protein heterodimerization activity; P:regulation of protein homodimerization activity; P:mitochondrial fragmentation involved in apoptotic process; P:positive regulation of release of sequestered calcium ion into cytosol; P:B cell negative selection; C:mitochondrial outer membrane; P:B cell homeostasis; C:intracellular; P:B cell apoptotic process; P:ovarian follicle development; P:regulation of mitochondrial membrane permeability involved in apoptotic process; F:BH3 domain binding; P:leukocyte homeostasis; C:mitochondrial membrane; P:T cell homeostatic proliferation; C:cytoplasm; C:mitochondrion; P:establishment or maintenance of transmembrane electrochemical gradient; P:positive regulation of B cell apoptotic process; P:positive regulation of calcium ion transport into cytosol; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of apoptotic signaling pathway; P:retina development in camera-type eye; P:positive regulation of mitochondrial membrane permeability involved in apoptotic process; C:pore complex; P:positive regulation of apoptotic DNA fragmentation; P:response to axon injury; P:negative regulation of protein binding; P:response to toxic substance; P:activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; C:endoplasmic reticulum membrane; P:thymocyte apoptotic process; P:apoptotic process; C:cytosol; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:regulation of cell cycle; P:response to gamma radiation; P:positive regulation of intrinsic apoptotic signaling pathway; P:response to ionizing radiation; P:ectopic germ cell programmed cell death; P:retinal cell programmed cell death; P:regulation of apoptotic process; P:cerebral cortex development; P:positive regulation of endoplasmic reticulum unfolded protein response; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:obsolete transformed cell apoptotic process; P:limb morphogenesis; P:regulation of nitrogen utilization; P:vagina development; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:response to wounding; P:nervous system development; P:hypothalamus development; P:odontogenesis of dentin-containing tooth; P:myeloid cell homeostasis; C:BAX complex; P:sex differentiation; P:apoptotic mitochondrial changes; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:cellular response to UV; P:apoptotic process involved in patterning of blood vessels; P:germ cell development; P:apoptotic process involved in embryonic digit morphogenesis; F:identical protein binding; P:positive regulation of apoptotic process involved in mammary gland involution; F:protein homodimerization activity; P:positive regulation of protein oligomerization; P:spermatogenesis; C:endoplasmic reticulum; P:blood vessel remodeling; P:homeostasis of number of cells within a tissue; P:homeostasis of number of cells; P:post-embryonic camera-type eye morphogenesis; P:B cell receptor apoptotic signaling pathway; P:positive regulation of apoptotic process; C:membrane; C:integral component of membrane; P:release of matrix enzymes from mitochondria		
sp|A2Q127|EF1G_HORSE	elongation factor 1-gamma	437	20	0E0	99.25%	13	C:GO:0005783; F:GO:0004364; P:GO:0009615; P:GO:0006414; P:GO:0006412; C:GO:0005634; F:GO:0005515; C:GO:0070062; F:GO:0003746; C:GO:0005737; P:GO:0006749; C:GO:0016020; C:GO:0005829	C:endoplasmic reticulum; F:glutathione transferase activity; P:response to virus; P:translational elongation; P:translation; C:nucleus; F:protein binding; C:extracellular exosome; F:translation elongation factor activity; C:cytoplasm; P:glutathione metabolic process; C:membrane; C:cytosol		
tr|F7CSN0|F7CSN0_HORSE	ras-specific guanine nucleotide-releasing factor 1 isoform X2	1247	20	0E0	98.1%	17	P:GO:0008283; P:GO:0035023; F:GO:0035254; P:GO:0090630; P:GO:0007264; P:GO:0031175; P:GO:0035020; F:GO:0005085; P:GO:0046578; F:GO:0005089; P:GO:0043547; C:GO:0005622; C:GO:0030426; P:GO:0048168; C:GO:0005829; P:GO:2000310; P:GO:0035556	P:cell proliferation; P:regulation of Rho protein signal transduction; F:glutamate receptor binding; P:activation of GTPase activity; P:small GTPase mediated signal transduction; P:neuron projection development; P:regulation of Rac protein signal transduction; F:guanyl-nucleotide exchange factor activity; P:regulation of Ras protein signal transduction; F:Rho guanyl-nucleotide exchange factor activity; P:positive regulation of GTPase activity; C:intracellular; C:growth cone; P:regulation of neuronal synaptic plasticity; C:cytosol; P:regulation of N-methyl-D-aspartate selective glutamate receptor activity; P:intracellular signal transduction		
tr|F6XJF9|F6XJF9_HORSE	nucleo TPR	2299	20	0E0	98.2%	78	P:GO:0007094; P:GO:0070849; F:GO:0015631; P:GO:0016925; P:GO:0015031; C:GO:0000776; P:GO:0051292; C:GO:0000775; P:GO:0019083; P:GO:0006913; C:GO:0005868; P:GO:0006999; P:GO:0075733; F:GO:0003729; P:GO:0031990; F:GO:0070840; F:GO:0031072; P:GO:0042306; P:GO:0008150; P:GO:0042307; P:GO:0046827; P:GO:0090267; P:GO:1901673; P:GO:0007067; P:GO:0006611; P:GO:0046825; F:GO:0005487; P:GO:0006810; P:GO:0000189; C:GO:0005643; C:GO:0005635; P:GO:0006406; P:GO:0010827; C:GO:0005634; P:GO:0006404; F:GO:0005515; P:GO:0006405; P:GO:0006606; P:GO:0006409; F:GO:0051019; P:GO:0090316; C:GO:0044615; P:GO:0045947; P:GO:0007077; P:GO:1900034; P:GO:0046832; C:GO:0005694; C:GO:0005575; F:GO:0003674; F:GO:0005215; C:GO:0005654; P:GO:0051301; P:GO:0000122; P:GO:0034605; C:GO:0072686; F:GO:0043495; P:GO:0016032; P:GO:0031453; P:GO:0010793; P:GO:0051028; P:GO:0035457; C:GO:0042405; F:GO:0042803; F:GO:0003682; P:GO:0043578; P:GO:0007049; C:GO:0005622; F:GO:0044822; C:GO:0031965; C:GO:0005856; P:GO:0031647; C:GO:0005737; C:GO:0016020; C:GO:0005819; P:GO:0031047; P:GO:0010965; C:GO:0034399; C:GO:0019898	P:mitotic spindle assembly checkpoint; P:response to epidermal growth factor; F:tubulin binding; P:protein sumoylation; P:protein transport; C:kinetochore; P:nuclear pore complex assembly; C:chromosome, centromeric region; P:viral transcription; P:nucleocytoplasmic transport; C:cytoplasmic dynein complex; P:nuclear pore organization; P:intracellular transport of virus; F:mRNA binding; P:mRNA export from nucleus in response to heat stress; F:dynein complex binding; F:heat shock protein binding; P:regulation of protein import into nucleus; P:biological_process; P:positive regulation of protein import into nucleus; P:positive regulation of protein export from nucleus; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:regulation of mitotic spindle assembly; P:mitotic nuclear division; P:protein export from nucleus; P:regulation of protein export from nucleus; F:nucleocytoplasmic transporter activity; P:transport; P:MAPK import into nucleus; C:nuclear pore; C:nuclear envelope; P:mRNA export from nucleus; P:regulation of glucose transport; C:nucleus; P:RNA import into nucleus; F:protein binding; P:RNA export from nucleus; P:protein import into nucleus; P:tRNA export from nucleus; F:mitogen-activated protein kinase binding; P:positive regulation of intracellular protein transport; C:nuclear pore nuclear basket; P:negative regulation of translational initiation; P:mitotic nuclear envelope disassembly; P:regulation of cellular response to heat; P:negative regulation of RNA export from nucleus; C:chromosome; C:cellular_component; F:molecular_function; F:transporter activity; C:nucleoplasm; P:cell division; P:negative regulation of transcription from RNA polymerase II promoter; P:cellular response to heat; C:mitotic spindle; F:protein anchor; P:viral process; P:positive regulation of heterochromatin assembly; P:regulation of mRNA export from nucleus; P:mRNA transport; P:cellular response to interferon-alpha; C:nuclear inclusion body; F:protein homodimerization activity; F:chromatin binding; P:nuclear matrix organization; P:cell cycle; C:intracellular; F:poly(A) RNA binding; C:nuclear membrane; C:cytoskeleton; P:regulation of protein stability; C:cytoplasm; C:membrane; C:spindle; P:gene silencing by RNA; P:regulation of mitotic sister chromatid separation; C:nuclear periphery; C:extrinsic component of membrane		
tr|F6Y257|F6Y257_HORSE	nucleo TPR	2313	20	0E0	98.9%	42	P:GO:0070849; P:GO:0007094; P:GO:0090316; C:GO:0044615; F:GO:0015631; P:GO:0045947; P:GO:0046832; C:GO:0000776; P:GO:0000122; P:GO:0006913; C:GO:0005868; P:GO:0006999; P:GO:0034605; C:GO:0072686; P:GO:0031453; F:GO:0003729; P:GO:0031990; F:GO:0070840; P:GO:0035457; F:GO:0031072; C:GO:0042405; P:GO:0042307; F:GO:0042803; P:GO:0090267; P:GO:1901673; F:GO:0003682; F:GO:0005487; C:GO:0005622; C:GO:0005643; P:GO:0000189; F:GO:0044822; C:GO:0005635; C:GO:0005634; C:GO:0031965; P:GO:0006404; P:GO:0006405; C:GO:0005737; P:GO:0006606; P:GO:0010965; C:GO:0034399; C:GO:0019898; F:GO:0051019	P:response to epidermal growth factor; P:mitotic spindle assembly checkpoint; P:positive regulation of intracellular protein transport; C:nuclear pore nuclear basket; F:tubulin binding; P:negative regulation of translational initiation; P:negative regulation of RNA export from nucleus; C:kinetochore; P:negative regulation of transcription from RNA polymerase II promoter; P:nucleocytoplasmic transport; C:cytoplasmic dynein complex; P:nuclear pore organization; P:cellular response to heat; C:mitotic spindle; P:positive regulation of heterochromatin assembly; F:mRNA binding; P:mRNA export from nucleus in response to heat stress; F:dynein complex binding; P:cellular response to interferon-alpha; F:heat shock protein binding; C:nuclear inclusion body; P:positive regulation of protein import into nucleus; F:protein homodimerization activity; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:regulation of mitotic spindle assembly; F:chromatin binding; F:nucleocytoplasmic transporter activity; C:intracellular; C:nuclear pore; P:MAPK import into nucleus; F:poly(A) RNA binding; C:nuclear envelope; C:nucleus; C:nuclear membrane; P:RNA import into nucleus; P:RNA export from nucleus; C:cytoplasm; P:protein import into nucleus; P:regulation of mitotic sister chromatid separation; C:nuclear periphery; C:extrinsic component of membrane; F:mitogen-activated protein kinase binding		
tr|F6VAW6|F6VAW6_HORSE	collagen alpha-1(XI) chain isoform X4	1689	20	0E0	98.2%	30	P:GO:0055010; C:GO:0005592; P:GO:0002063; C:GO:0005576; P:GO:0006029; C:GO:0005578; P:GO:0007605; C:GO:0005788; P:GO:0003007; P:GO:0001502; P:GO:0001503; C:GO:0031012; P:GO:0050910; C:GO:0005581; P:GO:0007601; F:GO:0005201; P:GO:0048705; P:GO:0048704; F:GO:0050840; F:GO:0046872; P:GO:0042472; C:GO:0016020; C:GO:0016021; P:GO:0030198; P:GO:0035987; P:GO:0035989; P:GO:0030574; P:GO:0030199; F:GO:0030674; P:GO:0051216	P:ventricular cardiac muscle tissue morphogenesis; C:collagen type XI trimer; P:chondrocyte development; C:extracellular region; P:proteoglycan metabolic process; C:proteinaceous extracellular matrix; P:sensory perception of sound; C:endoplasmic reticulum lumen; P:heart morphogenesis; P:cartilage condensation; P:ossification; C:extracellular matrix; P:detection of mechanical stimulus involved in sensory perception of sound; C:collagen trimer; P:visual perception; F:extracellular matrix structural constituent; P:skeletal system morphogenesis; P:embryonic skeletal system morphogenesis; F:extracellular matrix binding; F:metal ion binding; P:inner ear morphogenesis; C:membrane; C:integral component of membrane; P:extracellular matrix organization; P:endodermal cell differentiation; P:tendon development; P:collagen catabolic process; P:collagen fibril organization; F:protein binding, bridging; P:cartilage development		
tr|F6U661|F6U661_HORSE	collagen alpha-1(XI) chain isoform X2	1801	20	0E0	94.25%	19	P:GO:0055010; C:GO:0005592; C:GO:0005581; P:GO:0002063; P:GO:0007601; F:GO:0005201; P:GO:0006029; P:GO:0048705; C:GO:0005578; P:GO:0048704; P:GO:0007605; P:GO:0003007; P:GO:0001502; P:GO:0042472; P:GO:0035987; P:GO:0035989; P:GO:0030199; P:GO:0050910; P:GO:0051216	P:ventricular cardiac muscle tissue morphogenesis; C:collagen type XI trimer; C:collagen trimer; P:chondrocyte development; P:visual perception; F:extracellular matrix structural constituent; P:proteoglycan metabolic process; P:skeletal system morphogenesis; C:proteinaceous extracellular matrix; P:embryonic skeletal system morphogenesis; P:sensory perception of sound; P:heart morphogenesis; P:cartilage condensation; P:inner ear morphogenesis; P:endodermal cell differentiation; P:tendon development; P:collagen fibril organization; P:detection of mechanical stimulus involved in sensory perception of sound; P:cartilage development		
tr|F6VBF7|F6VBF7_HORSE	collagen alpha-1(XI) chain isoform X1	1805	20	0E0	98.5%	28	P:GO:0055010; C:GO:0005592; P:GO:0002063; C:GO:0005576; P:GO:0006029; C:GO:0005578; P:GO:0007605; C:GO:0005788; P:GO:0003007; P:GO:0001502; P:GO:0001503; C:GO:0031012; P:GO:0050910; C:GO:0005581; P:GO:0007601; F:GO:0005201; P:GO:0048705; P:GO:0048704; F:GO:0050840; F:GO:0046872; P:GO:0042472; P:GO:0030198; P:GO:0035987; P:GO:0035989; P:GO:0030574; P:GO:0030199; F:GO:0030674; P:GO:0051216	P:ventricular cardiac muscle tissue morphogenesis; C:collagen type XI trimer; P:chondrocyte development; C:extracellular region; P:proteoglycan metabolic process; C:proteinaceous extracellular matrix; P:sensory perception of sound; C:endoplasmic reticulum lumen; P:heart morphogenesis; P:cartilage condensation; P:ossification; C:extracellular matrix; P:detection of mechanical stimulus involved in sensory perception of sound; C:collagen trimer; P:visual perception; F:extracellular matrix structural constituent; P:skeletal system morphogenesis; P:embryonic skeletal system morphogenesis; F:extracellular matrix binding; F:metal ion binding; P:inner ear morphogenesis; P:extracellular matrix organization; P:endodermal cell differentiation; P:tendon development; P:collagen catabolic process; P:collagen fibril organization; F:protein binding, bridging; P:cartilage development		
tr|F6RL09|F6RL09_HORSE	glia maturation factor gamma isoform X1	142	20	1.36E-100	99.45%	11	F:GO:0008083; F:GO:0003779; P:GO:0043085; F:GO:0008047; P:GO:2000249; P:GO:0006468; F:GO:0004860; P:GO:0006469; C:GO:0005622; P:GO:0034316; F:GO:0071933	F:growth factor activity; F:actin binding; P:positive regulation of catalytic activity; F:enzyme activator activity; P:regulation of actin cytoskeleton reorganization; P:protein phosphorylation; F:protein kinase inhibitor activity; P:negative regulation of protein kinase activity; C:intracellular; P:negative regulation of Arp2/3 complex-mediated actin nucleation; F:Arp2/3 complex binding		
tr|F7BW76|F7BW76_HORSE	glia maturation factor beta isoform X1	155	20	1.13E-99	95.1%	15	F:GO:0008083; P:GO:0007165; P:GO:0007399; F:GO:0008047; P:GO:0007612; P:GO:0006468; F:GO:0004860; F:GO:0004871; P:GO:0006469; C:GO:0005622; P:GO:0007626; F:GO:0003779; P:GO:0043085; P:GO:0034316; F:GO:0071933	F:growth factor activity; P:signal transduction; P:nervous system development; F:enzyme activator activity; P:learning; P:protein phosphorylation; F:protein kinase inhibitor activity; F:signal transducer activity; P:negative regulation of protein kinase activity; C:intracellular; P:locomotory behavior; F:actin binding; P:positive regulation of catalytic activity; P:negative regulation of Arp2/3 complex-mediated actin nucleation; F:Arp2/3 complex binding		
tr|F6YBT5|F6YBT5_HORSE	V-type proton ATPase catalytic subunit A	617	20	0E0	99.05%	20	C:GO:0043209; P:GO:0015992; P:GO:0015991; F:GO:0046961; C:GO:0033180; P:GO:0006810; C:GO:0005886; C:GO:0005765; F:GO:0000166; F:GO:0005524; P:GO:0006811; C:GO:0070062; C:GO:0005902; C:GO:0005739; P:GO:0046034; C:GO:0005829; C:GO:0033178; C:GO:0016324; F:GO:0016820; F:GO:0016787	C:myelin sheath; P:proton transport; P:ATP hydrolysis coupled proton transport; F:proton-transporting ATPase activity, rotational mechanism; C:proton-transporting V-type ATPase, V1 domain; P:transport; C:plasma membrane; C:lysosomal membrane; F:nucleotide binding; F:ATP binding; P:ion transport; C:extracellular exosome; C:microvillus; C:mitochondrion; P:ATP metabolic process; C:cytosol; C:proton-transporting two-sector ATPase complex, catalytic domain; C:apical plasma membrane; F:hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; F:hydrolase activity		
tr|F6SP74|F6SP74_HORSE	properdin	465	20	0E0	88.3%	1	C:GO:0031012	C:extracellular matrix		
tr|F7AW38|F7AW38_HORSE	ran-binding 6 isoform X1	1105	20	0E0	99.15%	12	C:GO:0031965; C:GO:0005737; P:GO:0006607; P:GO:0000060; F:GO:0008565; C:GO:0034399; P:GO:0006886; P:GO:0000059; F:GO:0008536; F:GO:0008139; C:GO:0005622; P:GO:0006610	C:nuclear membrane; C:cytoplasm; P:NLS-bearing protein import into nucleus; P:protein import into nucleus, translocation; F:protein transporter activity; C:nuclear periphery; P:intracellular protein transport; P:protein import into nucleus, docking; F:Ran GTPase binding; F:nuclear localization sequence binding; C:intracellular; P:ribosomal protein import into nucleus		
tr|F7CDB4|F7CDB4_HORSE	aspartate cytoplasmic	413	20	0E0	96.95%	27	F:GO:0030170; F:GO:0080130; F:GO:0008483; P:GO:0006520; P:GO:0009058; F:GO:0004069; F:GO:0047801; P:GO:0032869; C:GO:0070062; F:GO:0003824; P:GO:0051384; C:GO:0005829; F:GO:0042802; P:GO:0055089; P:GO:0008652; P:GO:0006114; P:GO:0006532; P:GO:0006533; C:GO:0005634; P:GO:0006107; P:GO:0007219; C:GO:0005737; P:GO:0019551; P:GO:0019550; C:GO:0005739; F:GO:0004609; F:GO:0016740	F:pyridoxal phosphate binding; F:L-phenylalanine:2-oxoglutarate aminotransferase activity; F:transaminase activity; P:cellular amino acid metabolic process; P:biosynthetic process; F:L-aspartate:2-oxoglutarate aminotransferase activity; F:L-cysteine:2-oxoglutarate aminotransferase activity; P:cellular response to insulin stimulus; C:extracellular exosome; F:catalytic activity; P:response to glucocorticoid; C:cytosol; F:identical protein binding; P:fatty acid homeostasis; P:cellular amino acid biosynthetic process; P:glycerol biosynthetic process; P:aspartate biosynthetic process; P:aspartate catabolic process; C:nucleus; P:oxaloacetate metabolic process; P:Notch signaling pathway; C:cytoplasm; P:glutamate catabolic process to 2-oxoglutarate; P:glutamate catabolic process to aspartate; C:mitochondrion; F:phosphatidylserine decarboxylase activity; F:transferase activity		
tr|F6VCS1|F6VCS1_HORSE	carcinoembryonic antigen-related cell adhesion molecule 1-like isoform X1	522	20	0E0	89.65%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		
tr|F6PLF6|F6PLF6_HORSE	2-phosphoxylose phosphatase 1 isoform X1	479	20	0E0	96.9%	12	P:GO:0050650; F:GO:0005515; C:GO:0016020; F:GO:0016791; C:GO:0016021; P:GO:0006024; C:GO:0005794; C:GO:0000139; P:GO:0016311; P:GO:0010909; F:GO:0003993; F:GO:0016787	P:chondroitin sulfate proteoglycan biosynthetic process; F:protein binding; C:membrane; F:phosphatase activity; C:integral component of membrane; P:glycosaminoglycan biosynthetic process; C:Golgi apparatus; C:Golgi membrane; P:dephosphorylation; P:positive regulation of heparan sulfate proteoglycan biosynthetic process; F:acid phosphatase activity; F:hydrolase activity		
tr|F6V5D4|F6V5D4_HORSE	phosphatase and actin regulator 2 isoform X1	637	20	0E0	93.55%	3	F:GO:0004864; F:GO:0003779; P:GO:0043086	F:protein phosphatase inhibitor activity; F:actin binding; P:negative regulation of catalytic activity		
tr|F6XH74|F6XH74_HORSE	high mobility group B1	211	20	2.16E-143	98.85%	141	P:GO:0006281; P:GO:0006284; P:GO:0050718; F:GO:0003690; P:GO:1901224; F:GO:0003697; P:GO:0032727; C:GO:0005623; F:GO:0001786; P:GO:0006954; F:GO:0003725; P:GO:0032728; F:GO:0003727; P:GO:0050716; P:GO:0032689; P:GO:2001200; P:GO:0035711; P:GO:0045819; P:GO:0002250; F:GO:0005125; P:GO:0006974; P:GO:0045931; P:GO:0006334; P:GO:0002376; C:GO:0005886; P:GO:0002643; C:GO:0005634; F:GO:0005515; P:GO:1990774; F:GO:0042393; C:GO:0017053; P:GO:0002407; P:GO:0017055; P:GO:0071642; P:GO:0032392; C:GO:0005694; P:GO:0006265; P:GO:2000819; P:GO:0045944; C:GO:0005576; C:GO:0043005; P:GO:0097350; F:GO:0001530; F:GO:0097100; P:GO:0006935; F:GO:0003700; F:GO:0070182; P:GO:2000778; P:GO:0002218; P:GO:0043371; P:GO:0051384; P:GO:0032147; P:GO:0032425; P:GO:0034162; P:GO:0043537; P:GO:0031175; P:GO:0034165; P:GO:1903672; P:GO:0006310; F:GO:0003681; P:GO:1902741; P:GO:0043410; F:GO:0003684; P:GO:0001773; F:GO:0003677; P:GO:0001654; C:GO:0005615; P:GO:2000426; C:GO:0005737; P:GO:0006309; P:GO:0001934; P:GO:0001935; P:GO:0035767; F:GO:0019958; P:GO:0050918; P:GO:0002281; F:GO:0042056; F:GO:0008301; F:GO:0045322; P:GO:0043388; C:GO:0005793; P:GO:0002322; P:GO:0002437; P:GO:0006914; F:GO:0010858; C:GO:0005829; P:GO:0032760; P:GO:0090303; P:GO:0045859; P:GO:0034145; P:GO:0090026; P:GO:0043277; P:GO:0002053; P:GO:0042104; C:GO:0000793; P:GO:0002840; P:GO:0043280; P:GO:0045063; P:GO:0032757; C:GO:0000790; P:GO:0010506; P:GO:0034137; P:GO:0032755; P:GO:0030335; P:GO:0032072; F:GO:0030295; F:GO:0016829; F:GO:0044378; C:GO:0005654; P:GO:0051103; P:GO:0000122; C:GO:0005769; P:GO:0006338; C:GO:0005768; P:GO:0031497; P:GO:0030324; P:GO:0050930; P:GO:0051106; P:GO:0033151; P:GO:0045639; P:GO:0002270; F:GO:0000405; F:GO:0008134; F:GO:0000402; F:GO:0000401; F:GO:0000400; C:GO:0009986; P:GO:0007204; P:GO:0006357; F:GO:0044822; P:GO:0032735; F:GO:0070491; P:GO:0045089; P:GO:0046330; P:GO:0045087; P:GO:0043065; C:GO:0016020; P:GO:0070374; P:GO:0032733; F:GO:0050786; P:GO:0032732	P:DNA repair; P:base-excision repair; P:positive regulation of interleukin-1 beta secretion; F:double-stranded DNA binding; P:positive regulation of NIK/NF-kappaB signaling; F:single-stranded DNA binding; P:positive regulation of interferon-alpha production; C:cell; F:phosphatidylserine binding; P:inflammatory response; F:double-stranded RNA binding; P:positive regulation of interferon-beta production; F:single-stranded RNA binding; P:positive regulation of interleukin-1 secretion; P:negative regulation of interferon-gamma production; P:positive regulation of dendritic cell differentiation; P:T-helper 1 cell activation; P:positive regulation of glycogen catabolic process; P:adaptive immune response; F:cytokine activity; P:cellular response to DNA damage stimulus; P:positive regulation of mitotic cell cycle; P:nucleosome assembly; P:immune system process; C:plasma membrane; P:regulation of tolerance induction; C:nucleus; F:protein binding; P:tumor necrosis factor secretion; F:histone binding; C:transcriptional repressor complex; P:dendritic cell chemotaxis; P:negative regulation of RNA polymerase II transcriptional preinitiation complex assembly; P:positive regulation of macrophage inflammatory protein 1 alpha production; P:DNA geometric change; C:chromosome; P:DNA topological change; P:regulation of nucleotide-excision repair; P:positive regulation of transcription from RNA polymerase II promoter; C:extracellular region; C:neuron projection; P:neutrophil clearance; F:lipopolysaccharide binding; F:supercoiled DNA binding; P:chemotaxis; F:transcription factor activity, sequence-specific DNA binding; F:DNA polymerase binding; P:positive regulation of interleukin-6 secretion; P:activation of innate immune response; P:negative regulation of CD4-positive, alpha-beta T cell differentiation; P:response to glucocorticoid; P:activation of protein kinase activity; P:positive regulation of mismatch repair; P:toll-like receptor 9 signaling pathway; P:negative regulation of blood vessel endothelial cell migration; P:neuron projection development; P:positive regulation of toll-like receptor 9 signaling pathway; P:positive regulation of sprouting angiogenesis; P:DNA recombination; F:bent DNA binding; P:positive regulation of interferon-alpha secretion; P:positive regulation of MAPK cascade; F:damaged DNA binding; P:myeloid dendritic cell activation; F:DNA binding; P:eye development; C:extracellular space; P:negative regulation of apoptotic cell clearance; C:cytoplasm; P:apoptotic DNA fragmentation; P:positive regulation of protein phosphorylation; P:endothelial cell proliferation; P:endothelial cell chemotaxis; F:C-X-C chemokine binding; P:positive chemotaxis; P:macrophage activation involved in immune response; F:chemoattractant activity; F:DNA binding, bending; F:unmethylated CpG binding; P:positive regulation of DNA binding; C:endoplasmic reticulum-Golgi intermediate compartment; P:B cell proliferation involved in immune response; P:inflammatory response to antigenic stimulus; P:autophagy; F:calcium-dependent protein kinase regulator activity; C:cytosol; P:positive regulation of tumor necrosis factor production; P:positive regulation of wound healing; P:regulation of protein kinase activity; P:positive regulation of toll-like receptor 4 signaling pathway; P:positive regulation of monocyte chemotaxis; P:apoptotic cell clearance; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of activated T cell proliferation; C:condensed chromosome; P:regulation of T cell mediated immune response to tumor cell; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:T-helper 1 cell differentiation; P:positive regulation of interleukin-8 production; C:nuclear chromatin; P:regulation of autophagy; P:positive regulation of toll-like receptor 2 signaling pathway; P:positive regulation of interleukin-6 production; P:positive regulation of cell migration; P:regulation of restriction endodeoxyribonuclease activity; F:protein kinase activator activity; F:lyase activity; F:non-sequence-specific DNA binding, bending; C:nucleoplasm; P:DNA ligation involved in DNA repair; P:negative regulation of transcription from RNA polymerase II promoter; C:early endosome; P:chromatin remodeling; C:endosome; P:chromatin assembly; P:lung development; P:induction of positive chemotaxis; P:positive regulation of DNA ligation; P:V(D)J recombination; P:positive regulation of myeloid cell differentiation; P:plasmacytoid dendritic cell activation; F:bubble DNA binding; F:transcription factor binding; F:crossed form four-way junction DNA binding; F:open form four-way junction DNA binding; F:four-way junction DNA binding; C:cell surface; P:positive regulation of cytosolic calcium ion concentration; P:regulation of transcription from RNA polymerase II promoter; F:poly(A) RNA binding; P:positive regulation of interleukin-12 production; F:repressing transcription factor binding; P:positive regulation of innate immune response; P:positive regulation of JNK cascade; P:innate immune response; P:positive regulation of apoptotic process; C:membrane; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of interleukin-10 production; F:RAGE receptor binding; P:positive regulation of interleukin-1 production		
tr|F6S6S0|F6S6S0_HORSE	high mobility group B1	212	20	1.11E-139	96.15%	135	P:GO:0006281; P:GO:0006284; P:GO:0050718; F:GO:0003690; P:GO:1901224; F:GO:0003697; P:GO:0032727; C:GO:0005623; F:GO:0001786; P:GO:0006954; F:GO:0003725; P:GO:0032728; F:GO:0003727; P:GO:0050716; P:GO:0032689; P:GO:2001200; P:GO:0035711; P:GO:0045819; P:GO:0002250; F:GO:0005125; P:GO:0006974; P:GO:0045931; P:GO:0006334; P:GO:0002376; C:GO:0005886; P:GO:0002643; C:GO:0005634; F:GO:0005515; P:GO:1990774; C:GO:0017053; P:GO:0002407; P:GO:0017055; P:GO:0071642; P:GO:0032392; C:GO:0005694; P:GO:0006265; P:GO:2000819; P:GO:0045944; C:GO:0005576; C:GO:0043005; P:GO:0097350; F:GO:0001530; F:GO:0097100; P:GO:0006935; F:GO:0003700; F:GO:0070182; P:GO:2000778; P:GO:0002218; P:GO:0043371; P:GO:0051384; P:GO:0032147; P:GO:0032425; P:GO:0043537; P:GO:0031175; P:GO:0034165; P:GO:1903672; P:GO:0006310; F:GO:0003681; P:GO:0043410; F:GO:0003684; P:GO:0001773; F:GO:0003677; P:GO:0001654; C:GO:0005615; P:GO:2000426; C:GO:0005737; P:GO:0006309; P:GO:0001934; P:GO:0001935; P:GO:0035767; F:GO:0019958; P:GO:0050918; P:GO:0002281; F:GO:0042056; F:GO:0008301; P:GO:0043388; C:GO:0005793; P:GO:0002437; P:GO:0006914; F:GO:0010858; C:GO:0005829; P:GO:0032760; P:GO:0090303; P:GO:0045859; P:GO:0034145; P:GO:0090026; P:GO:0043277; P:GO:0002053; P:GO:0042104; C:GO:0000793; P:GO:0002840; P:GO:0043280; P:GO:0045063; P:GO:0032757; C:GO:0000790; P:GO:0010506; P:GO:0034137; P:GO:0032755; P:GO:0030335; P:GO:0032072; F:GO:0030295; F:GO:0016829; F:GO:0044378; C:GO:0005654; P:GO:0051103; P:GO:0000122; C:GO:0005769; C:GO:0005768; P:GO:0031497; P:GO:0030324; P:GO:0050930; P:GO:0051106; P:GO:0033151; P:GO:0045639; P:GO:0002270; F:GO:0000405; F:GO:0008134; F:GO:0000402; F:GO:0000401; F:GO:0000400; C:GO:0009986; P:GO:0007204; P:GO:0006357; F:GO:0044822; P:GO:0032735; F:GO:0070491; P:GO:0045089; P:GO:0046330; P:GO:0045087; P:GO:0043065; C:GO:0016020; P:GO:0070374; P:GO:0032733; F:GO:0050786; P:GO:0032732	P:DNA repair; P:base-excision repair; P:positive regulation of interleukin-1 beta secretion; F:double-stranded DNA binding; P:positive regulation of NIK/NF-kappaB signaling; F:single-stranded DNA binding; P:positive regulation of interferon-alpha production; C:cell; F:phosphatidylserine binding; P:inflammatory response; F:double-stranded RNA binding; P:positive regulation of interferon-beta production; F:single-stranded RNA binding; P:positive regulation of interleukin-1 secretion; P:negative regulation of interferon-gamma production; P:positive regulation of dendritic cell differentiation; P:T-helper 1 cell activation; P:positive regulation of glycogen catabolic process; P:adaptive immune response; F:cytokine activity; P:cellular response to DNA damage stimulus; P:positive regulation of mitotic cell cycle; P:nucleosome assembly; P:immune system process; C:plasma membrane; P:regulation of tolerance induction; C:nucleus; F:protein binding; P:tumor necrosis factor secretion; C:transcriptional repressor complex; P:dendritic cell chemotaxis; P:negative regulation of RNA polymerase II transcriptional preinitiation complex assembly; P:positive regulation of macrophage inflammatory protein 1 alpha production; P:DNA geometric change; C:chromosome; P:DNA topological change; P:regulation of nucleotide-excision repair; P:positive regulation of transcription from RNA polymerase II promoter; C:extracellular region; C:neuron projection; P:neutrophil clearance; F:lipopolysaccharide binding; F:supercoiled DNA binding; P:chemotaxis; F:transcription factor activity, sequence-specific DNA binding; F:DNA polymerase binding; P:positive regulation of interleukin-6 secretion; P:activation of innate immune response; P:negative regulation of CD4-positive, alpha-beta T cell differentiation; P:response to glucocorticoid; P:activation of protein kinase activity; P:positive regulation of mismatch repair; P:negative regulation of blood vessel endothelial cell migration; P:neuron projection development; P:positive regulation of toll-like receptor 9 signaling pathway; P:positive regulation of sprouting angiogenesis; P:DNA recombination; F:bent DNA binding; P:positive regulation of MAPK cascade; F:damaged DNA binding; P:myeloid dendritic cell activation; F:DNA binding; P:eye development; C:extracellular space; P:negative regulation of apoptotic cell clearance; C:cytoplasm; P:apoptotic DNA fragmentation; P:positive regulation of protein phosphorylation; P:endothelial cell proliferation; P:endothelial cell chemotaxis; F:C-X-C chemokine binding; P:positive chemotaxis; P:macrophage activation involved in immune response; F:chemoattractant activity; F:DNA binding, bending; P:positive regulation of DNA binding; C:endoplasmic reticulum-Golgi intermediate compartment; P:inflammatory response to antigenic stimulus; P:autophagy; F:calcium-dependent protein kinase regulator activity; C:cytosol; P:positive regulation of tumor necrosis factor production; P:positive regulation of wound healing; P:regulation of protein kinase activity; P:positive regulation of toll-like receptor 4 signaling pathway; P:positive regulation of monocyte chemotaxis; P:apoptotic cell clearance; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of activated T cell proliferation; C:condensed chromosome; P:regulation of T cell mediated immune response to tumor cell; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:T-helper 1 cell differentiation; P:positive regulation of interleukin-8 production; C:nuclear chromatin; P:regulation of autophagy; P:positive regulation of toll-like receptor 2 signaling pathway; P:positive regulation of interleukin-6 production; P:positive regulation of cell migration; P:regulation of restriction endodeoxyribonuclease activity; F:protein kinase activator activity; F:lyase activity; F:non-sequence-specific DNA binding, bending; C:nucleoplasm; P:DNA ligation involved in DNA repair; P:negative regulation of transcription from RNA polymerase II promoter; C:early endosome; C:endosome; P:chromatin assembly; P:lung development; P:induction of positive chemotaxis; P:positive regulation of DNA ligation; P:V(D)J recombination; P:positive regulation of myeloid cell differentiation; P:plasmacytoid dendritic cell activation; F:bubble DNA binding; F:transcription factor binding; F:crossed form four-way junction DNA binding; F:open form four-way junction DNA binding; F:four-way junction DNA binding; C:cell surface; P:positive regulation of cytosolic calcium ion concentration; P:regulation of transcription from RNA polymerase II promoter; F:poly(A) RNA binding; P:positive regulation of interleukin-12 production; F:repressing transcription factor binding; P:positive regulation of innate immune response; P:positive regulation of JNK cascade; P:innate immune response; P:positive regulation of apoptotic process; C:membrane; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of interleukin-10 production; F:RAGE receptor binding; P:positive regulation of interleukin-1 production		
sp|Q08IE6|HMGB1_HORSE	high mobility group B1	215	20	1.03E-148	99.8%	141	P:GO:0006281; P:GO:0006284; P:GO:0050718; F:GO:0003690; P:GO:1901224; F:GO:0003697; P:GO:0032727; C:GO:0005623; F:GO:0001786; P:GO:0006954; F:GO:0003725; P:GO:0032728; F:GO:0003727; P:GO:0050716; P:GO:0032689; P:GO:2001200; P:GO:0035711; P:GO:0045819; P:GO:0002250; F:GO:0005125; P:GO:0006974; P:GO:0045931; P:GO:0006334; P:GO:0002376; C:GO:0005886; P:GO:0002643; C:GO:0005634; F:GO:0005515; P:GO:1990774; F:GO:0042393; C:GO:0017053; P:GO:0002407; P:GO:0017055; P:GO:0071642; P:GO:0032392; C:GO:0005694; P:GO:0006265; P:GO:2000819; P:GO:0045944; C:GO:0005576; C:GO:0043005; P:GO:0097350; F:GO:0001530; F:GO:0097100; P:GO:0006935; F:GO:0003700; F:GO:0070182; P:GO:2000778; P:GO:0002218; P:GO:0043371; P:GO:0051384; P:GO:0032147; P:GO:0032425; P:GO:0034162; P:GO:0043537; P:GO:0031175; P:GO:0034165; P:GO:1903672; P:GO:0006310; F:GO:0003681; P:GO:1902741; P:GO:0043410; F:GO:0003684; P:GO:0001773; F:GO:0003677; P:GO:0001654; C:GO:0005615; P:GO:2000426; C:GO:0005737; P:GO:0006309; P:GO:0001934; P:GO:0001935; P:GO:0035767; F:GO:0019958; P:GO:0050918; P:GO:0002281; F:GO:0042056; F:GO:0008301; F:GO:0045322; P:GO:0043388; C:GO:0005793; P:GO:0002322; P:GO:0002437; P:GO:0006914; F:GO:0010858; C:GO:0005829; P:GO:0032760; P:GO:0090303; P:GO:0045859; P:GO:0034145; P:GO:0090026; P:GO:0043277; P:GO:0002053; P:GO:0042104; C:GO:0000793; P:GO:0002840; P:GO:0043280; P:GO:0045063; P:GO:0032757; C:GO:0000790; P:GO:0010506; P:GO:0034137; P:GO:0032755; P:GO:0030335; P:GO:0032072; F:GO:0030295; F:GO:0016829; F:GO:0044378; C:GO:0005654; P:GO:0051103; P:GO:0000122; C:GO:0005769; P:GO:0006338; C:GO:0005768; P:GO:0031497; P:GO:0030324; P:GO:0050930; P:GO:0051106; P:GO:0033151; P:GO:0045639; P:GO:0002270; F:GO:0000405; F:GO:0008134; F:GO:0000402; F:GO:0000401; F:GO:0000400; C:GO:0009986; P:GO:0007204; P:GO:0006357; F:GO:0044822; P:GO:0032735; F:GO:0070491; P:GO:0045089; P:GO:0046330; P:GO:0045087; P:GO:0043065; C:GO:0016020; P:GO:0070374; P:GO:0032733; F:GO:0050786; P:GO:0032732	P:DNA repair; P:base-excision repair; P:positive regulation of interleukin-1 beta secretion; F:double-stranded DNA binding; P:positive regulation of NIK/NF-kappaB signaling; F:single-stranded DNA binding; P:positive regulation of interferon-alpha production; C:cell; F:phosphatidylserine binding; P:inflammatory response; F:double-stranded RNA binding; P:positive regulation of interferon-beta production; F:single-stranded RNA binding; P:positive regulation of interleukin-1 secretion; P:negative regulation of interferon-gamma production; P:positive regulation of dendritic cell differentiation; P:T-helper 1 cell activation; P:positive regulation of glycogen catabolic process; P:adaptive immune response; F:cytokine activity; P:cellular response to DNA damage stimulus; P:positive regulation of mitotic cell cycle; P:nucleosome assembly; P:immune system process; C:plasma membrane; P:regulation of tolerance induction; C:nucleus; F:protein binding; P:tumor necrosis factor secretion; F:histone binding; C:transcriptional repressor complex; P:dendritic cell chemotaxis; P:negative regulation of RNA polymerase II transcriptional preinitiation complex assembly; P:positive regulation of macrophage inflammatory protein 1 alpha production; P:DNA geometric change; C:chromosome; P:DNA topological change; P:regulation of nucleotide-excision repair; P:positive regulation of transcription from RNA polymerase II promoter; C:extracellular region; C:neuron projection; P:neutrophil clearance; F:lipopolysaccharide binding; F:supercoiled DNA binding; P:chemotaxis; F:transcription factor activity, sequence-specific DNA binding; F:DNA polymerase binding; P:positive regulation of interleukin-6 secretion; P:activation of innate immune response; P:negative regulation of CD4-positive, alpha-beta T cell differentiation; P:response to glucocorticoid; P:activation of protein kinase activity; P:positive regulation of mismatch repair; P:toll-like receptor 9 signaling pathway; P:negative regulation of blood vessel endothelial cell migration; P:neuron projection development; P:positive regulation of toll-like receptor 9 signaling pathway; P:positive regulation of sprouting angiogenesis; P:DNA recombination; F:bent DNA binding; P:positive regulation of interferon-alpha secretion; P:positive regulation of MAPK cascade; F:damaged DNA binding; P:myeloid dendritic cell activation; F:DNA binding; P:eye development; C:extracellular space; P:negative regulation of apoptotic cell clearance; C:cytoplasm; P:apoptotic DNA fragmentation; P:positive regulation of protein phosphorylation; P:endothelial cell proliferation; P:endothelial cell chemotaxis; F:C-X-C chemokine binding; P:positive chemotaxis; P:macrophage activation involved in immune response; F:chemoattractant activity; F:DNA binding, bending; F:unmethylated CpG binding; P:positive regulation of DNA binding; C:endoplasmic reticulum-Golgi intermediate compartment; P:B cell proliferation involved in immune response; P:inflammatory response to antigenic stimulus; P:autophagy; F:calcium-dependent protein kinase regulator activity; C:cytosol; P:positive regulation of tumor necrosis factor production; P:positive regulation of wound healing; P:regulation of protein kinase activity; P:positive regulation of toll-like receptor 4 signaling pathway; P:positive regulation of monocyte chemotaxis; P:apoptotic cell clearance; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of activated T cell proliferation; C:condensed chromosome; P:regulation of T cell mediated immune response to tumor cell; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:T-helper 1 cell differentiation; P:positive regulation of interleukin-8 production; C:nuclear chromatin; P:regulation of autophagy; P:positive regulation of toll-like receptor 2 signaling pathway; P:positive regulation of interleukin-6 production; P:positive regulation of cell migration; P:regulation of restriction endodeoxyribonuclease activity; F:protein kinase activator activity; F:lyase activity; F:non-sequence-specific DNA binding, bending; C:nucleoplasm; P:DNA ligation involved in DNA repair; P:negative regulation of transcription from RNA polymerase II promoter; C:early endosome; P:chromatin remodeling; C:endosome; P:chromatin assembly; P:lung development; P:induction of positive chemotaxis; P:positive regulation of DNA ligation; P:V(D)J recombination; P:positive regulation of myeloid cell differentiation; P:plasmacytoid dendritic cell activation; F:bubble DNA binding; F:transcription factor binding; F:crossed form four-way junction DNA binding; F:open form four-way junction DNA binding; F:four-way junction DNA binding; C:cell surface; P:positive regulation of cytosolic calcium ion concentration; P:regulation of transcription from RNA polymerase II promoter; F:poly(A) RNA binding; P:positive regulation of interleukin-12 production; F:repressing transcription factor binding; P:positive regulation of innate immune response; P:positive regulation of JNK cascade; P:innate immune response; P:positive regulation of apoptotic process; C:membrane; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of interleukin-10 production; F:RAGE receptor binding; P:positive regulation of interleukin-1 production		
tr|F6TZ46|F6TZ46_HORSE	small nuclear ribonucleo Sm D3	126	20	1.14E-87	99.6%	43	P:GO:0008380; P:GO:0051170; C:GO:0005697; P:GO:0006369; P:GO:0000398; C:GO:0005654; C:GO:0000243; C:GO:0071010; C:GO:0005689; C:GO:0070062; F:GO:0003723; C:GO:0030529; C:GO:0071013; F:GO:1990446; C:GO:0071011; C:GO:0034709; C:GO:0097526; C:GO:0005829; F:GO:0030620; C:GO:0005682; C:GO:0005681; P:GO:0008334; P:GO:0006396; C:GO:0005683; P:GO:0006397; C:GO:0005686; P:GO:0006479; C:GO:0005685; P:GO:0000245; C:GO:0005687; P:GO:0000387; F:GO:0044822; C:GO:0005634; F:GO:0005515; C:GO:0034715; F:GO:0070034; C:GO:0005737; C:GO:0034719; C:GO:0019013; C:GO:0030532; F:GO:0071208; F:GO:0071209; F:GO:0019899	P:RNA splicing; P:nuclear import; C:telomerase holoenzyme complex; P:termination of RNA polymerase II transcription; P:mRNA splicing, via spliceosome; C:nucleoplasm; C:commitment complex; C:prespliceosome; C:U12-type spliceosomal complex; C:extracellular exosome; F:RNA binding; C:intracellular ribonucleoprotein complex; C:catalytic step 2 spliceosome; F:U1 snRNP binding; C:precatalytic spliceosome; C:methylosome; C:spliceosomal tri-snRNP complex; C:cytosol; F:U2 snRNA binding; C:U5 snRNP; C:spliceosomal complex; P:histone mRNA metabolic process; P:RNA processing; C:U7 snRNP; P:mRNA processing; C:U2 snRNP; P:protein methylation; C:U1 snRNP; P:spliceosomal complex assembly; C:U4 snRNP; P:spliceosomal snRNP assembly; F:poly(A) RNA binding; C:nucleus; F:protein binding; C:pICln-Sm protein complex; F:telomerase RNA binding; C:cytoplasm; C:SMN-Sm protein complex; C:viral nucleocapsid; C:small nuclear ribonucleoprotein complex; F:histone pre-mRNA DCP binding; F:U7 snRNA binding; F:enzyme binding		
tr|F6SDU8|F6SDU8_HORSE	myelin-oligodendrocyte glyco isoform X2	254	20	3.83E-179	96.55%	3	C:GO:0016020; C:GO:0016021; P:GO:0007155	C:membrane; C:integral component of membrane; P:cell adhesion		
tr|F6ZYA8|F6ZYA8_HORSE	testis-expressed sequence 264	313	20	0E0	95.05%	1	C:GO:0070062	C:extracellular exosome		
tr|F6X9D3|F6X9D3_HORSE	nucleophosmin isoform X1	294	20	0E0	99.3%	45	P:GO:0006281; P:GO:0045727; P:GO:0032071; P:GO:0007098; P:GO:1902751; P:GO:0008285; P:GO:0008284; F:GO:0043024; P:GO:0008104; F:GO:0043023; P:GO:0046599; C:GO:0005730; F:GO:0004860; P:GO:0051092; C:GO:0005654; P:GO:0006913; C:GO:0031616; F:GO:0003723; C:GO:0005925; C:GO:0030529; F:GO:0046982; P:GO:0045893; P:GO:1904030; F:GO:0019901; F:GO:0042803; P:GO:0044387; P:GO:0060735; F:GO:0051082; P:GO:0007569; P:GO:0006334; P:GO:0006950; P:GO:0060699; F:GO:0044822; F:GO:0051059; F:GO:0003676; C:GO:0005634; C:GO:0005813; F:GO:0003713; F:GO:0042393; F:GO:0030957; C:GO:0005737; P:GO:0043066; P:GO:0010826; C:GO:0016020; P:GO:0051259	P:DNA repair; P:positive regulation of translation; P:regulation of endodeoxyribonuclease activity; P:centrosome cycle; P:positive regulation of cell cycle G2/M phase transition; P:negative regulation of cell proliferation; P:positive regulation of cell proliferation; F:ribosomal small subunit binding; P:protein localization; F:ribosomal large subunit binding; P:regulation of centriole replication; C:nucleolus; F:protein kinase inhibitor activity; P:positive regulation of NF-kappaB transcription factor activity; C:nucleoplasm; P:nucleocytoplasmic transport; C:spindle pole centrosome; F:RNA binding; C:focal adhesion; C:intracellular ribonucleoprotein complex; F:protein heterodimerization activity; P:positive regulation of transcription, DNA-templated; P:negative regulation of cyclin-dependent protein kinase activity; F:protein kinase binding; F:protein homodimerization activity; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:regulation of eIF2 alpha phosphorylation by dsRNA; F:unfolded protein binding; P:cell aging; P:nucleosome assembly; P:response to stress; P:regulation of endoribonuclease activity; F:poly(A) RNA binding; F:NF-kappaB binding; F:nucleic acid binding; C:nucleus; C:centrosome; F:transcription coactivator activity; F:histone binding; F:Tat protein binding; C:cytoplasm; P:negative regulation of apoptotic process; P:negative regulation of centrosome duplication; C:membrane; P:protein oligomerization		
tr|F6TGG7|F6TGG7_HORSE	PIP5K1A and PSMD4	863	20	0E0	95.8%	22	F:GO:0016307; F:GO:0016308; P:GO:0090630; C:GO:0016607; P:GO:0008654; P:GO:0046854; P:GO:0046488; C:GO:0005886; C:GO:0005654; P:GO:0060326; C:GO:0005634; P:GO:0097178; C:GO:0005925; C:GO:0005847; C:GO:0005737; P:GO:0072661; C:GO:0032587; P:GO:0048041; P:GO:0010761; P:GO:0031532; F:GO:0019900; C:GO:0030027	F:phosphatidylinositol phosphate kinase activity; F:1-phosphatidylinositol-4-phosphate 5-kinase activity; P:activation of GTPase activity; C:nuclear speck; P:phospholipid biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol metabolic process; C:plasma membrane; C:nucleoplasm; P:cell chemotaxis; C:nucleus; P:ruffle assembly; C:focal adhesion; C:mRNA cleavage and polyadenylation specificity factor complex; C:cytoplasm; P:protein targeting to plasma membrane; C:ruffle membrane; P:focal adhesion assembly; P:fibroblast migration; P:actin cytoskeleton reorganization; F:kinase binding; C:lamellipodium		
tr|F7D8L3|F7D8L3_HORSE	scavenger receptor class F member 2	805	20	0E0	91.4%	8	F:GO:0005515; C:GO:0005925; C:GO:0016020; C:GO:0016021; F:GO:0005044; P:GO:0007157; P:GO:0007155; P:GO:0006898	F:protein binding; C:focal adhesion; C:membrane; C:integral component of membrane; F:scavenger receptor activity; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:receptor-mediated endocytosis		
tr|F7BDY5|F7BDY5_HORSE	tetraspanin-10	279	20	0E0	87.8%	6	C:GO:0005887; C:GO:0016020; P:GO:0090002; C:GO:0016021; P:GO:0007166; P:GO:0045747	C:integral component of plasma membrane; C:membrane; P:establishment of protein localization to plasma membrane; C:integral component of membrane; P:cell surface receptor signaling pathway; P:positive regulation of Notch signaling pathway		
tr|F6VSS2|F6VSS2_HORSE	sodium hydrogen exchanger 2	814	20	0E0	95.85%	14	P:GO:0055085; F:GO:0015299; F:GO:0015385; F:GO:0015297; P:GO:0008104; P:GO:1902600; P:GO:0006810; P:GO:0006885; P:GO:0006814; P:GO:0006811; P:GO:0006812; C:GO:0016020; C:GO:0016021; P:GO:0035725	P:transmembrane transport; F:solute:proton antiporter activity; F:sodium:proton antiporter activity; F:antiporter activity; P:protein localization; P:hydrogen ion transmembrane transport; P:transport; P:regulation of pH; P:sodium ion transport; P:ion transport; P:cation transport; C:membrane; C:integral component of membrane; P:sodium ion transmembrane transport		
tr|F6Y214|F6Y214_HORSE	zinc transporter ZIP2	308	20	0E0	92.25%	10	P:GO:0055085; P:GO:0006829; C:GO:0016020; C:GO:0016021; F:GO:0005385; F:GO:0046873; C:GO:0016023; P:GO:0030001; P:GO:0071577; C:GO:0005886	P:transmembrane transport; P:zinc II ion transport; C:membrane; C:integral component of membrane; F:zinc ion transmembrane transporter activity; F:metal ion transmembrane transporter activity; C:cytoplasmic, membrane-bounded vesicle; P:metal ion transport; P:zinc II ion transmembrane transport; C:plasma membrane		
tr|F7A7A2|F7A7A2_HORSE	DNA dC-	208	20	3.4E-151	81.1%	4	F:GO:0008270; F:GO:0016814; F:GO:0003824; F:GO:0016787	F:zinc ion binding; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines; F:catalytic activity; F:hydrolase activity		
tr|F7BZZ0|F7BZZ0_HORSE	heterogeneous nuclear ribonucleo H3 isoform X1	346	20	0E0	99.6%	15	P:GO:0008380; C:GO:0005681; P:GO:0006396; P:GO:0006397; P:GO:0000398; C:GO:0005654; F:GO:0044822; F:GO:0000166; P:GO:0030855; F:GO:0003676; C:GO:0005634; F:GO:0005515; F:GO:0003723; C:GO:0030529; C:GO:0019013	P:RNA splicing; C:spliceosomal complex; P:RNA processing; P:mRNA processing; P:mRNA splicing, via spliceosome; C:nucleoplasm; F:poly(A) RNA binding; F:nucleotide binding; P:epithelial cell differentiation; F:nucleic acid binding; C:nucleus; F:protein binding; F:RNA binding; C:intracellular ribonucleoprotein complex; C:viral nucleocapsid		
tr|F7CPZ3|F7CPZ3_HORSE	calsyntenin-1 isoform X2	941	20	0E0	96.25%	4	F:GO:0005509; C:GO:0016020; C:GO:0016021; P:GO:0007156	F:calcium ion binding; C:membrane; C:integral component of membrane; P:homophilic cell adhesion via plasma membrane adhesion molecules		
tr|F6QLC6|F6QLC6_HORSE	ras-related Rab-5C	216	20	1.86E-160	99.55%	22	P:GO:0007264; P:GO:0015031; P:GO:0048227; P:GO:0006810; C:GO:0005765; C:GO:0005886; C:GO:0005622; F:GO:0005525; F:GO:0000166; C:GO:0005811; C:GO:0031901; C:GO:0030139; C:GO:0005769; C:GO:0005768; F:GO:0005515; C:GO:0070062; C:GO:0042470; F:GO:0003924; C:GO:0043231; C:GO:0016020; F:GO:0019003; P:GO:0030100	P:small GTPase mediated signal transduction; P:protein transport; P:plasma membrane to endosome transport; P:transport; C:lysosomal membrane; C:plasma membrane; C:intracellular; F:GTP binding; F:nucleotide binding; C:lipid particle; C:early endosome membrane; C:endocytic vesicle; C:early endosome; C:endosome; F:protein binding; C:extracellular exosome; C:melanosome; F:GTPase activity; C:intracellular membrane-bounded organelle; C:membrane; F:GDP binding; P:regulation of endocytosis		
tr|F6Z904|F6Z904_HORSE	ras-related Rab-5A	215	20	7.99E-161	99.45%	61	C:GO:0008021; P:GO:0015031; C:GO:0043025; P:GO:0045921; P:GO:0051489; C:GO:0030425; C:GO:0043195; P:GO:0048169; F:GO:0003924; F:GO:0019001; C:GO:0015629; F:GO:0019003; C:GO:0005829; P:GO:0030100; C:GO:0030424; P:GO:0007264; C:GO:0045335; C:GO:0043234; P:GO:0006897; P:GO:0006810; C:GO:0042589; C:GO:0043679; C:GO:0005886; C:GO:0031901; C:GO:0030139; F:GO:0005515; C:GO:0042470; P:GO:0045022; P:GO:2000286; C:GO:0030136; C:GO:0036477; P:GO:0007032; P:GO:0007596; C:GO:0043005; C:GO:0042995; F:GO:0005525; P:GO:0048661; F:GO:0000166; C:GO:0005769; C:GO:0005768; C:GO:0070062; F:GO:0051021; C:GO:0001726; C:GO:0031410; C:GO:0098559; P:GO:0014911; P:GO:0036465; C:GO:0005622; C:GO:0005811; C:GO:0048471; P:GO:0051036; C:GO:0005737; C:GO:0045121; C:GO:0016020; P:GO:2000300; P:GO:0006909; P:GO:2000785; C:GO:0030670; C:GO:0016023; C:GO:0055037; C:GO:0010008	C:synaptic vesicle; P:protein transport; C:neuronal cell body; P:positive regulation of exocytosis; P:regulation of filopodium assembly; C:dendrite; C:terminal bouton; P:regulation of long-term neuronal synaptic plasticity; F:GTPase activity; F:guanyl nucleotide binding; C:actin cytoskeleton; F:GDP binding; C:cytosol; P:regulation of endocytosis; C:axon; P:small GTPase mediated signal transduction; C:phagocytic vesicle; C:protein complex; P:endocytosis; P:transport; C:zymogen granule membrane; C:axon terminus; C:plasma membrane; C:early endosome membrane; C:endocytic vesicle; F:protein binding; C:melanosome; P:early endosome to late endosome transport; P:receptor internalization involved in canonical Wnt signaling pathway; C:clathrin-coated vesicle; C:somatodendritic compartment; P:endosome organization; P:blood coagulation; C:neuron projection; C:cell projection; F:GTP binding; P:positive regulation of smooth muscle cell proliferation; F:nucleotide binding; C:early endosome; C:endosome; C:extracellular exosome; F:GDP-dissociation inhibitor binding; C:ruffle; C:cytoplasmic vesicle; C:cytoplasmic side of early endosome membrane; P:positive regulation of smooth muscle cell migration; P:synaptic vesicle recycling; C:intracellular; C:lipid particle; C:perinuclear region of cytoplasm; P:regulation of endosome size; C:cytoplasm; C:membrane raft; C:membrane; P:regulation of synaptic vesicle exocytosis; P:phagocytosis; P:regulation of autophagosome assembly; C:phagocytic vesicle membrane; C:cytoplasmic, membrane-bounded vesicle; C:recycling endosome; C:endosome membrane		
tr|F6WA92|F6WA92_HORSE	ras-related Rab-5B	215	20	1.13E-160	99.1%	22	P:GO:0007032; P:GO:0007264; P:GO:0015031; P:GO:0048227; P:GO:0006810; C:GO:0005886; C:GO:0005622; F:GO:0000166; F:GO:0005525; C:GO:0031901; C:GO:0030139; C:GO:0005769; F:GO:0005515; C:GO:0005768; C:GO:0070062; C:GO:0042470; F:GO:0003924; C:GO:0016020; F:GO:0019003; P:GO:0019882; P:GO:0030100; F:GO:0030742	P:endosome organization; P:small GTPase mediated signal transduction; P:protein transport; P:plasma membrane to endosome transport; P:transport; C:plasma membrane; C:intracellular; F:nucleotide binding; F:GTP binding; C:early endosome membrane; C:endocytic vesicle; C:early endosome; F:protein binding; C:endosome; C:extracellular exosome; C:melanosome; F:GTPase activity; C:membrane; F:GDP binding; P:antigen processing and presentation; P:regulation of endocytosis; F:GTP-dependent protein binding		
tr|F6U7Q8|F6U7Q8_HORSE	plexin-B3 isoform X1	1881	20	0E0	94.95%	19	P:GO:0008360; P:GO:0034260; F:GO:0019904; P:GO:0007165; P:GO:0050918; P:GO:0007162; P:GO:1902287; P:GO:0060326; C:GO:0005887; C:GO:0002116; P:GO:0050772; F:GO:0051022; P:GO:0043087; C:GO:0016020; F:GO:0017154; C:GO:0016021; P:GO:0001938; P:GO:0030336; P:GO:0071526	P:regulation of cell shape; P:negative regulation of GTPase activity; F:protein domain specific binding; P:signal transduction; P:positive chemotaxis; P:negative regulation of cell adhesion; P:semaphorin-plexin signaling pathway involved in axon guidance; P:cell chemotaxis; C:integral component of plasma membrane; C:semaphorin receptor complex; P:positive regulation of axonogenesis; F:Rho GDP-dissociation inhibitor binding; P:regulation of GTPase activity; C:membrane; F:semaphorin receptor activity; C:integral component of membrane; P:positive regulation of endothelial cell proliferation; P:negative regulation of cell migration; P:semaphorin-plexin signaling pathway		
tr|F6VNB1|F6VNB1_HORSE	myosin light chain 4	197	20	4.23E-142	96.35%	7	F:GO:0051015; P:GO:0002026; P:GO:0032781; F:GO:0005509; C:GO:0031672; P:GO:0060048; F:GO:0003785	F:actin filament binding; P:regulation of the force of heart contraction; P:positive regulation of ATPase activity; F:calcium ion binding; C:A band; P:cardiac muscle contraction; F:actin monomer binding		
tr|F6V7L0|F6V7L0_HORSE	eukaryotic translation initiation factor 5A-2	153	20	3.75E-110	99.85%	26	P:GO:0045905; P:GO:0008284; P:GO:0015031; P:GO:0045901; C:GO:0005789; F:GO:0003743; F:GO:0003723; F:GO:0003746; C:GO:0043231; C:GO:0005829; P:GO:0051028; P:GO:0007283; C:GO:0005783; P:GO:0006452; P:GO:0006413; P:GO:0006414; P:GO:0006810; P:GO:0008612; C:GO:0005643; P:GO:0006412; P:GO:0010509; C:GO:0005634; F:GO:0005515; C:GO:0005737; F:GO:0043022; C:GO:0016020	P:positive regulation of translational termination; P:positive regulation of cell proliferation; P:protein transport; P:positive regulation of translational elongation; C:endoplasmic reticulum membrane; F:translation initiation factor activity; F:RNA binding; F:translation elongation factor activity; C:intracellular membrane-bounded organelle; C:cytosol; P:mRNA transport; P:spermatogenesis; C:endoplasmic reticulum; P:translational frameshifting; P:translational initiation; P:translational elongation; P:transport; P:peptidyl-lysine modification to peptidyl-hypusine; C:nuclear pore; P:translation; P:polyamine homeostasis; C:nucleus; F:protein binding; C:cytoplasm; F:ribosome binding; C:membrane		
tr|F6SN52|F6SN52_HORSE	Eukaryotic translation initiation factor 5A-1	161	20	1.97E-115	99.8%	40	P:GO:0045905; P:GO:0008284; P:GO:0015031; C:GO:0043025; P:GO:0045901; C:GO:0005789; P:GO:0006913; F:GO:0003743; C:GO:0030425; F:GO:0003723; C:GO:0070062; F:GO:0003746; P:GO:0006915; C:GO:0005829; P:GO:0051149; P:GO:0051028; P:GO:2000379; C:GO:0005783; P:GO:0006452; C:GO:0005642; P:GO:0006413; P:GO:0006611; P:GO:0006810; P:GO:0006414; P:GO:0008612; C:GO:0005643; P:GO:0006412; P:GO:0007204; F:GO:0044822; P:GO:0006406; F:GO:0017070; C:GO:0005634; F:GO:0005515; C:GO:0005737; F:GO:0043022; P:GO:0043066; F:GO:0047485; P:GO:0043065; C:GO:0016020; P:GO:0010666	P:positive regulation of translational termination; P:positive regulation of cell proliferation; P:protein transport; C:neuronal cell body; P:positive regulation of translational elongation; C:endoplasmic reticulum membrane; P:nucleocytoplasmic transport; F:translation initiation factor activity; C:dendrite; F:RNA binding; C:extracellular exosome; F:translation elongation factor activity; P:apoptotic process; C:cytosol; P:positive regulation of muscle cell differentiation; P:mRNA transport; P:positive regulation of reactive oxygen species metabolic process; C:endoplasmic reticulum; P:translational frameshifting; C:annulate lamellae; P:translational initiation; P:protein export from nucleus; P:transport; P:translational elongation; P:peptidyl-lysine modification to peptidyl-hypusine; C:nuclear pore; P:translation; P:positive regulation of cytosolic calcium ion concentration; F:poly(A) RNA binding; P:mRNA export from nucleus; F:U6 snRNA binding; C:nucleus; F:protein binding; C:cytoplasm; F:ribosome binding; P:negative regulation of apoptotic process; F:protein N-terminus binding; P:positive regulation of apoptotic process; C:membrane; P:positive regulation of cardiac muscle cell apoptotic process		
tr|F7AAM8|F7AAM8_HORSE	AT-rich interactive domain-containing 1A isoform X1	1903	20	0E0	98.45%	26	F:GO:0016922; P:GO:0006344; P:GO:0006325; C:GO:0005654; P:GO:0000122; P:GO:0003205; P:GO:0006338; P:GO:0030900; P:GO:0001843; P:GO:0045893; P:GO:0003408; P:GO:0030521; P:GO:0030520; P:GO:0055007; P:GO:0042921; C:GO:0016514; C:GO:0090544; P:GO:0060674; F:GO:0031491; P:GO:1901998; P:GO:0006337; F:GO:0003677; C:GO:0000790; C:GO:0071564; P:GO:0043044; C:GO:0071565	F:ligand-dependent nuclear receptor binding; P:maintenance of chromatin silencing; P:chromatin organization; C:nucleoplasm; P:negative regulation of transcription from RNA polymerase II promoter; P:cardiac chamber development; P:chromatin remodeling; P:forebrain development; P:neural tube closure; P:positive regulation of transcription, DNA-templated; P:optic cup formation involved in camera-type eye development; P:androgen receptor signaling pathway; P:intracellular estrogen receptor signaling pathway; P:cardiac muscle cell differentiation; P:glucocorticoid receptor signaling pathway; C:SWI/SNF complex; C:BAF-type complex; P:placenta blood vessel development; F:nucleosome binding; P:toxin transport; P:nucleosome disassembly; F:DNA binding; C:nuclear chromatin; C:npBAF complex; P:ATP-dependent chromatin remodeling; C:nBAF complex		
tr|F7A5J4|F7A5J4_HORSE	AT-rich interactive domain-containing 1A isoform X2	1683	20	0E0	96.7%	36	P:GO:0006325; F:GO:0016922; P:GO:0007399; P:GO:0006344; P:GO:0006325; C:GO:0005654; P:GO:0000122; P:GO:0003205; P:GO:0006338; P:GO:0030900; P:GO:0001843; P:GO:0045893; P:GO:0003408; P:GO:0030521; P:GO:0030520; P:GO:0055007; P:GO:0042921; C:GO:0016514; C:GO:0090544; P:GO:0060674; P:GO:0006351; F:GO:0031491; P:GO:0006355; P:GO:1901998; P:GO:0006337; P:GO:0006357; P:GO:0042766; F:GO:0003677; C:GO:0005634; C:GO:0000790; F:GO:0005515; F:GO:0003713; C:GO:0071564; P:GO:0043044; C:GO:0071565; P:GO:0048096	P:chromatin organization; F:ligand-dependent nuclear receptor binding; P:nervous system development; P:maintenance of chromatin silencing; P:chromatin organization; C:nucleoplasm; P:negative regulation of transcription from RNA polymerase II promoter; P:cardiac chamber development; P:chromatin remodeling; P:forebrain development; P:neural tube closure; P:positive regulation of transcription, DNA-templated; P:optic cup formation involved in camera-type eye development; P:androgen receptor signaling pathway; P:intracellular estrogen receptor signaling pathway; P:cardiac muscle cell differentiation; P:glucocorticoid receptor signaling pathway; C:SWI/SNF complex; C:BAF-type complex; P:placenta blood vessel development; P:transcription, DNA-templated; F:nucleosome binding; P:regulation of transcription, DNA-templated; P:toxin transport; P:nucleosome disassembly; P:regulation of transcription from RNA polymerase II promoter; P:nucleosome mobilization; F:DNA binding; C:nucleus; C:nuclear chromatin; F:protein binding; F:transcription coactivator activity; C:npBAF complex; P:ATP-dependent chromatin remodeling; C:nBAF complex; P:chromatin-mediated maintenance of transcription		
tr|F6TQR2|F6TQR2_HORSE	calreticulin	412	20	0E0	97.9%	46	P:GO:0007050; P:GO:0033144; C:GO:0016529; P:GO:0090398; P:GO:0008284; P:GO:0045665; C:GO:0009897; P:GO:0045787; P:GO:0045740; F:GO:0005178; P:GO:0030866; C:GO:0005844; P:GO:0000122; C:GO:0005788; C:GO:0070062; C:GO:0005925; P:GO:0045892; F:GO:0005509; P:GO:0048387; P:GO:2000510; C:GO:0005829; F:GO:0003729; F:GO:0001948; F:GO:0030246; P:GO:0034504; C:GO:0033018; C:GO:0042824; P:GO:0040020; C:GO:0005783; F:GO:0051082; P:GO:1900026; P:GO:0006611; P:GO:0006457; F:GO:0044822; C:GO:0005634; C:GO:0005615; C:GO:0048471; F:GO:0031625; P:GO:0002502; F:GO:0050681; F:GO:0046872; C:GO:0005737; P:GO:0010628; C:GO:0016020; P:GO:0050821; P:GO:0050766	P:cell cycle arrest; P:negative regulation of intracellular steroid hormone receptor signaling pathway; C:sarcoplasmic reticulum; P:cellular senescence; P:positive regulation of cell proliferation; P:negative regulation of neuron differentiation; C:external side of plasma membrane; P:positive regulation of cell cycle; P:positive regulation of DNA replication; F:integrin binding; P:cortical actin cytoskeleton organization; C:polysome; P:negative regulation of transcription from RNA polymerase II promoter; C:endoplasmic reticulum lumen; C:extracellular exosome; C:focal adhesion; P:negative regulation of transcription, DNA-templated; F:calcium ion binding; P:negative regulation of retinoic acid receptor signaling pathway; P:positive regulation of dendritic cell chemotaxis; C:cytosol; F:mRNA binding; F:glycoprotein binding; F:carbohydrate binding; P:protein localization to nucleus; C:sarcoplasmic reticulum lumen; C:MHC class I peptide loading complex; P:regulation of meiotic nuclear division; C:endoplasmic reticulum; F:unfolded protein binding; P:positive regulation of substrate adhesion-dependent cell spreading; P:protein export from nucleus; P:protein folding; F:poly(A) RNA binding; C:nucleus; C:extracellular space; C:perinuclear region of cytoplasm; F:ubiquitin protein ligase binding; P:peptide antigen assembly with MHC class I protein complex; F:androgen receptor binding; F:metal ion binding; C:cytoplasm; P:positive regulation of gene expression; C:membrane; P:protein stabilization; P:positive regulation of phagocytosis		
tr|F6SC92|F6SC92_HORSE	helix-loop-helix 1	133	20	2.55E-91	96.6%	14	P:GO:0007275; P:GO:0006351; F:GO:0000977; P:GO:0006366; P:GO:0006355; F:GO:0046983; F:GO:0001228; P:GO:0045944; F:GO:0000981; F:GO:0003677; C:GO:0005634; F:GO:0005515; P:GO:0007417; P:GO:0030154	P:multicellular organism development; P:transcription, DNA-templated; F:RNA polymerase II regulatory region sequence-specific DNA binding; P:transcription from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; F:protein dimerization activity; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; P:positive regulation of transcription from RNA polymerase II promoter; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; F:DNA binding; C:nucleus; F:protein binding; P:central nervous system development; P:cell differentiation		
tr|F6VKF1|F6VKF1_HORSE	eukaryotic translation initiation factor 2-alpha kinase 4 isoform X1	1651	20	0E0	96.5%	49	P:GO:0007050; P:GO:0036492; P:GO:0034198; P:GO:0039520; P:GO:0046777; P:GO:0002286; P:GO:0007612; P:GO:0006446; P:GO:0019081; P:GO:1990253; F:GO:0003723; P:GO:0051607; P:GO:0002250; F:GO:0004672; F:GO:0004674; P:GO:0006413; P:GO:0002376; P:GO:0007616; P:GO:1990138; P:GO:0045947; C:GO:0022626; P:GO:0032792; P:GO:1900273; P:GO:0045665; P:GO:0007399; P:GO:0006468; C:GO:0005844; P:GO:0006417; F:GO:0000166; F:GO:0003743; F:GO:0005524; P:GO:0016032; P:GO:0034644; P:GO:0010998; P:GO:0016310; P:GO:0044828; F:GO:0004694; P:GO:0002230; F:GO:0000049; P:GO:0007049; P:GO:0060259; P:GO:0060733; P:GO:0002821; C:GO:0005737; P:GO:0071264; P:GO:0032057; F:GO:0016740; F:GO:0016301; P:GO:0070417	P:cell cycle arrest; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:cellular response to amino acid starvation; P:induction by virus of host autophagy; P:protein autophosphorylation; P:T cell activation involved in immune response; P:learning; P:regulation of translational initiation; P:viral translation; P:cellular response to leucine starvation; F:RNA binding; P:defense response to virus; P:adaptive immune response; F:protein kinase activity; F:protein serine/threonine kinase activity; P:translational initiation; P:immune system process; P:long-term memory; P:neuron projection extension; P:negative regulation of translational initiation; C:cytosolic ribosome; P:negative regulation of CREB transcription factor activity; P:positive regulation of long-term synaptic potentiation; P:negative regulation of neuron differentiation; P:nervous system development; P:protein phosphorylation; C:polysome; P:regulation of translation; F:nucleotide binding; F:translation initiation factor activity; F:ATP binding; P:viral process; P:cellular response to UV; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:phosphorylation; P:negative regulation by host of viral genome replication; F:eukaryotic translation initiation factor 2alpha kinase activity; P:positive regulation of defense response to virus by host; F:tRNA binding; P:cell cycle; P:regulation of feeding behavior; P:regulation of eIF2 alpha phosphorylation by amino acid starvation; P:positive regulation of adaptive immune response; C:cytoplasm; P:positive regulation of translational initiation in response to starvation; P:negative regulation of translational initiation in response to stress; F:transferase activity; F:kinase activity; P:cellular response to cold		
tr|F6YTL9|F6YTL9_HORSE	plexin-D1	1529	20	0E0	96.45%	24	F:GO:0019904; P:GO:0032092; P:GO:0007165; P:GO:1902287; P:GO:0003151; P:GO:0060976; P:GO:0045765; P:GO:0043542; P:GO:0060666; P:GO:0003279; P:GO:0021785; C:GO:0005887; C:GO:0002116; P:GO:0007416; P:GO:0048841; P:GO:0001569; P:GO:0035904; P:GO:0001525; C:GO:0016020; F:GO:0017154; C:GO:0016021; P:GO:0030334; C:GO:0030027; P:GO:0071526	F:protein domain specific binding; P:positive regulation of protein binding; P:signal transduction; P:semaphorin-plexin signaling pathway involved in axon guidance; P:outflow tract morphogenesis; P:coronary vasculature development; P:regulation of angiogenesis; P:endothelial cell migration; P:dichotomous subdivision of terminal units involved in salivary gland branching; P:cardiac septum development; P:branchiomotor neuron axon guidance; C:integral component of plasma membrane; C:semaphorin receptor complex; P:synapse assembly; P:regulation of axon extension involved in axon guidance; P:patterning of blood vessels; P:aorta development; P:angiogenesis; C:membrane; F:semaphorin receptor activity; C:integral component of membrane; P:regulation of cell migration; C:lamellipodium; P:semaphorin-plexin signaling pathway		
tr|F6XRU1|F6XRU1_HORSE	serpin B11	388	20	0E0	92.5%	3	C:GO:0005615; F:GO:0004867; P:GO:0010951	C:extracellular space; F:serine-type endopeptidase inhibitor activity; P:negative regulation of endopeptidase activity		
tr|F6YAV2|F6YAV2_HORSE	serpin B11 isoform X1	392	20	0E0	94.3%	3	C:GO:0005615; F:GO:0004867; P:GO:0010951	C:extracellular space; F:serine-type endopeptidase inhibitor activity; P:negative regulation of endopeptidase activity		
tr|F7D8G9|F7D8G9_HORSE	serine protease 27	295	20	0E0	94.5%	6	P:GO:0006508; F:GO:0004252; F:GO:0008236; F:GO:0008233; C:GO:0005886; F:GO:0016787	P:proteolysis; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:peptidase activity; C:plasma membrane; F:hydrolase activity		
tr|F6V3P6|F6V3P6_HORSE	ATP-dependent RNA helicase DDX19A	478	20	0E0	99.05%	18	P:GO:0015031; F:GO:0004386; P:GO:0006810; F:GO:0004004; C:GO:0005643; F:GO:0000166; P:GO:0006406; F:GO:0003676; C:GO:0005634; F:GO:0005524; C:GO:0031965; F:GO:0003723; C:GO:0005737; P:GO:0043065; C:GO:0016020; P:GO:0010501; P:GO:0051028; F:GO:0016787	P:protein transport; F:helicase activity; P:transport; F:ATP-dependent RNA helicase activity; C:nuclear pore; F:nucleotide binding; P:mRNA export from nucleus; F:nucleic acid binding; C:nucleus; F:ATP binding; C:nuclear membrane; F:RNA binding; C:cytoplasm; P:positive regulation of apoptotic process; C:membrane; P:RNA secondary structure unwinding; P:mRNA transport; F:hydrolase activity		
tr|F7CR22|F7CR22_HORSE	coatomer subunit delta	511	20	0E0	99.4%	17	P:GO:0006890; P:GO:0015031; C:GO:0005783; C:GO:0005794; P:GO:0008344; P:GO:0006810; F:GO:0044822; P:GO:0021691; P:GO:0016192; C:GO:0005737; P:GO:0043473; C:GO:0043231; C:GO:0016020; C:GO:0031410; P:GO:0048193; C:GO:0030126; C:GO:0030137	P:retrograde vesicle-mediated transport, Golgi to ER; P:protein transport; C:endoplasmic reticulum; C:Golgi apparatus; P:adult locomotory behavior; P:transport; F:poly(A) RNA binding; P:cerebellar Purkinje cell layer maturation; P:vesicle-mediated transport; C:cytoplasm; P:pigmentation; C:intracellular membrane-bounded organelle; C:membrane; C:cytoplasmic vesicle; P:Golgi vesicle transport; C:COPI vesicle coat; C:COPI-coated vesicle		
tr|F7BWE6|F7BWE6_HORSE	DNA repair complementing XP-G cells isoform X3	1628	20	0E0	88.65%	10	F:GO:0016788; F:GO:0003677; P:GO:0006281; P:GO:0090305; C:GO:0005634; F:GO:0003824; F:GO:0004519; F:GO:0004518; P:GO:0006289; F:GO:0003697	F:hydrolase activity, acting on ester bonds; F:DNA binding; P:DNA repair; P:nucleic acid phosphodiester bond hydrolysis; C:nucleus; F:catalytic activity; F:endonuclease activity; F:nuclease activity; P:nucleotide-excision repair; F:single-stranded DNA binding		
tr|F6PVN3|F6PVN3_HORSE	OX-2 membrane glyco	274	20	0E0	93.9%	13	F:GO:0042803; F:GO:0050839; P:GO:0007157; P:GO:0008037; P:GO:0007156; F:GO:0004872; F:GO:0005102; C:GO:0005887; P:GO:0043031; C:GO:0005913; C:GO:0016020; C:GO:0016021; P:GO:0050776	F:protein homodimerization activity; F:cell adhesion molecule binding; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell recognition; P:homophilic cell adhesion via plasma membrane adhesion molecules; F:receptor activity; F:receptor binding; C:integral component of plasma membrane; P:negative regulation of macrophage activation; C:cell-cell adherens junction; C:membrane; C:integral component of membrane; P:regulation of immune response		
tr|F6X6A6|F6X6A6_HORSE	peptidyl-prolyl cis-trans isomerase A	104	20	3.5E-71	99.95%	34	P:GO:0046677; P:GO:0045069; F:GO:0042277; P:GO:0000413; C:GO:0005694; C:GO:0000159; C:GO:0000775; C:GO:0005576; C:GO:0070062; P:GO:0008637; C:GO:0005925; C:GO:0005829; P:GO:0034389; P:GO:0050714; P:GO:0045070; F:GO:0016853; P:GO:0006470; C:GO:0000922; P:GO:0042542; P:GO:0006457; F:GO:0044822; C:GO:0005634; F:GO:0004721; P:GO:0043161; F:GO:0003755; C:GO:0005615; C:GO:0005856; F:GO:0005515; F:GO:0046872; C:GO:0005737; C:GO:0016020; P:GO:0010468; P:GO:0034976; F:GO:0016787	P:response to antibiotic; P:regulation of viral genome replication; F:peptide binding; P:protein peptidyl-prolyl isomerization; C:chromosome; C:protein phosphatase type 2A complex; C:chromosome, centromeric region; C:extracellular region; C:extracellular exosome; P:apoptotic mitochondrial changes; C:focal adhesion; C:cytosol; P:lipid particle organization; P:positive regulation of protein secretion; P:positive regulation of viral genome replication; F:isomerase activity; P:protein dephosphorylation; C:spindle pole; P:response to hydrogen peroxide; P:protein folding; F:poly(A) RNA binding; C:nucleus; F:phosphoprotein phosphatase activity; P:proteasome-mediated ubiquitin-dependent protein catabolic process; F:peptidyl-prolyl cis-trans isomerase activity; C:extracellular space; C:cytoskeleton; F:protein binding; F:metal ion binding; C:cytoplasm; C:membrane; P:regulation of gene expression; P:response to endoplasmic reticulum stress; F:hydrolase activity		
tr|F6PZR3|F6PZR3_HORSE	dnaJ homolog subfamily B member 5 isoform X1	382	20	0E0	99.2%	8	P:GO:0000122; C:GO:0005634; F:GO:0005515; F:GO:0051087; C:GO:0005829; F:GO:0051082; P:GO:0006457; P:GO:0006986	P:negative regulation of transcription from RNA polymerase II promoter; C:nucleus; F:protein binding; F:chaperone binding; C:cytosol; F:unfolded protein binding; P:protein folding; P:response to unfolded protein		
tr|F7AU23|F7AU23_HORSE	bifunctional UDP-N-acetylglucosamine 2-epimerase N-acetylmannosamine kinase isoform X2	722	20	0E0	99.1%	20	P:GO:0006054; F:GO:0009384; P:GO:0008152; P:GO:0006047; P:GO:0007155; F:GO:0008761; P:GO:0006045; F:GO:0004553; P:GO:0046835; F:GO:0000166; F:GO:0005524; F:GO:0005515; C:GO:0005737; F:GO:0003824; F:GO:0046872; C:GO:0005829; P:GO:0016310; F:GO:0016740; F:GO:0016301; F:GO:0016787	P:N-acetylneuraminate metabolic process; F:N-acylmannosamine kinase activity; P:metabolic process; P:UDP-N-acetylglucosamine metabolic process; P:cell adhesion; F:UDP-N-acetylglucosamine 2-epimerase activity; P:N-acetylglucosamine biosynthetic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds; P:carbohydrate phosphorylation; F:nucleotide binding; F:ATP binding; F:protein binding; C:cytoplasm; F:catalytic activity; F:metal ion binding; C:cytosol; P:phosphorylation; F:transferase activity; F:kinase activity; F:hydrolase activity		
tr|F7B5P1|F7B5P1_HORSE	cytosolic non-specific dipeptidase	475	20	0E0	97%	13	F:GO:0004180; F:GO:0016805; F:GO:0102008; P:GO:0008152; F:GO:0008233; F:GO:0008237; C:GO:0005654; C:GO:0070062; C:GO:0005737; F:GO:0046872; P:GO:0006508; F:GO:0034701; F:GO:0016787	F:carboxypeptidase activity; F:dipeptidase activity; F:cytosolic dipeptidase activity; P:metabolic process; F:peptidase activity; F:metallopeptidase activity; C:nucleoplasm; C:extracellular exosome; C:cytoplasm; F:metal ion binding; P:proteolysis; F:tripeptidase activity; F:hydrolase activity		
tr|F6XC16|F6XC16_HORSE	synaptic vesicle membrane VAT-1 homolog	400	20	0E0	94.35%	5	F:GO:0008270; C:GO:0070062; P:GO:0010637; F:GO:0016491; P:GO:0055114	F:zinc ion binding; C:extracellular exosome; P:negative regulation of mitochondrial fusion; F:oxidoreductase activity; P:oxidation-reduction process		
tr|F6PX23|F6PX23_HORSE	olfactory receptor 10J1	308	20	0E0	94.3%	13	P:GO:0007186; P:GO:0007165; P:GO:0050907; F:GO:0004871; C:GO:0005886; F:GO:0004984; F:GO:0004930; F:GO:0004888; C:GO:0016020; P:GO:0007608; C:GO:0016021; P:GO:0050911; P:GO:0050896	P:G-protein coupled receptor signaling pathway; P:signal transduction; P:detection of chemical stimulus involved in sensory perception; F:signal transducer activity; C:plasma membrane; F:olfactory receptor activity; F:G-protein coupled receptor activity; F:transmembrane signaling receptor activity; C:membrane; P:sensory perception of smell; C:integral component of membrane; P:detection of chemical stimulus involved in sensory perception of smell; P:response to stimulus		
tr|F7BCE3|F7BCE3_HORSE	cell division cycle-associated 7 isoform X1	448	20	0E0	95.9%	4	C:GO:0005634; C:GO:0005737; P:GO:0008284; C:GO:0005730	C:nucleus; C:cytoplasm; P:positive regulation of cell proliferation; C:nucleolus		
tr|F7C2M4|F7C2M4_HORSE	leucine-rich repeat and death domain-containing 1	862	20	0E0	91.1%	1	P:GO:0007165	P:signal transduction		
tr|F6YNL9|F6YNL9_HORSE	integrin beta-2	770	20	0E0	90.8%	47	P:GO:0008360; C:GO:1903561; P:GO:0045429; F:GO:0050839; P:GO:0007155; P:GO:0043542; P:GO:0051092; C:GO:0008305; P:GO:0045766; P:GO:0007159; P:GO:0050730; P:GO:0007229; P:GO:0006954; C:GO:0070062; F:GO:0046982; P:GO:0006915; C:GO:0034687; F:GO:0001948; P:GO:0030101; F:GO:0032403; F:GO:0030369; P:GO:0050776; P:GO:0007160; P:GO:0016337; F:GO:0019901; C:GO:0030141; P:GO:0034142; P:GO:0007267; C:GO:0043235; P:GO:0043113; F:GO:0004872; P:GO:0007568; C:GO:0005886; C:GO:0009986; P:GO:0002523; F:GO:0005515; P:GO:0045123; F:GO:0046872; C:GO:0016020; C:GO:0016021; P:GO:0030198; P:GO:0035987; P:GO:0030593; P:GO:0050900; P:GO:0034113; P:GO:0031623; P:GO:0071404	P:regulation of cell shape; C:extracellular vesicle; P:positive regulation of nitric oxide biosynthetic process; F:cell adhesion molecule binding; P:cell adhesion; P:endothelial cell migration; P:positive regulation of NF-kappaB transcription factor activity; C:integrin complex; P:positive regulation of angiogenesis; P:leukocyte cell-cell adhesion; P:regulation of peptidyl-tyrosine phosphorylation; P:integrin-mediated signaling pathway; P:inflammatory response; C:extracellular exosome; F:protein heterodimerization activity; P:apoptotic process; C:integrin alphaL-beta2 complex; F:glycoprotein binding; P:natural killer cell activation; F:protein complex binding; F:ICAM-3 receptor activity; P:regulation of immune response; P:cell-matrix adhesion; P:single organismal cell-cell adhesion; F:protein kinase binding; C:secretory granule; P:toll-like receptor 4 signaling pathway; P:cell-cell signaling; C:receptor complex; P:receptor clustering; F:receptor activity; P:aging; C:plasma membrane; C:cell surface; P:leukocyte migration involved in inflammatory response; F:protein binding; P:cellular extravasation; F:metal ion binding; C:membrane; C:integral component of membrane; P:extracellular matrix organization; P:endodermal cell differentiation; P:neutrophil chemotaxis; P:leukocyte migration; P:heterotypic cell-cell adhesion; P:receptor internalization; P:cellular response to low-density lipoprotein particle stimulus		
tr|F6PI70|F6PI70_HORSE	immmunoglobulin lambda light chain variable partial	99	20	9.85E-64	90.55%	9	P:GO:0006956; P:GO:0006958; P:GO:0006508; F:GO:0004252; P:GO:0038095; P:GO:0038096; C:GO:0005576; P:GO:0006898; P:GO:0050776	P:complement activation; P:complement activation, classical pathway; P:proteolysis; F:serine-type endopeptidase activity; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; C:extracellular region; P:receptor-mediated endocytosis; P:regulation of immune response		
tr|F6WJI6|F6WJI6_HORSE	immunoglobulin lambda light chain V-J partial	118	20	3.25E-72	92.3%	23	C:GO:0009897; P:GO:0038095; F:GO:0004252; P:GO:0038096; C:GO:0005576; P:GO:0006898; P:GO:0042742; C:GO:0005886; P:GO:0006956; C:GO:0005615; P:GO:0006910; C:GO:0070062; P:GO:0050871; P:GO:0006911; F:GO:0003823; P:GO:0045087; P:GO:0006958; C:GO:0072562; P:GO:0006508; C:GO:0042571; F:GO:0034987; P:GO:0050776; P:GO:0050853	C:external side of plasma membrane; P:Fc-epsilon receptor signaling pathway; F:serine-type endopeptidase activity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; C:extracellular region; P:receptor-mediated endocytosis; P:defense response to bacterium; C:plasma membrane; P:complement activation; C:extracellular space; P:phagocytosis, recognition; C:extracellular exosome; P:positive regulation of B cell activation; P:phagocytosis, engulfment; F:antigen binding; P:innate immune response; P:complement activation, classical pathway; C:blood microparticle; P:proteolysis; C:immunoglobulin complex, circulating; F:immunoglobulin receptor binding; P:regulation of immune response; P:B cell receptor signaling pathway		
tr|F6X256|F6X256_HORSE	platelet glyco V	553	20	0E0	85.25%	12	C:GO:0005887; F:GO:0005515; C:GO:0070062; P:GO:0007409; C:GO:0016020; C:GO:0016021; P:GO:0007597; P:GO:0007155; P:GO:0007596; P:GO:0030168; P:GO:0007599; C:GO:0005886	C:integral component of plasma membrane; F:protein binding; C:extracellular exosome; P:axonogenesis; C:membrane; C:integral component of membrane; P:blood coagulation, intrinsic pathway; P:cell adhesion; P:blood coagulation; P:platelet activation; P:hemostasis; C:plasma membrane		
tr|F7DW74|F7DW74_HORSE	39S ribosomal mitochondrial	93	20	1.08E-59	79.4%	7	F:GO:0003735; C:GO:0030529; C:GO:0005739; P:GO:0042254; C:GO:0005840; C:GO:0005622; P:GO:0006412	F:structural constituent of ribosome; C:intracellular ribonucleoprotein complex; C:mitochondrion; P:ribosome biogenesis; C:ribosome; C:intracellular; P:translation		
tr|F6T1Y0|F6T1Y0_HORSE	collagen alpha-1(XXVII) chain	1632	20	0E0	89.65%	6	C:GO:0005581; C:GO:0005583; P:GO:0030198; F:GO:0005201; P:GO:0003431; C:GO:0005578	C:collagen trimer; C:fibrillar collagen trimer; P:extracellular matrix organization; F:extracellular matrix structural constituent; P:growth plate cartilage chondrocyte development; C:proteinaceous extracellular matrix		
tr|F6ULE3|F6ULE3_HORSE	mannosyl-oligosaccharide glucosidase	733	20	0E0	96.2%	8	C:GO:0005789; C:GO:0070062; F:GO:0003824; C:GO:0016020; C:GO:0016021; P:GO:0006487; F:GO:0004573; P:GO:0009311	C:endoplasmic reticulum membrane; C:extracellular exosome; F:catalytic activity; C:membrane; C:integral component of membrane; P:protein N-linked glycosylation; F:mannosyl-oligosaccharide glucosidase activity; P:oligosaccharide metabolic process		
tr|F7AGM1|F7AGM1_HORSE	ATP-dependent RNA helicase DDX54	832	20	0E0	92.35%	21	P:GO:0006351; P:GO:0006355; P:GO:0006396; F:GO:0004386; C:GO:0005730; F:GO:0005102; P:GO:1903507; F:GO:0044822; F:GO:0004004; F:GO:0000166; F:GO:0003676; F:GO:0005524; C:GO:0005634; P:GO:0016070; F:GO:0003723; F:GO:0003714; C:GO:0016020; P:GO:0010501; F:GO:0030331; P:GO:0030520; F:GO:0016787	P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:RNA processing; F:helicase activity; C:nucleolus; F:receptor binding; P:negative regulation of nucleic acid-templated transcription; F:poly(A) RNA binding; F:ATP-dependent RNA helicase activity; F:nucleotide binding; F:nucleic acid binding; F:ATP binding; C:nucleus; P:RNA metabolic process; F:RNA binding; F:transcription corepressor activity; C:membrane; P:RNA secondary structure unwinding; F:estrogen receptor binding; P:intracellular estrogen receptor signaling pathway; F:hydrolase activity		
tr|F7BDV0|F7BDV0_HORSE	ATP-dependent RNA helicase DDX54	835	20	0E0	93%	21	P:GO:0006351; P:GO:0006355; P:GO:0006396; F:GO:0004386; C:GO:0005730; F:GO:0005102; P:GO:1903507; F:GO:0044822; F:GO:0004004; F:GO:0000166; F:GO:0003676; F:GO:0005524; C:GO:0005634; P:GO:0016070; F:GO:0003723; F:GO:0003714; C:GO:0016020; P:GO:0010501; F:GO:0030331; P:GO:0030520; F:GO:0016787	P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:RNA processing; F:helicase activity; C:nucleolus; F:receptor binding; P:negative regulation of nucleic acid-templated transcription; F:poly(A) RNA binding; F:ATP-dependent RNA helicase activity; F:nucleotide binding; F:nucleic acid binding; F:ATP binding; C:nucleus; P:RNA metabolic process; F:RNA binding; F:transcription corepressor activity; C:membrane; P:RNA secondary structure unwinding; F:estrogen receptor binding; P:intracellular estrogen receptor signaling pathway; F:hydrolase activity		
tr|F6ZTQ7|F6ZTQ7_HORSE	kazal-type serine protease inhibitor domain-containing 1	302	20	0E0	96.55%	8	C:GO:0005614; P:GO:0001558; P:GO:0006508; P:GO:0030198; F:GO:0008233; C:GO:0005576; F:GO:0005520; C:GO:0005578	C:interstitial matrix; P:regulation of cell growth; P:proteolysis; P:extracellular matrix organization; F:peptidase activity; C:extracellular region; F:insulin-like growth factor binding; C:proteinaceous extracellular matrix		
tr|F6ZAZ2|F6ZAZ2_HORSE	L-xylulose reductase	244	20	1.21E-163	91.85%	14	F:GO:0016614; C:GO:0005881; P:GO:0006006; P:GO:0005997; C:GO:0005634; P:GO:0051289; C:GO:0070062; C:GO:0005903; C:GO:0005902; F:GO:0016491; P:GO:0006739; P:GO:0055114; F:GO:0050038; F:GO:0016655	F:oxidoreductase activity, acting on CH-OH group of donors; C:cytoplasmic microtubule; P:glucose metabolic process; P:xylulose metabolic process; C:nucleus; P:protein homotetramerization; C:extracellular exosome; C:brush border; C:microvillus; F:oxidoreductase activity; P:NADP metabolic process; P:oxidation-reduction process; F:L-xylulose reductase (NADP+) activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor		
tr|F6VC27|F6VC27_HORSE	proto-oncogene vav	828	20	0E0	96%	22	P:GO:0035023; P:GO:0007186; P:GO:0007264; P:GO:0008361; F:GO:0005085; P:GO:0042110; F:GO:0005089; P:GO:0045785; P:GO:0043547; C:GO:0005622; P:GO:0045954; P:GO:0030217; P:GO:0072593; P:GO:0007229; C:GO:0005911; P:GO:0006955; F:GO:0046872; P:GO:0043087; P:GO:0006909; P:GO:0030593; P:GO:0035556; F:GO:0030676	P:regulation of Rho protein signal transduction; P:G-protein coupled receptor signaling pathway; P:small GTPase mediated signal transduction; P:regulation of cell size; F:guanyl-nucleotide exchange factor activity; P:T cell activation; F:Rho guanyl-nucleotide exchange factor activity; P:positive regulation of cell adhesion; P:positive regulation of GTPase activity; C:intracellular; P:positive regulation of natural killer cell mediated cytotoxicity; P:T cell differentiation; P:reactive oxygen species metabolic process; P:integrin-mediated signaling pathway; C:cell-cell junction; P:immune response; F:metal ion binding; P:regulation of GTPase activity; P:phagocytosis; P:neutrophil chemotaxis; P:intracellular signal transduction; F:Rac guanyl-nucleotide exchange factor activity		
tr|F7DYA1|F7DYA1_HORSE	ala Mutant Of Liver Alcohol Dehydrogenase Complexed With Cofactor Nad And Inhibitor Trifluoroethanol Solved To Angstrom Resolution	327	20	0E0	96%	6	F:GO:0008270; C:GO:0005737; F:GO:0016491; F:GO:0046872; P:GO:0055114; F:GO:0004022	F:zinc ion binding; C:cytoplasm; F:oxidoreductase activity; F:metal ion binding; P:oxidation-reduction process; F:alcohol dehydrogenase (NAD) activity		
sp|P00328|ADH1S_HORSE	ala Mutant Of Liver Alcohol Dehydrogenase Complexed With Cofactor Nad And Inhibitor Trifluoroethanol Solved To Angstrom Resolution	374	20	0E0	97.9%	6	F:GO:0008270; C:GO:0005737; F:GO:0016491; F:GO:0046872; P:GO:0055114; F:GO:0004022	F:zinc ion binding; C:cytoplasm; F:oxidoreductase activity; F:metal ion binding; P:oxidation-reduction process; F:alcohol dehydrogenase (NAD) activity		
tr|F6RFE4|F6RFE4_HORSE	FAM135A isoform X1	1509	20	0E0	93.35%	2	P:GO:0044255; F:GO:0052689	P:cellular lipid metabolic process; F:carboxylic ester hydrolase activity		
tr|F6QGN5|F6QGN5_HORSE	FAM135A isoform X1	1523	20	0E0	93.9%	2	P:GO:0044255; F:GO:0052689	P:cellular lipid metabolic process; F:carboxylic ester hydrolase activity		
tr|F7AGK7|F7AGK7_HORSE	collagen alpha-1(V) chain isoform X1	1775	20	0E0	94.85%	30	P:GO:0007155; P:GO:1903225; F:GO:0008201; F:GO:0005178; C:GO:0005576; P:GO:0043588; P:GO:0043206; C:GO:0005578; C:GO:0005788; P:GO:0003007; C:GO:0005604; C:GO:0070062; P:GO:0001568; F:GO:0043394; P:GO:0045112; C:GO:0031012; P:GO:0032964; P:GO:0035313; P:GO:0016477; P:GO:0051128; C:GO:0005581; F:GO:0005201; F:GO:0048407; C:GO:0005588; P:GO:0048592; F:GO:0046872; P:GO:0030198; P:GO:0035989; P:GO:0030574; P:GO:0030199	P:cell adhesion; P:negative regulation of endodermal cell differentiation; F:heparin binding; F:integrin binding; C:extracellular region; P:skin development; P:extracellular fibril organization; C:proteinaceous extracellular matrix; C:endoplasmic reticulum lumen; P:heart morphogenesis; C:basement membrane; C:extracellular exosome; P:blood vessel development; F:proteoglycan binding; P:integrin biosynthetic process; C:extracellular matrix; P:collagen biosynthetic process; P:wound healing, spreading of epidermal cells; P:cell migration; P:regulation of cellular component organization; C:collagen trimer; F:extracellular matrix structural constituent; F:platelet-derived growth factor binding; C:collagen type V trimer; P:eye morphogenesis; F:metal ion binding; P:extracellular matrix organization; P:tendon development; P:collagen catabolic process; P:collagen fibril organization		
tr|F7BG55|F7BG55_HORSE	ephrin type-B receptor 4	977	20	0E0	98.25%	20	P:GO:0018108; P:GO:0007169; P:GO:0046777; P:GO:0007155; P:GO:0002042; F:GO:0004672; P:GO:0006468; F:GO:0005003; F:GO:0000166; C:GO:0005887; F:GO:0005524; F:GO:0004713; C:GO:0070062; F:GO:0004714; P:GO:0048013; C:GO:0016020; C:GO:0016021; P:GO:0016310; F:GO:0016740; F:GO:0016301	P:peptidyl-tyrosine phosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:protein autophosphorylation; P:cell adhesion; P:cell migration involved in sprouting angiogenesis; F:protein kinase activity; P:protein phosphorylation; F:ephrin receptor activity; F:nucleotide binding; C:integral component of plasma membrane; F:ATP binding; F:protein tyrosine kinase activity; C:extracellular exosome; F:transmembrane receptor protein tyrosine kinase activity; P:ephrin receptor signaling pathway; C:membrane; C:integral component of membrane; P:phosphorylation; F:transferase activity; F:kinase activity		
tr|F6VZ73|F6VZ73_HORSE	hyaluronan-binding 2	523	20	0E0	87.55%	7	F:GO:0005509; P:GO:0006508; F:GO:0008236; F:GO:0004252; F:GO:0008233; C:GO:0005576; F:GO:0016787	F:calcium ion binding; P:proteolysis; F:serine-type peptidase activity; F:serine-type endopeptidase activity; F:peptidase activity; C:extracellular region; F:hydrolase activity		
tr|F6ZQE2|F6ZQE2_HORSE	T-complex 1 subunit theta	550	20	0E0	98.4%	28	P:GO:1904874; P:GO:1904851; P:GO:1904871; P:GO:0046931; C:GO:0042995; C:GO:0005654; C:GO:0005874; F:GO:0000166; F:GO:0005524; C:GO:0070062; C:GO:0045111; C:GO:0005929; C:GO:0005829; F:GO:0051082; P:GO:1901998; P:GO:0006457; C:GO:0002199; F:GO:0042623; C:GO:0005832; C:GO:0005813; P:GO:0007339; C:GO:0005856; F:GO:0005515; C:GO:0005815; C:GO:0005737; C:GO:0044297; P:GO:0032212; P:GO:0050821	P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:pore complex assembly; C:cell projection; C:nucleoplasm; C:microtubule; F:nucleotide binding; F:ATP binding; C:extracellular exosome; C:intermediate filament cytoskeleton; C:cilium; C:cytosol; F:unfolded protein binding; P:toxin transport; P:protein folding; C:zona pellucida receptor complex; F:ATPase activity, coupled; C:chaperonin-containing T-complex; C:centrosome; P:binding of sperm to zona pellucida; C:cytoskeleton; F:protein binding; C:microtubule organizing center; C:cytoplasm; C:cell body; P:positive regulation of telomere maintenance via telomerase; P:protein stabilization		
tr|F7C3H1|F7C3H1_HORSE	low-density lipo receptor-related 4	1905	20	0E0	98.7%	35	P:GO:1904395; P:GO:0048856; P:GO:0008104; P:GO:0042475; P:GO:0048513; P:GO:0009954; P:GO:0042733; P:GO:0009953; P:GO:0030326; P:GO:0050771; P:GO:0051124; P:GO:0001942; P:GO:0097104; P:GO:0001822; F:GO:0005509; P:GO:0030509; P:GO:0060828; P:GO:0097105; P:GO:0016055; C:GO:0031594; P:GO:0050731; F:GO:0042803; P:GO:0060173; P:GO:1901631; P:GO:0043113; C:GO:0005886; C:GO:0009986; P:GO:0090090; P:GO:0071340; P:GO:0001932; C:GO:0016020; C:GO:0016021; P:GO:0030178; P:GO:0030279; F:GO:0030971	P:positive regulation of skeletal muscle acetylcholine-gated channel clustering; P:anatomical structure development; P:protein localization; P:odontogenesis of dentin-containing tooth; P:animal organ development; P:proximal/distal pattern formation; P:embryonic digit morphogenesis; P:dorsal/ventral pattern formation; P:embryonic limb morphogenesis; P:negative regulation of axonogenesis; P:synaptic growth at neuromuscular junction; P:hair follicle development; P:postsynaptic membrane assembly; P:kidney development; F:calcium ion binding; P:BMP signaling pathway; P:regulation of canonical Wnt signaling pathway; P:presynaptic membrane assembly; P:Wnt signaling pathway; C:neuromuscular junction; P:positive regulation of peptidyl-tyrosine phosphorylation; F:protein homodimerization activity; P:limb development; P:positive regulation of presynaptic membrane organization; P:receptor clustering; C:plasma membrane; C:cell surface; P:negative regulation of canonical Wnt signaling pathway; P:skeletal muscle acetylcholine-gated channel clustering; P:regulation of protein phosphorylation; C:membrane; C:integral component of membrane; P:negative regulation of Wnt signaling pathway; P:negative regulation of ossification; F:receptor tyrosine kinase binding		
tr|F6WTY0|F6WTY0_HORSE	hypoxia-inducible factor 1-alpha inhibitor	349	20	0E0	98.85%	32	F:GO:0016706; P:GO:0045663; P:GO:0061418; F:GO:0005112; P:GO:0045746; C:GO:0005654; F:GO:0005506; F:GO:0016491; C:GO:0005829; F:GO:0071532; F:GO:0008270; F:GO:0019826; F:GO:0042803; F:GO:0036140; P:GO:0006351; P:GO:0042264; P:GO:0006355; P:GO:0042265; P:GO:0061428; F:GO:0051213; F:GO:0031406; F:GO:0051059; C:GO:0005634; C:GO:0048471; F:GO:0005515; F:GO:0046872; F:GO:0048037; C:GO:0005737; P:GO:2001214; P:GO:0055114; P:GO:0036138; F:GO:0036139	F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; P:positive regulation of myoblast differentiation; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; F:Notch binding; P:negative regulation of Notch signaling pathway; C:nucleoplasm; F:iron ion binding; F:oxidoreductase activity; C:cytosol; F:ankyrin repeat binding; F:zinc ion binding; F:oxygen sensor activity; F:protein homodimerization activity; F:peptidyl-asparagine 3-dioxygenase activity; P:transcription, DNA-templated; P:peptidyl-aspartic acid hydroxylation; P:regulation of transcription, DNA-templated; P:peptidyl-asparagine hydroxylation; P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; F:dioxygenase activity; F:carboxylic acid binding; F:NF-kappaB binding; C:nucleus; C:perinuclear region of cytoplasm; F:protein binding; F:metal ion binding; F:cofactor binding; C:cytoplasm; P:positive regulation of vasculogenesis; P:oxidation-reduction process; P:peptidyl-histidine hydroxylation; F:peptidyl-histidine dioxygenase activity		
tr|F6ZEX8|F6ZEX8_HORSE	ethanolamine-phosphate phospho-lyase isoform X1	499	20	0E0	95.1%	5	F:GO:0042802; F:GO:0030170; F:GO:0003824; F:GO:0008483; F:GO:0016740	F:identical protein binding; F:pyridoxal phosphate binding; F:catalytic activity; F:transaminase activity; F:transferase activity		
tr|F7DS15|F7DS15_HORSE	sulfotransferase family cytosolic 2B member 1	273	20	0E0	92.45%	8	C:GO:0070062; C:GO:0005737; F:GO:0050294; C:GO:0043231; P:GO:0008202; F:GO:0008146; F:GO:0016740; P:GO:0000103	C:extracellular exosome; C:cytoplasm; F:steroid sulfotransferase activity; C:intracellular membrane-bounded organelle; P:steroid metabolic process; F:sulfotransferase activity; F:transferase activity; P:sulfate assimilation		
tr|F6Q5M6|F6Q5M6_HORSE	serine threonine- kinase NLK	527	20	0E0	99.25%	32	P:GO:0007179; P:GO:0046777; P:GO:0006468; C:GO:0005654; F:GO:0000287; F:GO:0000166; F:GO:0005524; P:GO:0000165; C:GO:0005829; P:GO:0033136; P:GO:0016055; P:GO:0016310; P:GO:0035556; P:GO:0006351; P:GO:0007223; P:GO:0006355; F:GO:0004672; F:GO:0008134; F:GO:0004674; F:GO:0042169; C:GO:0005622; C:GO:0005634; F:GO:0005515; F:GO:0031625; F:GO:0046872; C:GO:0005737; F:GO:0004707; P:GO:0030178; F:GO:0016740; P:GO:0050821; F:GO:0016301; P:GO:0018107	P:transforming growth factor beta receptor signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; C:nucleoplasm; F:magnesium ion binding; F:nucleotide binding; F:ATP binding; P:MAPK cascade; C:cytosol; P:serine phosphorylation of STAT3 protein; P:Wnt signaling pathway; P:phosphorylation; P:intracellular signal transduction; P:transcription, DNA-templated; P:Wnt signaling pathway, calcium modulating pathway; P:regulation of transcription, DNA-templated; F:protein kinase activity; F:transcription factor binding; F:protein serine/threonine kinase activity; F:SH2 domain binding; C:intracellular; C:nucleus; F:protein binding; F:ubiquitin protein ligase binding; F:metal ion binding; C:cytoplasm; F:MAP kinase activity; P:negative regulation of Wnt signaling pathway; F:transferase activity; P:protein stabilization; F:kinase activity; P:peptidyl-threonine phosphorylation		
tr|F6YEX6|F6YEX6_HORSE	vascular endothelial growth factor receptor 1 isoform X1	1096	20	0E0	95.65%	54	P:GO:0018108; F:GO:0036332; F:GO:0019838; P:GO:0014068; P:GO:0046777; P:GO:0048514; P:GO:0045766; P:GO:0000186; P:GO:0001666; P:GO:0030949; F:GO:0036326; F:GO:0036327; P:GO:0036323; P:GO:0043552; C:GO:0043235; F:GO:0004672; C:GO:0005886; P:GO:0048010; F:GO:0005515; P:GO:0010863; P:GO:0030335; P:GO:0043406; P:GO:0007275; P:GO:0008284; C:GO:0005576; P:GO:0006468; P:GO:0006940; F:GO:0000166; P:GO:0048661; P:GO:0006935; C:GO:0005887; F:GO:0005524; F:GO:0004713; C:GO:0005768; C:GO:0005925; F:GO:0004714; P:GO:0001525; P:GO:0016310; P:GO:0016477; P:GO:0030522; P:GO:0038084; F:GO:0005021; P:GO:0007169; P:GO:0043410; C:GO:0005615; P:GO:0048598; C:GO:0005737; P:GO:0002548; C:GO:0016020; C:GO:0016021; P:GO:0030154; P:GO:0035924; F:GO:0016740; F:GO:0016301	P:peptidyl-tyrosine phosphorylation; F:placental growth factor-activated receptor activity; F:growth factor binding; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein autophosphorylation; P:blood vessel morphogenesis; P:positive regulation of angiogenesis; P:activation of MAPKK activity; P:response to hypoxia; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; F:VEGF-A-activated receptor activity; F:VEGF-B-activated receptor activity; P:vascular endothelial growth factor receptor-1 signaling pathway; P:positive regulation of phosphatidylinositol 3-kinase activity; C:receptor complex; F:protein kinase activity; C:plasma membrane; P:vascular endothelial growth factor receptor signaling pathway; F:protein binding; P:positive regulation of phospholipase C activity; P:positive regulation of cell migration; P:positive regulation of MAP kinase activity; P:multicellular organism development; P:positive regulation of cell proliferation; C:extracellular region; P:protein phosphorylation; P:regulation of smooth muscle contraction; F:nucleotide binding; P:positive regulation of smooth muscle cell proliferation; P:chemotaxis; C:integral component of plasma membrane; F:ATP binding; F:protein tyrosine kinase activity; C:endosome; C:focal adhesion; F:transmembrane receptor protein tyrosine kinase activity; P:angiogenesis; P:phosphorylation; P:cell migration; P:intracellular receptor signaling pathway; P:vascular endothelial growth factor signaling pathway; F:vascular endothelial growth factor-activated receptor activity; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:positive regulation of MAPK cascade; C:extracellular space; P:embryonic morphogenesis; C:cytoplasm; P:monocyte chemotaxis; C:membrane; C:integral component of membrane; P:cell differentiation; P:cellular response to vascular endothelial growth factor stimulus; F:transferase activity; F:kinase activity		
tr|F7CET7|F7CET7_HORSE	vascular endothelial growth factor receptor 2	1343	20	0E0	95.2%	70	P:GO:0018108; F:GO:0019838; P:GO:0014068; P:GO:0038033; P:GO:0035162; P:GO:0046777; P:GO:0002042; C:GO:0005794; P:GO:0023014; P:GO:0045766; C:GO:0097443; P:GO:2000352; P:GO:0016239; P:GO:0050927; F:GO:0004672; P:GO:0090141; C:GO:0005886; C:GO:0005634; P:GO:0048010; F:GO:0005515; P:GO:0051894; P:GO:0051770; P:GO:2001214; C:GO:0030054; P:GO:0030335; P:GO:0008360; P:GO:0035584; P:GO:0007275; P:GO:0008284; F:GO:0005178; P:GO:0001570; C:GO:0005576; P:GO:0006468; P:GO:0003158; F:GO:0000166; C:GO:0005887; F:GO:0005524; C:GO:0005769; F:GO:0004713; C:GO:0005768; F:GO:0004714; P:GO:0001525; F:GO:0004716; P:GO:0016032; C:GO:0031410; P:GO:0051901; P:GO:0016310; P:GO:0010595; P:GO:0038084; F:GO:0005021; P:GO:0007169; P:GO:0038083; C:GO:0005783; F:GO:0038085; P:GO:0043410; C:GO:0005737; P:GO:0043066; C:GO:0045121; C:GO:0016020; P:GO:0070374; P:GO:0001934; C:GO:0016021; P:GO:0030198; P:GO:0030154; C:GO:0016023; F:GO:0051879; P:GO:0035924; P:GO:0001938; F:GO:0016740; F:GO:0016301	P:peptidyl-tyrosine phosphorylation; F:growth factor binding; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; P:embryonic hemopoiesis; P:protein autophosphorylation; P:cell migration involved in sprouting angiogenesis; C:Golgi apparatus; P:signal transduction by protein phosphorylation; P:positive regulation of angiogenesis; C:sorting endosome; P:negative regulation of endothelial cell apoptotic process; P:positive regulation of macroautophagy; P:positive regulation of positive chemotaxis; F:protein kinase activity; P:positive regulation of mitochondrial fission; C:plasma membrane; C:nucleus; P:vascular endothelial growth factor receptor signaling pathway; F:protein binding; P:positive regulation of focal adhesion assembly; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of vasculogenesis; C:cell junction; P:positive regulation of cell migration; P:regulation of cell shape; P:calcium-mediated signaling using intracellular calcium source; P:multicellular organism development; P:positive regulation of cell proliferation; F:integrin binding; P:vasculogenesis; C:extracellular region; P:protein phosphorylation; P:endothelium development; F:nucleotide binding; C:integral component of plasma membrane; F:ATP binding; C:early endosome; F:protein tyrosine kinase activity; C:endosome; F:transmembrane receptor protein tyrosine kinase activity; P:angiogenesis; F:receptor signaling protein tyrosine kinase activity; P:viral process; C:cytoplasmic vesicle; P:positive regulation of mitochondrial depolarization; P:phosphorylation; P:positive regulation of endothelial cell migration; P:vascular endothelial growth factor signaling pathway; F:vascular endothelial growth factor-activated receptor activity; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:peptidyl-tyrosine autophosphorylation; C:endoplasmic reticulum; F:vascular endothelial growth factor binding; P:positive regulation of MAPK cascade; C:cytoplasm; P:negative regulation of apoptotic process; C:membrane raft; C:membrane; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of protein phosphorylation; C:integral component of membrane; P:extracellular matrix organization; P:cell differentiation; C:cytoplasmic, membrane-bounded vesicle; F:Hsp90 protein binding; P:cellular response to vascular endothelial growth factor stimulus; P:positive regulation of endothelial cell proliferation; F:transferase activity; F:kinase activity		
tr|F7DHE6|F7DHE6_HORSE	vascular endothelial growth factor receptor 2	1414	20	0E0	96.05%	70	P:GO:0018108; F:GO:0019838; P:GO:0014068; P:GO:0038033; P:GO:0035162; P:GO:0046777; P:GO:0002042; C:GO:0005794; P:GO:0023014; P:GO:0045766; C:GO:0097443; P:GO:2000352; P:GO:0016239; P:GO:0050927; F:GO:0004672; P:GO:0090141; C:GO:0005886; C:GO:0005634; P:GO:0048010; F:GO:0005515; P:GO:0051894; P:GO:0051770; P:GO:2001214; C:GO:0030054; P:GO:0030335; P:GO:0008360; P:GO:0035584; P:GO:0007275; P:GO:0008284; F:GO:0005178; P:GO:0001570; C:GO:0005576; P:GO:0006468; P:GO:0003158; F:GO:0000166; C:GO:0005887; F:GO:0005524; C:GO:0005769; F:GO:0004713; C:GO:0005768; F:GO:0004714; P:GO:0001525; F:GO:0004716; P:GO:0016032; C:GO:0031410; P:GO:0051901; P:GO:0016310; P:GO:0010595; P:GO:0038084; F:GO:0005021; P:GO:0007169; P:GO:0038083; C:GO:0005783; F:GO:0038085; P:GO:0043410; C:GO:0005737; P:GO:0043066; C:GO:0045121; C:GO:0016020; P:GO:0070374; P:GO:0001934; C:GO:0016021; P:GO:0030198; P:GO:0030154; C:GO:0016023; F:GO:0051879; P:GO:0035924; P:GO:0001938; F:GO:0016740; F:GO:0016301	P:peptidyl-tyrosine phosphorylation; F:growth factor binding; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; P:embryonic hemopoiesis; P:protein autophosphorylation; P:cell migration involved in sprouting angiogenesis; C:Golgi apparatus; P:signal transduction by protein phosphorylation; P:positive regulation of angiogenesis; C:sorting endosome; P:negative regulation of endothelial cell apoptotic process; P:positive regulation of macroautophagy; P:positive regulation of positive chemotaxis; F:protein kinase activity; P:positive regulation of mitochondrial fission; C:plasma membrane; C:nucleus; P:vascular endothelial growth factor receptor signaling pathway; F:protein binding; P:positive regulation of focal adhesion assembly; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of vasculogenesis; C:cell junction; P:positive regulation of cell migration; P:regulation of cell shape; P:calcium-mediated signaling using intracellular calcium source; P:multicellular organism development; P:positive regulation of cell proliferation; F:integrin binding; P:vasculogenesis; C:extracellular region; P:protein phosphorylation; P:endothelium development; F:nucleotide binding; C:integral component of plasma membrane; F:ATP binding; C:early endosome; F:protein tyrosine kinase activity; C:endosome; F:transmembrane receptor protein tyrosine kinase activity; P:angiogenesis; F:receptor signaling protein tyrosine kinase activity; P:viral process; C:cytoplasmic vesicle; P:positive regulation of mitochondrial depolarization; P:phosphorylation; P:positive regulation of endothelial cell migration; P:vascular endothelial growth factor signaling pathway; F:vascular endothelial growth factor-activated receptor activity; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:peptidyl-tyrosine autophosphorylation; C:endoplasmic reticulum; F:vascular endothelial growth factor binding; P:positive regulation of MAPK cascade; C:cytoplasm; P:negative regulation of apoptotic process; C:membrane raft; C:membrane; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of protein phosphorylation; C:integral component of membrane; P:extracellular matrix organization; P:cell differentiation; C:cytoplasmic, membrane-bounded vesicle; F:Hsp90 protein binding; P:cellular response to vascular endothelial growth factor stimulus; P:positive regulation of endothelial cell proliferation; F:transferase activity; F:kinase activity		
tr|F6T133|F6T133_HORSE	vascular endothelial growth factor receptor 1	1336	20	0E0	95.65%	54	P:GO:0018108; F:GO:0036332; F:GO:0019838; P:GO:0014068; P:GO:0046777; P:GO:0048514; P:GO:0045766; P:GO:0000186; P:GO:0001666; P:GO:0030949; F:GO:0036326; F:GO:0036327; P:GO:0036323; P:GO:0043552; C:GO:0043235; F:GO:0004672; C:GO:0005886; P:GO:0048010; F:GO:0005515; P:GO:0010863; P:GO:0030335; P:GO:0043406; P:GO:0007275; P:GO:0008284; C:GO:0005576; P:GO:0006468; P:GO:0006940; F:GO:0000166; P:GO:0048661; P:GO:0006935; C:GO:0005887; F:GO:0005524; F:GO:0004713; C:GO:0005768; C:GO:0005925; F:GO:0004714; P:GO:0001525; P:GO:0016310; P:GO:0016477; P:GO:0030522; P:GO:0038084; F:GO:0005021; P:GO:0007169; P:GO:0043410; C:GO:0005615; P:GO:0048598; C:GO:0005737; P:GO:0002548; C:GO:0016020; C:GO:0016021; P:GO:0030154; P:GO:0035924; F:GO:0016740; F:GO:0016301	P:peptidyl-tyrosine phosphorylation; F:placental growth factor-activated receptor activity; F:growth factor binding; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein autophosphorylation; P:blood vessel morphogenesis; P:positive regulation of angiogenesis; P:activation of MAPKK activity; P:response to hypoxia; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; F:VEGF-A-activated receptor activity; F:VEGF-B-activated receptor activity; P:vascular endothelial growth factor receptor-1 signaling pathway; P:positive regulation of phosphatidylinositol 3-kinase activity; C:receptor complex; F:protein kinase activity; C:plasma membrane; P:vascular endothelial growth factor receptor signaling pathway; F:protein binding; P:positive regulation of phospholipase C activity; P:positive regulation of cell migration; P:positive regulation of MAP kinase activity; P:multicellular organism development; P:positive regulation of cell proliferation; C:extracellular region; P:protein phosphorylation; P:regulation of smooth muscle contraction; F:nucleotide binding; P:positive regulation of smooth muscle cell proliferation; P:chemotaxis; C:integral component of plasma membrane; F:ATP binding; F:protein tyrosine kinase activity; C:endosome; C:focal adhesion; F:transmembrane receptor protein tyrosine kinase activity; P:angiogenesis; P:phosphorylation; P:cell migration; P:intracellular receptor signaling pathway; P:vascular endothelial growth factor signaling pathway; F:vascular endothelial growth factor-activated receptor activity; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:positive regulation of MAPK cascade; C:extracellular space; P:embryonic morphogenesis; C:cytoplasm; P:monocyte chemotaxis; C:membrane; C:integral component of membrane; P:cell differentiation; P:cellular response to vascular endothelial growth factor stimulus; F:transferase activity; F:kinase activity		
tr|F6S634|F6S634_HORSE	serpin A12	414	20	0E0	87.05%	10	F:GO:0004867; C:GO:0005615; P:GO:0014068; P:GO:0046628; P:GO:0051055; P:GO:0045721; P:GO:0010951; P:GO:0090207; C:GO:0005886; P:GO:0090181	F:serine-type endopeptidase inhibitor activity; C:extracellular space; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of insulin receptor signaling pathway; P:negative regulation of lipid biosynthetic process; P:negative regulation of gluconeogenesis; P:negative regulation of endopeptidase activity; P:regulation of triglyceride metabolic process; C:plasma membrane; P:regulation of cholesterol metabolic process		
tr|F6YZP7|F6YZP7_HORSE	coatomer subunit beta	953	20	0E0	99.05%	18	P:GO:0015031; F:GO:0005198; C:GO:0005794; C:GO:0000139; C:GO:0005793; P:GO:0006886; P:GO:0006810; C:GO:0005886; C:GO:0030117; P:GO:0016192; C:GO:0005737; C:GO:0043231; C:GO:0016020; C:GO:0005829; C:GO:0031410; C:GO:0030663; C:GO:0030137; C:GO:0030126	P:protein transport; F:structural molecule activity; C:Golgi apparatus; C:Golgi membrane; C:endoplasmic reticulum-Golgi intermediate compartment; P:intracellular protein transport; P:transport; C:plasma membrane; C:membrane coat; P:vesicle-mediated transport; C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:cytosol; C:cytoplasmic vesicle; C:COPI-coated vesicle membrane; C:COPI-coated vesicle; C:COPI vesicle coat		
tr|F6RTI8|F6RTI8_HORSE	collagen alpha-2(I) chain	1357	20	0E0	96.25%	23	F:GO:0042802; C:GO:0005581; P:GO:0007179; C:GO:0005584; P:GO:0007266; P:GO:0043589; C:GO:0005576; F:GO:0005201; P:GO:0008217; C:GO:0005578; C:GO:0005622; F:GO:0048407; P:GO:0071230; C:GO:0005615; C:GO:0070062; P:GO:0001501; P:GO:0001568; F:GO:0046332; F:GO:0046872; P:GO:0030199; C:GO:0031012; F:GO:0030674; P:GO:0070208	F:identical protein binding; C:collagen trimer; P:transforming growth factor beta receptor signaling pathway; C:collagen type I trimer; P:Rho protein signal transduction; P:skin morphogenesis; C:extracellular region; F:extracellular matrix structural constituent; P:regulation of blood pressure; C:proteinaceous extracellular matrix; C:intracellular; F:platelet-derived growth factor binding; P:cellular response to amino acid stimulus; C:extracellular space; C:extracellular exosome; P:skeletal system development; P:blood vessel development; F:SMAD binding; F:metal ion binding; P:collagen fibril organization; C:extracellular matrix; F:protein binding, bridging; P:protein heterotrimerization		
tr|F6RTH9|F6RTH9_HORSE	collagen alpha-2(I) chain	1357	20	0E0	96.25%	23	F:GO:0042802; C:GO:0005581; P:GO:0007179; C:GO:0005584; P:GO:0007266; P:GO:0043589; C:GO:0005576; F:GO:0005201; P:GO:0008217; C:GO:0005578; C:GO:0005622; F:GO:0048407; P:GO:0071230; C:GO:0005615; C:GO:0070062; P:GO:0001501; P:GO:0001568; F:GO:0046332; F:GO:0046872; P:GO:0030199; C:GO:0031012; F:GO:0030674; P:GO:0070208	F:identical protein binding; C:collagen trimer; P:transforming growth factor beta receptor signaling pathway; C:collagen type I trimer; P:Rho protein signal transduction; P:skin morphogenesis; C:extracellular region; F:extracellular matrix structural constituent; P:regulation of blood pressure; C:proteinaceous extracellular matrix; C:intracellular; F:platelet-derived growth factor binding; P:cellular response to amino acid stimulus; C:extracellular space; C:extracellular exosome; P:skeletal system development; P:blood vessel development; F:SMAD binding; F:metal ion binding; P:collagen fibril organization; C:extracellular matrix; F:protein binding, bridging; P:protein heterotrimerization		
tr|F6RTJ6|F6RTJ6_HORSE	collagen alpha-2(I) chain	1359	20	0E0	96.3%	23	F:GO:0042802; C:GO:0005581; P:GO:0007179; C:GO:0005584; P:GO:0007266; P:GO:0043589; C:GO:0005576; F:GO:0005201; P:GO:0008217; C:GO:0005578; C:GO:0005622; F:GO:0048407; P:GO:0071230; C:GO:0005615; C:GO:0070062; P:GO:0001501; P:GO:0001568; F:GO:0046332; F:GO:0046872; P:GO:0030199; C:GO:0031012; F:GO:0030674; P:GO:0070208	F:identical protein binding; C:collagen trimer; P:transforming growth factor beta receptor signaling pathway; C:collagen type I trimer; P:Rho protein signal transduction; P:skin morphogenesis; C:extracellular region; F:extracellular matrix structural constituent; P:regulation of blood pressure; C:proteinaceous extracellular matrix; C:intracellular; F:platelet-derived growth factor binding; P:cellular response to amino acid stimulus; C:extracellular space; C:extracellular exosome; P:skeletal system development; P:blood vessel development; F:SMAD binding; F:metal ion binding; P:collagen fibril organization; C:extracellular matrix; F:protein binding, bridging; P:protein heterotrimerization		
tr|F6RTN7|F6RTN7_HORSE	collagen alpha-2(I) chain	1364	20	0E0	96.4%	23	F:GO:0042802; C:GO:0005581; P:GO:0007179; C:GO:0005584; P:GO:0007266; P:GO:0043589; C:GO:0005576; F:GO:0005201; P:GO:0008217; C:GO:0005578; C:GO:0005622; F:GO:0048407; P:GO:0071230; C:GO:0005615; C:GO:0070062; P:GO:0001501; P:GO:0001568; F:GO:0046332; F:GO:0046872; P:GO:0030199; C:GO:0031012; F:GO:0030674; P:GO:0070208	F:identical protein binding; C:collagen trimer; P:transforming growth factor beta receptor signaling pathway; C:collagen type I trimer; P:Rho protein signal transduction; P:skin morphogenesis; C:extracellular region; F:extracellular matrix structural constituent; P:regulation of blood pressure; C:proteinaceous extracellular matrix; C:intracellular; F:platelet-derived growth factor binding; P:cellular response to amino acid stimulus; C:extracellular space; C:extracellular exosome; P:skeletal system development; P:blood vessel development; F:SMAD binding; F:metal ion binding; P:collagen fibril organization; C:extracellular matrix; F:protein binding, bridging; P:protein heterotrimerization		
tr|F6RUA6|F6RUA6_HORSE	collagen alpha-2(I) chain	1364	20	0E0	96.6%	23	F:GO:0042802; C:GO:0005581; P:GO:0007179; C:GO:0005584; P:GO:0007266; P:GO:0043589; C:GO:0005576; F:GO:0005201; P:GO:0008217; C:GO:0005578; C:GO:0005622; F:GO:0048407; P:GO:0071230; C:GO:0005615; C:GO:0070062; P:GO:0001501; P:GO:0001568; F:GO:0046332; F:GO:0046872; P:GO:0030199; C:GO:0031012; F:GO:0030674; P:GO:0070208	F:identical protein binding; C:collagen trimer; P:transforming growth factor beta receptor signaling pathway; C:collagen type I trimer; P:Rho protein signal transduction; P:skin morphogenesis; C:extracellular region; F:extracellular matrix structural constituent; P:regulation of blood pressure; C:proteinaceous extracellular matrix; C:intracellular; F:platelet-derived growth factor binding; P:cellular response to amino acid stimulus; C:extracellular space; C:extracellular exosome; P:skeletal system development; P:blood vessel development; F:SMAD binding; F:metal ion binding; P:collagen fibril organization; C:extracellular matrix; F:protein binding, bridging; P:protein heterotrimerization		
tr|F6RTL6|F6RTL6_HORSE	collagen alpha-2(I) chain	1364	20	0E0	96.4%	23	F:GO:0042802; C:GO:0005581; P:GO:0007179; C:GO:0005584; P:GO:0007266; P:GO:0043589; C:GO:0005576; F:GO:0005201; P:GO:0008217; C:GO:0005578; C:GO:0005622; F:GO:0048407; P:GO:0071230; C:GO:0005615; C:GO:0070062; P:GO:0001501; P:GO:0001568; F:GO:0046332; F:GO:0046872; P:GO:0030199; C:GO:0031012; F:GO:0030674; P:GO:0070208	F:identical protein binding; C:collagen trimer; P:transforming growth factor beta receptor signaling pathway; C:collagen type I trimer; P:Rho protein signal transduction; P:skin morphogenesis; C:extracellular region; F:extracellular matrix structural constituent; P:regulation of blood pressure; C:proteinaceous extracellular matrix; C:intracellular; F:platelet-derived growth factor binding; P:cellular response to amino acid stimulus; C:extracellular space; C:extracellular exosome; P:skeletal system development; P:blood vessel development; F:SMAD binding; F:metal ion binding; P:collagen fibril organization; C:extracellular matrix; F:protein binding, bridging; P:protein heterotrimerization		
tr|F6RTP3|F6RTP3_HORSE	collagen alpha-2(I) chain	1364	20	0E0	96.3%	23	F:GO:0042802; C:GO:0005581; P:GO:0007179; C:GO:0005584; P:GO:0007266; P:GO:0043589; C:GO:0005576; F:GO:0005201; P:GO:0008217; C:GO:0005578; C:GO:0005622; F:GO:0048407; P:GO:0071230; C:GO:0005615; C:GO:0070062; P:GO:0001501; P:GO:0001568; F:GO:0046332; F:GO:0046872; P:GO:0030199; C:GO:0031012; F:GO:0030674; P:GO:0070208	F:identical protein binding; C:collagen trimer; P:transforming growth factor beta receptor signaling pathway; C:collagen type I trimer; P:Rho protein signal transduction; P:skin morphogenesis; C:extracellular region; F:extracellular matrix structural constituent; P:regulation of blood pressure; C:proteinaceous extracellular matrix; C:intracellular; F:platelet-derived growth factor binding; P:cellular response to amino acid stimulus; C:extracellular space; C:extracellular exosome; P:skeletal system development; P:blood vessel development; F:SMAD binding; F:metal ion binding; P:collagen fibril organization; C:extracellular matrix; F:protein binding, bridging; P:protein heterotrimerization		
tr|F6XRY7|F6XRY7_HORSE	cystatin-M	133	20	6.71E-65	76.4%	9	F:GO:0030414; C:GO:0001533; C:GO:0070062; F:GO:0004869; P:GO:0008544; P:GO:0010951; P:GO:0009653; C:GO:0005576; P:GO:0010466	F:peptidase inhibitor activity; C:cornified envelope; C:extracellular exosome; F:cysteine-type endopeptidase inhibitor activity; P:epidermis development; P:negative regulation of endopeptidase activity; P:anatomical structure morphogenesis; C:extracellular region; P:negative regulation of peptidase activity		
tr|F6VRK8|F6VRK8_HORSE	electrogenic sodium bicarbonate cotransporter 4	1136	20	0E0	94.9%	26	P:GO:0015698; P:GO:0060041; P:GO:0003073; P:GO:0002064; F:GO:0005452; P:GO:0006820; P:GO:0003014; F:GO:0005215; P:GO:0006814; C:GO:0005887; P:GO:0006811; P:GO:0098656; P:GO:0015701; F:GO:0015301; F:GO:0008510; P:GO:0006810; C:GO:0005886; P:GO:0051453; P:GO:0048311; C:GO:0016020; F:GO:0008509; C:GO:0016021; P:GO:0010468; P:GO:0035725; C:GO:0016324; P:GO:0033326	P:inorganic anion transport; P:retina development in camera-type eye; P:regulation of systemic arterial blood pressure; P:epithelial cell development; F:inorganic anion exchanger activity; P:anion transport; P:renal system process; F:transporter activity; P:sodium ion transport; C:integral component of plasma membrane; P:ion transport; P:anion transmembrane transport; P:bicarbonate transport; F:anion:anion antiporter activity; F:sodium:bicarbonate symporter activity; P:transport; C:plasma membrane; P:regulation of intracellular pH; P:mitochondrion distribution; C:membrane; F:anion transmembrane transporter activity; C:integral component of membrane; P:regulation of gene expression; P:sodium ion transmembrane transport; C:apical plasma membrane; P:cerebrospinal fluid secretion		
tr|F6VRH5|F6VRH5_HORSE	electrogenic sodium bicarbonate cotransporter 4	1119	20	0E0	96.2%	20	P:GO:0015698; P:GO:0060041; P:GO:0003073; P:GO:0002064; F:GO:0005452; P:GO:0006820; P:GO:0006810; P:GO:0003014; F:GO:0005215; C:GO:0005887; P:GO:0051453; P:GO:0006811; P:GO:0098656; P:GO:0048311; F:GO:0008509; C:GO:0016020; C:GO:0016021; P:GO:0010468; P:GO:0015701; P:GO:0033326	P:inorganic anion transport; P:retina development in camera-type eye; P:regulation of systemic arterial blood pressure; P:epithelial cell development; F:inorganic anion exchanger activity; P:anion transport; P:transport; P:renal system process; F:transporter activity; C:integral component of plasma membrane; P:regulation of intracellular pH; P:ion transport; P:anion transmembrane transport; P:mitochondrion distribution; F:anion transmembrane transporter activity; C:membrane; C:integral component of membrane; P:regulation of gene expression; P:bicarbonate transport; P:cerebrospinal fluid secretion		
tr|F6PYA8|F6PYA8_HORSE	T-cell surface glyco CD5	463	20	0E0	83.1%	8	P:GO:0031295; C:GO:0016020; C:GO:0016021; F:GO:0005044; C:GO:0009897; P:GO:0097190; P:GO:0006898; C:GO:0005886	P:T cell costimulation; C:membrane; C:integral component of membrane; F:scavenger receptor activity; C:external side of plasma membrane; P:apoptotic signaling pathway; P:receptor-mediated endocytosis; C:plasma membrane		
tr|F7BEZ7|F7BEZ7_HORSE	beclin 1-associated autophagy-related key regulator	495	20	0E0	97.4%	32	C:GO:0044233; C:GO:0005776; C:GO:0005930; P:GO:0061635; C:GO:0005789; P:GO:0000045; P:GO:0006914; C:GO:0005829; C:GO:0031410; P:GO:0098779; C:GO:0097629; P:GO:0016236; C:GO:0034045; C:GO:0035032; P:GO:0043552; C:GO:0045335; P:GO:0008333; C:GO:0005783; P:GO:0009267; P:GO:0042149; C:GO:0000421; P:GO:0010608; P:GO:0010508; C:GO:0005634; F:GO:0005515; C:GO:0097632; C:GO:0005737; P:GO:0001932; P:GO:0001933; C:GO:0016020; P:GO:0001934; P:GO:0090207	C:ER-mitochondrion membrane contact site; C:autophagosome; C:axoneme; P:regulation of protein complex stability; C:endoplasmic reticulum membrane; P:autophagosome assembly; P:autophagy; C:cytosol; C:cytoplasmic vesicle; P:mitophagy in response to mitochondrial depolarization; C:extrinsic component of omegasome membrane; P:macroautophagy; C:pre-autophagosomal structure membrane; C:phosphatidylinositol 3-kinase complex, class III; P:positive regulation of phosphatidylinositol 3-kinase activity; C:phagocytic vesicle; P:endosome to lysosome transport; C:endoplasmic reticulum; P:cellular response to starvation; P:cellular response to glucose starvation; C:autophagosome membrane; P:posttranscriptional regulation of gene expression; P:positive regulation of autophagy; C:nucleus; F:protein binding; C:extrinsic component of pre-autophagosomal structure membrane; C:cytoplasm; P:regulation of protein phosphorylation; P:negative regulation of protein phosphorylation; C:membrane; P:positive regulation of protein phosphorylation; P:regulation of triglyceride metabolic process		
tr|F7BR99|F7BR99_HORSE	creatine kinase M-type	381	20	0E0	98.45%	11	F:GO:0000166; F:GO:0005524; C:GO:0005615; P:GO:0009408; F:GO:0005515; F:GO:0003824; F:GO:0004111; P:GO:0016310; F:GO:0016772; F:GO:0016740; F:GO:0016301	F:nucleotide binding; F:ATP binding; C:extracellular space; P:response to heat; F:protein binding; F:catalytic activity; F:creatine kinase activity; P:phosphorylation; F:transferase activity, transferring phosphorus-containing groups; F:transferase activity; F:kinase activity		
tr|F6VRW6|F6VRW6_HORSE	solute carrier family 7 member 13-like	433	20	0E0	90.55%	11	C:GO:0005887; F:GO:0015179; P:GO:1902475; F:GO:0015297; F:GO:0015175; P:GO:0015807; C:GO:0016020; C:GO:0016021; P:GO:0015804; F:GO:0015171; P:GO:0003333	C:integral component of plasma membrane; F:L-amino acid transmembrane transporter activity; P:L-alpha-amino acid transmembrane transport; F:antiporter activity; F:neutral amino acid transmembrane transporter activity; P:L-amino acid transport; C:membrane; C:integral component of membrane; P:neutral amino acid transport; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport		
sp|Q8HZI9|LAMC2_HORSE	laminin subunit gamma-2	1190	20	0E0	94.3%	5	C:GO:0005604; P:GO:0007155; F:GO:0008201; C:GO:0005576; C:GO:0005578	C:basement membrane; P:cell adhesion; F:heparin binding; C:extracellular region; C:proteinaceous extracellular matrix		
tr|F6WZ08|F6WZ08_HORSE	laminin subunit gamma-2	1190	20	0E0	94.25%	5	C:GO:0005604; P:GO:0007155; F:GO:0008201; C:GO:0005576; C:GO:0005578	C:basement membrane; P:cell adhesion; F:heparin binding; C:extracellular region; C:proteinaceous extracellular matrix		
tr|F6ZVY1|F6ZVY1_HORSE	synaptonemal complex 1 isoform X1	777	20	0E0	96.1%	13	P:GO:0032880; P:GO:0007283; P:GO:0007130; C:GO:0000802; C:GO:0000801; P:GO:0035092; P:GO:0000711; C:GO:0005694; C:GO:0000795; C:GO:0000794; C:GO:0001673; P:GO:0051026; P:GO:0051878	P:regulation of protein localization; P:spermatogenesis; P:synaptonemal complex assembly; C:transverse filament; C:central element; P:sperm chromatin condensation; P:meiotic DNA repair synthesis; C:chromosome; C:synaptonemal complex; C:condensed nuclear chromosome; C:male germ cell nucleus; P:chiasma assembly; P:lateral element assembly		
tr|F6R5B2|F6R5B2_HORSE	high mobility group B2	210	20	1.55E-146	99.05%	71	P:GO:0008584; F:GO:0008144; P:GO:0050918; F:GO:0003690; F:GO:0042056; F:GO:0008301; P:GO:0043388; P:GO:0045648; P:GO:0060326; F:GO:0003697; C:GO:0005623; P:GO:0006954; P:GO:0002437; P:GO:0045892; P:GO:0045893; P:GO:0032728; P:GO:0050830; P:GO:1902042; P:GO:0008150; F:GO:0019904; P:GO:0045654; C:GO:0043234; F:GO:0001158; P:GO:0006334; P:GO:0002376; C:GO:0000793; P:GO:0010629; C:GO:0005634; C:GO:0000790; P:GO:0010628; P:GO:0050767; P:GO:0032392; P:GO:0032075; P:GO:0072091; F:GO:0044212; F:GO:0044378; C:GO:0005694; P:GO:0006265; P:GO:0045944; C:GO:0005730; C:GO:0005576; C:GO:0005575; F:GO:0003674; F:GO:0097100; P:GO:0051103; P:GO:0006935; F:GO:0003700; P:GO:0045595; P:GO:0050829; P:GO:0006351; P:GO:0007283; P:GO:0007289; P:GO:0006310; P:GO:0006355; F:GO:0008134; P:GO:0048545; F:GO:0003684; F:GO:0000400; P:GO:0006357; F:GO:0044822; F:GO:0003677; C:GO:0005615; C:GO:0048471; P:GO:0045089; P:GO:0071222; C:GO:0005737; P:GO:0045087; P:GO:0042493; P:GO:0032496; P:GO:0001938; F:GO:0050786	P:male gonad development; F:drug binding; P:positive chemotaxis; F:double-stranded DNA binding; F:chemoattractant activity; F:DNA binding, bending; P:positive regulation of DNA binding; P:positive regulation of erythrocyte differentiation; P:cell chemotaxis; F:single-stranded DNA binding; C:cell; P:inflammatory response; P:inflammatory response to antigenic stimulus; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:positive regulation of interferon-beta production; P:defense response to Gram-positive bacterium; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:biological_process; F:protein domain specific binding; P:positive regulation of megakaryocyte differentiation; C:protein complex; F:enhancer sequence-specific DNA binding; P:nucleosome assembly; P:immune system process; C:condensed chromosome; P:negative regulation of gene expression; C:nucleus; C:nuclear chromatin; P:positive regulation of gene expression; P:regulation of neurogenesis; P:DNA geometric change; P:positive regulation of nuclease activity; P:regulation of stem cell proliferation; F:transcription regulatory region DNA binding; F:non-sequence-specific DNA binding, bending; C:chromosome; P:DNA topological change; P:positive regulation of transcription from RNA polymerase II promoter; C:nucleolus; C:extracellular region; C:cellular_component; F:molecular_function; F:supercoiled DNA binding; P:DNA ligation involved in DNA repair; P:chemotaxis; F:transcription factor activity, sequence-specific DNA binding; P:regulation of cell differentiation; P:defense response to Gram-negative bacterium; P:transcription, DNA-templated; P:spermatogenesis; P:spermatid nucleus differentiation; P:DNA recombination; P:regulation of transcription, DNA-templated; F:transcription factor binding; P:response to steroid hormone; F:damaged DNA binding; F:four-way junction DNA binding; P:regulation of transcription from RNA polymerase II promoter; F:poly(A) RNA binding; F:DNA binding; C:extracellular space; C:perinuclear region of cytoplasm; P:positive regulation of innate immune response; P:cellular response to lipopolysaccharide; C:cytoplasm; P:innate immune response; P:response to drug; P:response to lipopolysaccharide; P:positive regulation of endothelial cell proliferation; F:RAGE receptor binding		
tr|F6UCR9|F6UCR9_HORSE	centrosome-associated 350	3119	20	0E0	94.7%	6	C:GO:0005813; P:GO:0034453; C:GO:0005737; C:GO:0016020; F:GO:0008017; C:GO:0005654	C:centrosome; P:microtubule anchoring; C:cytoplasm; C:membrane; F:microtubule binding; C:nucleoplasm		
tr|F7BWP5|F7BWP5_HORSE	SPT2 homolog	680	20	0E0	93.4%	6	F:GO:0003677; F:GO:0042393; P:GO:0010847; P:GO:0043486; P:GO:0006355; P:GO:0006334	F:DNA binding; F:histone binding; P:regulation of chromatin assembly; P:histone exchange; P:regulation of transcription, DNA-templated; P:nucleosome assembly		
tr|F7B6Y9|F7B6Y9_HORSE	olfactory receptor 9I1-like	311	20	0E0	93.1%	12	F:GO:0004930; F:GO:0005549; P:GO:0007186; P:GO:0007165; C:GO:0016020; P:GO:0007608; C:GO:0016021; P:GO:0050911; F:GO:0004871; P:GO:0050896; C:GO:0005886; F:GO:0004984	F:G-protein coupled receptor activity; F:odorant binding; P:G-protein coupled receptor signaling pathway; P:signal transduction; C:membrane; P:sensory perception of smell; C:integral component of membrane; P:detection of chemical stimulus involved in sensory perception of smell; F:signal transducer activity; P:response to stimulus; C:plasma membrane; F:olfactory receptor activity		
tr|F6SZV7|F6SZV7_HORSE	semaphorin-6D isoform X3	1075	20	0E0	98.75%	13	P:GO:0050919; P:GO:0048843; F:GO:0045499; P:GO:0021591; C:GO:0005887; P:GO:0001755; C:GO:0016020; C:GO:0016021; P:GO:0014912; P:GO:0014911; F:GO:0030215; P:GO:0030335; P:GO:0071526	P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; F:chemorepellent activity; P:ventricular system development; C:integral component of plasma membrane; P:neural crest cell migration; C:membrane; C:integral component of membrane; P:negative regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell migration; F:semaphorin receptor binding; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway		
tr|F7DNZ3|F7DNZ3_HORSE	sorting nexin-25 isoform X1	839	20	0E0	97.3%	12	P:GO:0032801; C:GO:0005768; P:GO:0060394; C:GO:0016020; P:GO:0015031; F:GO:0035091; C:GO:0010008; C:GO:0005575; P:GO:0006810; F:GO:0034713; F:GO:0003674; P:GO:0030512	P:receptor catabolic process; C:endosome; P:negative regulation of pathway-restricted SMAD protein phosphorylation; C:membrane; P:protein transport; F:phosphatidylinositol binding; C:endosome membrane; C:cellular_component; P:transport; F:type I transforming growth factor beta receptor binding; F:molecular_function; P:negative regulation of transforming growth factor beta receptor signaling pathway		
tr|F7AGN4|F7AGN4_HORSE	zinc finger with UFM1-specific peptidase domain isoform X1	579	20	0E0	95.5%	1	F:GO:0046872	F:metal ion binding		
tr|F6ZU69|F6ZU69_HORSE	sodium-dependent phosphate transport 2B	693	20	0E0	94.35%	19	P:GO:0043627; F:GO:0015321; F:GO:0042301; C:GO:0005886; F:GO:0005436; F:GO:0005315; C:GO:0005903; P:GO:0006817; C:GO:0005737; P:GO:0001701; P:GO:0044341; C:GO:0016020; C:GO:0016021; C:GO:0031982; P:GO:0035725; F:GO:0031402; C:GO:0016324; P:GO:0035435; P:GO:0030643	P:response to estrogen; F:sodium-dependent phosphate transmembrane transporter activity; F:phosphate ion binding; C:plasma membrane; F:sodium:phosphate symporter activity; F:inorganic phosphate transmembrane transporter activity; C:brush border; P:phosphate ion transport; C:cytoplasm; P:in utero embryonic development; P:sodium-dependent phosphate transport; C:membrane; C:integral component of membrane; C:vesicle; P:sodium ion transmembrane transport; F:sodium ion binding; C:apical plasma membrane; P:phosphate ion transmembrane transport; P:cellular phosphate ion homeostasis		
tr|F6XKF5|F6XKF5_HORSE	collagen alpha-3(V) chain isoform X1	1384	20	0E0	85.6%	7	P:GO:0007160; C:GO:0070062; C:GO:0005581; F:GO:0008201; F:GO:0005201; C:GO:0005578; C:GO:0005588	P:cell-matrix adhesion; C:extracellular exosome; C:collagen trimer; F:heparin binding; F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix; C:collagen type V trimer		
tr|F6WU55|F6WU55_HORSE	deleted in malignant brain tumors 1	292	20	1.42E-161	82.1%	25	P:GO:0007275; P:GO:0015031; C:GO:0005576; P:GO:0002221; C:GO:0070062; P:GO:0043152; P:GO:0016032; P:GO:0051607; F:GO:0035375; F:GO:0005044; P:GO:0044267; F:GO:0048306; P:GO:0006898; P:GO:0006810; C:GO:0042589; P:GO:0030855; C:GO:0005615; F:GO:0005515; F:GO:0008329; C:GO:0005737; P:GO:0045087; C:GO:0016020; P:GO:0030154; C:GO:0030670; C:GO:0019898	P:multicellular organism development; P:protein transport; C:extracellular region; P:pattern recognition receptor signaling pathway; C:extracellular exosome; P:induction of bacterial agglutination; P:viral process; P:defense response to virus; F:zymogen binding; F:scavenger receptor activity; P:cellular protein metabolic process; F:calcium-dependent protein binding; P:receptor-mediated endocytosis; P:transport; C:zymogen granule membrane; P:epithelial cell differentiation; C:extracellular space; F:protein binding; F:signaling pattern recognition receptor activity; C:cytoplasm; P:innate immune response; C:membrane; P:cell differentiation; C:phagocytic vesicle membrane; C:extrinsic component of membrane		
tr|F6PMY4|F6PMY4_HORSE	prolow-density lipo receptor-related 1	4534	20	0E0	97.35%	51	P:GO:0032370; P:GO:0032374; C:GO:0043025; C:GO:0030425; P:GO:0097242; P:GO:0010977; F:GO:0005509; C:GO:0005905; F:GO:0070325; F:GO:0032403; C:GO:0030666; F:GO:0034185; F:GO:0005041; P:GO:0043277; C:GO:0043235; P:GO:0021987; F:GO:0004872; P:GO:0006897; P:GO:0006898; C:GO:0005765; C:GO:0005886; C:GO:0005634; P:GO:0035909; F:GO:0005515; P:GO:0032956; F:GO:0046872; P:GO:0030178; C:GO:0030136; F:GO:0042954; P:GO:0008283; P:GO:0007275; F:GO:0002020; P:GO:0042157; C:GO:0005730; P:GO:0043524; P:GO:0042953; P:GO:0032429; C:GO:0005887; P:GO:0051222; C:GO:0005768; P:GO:0001523; C:GO:0005925; P:GO:0010875; P:GO:0014912; P:GO:0007568; P:GO:0007205; F:GO:0044822; C:GO:0005737; C:GO:0016020; C:GO:0016021; P:GO:2000587	P:positive regulation of lipid transport; P:regulation of cholesterol transport; C:neuronal cell body; C:dendrite; P:beta-amyloid clearance; P:negative regulation of neuron projection development; F:calcium ion binding; C:clathrin-coated pit; F:lipoprotein particle receptor binding; F:protein complex binding; C:endocytic vesicle membrane; F:apolipoprotein binding; F:low-density lipoprotein receptor activity; P:apoptotic cell clearance; C:receptor complex; P:cerebral cortex development; F:receptor activity; P:endocytosis; P:receptor-mediated endocytosis; C:lysosomal membrane; C:plasma membrane; C:nucleus; P:aorta morphogenesis; F:protein binding; P:regulation of actin cytoskeleton organization; F:metal ion binding; P:negative regulation of Wnt signaling pathway; C:clathrin-coated vesicle; F:lipoprotein transporter activity; P:cell proliferation; P:multicellular organism development; F:protease binding; P:lipoprotein metabolic process; C:nucleolus; P:negative regulation of neuron apoptotic process; P:lipoprotein transport; P:regulation of phospholipase A2 activity; C:integral component of plasma membrane; P:positive regulation of protein transport; C:endosome; P:retinoid metabolic process; C:focal adhesion; P:positive regulation of cholesterol efflux; P:negative regulation of smooth muscle cell migration; P:aging; P:protein kinase C-activating G-protein coupled receptor signaling pathway; F:poly(A) RNA binding; C:cytoplasm; C:membrane; C:integral component of membrane; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway		
tr|F6Q221|F6Q221_HORSE	prolow-density lipo receptor-related 1	4541	20	0E0	97.55%	11	F:GO:0034185; C:GO:0005925; C:GO:0005737; F:GO:0005509; C:GO:0016020; C:GO:0016021; C:GO:0043235; C:GO:0005730; F:GO:0032403; C:GO:0005765; F:GO:0044822	F:apolipoprotein binding; C:focal adhesion; C:cytoplasm; F:calcium ion binding; C:membrane; C:integral component of membrane; C:receptor complex; C:nucleolus; F:protein complex binding; C:lysosomal membrane; F:poly(A) RNA binding		
sp|P49066|FETA_HORSE	alpha-feto	609	20	0E0	92%	9	P:GO:0042448; P:GO:0001542; C:GO:0005615; C:GO:0005737; F:GO:0046872; P:GO:0060395; C:GO:0005576; P:GO:0019953; P:GO:0006810	P:progesterone metabolic process; P:ovulation from ovarian follicle; C:extracellular space; C:cytoplasm; F:metal ion binding; P:SMAD protein signal transduction; C:extracellular region; P:sexual reproduction; P:transport		
tr|F6U4X2|F6U4X2_HORSE	alpha-feto	614	20	0E0	92%	9	P:GO:0042448; P:GO:0001542; C:GO:0005615; C:GO:0005737; F:GO:0046872; P:GO:0060395; C:GO:0005576; P:GO:0019953; P:GO:0006810	P:progesterone metabolic process; P:ovulation from ovarian follicle; C:extracellular space; C:cytoplasm; F:metal ion binding; P:SMAD protein signal transduction; C:extracellular region; P:sexual reproduction; P:transport		
tr|F6S8Z5|F6S8Z5_HORSE	nicotinamide phosphoribosyltransferase	473	20	0E0	99.05%	19	F:GO:0016757; P:GO:0009435; F:GO:0005125; C:GO:0005576; P:GO:0045944; P:GO:0007623; C:GO:0005654; C:GO:0005634; C:GO:0005615; P:GO:0032922; F:GO:0004514; C:GO:0070062; P:GO:0048511; P:GO:0051770; C:GO:0005737; P:GO:0019363; C:GO:0030054; F:GO:0016740; F:GO:0047280	F:transferase activity, transferring glycosyl groups; P:NAD biosynthetic process; F:cytokine activity; C:extracellular region; P:positive regulation of transcription from RNA polymerase II promoter; P:circadian rhythm; C:nucleoplasm; C:nucleus; C:extracellular space; P:circadian regulation of gene expression; F:nicotinate-nucleotide diphosphorylase (carboxylating) activity; C:extracellular exosome; P:rhythmic process; P:positive regulation of nitric-oxide synthase biosynthetic process; C:cytoplasm; P:pyridine nucleotide biosynthetic process; C:cell junction; F:transferase activity; F:nicotinamide phosphoribosyltransferase activity		
tr|F6PWM8|F6PWM8_HORSE	sushi domain-containing 1	713	20	0E0	92.05%	3	F:GO:0005509; C:GO:0016020; C:GO:0016021	F:calcium ion binding; C:membrane; C:integral component of membrane		
tr|F6U301|F6U301_HORSE	eukaryotic translation initiation factor 4 gamma 3 isoform X1	1623	20	0E0	96.35%	3	F:GO:0003743; F:GO:0003723; P:GO:0006413	F:translation initiation factor activity; F:RNA binding; P:translational initiation		
tr|F7CPA2|F7CPA2_HORSE	anoctamin-8	1064	20	0E0	86.85%	8	F:GO:0005229; P:GO:1902476; P:GO:0034220; C:GO:0016020; C:GO:0016021; P:GO:0006821; C:GO:0005622; C:GO:0005886	F:intracellular calcium activated chloride channel activity; P:chloride transmembrane transport; P:ion transmembrane transport; C:membrane; C:integral component of membrane; P:chloride transport; C:intracellular; C:plasma membrane		
tr|F6Z2E9|F6Z2E9_HORSE	limb region 1 homolog	470	20	0E0	97.9%	3	C:GO:0016020; C:GO:0016021; P:GO:0042733	C:membrane; C:integral component of membrane; P:embryonic digit morphogenesis		
tr|F7CM57|F7CM57_HORSE	AP-1 complex subunit beta-1 isoform X2	946	20	0E0	99.1%	13	F:GO:0019901; P:GO:0015031; F:GO:0008565; P:GO:0006886; P:GO:0006810; P:GO:0007368; P:GO:0007507; C:GO:0030117; C:GO:0030119; P:GO:0016192; C:GO:0005737; C:GO:0016020; C:GO:0030131	F:protein kinase binding; P:protein transport; F:protein transporter activity; P:intracellular protein transport; P:transport; P:determination of left/right symmetry; P:heart development; C:membrane coat; C:AP-type membrane coat adaptor complex; P:vesicle-mediated transport; C:cytoplasm; C:membrane; C:clathrin adaptor complex		
tr|F6XGW5|F6XGW5_HORSE	Hermansky-Pudlak syndrome 1 isoform X1	667	20	0E0	90.2%	10	P:GO:0007040; C:GO:0005887; F:GO:0005515; C:GO:0005737; C:GO:0031085; F:GO:0046983; C:GO:0016023; P:GO:0007601; P:GO:0050896; C:GO:0005764	P:lysosome organization; C:integral component of plasma membrane; F:protein binding; C:cytoplasm; C:BLOC-3 complex; F:protein dimerization activity; C:cytoplasmic, membrane-bounded vesicle; P:visual perception; P:response to stimulus; C:lysosome		
tr|F6XHD0|F6XHD0_HORSE	Hermansky-Pudlak syndrome 1 isoform X1	703	20	0E0	92.1%	3	C:GO:0031085; F:GO:0046983; C:GO:0016023	C:BLOC-3 complex; F:protein dimerization activity; C:cytoplasmic, membrane-bounded vesicle		
tr|F6WUZ3|F6WUZ3_HORSE	Hermansky-Pudlak syndrome 1 isoform X1	711	20	0E0	91.2%	3	C:GO:0031085; F:GO:0046983; C:GO:0016023	C:BLOC-3 complex; F:protein dimerization activity; C:cytoplasmic, membrane-bounded vesicle		
tr|F7DKN8|F7DKN8_HORSE	POU class transcription factor 3	334	20	0E0	98.85%	23	P:GO:0060113; P:GO:0031290; P:GO:0048839; P:GO:0006351; F:GO:0000978; P:GO:0006366; P:GO:0006355; F:GO:0043565; P:GO:0021562; P:GO:0045944; P:GO:0007601; C:GO:0005654; P:GO:0006357; P:GO:0007605; F:GO:0003677; C:GO:0005634; F:GO:0003700; F:GO:0001077; P:GO:0042491; P:GO:0048675; P:GO:0042472; P:GO:0051402; P:GO:0050885	P:inner ear receptor cell differentiation; P:retinal ganglion cell axon guidance; P:inner ear development; P:transcription, DNA-templated; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; P:transcription from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding; P:vestibulocochlear nerve development; P:positive regulation of transcription from RNA polymerase II promoter; P:visual perception; C:nucleoplasm; P:regulation of transcription from RNA polymerase II promoter; P:sensory perception of sound; F:DNA binding; C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; P:auditory receptor cell differentiation; P:axon extension; P:inner ear morphogenesis; P:neuron apoptotic process; P:neuromuscular process controlling balance		
tr|F7AIM2|F7AIM2_HORSE	acidic amino acid decarboxylase GADL1 isoform X1	502	20	0E0	98.5%	5	F:GO:0030170; F:GO:0003824; F:GO:0016829; P:GO:0019752; F:GO:0016831	F:pyridoxal phosphate binding; F:catalytic activity; F:lyase activity; P:carboxylic acid metabolic process; F:carboxy-lyase activity		
tr|F6PHH1|F6PHH1_HORSE	serine threonine- kinase Nek4 isoform X1	787	20	0E0	92.25%	14	P:GO:2001020; P:GO:1900062; F:GO:0004672; F:GO:0004674; P:GO:0006974; P:GO:0006468; P:GO:0023014; P:GO:0000278; F:GO:0000166; F:GO:0005524; F:GO:0004702; C:GO:0005737; P:GO:0045893; P:GO:2000772	P:regulation of response to DNA damage stimulus; P:regulation of replicative cell aging; F:protein kinase activity; F:protein serine/threonine kinase activity; P:cellular response to DNA damage stimulus; P:protein phosphorylation; P:signal transduction by protein phosphorylation; P:mitotic cell cycle; F:nucleotide binding; F:ATP binding; F:receptor signaling protein serine/threonine kinase activity; C:cytoplasm; P:positive regulation of transcription, DNA-templated; P:regulation of cellular senescence		
tr|F6PHX3|F6PHX3_HORSE	serine threonine- kinase Nek4 isoform X1	838	20	0E0	86.45%	24	P:GO:2001020; P:GO:1900062; P:GO:0007067; F:GO:0004672; F:GO:0004674; P:GO:0006468; P:GO:0006974; P:GO:0023014; C:GO:0042995; P:GO:0007049; P:GO:0000278; F:GO:0000166; P:GO:0051301; F:GO:0005524; F:GO:0004702; C:GO:0005737; F:GO:0046872; P:GO:0045893; C:GO:0005929; F:GO:0030145; P:GO:0016310; F:GO:0016740; F:GO:0016301; P:GO:2000772	P:regulation of response to DNA damage stimulus; P:regulation of replicative cell aging; P:mitotic nuclear division; F:protein kinase activity; F:protein serine/threonine kinase activity; P:protein phosphorylation; P:cellular response to DNA damage stimulus; P:signal transduction by protein phosphorylation; C:cell projection; P:cell cycle; P:mitotic cell cycle; F:nucleotide binding; P:cell division; F:ATP binding; F:receptor signaling protein serine/threonine kinase activity; C:cytoplasm; F:metal ion binding; P:positive regulation of transcription, DNA-templated; C:cilium; F:manganese ion binding; P:phosphorylation; F:transferase activity; F:kinase activity; P:regulation of cellular senescence		
tr|F6W627|F6W627_HORSE	tumor D54 isoform X1	206	20	2.36E-149	90.6%	5	F:GO:0042803; C:GO:0048471; C:GO:0005737; F:GO:0046982; F:GO:0044822	F:protein homodimerization activity; C:perinuclear region of cytoplasm; C:cytoplasm; F:protein heterodimerization activity; F:poly(A) RNA binding		
tr|F7BNH6|F7BNH6_HORSE	nck-associated 5-like isoform X1	1327	20	0E0	95.4%	9	C:GO:0005813; F:GO:0005515; C:GO:0005856; P:GO:0001578; C:GO:0005815; C:GO:0005737; C:GO:0035371; P:GO:0007019; C:GO:0005874	C:centrosome; F:protein binding; C:cytoskeleton; P:microtubule bundle formation; C:microtubule organizing center; C:cytoplasm; C:microtubule plus-end; P:microtubule depolymerization; C:microtubule		
tr|F6REQ2|F6REQ2_HORSE	nitric oxide endothelial	1213	20	0E0	96.4%	54	P:GO:0014740; F:GO:0010181; P:GO:0031284; C:GO:0005794; P:GO:0043542; P:GO:0043267; P:GO:0003057; P:GO:0045766; P:GO:0001542; C:GO:0005901; F:GO:0005506; P:GO:0001701; F:GO:0016491; P:GO:0051926; P:GO:0071499; P:GO:1902042; P:GO:0007263; P:GO:0045776; P:GO:0003100; C:GO:0005886; F:GO:0003785; P:GO:0006527; F:GO:0034618; C:GO:0005634; F:GO:0034617; F:GO:0005516; P:GO:0050880; F:GO:0046872; P:GO:0019430; P:GO:0031663; P:GO:0006809; P:GO:0045909; P:GO:0008285; P:GO:0007596; P:GO:0007599; P:GO:0051346; F:GO:0004517; P:GO:0001525; P:GO:0034405; P:GO:0030324; P:GO:1903038; P:GO:0007005; F:GO:0020037; F:GO:0097110; P:GO:0002028; F:GO:0050661; C:GO:0005856; P:GO:0001974; C:GO:0005737; F:GO:0050660; P:GO:0014806; C:GO:0016020; P:GO:0055114; F:GO:0051117	P:negative regulation of muscle hyperplasia; F:FMN binding; P:positive regulation of guanylate cyclase activity; C:Golgi apparatus; P:endothelial cell migration; P:negative regulation of potassium ion transport; P:regulation of the force of heart contraction by chemical signal; P:positive regulation of angiogenesis; P:ovulation from ovarian follicle; C:caveola; F:iron ion binding; P:in utero embryonic development; F:oxidoreductase activity; P:negative regulation of calcium ion transport; P:cellular response to laminar fluid shear stress; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:nitric oxide mediated signal transduction; P:negative regulation of blood pressure; P:regulation of systemic arterial blood pressure by endothelin; C:plasma membrane; F:actin monomer binding; P:arginine catabolic process; F:arginine binding; C:nucleus; F:tetrahydrobiopterin binding; F:calmodulin binding; P:regulation of blood vessel size; F:metal ion binding; P:removal of superoxide radicals; P:lipopolysaccharide-mediated signaling pathway; P:nitric oxide biosynthetic process; P:positive regulation of vasodilation; P:negative regulation of cell proliferation; P:blood coagulation; P:hemostasis; P:negative regulation of hydrolase activity; F:nitric-oxide synthase activity; P:angiogenesis; P:response to fluid shear stress; P:lung development; P:negative regulation of leukocyte cell-cell adhesion; P:mitochondrion organization; F:heme binding; F:scaffold protein binding; P:regulation of sodium ion transport; F:NADP binding; C:cytoskeleton; P:blood vessel remodeling; C:cytoplasm; F:flavin adenine dinucleotide binding; P:smooth muscle hyperplasia; C:membrane; P:oxidation-reduction process; F:ATPase binding		
tr|F6QGQ1|F6QGQ1_HORSE	cadherin-22 isoform X1	604	20	0E0	84.9%	9	P:GO:0016339; F:GO:0046872; F:GO:0005509; C:GO:0016020; C:GO:0016021; P:GO:0007155; P:GO:0007156; P:GO:0007420; C:GO:0005886	P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; F:metal ion binding; F:calcium ion binding; C:membrane; C:integral component of membrane; P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:brain development; C:plasma membrane		
tr|F7BI66|F7BI66_HORSE	lysine-specific demethylase hairless isoform X1	1184	20	0E0	92.15%	4	C:GO:0016604; P:GO:0045892; F:GO:0003714; C:GO:0005654	C:nuclear body; P:negative regulation of transcription, DNA-templated; F:transcription corepressor activity; C:nucleoplasm		
tr|F6WZW6|F6WZW6_HORSE	proteasome subunit alpha type-1	263	20	0E0	99.1%	40	P:GO:0038095; P:GO:0043488; P:GO:0006521; C:GO:0005654; F:GO:0001530; P:GO:0002223; C:GO:0005844; P:GO:0000165; P:GO:0002479; F:GO:0003723; C:GO:0070062; C:GO:0005829; P:GO:0060071; P:GO:0051603; P:GO:0050852; P:GO:0000209; F:GO:0004175; P:GO:0090263; P:GO:0038061; F:GO:0004298; C:GO:0000502; F:GO:0008233; P:GO:0002376; P:GO:0006511; P:GO:0090090; P:GO:0002862; C:GO:0005634; P:GO:0043161; C:GO:0005813; P:GO:0033209; F:GO:0005515; C:GO:0005737; C:GO:0005839; P:GO:0006508; C:GO:0019773; P:GO:0031145; P:GO:0000090; P:GO:0051437; F:GO:0016787; P:GO:0051436	P:Fc-epsilon receptor signaling pathway; P:regulation of mRNA stability; P:regulation of cellular amino acid metabolic process; C:nucleoplasm; F:lipopolysaccharide binding; P:stimulatory C-type lectin receptor signaling pathway; C:polysome; P:MAPK cascade; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; F:RNA binding; C:extracellular exosome; C:cytosol; P:Wnt signaling pathway, planar cell polarity pathway; P:proteolysis involved in cellular protein catabolic process; P:T cell receptor signaling pathway; P:protein polyubiquitination; F:endopeptidase activity; P:positive regulation of canonical Wnt signaling pathway; P:NIK/NF-kappaB signaling; F:threonine-type endopeptidase activity; C:proteasome complex; F:peptidase activity; P:immune system process; P:ubiquitin-dependent protein catabolic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:centrosome; P:tumor necrosis factor-mediated signaling pathway; F:protein binding; C:cytoplasm; C:proteasome core complex; P:proteolysis; C:proteasome core complex, alpha-subunit complex; P:anaphase-promoting complex-dependent catabolic process; P:mitotic anaphase; P:positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition; F:hydrolase activity; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle		
tr|F6ZN56|F6ZN56_HORSE	zinc finger 181 isoform X1	570	20	0E0	95.4%	5	F:GO:0003676; F:GO:0003677; F:GO:0046872; P:GO:0006355; C:GO:0005622	F:nucleic acid binding; F:DNA binding; F:metal ion binding; P:regulation of transcription, DNA-templated; C:intracellular		
tr|F7DUZ2|F7DUZ2_HORSE	kinesin KIF18A	895	20	0E0	93.95%	26	C:GO:0015630; P:GO:0070507; C:GO:0005871; C:GO:0000776; P:GO:0007018; P:GO:0007019; C:GO:0005874; C:GO:1990023; F:GO:0000166; F:GO:0005524; C:GO:0005901; F:GO:0070463; F:GO:0043130; P:GO:0072520; C:GO:0005828; C:GO:0001726; P:GO:0007140; F:GO:0008574; F:GO:0008017; C:GO:0005634; F:GO:0003777; F:GO:0003779; C:GO:0005737; F:GO:0051010; P:GO:0000070; P:GO:0007080	C:microtubule cytoskeleton; P:regulation of microtubule cytoskeleton organization; C:kinesin complex; C:kinetochore; P:microtubule-based movement; P:microtubule depolymerization; C:microtubule; C:mitotic spindle midzone; F:nucleotide binding; F:ATP binding; C:caveola; F:tubulin-dependent ATPase activity; F:ubiquitin binding; P:seminiferous tubule development; C:kinetochore microtubule; C:ruffle; P:male meiosis; F:ATP-dependent microtubule motor activity, plus-end-directed; F:microtubule binding; C:nucleus; F:microtubule motor activity; F:actin binding; C:cytoplasm; F:microtubule plus-end binding; P:mitotic sister chromatid segregation; P:mitotic metaphase plate congression		
tr|F7E1C0|F7E1C0_HORSE	olfactory receptor 11G2-like	306	20	0E0	93.35%	13	P:GO:0007186; P:GO:0007165; P:GO:0007166; F:GO:0004871; F:GO:0004984; C:GO:0005886; F:GO:0004930; C:GO:0005887; P:GO:0007608; C:GO:0016020; C:GO:0016021; P:GO:0050911; P:GO:0050896	P:G-protein coupled receptor signaling pathway; P:signal transduction; P:cell surface receptor signaling pathway; F:signal transducer activity; F:olfactory receptor activity; C:plasma membrane; F:G-protein coupled receptor activity; C:integral component of plasma membrane; P:sensory perception of smell; C:membrane; C:integral component of membrane; P:detection of chemical stimulus involved in sensory perception of smell; P:response to stimulus		
tr|F6RNK0|F6RNK0_HORSE	pre-mRNA-processing-splicing factor 8	2335	20	0E0	99.05%	27	P:GO:0008380; C:GO:0016607; P:GO:0000398; C:GO:0005654; F:GO:0000386; F:GO:0030623; F:GO:0003723; C:GO:0030529; C:GO:0071013; P:GO:0071356; F:GO:0030620; C:GO:0005682; C:GO:0005681; P:GO:0006397; P:GO:0000244; F:GO:0044822; P:GO:0000375; F:GO:0003676; F:GO:0017070; C:GO:0005634; F:GO:0097157; F:GO:0005515; P:GO:0071222; F:GO:0070530; F:GO:0030619; C:GO:0016020; C:GO:0030532	P:RNA splicing; C:nuclear speck; P:mRNA splicing, via spliceosome; C:nucleoplasm; F:second spliceosomal transesterification activity; F:U5 snRNA binding; F:RNA binding; C:intracellular ribonucleoprotein complex; C:catalytic step 2 spliceosome; P:cellular response to tumor necrosis factor; F:U2 snRNA binding; C:U5 snRNP; C:spliceosomal complex; P:mRNA processing; P:spliceosomal tri-snRNP complex assembly; F:poly(A) RNA binding; P:RNA splicing, via transesterification reactions; F:nucleic acid binding; F:U6 snRNA binding; C:nucleus; F:pre-mRNA intronic binding; F:protein binding; P:cellular response to lipopolysaccharide; F:K63-linked polyubiquitin binding; F:U1 snRNA binding; C:membrane; C:small nuclear ribonucleoprotein complex		
tr|F6T7B9|F6T7B9_HORSE	gigaxonin	545	20	0E0	99.15%	9	F:GO:0004842; C:GO:0005856; F:GO:0005515; P:GO:0007010; C:GO:0005737; C:GO:0031463; P:GO:0042787; F:GO:0003674; P:GO:0016567	F:ubiquitin-protein transferase activity; C:cytoskeleton; F:protein binding; P:cytoskeleton organization; C:cytoplasm; C:Cul3-RING ubiquitin ligase complex; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; F:molecular_function; P:protein ubiquitination		
tr|F6UN00|F6UN00_HORSE	RNA-binding 28	761	20	0E0	93.05%	3	F:GO:0000166; F:GO:0003676; F:GO:0044822	F:nucleotide binding; F:nucleic acid binding; F:poly(A) RNA binding		
tr|F6TR20|F6TR20_HORSE	insulin-like growth factor 2 mRNA-binding 2 isoform X1	531	20	0E0	98.7%	4	F:GO:0000166; F:GO:0003676; F:GO:0003723; F:GO:0003729	F:nucleotide binding; F:nucleic acid binding; F:RNA binding; F:mRNA binding		
tr|F6XLH9|F6XLH9_HORSE	cytochrome P450 4A11-like	510	20	0E0	91.35%	31	P:GO:0003091; F:GO:0016705; P:GO:0003095; P:GO:0055078; C:GO:0005789; P:GO:0097267; C:GO:0070062; F:GO:0005506; F:GO:0016491; C:GO:0043231; P:GO:0032305; P:GO:0019369; F:GO:0019825; P:GO:0036101; F:GO:0008392; P:GO:0006691; C:GO:0005783; F:GO:0050051; F:GO:0004497; C:GO:0031090; P:GO:0006631; F:GO:0020037; P:GO:0001676; P:GO:0019373; F:GO:0046872; C:GO:0005737; C:GO:0016020; C:GO:0016021; P:GO:0055114; F:GO:0018685; C:GO:0016324	P:renal water homeostasis; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:pressure natriuresis; P:sodium ion homeostasis; C:endoplasmic reticulum membrane; P:omega-hydroxylase P450 pathway; C:extracellular exosome; F:iron ion binding; F:oxidoreductase activity; C:intracellular membrane-bounded organelle; P:positive regulation of icosanoid secretion; P:arachidonic acid metabolic process; F:oxygen binding; P:leukotriene B4 catabolic process; F:arachidonic acid epoxygenase activity; P:leukotriene metabolic process; C:endoplasmic reticulum; F:leukotriene-B4 20-monooxygenase activity; F:monooxygenase activity; C:organelle membrane; P:fatty acid metabolic process; F:heme binding; P:long-chain fatty acid metabolic process; P:epoxygenase P450 pathway; F:metal ion binding; C:cytoplasm; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:alkane 1-monooxygenase activity; C:apical plasma membrane		
tr|F6WWI9|F6WWI9_HORSE	ZBED8	594	20	0E0	98%	7	F:GO:0003676; F:GO:0003677; F:GO:0005515; C:GO:0005737; F:GO:0000981; C:GO:0005654; P:GO:0006357	F:nucleic acid binding; F:DNA binding; F:protein binding; C:cytoplasm; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; C:nucleoplasm; P:regulation of transcription from RNA polymerase II promoter		
tr|F7AGL5|F7AGL5_HORSE	matrix metallo ase-9	714	20	0E0	89.3%	30	P:GO:0045742; P:GO:0043388; F:GO:0004222; P:GO:0001501; C:GO:0070062; P:GO:0001503; P:GO:0051549; C:GO:0031012; P:GO:2001243; P:GO:2001268; F:GO:0008270; F:GO:0042802; P:GO:1900122; P:GO:0090200; F:GO:0004175; F:GO:0008233; P:GO:0007566; F:GO:0008237; C:GO:0005615; F:GO:0046872; P:GO:0043066; P:GO:0043065; P:GO:0006508; P:GO:0001934; P:GO:0030198; P:GO:2001258; P:GO:0035987; P:GO:0030574; P:GO:0050900; F:GO:0016787	P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of DNA binding; F:metalloendopeptidase activity; P:skeletal system development; C:extracellular exosome; P:ossification; P:positive regulation of keratinocyte migration; C:extracellular matrix; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; F:zinc ion binding; F:identical protein binding; P:positive regulation of receptor binding; P:positive regulation of release of cytochrome c from mitochondria; F:endopeptidase activity; F:peptidase activity; P:embryo implantation; F:metallopeptidase activity; C:extracellular space; F:metal ion binding; P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; P:proteolysis; P:positive regulation of protein phosphorylation; P:extracellular matrix organization; P:negative regulation of cation channel activity; P:endodermal cell differentiation; P:collagen catabolic process; P:leukocyte migration; F:hydrolase activity		
tr|F6VT48|F6VT48_HORSE	papilin isoform X1	1255	20	0E0	89.2%	12	F:GO:0030414; F:GO:0008270; F:GO:0004867; P:GO:0006508; P:GO:0010951; F:GO:0008233; C:GO:0031012; C:GO:0005576; F:GO:0004222; P:GO:0010466; C:GO:0005578; F:GO:0008237	F:peptidase inhibitor activity; F:zinc ion binding; F:serine-type endopeptidase inhibitor activity; P:proteolysis; P:negative regulation of endopeptidase activity; F:peptidase activity; C:extracellular matrix; C:extracellular region; F:metalloendopeptidase activity; P:negative regulation of peptidase activity; C:proteinaceous extracellular matrix; F:metallopeptidase activity		
tr|F6PJF0|F6PJF0_HORSE	chromobox homolog 3	183	20	2.73E-131	98.7%	27	P:GO:0006325; P:GO:0016569; C:GO:0000779; F:GO:0000976; C:GO:0000775; P:GO:0006338; P:GO:0045892; F:GO:1990226; C:GO:0031618; F:GO:0042802; F:GO:0019904; P:GO:0006351; P:GO:0006355; C:GO:0000785; C:GO:0000784; C:GO:0005720; C:GO:0005635; C:GO:0005634; C:GO:0005637; F:GO:0005515; P:GO:0048511; C:GO:0005819; C:GO:0010369; C:GO:0005719; P:GO:0071549; C:GO:0035985; F:GO:0019899	P:chromatin organization; P:chromatin modification; C:condensed chromosome, centromeric region; F:transcription regulatory region sequence-specific DNA binding; C:chromosome, centromeric region; P:chromatin remodeling; P:negative regulation of transcription, DNA-templated; F:histone methyltransferase binding; C:nuclear pericentric heterochromatin; F:identical protein binding; F:protein domain specific binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; C:chromatin; C:nuclear chromosome, telomeric region; C:nuclear heterochromatin; C:nuclear envelope; C:nucleus; C:nuclear inner membrane; F:protein binding; P:rhythmic process; C:spindle; C:chromocenter; C:nuclear euchromatin; P:cellular response to dexamethasone stimulus; C:senescence-associated heterochromatin focus; F:enzyme binding		
tr|F7D8N7|F7D8N7_HORSE	strawberry notch homolog 1 isoform X1	1393	20	0E0	99.15%	1	P:GO:0006355	P:regulation of transcription, DNA-templated		
tr|F6RTZ0|F6RTZ0_HORSE	actin-related 3B isoform X1	403	20	0E0	99.45%	5	F:GO:0005524; C:GO:0070062; P:GO:0034314; P:GO:0007015; C:GO:0005885	F:ATP binding; C:extracellular exosome; P:Arp2/3 complex-mediated actin nucleation; P:actin filament organization; C:Arp2/3 protein complex		
tr|F7DE75|F7DE75_HORSE	alpha-soluble NSF attachment	295	20	0E0	98.95%	23	P:GO:0061025; C:GO:0043209; F:GO:0019905; P:GO:0030182; P:GO:0035494; P:GO:0015031; F:GO:0005483; P:GO:0007420; F:GO:0000149; C:GO:0005774; P:GO:0006886; P:GO:0006810; C:GO:0005622; F:GO:0005515; P:GO:0010807; C:GO:0070062; P:GO:0016192; C:GO:0043195; C:GO:0070044; C:GO:0016020; P:GO:0045176; C:GO:0031201; P:GO:0035249	P:membrane fusion; C:myelin sheath; F:syntaxin binding; P:neuron differentiation; P:SNARE complex disassembly; P:protein transport; F:soluble NSF attachment protein activity; P:brain development; F:SNARE binding; C:vacuolar membrane; P:intracellular protein transport; P:transport; C:intracellular; F:protein binding; P:regulation of synaptic vesicle priming; C:extracellular exosome; P:vesicle-mediated transport; C:terminal bouton; C:synaptobrevin 2-SNAP-25-syntaxin-1a complex; C:membrane; P:apical protein localization; C:SNARE complex; P:synaptic transmission, glutamatergic		
sp|Q2QLA8|CAZA2_HORSE	F-actin-capping subunit alpha-2	286	20	0E0	99.05%	10	P:GO:0051016; P:GO:0008150; F:GO:0005515; C:GO:0070062; F:GO:0003779; C:GO:0005903; P:GO:0051693; C:GO:0016020; C:GO:0008290; C:GO:0030863	P:barbed-end actin filament capping; P:biological_process; F:protein binding; C:extracellular exosome; F:actin binding; C:brush border; P:actin filament capping; C:membrane; C:F-actin capping protein complex; C:cortical cytoskeleton		
tr|F7D7V5|F7D7V5_HORSE	serine threonine- phosphatase 4 regulatory subunit 2 isoform X1	377	20	0E0	97.75%	7	C:GO:0005634; P:GO:0050790; F:GO:0030362; P:GO:0010569; C:GO:0030289; F:GO:0030674; C:GO:0005654	C:nucleus; P:regulation of catalytic activity; F:protein phosphatase type 4 regulator activity; P:regulation of double-strand break repair via homologous recombination; C:protein phosphatase 4 complex; F:protein binding, bridging; C:nucleoplasm		
tr|F7C3L4|F7C3L4_HORSE	nuclear receptor subfamily 1 group D member 2	572	20	0E0	98.75%	25	F:GO:0043565; P:GO:0042752; P:GO:0043401; P:GO:0006367; C:GO:0005654; F:GO:0003700; P:GO:0045892; F:GO:0004879; P:GO:0045893; F:GO:0003707; P:GO:0030522; F:GO:0008270; P:GO:0006351; P:GO:0055088; P:GO:0006355; F:GO:0001046; F:GO:0003677; C:GO:0005634; F:GO:0005515; P:GO:0048511; F:GO:0046872; P:GO:2000505; P:GO:0050727; P:GO:0019216; P:GO:2001014	F:sequence-specific DNA binding; P:regulation of circadian rhythm; P:steroid hormone mediated signaling pathway; P:transcription initiation from RNA polymerase II promoter; C:nucleoplasm; F:transcription factor activity, sequence-specific DNA binding; P:negative regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding; P:positive regulation of transcription, DNA-templated; F:steroid hormone receptor activity; P:intracellular receptor signaling pathway; F:zinc ion binding; P:transcription, DNA-templated; P:lipid homeostasis; P:regulation of transcription, DNA-templated; F:core promoter sequence-specific DNA binding; F:DNA binding; C:nucleus; F:protein binding; P:rhythmic process; F:metal ion binding; P:regulation of energy homeostasis; P:regulation of inflammatory response; P:regulation of lipid metabolic process; P:regulation of skeletal muscle cell differentiation		
tr|F7AQJ9|F7AQJ9_HORSE	band 2 isoform X4	994	20	0E0	90.05%	16	F:GO:0005198; F:GO:0042731; C:GO:0005886; C:GO:0005654; P:GO:0030866; C:GO:0005634; C:GO:0005856; C:GO:0070062; F:GO:0003779; C:GO:0005925; F:GO:0030507; C:GO:0005737; C:GO:0030054; C:GO:0008180; F:GO:0008092; C:GO:0019898	F:structural molecule activity; F:PH domain binding; C:plasma membrane; C:nucleoplasm; P:cortical actin cytoskeleton organization; C:nucleus; C:cytoskeleton; C:extracellular exosome; F:actin binding; C:focal adhesion; F:spectrin binding; C:cytoplasm; C:cell junction; C:COP9 signalosome; F:cytoskeletal protein binding; C:extrinsic component of membrane		
tr|F6SU72|F6SU72_HORSE	opioid growth factor receptor	652	20	0E0	73.65%	10	P:GO:0038003; C:GO:0005634; F:GO:0004985; F:GO:0005515; C:GO:0005737; P:GO:0001558; C:GO:0016020; F:GO:0004872; C:GO:0005575; P:GO:0040008	P:opioid receptor signaling pathway; C:nucleus; F:opioid receptor activity; F:protein binding; C:cytoplasm; P:regulation of cell growth; C:membrane; F:receptor activity; C:cellular_component; P:regulation of growth		
tr|F6S3W0|F6S3W0_HORSE	B-cell CLL lymphoma 9 isoform X1	1426	20	0E0	99.05%	10	C:GO:0005634; C:GO:0005801; P:GO:0014908; P:GO:0035914; C:GO:0005737; P:GO:0035019; P:GO:0060070; C:GO:0005794; F:GO:0008013; P:GO:0045944	C:nucleus; C:cis-Golgi network; P:myotube differentiation involved in skeletal muscle regeneration; P:skeletal muscle cell differentiation; C:cytoplasm; P:somatic stem cell population maintenance; P:canonical Wnt signaling pathway; C:Golgi apparatus; F:beta-catenin binding; P:positive regulation of transcription from RNA polymerase II promoter		
tr|F6TGN6|F6TGN6_HORSE	signal transducer and activator of transcription 5B isoform X1	788	20	0E0	99.1%	70	P:GO:0019915; F:GO:0000979; P:GO:0006366; P:GO:0045647; P:GO:0006600; P:GO:0000255; P:GO:0043029; P:GO:0007259; F:GO:0001077; P:GO:0060397; F:GO:0019903; P:GO:0050729; F:GO:0046983; P:GO:0046543; P:GO:0046544; P:GO:0006573; P:GO:0042104; F:GO:0004871; P:GO:0045931; P:GO:0045579; P:GO:0001553; C:GO:0005634; P:GO:0097531; P:GO:0030856; P:GO:0070672; P:GO:0070670; P:GO:0071363; P:GO:0071364; P:GO:0032355; P:GO:0032870; P:GO:0040014; P:GO:0008284; P:GO:0045588; P:GO:0045621; P:GO:0006101; P:GO:0007595; P:GO:0045944; P:GO:0006105; P:GO:0040018; P:GO:0006103; P:GO:0032825; F:GO:0003700; P:GO:0007548; P:GO:0019221; P:GO:0048541; P:GO:0070669; F:GO:0035259; P:GO:0042448; P:GO:0006351; P:GO:0007165; P:GO:0033077; P:GO:0038161; P:GO:0006355; P:GO:0007565; F:GO:0003682; P:GO:0006631; P:GO:0006357; P:GO:0045954; P:GO:0046449; P:GO:0006549; P:GO:0045086; F:GO:0003677; P:GO:0006107; C:GO:0005737; P:GO:0032819; P:GO:0043066; P:GO:0001779; P:GO:0019530; P:GO:0030155; P:GO:0019218	P:lipid storage; F:RNA polymerase II core promoter sequence-specific DNA binding; P:transcription from RNA polymerase II promoter; P:negative regulation of erythrocyte differentiation; P:creatine metabolic process; P:allantoin metabolic process; P:T cell homeostasis; P:JAK-STAT cascade; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; P:JAK-STAT cascade involved in growth hormone signaling pathway; F:protein phosphatase binding; P:positive regulation of inflammatory response; F:protein dimerization activity; P:development of secondary female sexual characteristics; P:development of secondary male sexual characteristics; P:valine metabolic process; P:positive regulation of activated T cell proliferation; F:signal transducer activity; P:positive regulation of mitotic cell cycle; P:positive regulation of B cell differentiation; P:luteinization; C:nucleus; P:mast cell migration; P:regulation of epithelial cell differentiation; P:response to interleukin-15; P:response to interleukin-4; P:cellular response to growth factor stimulus; P:cellular response to epidermal growth factor stimulus; P:response to estradiol; P:cellular response to hormone stimulus; P:regulation of multicellular organism growth; P:positive regulation of cell proliferation; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of lymphocyte differentiation; P:citrate metabolic process; P:lactation; P:positive regulation of transcription from RNA polymerase II promoter; P:succinate metabolic process; P:positive regulation of multicellular organism growth; P:2-oxoglutarate metabolic process; P:positive regulation of natural killer cell differentiation; F:transcription factor activity, sequence-specific DNA binding; P:sex differentiation; P:cytokine-mediated signaling pathway; P:Peyer's patch development; P:response to interleukin-2; F:glucocorticoid receptor binding; P:progesterone metabolic process; P:transcription, DNA-templated; P:signal transduction; P:T cell differentiation in thymus; P:prolactin signaling pathway; P:regulation of transcription, DNA-templated; P:female pregnancy; F:chromatin binding; P:fatty acid metabolic process; P:regulation of transcription from RNA polymerase II promoter; P:positive regulation of natural killer cell mediated cytotoxicity; P:creatinine metabolic process; P:isoleucine metabolic process; P:positive regulation of interleukin-2 biosynthetic process; F:DNA binding; P:oxaloacetate metabolic process; C:cytoplasm; P:positive regulation of natural killer cell proliferation; P:negative regulation of apoptotic process; P:natural killer cell differentiation; P:taurine metabolic process; P:regulation of cell adhesion; P:regulation of steroid metabolic process		
tr|F7A6J6|F7A6J6_HORSE	ribonuclease UK114	137	20	4.6E-94	96.1%	27	F:GO:1904012; F:GO:0046914; P:GO:1902074; F:GO:1904013; F:GO:0043167; C:GO:0070062; P:GO:0001822; F:GO:0004519; F:GO:0004518; C:GO:0005829; P:GO:0033993; F:GO:0016892; P:GO:0017148; P:GO:0030324; P:GO:0090502; F:GO:0042803; F:GO:0036041; P:GO:0007420; F:GO:0044822; C:GO:0005777; C:GO:0005634; P:GO:0006449; C:GO:0005737; C:GO:0005739; P:GO:0050680; P:GO:0070314; F:GO:0016787	F:platinum binding; F:transition metal ion binding; P:response to salt; F:xenon atom binding; F:ion binding; C:extracellular exosome; P:kidney development; F:endonuclease activity; F:nuclease activity; C:cytosol; P:response to lipid; F:endoribonuclease activity, producing 3'-phosphomonoesters; P:negative regulation of translation; P:lung development; P:RNA phosphodiester bond hydrolysis, endonucleolytic; F:protein homodimerization activity; F:long-chain fatty acid binding; P:brain development; F:poly(A) RNA binding; C:peroxisome; C:nucleus; P:regulation of translational termination; C:cytoplasm; C:mitochondrion; P:negative regulation of epithelial cell proliferation; P:G1 to G0 transition; F:hydrolase activity		
tr|F6PT23|F6PT23_HORSE	ubiquitin carboxyl-terminal hydrolase 11	910	20	0E0	96.6%	5	F:GO:0004843; P:GO:0016579; C:GO:0005634; F:GO:0036459; P:GO:0006511	F:thiol-dependent ubiquitin-specific protease activity; P:protein deubiquitination; C:nucleus; F:thiol-dependent ubiquitinyl hydrolase activity; P:ubiquitin-dependent protein catabolic process		
tr|F6ZNZ4|F6ZNZ4_HORSE	microtubule-associated 1B	2472	20	0E0	96.15%	18	C:GO:0014069; P:GO:0061162; P:GO:0007399; P:GO:0045773; P:GO:0000226; P:GO:0009987; C:GO:0005886; F:GO:0008017; C:GO:0005874; C:GO:0001750; P:GO:0001578; C:GO:0005737; P:GO:0048675; P:GO:0007409; P:GO:0047497; C:GO:0005829; P:GO:0032387; P:GO:0016358	C:postsynaptic density; P:establishment of monopolar cell polarity; P:nervous system development; P:positive regulation of axon extension; P:microtubule cytoskeleton organization; P:cellular process; C:plasma membrane; F:microtubule binding; C:microtubule; C:photoreceptor outer segment; P:microtubule bundle formation; C:cytoplasm; P:axon extension; P:axonogenesis; P:mitochondrion transport along microtubule; C:cytosol; P:negative regulation of intracellular transport; P:dendrite development		
gi|164229|gb|AAA30954.1|	interferon beta	186	20	2.85E-136	88.4%	4	P:GO:0007165; C:GO:0005576; P:GO:0006952; F:GO:0005126	P:signal transduction; C:extracellular region; P:defense response; F:cytokine receptor binding		IPR000471 (PRINTS); IPR000471 (SMART); IPR000471 (PFAM); IPR012351 (G3DSA:1.20.1250.GENE3D); IPR015588 (PTHR11691:PANTHER); IPR000471 (PANTHER); IPR000471 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR009079 (SUPERFAMILY)
gi|576647|gb|AAA53301.1|	secreted form immunoglobulin epsilon heavy chain constant partial	566	20	0E0	76.75%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); PTHR23266:SF90 (PANTHER); IPR003006 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|1041059|gb|AAD15251.1|	T cell receptor alpha partial	136	20	3.36E-97	59.7%	1	F:GO:0005515	F:protein binding		IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF130 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|2231157|gb|AAB61954.1|	immunoglobulin heavy chain variable partial	130	20	5.1E-89	83.45%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|2231163|gb|AAB61960.1|	immunoglobulin heavy chain V-D-J partial	125	20	2.04E-86	71.25%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266:SF105 (PANTHER); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|3121758|sp|Q95182.1|ALL1_HORSE	major allergen Equ c 1-like	187	20	7.2E-134	87.95%	5	F:GO:0005550; F:GO:0036094; C:GO:0005576; P:GO:0006810; F:GO:0005215	F:pheromone binding; F:small molecule binding; C:extracellular region; P:transport; F:transporter activity		
gi|6841026|gb|AAF28866.1|AF121140_1	E3 ubiquitin- ligase Mdm2 isoform X1	491	20	0E0	98.65%	48	F:GO:0061630; C:GO:0016604; P:GO:0003170; P:GO:0006461; P:GO:0042176; P:GO:0046677; P:GO:0045787; C:GO:0005730; C:GO:0005654; P:GO:0003203; P:GO:0000122; P:GO:0007507; F:GO:0002039; P:GO:0006977; P:GO:0001568; P:GO:0045892; P:GO:0071157; P:GO:0071456; P:GO:0034504; F:GO:0016874; F:GO:0008270; F:GO:0042802; P:GO:0043518; P:GO:0003181; P:GO:0003281; P:GO:0003283; P:GO:0007089; P:GO:1901797; C:GO:0043234; P:GO:0060411; P:GO:0045931; P:GO:0042787; P:GO:0045184; P:GO:0031648; P:GO:0002027; F:GO:0004842; C:GO:0005634; F:GO:0097110; P:GO:0001974; F:GO:0031625; F:GO:0046872; C:GO:0005737; P:GO:0043066; P:GO:0010468; P:GO:0032436; P:GO:0018205; F:GO:0019899; P:GO:0016567	F:ubiquitin protein ligase activity; C:nuclear body; P:heart valve development; P:protein complex assembly; P:regulation of protein catabolic process; P:response to antibiotic; P:positive regulation of cell cycle; C:nucleolus; C:nucleoplasm; P:endocardial cushion morphogenesis; P:negative regulation of transcription from RNA polymerase II promoter; P:heart development; F:p53 binding; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:blood vessel development; P:negative regulation of transcription, DNA-templated; P:negative regulation of cell cycle arrest; P:cellular response to hypoxia; P:protein localization to nucleus; F:ligase activity; F:zinc ion binding; F:identical protein binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:atrioventricular valve morphogenesis; P:ventricular septum development; P:atrial septum development; P:traversing start control point of mitotic cell cycle; P:negative regulation of signal transduction by p53 class mediator; C:protein complex; P:cardiac septum morphogenesis; P:positive regulation of mitotic cell cycle; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; P:establishment of protein localization; P:protein destabilization; P:regulation of heart rate; F:ubiquitin-protein transferase activity; C:nucleus; F:scaffold protein binding; P:blood vessel remodeling; F:ubiquitin protein ligase binding; F:metal ion binding; C:cytoplasm; P:negative regulation of apoptotic process; P:regulation of gene expression; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:peptidyl-lysine modification; F:enzyme binding; P:protein ubiquitination		
gi|15027003|emb|CAC44763.1|	immunoglobulin gamma 1 heavy chain constant partial	336	20	0E0	83.9%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266:SF83 (PANTHER); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|18996195|emb|CAC86340.1|	immunoglobulin gamma 1 heavy chain constant partial	326	20	0E0	80.45%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); PTHR23266:SF83 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|32331167|gb|AAP80145.1|	immunoglobulin heavy chain constant partial	343	20	0E0	77.65%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); PTHR23266:SF68 (PANTHER); IPR003006 (PROSITE_PATTERNS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|39980478|gb|AAR32992.1|	eukaryotic translation initiation factor 4 gamma 3 isoform X1	1623	20	0E0	96.95%	3	F:GO:0003743; F:GO:0003723; P:GO:0006413	F:translation initiation factor activity; F:RNA binding; P:translational initiation		
gi|50261267|gb|AAT72304.1|	2 -5 -oligoadenylate synthase 3	1084	20	0E0	86.6%	5	F:GO:0005524; F:GO:0016779; P:GO:0006955; F:GO:0003725; P:GO:0051607	F:ATP binding; F:nucleotidyltransferase activity; P:immune response; F:double-stranded RNA binding; P:defense response to virus		G3DSA:3.30.460.10 (GENE3D); IPR018952 (PFAM); IPR002934 (PFAM); IPR018952 (G3DSA:1.10.1410.GENE3D); PTHR11258:SF4 (PANTHER); IPR026774 (PANTHER); IPR006117 (PROSITE_PATTERNS); IPR006117 (PROSITE_PATTERNS); IPR006116 (PROSITE_PROFILES); SSF81631 (SUPERFAMILY); SSF81631 (SUPERFAMILY); SSF81301 (SUPERFAMILY); SSF81301 (SUPERFAMILY); SSF81631 (SUPERFAMILY); SSF81301 (SUPERFAMILY)
gi|71842627|gb|AAZ43314.1|	immunoglobulin heavy chain variable partial	120	20	4.26E-82	84.15%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|71842629|gb|AAZ43315.1|	immunoglobulin heavy chain variable partial	114	20	3.06E-76	85.1%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); PTHR23266:SF105 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|71842637|gb|AAZ43319.1|	immunoglobulin heavy chain variable partial	126	20	1.39E-85	80.1%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266:SF105 (PANTHER); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|71842649|gb|AAZ43325.1|	immunoglobulin heavy chain variable partial	113	20	6.89E-74	84.75%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|71842655|gb|AAZ43328.1|	immunoglobulin heavy chain variable partial	114	20	3.17E-76	80.3%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266:SF105 (PANTHER); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|71842669|gb|AAZ43335.1|	immunoglobulin heavy chain variable partial	122	20	1.61E-83	79.45%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); PTHR23266:SF105 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|71842671|gb|AAZ43336.1|	immunoglobulin heavy chain variable partial	119	20	2.42E-77	85.25%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266:SF105 (PANTHER); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|71842679|gb|AAZ43340.1|	immunoglobulin heavy chain variable partial	124	20	8.98E-83	83.3%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); PTHR23266:SF105 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|71842681|gb|AAZ43341.1|	immunoglobulin heavy chain variable partial	124	20	3.14E-86	85.9%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|71842697|gb|AAZ43349.1|	immunoglobulin heavy chain variable partial	119	20	1.05E-80	87.05%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|71842701|gb|AAZ43351.1|	immunoglobulin heavy chain variable partial	117	20	5.44E-80	85.45%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266:SF105 (PANTHER); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|71842703|gb|AAZ43352.1|	immunoglobulin heavy chain variable partial	116	20	3.13E-78	81.25%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266:SF105 (PANTHER); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|75039539|sp|Q28388.1|UCAL_HORSE	alpha-2u globulin	180	20	3.44E-131	68.6%	29	P:GO:0061179; P:GO:0008286; F:GO:0005550; P:GO:0045721; F:GO:0036094; C:GO:0005576; F:GO:0005215; F:GO:0005549; F:GO:0005009; P:GO:0070584; P:GO:0045892; P:GO:0045475; P:GO:0071396; C:GO:0005829; P:GO:0010951; P:GO:0006112; P:GO:0045834; P:GO:0006810; P:GO:0031649; C:GO:0005634; P:GO:0010907; C:GO:0005615; F:GO:0004866; P:GO:0051055; P:GO:0010628; P:GO:0042593; P:GO:0010888; P:GO:0009060; P:GO:0051897	P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; P:insulin receptor signaling pathway; F:pheromone binding; P:negative regulation of gluconeogenesis; F:small molecule binding; C:extracellular region; F:transporter activity; F:odorant binding; F:insulin-activated receptor activity; P:mitochondrion morphogenesis; P:negative regulation of transcription, DNA-templated; P:locomotor rhythm; P:cellular response to lipid; C:cytosol; P:negative regulation of endopeptidase activity; P:energy reserve metabolic process; P:positive regulation of lipid metabolic process; P:transport; P:heat generation; C:nucleus; P:positive regulation of glucose metabolic process; C:extracellular space; F:endopeptidase inhibitor activity; P:negative regulation of lipid biosynthetic process; P:positive regulation of gene expression; P:glucose homeostasis; P:negative regulation of lipid storage; P:aerobic respiration; P:positive regulation of protein kinase B signaling		
gi|75044181|sp|Q6SJP2.1|B3A2_HORSE	anion exchange 2 isoform X1	1237	20	0E0	97.4%	16	P:GO:0015698; F:GO:0015301; P:GO:1902476; F:GO:0015297; F:GO:0005452; P:GO:0006820; P:GO:0006810; F:GO:0005215; C:GO:0005887; P:GO:0051453; P:GO:0006811; C:GO:0005925; P:GO:0098656; F:GO:0008509; C:GO:0016020; C:GO:0016021	P:inorganic anion transport; F:anion:anion antiporter activity; P:chloride transmembrane transport; F:antiporter activity; F:inorganic anion exchanger activity; P:anion transport; P:transport; F:transporter activity; C:integral component of plasma membrane; P:regulation of intracellular pH; P:ion transport; C:focal adhesion; P:anion transmembrane transport; F:anion transmembrane transporter activity; C:membrane; C:integral component of membrane		
gi|126352369|ref|NP_001075236.1|	peptidyl-glycine alpha-amidating monooxygenase isoform X2	1020	20	0E0	93.25%	6	F:GO:0005515; F:GO:0005507; F:GO:0016715; P:GO:0006518; C:GO:0016020; P:GO:0055114	F:protein binding; F:copper ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen; P:peptide metabolic process; C:membrane; P:oxidation-reduction process	EC:1.14.17	IPR000720 (PRINTS); IPR014784 (G3DSA:2.60.120.GENE3D); IPR000323 (G3DSA:2.60.120.GENE3D); IPR024548 (PFAM); IPR000323 (PFAM); IPR001258 (PFAM); IPR011042 (G3DSA:2.120.10.GENE3D); PTHR10680:SF14 (PANTHER); PTHR10680 (PANTHER); IPR020611 (PROSITE_PATTERNS); IPR014783 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR013017 (PROSITE_PROFILES); IPR008977 (SUPERFAMILY); SSF63829 (SUPERFAMILY); IPR008977 (SUPERFAMILY)
gi|126352489|ref|NP_001075312.1|	cytosolic phospholipase A2	749	20	0E0	98.25%	64	P:GO:0009395; P:GO:0046697; C:GO:0005794; P:GO:0046456; P:GO:0006644; F:GO:0004620; C:GO:0005789; P:GO:0001542; F:GO:0005509; C:GO:0043231; C:GO:0005829; P:GO:0019369; P:GO:0030501; F:GO:0035035; P:GO:0010033; P:GO:0031394; P:GO:0008152; P:GO:0050729; P:GO:0006690; P:GO:0042542; P:GO:0009725; C:GO:0042588; P:GO:0006654; F:GO:0004623; P:GO:0001554; F:GO:0004622; C:GO:0005634; P:GO:0050482; F:GO:0046872; P:GO:0016042; P:GO:0010226; P:GO:0031622; P:GO:0033280; P:GO:0036151; P:GO:0036152; P:GO:0031340; P:GO:0008284; P:GO:0006663; P:GO:0036150; P:GO:0043129; P:GO:0009408; F:GO:0047498; P:GO:0051384; C:GO:0031410; P:GO:0071236; P:GO:0036148; P:GO:0036149; C:GO:0005783; F:GO:0008970; P:GO:0007568; C:GO:0005743; P:GO:0042127; F:GO:0005544; C:GO:0048471; P:GO:0051597; C:GO:0005737; P:GO:0051592; P:GO:0043065; P:GO:0006629; P:GO:0035965; C:GO:0016023; P:GO:0032496; P:GO:0010243; F:GO:0016787	P:phospholipid catabolic process; P:decidualization; C:Golgi apparatus; P:icosanoid biosynthetic process; P:phospholipid metabolic process; F:phospholipase activity; C:endoplasmic reticulum membrane; P:ovulation from ovarian follicle; F:calcium ion binding; C:intracellular membrane-bounded organelle; C:cytosol; P:arachidonic acid metabolic process; P:positive regulation of bone mineralization; F:histone acetyltransferase binding; P:response to organic substance; P:positive regulation of prostaglandin biosynthetic process; P:metabolic process; P:positive regulation of inflammatory response; P:icosanoid metabolic process; P:response to hydrogen peroxide; P:response to hormone; C:zymogen granule; P:phosphatidic acid biosynthetic process; F:phospholipase A2 activity; P:luteolysis; F:lysophospholipase activity; C:nucleus; P:arachidonic acid secretion; F:metal ion binding; P:lipid catabolic process; P:response to lithium ion; P:positive regulation of fever generation; P:response to vitamin D; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylethanolamine acyl-chain remodeling; P:positive regulation of vesicle fusion; P:positive regulation of cell proliferation; P:platelet activating factor biosynthetic process; P:phosphatidylserine acyl-chain remodeling; P:surfactant homeostasis; P:response to heat; F:calcium-dependent phospholipase A2 activity; P:response to glucocorticoid; C:cytoplasmic vesicle; P:cellular response to antibiotic; P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylinositol acyl-chain remodeling; C:endoplasmic reticulum; F:phosphatidylcholine 1-acylhydrolase activity; P:aging; C:mitochondrial inner membrane; P:regulation of cell proliferation; F:calcium-dependent phospholipid binding; C:perinuclear region of cytoplasm; P:response to methylmercury; C:cytoplasm; P:response to calcium ion; P:positive regulation of apoptotic process; P:lipid metabolic process; P:cardiolipin acyl-chain remodeling; C:cytoplasmic, membrane-bounded vesicle; P:response to lipopolysaccharide; P:response to organonitrogen compound; F:hydrolase activity		
gi|126352520|ref|NP_001075270.1|	hyaluronan synthase 2	552	20	0E0	99.05%	32	P:GO:0008284; P:GO:0060349; P:GO:0045226; P:GO:0085029; P:GO:0007155; P:GO:0001570; P:GO:0010838; C:GO:0005887; P:GO:0071498; P:GO:0001822; P:GO:0071356; P:GO:0051549; P:GO:0014911; P:GO:0036302; P:GO:0035810; F:GO:0016757; P:GO:0044849; P:GO:0090500; P:GO:0036120; P:GO:1900026; P:GO:1900127; P:GO:1900625; P:GO:0070295; C:GO:0005737; C:GO:0016020; C:GO:0016021; P:GO:0071347; F:GO:0016740; P:GO:0030213; P:GO:0030212; P:GO:0030335; F:GO:0050501	P:positive regulation of cell proliferation; P:bone morphogenesis; P:extracellular polysaccharide biosynthetic process; P:extracellular matrix assembly; P:cell adhesion; P:vasculogenesis; P:positive regulation of keratinocyte proliferation; C:integral component of plasma membrane; P:cellular response to fluid shear stress; P:kidney development; P:cellular response to tumor necrosis factor; P:positive regulation of keratinocyte migration; P:positive regulation of smooth muscle cell migration; P:atrioventricular canal development; P:positive regulation of urine volume; F:transferase activity, transferring glycosyl groups; P:estrous cycle; P:endocardial cushion to mesenchymal transition; P:cellular response to platelet-derived growth factor stimulus; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of hyaluronan biosynthetic process; P:positive regulation of monocyte aggregation; P:renal water absorption; C:cytoplasm; C:membrane; C:integral component of membrane; P:cellular response to interleukin-1; F:transferase activity; P:hyaluronan biosynthetic process; P:hyaluronan metabolic process; P:positive regulation of cell migration; F:hyaluronan synthase activity		
gi|126723289|ref|NP_001075964.1|	stromelysin-1	477	20	0E0	90%	15	F:GO:0008270; P:GO:0032461; F:GO:0004175; F:GO:0008233; C:GO:0005576; F:GO:0004222; C:GO:0005578; F:GO:0008237; F:GO:0046872; F:GO:0005509; P:GO:0010727; P:GO:0006508; P:GO:0030574; C:GO:0031012; F:GO:0016787	F:zinc ion binding; P:positive regulation of protein oligomerization; F:endopeptidase activity; F:peptidase activity; C:extracellular region; F:metalloendopeptidase activity; C:proteinaceous extracellular matrix; F:metallopeptidase activity; F:metal ion binding; F:calcium ion binding; P:negative regulation of hydrogen peroxide metabolic process; P:proteolysis; P:collagen catabolic process; C:extracellular matrix; F:hydrolase activity		
gi|149690020|ref|XP_001496034.1|	WD repeat-containing 11	1225	20	0E0	98.2%	4	C:GO:0015630; C:GO:0005737; C:GO:0016020; C:GO:0005765	C:microtubule cytoskeleton; C:cytoplasm; C:membrane; C:lysosomal membrane		
gi|149690204|ref|XP_001500869.1|	solute carrier family 35 member G1	338	20	0E0	92.2%	7	C:GO:0005789; P:GO:1990034; C:GO:0016020; C:GO:0016021; P:GO:0051480; C:GO:0005829; C:GO:0005886	C:endoplasmic reticulum membrane; P:calcium ion export from cell; C:membrane; C:integral component of membrane; P:regulation of cytosolic calcium ion concentration; C:cytosol; C:plasma membrane		
gi|149690639|ref|XP_001492135.1|	HEAT repeat-containing 1	2142	20	0E0	96.55%	1	F:GO:0005488	F:binding		IPR012954 (SMART); IPR022125 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR012954 (PFAM); PTHR13457:SF1 (PANTHER); PTHR13457 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
gi|149691047|ref|XP_001491293.1|	U3 small nucleolar ribonucleo MPP10	679	20	0E0	93.3%	3	C:GO:0034457; P:GO:0006364; C:GO:0005732	C:Mpp10 complex; P:rRNA processing; C:small nucleolar ribonucleoprotein complex		IPR012173 (PIRSF); IPR012173 (PFAM); IPR012173 (PANTHER); PTHR17039:SF1 (PANTHER)
gi|149691078|ref|XP_001490403.1|	Lines homolog	758	20	0E0	92.05%	1	P:GO:0050890	P:cognition		IPR032794 (PFAM); IPR029415 (PFAM); PTHR16057:SF1 (PANTHER); IPR024875 (PANTHER)
gi|149691911|ref|XP_001500420.1|	retinal dehydrogenase 2	518	20	0E0	99.5%	2	P:GO:0055114; F:GO:0016620	P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor		IPR015590 (PFAM); IPR016162 (G3DSA:3.40.605.GENE3D); IPR016163 (G3DSA:3.40.309.GENE3D); PTHR11699 (PANTHER); PTHR11699:SF102 (PANTHER); IPR016160 (PROSITE_PATTERNS); IPR029510 (PROSITE_PATTERNS); IPR016161 (SUPERFAMILY)
gi|149691931|ref|XP_001501172.1|	unc-13 homolog C	2216	20	0E0	96.85%	4	F:GO:0005515; F:GO:0019992; P:GO:0007268; P:GO:0035556	F:protein binding; F:diacylglycerol binding; P:chemical synaptic transmission; P:intracellular signal transduction		IPR000008 (PRINTS); IPR000008 (SMART); IPR010439 (SMART); IPR002219 (SMART); IPR010439 (PFAM); G3DSA:3.30.60.20 (GENE3D); IPR019558 (PFAM); IPR000008 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR000008 (G3DSA:2.60.40.GENE3D); IPR002219 (PFAM); IPR027087 (PTHR10480:PANTHER); IPR027080 (PANTHER); IPR002219 (PROSITE_PATTERNS); IPR014772 (PROSITE_PROFILES); IPR002219 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR014770 (PROSITE_PROFILES); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY); SSF57889 (SUPERFAMILY)
gi|149692218|ref|XP_001490744.1|	pseudopodium-enriched atypical kinase 1	1743	20	0E0	95.25%	3	F:GO:0005524; F:GO:0004672; P:GO:0006468	F:ATP binding; F:protein kinase activity; P:protein phosphorylation		IPR000719 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR22972 (PANTHER); PTHR22972:SF5 (PANTHER); IPR008266 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)
gi|149692841|ref|XP_001492624.1|	trafficking particle complex subunit 6B isoform X1	158	20	2.33E-114	99.6%	8	F:GO:0005515; P:GO:0016192; C:GO:0005829; C:GO:0005794; C:GO:0005783; C:GO:0000139; P:GO:0006810; P:GO:0048208	F:protein binding; P:vesicle-mediated transport; C:cytosol; C:Golgi apparatus; C:endoplasmic reticulum; C:Golgi membrane; P:transport; P:COPII vesicle coating		IPR007194 (PFAM); G3DSA:3.30.1380.20 (GENE3D); PTHR12817 (PANTHER); PTHR12817:SF3 (PANTHER); IPR024096 (SUPERFAMILY)
gi|149692897|ref|XP_001490017.1|	probable G- coupled receptor 33	340	20	0E0	89.05%	3	F:GO:0004930; P:GO:0007186; C:GO:0016021	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway; C:integral component of membrane		IPR000276 (PRINTS); PR00526 (PRINTS); IPR000276 (PFAM); G3DSA:1.20.1070.10 (GENE3D); IPR000826 (PANTHER); PTHR24225:SF5 (PANTHER); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR017452 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY)
gi|149693595|ref|XP_001488679.1|	39S ribosomal mitochondrial	423	20	0E0	95.55%	5	F:GO:0003735; C:GO:0005739; P:GO:0042254; C:GO:0005840; P:GO:0006412	F:structural constituent of ribosome; C:mitochondrion; P:ribosome biogenesis; C:ribosome; P:translation		IPR010793 (PFAM); PTHR15889 (PANTHER)
gi|149693676|ref|XP_001495117.1|	5-methylcytosine rRNA methyltransferase NSUN4 isoform X1	384	20	0E0	95.6%	1	F:GO:0008168	F:methyltransferase activity		IPR023267 (PRINTS); IPR029063 (G3DSA:3.40.50.GENE3D); IPR001678 (PFAM); PTHR22808 (PANTHER); PTHR22808:SF3 (PANTHER); IPR001678 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY)
gi|149693730|ref|XP_001498598.1|	elongation of very long chain fatty acids 1	279	20	0E0	97.3%	6	P:GO:0042967; C:GO:0016021; P:GO:0042761; P:GO:0019367; C:GO:0009923; F:GO:0009922	P:acyl-carrier-protein biosynthetic process; C:integral component of membrane; P:very long-chain fatty acid biosynthetic process; P:fatty acid elongation, saturated fatty acid; C:fatty acid elongase complex; F:fatty acid elongase activity	EC:2.3.1.85	IPR002076 (PFAM); PTHR11157:SF19 (PANTHER); IPR002076 (PANTHER); IPR030457 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR033681 (HAMAP)
gi|149695187|ref|XP_001501554.1|	ephrin type-A receptor 8	1025	20	0E0	98.15%	6	C:GO:0005887; F:GO:0005524; F:GO:0005515; P:GO:0048013; F:GO:0005004; P:GO:0006468	C:integral component of plasma membrane; F:ATP binding; F:protein binding; P:ephrin receptor signaling pathway; F:GPI-linked ephrin receptor activity; P:protein phosphorylation	EC:2.7.10; EC:2.7.10.1; EC:2.7.11	PR00014 (PRINTS); IPR001245 (PRINTS); IPR011641 (SMART); IPR003961 (SMART); IPR001090 (SMART); IPR001660 (SMART); IPR020635 (SMART); IPR016257 (PIRSF); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001660 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001090 (PFAM); IPR027936 (PFAM); IPR008979 (G3DSA:2.60.120.GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR001245 (PFAM); IPR013761 (G3DSA:1.10.150.GENE3D); IPR003961 (PFAM); IPR020691 (PTHR24416:PANTHER); PTHR24416 (PANTHER); IPR001426 (PROSITE_PATTERNS); IPR008266 (PROSITE_PATTERNS); IPR001426 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000719 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR001090 (PROSITE_PROFILES); IPR001660 (PROSITE_PROFILES); IPR013761 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR008979 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR009030 (SUPERFAMILY)
gi|149695378|ref|XP_001489818.1|	dnaJ homolog subfamily C member 16	782	20	0E0	97.3%	1	P:GO:0045454	P:cell redox homeostasis		IPR001623 (PRINTS); IPR001623 (SMART); IPR012336 (G3DSA:3.40.30.GENE3D); IPR001623 (PFAM); IPR001623 (G3DSA:1.10.287.GENE3D); IPR013766 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR24078 (PANTHER); PTHR24078:SF319 (PANTHER); IPR018253 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR013766 (PROSITE_PROFILES); IPR001623 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR001623 (SUPERFAMILY)
gi|149695430|ref|XP_001496162.1|	taste receptor type 1 member 1	843	20	0E0	89%	3	F:GO:0004930; P:GO:0007186; C:GO:0016021	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway; C:integral component of membrane		IPR000337 (PRINTS); PR00592 (PRINTS); G3DSA:3.40.50.2300 (GENE3D); IPR001828 (PFAM); IPR017978 (PFAM); G3DSA:3.40.50.2300 (GENE3D); IPR011500 (PFAM); PTHR24061 (PANTHER); PTHR24061:SF3 (PANTHER); IPR017979 (PROSITE_PATTERNS); IPR017979 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR017978 (PROSITE_PROFILES); PS51257 (PROSITE_PROFILES); IPR028082 (SUPERFAMILY)
gi|149695446|ref|XP_001497410.1|	centrosomal of 104 kDa isoform X1	925	20	0E0	91.95%	1	F:GO:0005488	F:binding		SM01349 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR13371 (PANTHER); PTHR13371:SF0 (PANTHER); IPR016024 (SUPERFAMILY); IPR008979 (SUPERFAMILY)
gi|149699777|ref|XP_001497860.1|	haptoglobin	347	20	0E0	90.65%	5	C:GO:0005833; F:GO:0030492; P:GO:0006508; F:GO:0004252; C:GO:0005576	C:hemoglobin complex; F:hemoglobin binding; P:proteolysis; F:serine-type endopeptidase activity; C:extracellular region	EC:3.4.21	IPR001314 (PRINTS); IPR008292 (PIRSF); IPR001254 (SMART); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.40.10.10 (GENE3D); IPR001254 (PFAM); G3DSA:2.40.10.10 (GENE3D); G3DSA:2.40.10.10 (GENE3D); PTHR24256:SF128 (PANTHER); PTHR24256 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000436 (PROSITE_PROFILES); IPR001254 (PROSITE_PROFILES); IPR000436 (SUPERFAMILY); IPR009003 (SUPERFAMILY)
gi|149703048|ref|XP_001495248.1|	beta-klotho	1045	20	0E0	95.25%	2	P:GO:0005975; F:GO:0004553	P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds		IPR001360 (PRINTS); IPR013781 (G3DSA:3.20.20.GENE3D); IPR001360 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR10353:SF68 (PANTHER); IPR001360 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR017853 (SUPERFAMILY); IPR017853 (SUPERFAMILY)
gi|149704653|ref|XP_001498451.1|	growth factor receptor-bound 10 isoform X1	594	20	0E0	96.7%	1	P:GO:0007165	P:signal transduction		IPR000980 (PRINTS); IPR001849 (SMART); IPR000980 (SMART); IPR000159 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); IPR015042 (PFAM); IPR001849 (PFAM); IPR000159 (PFAM); G3DSA:3.10.20.90 (GENE3D); IPR000980 (G3DSA:3.30.505.GENE3D); IPR000980 (PFAM); PTHR11243:SF4 (PANTHER); PTHR11243 (PANTHER); IPR000159 (PROSITE_PROFILES); IPR000980 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR000980 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR029071 (SUPERFAMILY)
gi|149704847|ref|XP_001496596.1|	ATP-binding cassette sub-family A member 13	5059	20	0E0	86.3%	5	F:GO:0016887; F:GO:0005524; C:GO:0016021; P:GO:0006810; F:GO:0005215	F:ATPase activity; F:ATP binding; C:integral component of membrane; P:transport; F:transporter activity	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR003593 (SMART); IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PF12698 (PFAM); IPR026082 (PANTHER); PTHR19229:SF113 (PANTHER); IPR017871 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|149705569|ref|XP_001495827.1|	sclerostin domain-containing 1	206	20	3.58E-154	99.05%	1	C:GO:0005615	C:extracellular space		IPR008835 (PFAM); PTHR14903:SF5 (PANTHER); IPR008835 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR006207 (PROSITE_PROFILES)
gi|149705834|ref|XP_001502597.1|	GRIP and coiled-coil domain-containing 1	775	20	0E0	97%	2	F:GO:0005515; P:GO:0000042	F:protein binding; P:protein targeting to Golgi		IPR000237 (SMART); IPR000237 (G3DSA:1.10.220.GENE3D); IPR000237 (PFAM); PTHR23157:SF25 (PANTHER); PTHR23157 (PANTHER); IPR000237 (PROSITE_PROFILES)
gi|149706127|ref|XP_001500369.1|	probable G- coupled receptor 141	302	20	0E0	89.45%	3	F:GO:0004930; P:GO:0007186; C:GO:0016021	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway; C:integral component of membrane		IPR000276 (PRINTS); PR01157 (PRINTS); IPR000276 (PFAM); G3DSA:1.20.1070.10 (GENE3D); PTHR24237:SF0 (PANTHER); PTHR24237 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR017452 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY)
gi|149707855|ref|XP_001494175.1|	TIP41	276	20	0E0	97.3%	5	P:GO:0000077; C:GO:0005737; C:GO:0043231; P:GO:0034048; F:GO:0003674	P:DNA damage checkpoint; C:cytoplasm; C:intracellular membrane-bounded organelle; P:negative regulation of protein phosphatase type 2A activity; F:molecular_function		IPR007303 (PFAM); PTHR21021:SF16 (PANTHER); PTHR21021 (PANTHER)
gi|149707904|ref|XP_001498272.1|	pappalysin-2	1790	20	0E0	92.55%	3	F:GO:0008270; P:GO:0006508; F:GO:0008237	F:zinc ion binding; P:proteolysis; F:metallopeptidase activity		IPR000436 (SMART); IPR000800 (SMART); IPR006558 (SMART); IPR013320 (G3DSA:2.60.120.GENE3D); IPR011936 (TIGRFAM); IPR000800 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); IPR024079 (G3DSA:3.40.390.GENE3D); PF13385 (PFAM); IPR008754 (PFAM); IPR000436 (PFAM); IPR026918 (PTHR19325:PANTHER); PTHR19325 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR000436 (PROSITE_PROFILES); IPR000436 (SUPERFAMILY); SSF55486 (SUPERFAMILY); SSF55486 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR013320 (SUPERFAMILY)
gi|149708889|ref|XP_001499961.1|	pre-mRNA-splicing factor SPF27	225	20	6.5E-168	99%	1	P:GO:0006397	P:mRNA processing		IPR008409 (PFAM); IPR008409 (PTHR13296:PANTHER); PTHR13296 (PANTHER)
gi|149710107|ref|XP_001488817.1|	receptor tyrosine- kinase erbB-4 isoform X1	1308	20	0E0	99.1%	6	F:GO:0005524; F:GO:0004714; F:GO:0004716; C:GO:0016021; P:GO:0007169; P:GO:0006468	F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity; F:receptor signaling protein tyrosine kinase activity; C:integral component of membrane; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:protein phosphorylation	EC:2.7.10; EC:2.7.10.1; EC:2.7.11	IPR001245 (PRINTS); IPR020635 (SMART); IPR016245 (PIRSF); IPR006212 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:4.10.1140.10 (GENE3D); G3DSA:2.10.220.10 (GENE3D); IPR000494 (G3DSA:3.80.20.GENE3D); G3DSA:2.10.220.10 (GENE3D); IPR000494 (PFAM); G3DSA:2.10.220.10 (GENE3D); IPR032778 (PFAM); IPR006211 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR000494 (G3DSA:3.80.20.GENE3D); IPR001245 (PFAM); G3DSA:2.10.220.10 (GENE3D); PTHR24416 (PANTHER); PTHR24416:SF90 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR008266 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000719 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR032675 (SUPERFAMILY)
gi|149711231|ref|XP_001499536.1|	transient receptor potential cation channel subfamily M member 8	1104	20	0E0	98.15%	21	F:GO:0042803; P:GO:0055085; P:GO:0009266; P:GO:0034220; F:GO:0005262; C:GO:0009897; P:GO:0006810; P:GO:0006874; P:GO:0009409; F:GO:0005216; P:GO:0006811; P:GO:0051289; P:GO:0006812; P:GO:0006816; C:GO:0016020; C:GO:0016021; P:GO:0070588; P:GO:0050955; P:GO:0070207; P:GO:0016048; P:GO:0050951	F:protein homodimerization activity; P:transmembrane transport; P:response to temperature stimulus; P:ion transmembrane transport; F:calcium channel activity; C:external side of plasma membrane; P:transport; P:cellular calcium ion homeostasis; P:response to cold; F:ion channel activity; P:ion transport; P:protein homotetramerization; P:cation transport; P:calcium ion transport; C:membrane; C:integral component of membrane; P:calcium ion transmembrane transport; P:thermoception; P:protein homotrimerization; P:detection of temperature stimulus; P:sensory perception of temperature stimulus		
gi|149713726|ref|XP_001500450.1|	taste receptor type 2 member 8	306	20	0E0	83.45%	4	F:GO:0004930; P:GO:0050909; P:GO:0007186; C:GO:0016021	F:G-protein coupled receptor activity; P:sensory perception of taste; P:G-protein coupled receptor signaling pathway; C:integral component of membrane		IPR007960 (PFAM); PTHR11394:SF31 (PANTHER); IPR007960 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SSF81321 (SUPERFAMILY)
gi|149716451|ref|XP_001500463.1|	DDI1 homolog 1	400	20	0E0	93.15%	3	F:GO:0004190; F:GO:0005515; P:GO:0006508	F:aspartic-type endopeptidase activity; F:protein binding; P:proteolysis	EC:3.4.23	IPR000626 (PFAM); IPR021109 (G3DSA:2.40.70.GENE3D); IPR019103 (PFAM); G3DSA:3.10.20.90 (GENE3D); PTHR12917:SF15 (PANTHER); PTHR12917 (PANTHER); IPR000626 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY); IPR021109 (SUPERFAMILY)
gi|149720589|ref|XP_001488921.1|	2-methoxy-6-polyprenyl-1,4-benzoquinol mitochondrial	327	20	0E0	95.3%	1	F:GO:0008168	F:methyltransferase activity		IPR004033 (PFAM); IPR004033 (TIGRFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); PTHR10108:SF24 (PANTHER); IPR023576 (PROSITE_PATTERNS); IPR023576 (PROSITE_PATTERNS); IPR004033 (PROSITE_PROFILES); IPR004033 (HAMAP); IPR029063 (SUPERFAMILY)
gi|149720862|ref|XP_001494386.1|	carbohydrate sulfotransferase 9 isoform X1	441	20	0E0	92.8%	2	C:GO:0016021; F:GO:0008146	C:integral component of membrane; F:sulfotransferase activity		IPR005331 (PFAM); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS)
gi|149721643|ref|XP_001497688.1|	zinc fingers and homeoboxes 1	873	20	0E0	97.85%	2	F:GO:0003677; F:GO:0046872	F:DNA binding; F:metal ion binding		IPR001356 (SMART); IPR015880 (SMART); IPR024578 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); IPR001356 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); PTHR15467 (PANTHER); PTHR15467:SF4 (PANTHER); IPR001356 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY); IPR009057 (SUPERFAMILY); IPR009057 (SUPERFAMILY); SSF57667 (SUPERFAMILY); IPR009057 (SUPERFAMILY); SSF57667 (SUPERFAMILY); IPR009057 (SUPERFAMILY)
gi|149721807|ref|XP_001498888.1|	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	342	20	0E0	95.3%	3	F:GO:0008373; C:GO:0030173; P:GO:0006486	F:sialyltransferase activity; C:integral component of Golgi membrane; P:protein glycosylation	EC:2.4.99	IPR012163 (PIRSF); IPR001675 (PFAM); PTHR13713 (PANTHER); PTHR13713:SF39 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS)
gi|149721891|ref|XP_001493689.1|	CAP-Gly domain-containing linker 3	547	20	0E0	99.05%	5	C:GO:0005802; F:GO:0005515; C:GO:0045121; C:GO:0010008; C:GO:0005886	C:trans-Golgi network; F:protein binding; C:membrane raft; C:endosome membrane; C:plasma membrane		IPR002110 (SMART); IPR000938 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR000938 (G3DSA:2.30.30.GENE3D); IPR020683 (PFAM); IPR000938 (PFAM); IPR030504 (PTHR18916:PANTHER); PTHR18916 (PANTHER); IPR000938 (PROSITE_PATTERNS); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR000938 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR000938 (SUPERFAMILY); IPR000938 (SUPERFAMILY)
gi|149722554|ref|XP_001488074.1|	40S ribosomal S9	194	20	1.02E-136	99.1%	5	F:GO:0003735; P:GO:0042254; C:GO:0015935; F:GO:0019843; P:GO:0006412	F:structural constituent of ribosome; P:ribosome biogenesis; C:small ribosomal subunit; F:rRNA binding; P:translation		IPR002942 (SMART); IPR001912 (SMART); IPR002942 (G3DSA:3.10.290.GENE3D); IPR005710 (TIGRFAM); IPR001912 (PFAM); IPR002942 (PFAM); PTHR11831:SF10 (PANTHER); IPR022801 (PANTHER); IPR018079 (PROSITE_PATTERNS); IPR002942 (PROSITE_PROFILES); SSF55174 (SUPERFAMILY)
gi|149723129|ref|XP_001504172.1|	trafficking particle complex subunit 3	181	20	1.74E-131	97%	2	C:GO:0030008; P:GO:0048193	C:TRAPP complex; P:Golgi vesicle transport		IPR016721 (PIRSF); IPR007194 (PFAM); G3DSA:3.30.1380.20 (GENE3D); PTHR13048:SF1 (PANTHER); IPR016721 (PANTHER); IPR024096 (SUPERFAMILY)
gi|149723351|ref|XP_001498845.1|	ATP-binding cassette sub-family A member 5	1642	20	0E0	97.2%	5	F:GO:0016887; F:GO:0005524; C:GO:0016021; P:GO:0006810; F:GO:0005215	F:ATPase activity; F:ATP binding; C:integral component of membrane; P:transport; F:transporter activity	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR003593 (SMART); IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PF12698 (PFAM); IPR026082 (PANTHER); IPR030367 (PTHR19229:PANTHER); IPR017871 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|149723994|ref|XP_001503781.1|	proline-rich 11	364	20	0E0	90.05%	4	C:GO:0005634; C:GO:0005737; C:GO:0016020; P:GO:0051726	C:nucleus; C:cytoplasm; C:membrane; P:regulation of cell cycle		PTHR23330 (PANTHER)
gi|149723996|ref|XP_001503783.1|	SMG8	991	20	0E0	98.15%	1	P:GO:0000184	P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay		IPR019354 (PFAM); PTHR13091 (PANTHER); IPR028802 (PTHR13091:PANTHER)
gi|149724483|ref|XP_001500535.1|	CASC3	703	20	0E0	97.65%	19	C:GO:0035145; F:GO:0042802; P:GO:0008380; P:GO:0008298; C:GO:0016607; P:GO:0006397; P:GO:0006810; F:GO:0044822; P:GO:0006417; C:GO:0005634; P:GO:0016070; F:GO:0031625; F:GO:0003723; C:GO:0048471; C:GO:0030529; P:GO:0000184; C:GO:0005737; P:GO:0051028; F:GO:0019899	C:exon-exon junction complex; F:identical protein binding; P:RNA splicing; P:intracellular mRNA localization; C:nuclear speck; P:mRNA processing; P:transport; F:poly(A) RNA binding; P:regulation of translation; C:nucleus; P:RNA metabolic process; F:ubiquitin protein ligase binding; F:RNA binding; C:perinuclear region of cytoplasm; C:intracellular ribonucleoprotein complex; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; C:cytoplasm; P:mRNA transport; F:enzyme binding		
gi|149724871|ref|XP_001502902.1|	rab GTPase-binding effector 1	884	20	0E0	98.55%	7	P:GO:0008283; F:GO:0008083; C:GO:0005768; P:GO:0007165; F:GO:0005096; P:GO:0006897; P:GO:0040007	P:cell proliferation; F:growth factor activity; C:endosome; P:signal transduction; F:GTPase activator activity; P:endocytosis; P:growth		IPR003914 (PRINTS); G3DSA:1.20.5.730 (GENE3D); IPR018514 (PFAM); IPR015390 (PFAM); PTHR31179 (PANTHER); IPR029880 (PTHR31179:PANTHER); SSF103652 (SUPERFAMILY); SSF103652 (SUPERFAMILY)
gi|149724951|ref|XP_001503245.1|	CST complex subunit CTC1	1229	20	0E0	91.8%	1	F:GO:0003697	F:single-stranded DNA binding		IPR029156 (PFAM); PTHR14865 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|149725925|ref|XP_001490542.1|	dnaJ homolog subfamily A member 1	397	20	0E0	99.75%	5	F:GO:0005524; F:GO:0031072; P:GO:0009408; F:GO:0051082; P:GO:0006457	F:ATP binding; F:heat shock protein binding; P:response to heat; F:unfolded protein binding; P:protein folding		IPR001623 (PRINTS); IPR001623 (SMART); IPR001305 (PFAM); IPR001305 (G3DSA:2.10.230.GENE3D); IPR001623 (G3DSA:1.10.287.GENE3D); IPR001623 (PFAM); IPR002939 (PFAM); G3DSA:2.60.260.20 (GENE3D); G3DSA:2.60.260.20 (GENE3D); PTHR24078:SF227 (PANTHER); PTHR24078 (PANTHER); IPR018253 (PROSITE_PATTERNS); IPR012724 (HAMAP); IPR001305 (PROSITE_PROFILES); IPR001623 (PROSITE_PROFILES); IPR008971 (SUPERFAMILY); IPR001623 (SUPERFAMILY); IPR008971 (SUPERFAMILY); IPR001305 (SUPERFAMILY)
gi|149726043|ref|XP_001502421.1|	vesicular integral-membrane VIP36	358	20	0E0	98.05%	1	C:GO:0016020	C:membrane		IPR005052 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); PTHR12223:SF22 (PANTHER); PTHR12223 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR005052 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY)
gi|149726047|ref|XP_001502458.1|	max dimerization 3	206	20	6.39E-144	96.25%	1	F:GO:0046983	F:protein dimerization activity		IPR011598 (SMART); IPR011598 (G3DSA:4.10.280.GENE3D); IPR011598 (PFAM); PTHR11969:SF6 (PANTHER); PTHR11969 (PANTHER); IPR011598 (PROSITE_PROFILES); IPR011598 (SUPERFAMILY)
gi|149726369|ref|XP_001504471.1|	AF4 FMR2 family member 4	1164	20	0E0	98.3%	4	C:GO:0005634; C:GO:0008023; P:GO:0007286; C:GO:0035327	C:nucleus; C:transcription elongation factor complex; P:spermatid development; C:transcriptionally active chromatin		IPR007797 (PFAM); IPR007797 (PANTHER); PTHR10528:SF15 (PANTHER)
gi|149726399|ref|XP_001504525.1|	long-chain fatty acid transport 6	619	20	0E0	94.25%	5	F:GO:0031957; P:GO:0015908; C:GO:0016021; F:GO:0004467; P:GO:0006631	F:very long-chain fatty acid-CoA ligase activity; P:fatty acid transport; C:integral component of membrane; F:long-chain fatty acid-CoA ligase activity; P:fatty acid metabolic process	EC:6.2.1.3; EC:6.2.1	G3DSA:3.30.300.30 (GENE3D); IPR000873 (PFAM); G3DSA:3.40.50.980 (GENE3D); G3DSA:2.30.38.10 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR025110 (PFAM); PTHR24096 (PANTHER); IPR030309 (PTHR24096:PANTHER); IPR020845 (PROSITE_PATTERNS); SSF56801 (SUPERFAMILY)
gi|149726491|ref|XP_001504666.1|	arrestin domain-containing 3	414	20	0E0	99.6%	1	P:GO:0007165	P:signal transduction		IPR011022 (SMART); IPR011022 (PFAM); IPR011021 (PFAM); IPR014752 (G3DSA:2.60.40.GENE3D); PTHR11188 (PANTHER); PTHR11188:SF49 (PANTHER); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY)
gi|149726511|ref|XP_001504676.1|	cyclin-H isoform X2	323	20	0E0	99.1%	5	F:GO:0016538; P:GO:0045859; P:GO:0051726; P:GO:0006351; C:GO:0070985	F:cyclin-dependent protein serine/threonine kinase regulator activity; P:regulation of protein kinase activity; P:regulation of cell cycle; P:transcription, DNA-templated; C:TFIIK complex	EC:2.7.1	IPR013763 (SMART); IPR013763 (G3DSA:1.10.472.GENE3D); IPR006671 (PFAM); IPR031658 (PFAM); IPR013763 (G3DSA:1.10.472.GENE3D); IPR027081 (TIGRFAM); PTHR10026 (PANTHER); IPR013763 (SUPERFAMILY); IPR013763 (SUPERFAMILY)
gi|149726853|ref|XP_001504339.1|	cell division cycle 23 homolog	597	20	0E0	98.3%	3	P:GO:0030071; F:GO:0005515; C:GO:0005680	P:regulation of mitotic metaphase/anaphase transition; F:protein binding; C:anaphase-promoting complex		IPR019734 (SMART); IPR019734 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR007192 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR12558 (PANTHER); PTHR12558:SF10 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY)
gi|149726917|ref|XP_001503253.1|	lamin-B1	557	20	0E0	96.25%	2	F:GO:0005198; C:GO:0005882	F:structural molecule activity; C:intermediate filament		IPR001664 (SMART); G3DSA:1.20.5.170 (GENE3D); IPR001664 (PFAM); IPR001322 (G3DSA:2.60.40.GENE3D); IPR001322 (PFAM); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); IPR001322 (SUPERFAMILY)
gi|149727487|ref|XP_001488416.1|	T-complex 1 subunit eta	543	20	0E0	99.1%	3	F:GO:0005524; F:GO:0051082; P:GO:0006457	F:ATP binding; F:unfolded protein binding; P:protein folding		IPR017998 (PRINTS); IPR027413 (G3DSA:1.10.560.GENE3D); IPR027409 (G3DSA:3.50.7.GENE3D); IPR002423 (PFAM); IPR027410 (G3DSA:3.30.260.GENE3D); IPR012720 (TIGRFAM); PTHR11353:SF105 (PANTHER); PTHR11353 (PANTHER); IPR002194 (PROSITE_PATTERNS); IPR002194 (PROSITE_PATTERNS); IPR002194 (PROSITE_PATTERNS); SSF48592 (SUPERFAMILY); SSF54849 (SUPERFAMILY); IPR027409 (SUPERFAMILY)
gi|149727614|ref|XP_001499637.1|	pleckstrin homology domain-containing family H member 2	1493	20	0E0	97.55%	1	C:GO:0005856	C:cytoskeleton		IPR019749 (SMART); IPR001849 (SMART); IPR000857 (SMART); IPR001849 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR014352 (G3DSA:1.20.80.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR019748 (PFAM); IPR000857 (PFAM); PTHR22903 (PANTHER); PTHR22903:SF3 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000857 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR000299 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR019748 (SUPERFAMILY)
gi|149727638|ref|XP_001500653.1|	aldose 1-epimerase	342	20	0E0	97.5%	3	P:GO:0019318; F:GO:0030246; F:GO:0016853	P:hexose metabolic process; F:carbohydrate binding; F:isomerase activity		IPR015443 (PIRSF); IPR008183 (PFAM); IPR014718 (G3DSA:2.70.98.GENE3D); PTHR10091 (PANTHER); PTHR10091:SF0 (PANTHER); IPR018052 (PROSITE_PATTERNS); IPR011013 (SUPERFAMILY)
gi|149728089|ref|XP_001502833.1|	trifunctional enzyme subunit mitochondrial	762	20	0E0	96.8%	13	C:GO:0016507; P:GO:0006552; P:GO:0006574; P:GO:0006550; F:GO:0004300; P:GO:0006633; P:GO:0006568; P:GO:0006554; P:GO:0046251; P:GO:0006635; F:GO:0003857; P:GO:0019482; P:GO:0018874	C:mitochondrial fatty acid beta-oxidation multienzyme complex; P:leucine catabolic process; P:valine catabolic process; P:isoleucine catabolic process; F:enoyl-CoA hydratase activity; P:fatty acid biosynthetic process; P:tryptophan metabolic process; P:lysine catabolic process; P:limonene catabolic process; P:fatty acid beta-oxidation; F:3-hydroxyacyl-CoA dehydrogenase activity; P:beta-alanine metabolic process; P:benzoate metabolic process	EC:1.1.1.35; EC:4.2.1.17	IPR016040 (G3DSA:3.40.50.GENE3D); IPR001753 (PFAM); IPR006176 (PFAM); IPR006108 (PFAM); IPR029045 (G3DSA:3.90.226.GENE3D); IPR013328 (G3DSA:1.10.1040.GENE3D); IPR013328 (G3DSA:1.10.1040.GENE3D); IPR012803 (TIGRFAM); PTHR23309:SF21 (PANTHER); PTHR23309 (PANTHER); IPR018376 (PROSITE_PATTERNS); IPR006180 (PROSITE_PATTERNS); IPR008927 (SUPERFAMILY); IPR008927 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR029045 (SUPERFAMILY)
gi|149728671|ref|XP_001498255.1|	laminin subunit beta-2	1801	20	0E0	96.9%	1	F:GO:0005515	F:protein binding		PR00011 (PRINTS); IPR002049 (SMART); IPR008211 (SMART); IPR000742 (SMART); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR008211 (PFAM); IPR002049 (PFAM); G3DSA:2.10.25.10 (GENE3D); PTHR10574 (PANTHER); PTHR10574:SF36 (PANTHER); IPR002049 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR013015 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); IPR008211 (PROSITE_PROFILES); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY)
gi|149728737|ref|XP_001501613.1|	vesicle-trafficking SEC22c	303	20	0E0	96.8%	1	P:GO:0006810	P:transport		IPR010908 (SMART); IPR010908 (PFAM); IPR010908 (G3DSA:3.30.450.GENE3D); PTHR21136:SF2 (PANTHER); PTHR21136 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR010908 (PROSITE_PROFILES); IPR011012 (SUPERFAMILY)
gi|149729885|ref|XP_001487897.1|	vomeronasal type-2 receptor 1-like	914	20	0E0	93.05%	3	F:GO:0004930; P:GO:0007186; C:GO:0016021	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway; C:integral component of membrane		IPR000337 (PRINTS); PR00592 (PRINTS); G3DSA:3.40.50.2300 (GENE3D); G3DSA:3.40.50.2300 (GENE3D); IPR017978 (PFAM); IPR001828 (PFAM); IPR011500 (PFAM); PTHR24061 (PANTHER); PTHR24061:SF1 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR017978 (PROSITE_PROFILES); IPR028082 (SUPERFAMILY)
gi|149730480|ref|XP_001492859.1|	sodium leak channel non-selective	1738	20	0E0	99.1%	4	P:GO:0055085; P:GO:0006812; C:GO:0016020; F:GO:0005261	P:transmembrane transport; P:cation transport; C:membrane; F:cation channel activity		IPR005821 (PFAM); G3DSA:1.10.287.70 (GENE3D); IPR027359 (G3DSA:1.20.120.GENE3D); IPR028823 (PTHR10037:PANTHER); PTHR10037 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY)
gi|149730502|ref|XP_001496717.1|	probable cysteine--tRNA mitochondrial	559	20	0E0	91.95%	7	F:GO:0000166; P:GO:0006418; F:GO:0005524; F:GO:0004812; C:GO:0005829; F:GO:0004817; P:GO:0006423	F:nucleotide binding; P:tRNA aminoacylation for protein translation; F:ATP binding; F:aminoacyl-tRNA ligase activity; C:cytosol; F:cysteine-tRNA ligase activity; P:cysteinyl-tRNA aminoacylation		
gi|149730792|ref|XP_001501867.1|	collagen alpha-2(V) chain	1499	20	0E0	98.95%	12	P:GO:0071230; P:GO:0001501; P:GO:0048592; F:GO:0046332; C:GO:0005581; P:GO:1903225; P:GO:0030199; C:GO:0031012; P:GO:0043588; F:GO:0005201; C:GO:0005578; C:GO:0005588	P:cellular response to amino acid stimulus; P:skeletal system development; P:eye morphogenesis; F:SMAD binding; C:collagen trimer; P:negative regulation of endodermal cell differentiation; P:collagen fibril organization; C:extracellular matrix; P:skin development; F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix; C:collagen type V trimer		
gi|149730810|ref|XP_001502368.1|	tomoregulin-2	374	20	0E0	99.15%	1	F:GO:0005515	F:protein binding		IPR002350 (SMART); G3DSA:2.10.25.10 (GENE3D); IPR002350 (PFAM); G3DSA:3.30.60.30 (GENE3D); PTHR10574:SF88 (PANTHER); PTHR10574 (PANTHER); IPR013032 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000742 (PROSITE_PROFILES); IPR002350 (PROSITE_PROFILES); SSF57196 (SUPERFAMILY); SSF100895 (SUPERFAMILY); SSF100895 (SUPERFAMILY)
gi|149731808|ref|XP_001492504.1|	glucose-fructose oxidoreductase domain-containing 1	390	20	0E0	99.05%	1	F:GO:0016491	F:oxidoreductase activity		G3DSA:3.30.360.10 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR000683 (PFAM); PTHR22604:SF100 (PANTHER); PTHR22604 (PANTHER); IPR016040 (SUPERFAMILY); SSF55347 (SUPERFAMILY)
gi|149731842|ref|XP_001496564.1|	E3 ubiquitin- ligase TRIM38	464	20	0E0	90.45%	3	F:GO:0008270; F:GO:0005515; C:GO:0005622	F:zinc ion binding; F:protein binding; C:intracellular		IPR003879 (PRINTS); IPR006574 (SMART); IPR001841 (SMART); IPR000315 (SMART); IPR003877 (SMART); IPR006574 (PFAM); IPR000315 (G3DSA:4.10.45.GENE3D); PF15227 (PFAM); IPR003877 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR000315 (PFAM); IPR017907 (PROSITE_PATTERNS); IPR000315 (PROSITE_PROFILES); IPR001870 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); SSF57845 (SUPERFAMILY); SSF57850 (SUPERFAMILY); IPR013320 (SUPERFAMILY)
gi|149732314|ref|XP_001503413.1|	PHD finger 3 isoform X1	2042	20	0E0	95.7%	3	F:GO:0008270; F:GO:0005515; P:GO:0006351	F:zinc ion binding; F:protein binding; P:transcription, DNA-templated		IPR001965 (SMART); IPR003618 (SMART); IPR003618 (G3DSA:1.10.472.GENE3D); IPR012921 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR003618 (PFAM); IPR019787 (PFAM); IPR019786 (PROSITE_PATTERNS); IPR003618 (PROSITE_PROFILES); IPR019787 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY); IPR003618 (SUPERFAMILY)
gi|149732359|ref|XP_001492943.1|	complement C4-A	1744	20	0E0	91.85%	7	P:GO:0006956; C:GO:0005615; P:GO:0006954; F:GO:0004866; P:GO:0016064; P:GO:0010951; C:GO:0005576	P:complement activation; C:extracellular space; P:inflammatory response; F:endopeptidase inhibitor activity; P:immunoglobulin mediated immune response; P:negative regulation of endopeptidase activity; C:extracellular region		
gi|149733339|ref|XP_001503613.1|	NFX1-type zinc finger-containing 1	1917	20	0E0	96.4%	6	C:GO:0005634; C:GO:0005667; F:GO:0003700; F:GO:0008270; P:GO:0006355; P:GO:0006355	C:nucleus; C:transcription factor complex; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; P:regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated		IPR000967 (SMART); PF13087 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PF13086 (PFAM); PTHR10887 (PANTHER); PTHR10887:SF379 (PANTHER); IPR027417 (SUPERFAMILY)
gi|149736849|ref|XP_001492713.1|	tyrosine- kinase JAK2	1131	20	0E0	98.35%	7	F:GO:0005524; C:GO:0005856; F:GO:0004715; F:GO:0042393; C:GO:0016020; P:GO:0006468; P:GO:0035556	F:ATP binding; C:cytoskeleton; F:non-membrane spanning protein tyrosine kinase activity; F:histone binding; C:membrane; P:protein phosphorylation; P:intracellular signal transduction	EC:2.7.10; EC:2.7.10.2	IPR016251 (PRINTS); IPR001245 (PRINTS); IPR020693 (PRINTS); IPR019749 (SMART); IPR016251 (PIRSF); IPR020635 (SMART); IPR000980 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000980 (PFAM); IPR001245 (PFAM); G3DSA:3.30.200.20 (GENE3D); IPR000980 (G3DSA:3.30.505.GENE3D); PTHR24418:SF179 (PANTHER); PTHR24418 (PANTHER); IPR008266 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); IPR000299 (PROSITE_PROFILES); IPR000980 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR019748 (SUPERFAMILY); IPR000980 (SUPERFAMILY); IPR011009 (SUPERFAMILY)
gi|149736920|ref|XP_001499420.1|	nucleolar 6 isoform X1	1146	20	0E0	96.15%	10	C:GO:0032040; C:GO:0005634; C:GO:0005739; P:GO:0006409; C:GO:0034456; P:GO:0006364; C:GO:0005730; C:GO:0000794; F:GO:0044822; C:GO:0032545	C:small-subunit processome; C:nucleus; C:mitochondrion; P:tRNA export from nucleus; C:UTP-C complex; P:rRNA processing; C:nucleolus; C:condensed nuclear chromosome; F:poly(A) RNA binding; C:CURI complex		IPR005554 (PFAM); IPR005554 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|149738827|ref|XP_001489373.1|	major allergen Equ c 1-like	187	20	2.9E-134	88.4%	4	F:GO:0005550; F:GO:0036094; P:GO:0006810; F:GO:0005215	F:pheromone binding; F:small molecule binding; P:transport; F:transporter activity		IPR002345 (PRINTS); IPR002971 (PRINTS); IPR000566 (PFAM); IPR012674 (G3DSA:2.40.128.GENE3D); PTHR11430:SF76 (PANTHER); PTHR11430 (PANTHER); IPR022272 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR011038 (SUPERFAMILY)
gi|149738843|ref|XP_001489495.1|	major allergen Equ c 1-like	185	20	1.49E-131	82.9%	3	F:GO:0005550; P:GO:0006810; F:GO:0005215	F:pheromone binding; P:transport; F:transporter activity		IPR002971 (PRINTS); IPR012674 (G3DSA:2.40.128.GENE3D); IPR000566 (PFAM); PTHR11430 (PANTHER); PTHR11430:SF76 (PANTHER); IPR022272 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR011038 (SUPERFAMILY)
gi|149740705|ref|XP_001495848.1|	calicin	591	20	0E0	95.35%	1	F:GO:0005515	F:protein binding		IPR011705 (SMART); IPR017096 (PIRSF); IPR006652 (SMART); IPR000210 (SMART); IPR011705 (PFAM); IPR015916 (G3DSA:2.130.10.GENE3D); IPR000210 (PFAM); IPR006652 (PFAM); G3DSA:3.30.710.10 (GENE3D); PTHR24412:SF163 (PANTHER); PTHR24412 (PANTHER); IPR000210 (PROSITE_PROFILES); SSF117281 (SUPERFAMILY); IPR011333 (SUPERFAMILY)
gi|149740987|ref|XP_001497183.1|	calicin	590	20	0E0	94.7%	1	F:GO:0005515	F:protein binding		IPR006652 (SMART); IPR011705 (SMART); IPR000210 (SMART); IPR015915 (G3DSA:2.120.10.GENE3D); IPR000210 (PFAM); IPR011705 (PFAM); PF13418 (PFAM); PF13415 (PFAM); G3DSA:3.30.710.10 (GENE3D); PTHR24412 (PANTHER); PTHR24412:SF163 (PANTHER); IPR000210 (PROSITE_PROFILES); SSF117281 (SUPERFAMILY); IPR011333 (SUPERFAMILY)
gi|149742327|ref|XP_001491278.1|	uromodulin-like 1	1360	20	0E0	85.9%	4	F:GO:0030414; F:GO:0005515; F:GO:0005509; C:GO:0005576	F:peptidase inhibitor activity; F:protein binding; F:calcium ion binding; C:extracellular region		IPR001881 (SMART); IPR000742 (SMART); IPR001507 (SMART); IPR008197 (SMART); IPR003961 (SMART); IPR000082 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR008197 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR008197 (G3DSA:4.10.75.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001881 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR001507 (PFAM); PTHR24044:SF262 (PANTHER); PTHR24044 (PANTHER); IPR018097 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR003961 (PROSITE_PROFILES); IPR000082 (PROSITE_PROFILES); IPR011489 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR008197 (PROSITE_PROFILES); IPR001507 (PROSITE_PROFILES); IPR003961 (SUPERFAMILY); IPR008197 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR000082 (SUPERFAMILY)
gi|149742508|ref|XP_001490154.1|	glycerol-3-phosphate acyltransferase 4	456	20	0E0	99.15%	18	F:GO:0016746; P:GO:0040014; P:GO:0002071; P:GO:0008152; P:GO:0008610; P:GO:0006641; P:GO:0007595; C:GO:0005783; F:GO:0004366; P:GO:0006656; P:GO:0006631; P:GO:0046339; P:GO:0006637; P:GO:0030879; C:GO:0016020; C:GO:0016021; P:GO:0019432; F:GO:0016740	F:transferase activity, transferring acyl groups; P:regulation of multicellular organism growth; P:glandular epithelial cell maturation; P:metabolic process; P:lipid biosynthetic process; P:triglyceride metabolic process; P:lactation; C:endoplasmic reticulum; F:glycerol-3-phosphate O-acyltransferase activity; P:phosphatidylcholine biosynthetic process; P:fatty acid metabolic process; P:diacylglycerol metabolic process; P:acyl-CoA metabolic process; P:mammary gland development; C:membrane; C:integral component of membrane; P:triglyceride biosynthetic process; F:transferase activity		
gi|149742587|ref|XP_001494444.1|	MAK16 homolog	298	20	0E0	97.9%	8	F:GO:0003676; C:GO:0005634; P:GO:0000460; P:GO:0000470; C:GO:0043231; C:GO:0005730; F:GO:0044822; C:GO:0030687	F:nucleic acid binding; C:nucleus; P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA; C:intracellular membrane-bounded organelle; C:nucleolus; F:poly(A) RNA binding; C:preribosome, large subunit precursor		IPR006958 (PIRSF); IPR029004 (PFAM); IPR006958 (PFAM); PTHR23405 (PANTHER); PTHR23405:SF4 (PANTHER)
gi|149742816|ref|XP_001494472.1|	ubiquitin carboxyl-terminal hydrolase 17 6	535	20	0E0	78.4%	5	P:GO:0016579; C:GO:0005634; P:GO:0006511; F:GO:0016787; F:GO:0036459	P:protein deubiquitination; C:nucleus; P:ubiquitin-dependent protein catabolic process; F:hydrolase activity; F:thiol-dependent ubiquitinyl hydrolase activity		
gi|149742885|ref|XP_001491334.1|	ras association domain-containing 9	435	20	0E0	96.85%	1	P:GO:0007165	P:signal transduction		IPR000159 (SMART); IPR000159 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY)
gi|149742972|ref|XP_001497778.1|	phenylalanine-4-hydroxylase	452	20	0E0	97.45%	8	P:GO:0006559; P:GO:0009094; P:GO:0000162; F:GO:0004505; F:GO:0005506; P:GO:0006571; P:GO:0055114; F:GO:0016597	P:L-phenylalanine catabolic process; P:L-phenylalanine biosynthetic process; P:tryptophan biosynthetic process; F:phenylalanine 4-monooxygenase activity; F:iron ion binding; P:tyrosine biosynthetic process; P:oxidation-reduction process; F:amino acid binding	EC:1.14.16.1; EC:1.14.16	IPR019774 (PRINTS); IPR019773 (PIRSF); IPR001273 (G3DSA:1.10.800.GENE3D); IPR005961 (TIGRFAM); IPR002912 (PFAM); IPR019774 (PFAM); IPR001273 (PANTHER); IPR018301 (PROSITE_PATTERNS); IPR002912 (PROSITE_PROFILES); IPR019774 (PROSITE_PROFILES); IPR019774 (SUPERFAMILY); SSF55021 (SUPERFAMILY)
gi|149742988|ref|XP_001499030.1|	DNA-directed RNA polymerase III subunit RPC2	1133	20	0E0	99.3%	7	F:GO:0003677; P:GO:0006206; F:GO:0003899; F:GO:0032549; P:GO:0006351; P:GO:0006144; C:GO:0005730	F:DNA binding; P:pyrimidine nucleobase metabolic process; F:DNA-directed RNA polymerase activity; F:ribonucleoside binding; P:transcription, DNA-templated; P:purine nucleobase metabolic process; C:nucleolus	EC:2.7.7.6	IPR014724 (G3DSA:2.40.50.GENE3D); IPR007120 (G3DSA:2.40.270.GENE3D); IPR007647 (PFAM); IPR007641 (PFAM); IPR007645 (PFAM); IPR007642 (G3DSA:3.90.1110.GENE3D); IPR007120 (PFAM); IPR007644 (PFAM); IPR007646 (PFAM); G3DSA:3.90.1100.10 (GENE3D); IPR007642 (PFAM); IPR015712 (PANTHER); PTHR20856:SF8 (PANTHER); IPR007121 (PROSITE_PATTERNS); SSF64484 (SUPERFAMILY)
gi|149743581|ref|XP_001499323.1|	probable 2-oxoglutarate dehydrogenase E1 component mitochondrial	920	20	0E0	96.7%	6	F:GO:0030976; F:GO:0004591; C:GO:0045252; P:GO:0006099; P:GO:0006568; P:GO:0006554	F:thiamine pyrophosphate binding; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; C:oxoglutarate dehydrogenase complex; P:tricarboxylic acid cycle; P:tryptophan metabolic process; P:lysine catabolic process	EC:1.2.4.2	IPR005475 (SMART); IPR011603 (PIRSF); IPR005475 (PFAM); IPR031717 (PFAM); IPR001017 (PFAM); IPR029061 (G3DSA:3.40.50.GENE3D); IPR029061 (G3DSA:3.40.50.GENE3D); IPR011603 (TIGRFAM); PTHR23152:SF11 (PANTHER); IPR011603 (PANTHER); IPR029061 (SUPERFAMILY); IPR029061 (SUPERFAMILY)
gi|149743856|ref|XP_001495985.1|	kelch 12	568	20	0E0	99.7%	1	F:GO:0005515	F:protein binding		PR00501 (PRINTS); IPR011705 (SMART); IPR006652 (SMART); IPR017096 (PIRSF); IPR000210 (SMART); IPR006652 (PFAM); IPR015916 (G3DSA:2.130.10.GENE3D); IPR011705 (PFAM); IPR000210 (PFAM); G3DSA:3.30.710.10 (GENE3D); PTHR24412:SF250 (PANTHER); PTHR24412 (PANTHER); IPR000210 (PROSITE_PROFILES); SSF117281 (SUPERFAMILY); IPR011333 (SUPERFAMILY)
gi|149744767|ref|XP_001500754.1|	kelch 4	718	20	0E0	96.1%	8	P:GO:0008150; F:GO:0004842; C:GO:0005856; F:GO:0003779; C:GO:0005737; C:GO:0031463; F:GO:0003674; P:GO:0016567	P:biological_process; F:ubiquitin-protein transferase activity; C:cytoskeleton; F:actin binding; C:cytoplasm; C:Cul3-RING ubiquitin ligase complex; F:molecular_function; P:protein ubiquitination		
gi|149749103|ref|XP_001492015.1|	RAC-gamma serine threonine- kinase isoform X1	479	20	0E0	99.7%	4	F:GO:0005524; P:GO:0009069; F:GO:0004674; P:GO:0006468	F:ATP binding; P:serine family amino acid metabolic process; F:protein serine/threonine kinase activity; P:protein phosphorylation	EC:2.7.11	IPR000961 (SMART); IPR001849 (SMART); IPR000719 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); IPR017892 (PFAM); IPR001849 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24356 (PANTHER); PTHR24356:SF190 (PANTHER); IPR008271 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); IPR000961 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR011993 (SUPERFAMILY)
gi|149750913|ref|XP_001498075.1|	transducin beta 3	804	20	0E0	96.15%	3	C:GO:0032040; F:GO:0005515; P:GO:0006364	C:small-subunit processome; F:protein binding; P:rRNA processing		IPR020472 (PRINTS); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); IPR013934 (PFAM); PTHR19854:SF15 (PANTHER); PTHR19854 (PANTHER); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR011047 (SUPERFAMILY)
gi|149750960|ref|XP_001502505.1|	ubinuclein-1 isoform X1	1133	20	0E0	94.65%	2	C:GO:0005634; P:GO:0006325	C:nucleus; P:chromatin organization		IPR014840 (PFAM); IPR026947 (PFAM); PTHR21669 (PANTHER); IPR026936 (PTHR21669:PANTHER)
gi|149751306|ref|XP_001495971.1|	nuclear pore membrane glyco 210-like	1887	20	0E0	95.35%	5	P:GO:0007286; C:GO:0016020; C:GO:0016021; P:GO:0060009; C:GO:0005643	P:spermatid development; C:membrane; C:integral component of membrane; P:Sertoli cell development; C:nuclear pore		
gi|149751390|ref|XP_001500063.1|	solute carrier family 25 member 44	314	20	0E0	99.1%	1	P:GO:0055085	P:transmembrane transport		IPR002067 (PRINTS); IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); PTHR24089:SF309 (PANTHER); PTHR24089 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY)
gi|149754677|ref|XP_001491446.1|	phostensin	615	20	0E0	92%	1	F:GO:0019902	F:phosphatase binding		IPR025907 (PFAM); IPR025903 (PFAM); PTHR21685:SF0 (PANTHER); IPR026671 (PANTHER)
gi|149754786|ref|XP_001489228.1|	transcription factor 19	345	20	0E0	94.65%	2	F:GO:0008270; F:GO:0005515	F:zinc ion binding; F:protein binding		IPR000253 (SMART); IPR001965 (SMART); IPR000253 (G3DSA:2.60.200.GENE3D); IPR000253 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR15464:SF1 (PANTHER); PTHR15464 (PANTHER); IPR019786 (PROSITE_PATTERNS); IPR000253 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY); IPR008984 (SUPERFAMILY)
gi|149755131|ref|XP_001491560.1|	hemicentin-1	5635	20	0E0	96.5%	2	F:GO:0005515; F:GO:0005509	F:protein binding; F:calcium ion binding		IPR000884 (SMART); IPR001881 (SMART); IPR013106 (SMART); IPR003598 (SMART); IPR003599 (SMART); IPR000742 (SMART); IPR006605 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:2.20.100.10 (GENE3D); PF13927 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002035 (G3DSA:3.40.50.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR026823 (PFAM); IPR000884 (PFAM); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR001881 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR023413 (G3DSA:2.40.155.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR006605 (PFAM); G3DSA:2.10.25.10 (GENE3D); PTHR10489:SF678 (PANTHER); PTHR10489 (PANTHER); IPR013032 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR000884 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR006605 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR009017 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR007110 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|149755277|ref|XP_001496308.1|	N-alpha-acetyltransferase auxiliary subunit	725	20	0E0	99.05%	5	C:GO:0005844; C:GO:0031417; C:GO:0005737; P:GO:0043066; P:GO:0048659	C:polysome; C:NatC complex; C:cytoplasm; P:negative regulation of apoptotic process; P:smooth muscle cell proliferation		IPR007244 (PFAM); PTHR21373 (PANTHER)
gi|149757884|ref|XP_001493912.1|	DNA polymerase delta catalytic subunit	1107	20	0E0	96.6%	6	F:GO:0000166; F:GO:0003677; F:GO:0008408; F:GO:0003887; P:GO:0006260; C:GO:0042575	F:nucleotide binding; F:DNA binding; F:3'-5' exonuclease activity; F:DNA-directed DNA polymerase activity; P:DNA replication; C:DNA polymerase complex	EC:3.1; EC:2.7.7.7	IPR006172 (PRINTS); IPR006172 (SMART); IPR006134 (PFAM); IPR023211 (G3DSA:3.90.1600.GENE3D); IPR006133 (PFAM); G3DSA:1.10.287.690 (GENE3D); IPR012337 (G3DSA:3.30.420.GENE3D); TIGR00592 (TIGRFAM); IPR025687 (PFAM); PTHR10322:SF23 (PANTHER); PTHR10322 (PANTHER); IPR017964 (PROSITE_PATTERNS); IPR012337 (SUPERFAMILY); SSF56672 (SUPERFAMILY)
gi|149758061|ref|XP_001497726.1|	nuclear pore complex Nup133	1156	20	0E0	97.15%	1	F:GO:0005515	F:protein binding		IPR015943 (G3DSA:2.130.10.GENE3D); IPR007187 (PFAM); PTHR13405 (PANTHER); PTHR13405:SF11 (PANTHER); SSF117289 (SUPERFAMILY)
gi|149758210|ref|XP_001488559.1|	Smith-Magenis syndrome chromosomal region candidate gene 8	937	20	0E0	95.15%	1	C:GO:0005654	C:nucleoplasm		PF11704 (PFAM); PTHR31334:SF1 (PANTHER); PTHR31334 (PANTHER)
gi|149758270|ref|XP_001489809.1|	ras and EF-hand domain-containing	728	20	0E0	93.85%	3	F:GO:0005525; P:GO:0007264; F:GO:0005509	F:GTP binding; P:small GTPase mediated signal transduction; F:calcium ion binding		PR00449 (PRINTS); IPR002048 (SMART); SM00175 (SMART); SM00174 (SMART); SM00173 (SMART); SM00176 (SMART); IPR001806 (PFAM); IPR002048 (PFAM); IPR005225 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR22621:SF4 (PANTHER); PTHR22621 (PANTHER); IPR018247 (PROSITE_PATTERNS); PS51419 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR011992 (SUPERFAMILY)
gi|153792266|ref|NP_001093235.1|	MHC class I antigen	359	20	0E0	87.2%	3	F:GO:0005515; P:GO:0006955; P:GO:0019882	F:protein binding; P:immune response; P:antigen processing and presentation		IPR001039 (PRINTS); IPR003597 (SMART); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR011161 (PFAM); IPR011161 (G3DSA:3.30.500.GENE3D); IPR010579 (PFAM); PTHR16675 (PANTHER); PTHR16675:SF179 (PANTHER); IPR003006 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR011162 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|157366676|gb|ABV45400.1|	glycogen debranching enzyme	1533	20	0E0	97.3%	6	P:GO:0005978; P:GO:0005980; F:GO:0004135; F:GO:0004134; P:GO:0005982; P:GO:0005985	P:glycogen biosynthetic process; P:glycogen catabolic process; F:amylo-alpha-1,6-glucosidase activity; F:4-alpha-glucanotransferase activity; P:starch metabolic process; P:sucrose metabolic process	EC:2.4.1.25; EC:3.2.1.33; EC:3.2.1	IPR032790 (PFAM); IPR006421 (TIGRFAM); IPR029436 (PFAM); IPR032792 (PFAM); IPR032788 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); IPR010401 (PANTHER); IPR017853 (SUPERFAMILY); IPR008928 (SUPERFAMILY)
gi|194205833|ref|XP_001502326.2|	lymphoid-specific helicase	837	20	0E0	97.75%	1	F:GO:0005524	F:ATP binding		IPR001650 (SMART); IPR014001 (SMART); IPR001650 (PFAM); IPR000330 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10799 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|194205841|ref|XP_001502425.2|	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 isoform X1	2299	20	0E0	95.55%	8	F:GO:0004435; F:GO:0005515; P:GO:0007264; P:GO:0035556; F:GO:0005085; P:GO:0009395; P:GO:0043087; P:GO:0046339	F:phosphatidylinositol phospholipase C activity; F:protein binding; P:small GTPase mediated signal transduction; P:intracellular signal transduction; F:guanyl-nucleotide exchange factor activity; P:phospholipid catabolic process; P:regulation of GTPase activity; P:diacylglycerol metabolic process	EC:3.1; EC:3.1.4.11; EC:3.1.1	IPR001192 (PRINTS); IPR001895 (SMART); IPR000159 (SMART); IPR000909 (SMART); IPR000008 (SMART); IPR001711 (SMART); IPR001895 (G3DSA:1.10.840.GENE3D); IPR001895 (PFAM); IPR000909 (PFAM); IPR015359 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); G3DSA:3.10.20.90 (GENE3D); IPR000008 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); IPR001711 (PFAM); IPR000159 (PFAM); IPR017946 (G3DSA:3.20.20.GENE3D); IPR001192 (PANTHER); IPR028398 (PTHR10336:PANTHER); IPR000008 (PROSITE_PROFILES); IPR000909 (PROSITE_PROFILES); IPR000159 (PROSITE_PROFILES); IPR001895 (PROSITE_PROFILES); IPR001711 (PROSITE_PROFILES); IPR000008 (SUPERFAMILY); IPR029071 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR017946 (SUPERFAMILY); IPR023578 (SUPERFAMILY); IPR029071 (SUPERFAMILY)
gi|194206259|ref|XP_001916274.1|	zinc finger 592 isoform X1	1271	20	0E0	95.15%	1	F:GO:0046872	F:metal ion binding		IPR015880 (SMART); IPR007087 (PFAM); PTHR24402 (PANTHER); PTHR24402:SF209 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY)
gi|194207637|ref|XP_001503386.2|	palmitoyl- thioesterase 1	317	20	0E0	95.75%	2	F:GO:0008474; P:GO:0002084	F:palmitoyl-(protein) hydrolase activity; P:protein depalmitoylation	EC:3.1.2.22	IPR002472 (PRINTS); IPR029058 (G3DSA:3.40.50.GENE3D); IPR002472 (PFAM); PTHR11247 (PANTHER); IPR030294 (PTHR11247:PANTHER); IPR029058 (SUPERFAMILY)
gi|194208054|ref|XP_001915151.1|	patched domain-containing 2	1393	20	0E0	96.25%	1	C:GO:0016021	C:integral component of membrane		IPR003392 (PFAM); G3DSA:1.20.1640.10 (GENE3D); PTHR10796 (PANTHER); PTHR10796:SF125 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000731 (PROSITE_PROFILES); SSF82866 (SUPERFAMILY); SSF82866 (SUPERFAMILY)
gi|194208489|ref|XP_001502260.2|	PR domain zinc finger 5	646	20	0E0	97.75%	3	F:GO:0005515; F:GO:0046872; F:GO:0000976	F:protein binding; F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding		IPR015880 (SMART); IPR017125 (PIRSF); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); PF13894 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); G3DSA:2.170.270.10 (GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PF12874 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); PTHR24409 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); IPR001214 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|194208730|ref|XP_001496757.2|	dipeptidase 2	458	20	0E0	89.75%	5	F:GO:0016805; C:GO:0016020; P:GO:0006508; F:GO:0008235; F:GO:0008239	F:dipeptidase activity; C:membrane; P:proteolysis; F:metalloexopeptidase activity; F:dipeptidyl-peptidase activity	EC:3.4.11; EC:3.4.13	IPR008257 (PFAM); G3DSA:3.20.20.140 (GENE3D); IPR008257 (PANTHER); IPR028531 (PTHR10443:PANTHER); IPR000180 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR008257 (PROSITE_PROFILES); IPR032466 (SUPERFAMILY)
gi|194208753|ref|XP_001497236.2|	conserved oligomeric Golgi complex subunit 8	624	20	0E0	95.6%	1	C:GO:0017119	C:Golgi transport complex		IPR016632 (PIRSF); IPR007255 (PFAM); IPR007255 (PANTHER); PTHR21311:SF0 (PANTHER); IPR016159 (SUPERFAMILY)
gi|194208857|ref|XP_001499912.2|	coactosin	142	20	1.94E-99	99.05%	2	F:GO:0003779; C:GO:0005622	F:actin binding; C:intracellular		IPR002108 (SMART); IPR029006 (G3DSA:3.40.20.GENE3D); IPR002108 (PFAM); PTHR10829 (PANTHER); IPR002108 (PROSITE_PROFILES); SSF55753 (SUPERFAMILY)
gi|194208862|ref|XP_001499958.2|	cysteine-rich secretory LCCL domain-containing 2	497	20	0E0	94.3%	1	C:GO:0005576	C:extracellular region		IPR001283 (PRINTS); IPR004043 (SMART); IPR014044 (SMART); IPR004043 (G3DSA:2.170.130.GENE3D); IPR014044 (PFAM); IPR014044 (G3DSA:3.40.33.GENE3D); IPR004043 (PFAM); IPR001283 (PANTHER); PTHR10334:SF64 (PANTHER); IPR018244 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR004043 (PROSITE_PROFILES); IPR004043 (SUPERFAMILY); IPR004043 (SUPERFAMILY); IPR014044 (SUPERFAMILY)
gi|194209014|ref|XP_001915516.1|	DNA transposase THAP9	902	20	0E0	95.95%	3	F:GO:0003676; F:GO:0004803; P:GO:0006313	F:nucleic acid binding; F:transposase activity; P:transposition, DNA-mediated		IPR006612 (SMART); IPR006612 (SMART); IPR021896 (PFAM); IPR006612 (PFAM); PTHR10725:SF5 (PANTHER); PTHR10725 (PANTHER); IPR006612 (PROSITE_PROFILES); SSF57716 (SUPERFAMILY)
gi|194209821|ref|XP_001917069.1|	phosphatase 1 regulatory subunit 3A	1119	20	0E0	89.55%	1	F:GO:0005515	F:protein binding		IPR005036 (PFAM); PTHR12307 (PANTHER); PTHR12307:SF2 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR005036 (PROSITE_PROFILES)
gi|194210081|ref|XP_001504677.2|	cullin-1	776	20	0E0	99.05%	3	F:GO:0031625; C:GO:0031461; P:GO:0006511	F:ubiquitin protein ligase binding; C:cullin-RING ubiquitin ligase complex; P:ubiquitin-dependent protein catabolic process		IPR019559 (SMART); IPR016158 (SMART); G3DSA:1.20.1310.10 (GENE3D); IPR001373 (PFAM); IPR019559 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); G3DSA:1.20.1310.10 (GENE3D); G3DSA:4.10.1030.10 (GENE3D); G3DSA:1.20.1310.10 (GENE3D); G3DSA:1.20.1310.10 (GENE3D); PTHR11932:SF81 (PANTHER); PTHR11932 (PANTHER); IPR016157 (PROSITE_PATTERNS); IPR016158 (PROSITE_PROFILES); IPR016159 (SUPERFAMILY); IPR011991 (SUPERFAMILY); IPR016158 (SUPERFAMILY)
gi|194210299|ref|XP_001496615.2|	methyltransferase 13	699	20	0E0	97.4%	2	P:GO:0008152; F:GO:0008168	P:metabolic process; F:methyltransferase activity		IPR013216 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR029063 (G3DSA:3.40.50.GENE3D); PF01564 (PFAM); PTHR12176 (PANTHER); PTHR12176:SF18 (PANTHER); IPR029063 (SUPERFAMILY); IPR029063 (SUPERFAMILY)
gi|194211286|ref|XP_001488940.2|	BRCA1-associated RING domain 1	748	20	0E0	91.55%	4	F:GO:0005515; P:GO:0043065; C:GO:0031436; P:GO:0016567	F:protein binding; P:positive regulation of apoptotic process; C:BRCA1-BARD1 complex; P:protein ubiquitination		IPR002110 (PRINTS); IPR002110 (SMART); IPR001357 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF14835 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR001357 (G3DSA:3.40.50.GENE3D); IPR020683 (PFAM); IPR001357 (G3DSA:3.40.50.GENE3D); PTHR24171 (PANTHER); IPR033097 (PTHR24171:PANTHER); IPR017907 (PROSITE_PATTERNS); IPR002110 (PROSITE_PROFILES); IPR001357 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR001357 (SUPERFAMILY); IPR001357 (SUPERFAMILY); IPR020683 (SUPERFAMILY); SSF57850 (SUPERFAMILY)
gi|194211553|ref|XP_001489981.2|	Wnt-5b	358	20	0E0	98.7%	4	P:GO:0007275; P:GO:0016055; C:GO:0005576; F:GO:0005102	P:multicellular organism development; P:Wnt signaling pathway; C:extracellular region; F:receptor binding		IPR005817 (PRINTS); IPR005817 (SMART); IPR005817 (PFAM); IPR026537 (PTHR12027:PANTHER); IPR005817 (PANTHER); IPR018161 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS)
gi|194211666|ref|XP_001916098.1|	beta-citrylglutamate synthase B	386	20	0E0	99.8%	4	F:GO:0005524; F:GO:0003824; F:GO:0046872; P:GO:0006464	F:ATP binding; F:catalytic activity; F:metal ion binding; P:cellular protein modification process		IPR013651 (PFAM); IPR016185 (G3DSA:3.40.50.GENE3D); IPR013816 (G3DSA:3.30.470.GENE3D); IPR013815 (G3DSA:3.30.1490.GENE3D); IPR004666 (TIGRFAM); PTHR21621 (PANTHER); PTHR21621:SF5 (PANTHER); IPR011761 (PROSITE_PROFILES); SSF56059 (SUPERFAMILY)
gi|194211675|ref|XP_001499173.2|	alpha-2-macroglobulin-like	1476	20	0E0	91.05%	2	C:GO:0005615; F:GO:0004866	C:extracellular space; F:endopeptidase inhibitor activity		IPR001599 (SMART); IPR011625 (SMART); IPR009048 (SMART); IPR009048 (PFAM); IPR011626 (PFAM); IPR019565 (PFAM); IPR001599 (PFAM); IPR008930 (G3DSA:1.50.10.GENE3D); IPR009048 (G3DSA:2.60.40.GENE3D); IPR002890 (PFAM); IPR011625 (PFAM); PTHR11412 (PANTHER); PTHR11412:SF103 (PANTHER); IPR010916 (PROSITE_PATTERNS); IPR019742 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR014756 (SUPERFAMILY); IPR009048 (SUPERFAMILY); IPR008930 (SUPERFAMILY)
gi|194211939|ref|XP_001504155.2|	voltage-dependent L-type calcium channel subunit beta-3 isoform X2	483	20	0E0	99.35%	4	F:GO:0005515; C:GO:0005891; P:GO:0070588; F:GO:0005245	F:protein binding; C:voltage-gated calcium channel complex; P:calcium ion transmembrane transport; F:voltage-gated calcium channel activity		IPR000584 (PRINTS); IPR008079 (PRINTS); IPR008145 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000584 (PFAM); IPR008145 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR000584 (PANTHER); IPR001452 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|194212541|ref|XP_001915589.1|	complement C3	1662	20	0E0	91.2%	3	C:GO:0005615; F:GO:0004866; F:GO:0005515	C:extracellular space; F:endopeptidase inhibitor activity; F:protein binding		IPR009048 (SMART); IPR001599 (SMART); IPR011625 (SMART); IPR000020 (SMART); IPR018933 (SMART); IPR019565 (PFAM); IPR018933 (PFAM); IPR018081 (G3DSA:1.20.91.GENE3D); IPR009048 (PFAM); IPR001599 (PFAM); IPR011626 (PFAM); IPR000020 (PFAM); IPR002890 (PFAM); IPR009048 (G3DSA:2.60.40.GENE3D); IPR008930 (G3DSA:1.50.10.GENE3D); IPR011625 (PFAM); PTHR11412 (PANTHER); PTHR11412:SF90 (PANTHER); IPR019742 (PROSITE_PATTERNS); IPR000020 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR000020 (PROSITE_PROFILES); IPR001134 (PROSITE_PROFILES); IPR008930 (SUPERFAMILY); IPR008993 (SUPERFAMILY); IPR018081 (SUPERFAMILY); IPR009048 (SUPERFAMILY)
gi|194212829|ref|XP_001501784.2|	olfactory receptor 10G7	311	20	0E0	93.55%	5	F:GO:0004930; P:GO:0007187; P:GO:0007608; C:GO:0016021; F:GO:0004984	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:sensory perception of smell; C:integral component of membrane; F:olfactory receptor activity		IPR000725 (PRINTS); IPR000276 (PRINTS); PF13853 (PFAM); G3DSA:1.20.1070.10 (GENE3D); PTHR26453 (PANTHER); IPR030779 (PTHR26453:PANTHER); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR017452 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY)
gi|194212847|ref|XP_001501860.2|	von Willebrand factor A domain-containing 5A	781	20	0E0	88.35%	2	C:GO:0005634; C:GO:0005654	C:nucleus; C:nucleoplasm		IPR013694 (SMART); IPR002035 (SMART); IPR013694 (PFAM); IPR002035 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); PTHR10338:SF100 (PANTHER); PTHR10338 (PANTHER); IPR002035 (PROSITE_PROFILES); IPR013694 (PROSITE_PROFILES); IPR002035 (SUPERFAMILY)
gi|194212968|ref|XP_001502415.2|	RNA pseudouridylate synthase domain-containing 4	377	20	0E0	92.55%	3	P:GO:0001522; F:GO:0003723; F:GO:0009982	P:pseudouridine synthesis; F:RNA binding; F:pseudouridine synthase activity	EC:5.4.99.12	IPR006145 (PFAM); PTHR11079:SF80 (PANTHER); PTHR11079 (PANTHER); IPR006224 (PROSITE_PATTERNS); IPR020103 (SUPERFAMILY)
gi|194213322|ref|XP_001495255.2|	EGF-like module-containing mucin-like hormone receptor-like 3	656	20	0E0	74.3%	4	F:GO:0004930; P:GO:0007186; C:GO:0016021; P:GO:0007166	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway; C:integral component of membrane; P:cell surface receptor signaling pathway		IPR000832 (PRINTS); IPR001740 (PRINTS); IPR000203 (SMART); IPR000832 (PFAM); IPR000203 (PFAM); G3DSA:2.10.25.10 (GENE3D); G3DSA:3.40.50.2300 (GENE3D); PTHR12011 (PANTHER); PTHR12011:SF295 (PANTHER); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR017981 (PROSITE_PROFILES); IPR000203 (PROSITE_PROFILES); IPR028082 (SUPERFAMILY)
gi|194213487|ref|XP_001496635.2|	short transient receptor potential channel 2-like	1262	20	0E0	93.1%	16	F:GO:0015279; P:GO:0055085; F:GO:0005262; P:GO:0051480; F:GO:0003684; P:GO:0006810; P:GO:0007338; P:GO:0000012; C:GO:0005634; C:GO:0005887; F:GO:0005216; P:GO:0006811; P:GO:0006828; C:GO:0016020; C:GO:0016021; P:GO:0070588	F:store-operated calcium channel activity; P:transmembrane transport; F:calcium channel activity; P:regulation of cytosolic calcium ion concentration; F:damaged DNA binding; P:transport; P:single fertilization; P:single strand break repair; C:nucleus; C:integral component of plasma membrane; F:ion channel activity; P:ion transport; P:manganese ion transport; C:membrane; C:integral component of membrane; P:calcium ion transmembrane transport		
gi|194213731|ref|XP_001918122.1|	protocadherin-16	3293	20	0E0	97.15%	3	F:GO:0005509; P:GO:0007156; C:GO:0005886	F:calcium ion binding; P:homophilic cell adhesion via plasma membrane adhesion molecules; C:plasma membrane		IPR002126 (PRINTS); IPR002126 (SMART); IPR002126 (PFAM); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (G3DSA:2.60.40.GENE3D); PTHR24027:SF335 (PANTHER); PTHR24027 (PANTHER); IPR020894 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR002126 (PROSITE_PROFILES); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY)
gi|194213846|ref|XP_001501212.2|	polypeptide N-acetylgalactosaminyltransferase 18	605	20	0E0	96.85%	10	F:GO:0016757; F:GO:0046872; C:GO:0016020; C:GO:0016021; P:GO:0006486; C:GO:0005794; C:GO:0000139; F:GO:0016740; F:GO:0030246; F:GO:0004653	F:transferase activity, transferring glycosyl groups; F:metal ion binding; C:membrane; C:integral component of membrane; P:protein glycosylation; C:Golgi apparatus; C:Golgi membrane; F:transferase activity; F:carbohydrate binding; F:polypeptide N-acetylgalactosaminyltransferase activity		IPR000772 (SMART); G3DSA:2.80.10.50 (GENE3D); IPR000772 (PFAM); IPR029044 (G3DSA:3.90.550.GENE3D); IPR001173 (PFAM); PTHR11675 (PANTHER); PTHR11675:SF37 (PANTHER); IPR000772 (PROSITE_PROFILES); IPR000772 (SUPERFAMILY); IPR029044 (SUPERFAMILY)
gi|194213863|ref|XP_001501470.2|	cGMP-inhibited 3 ,5 -cyclic phosphodiesterase B	1070	20	0E0	93.95%	3	P:GO:0007165; P:GO:0006144; F:GO:0004114	P:signal transduction; P:purine nucleobase metabolic process; F:3',5'-cyclic-nucleotide phosphodiesterase activity	EC:3.1.4; EC:3.1.4.17; EC:3.1	IPR003607 (SMART); IPR002073 (G3DSA:1.10.1300.GENE3D); IPR002073 (PFAM); PTHR11347:SF29 (PANTHER); PTHR11347 (PANTHER); IPR023174 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SSF109604 (SUPERFAMILY)
gi|194214017|ref|XP_001915304.1|		1654				1	F:GO:0005515	F:protein binding		IPR003961 (SMART); IPR001452 (SMART); G3DSA:2.30.30.40 (GENE3D); IPR011511 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR14234:SF21 (PANTHER); PTHR14234 (PANTHER); IPR003961 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR003961 (SUPERFAMILY); IPR001452 (SUPERFAMILY); IPR001452 (SUPERFAMILY); IPR001452 (SUPERFAMILY)
gi|194214484|ref|XP_001914776.1|	ralA-binding 1	655	20	0E0	98%	1	P:GO:0007165	P:signal transduction		IPR000198 (SMART); IPR000198 (G3DSA:1.10.555.GENE3D); IPR000198 (PFAM); PTHR12783 (PANTHER); IPR000198 (PROSITE_PROFILES); IPR008936 (SUPERFAMILY)
gi|194214554|ref|XP_001493930.2|	myomesin-1 isoform X1	1693	20	0E0	95.05%	1	F:GO:0005515	F:protein binding		PR00014 (PRINTS); IPR003598 (SMART); IPR003599 (SMART); IPR003961 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013098 (PFAM); IPR003961 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR13817 (PANTHER); IPR003961 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|194214732|ref|XP_001490881.2|	serpin B3-like	390	20	0E0	89.95%	1	C:GO:0005615	C:extracellular space		IPR023796 (SMART); G3DSA:2.30.39.10 (GENE3D); IPR023796 (PFAM); G3DSA:3.30.497.10 (GENE3D); PTHR11461:SF186 (PANTHER); IPR000215 (PANTHER); IPR023795 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR023796 (SUPERFAMILY)
gi|194214902|ref|XP_001497314.2|	proenkephalin-A	327	20	0E0	93.35%	1	P:GO:0007218	P:neuropeptide signaling pathway		IPR006024 (PRINTS); IPR000703 (PRINTS); IPR006024 (PFAM); IPR006024 (PANTHER); IPR000703 (PTHR11438:PANTHER)
gi|194215555|ref|XP_001499917.2|	DNA repair XRCC1	630	20	0E0	94.1%	3	P:GO:0000012; C:GO:0005634; F:GO:0003684	P:single strand break repair; C:nucleus; F:damaged DNA binding		IPR001357 (SMART); IPR001357 (PFAM); IPR008979 (G3DSA:2.60.120.GENE3D); IPR001357 (G3DSA:3.40.50.GENE3D); IPR001357 (PFAM); IPR002706 (PFAM); PTHR11370:SF3 (PANTHER); PTHR11370 (PANTHER); IPR001357 (PROSITE_PROFILES); IPR001357 (SUPERFAMILY); IPR001357 (SUPERFAMILY); IPR008979 (SUPERFAMILY)
gi|194216279|ref|XP_001503899.2|	MMS22-like	1241	20	0E0	95.05%	6	C:GO:0035101; C:GO:0043596; P:GO:0000724; P:GO:0031297; C:GO:0042555; C:GO:0005654	C:FACT complex; C:nuclear replication fork; P:double-strand break repair via homologous recombination; P:replication fork processing; C:MCM complex; C:nucleoplasm		IPR029424 (PFAM); IPR029425 (PFAM); PTHR28547 (PANTHER)
gi|194216626|ref|XP_001915704.1|	signal recognition particle subunit SRP68	623	20	0E0	95.85%	6	F:GO:0030942; F:GO:0005515; P:GO:0006614; F:GO:0008312; F:GO:0005047; C:GO:0005786	F:endoplasmic reticulum signal peptide binding; F:protein binding; P:SRP-dependent cotranslational protein targeting to membrane; F:7S RNA binding; F:signal recognition particle binding; C:signal recognition particle, endoplasmic reticulum targeting		IPR026258 (PIRSF); IPR026258 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR12860 (PANTHER)
gi|194216997|ref|XP_001497807.2|	cell division control 6 homolog isoform X1	560	20	0E0	96.3%	3	P:GO:0051301; F:GO:0005524; P:GO:0006270	P:cell division; F:ATP binding; P:DNA replication initiation		IPR015163 (SMART); IPR016314 (PIRSF); IPR003593 (SMART); IPR015163 (PFAM); G3DSA:1.10.8.60 (GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003959 (PFAM); PTHR10763:SF26 (PANTHER); PTHR10763 (PANTHER); IPR027417 (SUPERFAMILY); IPR011991 (SUPERFAMILY)
gi|194217375|ref|XP_001918376.1|	nuclear fragile X mental retardation-interacting 2	696	20	0E0	98.05%	1	F:GO:0003723	F:RNA binding		IPR032747 (PFAM); IPR032747 (PANTHER); PTHR28333:SF2 (PANTHER)
gi|194217560|ref|XP_001918158.1|	acetylcholine receptor subunit epsilon	491	20	0E0	95.05%	5	F:GO:0004889; P:GO:0006812; C:GO:0045211; P:GO:0007165; C:GO:0016021	F:acetylcholine-activated cation-selective channel activity; P:cation transport; C:postsynaptic membrane; P:signal transduction; C:integral component of membrane		IPR006201 (PRINTS); IPR002394 (PRINTS); IPR006202 (G3DSA:2.70.170.GENE3D); IPR006029 (PFAM); IPR027361 (G3DSA:1.20.120.GENE3D); IPR006202 (PFAM); PTHR18945:SF59 (PANTHER); IPR006201 (PANTHER); IPR018000 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR006029 (SUPERFAMILY); IPR006202 (SUPERFAMILY)
gi|194217815|ref|XP_001914756.1|	ankyrin repeat and BTB POZ domain-containing 2	839	20	0E0	97.25%	1	F:GO:0046982	F:protein heterodimerization activity		IPR000210 (SMART); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR000210 (PFAM); G3DSA:3.30.710.10 (GENE3D); PTHR24413 (PANTHER); PTHR24413:SF102 (PANTHER); IPR000210 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR009072 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR011333 (SUPERFAMILY)
gi|194218566|ref|XP_001492479.2|	tesmin	383	20	0E0	94%	2	C:GO:0005634; C:GO:0005737	C:nucleus; C:cytoplasm		IPR033467 (SMART); IPR005172 (PFAM); IPR028307 (PANTHER); PTHR12446:SF22 (PANTHER); IPR005172 (PROSITE_PROFILES)
gi|194219004|ref|XP_001500885.2|	zinc finger 646	1823	20	0E0	92.05%	2	F:GO:0003676; F:GO:0046872	F:nucleic acid binding; F:metal ion binding		IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24402 (PANTHER); PTHR24402:SF226 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|194219165|ref|XP_001491811.2|	ATP-binding cassette sub-family A member 3-like	1677	20	0E0	83.8%	11	F:GO:0000166; F:GO:0016887; P:GO:0006869; F:GO:0005524; F:GO:0042626; P:GO:0055085; C:GO:0043231; C:GO:0016020; C:GO:0016021; P:GO:0006810; F:GO:0005215	F:nucleotide binding; F:ATPase activity; P:lipid transport; F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:intracellular membrane-bounded organelle; C:membrane; C:integral component of membrane; P:transport; F:transporter activity		
gi|194219389|ref|XP_001915287.1|	telomere length regulation TEL2 homolog	821	20	0E0	91.35%	1	F:GO:0005488	F:binding		IPR011989 (G3DSA:1.25.10.GENE3D); IPR019337 (PFAM); PTHR15830 (PANTHER); IPR016024 (SUPERFAMILY)
gi|194219444|ref|XP_001915458.1|	39S ribosomal mitochondrial	258	20	0E0	96.3%	3	F:GO:0003735; P:GO:0042254; C:GO:0005840	F:structural constituent of ribosome; P:ribosome biogenesis; C:ribosome		IPR026569 (PFAM); G3DSA:2.30.170.40 (GENE3D); IPR026569 (PANTHER); PTHR13528:SF2 (PANTHER); SSF143800 (SUPERFAMILY)
gi|194219486|ref|XP_001916813.1|	vascular endothelial growth factor receptor 3	1533	20	0E0	95.2%	6	C:GO:0005887; F:GO:0005524; P:GO:0048010; F:GO:0005515; F:GO:0005021; P:GO:0006468	C:integral component of plasma membrane; F:ATP binding; P:vascular endothelial growth factor receptor signaling pathway; F:protein binding; F:vascular endothelial growth factor-activated receptor activity; P:protein phosphorylation	EC:2.7.10; EC:2.7.10.1; EC:2.7.11	IPR009137 (PRINTS); PR01832 (PRINTS); IPR020635 (SMART); IPR003599 (SMART); IPR003598 (SMART); G3DSA:1.10.510.10 (GENE3D); PF13927 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001245 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR24416 (PANTHER); IPR009137 (PTHR24416:PANTHER); IPR001824 (PROSITE_PATTERNS); IPR008266 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000719 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|194219840|ref|XP_001502292.2|	protocadherin beta-2	798	20	0E0	94.1%	3	F:GO:0005509; P:GO:0007156; C:GO:0005886	F:calcium ion binding; P:homophilic cell adhesion via plasma membrane adhesion molecules; C:plasma membrane		IPR002126 (PRINTS); IPR002126 (SMART); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (PFAM); IPR013164 (PFAM); IPR032455 (PFAM); IPR002126 (G3DSA:2.60.40.GENE3D); IPR030735 (PTHR24028:PANTHER); PTHR24028 (PANTHER); IPR020894 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR002126 (PROSITE_PROFILES); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY)
gi|194220071|ref|XP_001918372.1|	G- coupled receptor 98	6301	20	0E0	95.05%	4	F:GO:0004930; P:GO:0007186; C:GO:0016021; P:GO:0007166	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway; C:integral component of membrane; P:cell surface receptor signaling pathway		IPR003644 (SMART); IPR006558 (SMART); IPR000832 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); IPR005492 (PFAM); PF13385 (PFAM); IPR003644 (PFAM); IPR026919 (PTHR11878:PANTHER); PTHR11878 (PANTHER); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR017981 (PROSITE_PROFILES); IPR000203 (PROSITE_PROFILES); IPR009039 (PROSITE_PROFILES); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); IPR013320 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY); SSF141072 (SUPERFAMILY)
gi|194220540|ref|XP_001916921.1|	dynein heavy chain axonemal	4151	20	0E0	96.4%	8	F:GO:0000166; F:GO:0016887; F:GO:0005524; F:GO:0003777; C:GO:0005858; P:GO:0001539; C:GO:0030286; P:GO:0007018	F:nucleotide binding; F:ATPase activity; F:ATP binding; F:microtubule motor activity; C:axonemal dynein complex; P:cilium or flagellum-dependent cell motility; C:dynein complex; P:microtubule-based movement		
gi|194221296|ref|XP_001494092.2|	macrophage-stimulating receptor isoform X1	1401	20	0E0	96.1%	6	F:GO:0005524; F:GO:0005515; F:GO:0004714; C:GO:0016021; P:GO:0007169; P:GO:0006468	F:ATP binding; F:protein binding; F:transmembrane receptor protein tyrosine kinase activity; C:integral component of membrane; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:protein phosphorylation	EC:2.7.10; EC:2.7.10.1; EC:2.7.11	IPR001245 (PRINTS); IPR002909 (SMART); IPR016201 (SMART); IPR001627 (SMART); IPR020635 (SMART); IPR016244 (PIRSF); G3DSA:3.30.1680.10 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); IPR001627 (PFAM); G3DSA:3.30.200.20 (GENE3D); IPR001245 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR24416 (PANTHER); PTHR24416:SF113 (PANTHER); IPR008266 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000719 (PROSITE_PROFILES); IPR001627 (PROSITE_PROFILES); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR001627 (SUPERFAMILY); SSF103575 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR014756 (SUPERFAMILY)
gi|194221375|ref|XP_001495556.2|	tyrosine- phosphatase non-receptor type 23	1639	20	0E0	95.3%	7	F:GO:0005515; P:GO:0060271; P:GO:0006570; F:GO:0004725; P:GO:0043162; P:GO:0006470; P:GO:0030334	F:protein binding; P:cilium morphogenesis; P:tyrosine metabolic process; F:protein tyrosine phosphatase activity; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:protein dephosphorylation; P:regulation of cell migration	EC:3.1.3.16; EC:3.1; EC:3.1.3.48; EC:3.1.3.41	IPR000242 (PRINTS); IPR000242 (SMART); IPR003595 (SMART); IPR004328 (SMART); IPR000242 (PFAM); IPR025304 (PFAM); IPR004328 (PFAM); IPR004328 (G3DSA:1.25.40.GENE3D); G3DSA:1.20.140.50 (GENE3D); IPR029021 (G3DSA:3.90.190.GENE3D); IPR028770 (PTHR19134:PANTHER); PTHR19134 (PANTHER); IPR016130 (PROSITE_PATTERNS); IPR004328 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); IPR029021 (SUPERFAMILY)
gi|194221387|ref|XP_001916603.1|	neurobeachin 2	2748	20	0E0	96.05%	1	F:GO:0005515	F:protein binding		IPR001680 (SMART); IPR000409 (SMART); IPR023362 (G3DSA:2.30.29.GENE3D); IPR031570 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PF16057 (PFAM); IPR023362 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR001680 (PFAM); IPR000409 (G3DSA:1.10.1540.GENE3D); IPR000409 (PFAM); IPR026916 (PTHR13743:PANTHER); PTHR13743 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR000409 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR000409 (SUPERFAMILY); IPR017986 (SUPERFAMILY)
gi|194221478|ref|XP_001498347.2|	WD repeat-containing 48	677	20	0E0	99.45%	1	F:GO:0005515	F:protein binding		IPR020472 (PRINTS); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR021772 (PFAM); IPR001680 (PFAM); PTHR19862:SF14 (PANTHER); PTHR19862 (PANTHER); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY)
gi|194221647|ref|XP_001495466.2|	phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	1070	20	0E0	98.25%	4	F:GO:0005515; P:GO:0048015; P:GO:0046854; F:GO:0016301	F:protein binding; P:phosphatidylinositol-mediated signaling; P:phosphatidylinositol phosphorylation; F:kinase activity		IPR000341 (SMART); IPR002420 (SMART); IPR000403 (SMART); IPR001263 (SMART); IPR003113 (SMART); IPR001263 (PFAM); IPR000403 (G3DSA:1.10.1070.GENE3D); IPR000008 (G3DSA:2.60.40.GENE3D); G3DSA:3.10.20.90 (GENE3D); IPR000403 (PFAM); IPR000341 (PFAM); IPR001263 (G3DSA:1.25.40.GENE3D); IPR003113 (PFAM); G3DSA:3.10.20.90 (GENE3D); G3DSA:3.30.1010.10 (GENE3D); IPR002420 (PFAM); IPR015433 (PANTHER); PTHR10048:SF33 (PANTHER); IPR018936 (PROSITE_PATTERNS); IPR018936 (PROSITE_PATTERNS); IPR002420 (PROSITE_PROFILES); IPR000403 (PROSITE_PROFILES); IPR003113 (PROSITE_PROFILES); IPR000341 (PROSITE_PROFILES); IPR001263 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR029071 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR000008 (SUPERFAMILY)
gi|194222025|ref|XP_001493130.2|	tripeptidyl-peptidase 2 isoform X2	1288	20	0E0	94.5%	2	P:GO:0006508; F:GO:0004252	P:proteolysis; F:serine-type endopeptidase activity	EC:3.4.21	IPR015500 (PRINTS); IPR022229 (PFAM); IPR000209 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); IPR015500 (PANTHER); IPR022398 (PROSITE_PATTERNS); IPR023828 (PROSITE_PATTERNS); IPR000209 (SUPERFAMILY)
gi|194222558|ref|XP_001493978.2|	60S ribosomal export NMD3 isoform X1	503	20	0E0	98.15%	11	P:GO:0000055; C:GO:0005634; C:GO:0005737; C:GO:0016020; P:GO:0015031; F:GO:0043023; C:GO:0005730; F:GO:0030674; P:GO:0006810; F:GO:0044822; C:GO:0005654	P:ribosomal large subunit export from nucleus; C:nucleus; C:cytoplasm; C:membrane; P:protein transport; F:ribosomal large subunit binding; C:nucleolus; F:protein binding, bridging; P:transport; F:poly(A) RNA binding; C:nucleoplasm		IPR007064 (PFAM); PTHR12746 (PANTHER)
gi|194222641|ref|XP_001915891.1|	ATP-binding cassette sub-family F member 3	709	20	0E0	98.95%	2	F:GO:0016887; F:GO:0005524	F:ATPase activity; F:ATP binding	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); IPR032781 (PFAM); PTHR19211:SF45 (PANTHER); PTHR19211 (PANTHER); IPR017871 (PROSITE_PATTERNS); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|194223472|ref|XP_001918189.1|	MAM domain-containing glycosylphosphatidylinositol anchor 1 isoform X2	957	20	0E0	97%	2	F:GO:0005515; C:GO:0016020	F:protein binding; C:membrane		IPR003599 (SMART); IPR000998 (SMART); IPR003598 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PF13927 (PFAM); IPR000998 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23282:SF66 (PANTHER); PTHR23282 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR000998 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|194223516|ref|XP_001497411.2|	cullin-7	1692	20	0E0	95.2%	6	F:GO:0031625; P:GO:0000226; C:GO:1990393; C:GO:0031467; P:GO:0006511; P:GO:0016567	F:ubiquitin protein ligase binding; P:microtubule cytoskeleton organization; C:3M complex; C:Cul7-RING ubiquitin ligase complex; P:ubiquitin-dependent protein catabolic process; P:protein ubiquitination		IPR004939 (SMART); IPR019559 (SMART); IPR021097 (PFAM); IPR004939 (PFAM); IPR008979 (G3DSA:2.60.120.GENE3D); IPR011989 (G3DSA:1.25.10.GENE3D); G3DSA:4.10.1030.10 (GENE3D); IPR014722 (G3DSA:2.30.30.GENE3D); IPR001373 (PFAM); IPR031223 (PTHR22771:PANTHER); PTHR22771 (PANTHER); IPR016158 (PROSITE_PROFILES); IPR004939 (PROSITE_PROFILES); SSF63748 (SUPERFAMILY); IPR016158 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR008979 (SUPERFAMILY)
gi|194223609|ref|XP_001918309.1|	serine threonine- kinase ICK	632	20	0E0	97.75%	3	F:GO:0005524; F:GO:0004672; P:GO:0006468	F:ATP binding; F:protein kinase activity; P:protein phosphorylation		IPR000719 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); PTHR24055 (PANTHER); PTHR24055:SF194 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)
gi|194223861|ref|XP_001492787.2|	DEP domain-containing 1B isoform X1	529	20	0E0	98.6%	1	P:GO:0035556	P:intracellular signal transduction		IPR000591 (SMART); IPR000591 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); IPR000198 (PFAM); IPR000198 (G3DSA:1.10.555.GENE3D); PTHR16206:SF11 (PANTHER); PTHR16206 (PANTHER); IPR000591 (PROSITE_PROFILES); IPR000198 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY); IPR008936 (SUPERFAMILY)
gi|194223911|ref|XP_001916769.1|	potassium sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	746	20	0E0	97.8%	5	F:GO:0005249; P:GO:0071805; C:GO:0008076; F:GO:0030552; P:GO:0035725	F:voltage-gated potassium channel activity; P:potassium ion transmembrane transport; C:voltage-gated potassium channel complex; F:cAMP binding; P:sodium ion transmembrane transport		IPR003938 (PRINTS); IPR000595 (SMART); G3DSA:1.10.287.630 (GENE3D); IPR005821 (PFAM); IPR014710 (G3DSA:2.60.120.GENE3D); IPR000595 (PFAM); G3DSA:1.10.287.70 (GENE3D); PTHR10217 (PANTHER); IPR030169 (PTHR10217:PANTHER); IPR018488 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000595 (PROSITE_PROFILES); IPR018490 (SUPERFAMILY); SSF81324 (SUPERFAMILY)
gi|194224024|ref|XP_001917420.1|	semaphorin-5A isoform X1	1073	20	0E0	98.1%	1	F:GO:0005515	F:protein binding		PR01705 (PRINTS); IPR000884 (SMART); IPR016201 (SMART); IPR001627 (SMART); IPR000884 (PFAM); IPR001627 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); G3DSA:3.30.1680.10 (GENE3D); G3DSA:2.20.100.10 (GENE3D); PTHR11036:SF78 (PANTHER); IPR027231 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR000884 (PROSITE_PROFILES); IPR001627 (PROSITE_PROFILES); IPR000884 (SUPERFAMILY); IPR001627 (SUPERFAMILY); SSF103575 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY)
gi|194224036|ref|XP_001501273.2|	tRNA (cytosine(34)-C(5))-methyltransferase	759	20	0E0	93.7%	3	F:GO:0016428; P:GO:0008033; P:GO:0009451	F:tRNA (cytosine-5-)-methyltransferase activity; P:tRNA processing; P:RNA modification	EC:2.1.1	IPR023270 (PRINTS); IPR023267 (PRINTS); IPR029063 (G3DSA:3.40.50.GENE3D); IPR001678 (PFAM); PTHR22808:SF11 (PANTHER); PTHR22808 (PANTHER); IPR001678 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY)
gi|194224122|ref|XP_001493966.2|	cysteine-rich 2-binding	780	20	0E0	98.4%	2	P:GO:0042967; F:GO:0008080	P:acyl-carrier-protein biosynthetic process; F:N-acetyltransferase activity	EC:2.3.1	IPR000182 (PFAM); IPR016181 (G3DSA:3.40.630.GENE3D); PTHR20916 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY)
gi|194224153|ref|XP_001493323.2|	ankyrin repeat and EF-hand domain-containing 1	776	20	0E0	95.9%	1	F:GO:0005515	F:protein binding		IPR002110 (PRINTS); IPR002110 (SMART); IPR002110 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PF13637 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR020683 (PFAM); PTHR24127 (PANTHER); PTHR24127:SF1 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR020683 (SUPERFAMILY)
gi|194224626|ref|XP_001491434.2|	solute carrier organic anion transporter family member 4A1	736	20	0E0	90.4%	4	F:GO:0005515; C:GO:0016020; P:GO:0006810; F:GO:0005215	F:protein binding; C:membrane; P:transport; F:transporter activity		G3DSA:1.20.1250.20 (GENE3D); IPR002350 (PFAM); G3DSA:3.30.60.30 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR004156 (TIGRFAM); IPR004156 (PFAM); IPR004156 (PANTHER); PTHR11388:SF100 (PANTHER); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR002350 (PROSITE_PROFILES); IPR020846 (PROSITE_PROFILES); SSF100895 (SUPERFAMILY); IPR020846 (SUPERFAMILY)
gi|194224891|ref|XP_001498226.2|	phospholipase A-2-activating	863	20	0E0	97.1%	1	F:GO:0005515	F:protein binding		IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015155 (PFAM); IPR013535 (PFAM); IPR001680 (PFAM); PTHR19849 (PANTHER); IPR033510 (PTHR19849:PANTHER); IPR017986 (PROSITE_PROFILES); IPR013535 (PROSITE_PROFILES); IPR015155 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY)
gi|194225029|ref|XP_001914895.1|	beclin 1-associated autophagy-related key regulator	492	20	0E0	98.1%	1	P:GO:0010508	P:positive regulation of autophagy		IPR018791 (PFAM); PTHR13664 (PANTHER); PTHR13664:SF0 (PANTHER)
gi|194225274|ref|XP_001494140.2|	26S protease regulatory subunit 4	440	20	0E0	99.8%	4	F:GO:0005524; C:GO:0005737; P:GO:0030163; F:GO:0016787	F:ATP binding; C:cytoplasm; P:protein catabolic process; F:hydrolase activity		IPR003593 (SMART); IPR005937 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.8.60 (GENE3D); IPR003959 (PFAM); PTHR23073 (PANTHER); IPR003960 (PROSITE_PATTERNS); IPR027417 (SUPERFAMILY)
gi|194225493|ref|XP_001497363.2|	bifunctional UDP-N-acetylglucosamine 2-epimerase N-acetylmannosamine kinase isoform X1	753	20	0E0	98.35%	3	P:GO:0005975; P:GO:0006047; F:GO:0004553	P:carbohydrate metabolic process; P:UDP-N-acetylglucosamine metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds		PR00475 (PRINTS); IPR020004 (TIGRFAM); G3DSA:3.40.50.2000 (GENE3D); IPR003331 (PFAM); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR000600 (PFAM); G3DSA:3.40.50.2000 (GENE3D); PTHR18964 (PANTHER); PTHR18964:SF10 (PANTHER); SSF53756 (SUPERFAMILY); SSF53067 (SUPERFAMILY)
gi|194225621|ref|XP_001916184.1|	von Willebrand factor type EGF and pentraxin domain-containing 1	3570	20	0E0	95.8%	2	F:GO:0005515; F:GO:0005509	F:protein binding; F:calcium ion binding		IPR001759 (PRINTS); IPR000436 (SMART); IPR002035 (SMART); IPR000742 (SMART); IPR001881 (SMART); IPR011641 (SMART); IPR001759 (SMART); IPR023413 (G3DSA:2.40.155.GENE3D); IPR013320 (G3DSA:2.60.120.GENE3D); IPR001759 (PFAM); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR001881 (PFAM); G3DSA:2.10.70.10 (GENE3D); IPR000436 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR002035 (G3DSA:3.40.50.GENE3D); IPR003410 (PFAM); G3DSA:2.10.70.10 (GENE3D); IPR013032 (PFAM); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); IPR011641 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR000742 (PFAM); IPR002035 (PFAM); G3DSA:2.10.25.10 (GENE3D); PTHR19325 (PANTHER); PTHR19325:SF43 (PANTHER); IPR013032 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR000742 (PROSITE_PROFILES); IPR002035 (PROSITE_PROFILES); IPR000436 (PROSITE_PROFILES); IPR003410 (PROSITE_PROFILES); SSF57196 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR002035 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY)
gi|194225623|ref|XP_001491573.2|	skeletal receptor tyrosine- kinase isoform X1	869	20	0E0	97.35%	4	F:GO:0005524; F:GO:0004713; F:GO:0005515; P:GO:0006468	F:ATP binding; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation	EC:2.7.10	IPR001245 (PRINTS); IPR003599 (SMART); IPR020635 (SMART); IPR003598 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR020067 (G3DSA:1.10.2000.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001245 (PFAM); PF13927 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR020067 (PFAM); IPR013098 (PFAM); G3DSA:3.30.200.20 (GENE3D); PTHR24416:SF317 (PANTHER); PTHR24416 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR008266 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000719 (PROSITE_PROFILES); IPR020067 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|194225681|ref|XP_001916657.1|	tenascin isoform X3	2109	20	0E0	90.5%	4	F:GO:0005515; P:GO:0007155; C:GO:0031012; P:GO:0042127	F:protein binding; P:cell adhesion; C:extracellular matrix; P:regulation of cell proliferation		IPR002181 (SMART); IPR000742 (SMART); IPR003961 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013032 (PFAM); IPR014715 (G3DSA:4.10.530.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002181 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR014716 (G3DSA:3.90.215.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013111 (PFAM); IPR003961 (PFAM); G3DSA:2.170.300.10 (GENE3D); IPR033078 (PTHR19143:PANTHER); PTHR19143 (PANTHER); IPR013032 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); PD936484 (PRODOM); IPR000742 (PROSITE_PROFILES); IPR002181 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR002181 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY)
gi|194226459|ref|XP_001493923.2|	serine threonine- phosphatase 2A catalytic subunit beta isoform	309	20	0E0	99.35%	1	F:GO:0016787	F:hydrolase activity		IPR006186 (PRINTS); IPR006186 (SMART); IPR029052 (G3DSA:3.60.21.GENE3D); IPR004843 (PFAM); PTHR11668 (PANTHER); PTHR11668:SF279 (PANTHER); IPR006186 (PROSITE_PATTERNS); IPR029052 (SUPERFAMILY)
gi|194226638|ref|XP_001915085.1|	transmembrane and TPR repeat-containing 3	915	20	0E0	98.2%	1	F:GO:0005515	F:protein binding		IPR019734 (SMART); IPR001440 (PFAM); IPR019734 (PFAM); IPR019734 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR013618 (PFAM); PTHR23083:SF419 (PANTHER); PTHR23083 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); PS51257 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY)
gi|194226897|ref|XP_001502653.2|	meiosis inhibitor 1	1273	20	0E0	94.05%	1	F:GO:0005488	F:binding		PTHR12044 (PANTHER); PTHR12044:SF10 (PANTHER); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
gi|194226916|ref|XP_001500628.2|	CYP2D50	355	20	0E0	92.65%	10	F:GO:0016712; F:GO:0005506; F:GO:0016491; F:GO:0016705; F:GO:0046872; C:GO:0016020; C:GO:0016021; P:GO:0055114; F:GO:0004497; F:GO:0020037	F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:iron ion binding; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; F:metal ion binding; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding		
gi|194227172|ref|XP_001916636.1|	regulator of nonsense transcripts 2	1268	20	0E0	99.05%	2	F:GO:0003723; F:GO:0005515	F:RNA binding; F:protein binding		IPR003890 (SMART); IPR007193 (PFAM); IPR016021 (G3DSA:1.25.40.GENE3D); IPR003890 (PFAM); PTHR12839 (PANTHER); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
gi|194227183|ref|XP_001916967.1|	inter-alpha-trypsin inhibitor heavy chain H2	946	20	0E0	95.15%	2	F:GO:0004867; P:GO:0030212	F:serine-type endopeptidase inhibitor activity; P:hyaluronan metabolic process		IPR013694 (SMART); IPR002035 (SMART); IPR002035 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); IPR013694 (PFAM); IPR010600 (PFAM); PTHR10338:SF14 (PANTHER); PTHR10338 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR002035 (PROSITE_PROFILES); IPR013694 (PROSITE_PROFILES); IPR002035 (SUPERFAMILY)
gi|194227359|ref|XP_001915680.1|	usherin	5202	20	0E0	92.35%	1	F:GO:0005515	F:protein binding		PR00011 (PRINTS); IPR002049 (SMART); IPR003961 (SMART); IPR008211 (SMART); IPR006558 (SMART); IPR001791 (SMART); IPR013320 (G3DSA:2.60.120.GENE3D); IPR002049 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR013320 (G3DSA:2.60.120.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001791 (PFAM); IPR003961 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PF13385 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR008211 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR026915 (PTHR10574:PANTHER); PTHR10574 (PANTHER); IPR002049 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR003961 (PROSITE_PROFILES); IPR001791 (PROSITE_PROFILES); IPR008211 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY)
gi|194227931|ref|XP_001917445.1|	diacylglycerol kinase kappa	1260	20	0E0	92.2%	5	P:GO:0046486; P:GO:0009395; F:GO:0004143; P:GO:0007205; P:GO:0035556	P:glycerolipid metabolic process; P:phospholipid catabolic process; F:diacylglycerol kinase activity; P:protein kinase C-activating G-protein coupled receptor signaling pathway; P:intracellular signal transduction	EC:2.7.1.107	PR01217 (PRINTS); IPR000756 (SMART); IPR002219 (SMART); IPR001849 (SMART); IPR001206 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); IPR001206 (PFAM); IPR002219 (PFAM); IPR001849 (PFAM); G3DSA:3.30.60.20 (GENE3D); IPR000756 (PFAM); G3DSA:3.30.60.20 (GENE3D); PTHR11255 (PANTHER); PTHR11255:SF33 (PANTHER); IPR001206 (PROSITE_PROFILES); IPR002219 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR016064 (SUPERFAMILY); SSF57889 (SUPERFAMILY); SSF57889 (SUPERFAMILY)
gi|194228045|ref|XP_001505030.2|	KIAA2022 homolog	1515	20	0E0	96.1%	1	C:GO:0005634	C:nucleus		IPR032757 (PFAM); PTHR10322 (PANTHER); PTHR10322:SF22 (PANTHER)
gi|194228182|ref|XP_001492854.2|	RNA-binding 41 isoform X2	413	20	0E0	97.6%	2	F:GO:0000166; F:GO:0003676	F:nucleotide binding; F:nucleic acid binding		IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR16105:SF2 (PANTHER); PTHR16105 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY)
gi|194228229|ref|XP_001914740.1|	membrane-associated progesterone receptor component 1	195	20	2.2E-139	97.4%	12	C:GO:0005789; C:GO:0070062; C:GO:0043231; C:GO:0016020; C:GO:0016021; C:GO:0012505; C:GO:0005783; F:GO:0008289; F:GO:0005496; C:GO:0005730; C:GO:0031090; F:GO:0020037	C:endoplasmic reticulum membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:integral component of membrane; C:endomembrane system; C:endoplasmic reticulum; F:lipid binding; F:steroid binding; C:nucleolus; C:organelle membrane; F:heme binding		IPR001199 (SMART); IPR001199 (G3DSA:3.10.120.GENE3D); IPR001199 (PFAM); PTHR10281:SF23 (PANTHER); PTHR10281 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR001199 (SUPERFAMILY)
gi|194228591|ref|XP_001494126.2|	DNA-apurinic or apyrimidinic site lyase 2	512	20	0E0	93.3%	5	F:GO:0003677; P:GO:0006281; F:GO:0008270; F:GO:0004519; C:GO:0005622	F:DNA binding; P:DNA repair; F:zinc ion binding; F:endonuclease activity; C:intracellular	EC:3.1	IPR004808 (TIGRFAM); IPR005135 (PFAM); IPR010666 (PFAM); IPR005135 (G3DSA:3.60.10.GENE3D); IPR004808 (PANTHER); PTHR22748:SF4 (PANTHER); IPR020847 (PROSITE_PATTERNS); IPR004808 (PROSITE_PROFILES); IPR005135 (SUPERFAMILY)
gi|253720356|gb|ACT33419.1|	DNA dC-	224	20	5.5E-169	80.95%	3	F:GO:0008270; F:GO:0016814; P:GO:0006807	F:zinc ion binding; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines; P:nitrogen compound metabolic process		G3DSA:3.40.140.10 (GENE3D); IPR013158 (PFAM); PTHR13857 (PANTHER); PTHR13857:SF20 (PANTHER); IPR016192 (PROSITE_PATTERNS); IPR002125 (PROSITE_PROFILES); IPR016193 (SUPERFAMILY)
gi|255522899|ref|NP_001157353.1|	urokinase plasminogen activator surface receptor	334	20	0E0	85.65%	19	F:GO:0019904; P:GO:0030162; P:GO:0090200; P:GO:0045742; P:GO:0038195; P:GO:0043388; F:GO:0005102; C:GO:0005886; C:GO:0005887; C:GO:0070062; C:GO:0005925; P:GO:0043066; P:GO:0001934; P:GO:0016310; P:GO:2001243; F:GO:0030377; F:GO:0016301; F:GO:0019899; P:GO:2001268	F:protein domain specific binding; P:regulation of proteolysis; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of epidermal growth factor receptor signaling pathway; P:urokinase plasminogen activator signaling pathway; P:positive regulation of DNA binding; F:receptor binding; C:plasma membrane; C:integral component of plasma membrane; C:extracellular exosome; C:focal adhesion; P:negative regulation of apoptotic process; P:positive regulation of protein phosphorylation; P:phosphorylation; P:negative regulation of intrinsic apoptotic signaling pathway; F:urokinase plasminogen activator receptor activity; F:kinase activity; F:enzyme binding; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway		
gi|261291941|gb|ACX69975.1|	polymeric immunoglobulin receptor	764	20	0E0	82%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR11860:SF55 (PANTHER); PTHR11860 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300386573|gb|ADK09317.1|	immunoglobulin heavy chain V-D-J partial	175	20	5.31E-124	89.35%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386595|gb|ADK09328.1|	immunoglobulin heavy chain V-D-J partial	178	20	2.46E-124	84.75%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386623|gb|ADK09341.1|	immunoglobulin heavy chain V-D-J partial	180	20	3.31E-128	84.7%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); PTHR23266:SF105 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386627|gb|ADK09343.1|	immunoglobulin heavy chain V-D-J partial	176	20	1.62E-124	87.95%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386641|gb|ADK09350.1|	immunoglobulin heavy chain V-D-J partial	172	20	2.15E-121	84.7%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386649|gb|ADK09354.1|	immunoglobulin heavy chain V-D-J partial	173	20	6.34E-124	88.55%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386674|gb|ADK09365.1|	immunoglobulin heavy chain V-D-J partial	175	20	9.3E-124	89.75%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386684|gb|ADK09370.1|	immunoglobulin heavy chain V-D-J partial	176	20	6.18E-125	86.1%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); PTHR23266:SF105 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386692|gb|ADK09373.1|	immunoglobulin heavy chain V-D-J partial	183	20	1.2E-129	82.05%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386702|gb|ADK09378.1|	immunoglobulin heavy chain V-D-J partial	175	20	2.8E-125	88.55%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386706|gb|ADK09380.1|	immunoglobulin heavy chain V-D-J partial	180	20	3.95E-128	87.55%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386710|gb|ADK09382.1|	immunoglobulin heavy chain V-D-J partial	176	20	6.81E-126	88%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266:SF105 (PANTHER); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386714|gb|ADK09384.1|	immunoglobulin heavy chain V-D-J partial	184	20	1.05E-130	85.85%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266:SF105 (PANTHER); PTHR23266 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386720|gb|ADK09387.1|	immunoglobulin heavy chain V-D-J partial	173	20	2.5E-122	86.75%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386743|gb|ADK09398.1|	immunoglobulin heavy chain V-D-J partial	175	20	5.93E-124	87.75%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386745|gb|ADK09399.1|	immunoglobulin heavy chain V-D-J partial	175	20	1.2E-123	88.7%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386747|gb|ADK09400.1|	immunoglobulin heavy chain V-D-J partial	173	20	1.01E-120	86%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); PTHR23266:SF105 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386758|gb|ADK09405.1|	immunoglobulin heavy chain V-D-J partial	179	20	5.82E-127	87.7%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386764|gb|ADK09408.1|	immunoglobulin heavy chain V-D-J partial	171	20	1.74E-123	82.8%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386780|gb|ADK09415.1|	immunoglobulin heavy chain V-D-J partial	176	20	8.04E-125	87.65%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386788|gb|ADK09419.1|	immunoglobulin heavy chain V-D-J partial	176	20	3.54E-123	87%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); PTHR23266:SF105 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386794|gb|ADK09422.1|	immunoglobulin heavy chain V-D-J partial	175	20	3.87E-123	86%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386806|gb|ADK09428.1|	immunoglobulin heavy chain V-D-J partial	175	20	2.52E-124	86.25%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386808|gb|ADK09429.1|	immunoglobulin heavy chain V-D-J partial	175	20	3.58E-124	87.65%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386814|gb|ADK09432.1|	immunoglobulin heavy chain V-D-J partial	173	20	3.64E-122	86.25%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386828|gb|ADK09439.1|	immunoglobulin heavy chain V-D-J partial	170	20	3.91E-120	87.85%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386840|gb|ADK09445.1|	immunoglobulin heavy chain V-D-J partial	177	20	6.15E-127	84.6%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386842|gb|ADK09446.1|	immunoglobulin heavy chain V-D-J partial	177	20	4.74E-126	87.25%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266:SF105 (PANTHER); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386853|gb|ADK09451.1|	immunoglobulin heavy chain V-D-J partial	175	20	5.75E-123	84.15%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386861|gb|ADK09455.1|	immunoglobulin heavy chain V-D-J partial	175	20	1.62E-124	84.75%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); PTHR23266:SF105 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386865|gb|ADK09457.1|	immunoglobulin heavy chain V-D-J partial	177	20	6.88E-126	86.35%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386869|gb|ADK09459.1|	immunoglobulin heavy chain V-D-J partial	176	20	1.45E-125	85.4%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386875|gb|ADK09462.1|	immunoglobulin heavy chain V-D-J partial	177	20	1.3E-125	87.9%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386877|gb|ADK09463.1|	immunoglobulin heavy chain V-D-J partial	179	20	1.59E-127	86.9%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); PTHR23266:SF105 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386881|gb|ADK09465.1|	immunoglobulin heavy chain V-D-J partial	177	20	1.05E-126	87.4%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386885|gb|ADK09467.1|	immunoglobulin heavy chain V-D-J partial	178	20	2.4E-126	86.7%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); PTHR23266:SF105 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386903|gb|ADK09476.1|	immunoglobulin heavy chain V-D-J partial	176	20	1.08E-125	94.05%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300386960|gb|ADK09504.1|	immunoglobulin heavy chain V-D-J partial	174	20	2.79E-123	86.45%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|300387335|gb|ADK09686.1|	immmunoglobulin lambda light chain variable partial	208	20	1.86E-146	93%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF198 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387343|gb|ADK09690.1|	immmunoglobulin lambda light chain variable partial	207	20	7.5E-146	94.35%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR003597 (SMART); IPR013106 (PFAM); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387363|gb|ADK09700.1|	immmunoglobulin lambda light chain variable partial	209	20	1.08E-145	92.2%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013106 (PFAM); PTHR23267:SF198 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387368|gb|ADK09702.1|	immunoglobulin lambda light chain V-J partial	208	20	9E-149	88.8%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR003597 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387373|gb|ADK09704.1|	immunoglobulin lambda light chain V-J partial	209	20	8.46E-146	93.15%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR003597 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013106 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF198 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387379|gb|ADK09707.1|	immunoglobulin lambda light chain V-J partial	208	20	9.21E-148	91.75%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR003597 (SMART); IPR013106 (PFAM); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF198 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387381|gb|ADK09708.1|	immmunoglobulin lambda light chain variable partial	218	20	4.42E-155	93.05%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR003597 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387402|gb|ADK09718.1|	immunoglobulin lambda light chain V-J partial	218	20	1.65E-154	90.55%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR003597 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387412|gb|ADK09723.1|	immunoglobulin lambda light chain V-J partial	218	20	7.92E-154	92.1%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013106 (SMART); IPR003599 (SMART); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF198 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387414|gb|ADK09724.1|	immunoglobulin lambda light chain V-J partial	215	20	7.36E-151	91.75%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003597 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013106 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF198 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387439|gb|ADK09736.1|	immunoglobulin lambda light chain V-J partial	197	20	1.81E-139	91.15%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR003597 (PFAM); PTHR23267:SF187 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387449|gb|ADK09741.1|	immunoglobulin lambda light chain V-J partial	205	20	3.6E-145	93.6%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF198 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387477|gb|ADK09755.1|	immunoglobulin lambda light chain V-J partial	203	20	5.03E-142	93.7%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF198 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387483|gb|ADK09758.1|	immmunoglobulin lambda light chain variable partial	214	20	3.13E-151	93.6%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF198 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387487|gb|ADK09759.1|	immunoglobulin lambda light chain V-J partial	216	20	2.12E-153	93.35%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF198 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387496|gb|ADK09763.1|	immmunoglobulin lambda light chain variable partial	215	20	1.22E-152	93.45%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF198 (PANTHER); PTHR23267 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387508|gb|ADK09769.1|	immunoglobulin lambda light chain V-J partial	215	20	6.41E-155	90.5%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003597 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387512|gb|ADK09771.1|	immmunoglobulin lambda light chain variable partial	215	20	7.84E-153	92.7%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF198 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387516|gb|ADK09773.1|	immmunoglobulin lambda light chain variable partial	212	20	8.42E-149	91.8%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF198 (PANTHER); PTHR23267 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387518|gb|ADK09774.1|	immmunoglobulin lambda light chain variable partial	205	20	2.53E-146	88.25%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR003597 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387526|gb|ADK09778.1|	immunoglobulin lambda light chain V-J partial	205	20	3.27E-144	92.1%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR003597 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387533|gb|ADK09781.1|	immmunoglobulin lambda light chain variable partial	207	20	1.15E-147	92.25%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387547|gb|ADK09788.1|	immunoglobulin lambda light chain V-J partial	208	20	1.14E-146	91.3%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR003597 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387549|gb|ADK09789.1|	immunoglobulin lambda light chain V-J partial	206	20	1.17E-144	89.75%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003597 (SMART); IPR003599 (SMART); IPR003597 (PFAM); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387586|gb|ADK09807.1|	immunoglobulin lambda light chain V-J partial	207	20	1.67E-147	89.5%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003597 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR003597 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387592|gb|ADK09810.1|	immunoglobulin lambda light chain V-J partial	216	20	3.48E-153	88.2%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR003597 (SMART); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF161 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387597|gb|ADK09812.1|	immunoglobulin lambda light chain V-J partial	216	20	3.41E-153	89.8%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003597 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387611|gb|ADK09819.1|	immmunoglobulin lambda light chain variable partial	214	20	5.7E-153	90.8%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR003597 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387616|gb|ADK09821.1|	immmunoglobulin lambda light chain variable partial	213	20	4.03E-150	94.15%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR003597 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013106 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387624|gb|ADK09825.1|	immmunoglobulin lambda light chain variable partial	217	20	1.35E-154	93.1%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003597 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387626|gb|ADK09826.1|	immmunoglobulin lambda light chain variable partial	215	20	1.22E-152	92.65%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013106 (PFAM); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387630|gb|ADK09828.1|	immmunoglobulin lambda light chain variable partial	216	20	3.44E-153	93.2%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR003597 (SMART); IPR013106 (SMART); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387635|gb|ADK09830.1|	immunoglobulin lambda light chain V-J partial	208	20	2.98E-148	91.6%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013106 (SMART); IPR003599 (SMART); IPR003597 (PFAM); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF198 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387639|gb|ADK09832.1|	immmunoglobulin lambda light chain variable partial	217	20	3.72E-153	94.15%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR003597 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387643|gb|ADK09834.1|	immmunoglobulin lambda light chain variable partial	216	20	4.94E-153	93%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR003599 (SMART); IPR013106 (SMART); IPR003597 (PFAM); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387645|gb|ADK09835.1|	immmunoglobulin lambda light chain variable partial	218	20	4.01E-154	93.65%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR003597 (SMART); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF198 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387647|gb|ADK09836.1|	immunoglobulin lambda light chain V-J partial	217	20	2.45E-153	92.2%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003597 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387654|gb|ADK09839.1|	immunoglobulin lambda light chain V-J partial	218	20	4.33E-154	92.75%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF198 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387658|gb|ADK09841.1|	immmunoglobulin lambda light chain variable partial	217	20	9.95E-155	93.65%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR003597 (SMART); IPR013106 (PFAM); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387660|gb|ADK09842.1|	immunoglobulin lambda light chain V-J partial	218	20	5.37E-156	92.1%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR003597 (PFAM); PTHR23267:SF198 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387662|gb|ADK09843.1|	immmunoglobulin lambda light chain variable partial	218	20	6.28E-155	93.35%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003597 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF198 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387666|gb|ADK09845.1|	immmunoglobulin lambda light chain variable partial	216	20	6.35E-154	89.55%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003597 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387674|gb|ADK09849.1|	immmunoglobulin lambda light chain variable partial	208	20	1.44E-148	91.7%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR003597 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387676|gb|ADK09850.1|	immmunoglobulin lambda light chain variable partial	207	20	4.72E-147	92.1%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013106 (PFAM); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387680|gb|ADK09852.1|	immmunoglobulin lambda light chain variable partial	214	20	1.5E-151	91.65%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387688|gb|ADK09856.1|	immunoglobulin lambda light chain V-J partial	207	20	3.71E-147	89.1%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR003597 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF198 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387696|gb|ADK09860.1|	immunoglobulin lambda light chain V-J partial	203	20	6.38E-145	88.1%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR003597 (SMART); IPR013106 (SMART); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF161 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387698|gb|ADK09861.1|	immmunoglobulin lambda light chain variable partial	202	20	3.69E-144	85.7%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003597 (SMART); IPR003599 (SMART); IPR003597 (PFAM); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF174 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387700|gb|ADK09862.1|	immmunoglobulin lambda light chain variable partial	207	20	4.77E-148	83.5%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF174 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387718|gb|ADK09871.1|	immunoglobulin lambda light chain V-J partial	218	20	1.13E-152	91.95%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR003597 (SMART); IPR013106 (PFAM); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|300387728|gb|ADK09875.1|	immunoglobulin lambda light chain V-J partial	208	20	1.31E-146	92.05%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR003597 (SMART); IPR003597 (PFAM); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|310898521|emb|CBX51897.1|	Interferon-induced with tetratricopeptide repeats 1	435	20	0E0	90.85%	4	F:GO:0005515; P:GO:0071360; P:GO:0071357; P:GO:0050688	F:protein binding; P:cellular response to exogenous dsRNA; P:cellular response to type I interferon; P:regulation of defense response to virus		IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR019734 (PFAM); PF13424 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR019734 (PFAM); IPR024121 (PTHR10271:PANTHER); PTHR10271 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY)
gi|310898557|emb|CBX51913.1|	elongation of very long chain fatty acids 5 isoform X1	299	20	0E0	99%	6	P:GO:0042967; C:GO:0016021; P:GO:0042761; P:GO:0019367; C:GO:0009923; F:GO:0009922	P:acyl-carrier-protein biosynthetic process; C:integral component of membrane; P:very long-chain fatty acid biosynthetic process; P:fatty acid elongation, saturated fatty acid; C:fatty acid elongase complex; F:fatty acid elongase activity	EC:2.3.1.85	IPR002076 (PFAM); IPR002076 (PANTHER); IPR033677 (PTHR11157:PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR033677 (HAMAP)
gi|334962543|ref|NP_001229408.1|	chondroadherin isoform X1	733	20	0E0	90%	1	F:GO:0005515	F:protein binding		IPR003591 (SMART); SM00364 (SMART); IPR000483 (SMART); IPR000372 (SMART); IPR001611 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR24367:SF24 (PANTHER); PTHR24367 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR001611 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY); IPR032675 (SUPERFAMILY)
gi|335775038|gb|AEH58438.1|	cytochrome b-c1 complex subunit mitochondrial	453	20	0E0	96.8%	17	F:GO:0008270; C:GO:0043209; C:GO:0005750; P:GO:0006122; F:GO:0004222; C:GO:0005743; C:GO:0005654; C:GO:0070062; F:GO:0003824; F:GO:0046872; C:GO:0005739; P:GO:0006508; C:GO:0016020; P:GO:0016485; P:GO:0055114; P:GO:0009060; C:GO:0070469	F:zinc ion binding; C:myelin sheath; C:mitochondrial respiratory chain complex III; P:mitochondrial electron transport, ubiquinol to cytochrome c; F:metalloendopeptidase activity; C:mitochondrial inner membrane; C:nucleoplasm; C:extracellular exosome; F:catalytic activity; F:metal ion binding; C:mitochondrion; P:proteolysis; C:membrane; P:protein processing; P:oxidation-reduction process; P:aerobic respiration; C:respiratory chain		
gi|335775654|gb|AEH58644.1|	sorting nexin-2	458	20	0E0	99.65%	4	C:GO:0030904; F:GO:0035091; P:GO:0006886; P:GO:0006897	C:retromer complex; F:phosphatidylinositol binding; P:intracellular protein transport; P:endocytosis		IPR001683 (SMART); IPR001683 (G3DSA:3.30.1520.GENE3D); IPR015404 (PFAM); IPR001683 (PFAM); IPR027267 (G3DSA:1.20.1270.GENE3D); IPR005329 (PFAM); PTHR10555 (PANTHER); IPR028653 (PTHR10555:PANTHER); IPR001683 (PROSITE_PROFILES); SSF103657 (SUPERFAMILY); IPR001683 (SUPERFAMILY)
gi|338710456|ref|XP_001498078.3|	flavin reductase (NADPH)	207	20	3.36E-148	95.05%	9	F:GO:0042602; C:GO:0070062; C:GO:0005737; F:GO:0004074; C:GO:0005829; P:GO:0042167; P:GO:0055114; C:GO:0005886; C:GO:0005654	F:riboflavin reductase (NADPH) activity; C:extracellular exosome; C:cytoplasm; F:biliverdin reductase activity; C:cytosol; P:heme catabolic process; P:oxidation-reduction process; C:plasma membrane; C:nucleoplasm		IPR016040 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR15020 (PANTHER); PTHR15020:SF8 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR016040 (SUPERFAMILY)
gi|338710974|ref|XP_001918317.2|	probable ATP-dependent RNA helicase DHX40	779	20	0E0	99.05%	3	F:GO:0003676; F:GO:0005524; F:GO:0008026	F:nucleic acid binding; F:ATP binding; F:ATP-dependent helicase activity	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR001650 (SMART); IPR014001 (SMART); IPR007502 (SMART); IPR001650 (PFAM); IPR011709 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR007502 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011545 (PFAM); PTHR18934 (PANTHER); PTHR18934:SF114 (PANTHER); IPR002464 (PROSITE_PATTERNS); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
gi|338710993|ref|XP_001503831.2|	ubiquitin carboxyl-terminal hydrolase 32	1605	20	0E0	98.25%	7	F:GO:0004843; P:GO:0016579; C:GO:0005737; F:GO:0005509; C:GO:0005794; P:GO:0006511; F:GO:0036459	F:thiol-dependent ubiquitin-specific protease activity; P:protein deubiquitination; C:cytoplasm; F:calcium ion binding; C:Golgi apparatus; P:ubiquitin-dependent protein catabolic process; F:thiol-dependent ubiquitinyl hydrolase activity		
gi|338711599|ref|XP_003362550.1|	hematological and neurological expressed 1 isoform X2	181	20	1.06E-129	91.1%	3	C:GO:0005634; C:GO:0031965; C:GO:0005730	C:nucleus; C:nuclear membrane; C:nucleolus		IPR033335 (PANTHER); PTHR34930:SF3 (PANTHER)
gi|338711966|ref|XP_001492108.3|	UPF0606 KIAA1549L homolog	1856	20	0E0	87.15%	5	C:GO:0016020; C:GO:0016021; P:GO:0098779; P:GO:0002230; P:GO:0098792	C:membrane; C:integral component of membrane; P:mitophagy in response to mitochondrial depolarization; P:positive regulation of defense response to virus by host; P:xenophagy		IPR024606 (PFAM); IPR024606 (PANTHER); PTHR21590:SF3 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|338712085|ref|XP_001490892.3|	prothrombin	622	20	0E0	91.25%	5	F:GO:0005509; P:GO:0006508; F:GO:0004252; P:GO:0007596; C:GO:0005576	F:calcium ion binding; P:proteolysis; F:serine-type endopeptidase activity; P:blood coagulation; C:extracellular region	EC:3.4.21	IPR001314 (PRINTS); PR00018 (PRINTS); IPR000294 (PRINTS); IPR003966 (PRINTS); IPR003966 (PIRSF); IPR000001 (SMART); IPR001254 (SMART); IPR000294 (SMART); G3DSA:2.40.20.10 (GENE3D); IPR018992 (G3DSA:4.10.140.GENE3D); IPR018992 (PFAM); G3DSA:2.40.10.10 (GENE3D); IPR017857 (G3DSA:4.10.740.GENE3D); G3DSA:2.40.10.10 (GENE3D); IPR001254 (PFAM); G3DSA:2.40.10.10 (GENE3D); G3DSA:2.40.20.10 (GENE3D); IPR000001 (PFAM); IPR000294 (PFAM); IPR003966 (PTHR24254:PANTHER); PTHR24254 (PANTHER); IPR018114 (PROSITE_PATTERNS); IPR018056 (PROSITE_PATTERNS); IPR000294 (PROSITE_PATTERNS); IPR033116 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR000001 (PROSITE_PROFILES); IPR000294 (PROSITE_PROFILES); IPR001254 (PROSITE_PROFILES); IPR000294 (SUPERFAMILY); IPR009003 (SUPERFAMILY); IPR013806 (SUPERFAMILY); IPR013806 (SUPERFAMILY)
gi|338712256|ref|XP_001917588.2|	membrane-associated phosphatidylinositol transfer 1 isoform X1	1246	20	0E0	95.6%	3	F:GO:0046872; P:GO:0006810; C:GO:0005622	F:metal ion binding; P:transport; C:intracellular		IPR001666 (PRINTS); IPR004177 (SMART); IPR031315 (SMART); IPR023393 (G3DSA:3.30.530.GENE3D); IPR023214 (G3DSA:3.40.50.GENE3D); IPR004177 (PFAM); IPR001666 (PFAM); PTHR10658:SF40 (PANTHER); IPR001666 (PANTHER); IPR004177 (PROSITE_PROFILES); SSF55961 (SUPERFAMILY); IPR023214 (SUPERFAMILY)
gi|338712996|ref|XP_001499704.3|	periplakin	1811	20	0E0	96.3%	2	C:GO:0005856; C:GO:0070062	C:cytoskeleton; C:extracellular exosome		
gi|338713357|ref|XP_001918336.2|	probable ATP-dependent RNA helicase YTHDC2	1434	20	0E0	98.1%	18	P:GO:0044829; F:GO:0008186; P:GO:0006396; F:GO:0004386; C:GO:0005783; F:GO:0044822; F:GO:0004004; F:GO:0000166; F:GO:0070063; F:GO:0003676; C:GO:0005634; F:GO:0005524; F:GO:0003723; F:GO:1990247; C:GO:0005737; P:GO:0070555; P:GO:0034612; F:GO:0016787	P:positive regulation by host of viral genome replication; F:RNA-dependent ATPase activity; P:RNA processing; F:helicase activity; C:endoplasmic reticulum; F:poly(A) RNA binding; F:ATP-dependent RNA helicase activity; F:nucleotide binding; F:RNA polymerase binding; F:nucleic acid binding; C:nucleus; F:ATP binding; F:RNA binding; F:N6-methyladenosine-containing RNA binding; C:cytoplasm; P:response to interleukin-1; P:response to tumor necrosis factor; F:hydrolase activity		
gi|338713496|ref|XP_001916969.2|	metabotropic glutamate receptor 6	880	20	0E0	92.85%	3	F:GO:0004930; P:GO:0007186; C:GO:0016021	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway; C:integral component of membrane		IPR000112 (PRINTS); IPR000337 (PRINTS); IPR000162 (PRINTS); IPR011500 (PFAM); IPR001828 (PFAM); G3DSA:3.40.50.2300 (GENE3D); G3DSA:3.40.50.2300 (GENE3D); IPR017978 (PFAM); PTHR24060:SF24 (PANTHER); PTHR24060 (PANTHER); IPR017979 (PROSITE_PATTERNS); IPR017979 (PROSITE_PATTERNS); IPR017979 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR017978 (PROSITE_PROFILES); IPR028082 (SUPERFAMILY)
gi|338713575|ref|XP_003362917.1|	serine protease inhibitor Kazal-type 9	86	20	5.45E-58	83.45%	1	F:GO:0005515	F:protein binding		IPR002350 (SMART); G3DSA:1.10.1890.10 (GENE3D); IPR002350 (PFAM); PTHR21312:SF25 (PANTHER); PTHR21312 (PANTHER); IPR002350 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR002350 (PROSITE_PROFILES); SSF100895 (SUPERFAMILY)
gi|338713811|ref|XP_001503288.3|	kelch 29	875	20	0E0	99.05%	3	F:GO:0004842; C:GO:0031463; P:GO:0016567	F:ubiquitin-protein transferase activity; C:Cul3-RING ubiquitin ligase complex; P:protein ubiquitination		
gi|338714112|ref|XP_001916227.2|	DNA-directed RNA polymerase I subunit RPA1	1720	20	0E0	96.7%	7	F:GO:0003677; F:GO:0008270; P:GO:0006206; F:GO:0003899; P:GO:0006351; P:GO:0006144; C:GO:0005730	F:DNA binding; F:zinc ion binding; P:pyrimidine nucleobase metabolic process; F:DNA-directed RNA polymerase activity; P:transcription, DNA-templated; P:purine nucleobase metabolic process; C:nucleolus	EC:2.7.7.6	IPR006592 (SMART); IPR007080 (PFAM); G3DSA:2.40.40.20 (GENE3D); G3DSA:3.30.1490.180 (GENE3D); IPR000722 (PFAM); IPR007081 (PFAM); IPR007083 (PFAM); IPR007066 (PFAM); PTHR19376 (PANTHER); IPR015699 (PTHR19376:PANTHER); SSF64484 (SUPERFAMILY)
gi|338714206|ref|XP_001917001.2|	dysferlin isoform X6	2114	20	0E0	97.75%	2	F:GO:0005515; C:GO:0016021	F:protein binding; C:integral component of membrane		IPR000008 (SMART); IPR006614 (SMART); IPR006614 (SMART); IPR012561 (SMART); IPR012560 (SMART); IPR012968 (SMART); IPR012968 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR000008 (G3DSA:2.60.40.GENE3D); IPR012561 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR012560 (PFAM); IPR032362 (PFAM); IPR000008 (PFAM); PTHR12546 (PANTHER); PTHR12546:SF33 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000008 (PROSITE_PROFILES); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY)
gi|338714299|ref|XP_001917820.2|	DNA mismatch repair Msh2	937	20	0E0	97.2%	4	F:GO:0005524; C:GO:0032300; P:GO:0006298; F:GO:0030983	F:ATP binding; C:mismatch repair complex; P:mismatch repair; F:mismatched DNA binding		IPR000432 (SMART); IPR007696 (SMART); IPR011184 (PIRSF); G3DSA:1.10.1420.10 (GENE3D); IPR007696 (PFAM); IPR000432 (PFAM); IPR007695 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR007861 (PFAM); IPR007860 (PFAM); PTHR11361 (PANTHER); IPR032642 (PTHR11361:PANTHER); IPR000432 (PROSITE_PATTERNS); IPR007696 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|338714306|ref|XP_001917904.2|	calmodulin-lysine N-methyltransferase	323	20	0E0	95.55%	4	C:GO:0005737; F:GO:0018025; P:GO:0006479; P:GO:0006554	C:cytoplasm; F:calmodulin-lysine N-methyltransferase activity; P:protein methylation; P:lysine catabolic process	EC:2.1.1.60; EC:2.1.1	IPR029063 (G3DSA:3.40.50.GENE3D); IPR019410 (PFAM); PTHR13539:SF5 (PANTHER); PTHR13539 (PANTHER); IPR025800 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY)
gi|338714403|ref|XP_001502238.3|	intraflagellar transport 172 homolog	1749	20	0E0	99%	33	P:GO:0021915; C:GO:1903561; P:GO:0007275; P:GO:0060021; P:GO:0008544; C:GO:0005930; P:GO:0060348; P:GO:0009953; P:GO:0008589; P:GO:0007507; P:GO:0001841; P:GO:0001843; C:GO:0097225; P:GO:0042384; C:GO:0005929; C:GO:0097228; P:GO:0001947; P:GO:0070986; P:GO:0060271; C:GO:0036064; P:GO:0060173; P:GO:0021522; P:GO:0007224; P:GO:0007420; P:GO:0007368; P:GO:0061525; P:GO:0007219; C:GO:0097598; P:GO:0045880; P:GO:0050680; P:GO:0016485; C:GO:0030992; P:GO:0031122	P:neural tube development; C:extracellular vesicle; P:multicellular organism development; P:palate development; P:epidermis development; C:axoneme; P:bone development; P:dorsal/ventral pattern formation; P:regulation of smoothened signaling pathway; P:heart development; P:neural tube formation; P:neural tube closure; C:sperm midpiece; P:cilium assembly; C:cilium; C:sperm principal piece; P:heart looping; P:left/right axis specification; P:cilium morphogenesis; C:ciliary basal body; P:limb development; P:spinal cord motor neuron differentiation; P:smoothened signaling pathway; P:brain development; P:determination of left/right symmetry; P:hindgut development; P:Notch signaling pathway; C:sperm cytoplasmic droplet; P:positive regulation of smoothened signaling pathway; P:negative regulation of epithelial cell proliferation; P:protein processing; C:intraciliary transport particle B; P:cytoplasmic microtubule organization		
gi|338714718|ref|XP_001915928.2|	dynein heavy chain axonemal	4268	20	0E0	96.4%	6	F:GO:0016887; F:GO:0005524; F:GO:0003777; C:GO:0005858; P:GO:0003341; C:GO:0005874	F:ATPase activity; F:ATP binding; F:microtubule motor activity; C:axonemal dynein complex; P:cilium movement; C:microtubule	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	PF12774 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR013602 (PFAM); IPR011704 (PFAM); IPR004273 (PFAM); PF12775 (PFAM); PF12781 (PFAM); IPR024743 (PFAM); IPR024317 (PFAM); IPR026983 (PANTHER); IPR026975 (PTHR10676:PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|338714767|ref|XP_001916634.2|	sodium channel type 11 subunit alpha	1781	20	0E0	90.75%	4	P:GO:0006814; P:GO:0055085; C:GO:0001518; F:GO:0005248	P:sodium ion transport; P:transmembrane transport; C:voltage-gated sodium channel complex; F:voltage-gated sodium channel activity		IPR001696 (PRINTS); G3DSA:1.20.5.150 (GENE3D); IPR010526 (PFAM); IPR005821 (PFAM); IPR027359 (G3DSA:1.20.120.GENE3D); PTHR10037 (PANTHER); IPR028821 (PTHR10037:PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY)
gi|338714848|ref|XP_001494114.3|	serine threonine- kinase ATR	2641	20	0E0	97.55%	4	F:GO:0005515; P:GO:0009069; P:GO:0016310; F:GO:0004674	F:protein binding; P:serine family amino acid metabolic process; P:phosphorylation; F:protein serine/threonine kinase activity	EC:2.7.11	IPR012993 (SMART); IPR000403 (SMART); IPR003152 (SMART); IPR003152 (PFAM); IPR000403 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); G3DSA:3.30.1010.10 (GENE3D); IPR011989 (G3DSA:1.25.10.GENE3D); IPR003151 (PFAM); IPR000403 (G3DSA:1.10.1070.GENE3D); IPR012993 (PFAM); PTHR11139:SF69 (PANTHER); PTHR11139 (PANTHER); IPR018936 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000403 (PROSITE_PROFILES); IPR003152 (PROSITE_PROFILES); IPR014009 (PROSITE_PROFILES); IPR021133 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
gi|338715096|ref|XP_001495660.3|	prostatic acid phosphatase	418	20	0E0	92.95%	23	F:GO:0042802; P:GO:0060168; F:GO:0008253; P:GO:0006772; P:GO:0006144; F:GO:0003993; C:GO:0005622; C:GO:0005765; C:GO:0005886; P:GO:0009117; C:GO:0005634; C:GO:0005615; P:GO:0046085; F:GO:0052642; C:GO:0070062; C:GO:0012506; C:GO:0016020; F:GO:0042131; C:GO:0016021; F:GO:0016791; C:GO:0030175; P:GO:0016311; P:GO:0051930	F:identical protein binding; P:positive regulation of adenosine receptor signaling pathway; F:5'-nucleotidase activity; P:thiamine metabolic process; P:purine nucleobase metabolic process; F:acid phosphatase activity; C:intracellular; C:lysosomal membrane; C:plasma membrane; P:nucleotide metabolic process; C:nucleus; C:extracellular space; P:adenosine metabolic process; F:lysophosphatidic acid phosphatase activity; C:extracellular exosome; C:vesicle membrane; C:membrane; F:thiamine phosphate phosphatase activity; C:integral component of membrane; F:phosphatase activity; C:filopodium; P:dephosphorylation; P:regulation of sensory perception of pain		
gi|338715139|ref|XP_001918107.2|	zinc finger and BTB domain-containing 38	1196	20	0E0	95.35%	3	F:GO:0003676; F:GO:0005515; F:GO:0046872	F:nucleic acid binding; F:protein binding; F:metal ion binding		IPR015880 (SMART); IPR000210 (SMART); G3DSA:3.30.710.10 (GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PF12874 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); IPR000210 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR19303:SF267 (PANTHER); PTHR19303 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); IPR000210 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); IPR011333 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|338715471|ref|XP_001493080.3|	von Willebrand factor A domain-containing 8	2159	20	0E0	96.8%	2	F:GO:0016887; F:GO:0005524	F:ATPase activity; F:ATP binding	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR002035 (SMART); IPR003593 (SMART); IPR011704 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR21610 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR002035 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR002035 (SUPERFAMILY)
gi|338715509|ref|XP_003363282.1|	inactive dipeptidyl peptidase 10 isoform X1	800	20	0E0	98.25%	2	P:GO:0006508; F:GO:0008236	P:proteolysis; F:serine-type peptidase activity		IPR029058 (G3DSA:3.40.50.GENE3D); IPR002469 (PFAM); IPR002469 (G3DSA:2.140.10.GENE3D); IPR001375 (PFAM); PTHR11731:SF21 (PANTHER); PTHR11731 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SSF82171 (SUPERFAMILY); IPR029058 (SUPERFAMILY)
gi|338716422|ref|XP_001496512.3|	eukaryotic translation initiation factor 3 subunit A	1490	20	0E0	97.4%	15	C:GO:0005730; C:GO:0033290; P:GO:0006446; P:GO:0006413; C:GO:0005852; F:GO:0044822; P:GO:0006412; F:GO:0003743; C:GO:0005634; P:GO:0001731; P:GO:0001732; C:GO:0071541; C:GO:0005737; C:GO:0016282; C:GO:0016020	C:nucleolus; C:eukaryotic 48S preinitiation complex; P:regulation of translational initiation; P:translational initiation; C:eukaryotic translation initiation factor 3 complex; F:poly(A) RNA binding; P:translation; F:translation initiation factor activity; C:nucleus; P:formation of translation preinitiation complex; P:formation of cytoplasmic translation initiation complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:cytoplasm; C:eukaryotic 43S preinitiation complex; C:membrane		
gi|338716509|ref|XP_001917342.2|	monocarboxylate transporter 12	517	20	0E0	95.25%	2	P:GO:0055085; C:GO:0016021	P:transmembrane transport; C:integral component of membrane		G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11360:SF28 (PANTHER); PTHR11360 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY)
gi|338716956|ref|XP_001501762.3|	AP-4 complex subunit epsilon-1	1137	20	0E0	94.95%	4	C:GO:0030117; P:GO:0016192; F:GO:0005488; P:GO:0006886	C:membrane coat; P:vesicle-mediated transport; F:binding; P:intracellular protein transport		SM01356 (SMART); IPR017109 (PIRSF); IPR028269 (PFAM); IPR002553 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR017109 (PTHR22780:PANTHER); PTHR22780 (PANTHER); IPR016024 (SUPERFAMILY)
gi|338717048|ref|XP_001918335.2|	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1	1183	20	0E0	91.9%	7	F:GO:0004435; F:GO:0005515; P:GO:0035556; F:GO:0005509; P:GO:0009395; P:GO:0035556; P:GO:0046339	F:phosphatidylinositol phospholipase C activity; F:protein binding; P:intracellular signal transduction; F:calcium ion binding; P:phospholipid catabolic process; P:intracellular signal transduction; P:diacylglycerol metabolic process	EC:3.1; EC:3.1.4.11; EC:3.1.1	IPR001192 (PRINTS); IPR016280 (PIRSF); IPR001711 (SMART); IPR000008 (SMART); IPR000909 (SMART); IPR014815 (PFAM); IPR000909 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR017946 (G3DSA:3.20.20.GENE3D); IPR000008 (PFAM); IPR001711 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); G3DSA:1.20.1230.10 (GENE3D); IPR015359 (PFAM); IPR001192 (PANTHER); IPR028403 (PTHR10336:PANTHER); IPR001711 (PROSITE_PROFILES); IPR000909 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR017946 (SUPERFAMILY); IPR000008 (SUPERFAMILY); SSF69989 (SUPERFAMILY); IPR011992 (SUPERFAMILY)
gi|338717244|ref|XP_001493667.3|	olfactory receptor 6C74-like	320	20	0E0	90.85%	5	F:GO:0004930; P:GO:0007187; P:GO:0007608; C:GO:0016021; F:GO:0004984	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:sensory perception of smell; C:integral component of membrane; F:olfactory receptor activity		IPR000725 (PRINTS); IPR000276 (PRINTS); PF13853 (PFAM); G3DSA:1.20.1070.10 (GENE3D); PTHR26454 (PANTHER); PTHR26454:SF4 (PANTHER); IPR000276 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR017452 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY)
gi|338717695|ref|XP_001918362.2|	leucine-rich repeat-containing 16B isoform X5	1427	20	0E0	96.85%	1	F:GO:0005515	F:protein binding		SM00368 (SMART); IPR001611 (PFAM); IPR031943 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR24112 (PANTHER); IPR029766 (PTHR24112:PANTHER); SSF52047 (SUPERFAMILY); SSF52047 (SUPERFAMILY)
gi|338717875|ref|XP_001918080.2|	probable E3 ubiquitin- ligase HERC1 isoform X1	4860	20	0E0	99%	3	F:GO:0004842; F:GO:0005515; P:GO:0016567	F:ubiquitin-protein transferase activity; F:protein binding; P:protein ubiquitination		IPR000408 (PRINTS); IPR003877 (SMART); IPR000569 (SMART); IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR009091 (G3DSA:2.130.10.GENE3D); G3DSA:3.30.2160.10 (GENE3D); IPR003877 (PFAM); IPR000408 (PFAM); IPR000569 (PFAM); PTHR22870 (PANTHER); PTHR22870:SF188 (PANTHER); IPR000408 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR000408 (PROSITE_PROFILES); IPR001870 (PROSITE_PROFILES); IPR000569 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR009091 (SUPERFAMILY); IPR017986 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR000569 (SUPERFAMILY); IPR009091 (SUPERFAMILY)
gi|338718178|ref|XP_001503254.3|	FAM83B	1011	20	0E0	94.25%	9	P:GO:0008283; F:GO:0019901; F:GO:0036312; C:GO:0005737; P:GO:0007173; C:GO:0016020; F:GO:0005154; F:GO:0036313; F:GO:0004630	P:cell proliferation; F:protein kinase binding; F:phosphatidylinositol 3-kinase regulatory subunit binding; C:cytoplasm; P:epidermal growth factor receptor signaling pathway; C:membrane; F:epidermal growth factor receptor binding; F:phosphatidylinositol 3-kinase catalytic subunit binding; F:phospholipase D activity		IPR012461 (PFAM); G3DSA:3.30.870.10 (GENE3D); IPR012461 (PANTHER); PTHR16181:SF4 (PANTHER); SSF56024 (SUPERFAMILY)
gi|338718301|ref|XP_001488418.3|	serpin B6	425	20	0E0	93.45%	1	C:GO:0005615	C:extracellular space		IPR023796 (SMART); IPR023796 (PFAM); G3DSA:2.30.39.10 (GENE3D); G3DSA:3.30.497.10 (GENE3D); IPR000215 (PANTHER); PTHR11461:SF135 (PANTHER); IPR023795 (PROSITE_PATTERNS); IPR023796 (SUPERFAMILY)
gi|338719406|ref|XP_001488569.3|	zinc finger 64 isoform X3	645	20	0E0	96.5%	2	F:GO:0003676; F:GO:0046872	F:nucleic acid binding; F:metal ion binding		IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PF13909 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24403:SF34 (PANTHER); PTHR24403 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|338720343|ref|XP_001917300.2|	tyrosine- kinase ABL1	1160	20	0E0	96.25%	94	P:GO:0018108; P:GO:0090135; F:GO:0008022; P:GO:0022408; P:GO:0007173; P:GO:1904531; P:GO:0042770; P:GO:1902715; P:GO:0002322; P:GO:0051444; C:GO:0015629; C:GO:0005829; P:GO:0031113; C:GO:0031234; F:GO:0030145; P:GO:0051726; P:GO:2000352; P:GO:0050798; P:GO:0033690; P:GO:2001020; F:GO:0019904; P:GO:1903053; F:GO:0019905; P:GO:2000096; P:GO:0035791; P:GO:0045930; P:GO:0042100; P:GO:0048008; F:GO:0004672; P:GO:0006974; P:GO:0006975; P:GO:0045931; P:GO:0021587; P:GO:0002333; F:GO:0051015; P:GO:0045184; C:GO:0005634; P:GO:0032956; F:GO:0051019; P:GO:0050885; P:GO:0060020; P:GO:1900275; P:GO:0043123; P:GO:0048536; P:GO:0043124; P:GO:0046632; C:GO:0005730; P:GO:0006468; P:GO:0048538; C:GO:0005654; F:GO:0000287; F:GO:0000166; F:GO:0070064; P:GO:0006979; F:GO:0005524; F:GO:0004713; F:GO:0004715; P:GO:0001922; P:GO:0034446; P:GO:0016310; F:GO:0017124; P:GO:0050731; P:GO:2000772; P:GO:2000773; P:GO:0050853; P:GO:1900042; C:GO:0031252; P:GO:0007169; P:GO:0038083; P:GO:0048668; P:GO:0051281; F:GO:0005102; P:GO:1901216; P:GO:1904528; P:GO:0042127; P:GO:0007204; P:GO:0030514; P:GO:0030516; C:GO:0048471; P:GO:0071222; C:GO:0005737; P:GO:0051353; P:GO:0045087; P:GO:0070373; P:GO:0043065; P:GO:0001934; P:GO:0070374; P:GO:0030154; P:GO:0006909; P:GO:0030035; F:GO:0016740; P:GO:0071901; F:GO:0016301; P:GO:0030036	P:peptidyl-tyrosine phosphorylation; P:actin filament branching; F:protein C-terminus binding; P:negative regulation of cell-cell adhesion; P:epidermal growth factor receptor signaling pathway; P:positive regulation of actin filament binding; P:signal transduction in response to DNA damage; P:positive regulation of interferon-gamma secretion; P:B cell proliferation involved in immune response; P:negative regulation of ubiquitin-protein transferase activity; C:actin cytoskeleton; C:cytosol; P:regulation of microtubule polymerization; C:extrinsic component of cytoplasmic side of plasma membrane; F:manganese ion binding; P:regulation of cell cycle; P:negative regulation of endothelial cell apoptotic process; P:activated T cell proliferation; P:positive regulation of osteoblast proliferation; P:regulation of response to DNA damage stimulus; F:protein domain specific binding; P:regulation of extracellular matrix organization; F:syntaxin binding; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; P:platelet-derived growth factor receptor-beta signaling pathway; P:negative regulation of mitotic cell cycle; P:B cell proliferation; P:platelet-derived growth factor receptor signaling pathway; F:protein kinase activity; P:cellular response to DNA damage stimulus; P:DNA damage induced protein phosphorylation; P:positive regulation of mitotic cell cycle; P:cerebellum morphogenesis; P:transitional one stage B cell differentiation; F:actin filament binding; P:establishment of protein localization; C:nucleus; P:regulation of actin cytoskeleton organization; F:mitogen-activated protein kinase binding; P:neuromuscular process controlling balance; P:Bergmann glial cell differentiation; P:negative regulation of phospholipase C activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:spleen development; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:alpha-beta T cell differentiation; C:nucleolus; P:protein phosphorylation; P:thymus development; C:nucleoplasm; F:magnesium ion binding; F:nucleotide binding; F:proline-rich region binding; P:response to oxidative stress; F:ATP binding; F:protein tyrosine kinase activity; F:non-membrane spanning protein tyrosine kinase activity; P:B-1 B cell homeostasis; P:substrate adhesion-dependent cell spreading; P:phosphorylation; F:SH3 domain binding; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of cellular senescence; P:negative regulation of cellular senescence; P:B cell receptor signaling pathway; P:positive regulation of interleukin-2 secretion; C:cell leading edge; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:peptidyl-tyrosine autophosphorylation; P:collateral sprouting; P:positive regulation of release of sequestered calcium ion into cytosol; F:receptor binding; P:positive regulation of neuron death; P:positive regulation of microtubule binding; P:regulation of cell proliferation; P:positive regulation of cytosolic calcium ion concentration; P:negative regulation of BMP signaling pathway; P:regulation of axon extension; C:perinuclear region of cytoplasm; P:cellular response to lipopolysaccharide; C:cytoplasm; P:positive regulation of oxidoreductase activity; P:innate immune response; P:negative regulation of ERK1 and ERK2 cascade; P:positive regulation of apoptotic process; P:positive regulation of protein phosphorylation; P:positive regulation of ERK1 and ERK2 cascade; P:cell differentiation; P:phagocytosis; P:microspike assembly; F:transferase activity; P:negative regulation of protein serine/threonine kinase activity; F:kinase activity; P:actin cytoskeleton organization		
gi|338720346|ref|XP_001499447.3|	laminin subunit gamma-3	1458	20	0E0	91.05%	1	F:GO:0005515	F:protein binding		PR00011 (PRINTS); IPR000742 (SMART); IPR008211 (SMART); IPR002049 (SMART); IPR000034 (SMART); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR008211 (PFAM); IPR002049 (PFAM); IPR000034 (PFAM); PTHR10574:SF240 (PANTHER); PTHR10574 (PANTHER); IPR002049 (PROSITE_PATTERNS); IPR000034 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); IPR008211 (PROSITE_PROFILES); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY)
gi|338720394|ref|XP_001917531.2|	ATP-binding cassette sub-family A member 2	2468	20	0E0	96.05%	5	F:GO:0016887; F:GO:0005524; C:GO:0016021; P:GO:0006810; F:GO:0005215	F:ATPase activity; F:ATP binding; C:integral component of membrane; P:transport; F:transporter activity	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR003593 (SMART); PF12698 (PFAM); IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR030366 (PTHR19229:PANTHER); IPR026082 (PANTHER); IPR017871 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|338720924|ref|XP_001915472.2|	rab11 family-interacting 1 isoform X2	651	20	0E0	91.45%	1	F:GO:0005515	F:protein binding		IPR000008 (SMART); IPR019018 (PFAM); IPR000008 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); PTHR15746:SF22 (PANTHER); PTHR15746 (PANTHER); IPR000008 (PROSITE_PROFILES); IPR019018 (PROSITE_PROFILES); SSF144270 (SUPERFAMILY); IPR000008 (SUPERFAMILY)
gi|338721963|ref|XP_001503602.3|	splicing factor 3A subunit 3	501	20	0E0	99.3%	4	F:GO:0008270; F:GO:0003723; C:GO:0005681; P:GO:0000398	F:zinc ion binding; F:RNA binding; C:spliceosomal complex; P:mRNA splicing, via spliceosome		IPR031774 (PFAM); PF13297 (PFAM); IPR021966 (PFAM); IPR024598 (PFAM); IPR031776 (PTHR12786:PANTHER); PTHR12786 (PANTHER); IPR000690 (PROSITE_PROFILES)
gi|338722728|ref|XP_001915011.2|	inositol-trisphosphate 3-kinase B	942	20	0E0	89.8%	1	F:GO:0008440	F:inositol-1,4,5-trisphosphate 3-kinase activity	EC:2.7.1.127	IPR005522 (PFAM); PTHR12400:SF4 (PANTHER); IPR005522 (PANTHER); SSF56104 (SUPERFAMILY)
gi|338722737|ref|XP_001915146.2|	dynein heavy chain axonemal	4520	20	0E0	87.15%	4	F:GO:0003777; C:GO:0030286; P:GO:0007018; C:GO:0005874	F:microtubule motor activity; C:dynein complex; P:microtubule-based movement; C:microtubule	EC:3.6.1; EC:3.6.1.15	IPR003593 (SMART); IPR004273 (PFAM); IPR024317 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PF12774 (PFAM); PF12775 (PFAM); IPR013602 (PFAM); PF12781 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR024743 (PFAM); IPR026983 (PANTHER); PTHR10676:SF254 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|338723122|ref|XP_001494571.3|	katanin p80 WD40 repeat-containing subunit B1	655	20	0E0	97.3%	30	C:GO:0015630; C:GO:0043025; P:GO:0007079; F:GO:0045502; F:GO:0008568; C:GO:0005874; C:GO:0030426; P:GO:0051301; F:GO:0046982; P:GO:0010976; P:GO:0031117; C:GO:0030424; C:GO:0008352; C:GO:0000922; P:GO:0007026; P:GO:0007067; P:GO:0007049; C:GO:0005886; F:GO:0008017; P:GO:0006605; C:GO:0005634; C:GO:0005813; P:GO:0051013; C:GO:0005856; C:GO:0005815; C:GO:0005737; C:GO:0016020; C:GO:0005819; C:GO:0030496; P:GO:0010942	C:microtubule cytoskeleton; C:neuronal cell body; P:mitotic chromosome movement towards spindle pole; F:dynein binding; F:microtubule-severing ATPase activity; C:microtubule; C:growth cone; P:cell division; F:protein heterodimerization activity; P:positive regulation of neuron projection development; P:positive regulation of microtubule depolymerization; C:axon; C:katanin complex; C:spindle pole; P:negative regulation of microtubule depolymerization; P:mitotic nuclear division; P:cell cycle; C:plasma membrane; F:microtubule binding; P:protein targeting; C:nucleus; C:centrosome; P:microtubule severing; C:cytoskeleton; C:microtubule organizing center; C:cytoplasm; C:membrane; C:spindle; C:midbody; P:positive regulation of cell death		
gi|338723242|ref|XP_003364683.1|	Golgi apparatus 1	1179	20	0E0	97.65%	1	C:GO:0000139	C:Golgi membrane		IPR001893 (PFAM); PTHR11884 (PANTHER); PTHR11884:SF1 (PANTHER); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR017873 (PROSITE_PROFILES)
gi|338724479|ref|XP_001504700.3|	nitric oxide endothelial	1204	20	0E0	96.85%	44	P:GO:0014740; F:GO:0010181; P:GO:0031284; P:GO:0045909; P:GO:0008285; P:GO:0043542; P:GO:0043267; P:GO:0003057; P:GO:0045766; P:GO:0001542; P:GO:0051346; C:GO:0005901; F:GO:0004517; F:GO:0005506; P:GO:0001701; P:GO:0001525; F:GO:0016491; P:GO:0051926; P:GO:0034405; P:GO:0030324; P:GO:0007263; P:GO:0045776; P:GO:0003100; F:GO:0003785; F:GO:0020037; P:GO:0006527; F:GO:0034618; F:GO:0097110; C:GO:0005634; P:GO:0002028; F:GO:0034617; F:GO:0005516; F:GO:0050661; P:GO:0001974; F:GO:0046872; C:GO:0005737; P:GO:0050880; F:GO:0050660; P:GO:0019430; P:GO:0014806; P:GO:0031663; P:GO:0055114; P:GO:0006809; F:GO:0051117	P:negative regulation of muscle hyperplasia; F:FMN binding; P:positive regulation of guanylate cyclase activity; P:positive regulation of vasodilation; P:negative regulation of cell proliferation; P:endothelial cell migration; P:negative regulation of potassium ion transport; P:regulation of the force of heart contraction by chemical signal; P:positive regulation of angiogenesis; P:ovulation from ovarian follicle; P:negative regulation of hydrolase activity; C:caveola; F:nitric-oxide synthase activity; F:iron ion binding; P:in utero embryonic development; P:angiogenesis; F:oxidoreductase activity; P:negative regulation of calcium ion transport; P:response to fluid shear stress; P:lung development; P:nitric oxide mediated signal transduction; P:negative regulation of blood pressure; P:regulation of systemic arterial blood pressure by endothelin; F:actin monomer binding; F:heme binding; P:arginine catabolic process; F:arginine binding; F:scaffold protein binding; C:nucleus; P:regulation of sodium ion transport; F:tetrahydrobiopterin binding; F:calmodulin binding; F:NADP binding; P:blood vessel remodeling; F:metal ion binding; C:cytoplasm; P:regulation of blood vessel size; F:flavin adenine dinucleotide binding; P:removal of superoxide radicals; P:smooth muscle hyperplasia; P:lipopolysaccharide-mediated signaling pathway; P:oxidation-reduction process; P:nitric oxide biosynthetic process; F:ATPase binding		
gi|338724787|ref|XP_003365018.1|	SLAM family member 6-like isoform X2	168	20	7.8E-121	80.85%	1	F:GO:0005515	F:protein binding		IPR013783 (G3DSA:2.60.40.GENE3D); PTHR12080 (PANTHER); PTHR12080:SF50 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|338726394|ref|XP_001504896.3|	glutaminase liver mitochondrial isoform X1	602	20	0E0	97.95%	3	F:GO:0004359; F:GO:0005515; P:GO:0006541	F:glutaminase activity; F:protein binding; P:glutamine metabolic process	EC:3.5.1.2	IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR012338 (G3DSA:3.40.710.GENE3D); IPR015868 (PFAM); IPR015868 (TIGRFAM); PTHR12544:SF33 (PANTHER); IPR015868 (PANTHER); IPR015868 (HAMAP); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR012338 (SUPERFAMILY); IPR020683 (SUPERFAMILY)
gi|338726513|ref|XP_001505158.3|	A disintegrin and metallo ase with thrombospondin motifs 15	950	20	0E0	96.95%	4	F:GO:0008270; P:GO:0006508; F:GO:0004222; C:GO:0005578	F:zinc ion binding; P:proteolysis; F:metalloendopeptidase activity; C:proteinaceous extracellular matrix	EC:3.4.24	IPR013273 (PRINTS); IPR013277 (PRINTS); IPR000884 (SMART); IPR006586 (SMART); G3DSA:2.20.100.10 (GENE3D); IPR002870 (PFAM); IPR001590 (PFAM); IPR000884 (PFAM); IPR024079 (G3DSA:3.40.390.GENE3D); IPR010294 (PFAM); PTHR13723 (PANTHER); PTHR13723:SF39 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR001590 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); SSF55486 (SUPERFAMILY)
gi|338726619|ref|XP_001916974.2|	pre-mRNA-splicing factor SYF1	757	20	0E0	99.05%	2	F:GO:0005515; P:GO:0006396	F:protein binding; P:RNA processing		IPR003107 (SMART); IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR019734 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR11246 (PANTHER); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY)
gi|338728022|ref|XP_003365605.1|	mothers against decapentaplegic homolog 4	552	20	0E0	99.05%	6	C:GO:0005667; F:GO:0003700; F:GO:0005515; P:GO:0007179; P:GO:0006355; P:GO:0006355	C:transcription factor complex; F:transcription factor activity, sequence-specific DNA binding; F:protein binding; P:transforming growth factor beta receptor signaling pathway; P:regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated		IPR003619 (SMART); IPR001132 (SMART); IPR017855 (G3DSA:2.60.200.GENE3D); IPR003619 (PFAM); IPR013019 (G3DSA:3.90.520.GENE3D); IPR001132 (PFAM); PTHR13703:SF39 (PANTHER); IPR013790 (PANTHER); IPR013019 (PROSITE_PROFILES); IPR001132 (PROSITE_PROFILES); IPR013019 (SUPERFAMILY); IPR008984 (SUPERFAMILY)
gi|338728291|ref|XP_001914797.2|	peroxidasin isoform X1	1468	20	0E0	87.65%	6	F:GO:0004601; P:GO:0006979; F:GO:0005515; P:GO:0006804; P:GO:0055114; F:GO:0020037	F:peroxidase activity; P:response to oxidative stress; F:protein binding; P:obsolete peroxidase reaction; P:oxidation-reduction process; F:heme binding	EC:1.11.1.7	IPR019791 (PRINTS); IPR000483 (SMART); IPR003599 (SMART); IPR003598 (SMART); IPR003591 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:2.10.70.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013098 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); IPR019791 (G3DSA:1.10.640.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001611 (PFAM); IPR019791 (PFAM); IPR029610 (PTHR11475:PANTHER); PTHR11475 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR001611 (PROSITE_PROFILES); IPR019791 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); SSF57603 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR010255 (SUPERFAMILY); IPR032675 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|338728344|ref|XP_001488108.3|	cadherin-17	829	20	0E0	91.05%	3	F:GO:0005509; P:GO:0007156; C:GO:0005886	F:calcium ion binding; P:homophilic cell adhesion via plasma membrane adhesion molecules; C:plasma membrane		IPR002126 (PRINTS); IPR002126 (SMART); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (PFAM); IPR002126 (G3DSA:2.60.40.GENE3D); PTHR24027:SF292 (PANTHER); PTHR24027 (PANTHER); IPR020894 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR002126 (PROSITE_PROFILES); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY)
gi|338728901|ref|XP_001492571.3|	Ig heavy chain V region M315	244	20	4.18E-176	83.55%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|338729171|ref|XP_001489013.3|	male-specific lethal 3 homolog isoform X1	355	20	0E0	98.1%	3	C:GO:0005634; P:GO:0006355; P:GO:0006325	C:nucleus; P:regulation of transcription, DNA-templated; P:chromatin organization		IPR026541 (PFAM); PTHR10880:SF34 (PANTHER); IPR008676 (PANTHER); IPR026541 (PROSITE_PROFILES)
gi|338729635|ref|XP_003365944.1|	SLIT and NTRK 2	845	20	0E0	99.05%	1	F:GO:0005515	F:protein binding		IPR000483 (SMART); IPR000372 (SMART); IPR003591 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR001611 (PFAM); PTHR24373 (PANTHER); PTHR24373:SF36 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR001611 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY); IPR032675 (SUPERFAMILY)
gi|347825898|gb|AEP27030.1|	immunoglobulin heavy chain variable partial	119	20	3.39E-78	88.4%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|347825906|gb|AEP27034.1|	immunoglobulin heavy chain variable partial	124	20	6.98E-83	88.3%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); PTHR23266:SF105 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|347825926|gb|AEP27044.1|	immunoglobulin heavy chain variable partial	115	20	5.38E-78	85.75%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|347825934|gb|AEP27048.1|	immunoglobulin heavy chain variable partial	116	20	1.27E-79	73.4%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266:SF105 (PANTHER); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|347825938|gb|AEP27050.1|	immunoglobulin heavy chain variable partial	110	20	4.96E-73	78.55%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266:SF105 (PANTHER); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|347825944|gb|AEP27053.1|	immunoglobulin heavy chain variable partial	117	20	1.9E-79	83.25%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|349602804|gb|AEP98829.1|	probable ATP-dependent RNA helicase DHX40 isoform X2	226	20	8.25E-153	94.25%	11	F:GO:0000166; F:GO:0003676; F:GO:0005524; C:GO:0005737; F:GO:0008026; P:GO:0006396; F:GO:0004386; C:GO:0005730; F:GO:0004004; F:GO:0044822; F:GO:0016787	F:nucleotide binding; F:nucleic acid binding; F:ATP binding; C:cytoplasm; F:ATP-dependent helicase activity; P:RNA processing; F:helicase activity; C:nucleolus; F:ATP-dependent RNA helicase activity; F:poly(A) RNA binding; F:hydrolase activity		
gi|349604567|gb|AEQ00082.1|	afadin- and alpha-actinin-binding isoform X1	302	20	0E0	98.65%	9	P:GO:0051297; C:GO:0031252; C:GO:0036064; P:GO:0035020; C:GO:0034451; P:GO:0042384; P:GO:0035735; P:GO:2000145; C:GO:0043234	P:centrosome organization; C:cell leading edge; C:ciliary basal body; P:regulation of Rac protein signal transduction; C:centriolar satellite; P:cilium assembly; P:intraciliary transport involved in cilium morphogenesis; P:regulation of cell motility; C:protein complex		IPR021622 (PFAM); G3DSA:1.20.1460.10 (GENE3D); PTHR21736:SF21 (PANTHER); PTHR21736 (PANTHER)
gi|349604894|gb|AEQ00318.1|	peptidyl-glycine alpha-amidating monooxygenase isoform X1	285	20	0E0	94.85%	1	F:GO:0005515	F:protein binding		IPR001258 (PFAM); IPR011042 (G3DSA:2.120.10.GENE3D); PTHR10680:SF14 (PANTHER); PTHR10680 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR013017 (PROSITE_PROFILES); SSF75011 (SUPERFAMILY)
gi|371905531|emb|CAK55189.1|	G2 mitotic-specific cyclin-B3	1395	20	0E0	80.35%	4	C:GO:0005634; F:GO:0019901; P:GO:0010389; P:GO:0000079	C:nucleus; F:protein kinase binding; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of cyclin-dependent protein serine/threonine kinase activity		IPR013763 (SMART); IPR004367 (SMART); IPR013763 (G3DSA:1.10.472.GENE3D); IPR006671 (PFAM); IPR013763 (G3DSA:1.10.472.GENE3D); IPR004367 (PFAM); PTHR10177 (PANTHER); IPR015452 (PTHR10177:PANTHER); IPR006671 (PROSITE_PATTERNS); IPR013763 (SUPERFAMILY); IPR013763 (SUPERFAMILY)
gi|373249020|dbj|BAL46024.1|	succinyl- :3-ketoacid coenzyme A transferase mitochondrial	520	20	0E0	96.35%	2	P:GO:0046952; F:GO:0008410	P:ketone body catabolic process; F:CoA-transferase activity	EC:2.8.3	IPR004165 (SMART); IPR014388 (PIRSF); G3DSA:3.40.1080.10 (GENE3D); IPR012792 (TIGRFAM); IPR004165 (PFAM); G3DSA:3.40.810.20 (GENE3D); IPR012791 (TIGRFAM); PTHR13707:SF30 (PANTHER); IPR004165 (PANTHER); IPR004163 (PROSITE_PATTERNS); IPR004164 (PROSITE_PATTERNS); SSF100950 (SUPERFAMILY); SSF100950 (SUPERFAMILY)
gi|379991140|ref|NP_001244011.1|	ankyrin repeat domain-containing 34C	535	20	0E0	93.8%	1	F:GO:0005515	F:protein binding		IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); PTHR24157 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY)
gi|478683663|gb|AGJ50387.1|	immunoglobulin heavy chain variable partial	135	20	5.81E-94	91%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683665|gb|AGJ50388.1|	immunoglobulin heavy chain variable partial	136	20	4.08E-94	88.6%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683671|gb|AGJ50391.1|	immunoglobulin heavy chain variable partial	128	20	7.87E-88	89.45%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683699|gb|AGJ50405.1|	immunoglobulin heavy partial	136	20	8.88E-95	89.1%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683725|gb|AGJ50418.1|	immunoglobulin heavy partial	133	20	2.9E-92	88.65%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683727|gb|AGJ50419.1|	immunoglobulin heavy partial	129	20	2.61E-89	89.2%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683729|gb|AGJ50420.1|	immunoglobulin heavy partial	131	20	1.49E-89	89.75%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683733|gb|AGJ50422.1|	immunoglobulin heavy partial	136	20	2.05E-93	86.1%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683779|gb|AGJ50445.1|	immunoglobulin heavy chain variable partial	133	20	2.57E-92	87.15%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683781|gb|AGJ50446.1|	immunoglobulin heavy partial	135	20	4.33E-93	81.75%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683787|gb|AGJ50449.1|	immunoglobulin heavy partial	140	20	3.89E-98	84%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683789|gb|AGJ50450.1|	immunoglobulin heavy partial	134	20	9.34E-94	86.4%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683795|gb|AGJ50453.1|	immunoglobulin heavy chain variable partial	141	20	6.06E-100	82.15%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266:SF105 (PANTHER); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683799|gb|AGJ50455.1|	immunoglobulin heavy partial	138	20	2.42E-96	85.75%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683801|gb|AGJ50456.1|	immunoglobulin heavy chain variable partial	137	20	2.83E-95	86.3%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683807|gb|AGJ50459.1|	immunoglobulin heavy chain variable partial	144	20	1.71E-99	83.9%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683809|gb|AGJ50460.1|	immunoglobulin heavy partial	140	20	3.98E-97	86.95%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683811|gb|AGJ50461.1|	immunoglobulin heavy chain variable partial	135	20	5.58E-93	86.1%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683819|gb|AGJ50465.1|	immunoglobulin heavy partial	131	20	2.22E-91	80.05%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); PTHR23266:SF105 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683825|gb|AGJ50468.1|	immunoglobulin heavy partial	134	20	4.56E-95	80.45%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266:SF105 (PANTHER); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|478683827|gb|AGJ50469.1|	immunoglobulin heavy partial	132	20	7.95E-94	82.3%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); PTHR23266:SF105 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|545175545|ref|XP_005596285.1|	heterogeneous nuclear ribonucleo L isoform X2	456	20	0E0	99.1%	4	F:GO:0000166; C:GO:0005634; F:GO:0003723; P:GO:0006397	F:nucleotide binding; C:nucleus; F:RNA binding; P:mRNA processing		IPR000504 (SMART); PF13893 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR006536 (TIGRFAM); IPR000504 (PFAM); PTHR24012 (PANTHER); PTHR24012:SF472 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY)
gi|545175695|ref|XP_005596335.1|	carcinoembryonic antigen-related cell adhesion molecule 1-like isoform X1	542	20	0E0	88.4%	1	F:GO:0005515	F:protein binding		IPR003598 (SMART); IPR003599 (SMART); IPR007110 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PF13927 (PFAM); PTHR12231 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|545175733|ref|XP_005596347.1|	zinc finger 574	896	20	0E0	97.95%	2	F:GO:0003676; F:GO:0046872	F:nucleic acid binding; F:metal ion binding		IPR015880 (SMART); IPR007087 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); PF13894 (PFAM); PF12874 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24375 (PANTHER); PTHR24375:SF38 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|545175802|ref|XP_005596372.1|	cell adhesion molecule 4	376	20	0E0	98.85%	1	F:GO:0005515	F:protein binding		IPR003598 (SMART); IPR003599 (SMART); IPR003585 (SMART); PF13927 (PFAM); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013162 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR028807 (PTHR23277:PANTHER); PTHR23277 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|545176652|ref|XP_001503534.2|	bile acyl- synthetase	700	20	0E0	92.35%	7	F:GO:0031957; F:GO:0015245; P:GO:0015908; C:GO:0016021; P:GO:0006699; F:GO:0004467; P:GO:0006631	F:very long-chain fatty acid-CoA ligase activity; F:fatty acid transporter activity; P:fatty acid transport; C:integral component of membrane; P:bile acid biosynthetic process; F:long-chain fatty acid-CoA ligase activity; P:fatty acid metabolic process	EC:6.2.1.3; EC:6.2.1	G3DSA:2.30.38.10 (GENE3D); G3DSA:3.30.300.30 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR025110 (PFAM); IPR000873 (PFAM); G3DSA:3.40.50.980 (GENE3D); IPR030302 (PTHR24096:PANTHER); PTHR24096 (PANTHER); IPR020845 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SSF56801 (SUPERFAMILY)
gi|545176926|ref|XP_005614997.1|	serine threonine- kinase LMTK3	530	20	0E0	94.85%	3	F:GO:0005524; F:GO:0004672; P:GO:0006468	F:ATP binding; F:protein kinase activity; P:protein phosphorylation		IPR001245 (PRINTS); IPR001245 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24417 (PANTHER); PTHR24417:SF2 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR008266 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)
gi|545177225|ref|XP_005596882.1|	gamma-aminobutyric acid receptor subunit rho-1 isoform X2	504	20	0E0	95.75%	5	C:GO:0016021; F:GO:0004890; F:GO:0005230; P:GO:0006821; P:GO:0007214	C:integral component of membrane; F:GABA-A receptor activity; F:extracellular ligand-gated ion channel activity; P:chloride transport; P:gamma-aminobutyric acid signaling pathway		IPR008057 (PRINTS); IPR008058 (PRINTS); IPR006028 (PRINTS); IPR006201 (PRINTS); G3DSA:1.20.58.390 (GENE3D); IPR006202 (PFAM); IPR006029 (PFAM); IPR006201 (TIGRFAM); IPR006202 (G3DSA:2.70.170.GENE3D); PTHR18945:SF30 (PANTHER); IPR006201 (PANTHER); IPR018000 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR006029 (SUPERFAMILY); IPR006202 (SUPERFAMILY)
gi|545177280|ref|XP_005596897.1|	F-box LRR-repeat 4	621	20	0E0	97.95%	1	F:GO:0005515	F:protein binding		IPR001810 (SMART); IPR006553 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); IPR001810 (PFAM); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR001810 (PROSITE_PROFILES); SSF52047 (SUPERFAMILY); IPR001810 (SUPERFAMILY)
gi|545177695|ref|XP_005615115.1|	peptidase M20 domain-containing 2	388	20	0E0	93.9%	2	P:GO:0008152; F:GO:0016787	P:metabolic process; F:hydrolase activity		IPR017144 (PIRSF); G3DSA:3.40.630.10 (GENE3D); IPR011650 (G3DSA:3.30.70.GENE3D); IPR002933 (PFAM); IPR011650 (PFAM); PTHR30575:SF0 (PANTHER); PTHR30575 (PANTHER); SSF53187 (SUPERFAMILY); IPR011650 (SUPERFAMILY)
gi|545177842|ref|XP_005597070.1|	beta-1,3-N-acetylglucosaminyltransferase radical fringe	294	20	0E0	97.1%	6	F:GO:0016757; P:GO:0032092; C:GO:0070062; C:GO:0016020; F:GO:0016740; P:GO:0045747	F:transferase activity, transferring glycosyl groups; P:positive regulation of protein binding; C:extracellular exosome; C:membrane; F:transferase activity; P:positive regulation of Notch signaling pathway		
gi|545177852|ref|XP_005597075.1|	glial fibrillary acidic isoform X1	467	20	0E0	96.9%	25	P:GO:0014002; C:GO:0043209; P:GO:0060020; F:GO:0005198; P:GO:0045103; P:GO:0045109; C:GO:0042995; C:GO:0097450; P:GO:1904714; C:GO:0097386; C:GO:0045111; P:GO:0010977; C:GO:0097449; F:GO:0001948; P:GO:0060291; P:GO:0051580; C:GO:0005882; C:GO:0005622; F:GO:0005515; C:GO:0005737; P:GO:0010625; C:GO:0044297; C:GO:0016020; P:GO:0030198; P:GO:0031102	P:astrocyte development; C:myelin sheath; P:Bergmann glial cell differentiation; F:structural molecule activity; P:intermediate filament-based process; P:intermediate filament organization; C:cell projection; C:astrocyte end-foot; P:regulation of chaperone-mediated autophagy; C:glial cell projection; C:intermediate filament cytoskeleton; P:negative regulation of neuron projection development; C:astrocyte projection; F:glycoprotein binding; P:long-term synaptic potentiation; P:regulation of neurotransmitter uptake; C:intermediate filament; C:intracellular; F:protein binding; C:cytoplasm; P:positive regulation of Schwann cell proliferation; C:cell body; C:membrane; P:extracellular matrix organization; P:neuron projection regeneration		
gi|545177987|ref|XP_005597131.1|	lysosomal alpha-glucosidase	951	20	0E0	92.8%	3	P:GO:0005975; F:GO:0004553; F:GO:0030246	P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:carbohydrate binding		IPR000519 (SMART); IPR000519 (G3DSA:4.10.110.GENE3D); IPR000519 (PFAM); IPR000322 (PFAM); IPR025887 (PFAM); IPR031727 (PFAM); PTHR22762:SF92 (PANTHER); PTHR22762 (PANTHER); IPR030459 (PROSITE_PATTERNS); IPR017957 (PROSITE_PATTERNS); IPR030458 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR000519 (PROSITE_PROFILES); IPR017853 (SUPERFAMILY); SSF51011 (SUPERFAMILY); IPR000519 (SUPERFAMILY); IPR011013 (SUPERFAMILY)
gi|545178074|ref|XP_005597162.1|	septin-9 isoform X3	569	20	0E0	96.8%	1	F:GO:0005525	F:GTP binding		IPR027417 (G3DSA:3.40.50.GENE3D); IPR030379 (PFAM); IPR016491 (PANTHER); IPR030645 (PTHR18884:PANTHER); IPR030379 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
gi|545178455|ref|XP_005597295.1|	ATP-binding cassette sub-family A member 6	1626	20	0E0	90%	5	F:GO:0016887; F:GO:0005524; C:GO:0016021; P:GO:0006810; F:GO:0005215	F:ATPase activity; F:ATP binding; C:integral component of membrane; P:transport; F:transporter activity	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR003593 (SMART); PF12698 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); IPR026082 (PANTHER); IPR030368 (PTHR19229:PANTHER); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|545178565|ref|XP_005597334.1|	pre-rRNA processing FTSJ3	837	20	0E0	94.75%	3	C:GO:0005634; F:GO:0008649; P:GO:0031167	C:nucleus; F:rRNA methyltransferase activity; P:rRNA methylation	EC:2.1.1	IPR002877 (PFAM); IPR012920 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR024576 (PFAM); IPR015507 (PANTHER); IPR028589 (PTHR10920:PANTHER); IPR015507 (HAMAP); IPR028589 (HAMAP); IPR029063 (SUPERFAMILY)
gi|545178915|ref|XP_005597454.1|	kelch 11	646	20	0E0	99.05%	1	F:GO:0005515	F:protein binding		IPR011705 (SMART); IPR000210 (SMART); IPR006652 (SMART); IPR000210 (PFAM); IPR006652 (PFAM); IPR015915 (G3DSA:2.120.10.GENE3D); IPR011705 (PFAM); G3DSA:3.30.710.10 (GENE3D); PTHR24413:SF115 (PANTHER); PTHR24413 (PANTHER); IPR000210 (PROSITE_PROFILES); SSF117281 (SUPERFAMILY); IPR011333 (SUPERFAMILY); SSF117281 (SUPERFAMILY)
gi|545179273|ref|XP_001503369.2|	diacylglycerol kinase epsilon	588	20	0E0	97.65%	5	P:GO:0046486; P:GO:0009395; F:GO:0004143; P:GO:0007205; P:GO:0035556	P:glycerolipid metabolic process; P:phospholipid catabolic process; F:diacylglycerol kinase activity; P:protein kinase C-activating G-protein coupled receptor signaling pathway; P:intracellular signal transduction	EC:2.7.1.107	IPR002219 (SMART); IPR001206 (SMART); IPR000756 (SMART); G3DSA:3.30.60.20 (GENE3D); IPR000756 (PFAM); IPR002219 (PFAM); G3DSA:3.30.60.20 (GENE3D); IPR001206 (PFAM); PTHR11255:SF45 (PANTHER); PTHR11255 (PANTHER); IPR002219 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR001206 (PROSITE_PROFILES); IPR002219 (PROSITE_PROFILES); SSF57889 (SUPERFAMILY); IPR016064 (SUPERFAMILY); SSF57889 (SUPERFAMILY)
gi|545179443|ref|XP_005597615.1|	WAP four-disulfide core domain 2-like	162	20	6.54E-107	74.75%	2	F:GO:0030414; C:GO:0005576	F:peptidase inhibitor activity; C:extracellular region		IPR008197 (SMART); IPR008197 (PFAM); IPR008197 (G3DSA:4.10.75.GENE3D); IPR008197 (G3DSA:4.10.75.GENE3D); PTHR19441:SF34 (PANTHER); PTHR19441 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR008197 (PROSITE_PROFILES); IPR008197 (SUPERFAMILY)
gi|545179595|ref|XP_005597668.1|	BTB POZ domain-containing adapter for CUL3-mediated degradation 2	316	20	0E0	99.25%	2	F:GO:0005515; P:GO:0051260	F:protein binding; P:protein homooligomerization		IPR000210 (SMART); IPR003131 (PFAM); G3DSA:3.30.710.10 (GENE3D); PTHR11145 (PANTHER); PTHR11145:SF17 (PANTHER); IPR000210 (PROSITE_PROFILES); IPR011333 (SUPERFAMILY)
gi|545179820|ref|XP_005597733.1|	rabankyrin-5 isoform X1	1169	20	0E0	98.15%	2	F:GO:0005515; F:GO:0046872	F:protein binding; F:metal ion binding		IPR002110 (PRINTS); IPR002110 (SMART); IPR000306 (SMART); IPR000210 (SMART); IPR000306 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR002110 (PFAM); PF13857 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR000210 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); G3DSA:3.30.710.10 (GENE3D); PF13637 (PFAM); IPR020683 (PFAM); PTHR24189:SF34 (PANTHER); PTHR24189 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR000210 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR017455 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR011333 (SUPERFAMILY); IPR011011 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY)
gi|545179831|ref|XP_005597737.1|	myb-binding 1A	1425	20	0E0	89.65%	5	F:GO:0003677; F:GO:0003887; P:GO:0006351; P:GO:0006260; C:GO:0042575	F:DNA binding; F:DNA-directed DNA polymerase activity; P:transcription, DNA-templated; P:DNA replication; C:DNA polymerase complex	EC:2.7.7.7	PR01217 (PRINTS); IPR007015 (PFAM); PTHR13213:SF2 (PANTHER); IPR007015 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR016024 (SUPERFAMILY)
gi|545180178|ref|XP_005597841.1|	myosin-13	1938	20	0E0	97.7%	4	C:GO:0016459; F:GO:0005524; F:GO:0005515; F:GO:0003774	C:myosin complex; F:ATP binding; F:protein binding; F:motor activity	EC:3.6.1; EC:3.6.1.15	IPR001609 (PRINTS); IPR001609 (SMART); IPR002928 (PFAM); IPR027401 (G3DSA:4.10.270.GENE3D); IPR004009 (PFAM); IPR001609 (PFAM); G3DSA:1.20.5.340 (GENE3D); PTHR13140 (PANTHER); PTHR13140:SF504 (PANTHER); IPR001609 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); SSF90257 (SUPERFAMILY); IPR027417 (SUPERFAMILY); SSF90257 (SUPERFAMILY); SSF90257 (SUPERFAMILY); SSF57997 (SUPERFAMILY); SSF90257 (SUPERFAMILY)
gi|545180220|ref|XP_005597856.1|	tektin-3	490	20	0E0	96.45%	12	C:GO:0005634; P:GO:0030317; C:GO:0005856; C:GO:0070062; C:GO:0002080; P:GO:0060271; C:GO:0005737; P:GO:0080154; C:GO:0005929; C:GO:0036126; C:GO:0042995; C:GO:0005874	C:nucleus; P:flagellated sperm motility; C:cytoskeleton; C:extracellular exosome; C:acrosomal membrane; P:cilium morphogenesis; C:cytoplasm; P:regulation of fertilization; C:cilium; C:sperm flagellum; C:cell projection; C:microtubule		IPR000435 (PRINTS); PF03148 (PFAM); IPR000435 (PANTHER); PTHR19960:SF24 (PANTHER)
gi|545180399|ref|XP_005597925.1|	Fanconi anemia-associated of 100 kDa	837	20	0E0	87.9%	2	P:GO:0006281; C:GO:0043240	P:DNA repair; C:Fanconi anaemia nuclear complex		IPR029251 (PFAM); PTHR14890:SF1 (PANTHER); PTHR14890 (PANTHER)
gi|545180517|ref|XP_005597972.1|	pleckstrin homology domain-containing family H member 3	635	20	0E0	91.4%	2	C:GO:0005856; P:GO:0007165	C:cytoskeleton; P:signal transduction		IPR000857 (SMART); IPR001849 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); IPR000159 (PFAM); IPR000857 (PFAM); PTHR22903:SF17 (PANTHER); PTHR22903 (PANTHER); IPR000857 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY)
gi|545180714|ref|XP_005598035.1|	PHD finger 23	318	20	0E0	94.3%	9	C:GO:0005634; P:GO:1901097; F:GO:0008270; F:GO:0005515; C:GO:0005737; F:GO:0046872; P:GO:0006914; P:GO:0031398; P:GO:1902902	C:nucleus; P:negative regulation of autophagosome maturation; F:zinc ion binding; F:protein binding; C:cytoplasm; F:metal ion binding; P:autophagy; P:positive regulation of protein ubiquitination; P:negative regulation of autophagosome assembly		IPR013083 (G3DSA:3.30.40.GENE3D); PTHR14571:SF8 (PANTHER); PTHR14571 (PANTHER); IPR011011 (SUPERFAMILY)
gi|545180995|ref|XP_005598137.1|	cytoskeleton-associated 5	2032	20	0E0	98.25%	1	F:GO:0005488	F:binding		SM01349 (SMART); IPR024395 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR12609 (PANTHER); PTHR12609:SF0 (PANTHER); IPR021133 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
gi|545181110|ref|XP_005598175.1|	synaptotagmin-13	386	20	0E0	94.9%	1	F:GO:0005515	F:protein binding		IPR000008 (SMART); IPR000008 (G3DSA:2.60.40.GENE3D); IPR000008 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR028692 (PTHR10024:PANTHER); PTHR10024 (PANTHER); IPR000008 (PROSITE_PROFILES); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY)
gi|545181441|ref|XP_005598291.1|	secretoglobin family 1D member-like	90	20	1.89E-58	69.7%	2	P:GO:0007165; C:GO:0005576	P:signal transduction; C:extracellular region		G3DSA:1.10.210.10 (GENE3D); IPR016126 (PFAM); PTHR11332 (PANTHER); PTHR11332:SF6 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR016126 (PROSITE_PROFILES); IPR016126 (SUPERFAMILY)
gi|545181537|ref|XP_001488131.2|	atlastin-3 isoform X1	541	20	0E0	97.3%	10	F:GO:0000166; F:GO:0005525; F:GO:0042802; P:GO:0007030; F:GO:0003924; C:GO:0016020; C:GO:0016021; P:GO:0051260; C:GO:0005783; P:GO:0007029	F:nucleotide binding; F:GTP binding; F:identical protein binding; P:Golgi organization; F:GTPase activity; C:membrane; C:integral component of membrane; P:protein homooligomerization; C:endoplasmic reticulum; P:endoplasmic reticulum organization		
gi|545181754|ref|XP_005598386.1|	spectrin beta non-erythrocytic 2 isoform X1	2408	20	0E0	97.45%	4	F:GO:0003779; F:GO:0005200; F:GO:0005543; C:GO:0008091	F:actin binding; F:structural constituent of cytoskeleton; F:phospholipid binding; C:spectrin		IPR001605 (PRINTS); IPR016343 (PIRSF); IPR018159 (SMART); IPR001849 (SMART); IPR001715 (SMART); IPR002017 (PFAM); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); PF15410 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); G3DSA:1.20.58.60 (GENE3D); PTHR11915:SF325 (PANTHER); PTHR11915 (PANTHER); IPR001589 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); IPR001715 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR011993 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001715 (SUPERFAMILY)
gi|545181818|ref|XP_005598405.1|	NADH dehydrogenase [ubiquinone] flavo mitochondrial	464	20	0E0	98.95%	8	P:GO:0006814; P:GO:0015992; F:GO:0010181; F:GO:0051287; P:GO:0006120; F:GO:0008137; F:GO:0051539; P:GO:0006744	P:sodium ion transport; P:proton transport; F:FMN binding; F:NAD binding; P:mitochondrial electron transport, NADH to ubiquinone; F:NADH dehydrogenase (ubiquinone) activity; F:4 iron, 4 sulfur cluster binding; P:ubiquinone biosynthetic process	EC:1.6.99.5; EC:1.6.99.3; EC:1.6.5.3	IPR019575 (SMART); IPR019575 (PFAM); IPR011537 (TIGRFAM); IPR011538 (PFAM); IPR019554 (PFAM); PTHR11780 (PANTHER); IPR001949 (PROSITE_PATTERNS); IPR001949 (PROSITE_PATTERNS); SSF140490 (SUPERFAMILY); SSF142984 (SUPERFAMILY); SSF142019 (SUPERFAMILY)
gi|545182136|ref|XP_005598522.1|	phosphatase Slingshot homolog 3 isoform X2	722	20	0E0	94.1%	14	P:GO:0010591; P:GO:0008064; P:GO:0006470; F:GO:0008138; F:GO:0003677; C:GO:0005856; F:GO:0003779; F:GO:0004725; C:GO:0005737; P:GO:0050770; F:GO:0016791; P:GO:0016311; P:GO:0035335; F:GO:0016787	P:regulation of lamellipodium assembly; P:regulation of actin polymerization or depolymerization; P:protein dephosphorylation; F:protein tyrosine/serine/threonine phosphatase activity; F:DNA binding; C:cytoskeleton; F:actin binding; F:protein tyrosine phosphatase activity; C:cytoplasm; P:regulation of axonogenesis; F:phosphatase activity; P:dephosphorylation; P:peptidyl-tyrosine dephosphorylation; F:hydrolase activity		
gi|545182138|ref|XP_005598523.1|	cell cycle checkpoint control RAD9A isoform X1	563	20	0E0	92.45%	2	P:GO:0000077; C:GO:0030896	P:DNA damage checkpoint; C:checkpoint clamp complex		G3DSA:3.70.10.10 (GENE3D); IPR007268 (PFAM); PTHR15237:SF1 (PANTHER); IPR007268 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SSF55979 (SUPERFAMILY)
gi|545182363|ref|XP_005598610.1|	integrator complex subunit 1	2186	20	0E0	95.7%	1	F:GO:0005488	F:binding		IPR022145 (PFAM); PTHR21224:SF1 (PANTHER); PTHR21224 (PANTHER); IPR016024 (SUPERFAMILY)
gi|545182408|ref|XP_005598629.1|	transformation transcription domain-associated isoform X10	3847	20	0E0	97.9%	4	F:GO:0005515; P:GO:0016573; F:GO:0016301; C:GO:0000123	F:protein binding; P:histone acetylation; F:kinase activity; C:histone acetyltransferase complex		IPR003152 (SMART); IPR000403 (SMART); IPR000403 (G3DSA:1.10.1070.GENE3D); IPR003151 (PFAM); IPR000403 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR11139 (PANTHER); IPR033317 (PTHR11139:PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR014009 (PROSITE_PROFILES); IPR003152 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
gi|545182988|ref|XP_005598826.1|	helicase SRCAP isoform X1	3228	20	0E0	95.7%	2	F:GO:0003677; F:GO:0005524	F:DNA binding; F:ATP binding		IPR017956 (PRINTS); IPR017956 (SMART); IPR014012 (SMART); IPR001650 (SMART); IPR014001 (SMART); IPR001650 (PFAM); IPR000330 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR014012 (PFAM); PTHR10799 (PANTHER); PTHR10799:SF638 (PANTHER); IPR014012 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|545183483|ref|XP_005598984.1|	ubiquitin carboxyl-terminal hydrolase 7 isoform X1	1086	20	0E0	99.05%	4	P:GO:0016579; F:GO:0005515; F:GO:0036459; P:GO:0006511	P:protein deubiquitination; F:protein binding; F:thiol-dependent ubiquitinyl hydrolase activity; P:ubiquitin-dependent protein catabolic process	EC:3.4; EC:3.4.19.12	IPR002083 (SMART); G3DSA:2.20.210.10 (GENE3D); IPR001394 (PFAM); IPR029346 (PFAM); IPR024729 (PFAM); IPR002083 (PFAM); PTHR24006:SF487 (PANTHER); PTHR24006 (PANTHER); IPR018200 (PROSITE_PATTERNS); IPR018200 (PROSITE_PATTERNS); IPR002083 (PROSITE_PROFILES); IPR028889 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY); IPR008974 (SUPERFAMILY)
gi|545184036|ref|XP_005599171.1|	cytosolic Fe-S cluster assembly factor NUBP2 isoform X1	234	20	9.07E-168	78.6%	15	P:GO:0030030; C:GO:0042995; F:GO:0000166; C:GO:0031616; F:GO:0005524; C:GO:0005634; C:GO:0005856; C:GO:0005815; C:GO:0005737; C:GO:0005814; F:GO:0046872; C:GO:0005929; F:GO:0051539; F:GO:0051536; P:GO:0016226	P:cell projection organization; C:cell projection; F:nucleotide binding; C:spindle pole centrosome; F:ATP binding; C:nucleus; C:cytoskeleton; C:microtubule organizing center; C:cytoplasm; C:centriole; F:metal ion binding; C:cilium; F:4 iron, 4 sulfur cluster binding; F:iron-sulfur cluster binding; P:iron-sulfur cluster assembly		IPR033756 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR019591 (PANTHER); PTHR23264:SF32 (PANTHER); IPR027417 (SUPERFAMILY)
gi|545184259|ref|XP_001498550.4|	fibroblast growth factor receptor 4 isoform X1	824	20	0E0	96.35%	7	F:GO:0005007; F:GO:0005524; F:GO:0005515; P:GO:0008284; C:GO:0016021; P:GO:0008543; P:GO:0006468	F:fibroblast growth factor-activated receptor activity; F:ATP binding; F:protein binding; P:positive regulation of cell proliferation; C:integral component of membrane; P:fibroblast growth factor receptor signaling pathway; P:protein phosphorylation	EC:2.7.10; EC:2.7.10.1; EC:2.7.11	IPR001245 (PRINTS); IPR003598 (SMART); IPR003599 (SMART); IPR020635 (SMART); IPR016248 (PIRSF); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PF13927 (PFAM); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001245 (PFAM); PTHR24416:SF343 (PANTHER); PTHR24416 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR008266 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR011009 (SUPERFAMILY)
gi|545184469|ref|XP_001503614.3|	delta-sarcoglycan	348	20	0E0	97.85%	2	C:GO:0016021; C:GO:0016012	C:integral component of membrane; C:sarcoglycan complex		IPR006875 (PFAM); IPR027661 (PTHR12939:PANTHER); PTHR12939 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|545185287|ref|XP_005599584.1|	2 -5 -oligoadenylate synthase 3-like isoform X1	459	20	0E0	86.35%	6	F:GO:0005524; P:GO:0006955; F:GO:0003725; F:GO:0046872; P:GO:0051607; F:GO:0016740	F:ATP binding; P:immune response; F:double-stranded RNA binding; F:metal ion binding; P:defense response to virus; F:transferase activity		IPR015880 (SMART); IPR018952 (G3DSA:1.10.1410.GENE3D); IPR018952 (PFAM); G3DSA:3.30.460.10 (GENE3D); IPR026774 (PANTHER); PTHR11258:SF20 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); IPR006116 (PROSITE_PROFILES); SSF81631 (SUPERFAMILY); SSF81301 (SUPERFAMILY)
gi|545185350|ref|XP_005599612.1|	tetratricopeptide repeat 37	1564	20	0E0	97%	1	F:GO:0005515	F:protein binding		IPR019734 (SMART); IPR006597 (SMART); IPR019734 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PF13432 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR15704:SF7 (PANTHER); PTHR15704 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); SSF81901 (SUPERFAMILY); IPR011990 (SUPERFAMILY); SSF81901 (SUPERFAMILY); IPR011990 (SUPERFAMILY)
gi|545185439|ref|XP_005599640.1|	versican core isoform X1	3400	20	0E0	89.2%	4	F:GO:0005515; F:GO:0005509; P:GO:0007155; F:GO:0005540	F:protein binding; F:calcium ion binding; P:cell adhesion; F:hyaluronic acid binding		IPR000538 (PRINTS); IPR000436 (SMART); IPR001304 (SMART); IPR013106 (SMART); IPR003599 (SMART); IPR001881 (SMART); IPR000742 (SMART); IPR000538 (SMART); IPR000742 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR000436 (PFAM); IPR013106 (PFAM); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR001304 (PFAM); IPR000538 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR016186 (G3DSA:3.10.100.GENE3D); IPR016186 (G3DSA:3.10.100.GENE3D); PTHR22804 (PANTHER); PTHR22804:SF6 (PANTHER); IPR013032 (PROSITE_PATTERNS); IPR000538 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR018378 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR001304 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000538 (PROSITE_PROFILES); IPR000436 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR016187 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR016187 (SUPERFAMILY); IPR016187 (SUPERFAMILY); IPR000436 (SUPERFAMILY)
gi|545185832|ref|XP_005599772.1|	folliculin-interacting 1 isoform X1	1146	20	0E0	98%	15	F:GO:0005085; P:GO:0031929; P:GO:0009267; P:GO:0043547; P:GO:0000122; P:GO:0002327; C:GO:0005737; P:GO:0001932; P:GO:0043154; P:GO:0001934; P:GO:0002904; P:GO:2000973; P:GO:0032007; P:GO:0031334; P:GO:0033138	F:guanyl-nucleotide exchange factor activity; P:TOR signaling; P:cellular response to starvation; P:positive regulation of GTPase activity; P:negative regulation of transcription from RNA polymerase II promoter; P:immature B cell differentiation; C:cytoplasm; P:regulation of protein phosphorylation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of protein phosphorylation; P:positive regulation of B cell apoptotic process; P:regulation of pro-B cell differentiation; P:negative regulation of TOR signaling; P:positive regulation of protein complex assembly; P:positive regulation of peptidyl-serine phosphorylation		
gi|545186170|ref|XP_005599881.1|	mitotic checkpoint serine threonine- kinase BUB1	1023	20	0E0	89.35%	4	P:GO:0007094; F:GO:0005524; F:GO:0004672; P:GO:0006468	P:mitotic spindle assembly checkpoint; F:ATP binding; F:protein kinase activity; P:protein phosphorylation		IPR013212 (SMART); IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); IPR013212 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR015661 (PANTHER); PTHR14030:SF8 (PANTHER); IPR008271 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); IPR013212 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)
gi|545186204|ref|XP_005599894.1|	anaphase-promoting complex subunit 1 isoform X1	1944	20	0E0	98.75%	1	C:GO:0005680	C:anaphase-promoting complex		IPR024990 (PFAM); IPR024990 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|545186569|ref|XP_005599995.1|	SERTA domain-containing 2	315	20	0E0	92.65%	5	C:GO:0005634; F:GO:0003713; C:GO:0005737; P:GO:0030308; P:GO:0045893	C:nucleus; F:transcription coactivator activity; C:cytoplasm; P:negative regulation of cell growth; P:positive regulation of transcription, DNA-templated		IPR009263 (PFAM); PTHR16277:SF10 (PANTHER); PTHR16277 (PANTHER); IPR009263 (PROSITE_PROFILES)
gi|545186870|ref|XP_005600093.1|	ATP-dependent RNA helicase DHX57 isoform X1	1383	20	0E0	97.4%	5	F:GO:0003676; F:GO:0005524; F:GO:0005515; F:GO:0046872; F:GO:0004386	F:nucleic acid binding; F:ATP binding; F:protein binding; F:metal ion binding; F:helicase activity	EC:3.6.1; EC:3.6.1.15	IPR014001 (SMART); IPR000571 (SMART); IPR001650 (SMART); IPR015940 (SMART); IPR007502 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011709 (PFAM); IPR011545 (PFAM); IPR001650 (PFAM); IPR000571 (G3DSA:4.10.1000.GENE3D); IPR007502 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.8.10 (GENE3D); IPR000571 (PFAM); IPR006575 (PFAM); PTHR18934:SF145 (PANTHER); PTHR18934 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR015940 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR000571 (PROSITE_PROFILES); IPR009060 (SUPERFAMILY); IPR000571 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|545187530|ref|XP_005600315.1|	semaphorin-4C	674	20	0E0	96.7%	1	F:GO:0005515	F:protein binding		IPR001627 (SMART); IPR001627 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR027231 (PANTHER); PTHR11036:SF16 (PANTHER); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR001627 (PROSITE_PROFILES); IPR001627 (SUPERFAMILY)
gi|545187697|ref|XP_005600369.1|	kinase D-interacting substrate of 220 kDa isoform X3	1742	20	0E0	94.35%	1	F:GO:0005515	F:protein binding		IPR002110 (PRINTS); IPR002110 (SMART); IPR011646 (PFAM); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PF13637 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24116 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR013761 (SUPERFAMILY); IPR020683 (SUPERFAMILY)
gi|545187866|ref|XP_005600426.1|	ubiquitin-like modifier-activating enzyme ATG7 isoform X1	721	20	0E0	97.5%	3	C:GO:0005737; P:GO:0006914; F:GO:0008641	C:cytoplasm; P:autophagy; F:small protein activating enzyme activity		IPR006285 (TIGRFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR000594 (PFAM); IPR032197 (PFAM); IPR006285 (PTHR10953:PANTHER); PTHR10953 (PANTHER); IPR000594 (SUPERFAMILY)
gi|545187875|ref|XP_005600430.1|	sodium- and chloride-dependent GABA transporter 1	599	20	0E0	99.05%	7	C:GO:0005887; P:GO:0006836; P:GO:0006814; F:GO:0005328; F:GO:0005332; P:GO:0015846; P:GO:0015812	C:integral component of plasma membrane; P:neurotransmitter transport; P:sodium ion transport; F:neurotransmitter:sodium symporter activity; F:gamma-aminobutyric acid:sodium symporter activity; P:polyamine transport; P:gamma-aminobutyric acid transport		IPR000175 (PRINTS); IPR002980 (PRINTS); IPR000175 (PFAM); IPR000175 (PROSITE_PATTERNS); IPR000175 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000175 (PROSITE_PROFILES); SSF161070 (SUPERFAMILY)
gi|545188267|ref|XP_005600574.1|	monoacylglycerol lipase ABHD6 isoform X1	398	20	0E0	97.1%	1	F:GO:0003824	F:catalytic activity		IPR000073 (PRINTS); IPR000639 (PRINTS); IPR029058 (G3DSA:3.40.50.GENE3D); IPR000073 (PFAM); PTHR10992:SF910 (PANTHER); PTHR10992 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR029058 (SUPERFAMILY)
gi|545188348|ref|XP_005600604.1|	choline mitochondrial	594	20	0E0	95.05%	7	P:GO:0019285; F:GO:0050660; P:GO:0006563; P:GO:0055114; F:GO:0008812; P:GO:0006544; P:GO:0006566	P:glycine betaine biosynthetic process from choline; F:flavin adenine dinucleotide binding; P:L-serine metabolic process; P:oxidation-reduction process; F:choline dehydrogenase activity; P:glycine metabolic process; P:threonine metabolic process	EC:1.1.99.1	IPR012132 (PIRSF); IPR000172 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR007867 (PFAM); IPR011533 (TIGRFAM); PTHR11552:SF51 (PANTHER); PTHR11552 (PANTHER); IPR000172 (PROSITE_PATTERNS); IPR000172 (PROSITE_PATTERNS); SSF54373 (SUPERFAMILY); IPR023753 (SUPERFAMILY)
gi|545188361|ref|XP_005600608.1|	inter-alpha-trypsin inhibitor heavy chain H4 isoform X2	984	20	0E0	87.9%	2	F:GO:0004867; P:GO:0030212	F:serine-type endopeptidase inhibitor activity; P:hyaluronan metabolic process		IPR002035 (SMART); IPR013694 (SMART); IPR002035 (G3DSA:3.40.50.GENE3D); IPR002035 (PFAM); IPR010600 (PFAM); IPR013694 (PFAM); PTHR10338 (PANTHER); PTHR10338:SF119 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR013694 (PROSITE_PROFILES); IPR002035 (PROSITE_PROFILES); IPR002035 (SUPERFAMILY)
gi|545188499|ref|XP_005600664.1|	metabotropic glutamate receptor 2	872	20	0E0	98.2%	3	F:GO:0004930; P:GO:0007186; C:GO:0016021	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway; C:integral component of membrane		IPR000337 (PRINTS); IPR001458 (PRINTS); IPR000162 (PRINTS); G3DSA:3.40.50.2300 (GENE3D); IPR001828 (PFAM); IPR017978 (PFAM); IPR011500 (PFAM); G3DSA:3.40.50.2300 (GENE3D); PTHR24060 (PANTHER); PTHR24060:SF111 (PANTHER); IPR017979 (PROSITE_PATTERNS); IPR017979 (PROSITE_PATTERNS); IPR017979 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR017978 (PROSITE_PROFILES); IPR028082 (SUPERFAMILY)
gi|545189118|ref|XP_005600889.1|	TPR and ankyrin repeat-containing 1 isoform X1	2988	20	0E0	92.65%	2	F:GO:0005524; F:GO:0005515	F:ATP binding; F:protein binding		IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR014016 (PFAM); PTHR21529 (PANTHER); PTHR21529:SF4 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR011990 (SUPERFAMILY)
gi|545189374|ref|XP_001495285.4|	collagen alpha-6(VI) chain	2272	20	0E0	93.95%	2	C:GO:0005576; C:GO:0005578	C:extracellular region; C:proteinaceous extracellular matrix		PR00453 (PRINTS); IPR002035 (SMART); IPR002035 (G3DSA:3.40.50.GENE3D); IPR002035 (G3DSA:3.40.50.GENE3D); IPR002035 (PFAM); IPR008160 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); IPR002035 (G3DSA:3.40.50.GENE3D); PTHR11132:SF61 (PANTHER); PTHR11132 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR002035 (PROSITE_PROFILES); IPR002035 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR002035 (SUPERFAMILY)
gi|545189697|ref|XP_005614930.1|	transmembrane 115	262	20	0E0	94.15%	10	C:GO:0017119; C:GO:0005634; F:GO:0042802; P:GO:0006890; C:GO:0032580; C:GO:0016020; C:GO:0016021; P:GO:0006486; C:GO:0005794; C:GO:0005622	C:Golgi transport complex; C:nucleus; F:identical protein binding; P:retrograde vesicle-mediated transport, Golgi to ER; C:Golgi cisterna membrane; C:membrane; C:integral component of membrane; P:protein glycosylation; C:Golgi apparatus; C:intracellular		PTHR13377 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS)
gi|545189721|ref|XP_001495700.4|	histone-lysine N-methyltransferase SETD2	2548	20	0E0	96.05%	7	C:GO:0005634; F:GO:0005515; P:GO:0034968; F:GO:0018024; P:GO:0006355; C:GO:0005694; P:GO:0006554	C:nucleus; F:protein binding; P:histone lysine methylation; F:histone-lysine N-methyltransferase activity; P:regulation of transcription, DNA-templated; C:chromosome; P:lysine catabolic process	EC:2.1.1.43; EC:2.1.1	IPR003616 (SMART); IPR006560 (SMART); IPR001214 (SMART); IPR001202 (SMART); IPR001202 (PFAM); G3DSA:2.170.270.10 (GENE3D); IPR013257 (PFAM); IPR001214 (PFAM); G3DSA:2.20.70.10 (GENE3D); PTHR22884 (PANTHER); PTHR22884:SF344 (PANTHER); IPR001202 (PROSITE_PATTERNS); IPR001214 (PROSITE_PROFILES); IPR001202 (PROSITE_PROFILES); IPR003616 (PROSITE_PROFILES); IPR006560 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY); IPR001202 (SUPERFAMILY)
gi|545189786|ref|XP_005601115.1|	solute carrier organic anion transporter family member 2A1	668	20	0E0	92.05%	4	F:GO:0005515; C:GO:0016020; P:GO:0006810; F:GO:0005215	F:protein binding; C:membrane; P:transport; F:transporter activity		IPR004156 (PFAM); G3DSA:3.30.60.30 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR002350 (PFAM); IPR004156 (TIGRFAM); PTHR11388:SF14 (PANTHER); IPR004156 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR020846 (PROSITE_PROFILES); IPR002350 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); SSF100895 (SUPERFAMILY)
gi|545189792|ref|XP_005601117.1|	extended synaptotagmin-3	874	20	0E0	95.35%	2	F:GO:0005515; F:GO:0008289	F:protein binding; F:lipid binding		IPR000008 (PRINTS); IPR000008 (SMART); IPR000008 (G3DSA:2.60.40.GENE3D); IPR000008 (G3DSA:2.60.40.GENE3D); IPR031468 (PFAM); IPR000008 (PFAM); PTHR10774 (PANTHER); PTHR10774:SF74 (PANTHER); IPR000008 (PROSITE_PROFILES); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY)
gi|545190520|ref|XP_005601362.1|	importin-5	1037	20	0E0	99.6%	1	F:GO:0005515	F:protein binding		SM01349 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); PF13646 (PFAM); IPR000357 (PFAM); PTHR10527:SF22 (PANTHER); PTHR10527 (PANTHER); IPR016024 (SUPERFAMILY)
gi|545190662|ref|XP_005601414.1|	transcription factor Dp-1 isoform X1	413	20	0E0	98.25%	26	P:GO:0008283; P:GO:0008544; P:GO:0045944; P:GO:0000278; C:GO:0005654; C:GO:0005667; F:GO:0003700; P:GO:0006977; P:GO:0045893; P:GO:2000278; P:GO:0000080; P:GO:0070345; F:GO:0019904; P:GO:0006351; P:GO:1900740; P:GO:0006355; P:GO:0043276; F:GO:0008134; P:GO:0007049; P:GO:0006357; F:GO:0000981; F:GO:0003677; C:GO:0005634; F:GO:0005515; F:GO:0003713; C:GO:0005739	P:cell proliferation; P:epidermis development; P:positive regulation of transcription from RNA polymerase II promoter; P:mitotic cell cycle; C:nucleoplasm; C:transcription factor complex; F:transcription factor activity, sequence-specific DNA binding; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:positive regulation of transcription, DNA-templated; P:regulation of DNA biosynthetic process; P:mitotic G1 phase; P:negative regulation of fat cell proliferation; F:protein domain specific binding; P:transcription, DNA-templated; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of transcription, DNA-templated; P:anoikis; F:transcription factor binding; P:cell cycle; P:regulation of transcription from RNA polymerase II promoter; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; F:DNA binding; C:nucleus; F:protein binding; F:transcription coactivator activity; C:mitochondrion		
gi|545190669|ref|XP_001499088.3|	ras GTPase-activating 3	827	20	0E0	97.4%	3	F:GO:0005515; P:GO:0043087; P:GO:0035556	F:protein binding; P:regulation of GTPase activity; P:intracellular signal transduction		IPR001562 (PRINTS); IPR000008 (SMART); IPR001562 (SMART); IPR001849 (SMART); IPR001936 (SMART); IPR000008 (PFAM); IPR001849 (PFAM); IPR001936 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR001562 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR001936 (G3DSA:1.10.506.GENE3D); PTHR10194 (PANTHER); PTHR10194:SF53 (PANTHER); IPR023152 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR001936 (PROSITE_PROFILES); IPR001562 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR008936 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY)
gi|545190734|ref|XP_005601435.1|	unconventional myosin-XVI	1875	20	0E0	89%	4	C:GO:0016459; F:GO:0005524; F:GO:0005515; F:GO:0003774	C:myosin complex; F:ATP binding; F:protein binding; F:motor activity	EC:3.6.1; EC:3.6.1.15	IPR001609 (PRINTS); IPR001609 (SMART); IPR002110 (SMART); IPR020683 (PFAM); IPR001609 (PFAM); PF15439 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR13140 (PANTHER); IPR001609 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR020683 (SUPERFAMILY)
gi|545190736|ref|XP_005601436.1|	insulin receptor substrate 2	1437	20	0E0	90.15%	3	C:GO:0005899; P:GO:0007165; F:GO:0005158	C:insulin receptor complex; P:signal transduction; F:insulin receptor binding		IPR002404 (PRINTS); SM01244 (SMART); IPR002404 (SMART); IPR002404 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); PTHR10614:SF7 (PANTHER); PTHR10614 (PANTHER); IPR002404 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR011993 (SUPERFAMILY)
gi|545191036|ref|XP_001915750.3|	enhancer of polycomb homolog 2 isoform X1	807	20	0E0	98.85%	2	C:GO:0032777; P:GO:0006357	C:Piccolo NuA4 histone acetyltransferase complex; P:regulation of transcription from RNA polymerase II promoter		IPR009607 (PFAM); IPR019542 (PFAM); PTHR14898:SF4 (PANTHER); IPR024943 (PANTHER)
gi|545191056|ref|XP_001915890.3|	nebulin isoform X1	8071	20	0E0	84.6%	1	F:GO:0003779	F:actin binding		IPR013998 (PRINTS); IPR000900 (SMART); IPR001452 (SMART); IPR000900 (PFAM); IPR001452 (PFAM); G3DSA:2.30.30.40 (GENE3D); PTHR11039 (PANTHER); PTHR11039:SF37 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR000900 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY)
gi|545191816|ref|XP_005601791.1|	fibrous sheath-interacting 2	7016	20	0E0	88.25%	1	C:GO:0005739	C:mitochondrion		IPR031554 (PFAM); PTHR21856 (PANTHER); PTHR21856:SF6 (PANTHER)
gi|545191856|ref|XP_005601803.1|	partitioning defective 3 homolog B isoform X1	1206	20	0E0	94.55%	1	F:GO:0005515	F:protein binding		IPR001478 (SMART); IPR001478 (G3DSA:2.30.42.GENE3D); IPR001478 (PFAM); IPR021922 (PFAM); IPR001478 (G3DSA:2.30.42.GENE3D); PTHR16484:SF4 (PANTHER); PTHR16484 (PANTHER); IPR001478 (PROSITE_PROFILES); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY)
gi|545192045|ref|XP_001494218.3|	ECT2 isoform X1	914	20	0E0	97.75%	9	C:GO:0005634; P:GO:0035023; C:GO:0005737; P:GO:0000902; F:GO:0005096; P:GO:0043087; P:GO:0000910; P:GO:0045666; F:GO:0005089	C:nucleus; P:regulation of Rho protein signal transduction; C:cytoplasm; P:cell morphogenesis; F:GTPase activator activity; P:regulation of GTPase activity; P:cytokinesis; P:positive regulation of neuron differentiation; F:Rho guanyl-nucleotide exchange factor activity		IPR001357 (SMART); IPR000219 (SMART); IPR001357 (PFAM); IPR001357 (G3DSA:3.40.50.GENE3D); IPR001357 (PFAM); IPR000219 (PFAM); IPR000219 (G3DSA:1.20.900.GENE3D); IPR001357 (G3DSA:3.40.50.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR026817 (PANTHER); PTHR16777:SF2 (PANTHER); IPR001331 (PROSITE_PATTERNS); IPR001357 (PROSITE_PROFILES); IPR000219 (PROSITE_PROFILES); IPR001357 (SUPERFAMILY); IPR000219 (SUPERFAMILY); IPR001357 (SUPERFAMILY); IPR011993 (SUPERFAMILY)
gi|545192054|ref|XP_005601872.1|	neuroligin-1 isoform X3	823	20	0E0	99.1%	6	C:GO:0005887; P:GO:0050808; C:GO:0060076; F:GO:0042043; P:GO:0050804; P:GO:0007155	C:integral component of plasma membrane; P:synapse organization; C:excitatory synapse; F:neurexin family protein binding; P:modulation of synaptic transmission; P:cell adhesion		IPR000460 (PRINTS); IPR029058 (G3DSA:3.40.50.GENE3D); IPR002018 (PFAM); IPR030022 (PTHR11559:PANTHER); PTHR11559 (PANTHER); IPR019819 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR029058 (SUPERFAMILY)
gi|545192135|ref|XP_005601897.1|	multidrug resistance-associated 5 isoform X1	1437	20	0E0	98.45%	6	F:GO:0005524; F:GO:0042626; P:GO:0055085; C:GO:0016021; F:GO:0008514; P:GO:0015711	F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane; F:organic anion transmembrane transporter activity; P:organic anion transport	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR003593 (SMART); G3DSA:1.20.1560.10 (GENE3D); IPR003439 (PFAM); IPR011527 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR030238 (PTHR24223:PANTHER); PTHR24223 (PANTHER); IPR017871 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY)
gi|545192230|ref|XP_005601929.1|	alpha-2-HS-glyco	363	20	0E0	84%	2	C:GO:0005615; F:GO:0004869	C:extracellular space; F:cysteine-type endopeptidase inhibitor activity		IPR000010 (SMART); G3DSA:3.10.450.10 (GENE3D); IPR000010 (PFAM); IPR001363 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR025760 (PROSITE_PROFILES); SSF54403 (SUPERFAMILY); SSF54403 (SUPERFAMILY)
gi|545192331|ref|XP_005601955.1|	melanotransferrin	739	20	0E0	95.85%	1	C:GO:0005615	C:extracellular space		IPR001156 (PRINTS); IPR016357 (PIRSF); IPR001156 (SMART); G3DSA:3.40.190.10 (GENE3D); G3DSA:3.40.190.10 (GENE3D); G3DSA:3.40.190.10 (GENE3D); IPR001156 (PFAM); G3DSA:3.40.190.10 (GENE3D); PTHR11485:SF21 (PANTHER); PTHR11485 (PANTHER); IPR018195 (PROSITE_PATTERNS); IPR018195 (PROSITE_PATTERNS); IPR018195 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR001156 (PROSITE_PROFILES); SSF53850 (SUPERFAMILY); SSF53850 (SUPERFAMILY)
gi|545192406|ref|XP_005601980.1|	myosin light chain smooth muscle isoform X1	2069	20	0E0	88.95%	4	F:GO:0005524; F:GO:0005515; F:GO:0004672; P:GO:0006468	F:ATP binding; F:protein binding; F:protein kinase activity; P:protein phosphorylation		IPR003961 (SMART); IPR003598 (SMART); IPR000719 (SMART); IPR003599 (SMART); IPR003961 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:3.30.200.20 (GENE3D); PF16620 (PFAM); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR015725 (PTHR10489:PANTHER); PTHR10489 (PANTHER); IPR008271 (PROSITE_PATTERNS); IPR003961 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|545192467|ref|XP_005602003.1|	F-box only 40 isoform X1	710	20	0E0	95%	4	F:GO:0008270; F:GO:0061630; F:GO:0005515; P:GO:0016567	F:zinc ion binding; F:ubiquitin protein ligase activity; F:protein binding; P:protein ubiquitination		IPR001810 (PFAM); IPR001293 (PFAM); IPR013323 (G3DSA:3.90.890.GENE3D); G3DSA:1.20.1280.50 (GENE3D); IPR031890 (PANTHER); PTHR15933:SF1 (PANTHER); IPR001293 (PROSITE_PROFILES); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY); IPR008974 (SUPERFAMILY)
gi|545192701|ref|XP_005602084.1|	zona pellucida-like domain-containing 1	415	20	0E0	96.95%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		IPR001507 (SMART); IPR001507 (PFAM); PTHR24044 (PANTHER); PTHR24044:SF333 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR001507 (PROSITE_PROFILES)
gi|545193092|ref|XP_005602231.1|	short branched chain specific acyl- mitochondrial	432	20	0E0	92.5%	4	F:GO:0003995; P:GO:0006118; F:GO:0050660; P:GO:0055114	F:acyl-CoA dehydrogenase activity; P:obsolete electron transport; F:flavin adenine dinucleotide binding; P:oxidation-reduction process	EC:1.3.99.3	IPR006091 (PFAM); IPR013786 (G3DSA:1.10.540.GENE3D); IPR013786 (PFAM); G3DSA:1.20.140.10 (GENE3D); G3DSA:2.40.110.10 (GENE3D); IPR009075 (PFAM); PTHR10909 (PANTHER); PTHR10909:SF10 (PANTHER); IPR006089 (PROSITE_PATTERNS); IPR009075 (SUPERFAMILY); IPR009100 (SUPERFAMILY)
gi|545193295|ref|XP_005602303.1|	cilia- and flagella-associated 58	873	20	0E0	97.9%	1	C:GO:0005615	C:extracellular space		PTHR32083 (PANTHER); PTHR32083:SF31 (PANTHER)
gi|545194294|ref|XP_001500286.4|	metal transporter CNNM1 isoform X1	950	20	0E0	96.4%	1	C:GO:0005886	C:plasma membrane		IPR000644 (PFAM); G3DSA:3.10.580.10 (GENE3D); IPR014710 (G3DSA:2.60.120.GENE3D); IPR002550 (PFAM); PTHR12064:SF28 (PANTHER); PTHR12064 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000644 (PROSITE_PROFILES); SSF54631 (SUPERFAMILY)
gi|545194301|ref|XP_005602623.1|	slit homolog 1	1515	20	0E0	97.1%	2	F:GO:0005515; F:GO:0005509	F:protein binding; F:calcium ion binding		IPR000372 (SMART); IPR003645 (SMART); IPR000742 (SMART); IPR001791 (SMART); IPR003591 (SMART); IPR000483 (SMART); IPR001881 (SMART); SM00365 (SMART); IPR001791 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); IPR013032 (PFAM); IPR001611 (PFAM); IPR000483 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR013320 (G3DSA:2.60.120.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR000372 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR000742 (PFAM); G3DSA:2.170.300.10 (GENE3D); PTHR24373:SF39 (PANTHER); PTHR24373 (PANTHER); IPR013032 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR001611 (PROSITE_PROFILES); IPR001791 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY); IPR009030 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR032675 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR032675 (SUPERFAMILY)
gi|545194798|ref|XP_001916002.3|	pro-interleukin-16 isoform X2	1371	20	0E0	86.95%	2	P:GO:0007165; F:GO:0005125	P:signal transduction; F:cytokine activity		IPR020450 (PRINTS); IPR001478 (SMART); IPR001478 (PFAM); IPR001478 (G3DSA:2.30.42.GENE3D); IPR001478 (G3DSA:2.30.42.GENE3D); PTHR11324 (PANTHER); PTHR11324:SF2 (PANTHER); IPR001478 (PROSITE_PROFILES); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY)
gi|545194804|ref|XP_005602809.1|	ADAMTS 3 isoform X1	1692	20	0E0	92.55%	4	F:GO:0008270; F:GO:0005515; C:GO:0005578; F:GO:0008237	F:zinc ion binding; F:protein binding; C:proteinaceous extracellular matrix; F:metallopeptidase activity		IPR013273 (PRINTS); IPR003599 (SMART); IPR003598 (SMART); IPR000884 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013098 (PFAM); G3DSA:2.20.100.10 (GENE3D); IPR000884 (PFAM); G3DSA:2.20.100.10 (GENE3D); IPR010909 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR13723 (PANTHER); PTHR13723:SF169 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR000884 (PROSITE_PROFILES); IPR010909 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|545194992|ref|XP_005602874.1|	multiple C2 and transmembrane domain-containing 2 isoform X1	879	20	0E0	96.45%	6	C:GO:0005737; F:GO:0005509; C:GO:0016020; C:GO:0016021; C:GO:0005783; C:GO:0005654	C:cytoplasm; F:calcium ion binding; C:membrane; C:integral component of membrane; C:endoplasmic reticulum; C:nucleoplasm		
gi|545195150|ref|XP_005602925.1|	TBC1 domain family member 2B isoform X1	838	20	0E0	96.8%	7	P:GO:0031338; P:GO:0090630; F:GO:0005096; C:GO:0012505; P:GO:0006886; F:GO:0017137; C:GO:0005622	P:regulation of vesicle fusion; P:activation of GTPase activity; F:GTPase activator activity; C:endomembrane system; P:intracellular protein transport; F:Rab GTPase binding; C:intracellular		
gi|545195579|ref|XP_005603073.1|	unconventional myosin-Ie	1109	20	0E0	97.55%	4	C:GO:0016459; F:GO:0005524; F:GO:0005515; F:GO:0003774	C:myosin complex; F:ATP binding; F:protein binding; F:motor activity	EC:3.6.1; EC:3.6.1.15	IPR001452 (PRINTS); IPR001609 (PRINTS); IPR001452 (SMART); IPR001609 (SMART); IPR001452 (PFAM); IPR010926 (PFAM); IPR001609 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR13140 (PANTHER); PTHR13140:SF288 (PANTHER); IPR000048 (PROSITE_PROFILES); IPR010926 (PROSITE_PROFILES); IPR001609 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR001452 (SUPERFAMILY)
gi|545195666|ref|XP_005603101.1|	unconventional myosin-Vc	1742	20	0E0	97.65%	8	F:GO:0000166; C:GO:0016459; F:GO:0005524; F:GO:0005516; C:GO:0070062; F:GO:0003779; F:GO:0046872; F:GO:0003774	F:nucleotide binding; C:myosin complex; F:ATP binding; F:calmodulin binding; C:extracellular exosome; F:actin binding; F:metal ion binding; F:motor activity		
gi|545195878|ref|XP_001503318.3|	zinc finger 106 isoform X1	1902	20	0E0	94.6%	2	F:GO:0046872; F:GO:0044822	F:metal ion binding; F:poly(A) RNA binding		
gi|545196100|ref|XP_005603236.1|	kelch 33	737	20	0E0	94.2%	5	F:GO:0004842; F:GO:0003779; C:GO:0015629; C:GO:0031463; P:GO:0016567	F:ubiquitin-protein transferase activity; F:actin binding; C:actin cytoskeleton; C:Cul3-RING ubiquitin ligase complex; P:protein ubiquitination		
gi|545196159|ref|XP_005603258.1|	zinc finger 219	715	20	0E0	95.7%	2	F:GO:0003676; F:GO:0046872	F:nucleic acid binding; F:metal ion binding		IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR23233:SF47 (PANTHER); PTHR23233 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|545196402|ref|XP_005615273.1|	vesicular acetylcholine transporter	526	20	0E0	92.3%	2	P:GO:0055085; C:GO:0016021	P:transmembrane transport; C:integral component of membrane		IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23506:SF13 (PANTHER); PTHR23506 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY)
gi|545196447|ref|XP_005603350.1|	alpha- kinase 3	1652	20	0E0	88.95%	5	F:GO:0005524; F:GO:0005515; P:GO:0009069; F:GO:0004674; P:GO:0006468	F:ATP binding; F:protein binding; P:serine family amino acid metabolic process; F:protein serine/threonine kinase activity; P:protein phosphorylation	EC:2.7.11	IPR003598 (SMART); IPR004166 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR004166 (PFAM); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR10489 (PANTHER); PTHR10489:SF667 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR004166 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR011009 (SUPERFAMILY)
gi|545196477|ref|XP_005614856.1|		1375				4	F:GO:0008307; P:GO:0045104; C:GO:0005882; F:GO:0005200	F:structural constituent of muscle; P:intermediate filament cytoskeleton organization; C:intermediate filament; F:structural constituent of cytoskeleton		G3DSA:1.20.5.170 (GENE3D); IPR001664 (PFAM); IPR030634 (PTHR23239:PANTHER); IPR001664 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY)
gi|545196702|ref|XP_005603439.1|	X-linked retinitis pigmentosa GTPase regulator-interacting 1	1278	20	0E0	89%	4	C:GO:0032391; F:GO:0005515; P:GO:0042462; P:GO:0007601	C:photoreceptor connecting cilium; F:protein binding; P:eye photoreceptor cell development; P:visual perception		IPR000008 (SMART); IPR021656 (PFAM); IPR000008 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR031134 (PTHR14240:PANTHER); IPR031139 (PANTHER); IPR000008 (PROSITE_PROFILES); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY)
gi|545196987|ref|XP_005603533.1|	NF-kappa-B inhibitor alpha	508	20	0E0	95.45%	1	F:GO:0005515	F:protein binding		IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR002110 (PFAM); PTHR24139:SF36 (PANTHER); PTHR24139 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY)
gi|545197010|ref|XP_005603540.1|	kintoun isoform X1	524	20	0E0	80.4%	10	P:GO:0010033; P:GO:0032526; F:GO:0005515; C:GO:0005737; P:GO:0070286; P:GO:0060285; P:GO:0098779; P:GO:0071973; P:GO:0002230; P:GO:0098792	P:response to organic substance; P:response to retinoic acid; F:protein binding; C:cytoplasm; P:axonemal dynein complex assembly; P:cilium-dependent cell motility; P:mitophagy in response to mitochondrial depolarization; P:bacterial-type flagellum-dependent cell motility; P:positive regulation of defense response to virus by host; P:xenophagy		IPR012981 (PFAM); PTHR22997:SF3 (PANTHER); IPR012981 (PANTHER); PD319978 (PRODOM)
gi|545197296|ref|XP_005603642.1|	Jumonji isoform X1	1250	20	0E0	97%	1	F:GO:0003677	F:DNA binding		IPR003349 (SMART); IPR003347 (SMART); SM01014 (SMART); IPR001606 (SMART); IPR004198 (PFAM); IPR001606 (G3DSA:1.10.150.GENE3D); IPR003349 (PFAM); IPR003347 (PFAM); IPR001606 (PFAM); PTHR10694:SF44 (PANTHER); PTHR10694 (PANTHER); IPR003349 (PROSITE_PROFILES); IPR003347 (PROSITE_PROFILES); IPR001606 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY); IPR001606 (SUPERFAMILY)
gi|545198151|ref|XP_001918195.3|	dynein heavy chain axonemal	4610	20	0E0	97.85%	6	F:GO:0016887; F:GO:0005524; F:GO:0003777; C:GO:0030286; P:GO:0007018; C:GO:0005874	F:ATPase activity; F:ATP binding; F:microtubule motor activity; C:dynein complex; P:microtubule-based movement; C:microtubule	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR003593 (SMART); PF12775 (PFAM); IPR024743 (PFAM); PF12781 (PFAM); IPR011704 (PFAM); IPR013594 (PFAM); IPR024317 (PFAM); PF12774 (PFAM); IPR013602 (PFAM); IPR004273 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR026983 (PANTHER); PTHR10676:SF280 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|545198253|ref|XP_001501224.2|	prickle 4	416	20	0E0	88.95%	1	F:GO:0008270	F:zinc ion binding		IPR001781 (SMART); IPR001781 (PFAM); IPR001781 (G3DSA:2.10.110.GENE3D); IPR010442 (PFAM); IPR001781 (G3DSA:2.10.110.GENE3D); PTHR24214:SF34 (PANTHER); PTHR24214 (PANTHER); IPR001781 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR010442 (PROSITE_PROFILES); IPR001781 (PROSITE_PROFILES); SSF57716 (SUPERFAMILY)
gi|545198533|ref|XP_005604055.1|	dystonin isoform X2	1558	20	0E0	94.9%	4	P:GO:0016337; C:GO:0005856; F:GO:0050839; C:GO:0030054	P:single organismal cell-cell adhesion; C:cytoskeleton; F:cell adhesion molecule binding; C:cell junction		IPR001101 (SMART); IPR001101 (G3DSA:3.90.1290.GENE3D); IPR001101 (PFAM); IPR001101 (G3DSA:3.90.1290.GENE3D); IPR028462 (PTHR11915:PANTHER); PTHR11915 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SSF57997 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY)
gi|545199064|ref|XP_005604222.1|	NACHT domain- and WD repeat-containing 1	1497	20	0E0	87.35%	1	F:GO:0005515	F:protein binding		IPR001680 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); PF05729 (PFAM); IPR024977 (PFAM); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22847:SF472 (PANTHER); PTHR22847 (PANTHER); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); SSF69322 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|545199068|ref|XP_005615291.1|	C3 and PZP-like alpha-2-macroglobulin domain-containing 8	1016	20	0E0	84%	2	C:GO:0005615; F:GO:0004866	C:extracellular space; F:endopeptidase inhibitor activity		IPR009048 (SMART); IPR001599 (SMART); IPR009048 (PFAM); IPR022041 (PFAM); IPR008930 (G3DSA:1.50.10.GENE3D); IPR019565 (PFAM); IPR001599 (PFAM); IPR011626 (PFAM); IPR009048 (G3DSA:2.60.40.GENE3D); PTHR11412:SF84 (PANTHER); PTHR11412 (PANTHER); IPR014756 (SUPERFAMILY); IPR009048 (SUPERFAMILY); IPR008930 (SUPERFAMILY)
gi|545199225|ref|XP_005604281.1|	E3 ubiquitin- ligase TRIM23	574	20	0E0	99.1%	5	F:GO:0005525; F:GO:0008270; F:GO:0005515; P:GO:0007264; C:GO:0005622	F:GTP binding; F:zinc ion binding; F:protein binding; P:small GTPase mediated signal transduction; C:intracellular		IPR006689 (PRINTS); IPR001841 (SMART); IPR003649 (SMART); SM00178 (SMART); IPR000315 (SMART); SM00177 (SMART); SM00175 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001841 (PFAM); IPR006689 (PFAM); IPR000315 (PFAM); IPR005225 (TIGRFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR11711 (PANTHER); IPR017907 (PROSITE_PATTERNS); IPR024156 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR000315 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF57850 (SUPERFAMILY); SSF57845 (SUPERFAMILY)
gi|545199310|ref|XP_005604311.1|	ankyrin repeat domain-containing 55	613	20	0E0	94.85%	1	F:GO:0005515	F:protein binding		IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24158 (PANTHER); PTHR24158:SF24 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY)
gi|545199428|ref|XP_005604353.1|	complement component C7	843	20	0E0	93.6%	3	C:GO:0005579; F:GO:0005515; P:GO:0006955	C:membrane attack complex; F:protein binding; P:immune response		PR01705 (PRINTS); IPR001862 (PRINTS); IPR002172 (SMART); IPR000884 (SMART); IPR020864 (SMART); IPR000436 (SMART); IPR003884 (SMART); G3DSA:2.10.70.10 (GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR020864 (PFAM); IPR002172 (PFAM); IPR000884 (PFAM); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.20.100.10 (GENE3D); IPR000436 (PFAM); PTHR19325:SF389 (PANTHER); PTHR19325 (PANTHER); IPR023415 (PROSITE_PATTERNS); IPR020863 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR000884 (PROSITE_PROFILES); IPR000436 (PROSITE_PROFILES); IPR002172 (PROSITE_PROFILES); IPR020864 (PROSITE_PROFILES); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR000884 (SUPERFAMILY)
gi|545199437|ref|XP_005604354.1|	FYN-binding isoform X1	836	20	0E0	93%	3	F:GO:0005515; P:GO:0006955; C:GO:0015629	F:protein binding; P:immune response; C:actin cytoskeleton		IPR001452 (SMART); IPR011511 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR029294 (PFAM); PTHR16830 (PANTHER); IPR030635 (PTHR16830:PANTHER); IPR001452 (SUPERFAMILY); IPR001452 (SUPERFAMILY)
gi|545199569|ref|XP_005604401.1|	ankyrin repeat domain-containing 33B	307	20	0E0	91.75%	1	F:GO:0005515	F:protein binding		IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); PTHR24173 (PANTHER); PTHR24173:SF1 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY)
gi|545199721|ref|XP_005604453.1|	myotubularin-related 12	738	20	0E0	96.75%	1	F:GO:0019208	F:phosphatase regulator activity		IPR022587 (PFAM); IPR010569 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR030564 (PANTHER); IPR030576 (PTHR10807:PANTHER); IPR010569 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR029021 (SUPERFAMILY)
gi|545199735|ref|XP_005604459.1|	dynein heavy chain axonemal	4634	20	0E0	96.8%	16	F:GO:0016887; C:GO:0036157; P:GO:0036158; P:GO:0003341; P:GO:0007018; P:GO:0007368; C:GO:0005930; F:GO:0000166; P:GO:0007507; F:GO:0005524; F:GO:0003777; P:GO:0021670; P:GO:0030317; C:GO:0005858; P:GO:0042384; C:GO:0030286	F:ATPase activity; C:outer dynein arm; P:outer dynein arm assembly; P:cilium movement; P:microtubule-based movement; P:determination of left/right symmetry; C:axoneme; F:nucleotide binding; P:heart development; F:ATP binding; F:microtubule motor activity; P:lateral ventricle development; P:flagellated sperm motility; C:axonemal dynein complex; P:cilium assembly; C:dynein complex		
gi|545199758|ref|XP_005615297.1|	pleckstrin homology domain-containing family G member 4B	1087	20	0E0	75.65%	3	P:GO:0035023; P:GO:0043087; F:GO:0005089	P:regulation of Rho protein signal transduction; P:regulation of GTPase activity; F:Rho guanyl-nucleotide exchange factor activity		IPR001849 (SMART); IPR000219 (SMART); IPR001849 (PFAM); IPR000219 (PFAM); IPR000219 (G3DSA:1.20.900.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); PTHR22826:SF119 (PANTHER); PTHR22826 (PANTHER); IPR001849 (PROSITE_PROFILES); IPR000219 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR000219 (SUPERFAMILY)
gi|545199863|ref|XP_005604508.1|	crooked neck 1	687	20	0E0	99.05%	2	F:GO:0005515; P:GO:0006396	F:protein binding; P:RNA processing		IPR003107 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR003107 (PFAM); PTHR11246 (PANTHER); IPR013026 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY)
gi|545199964|ref|XP_001493549.2|	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1	1206	20	0E0	99.05%	14	C:GO:0014069; P:GO:0007165; C:GO:0005790; F:GO:0004871; C:GO:0005622; C:GO:0030425; C:GO:0005634; F:GO:0004435; F:GO:0005509; P:GO:0006629; P:GO:0016042; F:GO:0008081; P:GO:0035556; F:GO:0016787	C:postsynaptic density; P:signal transduction; C:smooth endoplasmic reticulum; F:signal transducer activity; C:intracellular; C:dendrite; C:nucleus; F:phosphatidylinositol phospholipase C activity; F:calcium ion binding; P:lipid metabolic process; P:lipid catabolic process; F:phosphoric diester hydrolase activity; P:intracellular signal transduction; F:hydrolase activity		
gi|545200274|ref|XP_005604637.1|	E3 ubiquitin- ligase Itchy homolog	862	20	0E0	98.5%	3	F:GO:0004842; F:GO:0005515; P:GO:0016567	F:ubiquitin-protein transferase activity; F:protein binding; P:protein ubiquitination		IPR001202 (SMART); IPR000008 (SMART); IPR024928 (PIRSF); IPR000569 (SMART); IPR000008 (G3DSA:2.60.40.GENE3D); G3DSA:2.20.70.10 (GENE3D); G3DSA:3.30.2160.10 (GENE3D); G3DSA:2.20.70.10 (GENE3D); G3DSA:2.20.70.10 (GENE3D); IPR000569 (PFAM); IPR001202 (PFAM); IPR000008 (PFAM); PTHR11254 (PANTHER); PTHR11254:SF66 (PANTHER); IPR001202 (PROSITE_PATTERNS); IPR000569 (PROSITE_PROFILES); IPR001202 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR001202 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR001202 (SUPERFAMILY); IPR001202 (SUPERFAMILY); IPR000569 (SUPERFAMILY); IPR001202 (SUPERFAMILY)
gi|545200409|ref|XP_005604683.1|	TELO2-interacting 1 homolog	1092	20	0E0	94.9%	1	F:GO:0005488	F:binding		IPR016441 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR18460 (PANTHER); IPR016024 (SUPERFAMILY)
gi|545200800|ref|XP_005604817.1|	probable ATP-dependent RNA helicase DHX35 isoform X1	716	20	0E0	99.1%	3	F:GO:0003676; F:GO:0005524; F:GO:0008026	F:nucleic acid binding; F:ATP binding; F:ATP-dependent helicase activity	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR014001 (SMART); IPR007502 (SMART); IPR001650 (SMART); IPR007502 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011709 (PFAM); PTHR18934 (PANTHER); IPR002464 (PROSITE_PATTERNS); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
gi|545200835|ref|XP_005604829.1|	brefeldin A-inhibited guanine nucleotide-exchange 2 isoform X1	1786	20	0E0	98.35%	4	F:GO:0005086; P:GO:0043087; P:GO:0032012; F:GO:0005488	F:ARF guanyl-nucleotide exchange factor activity; P:regulation of GTPase activity; P:regulation of ARF protein signal transduction; F:binding		IPR000904 (SMART); IPR015403 (PFAM); G3DSA:1.10.220.20 (GENE3D); IPR032691 (PFAM); IPR000904 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR023394 (G3DSA:1.10.1000.GENE3D); IPR032629 (PFAM); PTHR10663 (PANTHER); PTHR10663:SF124 (PANTHER); IPR000904 (PROSITE_PROFILES); IPR000904 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
gi|545201386|ref|XP_001488484.3|	guanine deaminase	454	20	0E0	96.5%	3	F:GO:0008270; F:GO:0008892; P:GO:0006147	F:zinc ion binding; F:guanine deaminase activity; P:guanine catabolic process	EC:3.5.4.3	IPR006680 (PFAM); IPR014311 (TIGRFAM); G3DSA:3.20.20.140 (GENE3D); IPR014311 (PTHR11271:PANTHER); PTHR11271 (PANTHER); IPR032466 (SUPERFAMILY)
gi|545201420|ref|XP_005605025.1|	tight junction ZO-2 isoform X2	1151	20	0E0	96.1%	2	C:GO:0005923; F:GO:0005515	C:bicellular tight junction; F:protein binding		IPR005419 (PRINTS); IPR005417 (PRINTS); IPR001478 (SMART); IPR008145 (SMART); IPR008145 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR001478 (G3DSA:2.30.42.GENE3D); IPR001478 (G3DSA:2.30.42.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001478 (G3DSA:2.30.42.GENE3D); IPR001478 (PFAM); IPR011511 (PFAM); PTHR13865 (PANTHER); PTHR13865:SF26 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR001478 (PROSITE_PROFILES); IPR008144 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY)
gi|545201519|ref|XP_005605057.1|	E3 ubiquitin- ligase UHRF2	536	20	0E0	98.55%	2	F:GO:0008270; F:GO:0042393	F:zinc ion binding; F:histone binding		IPR003105 (SMART); IPR001965 (SMART); IPR003105 (G3DSA:2.30.280.GENE3D); IPR021991 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR003105 (PFAM); IPR014722 (G3DSA:2.30.30.GENE3D); IPR019787 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR14140:SF3 (PANTHER); PTHR14140 (PANTHER); IPR019786 (PROSITE_PATTERNS); IPR003105 (PROSITE_PROFILES); IPR019787 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY); IPR015947 (SUPERFAMILY); SSF57850 (SUPERFAMILY)
gi|545201580|ref|XP_005605082.1|	stabilizer of axonemal microtubules 1	477	20	0E0	93.2%	2	C:GO:0045298; F:GO:0008017	C:tubulin complex; F:microtubule binding		PTHR31516:SF9 (PANTHER); IPR033336 (PANTHER)
gi|545201883|ref|XP_005605187.1|	spermatogenesis-associated 31D3	1571	20	0E0	82.55%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		PF14650 (PFAM); IPR027970 (PFAM); PTHR21859:SF12 (PANTHER); PTHR21859 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS)
gi|545202812|ref|XP_005605508.1|	retrotransposon 1	1349	20	0E0	87.5%	3	P:GO:0007275; C:GO:0016020; C:GO:0016021	P:multicellular organism development; C:membrane; C:integral component of membrane		IPR032549 (PFAM); PTHR15503:SF9 (PANTHER); IPR032567 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR021109 (SUPERFAMILY); SSF56672 (SUPERFAMILY)
gi|545203052|ref|XP_005605599.1|	echinoderm microtubule-associated -like 5 isoform X1	2016	20	0E0	98.15%	1	F:GO:0005515	F:protein binding		IPR001680 (SMART); IPR001680 (PFAM); IPR024977 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR005108 (PFAM); PTHR13720:SF16 (PANTHER); PTHR13720 (PANTHER); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR017986 (SUPERFAMILY); IPR017986 (SUPERFAMILY); IPR017986 (SUPERFAMILY); IPR017986 (SUPERFAMILY); IPR017986 (SUPERFAMILY)
gi|545203082|ref|XP_005605609.1|	autophagy-related 2 homolog B	2133	20	0E0	97.45%	1	P:GO:0006914	P:autophagy		IPR026854 (PFAM); IPR015412 (PFAM); IPR026885 (PFAM); IPR026849 (PANTHER); PTHR13190:SF20 (PANTHER)
gi|545203109|ref|XP_005605615.1|	MAP microtubule affinity-regulating kinase 3 isoform X6	765	20	0E0	98.95%	6	F:GO:0005524; P:GO:0030010; P:GO:0000226; P:GO:0009069; F:GO:0004674; P:GO:0006468	F:ATP binding; P:establishment of cell polarity; P:microtubule cytoskeleton organization; P:serine family amino acid metabolic process; F:protein serine/threonine kinase activity; P:protein phosphorylation	EC:2.7.11	IPR000719 (SMART); IPR015940 (SMART); IPR028375 (G3DSA:3.30.310.GENE3D); IPR015940 (PFAM); IPR001772 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.8.10 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); IPR033628 (PTHR24346:PANTHER); IPR033624 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR015940 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR001772 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR028375 (SUPERFAMILY)
gi|545203252|ref|XP_005605667.1|	transmembrane 8B isoform X2	932	20	0E0	94.1%	5	P:GO:0007160; C:GO:0016020; C:GO:0016021; C:GO:0005886; C:GO:0009986	P:cell-matrix adhesion; C:membrane; C:integral component of membrane; C:plasma membrane; C:cell surface		IPR021910 (PFAM); PTHR14319 (PANTHER); PTHR14319:SF6 (PANTHER); IPR013032 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|545203495|ref|XP_005605741.1|	Krueppel-like factor 4	485	20	0E0	96.6%	2	F:GO:0003676; F:GO:0046872	F:nucleic acid binding; F:metal ion binding		IPR015880 (SMART); IPR007087 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24409 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|545203567|ref|XP_005605766.1|	major allergen Equ c 1-like	179	20	1.63E-127	86.7%	3	F:GO:0005550; P:GO:0006810; F:GO:0005215	F:pheromone binding; P:transport; F:transporter activity		IPR002971 (PRINTS); IPR000566 (PFAM); IPR012674 (G3DSA:2.40.128.GENE3D); PTHR11430:SF76 (PANTHER); PTHR11430 (PANTHER); IPR022272 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR011038 (SUPERFAMILY)
gi|545203957|ref|XP_005605903.1|	nucleoporin GLE1	698	20	0E0	95.45%	2	P:GO:0016973; C:GO:0005643	P:poly(A)+ mRNA export from nucleus; C:nuclear pore		IPR012476 (PFAM); PTHR12960:SF0 (PANTHER); IPR012476 (PANTHER)
gi|545204435|ref|XP_001487981.4|	pappalysin-1	1525	20	0E0	97.65%	2	P:GO:0006508; F:GO:0004222	P:proteolysis; F:metalloendopeptidase activity	EC:3.4.24	IPR006558 (SMART); IPR000436 (SMART); IPR000800 (SMART); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); IPR000436 (PFAM); IPR011936 (TIGRFAM); IPR013320 (G3DSA:2.60.120.GENE3D); PF13385 (PFAM); IPR008754 (PFAM); G3DSA:2.10.70.10 (GENE3D); IPR024079 (G3DSA:3.40.390.GENE3D); PTHR19325 (PANTHER); IPR030433 (PTHR19325:PANTHER); IPR000436 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY); IPR000436 (SUPERFAMILY); SSF55486 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); SSF55486 (SUPERFAMILY); IPR000436 (SUPERFAMILY)
gi|545204553|ref|XP_005614927.1|	sulfhydryl oxidase 2	649	20	0E0	89.6%	2	P:GO:0055114; F:GO:0016972	P:oxidation-reduction process; F:thiol oxidase activity	EC:1.8.3.2	IPR017905 (PFAM); IPR017905 (G3DSA:1.20.120.GENE3D); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR22897:SF7 (PANTHER); PTHR22897 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR017905 (PROSITE_PROFILES); IPR017905 (SUPERFAMILY)
gi|545204720|ref|XP_001915227.3|	E3 ubiquitin- ligase listerin	1766	20	0E0	97%	2	F:GO:0008270; F:GO:0005515	F:zinc ion binding; F:protein binding		IPR011016 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001841 (PFAM); PTHR12389 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
gi|545204748|ref|XP_001499313.2|	keratin-associated 13-1	171	20	8.96E-109	80.05%	1	C:GO:0005882	C:intermediate filament		IPR007951 (PFAM); IPR007951 (PANTHER)
gi|545204867|ref|XP_005606212.1|	bromodomain and WD repeat-containing 1 isoform X1	2190	20	0E0	94.2%	1	F:GO:0005515	F:protein binding		IPR001487 (PRINTS); IPR001680 (SMART); IPR001487 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001487 (G3DSA:1.20.920.GENE3D); IPR001680 (PFAM); IPR001487 (G3DSA:1.20.920.GENE3D); IPR001487 (PFAM); PTHR16266:SF26 (PANTHER); PTHR16266 (PANTHER); IPR019775 (PROSITE_PATTERNS); IPR018359 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001487 (SUPERFAMILY); IPR001487 (SUPERFAMILY); IPR017986 (SUPERFAMILY)
gi|545204888|ref|XP_005606218.1|	zinc finger and BTB domain-containing 21 isoform X1	1060	20	0E0	92.85%	3	F:GO:0003676; F:GO:0005515; F:GO:0046872	F:nucleic acid binding; F:protein binding; F:metal ion binding		IPR000210 (SMART); IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); G3DSA:3.30.710.10 (GENE3D); IPR000210 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR19303 (PANTHER); PTHR19303:SF268 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR000210 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR011333 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|545205072|ref|XP_001496737.4|	39S ribosomal mitochondrial	433	20	0E0	94.25%	1	F:GO:0000166	F:nucleotide binding		G3DSA:3.30.54.20 (GENE3D); IPR012675 (G3DSA:3.10.20.GENE3D); G3DSA:3.30.980.10 (GENE3D); PTHR11451:SF34 (PANTHER); PTHR11451 (PANTHER); IPR018163 (SUPERFAMILY); IPR012676 (SUPERFAMILY)
gi|545205171|ref|XP_005606315.1|	chondroitin sulfate N-acetylgalactosaminyltransferase 1	532	20	0E0	96.35%	2	C:GO:0032580; F:GO:0008376	C:Golgi cisterna membrane; F:acetylgalactosaminyltransferase activity	EC:2.4.1	IPR008428 (PFAM); IPR029044 (G3DSA:3.90.550.GENE3D); PTHR12369 (PANTHER); PTHR12369:SF19 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR029044 (SUPERFAMILY)
gi|545206183|ref|XP_005606626.1|	F-box only 7 isoform X2	444	20	0E0	95.5%	1	F:GO:0005515	F:protein binding		G3DSA:1.20.1280.50 (GENE3D); IPR001810 (PFAM); IPR021625 (PFAM); PTHR15537:SF2 (PANTHER); PTHR15537 (PANTHER); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY)
gi|545206743|ref|XP_005606819.1|	zinc finger BED domain-containing 4	1174	20	0E0	93.85%	2	F:GO:0003677; F:GO:0046983	F:DNA binding; F:protein dimerization activity		IPR003656 (SMART); IPR003656 (PFAM); IPR008906 (PFAM); PTHR23272:SF6 (PANTHER); PTHR23272 (PANTHER); IPR003656 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF140996 (SUPERFAMILY); IPR012337 (SUPERFAMILY)
gi|545206745|ref|XP_005606820.1|	EF-hand calcium-binding domain-containing 6	1521	20	0E0	89.45%	1	F:GO:0005509	F:calcium ion binding		IPR002048 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR002048 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); IPR015070 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR10891 (PANTHER); PTHR10891:SF632 (PANTHER); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR011992 (SUPERFAMILY)
gi|545206886|ref|XP_005606871.1|	arylsulfatase A	507	20	0E0	95.4%	2	F:GO:0008484; P:GO:0008152	F:sulfuric ester hydrolase activity; P:metabolic process		IPR000917 (PFAM); IPR017849 (G3DSA:3.40.720.GENE3D); PF14707 (PFAM); G3DSA:3.30.1120.10 (GENE3D); PTHR10342:SF229 (PANTHER); PTHR10342 (PANTHER); IPR024607 (PROSITE_PATTERNS); IPR024607 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR017850 (SUPERFAMILY)
gi|545207429|ref|XP_005607039.1|	zinc finger E-box-binding homeobox 1 isoform X1	1141	20	0E0	94.2%	2	F:GO:0003677; F:GO:0046872	F:DNA binding; F:metal ion binding		IPR001356 (SMART); IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR001356 (PFAM); IPR008598 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24391:SF17 (PANTHER); PTHR24391 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); IPR009057 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|545207444|ref|XP_005607044.1|	ankyrin repeat domain-containing 26	1831	20	0E0	91.7%	1	F:GO:0005515	F:protein binding		IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR021885 (PFAM); IPR002110 (PFAM); PF14915 (PFAM); IPR020683 (PFAM); PTHR24147 (PANTHER); PTHR24147:SF24 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY)
gi|545208018|ref|XP_005607229.1|	zinc finger ZFP69B	534	20	0E0	94.45%	6	F:GO:0003676; C:GO:0005667; F:GO:0003700; F:GO:0046872; P:GO:0006355; P:GO:0006355	F:nucleic acid binding; C:transcription factor complex; F:transcription factor activity, sequence-specific DNA binding; F:metal ion binding; P:regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated		IPR001909 (SMART); IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR003309 (PFAM); IPR007087 (PFAM); IPR001909 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); PTHR24381:SF135 (PANTHER); PTHR24381 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); IPR003309 (PROSITE_PROFILES); IPR001909 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); IPR008916 (SUPERFAMILY); IPR001909 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|545208907|ref|XP_005607523.1|	transmembrane 200B	241	20	2.6E-169	91.5%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		IPR018787 (PFAM); PTHR31815 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS)
gi|545209044|ref|XP_001489243.4|	kazrin isoform X1	681	20	0E0	99.05%	1	F:GO:0005515	F:protein binding		IPR001660 (SMART); IPR013761 (G3DSA:1.10.150.GENE3D); IPR013761 (G3DSA:1.10.150.GENE3D); IPR001660 (PFAM); IPR001660 (PFAM); PTHR12776:SF1 (PANTHER); PTHR12776 (PANTHER); IPR001660 (PROSITE_PROFILES); IPR013761 (SUPERFAMILY); IPR013761 (SUPERFAMILY); IPR013761 (SUPERFAMILY)
gi|545209255|ref|XP_005607631.1|	WD repeat-containing WRAP73 isoform X1	513	20	0E0	95.8%	5	C:GO:0005813; C:GO:0005737; C:GO:0036064; P:GO:1902857; P:GO:0090307	C:centrosome; C:cytoplasm; C:ciliary basal body; P:positive regulation of nonmotile primary cilium assembly; P:mitotic spindle assembly		
gi|545210341|ref|XP_005607977.1|	alpha-1,3-mannosyl-glyco 4-beta-N-acetylglucosaminyltransferase MGAT4D	384	20	0E0	88.45%	3	P:GO:0005975; F:GO:0016758; C:GO:0016020	P:carbohydrate metabolic process; F:transferase activity, transferring hexosyl groups; C:membrane		IPR006759 (PFAM); IPR006759 (PANTHER); PTHR12062:SF10 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); PS51257 (PROSITE_PROFILES)
gi|545210373|ref|XP_005607989.1|	methylcytosine dioxygenase TET2	1940	20	0E0	89.95%	30	P:GO:0006325; P:GO:0019858; P:GO:0019857; F:GO:0016706; P:GO:0030097; P:GO:0080111; P:GO:0009791; P:GO:0048536; P:GO:0045944; P:GO:0020027; P:GO:0001822; F:GO:0016491; P:GO:0002318; P:GO:0080182; F:GO:0008270; P:GO:0006493; F:GO:0008198; P:GO:0061484; P:GO:0006211; P:GO:0014070; P:GO:0007049; F:GO:0051213; F:GO:0003677; F:GO:0005515; P:GO:0072576; F:GO:0046872; P:GO:0048872; P:GO:0030099; P:GO:0055114; F:GO:0070579	P:chromatin organization; P:cytosine metabolic process; P:5-methylcytosine metabolic process; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; P:hemopoiesis; P:DNA demethylation; P:post-embryonic development; P:spleen development; P:positive regulation of transcription from RNA polymerase II promoter; P:hemoglobin metabolic process; P:kidney development; F:oxidoreductase activity; P:myeloid progenitor cell differentiation; P:histone H3-K4 trimethylation; F:zinc ion binding; P:protein O-linked glycosylation; F:ferrous iron binding; P:hematopoietic stem cell homeostasis; P:5-methylcytosine catabolic process; P:response to organic cyclic compound; P:cell cycle; F:dioxygenase activity; F:DNA binding; F:protein binding; P:liver morphogenesis; F:metal ion binding; P:homeostasis of number of cells; P:myeloid cell differentiation; P:oxidation-reduction process; F:methylcytosine dioxygenase activity		IPR024779 (SMART); IPR024779 (PFAM); PTHR23358 (PANTHER); PTHR23358:SF3 (PANTHER)
gi|545211109|ref|XP_005608244.1|	NKG2D ligand 1-like	244	20	0E0	71.8%	3	P:GO:0006955; C:GO:0016020; C:GO:0016021	P:immune response; C:membrane; C:integral component of membrane		IPR011161 (PFAM); IPR011161 (G3DSA:3.30.500.GENE3D); PTHR16675:SF1 (PANTHER); PTHR16675 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR011162 (SUPERFAMILY)
gi|545211164|ref|XP_005608264.1|	utrophin isoform X5	3433	20	0E0	99.05%	2	F:GO:0008270; F:GO:0005515	F:zinc ion binding; F:protein binding		IPR018159 (SMART); IPR001202 (SMART); IPR000433 (SMART); IPR001715 (SMART); G3DSA:2.20.70.10 (GENE3D); IPR001715 (PFAM); IPR000433 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); IPR015154 (PFAM); IPR002017 (PFAM); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR015153 (PFAM); G3DSA:1.20.58.60 (GENE3D); PTHR11915:SF225 (PANTHER); PTHR11915 (PANTHER); IPR001202 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); IPR000433 (PROSITE_PATTERNS); IPR001715 (PROSITE_PROFILES); IPR001202 (PROSITE_PROFILES); IPR000433 (PROSITE_PROFILES); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001715 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF57850 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR011992 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001202 (SUPERFAMILY); IPR011992 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY)
gi|545211299|ref|XP_005608314.1|	sal 1	1301	20	0E0	96.2%	2	F:GO:0003676; F:GO:0046872	F:nucleic acid binding; F:metal ion binding		IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PF12874 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); PF13894 (PFAM); IPR007087 (PFAM); PTHR23233 (PANTHER); PTHR23233:SF51 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|545211963|ref|XP_005608541.1|	F-box only 31 isoform X2	427	20	0E0	93.65%	4	P:GO:0031571; P:GO:0031146; C:GO:0019005; F:GO:0030332	P:mitotic G1 DNA damage checkpoint; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; C:SCF ubiquitin ligase complex; F:cyclin binding		PTHR10706 (PANTHER); IPR026941 (PTHR10706:PANTHER)
gi|545212065|ref|XP_001914749.2|	lon protease homolog peroxisomal	884	20	0E0	96.4%	27	F:GO:0016887; P:GO:0007031; F:GO:0002020; F:GO:0000166; F:GO:0005524; P:GO:0031998; P:GO:0006515; P:GO:0016558; P:GO:0030163; F:GO:0008236; F:GO:0004252; F:GO:0008233; F:GO:0004176; C:GO:0005782; P:GO:0014070; F:GO:0005102; F:GO:0003676; C:GO:0005777; C:GO:0005634; F:GO:0005515; P:GO:0006625; C:GO:0005737; C:GO:0016020; P:GO:0006508; P:GO:0016485; F:GO:0019899; F:GO:0016787	F:ATPase activity; P:peroxisome organization; F:protease binding; F:nucleotide binding; F:ATP binding; P:regulation of fatty acid beta-oxidation; P:misfolded or incompletely synthesized protein catabolic process; P:protein import into peroxisome matrix; P:protein catabolic process; F:serine-type peptidase activity; F:serine-type endopeptidase activity; F:peptidase activity; F:ATP-dependent peptidase activity; C:peroxisomal matrix; P:response to organic cyclic compound; F:receptor binding; F:nucleic acid binding; C:peroxisome; C:nucleus; F:protein binding; P:protein targeting to peroxisome; C:cytoplasm; C:membrane; P:proteolysis; P:protein processing; F:enzyme binding; F:hydrolase activity		
gi|545212807|ref|XP_005608836.1|	leucine-rich repeat-containing 66	1060	20	0E0	77.15%	1	F:GO:0005515	F:protein binding		IPR003591 (SMART); IPR001611 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR24369 (PANTHER); PTHR24369:SF90 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR001611 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY)
gi|545212860|ref|XP_005608853.1|	LIM and calponin homology domains-containing 1 isoform X1	1471	20	0E0	96.5%	1	F:GO:0008270	F:zinc ion binding		IPR001781 (SMART); IPR001781 (PFAM); IPR001781 (G3DSA:2.10.110.GENE3D); IPR031865 (PFAM); IPR029980 (PTHR15551:PANTHER); PTHR15551 (PANTHER); IPR001781 (PROSITE_PATTERNS); IPR001781 (PROSITE_PROFILES)
gi|545212937|ref|XP_005608879.1|	WD repeat-containing 19	1342	20	0E0	98%	1	F:GO:0005515	F:protein binding		IPR001680 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); PF15911 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR14920 (PANTHER); PTHR14920:SF0 (PANTHER); IPR017986 (PROSITE_PROFILES); SSF117289 (SUPERFAMILY); IPR011990 (SUPERFAMILY); SSF69322 (SUPERFAMILY)
gi|545213249|ref|XP_005608989.1|	regulator of G- signaling 12 isoform X2	1157	20	0E0	95.7%	3	F:GO:0005515; P:GO:0007165; F:GO:0005057	F:protein binding; P:signal transduction; F:receptor signaling protein activity		IPR016137 (PRINTS); IPR001478 (SMART); IPR006020 (SMART); IPR016137 (SMART); IPR003116 (SMART); G3DSA:1.10.167.10 (GENE3D); IPR001478 (G3DSA:2.30.42.GENE3D); PF16613 (PFAM); IPR024066 (G3DSA:1.10.196.GENE3D); IPR016137 (PFAM); IPR001478 (PFAM); G3DSA:3.10.20.90 (GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR003116 (PFAM); PTHR10845:SF149 (PANTHER); PTHR10845 (PANTHER); IPR001478 (PROSITE_PROFILES); IPR016137 (PROSITE_PROFILES); IPR003116 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR029071 (SUPERFAMILY); IPR016137 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR029071 (SUPERFAMILY)
gi|545213822|ref|XP_005609183.1|	tensin-3 isoform X2	1450	20	0E0	92.45%	1	F:GO:0005515	F:protein binding		IPR003595 (SMART); IPR000980 (SMART); IPR006020 (SMART); IPR014020 (SMART); IPR000980 (G3DSA:3.30.505.GENE3D); G3DSA:2.60.40.1110 (GENE3D); IPR000980 (PFAM); IPR029021 (G3DSA:3.90.190.GENE3D); IPR014020 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR013625 (PFAM); PTHR12305:SF42 (PANTHER); PTHR12305 (PANTHER); IPR029023 (PROSITE_PROFILES); IPR014020 (PROSITE_PROFILES); IPR000980 (PROSITE_PROFILES); IPR000008 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR029021 (SUPERFAMILY); IPR000980 (SUPERFAMILY)
gi|545214339|ref|XP_005609340.1|	neurogenic differentiation factor 6	337	20	0E0	99.15%	3	P:GO:0007399; P:GO:0006355; F:GO:0046983	P:nervous system development; P:regulation of transcription, DNA-templated; F:protein dimerization activity		IPR016637 (PIRSF); IPR011598 (SMART); IPR022575 (PFAM); IPR011598 (PFAM); IPR011598 (G3DSA:4.10.280.GENE3D); PTHR19290 (PANTHER); IPR032650 (PTHR19290:PANTHER); IPR011598 (PROSITE_PROFILES); IPR011598 (SUPERFAMILY)
gi|545214425|ref|XP_005609370.1|	dedicator of cytokinesis 4 isoform X2	1965	20	0E0	98.25%	4	F:GO:0005515; P:GO:0007264; F:GO:0005085; P:GO:0043087	F:protein binding; P:small GTPase mediated signal transduction; F:guanyl-nucleotide exchange factor activity; P:regulation of GTPase activity		IPR001452 (SMART); IPR011511 (PFAM); IPR027007 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR010703 (PFAM); IPR032376 (PFAM); PTHR23317:SF75 (PANTHER); IPR026791 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR027357 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR027007 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY)
gi|545214484|ref|XP_005609388.1|	receptor-type tyrosine- phosphatase zeta isoform X1	2327	20	0E0	94.5%	4	F:GO:0005515; P:GO:0006570; F:GO:0004725; P:GO:0006470	F:protein binding; P:tyrosine metabolic process; F:protein tyrosine phosphatase activity; P:protein dephosphorylation	EC:3.1.3.16; EC:3.1; EC:3.1.3.48; EC:3.1.3.41	IPR000242 (PRINTS); IPR003961 (SMART); IPR001148 (SMART); IPR003595 (SMART); IPR000242 (SMART); IPR029021 (G3DSA:3.90.190.GENE3D); IPR003961 (PFAM); IPR001148 (PFAM); IPR029021 (G3DSA:3.90.190.GENE3D); IPR000242 (PFAM); IPR001148 (G3DSA:3.10.200.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR19134 (PANTHER); PTHR19134:SF214 (PANTHER); IPR016130 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR003961 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); IPR001148 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES); IPR029021 (SUPERFAMILY); IPR001148 (SUPERFAMILY); IPR029021 (SUPERFAMILY); IPR003961 (SUPERFAMILY)
gi|545214934|ref|XP_005609526.1|	FAM131B isoform X1	332	20	0E0	98.5%	5	C:GO:0005737; P:GO:0098779; P:GO:0002230; P:GO:0098792; C:GO:0005654	C:cytoplasm; P:mitophagy in response to mitochondrial depolarization; P:positive regulation of defense response to virus by host; P:xenophagy; C:nucleoplasm		
gi|545214937|ref|XP_001490110.4|	ephrin type-A receptor 1	976	20	0E0	94.35%	6	C:GO:0005887; F:GO:0005524; F:GO:0005515; P:GO:0048013; P:GO:0006468; F:GO:0005003	C:integral component of plasma membrane; F:ATP binding; F:protein binding; P:ephrin receptor signaling pathway; P:protein phosphorylation; F:ephrin receptor activity	EC:2.7.10; EC:2.7.10.1; EC:2.7.11	IPR001245 (PRINTS); IPR016257 (PIRSF); IPR011641 (SMART); IPR003961 (SMART); IPR001660 (SMART); IPR001090 (SMART); IPR020635 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR001245 (PFAM); IPR001090 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR001660 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR027936 (PFAM); IPR003961 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR008979 (G3DSA:2.60.120.GENE3D); IPR013761 (G3DSA:1.10.150.GENE3D); PTHR24416:SF28 (PANTHER); PTHR24416 (PANTHER); IPR001426 (PROSITE_PATTERNS); IPR001426 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); IPR008266 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR003961 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR001660 (PROSITE_PROFILES); IPR001090 (PROSITE_PROFILES); IPR003961 (SUPERFAMILY); IPR013761 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR008979 (SUPERFAMILY)
gi|545215528|ref|XP_005609720.1|	myocilin	490	20	0E0	92.55%	4	C:GO:0005615; P:GO:0001952; P:GO:0051492; P:GO:0030335	C:extracellular space; P:regulation of cell-matrix adhesion; P:regulation of stress fiber assembly; P:positive regulation of cell migration		IPR003112 (SMART); IPR003112 (PFAM); IPR031213 (PTHR23192:PANTHER); PTHR23192 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR003112 (PROSITE_PROFILES)
gi|545215695|ref|XP_005609776.1|	inactive dual specificity phosphatase 27	1202	20	0E0	93%	2	P:GO:0006470; F:GO:0008138	P:protein dephosphorylation; F:protein tyrosine/serine/threonine phosphatase activity	EC:3.1.3.16; EC:3.1; EC:3.1.3.41; EC:3.1.3	IPR020417 (PRINTS); IPR020405 (PRINTS); IPR020422 (SMART); IPR000340 (PFAM); IPR029021 (G3DSA:3.90.190.GENE3D); PTHR10159:SF25 (PANTHER); IPR024950 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR000387 (PROSITE_PROFILES); IPR020422 (PROSITE_PROFILES); IPR029021 (SUPERFAMILY)
gi|545215703|ref|XP_005609779.1|	coagulation factor V	2096	20	0E0	83.85%	2	F:GO:0005507; P:GO:0007596	F:copper ion binding; P:blood coagulation		IPR000421 (SMART); IPR000421 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); IPR008979 (G3DSA:2.60.120.GENE3D); IPR011707 (PFAM); IPR009271 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); IPR029821 (PTHR10127:PANTHER); PTHR10127 (PANTHER); IPR033138 (PROSITE_PATTERNS); IPR000421 (PROSITE_PATTERNS); IPR000421 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR000421 (PROSITE_PROFILES); PS51257 (PROSITE_PROFILES); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008979 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008979 (SUPERFAMILY); IPR008972 (SUPERFAMILY)
gi|545216436|ref|XP_001491068.3|	Fc receptor 6 isoform X1	435	20	0E0	80.3%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR003598 (SMART); IPR007110 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR11481:SF62 (PANTHER); PTHR11481 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|545217343|ref|XP_001917731.3|	transcription termination factor 2	1167	20	0E0	88.65%	5	F:GO:0003676; F:GO:0005524; F:GO:0008270; C:GO:0005737; F:GO:0008026	F:nucleic acid binding; F:ATP binding; F:zinc ion binding; C:cytoplasm; F:ATP-dependent helicase activity		
gi|545217514|ref|XP_005610401.1|	RNA-binding 15	962	20	0E0	98.2%	14	P:GO:0045638; P:GO:0060674; C:GO:0016607; P:GO:0048536; P:GO:0007221; P:GO:0060412; P:GO:0000398; F:GO:0044822; C:GO:0005654; P:GO:0000122; F:GO:0000166; F:GO:0003676; C:GO:0005634; P:GO:0001569	P:negative regulation of myeloid cell differentiation; P:placenta blood vessel development; C:nuclear speck; P:spleen development; P:positive regulation of transcription of Notch receptor target; P:ventricular septum morphogenesis; P:mRNA splicing, via spliceosome; F:poly(A) RNA binding; C:nucleoplasm; P:negative regulation of transcription from RNA polymerase II promoter; F:nucleotide binding; F:nucleic acid binding; C:nucleus; P:patterning of blood vessels		
gi|545218568|ref|XP_001498134.2|	5-hydroxytryptamine receptor 2B	503	20	0E0	95.2%	7	P:GO:0050795; C:GO:0005887; P:GO:0007507; P:GO:0006939; P:GO:0007187; P:GO:0042310; F:GO:0004993	P:regulation of behavior; C:integral component of plasma membrane; P:heart development; P:smooth muscle contraction; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:vasoconstriction; F:G-protein coupled serotonin receptor activity		IPR000482 (PRINTS); IPR000276 (PRINTS); IPR002231 (PRINTS); IPR000276 (SMART); G3DSA:1.20.1070.10 (GENE3D); IPR000276 (PFAM); PTHR24247 (PANTHER); IPR000482 (PTHR24247:PANTHER); IPR000276 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR017452 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY)
gi|545218863|ref|XP_005610855.1|	espin	867	20	0E0	83.3%	1	F:GO:0005515	F:protein binding		IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); PTHR24153 (PANTHER); PTHR24153:SF0 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY)
gi|545219146|ref|XP_005610946.1|	leucine-rich repeat-containing 23	345	20	0E0	94.85%	1	F:GO:0005515	F:protein binding		SM00365 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); PF14580 (PFAM); IPR001611 (PFAM); PTHR24365 (PANTHER); PTHR24365:SF298 (PANTHER); IPR001611 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY)
gi|545219192|ref|XP_005610963.1|	scavenger receptor cysteine-rich type 1 M130	1108	20	0E0	93.85%	3	P:GO:0007165; C:GO:0016020; F:GO:0005044	P:signal transduction; C:membrane; F:scavenger receptor activity		IPR001190 (PRINTS); IPR017448 (SMART); IPR001190 (PFAM); IPR017448 (G3DSA:3.10.250.GENE3D); PTHR19331 (PANTHER); PTHR19331:SF324 (PANTHER); IPR001190 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR001190 (PROSITE_PROFILES); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY)
gi|545219469|ref|XP_005611048.1|	inositol 1,4,5-trisphosphate receptor type 2	2701	20	0E0	98.3%	5	C:GO:0016020; F:GO:0005220; P:GO:0070588; C:GO:0005783; F:GO:0005488	C:membrane; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:calcium ion transmembrane transport; C:endoplasmic reticulum; F:binding		IPR000493 (PRINTS); IPR016093 (SMART); IPR014821 (PFAM); IPR000699 (G3DSA:1.25.10.GENE3D); IPR016093 (PFAM); IPR000699 (PFAM); IPR005821 (PFAM); IPR013662 (PFAM); G3DSA:2.80.10.50 (GENE3D); G3DSA:2.80.10.50 (GENE3D); PTHR13715:SF53 (PANTHER); IPR015925 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR016093 (PROSITE_PROFILES); IPR000699 (SUPERFAMILY); IPR016093 (SUPERFAMILY); IPR016093 (SUPERFAMILY); IPR000699 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
gi|545219616|ref|XP_005611099.1|	taste receptor type 2 member 46-like	302	20	0E0	85.95%	4	F:GO:0004930; P:GO:0050909; P:GO:0007186; C:GO:0016021	F:G-protein coupled receptor activity; P:sensory perception of taste; P:G-protein coupled receptor signaling pathway; C:integral component of membrane		G3DSA:1.20.1070.10 (GENE3D); IPR007960 (PFAM); PTHR11394:SF27 (PANTHER); IPR007960 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SSF81321 (SUPERFAMILY)
gi|545219656|ref|XP_005611115.1|	plakophilin-2	902	20	0E0	95.35%	2	P:GO:0016337; F:GO:0005515	P:single organismal cell-cell adhesion; F:protein binding		IPR000225 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR000225 (PFAM); IPR028435 (PANTHER); PTHR10372:SF25 (PANTHER); IPR000225 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)
gi|545219705|ref|XP_005611137.1|	amphoterin-induced 2	521	20	0E0	96.8%	2	F:GO:0005515; P:GO:0043066	F:protein binding; P:negative regulation of apoptotic process		IPR000483 (SMART); IPR003599 (SMART); IPR003591 (SMART); IPR013151 (PFAM); IPR001611 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR031283 (PANTHER); IPR031286 (PTHR24368:PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|545219876|ref|XP_005611196.1|	histone-lysine N-methyltransferase 2D	5560	20	0E0	93.2%	3	C:GO:0005634; F:GO:0008270; F:GO:0005515	C:nucleus; F:zinc ion binding; F:protein binding		IPR001214 (SMART); IPR003888 (SMART); IPR001965 (SMART); IPR001841 (SMART); IPR003889 (SMART); IPR003616 (SMART); IPR009071 (SMART); G3DSA:2.170.270.10 (GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); IPR009071 (G3DSA:1.10.30.GENE3D); IPR003889 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PF13771 (PFAM); PF13832 (PFAM); IPR003888 (PFAM); IPR019787 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001214 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR22884 (PANTHER); PTHR22884:SF380 (PANTHER); IPR003889 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR003888 (PROSITE_PROFILES); IPR001214 (PROSITE_PROFILES); IPR003616 (PROSITE_PROFILES); IPR019787 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY); IPR011011 (SUPERFAMILY); IPR009071 (SUPERFAMILY); SSF82199 (SUPERFAMILY); IPR011011 (SUPERFAMILY); IPR011011 (SUPERFAMILY); IPR011011 (SUPERFAMILY)
gi|545220722|ref|XP_001916726.3|	prolow-density lipo receptor-related 1	4490	20	0E0	97.2%	2	F:GO:0005515; F:GO:0005509	F:protein binding; F:calcium ion binding		IPR002172 (PRINTS); IPR000742 (SMART); IPR000033 (SMART); IPR002172 (SMART); IPR001881 (SMART); G3DSA:4.10.1220.10 (GENE3D); IPR011042 (G3DSA:2.120.10.GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR001881 (PFAM); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR002172 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR032485 (PFAM); IPR000033 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); PF14670 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); IPR011042 (G3DSA:2.120.10.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR026823 (PFAM); PTHR10529 (PANTHER); PTHR10529:SF100 (PANTHER); IPR000152 (PROSITE_PATTERNS); IPR023415 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR002172 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000033 (PROSITE_PROFILES); SSF63825 (SUPERFAMILY); IPR009030 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR009030 (SUPERFAMILY)
gi|545220918|ref|XP_005611543.1|	ran-binding 3	498	20	0E0	91.35%	1	P:GO:0046907	P:intracellular transport		IPR000156 (SMART); IPR000156 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); PTHR23138:SF91 (PANTHER); PTHR23138 (PANTHER); IPR000156 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY)
gi|545220950|ref|XP_005611550.1|	tubulin beta-4A chain	372	20	0E0	100%	5	F:GO:0005525; F:GO:0003924; F:GO:0005200; C:GO:0005874; P:GO:0007017	F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton; C:microtubule; P:microtubule-based process	EC:3.6.1; EC:3.6.1.15	IPR000217 (PRINTS); IPR002453 (PRINTS); IPR003008 (SMART); IPR018316 (SMART); IPR003008 (G3DSA:3.40.50.GENE3D); IPR018316 (G3DSA:3.30.1330.GENE3D); IPR023123 (G3DSA:1.10.287.GENE3D); IPR003008 (PFAM); IPR018316 (PFAM); PTHR11588:SF121 (PANTHER); IPR000217 (PANTHER); IPR017975 (PROSITE_PATTERNS); IPR008280 (SUPERFAMILY); IPR003008 (SUPERFAMILY)
gi|545221314|ref|XP_005611669.1|	myelin zero 3	234	20	2.09E-172	94.15%	2	F:GO:0005515; C:GO:0016020	F:protein binding; C:membrane		IPR000920 (PRINTS); IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR000920 (PANTHER); IPR029862 (PTHR13869:PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|545221357|ref|XP_005611684.1|	probable ATP-dependent RNA helicase DDX6	483	20	0E0	99.65%	2	F:GO:0003676; F:GO:0005524	F:nucleic acid binding; F:ATP binding		IPR001650 (SMART); IPR014001 (SMART); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24031:SF258 (PANTHER); PTHR24031 (PANTHER); IPR000629 (PROSITE_PATTERNS); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
gi|545221752|ref|XP_005611816.1|	tight junction ZO-3 isoform X1	808	20	0E0	90.15%	2	C:GO:0005923; F:GO:0005515	C:bicellular tight junction; F:protein binding		IPR005420 (PRINTS); IPR005417 (PRINTS); IPR008145 (SMART); IPR001478 (SMART); IPR001452 (SMART); G3DSA:2.30.30.40 (GENE3D); IPR011511 (PFAM); IPR001478 (G3DSA:2.30.42.GENE3D); IPR001478 (G3DSA:2.30.42.GENE3D); IPR001478 (G3DSA:2.30.42.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR008145 (PFAM); IPR001478 (PFAM); IPR005420 (PTHR13865:PANTHER); PTHR13865 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR008144 (PROSITE_PROFILES); IPR001478 (PROSITE_PROFILES); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR001452 (SUPERFAMILY)
gi|545221895|ref|XP_005611871.1|	sortilin-related receptor	2166	20	0E0	96.3%	2	F:GO:0005515; C:GO:0016021	F:protein binding; C:integral component of membrane		IPR002172 (PRINTS); IPR006581 (SMART); IPR003961 (SMART); IPR000033 (SMART); IPR002172 (SMART); G3DSA:2.130.10.140 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003961 (PFAM); IPR002172 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:4.10.1220.10 (GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR031777 (PFAM); IPR031778 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR000033 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); IPR011042 (G3DSA:2.120.10.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR12106 (PANTHER); PTHR12106:SF20 (PANTHER); IPR023415 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR003961 (PROSITE_PROFILES); IPR000033 (PROSITE_PROFILES); IPR002172 (PROSITE_PROFILES); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF110296 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR002172 (SUPERFAMILY)
gi|545221915|ref|XP_001917834.2|	roundabout homolog 3	1419	20	0E0	93.95%	4	P:GO:0035385; F:GO:0005515; P:GO:0007411; C:GO:0030424	P:Roundabout signaling pathway; F:protein binding; P:axon guidance; C:axon		IPR003599 (SMART); IPR003961 (SMART); IPR003598 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003961 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PF13927 (PFAM); IPR032987 (PTHR10489:PANTHER); PTHR10489 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR003961 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|545222659|ref|XP_005612136.1|	E3 ubiquitin- ligase TRIM21	469	20	0E0	91.4%	3	F:GO:0008270; F:GO:0005515; C:GO:0005622	F:zinc ion binding; F:protein binding; C:intracellular		IPR020457 (PRINTS); IPR003879 (PRINTS); IPR000315 (SMART); IPR001841 (SMART); IPR006574 (SMART); IPR003877 (SMART); IPR000315 (PFAM); IPR003877 (PFAM); PF15227 (PFAM); IPR000315 (G3DSA:4.10.45.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); IPR006574 (PFAM); PTHR24103 (PANTHER); PTHR24103:SF46 (PANTHER); IPR017907 (PROSITE_PATTERNS); IPR001841 (PROSITE_PROFILES); IPR001870 (PROSITE_PROFILES); IPR000315 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); SSF57845 (SUPERFAMILY); IPR013320 (SUPERFAMILY)
gi|545223276|ref|XP_005612349.1|	C2 domain-containing 3 isoform X1	2298	20	0E0	93.05%	1	F:GO:0005515	F:protein binding		IPR000008 (SMART); IPR000008 (G3DSA:2.60.40.GENE3D); IPR000008 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); PTHR21254:SF1 (PANTHER); PTHR21254 (PANTHER); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY)
gi|545223446|ref|XP_005612406.1|	melanoma antigen preferentially expressed in tumors	468	20	0E0	85.9%	4	P:GO:0045892; P:GO:0045596; P:GO:0043066; P:GO:0008284	P:negative regulation of transcription, DNA-templated; P:negative regulation of cell differentiation; P:negative regulation of apoptotic process; P:positive regulation of cell proliferation		IPR026271 (PIRSF); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR14224:SF36 (PANTHER); PTHR14224 (PANTHER); SSF52047 (SUPERFAMILY)
gi|545223905|ref|XP_005612559.1|	coronin-1C isoform X2	474	20	0E0	99.15%	3	F:GO:0051015; C:GO:0015629; P:GO:0030036	F:actin filament binding; C:actin cytoskeleton; P:actin cytoskeleton organization		IPR015048 (SMART); SM01167 (SMART); IPR001680 (SMART); PF16300 (PFAM); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015048 (PFAM); IPR015505 (PANTHER); IPR027333 (PTHR10856:PANTHER); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY)
gi|545223999|ref|XP_005612594.1|	tetratricopeptide repeat 28	2475	20	0E0	98.1%	4	C:GO:0005813; F:GO:0005515; C:GO:0030496; P:GO:0007346	C:centrosome; F:protein binding; C:midbody; P:regulation of mitotic cell cycle		IPR019734 (SMART); IPR019734 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); PF13424 (PFAM); IPR019734 (PFAM); IPR024983 (PFAM); IPR028833 (PTHR10098:PANTHER); PTHR10098 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY)
gi|545224116|ref|XP_001915005.3|	nitric oxide brain isoform X1	1468	20	0E0	97.35%	9	F:GO:0005516; F:GO:0050661; F:GO:0004517; F:GO:0010181; F:GO:0005506; F:GO:0050660; P:GO:0055114; P:GO:0006809; F:GO:0020037	F:calmodulin binding; F:NADP binding; F:nitric-oxide synthase activity; F:FMN binding; F:iron ion binding; F:flavin adenine dinucleotide binding; P:oxidation-reduction process; P:nitric oxide biosynthetic process; F:heme binding	EC:1.14.13.39; EC:1.14.13	IPR001094 (PRINTS); IPR001709 (PRINTS); IPR012144 (PIRSF); IPR001478 (SMART); G3DSA:3.90.1230.10 (GENE3D); IPR001433 (PFAM); IPR004030 (PFAM); IPR001478 (G3DSA:2.30.42.GENE3D); IPR003097 (PFAM); G3DSA:2.40.30.10 (GENE3D); IPR001478 (PFAM); IPR029039 (G3DSA:3.40.50.GENE3D); IPR023173 (G3DSA:1.20.990.GENE3D); IPR008254 (PFAM); G3DSA:3.40.50.80 (GENE3D); IPR004030 (G3DSA:3.90.340.GENE3D); PTHR19384:SF63 (PANTHER); PTHR19384 (PANTHER); IPR004030 (PROSITE_PATTERNS); IPR001478 (PROSITE_PROFILES); IPR008254 (PROSITE_PROFILES); IPR017927 (PROSITE_PROFILES); IPR029039 (SUPERFAMILY); IPR001478 (SUPERFAMILY); SSF52343 (SUPERFAMILY); IPR004030 (SUPERFAMILY); IPR017938 (SUPERFAMILY)
gi|545224150|ref|XP_005612643.1|	probable RNA-binding 19	962	20	0E0	94.1%	2	F:GO:0000166; F:GO:0003676	F:nucleotide binding; F:nucleic acid binding		IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR24012 (PANTHER); PTHR24012:SF360 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY)
gi|545224275|ref|XP_005612677.1|	kinetochore-associated 1	2208	20	0E0	96.2%	1	F:GO:0005515	F:protein binding		IPR019527 (PFAM); PTHR15688:SF1 (PANTHER); PTHR15688 (PANTHER); IPR017986 (SUPERFAMILY)
gi|545224395|ref|XP_001915746.2|	DNA polymerase epsilon catalytic subunit A	2243	20	0E0	97.3%	8	F:GO:0000166; F:GO:0003677; F:GO:0008408; P:GO:0006281; F:GO:0003887; F:GO:0008270; P:GO:0006260; C:GO:0008622	F:nucleotide binding; F:DNA binding; F:3'-5' exonuclease activity; P:DNA repair; F:DNA-directed DNA polymerase activity; F:zinc ion binding; P:DNA replication; C:epsilon DNA polymerase complex	EC:3.1; EC:2.7.7.7	IPR006172 (SMART); IPR013697 (SMART); IPR013697 (PFAM); IPR006134 (PFAM); IPR006133 (PFAM); IPR012337 (G3DSA:3.30.420.GENE3D); IPR029703 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR012337 (SUPERFAMILY); SSF56672 (SUPERFAMILY)
gi|545224411|ref|XP_005612724.1|	zinc finger 84	738	20	0E0	95.35%	4	F:GO:0003676; F:GO:0046872; P:GO:0006355; C:GO:0005622	F:nucleic acid binding; F:metal ion binding; P:regulation of transcription, DNA-templated; C:intracellular		
gi|545224487|ref|XP_001915485.2|	dynein heavy chain axonemal	4557	20	0E0	96.35%	6	F:GO:0016887; F:GO:0005524; F:GO:0003777; C:GO:0030286; P:GO:0007018; C:GO:0005874	F:ATPase activity; F:ATP binding; F:microtubule motor activity; C:dynein complex; P:microtubule-based movement; C:microtubule	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR003593 (SMART); IPR024317 (PFAM); IPR013594 (PFAM); IPR004273 (PFAM); PF12781 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR013602 (PFAM); IPR011704 (PFAM); IPR024743 (PFAM); PF12775 (PFAM); PF12774 (PFAM); IPR026983 (PANTHER); PTHR10676:SF135 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|545224670|ref|XP_005612823.1|	serine threonine- kinase RIO3	513	20	0E0	97.3%	4	F:GO:0005524; P:GO:0009069; F:GO:0004674; P:GO:0006468	F:ATP binding; P:serine family amino acid metabolic process; F:protein serine/threonine kinase activity; P:protein phosphorylation	EC:2.7.11	IPR000687 (SMART); IPR017406 (PIRSF); G3DSA:1.10.510.10 (GENE3D); PF01163 (PFAM); G3DSA:3.30.200.20 (GENE3D); IPR017406 (PTHR10593:PANTHER); PTHR10593 (PANTHER); IPR018935 (PROSITE_PATTERNS); IPR011009 (SUPERFAMILY)
gi|545224716|ref|XP_003365562.2|	phosphatidate phosphatase LPIN2 isoform X1	936	20	0E0	95.85%	8	F:GO:0008195; C:GO:0005667; F:GO:0003713; P:GO:0046486; P:GO:0009395; P:GO:0045893; P:GO:0045944; P:GO:0006687	F:phosphatidate phosphatase activity; C:transcription factor complex; F:transcription coactivator activity; P:glycerolipid metabolic process; P:phospholipid catabolic process; P:positive regulation of transcription, DNA-templated; P:positive regulation of transcription from RNA polymerase II promoter; P:glycosphingolipid metabolic process	EC:3.1; EC:3.1.3.4; EC:3.1.3.41	IPR031315 (SMART); IPR031703 (PFAM); IPR007651 (PFAM); IPR013209 (PFAM); IPR023214 (G3DSA:3.40.50.GENE3D); PTHR12181 (PANTHER); IPR026744 (PTHR12181:PANTHER); IPR023214 (SUPERFAMILY)
gi|545225027|ref|XP_005612951.1|	unconventional myosin-Vb isoform X2	1832	20	0E0	96.9%	4	C:GO:0016459; F:GO:0005524; F:GO:0005515; F:GO:0003774	C:myosin complex; F:ATP binding; F:protein binding; F:motor activity	EC:3.6.1; EC:3.6.1.15	IPR001609 (PRINTS); IPR001609 (SMART); IPR002710 (SMART); IPR000048 (SMART); IPR001609 (PFAM); IPR002710 (PFAM); IPR000048 (PFAM); PTHR13140:SF356 (PANTHER); PTHR13140 (PANTHER); IPR001609 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); IPR002710 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|545225133|ref|XP_005612986.1|	desmoglein-2	1096	20	0E0	87.9%	3	F:GO:0005509; P:GO:0007156; C:GO:0005886	F:calcium ion binding; P:homophilic cell adhesion via plasma membrane adhesion molecules; C:plasma membrane		IPR002126 (PRINTS); IPR009123 (PRINTS); IPR009122 (PRINTS); IPR002126 (SMART); IPR002126 (PFAM); IPR002126 (G3DSA:2.60.40.GENE3D); IPR027397 (G3DSA:4.10.900.GENE3D); IPR002126 (G3DSA:2.60.40.GENE3D); PTHR24025:SF1 (PANTHER); IPR009122 (PANTHER); IPR020894 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR002126 (PROSITE_PROFILES); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY)
gi|545225358|ref|XP_005613061.1|	zinc finger 532 isoform X1	1269	20	0E0	95.5%	2	F:GO:0003676; F:GO:0046872	F:nucleic acid binding; F:metal ion binding		IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); PTHR26374 (PANTHER); PTHR26374:SF204 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|545225582|ref|XP_005613139.1|	brefeldin A-inhibited guanine nucleotide-exchange 1	1816	20	0E0	99.05%	4	F:GO:0005086; P:GO:0043087; P:GO:0032012; F:GO:0005488	F:ARF guanyl-nucleotide exchange factor activity; P:regulation of GTPase activity; P:regulation of ARF protein signal transduction; F:binding		IPR000904 (SMART); IPR032691 (PFAM); IPR015403 (PFAM); IPR023394 (G3DSA:1.10.1000.GENE3D); IPR032629 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR000904 (PFAM); G3DSA:1.10.220.20 (GENE3D); PTHR10663 (PANTHER); PTHR10663:SF137 (PANTHER); IPR000904 (PROSITE_PROFILES); IPR000904 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
gi|545225759|ref|XP_005613203.1|	solute carrier family 7 member 13	478	20	0E0	81.3%	3	C:GO:0016020; F:GO:0015171; P:GO:0003333	C:membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport		IPR002293 (PIRSF); IPR002293 (PFAM); PTHR11785:SF238 (PANTHER); IPR002293 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|545225779|ref|XP_005613209.1|	retinol dehydrogenase 10	313	20	0E0	99.7%	2	P:GO:0002138; F:GO:0052650	P:retinoic acid biosynthetic process; F:NADP-retinol dehydrogenase activity	EC:1.1.1.300; EC:1.1.1; EC:1.1.1.2	IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); IPR032970 (PTHR24322:PANTHER); IPR002347 (PANTHER); IPR020904 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR016040 (SUPERFAMILY)
gi|545225781|ref|XP_005615173.1|	somatomedin-B and thrombospondin type-1 domain-containing	382	20	0E0	95.2%	4	P:GO:0006955; P:GO:0007165; F:GO:0005044; F:GO:0030247	P:immune response; P:signal transduction; F:scavenger receptor activity; F:polysaccharide binding		G3DSA:2.20.100.10 (GENE3D); PTHR20920:SF2 (PANTHER); PTHR20920 (PANTHER); IPR000884 (PROSITE_PROFILES); IPR000884 (SUPERFAMILY); IPR001212 (SUPERFAMILY)
gi|545225938|ref|XP_005613261.1|	epithelial splicing regulatory 1 isoform X5	636	20	0E0	99.1%	2	F:GO:0000166; F:GO:0003676	F:nucleotide binding; F:nucleic acid binding		IPR000504 (SMART); IPR012337 (G3DSA:3.30.420.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR13976:SF37 (PANTHER); PTHR13976 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR000504 (PROSITE_PROFILES); IPR012337 (SUPERFAMILY); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY)
gi|545226565|ref|XP_005613463.1|	nicotinate phosphoribosyltransferase	563	20	0E0	95.15%	4	F:GO:0004514; F:GO:0004516; P:GO:0009435; P:GO:0019358	F:nicotinate-nucleotide diphosphorylase (carboxylating) activity; F:nicotinate phosphoribosyltransferase activity; P:NAD biosynthetic process; P:nicotinate nucleotide salvage	EC:2.4.2.19; EC:2.4.2.11	IPR007229 (PIRSF); G3DSA:3.20.140.10 (GENE3D); IPR006405 (TIGRFAM); PTHR11098:SF1 (PANTHER); IPR007229 (PANTHER); IPR002638 (SUPERFAMILY); SSF54675 (SUPERFAMILY)
gi|545227405|ref|XP_005613749.1|	collagen alpha-1(XX) chain	494	20	0E0	89.15%	1	F:GO:0005515	F:protein binding		IPR001791 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR11132:SF131 (PANTHER); PTHR11132 (PANTHER); IPR003961 (SUPERFAMILY); IPR013320 (SUPERFAMILY)
gi|545228040|ref|XP_005613978.1|	Ig heavy chain Mem5-like	303	20	0E0	73.8%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|545228733|ref|XP_005614219.1|	FERM and PDZ domain-containing 4 isoform X1	1776	20	0E0	95.4%	2	C:GO:0005856; F:GO:0005515	C:cytoskeleton; F:protein binding		IPR001478 (SMART); IPR019749 (SMART); G3DSA:2.20.70.10 (GENE3D); IPR001478 (PFAM); IPR001478 (G3DSA:2.30.42.GENE3D); IPR014352 (G3DSA:1.20.80.GENE3D); IPR019748 (PFAM); PTHR24365 (PANTHER); PTHR24365:SF362 (PANTHER); IPR001202 (PROSITE_PROFILES); IPR001478 (PROSITE_PROFILES); IPR000299 (PROSITE_PROFILES); IPR001478 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR029071 (SUPERFAMILY); IPR019748 (SUPERFAMILY)
gi|545228902|ref|XP_005614282.1|	APC membrane recruitment 1	1126	20	0E0	90.4%	13	P:GO:0048856; P:GO:0090263; F:GO:0008013; P:GO:0072161; C:GO:0005886; P:GO:0060348; P:GO:0060612; P:GO:0090090; F:GO:0005546; C:GO:0005634; P:GO:0001822; P:GO:0060828; C:GO:0043231	P:anatomical structure development; P:positive regulation of canonical Wnt signaling pathway; F:beta-catenin binding; P:mesenchymal cell differentiation involved in kidney development; C:plasma membrane; P:bone development; P:adipose tissue development; P:negative regulation of canonical Wnt signaling pathway; F:phosphatidylinositol-4,5-bisphosphate binding; C:nucleus; P:kidney development; P:regulation of canonical Wnt signaling pathway; C:intracellular membrane-bounded organelle		IPR019003 (PFAM); PTHR22237 (PANTHER); PTHR22237:SF0 (PANTHER)
gi|545228924|ref|XP_005614290.1|	hephaestin isoform X1	1161	20	0E0	94.3%	6	P:GO:0006879; F:GO:0005507; F:GO:0016491; P:GO:0006826; P:GO:0055114; C:GO:0005886	P:cellular iron ion homeostasis; F:copper ion binding; F:oxidoreductase activity; P:iron ion transport; P:oxidation-reduction process; C:plasma membrane		IPR011707 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); IPR011706 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); IPR027154 (PTHR10127:PANTHER); PTHR10127 (PANTHER); IPR033138 (PROSITE_PATTERNS); IPR002355 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY)
gi|545228928|ref|XP_005614292.1|	oligophrenin-1	802	20	0E0	97.6%	1	P:GO:0007165	P:signal transduction		IPR000198 (SMART); IPR001849 (SMART); IPR000198 (G3DSA:1.10.555.GENE3D); G3DSA:1.20.1270.80 (GENE3D); IPR001849 (PFAM); IPR000198 (PFAM); PF16746 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); PTHR12552 (PANTHER); PTHR12552:SF2 (PANTHER); IPR001849 (PROSITE_PROFILES); IPR000198 (PROSITE_PROFILES); IPR008936 (SUPERFAMILY); SSF103657 (SUPERFAMILY); IPR011993 (SUPERFAMILY)
gi|545228932|ref|XP_005614293.1|	stAR-related lipid transfer 8 isoform X2	1080	20	0E0	93.05%	2	P:GO:0007165; F:GO:0008289	P:signal transduction; F:lipid binding		IPR002913 (SMART); IPR000198 (SMART); IPR000198 (PFAM); IPR002913 (PFAM); IPR023393 (G3DSA:3.30.530.GENE3D); IPR000198 (G3DSA:1.10.555.GENE3D); PTHR12659 (PANTHER); PTHR12659:SF3 (PANTHER); IPR000198 (PROSITE_PROFILES); IPR002913 (PROSITE_PROFILES); SSF55961 (SUPERFAMILY); IPR008936 (SUPERFAMILY); IPR013761 (SUPERFAMILY)
gi|545229857|ref|XP_005614612.1|	probable G- coupled receptor 101	487	20	0E0	92.35%	3	F:GO:0004930; P:GO:0007186; C:GO:0016021	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway; C:integral component of membrane		IPR000276 (PRINTS); IPR000276 (PFAM); G3DSA:1.20.1070.10 (GENE3D); PTHR24248 (PANTHER); PTHR24248:SF2 (PANTHER); IPR000276 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR017452 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY)
gi|558515853|ref|NP_001273792.1|	ataxin-3 isoform X1	359	20	0E0	96.7%	2	F:GO:0004843; P:GO:0016579	F:thiol-dependent ubiquitin-specific protease activity; P:protein deubiquitination	EC:3.4; EC:3.4.19.12	PR01233 (PRINTS); IPR006155 (SMART); IPR003903 (SMART); IPR003903 (PFAM); PF16619 (PFAM); IPR006155 (PFAM); PTHR14159:SF1 (PANTHER); IPR033865 (PANTHER); IPR003903 (PROSITE_PROFILES); IPR006155 (PROSITE_PROFILES)
gi|664646458|gb|AIF32608.1|	immunoglobulin heavy partial	124	20	3.87E-86	74.15%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266:SF105 (PANTHER); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|664646462|gb|AIF32610.1|	immunoglobulin heavy chain variable partial	122	20	5.86E-84	84.35%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|664646464|gb|AIF32611.1|	immunoglobulin heavy partial	125	20	6.39E-86	85.2%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); PTHR23266:SF105 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|664646472|gb|AIF32615.1|	immunoglobulin heavy partial	123	20	4.23E-82	85.9%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|664646476|gb|AIF32617.1|	immunoglobulin heavy partial	123	20	1.68E-82	90.65%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|667477813|ref|NP_001288071.1|	zinc transporter 5	736	20	0E0	98.5%	4	P:GO:0006812; P:GO:0055085; C:GO:0016021; F:GO:0008324	P:cation transport; P:transmembrane transport; C:integral component of membrane; F:cation transmembrane transporter activity		IPR002524 (PFAM); IPR027469 (G3DSA:1.20.1510.GENE3D); IPR002524 (TIGRFAM); PTHR11562:SF49 (PANTHER); IPR002524 (PANTHER); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SSF161111 (SUPERFAMILY)
gi|669174617|ref|NP_001288176.1|	serine threonine- kinase TAO1	1001	20	0E0	99.45%	3	F:GO:0005524; F:GO:0004672; P:GO:0006468	F:ATP binding; F:protein kinase activity; P:protein phosphorylation		IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24361:SF369 (PANTHER); PTHR24361 (PANTHER); IPR008271 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)
gi|677285121|gb|AIM46359.1|	immmunoglobulin lambda light chain variable partial	129	20	2.99E-88	90.9%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285147|gb|AIM46372.1|	immmunoglobulin lambda light chain variable partial	131	20	3.37E-91	84.15%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285153|gb|AIM46375.1|	immmunoglobulin lambda light chain variable partial	131	20	7.51E-91	82.7%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285171|gb|AIM46384.1|	immmunoglobulin lambda light chain variable partial	130	20	5.67E-90	90.85%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF198 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285179|gb|AIM46388.1|	immunoglobulin lambda light chain V-J partial	130	20	3.21E-89	85.7%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285183|gb|AIM46390.1|	immunoglobulin lambda light chain variable partial	122	20	3.54E-80	85.6%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF198 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285307|gb|AIM46452.1|	immunoglobulin heavy chain variable partial	138	20	1.17E-95	91.75%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285319|gb|AIM46458.1|	immunoglobulin heavy partial	128	20	1.82E-89	86.45%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285321|gb|AIM46459.1|	immunoglobulin heavy partial	135	20	2.38E-95	83.8%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285323|gb|AIM46460.1|	immunoglobulin heavy chain variable partial	137	20	2.64E-96	85.65%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285327|gb|AIM46462.1|	immunoglobulin heavy partial	136	20	1.3E-95	83%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285329|gb|AIM46463.1|	immunoglobulin heavy chain variable partial	139	20	1.26E-97	85.2%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285333|gb|AIM46465.1|	immunoglobulin heavy chain variable partial	129	20	1.68E-90	80.05%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266:SF105 (PANTHER); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285339|gb|AIM46468.1|	immunoglobulin heavy partial	139	20	2.13E-98	83.05%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285341|gb|AIM46469.1|	immunoglobulin heavy partial	134	20	2.83E-93	83.8%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); PTHR23266:SF105 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285343|gb|AIM46470.1|	immunoglobulin heavy partial	136	20	1.79E-95	86.6%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285349|gb|AIM46473.1|	immunoglobulin heavy chain variable partial	139	20	4.41E-96	85.7%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285351|gb|AIM46474.1|	immunoglobulin heavy chain variable partial	137	20	1.35E-96	84.2%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285353|gb|AIM46475.1|	immunoglobulin heavy chain variable partial	125	20	8.79E-86	88.05%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285355|gb|AIM46476.1|	immunoglobulin heavy partial	144	20	3.18E-101	79.15%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285361|gb|AIM46479.1|	immunoglobulin heavy chain variable partial	135	20	1.56E-93	86.15%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285363|gb|AIM46480.1|	immunoglobulin heavy chain variable partial	129	20	4.55E-91	85.4%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|677285365|gb|AIM46481.1|	immunoglobulin heavy chain variable partial	131	20	5.69E-92	79.1%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|683488366|emb|CEF28577.1|	katanin p60 ATPase-containing subunit A-like 1	670	20	0E0	98.2%	6	F:GO:0005524; P:GO:0051013; C:GO:0045298; F:GO:0008568; C:GO:0005874; F:GO:0008017	F:ATP binding; P:microtubule severing; C:tubulin complex; F:microtubule-severing ATPase activity; C:microtubule; F:microtubule binding	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15; EC:3.6.4.3	IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.8.60 (GENE3D); IPR003959 (PFAM); IPR015415 (PFAM); PTHR23074:SF65 (PANTHER); PTHR23074 (PANTHER); IPR003960 (PROSITE_PATTERNS); IPR028594 (HAMAP); IPR028596 (HAMAP); IPR027417 (SUPERFAMILY)
gi|723943061|gb|AIY24750.1|	immmunoglobulin lambda light chain variable partial	221	20	2.89E-159	83.9%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF174 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|723943163|gb|AIY24783.1|	immmunoglobulin lambda light chain variable partial	225	20	4.25E-160	95.55%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|723943197|gb|AIY24794.1|	immmunoglobulin lambda light chain variable partial	225	20	6.37E-160	94.4%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR003597 (PFAM); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|723943218|gb|AIY24801.1|	immmunoglobulin lambda light chain variable partial	209	20	9.95E-148	93.15%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR003599 (SMART); IPR013106 (SMART); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|723943221|gb|AIY24802.1|	immmunoglobulin lambda light chain variable partial	221	20	4.43E-160	84.15%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF174 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|723943239|gb|AIY24808.1|	immmunoglobulin lambda light chain variable partial	226	20	8.22E-159	94.15%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR003597 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|723943305|gb|AIY24830.1|	immmunoglobulin lambda light chain variable partial	221	20	1.94E-157	95.35%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003597 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013106 (PFAM); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|723943317|gb|AIY24834.1|	immmunoglobulin lambda light chain variable partial	225	20	2.27E-160	92.65%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|723943320|gb|AIY24835.1|	immmunoglobulin lambda light chain variable partial	224	20	4.36E-157	90.8%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003597 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); PTHR23267:SF198 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|723943335|gb|AIY24840.1|	immmunoglobulin lambda light chain variable partial	225	20	2.68E-159	91.5%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003597 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF198 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|723943344|gb|AIY24843.1|	immmunoglobulin lambda light chain variable partial	225	20	8.74E-162	92.6%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR003597 (SMART); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|723943350|gb|AIY24845.1|	immmunoglobulin lambda light chain variable partial	225	20	1.71E-161	93.2%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003597 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF198 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|723943356|gb|AIY24847.1|	immmunoglobulin lambda light chain variable partial	226	20	9.03E-162	95.4%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|723943359|gb|AIY24848.1|	immmunoglobulin lambda light chain variable partial	221	20	1.72E-157	92.2%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013106 (PFAM); PTHR23267:SF198 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|723943374|gb|AIY24853.1|	immmunoglobulin lambda light chain variable partial	221	20	6.52E-159	91.75%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR003597 (SMART); IPR003597 (PFAM); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|723943383|gb|AIY24856.1|	immmunoglobulin lambda light chain variable partial	225	20	6.79E-162	91.95%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF198 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|723943389|gb|AIY24858.1|	immmunoglobulin lambda light chain variable partial	225	20	4.59E-159	92.65%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|816197615|ref|NP_001295298.1|	U5 small nuclear ribonucleo 200 kDa helicase	2136	20	0E0	99.05%	3	F:GO:0003676; F:GO:0005524; F:GO:0005515	F:nucleic acid binding; F:ATP binding; F:protein binding		PIRSF039073 (PIRSF); IPR014001 (SMART); IPR004179 (SMART); IPR001650 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.150.20 (GENE3D); G3DSA:1.10.3380.10 (GENE3D); IPR004179 (PFAM); IPR001650 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24075 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR011991 (SUPERFAMILY); SSF158702 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011991 (SUPERFAMILY); SSF158702 (SUPERFAMILY)
gi|822092510|ref|NP_001295891.1|	centriolin isoform X1	2328	20	0E0	94.45%	3	P:GO:0051301; F:GO:0005515; P:GO:0000278	P:cell division; F:protein binding; P:mitotic cell cycle		SM00365 (SMART); IPR003591 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); PF14580 (PFAM); PTHR24365 (PANTHER); IPR028640 (PTHR24365:PANTHER); IPR001611 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY)
gi|822476259|ref|NP_001296100.1|	dedicator of cytokinesis 8 isoform X1	2102	20	0E0	97.85%	4	P:GO:0007264; F:GO:0005085; P:GO:0043087; F:GO:0005488	P:small GTPase mediated signal transduction; F:guanyl-nucleotide exchange factor activity; P:regulation of GTPase activity; F:binding		IPR010703 (PFAM); IPR027007 (PFAM); IPR021816 (PFAM); PTHR23317:SF74 (PANTHER); IPR026791 (PANTHER); IPR027357 (PROSITE_PROFILES); IPR027007 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)
gi|822885154|ref|NP_001296178.1|	E3 ubiquitin- ligase MYCBP2	4640	20	0E0	99%	2	F:GO:0008270; F:GO:0005515	F:zinc ion binding; F:protein binding		IPR000408 (PRINTS); IPR001841 (SMART); IPR004939 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR004939 (PFAM); IPR012983 (PFAM); PF13540 (PFAM); IPR003646 (PFAM); IPR008979 (G3DSA:2.60.120.GENE3D); IPR009091 (G3DSA:2.130.10.GENE3D); IPR001841 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR017868 (PFAM); IPR000408 (PFAM); PTHR22870 (PANTHER); IPR000408 (PROSITE_PATTERNS); IPR017868 (PROSITE_PROFILES); IPR000408 (PROSITE_PROFILES); IPR004939 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR014756 (SUPERFAMILY); IPR009091 (SUPERFAMILY); SSF57850 (SUPERFAMILY); IPR008979 (SUPERFAMILY)
gi|823270959|ref|NP_001296265.1|	serine threonine- kinase Chk1	476	20	0E0	98.95%	3	F:GO:0005524; F:GO:0004672; P:GO:0006468	F:ATP binding; F:protein kinase activity; P:protein phosphorylation		IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); PTHR24343 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)
gi|823270985|ref|NP_001296266.1|	mitochondrial import inner membrane translocase subunit Tim10 B	105	20	3.02E-71	98.65%	10	P:GO:0006626; P:GO:0007160; C:GO:0005758; F:GO:0046872; C:GO:0005739; C:GO:0042719; C:GO:0016020; P:GO:0015031; P:GO:0006810; C:GO:0005743	P:protein targeting to mitochondrion; P:cell-matrix adhesion; C:mitochondrial intermembrane space; F:metal ion binding; C:mitochondrion; C:mitochondrial intermembrane space protein transporter complex; C:membrane; P:protein transport; P:transport; C:mitochondrial inner membrane		IPR004217 (G3DSA:1.10.287.GENE3D); IPR004217 (PFAM); PTHR13172:SF0 (PANTHER); PTHR13172 (PANTHER); IPR004217 (SUPERFAMILY)
gi|823271001|ref|NP_001296217.1|	LAP2 isoform X4	1374	20	0E0	97.2%	3	P:GO:0007165; P:GO:0032088; F:GO:0005176	P:signal transduction; P:negative regulation of NF-kappaB transcription factor activity; F:ErbB-2 class receptor binding		IPR003591 (SMART); SM00364 (SMART); SM00365 (SMART); IPR001478 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR001611 (PFAM); IPR001478 (G3DSA:2.30.42.GENE3D); IPR001478 (PFAM); IPR032927 (PTHR23155:PANTHER); PTHR23155 (PANTHER); IPR001611 (PROSITE_PROFILES); IPR001478 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY); IPR032675 (SUPERFAMILY); IPR001478 (SUPERFAMILY)
gi|953841042|ref|XP_014588464.1|	cilia- and flagella-associated 46	2593	20	0E0	88.7%	1	F:GO:0005515	F:protein binding		IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR15977:SF15 (PANTHER); PTHR15977 (PANTHER)
gi|953841060|ref|XP_014588470.1|	deleted in malignant brain tumors 1 -like	1364	20	0E0	67.5%	3	P:GO:0007165; C:GO:0016020; F:GO:0005044	P:signal transduction; C:membrane; F:scavenger receptor activity		IPR001190 (PRINTS); IPR017448 (SMART); IPR000859 (SMART); IPR000859 (G3DSA:2.60.120.GENE3D); IPR017448 (G3DSA:3.10.250.GENE3D); IPR000859 (PFAM); IPR001190 (PFAM); PTHR19331 (PANTHER); PTHR19331:SF309 (PANTHER); IPR001190 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR001190 (PROSITE_PROFILES); IPR000859 (PROSITE_PROFILES); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY)
gi|953841064|ref|XP_014588472.1|	deleted in malignant brain tumors 1	1023	20	0E0	73.45%	3	P:GO:0007165; C:GO:0016020; F:GO:0005044	P:signal transduction; C:membrane; F:scavenger receptor activity		IPR001190 (PRINTS); IPR000859 (SMART); IPR017448 (SMART); IPR001190 (PFAM); IPR017448 (G3DSA:3.10.250.GENE3D); IPR000859 (PFAM); IPR000859 (G3DSA:2.60.120.GENE3D); PTHR19331 (PANTHER); PTHR19331:SF22 (PANTHER); IPR001190 (PROSITE_PATTERNS); IPR001190 (PROSITE_PROFILES); IPR000859 (PROSITE_PROFILES); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR000859 (SUPERFAMILY)
gi|953841083|ref|XP_014588478.1|	actin filament-associated 1-like 2 isoform X1	1032	20	0E0	93.45%	3	C:GO:0005737; F:GO:0035591; P:GO:0009966	C:cytoplasm; F:signaling adaptor activity; P:regulation of signal transduction		IPR001849 (SMART); IPR001849 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR030113 (PANTHER); IPR030115 (PTHR14338:PANTHER); IPR001849 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY)
gi|953841085|ref|XP_014588479.1|	von Willebrand factor A domain-containing 2 isoform X1	822	20	0E0	91.75%	4	C:GO:0005604; C:GO:0005615; F:GO:0005515; F:GO:0005509	C:basement membrane; C:extracellular space; F:protein binding; F:calcium ion binding		PR00453 (PRINTS); IPR002035 (SMART); IPR001881 (SMART); IPR000742 (SMART); IPR002035 (G3DSA:3.40.50.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR002035 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR000742 (PFAM); PTHR11132 (PANTHER); IPR030755 (PTHR11132:PANTHER); IPR013032 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR002035 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR002035 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR002035 (SUPERFAMILY)
gi|953841089|ref|XP_014588481.1|	guanylate cyclase 2G-like	1049	20	0E0	79.25%	7	F:GO:0005524; F:GO:0016849; C:GO:0016021; F:GO:0004672; P:GO:0006468; P:GO:0009190; P:GO:0035556	F:ATP binding; F:phosphorus-oxygen lyase activity; C:integral component of membrane; F:protein kinase activity; P:protein phosphorylation; P:cyclic nucleotide biosynthetic process; P:intracellular signal transduction		IPR001170 (PRINTS); IPR001054 (SMART); IPR001828 (PFAM); IPR001054 (PFAM); G3DSA:3.40.50.2300 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR001054 (G3DSA:3.30.70.GENE3D); G3DSA:3.40.50.2300 (GENE3D); IPR001245 (PFAM); PTHR11920:SF313 (PANTHER); PTHR11920 (PANTHER); IPR018297 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000719 (PROSITE_PROFILES); IPR001054 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR029787 (SUPERFAMILY); IPR028082 (SUPERFAMILY)
gi|953841095|ref|XP_014588483.1|	VPS10 domain-containing receptor 1 isoform X1	1152	20	0E0	97.3%	1	C:GO:0016021	C:integral component of membrane		IPR006581 (SMART); IPR031777 (PFAM); IPR000601 (PFAM); G3DSA:2.130.10.140 (GENE3D); IPR000601 (G3DSA:2.60.40.GENE3D); IPR031778 (PFAM); PTHR12106 (PANTHER); PTHR12106:SF8 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000601 (PROSITE_PROFILES); IPR000601 (SUPERFAMILY); SSF110296 (SUPERFAMILY); IPR000601 (SUPERFAMILY)
gi|953841108|ref|XP_005602621.2|	mitoferrin-2	379	20	0E0	99.15%	10	P:GO:0055072; P:GO:0006811; P:GO:0055085; F:GO:0003735; C:GO:0005739; C:GO:0016020; C:GO:0016021; P:GO:0006810; C:GO:0005743; P:GO:0006412	P:iron ion homeostasis; P:ion transport; P:transmembrane transport; F:structural constituent of ribosome; C:mitochondrion; C:membrane; C:integral component of membrane; P:transport; C:mitochondrial inner membrane; P:translation		IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089 (PANTHER); PTHR24089:SF205 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY)
gi|953841150|ref|XP_014588503.1|	2-aminoethanethiol dioxygenase	373	20	0E0	84.4%	2	F:GO:0016702; P:GO:0055114	F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; P:oxidation-reduction process	EC:1.13.11	IPR012864 (PFAM); IPR014710 (G3DSA:2.60.120.GENE3D); PTHR22966 (PANTHER); IPR011051 (SUPERFAMILY)
gi|953841165|ref|XP_005602568.2|	disks large homolog 5 isoform X1	2019	20	0E0	97.45%	1	F:GO:0005515	F:protein binding		IPR008145 (SMART); IPR001452 (SMART); IPR001478 (SMART); PF16610 (PFAM); IPR001478 (G3DSA:2.30.42.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR008145 (PFAM); IPR001478 (PFAM); IPR001478 (G3DSA:2.30.42.GENE3D); IPR006907 (PFAM); IPR001478 (G3DSA:2.30.42.GENE3D); IPR001478 (G3DSA:2.30.42.GENE3D); G3DSA:2.30.30.40 (GENE3D); PTHR13865:SF31 (PANTHER); PTHR13865 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR001478 (PROSITE_PROFILES); IPR008144 (PROSITE_PROFILES); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001452 (SUPERFAMILY); IPR001478 (SUPERFAMILY)
gi|953841561|ref|XP_014588652.1|	ankyrin-3 isoform X3	4382	20	0E0	98.75%	2	F:GO:0005515; P:GO:0007165	F:protein binding; P:signal transduction		IPR002110 (PRINTS); IPR000906 (SMART); IPR000488 (SMART); IPR002110 (SMART); IPR002110 (PFAM); IPR000906 (PFAM); IPR002110 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR011029 (G3DSA:1.10.533.GENE3D); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR000488 (PFAM); PF13637 (PFAM); PTHR24123:SF22 (PANTHER); PTHR24123 (PANTHER); IPR000906 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR011029 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY)
gi|953842087|ref|XP_014588815.1|	calcium-activated potassium channel subunit alpha-1 isoform X24	1205	20	0E0	98.35%	5	F:GO:0015269; P:GO:0006813; F:GO:0005249; P:GO:0055085; C:GO:0008076	F:calcium-activated potassium channel activity; P:potassium ion transport; F:voltage-gated potassium channel activity; P:transmembrane transport; C:voltage-gated potassium channel complex		IPR028325 (PRINTS); IPR003929 (PRINTS); IPR005821 (PFAM); G3DSA:1.10.287.70 (GENE3D); IPR003929 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10027:SF28 (PANTHER); PTHR10027 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR016040 (SUPERFAMILY); SSF81324 (SUPERFAMILY)
gi|953842208|ref|XP_014588847.1|	deleted in malignant brain tumors 1 -like	570	20	0E0	84.15%	3	P:GO:0007165; C:GO:0016020; F:GO:0005044	P:signal transduction; C:membrane; F:scavenger receptor activity		IPR001190 (PRINTS); IPR001507 (PRINTS); IPR017448 (SMART); IPR001507 (SMART); IPR000859 (SMART); IPR000859 (PFAM); IPR000859 (G3DSA:2.60.120.GENE3D); IPR001190 (PFAM); IPR017448 (G3DSA:3.10.250.GENE3D); IPR001507 (PFAM); PTHR24044:SF318 (PANTHER); PTHR24044 (PANTHER); IPR017977 (PROSITE_PATTERNS); IPR001190 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR001190 (PROSITE_PROFILES); IPR001507 (PROSITE_PROFILES); IPR000859 (PROSITE_PROFILES); IPR017448 (SUPERFAMILY); IPR000859 (SUPERFAMILY)
gi|953842254|ref|XP_005602416.2|	TBC1 domain family member 12	368	20	0E0	98.85%	8	P:GO:0031338; P:GO:0090630; F:GO:0005096; P:GO:2000785; C:GO:0055037; P:GO:0006886; F:GO:0017137; C:GO:0005776	P:regulation of vesicle fusion; P:activation of GTPase activity; F:GTPase activator activity; P:regulation of autophagosome assembly; C:recycling endosome; P:intracellular protein transport; F:Rab GTPase binding; C:autophagosome		IPR000195 (SMART); IPR000195 (PFAM); G3DSA:1.10.8.270 (GENE3D); PTHR22957:SF201 (PANTHER); PTHR22957 (PANTHER); IPR000195 (PROSITE_PROFILES); IPR000195 (SUPERFAMILY); IPR000195 (SUPERFAMILY)
gi|953842567|ref|XP_014588965.1|	ryanodine receptor 2	4886	20	0E0	99%	7	F:GO:0005219; F:GO:0005515; F:GO:0005509; C:GO:0016021; P:GO:0070588; C:GO:0005622; P:GO:0006874	F:ryanodine-sensitive calcium-release channel activity; F:protein binding; F:calcium ion binding; C:integral component of membrane; P:calcium ion transmembrane transport; C:intracellular; P:cellular calcium ion homeostasis		IPR013333 (PRINTS); IPR016093 (SMART); IPR003877 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR003032 (PFAM); IPR016093 (PFAM); IPR005821 (PFAM); G3DSA:2.80.10.50 (GENE3D); IPR003877 (PFAM); IPR013662 (PFAM); IPR000699 (PFAM); IPR014821 (PFAM); IPR002048 (PFAM); IPR000699 (G3DSA:1.25.10.GENE3D); G3DSA:2.80.10.50 (GENE3D); IPR009460 (PFAM); PTHR13715:SF75 (PANTHER); IPR015925 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR001870 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR016093 (PROSITE_PROFILES); IPR016093 (SUPERFAMILY); IPR016093 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR000699 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR000699 (SUPERFAMILY)
gi|953842573|ref|XP_005602744.2|	probable methyltransferase TARBP1	1460	20	0E0	93.6%	4	F:GO:0008173; F:GO:0003723; P:GO:0009451; P:GO:0006396	F:RNA methyltransferase activity; F:RNA binding; P:RNA modification; P:RNA processing	EC:2.1.1	IPR029026 (G3DSA:3.40.1280.GENE3D); IPR001537 (PFAM); PTHR12029 (PANTHER); PTHR12029:SF11 (PANTHER); IPR025806 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR029028 (SUPERFAMILY)
gi|953842592|ref|XP_014588974.1|	adipogenesis regulatory factor	205	20	2.27E-145	91.5%	9	P:GO:0072719; C:GO:0005634; C:GO:0070062; C:GO:0005737; P:GO:0045600; P:GO:0071478; P:GO:2001023; P:GO:0045944; C:GO:0005654	P:cellular response to cisplatin; C:nucleus; C:extracellular exosome; C:cytoplasm; P:positive regulation of fat cell differentiation; P:cellular response to radiation; P:regulation of response to drug; P:positive regulation of transcription from RNA polymerase II promoter; C:nucleoplasm		PTHR39227:SF1 (PANTHER); PTHR39227 (PANTHER)
gi|953842640|ref|XP_014588992.1|	HAUS augmin-like complex subunit 4	363	20	0E0	98%	3	P:GO:0051225; P:GO:0051297; C:GO:0070652	P:spindle assembly; P:centrosome organization; C:HAUS complex		IPR026214 (PRINTS); IPR029327 (PFAM); PTHR16219:SF1 (PANTHER); PTHR16219 (PANTHER); PD360721 (PRODOM)
gi|953842662|ref|XP_014588999.1|	WASP homolog-associated with membranes and microtubules	682	20	0E0	84.35%	1	F:GO:0003779	F:actin binding		IPR031738 (PFAM); IPR031808 (PFAM); PTHR23330 (PANTHER); IPR026688 (PTHR23330:PANTHER); IPR003124 (PROSITE_PROFILES)
gi|953842679|ref|XP_014589006.1|	kinesin KIF7	1146	20	0E0	91.8%	6	F:GO:0005524; F:GO:0003777; C:GO:0045298; P:GO:0007018; F:GO:0008017; C:GO:0005874	F:ATP binding; F:microtubule motor activity; C:tubulin complex; P:microtubule-based movement; F:microtubule binding; C:microtubule	EC:3.6.1; EC:3.6.1.15	IPR001752 (PRINTS); IPR001752 (SMART); IPR001752 (G3DSA:3.40.850.GENE3D); IPR001752 (PFAM); IPR027640 (PANTHER); PTHR24115:SF445 (PANTHER); IPR019821 (PROSITE_PATTERNS); IPR001752 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
gi|953842685|ref|XP_014589010.1|	A-kinase anchor 13	2754	20	0E0	94.05%	7	P:GO:0035023; P:GO:0043087; F:GO:0004691; F:GO:0005089; P:GO:0009069; P:GO:0016310; C:GO:0005952	P:regulation of Rho protein signal transduction; P:regulation of GTPase activity; F:cAMP-dependent protein kinase activity; F:Rho guanyl-nucleotide exchange factor activity; P:serine family amino acid metabolic process; P:phosphorylation; C:cAMP-dependent protein kinase complex	EC:2.7.11; EC:2.7.11.11	IPR002219 (SMART); IPR000219 (SMART); IPR001849 (SMART); IPR001849 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR000219 (G3DSA:1.20.900.GENE3D); G3DSA:3.30.60.20 (GENE3D); IPR000219 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR13944 (PANTHER); IPR028852 (PTHR13944:PANTHER); IPR002219 (PROSITE_PATTERNS); IPR000219 (PROSITE_PROFILES); IPR002219 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR000219 (SUPERFAMILY); SSF57889 (SUPERFAMILY)
gi|953842700|ref|XP_014589016.1|	E3 ubiquitin- ligase HERC2 isoform X1	4840	20	0E0	98.3%	3	F:GO:0004842; F:GO:0008270; P:GO:0016567	F:ubiquitin-protein transferase activity; F:zinc ion binding; P:protein ubiquitination		IPR000408 (PRINTS); IPR004939 (SMART); IPR000433 (SMART); IPR001199 (SMART); IPR000569 (SMART); IPR006624 (SMART); IPR021097 (PFAM); IPR008979 (G3DSA:2.60.120.GENE3D); IPR014722 (G3DSA:2.30.30.GENE3D); IPR000408 (PFAM); IPR009091 (G3DSA:2.130.10.GENE3D); IPR001199 (G3DSA:3.10.120.GENE3D); IPR000433 (PFAM); IPR010606 (PFAM); IPR000569 (PFAM); IPR001199 (PFAM); IPR004939 (PFAM); G3DSA:3.30.2160.10 (GENE3D); PTHR11254:SF325 (PANTHER); PTHR11254 (PANTHER); IPR000433 (PROSITE_PATTERNS); IPR000408 (PROSITE_PATTERNS); IPR004939 (PROSITE_PROFILES); IPR000408 (PROSITE_PROFILES); IPR001199 (PROSITE_PROFILES); IPR010606 (PROSITE_PROFILES); IPR000569 (PROSITE_PROFILES); IPR000433 (PROSITE_PROFILES); SSF63748 (SUPERFAMILY); IPR009091 (SUPERFAMILY); IPR009091 (SUPERFAMILY); IPR001199 (SUPERFAMILY); IPR008979 (SUPERFAMILY); IPR009091 (SUPERFAMILY); SSF159034 (SUPERFAMILY); IPR000569 (SUPERFAMILY)
gi|953842705|ref|XP_014589018.1|	A disintegrin and metallo ase with thrombospondin motifs 7	1628	20	0E0	89.8%	4	F:GO:0008270; P:GO:0006508; F:GO:0004222; C:GO:0005578	F:zinc ion binding; P:proteolysis; F:metalloendopeptidase activity; C:proteinaceous extracellular matrix	EC:3.4.24	IPR013273 (PRINTS); IPR000884 (SMART); IPR024079 (G3DSA:3.40.390.GENE3D); IPR002870 (PFAM); IPR001590 (PFAM); IPR000884 (PFAM); G3DSA:2.20.100.10 (GENE3D); IPR010294 (PFAM); PTHR13723:SF142 (PANTHER); PTHR13723 (PANTHER); IPR000884 (PROSITE_PROFILES); IPR001590 (PROSITE_PROFILES); SSF55486 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY)
gi|953842712|ref|XP_014589022.1|	immunoglobulin superfamily containing leucine-rich repeat 2	645	20	0E0	94.15%	1	F:GO:0005515	F:protein binding		IPR003591 (SMART); IPR000483 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); IPR001611 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR24366 (PANTHER); PTHR24366:SF15 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR032675 (SUPERFAMILY)
gi|953842718|ref|XP_014589025.1|	potassium sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	1198	20	0E0	81.85%	7	P:GO:0006813; F:GO:0005249; P:GO:0002027; P:GO:0006814; P:GO:0055085; C:GO:0008076; F:GO:0030552	P:potassium ion transport; F:voltage-gated potassium channel activity; P:regulation of heart rate; P:sodium ion transport; P:transmembrane transport; C:voltage-gated potassium channel complex; F:cAMP binding		G3DSA:1.10.287.70 (GENE3D); IPR013621 (PFAM); IPR014710 (G3DSA:2.60.120.GENE3D); IPR005821 (PFAM); G3DSA:1.10.287.630 (GENE3D); PTHR10217 (PANTHER); IPR030173 (PTHR10217:PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000595 (PROSITE_PROFILES); SSF81324 (SUPERFAMILY); IPR018490 (SUPERFAMILY)
gi|953842724|ref|XP_014589027.1|	thrombospondin type-1 domain-containing 4 isoform X2	661	20	0E0	90.3%	2	C:GO:0031012; F:GO:0004222	C:extracellular matrix; F:metalloendopeptidase activity	EC:3.4.24	IPR000884 (SMART); IPR010294 (PFAM); IPR000884 (PFAM); IPR010909 (PFAM); G3DSA:2.20.100.10 (GENE3D); PTHR13723:SF16 (PANTHER); PTHR13723 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR010909 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY)
gi|953842761|ref|XP_014589044.1|	protogenin	1189	20	0E0	97.15%	2	F:GO:0005515; P:GO:0007275	F:protein binding; P:multicellular organism development		PR00014 (PRINTS); IPR003961 (SMART); IPR003599 (SMART); IPR003598 (SMART); PF13927 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003961 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR033011 (PTHR10489:PANTHER); PTHR10489 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY)
gi|953842773|ref|XP_014589047.1|	transient receptor potential cation channel subfamily M member 7	1088	20	0E0	98.2%	9	F:GO:0005216; P:GO:0006812; P:GO:0055085; P:GO:0051262; C:GO:0016021; P:GO:0009069; P:GO:0016310; F:GO:0004674; P:GO:0010961	F:ion channel activity; P:cation transport; P:transmembrane transport; P:protein tetramerization; C:integral component of membrane; P:serine family amino acid metabolic process; P:phosphorylation; F:protein serine/threonine kinase activity; P:cellular magnesium ion homeostasis	EC:2.7.11	IPR032415 (PFAM); IPR005821 (PFAM); G3DSA:1.20.5.1010 (GENE3D); IPR029601 (PTHR13800:PANTHER); PTHR13800 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|953842780|ref|XP_014589051.1|	myelin expression factor 2	593	20	0E0	98.05%	2	F:GO:0000166; F:GO:0003676	F:nucleotide binding; F:nucleic acid binding		IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR23003 (PANTHER); PTHR23003:SF15 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY)
gi|953842788|ref|XP_014589056.1|	spatacsin	2502	20	0E0	94.85%	11	C:GO:0030425; C:GO:0070062; C:GO:0005737; P:GO:0008088; P:GO:0048675; C:GO:0031410; C:GO:0045202; C:GO:0005730; C:GO:0030424; C:GO:0005765; C:GO:0005886	C:dendrite; C:extracellular exosome; C:cytoplasm; P:axo-dendritic transport; P:axon extension; C:cytoplasmic vesicle; C:synapse; C:nucleolus; C:axon; C:lysosomal membrane; C:plasma membrane		IPR028107 (PFAM); PTHR13650:SF0 (PANTHER); IPR028103 (PANTHER)
gi|953842804|ref|XP_014589063.1|		3954				2	F:GO:0005515; F:GO:0005543	F:protein binding; F:phospholipid binding		IPR001605 (PRINTS); IPR018159 (SMART); IPR001849 (SMART); IPR001715 (SMART); IPR001715 (G3DSA:1.10.418.GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (PFAM); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR002017 (PFAM); IPR001849 (PFAM); PTHR11915:SF265 (PANTHER); PTHR11915 (PANTHER); IPR001589 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); IPR001715 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001715 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR011993 (SUPERFAMILY); SSF46966 (SUPERFAMILY)
gi|953842806|ref|XP_014589064.1|	MAX gene-associated isoform X1	3040	20	0E0	96.4%	6	C:GO:0005634; C:GO:0005667; F:GO:0003700; P:GO:0006355; F:GO:0046983; P:GO:0006355	C:nucleus; C:transcription factor complex; F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:protein dimerization activity; P:regulation of transcription, DNA-templated		IPR001699 (PRINTS); IPR001699 (SMART); IPR011598 (SMART); IPR011598 (G3DSA:4.10.280.GENE3D); IPR011598 (PFAM); IPR032060 (PFAM); IPR001699 (G3DSA:2.60.40.GENE3D); IPR001699 (PFAM); IPR001699 (PANTHER); PTHR11267:SF32 (PANTHER); IPR018186 (PROSITE_PATTERNS); IPR011598 (PROSITE_PROFILES); IPR001699 (PROSITE_PROFILES); IPR008967 (SUPERFAMILY); IPR011598 (SUPERFAMILY)
gi|953842811|ref|XP_014589066.1|	glutathione-specific gamma-glutamylcyclotransferase 1	499	20	0E0	94.9%	2	F:GO:0003839; P:GO:0006751	F:gamma-glutamylcyclotransferase activity; P:glutathione catabolic process	EC:2.3.2.4	IPR013024 (G3DSA:3.10.490.GENE3D); IPR006840 (PFAM); IPR006840 (PANTHER); PTHR12192:SF8 (PANTHER); IPR013024 (SUPERFAMILY)
gi|953842820|ref|XP_014589070.1|	ryanodine receptor 3	4894	20	0E0	97.2%	7	F:GO:0005219; F:GO:0005515; F:GO:0005509; C:GO:0016021; P:GO:0070588; C:GO:0005622; P:GO:0006874	F:ryanodine-sensitive calcium-release channel activity; F:protein binding; F:calcium ion binding; C:integral component of membrane; P:calcium ion transmembrane transport; C:intracellular; P:cellular calcium ion homeostasis		IPR013333 (PRINTS); IPR003877 (SMART); IPR016093 (SMART); IPR000699 (G3DSA:1.25.10.GENE3D); IPR009460 (PFAM); IPR003032 (PFAM); IPR013662 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); IPR016093 (PFAM); G3DSA:2.80.10.50 (GENE3D); IPR005821 (PFAM); G3DSA:2.80.10.50 (GENE3D); IPR003877 (PFAM); IPR014821 (PFAM); IPR000699 (PFAM); IPR015925 (PANTHER); PTHR13715:SF16 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR016093 (PROSITE_PROFILES); IPR001870 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR016093 (SUPERFAMILY); IPR016093 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR000699 (SUPERFAMILY); IPR000699 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR013320 (SUPERFAMILY)
gi|953842891|ref|XP_014589101.1|	cadherin-24	702	20	0E0	83.5%	11	F:GO:0045294; P:GO:0016337; F:GO:0070097; C:GO:0005911; F:GO:0005509; C:GO:0016020; C:GO:0016021; P:GO:0007155; F:GO:0008013; P:GO:0007156; C:GO:0005886	F:alpha-catenin binding; P:single organismal cell-cell adhesion; F:delta-catenin binding; C:cell-cell junction; F:calcium ion binding; C:membrane; C:integral component of membrane; P:cell adhesion; F:beta-catenin binding; P:homophilic cell adhesion via plasma membrane adhesion molecules; C:plasma membrane		
gi|953843024|ref|XP_014589134.1|	RPE-retinal G -coupled receptor isoform X1	295	20	0E0	93.35%	5	F:GO:0004930; P:GO:0007186; C:GO:0016021; P:GO:0007601; P:GO:0007602	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway; C:integral component of membrane; P:visual perception; P:phototransduction		IPR001793 (PRINTS); IPR000276 (PRINTS); IPR000276 (PFAM); G3DSA:1.20.1070.10 (GENE3D); PTHR24240 (PANTHER); IPR027430 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR017452 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY)
gi|953843269|ref|XP_014589201.1|	WD repeat- and FYVE domain-containing 4	3186	20	0E0	94.7%	1	F:GO:0005515	F:protein binding		IPR001680 (SMART); IPR000409 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR031570 (PFAM); IPR023362 (G3DSA:2.30.29.GENE3D); IPR000409 (G3DSA:1.10.1540.GENE3D); IPR000409 (PFAM); IPR023362 (PFAM); PTHR13743:SF85 (PANTHER); PTHR13743 (PANTHER); IPR019775 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR001680 (PROSITE_PROFILES); IPR000409 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR000409 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
gi|953844068|ref|XP_014589402.1|	neuronal acetylcholine receptor subunit alpha-3	477	20	0E0	91.25%	3	P:GO:0006811; C:GO:0016021; F:GO:0005230	P:ion transport; C:integral component of membrane; F:extracellular ligand-gated ion channel activity		IPR006201 (PRINTS); IPR027361 (G3DSA:1.20.120.GENE3D); IPR006201 (TIGRFAM); IPR006029 (PFAM); IPR006202 (G3DSA:2.70.170.GENE3D); IPR006202 (PFAM); PTHR18945:SF445 (PANTHER); IPR006201 (PANTHER); IPR018000 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR006202 (SUPERFAMILY); IPR006029 (SUPERFAMILY)
gi|953844074|ref|XP_005603197.2|	kunitz-type protease inhibitor 1	728	20	0E0	92.6%	2	F:GO:0004867; F:GO:0005515	F:serine-type endopeptidase inhibitor activity; F:protein binding		IPR002223 (PRINTS); IPR002172 (SMART); IPR002223 (SMART); IPR011106 (SMART); IPR002223 (PFAM); IPR002223 (G3DSA:4.10.410.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (PFAM); IPR002223 (G3DSA:4.10.410.GENE3D); IPR011106 (PFAM); PTHR10083:SF231 (PANTHER); PTHR10083 (PANTHER); IPR023415 (PROSITE_PATTERNS); IPR020901 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR002172 (PROSITE_PROFILES); IPR002223 (PROSITE_PROFILES); IPR013980 (PROSITE_PROFILES); IPR002172 (SUPERFAMILY); IPR002223 (SUPERFAMILY); IPR002223 (SUPERFAMILY)
gi|953844237|ref|XP_014589452.1|	stimulated by retinoic acid gene 6 homolog isoform X1	659	20	0E0	90.45%	4	P:GO:0007165; F:GO:0051183; F:GO:0004872; P:GO:0006810	P:signal transduction; F:vitamin transporter activity; F:receptor activity; P:transport		PF14752 (PFAM); PTHR21444 (PANTHER); IPR026612 (PTHR21444:PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS)
gi|953844428|ref|XP_014589515.1|	WD repeat-containing 72	1102	20	0E0	95%	1	F:GO:0005515	F:protein binding		IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR22847 (PANTHER); PTHR22847:SF408 (PANTHER); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR017986 (SUPERFAMILY)
gi|953844506|ref|XP_014589536.1|	sodium nucleoside cotransporter 1 isoform X1	646	20	0E0	92.45%	3	F:GO:0005337; C:GO:0016020; P:GO:1901642	F:nucleoside transmembrane transporter activity; C:membrane; P:nucleoside transmembrane transport		IPR011657 (PFAM); IPR002668 (PFAM); IPR018270 (TIGRFAM); IPR008276 (PANTHER); PTHR10590:SF16 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|953844831|ref|XP_001492497.5|	tetratricopeptide repeat 6	1860	20	0E0	84.25%	1	F:GO:0005515	F:protein binding		IPR019734 (SMART); IPR006597 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR019734 (PFAM); IPR013105 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR001440 (PFAM); PTHR23083 (PANTHER); PTHR23083:SF351 (PANTHER); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY)
gi|953844894|ref|XP_014589645.1|	FAM179B isoform X2	1769	20	0E0	95.85%	1	F:GO:0005488	F:binding		SM01349 (SMART); IPR024395 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR028401 (PTHR21567:PANTHER); PTHR21567 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
gi|953845094|ref|XP_014592668.1|	ubiquitin carboxyl-terminal hydrolase 24	2481	20	0E0	95.35%	4	P:GO:0016579; F:GO:0005488; F:GO:0036459; P:GO:0006511	P:protein deubiquitination; F:binding; F:thiol-dependent ubiquitinyl hydrolase activity; P:ubiquitin-dependent protein catabolic process	EC:3.4; EC:3.4.19.12	G3DSA:2.20.210.10 (GENE3D); IPR001394 (PFAM); G3DSA:3.10.20.90 (GENE3D); PTHR24006 (PANTHER); IPR033382 (PTHR24006:PANTHER); IPR018200 (PROSITE_PATTERNS); IPR018200 (PROSITE_PATTERNS); IPR028889 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY); IPR016024 (SUPERFAMILY); SSF54001 (SUPERFAMILY)
gi|953845106|ref|XP_014592673.1|	low-density lipo receptor-related 8 isoform X1	964	20	0E0	95.55%	2	F:GO:0005515; F:GO:0005509	F:protein binding; F:calcium ion binding		IPR002172 (PRINTS); IPR001881 (SMART); IPR000033 (SMART); IPR000742 (SMART); IPR002172 (SMART); IPR001881 (PFAM); IPR011042 (G3DSA:2.120.10.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR000033 (PFAM); PF14670 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (PFAM); PTHR10529 (PANTHER); PTHR10529:SF99 (PANTHER); IPR000152 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR023415 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000742 (PROSITE_PROFILES); IPR002172 (PROSITE_PROFILES); IPR000033 (PROSITE_PROFILES); SSF57196 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY)
gi|953845148|ref|XP_014592692.1|	tyrosine- kinase receptor Tie-1	1031	20	0E0	96.4%	4	F:GO:0005524; F:GO:0004713; F:GO:0005515; P:GO:0006468	F:ATP binding; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation	EC:2.7.10	IPR001245 (PRINTS); IPR003961 (SMART); IPR000742 (SMART); IPR020635 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001245 (PFAM); G3DSA:3.30.200.20 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:2.170.300.10 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR003961 (PFAM); IPR013151 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR24416:SF341 (PANTHER); PTHR24416 (PANTHER); IPR013032 (PROSITE_PATTERNS); IPR008266 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR003961 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY)
gi|953845177|ref|XP_014592705.1|	SH3 domain-containing 21	769	20	0E0	71.3%	1	F:GO:0005515	F:protein binding		IPR001452 (PRINTS); IPR001452 (SMART); G3DSA:2.30.30.40 (GENE3D); G3DSA:2.30.30.40 (GENE3D); IPR011511 (PFAM); PTHR14167 (PANTHER); PTHR14167:SF28 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY); IPR001452 (SUPERFAMILY); IPR001452 (SUPERFAMILY)
gi|953845184|ref|XP_014592708.1|	CUB and sushi domain-containing 2	913	20	0E0	98.95%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		IPR000436 (SMART); IPR000859 (SMART); G3DSA:2.10.70.10 (GENE3D); IPR000859 (G3DSA:2.60.120.GENE3D); IPR000859 (PFAM); G3DSA:2.10.70.10 (GENE3D); IPR000436 (PFAM); IPR000859 (G3DSA:2.60.120.GENE3D); G3DSA:2.10.70.10 (GENE3D); PTHR10127:SF669 (PANTHER); PTHR10127 (PANTHER); IPR000436 (PROSITE_PROFILES); IPR000859 (PROSITE_PROFILES); IPR000859 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY)
gi|953845211|ref|XP_014592718.1|	receptor-type tyrosine- phosphatase U isoform X1	1517	20	0E0	95.5%	5	F:GO:0005515; P:GO:0006570; F:GO:0004725; C:GO:0016020; P:GO:0006470	F:protein binding; P:tyrosine metabolic process; F:protein tyrosine phosphatase activity; C:membrane; P:protein dephosphorylation	EC:3.1.3.16; EC:3.1; EC:3.1.3.48; EC:3.1.3.41	IPR000998 (PRINTS); IPR000242 (PRINTS); IPR000998 (SMART); IPR003595 (SMART); IPR003961 (SMART); IPR000242 (SMART); IPR003961 (PFAM); IPR000998 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR029021 (G3DSA:3.90.190.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR029021 (G3DSA:3.90.190.GENE3D); IPR000242 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR19134 (PANTHER); PTHR19134:SF207 (PANTHER); IPR000998 (PROSITE_PATTERNS); IPR016130 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000998 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR029021 (SUPERFAMILY); IPR029021 (SUPERFAMILY); IPR003961 (SUPERFAMILY)
gi|953845226|ref|XP_014592723.1|	UBX domain-containing 11 isoform X1	437	20	0E0	82.9%	1	F:GO:0005515	F:protein binding		G3DSA:3.10.20.90 (GENE3D); IPR001012 (PFAM); IPR012989 (PFAM); PTHR23333:SF4 (PANTHER); PTHR23333 (PANTHER); IPR001012 (PROSITE_PROFILES); IPR012989 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY); IPR012989 (SUPERFAMILY)
gi|953845243|ref|XP_014592730.1|	basement membrane-specific heparan sulfate proteoglycan core	4393	20	0E0	94.4%	2	F:GO:0005515; F:GO:0005509	F:protein binding; F:calcium ion binding		IPR002172 (PRINTS); IPR013106 (SMART); IPR000742 (SMART); IPR002172 (SMART); IPR002049 (SMART); IPR003598 (SMART); IPR001791 (SMART); IPR003599 (SMART); IPR000082 (SMART); IPR000034 (SMART); IPR001881 (SMART); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.170.300.10 (GENE3D); IPR013320 (G3DSA:2.60.120.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002172 (PFAM); IPR013098 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR013320 (G3DSA:2.60.120.GENE3D); PF13927 (PFAM); IPR000034 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002049 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR000742 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001791 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013320 (G3DSA:2.60.120.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR10574:SF273 (PANTHER); PTHR10574 (PANTHER); IPR002049 (PROSITE_PATTERNS); IPR023415 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR007110 (PROSITE_PROFILES); IPR000034 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); IPR000082 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR001791 (PROSITE_PROFILES); IPR002172 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR007110 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR013320 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR007110 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF57196 (SUPERFAMILY)
gi|953845819|ref|XP_014592897.1|	zyg-11 homolog B	760	20	0E0	99%	1	F:GO:0005515	F:protein binding		IPR000225 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR12904 (PANTHER); PTHR12904:SF21 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR001611 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); SSF52047 (SUPERFAMILY)
gi|953845981|ref|XP_014592942.1|	Hook homolog 1	686	20	0E0	97.75%	12	P:GO:0007040; F:GO:0042802; C:GO:0015630; F:GO:0003779; P:GO:0007032; C:GO:0070695; P:GO:0007286; P:GO:0045022; C:GO:0005829; P:GO:0008333; C:GO:0030897; F:GO:0008017	P:lysosome organization; F:identical protein binding; C:microtubule cytoskeleton; F:actin binding; P:endosome organization; C:FHF complex; P:spermatid development; P:early endosome to late endosome transport; C:cytosol; P:endosome to lysosome transport; C:HOPS complex; F:microtubule binding		IPR008636 (PFAM); PTHR18947:SF36 (PANTHER); IPR008636 (PANTHER); SSF116907 (SUPERFAMILY)
gi|953845992|ref|XP_001504058.3|	nuclear inhibitor of phosphatase 1	351	20	0E0	99.55%	1	F:GO:0005515	F:protein binding		IPR000253 (SMART); IPR000253 (G3DSA:2.60.200.GENE3D); IPR000253 (PFAM); PTHR23308:SF28 (PANTHER); PTHR23308 (PANTHER); IPR000253 (PROSITE_PROFILES); IPR008984 (SUPERFAMILY)
gi|953846252|ref|XP_014593013.1|	zinc finger 691	315	20	0E0	94.8%	2	F:GO:0003676; F:GO:0046872	F:nucleic acid binding; F:metal ion binding		IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); IPR007087 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24387 (PANTHER); PTHR24387:SF202 (PANTHER); IPR007087 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|953846341|ref|XP_014593032.1|	SH2 domain-containing 5 isoform X1	462	20	0E0	95.6%	1	F:GO:0005515	F:protein binding		IPR006020 (SMART); IPR000980 (G3DSA:3.30.505.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR006020 (PROSITE_PROFILES); IPR000980 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR000980 (SUPERFAMILY)
gi|953846432|ref|XP_014593058.1|	probable cation-transporting ATPase 13A2 isoform X2	1328	20	0E0	94.75%	5	F:GO:0000166; F:GO:0016887; P:GO:0006812; F:GO:0046872; C:GO:0016021	F:nucleotide binding; F:ATPase activity; P:cation transport; F:metal ion binding; C:integral component of membrane	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	PR00119 (PRINTS); IPR001757 (TIGRFAM); IPR006544 (TIGRFAM); IPR023214 (G3DSA:3.40.50.GENE3D); IPR008250 (G3DSA:2.70.150.GENE3D); IPR008250 (PFAM); IPR006544 (PFAM); PF00702 (PFAM); IPR023299 (G3DSA:3.40.1110.GENE3D); PTHR24093 (PANTHER); PTHR24093:SF86 (PANTHER); IPR018303 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR023299 (SUPERFAMILY); SSF81653 (SUPERFAMILY); SSF81665 (SUPERFAMILY); IPR023214 (SUPERFAMILY)
gi|953846434|ref|XP_014593059.1|		1796				2	C:GO:0035253; P:GO:0051297	C:ciliary rootlet; P:centrosome organization		PF15035 (PFAM); PTHR23159 (PANTHER); IPR026733 (PTHR23159:PANTHER); SSF57997 (SUPERFAMILY); SSF57997 (SUPERFAMILY)
gi|953846461|ref|XP_014593071.1|	nephrocystin-4 isoform X1	1430	20	0E0	88.35%	3	P:GO:0090090; C:GO:0005856; C:GO:0097730	P:negative regulation of canonical Wnt signaling pathway; C:cytoskeleton; C:non-motile cilium		PTHR31043 (PANTHER); IPR029775 (PTHR31043:PANTHER)
gi|953846923|ref|XP_014593220.1|	tripartite motif-containing 35	453	20	0E0	94.65%	3	F:GO:0008270; F:GO:0005515; C:GO:0005622	F:zinc ion binding; F:protein binding; C:intracellular		IPR003879 (PRINTS); IPR006574 (SMART); IPR000315 (SMART); IPR003877 (SMART); IPR003877 (PFAM); IPR000315 (G3DSA:4.10.45.GENE3D); IPR006574 (PFAM); IPR000315 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR24103 (PANTHER); PTHR24103:SF404 (PANTHER); IPR000315 (PROSITE_PROFILES); IPR001870 (PROSITE_PROFILES); SSF57845 (SUPERFAMILY); IPR013320 (SUPERFAMILY); SSF57850 (SUPERFAMILY)
gi|953846925|ref|XP_014593221.1|	kinesin KIF13B	1961	20	0E0	92.05%	6	F:GO:0005524; F:GO:0003777; C:GO:0045298; P:GO:0007018; F:GO:0008017; C:GO:0005874	F:ATP binding; F:microtubule motor activity; C:tubulin complex; P:microtubule-based movement; F:microtubule binding; C:microtubule	EC:3.6.1; EC:3.6.1.15	IPR001752 (PRINTS); IPR000938 (SMART); IPR001752 (SMART); IPR022140 (PFAM); IPR032405 (PFAM); IPR001752 (PFAM); IPR000253 (PFAM); IPR001752 (G3DSA:3.40.850.GENE3D); IPR000938 (G3DSA:2.30.30.GENE3D); IPR000253 (G3DSA:2.60.200.GENE3D); IPR000938 (PFAM); IPR022164 (PFAM); IPR027640 (PANTHER); PTHR24115:SF338 (PANTHER); IPR019821 (PROSITE_PATTERNS); IPR000938 (PROSITE_PATTERNS); IPR000938 (PROSITE_PROFILES); IPR001752 (PROSITE_PROFILES); IPR000938 (SUPERFAMILY); IPR008984 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|953846977|ref|XP_001498366.3|	glycine receptor subunit alpha-3 isoform X1	464	20	0E0	99.2%	6	F:GO:0016934; F:GO:0022824; C:GO:0016935; C:GO:0045211; F:GO:0016594; P:GO:0006821	F:extracellular-glycine-gated chloride channel activity; F:transmitter-gated ion channel activity; C:glycine-gated chloride channel complex; C:postsynaptic membrane; F:glycine binding; P:chloride transport		IPR008127 (PRINTS); IPR008130 (PRINTS); IPR006028 (PRINTS); IPR006201 (PRINTS); IPR006202 (G3DSA:2.70.170.GENE3D); IPR006202 (PFAM); IPR006201 (TIGRFAM); G3DSA:1.20.58.390 (GENE3D); IPR006029 (PFAM); PTHR18945:SF455 (PANTHER); IPR006201 (PANTHER); IPR018000 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR006202 (SUPERFAMILY); IPR006029 (SUPERFAMILY)
gi|953847260|ref|XP_014593320.1|	disintegrin and metallo ase domain-containing 7	813	20	0E0	87.9%	2	P:GO:0006508; F:GO:0004222	P:proteolysis; F:metalloendopeptidase activity	EC:3.4.24	IPR001762 (PRINTS); IPR001762 (SMART); IPR006586 (SMART); IPR001762 (PFAM); IPR001762 (G3DSA:4.10.70.GENE3D); IPR002870 (PFAM); IPR006586 (PFAM); IPR024079 (G3DSA:3.40.390.GENE3D); IPR001590 (PFAM); PTHR11905:SF21 (PANTHER); PTHR11905 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR001762 (PROSITE_PROFILES); IPR001590 (PROSITE_PROFILES); IPR001762 (SUPERFAMILY); SSF55486 (SUPERFAMILY)
gi|953847316|ref|XP_005607862.2|	transmembrane 131-like	1588	20	0E0	95.05%	4	P:GO:0090090; C:GO:0005737; P:GO:0033088; C:GO:0005886	P:negative regulation of canonical Wnt signaling pathway; C:cytoplasm; P:negative regulation of immature T cell proliferation in thymus; C:plasma membrane		IPR022113 (PFAM); PTHR22050:SF2 (PANTHER); PTHR22050 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS)
gi|953847321|ref|XP_014593336.1|	zinc finger 827 isoform X1	1541	20	0E0	98.15%	2	F:GO:0003676; F:GO:0046872	F:nucleic acid binding; F:metal ion binding		IPR015880 (SMART); PF13909 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24375 (PANTHER); PTHR24375:SF4 (PANTHER); IPR007087 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF101447 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|953847402|ref|XP_014593354.1|	PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein KIAA1109 homolog	5006	20	0E0	98.45%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		IPR018863 (SMART); IPR018863 (PFAM); IPR033616 (PANTHER); PTHR31640:SF1 (PANTHER); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|953847492|ref|XP_014593389.1|	lipopolysaccharide-responsive and beige-like anchor isoform X2	2855	20	0E0	95.65%	1	F:GO:0005515	F:protein binding		IPR000409 (SMART); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR000409 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); IPR001680 (PFAM); IPR010508 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR031570 (PFAM); IPR000409 (G3DSA:1.10.1540.GENE3D); PF13385 (PFAM); IPR023362 (G3DSA:2.30.29.GENE3D); IPR023362 (PFAM); PTHR13743 (PANTHER); PTHR13743:SF64 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); PD329443 (PRODOM); IPR000409 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR000409 (SUPERFAMILY); IPR017986 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
gi|953847787|ref|XP_014593474.1|	protocadherin-23	3367	20	0E0	90.55%	3	F:GO:0005509; P:GO:0007156; C:GO:0005886	F:calcium ion binding; P:homophilic cell adhesion via plasma membrane adhesion molecules; C:plasma membrane		IPR002126 (PRINTS); IPR002126 (SMART); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (PFAM); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (G3DSA:2.60.40.GENE3D); PTHR24027 (PANTHER); PTHR24027:SF305 (PANTHER); IPR020894 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR002126 (PROSITE_PROFILES); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY)
gi|953847810|ref|XP_001502734.2|	ZGRF1	2125	20	0E0	88.2%	1	F:GO:0008270	F:zinc ion binding		IPR010666 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR018838 (PFAM); PF13087 (PFAM); PF13086 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10887 (PANTHER); PTHR10887:SF325 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR027417 (SUPERFAMILY)
gi|953847865|ref|XP_014593738.1|	chromodomain-helicase-DNA-binding 9 isoform X1	2849	20	0E0	95.4%	3	F:GO:0005524; F:GO:0005515; F:GO:0016817	F:ATP binding; F:protein binding; F:hydrolase activity, acting on acid anhydrides		IPR001650 (SMART); IPR014001 (SMART); IPR000953 (SMART); IPR006576 (SMART); IPR000330 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR006576 (PFAM); IPR001650 (PFAM); IPR023780 (PFAM); G3DSA:2.40.50.40 (GENE3D); PTHR10799:SF48 (PANTHER); PTHR10799 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR001650 (PROSITE_PROFILES); IPR000953 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); SSF160481 (SUPERFAMILY); SSF160481 (SUPERFAMILY); IPR016197 (SUPERFAMILY); IPR016197 (SUPERFAMILY)
gi|953847915|ref|XP_005608607.2|	hydrocephalus-inducing homolog	5068	20	0E0	92.2%	1	P:GO:0003341	P:cilium movement		PF14874 (PFAM); IPR031549 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR008962 (G3DSA:2.60.40.GENE3D); IPR033768 (PFAM); PTHR23053 (PANTHER); IPR033305 (PTHR23053:PANTHER)
gi|953847924|ref|XP_005608611.2|	chymotrypsinogen B-like	378	20	0E0	73.45%	2	P:GO:0006508; F:GO:0004252	P:proteolysis; F:serine-type endopeptidase activity	EC:3.4.21	IPR001314 (PRINTS); IPR001254 (SMART); IPR001254 (PFAM); G3DSA:2.40.10.10 (GENE3D); G3DSA:2.40.10.10 (GENE3D); G3DSA:2.40.10.10 (GENE3D); PTHR24250:SF31 (PANTHER); PTHR24250 (PANTHER); IPR033116 (PROSITE_PATTERNS); IPR018114 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR001254 (PROSITE_PROFILES); IPR009003 (SUPERFAMILY)
gi|953848022|ref|XP_014593792.1|	ankyrin repeat domain-containing 11 isoform X1	2667	20	0E0	96.55%	1	F:GO:0005515	F:protein binding		IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); PTHR24145:SF3 (PANTHER); PTHR24145 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY)
gi|953848082|ref|XP_014593813.1|	piezo-type mechanosensitive ion channel component 1	2518	20	0E0	92.55%	3	F:GO:0008381; P:GO:0006811; C:GO:0016021	F:mechanically-gated ion channel activity; P:ion transport; C:integral component of membrane		IPR031805 (PFAM); IPR031334 (PFAM); PTHR13167:SF40 (PANTHER); IPR027272 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|953848545|ref|XP_014593925.1|	RNA-binding NOB1	442	20	0E0	96.25%	9	P:GO:0090502; C:GO:0005634; P:GO:0030490; F:GO:0046872; P:GO:0042274; P:GO:0000469; P:GO:0007601; C:GO:0030688; F:GO:0004521	P:RNA phosphodiester bond hydrolysis, endonucleolytic; C:nucleus; P:maturation of SSU-rRNA; F:metal ion binding; P:ribosomal small subunit biogenesis; P:cleavage involved in rRNA processing; P:visual perception; C:preribosome, small subunit precursor; F:endoribonuclease activity		IPR033411 (PFAM); IPR014881 (PFAM); IPR033461 (PFAM); PTHR12814 (PANTHER); PTHR12814:SF2 (PANTHER); IPR014881 (SUPERFAMILY)
gi|953848624|ref|XP_014593950.1|	liver carboxylesterase-like isoform X1	550	20	0E0	89.4%	3	C:GO:0005615; F:GO:0052689; F:GO:0016787	C:extracellular space; F:carboxylic ester hydrolase activity; F:hydrolase activity		IPR002018 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR11559:SF179 (PANTHER); PTHR11559 (PANTHER); IPR019826 (PROSITE_PATTERNS); IPR019819 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR029058 (SUPERFAMILY)
gi|953848683|ref|XP_014593972.1|	polycystic kidney disease 1-like 2	2383	20	0E0	89.05%	4	F:GO:0005515; F:GO:0005509; C:GO:0016020; F:GO:0030246	F:protein binding; F:calcium ion binding; C:membrane; F:carbohydrate binding		IPR003915 (PRINTS); IPR001304 (SMART); IPR000203 (SMART); IPR001024 (SMART); IPR001304 (PFAM); IPR000203 (PFAM); IPR001024 (G3DSA:2.60.60.GENE3D); IPR013122 (PFAM); IPR002859 (PFAM); IPR001024 (PFAM); IPR016186 (G3DSA:3.10.100.GENE3D); IPR000922 (PFAM); PTHR10877 (PANTHER); PTHR10877:SF134 (PANTHER); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR001024 (PROSITE_PROFILES); IPR001304 (PROSITE_PROFILES); IPR000922 (PROSITE_PROFILES); IPR014010 (PROSITE_PROFILES); IPR000203 (PROSITE_PROFILES); IPR000601 (SUPERFAMILY); IPR001024 (SUPERFAMILY); IPR016187 (SUPERFAMILY)
gi|953848707|ref|XP_014593979.1|	BTB POZ domain-containing KCTD19	922	20	0E0	96.65%	1	P:GO:0051260	P:protein homooligomerization		IPR003131 (PFAM); G3DSA:3.30.710.10 (GENE3D); PTHR14499 (PANTHER); PTHR14499:SF20 (PANTHER); IPR011333 (SUPERFAMILY); IPR011333 (SUPERFAMILY); IPR011333 (SUPERFAMILY)
gi|953848839|ref|XP_014594015.1|	PR domain zinc finger 8	499	20	0E0	86.1%	3	F:GO:0003676; F:GO:0005515; F:GO:0046872	F:nucleic acid binding; F:protein binding; F:metal ion binding		IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); G3DSA:2.170.270.10 (GENE3D); PTHR16516 (PANTHER); PTHR16516:SF7 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR001214 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|953848844|ref|XP_014594017.1|	Shroom3	1753	20	0E0	87.05%	4	F:GO:0051015; P:GO:0001843; P:GO:0000902; P:GO:0002064	F:actin filament binding; P:neural tube closure; P:cell morphogenesis; P:epithelial cell development		IPR001478 (SMART); IPR001478 (G3DSA:2.30.42.GENE3D); IPR014799 (PFAM); IPR027685 (PANTHER); IPR030494 (PTHR15012:PANTHER); IPR001478 (PROSITE_PROFILES); IPR014799 (PROSITE_PROFILES); IPR001478 (SUPERFAMILY)
gi|953848903|ref|XP_014594044.1|	coiled-coil domain-containing 149 isoform X1	539	20	0E0	94%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		IPR019179 (PFAM); IPR019179 (PANTHER); PTHR21682:SF2 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|953849071|ref|XP_014594089.1|	huntingtin	3019	20	0E0	96.3%	30	F:GO:0034452; P:GO:0007030; C:GO:0005770; P:GO:0048513; C:GO:0005794; P:GO:0045724; F:GO:0045505; C:GO:0005776; C:GO:0005654; C:GO:0030425; F:GO:0002039; F:GO:0048487; P:GO:0047496; C:GO:0005829; P:GO:0034047; C:GO:0030424; F:GO:0042802; P:GO:0006890; C:GO:0005783; F:GO:0008134; C:GO:0043234; F:GO:0044325; F:GO:0005522; P:GO:0000132; C:GO:0005634; C:GO:0030659; C:GO:0005814; C:GO:0005737; P:GO:2001237; P:GO:0031587	F:dynactin binding; P:Golgi organization; C:late endosome; P:animal organ development; C:Golgi apparatus; P:positive regulation of cilium assembly; F:dynein intermediate chain binding; C:autophagosome; C:nucleoplasm; C:dendrite; F:p53 binding; F:beta-tubulin binding; P:vesicle transport along microtubule; C:cytosol; P:regulation of protein phosphatase type 2A activity; C:axon; F:identical protein binding; P:retrograde vesicle-mediated transport, Golgi to ER; C:endoplasmic reticulum; F:transcription factor binding; C:protein complex; F:ion channel binding; F:profilin binding; P:establishment of mitotic spindle orientation; C:nucleus; C:cytoplasmic vesicle membrane; C:centriole; C:cytoplasm; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity		
gi|953849147|ref|XP_014594121.1|	furry homolog-like isoform X1	3014	20	0E0	98.75%	1	F:GO:0005488	F:binding		IPR029473 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR025481 (PFAM); IPR025614 (PFAM); PTHR12295 (PANTHER); PTHR12295:SF9 (PANTHER); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
gi|953849224|ref|XP_014594151.1|	tyrosine- phosphatase non-receptor type 13 isoform X2	2506	20	0E0	96.15%	5	C:GO:0005856; F:GO:0005515; P:GO:0006570; F:GO:0004725; P:GO:0006470	C:cytoskeleton; F:protein binding; P:tyrosine metabolic process; F:protein tyrosine phosphatase activity; P:protein dephosphorylation	EC:3.1.3.16; EC:3.1; EC:3.1.3.48; EC:3.1.3.41	IPR000242 (PRINTS); IPR019749 (PRINTS); IPR012153 (PIRSF); IPR018980 (SMART); IPR001478 (SMART); IPR011019 (SMART); IPR000242 (SMART); IPR019749 (SMART); IPR003595 (SMART); IPR018979 (PFAM); G3DSA:3.10.20.90 (GENE3D); IPR029021 (G3DSA:3.90.190.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR001478 (G3DSA:2.30.42.GENE3D); IPR019748 (PFAM); IPR014352 (G3DSA:1.20.80.GENE3D); IPR018980 (PFAM); PF16599 (PFAM); IPR001478 (G3DSA:2.30.42.GENE3D); IPR001478 (PFAM); IPR001478 (G3DSA:2.30.42.GENE3D); IPR000242 (PFAM); PTHR19134 (PANTHER); IPR012153 (PTHR19134:PANTHER); IPR001478 (PROSITE_PROFILES); IPR011019 (PROSITE_PROFILES); IPR000299 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); IPR019748 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR029021 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR029071 (SUPERFAMILY)
gi|953849323|ref|XP_014594182.1|	probable E3 ubiquitin- ligase HERC6 isoform X1	761	20	0E0	90.6%	2	F:GO:0004842; P:GO:0016567	F:ubiquitin-protein transferase activity; P:protein ubiquitination		IPR000408 (PRINTS); PF13540 (PFAM); IPR009091 (G3DSA:2.130.10.GENE3D); IPR000569 (PFAM); IPR000408 (PFAM); PTHR11254:SF315 (PANTHER); PTHR11254 (PANTHER); IPR000408 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000569 (PROSITE_PROFILES); IPR000408 (PROSITE_PROFILES); IPR009091 (SUPERFAMILY); IPR000569 (SUPERFAMILY)
gi|953849384|ref|XP_014594203.1|	coiled-coil and C2 domain-containing 2A isoform X1	1621	20	0E0	96.35%	1	F:GO:0005515	F:protein binding		IPR000008 (SMART); IPR000008 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR028928 (PFAM); PTHR20837 (PANTHER); PTHR20837:SF7 (PANTHER)
gi|953849397|ref|XP_014594207.1|	phosphatase mitochondrial	372	20	0E0	96.8%	4	F:GO:0004722; C:GO:0008287; P:GO:0006470; F:GO:0043169	F:protein serine/threonine phosphatase activity; C:protein serine/threonine phosphatase complex; P:protein dephosphorylation; F:cation binding	EC:3.1.3.16; EC:3.1; EC:3.1.3.41	IPR001932 (SMART); IPR001932 (SMART); IPR001932 (PFAM); IPR001932 (G3DSA:3.60.40.GENE3D); PTHR13832:SF267 (PANTHER); IPR015655 (PANTHER); IPR000222 (PROSITE_PATTERNS); IPR001932 (PROSITE_PROFILES); IPR001932 (SUPERFAMILY)
gi|953849500|ref|XP_014594234.1|	B-cell scaffold with ankyrin repeats	759	20	0E0	88.6%	6	P:GO:0045947; P:GO:1900165; P:GO:0050869; P:GO:0043410; P:GO:0042113; P:GO:0051898	P:negative regulation of translational initiation; P:negative regulation of interleukin-6 secretion; P:negative regulation of B cell activation; P:positive regulation of MAPK cascade; P:B cell activation; P:negative regulation of protein kinase B signaling		IPR017893 (SMART); IPR017893 (PFAM); PTHR16267:SF13 (PANTHER); PTHR16267 (PANTHER); IPR017893 (PROSITE_PROFILES)
gi|953849618|ref|XP_014594259.1|	vascular endothelial growth factor receptor 2	1267	20	0E0	96.8%	6	F:GO:0005524; F:GO:0019838; P:GO:0048010; C:GO:0016021; F:GO:0005021; P:GO:0006468	F:ATP binding; F:growth factor binding; P:vascular endothelial growth factor receptor signaling pathway; C:integral component of membrane; F:vascular endothelial growth factor-activated receptor activity; P:protein phosphorylation	EC:2.7.10; EC:2.7.10.1; EC:2.7.11	PR01832 (PRINTS); IPR009136 (PRINTS); IPR020635 (SMART); IPR003598 (SMART); IPR003599 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001245 (PFAM); IPR013098 (PFAM); IPR013151 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:1.10.510.10 (GENE3D); PF13927 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR24416 (PANTHER); IPR009136 (PTHR24416:PANTHER); IPR008266 (PROSITE_PATTERNS); IPR001824 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|953849878|ref|XP_014594327.1|	gamma-aminobutyric acid receptor subunit alpha-2 isoform X2	458	20	0E0	98.6%	5	C:GO:0016021; F:GO:0004890; F:GO:0005230; P:GO:0006821; P:GO:0007214	C:integral component of membrane; F:GABA-A receptor activity; F:extracellular ligand-gated ion channel activity; P:chloride transport; P:gamma-aminobutyric acid signaling pathway		IPR006201 (PRINTS); IPR006028 (PRINTS); IPR005432 (PRINTS); IPR001390 (PRINTS); G3DSA:1.20.58.390 (GENE3D); IPR006029 (PFAM); IPR006202 (PFAM); IPR006202 (G3DSA:2.70.170.GENE3D); IPR006201 (TIGRFAM); PTHR18945:SF218 (PANTHER); IPR006201 (PANTHER); IPR018000 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR006029 (SUPERFAMILY); IPR006202 (SUPERFAMILY)
gi|953850028|ref|XP_014594371.1|	fidgetin 1 isoform X1	677	20	0E0	93.2%	20	C:GO:0000228; F:GO:0008568; F:GO:0000166; F:GO:0000287; C:GO:0005634; F:GO:0005524; F:GO:0005515; C:GO:0070062; C:GO:0005737; F:GO:0046872; P:GO:0043066; P:GO:0046034; P:GO:0001649; P:GO:0033687; P:GO:0071479; P:GO:0010569; P:GO:0031122; P:GO:0051726; P:GO:2001243; F:GO:0016787	C:nuclear chromosome; F:microtubule-severing ATPase activity; F:nucleotide binding; F:magnesium ion binding; C:nucleus; F:ATP binding; F:protein binding; C:extracellular exosome; C:cytoplasm; F:metal ion binding; P:negative regulation of apoptotic process; P:ATP metabolic process; P:osteoblast differentiation; P:osteoblast proliferation; P:cellular response to ionizing radiation; P:regulation of double-strand break repair via homologous recombination; P:cytoplasmic microtubule organization; P:regulation of cell cycle; P:negative regulation of intrinsic apoptotic signaling pathway; F:hydrolase activity		
gi|953850063|ref|XP_014594380.1|	TCR gamma alternate reading frame	295	20	0E0	72.65%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR003599 (SMART); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR19256:SF27 (PANTHER); PTHR19256 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|953850083|ref|XP_014594388.1|		2663				1	F:GO:0005515	F:protein binding		IPR001024 (SMART); IPR022409 (SMART); IPR000601 (G3DSA:2.60.40.GENE3D); IPR001024 (G3DSA:2.60.60.GENE3D); IPR013122 (PFAM); IPR002859 (PFAM); IPR001024 (PFAM); IPR000601 (PFAM); PTHR10877:SF145 (PANTHER); PTHR10877 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR014010 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR000601 (PROSITE_PROFILES); IPR001024 (SUPERFAMILY); IPR000601 (SUPERFAMILY)
gi|953850354|ref|XP_014594467.1|	E3 ubiquitin- ligase HECW1	1584	20	0E0	91.85%	3	F:GO:0004842; F:GO:0005515; P:GO:0016567	F:ubiquitin-protein transferase activity; F:protein binding; P:protein ubiquitination		IPR000569 (SMART); IPR000008 (SMART); IPR001202 (SMART); IPR000569 (PFAM); IPR001202 (PFAM); IPR032348 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); G3DSA:2.20.70.10 (GENE3D); IPR000008 (PFAM); G3DSA:3.30.2160.10 (GENE3D); PTHR11254 (PANTHER); PTHR11254:SF79 (PANTHER); IPR001202 (PROSITE_PATTERNS); IPR001202 (PROSITE_PROFILES); IPR000569 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR001202 (SUPERFAMILY); IPR000569 (SUPERFAMILY); IPR001202 (SUPERFAMILY); IPR000008 (SUPERFAMILY)
gi|953850374|ref|XP_014594474.1|	laminin subunit beta-4	1791	20	0E0	90.05%	1	F:GO:0005515	F:protein binding		PR00011 (PRINTS); IPR000742 (SMART); IPR008211 (SMART); IPR002049 (SMART); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR002049 (PFAM); IPR008211 (PFAM); PTHR10574 (PANTHER); PTHR10574:SF279 (PANTHER); IPR013032 (PROSITE_PATTERNS); IPR002049 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR008211 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); IPR013015 (PROSITE_PROFILES); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY)
gi|953850436|ref|XP_014594492.1|	High mobility group nucleosome-binding domain-containing 4	376	20	0E0	78.05%	3	C:GO:0005634; F:GO:0031492; C:GO:0000785	C:nucleus; F:nucleosomal DNA binding; C:chromatin		IPR000079 (PRINTS); IPR000079 (SMART); IPR000079 (PFAM); PTHR23087 (PANTHER); PTHR23087:SF16 (PANTHER); IPR000079 (PROSITE_PATTERNS)
gi|953850438|ref|XP_014594493.1|	piccolo	5130	20	0E0	90.75%	4	P:GO:0007416; F:GO:0005515; C:GO:0048786; F:GO:0046872	P:synapse assembly; F:protein binding; C:presynaptic active zone; F:metal ion binding		IPR000008 (SMART); IPR001478 (SMART); IPR000008 (PFAM); IPR008899 (PFAM); IPR001478 (G3DSA:2.30.42.GENE3D); IPR001478 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); IPR000008 (G3DSA:2.60.40.GENE3D); IPR030629 (PTHR14113:PANTHER); PTHR14113 (PANTHER); IPR000008 (PROSITE_PROFILES); IPR001478 (PROSITE_PROFILES); IPR000409 (PROSITE_PROFILES); IPR001478 (SUPERFAMILY); IPR011011 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR011011 (SUPERFAMILY)
gi|953850474|ref|XP_014594506.1|	E3 ubiquitin- ligase ZNRF2	140	20	2.47E-99	98.85%	9	F:GO:0061630; F:GO:0008270; C:GO:0030659; C:GO:0005737; F:GO:0046872; C:GO:0043234; F:GO:0016874; C:GO:0005886; P:GO:0016567	F:ubiquitin protein ligase activity; F:zinc ion binding; C:cytoplasmic vesicle membrane; C:cytoplasm; F:metal ion binding; C:protein complex; F:ligase activity; C:plasma membrane; P:protein ubiquitination		IPR013083 (G3DSA:3.30.40.GENE3D); SSF57850 (SUPERFAMILY)
gi|953850521|ref|XP_014594524.1|	leucine-rich repeat and death domain-containing 1	870	20	0E0	92%	1	F:GO:0005515	F:protein binding		PR00019 (PRINTS); SM00365 (SMART); SM00364 (SMART); IPR003591 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); IPR011029 (G3DSA:1.10.533.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR001611 (PFAM); PTHR23155:SF581 (PANTHER); PTHR23155 (PANTHER); IPR001611 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY); IPR032675 (SUPERFAMILY)
gi|953850851|ref|XP_014594614.1|	centrosomal of 41 kDa isoform X1	414	20	0E0	95.8%	19	P:GO:0016337; C:GO:0036064; P:GO:0030030; P:GO:0015031; P:GO:0006810; C:GO:0042995; C:GO:0005886; C:GO:0009986; C:GO:0072372; P:GO:0018095; C:GO:0005813; C:GO:0005856; C:GO:0005911; C:GO:0005815; C:GO:0005814; C:GO:0005737; P:GO:0042384; C:GO:0016020; C:GO:0005929	P:single organismal cell-cell adhesion; C:ciliary basal body; P:cell projection organization; P:protein transport; P:transport; C:cell projection; C:plasma membrane; C:cell surface; C:primary cilium; P:protein polyglutamylation; C:centrosome; C:cytoskeleton; C:cell-cell junction; C:microtubule organizing center; C:centriole; C:cytoplasm; P:cilium assembly; C:membrane; C:cilium		IPR001763 (SMART); IPR001763 (PFAM); IPR001763 (G3DSA:3.40.250.GENE3D); PTHR12231 (PANTHER); PTHR12231:SF152 (PANTHER); IPR001763 (PROSITE_PROFILES); IPR001763 (SUPERFAMILY)
gi|953850872|ref|XP_014594617.1|	WD repeat-containing mio	875	20	0E0	99.1%	1	F:GO:0005515	F:protein binding		IPR001680 (SMART); IPR031488 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR16453 (PANTHER); PTHR16453:SF9 (PANTHER); IPR017986 (SUPERFAMILY)
gi|953851199|ref|XP_014594709.1|	UPF0606 KIAA1549 homolog	1624	20	0E0	94.05%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		IPR024606 (PFAM); IPR024606 (PANTHER); PTHR21590:SF4 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS)
gi|953851211|ref|XP_014594715.1|	maltase-glucoamylase FLJ16351	1953	20	0E0	88.8%	3	P:GO:0005975; F:GO:0004553; F:GO:0030246	P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:carbohydrate binding		IPR000519 (SMART); IPR025887 (PFAM); IPR031727 (PFAM); IPR000519 (G3DSA:4.10.110.GENE3D); IPR000322 (PFAM); IPR000519 (PFAM); PTHR22762:SF55 (PANTHER); PTHR22762 (PANTHER); IPR030458 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000519 (PROSITE_PROFILES); IPR017853 (SUPERFAMILY); IPR000519 (SUPERFAMILY); IPR017853 (SUPERFAMILY); SSF51011 (SUPERFAMILY); IPR011013 (SUPERFAMILY); SSF51011 (SUPERFAMILY); IPR011013 (SUPERFAMILY); IPR000519 (SUPERFAMILY)
gi|953851227|ref|XP_014594725.1|		1670				4	P:GO:0035023; F:GO:0005515; P:GO:0043087; F:GO:0005089	P:regulation of Rho protein signal transduction; F:protein binding; P:regulation of GTPase activity; F:Rho guanyl-nucleotide exchange factor activity		IPR001452 (SMART); IPR001849 (SMART); IPR000219 (SMART); IPR001452 (PFAM); IPR029212 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR000219 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR000219 (G3DSA:1.20.900.GENE3D); PTHR12845 (PANTHER); PTHR12845:SF2 (PANTHER); IPR001331 (PROSITE_PATTERNS); IPR000219 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR000219 (SUPERFAMILY); IPR001452 (SUPERFAMILY)
gi|953851239|ref|XP_014594731.1|	SCO-spondin	5103	20	0E0	85.85%	1	F:GO:0005515	F:protein binding		IPR002172 (PRINTS); IPR000884 (SMART); IPR000421 (SMART); IPR014853 (SMART); IPR006207 (SMART); IPR002172 (SMART); IPR001007 (SMART); IPR001007 (SMART); IPR001846 (SMART); IPR001007 (PFAM); IPR008979 (G3DSA:2.60.120.GENE3D); IPR000884 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR002919 (PFAM); G3DSA:4.10.1220.10 (GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.20.100.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR000421 (PFAM); IPR001846 (PFAM); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.20.100.10 (GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (PFAM); IPR014853 (PFAM); PTHR11339:SF294 (PANTHER); PTHR11339 (PANTHER); IPR001007 (PROSITE_PATTERNS); IPR023415 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR000884 (PROSITE_PROFILES); IPR000421 (PROSITE_PROFILES); IPR002172 (PROSITE_PROFILES); IPR006207 (PROSITE_PROFILES); IPR001007 (PROSITE_PROFILES); IPR001846 (PROSITE_PROFILES); IPR000884 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR008979 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR000884 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR000884 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR000884 (SUPERFAMILY)
gi|953851249|ref|XP_014594735.1|	ubinuclein-2 isoform X1	1334	20	0E0	94.95%	1	C:GO:0005634	C:nucleus		IPR026947 (PFAM); IPR014840 (PFAM); PTHR21669 (PANTHER); IPR026943 (PTHR21669:PANTHER)
gi|953851605|ref|XP_014594846.1|	histone-lysine N-methyltransferase 2C	4960	20	0E0	96.5%	3	C:GO:0005634; F:GO:0008270; F:GO:0005515	C:nucleus; F:zinc ion binding; F:protein binding		IPR001214 (SMART); IPR001965 (SMART); IPR001841 (SMART); IPR003889 (SMART); IPR003616 (SMART); IPR003888 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001214 (PFAM); G3DSA:2.170.270.10 (GENE3D); IPR019787 (PFAM); PF13832 (PFAM); IPR003888 (PFAM); PF13771 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR003889 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR22884:SF373 (PANTHER); PTHR22884 (PANTHER); IPR003888 (PROSITE_PROFILES); IPR001214 (PROSITE_PROFILES); IPR001594 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR019787 (PROSITE_PROFILES); IPR003616 (PROSITE_PROFILES); IPR003889 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY); IPR011011 (SUPERFAMILY); SSF82199 (SUPERFAMILY); IPR011011 (SUPERFAMILY); IPR011011 (SUPERFAMILY); IPR011011 (SUPERFAMILY); IPR011011 (SUPERFAMILY)
gi|953851622|ref|XP_014594852.1|	RNA-binding 33	1086	20	0E0	96.7%	2	F:GO:0000166; F:GO:0003676	F:nucleotide binding; F:nucleic acid binding		IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR22014:SF2 (PANTHER); PTHR22014 (PANTHER); IPR012677 (SUPERFAMILY)
gi|953852095|ref|XP_014595008.1|	transmembrane and coiled-coil domains 2 isoform X2	624	20	0E0	98.2%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		IPR019394 (PFAM); PTHR17613 (PANTHER); PTHR17613:SF9 (PANTHER); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|953852129|ref|XP_014595014.1|	contactin-2	1070	20	0E0	96.9%	6	P:GO:0001764; F:GO:0005515; P:GO:0007417; P:GO:0007409; P:GO:0071205; P:GO:0007155	P:neuron migration; F:protein binding; P:central nervous system development; P:axonogenesis; P:protein localization to juxtaparanode region of axon; P:cell adhesion		IPR003961 (SMART); IPR003599 (SMART); IPR003598 (SMART); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003961 (PFAM); PF13927 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR10489 (PANTHER); IPR032993 (PTHR10489:PANTHER); IPR007110 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY)
gi|953852186|ref|XP_014595030.1|	tenascin-N isoform X1	1384	20	0E0	91.65%	2	F:GO:0005515; C:GO:0005578	F:protein binding; C:proteinaceous extracellular matrix		IPR000742 (SMART); IPR003961 (SMART); IPR002181 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR014715 (G3DSA:4.10.530.GENE3D); IPR003961 (PFAM); IPR014716 (G3DSA:3.90.215.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR002181 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR033080 (PTHR19143:PANTHER); PTHR19143 (PANTHER); IPR013032 (PROSITE_PATTERNS); IPR020837 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR003961 (PROSITE_PROFILES); IPR002181 (PROSITE_PROFILES); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR002181 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY)
gi|953852608|ref|XP_014595148.1|	N-lysine methyltransferase SMYD2	349	20	0E0	99.05%	1	F:GO:0005515	F:protein binding		IPR011990 (G3DSA:1.25.40.GENE3D); IPR001214 (PFAM); G3DSA:2.170.270.10 (GENE3D); PTHR12197 (PANTHER); PTHR12197:SF177 (PANTHER); IPR001214 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY); IPR011990 (SUPERFAMILY)
gi|953852825|ref|XP_014595224.1|	thrombospondin-3 isoform X1	1036	20	0E0	98.65%	5	F:GO:0005515; F:GO:0005509; F:GO:0008201; P:GO:0007155; C:GO:0005576	F:protein binding; F:calcium ion binding; F:heparin binding; P:cell adhesion; C:extracellular region		IPR001791 (SMART); IPR001881 (SMART); IPR000742 (SMART); IPR024665 (PFAM); IPR008859 (PFAM); IPR003367 (PFAM); IPR001881 (PFAM); G3DSA:1.20.5.10 (GENE3D); IPR013320 (G3DSA:2.60.120.GENE3D); IPR028974 (G3DSA:4.10.1080.GENE3D); G3DSA:2.10.25.10 (GENE3D); PTHR10199 (PANTHER); IPR028507 (PTHR10199:PANTHER); IPR018097 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR008859 (PROSITE_PROFILES); IPR017897 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR028974 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR013320 (SUPERFAMILY); SSF58006 (SUPERFAMILY); IPR028974 (SUPERFAMILY); IPR028974 (SUPERFAMILY); IPR013320 (SUPERFAMILY)
gi|953853323|ref|XP_014595372.1|	tropomodulin-4 isoform X1	345	20	0E0	99.1%	3	F:GO:0051015; P:GO:0051694; F:GO:0005523	F:actin filament binding; P:pointed-end actin filament capping; F:tropomyosin binding		IPR004934 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); IPR030129 (PTHR10901:PANTHER); IPR004934 (PANTHER); SSF52047 (SUPERFAMILY)
gi|953853680|ref|XP_005610286.2|	SLAM family member 8-like	289	20	0E0	88.65%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR12080 (PANTHER); PTHR12080:SF57 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|953853727|ref|XP_014595490.1|	neurogenic locus notch homolog 2	2507	20	0E0	97.5%	9	P:GO:0050793; F:GO:0005515; P:GO:0007219; P:GO:0007275; F:GO:0005509; C:GO:0016021; P:GO:0030154; P:GO:0006355; F:GO:0004872	P:regulation of developmental process; F:protein binding; P:Notch signaling pathway; P:multicellular organism development; F:calcium ion binding; C:integral component of membrane; P:cell differentiation; P:regulation of transcription, DNA-templated; F:receptor activity		PR01983 (PRINTS); PR00010 (PRINTS); IPR022336 (PRINTS); IPR000800 (PRINTS); IPR002110 (SMART); IPR024600 (SMART); IPR008297 (PIRSF); IPR011656 (SMART); IPR010660 (SMART); IPR000800 (SMART); IPR001881 (SMART); IPR000742 (SMART); IPR020683 (PFAM); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR000742 (PFAM); IPR001881 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR000800 (PFAM); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR024600 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR011656 (PFAM); G3DSA:2.170.300.10 (GENE3D); IPR013032 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR010660 (PFAM); PTHR24033:SF66 (PANTHER); PTHR24033 (PANTHER); IPR000152 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); PD936484 (PRODOM); IPR020683 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR000800 (PROSITE_PROFILES); IPR000800 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR009030 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR009030 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR009030 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR020683 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR009030 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR000800 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR009030 (SUPERFAMILY)
gi|953853737|ref|XP_014595495.1|	bile acid receptor-like	613	20	0E0	85.75%	9	C:GO:0005634; C:GO:0005667; F:GO:0003700; F:GO:0008270; F:GO:0003707; P:GO:0006355; F:GO:0043565; P:GO:0006355; P:GO:0043401	C:nucleus; C:transcription factor complex; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; F:steroid hormone receptor activity; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding; P:regulation of transcription, DNA-templated; P:steroid hormone mediated signaling pathway		IPR001628 (PRINTS); IPR001723 (PRINTS); IPR001628 (SMART); IPR000536 (PFAM); IPR001628 (PFAM); IPR013088 (G3DSA:3.30.50.GENE3D); IPR000536 (G3DSA:1.10.565.GENE3D); PTHR24082 (PANTHER); PTHR24082:SF313 (PANTHER); IPR001628 (PROSITE_PATTERNS); IPR001628 (PROSITE_PROFILES); IPR000536 (SUPERFAMILY); SSF57716 (SUPERFAMILY)
gi|953853797|ref|XP_014595518.1|	choline transporter 5	741	20	0E0	92.85%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		IPR007603 (PFAM); PTHR12385:SF42 (PANTHER); IPR007603 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS)
gi|953853813|ref|XP_014595525.1|	VWFA and cache domain-containing 1	1315	20	0E0	97.5%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		IPR013608 (PFAM); IPR002035 (PFAM); G3DSA:3.30.450.20 (GENE3D); IPR002035 (G3DSA:3.40.50.GENE3D); PTHR10166 (PANTHER); PTHR10166:SF40 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR002035 (PROSITE_PROFILES); IPR029151 (SUPERFAMILY); IPR002035 (SUPERFAMILY)
gi|953853942|ref|XP_014595558.1|	membrane-associated guanylate WW and PDZ domain-containing 3 isoform X1	1481	20	0E0	95.25%	3	F:GO:0032947; C:GO:0005911; P:GO:0046328	F:protein complex scaffold; C:cell-cell junction; P:regulation of JNK cascade		IPR001202 (SMART); IPR008145 (SMART); IPR001478 (SMART); G3DSA:2.20.70.10 (GENE3D); IPR001478 (G3DSA:2.30.42.GENE3D); IPR008145 (PFAM); IPR001202 (PFAM); IPR001478 (PFAM); G3DSA:2.20.70.10 (GENE3D); G3DSA:3.30.63.10 (GENE3D); IPR001478 (G3DSA:2.30.42.GENE3D); PTHR10316 (PANTHER); IPR030035 (PTHR10316:PANTHER); IPR001202 (PROSITE_PATTERNS); IPR020590 (PROSITE_PATTERNS); IPR008144 (PROSITE_PROFILES); IPR001478 (PROSITE_PROFILES); IPR001202 (PROSITE_PROFILES); IPR001478 (SUPERFAMILY); IPR001202 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001202 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR001478 (SUPERFAMILY)
gi|953854232|ref|XP_014595648.1|	rho GTPase-activating 29	1268	20	0E0	93.75%	1	P:GO:0035556	P:intracellular signal transduction		IPR002219 (SMART); IPR000198 (SMART); G3DSA:3.30.60.20 (GENE3D); IPR000198 (G3DSA:1.10.555.GENE3D); IPR002219 (PFAM); IPR000198 (PFAM); PTHR15228 (PANTHER); PTHR15228:SF7 (PANTHER); IPR002219 (PROSITE_PATTERNS); IPR002219 (PROSITE_PROFILES); IPR031160 (PROSITE_PROFILES); IPR000198 (PROSITE_PROFILES); SSF57889 (SUPERFAMILY); IPR008936 (SUPERFAMILY); SSF103657 (SUPERFAMILY)
gi|953854283|ref|XP_014595656.1|	volume-regulated anion channel subunit LRRC8B	803	20	0E0	98.95%	1	F:GO:0005515	F:protein binding		IPR003591 (SMART); IPR001611 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR026906 (PFAM); IPR021040 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR23155:SF465 (PANTHER); PTHR23155 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR001611 (PROSITE_PROFILES); SSF52047 (SUPERFAMILY)
gi|953854396|ref|XP_014595685.1|	hydroxyacid oxidase 2 isoform X2	325	20	0E0	82.7%	3	F:GO:0010181; F:GO:0016491; P:GO:0055114	F:FMN binding; F:oxidoreductase activity; P:oxidation-reduction process		IPR013785 (G3DSA:3.20.20.GENE3D); IPR000262 (PFAM); PTHR10578:SF68 (PANTHER); PTHR10578 (PANTHER); IPR008259 (PROSITE_PATTERNS); IPR012133 (PROSITE_PROFILES); SSF51395 (SUPERFAMILY)
gi|953854404|ref|XP_014595687.1|	D-3-phosphoglycerate dehydrogenase	488	20	0E0	95.95%	3	F:GO:0016616; F:GO:0051287; P:GO:0055114	F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:NAD binding; P:oxidation-reduction process		IPR029009 (G3DSA:3.30.1330.GENE3D); IPR006140 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR006139 (PFAM); PTHR10996:SF20 (PANTHER); PTHR10996 (PANTHER); IPR029752 (PROSITE_PATTERNS); IPR029753 (PROSITE_PATTERNS); IPR029753 (PROSITE_PATTERNS); SSF52283 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR029009 (SUPERFAMILY)
gi|953854597|ref|XP_014595745.1|	long-chain specific acyl- mitochondrial	261	20	0E0	62.35%	2	F:GO:0016627; P:GO:0055114	F:oxidoreductase activity, acting on the CH-CH group of donors; P:oxidation-reduction process		PTHR10909:SF196 (PANTHER); PTHR10909 (PANTHER); IPR009100 (SUPERFAMILY)
gi|953854627|ref|XP_001489154.4|	fibronectin isoform X1	2477	20	0E0	97.7%	2	F:GO:0005515; C:GO:0005576	F:protein binding; C:extracellular region		PR00013 (PRINTS); IPR003961 (SMART); IPR000083 (SMART); IPR000562 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR000083 (PFAM); IPR003961 (PFAM); G3DSA:2.10.70.10 (GENE3D); IPR000562 (PFAM); IPR000562 (G3DSA:2.10.10.GENE3D); G3DSA:2.10.70.10 (GENE3D); PTHR19143:SF210 (PANTHER); PTHR19143 (PANTHER); IPR000083 (PROSITE_PATTERNS); IPR000562 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR003961 (PROSITE_PROFILES); IPR000562 (PROSITE_PROFILES); IPR000083 (PROSITE_PROFILES); IPR003961 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF57603 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR013806 (SUPERFAMILY); SSF57603 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR013806 (SUPERFAMILY); SSF57603 (SUPERFAMILY); SSF57603 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY)
gi|953854737|ref|XP_014595794.1|	PREDICTED: LOW QUALITY PROTEIN: striated muscle preferentially expressed protein kinase	3089	20	0E0	91.45%	5	F:GO:0005524; F:GO:0005515; P:GO:0009069; F:GO:0004674; P:GO:0006468	F:ATP binding; F:protein binding; P:serine family amino acid metabolic process; F:protein serine/threonine kinase activity; P:protein phosphorylation	EC:2.7.11	IPR003598 (SMART); IPR003961 (SMART); IPR003599 (SMART); IPR000719 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:1.10.510.10 (GENE3D); PF16650 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013098 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); PTHR10489 (PANTHER); IPR015726 (PTHR10489:PANTHER); IPR008271 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); IPR003961 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY)
gi|953854780|ref|XP_014595807.1|	kinesin KIF1A isoform X6	1809	20	0E0	95.55%	6	F:GO:0005524; F:GO:0003777; C:GO:0045298; P:GO:0007018; F:GO:0008017; C:GO:0005874	F:ATP binding; F:microtubule motor activity; C:tubulin complex; P:microtubule-based movement; F:microtubule binding; C:microtubule	EC:3.6.1; EC:3.6.1.15	IPR001752 (PRINTS); IPR001849 (SMART); IPR001752 (SMART); IPR000253 (SMART); IPR001849 (PFAM); IPR032405 (PFAM); IPR000253 (G3DSA:2.60.200.GENE3D); IPR001752 (G3DSA:3.40.850.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR000253 (PFAM); IPR022164 (PFAM); IPR001752 (PFAM); IPR022140 (PFAM); IPR027640 (PANTHER); PTHR24115:SF361 (PANTHER); IPR019821 (PROSITE_PATTERNS); IPR000253 (PROSITE_PROFILES); IPR001752 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR008984 (SUPERFAMILY)
gi|953854858|ref|XP_014595833.1|	ubiquitin carboxyl-terminal hydrolase 40 isoform X1	1248	20	0E0	95.1%	3	P:GO:0016579; F:GO:0036459; P:GO:0006511	P:protein deubiquitination; F:thiol-dependent ubiquitinyl hydrolase activity; P:ubiquitin-dependent protein catabolic process	EC:3.4; EC:3.4.19.12	G3DSA:2.20.210.10 (GENE3D); IPR001394 (PFAM); PTHR24006 (PANTHER); IPR033384 (PTHR24006:PANTHER); IPR018200 (PROSITE_PATTERNS); IPR018200 (PROSITE_PATTERNS); IPR028889 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY)
gi|953854979|ref|XP_014595871.1|	collagen alpha-3(VI) chain	2960	20	0E0	94.65%	2	F:GO:0004867; F:GO:0005515	F:serine-type endopeptidase inhibitor activity; F:protein binding		PR00453 (PRINTS); IPR002223 (PRINTS); IPR002223 (SMART); IPR002035 (SMART); IPR002223 (G3DSA:4.10.410.GENE3D); IPR002035 (G3DSA:3.40.50.GENE3D); IPR002223 (PFAM); IPR002035 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002035 (G3DSA:3.40.50.GENE3D); IPR002035 (G3DSA:3.40.50.GENE3D); IPR002035 (G3DSA:3.40.50.GENE3D); IPR008160 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); IPR002035 (G3DSA:3.40.50.GENE3D); PTHR11132 (PANTHER); PTHR11132:SF74 (PANTHER); IPR020901 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR002223 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR002035 (PROSITE_PROFILES); IPR002223 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR002035 (SUPERFAMILY)
gi|953855181|ref|XP_014595932.1|	anion exchange 3 isoform X1	1169	20	0E0	93.45%	4	C:GO:0016021; F:GO:0005452; P:GO:0006821; P:GO:0015701	C:integral component of membrane; F:inorganic anion exchanger activity; P:chloride transport; P:bicarbonate transport		IPR002979 (PRINTS); IPR003020 (PRINTS); IPR001717 (PRINTS); G3DSA:1.10.287.570 (GENE3D); IPR013769 (PFAM); IPR013769 (G3DSA:3.40.1100.GENE3D); IPR003020 (TIGRFAM); IPR011531 (PFAM); IPR002979 (PTHR11453:PANTHER); IPR003020 (PANTHER); IPR018241 (PROSITE_PATTERNS); IPR018241 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR016152 (SUPERFAMILY)
gi|953855261|ref|XP_001498837.2|	acetylcholine receptor subunit gamma	547	20	0E0	95.35%	21	P:GO:0007271; F:GO:0015464; P:GO:0007274; P:GO:0007165; P:GO:0034220; F:GO:0005230; F:GO:0042166; C:GO:0005892; P:GO:0035094; C:GO:0045202; P:GO:0006810; C:GO:0005886; P:GO:0099565; F:GO:0005216; F:GO:0004889; P:GO:0006811; C:GO:0045211; C:GO:0016020; P:GO:0098655; C:GO:0016021; C:GO:0030054	P:synaptic transmission, cholinergic; F:acetylcholine receptor activity; P:neuromuscular synaptic transmission; P:signal transduction; P:ion transmembrane transport; F:extracellular ligand-gated ion channel activity; F:acetylcholine binding; C:acetylcholine-gated channel complex; P:response to nicotine; C:synapse; P:transport; C:plasma membrane; P:chemical synaptic transmission, postsynaptic; F:ion channel activity; F:acetylcholine-activated cation-selective channel activity; P:ion transport; C:postsynaptic membrane; C:membrane; P:cation transmembrane transport; C:integral component of membrane; C:cell junction		
gi|953855333|ref|XP_014595978.1|	IQ motif and SEC7 domain-containing 3 isoform X1	835	20	0E0	86.95%	4	F:GO:0005515; F:GO:0005086; P:GO:0043087; P:GO:0032012	F:protein binding; F:ARF guanyl-nucleotide exchange factor activity; P:regulation of GTPase activity; P:regulation of ARF protein signal transduction		IPR000904 (SMART); G3DSA:1.10.220.20 (GENE3D); IPR033742 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR023394 (G3DSA:1.10.1000.GENE3D); IPR000904 (PFAM); PTHR10663:SF62 (PANTHER); PTHR10663 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000048 (PROSITE_PROFILES); IPR000904 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR000904 (SUPERFAMILY)
gi|953855474|ref|XP_014596032.1|	-methionine sulfoxide oxidase MICAL3 isoform X1	2017	20	0E0	93.6%	6	F:GO:0071949; F:GO:0008270; F:GO:0016709; P:GO:0055114; F:GO:0017137; P:GO:0006887	F:FAD binding; F:zinc ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; P:oxidation-reduction process; F:Rab GTPase binding; P:exocytosis	EC:1.14.13	PR00420 (PRINTS); SM01203 (SMART); IPR001781 (SMART); IPR001715 (SMART); IPR022735 (PFAM); IPR001781 (G3DSA:2.10.110.GENE3D); IPR001715 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR001781 (PFAM); IPR029941 (PTHR11915:PANTHER); PTHR11915 (PANTHER); IPR001781 (PROSITE_PATTERNS); IPR001715 (PROSITE_PROFILES); IPR001781 (PROSITE_PROFILES); SSF57716 (SUPERFAMILY); IPR023753 (SUPERFAMILY); IPR001715 (SUPERFAMILY)
gi|953855559|ref|XP_014596057.1|	N-lysine methyltransferase METTL20	266	20	0E0	93.4%	6	C:GO:0005759; P:GO:0018022; P:GO:0018023; P:GO:1904733; F:GO:0016279; P:GO:1904736	C:mitochondrial matrix; P:peptidyl-lysine methylation; P:peptidyl-lysine trimethylation; P:negative regulation of electron carrier activity; F:protein-lysine N-methyltransferase activity; P:negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase		IPR029063 (G3DSA:3.40.50.GENE3D); PF06325 (PFAM); PTHR18895:SF3 (PANTHER); PTHR18895 (PANTHER); IPR029063 (SUPERFAMILY)
gi|953855617|ref|XP_014596075.1|	alpha-2-macroglobulin 1 isoform X2	1439	20	0E0	94.55%	2	C:GO:0005615; F:GO:0004866	C:extracellular space; F:endopeptidase inhibitor activity		IPR001599 (SMART); IPR009048 (SMART); IPR011625 (SMART); IPR009048 (G3DSA:2.60.40.GENE3D); IPR011625 (PFAM); IPR008930 (G3DSA:1.50.10.GENE3D); IPR001599 (PFAM); IPR002890 (PFAM); IPR019565 (PFAM); IPR009048 (PFAM); IPR011626 (PFAM); PTHR11412 (PANTHER); PTHR11412:SF95 (PANTHER); IPR019742 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR009048 (SUPERFAMILY); IPR008930 (SUPERFAMILY); IPR014756 (SUPERFAMILY)
gi|953855747|ref|XP_014596120.1|	pleckstrin homology domain-containing family G member 6	792	20	0E0	91.7%	3	P:GO:0035023; P:GO:0043087; F:GO:0005089	P:regulation of Rho protein signal transduction; P:regulation of GTPase activity; F:Rho guanyl-nucleotide exchange factor activity		IPR000219 (SMART); IPR001849 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); IPR000219 (G3DSA:1.20.900.GENE3D); IPR000219 (PFAM); PTHR12673:SF143 (PANTHER); PTHR12673 (PANTHER); IPR001849 (PROSITE_PROFILES); IPR000219 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR000219 (SUPERFAMILY)
gi|953855938|ref|XP_014596179.1|	alpha-2-macroglobulin-like	1477	20	0E0	90.95%	2	C:GO:0005615; F:GO:0004866	C:extracellular space; F:endopeptidase inhibitor activity		IPR001599 (SMART); IPR011625 (SMART); IPR009048 (SMART); IPR001599 (PFAM); IPR009048 (G3DSA:2.60.40.GENE3D); IPR011625 (PFAM); IPR019565 (PFAM); IPR011626 (PFAM); IPR008930 (G3DSA:1.50.10.GENE3D); IPR009048 (PFAM); IPR002890 (PFAM); PTHR11412:SF101 (PANTHER); PTHR11412 (PANTHER); IPR019742 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR008930 (SUPERFAMILY); IPR009048 (SUPERFAMILY); IPR014756 (SUPERFAMILY)
gi|953856063|ref|XP_014596217.1|	glutamate receptor NMDA 2B	1327	20	0E0	99.05%	6	P:GO:0006811; P:GO:0007165; C:GO:0016020; P:GO:0007268; F:GO:0004970; F:GO:0005234	P:ion transport; P:signal transduction; C:membrane; P:chemical synaptic transmission; F:ionotropic glutamate receptor activity; F:extracellular-glutamate-gated ion channel activity		IPR001508 (PRINTS); IPR001320 (SMART); IPR019594 (SMART); IPR001320 (PFAM); G3DSA:3.40.190.10 (GENE3D); G3DSA:3.40.190.10 (GENE3D); IPR019594 (PFAM); G3DSA:1.10.287.70 (GENE3D); G3DSA:3.40.50.2300 (GENE3D); IPR018884 (PFAM); PTHR18966:SF192 (PANTHER); PTHR18966 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR028082 (SUPERFAMILY); SSF53850 (SUPERFAMILY)
gi|953856071|ref|XP_014596219.1|	ovostatin homolog 2-like	1454	20	0E0	91.7%	2	C:GO:0005615; F:GO:0004866	C:extracellular space; F:endopeptidase inhibitor activity		IPR011625 (SMART); IPR001599 (SMART); IPR009048 (SMART); IPR011626 (PFAM); IPR008930 (G3DSA:1.50.10.GENE3D); IPR019565 (PFAM); IPR002890 (PFAM); IPR009048 (G3DSA:2.60.40.GENE3D); IPR011625 (PFAM); IPR009048 (PFAM); IPR001599 (PFAM); PTHR11412:SF77 (PANTHER); PTHR11412 (PANTHER); IPR019742 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR008930 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR009048 (SUPERFAMILY)
gi|953856182|ref|XP_014596260.1|	disco-interacting 2 homolog B	1594	20	0E0	98.45%	2	F:GO:0003824; P:GO:0008152	F:catalytic activity; P:metabolic process		IPR010506 (SMART); G3DSA:3.40.50.980 (GENE3D); G3DSA:3.40.50.980 (GENE3D); G3DSA:2.30.38.10 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR000873 (PFAM); IPR010506 (PFAM); PTHR22754:SF22 (PANTHER); PTHR22754 (PANTHER); SSF56801 (SUPERFAMILY); SSF56801 (SUPERFAMILY)
gi|953856186|ref|XP_014596262.1|	sodium channel type 8 subunit alpha isoform X1	1944	20	0E0	97.05%	5	P:GO:0006814; F:GO:0005515; P:GO:0055085; C:GO:0001518; F:GO:0005248	P:sodium ion transport; F:protein binding; P:transmembrane transport; C:voltage-gated sodium channel complex; F:voltage-gated sodium channel activity		IPR008054 (PRINTS); IPR001696 (PRINTS); IPR000048 (SMART); G3DSA:1.10.287.930 (GENE3D); IPR024583 (PFAM); IPR010526 (PFAM); IPR027359 (G3DSA:1.20.120.GENE3D); G3DSA:1.20.5.150 (GENE3D); IPR000048 (PFAM); IPR005821 (PFAM); PTHR10037 (PANTHER); PTHR10037:SF23 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000048 (PROSITE_PROFILES); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY)
gi|953856200|ref|XP_014596271.1|	type II cytoskeletal 78	561	20	0E0	75.25%	2	C:GO:0045095; F:GO:0005198	C:keratin filament; F:structural molecule activity		IPR003054 (PRINTS); IPR001664 (SMART); G3DSA:1.20.5.170 (GENE3D); IPR032444 (PFAM); IPR001664 (PFAM); IPR001664 (PANTHER); PTHR23239:SF127 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
gi|953856203|ref|XP_014596272.1|	anti-Muellerian hormone type-2 receptor isoform X1	627	20	0E0	88%	7	F:GO:0005524; F:GO:0004702; C:GO:0016020; P:GO:0007178; P:GO:0009069; P:GO:0006468; F:GO:0004675	F:ATP binding; F:receptor signaling protein serine/threonine kinase activity; C:membrane; P:transmembrane receptor protein serine/threonine kinase signaling pathway; P:serine family amino acid metabolic process; P:protein phosphorylation; F:transmembrane receptor protein serine/threonine kinase activity	EC:2.7.11	IPR015771 (PIRSF); G3DSA:2.10.60.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR23255:SF49 (PANTHER); IPR000333 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); SSF57302 (SUPERFAMILY)
gi|953856248|ref|XP_014596292.1|	integrin alpha-7 isoform X4	1020	20	0E0	95.5%	2	P:GO:0007155; C:GO:0008305	P:cell adhesion; C:integrin complex		IPR000413 (PRINTS); IPR013519 (SMART); IPR013649 (PFAM); G3DSA:1.20.5.930 (GENE3D); G3DSA:2.60.40.1460 (GENE3D); G3DSA:2.60.40.1530 (GENE3D); G3DSA:2.130.10.130 (GENE3D); IPR013517 (PFAM); PTHR23220 (PANTHER); PTHR23220:SF90 (PANTHER); IPR018184 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR013519 (PROSITE_PROFILES); IPR032695 (SUPERFAMILY); SSF69318 (SUPERFAMILY); IPR032695 (SUPERFAMILY)
gi|953856582|ref|XP_014596383.1|	sulfite mitochondrial	564	20	0E0	96.9%	5	F:GO:0016491; F:GO:0030151; P:GO:0055114; F:GO:0020037; P:GO:0042128	F:oxidoreductase activity; F:molybdenum ion binding; P:oxidation-reduction process; F:heme binding; P:nitrate assimilation		IPR008335 (PRINTS); IPR001199 (PRINTS); IPR001199 (SMART); IPR000572 (G3DSA:3.90.420.GENE3D); IPR001199 (PFAM); IPR005066 (G3DSA:2.60.40.GENE3D); IPR005066 (PFAM); IPR000572 (PFAM); IPR001199 (G3DSA:3.10.120.GENE3D); PTHR19372:SF7 (PANTHER); PTHR19372 (PANTHER); IPR018506 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR001199 (PROSITE_PROFILES); IPR000572 (SUPERFAMILY); IPR001199 (SUPERFAMILY); IPR014756 (SUPERFAMILY)
gi|953856709|ref|XP_001492201.5|	N-acetylglucosamine-6-sulfatase	554	20	0E0	96.7%	3	F:GO:0008449; C:GO:0005764; P:GO:0006027	F:N-acetylglucosamine-6-sulfatase activity; C:lysosome; P:glycosaminoglycan catabolic process	EC:3.1.6.14	IPR012251 (PIRSF); G3DSA:3.30.1120.10 (GENE3D); IPR000917 (PFAM); IPR017849 (G3DSA:3.40.720.GENE3D); G3DSA:3.30.30.70 (GENE3D); PTHR10342 (PANTHER); IPR015981 (PTHR10342:PANTHER); IPR024607 (PROSITE_PATTERNS); IPR024607 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR017850 (SUPERFAMILY)
gi|953856807|ref|XP_014596449.1|	PC-esterase domain-containing 1B	500	20	0E0	82.45%	1	F:GO:0016788	F:hydrolase activity, acting on ester bonds		IPR013830 (G3DSA:3.40.50.GENE3D); PTHR14469 (PANTHER); PTHR14469:SF1 (PANTHER); IPR013830 (SUPERFAMILY)
gi|953857173|ref|XP_005611801.2|	phospholipid-transporting ATPase IK	1490	20	0E0	79.45%	6	F:GO:0000287; F:GO:0005524; P:GO:0006812; P:GO:0015917; C:GO:0016021; F:GO:0004012	F:magnesium ion binding; F:ATP binding; P:cation transport; P:aminophospholipid transport; C:integral component of membrane; F:phospholipid-translocating ATPase activity	EC:3.6.1; EC:3.6.1.3; EC:3.6.3.1; EC:3.6.1.15	PR00119 (PRINTS); IPR032630 (PFAM); IPR001757 (TIGRFAM); IPR008250 (PFAM); IPR008250 (G3DSA:2.70.150.GENE3D); IPR006539 (TIGRFAM); PF13246 (PFAM); IPR023214 (G3DSA:3.40.50.GENE3D); IPR023299 (G3DSA:3.40.1110.GENE3D); IPR032631 (PFAM); IPR030349 (PTHR24092:PANTHER); IPR006539 (PANTHER); IPR018303 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SSF81665 (SUPERFAMILY); IPR023214 (SUPERFAMILY); IPR023299 (SUPERFAMILY); SSF81653 (SUPERFAMILY)
gi|953857175|ref|XP_014596538.1|	RNA exonuclease 1 homolog	1230	20	0E0	86.95%	1	F:GO:0003676	F:nucleic acid binding		IPR013520 (SMART); IPR031736 (PFAM); IPR012337 (G3DSA:3.30.420.GENE3D); PTHR12801 (PANTHER); PTHR12801:SF62 (PANTHER); IPR012337 (SUPERFAMILY)
gi|953857221|ref|XP_014596557.1|	receptor-type tyrosine- phosphatase S isoform X3	649	20	0E0	82.95%	1	F:GO:0005515	F:protein binding		PR00014 (PRINTS); IPR003961 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003961 (PFAM); PTHR19134 (PANTHER); PTHR19134:SF204 (PANTHER); IPR003961 (PROSITE_PROFILES); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY)
gi|953857243|ref|XP_014596564.1|	complement C3	1642	20	0E0	90.25%	3	C:GO:0005615; F:GO:0004866; F:GO:0005515	C:extracellular space; F:endopeptidase inhibitor activity; F:protein binding		IPR018933 (SMART); IPR009048 (SMART); IPR001599 (SMART); IPR011625 (SMART); IPR000020 (PFAM); IPR011626 (PFAM); IPR011625 (PFAM); IPR009048 (PFAM); IPR002890 (PFAM); IPR009048 (G3DSA:2.60.40.GENE3D); IPR018933 (PFAM); IPR019565 (PFAM); IPR008930 (G3DSA:1.50.10.GENE3D); IPR018081 (G3DSA:1.20.91.GENE3D); IPR001599 (PFAM); PTHR11412 (PANTHER); PTHR11412:SF90 (PANTHER); IPR019742 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR001134 (PROSITE_PROFILES); IPR008993 (SUPERFAMILY); IPR009048 (SUPERFAMILY); IPR008930 (SUPERFAMILY); IPR018081 (SUPERFAMILY)
gi|953857254|ref|XP_014596570.1|	calmodulin-regulated spectrin-associated 3	881	20	0E0	92.55%	3	F:GO:0005516; C:GO:0045298; F:GO:0008017	F:calmodulin binding; C:tubulin complex; F:microtubule binding		IPR014797 (SMART); IPR022613 (PFAM); IPR014797 (PFAM); IPR032940 (PANTHER); PTHR21595:SF2 (PANTHER); IPR014797 (PROSITE_PROFILES); IPR011033 (SUPERFAMILY); IPR001715 (SUPERFAMILY)
gi|953857283|ref|XP_014596582.1|	cytoplasmic dynein 2 heavy chain 1	4277	20	0E0	95.5%	6	F:GO:0016887; F:GO:0005524; F:GO:0003777; C:GO:0030286; P:GO:0007018; C:GO:0005874	F:ATPase activity; F:ATP binding; F:microtubule motor activity; C:dynein complex; P:microtubule-based movement; C:microtubule	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR003593 (SMART); PF12774 (PFAM); IPR013594 (PFAM); IPR024743 (PFAM); PF12775 (PFAM); IPR013602 (PFAM); IPR024317 (PFAM); IPR011704 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR004273 (PFAM); PF12781 (PFAM); IPR026983 (PANTHER); PTHR10676:SF282 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|953857302|ref|XP_014596589.1|	serine threonine- phosphatase 2A 65 kDa regulatory subunit A beta isoform isoform X1	726	20	0E0	91.85%	2	F:GO:0005515; P:GO:0006461	F:protein binding; P:protein complex assembly		PF13646 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR000357 (PFAM); IPR031090 (PTHR10648:PANTHER); PTHR10648 (PANTHER); IPR021133 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)
gi|953857306|ref|XP_014596591.1|	transmembrane protease serine 5	485	20	0E0	90.7%	5	P:GO:0007165; C:GO:0016020; P:GO:0006508; F:GO:0004252; F:GO:0005044	P:signal transduction; C:membrane; P:proteolysis; F:serine-type endopeptidase activity; F:scavenger receptor activity	EC:3.4.21	IPR001314 (PRINTS); IPR001254 (SMART); IPR001254 (PFAM); G3DSA:2.40.10.10 (GENE3D); IPR017448 (G3DSA:3.10.250.GENE3D); G3DSA:2.40.10.10 (GENE3D); IPR017448 (PFAM); PTHR24256 (PANTHER); PTHR24256:SF144 (PANTHER); IPR018114 (PROSITE_PATTERNS); IPR033116 (PROSITE_PATTERNS); IPR001190 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR001254 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR017448 (SUPERFAMILY); IPR009003 (SUPERFAMILY)
gi|953857316|ref|XP_014596597.1|	histone-lysine N-methyltransferase 2A isoform X3	4031	20	0E0	97.15%	7	F:GO:0042800; F:GO:0003677; F:GO:0008270; F:GO:0005515; C:GO:0035097; P:GO:0006355; P:GO:0051568	F:histone methyltransferase activity (H3-K4 specific); F:DNA binding; F:zinc ion binding; F:protein binding; C:histone methyltransferase complex; P:regulation of transcription, DNA-templated; P:histone H3-K4 methylation	EC:2.1.1.43; EC:2.1.1	IPR001214 (SMART); IPR003888 (SMART); IPR001487 (SMART); IPR001965 (SMART); IPR016569 (PIRSF); IPR003889 (SMART); IPR003616 (SMART); IPR001214 (PFAM); PF13771 (PFAM); IPR001487 (G3DSA:1.20.920.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); IPR019787 (PFAM); IPR003888 (PFAM); IPR003889 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR002857 (PFAM); G3DSA:2.170.270.10 (GENE3D); PTHR22884:SF387 (PANTHER); PTHR22884 (PANTHER); IPR003889 (PROSITE_PROFILES); IPR019787 (PROSITE_PROFILES); IPR001214 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); IPR003888 (PROSITE_PROFILES); IPR002857 (PROSITE_PROFILES); IPR003616 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY); SSF82199 (SUPERFAMILY); IPR011011 (SUPERFAMILY); IPR001487 (SUPERFAMILY)
gi|953857327|ref|XP_014596602.1|	ubiquitin fubi and ribosomal S30	616	20	0E0	81.15%	4	F:GO:0003735; P:GO:0042254; C:GO:0005840; P:GO:0006412	F:structural constituent of ribosome; P:ribosome biogenesis; C:ribosome; P:translation		IPR006846 (PFAM); PTHR12650:SF18 (PANTHER); PTHR12650 (PANTHER)
gi|953857352|ref|XP_014596614.1|	rho GTPase-activating 32 isoform X1	2096	20	0E0	92.5%	3	F:GO:0005515; P:GO:0007165; F:GO:0035091	F:protein binding; P:signal transduction; F:phosphatidylinositol binding		IPR001452 (SMART); IPR000198 (SMART); IPR000198 (G3DSA:1.10.555.GENE3D); IPR001683 (PFAM); IPR001452 (PFAM); IPR000198 (PFAM); IPR001683 (G3DSA:3.30.1520.GENE3D); G3DSA:2.30.30.40 (GENE3D); PTHR15729 (PANTHER); PTHR15729:SF9 (PANTHER); IPR000198 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY); IPR001683 (SUPERFAMILY); IPR008936 (SUPERFAMILY)
gi|953857356|ref|XP_014596616.1|	condensin-2 complex subunit D3	1479	20	0E0	89.65%	2	P:GO:0007076; F:GO:0005488	P:mitotic chromosome condensation; F:binding		IPR032682 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR14222:SF1 (PANTHER); IPR026971 (PANTHER); IPR016024 (SUPERFAMILY)
gi|953857948|ref|XP_014596795.1|	zinc finger 77-like	503	20	0E0	80.3%	4	F:GO:0003676; F:GO:0046872; P:GO:0006355; C:GO:0005622	F:nucleic acid binding; F:metal ion binding; P:regulation of transcription, DNA-templated; C:intracellular		IPR015880 (SMART); IPR001909 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); IPR001909 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); PF13894 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); PTHR24381:SF51 (PANTHER); PTHR24381 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); IPR001909 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); IPR001909 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|953858257|ref|XP_005611949.2|	interleukin-27 receptor subunit alpha	621	20	0E0	75.85%	1	F:GO:0005515	F:protein binding		PTHR23036:SF6 (PANTHER); PTHR23036 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR003961 (PROSITE_PROFILES); IPR003961 (SUPERFAMILY)
gi|953858263|ref|XP_014596891.1|	zinc finger SWIM domain-containing 4 isoform X2	914	20	0E0	85.95%	1	F:GO:0008270	F:zinc ion binding		PTHR22619 (PANTHER); PTHR22619:SF4 (PANTHER); IPR007527 (PROSITE_PROFILES)
gi|953858280|ref|XP_014596899.1|	lysosomal alpha-mannosidase isoform X1	1027	20	0E0	89.55%	15	F:GO:0008270; P:GO:0008152; P:GO:0006013; F:GO:0004553; C:GO:0005764; P:GO:0007611; P:GO:0006517; P:GO:0005975; F:GO:0004559; F:GO:0003824; F:GO:0046872; F:GO:0015923; F:GO:0030246; F:GO:0016787; F:GO:0016798	F:zinc ion binding; P:metabolic process; P:mannose metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds; C:lysosome; P:learning or memory; P:protein deglycosylation; P:carbohydrate metabolic process; F:alpha-mannosidase activity; F:catalytic activity; F:metal ion binding; F:mannosidase activity; F:carbohydrate binding; F:hydrolase activity; F:hydrolase activity, acting on glycosyl bonds		
gi|953858552|ref|XP_005612010.2|	retinol dehydrogenase 8	337	20	0E0	90.05%	14	P:GO:0042572; P:GO:0007601; C:GO:0001750; P:GO:0006703; F:GO:0004303; F:GO:0004745; P:GO:0001523; F:GO:0052650; C:GO:0005737; F:GO:0016491; C:GO:0016020; C:GO:0016021; P:GO:0055114; P:GO:0050896	P:retinol metabolic process; P:visual perception; C:photoreceptor outer segment; P:estrogen biosynthetic process; F:estradiol 17-beta-dehydrogenase activity; F:retinol dehydrogenase activity; P:retinoid metabolic process; F:NADP-retinol dehydrogenase activity; C:cytoplasm; F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process; P:response to stimulus		
gi|953858563|ref|XP_014597006.1|	gustatory receptor clone PTE01	329	20	0E0	89.9%	5	F:GO:0004930; P:GO:0007187; P:GO:0007608; C:GO:0016021; F:GO:0004984	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:sensory perception of smell; C:integral component of membrane; F:olfactory receptor activity		IPR000725 (PRINTS); IPR000276 (PRINTS); PF13853 (PFAM); G3DSA:1.20.1070.10 (GENE3D); PTHR26451:SF421 (PANTHER); PTHR26451 (PANTHER); IPR000276 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR017452 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY)
gi|953858622|ref|XP_014597036.1|	protocadherin Fat 3	3178	20	0E0	98.15%	4	F:GO:0005515; F:GO:0005509; P:GO:0007156; C:GO:0005886	F:protein binding; F:calcium ion binding; P:homophilic cell adhesion via plasma membrane adhesion molecules; C:plasma membrane		IPR002126 (PRINTS); IPR001791 (SMART); IPR002126 (SMART); IPR000742 (SMART); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR002126 (G3DSA:2.60.40.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR002126 (G3DSA:2.60.40.GENE3D); IPR001791 (PFAM); PTHR24026:SF49 (PANTHER); PTHR24026 (PANTHER); IPR020894 (PROSITE_PATTERNS); IPR000742 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR001791 (PROSITE_PROFILES); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY)
gi|953858624|ref|XP_005615068.2|	CREB ATF bZIP transcription factor isoform X1	362	20	0E0	92.7%	10	C:GO:0005634; F:GO:0003700; F:GO:0042802; P:GO:0045814; P:GO:0045892; P:GO:0006351; P:GO:0006355; F:GO:0043565; P:GO:0009615; P:GO:0051090	C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:identical protein binding; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription, DNA-templated; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding; P:response to virus; P:regulation of sequence-specific DNA binding transcription factor activity		
gi|953858730|ref|XP_014597067.1|	autophagy-related 16-2	603	20	0E0	90.9%	4	P:GO:0000045; P:GO:0039689; C:GO:0000421; C:GO:0005654	P:autophagosome assembly; P:negative stranded viral RNA replication; C:autophagosome membrane; C:nucleoplasm		
gi|953858789|ref|XP_005612223.2|	switch-associated 70	779	20	0E0	97.7%	1	F:GO:0005509	F:calcium ion binding		IPR001849 (SMART); IPR001849 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); PTHR14383 (PANTHER); PTHR14383:SF6 (PANTHER); IPR002048 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR011992 (SUPERFAMILY)
gi|953858791|ref|XP_014597089.1|	RNA polymerase-associated CTR9 homolog	1196	20	0E0	99.15%	4	F:GO:0005515; P:GO:0016570; C:GO:0016593; P:GO:0006355	F:protein binding; P:histone modification; C:Cdc73/Paf1 complex; P:regulation of transcription, DNA-templated		IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); PF14559 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR019734 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PF13432 (PFAM); IPR031101 (PTHR14027:PANTHER); PTHR14027 (PANTHER); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); SSF81901 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY)
gi|953858793|ref|XP_014597090.1|	ubiquitin carboxyl-terminal hydrolase 47 isoform X1	1435	20	0E0	99%	3	P:GO:0016579; F:GO:0036459; P:GO:0006511	P:protein deubiquitination; F:thiol-dependent ubiquitinyl hydrolase activity; P:ubiquitin-dependent protein catabolic process	EC:3.4; EC:3.4.19.12	IPR001394 (PFAM); G3DSA:2.20.210.10 (GENE3D); PTHR24006 (PANTHER); IPR018200 (PROSITE_PATTERNS); IPR018200 (PROSITE_PATTERNS); IPR028889 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY)
gi|953858808|ref|XP_014597093.1|	immunoglobulin superfamily member 22	1235	20	0E0	74.6%	1	F:GO:0005515	F:protein binding		IPR003598 (SMART); IPR003599 (SMART); IPR003961 (SMART); IPR003961 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR13817 (PANTHER); IPR003961 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|953859034|ref|XP_014597184.1|	nuclear pore complex Nup98-Nup96 isoform X2	1800	20	0E0	98.2%	2	P:GO:0006810; C:GO:0005643	P:transport; C:nuclear pore		IPR007230 (G3DSA:3.30.1610.GENE3D); IPR007230 (PFAM); IPR021967 (PFAM); PTHR23198:SF6 (PANTHER); PTHR23198 (PANTHER); IPR007230 (PROSITE_PROFILES); IPR007230 (SUPERFAMILY)
gi|953859109|ref|XP_014597215.1|		2510				1	C:GO:0005813	C:centrosome		IPR029299 (PFAM); PTHR21553 (PANTHER); IPR029560 (PTHR21553:PANTHER)
gi|953859206|ref|XP_014597253.1|	DENN domain-containing 5A	1263	20	0E0	99.05%	1	F:GO:0005515	F:protein binding		IPR005112 (SMART); IPR004012 (SMART); IPR005113 (SMART); IPR001194 (SMART); IPR001024 (PFAM); IPR004012 (PFAM); IPR001194 (PFAM); IPR001024 (G3DSA:2.60.60.GENE3D); IPR005113 (PFAM); IPR005112 (PFAM); PTHR10877 (PANTHER); PTHR10877:SF109 (PANTHER); IPR001194 (PROSITE_PROFILES); IPR005113 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR005112 (PROSITE_PROFILES); IPR004012 (PROSITE_PROFILES); IPR001024 (SUPERFAMILY); SSF140741 (SUPERFAMILY); SSF140741 (SUPERFAMILY)
gi|953859241|ref|XP_014597265.1|	leucine-rich repeat-containing G- coupled receptor 4	886	20	0E0	97.55%	4	F:GO:0005515; P:GO:0007187; C:GO:0016021; F:GO:0016500	F:protein binding; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; C:integral component of membrane; F:protein-hormone receptor activity		IPR002131 (PRINTS); IPR000276 (PRINTS); IPR003591 (SMART); SM00364 (SMART); SM00365 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR000276 (PFAM); G3DSA:1.20.1070.10 (GENE3D); IPR001611 (PFAM); PTHR24367:SF246 (PANTHER); PTHR24367 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR001611 (PROSITE_PROFILES); IPR017452 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY); SSF81321 (SUPERFAMILY); IPR032675 (SUPERFAMILY)
gi|953859244|ref|XP_014597266.1|	interferon-induced very large GTPase 1-like	2092	20	0E0	90.55%	1	F:GO:0005525	F:GTP binding		IPR027417 (G3DSA:3.40.50.GENE3D); IPR022812 (PFAM); PTHR14819 (PANTHER); PTHR14819:SF3 (PANTHER); IPR030383 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
gi|953859366|ref|XP_014597307.1|	transcription factor SOX-6 isoform X9	828	20	0E0	98.3%	3	F:GO:0003677; P:GO:0007275; P:GO:0006355	F:DNA binding; P:multicellular organism development; P:regulation of transcription, DNA-templated		IPR009071 (SMART); IPR009071 (PFAM); IPR009071 (G3DSA:1.10.30.GENE3D); IPR027153 (PTHR10270:PANTHER); PTHR10270 (PANTHER); IPR009071 (PROSITE_PROFILES); IPR009071 (SUPERFAMILY)
gi|953859377|ref|XP_014597311.1|	DNA (cytosine-5)-methyltransferase 1	1615	20	0E0	96.45%	8	C:GO:0005634; F:GO:0003677; F:GO:0003886; F:GO:0008270; P:GO:0090116; F:GO:0003682; C:GO:0000785; P:GO:0006555	C:nucleus; F:DNA binding; F:DNA (cytosine-5-)-methyltransferase activity; F:zinc ion binding; P:C-5 methylation of cytosine; F:chromatin binding; C:chromatin; P:methionine metabolic process	EC:2.1.1.37; EC:2.1.1	IPR001525 (PRINTS); IPR017198 (PIRSF); IPR001025 (SMART); IPR010506 (SMART); IPR001025 (PFAM); IPR022702 (PFAM); IPR029063 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR002857 (PFAM); G3DSA:3.90.120.10 (GENE3D); IPR010506 (PFAM); PTHR10629:SF11 (PANTHER); PTHR10629 (PANTHER); IPR031303 (PROSITE_PATTERNS); IPR018117 (PROSITE_PATTERNS); IPR002857 (PROSITE_PROFILES); IPR001025 (PROSITE_PROFILES); IPR001525 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY)
gi|953859577|ref|XP_014597361.1|	E3 ubiquitin- ligase MARCH2	246	20	1.42E-179	95.8%	1	F:GO:0008270	F:zinc ion binding		IPR011016 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR011016 (PFAM); IPR033275 (PANTHER); PTHR23012:SF77 (PANTHER); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR011016 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY)
gi|953859716|ref|XP_014597400.1|	ubiquilin-3	658	20	0E0	87.25%	1	F:GO:0005515	F:protein binding		IPR015940 (SMART); IPR000626 (SMART); IPR006636 (SMART); G3DSA:3.10.20.90 (GENE3D); IPR015940 (PFAM); IPR000626 (PFAM); G3DSA:1.10.8.10 (GENE3D); IPR015496 (PANTHER); PTHR10677:SF4 (PANTHER); IPR015940 (PROSITE_PROFILES); IPR000626 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY); IPR009060 (SUPERFAMILY)
gi|953859737|ref|XP_014597404.1|	noelin-2 isoform X1	538	20	0E0	97.4%	13	C:GO:0032281; C:GO:0097060; C:GO:0045202; C:GO:0005576; P:GO:0007601; P:GO:0009306; C:GO:0005634; F:GO:0005515; P:GO:0007626; C:GO:0005737; P:GO:0051152; C:GO:0016020; C:GO:0030054	C:AMPA glutamate receptor complex; C:synaptic membrane; C:synapse; C:extracellular region; P:visual perception; P:protein secretion; C:nucleus; F:protein binding; P:locomotory behavior; C:cytoplasm; P:positive regulation of smooth muscle cell differentiation; C:membrane; C:cell junction		
gi|953859904|ref|XP_014597458.1|	phosphatidylinositol 4-kinase alpha	2056	20	0E0	97.25%	4	P:GO:0048015; P:GO:0046854; F:GO:0005488; F:GO:0016301	P:phosphatidylinositol-mediated signaling; P:phosphatidylinositol phosphorylation; F:binding; F:kinase activity		IPR001263 (SMART); IPR000403 (SMART); IPR001263 (PFAM); G3DSA:3.30.1010.10 (GENE3D); IPR001263 (G3DSA:1.25.40.GENE3D); IPR000403 (PFAM); IPR000403 (G3DSA:1.10.1070.GENE3D); IPR015433 (PANTHER); PTHR10048:SF58 (PANTHER); IPR018936 (PROSITE_PATTERNS); IPR018936 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000403 (PROSITE_PROFILES); IPR001263 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
gi|953859935|ref|XP_014597470.1|	unconventional myosin-XVIIIb	2536	20	0E0	90.2%	4	C:GO:0016459; F:GO:0005524; F:GO:0005515; F:GO:0003774	C:myosin complex; F:ATP binding; F:protein binding; F:motor activity	EC:3.6.1; EC:3.6.1.15	IPR001609 (PRINTS); IPR001609 (SMART); IPR027401 (G3DSA:4.10.270.GENE3D); IPR001609 (PFAM); IPR028561 (PTHR13140:PANTHER); PTHR13140 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR001609 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF57997 (SUPERFAMILY)
gi|953860253|ref|XP_014597555.1|	alpha-ketoglutarate-dependent dioxygenase alkB homolog 2 isoform X1	260	20	0E0	92%	3	P:GO:0006281; F:GO:0016491; P:GO:0055114	P:DNA repair; F:oxidoreductase activity; P:oxidation-reduction process		IPR027450 (PFAM); IPR027450 (G3DSA:2.60.120.GENE3D); IPR032852 (PANTHER); PTHR31573:SF1 (PANTHER); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY)
gi|953860294|ref|XP_014597569.1|	gamma-glutamyltranspeptidase 1 isoform X1	568	20	0E0	93.65%	5	P:GO:0006691; P:GO:0006749; P:GO:0019530; P:GO:0006693; F:GO:0003840	P:leukotriene metabolic process; P:glutathione metabolic process; P:taurine metabolic process; P:prostaglandin metabolic process; F:gamma-glutamyltransferase activity	EC:2.3.2.2	IPR000101 (PRINTS); IPR000101 (TIGRFAM); IPR000101 (PFAM); PTHR11686:SF28 (PANTHER); IPR000101 (PANTHER); IPR000101 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR029055 (SUPERFAMILY)
gi|953860534|ref|XP_014597651.1|	nuclear receptor corepressor 2	2517	20	0E0	93%	1	F:GO:0003677	F:DNA binding		IPR001005 (SMART); IPR001005 (PFAM); IPR031557 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); PTHR13992:SF21 (PANTHER); PTHR13992 (PANTHER); IPR017884 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY)
gi|953860538|ref|XP_014597653.1|	transmembrane 132C	1113	20	0E0	92.15%	5	P:GO:0008150; C:GO:0016020; C:GO:0016021; C:GO:0005575; F:GO:0003674	P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function		IPR031435 (PFAM); IPR031437 (PFAM); IPR031436 (PFAM); IPR026307 (PANTHER); PTHR13388:SF4 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|953860908|ref|XP_014583075.1|	rasGAP-activating 1 isoform X1	813	20	0E0	93.25%	3	F:GO:0005515; P:GO:0043087; P:GO:0035556	F:protein binding; P:regulation of GTPase activity; P:intracellular signal transduction		IPR001562 (SMART); IPR001849 (SMART); IPR001936 (SMART); IPR000008 (SMART); IPR000008 (G3DSA:2.60.40.GENE3D); IPR001562 (PFAM); IPR001936 (PFAM); IPR001849 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR000008 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR001936 (G3DSA:1.10.506.GENE3D); IPR001562 (G3DSA:4.10.1130.GENE3D); PTHR10194 (PANTHER); IPR028555 (PTHR10194:PANTHER); IPR023152 (PROSITE_PATTERNS); IPR000008 (PROSITE_PROFILES); IPR001936 (PROSITE_PROFILES); IPR001562 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR008936 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR000008 (SUPERFAMILY)
gi|953861519|ref|XP_001916223.3|	urea transporter 2	928	20	0E0	92.95%	3	P:GO:0071918; C:GO:0016021; F:GO:0015204	P:urea transmembrane transport; C:integral component of membrane; F:urea transmembrane transporter activity		IPR004937 (PFAM); IPR029020 (G3DSA:1.10.3430.GENE3D); IPR004937 (PANTHER); PTHR10464:SF6 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|953861714|ref|XP_014583330.1|	PH domain leucine-rich repeat-containing phosphatase 1	1201	20	0E0	97.45%	2	F:GO:0005515; F:GO:0003824	F:protein binding; F:catalytic activity		IPR001932 (SMART); IPR003591 (SMART); SM00364 (SMART); IPR001932 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR001611 (PFAM); IPR001849 (PFAM); IPR001611 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); IPR001932 (G3DSA:3.60.40.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR23155:SF252 (PANTHER); PTHR23155 (PANTHER); IPR001932 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR001932 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR032675 (SUPERFAMILY); IPR032675 (SUPERFAMILY)
gi|953861786|ref|XP_014583355.1|	beta-Ala-His dipeptidase	484	20	0E0	94.95%	3	F:GO:0016805; P:GO:0006508; F:GO:0008237	F:dipeptidase activity; P:proteolysis; F:metallopeptidase activity	EC:3.4.13	IPR017153 (PIRSF); IPR011650 (PFAM); G3DSA:3.40.630.10 (GENE3D); IPR002933 (PFAM); IPR011650 (G3DSA:3.30.70.GENE3D); PTHR11014:SF58 (PANTHER); PTHR11014 (PANTHER); IPR001261 (PROSITE_PATTERNS); SSF53187 (SUPERFAMILY)
gi|953862020|ref|XP_014583428.1|	zinc finger homeobox 4 isoform X1	3619	20	0E0	97%	3	F:GO:0008270; P:GO:0006355; F:GO:0043565	F:zinc ion binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding		IPR001356 (SMART); IPR003604 (SMART); IPR015880 (SMART); IPR001356 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR009057 (G3DSA:1.10.10.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PF12874 (PFAM); PTHR24208 (PANTHER); PTHR24208:SF40 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR017970 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); IPR001356 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY); IPR009057 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); IPR009057 (SUPERFAMILY); IPR009057 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|953862123|ref|XP_014583468.1|	phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2	1597	20	0E0	97.95%	4	P:GO:0035023; F:GO:0005515; P:GO:0043087; F:GO:0005089	P:regulation of Rho protein signal transduction; F:protein binding; P:regulation of GTPase activity; F:Rho guanyl-nucleotide exchange factor activity		IPR000591 (SMART); IPR000219 (SMART); IPR001849 (SMART); IPR011991 (G3DSA:1.10.10.GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); IPR000219 (PFAM); IPR000591 (PFAM); IPR000219 (G3DSA:1.20.900.GENE3D); IPR001849 (PFAM); IPR001478 (G3DSA:2.30.42.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); PTHR22829 (PANTHER); PTHR22829:SF1 (PANTHER); IPR001331 (PROSITE_PATTERNS); IPR001478 (PROSITE_PROFILES); IPR000591 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR000219 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR011991 (SUPERFAMILY); IPR000219 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR011991 (SUPERFAMILY)
gi|953862325|ref|XP_014583522.1|	nibrin isoform X1	754	20	0E0	90.4%	5	P:GO:0006281; F:GO:0005515; P:GO:0007093; P:GO:0000723; C:GO:0030870	P:DNA repair; F:protein binding; P:mitotic cell cycle checkpoint; P:telomere maintenance; C:Mre11 complex		IPR016592 (PIRSF); IPR013908 (SMART); IPR000253 (SMART); IPR000253 (PFAM); IPR001357 (G3DSA:3.40.50.GENE3D); IPR000253 (G3DSA:2.60.200.GENE3D); IPR032429 (PFAM); IPR013908 (PFAM); PTHR12162 (PANTHER); PTHR12162:SF0 (PANTHER); IPR000253 (PROSITE_PROFILES); IPR008984 (SUPERFAMILY); IPR001357 (SUPERFAMILY)
gi|953862419|ref|XP_014583549.1|	fibrocystin-L	4271	20	0E0	94.7%	1	F:GO:0005515	F:protein binding		IPR019316 (SMART); IPR011658 (SMART); IPR002909 (SMART); IPR006626 (SMART); IPR002909 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR011658 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR011658 (G3DSA:3.90.182.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR019316 (PFAM); IPR029927 (PTHR11915:PANTHER); PTHR11915 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR019316 (PROSITE_PROFILES); IPR011050 (SUPERFAMILY); IPR014756 (SUPERFAMILY); SSF56988 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR011050 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY)
gi|953862657|ref|XP_014583612.1|	cleavage and polyadenylation specificity factor subunit 1	1444	20	0E0	98.35%	2	F:GO:0003676; C:GO:0005634	F:nucleic acid binding; C:nucleus		PF10433 (PFAM); IPR004871 (PFAM); PTHR10644 (PANTHER); PTHR10644:SF2 (PANTHER)
gi|953862708|ref|XP_014583632.1|	zinc finger 250 isoform X1	449	20	0E0	91.7%	4	F:GO:0003676; F:GO:0046872; P:GO:0006355; C:GO:0005622	F:nucleic acid binding; F:metal ion binding; P:regulation of transcription, DNA-templated; C:intracellular		IPR015880 (SMART); IPR001909 (SMART); IPR001909 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); PF13894 (PFAM); PTHR24377 (PANTHER); PTHR24377:SF112 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR001909 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); IPR001909 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|953862724|ref|XP_014583637.1|	E3 ubiquitin- ligase UBR5	2813	20	0E0	99.05%	5	F:GO:0004842; F:GO:0008270; F:GO:0003723; F:GO:0043130; P:GO:0016567	F:ubiquitin-protein transferase activity; F:zinc ion binding; F:RNA binding; F:ubiquitin binding; P:protein ubiquitination		IPR003126 (SMART); IPR002004 (SMART); IPR000569 (SMART); IPR024725 (PFAM); IPR009091 (G3DSA:2.130.10.GENE3D); IPR002004 (PFAM); IPR000569 (PFAM); IPR002004 (G3DSA:1.10.1900.GENE3D); G3DSA:3.30.2160.10 (GENE3D); PTHR11254:SF337 (PANTHER); PTHR11254 (PANTHER); IPR000569 (PROSITE_PROFILES); IPR003126 (PROSITE_PROFILES); IPR002004 (PROSITE_PROFILES); IPR002004 (SUPERFAMILY); IPR009091 (SUPERFAMILY); IPR000569 (SUPERFAMILY)
gi|953862764|ref|XP_014583654.1|	plectin isoform X1	4567	20	0E0	93.15%	2	C:GO:0005856; F:GO:0008092	C:cytoskeleton; F:cytoskeletal protein binding		IPR001715 (SMART); IPR001101 (SMART); IPR018159 (SMART); IPR005326 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); IPR001101 (PFAM); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); IPR001101 (G3DSA:3.90.1290.GENE3D); IPR001715 (PFAM); G3DSA:1.20.58.60 (GENE3D); PTHR11915 (PANTHER); IPR030269 (PTHR11915:PANTHER); IPR001589 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); IPR001715 (PROSITE_PROFILES); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001715 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY)
gi|953863088|ref|XP_014587899.1|	zinc finger 536	1301	20	0E0	95.65%	14	P:GO:0007275; P:GO:0007165; F:GO:0000978; F:GO:0044212; P:GO:0045665; P:GO:0006366; F:GO:0043565; F:GO:0044323; P:GO:0000122; F:GO:0003676; F:GO:0001078; C:GO:0005634; F:GO:0046872; P:GO:0048387	P:multicellular organism development; P:signal transduction; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; F:transcription regulatory region DNA binding; P:negative regulation of neuron differentiation; P:transcription from RNA polymerase II promoter; F:sequence-specific DNA binding; F:retinoic acid-responsive element binding; P:negative regulation of transcription from RNA polymerase II promoter; F:nucleic acid binding; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; C:nucleus; F:metal ion binding; P:negative regulation of retinoic acid receptor signaling pathway		
gi|953863290|ref|XP_014594073.1|	capicua homolog isoform X1	2525	20	0E0	96.4%	4	P:GO:0000122; P:GO:0048286; C:GO:0005634; F:GO:0003682	P:negative regulation of transcription from RNA polymerase II promoter; P:lung alveolus development; C:nucleus; F:chromatin binding		IPR009071 (SMART); IPR032147 (PFAM); IPR009071 (PFAM); IPR009071 (G3DSA:1.10.30.GENE3D); PTHR13059 (PANTHER); PTHR13059:SF13 (PANTHER); IPR009071 (PROSITE_PROFILES); IPR009071 (SUPERFAMILY)
gi|953863922|ref|XP_001495571.3|	vomeronasal type-1 receptor 4-like	343	20	0E0	86.1%	5	F:GO:0016503; P:GO:0007606; P:GO:0007186; C:GO:0016021; P:GO:0019236	F:pheromone receptor activity; P:sensory perception of chemical stimulus; P:G-protein coupled receptor signaling pathway; C:integral component of membrane; P:response to pheromone		IPR004072 (PRINTS); IPR004072 (PFAM); G3DSA:1.20.1070.10 (GENE3D); PTHR24062 (PANTHER); PTHR24062:SF77 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR017452 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY)
gi|953864188|ref|XP_014586458.1|	zinc finger 835	541	20	0E0	85%	2	F:GO:0003676; F:GO:0046872	F:nucleic acid binding; F:metal ion binding		IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|953864440|ref|XP_014587158.1|	ryanodine receptor 1	3976	20	0E0	96.85%	28	F:GO:0015278; C:GO:0016529; P:GO:0007275; P:GO:0003151; P:GO:0043588; C:GO:0005623; P:GO:0006811; P:GO:0048741; P:GO:0006936; F:GO:0005509; P:GO:0006816; P:GO:0070588; P:GO:0051209; P:GO:0071313; C:GO:0033017; P:GO:0055085; F:GO:0005262; F:GO:0005245; P:GO:0006810; C:GO:0005622; P:GO:0006874; P:GO:0043931; F:GO:0005216; F:GO:0005219; F:GO:0005516; P:GO:0014808; C:GO:0016020; C:GO:0016021	F:calcium-release channel activity; C:sarcoplasmic reticulum; P:multicellular organism development; P:outflow tract morphogenesis; P:skin development; C:cell; P:ion transport; P:skeletal muscle fiber development; P:muscle contraction; F:calcium ion binding; P:calcium ion transport; P:calcium ion transmembrane transport; P:release of sequestered calcium ion into cytosol; P:cellular response to caffeine; C:sarcoplasmic reticulum membrane; P:transmembrane transport; F:calcium channel activity; F:voltage-gated calcium channel activity; P:transport; C:intracellular; P:cellular calcium ion homeostasis; P:ossification involved in bone maturation; F:ion channel activity; F:ryanodine-sensitive calcium-release channel activity; F:calmodulin binding; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; C:membrane; C:integral component of membrane		
gi|953864464|ref|XP_014587228.1|	c-binding	2382	20	0E0	89.35%	1	F:GO:0005515	F:protein binding		IPR003645 (SMART); IPR014853 (SMART); IPR001846 (SMART); IPR001007 (SMART); IPR001007 (SMART); IPR025615 (PFAM); IPR001846 (PFAM); IPR014853 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR002919 (PFAM); PTHR11339:SF244 (PANTHER); PTHR11339 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR001846 (PROSITE_PROFILES); IPR002919 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR002919 (SUPERFAMILY)
gi|953864485|ref|XP_014587345.1|	multiple epidermal growth factor-like domains 8	2573	20	0E0	91.95%	22	P:GO:0060971; P:GO:0061371; P:GO:0071907; P:GO:0060976; P:GO:0097094; P:GO:0048842; P:GO:0003143; P:GO:0060972; P:GO:0007368; P:GO:0048704; P:GO:0097155; P:GO:0030326; C:GO:0005634; C:GO:0070062; P:GO:0042074; P:GO:0030509; F:GO:0005509; C:GO:0016020; C:GO:0016021; P:GO:0010468; P:GO:0055113; P:GO:0035108	P:embryonic heart tube left/right pattern formation; P:determination of heart left/right asymmetry; P:determination of digestive tract left/right asymmetry; P:coronary vasculature development; P:craniofacial suture morphogenesis; P:positive regulation of axon extension involved in axon guidance; P:embryonic heart tube morphogenesis; P:left/right pattern formation; P:determination of left/right symmetry; P:embryonic skeletal system morphogenesis; P:fasciculation of sensory neuron axon; P:embryonic limb morphogenesis; C:nucleus; C:extracellular exosome; P:cell migration involved in gastrulation; P:BMP signaling pathway; F:calcium ion binding; C:membrane; C:integral component of membrane; P:regulation of gene expression; P:epiboly involved in gastrulation with mouth forming second; P:limb morphogenesis		
gi|953864495|ref|XP_014587374.1|	sodium potassium-transporting ATPase subunit alpha-3 isoform X1	1048	20	0E0	99.05%	6	P:GO:0006813; F:GO:0005524; P:GO:0006814; F:GO:0005391; F:GO:0046872; C:GO:0005890	P:potassium ion transport; F:ATP binding; P:sodium ion transport; F:sodium:potassium-exchanging ATPase activity; F:metal ion binding; C:sodium:potassium-exchanging ATPase complex	EC:3.6.1; EC:3.6.1.3; EC:3.6.3.12; EC:3.6.3.9; EC:3.6.1.15	PR00121 (PRINTS); PR00119 (PRINTS); IPR004014 (SMART); IPR001757 (TIGRFAM); IPR023298 (G3DSA:1.20.1110.GENE3D); IPR005775 (TIGRFAM); IPR004014 (PFAM); IPR023299 (G3DSA:3.40.1110.GENE3D); IPR008250 (G3DSA:2.70.150.GENE3D); PF13246 (PFAM); IPR008250 (PFAM); G3DSA:4.10.6.10 (GENE3D); IPR006068 (PFAM); PTHR24093 (PANTHER); PTHR24093:SF259 (PANTHER); IPR018303 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SSF81653 (SUPERFAMILY); SSF81665 (SUPERFAMILY); IPR023299 (SUPERFAMILY); IPR023214 (SUPERFAMILY)
gi|953864530|ref|XP_014587457.1|	MAP microtubule affinity-regulating kinase 4 isoform X1	796	20	0E0	92.45%	6	F:GO:0005524; P:GO:0030010; P:GO:0000226; P:GO:0009069; F:GO:0004674; P:GO:0006468	F:ATP binding; P:establishment of cell polarity; P:microtubule cytoskeleton organization; P:serine family amino acid metabolic process; F:protein serine/threonine kinase activity; P:protein phosphorylation	EC:2.7.11	IPR000719 (SMART); IPR015940 (SMART); IPR000719 (PFAM); IPR015940 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.8.10 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR028375 (G3DSA:3.30.310.GENE3D); IPR033624 (PANTHER); IPR008271 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); IPR015940 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR028375 (SUPERFAMILY)
gi|953864533|ref|XP_014587464.1|	relA-associated inhibitor	771	20	0E0	77.15%	16	P:GO:0035264; F:GO:0042802; P:GO:0006351; P:GO:0031076; P:GO:0009791; F:GO:0008134; P:GO:0060048; P:GO:0042633; P:GO:0000122; P:GO:0003215; C:GO:0045171; P:GO:0003229; C:GO:0005737; P:GO:0048871; P:GO:0006915; C:GO:0030054	P:multicellular organism growth; F:identical protein binding; P:transcription, DNA-templated; P:embryonic camera-type eye development; P:post-embryonic development; F:transcription factor binding; P:cardiac muscle contraction; P:hair cycle; P:negative regulation of transcription from RNA polymerase II promoter; P:cardiac right ventricle morphogenesis; C:intercellular bridge; P:ventricular cardiac muscle tissue development; C:cytoplasm; P:multicellular organismal homeostasis; P:apoptotic process; C:cell junction		
gi|953864573|ref|XP_014587549.1|	bile salt sulfotransferase-like	165	20	4.99E-120	87.9%	1	F:GO:0008146	F:sulfotransferase activity		IPR000863 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11783 (PANTHER); PTHR11783:SF8 (PANTHER); IPR027417 (SUPERFAMILY)
gi|953864700|ref|XP_014588056.1|	platelet glyco VI	334	20	0E0	87.3%	1	F:GO:0005515	F:protein binding		IPR003598 (SMART); IPR003599 (SMART); IPR007110 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR11738 (PANTHER); PTHR11738:SF104 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|953864752|ref|XP_014588276.1|	transcription intermediary factor 1-beta	599	20	0E0	98.7%	3	F:GO:0008270; F:GO:0005515; C:GO:0005622	F:zinc ion binding; F:protein binding; C:intracellular		IPR001487 (SMART); IPR003649 (SMART); IPR000315 (SMART); IPR001487 (G3DSA:1.20.920.GENE3D); IPR000315 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR000315 (G3DSA:4.10.45.GENE3D); PTHR24103 (PANTHER); PTHR24103:SF346 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000315 (PROSITE_PROFILES); SSF57845 (SUPERFAMILY)
gi|953864835|ref|XP_014588542.1|	zinc finger 569	698	20	0E0	96.1%	4	F:GO:0003676; F:GO:0046872; P:GO:0006355; C:GO:0005622	F:nucleic acid binding; F:metal ion binding; P:regulation of transcription, DNA-templated; C:intracellular		IPR001909 (SMART); IPR015880 (SMART); IPR007087 (PFAM); IPR001909 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); PF13894 (PFAM); PTHR24375 (PANTHER); PTHR24375:SF68 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); IPR001909 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); IPR001909 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|953865229|ref|XP_014589571.1|	zinc finger 292 isoform X1	2724	20	0E0	96.1%	2	F:GO:0003676; F:GO:0046872	F:nucleic acid binding; F:metal ion binding		
gi|953865266|ref|XP_014589646.1|	midasin	5608	20	0E0	96.3%	4	F:GO:0016887; C:GO:0005634; F:GO:0005524; P:GO:0000027	F:ATPase activity; C:nucleus; F:ATP binding; P:ribosomal large subunit assembly	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR029317 (SMART); IPR012099 (PIRSF); IPR003593 (SMART); IPR002035 (SMART); IPR011704 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR002035 (G3DSA:3.40.50.GENE3D); IPR012099 (PTHR22908:PANTHER); PTHR22908 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR002035 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|953865480|ref|XP_014590201.1|	proto-oncogene tyrosine- kinase ROS	2342	20	0E0	93.75%	6	F:GO:0005524; F:GO:0005515; F:GO:0004714; C:GO:0016020; P:GO:0007169; P:GO:0006468	F:ATP binding; F:protein binding; F:transmembrane receptor protein tyrosine kinase activity; C:membrane; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:protein phosphorylation	EC:2.7.10; EC:2.7.10.1; EC:2.7.11	IPR001245 (PRINTS); IPR000033 (SMART); IPR020635 (SMART); IPR003961 (SMART); IPR011042 (G3DSA:2.120.10.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001245 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR011042 (G3DSA:2.120.10.GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR003961 (PFAM); IPR017441 (PROSITE_PATTERNS); IPR002011 (PROSITE_PATTERNS); IPR008266 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000719 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF63825 (SUPERFAMILY)
gi|953865636|ref|XP_014590559.1|	CD109 antigen	1476	20	0E0	94.1%	2	C:GO:0005615; F:GO:0004866	C:extracellular space; F:endopeptidase inhibitor activity		IPR011625 (SMART); IPR001599 (SMART); IPR009048 (SMART); IPR011626 (PFAM); IPR001599 (PFAM); IPR009048 (PFAM); IPR019565 (PFAM); IPR009048 (G3DSA:2.60.40.GENE3D); IPR002890 (PFAM); IPR011625 (PFAM); IPR008930 (G3DSA:1.50.10.GENE3D); PTHR11412 (PANTHER); PTHR11412:SF80 (PANTHER); IPR019742 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR008930 (SUPERFAMILY); IPR009048 (SUPERFAMILY); IPR014756 (SUPERFAMILY)
gi|953865707|ref|XP_014590789.1|	DNA polymerase zeta catalytic subunit	2880	20	0E0	96.2%	7	F:GO:0000166; F:GO:0003677; F:GO:0008408; F:GO:0003887; P:GO:0006260; C:GO:0016035; P:GO:0019985	F:nucleotide binding; F:DNA binding; F:3'-5' exonuclease activity; F:DNA-directed DNA polymerase activity; P:DNA replication; C:zeta DNA polymerase complex; P:translesion synthesis	EC:3.1; EC:2.7.7.7	IPR006172 (PRINTS); IPR006172 (SMART); G3DSA:1.10.287.690 (GENE3D); IPR023211 (G3DSA:3.90.1600.GENE3D); IPR006134 (PFAM); IPR012337 (G3DSA:3.30.420.GENE3D); IPR025687 (PFAM); IPR006133 (PFAM); IPR032757 (PFAM); IPR030559 (PTHR10322:PANTHER); PTHR10322 (PANTHER); IPR017964 (PROSITE_PATTERNS); SSF56672 (SUPERFAMILY); IPR012337 (SUPERFAMILY)
gi|953865744|ref|XP_014590950.1|	brefeldin A-inhibited guanine nucleotide-exchange 3	2066	20	0E0	95.15%	4	F:GO:0005086; P:GO:0043087; P:GO:0032012; F:GO:0005488	F:ARF guanyl-nucleotide exchange factor activity; P:regulation of GTPase activity; P:regulation of ARF protein signal transduction; F:binding		IPR000904 (SMART); IPR015403 (PFAM); IPR032629 (PFAM); PTHR10663:SF173 (PANTHER); PTHR10663 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR016024 (SUPERFAMILY)
gi|953865932|ref|XP_014591948.1|		5418				5	F:GO:0016887; F:GO:0004842; F:GO:0008270; F:GO:0005515; P:GO:0016567	F:ATPase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding; F:protein binding; P:protein ubiquitination	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR001841 (SMART); IPR003593 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR018957 (PFAM); PTHR22605 (PANTHER); IPR031248 (PTHR22605:PANTHER); IPR017907 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|953865980|ref|XP_014592082.1|	kinesin KIF19	935	20	0E0	96.3%	6	F:GO:0005524; F:GO:0003777; C:GO:0045298; P:GO:0007018; F:GO:0008017; C:GO:0005874	F:ATP binding; F:microtubule motor activity; C:tubulin complex; P:microtubule-based movement; F:microtubule binding; C:microtubule	EC:3.6.1; EC:3.6.1.15	IPR001752 (PRINTS); IPR001752 (SMART); IPR001752 (G3DSA:3.40.850.GENE3D); IPR001752 (PFAM); PTHR24115:SF434 (PANTHER); IPR027640 (PANTHER); IPR019821 (PROSITE_PATTERNS); IPR001752 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
gi|953865990|ref|XP_014592136.1|	nucleosome-remodeling factor subunit BPTF isoform X1	3072	20	0E0	95.75%	2	F:GO:0008270; F:GO:0005515	F:zinc ion binding; F:protein binding		IPR001487 (PRINTS); IPR001487 (SMART); IPR018501 (SMART); IPR001965 (SMART); IPR019787 (PFAM); IPR028942 (PFAM); IPR028941 (PFAM); IPR001487 (G3DSA:1.20.920.GENE3D); IPR018501 (PFAM); IPR001487 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR22880:SF5 (PANTHER); PTHR22880 (PANTHER); IPR018359 (PROSITE_PATTERNS); IPR019786 (PROSITE_PATTERNS); IPR001487 (PROSITE_PROFILES); IPR018501 (PROSITE_PROFILES); IPR019787 (PROSITE_PROFILES); IPR001487 (SUPERFAMILY); IPR011011 (SUPERFAMILY); IPR011011 (SUPERFAMILY); IPR011011 (SUPERFAMILY)
gi|953866007|ref|XP_014592197.1|	spindle pole body component 110-like	790	20	0E0	63.65%	3	C:GO:0005634; C:GO:0005737; C:GO:0005654	C:nucleus; C:cytoplasm; C:nucleoplasm		IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR22656:SF1 (PANTHER); PTHR22656 (PANTHER); IPR011992 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR011992 (SUPERFAMILY)
gi|953866042|ref|XP_014592265.1|	type I cytoskeletal 9	408	20	0E0	85.75%	2	F:GO:0005198; C:GO:0005882	F:structural molecule activity; C:intermediate filament		IPR002957 (PRINTS); IPR001664 (SMART); IPR001664 (PFAM); PTHR23239:SF96 (PANTHER); IPR001664 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SSF64593 (SUPERFAMILY)
gi|953866089|ref|XP_014592420.1|	voltage-dependent T-type calcium channel subunit alpha-1G isoform X9	2105	20	0E0	97.05%	4	P:GO:0070509; C:GO:0005891; P:GO:0070588; F:GO:0008332	P:calcium ion import; C:voltage-gated calcium channel complex; P:calcium ion transmembrane transport; F:low voltage-gated calcium channel activity		IPR002077 (PRINTS); IPR005445 (PRINTS); IPR027359 (G3DSA:1.20.120.GENE3D); IPR005821 (PFAM); PTHR10037 (PANTHER); IPR030154 (PTHR10037:PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY)
gi|953866113|ref|XP_014592497.1|	T-box transcription factor TBX2	634	20	0E0	91.65%	5	C:GO:0005634; C:GO:0005667; F:GO:0003700; P:GO:0006355; P:GO:0006355	C:nucleus; C:transcription factor complex; F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated		IPR001699 (SMART); IPR022582 (PFAM); IPR001699 (G3DSA:2.60.40.GENE3D); IPR001699 (PFAM); IPR001699 (PANTHER); PTHR11267:SF82 (PANTHER); IPR001699 (PROSITE_PROFILES); IPR008967 (SUPERFAMILY); IPR008967 (SUPERFAMILY)
gi|953866130|ref|XP_014592560.1|	schlafen family member 11	718	20	0E0	82.9%	5	C:GO:0005634; F:GO:0005524; P:GO:0051607; P:GO:2000134; F:GO:0000049	C:nucleus; F:ATP binding; P:defense response to virus; P:negative regulation of G1/S transition of mitotic cell cycle; F:tRNA binding		IPR027417 (G3DSA:3.40.50.GENE3D); IPR007421 (PFAM); IPR029684 (PANTHER); IPR029682 (PTHR12155:PANTHER); IPR027417 (SUPERFAMILY)
gi|953866134|ref|XP_014592569.1|	transmembrane 132E	1397	20	0E0	96.2%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		IPR031436 (PFAM); IPR031437 (PFAM); IPR031435 (PFAM); PTHR13388:SF7 (PANTHER); IPR026307 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS)
gi|953866159|ref|XP_014592658.1|	carboxypeptidase D	1182	20	0E0	94.7%	4	F:GO:0008270; F:GO:0004181; P:GO:0006508; F:GO:0004185	F:zinc ion binding; F:metallocarboxypeptidase activity; P:proteolysis; F:serine-type carboxypeptidase activity	EC:3.4.21; EC:3.4.17; EC:3.4.16	IPR000834 (PRINTS); IPR000834 (SMART); G3DSA:3.40.630.10 (GENE3D); IPR014766 (G3DSA:2.60.40.GENE3D); PF13620 (PFAM); IPR014766 (G3DSA:2.60.40.GENE3D); IPR000834 (PFAM); PTHR11532 (PANTHER); IPR015567 (PTHR11532:PANTHER); IPR000834 (PROSITE_PATTERNS); IPR000834 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR008969 (SUPERFAMILY); IPR008969 (SUPERFAMILY); SSF53187 (SUPERFAMILY); IPR008969 (SUPERFAMILY); SSF53187 (SUPERFAMILY); SSF53187 (SUPERFAMILY)
gi|953866183|ref|XP_014592769.1|	zinc finger ZZ-type and EF-hand domain-containing 1	2969	20	0E0	95.1%	2	F:GO:0008270; F:GO:0005509	F:zinc ion binding; F:calcium ion binding		IPR000433 (SMART); IPR002048 (SMART); IPR004939 (SMART); IPR008979 (G3DSA:2.60.120.GENE3D); IPR000859 (G3DSA:2.60.120.GENE3D); IPR004939 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); IPR000433 (PFAM); PTHR22772 (PANTHER); PTHR22772:SF4 (PANTHER); IPR000433 (PROSITE_PATTERNS); IPR004939 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR000433 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR008979 (SUPERFAMILY); SSF57850 (SUPERFAMILY)
gi|953866217|ref|XP_005614756.2|	netrin-1	507	20	0E0	79.35%	1	F:GO:0005515	F:protein binding		IPR018933 (SMART); IPR008211 (SMART); IPR002049 (SMART); G3DSA:2.10.25.10 (GENE3D); IPR008211 (PFAM); IPR018933 (PFAM); IPR002049 (PFAM); G3DSA:2.40.50.120 (GENE3D); G3DSA:2.10.25.10 (GENE3D); PTHR10574:SF278 (PANTHER); PTHR10574 (PANTHER); IPR002049 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR002049 (PROSITE_PROFILES); IPR008211 (PROSITE_PROFILES); IPR001134 (PROSITE_PROFILES); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR008993 (SUPERFAMILY); SSF57196 (SUPERFAMILY)
gi|953866227|ref|XP_014592932.1|	dual specificity mitogen-activated kinase kinase 4 isoform X1	411	20	0E0	98.15%	3	F:GO:0005524; F:GO:0004672; P:GO:0006468	F:ATP binding; F:protein kinase activity; P:protein phosphorylation		IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24361:SF339 (PANTHER); PTHR24361 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)
gi|953866234|ref|XP_014592956.1|	flightless-1 homolog isoform X1	1284	20	0E0	97.25%	3	P:GO:0051014; F:GO:0003779; P:GO:0030036	P:actin filament severing; F:actin binding; P:actin cytoskeleton organization		IPR007122 (PRINTS); PR00019 (PRINTS); SM00364 (SMART); SM00365 (SMART); IPR007122 (SMART); IPR003591 (SMART); IPR007123 (PFAM); IPR029006 (G3DSA:3.40.20.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR029006 (G3DSA:3.40.20.GENE3D); IPR001611 (PFAM); IPR029006 (G3DSA:3.40.20.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR025875 (PFAM); IPR029919 (PTHR11977:PANTHER); IPR007122 (PANTHER); IPR001611 (PROSITE_PROFILES); SSF55753 (SUPERFAMILY); SSF55753 (SUPERFAMILY); SSF55753 (SUPERFAMILY); SSF55753 (SUPERFAMILY); SSF55753 (SUPERFAMILY); SSF55753 (SUPERFAMILY); IPR032675 (SUPERFAMILY)
gi|953867234|ref|XP_014595707.1|	probable ATP-dependent RNA helicase DHX58	667	20	0E0	85.35%	3	F:GO:0003677; F:GO:0005524; F:GO:0016817	F:DNA binding; F:ATP binding; F:hydrolase activity, acting on acid anhydrides		IPR014001 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR006935 (PFAM); IPR021673 (PFAM); IPR001650 (PFAM); PTHR14074:SF7 (PANTHER); PTHR14074 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|953867527|ref|XP_014596522.1|	speckle-type POZ	374	20	0E0	99.8%	1	F:GO:0005515	F:protein binding		IPR002083 (SMART); IPR000210 (SMART); IPR002083 (PFAM); G3DSA:3.30.710.10 (GENE3D); IPR008974 (G3DSA:2.60.210.GENE3D); IPR000210 (PFAM); PTHR24413 (PANTHER); PTHR24413:SF97 (PANTHER); IPR000210 (PROSITE_PROFILES); IPR002083 (PROSITE_PROFILES); IPR008974 (SUPERFAMILY); IPR011333 (SUPERFAMILY)
gi|953867687|ref|XP_014596920.1|	myeloperoxidase	724	20	0E0	94.8%	7	F:GO:0004601; P:GO:0006979; P:GO:0002149; P:GO:0006804; P:GO:0055114; P:GO:0006952; F:GO:0020037	F:peroxidase activity; P:response to oxidative stress; P:hypochlorous acid biosynthetic process; P:obsolete peroxidase reaction; P:oxidation-reduction process; P:defense response; F:heme binding	EC:1.11.1.7	IPR019791 (PRINTS); IPR019791 (PFAM); IPR019791 (G3DSA:1.10.640.GENE3D); PTHR11475 (PANTHER); IPR029609 (PTHR11475:PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR019791 (PROSITE_PROFILES); IPR010255 (SUPERFAMILY)
gi|953867798|ref|XP_014597156.1|	synergin gamma isoform X6	1082	20	0E0	92.05%	1	F:GO:0005515	F:protein binding		IPR011992 (G3DSA:1.10.238.GENE3D); PTHR15463:SF2 (PANTHER); PTHR15463 (PANTHER); IPR000261 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
gi|953867877|ref|XP_014597436.1|	ATPase family AAA domain-containing 5	1899	20	0E0	91.75%	1	F:GO:0005524	F:ATP binding		IPR003593 (SMART); G3DSA:1.10.8.60 (GENE3D); IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23389 (PANTHER); PTHR23389:SF6 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR027417 (SUPERFAMILY)
gi|953867883|ref|XP_014597453.1|	neurofibromin isoform X1	2802	20	0E0	99.05%	4	P:GO:0007165; F:GO:0005096; F:GO:0005488; P:GO:0043547	P:signal transduction; F:GTPase activator activity; F:binding; P:positive regulation of GTPase activity		IPR001936 (SMART); IPR001251 (SMART); G3DSA:1.10.494.10 (GENE3D); G3DSA:1.10.494.10 (GENE3D); IPR001936 (PFAM); IPR001251 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR10194 (PANTHER); IPR028553 (PTHR10194:PANTHER); IPR023152 (PROSITE_PATTERNS); IPR001936 (PROSITE_PROFILES); IPR001251 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR008936 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
gi|953867967|ref|XP_014597695.1|	transcription elongation factor SPT6	1726	20	0E0	99.1%	3	F:GO:0003677; P:GO:0032784; P:GO:0006357	F:DNA binding; P:regulation of DNA-templated transcription, elongation; P:regulation of transcription from RNA polymerase II promoter		IPR022967 (SMART); IPR017072 (PIRSF); IPR000980 (SMART); IPR006641 (SMART); G3DSA:2.40.50.140 (GENE3D); IPR028231 (PFAM); IPR032706 (PFAM); IPR006641 (G3DSA:3.30.420.GENE3D); IPR028083 (PFAM); IPR000980 (G3DSA:3.30.505.GENE3D); IPR028088 (PFAM); IPR000980 (PFAM); IPR003029 (PFAM); IPR027999 (PFAM); IPR023323 (G3DSA:1.10.3500.GENE3D); IPR023097 (G3DSA:1.10.150.GENE3D); PTHR10145 (PANTHER); IPR017072 (PTHR10145:PANTHER); IPR003029 (PROSITE_PROFILES); IPR000980 (PROSITE_PROFILES); IPR000980 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR010994 (SUPERFAMILY); SSF158832 (SUPERFAMILY); IPR010994 (SUPERFAMILY); IPR012337 (SUPERFAMILY)
gi|953868138|ref|XP_014583458.1|	transient receptor potential cation channel subfamily V member 1 isoform X1	908	20	0E0	94.65%	5	F:GO:0005216; P:GO:0006811; F:GO:0005515; P:GO:0055085; C:GO:0016021	F:ion channel activity; P:ion transport; F:protein binding; P:transmembrane transport; C:integral component of membrane		IPR008347 (PRINTS); IPR002110 (SMART); IPR004729 (TIGRFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR005821 (PFAM); PTHR10582 (PANTHER); IPR024863 (PTHR10582:PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY)
gi|953868227|ref|XP_014583665.1|	LRR and PYD domains-containing 1 isoform X1	1429	20	0E0	78.7%	5	P:GO:0006954; F:GO:0005515; P:GO:0045087; C:GO:0072558; P:GO:0042981	P:inflammatory response; F:protein binding; P:innate immune response; C:NLRP1 inflammasome complex; P:regulation of apoptotic process		SM00368 (SMART); IPR025307 (PFAM); IPR004020 (PFAM); IPR001611 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001315 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); IPR011029 (G3DSA:1.10.533.GENE3D); PF05729 (PFAM); IPR011029 (G3DSA:1.10.533.GENE3D); PTHR24106 (PANTHER); IPR033516 (PTHR24106:PANTHER); IPR001315 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR007111 (PROSITE_PROFILES); IPR004020 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY); SSF52047 (SUPERFAMILY)
gi|953868241|ref|XP_001918152.4|	ATP-dependent RNA helicase DHX33 isoform X1	709	20	0E0	96.75%	3	F:GO:0003676; F:GO:0005524; F:GO:0008026	F:nucleic acid binding; F:ATP binding; F:ATP-dependent helicase activity	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR007502 (SMART); IPR014001 (SMART); IPR001650 (SMART); IPR001650 (PFAM); IPR007502 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011709 (PFAM); IPR011545 (PFAM); PTHR18934 (PANTHER); IPR002464 (PROSITE_PATTERNS); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
gi|953868412|ref|XP_014584074.1|	dynein heavy chain axonemal	4510	20	0E0	96.85%	6	F:GO:0000166; F:GO:0016887; F:GO:0005524; F:GO:0003777; C:GO:0030286; P:GO:0007018	F:nucleotide binding; F:ATPase activity; F:ATP binding; F:microtubule motor activity; C:dynein complex; P:microtubule-based movement		
gi|953868570|ref|XP_014584422.1|	nuclear receptor corepressor 1 isoform X9	2435	20	0E0	97.75%	1	F:GO:0003677	F:DNA binding		IPR001005 (SMART); IPR009057 (G3DSA:1.10.10.GENE3D); IPR031557 (PFAM); IPR001005 (PFAM); PTHR13992 (PANTHER); PTHR13992:SF5 (PANTHER); IPR017884 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY); IPR009057 (SUPERFAMILY)
gi|953868591|ref|XP_005597870.2|	aldehyde dimeric NADP-preferring	470	20	0E0	94.5%	8	P:GO:0006094; P:GO:0006547; P:GO:0006558; P:GO:0006081; P:GO:0006570; F:GO:0004030; P:GO:0006096; P:GO:0055114	P:gluconeogenesis; P:histidine metabolic process; P:L-phenylalanine metabolic process; P:cellular aldehyde metabolic process; P:tyrosine metabolic process; F:aldehyde dehydrogenase [NAD(P)+] activity; P:glycolytic process; P:oxidation-reduction process	EC:1.2.1.5	IPR012394 (PIRSF); IPR015590 (PFAM); IPR016163 (G3DSA:3.40.309.GENE3D); IPR016162 (G3DSA:3.40.605.GENE3D); PTHR11699 (PANTHER); PTHR11699:SF105 (PANTHER); IPR016160 (PROSITE_PATTERNS); IPR029510 (PROSITE_PATTERNS); IPR016161 (SUPERFAMILY)
gi|953868811|ref|XP_014584861.1|	diacylglycerol kinase zeta isoform X2	1097	20	0E0	87.7%	6	F:GO:0005515; P:GO:0046486; P:GO:0009395; F:GO:0004143; P:GO:0007205; P:GO:0035556	F:protein binding; P:glycerolipid metabolic process; P:phospholipid catabolic process; F:diacylglycerol kinase activity; P:protein kinase C-activating G-protein coupled receptor signaling pathway; P:intracellular signal transduction	EC:2.7.1.107	IPR000756 (SMART); IPR001206 (SMART); IPR002219 (SMART); IPR002110 (SMART); IPR020683 (PFAM); G3DSA:3.30.60.20 (GENE3D); IPR001206 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR000756 (PFAM); IPR002219 (PFAM); PTHR11255:SF43 (PANTHER); PTHR11255 (PANTHER); IPR001206 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR016064 (SUPERFAMILY)
gi|953868814|ref|XP_014584862.1|	low-density lipo receptor-related 4	2005	20	0E0	98.25%	5	F:GO:0005515; F:GO:0005509; P:GO:0030509; P:GO:0060828; P:GO:0048513	F:protein binding; F:calcium ion binding; P:BMP signaling pathway; P:regulation of canonical Wnt signaling pathway; P:animal organ development		IPR002172 (PRINTS); IPR002172 (SMART); IPR000033 (SMART); IPR001881 (SMART); IPR000742 (SMART); G3DSA:2.10.25.10 (GENE3D); IPR002172 (PFAM); G3DSA:2.10.25.10 (GENE3D); PF14670 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR011042 (G3DSA:2.120.10.GENE3D); IPR000033 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR026823 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:4.10.1220.10 (GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); PTHR10529 (PANTHER); IPR030799 (PTHR10529:PANTHER); IPR013032 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR023415 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR002172 (PROSITE_PROFILES); IPR000033 (PROSITE_PROFILES); SSF63825 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR009030 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY)
gi|953868936|ref|XP_014584915.1|	tetratricopeptide repeat 17 isoform X1	1198	20	0E0	98%	1	F:GO:0005515	F:protein binding		IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR019734 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR16091 (PANTHER); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY)
gi|953868972|ref|XP_014584924.1|	PR domain-containing 11 isoform X4	513	20	0E0	92.4%	1	F:GO:0003677	F:DNA binding		IPR001005 (SMART); IPR009057 (G3DSA:1.10.10.GENE3D); IPR028002 (PFAM); G3DSA:2.170.270.10 (GENE3D); PTHR16515:SF11 (PANTHER); PTHR16515 (PANTHER); IPR017877 (PROSITE_PROFILES)
gi|953869065|ref|XP_014584941.1|	43 kDa receptor-associated of the synapse isoform X1	330	20	0E0	99.2%	4	F:GO:0043495; F:GO:0033130; P:GO:0007268; C:GO:0045202	F:protein anchor; F:acetylcholine receptor binding; P:chemical synaptic transmission; C:synapse		IPR001237 (PRINTS); IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR019734 (PFAM); IPR019568 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR10098 (PANTHER); IPR018293 (PROSITE_PATTERNS); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY)
gi|953869154|ref|XP_014584976.1|	olfactory receptor 5B2-like	312	20	0E0	93.65%	5	F:GO:0004930; P:GO:0007187; P:GO:0007608; C:GO:0016021; F:GO:0004984	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:sensory perception of smell; C:integral component of membrane; F:olfactory receptor activity		IPR000276 (PRINTS); IPR000725 (PRINTS); G3DSA:1.20.1070.10 (GENE3D); PF13853 (PFAM); PTHR26452:SF40 (PANTHER); PTHR26452 (PANTHER); IPR000276 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR017452 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY)
gi|953869345|ref|XP_014585033.1|	kinesin light chain 2	568	20	0E0	88.25%	5	F:GO:0003777; F:GO:0005515; C:GO:0005871; C:GO:0005874; P:GO:0007017	F:microtubule motor activity; F:protein binding; C:kinesin complex; C:microtubule; P:microtubule-based process	EC:3.6.1; EC:3.6.1.15	IPR002151 (PRINTS); IPR019734 (SMART); IPR011990 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PF13424 (PFAM); PTHR19959 (PANTHER); PTHR19959:SF148 (PANTHER); IPR013026 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY)
gi|953869413|ref|XP_014585058.1|	mucin-5AC	4643	20	0E0	82.8%	1	F:GO:0005515	F:protein binding		IPR001007 (SMART); IPR006207 (SMART); IPR001846 (SMART); IPR014853 (SMART); IPR001007 (SMART); IPR014853 (PFAM); IPR025155 (PFAM); IPR001846 (PFAM); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR002919 (PFAM); PTHR11339 (PANTHER); PTHR11339:SF291 (PANTHER); IPR001007 (PROSITE_PATTERNS); IPR006207 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); PS51257 (PROSITE_PROFILES); IPR001007 (PROSITE_PROFILES); IPR006207 (PROSITE_PROFILES); IPR001846 (PROSITE_PROFILES); IPR002919 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR002919 (SUPERFAMILY)
gi|953869540|ref|XP_014585086.1|	sn1-specific diacylglycerol lipase alpha	1039	20	0E0	98.3%	1	P:GO:0006629	P:lipid metabolic process		IPR029058 (G3DSA:3.40.50.GENE3D); IPR002921 (PFAM); PTHR21493:SF102 (PANTHER); PTHR21493 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR029058 (SUPERFAMILY)
gi|953869573|ref|XP_014585100.1|	neuroblast differentiation-associated AHNAK isoform X1	1964	20	0E0	92.95%	1	F:GO:0005515	F:protein binding		IPR001478 (SMART); IPR001478 (G3DSA:2.30.42.GENE3D); PTHR23348:SF41 (PANTHER); PTHR23348 (PANTHER); IPR001478 (PROSITE_PROFILES); IPR001478 (SUPERFAMILY)
gi|953869620|ref|XP_014585118.1|	zinc finger and BTB domain-containing 3	478	20	0E0	92.55%	3	F:GO:0003676; F:GO:0005515; F:GO:0046872	F:nucleic acid binding; F:protein binding; F:metal ion binding		IPR015880 (SMART); IPR000210 (SMART); IPR000210 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); G3DSA:3.30.710.10 (GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR19303:SF293 (PANTHER); PTHR19303 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR000210 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR011333 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|953869943|ref|XP_014585206.1|	pyruvate mitochondrial isoform X2	1178	20	0E0	98.2%	13	P:GO:0006094; C:GO:0009343; F:GO:0009374; F:GO:0004075; P:GO:0006531; P:GO:0006099; P:GO:0006633; P:GO:0006522; F:GO:0003677; F:GO:0005524; F:GO:0004736; F:GO:0046872; P:GO:0006090	P:gluconeogenesis; C:biotin carboxylase complex; F:biotin binding; F:biotin carboxylase activity; P:aspartate metabolic process; P:tricarboxylic acid cycle; P:fatty acid biosynthetic process; P:alanine metabolic process; F:DNA binding; F:ATP binding; F:pyruvate carboxylase activity; F:metal ion binding; P:pyruvate metabolic process	EC:6.4.1.1; EC:6.3.4.14	IPR005930 (PIRSF); IPR005482 (SMART); IPR000089 (PFAM); IPR016185 (G3DSA:3.40.50.GENE3D); IPR013816 (G3DSA:3.30.470.GENE3D); G3DSA:3.10.600.10 (GENE3D); IPR000891 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); G3DSA:2.40.50.100 (GENE3D); IPR005482 (PFAM); IPR005930 (TIGRFAM); IPR013815 (G3DSA:3.30.1490.GENE3D); IPR005481 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); IPR005479 (PFAM); IPR003379 (PFAM); PTHR18866 (PANTHER); PTHR18866:SF110 (PANTHER); IPR001882 (PROSITE_PATTERNS); IPR000089 (PROSITE_PROFILES); IPR011764 (PROSITE_PROFILES); IPR011761 (PROSITE_PROFILES); IPR000891 (PROSITE_PROFILES); IPR011053 (SUPERFAMILY); IPR016185 (SUPERFAMILY); SSF51569 (SUPERFAMILY); IPR011054 (SUPERFAMILY); SSF89000 (SUPERFAMILY); SSF56059 (SUPERFAMILY)
gi|953870774|ref|XP_014585451.1|	general transcription factor 3C polypeptide 1	2015	20	0E0	91.65%	14	P:GO:0006383; P:GO:0006351; P:GO:0009303; C:GO:0000127; C:GO:0005730; P:GO:0042797; P:GO:0009304; C:GO:0005654; F:GO:0003677; C:GO:0005634; F:GO:0005515; C:GO:0030529; C:GO:0016020; P:GO:0042791	P:transcription from RNA polymerase III promoter; P:transcription, DNA-templated; P:rRNA transcription; C:transcription factor TFIIIC complex; C:nucleolus; P:tRNA transcription from RNA polymerase III promoter; P:tRNA transcription; C:nucleoplasm; F:DNA binding; C:nucleus; F:protein binding; C:intracellular ribonucleoprotein complex; C:membrane; P:5S class rRNA transcription from RNA polymerase III type 1 promoter		IPR007309 (PFAM); PTHR15180 (PANTHER); PTHR15180:SF1 (PANTHER)
gi|953870800|ref|XP_014585463.1|	serine threonine- kinase SMG1	3573	20	0E0	99.15%	5	F:GO:0005515; P:GO:0000184; P:GO:0016310; P:GO:0009069; F:GO:0004674	F:protein binding; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:phosphorylation; P:serine family amino acid metabolic process; F:protein serine/threonine kinase activity	EC:2.7.11	IPR003152 (SMART); IPR000403 (SMART); SM01345 (SMART); IPR031559 (PFAM); IPR000403 (PFAM); IPR000403 (G3DSA:1.10.1070.GENE3D); IPR003152 (PFAM); G3DSA:3.30.1010.10 (GENE3D); PTHR11139 (PANTHER); PTHR11139:SF71 (PANTHER); IPR018936 (PROSITE_PATTERNS); IPR000403 (PROSITE_PROFILES); IPR003152 (PROSITE_PROFILES); IPR014009 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR011009 (SUPERFAMILY)
gi|953870814|ref|XP_014585468.1|	thioredoxin domain-containing 11	876	20	0E0	90.25%	1	P:GO:0045454	P:cell redox homeostasis		IPR013766 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR18929:SF114 (PANTHER); PTHR18929 (PANTHER); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY)
gi|953870824|ref|XP_014585473.1|	glutamate receptor NMDA 2A isoform X1	1418	20	0E0	96.4%	6	P:GO:0006811; P:GO:0007165; C:GO:0016020; P:GO:0007268; F:GO:0004970; F:GO:0005234	P:ion transport; P:signal transduction; C:membrane; P:chemical synaptic transmission; F:ionotropic glutamate receptor activity; F:extracellular-glutamate-gated ion channel activity		IPR001508 (PRINTS); IPR019594 (SMART); IPR001320 (SMART); IPR018884 (PFAM); IPR001320 (PFAM); G3DSA:3.40.190.10 (GENE3D); G3DSA:3.40.190.10 (GENE3D); IPR001828 (PFAM); G3DSA:1.10.287.70 (GENE3D); IPR019594 (PFAM); G3DSA:3.40.50.2300 (GENE3D); PTHR18966:SF16 (PANTHER); PTHR18966 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR028082 (SUPERFAMILY); SSF53850 (SUPERFAMILY)
gi|953870967|ref|XP_014585513.1|	double C2-like domain-containing alpha isoform X1	419	20	0E0	93%	6	F:GO:0005515; F:GO:0005509; C:GO:0016020; P:GO:0007268; P:GO:0017158; F:GO:0005544	F:protein binding; F:calcium ion binding; C:membrane; P:chemical synaptic transmission; P:regulation of calcium ion-dependent exocytosis; F:calcium-dependent phospholipid binding		IPR001565 (PRINTS); IPR000008 (PRINTS); IPR000008 (SMART); IPR014638 (PIRSF); IPR000008 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR000008 (G3DSA:2.60.40.GENE3D); PTHR10024 (PANTHER); IPR030535 (PTHR10024:PANTHER); IPR000008 (PROSITE_PROFILES); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY)
gi|953871192|ref|XP_014585569.1|	dynein heavy chain axonemal	4069	20	0E0	96.45%	4	F:GO:0003777; C:GO:0030286; P:GO:0007018; C:GO:0005874	F:microtubule motor activity; C:dynein complex; P:microtubule-based movement; C:microtubule	EC:3.6.1; EC:3.6.1.15	IPR003593 (SMART); IPR024317 (PFAM); PF12774 (PFAM); IPR024743 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR004273 (PFAM); PF12781 (PFAM); PF12775 (PFAM); IPR013602 (PFAM); PTHR10676:SF242 (PANTHER); IPR026983 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|953871403|ref|XP_014585624.1|	BTB POZ domain-containing KCTD5 isoform X1	243	20	0E0	87.9%	2	F:GO:0005515; P:GO:0051260	F:protein binding; P:protein homooligomerization		IPR000210 (SMART); G3DSA:3.30.710.10 (GENE3D); IPR003131 (PFAM); PTHR14958 (PANTHER); PTHR14958:SF12 (PANTHER); IPR011333 (SUPERFAMILY)
gi|953871413|ref|XP_014585628.1|	polycystin-1	4138	20	0E0	91.4%	3	F:GO:0005515; P:GO:0001822; C:GO:0016021	F:protein binding; P:kidney development; C:integral component of membrane		IPR000434 (PRINTS); IPR001024 (SMART); IPR003591 (SMART); IPR022409 (SMART); IPR002889 (SMART); IPR001304 (SMART); IPR000483 (SMART); IPR000203 (SMART); IPR013122 (PFAM); IPR000601 (G3DSA:2.60.40.GENE3D); IPR001611 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); IPR002889 (PFAM); IPR016186 (G3DSA:3.10.100.GENE3D); IPR002859 (PFAM); IPR000601 (PFAM); IPR001024 (PFAM); IPR001024 (G3DSA:2.60.60.GENE3D); IPR001304 (PFAM); IPR006228 (TIGRFAM); PTHR10877:SF143 (PANTHER); PTHR10877 (PANTHER); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR001024 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR000203 (PROSITE_PROFILES); IPR014010 (PROSITE_PROFILES); IPR000601 (PROSITE_PROFILES); IPR001304 (PROSITE_PROFILES); IPR002889 (PROSITE_PROFILES); IPR000601 (SUPERFAMILY); IPR016187 (SUPERFAMILY); IPR000601 (SUPERFAMILY); IPR001024 (SUPERFAMILY); IPR000601 (SUPERFAMILY); IPR000601 (SUPERFAMILY); IPR000601 (SUPERFAMILY); IPR000601 (SUPERFAMILY); IPR000601 (SUPERFAMILY); IPR000601 (SUPERFAMILY); IPR000601 (SUPERFAMILY); IPR000601 (SUPERFAMILY); IPR032675 (SUPERFAMILY); IPR000601 (SUPERFAMILY); IPR000601 (SUPERFAMILY)
gi|953871425|ref|XP_014585632.1|	voltage-dependent T-type calcium channel subunit alpha-1H	2372	20	0E0	93.55%	4	P:GO:0070509; C:GO:0005891; P:GO:0070588; F:GO:0008332	P:calcium ion import; C:voltage-gated calcium channel complex; P:calcium ion transmembrane transport; F:low voltage-gated calcium channel activity		IPR002077 (PRINTS); IPR005445 (PRINTS); IPR027359 (G3DSA:1.20.120.GENE3D); IPR005821 (PFAM); IPR030160 (PTHR10037:PANTHER); PTHR10037 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY)
gi|953871440|ref|XP_014585639.1|	rho GDP-dissociation inhibitor 3	271	20	0E0	93.2%	2	C:GO:0005737; F:GO:0005094	C:cytoplasm; F:Rho GDP-dissociation inhibitor activity		IPR000406 (PRINTS); IPR000406 (PFAM); IPR024792 (G3DSA:2.70.50.GENE3D); PTHR10980:SF8 (PANTHER); IPR000406 (PANTHER); IPR014756 (SUPERFAMILY)
gi|953871558|ref|XP_014585679.1|	CREB-binding isoform X1	2325	20	0E0	98.05%	9	F:GO:0004402; C:GO:0005667; F:GO:0008270; P:GO:0042967; F:GO:0005515; F:GO:0003713; P:GO:0045893; P:GO:0016573; C:GO:0000123	F:histone acetyltransferase activity; C:transcription factor complex; F:zinc ion binding; P:acyl-carrier-protein biosynthetic process; F:protein binding; F:transcription coactivator activity; P:positive regulation of transcription, DNA-templated; P:histone acetylation; C:histone acetyltransferase complex	EC:2.3.1.48; EC:2.3.1	IPR001487 (PRINTS); IPR000197 (SMART); IPR013178 (SMART); IPR001487 (SMART); IPR000433 (SMART); IPR014744 (PFAM); IPR013178 (PFAM); IPR010303 (PFAM); IPR000197 (G3DSA:1.20.1020.GENE3D); IPR001487 (G3DSA:1.20.920.GENE3D); IPR001487 (PFAM); IPR000433 (PFAM); IPR003101 (G3DSA:1.10.246.GENE3D); IPR014744 (G3DSA:1.10.1630.GENE3D); IPR000197 (PFAM); IPR000197 (G3DSA:1.20.1020.GENE3D); IPR003101 (PFAM); PTHR13808:SF5 (PANTHER); PTHR13808 (PANTHER); IPR000433 (PROSITE_PATTERNS); IPR018359 (PROSITE_PATTERNS); IPR000197 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); IPR031162 (PROSITE_PROFILES); IPR003101 (PROSITE_PROFILES); IPR000433 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR000197 (SUPERFAMILY); IPR009110 (SUPERFAMILY); IPR001487 (SUPERFAMILY); IPR003101 (SUPERFAMILY); IPR000197 (SUPERFAMILY)
gi|953871763|ref|XP_014585745.1|	intraflagellar transport 140 homolog	1463	20	0E0	94.7%	1	F:GO:0005515	F:protein binding		IPR001680 (SMART); IPR024977 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR15722:SF7 (PANTHER); PTHR15722 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY)
gi|953871772|ref|XP_014585748.1|	E3 ubiquitin- ligase UNKL isoform X2	545	20	0E0	92%	2	F:GO:0008270; F:GO:0005515	F:zinc ion binding; F:protein binding		IPR001841 (SMART); IPR000571 (SMART); PF13920 (PFAM); IPR000571 (PFAM); IPR000571 (G3DSA:4.10.1000.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR14493:SF37 (PANTHER); PTHR14493 (PANTHER); IPR000571 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR000571 (SUPERFAMILY)
gi|953872020|ref|XP_014585844.1|	la-related 1	1028	20	0E0	96.85%	16	P:GO:0008283; P:GO:0016239; P:GO:0045727; F:GO:0008494; F:GO:0000339; P:GO:0031929; P:GO:0006413; C:GO:0005654; F:GO:0044822; F:GO:0003730; F:GO:0048027; C:GO:0005737; C:GO:0016020; F:GO:0031369; C:GO:0031931; F:GO:0008190	P:cell proliferation; P:positive regulation of macroautophagy; P:positive regulation of translation; F:translation activator activity; F:RNA cap binding; P:TOR signaling; P:translational initiation; C:nucleoplasm; F:poly(A) RNA binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; C:cytoplasm; C:membrane; F:translation initiation factor binding; C:TORC1 complex; F:eukaryotic initiation factor 4E binding		IPR006607 (SMART); IPR006630 (SMART); IPR011991 (G3DSA:1.10.10.GENE3D); IPR006630 (PFAM); PTHR22792 (PANTHER); PTHR22792:SF51 (PANTHER); IPR006630 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY)
gi|953872029|ref|XP_014585848.1|	double-headed protease submandibular gland-like	144	20	3.21E-102	75.45%	2	F:GO:0004867; F:GO:0005515	F:serine-type endopeptidase inhibitor activity; F:protein binding		IPR001239 (PRINTS); IPR002350 (SMART); G3DSA:1.10.1890.10 (GENE3D); IPR002350 (PFAM); PTHR21312 (PANTHER); PTHR21312:SF27 (PANTHER); IPR002350 (PROSITE_PATTERNS); IPR002350 (PROSITE_PROFILES); SSF100895 (SUPERFAMILY); SSF100895 (SUPERFAMILY)
gi|953872037|ref|XP_014585851.1|	rho GTPase-activating 26 isoform X1	978	20	0E0	98.25%	4	F:GO:0005515; P:GO:0051056; F:GO:0005096; P:GO:0030036	F:protein binding; P:regulation of small GTPase mediated signal transduction; F:GTPase activator activity; P:actin cytoskeleton organization		IPR001452 (SMART); IPR001849 (SMART); IPR000198 (SMART); IPR001452 (PFAM); IPR000198 (G3DSA:1.10.555.GENE3D); G3DSA:1.20.1270.80 (GENE3D); IPR000198 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); PF16746 (PFAM); IPR001849 (PFAM); IPR030061 (PTHR12552:PANTHER); PTHR12552 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000198 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY); SSF103657 (SUPERFAMILY); IPR008936 (SUPERFAMILY); IPR011993 (SUPERFAMILY)
gi|953872068|ref|XP_014585865.1|	protocadherin alpha-2-like	799	20	0E0	92%	3	F:GO:0005509; P:GO:0007156; C:GO:0005886	F:calcium ion binding; P:homophilic cell adhesion via plasma membrane adhesion molecules; C:plasma membrane		IPR002126 (PRINTS); IPR002126 (SMART); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (PFAM); IPR013164 (PFAM); IPR002126 (G3DSA:2.60.40.GENE3D); PTHR24028 (PANTHER); PTHR24028:SF60 (PANTHER); IPR020894 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR002126 (PROSITE_PROFILES); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY)
gi|953872073|ref|XP_014585866.1|	proheparin-binding EGF-like growth factor	276	20	0E0	96.4%	1	F:GO:0005515	F:protein binding		IPR000742 (PFAM); G3DSA:2.10.25.10 (GENE3D); PTHR10740:SF4 (PANTHER); IPR015497 (PANTHER); IPR013032 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000742 (PROSITE_PROFILES); SSF57196 (SUPERFAMILY)
gi|953872079|ref|XP_014585868.1|	lysine-specific demethylase 3B isoform X1	1763	20	0E0	97.4%	2	F:GO:0008168; P:GO:0032259	F:methyltransferase activity; P:methylation		IPR003347 (SMART); IPR003347 (PFAM); PTHR12549:SF8 (PANTHER); PTHR12549 (PANTHER); IPR003347 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY)
gi|953872141|ref|XP_014585888.1|	dimethylglycine mitochondrial	934	20	0E0	96.75%	3	F:GO:0005515; F:GO:0016491; P:GO:0055114	F:protein binding; F:oxidoreductase activity; P:oxidation-reduction process		IPR027266 (G3DSA:3.30.1360.GENE3D); IPR013977 (PFAM); IPR006076 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR032503 (PFAM); G3DSA:3.30.9.10 (GENE3D); IPR013977 (G3DSA:2.40.30.GENE3D); IPR006222 (PFAM); G3DSA:3.30.70.1400 (GENE3D); PTHR13847:SF187 (PANTHER); PTHR13847 (PANTHER); IPR023753 (SUPERFAMILY); SSF103025 (SUPERFAMILY); IPR029043 (SUPERFAMILY); SSF54373 (SUPERFAMILY)
gi|953872152|ref|XP_014585892.1|		1856				1	F:GO:0005515	F:protein binding		IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR002110 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24176 (PANTHER); PTHR24176:SF14 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY)
gi|953872182|ref|XP_014585903.1|		7195				4	P:GO:0035023; F:GO:0005515; P:GO:0043087; F:GO:0005089	P:regulation of Rho protein signal transduction; F:protein binding; P:regulation of GTPase activity; F:Rho guanyl-nucleotide exchange factor activity		IPR003599 (SMART); IPR000048 (SMART); IPR000219 (SMART); IPR003961 (SMART); IPR003598 (SMART); IPR013106 (SMART); IPR001849 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR000219 (G3DSA:1.20.900.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:2.30.30.40 (GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR000219 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR000048 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001849 (PFAM); IPR003961 (PFAM); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR10489:SF685 (PANTHER); PTHR10489 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR000219 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR001452 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR000219 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|953872886|ref|XP_014586094.1|	protocadherin gamma-C3 isoform X3	863	20	0E0	96.6%	3	F:GO:0005509; P:GO:0007156; C:GO:0005886	F:calcium ion binding; P:homophilic cell adhesion via plasma membrane adhesion molecules; C:plasma membrane		IPR002126 (PRINTS); IPR002126 (SMART); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (G3DSA:2.60.40.GENE3D); IPR032455 (PFAM); IPR002126 (PFAM); IPR013164 (PFAM); IPR002126 (G3DSA:2.60.40.GENE3D); IPR030728 (PTHR24028:PANTHER); PTHR24028 (PANTHER); IPR020894 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR002126 (PROSITE_PROFILES); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY)
gi|953872902|ref|XP_014586098.1|	protocadherin beta-10	798	20	0E0	91.15%	6	F:GO:0005509; C:GO:0016020; C:GO:0016021; P:GO:0007155; P:GO:0007156; C:GO:0005886	F:calcium ion binding; C:membrane; C:integral component of membrane; P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; C:plasma membrane		
gi|953872914|ref|XP_014586102.1|	protocadherin alpha-11 isoform X4	907	20	0E0	91.35%	3	F:GO:0005509; P:GO:0007156; C:GO:0005886	F:calcium ion binding; P:homophilic cell adhesion via plasma membrane adhesion molecules; C:plasma membrane		IPR002126 (PRINTS); IPR002126 (SMART); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (PFAM); IPR013164 (PFAM); IPR031904 (PFAM); IPR032455 (PFAM); IPR002126 (G3DSA:2.60.40.GENE3D); PTHR24028 (PANTHER); PTHR24028:SF68 (PANTHER); IPR020894 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR002126 (PROSITE_PROFILES); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY)
gi|953872927|ref|XP_014586106.1|	Red	555	20	0E0	99.6%	1	C:GO:0005634	C:nucleus		IPR012916 (PFAM); IPR012492 (PFAM); PTHR12765:SF5 (PANTHER); PTHR12765 (PANTHER); IPR012492 (PRODOM)
gi|953873488|ref|XP_014586271.1|	transmembrane 161B isoform X1	476	20	0E0	95.3%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		IPR019395 (PFAM); PTHR13624:SF3 (PANTHER); PTHR13624 (PANTHER); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS)
gi|953873553|ref|XP_014586287.1|	corticotropin-releasing factor-binding	321	20	0E0	91.6%	1	F:GO:0051424	F:corticotropin-releasing hormone binding		IPR008435 (PIRSF); IPR008435 (PFAM); IPR008435 (PTHR10278:PANTHER); PTHR10278 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR000859 (SUPERFAMILY)
gi|953873832|ref|XP_014586384.1|	fer-1 5	2063	20	0E0	90.25%	3	F:GO:0005515; C:GO:0016021; P:GO:0007520	F:protein binding; C:integral component of membrane; P:myoblast fusion		IPR012561 (SMART); IPR012968 (SMART); IPR012560 (SMART); IPR006614 (SMART); IPR006614 (SMART); IPR000008 (SMART); IPR000008 (G3DSA:2.60.40.GENE3D); IPR032362 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR000008 (G3DSA:2.60.40.GENE3D); IPR012561 (PFAM); IPR012560 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR000008 (PFAM); IPR029997 (PTHR12546:PANTHER); PTHR12546 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000008 (PROSITE_PROFILES); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY)
gi|953873879|ref|XP_014586409.1|	girdin isoform X1	1881	20	0E0	97.45%	3	P:GO:0032956; F:GO:0003779; P:GO:0016477	P:regulation of actin cytoskeleton organization; F:actin binding; P:cell migration		IPR008636 (PFAM); IPR027717 (PTHR18947:PANTHER); IPR008636 (PANTHER); IPR001202 (PROSITE_PATTERNS); SSF116907 (SUPERFAMILY)
gi|953873926|ref|XP_014586433.1|	apolipo B-100	4552	20	0E0	89.65%	27	P:GO:0034374; P:GO:0008203; C:GO:0005794; F:GO:0008201; C:GO:0043025; P:GO:0009615; P:GO:0042632; F:GO:0050750; C:GO:0070062; C:GO:0015629; P:GO:0030301; F:GO:0017127; P:GO:0034383; C:GO:0034361; F:GO:0035473; C:GO:0042627; C:GO:0034363; C:GO:0034362; F:GO:0005543; C:GO:0005886; P:GO:0006869; F:GO:0005319; C:GO:0005737; P:GO:0010886; P:GO:0010744; P:GO:0010884; C:GO:0034359	P:low-density lipoprotein particle remodeling; P:cholesterol metabolic process; C:Golgi apparatus; F:heparin binding; C:neuronal cell body; P:response to virus; P:cholesterol homeostasis; F:low-density lipoprotein particle receptor binding; C:extracellular exosome; C:actin cytoskeleton; P:cholesterol transport; F:cholesterol transporter activity; P:low-density lipoprotein particle clearance; C:very-low-density lipoprotein particle; F:lipase binding; C:chylomicron; C:intermediate-density lipoprotein particle; C:low-density lipoprotein particle; F:phospholipid binding; C:plasma membrane; P:lipid transport; F:lipid transporter activity; C:cytoplasm; P:positive regulation of cholesterol storage; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of lipid storage; C:mature chylomicron		
gi|953873928|ref|XP_014586434.1|	growth differentiation factor 7	410	20	0E0	77.5%	4	P:GO:0008283; F:GO:0008083; P:GO:0007165; P:GO:0040007	P:cell proliferation; F:growth factor activity; P:signal transduction; P:growth		IPR001839 (SMART); IPR001111 (PFAM); IPR001839 (PFAM); IPR029034 (G3DSA:2.10.90.GENE3D); PTHR11848:SF160 (PANTHER); IPR015615 (PANTHER); IPR017948 (PROSITE_PATTERNS); IPR001839 (PROSITE_PROFILES); IPR029034 (SUPERFAMILY)
gi|953873952|ref|XP_014586445.1|	peroxidasin homolog	1445	20	0E0	96%	6	F:GO:0004601; P:GO:0006979; F:GO:0005515; P:GO:0006804; P:GO:0055114; F:GO:0020037	F:peroxidase activity; P:response to oxidative stress; F:protein binding; P:obsolete peroxidase reaction; P:oxidation-reduction process; F:heme binding	EC:1.11.1.7	IPR019791 (PRINTS); IPR003598 (SMART); IPR000483 (SMART); IPR003599 (SMART); IPR001007 (SMART); IPR003591 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001007 (PFAM); IPR019791 (G3DSA:1.10.640.GENE3D); G3DSA:2.10.70.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013098 (PFAM); IPR019791 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001611 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR11475:SF75 (PANTHER); PTHR11475 (PANTHER); IPR001007 (PROSITE_PATTERNS); IPR001611 (PROSITE_PROFILES); IPR019791 (PROSITE_PROFILES); IPR001007 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR010255 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR032675 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); SSF57603 (SUPERFAMILY)
gi|953874097|ref|XP_014586468.1|	testis-specific gene 10 isoform X1	892	20	0E0	97.7%	5	C:GO:0031514; C:GO:0005737; P:GO:0007283; P:GO:0030031; C:GO:0043005	C:motile cilium; C:cytoplasm; P:spermatogenesis; P:cell projection assembly; C:neuron projection		
gi|953874336|ref|XP_014586545.1|	S-adenosylmethionine synthase isoform type-2	439	20	0E0	98.95%	4	F:GO:0005524; P:GO:0006556; F:GO:0004478; P:GO:0006555	F:ATP binding; P:S-adenosylmethionine biosynthetic process; F:methionine adenosyltransferase activity; P:methionine metabolic process	EC:2.5.1.6	IPR002133 (PIRSF); IPR022628 (PFAM); IPR002133 (TIGRFAM); G3DSA:3.30.300.10 (GENE3D); IPR022630 (PFAM); G3DSA:3.30.300.10 (GENE3D); IPR022629 (PFAM); G3DSA:3.30.300.10 (GENE3D); IPR002133 (PANTHER); IPR022631 (PROSITE_PATTERNS); IPR022631 (PROSITE_PATTERNS); IPR002133 (HAMAP); IPR022636 (SUPERFAMILY); IPR022636 (SUPERFAMILY); IPR022636 (SUPERFAMILY)
gi|953874673|ref|XP_014586631.1|	ubiquitin carboxyl-terminal hydrolase 34	3391	20	0E0	99.1%	3	P:GO:0016579; F:GO:0036459; P:GO:0006511	P:protein deubiquitination; F:thiol-dependent ubiquitinyl hydrolase activity; P:ubiquitin-dependent protein catabolic process	EC:3.4; EC:3.4.19.12	IPR001394 (PFAM); G3DSA:2.20.210.10 (GENE3D); PTHR24006 (PANTHER); PTHR24006:SF97 (PANTHER); IPR018200 (PROSITE_PATTERNS); IPR018200 (PROSITE_PATTERNS); IPR028889 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY)
gi|953874702|ref|XP_005600024.2|	B-cell lymphoma leukemia 11A isoform X4	774	20	0E0	97.15%	2	F:GO:0003676; F:GO:0046872	F:nucleic acid binding; F:metal ion binding		IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR23233:SF43 (PANTHER); PTHR23233 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY)
gi|953874945|ref|XP_014586698.1|	baculoviral IAP repeat-containing 6 isoform X5	4873	20	0E0	98.6%	5	F:GO:0004842; F:GO:0005515; P:GO:0006915; P:GO:0032465; P:GO:0016567	F:ubiquitin-protein transferase activity; F:protein binding; P:apoptotic process; P:regulation of cytokinesis; P:protein ubiquitination		SM00212 (SMART); IPR001370 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR000608 (PFAM); IPR001370 (G3DSA:1.10.1170.GENE3D); IPR022103 (PFAM); IPR001370 (PFAM); IPR016135 (G3DSA:3.10.110.GENE3D); PTHR10044 (PANTHER); PTHR10044:SF123 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR001370 (PROSITE_PROFILES); SSF57924 (SUPERFAMILY); IPR016135 (SUPERFAMILY)
gi|953875007|ref|XP_014586718.1|	CAP-Gly domain-containing linker 4 isoform X1	703	20	0E0	94.75%	1	F:GO:0005515	F:protein binding		IPR000938 (SMART); IPR002110 (SMART); IPR000938 (G3DSA:2.30.30.GENE3D); IPR000938 (G3DSA:2.30.30.GENE3D); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR000938 (PFAM); IPR028397 (PTHR18916:PANTHER); PTHR18916 (PANTHER); IPR000938 (PROSITE_PATTERNS); IPR020683 (PROSITE_PROFILES); IPR000938 (PROSITE_PROFILES); IPR000938 (SUPERFAMILY); IPR000938 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR000938 (SUPERFAMILY)
gi|953875213|ref|XP_014586773.1|	intersectin-2 isoform X1	1684	20	0E0	96.4%	6	P:GO:0035023; F:GO:0005515; F:GO:0005509; P:GO:0043087; F:GO:0005089; P:GO:0006897	P:regulation of Rho protein signal transduction; F:protein binding; F:calcium ion binding; P:regulation of GTPase activity; F:Rho guanyl-nucleotide exchange factor activity; P:endocytosis		IPR001452 (PRINTS); PR00499 (PRINTS); IPR000261 (SMART); IPR000219 (SMART); IPR000008 (SMART); IPR002048 (SMART); IPR001452 (SMART); IPR001849 (SMART); IPR001849 (PFAM); IPR001452 (PFAM); IPR000219 (PFAM); IPR000219 (G3DSA:1.20.900.GENE3D); IPR000261 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR000008 (G3DSA:2.60.40.GENE3D); G3DSA:2.30.30.40 (GENE3D); IPR011511 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR000008 (PFAM); IPR001452 (PFAM); G3DSA:2.30.30.40 (GENE3D); G3DSA:2.30.30.40 (GENE3D); PTHR11216 (PANTHER); IPR027029 (PTHR11216:PANTHER); IPR018247 (PROSITE_PATTERNS); IPR001452 (PROSITE_PROFILES); IPR000261 (PROSITE_PROFILES); IPR000219 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR001452 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR001452 (SUPERFAMILY); IPR001452 (SUPERFAMILY); IPR001452 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR000219 (SUPERFAMILY); IPR001452 (SUPERFAMILY)
gi|953875250|ref|XP_014586783.1|	flap endonuclease GEN homolog 1	908	20	0E0	91.55%	3	F:GO:0003677; P:GO:0006281; F:GO:0004518	F:DNA binding; P:DNA repair; F:nuclease activity	EC:3.1	IPR006084 (PRINTS); IPR006086 (SMART); IPR008918 (SMART); IPR006085 (SMART); IPR006085 (PFAM); IPR006086 (PFAM); G3DSA:1.10.150.20 (GENE3D); IPR029060 (G3DSA:3.40.50.GENE3D); IPR006084 (PANTHER); PTHR11081:SF23 (PANTHER); IPR029060 (SUPERFAMILY); IPR020045 (SUPERFAMILY)
gi|953875420|ref|XP_014586838.1|	plexin-D1	1555	20	0E0	96.45%	4	F:GO:0005515; C:GO:0016020; F:GO:0017154; P:GO:0071526	F:protein binding; C:membrane; F:semaphorin receptor activity; P:semaphorin-plexin signaling pathway		IPR002909 (SMART); IPR016201 (SMART); G3DSA:3.10.20.90 (GENE3D); IPR001627 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013548 (PFAM); G3DSA:3.30.1680.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR002165 (PFAM); G3DSA:3.30.1680.10 (GENE3D); IPR031148 (PANTHER); PTHR22625:SF7 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR001627 (PROSITE_PROFILES); IPR008936 (SUPERFAMILY); IPR014756 (SUPERFAMILY); SSF103575 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR001627 (SUPERFAMILY)
gi|953875547|ref|XP_014586879.1|	PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein C3orf20 homolog	902	20	0E0	83.25%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		IPR029281 (PFAM); PTHR23093:SF16 (PANTHER); PTHR23093 (PANTHER)
gi|953875711|ref|XP_014586929.1|	SLIT-ROBO Rho GTPase-activating 3 isoform X1	863	20	0E0	99%	2	F:GO:0005515; P:GO:0007165	F:protein binding; P:signal transduction		IPR001452 (SMART); IPR001060 (SMART); IPR000198 (SMART); IPR001060 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR000198 (G3DSA:1.10.555.GENE3D); IPR011511 (PFAM); IPR000198 (PFAM); PTHR14166:SF8 (PANTHER); PTHR14166 (PANTHER); IPR031160 (PROSITE_PROFILES); IPR000198 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR008936 (SUPERFAMILY); IPR001452 (SUPERFAMILY); SSF103657 (SUPERFAMILY)
gi|953875883|ref|XP_014586979.1|	dynein heavy chain axonemal	3908	20	0E0	94.65%	6	F:GO:0016887; F:GO:0005524; F:GO:0003777; C:GO:0030286; P:GO:0007018; C:GO:0005874	F:ATPase activity; F:ATP binding; F:microtubule motor activity; C:dynein complex; P:microtubule-based movement; C:microtubule	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR003593 (SMART); IPR024317 (PFAM); IPR013602 (PFAM); IPR011704 (PFAM); PF12781 (PFAM); PF12774 (PFAM); IPR004273 (PFAM); PF12775 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR024743 (PFAM); PTHR10676:SF255 (PANTHER); IPR026983 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|953875889|ref|XP_014586982.1|	voltage-dependent calcium channel subunit alpha-2 delta-3	1055	20	0E0	99%	15	F:GO:0005262; C:GO:0005891; F:GO:0005244; F:GO:0005246; P:GO:0006810; P:GO:0061337; C:GO:0005886; P:GO:0006811; F:GO:0046872; P:GO:0006816; C:GO:0016020; C:GO:0016021; P:GO:0034765; P:GO:0070588; P:GO:0051924	F:calcium channel activity; C:voltage-gated calcium channel complex; F:voltage-gated ion channel activity; F:calcium channel regulator activity; P:transport; P:cardiac conduction; C:plasma membrane; P:ion transport; F:metal ion binding; P:calcium ion transport; C:membrane; C:integral component of membrane; P:regulation of ion transmembrane transport; P:calcium ion transmembrane transport; P:regulation of calcium ion transport		IPR002035 (SMART); IPR013680 (PFAM); G3DSA:3.30.450.20 (GENE3D); IPR013608 (PFAM); IPR002035 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); PTHR10166:SF25 (PANTHER); PTHR10166 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR002035 (PROSITE_PROFILES); IPR002035 (SUPERFAMILY)
gi|953875899|ref|XP_005600638.2|	nischarin isoform X1	1519	20	0E0	94.6%	2	F:GO:0005515; F:GO:0035091	F:protein binding; F:phosphatidylinositol binding		IPR001683 (SMART); SM00365 (SMART); IPR003591 (SMART); IPR001683 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); IPR001683 (G3DSA:3.30.1520.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR15454:SF17 (PANTHER); PTHR15454 (PANTHER); IPR001683 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); SSF52075 (SUPERFAMILY); IPR001683 (SUPERFAMILY)
gi|953875912|ref|XP_014586992.1|	NCK-interacting with SH3 domain	601	20	0E0	95.35%	1	F:GO:0005515	F:protein binding		IPR001452 (SMART); IPR001452 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR018556 (PFAM); PTHR13357 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY)
gi|953875914|ref|XP_014586993.1|	cadherin EGF LAG seven-pass G-type receptor 3	3965	20	0E0	96.5%	19	P:GO:0007186; P:GO:0007165; P:GO:0032880; P:GO:0007155; P:GO:0007166; P:GO:0007156; F:GO:0004871; C:GO:0005886; P:GO:0007413; F:GO:0004930; P:GO:0001764; F:GO:0004888; P:GO:0001932; F:GO:0005509; C:GO:0016020; P:GO:0042384; C:GO:0016021; P:GO:0036515; P:GO:0036514	P:G-protein coupled receptor signaling pathway; P:signal transduction; P:regulation of protein localization; P:cell adhesion; P:cell surface receptor signaling pathway; P:homophilic cell adhesion via plasma membrane adhesion molecules; F:signal transducer activity; C:plasma membrane; P:axonal fasciculation; F:G-protein coupled receptor activity; P:neuron migration; F:transmembrane signaling receptor activity; P:regulation of protein phosphorylation; F:calcium ion binding; C:membrane; P:cilium assembly; C:integral component of membrane; P:serotonergic neuron axon guidance; P:dopaminergic neuron axon guidance		
gi|953875930|ref|XP_014586999.1|	zinc finger 502 isoform X1	1679	20	0E0	93.35%	2	F:GO:0003676; F:GO:0046872	F:nucleic acid binding; F:metal ion binding		IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); PTHR24376 (PANTHER); PTHR24376:SF19 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|953875956|ref|XP_014587009.1|	prothymosin alpha	198	20	6.24E-139	95.2%	6	C:GO:0005634; F:GO:0005515; C:GO:0070062; C:GO:0005737; P:GO:0006351; C:GO:0005654	C:nucleus; F:protein binding; C:extracellular exosome; C:cytoplasm; P:transcription, DNA-templated; C:nucleoplasm		IPR004931 (PFAM); IPR004931 (PANTHER); PTHR22745:SF0 (PANTHER)
gi|953875960|ref|XP_014587011.1|	inhibitor of carbonic anhydrase-like	691	20	0E0	88.1%	3	C:GO:0005615; P:GO:0043086; F:GO:0004857	C:extracellular space; P:negative regulation of catalytic activity; F:enzyme inhibitor activity		IPR001156 (PRINTS); IPR001156 (SMART); IPR016357 (PIRSF); G3DSA:3.40.190.10 (GENE3D); IPR001156 (PFAM); G3DSA:3.40.190.10 (GENE3D); G3DSA:3.40.190.10 (GENE3D); G3DSA:3.40.190.10 (GENE3D); IPR029785 (PTHR11485:PANTHER); PTHR11485 (PANTHER); IPR018195 (PROSITE_PATTERNS); IPR018195 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR001156 (PROSITE_PROFILES); SSF53850 (SUPERFAMILY); SSF53850 (SUPERFAMILY)
gi|953875989|ref|XP_014587022.1|	ceruloplasmin-like	955	20	0E0	91.45%	6	P:GO:0006879; P:GO:0006825; P:GO:0015994; F:GO:0005507; P:GO:0055114; F:GO:0004322	P:cellular iron ion homeostasis; P:copper ion transport; P:chlorophyll metabolic process; F:copper ion binding; P:oxidation-reduction process; F:ferroxidase activity	EC:1.16.3.1; EC:1.16.3	IPR008972 (G3DSA:2.60.40.GENE3D); IPR008972 (G3DSA:2.60.40.GENE3D); IPR011707 (PFAM); IPR011706 (PFAM); IPR027150 (PTHR10127:PANTHER); PTHR10127 (PANTHER); IPR033138 (PROSITE_PATTERNS); IPR002355 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY)
gi|953876243|ref|XP_014587105.1|	inter-alpha-trypsin inhibitor heavy chain H3	884	20	0E0	94.5%	2	F:GO:0004867; P:GO:0030212	F:serine-type endopeptidase inhibitor activity; P:hyaluronan metabolic process		IPR013694 (SMART); IPR002035 (SMART); IPR013694 (PFAM); IPR002035 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); IPR010600 (PFAM); PTHR10338:SF115 (PANTHER); PTHR10338 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR002035 (PROSITE_PROFILES); IPR013694 (PROSITE_PROFILES); IPR002035 (SUPERFAMILY)
gi|953876333|ref|XP_014587130.1|	helicase ARIP4	1467	20	0E0	98.55%	1	F:GO:0005524	F:ATP binding		IPR014001 (SMART); IPR001650 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000330 (PFAM); PTHR10799 (PANTHER); PTHR10799:SF593 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|953876340|ref|XP_014587133.1|	dedicator of cytokinesis 3 isoform X4	1940	20	0E0	98.3%	4	P:GO:0007264; F:GO:0005085; P:GO:0043087; F:GO:0005488	P:small GTPase mediated signal transduction; F:guanyl-nucleotide exchange factor activity; P:regulation of GTPase activity; F:binding		IPR032376 (PFAM); IPR010703 (PFAM); IPR027007 (PFAM); IPR026800 (PTHR23317:PANTHER); IPR026791 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR027007 (PROSITE_PROFILES); IPR027357 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)
gi|953876437|ref|XP_014587160.1|	cadherin-related family member 4	768	20	0E0	92.5%	3	F:GO:0005509; P:GO:0007156; C:GO:0005886	F:calcium ion binding; P:homophilic cell adhesion via plasma membrane adhesion molecules; C:plasma membrane		IPR002126 (PRINTS); IPR002126 (SMART); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (PFAM); PTHR24028 (PANTHER); PTHR24028:SF123 (PANTHER); IPR020894 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR002126 (PROSITE_PROFILES); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY)
gi|953876756|ref|XP_014587245.1|	zinc finger 619 isoform X2	574	20	0E0	89.65%	4	F:GO:0003676; F:GO:0046872; P:GO:0006355; C:GO:0005622	F:nucleic acid binding; F:metal ion binding; P:regulation of transcription, DNA-templated; C:intracellular		IPR015880 (SMART); IPR001909 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR001909 (PFAM); IPR007087 (PFAM); PF13894 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24381 (PANTHER); PTHR24381:SF138 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); IPR001909 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); IPR001909 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|953877294|ref|XP_014587410.1|	arylacetamide deacetylase	399	20	0E0	92.65%	3	P:GO:0008152; C:GO:0016021; F:GO:0052689	P:metabolic process; C:integral component of membrane; F:carboxylic ester hydrolase activity	EC:3.1.1.1	IPR017157 (PIRSF); IPR013094 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR23024 (PANTHER); PTHR23024:SF222 (PANTHER); IPR033140 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR029058 (SUPERFAMILY)
gi|953877446|ref|XP_014587454.1|	gamma-sarcoglycan isoform X1	309	20	0E0	94.3%	2	C:GO:0016021; C:GO:0016012	C:integral component of membrane; C:sarcoglycan complex		IPR006875 (PFAM); PTHR12939 (PANTHER); IPR027660 (PTHR12939:PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS)
gi|953877543|ref|XP_014587475.1|		3439				1	P:GO:0000724	P:double-strand break repair via homologous recombination		IPR015525 (PIRSF); IPR015205 (SMART); IPR015188 (PFAM); IPR015205 (PFAM); G3DSA:2.40.50.140 (GENE3D); G3DSA:2.40.50.140 (GENE3D); IPR002093 (PFAM); IPR015252 (PFAM); IPR015187 (PFAM); G3DSA:2.40.50.140 (GENE3D); IPR015525 (PANTHER); PTHR11289:SF0 (PANTHER); IPR002093 (PROSITE_PROFILES); SSF81878 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR015252 (SUPERFAMILY)
gi|953877580|ref|XP_014587491.1|	spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing 2	602	20	0E0	88.25%	4	P:GO:0048477; P:GO:0007283; P:GO:0006355; F:GO:0046983	P:oogenesis; P:spermatogenesis; P:regulation of transcription, DNA-templated; F:protein dimerization activity		IPR011598 (SMART); IPR011598 (G3DSA:4.10.280.GENE3D); IPR028022 (PFAM); IPR011598 (PFAM); PTHR16223 (PANTHER); IPR032669 (PTHR16223:PANTHER); IPR011598 (PROSITE_PROFILES); IPR011598 (SUPERFAMILY)
gi|953877668|ref|XP_014587517.1|	guanylate cyclase soluble subunit beta-2-like	811	20	0E0	91.05%	9	F:GO:0000166; P:GO:0006182; F:GO:0016849; F:GO:0016829; F:GO:0004383; P:GO:0035556; P:GO:0009190; C:GO:0005622; F:GO:0020037	F:nucleotide binding; P:cGMP biosynthetic process; F:phosphorus-oxygen lyase activity; F:lyase activity; F:guanylate cyclase activity; P:intracellular signal transduction; P:cyclic nucleotide biosynthetic process; C:intracellular; F:heme binding		
gi|953877806|ref|XP_014587563.1|	SPRY domain-containing 7	172	20	4.91E-126	99.95%	1	F:GO:0005515	F:protein binding		
gi|953877978|ref|XP_014587611.1|	protocadherin-20	952	20	0E0	97.1%	3	F:GO:0005509; P:GO:0007156; C:GO:0005886	F:calcium ion binding; P:homophilic cell adhesion via plasma membrane adhesion molecules; C:plasma membrane		IPR002126 (PRINTS); IPR002126 (SMART); IPR002126 (PFAM); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (G3DSA:2.60.40.GENE3D); PTHR24027 (PANTHER); IPR020894 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR002126 (PROSITE_PROFILES); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY)
gi|953878059|ref|XP_005601429.2|	glypican-5	572	20	0E0	94.3%	3	C:GO:0016020; F:GO:0043395; C:GO:0005578	C:membrane; F:heparan sulfate proteoglycan binding; C:proteinaceous extracellular matrix		IPR001863 (PFAM); IPR031188 (PTHR10822:PANTHER); IPR001863 (PANTHER); IPR019803 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS)
gi|953878308|ref|XP_014587735.1|	zinc finger GLI2	1351	20	0E0	90.15%	80	P:GO:0021915; P:GO:0060322; C:GO:0016607; P:GO:0021517; F:GO:0000978; P:GO:0009952; P:GO:0060603; P:GO:0007411; P:GO:0006366; P:GO:0021513; P:GO:0048754; P:GO:0009954; P:GO:0042733; P:GO:0009953; P:GO:0008589; F:GO:0001077; P:GO:0001501; P:GO:0048566; P:GO:0030902; P:GO:0001701; P:GO:0001822; P:GO:0045893; C:GO:0031512; P:GO:0021508; P:GO:0021904; F:GO:0008270; P:GO:0090103; P:GO:0060032; P:GO:0048646; P:GO:0007224; P:GO:0007389; P:GO:0060831; P:GO:0021983; P:GO:0060513; P:GO:0098586; P:GO:0007418; C:GO:0005634; C:GO:0072372; P:GO:0009913; P:GO:0002009; F:GO:0046872; P:GO:0071407; P:GO:0008283; P:GO:0021938; P:GO:0008284; F:GO:0044212; P:GO:0048856; P:GO:0021775; P:GO:0002062; P:GO:0021776; P:GO:0045666; P:GO:0045740; P:GO:0042475; F:GO:0043565; P:GO:0045944; P:GO:0021696; C:GO:0005930; P:GO:0000122; P:GO:0007507; F:GO:0003700; C:GO:0097542; P:GO:0001649; C:GO:0005929; P:GO:0030324; P:GO:0035295; P:GO:0021522; P:GO:0007442; P:GO:0002076; F:GO:0003682; P:GO:0048589; P:GO:0048666; P:GO:0021965; F:GO:0003676; F:GO:0003677; P:GO:0030879; C:GO:0005737; P:GO:0043066; C:GO:0016020; P:GO:0030154; P:GO:0032331	P:neural tube development; P:head development; C:nuclear speck; P:ventral spinal cord development; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; P:anterior/posterior pattern specification; P:mammary gland duct morphogenesis; P:axon guidance; P:transcription from RNA polymerase II promoter; P:spinal cord dorsal/ventral patterning; P:branching morphogenesis of an epithelial tube; P:proximal/distal pattern formation; P:embryonic digit morphogenesis; P:dorsal/ventral pattern formation; P:regulation of smoothened signaling pathway; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; P:skeletal system development; P:embryonic digestive tract development; P:hindbrain development; P:in utero embryonic development; P:kidney development; P:positive regulation of transcription, DNA-templated; C:motile primary cilium; P:floor plate formation; P:dorsal/ventral neural tube patterning; F:zinc ion binding; P:cochlea morphogenesis; P:notochord regression; P:anatomical structure formation involved in morphogenesis; P:smoothened signaling pathway; P:pattern specification process; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:pituitary gland development; P:prostatic bud formation; P:cellular response to virus; P:ventral midline development; C:nucleus; C:primary cilium; P:epidermal cell differentiation; P:morphogenesis of an epithelium; F:metal ion binding; P:cellular response to organic cyclic compound; P:cell proliferation; P:smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation; P:positive regulation of cell proliferation; F:transcription regulatory region DNA binding; P:anatomical structure development; P:smoothened signaling pathway involved in ventral spinal cord interneuron specification; P:chondrocyte differentiation; P:smoothened signaling pathway involved in spinal cord motor neuron cell fate specification; P:positive regulation of neuron differentiation; P:positive regulation of DNA replication; P:odontogenesis of dentin-containing tooth; F:sequence-specific DNA binding; P:positive regulation of transcription from RNA polymerase II promoter; P:cerebellar cortex morphogenesis; C:axoneme; P:negative regulation of transcription from RNA polymerase II promoter; P:heart development; F:transcription factor activity, sequence-specific DNA binding; C:ciliary tip; P:osteoblast differentiation; C:cilium; P:lung development; P:tube development; P:spinal cord motor neuron differentiation; P:hindgut morphogenesis; P:osteoblast development; F:chromatin binding; P:developmental growth; P:neuron development; P:spinal cord ventral commissure morphogenesis; F:nucleic acid binding; F:DNA binding; P:mammary gland development; C:cytoplasm; P:negative regulation of apoptotic process; C:membrane; P:cell differentiation; P:negative regulation of chondrocyte differentiation		
gi|953878344|ref|XP_014587749.1|	cordon-bleu -like 1 isoform X1	1203	20	0E0	90.25%	5	C:GO:0070062; F:GO:0003779; P:GO:0030041; P:GO:0051639; F:GO:0003785	C:extracellular exosome; F:actin binding; P:actin filament polymerization; P:actin filament network formation; F:actin monomer binding		IPR019025 (PFAM); PTHR21557 (PANTHER); PTHR21557:SF2 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS)
gi|953878352|ref|XP_014587754.1|	E3 ubiquitin- ligase UBR3 isoform X4	1785	20	0E0	98.15%	1	F:GO:0008270	F:zinc ion binding		IPR003126 (SMART); IPR003126 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR21497 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SSF57850 (SUPERFAMILY)
gi|953878627|ref|XP_014587852.1|	unconventional myosin-VIIb	2143	20	0E0	93.1%	4	C:GO:0016459; F:GO:0005524; F:GO:0005515; F:GO:0003774	C:myosin complex; F:ATP binding; F:protein binding; F:motor activity	EC:3.6.1; EC:3.6.1.15	IPR001609 (PRINTS); IPR000857 (SMART); IPR000048 (SMART); IPR019749 (SMART); IPR001609 (SMART); IPR001452 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); IPR001609 (PFAM); IPR000048 (PFAM); IPR000857 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR014352 (G3DSA:1.20.80.GENE3D); IPR019748 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR13140:SF505 (PANTHER); PTHR13140 (PANTHER); IPR000857 (PROSITE_PROFILES); IPR000299 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); IPR001609 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR019748 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR029071 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR001452 (SUPERFAMILY); IPR019748 (SUPERFAMILY); IPR029071 (SUPERFAMILY)
gi|953878844|ref|XP_014587932.1|	lactase-phlorizin hydrolase	1928	20	0E0	93.4%	2	P:GO:0005975; F:GO:0004553	P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds		IPR001360 (PRINTS); IPR013781 (G3DSA:3.20.20.GENE3D); IPR001360 (PFAM); IPR001360 (PANTHER); PTHR10353:SF38 (PANTHER); IPR018120 (PROSITE_PATTERNS); IPR033132 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR017853 (SUPERFAMILY); IPR017853 (SUPERFAMILY); IPR017853 (SUPERFAMILY); IPR017853 (SUPERFAMILY)
gi|953879220|ref|XP_014588046.1|		33443				4	F:GO:0005524; F:GO:0005515; F:GO:0004672; P:GO:0006468	F:ATP binding; F:protein binding; F:protein kinase activity; P:protein phosphorylation		PR00014 (PRINTS); IPR013106 (SMART); IPR003961 (SMART); IPR003598 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR015129 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:1.20.5.510 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR000719 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR004168 (PFAM); IPR003961 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR13817:SF10 (PANTHER); PTHR13817 (PANTHER); IPR008266 (PROSITE_PATTERNS); IPR007110 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|953879519|ref|XP_014588134.1|	elongation factor mitochondrial	388	20	0E0	95.6%	11	F:GO:0005525; F:GO:0000166; F:GO:0003746; C:GO:0005759; F:GO:0003924; C:GO:0005739; P:GO:0070125; P:GO:0006414; C:GO:0005622; F:GO:0044822; P:GO:0006412	F:GTP binding; F:nucleotide binding; F:translation elongation factor activity; C:mitochondrial matrix; F:GTPase activity; C:mitochondrion; P:mitochondrial translational elongation; P:translational elongation; C:intracellular; F:poly(A) RNA binding; P:translation		
gi|953879534|ref|XP_014588140.1|	probable phospholipid-transporting ATPase IF isoform X2	1211	20	0E0	95.5%	13	F:GO:0004012; C:GO:0005783; C:GO:0005886; F:GO:0000166; F:GO:0000287; F:GO:0005524; F:GO:0046872; P:GO:0045332; C:GO:0016020; C:GO:0016021; P:GO:0015914; C:GO:0055037; F:GO:0016787	F:phospholipid-translocating ATPase activity; C:endoplasmic reticulum; C:plasma membrane; F:nucleotide binding; F:magnesium ion binding; F:ATP binding; F:metal ion binding; P:phospholipid translocation; C:membrane; C:integral component of membrane; P:phospholipid transport; C:recycling endosome; F:hydrolase activity		
gi|953879572|ref|XP_001501353.3|	sodium hydrogen exchanger 10	1180	20	0E0	89.9%	7	F:GO:0005216; F:GO:0015299; P:GO:0006812; P:GO:0030317; P:GO:0055085; C:GO:0016021; P:GO:0006885	F:ion channel activity; F:solute:proton antiporter activity; P:cation transport; P:flagellated sperm motility; P:transmembrane transport; C:integral component of membrane; P:regulation of pH		IPR006153 (PFAM); IPR027359 (G3DSA:1.20.120.GENE3D); IPR014710 (G3DSA:2.60.120.GENE3D); IPR000595 (PFAM); IPR005821 (PFAM); IPR018422 (PANTHER); IPR028483 (PTHR10110:PANTHER); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000595 (PROSITE_PROFILES); IPR018490 (SUPERFAMILY); SSF81324 (SUPERFAMILY)
gi|953879579|ref|XP_014588154.1|	zinc finger and BTB domain-containing 11	1031	20	0E0	91.7%	3	F:GO:0003676; F:GO:0005515; F:GO:0046872	F:nucleic acid binding; F:protein binding; F:metal ion binding		IPR000210 (SMART); IPR015880 (SMART); G3DSA:3.30.710.10 (GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR000210 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24387 (PANTHER); PTHR24387:SF4 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR000210 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR011333 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|953879940|ref|XP_001497792.3|	26S proteasome non-ATPase regulatory subunit 2	908	20	0E0	99.15%	4	P:GO:0042176; C:GO:0000502; F:GO:0005488; F:GO:0030234	P:regulation of protein catabolic process; C:proteasome complex; F:binding; F:enzyme regulator activity		IPR016643 (PIRSF); IPR002015 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR10943 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR016024 (SUPERFAMILY)
gi|953880017|ref|XP_014588286.1|	mannan-binding lectin serine protease 1 isoform X2	699	20	0E0	94.15%	5	P:GO:0006956; F:GO:0005509; P:GO:0006508; F:GO:0004252; C:GO:0005576	P:complement activation; F:calcium ion binding; P:proteolysis; F:serine-type endopeptidase activity; C:extracellular region	EC:3.4.21	IPR001314 (PRINTS); IPR000859 (SMART); IPR000436 (SMART); IPR024175 (PIRSF); IPR001881 (SMART); IPR001254 (SMART); IPR000436 (PFAM); G3DSA:2.40.10.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); IPR000859 (G3DSA:2.60.120.GENE3D); IPR000859 (PFAM); G3DSA:2.40.10.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR001254 (PFAM); IPR000859 (G3DSA:2.60.120.GENE3D); G3DSA:2.40.10.10 (GENE3D); PTHR24255 (PANTHER); PTHR24255:SF13 (PANTHER); IPR013032 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR033116 (PROSITE_PATTERNS); IPR018114 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR001254 (PROSITE_PROFILES); IPR000859 (PROSITE_PROFILES); IPR000436 (PROSITE_PROFILES); IPR000436 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR009003 (SUPERFAMILY); IPR000859 (SUPERFAMILY)
gi|953880258|ref|XP_014588352.1|	DNA polymerase theta	2601	20	0E0	94.15%	5	F:GO:0003677; F:GO:0005524; F:GO:0003887; P:GO:0006261; C:GO:0042575	F:DNA binding; F:ATP binding; F:DNA-directed DNA polymerase activity; P:DNA-dependent DNA replication; C:DNA polymerase complex	EC:2.7.7.7	IPR002298 (PRINTS); IPR001098 (SMART); IPR014001 (SMART); IPR001650 (SMART); G3DSA:1.20.1060.10 (GENE3D); G3DSA:1.10.150.20 (GENE3D); IPR011545 (PFAM); IPR001098 (PFAM); G3DSA:3.30.70.370 (GENE3D); IPR012337 (G3DSA:3.30.420.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); PTHR10133 (PANTHER); PTHR10133:SF33 (PANTHER); IPR019760 (PROSITE_PATTERNS); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR012337 (SUPERFAMILY); SSF158702 (SUPERFAMILY); SSF56672 (SUPERFAMILY)
gi|953880348|ref|XP_014588372.1|	cilia- and flagella-associated 44	1873	20	0E0	93.8%	1	F:GO:0005515	F:protein binding		IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR13720 (PANTHER); PTHR13720:SF18 (PANTHER); IPR019775 (PROSITE_PATTERNS); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR017986 (SUPERFAMILY)
gi|953880413|ref|XP_014588387.1|	myosin-15	1938	20	0E0	91.45%	4	C:GO:0016459; F:GO:0005524; F:GO:0005515; F:GO:0003774	C:myosin complex; F:ATP binding; F:protein binding; F:motor activity	EC:3.6.1; EC:3.6.1.15	IPR001609 (PRINTS); IPR001609 (SMART); IPR002928 (PFAM); IPR004009 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.20.5.340 (GENE3D); IPR027401 (G3DSA:4.10.270.GENE3D); IPR001609 (PFAM); PTHR13140 (PANTHER); PTHR13140:SF475 (PANTHER); IPR001609 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); SSF90257 (SUPERFAMILY); SSF90257 (SUPERFAMILY); IPR027417 (SUPERFAMILY); SSF90257 (SUPERFAMILY); SSF57997 (SUPERFAMILY); SSF90257 (SUPERFAMILY)
gi|953880974|ref|XP_014589801.1|	negative elongation factor E isoform X1	440	20	0E0	98.6%	4	F:GO:0000166; F:GO:0003676; C:GO:0032021; P:GO:0006355	F:nucleotide binding; F:nucleic acid binding; C:NELF complex; P:regulation of transcription, DNA-templated		IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR013957 (PFAM); IPR000504 (PFAM); PTHR17250 (PANTHER); IPR033102 (PTHR17250:PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY)
gi|953881086|ref|XP_014589833.1|	beta-1,3-galactosyltransferase 4	384	20	0E0	92.7%	3	C:GO:0016020; P:GO:0006486; F:GO:0008378	C:membrane; P:protein glycosylation; F:galactosyltransferase activity	EC:2.4.1	IPR002659 (PFAM); IPR002659 (PANTHER); PTHR11214:SF114 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS)
gi|953881423|ref|XP_014589922.1|	cullin-9 isoform X1	2521	20	0E0	96.1%	7	F:GO:0008270; F:GO:0031625; C:GO:0031461; P:GO:0007088; P:GO:0000226; P:GO:0006511; P:GO:0016567	F:zinc ion binding; F:ubiquitin protein ligase binding; C:cullin-RING ubiquitin ligase complex; P:regulation of mitotic nuclear division; P:microtubule cytoskeleton organization; P:ubiquitin-dependent protein catabolic process; P:protein ubiquitination		IPR019559 (SMART); IPR002867 (SMART); IPR004939 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR019559 (PFAM); IPR001373 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); IPR021097 (PFAM); G3DSA:4.10.1030.10 (GENE3D); IPR014722 (G3DSA:2.30.30.GENE3D); IPR008979 (G3DSA:2.60.120.GENE3D); IPR004939 (PFAM); IPR002867 (PFAM); IPR031222 (PTHR22771:PANTHER); PTHR22771 (PANTHER); IPR016157 (PROSITE_PATTERNS); IPR017907 (PROSITE_PATTERNS); IPR001841 (PROSITE_PROFILES); IPR016158 (PROSITE_PROFILES); IPR004939 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR008979 (SUPERFAMILY); SSF63748 (SUPERFAMILY); SSF57850 (SUPERFAMILY); IPR016158 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
gi|953881643|ref|XP_014589999.1|	dystonin isoform X1	5665	20	0E0	97.6%	4	P:GO:0007010; C:GO:0045298; F:GO:0005509; F:GO:0008017	P:cytoskeleton organization; C:tubulin complex; F:calcium ion binding; F:microtubule binding		IPR002048 (SMART); IPR018159 (SMART); IPR003108 (SMART); IPR001715 (SMART); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR002048 (PFAM); IPR003108 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR002017 (PFAM); IPR001715 (PFAM); G3DSA:1.20.58.60 (GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR003108 (G3DSA:3.30.920.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR11915 (PANTHER); IPR029926 (PTHR11915:PANTHER); IPR001589 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); IPR018247 (PROSITE_PATTERNS); IPR003108 (PROSITE_PROFILES); IPR001715 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR003108 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001715 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR011992 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY)
gi|953881736|ref|XP_014590031.1|	FAM50B	292	20	0E0	81.15%	1	C:GO:0005634	C:nucleus		IPR007005 (PFAM); IPR007005 (PANTHER); PTHR12722:SF1 (PANTHER)
gi|953881741|ref|XP_014590033.1|	desmoplakin isoform X1	2812	20	0E0	92.9%	4	P:GO:0016337; C:GO:0005856; F:GO:0050839; C:GO:0030054	P:single organismal cell-cell adhesion; C:cytoskeleton; F:cell adhesion molecule binding; C:cell junction		IPR001101 (SMART); IPR001101 (G3DSA:3.90.1290.GENE3D); IPR001101 (PFAM); IPR028462 (PTHR11915:PANTHER); PTHR11915 (PANTHER); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY)
gi|953881755|ref|XP_014590039.1|	kinesin KIF13A isoform X1	1889	20	0E0	97.6%	6	F:GO:0005524; F:GO:0003777; P:GO:0072383; C:GO:0045298; F:GO:0008017; C:GO:0005874	F:ATP binding; F:microtubule motor activity; P:plus-end-directed vesicle transport along microtubule; C:tubulin complex; F:microtubule binding; C:microtubule	EC:3.6.1; EC:3.6.1.15	IPR001752 (PRINTS); IPR001752 (SMART); IPR001752 (PFAM); IPR000253 (G3DSA:2.60.200.GENE3D); IPR022164 (PFAM); IPR022140 (PFAM); IPR032405 (PFAM); IPR001752 (G3DSA:3.40.850.GENE3D); IPR032923 (PTHR24115:PANTHER); IPR027640 (PANTHER); IPR019821 (PROSITE_PATTERNS); IPR001752 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR008984 (SUPERFAMILY)
gi|953881817|ref|XP_014590071.1|	inositol 1,4,5-trisphosphate receptor type 3	2735	20	0E0	95.3%	4	C:GO:0016020; F:GO:0005220; P:GO:0070588; C:GO:0005783	C:membrane; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:calcium ion transmembrane transport; C:endoplasmic reticulum		IPR000493 (PRINTS); IPR016093 (SMART); G3DSA:2.80.10.50 (GENE3D); IPR000699 (PFAM); IPR000699 (G3DSA:1.25.10.GENE3D); IPR014821 (PFAM); G3DSA:2.80.10.50 (GENE3D); IPR016093 (PFAM); IPR005821 (PFAM); IPR013662 (PFAM); PTHR13715:SF51 (PANTHER); IPR015925 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR016093 (PROSITE_PROFILES); IPR016093 (SUPERFAMILY); IPR000699 (SUPERFAMILY); IPR016093 (SUPERFAMILY); IPR000699 (SUPERFAMILY)
gi|953881843|ref|XP_014590081.1|	cap-specific mRNA (nucleoside-2 -O-)-methyltransferase 1	896	20	0E0	88.9%	5	F:GO:0003676; F:GO:0005515; P:GO:0006370; F:GO:0004483; P:GO:0080009	F:nucleic acid binding; F:protein binding; P:7-methylguanosine mRNA capping; F:mRNA (nucleoside-2'-O-)-methyltransferase activity; P:mRNA methylation	EC:2.1.1.57; EC:2.1.1	IPR001202 (SMART); IPR000467 (SMART); IPR002877 (PFAM); IPR000467 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR030376 (PTHR16121:PANTHER); PTHR16121 (PANTHER); IPR001202 (PROSITE_PATTERNS); IPR001202 (PROSITE_PROFILES); IPR000467 (PROSITE_PROFILES); IPR025816 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY)
gi|953881875|ref|XP_014590098.1|	tudor domain-containing 6 isoform X1	2050	20	0E0	90.8%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		IPR002999 (SMART); G3DSA:2.30.30.140 (GENE3D); G3DSA:2.30.30.140 (GENE3D); IPR016071 (G3DSA:2.40.50.GENE3D); IPR002999 (PFAM); PTHR22948:SF15 (PANTHER); PTHR22948 (PANTHER); IPR002999 (PROSITE_PROFILES); SSF63748 (SUPERFAMILY); SSF63748 (SUPERFAMILY); SSF63748 (SUPERFAMILY); SSF63748 (SUPERFAMILY); SSF63748 (SUPERFAMILY); SSF63748 (SUPERFAMILY)
gi|953881889|ref|XP_014590106.1|	zinc finger 451 isoform X1	1089	20	0E0	95.45%	1	F:GO:0046872	F:metal ion binding		IPR015880 (SMART); PTHR24409:SF13 (PANTHER); PTHR24409 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES)
gi|953882619|ref|XP_014590302.1|	tyrosine- kinase JAK3	1090	20	0E0	86.45%	6	F:GO:0005524; C:GO:0005856; F:GO:0004715; C:GO:0016020; P:GO:0006468; P:GO:0035556	F:ATP binding; C:cytoskeleton; F:non-membrane spanning protein tyrosine kinase activity; C:membrane; P:protein phosphorylation; P:intracellular signal transduction	EC:2.7.10; EC:2.7.10.2	IPR016251 (PRINTS); IPR020775 (PRINTS); IPR019749 (SMART); IPR000980 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR001245 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000980 (G3DSA:3.30.505.GENE3D); PTHR24418:SF233 (PANTHER); PTHR24418 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR000299 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR000980 (SUPERFAMILY)
gi|953883035|ref|XP_014590421.1|	E3 ubiquitin- ligase MARCH6	912	20	0E0	99.05%	1	F:GO:0008270	F:zinc ion binding		IPR011016 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR011016 (PFAM); PTHR13145 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR011016 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY)
gi|953883129|ref|XP_014590449.1|	mitogen-activated kinase kinase kinase 1	1387	20	0E0	95.15%	5	F:GO:0005524; F:GO:0008270; F:GO:0005515; F:GO:0004672; P:GO:0006468	F:ATP binding; F:zinc ion binding; F:protein binding; F:protein kinase activity; P:protein phosphorylation		IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR24361 (PANTHER); PTHR24361:SF414 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR001841 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
gi|953883173|ref|XP_014590465.1|	little elongation complex subunit 1	1983	20	0E0	89.7%	15	C:GO:0035363; P:GO:0090316; F:GO:0042803; C:GO:0008023; P:GO:0006351; C:GO:0015030; P:GO:0006355; P:GO:0042795; P:GO:0042796; P:GO:0045945; C:GO:0005654; C:GO:0005634; F:GO:0005515; C:GO:0035327; P:GO:0031334	C:histone locus body; P:positive regulation of intracellular protein transport; F:protein homodimerization activity; C:transcription elongation factor complex; P:transcription, DNA-templated; C:Cajal body; P:regulation of transcription, DNA-templated; P:snRNA transcription from RNA polymerase II promoter; P:snRNA transcription from RNA polymerase III promoter; P:positive regulation of transcription from RNA polymerase III promoter; C:nucleoplasm; C:nucleus; F:protein binding; C:transcriptionally active chromatin; P:positive regulation of protein complex assembly		
gi|953883212|ref|XP_014590479.1|	sweat gland latherin partial	292	20	0E0	78.25%	4	P:GO:0001659; P:GO:0050828; F:GO:0008289; C:GO:0005576	P:temperature homeostasis; P:regulation of liquid surface tension; F:lipid binding; C:extracellular region		
gi|953883556|ref|XP_014590563.1|	signal-regulatory beta-1 isoform 3-like	394	20	0E0	90.8%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR19971 (PANTHER); PTHR19971:SF3 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|953883687|ref|XP_014590597.1|	zinc finger 341 isoform X1	894	20	0E0	96.1%	2	F:GO:0003676; F:GO:0046872	F:nucleic acid binding; F:metal ion binding		IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); PF12874 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR24388:SF32 (PANTHER); PTHR24388 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|953883735|ref|XP_014590609.1|	myosin-7B isoform X2	1941	20	0E0	98.25%	5	F:GO:0000166; C:GO:0016459; F:GO:0005524; F:GO:0003779; F:GO:0003774	F:nucleotide binding; C:myosin complex; F:ATP binding; F:actin binding; F:motor activity		
gi|953884078|ref|XP_014590706.1|	ribosome-binding 1	980	20	0E0	95.25%	2	P:GO:0015031; C:GO:0030176	P:protein transport; C:integral component of endoplasmic reticulum membrane		IPR007794 (PFAM); PTHR18939 (PANTHER); PTHR18939:SF4 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|953884126|ref|XP_014590727.1|	CBFA2T2 isoform X1	818	20	0E0	98%	6	C:GO:0005667; F:GO:0003700; P:GO:0045892; F:GO:0003714; P:GO:0045892; P:GO:0006355	C:transcription factor complex; F:transcription factor activity, sequence-specific DNA binding; P:negative regulation of transcription, DNA-templated; F:transcription corepressor activity; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated		IPR013291 (PRINTS); IPR013289 (PRINTS); IPR003894 (SMART); IPR003894 (PFAM); IPR002893 (PFAM); IPR014896 (PFAM); PTHR10379:SF13 (PANTHER); PTHR10379 (PANTHER); IPR002893 (PROSITE_PATTERNS); IPR002893 (PROSITE_PROFILES); IPR003894 (PROSITE_PROFILES); SSF144232 (SUPERFAMILY); SSF158553 (SUPERFAMILY)
gi|953884136|ref|XP_014590731.1|	fer-1 4	1953	20	0E0	93.95%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		
gi|953884146|ref|XP_014590735.1|	ral GTPase-activating subunit beta isoform X4	1473	20	0E0	97.15%	2	P:GO:0051056; F:GO:0005096	P:regulation of small GTPase mediated signal transduction; F:GTPase activator activity		PTHR21344 (PANTHER); IPR000331 (PROSITE_PROFILES); IPR000331 (SUPERFAMILY)
gi|953884178|ref|XP_014590747.1|	cadherin-22	649	20	0E0	75.45%	3	F:GO:0005509; P:GO:0007156; C:GO:0005886	F:calcium ion binding; P:homophilic cell adhesion via plasma membrane adhesion molecules; C:plasma membrane		IPR002126 (PRINTS); IPR002126 (SMART); IPR000233 (PFAM); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (PFAM); IPR002126 (G3DSA:2.60.40.GENE3D); PTHR24027:SF311 (PANTHER); PTHR24027 (PANTHER); IPR020894 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR002126 (PROSITE_PROFILES); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY)
gi|953884546|ref|XP_014590849.1|	transcription elongation factor A 2 isoform X2	405	20	0E0	90.4%	4	F:GO:0003676; C:GO:0005634; F:GO:0008270; P:GO:0006355	F:nucleic acid binding; C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated		IPR003617 (SMART); IPR001222 (SMART); IPR003618 (SMART); IPR017923 (G3DSA:1.20.930.GENE3D); G3DSA:2.20.25.10 (GENE3D); IPR017923 (PFAM); IPR003618 (PFAM); IPR003618 (G3DSA:1.10.472.GENE3D); IPR001222 (PFAM); IPR006289 (TIGRFAM); PTHR11477:SF3 (PANTHER); PTHR11477 (PANTHER); IPR001222 (PROSITE_PATTERNS); IPR001222 (PROSITE_PROFILES); IPR017923 (PROSITE_PROFILES); IPR003618 (PROSITE_PROFILES); IPR003618 (SUPERFAMILY); SSF57783 (SUPERFAMILY); IPR017923 (SUPERFAMILY)
gi|953885071|ref|XP_014590981.1|	focadhesin isoform X2	1816	20	0E0	95.95%	1	F:GO:0005488	F:binding		IPR021392 (PFAM); IPR022542 (PFAM); PTHR16212:SF4 (PANTHER); PTHR16212 (PANTHER); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR016024 (SUPERFAMILY)
gi|953885150|ref|XP_014590996.1|	ubiquitin-associated 2 isoform X1	1113	20	0E0	95.8%	1	F:GO:0005515	F:protein binding		IPR015940 (SMART); G3DSA:1.10.8.10 (GENE3D); IPR022166 (PFAM); PTHR16308:SF17 (PANTHER); PTHR16308 (PANTHER); IPR015940 (PROSITE_PROFILES); IPR009060 (SUPERFAMILY)
gi|953885313|ref|XP_005605177.2|	DNA excision repair ERCC-6-like 2 isoform X4	1549	20	0E0	93.15%	3	F:GO:0003676; F:GO:0005524; F:GO:0008026	F:nucleic acid binding; F:ATP binding; F:ATP-dependent helicase activity	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR014001 (SMART); IPR001650 (SMART); G3DSA:2.30.30.140 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR029256 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR000330 (PFAM); PTHR10799 (PANTHER); IPR002464 (PROSITE_PATTERNS); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|953885320|ref|XP_014591037.1|	spermatogenesis-associated 31D3	806	20	0E0	81.9%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		
gi|953885332|ref|XP_014591041.1|	spermatogenesis-associated 31D3	1103	20	0E0	89.45%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		PF14650 (PFAM); PTHR21859:SF12 (PANTHER); PTHR21859 (PANTHER)
gi|953885371|ref|XP_014591054.1|	multiple PDZ domain isoform X1	2070	20	0E0	95.2%	1	F:GO:0005515	F:protein binding		IPR001478 (SMART); IPR004172 (SMART); IPR001478 (G3DSA:2.30.42.GENE3D); IPR001478 (G3DSA:2.30.42.GENE3D); IPR001478 (G3DSA:2.30.42.GENE3D); IPR001478 (G3DSA:2.30.42.GENE3D); IPR001478 (G3DSA:2.30.42.GENE3D); IPR015132 (PFAM); IPR001478 (PFAM); IPR001478 (G3DSA:2.30.42.GENE3D); IPR032078 (PFAM); PTHR19964 (PANTHER); PTHR19964:SF10 (PANTHER); IPR004172 (PROSITE_PROFILES); IPR001478 (PROSITE_PROFILES); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR004172 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY)
gi|953885718|ref|XP_014591152.1|	zinc finger FYVE domain-containing 26	2540	20	0E0	94.05%	4	F:GO:0046872; P:GO:0000724; P:GO:0000910; F:GO:0032266	F:metal ion binding; P:double-strand break repair via homologous recombination; P:cytokinesis; F:phosphatidylinositol-3-phosphate binding		IPR000306 (SMART); IPR000306 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR028730 (PTHR22835:PANTHER); PTHR22835 (PANTHER); IPR017455 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY)
gi|953886057|ref|XP_014591235.1|	tyrosine- phosphatase non-receptor type 21	1176	20	0E0	96.25%	4	C:GO:0005856; P:GO:0006570; F:GO:0004725; P:GO:0006470	C:cytoskeleton; P:tyrosine metabolic process; F:protein tyrosine phosphatase activity; P:protein dephosphorylation	EC:3.1.3.16; EC:3.1; EC:3.1.3.48; EC:3.1.3.41	IPR000242 (PRINTS); IPR019749 (PRINTS); IPR018980 (SMART); IPR019749 (SMART); IPR014392 (PIRSF); IPR003595 (SMART); IPR000242 (SMART); G3DSA:3.10.20.90 (GENE3D); IPR000242 (PFAM); IPR019748 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR014352 (G3DSA:1.20.80.GENE3D); IPR029021 (G3DSA:3.90.190.GENE3D); IPR018979 (PFAM); IPR018980 (PFAM); PTHR19134 (PANTHER); PTHR19134:SF78 (PANTHER); IPR016130 (PROSITE_PATTERNS); IPR019747 (PROSITE_PATTERNS); IPR019747 (PROSITE_PATTERNS); IPR000299 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES); IPR029021 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR029071 (SUPERFAMILY); IPR019748 (SUPERFAMILY)
gi|953886252|ref|XP_014591269.1|	exocyst complex component 3 4	728	20	0E0	85.7%	2	P:GO:0006887; C:GO:0000145	P:exocytosis; C:exocyst		IPR010326 (PFAM); IPR010326 (PANTHER); PTHR21292:SF14 (PANTHER)
gi|953886370|ref|XP_014591305.1|	leucine-rich repeat-containing 9	1452	20	0E0	96.35%	1	F:GO:0005515	F:protein binding		IPR003591 (SMART); SM00365 (SMART); IPR003603 (SMART); SM00364 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); PF14580 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR24365:SF321 (PANTHER); PTHR24365 (PANTHER); IPR001611 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY); SSF52075 (SUPERFAMILY); IPR032675 (SUPERFAMILY)
gi|953886378|ref|XP_014591310.1|	nesprin-2 isoform X1	6872	20	0E0	94.5%	4	F:GO:0051015; C:GO:0016021; P:GO:0090286; C:GO:0034993	F:actin filament binding; C:integral component of membrane; P:cytoskeletal anchoring at nuclear membrane; C:LINC complex		IPR001715 (SMART); IPR012315 (SMART); IPR018159 (SMART); IPR001715 (G3DSA:1.10.418.GENE3D); IPR002017 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (PFAM); IPR012315 (PFAM); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR030266 (PTHR11915:PANTHER); PTHR11915 (PANTHER); IPR001589 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR001715 (PROSITE_PROFILES); IPR012315 (PROSITE_PROFILES); IPR001715 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY)
gi|953886406|ref|XP_005605445.2|	spermatogenesis-associated 7 isoform X1	598	20	0E0	86.9%	7	C:GO:0032391; C:GO:0015630; C:GO:0036064; P:GO:0045494; P:GO:1903546; P:GO:1903621; C:GO:0005930	C:photoreceptor connecting cilium; C:microtubule cytoskeleton; C:ciliary basal body; P:photoreceptor cell maintenance; P:protein localization to photoreceptor outer segment; P:protein localization to photoreceptor connecting cilium; C:axoneme		IPR029357 (PFAM); PTHR14917 (PANTHER); PTHR14917:SF2 (PANTHER)
gi|953886417|ref|XP_014591326.1|	cation channel sperm-associated subunit beta isoform X1	1104	20	0E0	90.95%	1	C:GO:0036128	C:CatSper complex		IPR028748 (PFAM); IPR028748 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|953886420|ref|XP_014591327.1|	ras and Rab interactor 3 isoform X1	1094	20	0E0	82.3%	1	P:GO:0007165	P:signal transduction		PR01217 (PRINTS); IPR000980 (SMART); IPR003123 (SMART); IPR000980 (G3DSA:3.30.505.GENE3D); IPR003123 (PFAM); IPR000980 (PFAM); PTHR23101 (PANTHER); PTHR23101:SF58 (PANTHER); IPR000159 (PROSITE_PROFILES); IPR003123 (PROSITE_PROFILES); IPR000980 (PROSITE_PROFILES); IPR000980 (SUPERFAMILY); SSF109993 (SUPERFAMILY)
gi|953886588|ref|XP_014591381.1|	cyclic AMP-responsive element-binding 3	375	20	0E0	86.55%	7	C:GO:0005667; F:GO:0003700; F:GO:0035497; P:GO:0030968; F:GO:0043565; P:GO:0045944; P:GO:0006355	C:transcription factor complex; F:transcription factor activity, sequence-specific DNA binding; F:cAMP response element binding; P:endoplasmic reticulum unfolded protein response; F:sequence-specific DNA binding; P:positive regulation of transcription from RNA polymerase II promoter; P:regulation of transcription, DNA-templated		IPR004827 (SMART); G3DSA:1.20.5.170 (GENE3D); IPR004827 (PFAM); IPR029808 (PTHR22952:PANTHER); PTHR22952 (PANTHER); IPR004827 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR004827 (PROSITE_PROFILES); SSF57959 (SUPERFAMILY)
gi|953886854|ref|XP_001490299.3|	major allergen Equ c 1-like	218	20	1.07E-157	88.15%	3	F:GO:0005550; P:GO:0006810; F:GO:0005215	F:pheromone binding; P:transport; F:transporter activity		IPR002971 (PRINTS); IPR012674 (G3DSA:2.40.128.GENE3D); IPR000566 (PFAM); PTHR11430 (PANTHER); PTHR11430:SF76 (PANTHER); IPR022272 (PROSITE_PATTERNS); IPR011038 (SUPERFAMILY)
gi|953886937|ref|XP_014591482.1|	kinesin KIF12 isoform X2	509	20	0E0	94.25%	6	F:GO:0005524; F:GO:0003777; C:GO:0045298; P:GO:0007018; F:GO:0008017; C:GO:0005874	F:ATP binding; F:microtubule motor activity; C:tubulin complex; P:microtubule-based movement; F:microtubule binding; C:microtubule	EC:3.6.1; EC:3.6.1.15	IPR001752 (PRINTS); IPR001752 (SMART); IPR001752 (PFAM); IPR001752 (G3DSA:3.40.850.GENE3D); IPR028763 (PTHR24115:PANTHER); IPR027640 (PANTHER); IPR019821 (PROSITE_PATTERNS); IPR001752 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
gi|953887188|ref|XP_014591542.1|	probable inactive glycosyltransferase 25 family member 3 isoform X1	600	20	0E0	96.95%	2	P:GO:0007155; F:GO:0016740	P:cell adhesion; F:transferase activity		PF13704 (PFAM); IPR002654 (PFAM); PTHR10730 (PANTHER); PTHR10730:SF9 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR029044 (SUPERFAMILY)
gi|953887340|ref|XP_014591585.1|	probable helicase senataxin isoform X1	2680	20	0E0	90.65%	1	P:GO:0006302	P:double-strand break repair		IPR027417 (G3DSA:3.40.50.GENE3D); PF13086 (PFAM); PF13087 (PFAM); PTHR10887 (PANTHER); IPR026121 (PTHR10887:PANTHER); IPR027417 (SUPERFAMILY)
gi|953887611|ref|XP_014591677.1|	coiled-coil domain-containing 180	1355	20	0E0	79.35%	1	C:GO:0016020	C:membrane		IPR028089 (PFAM); PTHR21444 (PANTHER); IPR026701 (PTHR21444:PANTHER)
gi|953887613|ref|XP_005606055.2|	acidic leucine-rich nuclear phospho 32 family member B	554	20	0E0	96.9%	1	F:GO:0005515	F:protein binding		IPR003603 (SMART); PF14580 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR11375 (PANTHER); PTHR11375:SF2 (PANTHER); IPR001611 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY)
gi|953887648|ref|XP_014591690.1|	transmembrane 245	889	20	0E0	91.8%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		IPR002549 (PFAM); PTHR21716:SF4 (PANTHER); IPR002549 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS)
gi|953887670|ref|XP_014591698.1|	complement C5	1630	20	0E0	90.1%	5	P:GO:0006956; C:GO:0005615; P:GO:0006954; F:GO:0004866; F:GO:0005515	P:complement activation; C:extracellular space; P:inflammatory response; F:endopeptidase inhibitor activity; F:protein binding		IPR001840 (PRINTS); IPR009048 (SMART); IPR001599 (SMART); IPR011625 (SMART); IPR000020 (SMART); IPR018933 (SMART); IPR008930 (G3DSA:1.50.10.GENE3D); IPR011625 (PFAM); IPR009048 (PFAM); IPR011626 (PFAM); IPR018081 (G3DSA:1.20.91.GENE3D); IPR009048 (G3DSA:2.60.40.GENE3D); G3DSA:2.40.50.120 (GENE3D); IPR000020 (PFAM); IPR001599 (PFAM); IPR018933 (PFAM); PTHR11412 (PANTHER); PTHR11412:SF83 (PANTHER); IPR000020 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR001134 (PROSITE_PROFILES); IPR000020 (PROSITE_PROFILES); IPR008930 (SUPERFAMILY); IPR008993 (SUPERFAMILY); IPR018081 (SUPERFAMILY); IPR009048 (SUPERFAMILY)
gi|953887701|ref|XP_001500962.4|	olfactory receptor 1L6-like	309	20	0E0	94.2%	5	F:GO:0004930; P:GO:0007187; P:GO:0007608; C:GO:0016021; F:GO:0004984	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:sensory perception of smell; C:integral component of membrane; F:olfactory receptor activity		IPR000725 (PRINTS); IPR000276 (PRINTS); G3DSA:1.20.1070.10 (GENE3D); PF13853 (PFAM); PTHR26451:SF102 (PANTHER); PTHR26451 (PANTHER); IPR000276 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR017452 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY)
gi|953887703|ref|XP_014591709.1|	olfactory receptor 5C1	320	20	0E0	94.15%	5	F:GO:0004930; P:GO:0007187; P:GO:0007608; C:GO:0016021; F:GO:0004984	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:sensory perception of smell; C:integral component of membrane; F:olfactory receptor activity		IPR000725 (PRINTS); IPR000276 (PRINTS); PF13853 (PFAM); G3DSA:1.20.1070.10 (GENE3D); PTHR26452:SF119 (PANTHER); PTHR26452 (PANTHER); IPR000276 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR017452 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY)
gi|953887748|ref|XP_014591726.1|	nuclear pore complex Nup214 isoform X1	2186	20	0E0	89.95%	1	F:GO:0005515	F:protein binding		IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR23193 (PANTHER); PTHR23193:SF21 (PANTHER); SSF117289 (SUPERFAMILY)
gi|953887772|ref|XP_014591733.1|		2118				4	C:GO:0005813; P:GO:0034453; C:GO:0045298; F:GO:0008017	C:centrosome; P:microtubule anchoring; C:tubulin complex; F:microtubule binding		IPR028750 (PANTHER); PTHR13958:SF5 (PANTHER)
gi|953887996|ref|XP_014591805.1|	coxsackievirus and adenovirus receptor isoform X1	243	20	2.28E-178	95.55%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR12231 (PANTHER); PTHR12231:SF146 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|953888114|ref|XP_014591833.1|	SON isoform X1	2459	20	0E0	93.5%	12	F:GO:0003676; F:GO:0003723; C:GO:0016607; P:GO:0043484; P:GO:0043066; P:GO:0000910; P:GO:0006397; P:GO:0051726; P:GO:0000226; F:GO:0050733; C:GO:0005654; F:GO:0044822	F:nucleic acid binding; F:RNA binding; C:nuclear speck; P:regulation of RNA splicing; P:negative regulation of apoptotic process; P:cytokinesis; P:mRNA processing; P:regulation of cell cycle; P:microtubule cytoskeleton organization; F:RS domain binding; C:nucleoplasm; F:poly(A) RNA binding		
gi|953888300|ref|XP_014591897.1|	ribosomal RNA processing 1 homolog A	459	20	0E0	92.9%	2	P:GO:0006364; C:GO:0030688	P:rRNA processing; C:preribosome, small subunit precursor		IPR010301 (PFAM); IPR010301 (PANTHER); PTHR13026:SF1 (PANTHER)
gi|953888450|ref|XP_014591951.1|	dopey-2 isoform X2	2276	20	0E0	94.25%	10	C:GO:0070062; P:GO:0050890; P:GO:0007275; P:GO:0015031; C:GO:0005829; C:GO:0000139; P:GO:0007029; P:GO:0006810; P:GO:0006895; F:GO:0003674	C:extracellular exosome; P:cognition; P:multicellular organism development; P:protein transport; C:cytosol; C:Golgi membrane; P:endoplasmic reticulum organization; P:transport; P:Golgi to endosome transport; F:molecular_function		IPR007249 (PFAM); PTHR14042:SF23 (PANTHER); PTHR14042 (PANTHER)
gi|953888457|ref|XP_014591953.1|	biotin-- ligase	980	20	0E0	90.35%	3	P:GO:0006768; P:GO:0006464; F:GO:0004077	P:biotin metabolic process; P:cellular protein modification process; F:biotin-[acetyl-CoA-carboxylase] ligase activity	EC:6.3.4.15; EC:6.3.4	IPR019197 (PFAM); G3DSA:3.30.930.10 (GENE3D); IPR004408 (TIGRFAM); IPR003142 (PFAM); IPR004143 (PFAM); PTHR12835:SF9 (PANTHER); IPR004408 (PANTHER); IPR004143 (PROSITE_PROFILES); SSF55681 (SUPERFAMILY)
gi|953888460|ref|XP_014591954.1|	Down syndrome cell adhesion molecule	1854	20	0E0	99.1%	4	C:GO:0005887; F:GO:0005515; P:GO:0007399; P:GO:0007155	C:integral component of plasma membrane; F:protein binding; P:nervous system development; P:cell adhesion		IPR003599 (SMART); IPR013106 (SMART); IPR003961 (SMART); IPR003598 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003961 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PF13927 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR033027 (PTHR10489:PANTHER); PTHR10489 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|953888474|ref|XP_014591962.1|	DNA (cytosine-5)-methyltransferase 3-like	493	20	0E0	79.55%	3	P:GO:0006306; F:GO:0030234; F:GO:0019899	P:DNA methylation; F:enzyme regulator activity; F:enzyme binding		IPR013083 (G3DSA:3.30.40.GENE3D); IPR030486 (PTHR23068:PANTHER); PTHR23068 (PANTHER); IPR025766 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY)
gi|953888476|ref|XP_014591963.1|	autoimmune regulator	486	20	0E0	84.65%	8	C:GO:0005634; F:GO:0003677; F:GO:0008270; F:GO:0045182; F:GO:0005515; C:GO:0005737; P:GO:0006959; P:GO:0006417	C:nucleus; F:DNA binding; F:zinc ion binding; F:translation regulator activity; F:protein binding; C:cytoplasm; P:humoral immune response; P:regulation of translation		IPR008087 (PRINTS); IPR001965 (SMART); IPR000770 (SMART); IPR010919 (G3DSA:3.10.390.GENE3D); IPR004865 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR019787 (PFAM); IPR000770 (PFAM); PTHR24102 (PANTHER); PTHR24102:SF15 (PANTHER); IPR019786 (PROSITE_PATTERNS); IPR004865 (PROSITE_PROFILES); IPR000770 (PROSITE_PROFILES); IPR019787 (PROSITE_PROFILES); IPR010919 (SUPERFAMILY); IPR011011 (SUPERFAMILY)
gi|953888530|ref|XP_014591982.1|	trefoil factor 1	81	20	7.36E-52	79.9%	12	P:GO:0005975; F:GO:0008083; C:GO:0005615; F:GO:0005515; P:GO:0008285; P:GO:0030154; P:GO:0010039; P:GO:0007586; P:GO:0030277; P:GO:0035902; C:GO:0005576; P:GO:0043434	P:carbohydrate metabolic process; F:growth factor activity; C:extracellular space; F:protein binding; P:negative regulation of cell proliferation; P:cell differentiation; P:response to iron ion; P:digestion; P:maintenance of gastrointestinal epithelium; P:response to immobilization stress; C:extracellular region; P:response to peptide hormone		IPR017994 (PRINTS); IPR000519 (SMART); IPR000519 (G3DSA:4.10.110.GENE3D); IPR000519 (PFAM); PTHR13826 (PANTHER); IPR017957 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR000519 (PROSITE_PROFILES); IPR000519 (SUPERFAMILY)
gi|953888611|ref|XP_005606332.2|	DNA polymerase beta	181	20	2.02E-133	98.25%	5	F:GO:0003677; P:GO:0006281; F:GO:0003887; P:GO:0006260; C:GO:0042575	F:DNA binding; P:DNA repair; F:DNA-directed DNA polymerase activity; P:DNA replication; C:DNA polymerase complex	EC:2.7.7.7	IPR022312 (PRINTS); IPR002008 (PRINTS); IPR002054 (SMART); IPR029398 (G3DSA:3.30.210.GENE3D); IPR028207 (PFAM); IPR029398 (PFAM); G3DSA:3.30.460.10 (GENE3D); PTHR11276:SF26 (PANTHER); PTHR11276 (PANTHER); IPR019843 (PROSITE_PATTERNS); SSF81301 (SUPERFAMILY)
gi|953889015|ref|XP_014592133.1|	WD repeat-containing 17 isoform X1	1316	20	0E0	97%	1	F:GO:0005515	F:protein binding		IPR020472 (PRINTS); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); IPR024977 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22847 (PANTHER); PTHR22847:SF355 (PANTHER); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR011047 (SUPERFAMILY); IPR017986 (SUPERFAMILY)
gi|953889061|ref|XP_014592146.1|	rho guanine nucleotide exchange factor 10	1346	20	0E0	93.4%	8	P:GO:0035023; C:GO:0005813; P:GO:0022011; F:GO:0005515; P:GO:0043087; C:GO:0005829; F:GO:0005089; P:GO:0090307	P:regulation of Rho protein signal transduction; C:centrosome; P:myelination in peripheral nervous system; F:protein binding; P:regulation of GTPase activity; C:cytosol; F:Rho guanyl-nucleotide exchange factor activity; P:mitotic spindle assembly		IPR000219 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR000219 (PFAM); IPR000219 (G3DSA:1.20.900.GENE3D); IPR030632 (PTHR12877:PANTHER); PTHR12877 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000219 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR000219 (SUPERFAMILY); IPR017986 (SUPERFAMILY)
gi|953889123|ref|XP_001915660.4|	G- coupled receptor 124	1234	20	0E0	90.7%	18	P:GO:0007186; P:GO:0007165; P:GO:0090210; P:GO:0002040; P:GO:0045765; P:GO:0007166; P:GO:0043542; F:GO:0004871; C:GO:0009986; F:GO:0004930; P:GO:1900747; F:GO:0004888; P:GO:0007417; P:GO:0001525; C:GO:0016020; C:GO:0016021; P:GO:0050920; P:GO:0010595	P:G-protein coupled receptor signaling pathway; P:signal transduction; P:regulation of establishment of blood-brain barrier; P:sprouting angiogenesis; P:regulation of angiogenesis; P:cell surface receptor signaling pathway; P:endothelial cell migration; F:signal transducer activity; C:cell surface; F:G-protein coupled receptor activity; P:negative regulation of vascular endothelial growth factor signaling pathway; F:transmembrane signaling receptor activity; P:central nervous system development; P:angiogenesis; C:membrane; C:integral component of membrane; P:regulation of chemotaxis; P:positive regulation of endothelial cell migration		
gi|953889143|ref|XP_014592179.1|	rho GTPase-activating 7-like	476	20	0E0	92.3%	9	P:GO:0035023; C:GO:0005925; C:GO:0005737; P:GO:0007165; F:GO:0005096; C:GO:0016020; C:GO:0030054; F:GO:0008289; P:GO:0043547	P:regulation of Rho protein signal transduction; C:focal adhesion; C:cytoplasm; P:signal transduction; F:GTPase activator activity; C:membrane; C:cell junction; F:lipid binding; P:positive regulation of GTPase activity		PTHR12659 (PANTHER)
gi|953889165|ref|XP_014592191.1|	CUB and sushi domain-containing 1	3285	20	0E0	97.25%	4	P:GO:0001964; C:GO:0016020; P:GO:0042593; C:GO:0016021	P:startle response; C:membrane; P:glucose homeostasis; C:integral component of membrane		IPR000436 (SMART); IPR000859 (SMART); IPR000859 (PFAM); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); IPR000859 (G3DSA:2.60.120.GENE3D); IPR000436 (PFAM); G3DSA:2.10.70.10 (GENE3D); IPR000859 (G3DSA:2.60.120.GENE3D); IPR000859 (G3DSA:2.60.120.GENE3D); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); PTHR19325 (PANTHER); PTHR19325:SF350 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR000859 (PROSITE_PROFILES); IPR000436 (PROSITE_PROFILES); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000436 (SUPERFAMILY)
gi|953889236|ref|XP_014592208.1|	calcyphosin-2 isoform X2	556	20	0E0	90.85%	1	F:GO:0005509	F:calcium ion binding		IPR011992 (G3DSA:1.10.238.GENE3D); PTHR10891:SF561 (PANTHER); PTHR10891 (PANTHER); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
gi|953889277|ref|XP_014592219.1|	neuron navigator 3 isoform X2	1696	20	0E0	97.95%	1	F:GO:0005524	F:ATP binding		IPR003593 (SMART); IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR12784 (PANTHER); PTHR12784:SF18 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|953889454|ref|XP_014592264.1|	host cell factor 2	515	20	0E0	97.45%	4	C:GO:0005634; C:GO:0005737; C:GO:0005886; C:GO:0005654	C:nucleus; C:cytoplasm; C:plasma membrane; C:nucleoplasm		
gi|953889491|ref|XP_014592274.1|	ankyrin repeat and BTB POZ domain-containing BTBD11 isoform X1	1097	20	0E0	95.85%	1	F:GO:0046982	F:protein heterodimerization activity		IPR002110 (SMART); IPR000210 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR009072 (G3DSA:1.10.20.GENE3D); IPR009072 (G3DSA:1.10.20.GENE3D); IPR020683 (PFAM); IPR002110 (PFAM); IPR000210 (PFAM); G3DSA:3.30.710.10 (GENE3D); PTHR24413:SF76 (PANTHER); PTHR24413 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000210 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR009072 (SUPERFAMILY); IPR009072 (SUPERFAMILY); IPR011333 (SUPERFAMILY); IPR020683 (SUPERFAMILY)
gi|953889883|ref|XP_014592385.1|	stabilin-2	2591	20	0E0	90.4%	4	F:GO:0005515; F:GO:0005509; P:GO:0007155; F:GO:0005540	F:protein binding; F:calcium ion binding; P:cell adhesion; F:hyaluronic acid binding		IPR001881 (SMART); IPR000782 (SMART); IPR000742 (SMART); IPR000538 (SMART); IPR016186 (G3DSA:3.10.100.GENE3D); IPR000782 (PFAM); IPR000782 (G3DSA:2.30.180.GENE3D); IPR000782 (G3DSA:2.30.180.GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR000782 (G3DSA:2.30.180.GENE3D); IPR023413 (G3DSA:2.40.155.GENE3D); IPR000538 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR024731 (PFAM); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.170.300.10 (GENE3D); PTHR24038:SF0 (PANTHER); PTHR24038 (PANTHER); IPR013032 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR000538 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000538 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000782 (PROSITE_PROFILES); IPR000782 (SUPERFAMILY); IPR016187 (SUPERFAMILY); IPR000782 (SUPERFAMILY); IPR000782 (SUPERFAMILY); IPR000782 (SUPERFAMILY); IPR000782 (SUPERFAMILY); IPR000782 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR000782 (SUPERFAMILY); SSF57196 (SUPERFAMILY)
gi|953889929|ref|XP_014592401.1|	voltage-dependent T-type calcium channel subunit alpha-1I	2000	20	0E0	90.2%	6	P:GO:0070509; P:GO:0030317; C:GO:0005891; P:GO:0070588; F:GO:0008332; P:GO:0019228	P:calcium ion import; P:flagellated sperm motility; C:voltage-gated calcium channel complex; P:calcium ion transmembrane transport; F:low voltage-gated calcium channel activity; P:neuronal action potential		IPR005445 (PRINTS); IPR002077 (PRINTS); IPR005821 (PFAM); IPR027359 (G3DSA:1.20.120.GENE3D); PTHR10037 (PANTHER); IPR030162 (PTHR10037:PANTHER); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY)
gi|953890233|ref|XP_001493304.3|	kinesin-1 heavy chain	952	20	0E0	99.1%	6	F:GO:0005524; F:GO:0003777; C:GO:0045298; P:GO:0007018; F:GO:0008017; C:GO:0005874	F:ATP binding; F:microtubule motor activity; C:tubulin complex; P:microtubule-based movement; F:microtubule binding; C:microtubule	EC:3.6.1; EC:3.6.1.15	IPR001752 (PRINTS); IPR001752 (SMART); IPR001752 (PFAM); IPR001752 (G3DSA:3.40.850.GENE3D); PTHR24115:SF513 (PANTHER); IPR027640 (PANTHER); IPR019821 (PROSITE_PATTERNS); IPR001752 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
gi|953890311|ref|XP_001915880.3|	amyloid beta A4 precursor -binding family B member 1-interacting	658	20	0E0	88.1%	1	P:GO:0007165	P:signal transduction		IPR001849 (SMART); IPR000159 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); G3DSA:3.10.20.90 (GENE3D); IPR001849 (PFAM); IPR000159 (PFAM); PTHR11243:SF14 (PANTHER); PTHR11243 (PANTHER); IPR001849 (PROSITE_PROFILES); IPR000159 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR029071 (SUPERFAMILY)
gi|953890490|ref|XP_014592572.1|	enoyl- hydratase domain-containing mitochondrial	227	20	8.12E-167	95.8%	2	F:GO:0003824; P:GO:0008152	F:catalytic activity; P:metabolic process		IPR029045 (G3DSA:3.90.226.GENE3D); IPR001753 (PFAM); PTHR11941:SF28 (PANTHER); PTHR11941 (PANTHER); IPR029045 (SUPERFAMILY)
gi|953890667|ref|XP_014592629.1|	cubilin	3577	20	0E0	91.55%	6	F:GO:0005515; P:GO:0007165; F:GO:0005509; C:GO:0016020; F:GO:0004872; P:GO:0006898	F:protein binding; P:signal transduction; F:calcium ion binding; C:membrane; F:receptor activity; P:receptor-mediated endocytosis		IPR001881 (SMART); IPR000859 (SMART); IPR000742 (SMART); IPR000859 (G3DSA:2.60.120.GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR024731 (PFAM); IPR000859 (G3DSA:2.60.120.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR000859 (G3DSA:2.60.120.GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR000859 (G3DSA:2.60.120.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR001881 (PFAM); IPR000859 (PFAM); IPR000742 (PFAM); IPR028876 (PTHR10127:PANTHER); PTHR10127 (PANTHER); IPR013032 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR000742 (PROSITE_PROFILES); IPR000859 (PROSITE_PROFILES); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY)
gi|953890942|ref|XP_014593543.1|	TATA box-binding -associated factor RNA polymerase I subunit A isoform X1	445	20	0E0	91.6%	5	C:GO:0005634; C:GO:0015630; C:GO:0000120; C:GO:0043231; P:GO:0006360	C:nucleus; C:microtubule cytoskeleton; C:RNA polymerase I transcription factor complex; C:intracellular membrane-bounded organelle; P:transcription from RNA polymerase I promoter		PF14929 (PFAM); PTHR32122:SF1 (PANTHER); PTHR32122 (PANTHER)
gi|953891116|ref|XP_005608127.2|	lysine-specific demethylase 5B isoform X2	1489	20	0E0	98.4%	5	F:GO:0003677; F:GO:0008270; F:GO:0005515; F:GO:0016706; P:GO:0055114	F:DNA binding; F:zinc ion binding; F:protein binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; P:oxidation-reduction process	EC:1.14.11	IPR003347 (SMART); IPR001965 (SMART); IPR001606 (SMART); SM01014 (SMART); IPR013637 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001606 (G3DSA:1.10.150.GENE3D); IPR003347 (PFAM); IPR001606 (PFAM); IPR019787 (PFAM); IPR004198 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR10694 (PANTHER); PTHR10694:SF3 (PANTHER); IPR019786 (PROSITE_PATTERNS); IPR001606 (PROSITE_PROFILES); IPR019787 (PROSITE_PROFILES); IPR003347 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY); IPR011011 (SUPERFAMILY); SSF51197 (SUPERFAMILY); IPR011011 (SUPERFAMILY); IPR001606 (SUPERFAMILY)
gi|953891124|ref|XP_014593598.1|	alpha-1,3-mannosyl-glyco 4-beta-N-acetylglucosaminyltransferase C-like isoform X1	466	20	0E0	90.3%	3	P:GO:0005975; F:GO:0016758; C:GO:0016020	P:carbohydrate metabolic process; F:transferase activity, transferring hexosyl groups; C:membrane		IPR006759 (PFAM); IPR006759 (PANTHER); PTHR12062:SF11 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS)
gi|953891156|ref|XP_014593608.1|	kinesin KIF21B	1619	20	0E0	97.55%	6	F:GO:0005524; F:GO:0003777; C:GO:0045298; P:GO:0007018; F:GO:0008017; C:GO:0005874	F:ATP binding; F:microtubule motor activity; C:tubulin complex; P:microtubule-based movement; F:microtubule binding; C:microtubule	EC:3.6.1; EC:3.6.1.15	IPR001752 (PRINTS); IPR001680 (SMART); IPR001752 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); IPR001752 (PFAM); IPR001752 (G3DSA:3.40.850.GENE3D); IPR027640 (PANTHER); PTHR24115:SF335 (PANTHER); IPR019821 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR001752 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR009053 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
gi|953891234|ref|XP_014593629.1|	poly(A)-specific ribonuclease PARN-like domain-containing 1	467	20	0E0	96.65%	4	F:GO:0003676; F:GO:0004535; P:GO:0051252; P:GO:0000289	F:nucleic acid binding; F:poly(A)-specific ribonuclease activity; P:regulation of RNA metabolic process; P:nuclear-transcribed mRNA poly(A) tail shortening	EC:3.1; EC:3.1.13; EC:3.1.15; EC:3.1.13.4	IPR006941 (PFAM); IPR012337 (G3DSA:3.30.420.GENE3D); PTHR15092 (PANTHER); PTHR15092:SF29 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR012337 (SUPERFAMILY)
gi|953891338|ref|XP_014593655.1|	sorting nexin-9	660	20	0E0	97.55%	5	F:GO:0005515; P:GO:0000281; F:GO:0035091; P:GO:0006886; P:GO:0006897	F:protein binding; P:mitotic cytokinesis; F:phosphatidylinositol binding; P:intracellular protein transport; P:endocytosis		IPR001683 (SMART); IPR001452 (SMART); IPR001683 (G3DSA:3.30.1520.GENE3D); G3DSA:2.30.30.40 (GENE3D); IPR019497 (PFAM); IPR001683 (PFAM); IPR001452 (PFAM); IPR028644 (PTHR10555:PANTHER); PTHR10555 (PANTHER); IPR001683 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY); IPR001683 (SUPERFAMILY); SSF103657 (SUPERFAMILY)
gi|953891552|ref|XP_014593720.1|	syntaxin-binding 5 isoform X1	1179	20	0E0	98.15%	3	F:GO:0005515; P:GO:0016192; C:GO:0016021	F:protein binding; P:vesicle-mediated transport; C:integral component of membrane		IPR000664 (PRINTS); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR013577 (PFAM); IPR013905 (PFAM); IPR001680 (PFAM); G3DSA:1.20.5.110 (GENE3D); PTHR10241 (PANTHER); PTHR10241:SF22 (PANTHER); IPR019775 (PROSITE_PATTERNS); IPR017986 (PROSITE_PROFILES); IPR001388 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); SSF58038 (SUPERFAMILY); IPR017986 (SUPERFAMILY); IPR017986 (SUPERFAMILY)
gi|953891554|ref|XP_014593721.1|	androglobin	1562	20	0E0	91.3%	6	F:GO:0019825; F:GO:0005515; P:GO:0006508; F:GO:0004198; C:GO:0005622; F:GO:0020037	F:oxygen binding; F:protein binding; P:proteolysis; F:calcium-dependent cysteine-type endopeptidase activity; C:intracellular; F:heme binding	EC:3.4.22; EC:3.4	IPR001300 (PFAM); IPR012292 (G3DSA:1.10.490.GENE3D); PTHR10183:SF304 (PANTHER); PTHR10183 (PANTHER); IPR001300 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY)
gi|953891556|ref|XP_014593722.1|	E3 ubiquitin- ligase SHPRH isoform X1	1724	20	0E0	90.25%	7	C:GO:0005634; F:GO:0003677; F:GO:0005524; F:GO:0008270; F:GO:0005515; C:GO:0000786; P:GO:0006334	C:nucleus; F:DNA binding; F:ATP binding; F:zinc ion binding; F:protein binding; C:nucleosome; P:nucleosome assembly		IPR001965 (SMART); IPR005818 (SMART); IPR001650 (SMART); IPR014001 (SMART); IPR001841 (SMART); IPR011991 (G3DSA:1.10.10.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR000330 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR005818 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10799 (PANTHER); PTHR10799:SF552 (PANTHER); IPR017907 (PROSITE_PATTERNS); IPR019786 (PROSITE_PATTERNS); IPR001841 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR005818 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF57850 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011011 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011991 (SUPERFAMILY)
gi|953891633|ref|XP_014584236.1|	odorant-binding -like	195	20	2.36E-143	69.95%	3	F:GO:0005549; P:GO:0006810; F:GO:0005215	F:odorant binding; P:transport; F:transporter activity		IPR002448 (PRINTS); IPR000566 (PFAM); IPR012674 (G3DSA:2.40.128.GENE3D); PTHR11430 (PANTHER); PTHR11430:SF75 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR011038 (SUPERFAMILY)
gi|953892040|ref|XP_014584339.1|	zinc finger BED domain-containing 1	744	20	0E0	94.05%	2	F:GO:0003677; F:GO:0046983	F:DNA binding; F:protein dimerization activity		IPR003656 (SMART); IPR008906 (PFAM); IPR003656 (PFAM); PTHR23272:SF35 (PANTHER); PTHR23272 (PANTHER); IPR003656 (PROSITE_PROFILES); SSF140996 (SUPERFAMILY); IPR012337 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
gi|953892046|ref|XP_014584342.1|	cAMP-dependent kinase catalytic subunit PRKX	338	20	0E0	96.6%	4	F:GO:0005524; P:GO:0009069; F:GO:0004674; P:GO:0006468	F:ATP binding; P:serine family amino acid metabolic process; F:protein serine/threonine kinase activity; P:protein phosphorylation	EC:2.7.11	IPR000719 (SMART); IPR000961 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); PTHR24353 (PANTHER); IPR008271 (PROSITE_PATTERNS); IPR000961 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)
gi|953892083|ref|XP_014584358.1|	dystrophin isoform X5	3703	20	0E0	96.2%	6	F:GO:0008270; C:GO:0005856; F:GO:0003779; F:GO:0002162; F:GO:0005200; P:GO:0016203	F:zinc ion binding; C:cytoskeleton; F:actin binding; F:dystroglycan binding; F:structural constituent of cytoskeleton; P:muscle attachment		IPR016344 (PIRSF); IPR001715 (SMART); IPR001202 (SMART); IPR000433 (SMART); IPR018159 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR000433 (PFAM); IPR001202 (PFAM); G3DSA:2.20.70.10 (GENE3D); IPR001715 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); IPR015153 (PFAM); G3DSA:1.20.58.60 (GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR015154 (PFAM); IPR002017 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR11915 (PANTHER); PTHR11915:SF261 (PANTHER); IPR000433 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); IPR001202 (PROSITE_PATTERNS); IPR001715 (PROSITE_PROFILES); IPR001202 (PROSITE_PROFILES); IPR000433 (PROSITE_PROFILES); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001715 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR011992 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001202 (SUPERFAMILY); SSF57850 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR011992 (SUPERFAMILY)
gi|953892085|ref|XP_014584359.1|		3504				1	F:GO:0005515	F:protein binding		IPR001715 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); PTHR23053 (PANTHER); IPR001715 (PROSITE_PROFILES); IPR001715 (SUPERFAMILY)
gi|953892111|ref|XP_014584371.1|	histone-lysine N-methyltransferase SUV39H1	385	20	0E0	99.2%	6	C:GO:0005634; F:GO:0008270; F:GO:0005515; P:GO:0034968; F:GO:0018024; P:GO:0006554	C:nucleus; F:zinc ion binding; F:protein binding; P:histone lysine methylation; F:histone-lysine N-methyltransferase activity; P:lysine catabolic process	EC:2.1.1.43; EC:2.1.1	IPR011381 (PIRSF); IPR000953 (SMART); IPR007728 (SMART); IPR001214 (SMART); IPR023780 (PFAM); IPR007728 (PFAM); G3DSA:2.170.270.10 (GENE3D); G3DSA:2.40.50.40 (GENE3D); IPR001214 (PFAM); PTHR22884 (PANTHER); PTHR22884:SF316 (PANTHER); IPR023779 (PROSITE_PATTERNS); IPR011381 (PROSITE_PROFILES); IPR000953 (PROSITE_PROFILES); IPR001214 (PROSITE_PROFILES); IPR007728 (PROSITE_PROFILES); IPR016197 (SUPERFAMILY); SSF82199 (SUPERFAMILY)
gi|953892389|ref|XP_014584461.1|	testis-expressed sequence 11	907	20	0E0	90.5%	2	P:GO:0051321; F:GO:0005515	P:meiotic cell cycle; F:protein binding		IPR013940 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR22904 (PANTHER); PTHR22904:SF386 (PANTHER); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY)
gi|953892683|ref|XP_014584542.1|	armadillo repeat-containing X-linked 5	572	20	0E0	90%	1	F:GO:0005488	F:binding		IPR006911 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR15712 (PANTHER); PTHR15712:SF12 (PANTHER); IPR016024 (SUPERFAMILY)
gi|953892724|ref|XP_014584548.1|	nik-related kinase isoform X2	1519	20	0E0	92.9%	3	F:GO:0005524; F:GO:0004672; P:GO:0006468	F:ATP binding; F:protein kinase activity; P:protein phosphorylation		IPR001180 (SMART); IPR000719 (SMART); IPR001180 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24361:SF417 (PANTHER); PTHR24361 (PANTHER); IPR008271 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); IPR001180 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)
gi|953892846|ref|XP_014584590.1|	G- coupled receptor-associated sorting 1	1250	20	0E0	74.5%	3	C:GO:0005737; P:GO:0008333; P:GO:1990172	C:cytoplasm; P:endosome to lysosome transport; P:G-protein coupled receptor catabolic process		
gi|953892972|ref|XP_014584631.1|	lysosome-associated membrane glyco 2 isoform X1	468	20	0E0	93.8%	17	P:GO:0061684; F:GO:0019904; P:GO:0046716; C:GO:0005770; C:GO:0061742; C:GO:0005765; C:GO:0005764; C:GO:0031902; C:GO:0005615; P:GO:0031647; C:GO:0070062; C:GO:0016020; C:GO:0016021; C:GO:0030670; C:GO:0031088; P:GO:0050821; F:GO:0019899	P:chaperone-mediated autophagy; F:protein domain specific binding; P:muscle cell cellular homeostasis; C:late endosome; C:chaperone-mediated autophagy translocation complex; C:lysosomal membrane; C:lysosome; C:late endosome membrane; C:extracellular space; P:regulation of protein stability; C:extracellular exosome; C:membrane; C:integral component of membrane; C:phagocytic vesicle membrane; C:platelet dense granule membrane; P:protein stabilization; F:enzyme binding		
gi|953892975|ref|XP_014584632.1|	lysosome-associated membrane glyco 2 isoform X2	417	20	0E0	93.6%	1	C:GO:0016020	C:membrane		IPR002000 (PRINTS); IPR002000 (PFAM); PTHR11506:SF6 (PANTHER); IPR002000 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR002000 (PROSITE_PROFILES)
gi|953893019|ref|XP_014584648.1|	teneurin-1 isoform X1	2504	20	0E0	97.25%	16	P:GO:0043406; F:GO:0042803; P:GO:0007165; P:GO:0051491; C:GO:0005576; P:GO:0006359; C:GO:0005886; C:GO:0005634; C:GO:0005887; C:GO:0048471; C:GO:0005737; F:GO:0046982; P:GO:0030838; C:GO:0016020; C:GO:0016021; P:GO:0033138	P:positive regulation of MAP kinase activity; F:protein homodimerization activity; P:signal transduction; P:positive regulation of filopodium assembly; C:extracellular region; P:regulation of transcription from RNA polymerase III promoter; C:plasma membrane; C:nucleus; C:integral component of plasma membrane; C:perinuclear region of cytoplasm; C:cytoplasm; F:protein heterodimerization activity; P:positive regulation of actin filament polymerization; C:membrane; C:integral component of membrane; P:positive regulation of peptidyl-serine phosphorylation		
gi|953893175|ref|XP_014584699.1|	dedicator of cytokinesis 11 isoform X1	2113	20	0E0	98.1%	6	P:GO:0007264; F:GO:0005085; F:GO:0005089; F:GO:0017048; P:GO:0043547; C:GO:0005622	P:small GTPase mediated signal transduction; F:guanyl-nucleotide exchange factor activity; F:Rho guanyl-nucleotide exchange factor activity; F:Rho GTPase binding; P:positive regulation of GTPase activity; C:intracellular		
gi|953893359|ref|XP_014584755.1|	paraneoplastic antigen 5	444	20	0E0	86.6%	1	F:GO:0042802	F:identical protein binding		IPR026523 (PFAM); IPR026523 (PANTHER); IPR026527 (PTHR23095:PANTHER)
gi|953893589|ref|XP_014584032.1|	spermatogenesis-associated 31D1-like	274	20	0E0	73.35%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		PTHR21859 (PANTHER)
gi|953893906|ref|XP_014584140.1|	zinc finger C3H1 domain-containing	1596	20	0E0	98.3%	2	F:GO:0005515; P:GO:0006396	F:protein binding; P:RNA processing		IPR003107 (SMART); IPR019607 (PFAM); G3DSA:1.25.40.120 (GENE3D); PTHR21563 (PANTHER); IPR013026 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY)
gi|953893917|ref|XP_005613926.2|	receptor-type tyrosine- phosphatase beta isoform X1	2215	20	0E0	93.6%	4	F:GO:0005515; P:GO:0006570; F:GO:0004725; P:GO:0006470	F:protein binding; P:tyrosine metabolic process; F:protein tyrosine phosphatase activity; P:protein dephosphorylation	EC:3.1.3.16; EC:3.1; EC:3.1.3.48; EC:3.1.3.41	IPR000242 (PRINTS); IPR003595 (SMART); IPR000242 (SMART); IPR003961 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR000242 (PFAM); G3DSA:2.80.10.50 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR029021 (G3DSA:3.90.190.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003961 (PFAM); PTHR19134 (PANTHER); PTHR19134:SF288 (PANTHER); IPR016130 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR000772 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR029021 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR000772 (SUPERFAMILY); IPR003961 (SUPERFAMILY)
gi|953894031|ref|XP_014584198.1|	liprin-alpha-1 isoform X1	1356	20	0E0	96.55%	1	F:GO:0005515	F:protein binding		IPR001660 (SMART); IPR013761 (G3DSA:1.10.150.GENE3D); IPR001660 (PFAM); IPR001660 (PFAM); IPR029515 (PANTHER); IPR030438 (PTHR12587:PANTHER); IPR001660 (PROSITE_PROFILES); IPR013761 (SUPERFAMILY); IPR013761 (SUPERFAMILY); IPR013761 (SUPERFAMILY)
gi|953894050|ref|XP_014584206.1|	Ig heavy chain Mem5-like	374	20	0E0	71.45%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|953894081|ref|XP_014584216.1|	WD repeat-containing 60	1110	20	0E0	89.05%	1	F:GO:0005515	F:protein binding		IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR12442 (PANTHER); PTHR12442:SF30 (PANTHER); IPR017986 (SUPERFAMILY)
gi|953894124|ref|XP_014583740.1|	olfactory receptor 11L1-like	323	20	0E0	91.2%	5	F:GO:0004930; P:GO:0007187; P:GO:0007608; C:GO:0016021; F:GO:0004984	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:sensory perception of smell; C:integral component of membrane; F:olfactory receptor activity		IPR000725 (PRINTS); IPR000276 (PRINTS); G3DSA:1.20.1070.10 (GENE3D); PF13853 (PFAM); PTHR26452:SF295 (PANTHER); PTHR26452 (PANTHER); IPR000276 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR017452 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY)
gi|953894742|ref|XP_014583989.1|	SHC-transforming 2	406	20	0E0	82%	2	P:GO:0000187; F:GO:0030971	P:activation of MAPK activity; F:receptor tyrosine kinase binding		IPR006019 (PRINTS); IPR000980 (PRINTS); IPR000980 (SMART); IPR006020 (SMART); IPR000980 (PFAM); IPR006020 (PFAM); IPR000980 (G3DSA:3.30.505.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR029591 (PTHR10337:PANTHER); PTHR10337 (PANTHER); IPR000980 (PROSITE_PROFILES); IPR006020 (PROSITE_PROFILES); IPR000980 (SUPERFAMILY); IPR011993 (SUPERFAMILY)
gi|953894956|ref|XP_005613789.2|	V-set and immunoglobulin domain-containing IGHV4OR15-8	240	20	1.98E-176	81.9%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
gi|1008835988|gb|AMR08099.1|	immunoglobulin lambda light chain variable partial	121	20	1.13E-81	92.5%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF198 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|1008836010|gb|AMR08110.1|	immunoglobulin lambda light chain variable partial	122	20	1.91E-81	93.7%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF198 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|1008836026|gb|AMR08118.1|	immunoglobulin lambda light chain variable partial	121	20	6.04E-82	88.8%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|1008836032|gb|AMR08121.1|	immunoglobulin lambda light chain variable partial	120	20	2.29E-81	93.35%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF198 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|1008836100|gb|AMR08155.1|	immunoglobulin lambda light chain variable partial	119	20	2.1E-81	91.45%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF174 (PANTHER); PTHR23267 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|1008836114|gb|AMR08162.1|	immunoglobulin lambda light chain variable partial	121	20	1.9E-80	87.3%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|1008836118|gb|AMR08164.1|	immunoglobulin lambda light chain variable partial	123	20	6.84E-83	91.7%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|1008836128|gb|AMR08169.1|	immunoglobulin lambda light chain variable partial	123	20	8.62E-83	90.4%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|1008836146|gb|AMR08178.1|	immunoglobulin lambda light chain variable partial	123	20	1.89E-84	86.75%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF138 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|1008836148|gb|AMR08179.1|	immunoglobulin lambda light chain variable partial	122	20	3.15E-82	93.85%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|1008836212|gb|AMR08211.1|	immunoglobulin lambda light chain variable partial	121	20	3.95E-81	91.7%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF198 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|1008836218|gb|AMR08214.1|	immunoglobulin lambda light chain variable partial	121	20	2.04E-82	95.1%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF174 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|1008836226|gb|AMR08218.1|	immunoglobulin lambda light chain variable partial	118	20	2.52E-79	91.3%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF174 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|1008836228|gb|AMR08219.1|	immunoglobulin lambda light chain variable partial	119	20	1.14E-81	91.65%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF174 (PANTHER); PTHR23267 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
gi|1072314140|ref|NP_001333142.1|	type II cuticular Hb2	518	20	0E0	93.7%	2	C:GO:0045095; F:GO:0005198	C:keratin filament; F:structural molecule activity		IPR003054 (PRINTS); IPR001664 (SMART); IPR001664 (PFAM); G3DSA:1.20.5.170 (GENE3D); IPR032444 (PFAM); PTHR23239:SF129 (PANTHER); IPR001664 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
gi|1072314146|ref|NP_001333140.1|	type II component 7C	491	20	0E0	96.2%	2	C:GO:0045095; F:GO:0005198	C:keratin filament; F:structural molecule activity		IPR003054 (PRINTS); IPR001664 (SMART); G3DSA:1.20.5.170 (GENE3D); IPR001664 (PFAM); IPR032444 (PFAM); PTHR23239:SF191 (PANTHER); IPR001664 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
F6W1N4	polymeric immunoglobulin receptor	762	20	0E0	82%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR11860:SF55 (PANTHER); PTHR11860 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F7CPJ5	major allergen Equ c 1-like	188	20	3.48E-134	88.45%	4	F:GO:0005550; F:GO:0036094; P:GO:0006810; F:GO:0005215	F:pheromone binding; F:small molecule binding; P:transport; F:transporter activity		IPR002971 (PRINTS); IPR002345 (PRINTS); IPR012674 (G3DSA:2.40.128.GENE3D); IPR000566 (PFAM); PTHR11430:SF76 (PANTHER); PTHR11430 (PANTHER); IPR022272 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR011038 (SUPERFAMILY)
F6RI47	alpha-2-macroglobulin-like	1477	20	0E0	90.95%	2	C:GO:0005615; F:GO:0004866	C:extracellular space; F:endopeptidase inhibitor activity		IPR009048 (SMART); IPR011625 (SMART); IPR001599 (SMART); IPR009048 (PFAM); IPR011625 (PFAM); IPR011626 (PFAM); IPR001599 (PFAM); IPR019565 (PFAM); IPR002890 (PFAM); IPR009048 (G3DSA:2.60.40.GENE3D); IPR008930 (G3DSA:1.50.10.GENE3D); PTHR11412 (PANTHER); PTHR11412:SF103 (PANTHER); IPR010916 (PROSITE_PATTERNS); IPR019742 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR008930 (SUPERFAMILY); IPR009048 (SUPERFAMILY); IPR014756 (SUPERFAMILY)
P27425	serotransferrin	706	20	0E0	88.55%	5	P:GO:0006879; C:GO:0005615; F:GO:0008199; P:GO:0015682; F:GO:0015091	P:cellular iron ion homeostasis; C:extracellular space; F:ferric iron binding; P:ferric iron transport; F:ferric iron transmembrane transporter activity		IPR001156 (PRINTS); IPR030685 (PIRSF); IPR016357 (PIRSF); IPR001156 (SMART); G3DSA:3.40.190.10 (GENE3D); G3DSA:3.40.190.10 (GENE3D); IPR001156 (PFAM); G3DSA:3.40.190.10 (GENE3D); PTHR11485:SF31 (PANTHER); PTHR11485 (PANTHER); IPR018195 (PROSITE_PATTERNS); IPR018195 (PROSITE_PATTERNS); IPR018195 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR001156 (PROSITE_PROFILES); SSF53850 (SUPERFAMILY); SSF53850 (SUPERFAMILY)
H9GZN9	immunoglobulin M heavy partial	450	20	0E0	81.5%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266:SF98 (PANTHER); PTHR23266 (PANTHER); IPR003006 (PROSITE_PATTERNS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F6ZEH8	serotransferrin-like	990	20	0E0	84.55%	8	F:GO:0005525; P:GO:0006879; C:GO:0005615; F:GO:0008199; P:GO:0007264; P:GO:0015682; F:GO:0015091; C:GO:0005622	F:GTP binding; P:cellular iron ion homeostasis; C:extracellular space; F:ferric iron binding; P:small GTPase mediated signal transduction; P:ferric iron transport; F:ferric iron transmembrane transporter activity; C:intracellular		IPR001156 (PRINTS); IPR001156 (SMART); IPR030685 (PIRSF); IPR016357 (PIRSF); G3DSA:3.40.190.10 (GENE3D); G3DSA:3.40.190.10 (GENE3D); IPR001156 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR019009 (PFAM); G3DSA:3.40.190.10 (GENE3D); PTHR11485 (PANTHER); PTHR11485:SF31 (PANTHER); IPR018195 (PROSITE_PATTERNS); IPR018195 (PROSITE_PATTERNS); IPR018195 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR001156 (PROSITE_PROFILES); IPR024156 (PROSITE_PROFILES); SSF53850 (SUPERFAMILY); IPR027417 (SUPERFAMILY); SSF53850 (SUPERFAMILY)
F6UDZ6	ovostatin homolog 2-like	1404	20	0E0	90.75%	2	C:GO:0005615; F:GO:0004866	C:extracellular space; F:endopeptidase inhibitor activity		IPR009048 (SMART); IPR001599 (SMART); IPR011625 (SMART); IPR001599 (PFAM); IPR008930 (G3DSA:1.50.10.GENE3D); IPR011626 (PFAM); IPR002890 (PFAM); IPR009048 (G3DSA:2.60.40.GENE3D); IPR009048 (PFAM); IPR019565 (PFAM); IPR011625 (PFAM); PTHR11412:SF77 (PANTHER); PTHR11412 (PANTHER); IPR019742 (PROSITE_PATTERNS); IPR009048 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR008930 (SUPERFAMILY)
F7E454	complement C3	1640	20	0E0	90.75%	3	C:GO:0005615; F:GO:0004866; F:GO:0005515	C:extracellular space; F:endopeptidase inhibitor activity; F:protein binding		IPR000020 (SMART); IPR001599 (SMART); IPR011625 (SMART); IPR018933 (SMART); IPR009048 (SMART); IPR009048 (G3DSA:2.60.40.GENE3D); IPR002890 (PFAM); IPR009048 (PFAM); IPR000020 (PFAM); IPR011626 (PFAM); IPR001599 (PFAM); IPR008930 (G3DSA:1.50.10.GENE3D); IPR018081 (G3DSA:1.20.91.GENE3D); IPR019565 (PFAM); IPR018933 (PFAM); IPR011625 (PFAM); PTHR11412:SF90 (PANTHER); PTHR11412 (PANTHER); IPR000020 (PROSITE_PATTERNS); IPR019742 (PROSITE_PATTERNS); IPR001134 (PROSITE_PROFILES); IPR000020 (PROSITE_PROFILES); IPR009048 (SUPERFAMILY); IPR008993 (SUPERFAMILY); IPR018081 (SUPERFAMILY); IPR008930 (SUPERFAMILY)
F7BTW7	complement C3	1664	20	0E0	91.15%	3	C:GO:0005615; F:GO:0004866; F:GO:0005515	C:extracellular space; F:endopeptidase inhibitor activity; F:protein binding		IPR009048 (SMART); IPR001599 (SMART); IPR018933 (SMART); IPR011625 (SMART); IPR000020 (SMART); IPR019565 (PFAM); IPR018081 (G3DSA:1.20.91.GENE3D); IPR009048 (PFAM); IPR018933 (PFAM); IPR011626 (PFAM); IPR001599 (PFAM); IPR000020 (PFAM); IPR008930 (G3DSA:1.50.10.GENE3D); IPR002890 (PFAM); IPR011625 (PFAM); IPR009048 (G3DSA:2.60.40.GENE3D); PTHR11412 (PANTHER); PTHR11412:SF90 (PANTHER); IPR019742 (PROSITE_PATTERNS); IPR000020 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR001134 (PROSITE_PROFILES); IPR000020 (PROSITE_PROFILES); IPR008930 (SUPERFAMILY); IPR009048 (SUPERFAMILY); IPR018081 (SUPERFAMILY); IPR008993 (SUPERFAMILY)
P35747	serum albumin	607	20	0E0	91.95%	2	C:GO:0005615; P:GO:0006810	C:extracellular space; P:transport		IPR000264 (PRINTS); IPR014760 (SMART); IPR021177 (PIRSF); G3DSA:1.10.246.10 (GENE3D); IPR014760 (PFAM); G3DSA:1.10.246.10 (GENE3D); G3DSA:1.10.246.10 (GENE3D); G3DSA:1.10.246.10 (GENE3D); PTHR11385:SF13 (PANTHER); PTHR11385 (PANTHER); IPR020857 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); PD002486 (PRODOM); IPR014760 (PROSITE_PROFILES); IPR020858 (SUPERFAMILY); IPR020858 (SUPERFAMILY); IPR020858 (SUPERFAMILY)
H9GZV1	immunoglobulin alpha heavy chain constant partial	330	20	0E0	71.3%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); PTHR23266:SF68 (PANTHER); IPR003006 (PROSITE_PATTERNS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
P60708	cytoplasmic 1	375	20	0E0	100%	54	C:GO:0014069; F:GO:0000978; F:GO:0000980; P:GO:0007409; P:GO:0051086; C:GO:0015629; C:GO:0005829; C:GO:0070688; P:GO:0071257; F:GO:0050998; P:GO:0070527; C:GO:0030424; C:GO:0030863; C:GO:0030027; F:GO:0019901; P:GO:0045815; P:GO:0045214; F:GO:0005200; C:GO:0043234; P:GO:0006457; C:GO:0005886; C:GO:0005634; P:GO:0048010; F:GO:0005515; F:GO:0031625; C:GO:0000790; P:GO:0006928; P:GO:0043044; P:GO:0048013; C:GO:0031941; C:GO:0030016; C:GO:0035267; C:GO:0043209; P:GO:0038096; C:GO:0005654; F:GO:0000166; F:GO:0005524; C:GO:0070062; C:GO:0005925; C:GO:0030529; C:GO:0072562; P:GO:0034329; C:GO:0036464; F:GO:0042802; F:GO:0031492; P:GO:0021762; P:GO:0001895; C:GO:0005615; C:GO:0005856; F:GO:0030957; C:GO:0005737; C:GO:0097433; C:GO:0016020; F:GO:0019894	C:postsynaptic density; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; F:RNA polymerase II distal enhancer sequence-specific DNA binding; P:axonogenesis; P:chaperone mediated protein folding independent of cofactor; C:actin cytoskeleton; C:cytosol; C:MLL5-L complex; P:cellular response to electrical stimulus; F:nitric-oxide synthase binding; P:platelet aggregation; C:axon; C:cortical cytoskeleton; C:lamellipodium; F:protein kinase binding; P:positive regulation of gene expression, epigenetic; P:sarcomere organization; F:structural constituent of cytoskeleton; C:protein complex; P:protein folding; C:plasma membrane; C:nucleus; P:vascular endothelial growth factor receptor signaling pathway; F:protein binding; F:ubiquitin protein ligase binding; C:nuclear chromatin; P:movement of cell or subcellular component; P:ATP-dependent chromatin remodeling; P:ephrin receptor signaling pathway; C:filamentous actin; C:myofibril; C:NuA4 histone acetyltransferase complex; C:myelin sheath; P:Fc-gamma receptor signaling pathway involved in phagocytosis; C:nucleoplasm; F:nucleotide binding; F:ATP binding; C:extracellular exosome; C:focal adhesion; C:intracellular ribonucleoprotein complex; C:blood microparticle; P:cell junction assembly; C:cytoplasmic ribonucleoprotein granule; F:identical protein binding; F:nucleosomal DNA binding; P:substantia nigra development; P:retina homeostasis; C:extracellular space; C:cytoskeleton; F:Tat protein binding; C:cytoplasm; C:dense body; C:membrane; F:kinesin binding		IPR004000 (PRINTS); IPR004000 (SMART); G3DSA:3.90.640.10 (GENE3D); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR004000 (PFAM); PTHR11937:SF244 (PANTHER); IPR004000 (PANTHER); IPR004001 (PROSITE_PATTERNS); IPR004001 (PROSITE_PATTERNS); IPR020902 (PROSITE_PATTERNS); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY)
F7AAK7	cytoplasmic 2	375	20	0E0	99.85%	32	C:GO:0043209; P:GO:0034332; P:GO:0038096; F:GO:0000166; F:GO:0005524; C:GO:0070062; C:GO:0005925; C:GO:0072562; C:GO:0015629; C:GO:0005829; C:GO:0031012; P:GO:0034329; P:GO:0070527; F:GO:0042802; P:GO:0045214; C:GO:0043034; F:GO:0005200; C:GO:0005886; P:GO:0001895; C:GO:0005634; P:GO:0048010; C:GO:0005615; F:GO:0005515; C:GO:0005856; F:GO:0031625; C:GO:0097433; C:GO:0005737; P:GO:0006928; P:GO:0048013; C:GO:0016020; C:GO:0031941; C:GO:0030016	C:myelin sheath; P:adherens junction organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; F:nucleotide binding; F:ATP binding; C:extracellular exosome; C:focal adhesion; C:blood microparticle; C:actin cytoskeleton; C:cytosol; C:extracellular matrix; P:cell junction assembly; P:platelet aggregation; F:identical protein binding; P:sarcomere organization; C:costamere; F:structural constituent of cytoskeleton; C:plasma membrane; P:retina homeostasis; C:nucleus; P:vascular endothelial growth factor receptor signaling pathway; C:extracellular space; F:protein binding; C:cytoskeleton; F:ubiquitin protein ligase binding; C:dense body; C:cytoplasm; P:movement of cell or subcellular component; P:ephrin receptor signaling pathway; C:membrane; C:filamentous actin; C:myofibril		IPR004000 (PRINTS); IPR004000 (SMART); G3DSA:3.90.640.10 (GENE3D); IPR004000 (PFAM); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR004000 (PANTHER); PTHR11937:SF244 (PANTHER); IPR004001 (PROSITE_PATTERNS); IPR004001 (PROSITE_PATTERNS); IPR020902 (PROSITE_PATTERNS); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY)
F6PJ64	major allergen Equ c 1-like	182	20	2.07E-129	88.3%	3	F:GO:0005550; P:GO:0006810; F:GO:0005215	F:pheromone binding; P:transport; F:transporter activity		IPR002971 (PRINTS); IPR012674 (G3DSA:2.40.128.GENE3D); IPR000566 (PFAM); PTHR11430 (PANTHER); PTHR11430:SF76 (PANTHER); IPR022272 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR011038 (SUPERFAMILY)
F6QC83	mucin-5AC	556	20	0E0	84.05%	1	F:GO:0005515	F:protein binding		IPR001846 (SMART); IPR014853 (SMART); IPR001007 (SMART); IPR001007 (SMART); IPR006207 (SMART); IPR025155 (PFAM); IPR014853 (PFAM); G3DSA:2.10.70.10 (GENE3D); IPR001846 (PFAM); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR002919 (PFAM); PTHR11339:SF291 (PANTHER); PTHR11339 (PANTHER); IPR006207 (PROSITE_PATTERNS); IPR001007 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); PS51257 (PROSITE_PROFILES); IPR006207 (PROSITE_PROFILES); IPR001007 (PROSITE_PROFILES); IPR001846 (PROSITE_PROFILES); IPR002919 (SUPERFAMILY); IPR002919 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR002919 (SUPERFAMILY)
F6YR34	thrombospondin-1	1170	20	0E0	99.05%	8	F:GO:0050840; P:GO:0016525; C:GO:0005615; P:GO:0006954; F:GO:0005515; F:GO:0005509; F:GO:0008201; P:GO:0007155	F:extracellular matrix binding; P:negative regulation of angiogenesis; C:extracellular space; P:inflammatory response; F:protein binding; F:calcium ion binding; F:heparin binding; P:cell adhesion		PR01705 (PRINTS); IPR001791 (SMART); IPR001007 (SMART); IPR000884 (SMART); IPR001881 (SMART); IPR000742 (SMART); G3DSA:2.10.25.10 (GENE3D); IPR028974 (G3DSA:4.10.1080.GENE3D); IPR013320 (G3DSA:2.60.120.GENE3D); IPR013320 (G3DSA:2.60.120.GENE3D); G3DSA:2.20.100.10 (GENE3D); IPR000884 (PFAM); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); IPR008859 (PFAM); IPR003367 (PFAM); IPR001007 (PFAM); IPR028499 (PTHR10199:PANTHER); PTHR10199 (PANTHER); IPR001007 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR008859 (PROSITE_PROFILES); IPR001007 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR017897 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (SUPERFAMILY); IPR028974 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR000884 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR028974 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR028974 (SUPERFAMILY)
F7CS60	fibronectin isoform X3	588	20	0E0	99.1%	2	F:GO:0005515; C:GO:0005576	F:protein binding; C:extracellular region		PR00013 (PRINTS); IPR003961 (SMART); IPR000562 (SMART); IPR000083 (SMART); IPR000083 (PFAM); IPR000562 (G3DSA:2.10.10.GENE3D); IPR000562 (PFAM); IPR003961 (PFAM); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:2.10.70.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR19143:SF210 (PANTHER); PTHR19143 (PANTHER); IPR000562 (PROSITE_PATTERNS); IPR000083 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR000562 (PROSITE_PROFILES); IPR000083 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR013806 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR013806 (SUPERFAMILY); SSF57603 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF57603 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF57603 (SUPERFAMILY); SSF57603 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF57603 (SUPERFAMILY); SSF57603 (SUPERFAMILY); SSF57603 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY)
A2Q0Z1	Heat shock cognate 71 kDa	646	20	0E0	99.75%	116	F:GO:0016887; C:GO:0014069; P:GO:0061738; C:GO:0000974; P:GO:0043624; C:GO:0005874; C:GO:0098575; F:GO:0001664; C:GO:0030425; C:GO:1990124; F:GO:0001786; F:GO:0003723; P:GO:0045892; C:GO:0043195; C:GO:0043198; C:GO:0043197; C:GO:0030424; F:GO:0031072; P:GO:0061684; C:GO:0061202; C:GO:0005882; C:GO:0043234; P:GO:1904589; P:GO:0042026; P:GO:0006457; P:GO:0007269; C:GO:0005886; C:GO:0005765; C:GO:0005764; C:GO:0005634; F:GO:0005515; F:GO:0031625; C:GO:0005913; P:GO:0043085; P:GO:0006606; C:GO:0032279; P:GO:0010667; F:GO:1904593; P:GO:1904592; P:GO:1900034; P:GO:0061077; F:GO:0042277; P:GO:0043488; C:GO:0005730; C:GO:0043005; P:GO:0000398; P:GO:0061635; F:GO:0000166; C:GO:0098793; C:GO:0070062; C:GO:0030529; P:GO:0048026; P:GO:0061740; P:GO:0061741; P:GO:1904764; P:GO:0043254; P:GO:0009267; P:GO:0006397; F:GO:0043531; F:GO:0023026; F:GO:0005102; C:GO:0005622; C:GO:0005615; C:GO:0005737; F:GO:1990833; C:GO:1990836; F:GO:0031686; P:GO:0008380; F:GO:0055131; C:GO:0008021; P:GO:0046777; C:GO:0043025; P:GO:1902904; C:GO:0005829; P:GO:0051726; C:GO:0005681; F:GO:0042623; C:GO:0000151; P:GO:0097214; C:GO:0042470; P:GO:0010628; P:GO:0046034; P:GO:0001916; C:GO:0001917; P:GO:0050766; C:GO:0043209; C:GO:0005770; C:GO:0043202; P:GO:0045862; C:GO:0043204; P:GO:0006622; P:GO:0006986; C:GO:0005776; C:GO:0005654; F:GO:0005524; C:GO:0005925; C:GO:0072562; P:GO:0016032; C:GO:0031012; P:GO:0044829; P:GO:0006351; P:GO:0051085; P:GO:0006355; F:GO:0051082; F:GO:0008134; P:GO:0044788; C:GO:0009986; F:GO:0044822; F:GO:0098641; C:GO:0048471; P:GO:0031647; C:GO:0045121; C:GO:0016020; C:GO:0016021; P:GO:0072318; F:GO:0019899	F:ATPase activity; C:postsynaptic density; P:late endosomal microautophagy; C:Prp19 complex; P:cellular protein complex disassembly; C:microtubule; C:lumenal side of lysosomal membrane; F:G-protein coupled receptor binding; C:dendrite; C:messenger ribonucleoprotein complex; F:phosphatidylserine binding; F:RNA binding; P:negative regulation of transcription, DNA-templated; C:terminal bouton; C:dendritic shaft; C:dendritic spine; C:axon; F:heat shock protein binding; P:chaperone-mediated autophagy; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; C:intermediate filament; C:protein complex; P:regulation of protein import; P:protein refolding; P:protein folding; P:neurotransmitter secretion; C:plasma membrane; C:lysosomal membrane; C:lysosome; C:nucleus; F:protein binding; F:ubiquitin protein ligase binding; C:cell-cell adherens junction; P:positive regulation of catalytic activity; P:protein import into nucleus; C:asymmetric synapse; P:negative regulation of cardiac muscle cell apoptotic process; F:prostaglandin binding; P:positive regulation of protein refolding; P:regulation of cellular response to heat; P:chaperone-mediated protein folding; F:peptide binding; P:regulation of mRNA stability; C:nucleolus; C:neuron projection; P:mRNA splicing, via spliceosome; P:regulation of protein complex stability; F:nucleotide binding; C:presynapse; C:extracellular exosome; C:intracellular ribonucleoprotein complex; P:positive regulation of mRNA splicing, via spliceosome; P:protein targeting to lysosome involved in chaperone-mediated autophagy; P:chaperone-mediated protein transport involved in chaperone-mediated autophagy; P:chaperone-mediated autophagy translocation complex disassembly; P:regulation of protein complex assembly; P:cellular response to starvation; P:mRNA processing; F:ADP binding; F:MHC class II protein complex binding; F:receptor binding; C:intracellular; C:extracellular space; C:cytoplasm; F:clathrin-uncoating ATPase activity; C:lysosomal matrix; F:A1 adenosine receptor binding; P:RNA splicing; F:C3HC4-type RING finger domain binding; C:synaptic vesicle; P:protein autophosphorylation; C:neuronal cell body; P:negative regulation of fibril organization; C:cytosol; P:regulation of cell cycle; C:spliceosomal complex; F:ATPase activity, coupled; C:ubiquitin ligase complex; P:positive regulation of lysosomal membrane permeability; C:melanosome; P:positive regulation of gene expression; P:ATP metabolic process; P:positive regulation of T cell mediated cytotoxicity; C:photoreceptor inner segment; P:positive regulation of phagocytosis; C:myelin sheath; C:late endosome; C:lysosomal lumen; P:positive regulation of proteolysis; C:perikaryon; P:protein targeting to lysosome; P:response to unfolded protein; C:autophagosome; C:nucleoplasm; F:ATP binding; C:focal adhesion; C:blood microparticle; P:viral process; C:extracellular matrix; P:positive regulation by host of viral genome replication; P:transcription, DNA-templated; P:chaperone mediated protein folding requiring cofactor; P:regulation of transcription, DNA-templated; F:unfolded protein binding; F:transcription factor binding; P:modulation by host of viral process; C:cell surface; F:poly(A) RNA binding; F:cadherin binding involved in cell-cell adhesion; C:perinuclear region of cytoplasm; P:regulation of protein stability; C:membrane raft; C:membrane; C:integral component of membrane; P:clathrin coat disassembly; F:enzyme binding		IPR013126 (PRINTS); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR029047 (G3DSA:2.60.34.GENE3D); IPR029048 (G3DSA:1.20.1270.GENE3D); IPR013126 (PFAM); G3DSA:3.90.640.10 (GENE3D); G3DSA:3.30.30.30 (GENE3D); IPR018181 (PROSITE_PATTERNS); IPR018181 (PROSITE_PATTERNS); IPR018181 (PROSITE_PATTERNS); SSF53067 (SUPERFAMILY); IPR029047 (SUPERFAMILY); IPR029048 (SUPERFAMILY); SSF53067 (SUPERFAMILY)
F7AUW2	Heat shock cognate 71 kDa	647	20	0E0	99.85%	116	F:GO:0016887; C:GO:0014069; P:GO:0061738; C:GO:0000974; P:GO:0043624; C:GO:0005874; C:GO:0098575; F:GO:0001664; C:GO:0030425; F:GO:0001786; C:GO:1990124; F:GO:0003723; P:GO:0045892; C:GO:0043195; C:GO:0043198; C:GO:0043197; C:GO:0030424; F:GO:0031072; P:GO:0061684; C:GO:0061202; C:GO:0005882; C:GO:0043234; P:GO:1904589; P:GO:0042026; P:GO:0006457; P:GO:0007269; C:GO:0005886; C:GO:0005765; C:GO:0005764; C:GO:0005634; F:GO:0005515; F:GO:0031625; C:GO:0005913; P:GO:0043085; P:GO:0006606; C:GO:0032279; P:GO:0010667; F:GO:1904593; P:GO:1904592; P:GO:1900034; P:GO:0061077; F:GO:0042277; P:GO:0043488; C:GO:0005730; C:GO:0043005; P:GO:0000398; P:GO:0061635; F:GO:0000166; C:GO:0098793; C:GO:0070062; C:GO:0030529; P:GO:0048026; P:GO:0061740; P:GO:0061741; P:GO:1904764; P:GO:0043254; P:GO:0009267; P:GO:0006397; F:GO:0043531; F:GO:0023026; F:GO:0005102; C:GO:0005622; C:GO:0005615; C:GO:0005737; F:GO:1990833; C:GO:1990836; F:GO:0031686; P:GO:0008380; F:GO:0055131; C:GO:0008021; P:GO:0046777; C:GO:0043025; P:GO:1902904; C:GO:0005829; P:GO:0051726; C:GO:0005681; F:GO:0042623; C:GO:0000151; P:GO:0097214; C:GO:0042470; P:GO:0010628; P:GO:0046034; P:GO:0001916; C:GO:0001917; P:GO:0050766; C:GO:0043209; C:GO:0005770; C:GO:0043202; P:GO:0045862; C:GO:0043204; P:GO:0006622; P:GO:0006986; C:GO:0005776; C:GO:0005654; F:GO:0005524; C:GO:0005925; C:GO:0072562; P:GO:0016032; C:GO:0031012; P:GO:0044829; P:GO:0006351; P:GO:0051085; P:GO:0006355; F:GO:0051082; F:GO:0008134; P:GO:0044788; C:GO:0009986; F:GO:0044822; F:GO:0098641; C:GO:0048471; P:GO:0031647; C:GO:0045121; C:GO:0016020; C:GO:0016021; P:GO:0072318; F:GO:0019899	F:ATPase activity; C:postsynaptic density; P:late endosomal microautophagy; C:Prp19 complex; P:cellular protein complex disassembly; C:microtubule; C:lumenal side of lysosomal membrane; F:G-protein coupled receptor binding; C:dendrite; F:phosphatidylserine binding; C:messenger ribonucleoprotein complex; F:RNA binding; P:negative regulation of transcription, DNA-templated; C:terminal bouton; C:dendritic shaft; C:dendritic spine; C:axon; F:heat shock protein binding; P:chaperone-mediated autophagy; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; C:intermediate filament; C:protein complex; P:regulation of protein import; P:protein refolding; P:protein folding; P:neurotransmitter secretion; C:plasma membrane; C:lysosomal membrane; C:lysosome; C:nucleus; F:protein binding; F:ubiquitin protein ligase binding; C:cell-cell adherens junction; P:positive regulation of catalytic activity; P:protein import into nucleus; C:asymmetric synapse; P:negative regulation of cardiac muscle cell apoptotic process; F:prostaglandin binding; P:positive regulation of protein refolding; P:regulation of cellular response to heat; P:chaperone-mediated protein folding; F:peptide binding; P:regulation of mRNA stability; C:nucleolus; C:neuron projection; P:mRNA splicing, via spliceosome; P:regulation of protein complex stability; F:nucleotide binding; C:presynapse; C:extracellular exosome; C:intracellular ribonucleoprotein complex; P:positive regulation of mRNA splicing, via spliceosome; P:protein targeting to lysosome involved in chaperone-mediated autophagy; P:chaperone-mediated protein transport involved in chaperone-mediated autophagy; P:chaperone-mediated autophagy translocation complex disassembly; P:regulation of protein complex assembly; P:cellular response to starvation; P:mRNA processing; F:ADP binding; F:MHC class II protein complex binding; F:receptor binding; C:intracellular; C:extracellular space; C:cytoplasm; F:clathrin-uncoating ATPase activity; C:lysosomal matrix; F:A1 adenosine receptor binding; P:RNA splicing; F:C3HC4-type RING finger domain binding; C:synaptic vesicle; P:protein autophosphorylation; C:neuronal cell body; P:negative regulation of fibril organization; C:cytosol; P:regulation of cell cycle; C:spliceosomal complex; F:ATPase activity, coupled; C:ubiquitin ligase complex; P:positive regulation of lysosomal membrane permeability; C:melanosome; P:positive regulation of gene expression; P:ATP metabolic process; P:positive regulation of T cell mediated cytotoxicity; C:photoreceptor inner segment; P:positive regulation of phagocytosis; C:myelin sheath; C:late endosome; C:lysosomal lumen; P:positive regulation of proteolysis; C:perikaryon; P:protein targeting to lysosome; P:response to unfolded protein; C:autophagosome; C:nucleoplasm; F:ATP binding; C:focal adhesion; C:blood microparticle; P:viral process; C:extracellular matrix; P:positive regulation by host of viral genome replication; P:transcription, DNA-templated; P:chaperone mediated protein folding requiring cofactor; P:regulation of transcription, DNA-templated; F:unfolded protein binding; F:transcription factor binding; P:modulation by host of viral process; C:cell surface; F:poly(A) RNA binding; F:cadherin binding involved in cell-cell adhesion; C:perinuclear region of cytoplasm; P:regulation of protein stability; C:membrane raft; C:membrane; C:integral component of membrane; P:clathrin coat disassembly; F:enzyme binding		IPR013126 (PRINTS); G3DSA:3.30.30.30 (GENE3D); IPR029048 (G3DSA:1.20.1270.GENE3D); IPR029047 (G3DSA:2.60.34.GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR013126 (PFAM); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.90.640.10 (GENE3D); PTHR19375 (PANTHER); PTHR19375:SF150 (PANTHER); IPR018181 (PROSITE_PATTERNS); IPR018181 (PROSITE_PATTERNS); IPR018181 (PROSITE_PATTERNS); SSF53067 (SUPERFAMILY); IPR029047 (SUPERFAMILY); IPR029048 (SUPERFAMILY); SSF53067 (SUPERFAMILY)
F7CKH3	retinal dehydrogenase 1	500	20	0E0	96.4%	2	P:GO:0055114; F:GO:0016620	P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor		IPR016162 (G3DSA:3.40.605.GENE3D); IPR016163 (G3DSA:3.40.309.GENE3D); IPR015590 (PFAM); PTHR11699 (PANTHER); PTHR11699:SF140 (PANTHER); IPR016160 (PROSITE_PATTERNS); IPR029510 (PROSITE_PATTERNS); IPR016161 (SUPERFAMILY)
F7CT65	major allergen Equ c 1-like	188	20	6.87E-134	87.95%	4	F:GO:0005550; F:GO:0036094; P:GO:0006810; F:GO:0005215	F:pheromone binding; F:small molecule binding; P:transport; F:transporter activity		IPR002345 (PRINTS); IPR002971 (PRINTS); IPR000566 (PFAM); IPR012674 (G3DSA:2.40.128.GENE3D); PTHR11430:SF76 (PANTHER); PTHR11430 (PANTHER); IPR022272 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR011038 (SUPERFAMILY)
F6Z2L5	apolipo A-I	266	20	0E0	90.4%	4	P:GO:0006869; F:GO:0008289; P:GO:0042157; C:GO:0005576	P:lipid transport; F:lipid binding; P:lipoprotein metabolic process; C:extracellular region		G3DSA:1.20.5.20 (GENE3D); G3DSA:1.20.120.20 (GENE3D); IPR000074 (PFAM); PTHR18976 (PANTHER); PTHR18976:SF11 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SSF58113 (SUPERFAMILY)
F7CJG3	complement C3	1661	20	0E0	90.55%	3	C:GO:0005615; F:GO:0004866; F:GO:0005515	C:extracellular space; F:endopeptidase inhibitor activity; F:protein binding		IPR011625 (SMART); IPR018933 (SMART); IPR001599 (SMART); IPR000020 (SMART); IPR009048 (SMART); IPR011626 (PFAM); IPR008930 (G3DSA:1.50.10.GENE3D); IPR018081 (G3DSA:1.20.91.GENE3D); IPR001599 (PFAM); IPR019565 (PFAM); IPR011625 (PFAM); IPR009048 (PFAM); IPR000020 (PFAM); IPR018933 (PFAM); IPR002890 (PFAM); IPR009048 (G3DSA:2.60.40.GENE3D); PTHR11412:SF90 (PANTHER); PTHR11412 (PANTHER); IPR000020 (PROSITE_PATTERNS); IPR019742 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR000020 (PROSITE_PROFILES); IPR001134 (PROSITE_PROFILES); IPR018081 (SUPERFAMILY); IPR008993 (SUPERFAMILY); IPR008930 (SUPERFAMILY); IPR009048 (SUPERFAMILY)
F7BAY6	serum albumin	607	20	0E0	92.05%	2	C:GO:0005615; P:GO:0006810	C:extracellular space; P:transport		IPR000264 (PRINTS); IPR014760 (SMART); IPR021177 (PIRSF); G3DSA:1.10.246.10 (GENE3D); G3DSA:1.10.246.10 (GENE3D); IPR014760 (PFAM); G3DSA:1.10.246.10 (GENE3D); G3DSA:1.10.246.10 (GENE3D); PTHR11385 (PANTHER); PTHR11385:SF13 (PANTHER); IPR020857 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); PD002486 (PRODOM); IPR014760 (PROSITE_PROFILES); IPR020858 (SUPERFAMILY); IPR020858 (SUPERFAMILY); IPR020858 (SUPERFAMILY)
F6ZXW9	PREDICTED: LOW QUALITY PROTEIN: IgGFc-binding protein	20	3	3.29E-5	100%	1	F:GO:0005515	F:protein binding		IPR014853 (SMART); IPR003645 (SMART); IPR001846 (SMART); IPR001007 (SMART); IPR001007 (SMART); IPR014853 (PFAM); IPR002919 (PFAM); IPR025615 (PFAM); IPR001846 (PFAM); G3DSA:2.10.25.10 (GENE3D); PTHR11339 (PANTHER); PTHR11339:SF244 (PANTHER); IPR001846 (PROSITE_PROFILES); IPR002919 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR002919 (SUPERFAMILY); IPR002919 (SUPERFAMILY)
F6XLB1	lactotransferrin	708	20	0E0	91.3%	1	C:GO:0005615	C:extracellular space		IPR001156 (PRINTS); IPR001156 (SMART); IPR016357 (PIRSF); G3DSA:3.40.190.10 (GENE3D); G3DSA:3.40.190.10 (GENE3D); G3DSA:3.40.190.10 (GENE3D); IPR001156 (PFAM); PTHR11485 (PANTHER); PTHR11485:SF33 (PANTHER); IPR018195 (PROSITE_PATTERNS); IPR018195 (PROSITE_PATTERNS); IPR018195 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR001156 (PROSITE_PROFILES); SSF53850 (SUPERFAMILY); SSF53850 (SUPERFAMILY)
F6XSF7	complement C4-A	1750	20	0E0	91.85%	5	P:GO:0006956; C:GO:0005615; P:GO:0006954; F:GO:0004866; F:GO:0005515	P:complement activation; C:extracellular space; P:inflammatory response; F:endopeptidase inhibitor activity; F:protein binding		IPR001840 (PRINTS); IPR000020 (SMART); IPR009048 (SMART); IPR001599 (SMART); IPR018933 (SMART); IPR011625 (SMART); IPR009048 (PFAM); IPR011625 (PFAM); IPR011626 (PFAM); IPR001599 (PFAM); IPR018933 (PFAM); IPR018081 (G3DSA:1.20.91.GENE3D); IPR002890 (PFAM); IPR009048 (G3DSA:2.60.40.GENE3D); IPR008930 (G3DSA:1.50.10.GENE3D); IPR000020 (PFAM); IPR019565 (PFAM); PTHR11412 (PANTHER); PTHR11412:SF96 (PANTHER); IPR019742 (PROSITE_PATTERNS); IPR000020 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR000020 (PROSITE_PROFILES); IPR001134 (PROSITE_PROFILES); IPR008930 (SUPERFAMILY); IPR018081 (SUPERFAMILY); IPR009048 (SUPERFAMILY); IPR008993 (SUPERFAMILY)
H9GZU8	immunoglobulin gamma 1 heavy chain constant partial	324	20	0E0	80.55%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); PTHR23266:SF83 (PANTHER); PTHR23266 (PANTHER); IPR003006 (PROSITE_PATTERNS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F6USP9	plasminogen isoform X1	817	20	0E0	87.6%	2	P:GO:0006508; F:GO:0004252	P:proteolysis; F:serine-type endopeptidase activity	EC:3.4.21	PR00018 (PRINTS); IPR001314 (PRINTS); IPR023317 (PIRSF); IPR000001 (SMART); IPR001254 (SMART); IPR003609 (SMART); IPR000001 (PFAM); G3DSA:2.40.10.10 (GENE3D); IPR001254 (PFAM); G3DSA:2.40.20.10 (GENE3D); IPR003609 (PFAM); G3DSA:3.50.4.10 (GENE3D); G3DSA:2.40.10.10 (GENE3D); G3DSA:2.40.20.10 (GENE3D); PTHR24261 (PANTHER); PTHR24261:SF2 (PANTHER); IPR018056 (PROSITE_PATTERNS); IPR018114 (PROSITE_PATTERNS); IPR033116 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR001254 (PROSITE_PROFILES); IPR000001 (PROSITE_PROFILES); IPR003609 (PROSITE_PROFILES); IPR013806 (SUPERFAMILY); IPR009003 (SUPERFAMILY); IPR013806 (SUPERFAMILY); IPR013806 (SUPERFAMILY); IPR013806 (SUPERFAMILY); SSF57414 (SUPERFAMILY); IPR013806 (SUPERFAMILY)
F6RMD0	complement factor B	768	20	0E0	93%	4	P:GO:0006956; P:GO:0006508; F:GO:0004252; C:GO:0005576	P:complement activation; P:proteolysis; F:serine-type endopeptidase activity; C:extracellular region	EC:3.4.21	PR00453 (PRINTS); IPR001314 (PRINTS); IPR002035 (SMART); IPR011360 (PIRSF); IPR000436 (SMART); IPR001254 (SMART); IPR001254 (PFAM); G3DSA:2.40.10.10 (GENE3D); IPR002035 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); G3DSA:2.10.70.10 (GENE3D); IPR000436 (PFAM); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.40.10.10 (GENE3D); PTHR19325 (PANTHER); PTHR19325:SF394 (PANTHER); IPR018114 (PROSITE_PATTERNS); IPR033116 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR000436 (PROSITE_PROFILES); IPR001254 (PROSITE_PROFILES); IPR002035 (PROSITE_PROFILES); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR009003 (SUPERFAMILY)
F7CAB8	zinc-alpha-2-glyco	285	20	0E0	90.35%	1	F:GO:0005515	F:protein binding		IPR001039 (PRINTS); IPR013783 (G3DSA:2.60.40.GENE3D); IPR011161 (G3DSA:3.30.500.GENE3D); IPR003597 (PFAM); IPR011161 (PFAM); PTHR16675 (PANTHER); PTHR16675:SF168 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR011162 (SUPERFAMILY)
Q8HZM6	annexin A1	346	20	0E0	95.3%	3	F:GO:0005509; F:GO:0004859; F:GO:0005544	F:calcium ion binding; F:phospholipase inhibitor activity; F:calcium-dependent phospholipid binding		IPR002388 (PRINTS); IPR001464 (PRINTS); IPR018502 (SMART); IPR018502 (G3DSA:1.10.220.GENE3D); IPR018502 (G3DSA:1.10.220.GENE3D); IPR018502 (PFAM); IPR018502 (G3DSA:1.10.220.GENE3D); IPR018502 (G3DSA:1.10.220.GENE3D); PTHR10502 (PANTHER); IPR002388 (PTHR10502:PANTHER); IPR018252 (PROSITE_PATTERNS); SSF47874 (SUPERFAMILY)
F6YA47	alpha-2-macroglobulin 1 isoform X1	1185	20	0E0	94.2%	2	C:GO:0005615; F:GO:0004866	C:extracellular space; F:endopeptidase inhibitor activity		IPR001599 (SMART); IPR009048 (SMART); IPR011625 (SMART); IPR009048 (G3DSA:2.60.40.GENE3D); IPR008930 (G3DSA:1.50.10.GENE3D); IPR011625 (PFAM); IPR009048 (PFAM); IPR019565 (PFAM); IPR001599 (PFAM); IPR011626 (PFAM); PTHR11412 (PANTHER); PTHR11412:SF95 (PANTHER); IPR019742 (PROSITE_PATTERNS); IPR009048 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR008930 (SUPERFAMILY)
F6PQ46	ceruloplasmin isoform X2	1068	20	0E0	93.2%	6	P:GO:0006879; P:GO:0006825; P:GO:0015994; F:GO:0005507; P:GO:0055114; F:GO:0004322	P:cellular iron ion homeostasis; P:copper ion transport; P:chlorophyll metabolic process; F:copper ion binding; P:oxidation-reduction process; F:ferroxidase activity	EC:1.16.3.1; EC:1.16.3	IPR001117 (PFAM); IPR011706 (PFAM); IPR011707 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); IPR008972 (G3DSA:2.60.40.GENE3D); IPR027150 (PTHR10127:PANTHER); PTHR10127 (PANTHER); IPR033138 (PROSITE_PATTERNS); IPR002355 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY)
H9GZT5	heavy chain precursor	335	20	0E0	83.5%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266:SF83 (PANTHER); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
Q28372	gelsolin isoform X2	731	20	0E0	97.7%	5	P:GO:0051016; P:GO:0051014; F:GO:0003779; F:GO:0005509; P:GO:0045010	P:barbed-end actin filament capping; P:actin filament severing; F:actin binding; F:calcium ion binding; P:actin nucleation		IPR007122 (PRINTS); IPR007122 (SMART); IPR007123 (PFAM); IPR029006 (G3DSA:3.40.20.GENE3D); IPR029006 (G3DSA:3.40.20.GENE3D); IPR029006 (G3DSA:3.40.20.GENE3D); IPR029006 (G3DSA:3.40.20.GENE3D); IPR029006 (G3DSA:3.40.20.GENE3D); IPR030004 (PTHR11977:PANTHER); IPR007122 (PANTHER); SSF55753 (SUPERFAMILY); SSF55753 (SUPERFAMILY); SSF55753 (SUPERFAMILY); SSF55753 (SUPERFAMILY); SSF55753 (SUPERFAMILY); SSF55753 (SUPERFAMILY)
F6YE73	apolipo B-100	604	20	0E0	84.85%	2	P:GO:0006869; F:GO:0005319	P:lipid transport; F:lipid transporter activity		IPR001747 (SMART); IPR015255 (SMART); IPR015816 (G3DSA:2.30.230.GENE3D); IPR015817 (G3DSA:2.20.50.GENE3D); IPR015818 (G3DSA:2.20.80.GENE3D); IPR015255 (PFAM); IPR022176 (PFAM); IPR001747 (PFAM); IPR009454 (PFAM); IPR011030 (G3DSA:1.25.10.GENE3D); PTHR13769:SF1 (PANTHER); PTHR13769 (PANTHER); IPR001747 (PROSITE_PROFILES); IPR015819 (SUPERFAMILY); IPR011030 (SUPERFAMILY); IPR015819 (SUPERFAMILY)
H9GZR2	immunoglobulin gamma 1 heavy chain constant partial	338	20	0E0	77.35%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266:SF83 (PANTHER); PTHR23266 (PANTHER); IPR003006 (PROSITE_PATTERNS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F6X485	myosin-9	1781	20	0E0	98.55%	4	C:GO:0016459; F:GO:0005524; F:GO:0005515; F:GO:0003774	C:myosin complex; F:ATP binding; F:protein binding; F:motor activity	EC:3.6.1; EC:3.6.1.15	IPR001609 (PRINTS); IPR000048 (SMART); IPR001609 (SMART); IPR004009 (PFAM); IPR002928 (PFAM); IPR027401 (G3DSA:4.10.270.GENE3D); G3DSA:1.20.5.340 (GENE3D); IPR001609 (PFAM); PTHR13140 (PANTHER); PTHR13140:SF317 (PANTHER); IPR000048 (PROSITE_PROFILES); IPR001609 (PROSITE_PROFILES); SSF90257 (SUPERFAMILY); SSF90257 (SUPERFAMILY); SSF90257 (SUPERFAMILY); SSF90257 (SUPERFAMILY); IPR027417 (SUPERFAMILY); SSF90257 (SUPERFAMILY); SSF90257 (SUPERFAMILY)
F6PH38	fibrinogen beta chain	490	20	0E0	91.95%	6	P:GO:0051258; P:GO:0007165; F:GO:0005102; F:GO:0030674; P:GO:0030168; C:GO:0005577	P:protein polymerization; P:signal transduction; F:receptor binding; F:protein binding, bridging; P:platelet activation; C:fibrinogen complex		IPR002181 (SMART); IPR012290 (SMART); IPR014716 (G3DSA:3.90.215.GENE3D); G3DSA:1.20.5.50 (GENE3D); IPR002181 (PFAM); IPR014715 (G3DSA:4.10.530.GENE3D); IPR012290 (PFAM); G3DSA:1.20.5.50 (GENE3D); PTHR19143:SF203 (PANTHER); PTHR19143 (PANTHER); IPR020837 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR002181 (PROSITE_PROFILES); SSF58010 (SUPERFAMILY); IPR002181 (SUPERFAMILY)
F7CYP1	alpha-1-antitrypsin	423	20	0E0	88.85%	1	C:GO:0005615	C:extracellular space		IPR023796 (SMART); IPR023796 (PFAM); G3DSA:2.30.39.10 (GENE3D); G3DSA:3.30.497.10 (GENE3D); PTHR11461:SF165 (PANTHER); IPR000215 (PANTHER); IPR023795 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR023796 (SUPERFAMILY)
H9GZU9	immunoglobulin gamma 1 heavy chain constant partial	325	20	0E0	79.8%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); PTHR23266:SF83 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F6W3M5	pyruvate kinase PKM isoform X2	541	20	0E0	97.65%	7	F:GO:0000287; F:GO:0004743; P:GO:0006094; F:GO:0030955; P:GO:0006096; P:GO:0006144; P:GO:0015976	F:magnesium ion binding; F:pyruvate kinase activity; P:gluconeogenesis; F:potassium ion binding; P:glycolytic process; P:purine nucleobase metabolic process; P:carbon utilization	EC:2.7.1.40	IPR001697 (PRINTS); IPR015793 (PFAM); IPR001697 (TIGRFAM); IPR015795 (PFAM); IPR015813 (G3DSA:3.20.20.GENE3D); IPR015794 (G3DSA:3.40.1380.GENE3D); IPR015806 (G3DSA:2.40.33.GENE3D); IPR001697 (PANTHER); PTHR11817:SF23 (PANTHER); IPR018209 (PROSITE_PATTERNS); IPR015813 (SUPERFAMILY); IPR011037 (SUPERFAMILY); IPR015795 (SUPERFAMILY)
F6V7C1	alpha-enolase	434	20	0E0	98.9%	8	F:GO:0000287; F:GO:0004634; P:GO:0006094; P:GO:0009094; P:GO:0000162; P:GO:0006571; P:GO:0006096; C:GO:0000015	F:magnesium ion binding; F:phosphopyruvate hydratase activity; P:gluconeogenesis; P:L-phenylalanine biosynthetic process; P:tryptophan biosynthetic process; P:tyrosine biosynthetic process; P:glycolytic process; C:phosphopyruvate hydratase complex	EC:4.2.1.11	IPR000941 (PRINTS); IPR000941 (PIRSF); IPR020811 (SMART); IPR020810 (SMART); IPR020811 (PFAM); IPR029017 (G3DSA:3.30.390.GENE3D); IPR029065 (G3DSA:3.20.20.GENE3D); IPR000941 (TIGRFAM); IPR020810 (PFAM); IPR000941 (PANTHER); IPR020809 (PROSITE_PATTERNS); IPR000941 (HAMAP); IPR029017 (SUPERFAMILY); IPR029065 (SUPERFAMILY)
P02062	hemoglobin subunit beta	146	20	6.55E-102	93.4%	5	C:GO:0005833; F:GO:0019825; F:GO:0005506; P:GO:0015671; F:GO:0020037	C:hemoglobin complex; F:oxygen binding; F:iron ion binding; P:oxygen transport; F:heme binding		IPR002337 (PRINTS); IPR012292 (G3DSA:1.10.490.GENE3D); IPR000971 (PFAM); PTHR11442:SF42 (PANTHER); PTHR11442 (PANTHER); IPR000971 (PROSITE_PROFILES); IPR009050 (SUPERFAMILY)
H9GZS6	immunoglobulin gamma 1 heavy chain constant partial	338	20	0E0	76.65%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); PTHR23266 (PANTHER); PTHR23266:SF83 (PANTHER); IPR003006 (PROSITE_PATTERNS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F7CU94	lysozyme C	148	20	2.38E-105	93.2%	2	P:GO:0005975; F:GO:0003796	P:carbohydrate metabolic process; F:lysozyme activity	EC:3.2.1.17	IPR000974 (PRINTS); IPR001916 (PRINTS); IPR001916 (SMART); IPR001916 (PFAM); G3DSA:1.10.530.10 (GENE3D); PTHR11407 (PANTHER); PTHR11407:SF28 (PANTHER); IPR019799 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR001916 (PROSITE_PROFILES); IPR023346 (SUPERFAMILY)
F6QAU5	immunoglobulin lambda light chain constant partial	107	20	9.12E-71	97.35%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F7CAC5	immmunoglobulin lambda light chain variable partial	117	20	6.67E-78	99.65%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F7DZ01	coagulation factor V	1476	20	0E0	79.65%	1	P:GO:0007596	P:blood coagulation		IPR000421 (SMART); IPR008979 (G3DSA:2.60.120.GENE3D); IPR008972 (G3DSA:2.60.40.GENE3D); IPR008972 (G3DSA:2.60.40.GENE3D); IPR000421 (PFAM); IPR009271 (PFAM); IPR029821 (PTHR10127:PANTHER); PTHR10127 (PANTHER); IPR000421 (PROSITE_PATTERNS); IPR000421 (PROSITE_PATTERNS); IPR033138 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000421 (PROSITE_PROFILES); IPR008979 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008979 (SUPERFAMILY)
F6T0P6	vitamin D-binding	474	20	0E0	93.15%	4	C:GO:0005615; F:GO:0051183; F:GO:0005499; P:GO:0051180	C:extracellular space; F:vitamin transporter activity; F:vitamin D binding; P:vitamin transport		IPR000264 (PRINTS); IPR000213 (PRINTS); IPR014760 (SMART); G3DSA:1.10.246.10 (GENE3D); IPR015247 (PFAM); G3DSA:1.10.246.10 (GENE3D); IPR014760 (PFAM); G3DSA:1.10.246.10 (GENE3D); PTHR11385:SF11 (PANTHER); PTHR11385 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR014760 (PROSITE_PROFILES); IPR020858 (SUPERFAMILY); IPR020858 (SUPERFAMILY); IPR020858 (SUPERFAMILY)
F6T7K7	transcobalamin-1	429	20	0E0	83.65%	2	F:GO:0031419; P:GO:0015889	F:cobalamin binding; P:cobalamin transport		IPR002157 (PFAM); IPR027954 (PFAM); PTHR10559:SF13 (PANTHER); IPR002157 (PANTHER); IPR002157 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS)
H9GZQ9	immunoglobulin gamma 1 heavy chain constant partial	337	20	0E0	84%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); PTHR23266:SF83 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F6SQD7	immunoglobulin lambda light chain constant partial	107	20	3.31E-64	90.7%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
Q2TU62	calcium-activated chloride channel regulator 1	913	20	0E0	92.45%	3	F:GO:0005229; P:GO:0006821; C:GO:0005622	F:intracellular calcium activated chloride channel activity; P:chloride transport; C:intracellular		IPR002035 (SMART); IPR002035 (G3DSA:3.40.50.GENE3D); IPR013642 (PFAM); IPR004727 (TIGRFAM); IPR002035 (PFAM); PTHR10579:SF52 (PANTHER); PTHR10579 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR002035 (PROSITE_PROFILES); IPR002035 (SUPERFAMILY)
F7CYR1	antithrombin-III	463	20	0E0	95%	4	C:GO:0005615; F:GO:0004867; P:GO:2000266; F:GO:0008201	C:extracellular space; F:serine-type endopeptidase inhibitor activity; P:regulation of blood coagulation, intrinsic pathway; F:heparin binding		IPR023796 (SMART); G3DSA:2.30.39.10 (GENE3D); IPR023796 (PFAM); G3DSA:3.30.497.10 (GENE3D); IPR015555 (PTHR11461:PANTHER); IPR000215 (PANTHER); IPR023795 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR023796 (SUPERFAMILY)
F6SP11	immmunoglobulin lambda light chain variable partial	106	20	1.5E-67	98.5%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
H9GZS9	immunoglobulin gamma 3 heavy chain constant partial	354	20	0E0	78.6%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); PTHR23266:SF83 (PANTHER); IPR003006 (PROSITE_PATTERNS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F7APU2	complement factor I	559	20	0E0	89.25%	6	F:GO:0005515; P:GO:0007165; C:GO:0016020; P:GO:0006508; F:GO:0004252; F:GO:0005044	F:protein binding; P:signal transduction; C:membrane; P:proteolysis; F:serine-type endopeptidase activity; F:scavenger receptor activity	EC:3.4.21	IPR001314 (PRINTS); IPR001254 (SMART); IPR002172 (SMART); IPR017448 (SMART); IPR003884 (SMART); IPR017448 (G3DSA:3.10.250.GENE3D); G3DSA:3.30.60.30 (GENE3D); G3DSA:2.40.10.10 (GENE3D); IPR002172 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); IPR001190 (PFAM); IPR001254 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.40.10.10 (GENE3D); G3DSA:2.40.10.10 (GENE3D); PTHR24256:SF197 (PANTHER); PTHR24256 (PANTHER); IPR018114 (PROSITE_PATTERNS); IPR023415 (PROSITE_PATTERNS); IPR033116 (PROSITE_PATTERNS); IPR001254 (PROSITE_PROFILES); IPR002350 (PROSITE_PROFILES); IPR002172 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR009003 (SUPERFAMILY); SSF100895 (SUPERFAMILY); IPR017448 (SUPERFAMILY)
F6QX36	inter-alpha-trypsin inhibitor heavy chain H1 isoform X1	909	20	0E0	95.2%	2	F:GO:0004867; P:GO:0030212	F:serine-type endopeptidase inhibitor activity; P:hyaluronan metabolic process		IPR002035 (SMART); IPR013694 (SMART); IPR013694 (PFAM); IPR002035 (PFAM); IPR010600 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); PTHR10338:SF106 (PANTHER); PTHR10338 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR013694 (PROSITE_PROFILES); IPR002035 (PROSITE_PROFILES); IPR002035 (SUPERFAMILY)
F6RZ27	apolipo A-IV	381	20	0E0	92.7%	4	P:GO:0006869; F:GO:0008289; P:GO:0042157; C:GO:0005576	P:lipid transport; F:lipid binding; P:lipoprotein metabolic process; C:extracellular region		IPR000074 (PFAM); G3DSA:1.20.120.20 (GENE3D); PTHR18976 (PANTHER); PTHR18976:SF1 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SSF58113 (SUPERFAMILY)
F6VJR6	alpha-1B-glyco	500	20	0E0	68.95%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR007110 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR11738 (PANTHER); PTHR11738:SF3 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F6YV53	alpha-actinin-4 isoform X1	747	20	0E0	96.3%	4	F:GO:0051015; F:GO:0005509; P:GO:1902396; P:GO:0070830	F:actin filament binding; F:calcium ion binding; P:protein localization to bicellular tight junction; P:bicellular tight junction assembly		IPR018159 (SMART); IPR001715 (SMART); IPR001715 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR002017 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR11915 (PANTHER); IPR029637 (PTHR11915:PANTHER); IPR001589 (PROSITE_PATTERNS); IPR001715 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR001715 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR011992 (SUPERFAMILY)
F6SRP7	adenylyl cyclase-associated 1 isoform X1	475	20	0E0	97.75%	3	F:GO:0003779; P:GO:0000902; P:GO:0030036	F:actin binding; P:cell morphogenesis; P:actin cytoskeleton organization		IPR006599 (SMART); IPR016098 (G3DSA:2.160.20.GENE3D); IPR013992 (PFAM); IPR013912 (PFAM); IPR001837 (PANTHER); IPR028415 (PTHR10652:PANTHER); IPR028417 (PROSITE_PATTERNS); IPR018106 (PROSITE_PATTERNS); IPR017901 (PROSITE_PROFILES); IPR013992 (SUPERFAMILY); IPR013912 (SUPERFAMILY)
F7DA17	-glutamine gamma-glutamyltransferase 2	697	20	0E0	94.2%	2	F:GO:0003810; P:GO:0018149	F:protein-glutamine gamma-glutamyltransferase activity; P:peptide cross-linking	EC:2.3.2.13	IPR023608 (PIRSF); IPR002931 (SMART); IPR002931 (G3DSA:3.90.260.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001102 (PFAM); IPR002931 (PFAM); IPR008958 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR11590:SF6 (PANTHER); IPR023608 (PANTHER); IPR013808 (PROSITE_PATTERNS); IPR008958 (SUPERFAMILY); IPR014756 (SUPERFAMILY); SSF54001 (SUPERFAMILY)
F7CIM1	14-3-3 sigma	248	20	0E0	99.05%	1	F:GO:0019904	F:protein domain specific binding		IPR000308 (PRINTS); IPR000308 (PIRSF); IPR023410 (SMART); IPR023410 (PFAM); G3DSA:1.20.190.20 (GENE3D); IPR000308 (PANTHER); PTHR18860:SF14 (PANTHER); IPR023409 (PROSITE_PATTERNS); IPR023409 (PROSITE_PATTERNS); IPR023410 (SUPERFAMILY)
F7BFJ1	prothrombin	623	20	0E0	90.7%	5	F:GO:0005509; P:GO:0006508; F:GO:0004252; P:GO:0007596; C:GO:0005576	F:calcium ion binding; P:proteolysis; F:serine-type endopeptidase activity; P:blood coagulation; C:extracellular region	EC:3.4.21	IPR003966 (PRINTS); IPR001314 (PRINTS); PR00018 (PRINTS); IPR000294 (PRINTS); IPR001254 (SMART); IPR000294 (SMART); IPR000001 (SMART); IPR003966 (PIRSF); G3DSA:2.40.10.10 (GENE3D); G3DSA:2.40.10.10 (GENE3D); IPR001254 (PFAM); IPR000001 (PFAM); IPR017857 (G3DSA:4.10.740.GENE3D); G3DSA:2.40.20.10 (GENE3D); IPR018992 (G3DSA:4.10.140.GENE3D); IPR018992 (PFAM); G3DSA:2.40.10.10 (GENE3D); IPR000294 (PFAM); G3DSA:2.40.20.10 (GENE3D); IPR003966 (PTHR24254:PANTHER); PTHR24254 (PANTHER); IPR033116 (PROSITE_PATTERNS); IPR018056 (PROSITE_PATTERNS); IPR000294 (PROSITE_PATTERNS); IPR018114 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR000294 (PROSITE_PROFILES); IPR000001 (PROSITE_PROFILES); IPR001254 (PROSITE_PROFILES); IPR000294 (SUPERFAMILY); IPR013806 (SUPERFAMILY); IPR009003 (SUPERFAMILY); IPR013806 (SUPERFAMILY)
F7B7X0	type II cytoskeletal 1	639	20	0E0	91.9%	2	C:GO:0045095; F:GO:0005198	C:keratin filament; F:structural molecule activity		IPR003054 (PRINTS); IPR001664 (SMART); IPR001664 (PFAM); G3DSA:1.20.5.170 (GENE3D); IPR032449 (PFAM); IPR032444 (PFAM); IPR001664 (PANTHER); PTHR23239:SF95 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
F6XWM5	haptoglobin	346	20	0E0	90.75%	5	C:GO:0005833; F:GO:0030492; P:GO:0006508; F:GO:0004252; C:GO:0005576	C:hemoglobin complex; F:hemoglobin binding; P:proteolysis; F:serine-type endopeptidase activity; C:extracellular region	EC:3.4.21	IPR001314 (PRINTS); IPR008292 (PIRSF); IPR001254 (SMART); G3DSA:2.40.10.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.40.10.10 (GENE3D); G3DSA:2.40.10.10 (GENE3D); IPR001254 (PFAM); PTHR24256 (PANTHER); PTHR24256:SF128 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR000436 (PROSITE_PROFILES); IPR001254 (PROSITE_PROFILES); IPR000436 (SUPERFAMILY); IPR009003 (SUPERFAMILY)
F7D9J2	transketolase	595	20	0E0	98.15%	2	F:GO:0003824; P:GO:0008152	F:catalytic activity; P:metabolic process		IPR005475 (SMART); IPR033248 (PFAM); IPR005475 (PFAM); IPR029061 (G3DSA:3.40.50.GENE3D); IPR005474 (PFAM); IPR009014 (G3DSA:3.40.50.GENE3D); IPR029061 (G3DSA:3.40.50.GENE3D); IPR033247 (PANTHER); PTHR11624:SF59 (PANTHER); IPR020826 (PROSITE_PATTERNS); IPR029061 (SUPERFAMILY); IPR029061 (SUPERFAMILY); IPR009014 (SUPERFAMILY)
F6SJK9	type I cytoskeletal 10	346	20	0E0	97.55%	2	F:GO:0005198; C:GO:0005882	F:structural molecule activity; C:intermediate filament		IPR002957 (PRINTS); IPR001664 (SMART); IPR001664 (PFAM); G3DSA:1.20.5.170 (GENE3D); IPR001664 (PANTHER); PTHR23239:SF137 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
F6SS14	type I cytoskeletal 10 isoform X1	471	20	0E0	98.15%	2	F:GO:0005198; C:GO:0005882	F:structural molecule activity; C:intermediate filament		IPR002957 (PRINTS); IPR001664 (SMART); G3DSA:1.20.5.170 (GENE3D); IPR001664 (PFAM); IPR001664 (PANTHER); PTHR23239:SF137 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
F6Z041	beta-2-glyco 1	345	20	0E0	93.25%	27	P:GO:0016525; P:GO:0034392; P:GO:0030193; P:GO:0030195; P:GO:0007597; P:GO:0006641; F:GO:0008289; F:GO:0008201; C:GO:0005576; C:GO:0070062; P:GO:0031639; F:GO:0001948; C:GO:0031012; P:GO:0010596; P:GO:0051006; C:GO:0034361; F:GO:0042802; C:GO:0042627; P:GO:0051918; C:GO:0034364; P:GO:0033033; P:GO:0051917; F:GO:0060230; F:GO:0005543; C:GO:0009986; C:GO:0005615; P:GO:0001937	P:negative regulation of angiogenesis; P:negative regulation of smooth muscle cell apoptotic process; P:regulation of blood coagulation; P:negative regulation of blood coagulation; P:blood coagulation, intrinsic pathway; P:triglyceride metabolic process; F:lipid binding; F:heparin binding; C:extracellular region; C:extracellular exosome; P:plasminogen activation; F:glycoprotein binding; C:extracellular matrix; P:negative regulation of endothelial cell migration; P:positive regulation of lipoprotein lipase activity; C:very-low-density lipoprotein particle; F:identical protein binding; C:chylomicron; P:negative regulation of fibrinolysis; C:high-density lipoprotein particle; P:negative regulation of myeloid cell apoptotic process; P:regulation of fibrinolysis; F:lipoprotein lipase activator activity; F:phospholipid binding; C:cell surface; C:extracellular space; P:negative regulation of endothelial cell proliferation		IPR000436 (SMART); IPR000436 (PFAM); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); IPR015104 (PFAM); G3DSA:2.10.70.10 (GENE3D); PTHR19325:SF323 (PANTHER); PTHR19325 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR015104 (PRODOM); IPR000436 (PROSITE_PROFILES); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY)
F6UPN4	spectrin alpha non-erythrocytic 1 isoform X1	588	20	0E0	99.9%	2	F:GO:0005515; F:GO:0005509	F:protein binding; F:calcium ion binding		IPR001452 (PRINTS); IPR013315 (PRINTS); IPR002048 (SMART); IPR018159 (SMART); IPR001452 (SMART); SM01184 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR002048 (PFAM); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.5.170 (GENE3D); IPR014837 (PFAM); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR002017 (PFAM); IPR001452 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); G3DSA:2.30.30.40 (GENE3D); G3DSA:1.20.58.60 (GENE3D); PTHR11915 (PANTHER); PTHR11915:SF283 (PANTHER); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR011992 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001452 (SUPERFAMILY); SSF46966 (SUPERFAMILY)
F6RUZ6	fibrinogen alpha chain	795	20	0E0	78.55%	6	P:GO:0051258; P:GO:0007165; F:GO:0005102; F:GO:0030674; P:GO:0030168; C:GO:0005577	P:protein polymerization; P:signal transduction; F:receptor binding; F:protein binding, bridging; P:platelet activation; C:fibrinogen complex		IPR012290 (SMART); IPR002181 (SMART); IPR014716 (G3DSA:3.90.215.GENE3D); IPR014715 (G3DSA:4.10.530.GENE3D); IPR021996 (PFAM); IPR002181 (PFAM); G3DSA:1.20.5.50 (GENE3D); IPR012290 (PFAM); PTHR19143 (PANTHER); PTHR19143:SF232 (PANTHER); IPR020837 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR002181 (PROSITE_PROFILES); IPR002181 (SUPERFAMILY); SSF58010 (SUPERFAMILY)
F7D7M0	galectin-3-binding isoform X1	567	20	0E0	87.4%	4	F:GO:0005515; P:GO:0007165; C:GO:0016020; F:GO:0005044	F:protein binding; P:signal transduction; C:membrane; F:scavenger receptor activity		IPR001190 (PRINTS); IPR017448 (SMART); IPR000210 (SMART); IPR011705 (SMART); G3DSA:3.30.710.10 (GENE3D); IPR001190 (PFAM); IPR011705 (PFAM); IPR017448 (G3DSA:3.10.250.GENE3D); IPR001190 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR001190 (PROSITE_PROFILES); IPR000210 (PROSITE_PROFILES); IPR017448 (SUPERFAMILY); IPR011333 (SUPERFAMILY)
F6SQQ0	type I cytoskeletal 10	381	20	0E0	97.6%	2	F:GO:0005198; C:GO:0005882	F:structural molecule activity; C:intermediate filament		IPR002957 (PRINTS); IPR001664 (SMART); IPR001664 (PFAM); G3DSA:1.20.5.170 (GENE3D); IPR001664 (PANTHER); PTHR23239:SF137 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
F6WDW3	type I cytoskeletal 10 isoform X1	393	20	0E0	98.45%	2	F:GO:0005198; C:GO:0005882	F:structural molecule activity; C:intermediate filament		IPR002957 (PRINTS); IPR001664 (SMART); IPR001664 (PFAM); G3DSA:1.20.5.170 (GENE3D); PTHR23239:SF137 (PANTHER); IPR001664 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
F6UZH0	AMBP	352	20	0E0	89.8%	2	F:GO:0004867; F:GO:0036094	F:serine-type endopeptidase inhibitor activity; F:small molecule binding		IPR002223 (PRINTS); IPR002968 (PRINTS); IPR002345 (PRINTS); IPR002223 (SMART); IPR002223 (G3DSA:4.10.410.GENE3D); IPR000566 (PFAM); IPR012674 (G3DSA:2.40.128.GENE3D); IPR002223 (G3DSA:4.10.410.GENE3D); IPR002223 (PFAM); PTHR10083 (PANTHER); IPR029856 (PTHR10083:PANTHER); IPR020901 (PROSITE_PATTERNS); IPR022272 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR002223 (PROSITE_PROFILES); IPR011038 (SUPERFAMILY); IPR002223 (SUPERFAMILY); IPR002223 (SUPERFAMILY)
F7DXM5	alpha-1-antitrypsin	422	20	0E0	96.05%	1	C:GO:0005615	C:extracellular space		IPR023796 (SMART); G3DSA:3.30.497.10 (GENE3D); IPR023796 (PFAM); G3DSA:2.30.39.10 (GENE3D); PTHR11461:SF165 (PANTHER); IPR000215 (PANTHER); IPR023795 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR023796 (SUPERFAMILY)
A0A0B4J1C4	immunoglobulin J chain	158	20	1.12E-113	93.4%	22	F:GO:0042834; P:GO:0060267; F:GO:0042803; P:GO:0032461; P:GO:0003094; P:GO:0002250; F:GO:0003697; P:GO:0001895; C:GO:0005615; C:GO:0070062; C:GO:0071750; C:GO:0071751; P:GO:0045087; C:GO:0072562; P:GO:0006959; C:GO:0071752; P:GO:0019731; F:GO:0019862; F:GO:0031210; C:GO:0071748; C:GO:0071756; F:GO:0034987	F:peptidoglycan binding; P:positive regulation of respiratory burst; F:protein homodimerization activity; P:positive regulation of protein oligomerization; P:glomerular filtration; P:adaptive immune response; F:single-stranded DNA binding; P:retina homeostasis; C:extracellular space; C:extracellular exosome; C:dimeric IgA immunoglobulin complex; C:secretory IgA immunoglobulin complex; P:innate immune response; C:blood microparticle; P:humoral immune response; C:secretory dimeric IgA immunoglobulin complex; P:antibacterial humoral response; F:IgA binding; F:phosphatidylcholine binding; C:monomeric IgA immunoglobulin complex; C:pentameric IgM immunoglobulin complex; F:immunoglobulin receptor binding		IPR024110 (PFAM); PTHR10070:SF2 (PANTHER); IPR024110 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR024110 (PRODOM)
F6X1X3	vitelline membrane outer layer 1 homolog	200	20	4.6E-144	89.65%	1	C:GO:0070062	C:extracellular exosome		IPR005515 (G3DSA:2.100.10.GENE3D); IPR005515 (PFAM); PTHR18841:SF3 (PANTHER); IPR005515 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR005515 (SUPERFAMILY)
F6UPQ8	spectrin alpha non-erythrocytic 1 isoform X1	593	20	0E0	99.9%	2	F:GO:0005515; F:GO:0005509	F:protein binding; F:calcium ion binding		IPR001452 (PRINTS); IPR013315 (PRINTS); IPR018159 (SMART); SM01184 (SMART); IPR002048 (SMART); IPR001452 (SMART); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR002048 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); G3DSA:1.20.5.170 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR002017 (PFAM); IPR001452 (PFAM); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR014837 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); G3DSA:2.30.30.40 (GENE3D); PTHR11915:SF283 (PANTHER); PTHR11915 (PANTHER); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR011992 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001452 (SUPERFAMILY); SSF46966 (SUPERFAMILY)
F6RGN2	fatty acid-binding epidermal	135	20	7.97E-95	97.7%	3	F:GO:0008289; P:GO:0006810; F:GO:0005215	F:lipid binding; P:transport; F:transporter activity		IPR000463 (PRINTS); IPR012674 (G3DSA:2.40.128.GENE3D); IPR000566 (PFAM); PTHR11955:SF58 (PANTHER); IPR031259 (PANTHER); IPR000463 (PROSITE_PATTERNS); IPR011038 (SUPERFAMILY)
F6YG82	78 kDa glucose-regulated	652	20	0E0	99%	39	F:GO:0016887; C:GO:0043209; C:GO:0005793; P:GO:0006983; C:GO:0005789; F:GO:0000166; F:GO:0005524; C:GO:0005788; P:GO:0021680; C:GO:0070062; C:GO:0005925; P:GO:0071353; P:GO:0031398; P:GO:0035437; F:GO:0001948; C:GO:0034663; C:GO:0008180; P:GO:0051603; F:GO:0051787; F:GO:0019904; P:GO:0021589; C:GO:0005783; F:GO:0051082; P:GO:1901998; C:GO:0005886; P:GO:0042149; P:GO:0021762; C:GO:0009986; C:GO:0005634; P:GO:0006987; F:GO:0031625; P:GO:0043066; F:GO:0043022; C:GO:0016020; C:GO:0030176; C:GO:0030496; P:GO:0030512; F:GO:0019899; P:GO:0030335	F:ATPase activity; C:myelin sheath; C:endoplasmic reticulum-Golgi intermediate compartment; P:ER overload response; C:endoplasmic reticulum membrane; F:nucleotide binding; F:ATP binding; C:endoplasmic reticulum lumen; P:cerebellar Purkinje cell layer development; C:extracellular exosome; C:focal adhesion; P:cellular response to interleukin-4; P:positive regulation of protein ubiquitination; P:maintenance of protein localization in endoplasmic reticulum; F:glycoprotein binding; C:endoplasmic reticulum chaperone complex; C:COP9 signalosome; P:proteolysis involved in cellular protein catabolic process; F:misfolded protein binding; F:protein domain specific binding; P:cerebellum structural organization; C:endoplasmic reticulum; F:unfolded protein binding; P:toxin transport; C:plasma membrane; P:cellular response to glucose starvation; P:substantia nigra development; C:cell surface; C:nucleus; P:activation of signaling protein activity involved in unfolded protein response; F:ubiquitin protein ligase binding; P:negative regulation of apoptotic process; F:ribosome binding; C:membrane; C:integral component of endoplasmic reticulum membrane; C:midbody; P:negative regulation of transforming growth factor beta receptor signaling pathway; F:enzyme binding; P:positive regulation of cell migration		IPR013126 (PRINTS); IPR029047 (G3DSA:2.60.34.GENE3D); IPR013126 (PFAM); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR029048 (G3DSA:1.20.1270.GENE3D); G3DSA:3.90.640.10 (GENE3D); G3DSA:3.30.30.30 (GENE3D); PTHR19375 (PANTHER); PTHR19375:SF157 (PANTHER); IPR018181 (PROSITE_PATTERNS); IPR018181 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SSF53067 (SUPERFAMILY); IPR029048 (SUPERFAMILY); IPR029047 (SUPERFAMILY); SSF53067 (SUPERFAMILY)
F6QIZ4	talin-1 isoform X2	652	20	0E0	99.2%	7	F:GO:0051015; C:GO:0005856; C:GO:0005925; C:GO:0001726; F:GO:0005200; P:GO:0007155; P:GO:0007016	F:actin filament binding; C:cytoskeleton; C:focal adhesion; C:ruffle; F:structural constituent of cytoskeleton; P:cell adhesion; P:cytoskeletal anchoring at plasma membrane		SM01244 (SMART); IPR019749 (SMART); IPR002558 (SMART); G3DSA:1.20.1490.10 (GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR018979 (PFAM); IPR032425 (PFAM); IPR015009 (PFAM); IPR014352 (G3DSA:1.20.80.GENE3D); G3DSA:1.20.1440.10 (GENE3D); IPR019748 (PFAM); IPR015224 (PFAM); IPR015224 (G3DSA:1.20.1420.GENE3D); IPR002558 (PFAM); IPR002558 (G3DSA:1.20.1410.GENE3D); PTHR19981 (PANTHER); IPR015710 (PTHR19981:PANTHER); IPR019747 (PROSITE_PATTERNS); IPR019747 (PROSITE_PATTERNS); IPR002558 (PRODOM); IPR002558 (PROSITE_PROFILES); IPR000299 (PROSITE_PROFILES); IPR006077 (SUPERFAMILY); IPR002558 (SUPERFAMILY); IPR015224 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR002558 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR019748 (SUPERFAMILY); IPR002558 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR002558 (SUPERFAMILY); IPR029071 (SUPERFAMILY)
F6RZP8	talin-1 isoform X2	655	20	0E0	99.2%	7	F:GO:0051015; C:GO:0005856; C:GO:0005925; C:GO:0001726; F:GO:0005200; P:GO:0007155; P:GO:0007016	F:actin filament binding; C:cytoskeleton; C:focal adhesion; C:ruffle; F:structural constituent of cytoskeleton; P:cell adhesion; P:cytoskeletal anchoring at plasma membrane		SM01244 (SMART); IPR019749 (SMART); IPR002558 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); IPR032425 (PFAM); G3DSA:1.20.1440.10 (GENE3D); IPR002558 (G3DSA:1.20.1410.GENE3D); IPR015224 (PFAM); IPR019748 (PFAM); IPR015224 (G3DSA:1.20.1420.GENE3D); IPR015009 (PFAM); IPR002558 (PFAM); IPR018979 (PFAM); IPR014352 (G3DSA:1.20.80.GENE3D); G3DSA:1.20.1490.10 (GENE3D); PTHR19981 (PANTHER); IPR015710 (PTHR19981:PANTHER); IPR019747 (PROSITE_PATTERNS); IPR019747 (PROSITE_PATTERNS); IPR002558 (PRODOM); IPR002558 (PROSITE_PROFILES); IPR000299 (PROSITE_PROFILES); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR002558 (SUPERFAMILY); IPR002558 (SUPERFAMILY); IPR015224 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR019748 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR002558 (SUPERFAMILY); IPR002558 (SUPERFAMILY); IPR029071 (SUPERFAMILY)
F6PN89	talin-1 isoform X2	674	20	0E0	99.2%	7	F:GO:0051015; C:GO:0005856; C:GO:0005925; C:GO:0001726; F:GO:0005200; P:GO:0007155; P:GO:0007016	F:actin filament binding; C:cytoskeleton; C:focal adhesion; C:ruffle; F:structural constituent of cytoskeleton; P:cell adhesion; P:cytoskeletal anchoring at plasma membrane		SM01244 (SMART); IPR002558 (SMART); IPR019749 (SMART); G3DSA:1.20.1440.10 (GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR002558 (PFAM); IPR018979 (PFAM); IPR015009 (PFAM); IPR032425 (PFAM); IPR015224 (PFAM); G3DSA:1.20.1490.10 (GENE3D); IPR002558 (G3DSA:1.20.1410.GENE3D); IPR015224 (G3DSA:1.20.1420.GENE3D); IPR019748 (PFAM); IPR014352 (G3DSA:1.20.80.GENE3D); PTHR19981 (PANTHER); IPR015710 (PTHR19981:PANTHER); IPR019747 (PROSITE_PATTERNS); IPR019747 (PROSITE_PATTERNS); IPR002558 (PRODOM); IPR002558 (PROSITE_PROFILES); IPR000299 (PROSITE_PROFILES); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR029071 (SUPERFAMILY); IPR002558 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR002558 (SUPERFAMILY); IPR002558 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR015224 (SUPERFAMILY); IPR019748 (SUPERFAMILY); IPR002558 (SUPERFAMILY); IPR006077 (SUPERFAMILY)
Q9GKX7	heat shock HSP 90-alpha	733	20	0E0	99.15%	4	F:GO:0005524; F:GO:0051082; P:GO:0006457; P:GO:0006950	F:ATP binding; F:unfolded protein binding; P:protein folding; P:response to stress		IPR020575 (PRINTS); IPR001404 (PIRSF); IPR003594 (SMART); IPR001404 (PFAM); IPR003594 (G3DSA:3.30.565.GENE3D); IPR003594 (PFAM); PTHR11528:SF58 (PANTHER); IPR001404 (PANTHER); IPR019805 (PROSITE_PATTERNS); IPR001404 (HAMAP); IPR003594 (SUPERFAMILY); SSF110942 (SUPERFAMILY); IPR020568 (SUPERFAMILY)
F7B762	pro-epidermal growth factor isoform X1	1211	20	0E0	88.25%	2	F:GO:0005515; F:GO:0005509	F:protein binding; F:calcium ion binding		PR00009 (PRINTS); IPR000033 (SMART); IPR016317 (PIRSF); IPR000742 (SMART); IPR001881 (SMART); G3DSA:2.10.25.10 (GENE3D); PF14670 (PFAM); IPR000742 (PFAM); IPR011042 (G3DSA:2.120.10.GENE3D); IPR000033 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR001881 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR023413 (G3DSA:2.40.155.GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR011042 (G3DSA:2.120.10.GENE3D); PTHR10529 (PANTHER); PTHR10529:SF200 (PANTHER); IPR018097 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000033 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF63825 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR009030 (SUPERFAMILY); SSF63825 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR009030 (SUPERFAMILY)
F7B726	pro-epidermal growth factor isoform X1	1210	20	0E0	88.2%	2	F:GO:0005515; F:GO:0005509	F:protein binding; F:calcium ion binding		PR00009 (PRINTS); IPR000033 (SMART); IPR001881 (SMART); IPR000742 (SMART); IPR016317 (PIRSF); IPR011042 (G3DSA:2.120.10.GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR001881 (PFAM); IPR023413 (G3DSA:2.40.155.GENE3D); PF14670 (PFAM); IPR000742 (PFAM); IPR000033 (PFAM); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR011042 (G3DSA:2.120.10.GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); PTHR10529 (PANTHER); PTHR10529:SF200 (PANTHER); IPR013032 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR000742 (PROSITE_PROFILES); IPR000033 (PROSITE_PROFILES); IPR009030 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF63825 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF63825 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY)
F6WFZ5	serpin B3-like	374	20	0E0	87.3%	1	C:GO:0005615	C:extracellular space		IPR023796 (SMART); IPR023796 (PFAM); G3DSA:2.30.39.10 (GENE3D); G3DSA:3.30.497.10 (GENE3D); PTHR11461:SF186 (PANTHER); IPR000215 (PANTHER); IPR023795 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR023796 (SUPERFAMILY)
F7DU87	BPI fold-containing family A member 2	249	20	1.51E-174	76.15%	1	F:GO:0008289	F:lipid binding		G3DSA:3.15.10.10 (GENE3D); IPR017942 (PFAM); IPR032942 (PANTHER); PTHR10504:SF6 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR017943 (SUPERFAMILY)
F7C0D9	kininogen-1 isoform X1	645	20	0E0	84.05%	1	F:GO:0004869	F:cysteine-type endopeptidase inhibitor activity		IPR002395 (PRINTS); IPR000010 (SMART); IPR000010 (PFAM); G3DSA:3.10.450.10 (GENE3D); PTHR13814:SF12 (PANTHER); PTHR13814 (PANTHER); IPR018073 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); PD001838 (PRODOM); IPR027358 (PROSITE_PROFILES); SSF54403 (SUPERFAMILY); SSF54403 (SUPERFAMILY); SSF54403 (SUPERFAMILY)
F7D917	6-phosphogluconate decarboxylating	483	20	0E0	97.95%	4	F:GO:0004616; P:GO:0006098; P:GO:0055114; P:GO:0019521	F:phosphogluconate dehydrogenase (decarboxylating) activity; P:pentose-phosphate shunt; P:oxidation-reduction process; P:D-gluconate metabolic process	EC:1.1.1.44	IPR006183 (PRINTS); IPR006113 (PIRSF); IPR006114 (SMART); IPR013328 (G3DSA:1.10.1040.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR006113 (TIGRFAM); IPR012284 (G3DSA:1.20.5.GENE3D); IPR006114 (PFAM); IPR006115 (PFAM); PTHR11811 (PANTHER); PTHR11811:SF31 (PANTHER); IPR006184 (PROSITE_PATTERNS); IPR016040 (SUPERFAMILY); IPR008927 (SUPERFAMILY)
F6X1I8	hemopexin	462	20	0E0	89.1%	3	P:GO:0006879; F:GO:0015232; P:GO:0015886	P:cellular iron ion homeostasis; F:heme transporter activity; P:heme transport		IPR018487 (SMART); IPR016358 (PIRSF); IPR000585 (G3DSA:2.110.10.GENE3D); IPR018487 (PFAM); IPR000585 (G3DSA:2.110.10.GENE3D); PTHR10201 (PANTHER); PTHR10201:SF136 (PANTHER); IPR018486 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR018487 (PROSITE_PROFILES); IPR000585 (SUPERFAMILY); IPR000585 (SUPERFAMILY)
F6QXN5	transgelin-2	204	20	1.39E-146	97.9%	1	F:GO:0005515	F:protein binding		PR00890 (PRINTS); IPR003096 (PRINTS); IPR001715 (SMART); IPR001715 (G3DSA:1.10.418.GENE3D); IPR000557 (PFAM); IPR001715 (PFAM); PTHR18959 (PANTHER); IPR000557 (PROSITE_PATTERNS); IPR001715 (PROSITE_PROFILES); IPR000557 (PROSITE_PROFILES); IPR001715 (SUPERFAMILY)
F6WA57	plastin-2	628	20	0E0	99.05%	2	F:GO:0005515; F:GO:0005509	F:protein binding; F:calcium ion binding		IPR002048 (SMART); IPR001715 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); IPR002048 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); IPR001715 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); PTHR19961 (PANTHER); PTHR19961:SF35 (PANTHER); IPR001589 (PROSITE_PATTERNS); IPR018247 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); IPR001715 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY); IPR001715 (SUPERFAMILY)
P00559	phosphoglycerate kinase 1	417	20	0E0	98.25%	4	P:GO:0006094; F:GO:0004618; P:GO:0006096; P:GO:0015976	P:gluconeogenesis; F:phosphoglycerate kinase activity; P:glycolytic process; P:carbon utilization	EC:2.7.2.3	IPR001576 (PRINTS); IPR001576 (PIRSF); IPR015901 (G3DSA:3.40.50.GENE3D); IPR015824 (G3DSA:3.40.50.GENE3D); IPR001576 (PFAM); PTHR11406:SF12 (PANTHER); IPR001576 (PANTHER); IPR015911 (PROSITE_PATTERNS); IPR001576 (HAMAP); IPR001576 (SUPERFAMILY)
F7A559		610				2	C:GO:0045095; F:GO:0005198	C:keratin filament; F:structural molecule activity		IPR003054 (PRINTS); IPR001664 (SMART); G3DSA:1.20.5.170 (GENE3D); IPR032444 (PFAM); IPR032449 (PFAM); IPR001664 (PFAM); IPR001664 (PANTHER); PTHR23239:SF134 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
F6R1X9	alpha cardiac muscle 1	377	20	0E0	99.75%	37	F:GO:0016887; P:GO:0060047; P:GO:0090131; P:GO:0060048; F:GO:0000166; F:GO:0005524; P:GO:0045471; C:GO:0070062; C:GO:0005925; C:GO:0072562; P:GO:0006915; F:GO:0017022; C:GO:0005829; P:GO:0055003; C:GO:0031674; P:GO:0030048; P:GO:0055008; P:GO:0030049; C:GO:0030027; P:GO:0031032; P:GO:0033275; P:GO:0030240; P:GO:0035050; C:GO:0005884; C:GO:0042643; C:GO:0005615; C:GO:0005856; F:GO:0005515; C:GO:0005737; P:GO:0042493; P:GO:0043066; P:GO:0070252; P:GO:0010628; C:GO:0044297; C:GO:0016020; C:GO:0030175; C:GO:0030017	F:ATPase activity; P:heart contraction; P:mesenchyme migration; P:cardiac muscle contraction; F:nucleotide binding; F:ATP binding; P:response to ethanol; C:extracellular exosome; C:focal adhesion; C:blood microparticle; P:apoptotic process; F:myosin binding; C:cytosol; P:cardiac myofibril assembly; C:I band; P:actin filament-based movement; P:cardiac muscle tissue morphogenesis; P:muscle filament sliding; C:lamellipodium; P:actomyosin structure organization; P:actin-myosin filament sliding; P:skeletal muscle thin filament assembly; P:embryonic heart tube development; C:actin filament; C:actomyosin, actin portion; C:extracellular space; C:cytoskeleton; F:protein binding; C:cytoplasm; P:response to drug; P:negative regulation of apoptotic process; P:actin-mediated cell contraction; P:positive regulation of gene expression; C:cell body; C:membrane; C:filopodium; C:sarcomere		IPR004000 (PRINTS); IPR004000 (SMART); G3DSA:3.90.640.10 (GENE3D); IPR004000 (PFAM); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); PTHR11937:SF238 (PANTHER); IPR004000 (PANTHER); IPR020902 (PROSITE_PATTERNS); IPR004001 (PROSITE_PATTERNS); IPR004001 (PROSITE_PATTERNS); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY)
F7CW82	aortic smooth muscle	377	20	0E0	99.55%	29	P:GO:0090131; P:GO:0009615; F:GO:0000166; F:GO:0005524; C:GO:0005865; C:GO:0070062; P:GO:0048741; P:GO:0006936; P:GO:0072144; C:GO:0001725; C:GO:0015629; C:GO:0032982; C:GO:0005829; C:GO:0030485; C:GO:0030027; F:GO:0019901; P:GO:0030240; F:GO:0005200; C:GO:0043234; C:GO:0005884; P:GO:0008217; C:GO:0005615; C:GO:0005856; F:GO:0005515; C:GO:0005737; P:GO:0014829; P:GO:0010628; C:GO:0044297; C:GO:0030175	P:mesenchyme migration; P:response to virus; F:nucleotide binding; F:ATP binding; C:striated muscle thin filament; C:extracellular exosome; P:skeletal muscle fiber development; P:muscle contraction; P:glomerular mesangial cell development; C:stress fiber; C:actin cytoskeleton; C:myosin filament; C:cytosol; C:smooth muscle contractile fiber; C:lamellipodium; F:protein kinase binding; P:skeletal muscle thin filament assembly; F:structural constituent of cytoskeleton; C:protein complex; C:actin filament; P:regulation of blood pressure; C:extracellular space; C:cytoskeleton; F:protein binding; C:cytoplasm; P:vascular smooth muscle contraction; P:positive regulation of gene expression; C:cell body; C:filopodium		IPR004000 (PRINTS); IPR004000 (SMART); G3DSA:3.90.640.10 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR004000 (PFAM); G3DSA:3.30.420.40 (GENE3D); IPR004000 (PANTHER); PTHR11937:SF176 (PANTHER); IPR004001 (PROSITE_PATTERNS); IPR020902 (PROSITE_PATTERNS); IPR004001 (PROSITE_PATTERNS); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY)
P38029	alpha-1-antitrypsin	421	20	0E0	96%	1	C:GO:0005615	C:extracellular space		IPR023796 (SMART); IPR023796 (PFAM); G3DSA:3.30.497.10 (GENE3D); G3DSA:2.30.39.10 (GENE3D); PTHR11461:SF165 (PANTHER); IPR000215 (PANTHER); IPR023795 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR023796 (SUPERFAMILY)
F7DW69	heat shock 70 kDa 1B-like	642	20	0E0	99.25%	11	F:GO:0000166; F:GO:0005524; P:GO:0009408; P:GO:0007339; C:GO:0005737; P:GO:0043066; P:GO:0043154; C:GO:0044297; C:GO:0005739; C:GO:0002199; C:GO:0005622	F:nucleotide binding; F:ATP binding; P:response to heat; P:binding of sperm to zona pellucida; C:cytoplasm; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; C:cell body; C:mitochondrion; C:zona pellucida receptor complex; C:intracellular		IPR013126 (PRINTS); IPR029048 (G3DSA:1.20.1270.GENE3D); IPR029047 (G3DSA:2.60.34.GENE3D); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.30.30 (GENE3D); IPR013126 (PFAM); G3DSA:3.90.640.10 (GENE3D); G3DSA:3.30.420.40 (GENE3D); PTHR19375 (PANTHER); PTHR19375:SF236 (PANTHER); IPR018181 (PROSITE_PATTERNS); IPR018181 (PROSITE_PATTERNS); IPR018181 (PROSITE_PATTERNS); SSF53067 (SUPERFAMILY); IPR029048 (SUPERFAMILY); IPR029047 (SUPERFAMILY); SSF53067 (SUPERFAMILY)
Q9GKX8	heat shock HSP 90-beta	724	20	0E0	99.2%	4	F:GO:0005524; F:GO:0051082; P:GO:0006457; P:GO:0006950	F:ATP binding; F:unfolded protein binding; P:protein folding; P:response to stress		IPR020575 (PRINTS); IPR003594 (SMART); IPR001404 (PIRSF); IPR003594 (G3DSA:3.30.565.GENE3D); IPR003594 (PFAM); IPR001404 (PFAM); IPR001404 (PANTHER); IPR019805 (PROSITE_PATTERNS); IPR001404 (HAMAP); IPR003594 (SUPERFAMILY); SSF110942 (SUPERFAMILY); IPR020568 (SUPERFAMILY)
F6WIP4	major allergen Can f 1-like	176	20	3.19E-127	79.9%	5	P:GO:0001895; C:GO:0005615; C:GO:0070062; C:GO:0005576; P:GO:0006810	P:retina homeostasis; C:extracellular space; C:extracellular exosome; C:extracellular region; P:transport		IPR002450 (PRINTS); IPR012674 (G3DSA:2.40.128.GENE3D); IPR000566 (PFAM); PTHR11430:SF3 (PANTHER); PTHR11430 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR011038 (SUPERFAMILY)
F6Z8K0	gamma-enteric smooth muscle	376	20	0E0	99.8%	23	P:GO:0030240; P:GO:0090131; C:GO:0005884; F:GO:0000166; F:GO:0005524; C:GO:0005865; C:GO:0005615; C:GO:0005856; C:GO:0070062; C:GO:0005737; P:GO:0048741; P:GO:0006936; P:GO:0010628; C:GO:0072562; C:GO:0044297; C:GO:0001725; C:GO:0015629; C:GO:0032982; C:GO:0005829; C:GO:0030175; C:GO:0030017; C:GO:0030027; C:GO:0071944	P:skeletal muscle thin filament assembly; P:mesenchyme migration; C:actin filament; F:nucleotide binding; F:ATP binding; C:striated muscle thin filament; C:extracellular space; C:cytoskeleton; C:extracellular exosome; C:cytoplasm; P:skeletal muscle fiber development; P:muscle contraction; P:positive regulation of gene expression; C:blood microparticle; C:cell body; C:stress fiber; C:actin cytoskeleton; C:myosin filament; C:cytosol; C:filopodium; C:sarcomere; C:lamellipodium; C:cell periphery		IPR004000 (PRINTS); IPR004000 (SMART); G3DSA:3.90.640.10 (GENE3D); IPR004000 (PFAM); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR020902 (PROSITE_PATTERNS); IPR004001 (PROSITE_PATTERNS); IPR004001 (PROSITE_PATTERNS); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY)
F6RVM2	cornulin isoform X1	596	20	0E0	76.35%	1	F:GO:0005509	F:calcium ion binding		IPR013787 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR013787 (PFAM); IPR026792 (PTHR11639:PANTHER); PTHR11639 (PANTHER); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F7BTD2	serpin B3-like	378	20	0E0	88%	1	C:GO:0005615	C:extracellular space		IPR023796 (SMART); G3DSA:2.30.39.10 (GENE3D); IPR023796 (PFAM); G3DSA:3.30.497.10 (GENE3D); PTHR11461:SF186 (PANTHER); IPR000215 (PANTHER); IPR023795 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR023796 (SUPERFAMILY)
F7C6T2	adenosylhomocysteinase	431	20	0E0	93.35%	5	F:GO:0051287; P:GO:0019510; F:GO:0004013; P:GO:0006730; P:GO:0006555	F:NAD binding; P:S-adenosylhomocysteine catabolic process; F:adenosylhomocysteinase activity; P:one-carbon metabolic process; P:methionine metabolic process	EC:3.3.1.1; EC:3.3.1	IPR000043 (SMART); IPR015878 (SMART); IPR000043 (PIRSF); G3DSA:3.40.50.1480 (GENE3D); G3DSA:3.40.50.1480 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR000043 (PFAM); IPR000043 (TIGRFAM); IPR015878 (PFAM); IPR000043 (PANTHER); IPR020082 (PROSITE_PATTERNS); IPR020082 (PROSITE_PATTERNS); IPR000043 (HAMAP); SSF52283 (SUPERFAMILY); IPR016040 (SUPERFAMILY)
F6ZXQ2	type I cytoskeletal 19	394	20	0E0	94.55%	2	F:GO:0005198; C:GO:0005882	F:structural molecule activity; C:intermediate filament		IPR002957 (PRINTS); IPR001664 (SMART); G3DSA:1.20.5.170 (GENE3D); IPR001664 (PFAM); PTHR23239:SF14 (PANTHER); IPR001664 (PANTHER); IPR018039 (PROSITE_PATTERNS); IPR009053 (SUPERFAMILY); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
F6YU15	sweat gland latherin partial	228	20	2.59E-155	77.95%	1	F:GO:0008289	F:lipid binding		IPR017942 (PFAM); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR017943 (SUPERFAMILY)
F6TIR2	neutrophil gelatinase-associated lipocalin	199	20	4E-147	90.2%	3	F:GO:0036094; P:GO:0006810; F:GO:0005215	F:small molecule binding; P:transport; F:transporter activity		IPR003087 (PRINTS); IPR002345 (PRINTS); IPR000566 (PFAM); IPR012674 (G3DSA:2.40.128.GENE3D); PTHR11430 (PANTHER); PTHR11430:SF13 (PANTHER); IPR022272 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR011038 (SUPERFAMILY)
F7E0H3	tubulin beta chain	444	20	0E0	99.3%	5	F:GO:0005525; F:GO:0003924; F:GO:0005200; C:GO:0005874; P:GO:0007017	F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton; C:microtubule; P:microtubule-based process	EC:3.6.1; EC:3.6.1.15	IPR002453 (PRINTS); IPR000217 (PRINTS); IPR003008 (SMART); IPR018316 (SMART); IPR003008 (PFAM); IPR018316 (G3DSA:3.30.1330.GENE3D); IPR018316 (PFAM); IPR023123 (G3DSA:1.10.287.GENE3D); IPR003008 (G3DSA:3.40.50.GENE3D); IPR000217 (PANTHER); PTHR11588:SF105 (PANTHER); IPR013838 (PROSITE_PATTERNS); IPR017975 (PROSITE_PATTERNS); IPR008280 (SUPERFAMILY); IPR003008 (SUPERFAMILY)
F6V6R7	prolactin-inducible	146	20	6.09E-104	84.6%	1	C:GO:0005576	C:extracellular region		IPR007990 (PIRSF); IPR007990 (PFAM); PTHR15096:SF5 (PANTHER); PTHR15096 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007990 (PRODOM); IPR014756 (SUPERFAMILY)
F7E3Y7	heat shock beta-1	209	20	2.52E-150	93.2%	46	P:GO:0038033; P:GO:1903202; P:GO:1902176; P:GO:0043122; C:GO:0045202; C:GO:0043204; P:GO:0009615; P:GO:0006469; P:GO:0006986; F:GO:0008426; P:GO:0045766; P:GO:0042535; C:GO:0030425; C:GO:0070062; C:GO:0043292; C:GO:0005925; F:GO:0043130; P:GO:2001028; C:GO:0031674; P:GO:0010976; C:GO:0031012; C:GO:0031430; P:GO:0070527; P:GO:0035556; C:GO:0030424; C:GO:0098839; F:GO:0005080; F:GO:0019901; F:GO:0042802; C:GO:0000502; C:GO:0005886; C:GO:0005622; P:GO:0043536; F:GO:0044822; P:GO:0001895; C:GO:0030018; C:GO:0005634; C:GO:0005615; C:GO:0005856; C:GO:0005737; C:GO:0097512; C:GO:0005819; P:GO:0035924; P:GO:0071901; P:GO:0032731; P:GO:2001234	P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; P:negative regulation of oxidative stress-induced cell death; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:regulation of I-kappaB kinase/NF-kappaB signaling; C:synapse; C:perikaryon; P:response to virus; P:negative regulation of protein kinase activity; P:response to unfolded protein; F:protein kinase C inhibitor activity; P:positive regulation of angiogenesis; P:positive regulation of tumor necrosis factor biosynthetic process; C:dendrite; C:extracellular exosome; C:contractile fiber; C:focal adhesion; F:ubiquitin binding; P:positive regulation of endothelial cell chemotaxis; C:I band; P:positive regulation of neuron projection development; C:extracellular matrix; C:M band; P:platelet aggregation; P:intracellular signal transduction; C:axon; C:postsynaptic density membrane; F:protein kinase C binding; F:protein kinase binding; F:identical protein binding; C:proteasome complex; C:plasma membrane; C:intracellular; P:positive regulation of blood vessel endothelial cell migration; F:poly(A) RNA binding; P:retina homeostasis; C:Z disc; C:nucleus; C:extracellular space; C:cytoskeleton; C:cytoplasm; C:cardiac myofibril; C:spindle; P:cellular response to vascular endothelial growth factor stimulus; P:negative regulation of protein serine/threonine kinase activity; P:positive regulation of interleukin-1 beta production; P:negative regulation of apoptotic signaling pathway		IPR001436 (PRINTS); IPR008978 (G3DSA:2.60.40.GENE3D); IPR002068 (PFAM); IPR031107 (PANTHER); PTHR11527:SF114 (PANTHER); IPR002068 (PROSITE_PROFILES); IPR008978 (SUPERFAMILY)
F7BV85	clathrin heavy chain 1 isoform X2	1685	20	0E0	99.3%	6	F:GO:0005515; P:GO:0016192; C:GO:0030130; C:GO:0030132; F:GO:0005198; P:GO:0006886	F:protein binding; P:vesicle-mediated transport; C:clathrin coat of trans-Golgi network vesicle; C:clathrin coat of coated pit; F:structural molecule activity; P:intracellular protein transport		IPR000547 (SMART); IPR016341 (PIRSF); IPR000547 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR022365 (PFAM); IPR016025 (G3DSA:2.130.10.GENE3D); IPR015348 (PFAM); PF13838 (PFAM); PTHR10292 (PANTHER); PTHR10292:SF7 (PANTHER); IPR000547 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR001473 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
F6UUS3	elongation factor 2	856	20	0E0	99%	2	F:GO:0005525; F:GO:0003924	F:GTP binding; F:GTPase activity	EC:3.6.1; EC:3.6.1.15	IPR000795 (PRINTS); IPR005517 (SMART); IPR000640 (SMART); G3DSA:2.40.30.10 (GENE3D); IPR005517 (PFAM); G3DSA:3.90.1430.10 (GENE3D); IPR000640 (G3DSA:3.30.70.GENE3D); IPR004161 (PFAM); G3DSA:3.30.70.870 (GENE3D); IPR000640 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PF00009 (PFAM); IPR009022 (PFAM); IPR014721 (G3DSA:3.30.230.GENE3D); IPR005225 (TIGRFAM); PTHR23115 (PANTHER); PTHR23115:SF103 (PANTHER); IPR031157 (PROSITE_PATTERNS); IPR000795 (PROSITE_PROFILES); IPR009022 (SUPERFAMILY); IPR009000 (SUPERFAMILY); IPR020568 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR009022 (SUPERFAMILY)
F6ZR63	complement factor H	1242	20	0E0	82.85%	12	P:GO:0006956; P:GO:0006957; C:GO:0005615; F:GO:0005515; P:GO:0030449; C:GO:0070062; P:GO:0045087; C:GO:0072562; F:GO:0043395; F:GO:0008201; C:GO:0005576; P:GO:0002376	P:complement activation; P:complement activation, alternative pathway; C:extracellular space; F:protein binding; P:regulation of complement activation; C:extracellular exosome; P:innate immune response; C:blood microparticle; F:heparan sulfate proteoglycan binding; F:heparin binding; C:extracellular region; P:immune system process		IPR000436 (SMART); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); IPR000436 (PFAM); G3DSA:2.10.70.10 (GENE3D); PTHR19325 (PANTHER); PTHR19325:SF373 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000436 (PROSITE_PROFILES); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY); IPR000436 (SUPERFAMILY)
F6SU04	calpain-1 catalytic subunit	713	20	0E0	96.9%	4	F:GO:0005509; P:GO:0006508; F:GO:0004198; C:GO:0005622	F:calcium ion binding; P:proteolysis; F:calcium-dependent cysteine-type endopeptidase activity; C:intracellular	EC:3.4.22; EC:3.4	IPR022684 (PRINTS); IPR001300 (SMART); IPR022683 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR001300 (PFAM); G3DSA:3.90.70.10 (GENE3D); IPR002048 (PFAM); IPR022682 (PFAM); G3DSA:2.60.120.380 (GENE3D); IPR029643 (PTHR10183:PANTHER); PTHR10183 (PANTHER); IPR000169 (PROSITE_PATTERNS); IPR018247 (PROSITE_PATTERNS); IPR001300 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY); SSF54001 (SUPERFAMILY); IPR022682 (SUPERFAMILY)
F6XEB4	14-3-3 zeta delta	245	20	2.07E-180	99.85%	1	F:GO:0019904	F:protein domain specific binding		IPR000308 (PRINTS); IPR000308 (PIRSF); IPR023410 (SMART); IPR023410 (PFAM); G3DSA:1.20.190.20 (GENE3D); IPR000308 (PANTHER); IPR023409 (PROSITE_PATTERNS); IPR023409 (PROSITE_PATTERNS); IPR023410 (SUPERFAMILY)
F6PKE1	inhibitor of carbonic anhydrase-like isoform X2	340	20	0E0	85.9%	3	P:GO:0043086; F:GO:0004857; C:GO:0005576	P:negative regulation of catalytic activity; F:enzyme inhibitor activity; C:extracellular region		IPR001156 (PRINTS); IPR001156 (SMART); G3DSA:3.40.190.10 (GENE3D); G3DSA:3.40.190.10 (GENE3D); IPR001156 (PFAM); PTHR11485 (PANTHER); IPR029785 (PTHR11485:PANTHER); IPR018195 (PROSITE_PATTERNS); IPR018195 (PROSITE_PATTERNS); IPR001156 (PROSITE_PROFILES); SSF53850 (SUPERFAMILY)
F6VIZ0	mucin-4 isoform X1	227	20	2.66E-150	86.55%	2	P:GO:0007160; F:GO:0005515	P:cell-matrix adhesion; F:protein binding		IPR003886 (SMART); IPR005533 (SMART); IPR000742 (SMART); IPR001846 (SMART); G3DSA:2.10.25.10 (GENE3D); IPR001846 (PFAM); IPR003886 (PFAM); PTHR13802 (PANTHER); PTHR13802:SF42 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR003886 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR005533 (PROSITE_PROFILES); IPR001846 (PROSITE_PROFILES)
F7DXG8	cofilin-1	166	20	1.17E-116	99.45%	3	F:GO:0003779; P:GO:0030042; C:GO:0015629	F:actin binding; P:actin filament depolymerization; C:actin cytoskeleton		IPR017904 (PRINTS); IPR002108 (SMART); IPR029006 (G3DSA:3.40.20.GENE3D); IPR002108 (PFAM); IPR017904 (PANTHER); IPR027234 (PTHR11913:PANTHER); IPR002108 (PROSITE_PROFILES); SSF55753 (SUPERFAMILY)
F7AY97	involucrin	276	20	2.57E-169	78.85%	9	P:GO:0030216; C:GO:0001533; C:GO:0070062; C:GO:0005737; F:GO:0005198; P:GO:0018149; P:GO:0031424; F:GO:0030674; P:GO:0010224	P:keratinocyte differentiation; C:cornified envelope; C:extracellular exosome; C:cytoplasm; F:structural molecule activity; P:peptide cross-linking; P:keratinization; F:protein binding, bridging; P:response to UV-B		IPR019571 (PFAM)
F7BPT4	ezrin isoform X1	586	20	0E0	98.15%	4	C:GO:0005856; F:GO:0003779; C:GO:0005737; C:GO:0019898	C:cytoskeleton; F:actin binding; C:cytoplasm; C:extrinsic component of membrane		IPR019749 (PRINTS); IPR000798 (PRINTS); IPR019749 (SMART); IPR011174 (PIRSF); IPR018980 (SMART); G3DSA:3.10.20.90 (GENE3D); IPR019748 (PFAM); IPR018979 (PFAM); IPR011259 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); G3DSA:1.20.5.450 (GENE3D); IPR014352 (G3DSA:1.20.80.GENE3D); IPR018980 (PFAM); PTHR23281 (PANTHER); PTHR23281:SF13 (PANTHER); IPR019747 (PROSITE_PATTERNS); IPR019747 (PROSITE_PATTERNS); IPR000299 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR019748 (SUPERFAMILY); IPR008954 (SUPERFAMILY)
F7BPX8	cathepsin L2	334	20	0E0	95.15%	2	P:GO:0006508; F:GO:0008234	P:proteolysis; F:cysteine-type peptidase activity	EC:3.4	IPR000668 (PRINTS); IPR013201 (SMART); IPR000668 (SMART); IPR013201 (PFAM); G3DSA:3.90.70.10 (GENE3D); IPR000668 (PFAM); IPR013128 (PANTHER); PTHR12411:SF390 (PANTHER); IPR025661 (PROSITE_PATTERNS); IPR025660 (PROSITE_PATTERNS); IPR000169 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SSF54001 (SUPERFAMILY)
F6VSN2	glutathione S-transferase P	210	20	6.27E-155	96.05%	4	P:GO:0006803; F:GO:0005515; P:GO:0006749; F:GO:0004364	P:obsolete glutathione conjugation reaction; F:protein binding; P:glutathione metabolic process; F:glutathione transferase activity	EC:2.5.1.18	IPR003082 (PRINTS); IPR012336 (G3DSA:3.40.30.GENE3D); IPR004046 (PFAM); IPR004045 (PFAM); IPR010987 (G3DSA:1.20.1050.GENE3D); PTHR11571 (PANTHER); PTHR11571:SF113 (PANTHER); IPR004045 (PROSITE_PROFILES); IPR010987 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR010987 (SUPERFAMILY)
F6RRV1	fetuin-B	374	20	0E0	78.05%	2	C:GO:0005615; F:GO:0004869	C:extracellular space; F:cysteine-type endopeptidase inhibitor activity		IPR000010 (SMART); G3DSA:3.10.450.10 (GENE3D); IPR000010 (PFAM); PTHR13814:SF10 (PANTHER); PTHR13814 (PANTHER); IPR001363 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR025764 (PROSITE_PROFILES); SSF54403 (SUPERFAMILY); SSF54403 (SUPERFAMILY)
F7ATS5	Golgi membrane 1	368	20	0E0	87.2%	7	C:GO:0005615; C:GO:0070062; C:GO:0016020; C:GO:0016021; C:GO:0005794; P:GO:0019216; P:GO:0006997	C:extracellular space; C:extracellular exosome; C:membrane; C:integral component of membrane; C:Golgi apparatus; P:regulation of lipid metabolic process; P:nucleus organization		IPR026139 (PRINTS); IPR026143 (PTHR15896:PANTHER); IPR026139 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); PS51257 (PROSITE_PROFILES)
P05619	leukocyte elastase inhibitor	379	20	0E0	93.2%	2	C:GO:0005615; F:GO:0004867	C:extracellular space; F:serine-type endopeptidase inhibitor activity		IPR023796 (SMART); G3DSA:3.30.497.10 (GENE3D); G3DSA:2.30.39.10 (GENE3D); IPR023796 (PFAM); IPR015557 (PTHR11461:PANTHER); IPR000215 (PANTHER); IPR023795 (PROSITE_PATTERNS); IPR023796 (SUPERFAMILY)
F6YCC0	cystatin-A	102	20	1.92E-69	92.4%	2	F:GO:0004869; C:GO:0005622	F:cysteine-type endopeptidase inhibitor activity; C:intracellular		IPR001713 (PRINTS); IPR000010 (SMART); IPR000010 (PFAM); G3DSA:3.10.450.10 (GENE3D); PTHR11414:SF20 (PANTHER); PTHR11414 (PANTHER); IPR018073 (PROSITE_PATTERNS); SSF54403 (SUPERFAMILY)
F6XAH7	deoxynucleoside triphosphate triphosphohydrolase SAMHD1	670	20	0E0	92.65%	1	F:GO:0005515	F:protein binding		IPR001660 (SMART); IPR003607 (SMART); IPR006674 (G3DSA:1.10.3210.GENE3D); IPR006674 (PFAM); IPR013761 (G3DSA:1.10.150.GENE3D); IPR001660 (PFAM); PTHR11373 (PANTHER); PTHR11373:SF28 (PANTHER); IPR001660 (PROSITE_PROFILES); IPR013761 (SUPERFAMILY); SSF109604 (SUPERFAMILY)
F6ZI35	histidine-rich glyco	236	20	1.16E-171	84.1%	1	F:GO:0004869	F:cysteine-type endopeptidase inhibitor activity		IPR000010 (SMART); IPR000010 (PFAM); G3DSA:3.10.450.10 (GENE3D); PTHR13814 (PANTHER); PTHR13814:SF3 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SSF54403 (SUPERFAMILY); SSF54403 (SUPERFAMILY)
F7E419	annexin A8	327	20	0E0	96.8%	2	F:GO:0005509; F:GO:0005544	F:calcium ion binding; F:calcium-dependent phospholipid binding		IPR001464 (PRINTS); IPR009115 (PRINTS); IPR018502 (SMART); IPR018502 (G3DSA:1.10.220.GENE3D); IPR018502 (G3DSA:1.10.220.GENE3D); IPR018502 (G3DSA:1.10.220.GENE3D); IPR018502 (PFAM); PTHR10502 (PANTHER); IPR018252 (PROSITE_PATTERNS); SSF47874 (SUPERFAMILY)
H9GZQ2	immunoglobulin heavy chain variable partial	98	20	6.08E-63	98.3%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F7DL17	inter-alpha-trypsin inhibitor heavy chain H2	946	20	0E0	95%	2	F:GO:0004867; P:GO:0030212	F:serine-type endopeptidase inhibitor activity; P:hyaluronan metabolic process		IPR002035 (SMART); IPR013694 (SMART); IPR002035 (PFAM); IPR010600 (PFAM); IPR013694 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); PTHR10338:SF14 (PANTHER); PTHR10338 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR013694 (PROSITE_PROFILES); IPR002035 (PROSITE_PROFILES); IPR002035 (SUPERFAMILY)
F7DAF6	inter-alpha-trypsin inhibitor heavy chain H2	949	20	0E0	94.8%	2	F:GO:0004867; P:GO:0030212	F:serine-type endopeptidase inhibitor activity; P:hyaluronan metabolic process		IPR002035 (SMART); IPR013694 (SMART); IPR010600 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); IPR013694 (PFAM); IPR002035 (PFAM); PTHR10338 (PANTHER); PTHR10338:SF14 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR013694 (PROSITE_PROFILES); IPR002035 (PROSITE_PROFILES); IPR002035 (SUPERFAMILY)
F7BSX5	MHC class I partial	387	20	0E0	85.9%	3	F:GO:0005515; P:GO:0006955; P:GO:0019882	F:protein binding; P:immune response; P:antigen processing and presentation		IPR001039 (PRINTS); IPR003597 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR011161 (PFAM); IPR011161 (G3DSA:3.30.500.GENE3D); IPR003597 (PFAM); IPR010579 (PFAM); PTHR16675 (PANTHER); PTHR16675:SF181 (PANTHER); IPR003006 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR011162 (SUPERFAMILY)
F7CY85	tubulin beta-2B chain	445	20	0E0	99.4%	5	F:GO:0005525; F:GO:0003924; F:GO:0005200; C:GO:0005874; P:GO:0007017	F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton; C:microtubule; P:microtubule-based process	EC:3.6.1; EC:3.6.1.15	IPR002453 (PRINTS); IPR000217 (PRINTS); IPR018316 (SMART); IPR003008 (SMART); IPR003008 (G3DSA:3.40.50.GENE3D); IPR003008 (PFAM); IPR023123 (G3DSA:1.10.287.GENE3D); IPR018316 (G3DSA:3.30.1330.GENE3D); IPR018316 (PFAM); IPR000217 (PANTHER); PTHR11588:SF138 (PANTHER); IPR017975 (PROSITE_PATTERNS); IPR013838 (PROSITE_PATTERNS); IPR008280 (SUPERFAMILY); IPR003008 (SUPERFAMILY)
F7C3Z3	lactoperoxidase	710	20	0E0	93.15%	5	P:GO:0006979; F:GO:0036393; P:GO:0055114; P:GO:0042742; F:GO:0020037	P:response to oxidative stress; F:thiocyanate peroxidase activity; P:oxidation-reduction process; P:defense response to bacterium; F:heme binding	EC:1.11.1.7	IPR019791 (PRINTS); IPR019791 (G3DSA:1.10.640.GENE3D); IPR019791 (PFAM); IPR029587 (PTHR11475:PANTHER); PTHR11475 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR019791 (PROSITE_PROFILES); IPR010255 (SUPERFAMILY)
F6Y014	F-actin-capping subunit beta isoform X2	272	20	0E0	100%	4	P:GO:0051016; F:GO:0003779; C:GO:0005737; C:GO:0008290	P:barbed-end actin filament capping; F:actin binding; C:cytoplasm; C:F-actin capping protein complex		IPR001698 (PRINTS); IPR001698 (PFAM); IPR001698 (PANTHER); IPR019771 (PROSITE_PATTERNS); SSF90096 (SUPERFAMILY)
F7CTJ3	inter-alpha-trypsin inhibitor heavy chain H2	947	20	0E0	94.7%	2	F:GO:0004867; P:GO:0030212	F:serine-type endopeptidase inhibitor activity; P:hyaluronan metabolic process		IPR002035 (SMART); IPR013694 (SMART); IPR002035 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); IPR013694 (PFAM); IPR010600 (PFAM); PTHR10338:SF14 (PANTHER); PTHR10338 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR013694 (PROSITE_PROFILES); IPR002035 (PROSITE_PROFILES); IPR002035 (SUPERFAMILY)
H9GZQ3	immunoglobulin heavy chain variable partial	100	20	1.53E-64	92.9%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F6QBE4	immunoglobulin lambda light chain variable partial	100	20	6.43E-64	96.95%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF198 (PANTHER); PTHR23267 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F6PP62	immunoglobulin lambda light chain variable partial	99	20	3.12E-63	98.5%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F7ATL5	type I cytoskeletal 14	354	20	0E0	98.4%	2	F:GO:0005198; C:GO:0005882	F:structural molecule activity; C:intermediate filament		IPR002957 (PRINTS); IPR001664 (SMART); G3DSA:1.20.5.170 (GENE3D); IPR001664 (PFAM); IPR001664 (PANTHER); PTHR23239:SF201 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY); IPR009053 (SUPERFAMILY)
F7AJE4	immunoglobulin lambda light chain variable partial	93	20	2.39E-58	97.6%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF198 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F7AIT9	immunoglobulin lambda light chain variable partial	107	20	1.51E-69	98.85%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF198 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
P30441	beta-2-microglobulin precursor	118	20	3.05E-82	91.8%	3	F:GO:0005515; P:GO:0006955; C:GO:0042612	F:protein binding; P:immune response; C:MHC class I protein complex		IPR003597 (SMART); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR19944 (PANTHER); IPR015707 (PTHR19944:PANTHER); IPR003006 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
A2Q0Z0	elongation factor 1-alpha 1	462	20	0E0	99.05%	5	F:GO:0005525; P:GO:0006448; F:GO:0003746; F:GO:0003924; C:GO:0005840	F:GTP binding; P:regulation of translational elongation; F:translation elongation factor activity; F:GTPase activity; C:ribosome	EC:3.6.1; EC:3.6.1.15	IPR000795 (PRINTS); IPR004539 (TIGRFAM); IPR004161 (PFAM); G3DSA:2.40.30.10 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:2.40.30.10 (GENE3D); IPR004160 (PFAM); PF00009 (PFAM); PTHR23115:SF116 (PANTHER); PTHR23115 (PANTHER); IPR031157 (PROSITE_PATTERNS); IPR004539 (HAMAP); IPR000795 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR009000 (SUPERFAMILY); IPR009001 (SUPERFAMILY)
F6UME7	elongation factor 1-alpha 1	462	20	0E0	99.7%	5	F:GO:0005525; P:GO:0006448; F:GO:0003746; F:GO:0003924; C:GO:0005840	F:GTP binding; P:regulation of translational elongation; F:translation elongation factor activity; F:GTPase activity; C:ribosome	EC:3.6.1; EC:3.6.1.15	IPR000795 (PRINTS); IPR004161 (PFAM); IPR004160 (PFAM); G3DSA:2.40.30.10 (GENE3D); IPR004539 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PF00009 (PFAM); G3DSA:2.40.30.10 (GENE3D); PTHR23115:SF116 (PANTHER); PTHR23115 (PANTHER); IPR031157 (PROSITE_PATTERNS); IPR004539 (HAMAP); IPR000795 (PROSITE_PROFILES); IPR009001 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR009000 (SUPERFAMILY)
F6REX3	alpha-2-macroglobulin-like	1475	20	0E0	90.75%	2	C:GO:0005615; F:GO:0004866	C:extracellular space; F:endopeptidase inhibitor activity		IPR001599 (SMART); IPR009048 (SMART); IPR011625 (SMART); IPR011626 (PFAM); IPR001599 (PFAM); IPR009048 (G3DSA:2.60.40.GENE3D); IPR011625 (PFAM); IPR009048 (PFAM); IPR019565 (PFAM); IPR008930 (G3DSA:1.50.10.GENE3D); IPR002890 (PFAM); PTHR11412 (PANTHER); PTHR11412:SF101 (PANTHER); IPR019742 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR014756 (SUPERFAMILY); IPR009048 (SUPERFAMILY); IPR008930 (SUPERFAMILY)
F6SHJ8	type II cytoskeletal 2 epidermal	594	20	0E0	90.55%	2	C:GO:0045095; F:GO:0005198	C:keratin filament; F:structural molecule activity		IPR003054 (PRINTS); IPR001664 (SMART); IPR001664 (PFAM); IPR032444 (PFAM); G3DSA:1.20.5.170 (GENE3D); IPR001664 (PANTHER); PTHR23239:SF200 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
F6VP61	serpin B10	397	20	0E0	91.7%	1	C:GO:0005615	C:extracellular space		IPR023796 (SMART); G3DSA:3.30.497.10 (GENE3D); IPR023796 (PFAM); G3DSA:2.30.39.10 (GENE3D); PTHR11461:SF175 (PANTHER); IPR000215 (PANTHER); IPR023795 (PROSITE_PATTERNS); IPR023796 (SUPERFAMILY)
F6TJS5	deleted in malignant brain tumors 1 - partial	233	20	2.17E-138	81.35%	3	P:GO:0007165; C:GO:0016020; F:GO:0005044	P:signal transduction; C:membrane; F:scavenger receptor activity		IPR001190 (PRINTS); IPR017448 (SMART); IPR001190 (PFAM); IPR017448 (G3DSA:3.10.250.GENE3D); PTHR19331 (PANTHER); PTHR19331:SF22 (PANTHER); IPR001190 (PROSITE_PATTERNS); IPR001190 (PROSITE_PROFILES); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY)
F6QMA1	serpin B3-like	388	20	0E0	91.95%	1	C:GO:0005615	C:extracellular space		IPR023796 (SMART); IPR023796 (PFAM); G3DSA:3.30.497.10 (GENE3D); G3DSA:2.30.39.10 (GENE3D); PTHR11461:SF186 (PANTHER); IPR000215 (PANTHER); IPR023795 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR023796 (SUPERFAMILY)
F7D2D9	flavin reductase (NADPH)	208	20	1.03E-144	93.55%	9	F:GO:0042602; C:GO:0070062; C:GO:0005737; F:GO:0004074; C:GO:0005829; P:GO:0042167; P:GO:0055114; C:GO:0005886; C:GO:0005654	F:riboflavin reductase (NADPH) activity; C:extracellular exosome; C:cytoplasm; F:biliverdin reductase activity; C:cytosol; P:heme catabolic process; P:oxidation-reduction process; C:plasma membrane; C:nucleoplasm		IPR016040 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR15020:SF8 (PANTHER); PTHR15020 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR016040 (SUPERFAMILY)
F7DS76	immunoglobulin lambda light chain variable partial	128	20	4.88E-76	96.3%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF198 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F6WQ44	sulfhydryl oxidase 1	710	20	0E0	83.7%	3	P:GO:0045454; P:GO:0055114; F:GO:0016972	P:cell redox homeostasis; P:oxidation-reduction process; F:thiol oxidase activity	EC:1.8.3.2	IPR013766 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR017905 (G3DSA:1.20.120.GENE3D); IPR017905 (PFAM); PTHR22897:SF6 (PANTHER); PTHR22897 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR013766 (PROSITE_PROFILES); IPR017905 (PROSITE_PROFILES); IPR017905 (SUPERFAMILY); IPR012336 (SUPERFAMILY)
F6WR95	sulfhydryl oxidase 1	742	20	0E0	84.2%	3	P:GO:0045454; P:GO:0055114; F:GO:0016972	P:cell redox homeostasis; P:oxidation-reduction process; F:thiol oxidase activity	EC:1.8.3.2	IPR017905 (G3DSA:1.20.120.GENE3D); IPR017905 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR013766 (PFAM); PTHR22897:SF6 (PANTHER); PTHR22897 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR017905 (PROSITE_PROFILES); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR017905 (SUPERFAMILY)
F6SYI2	alpha-crystallin B chain	174	20	1.24E-122	98.35%	2	F:GO:0005212; P:GO:0007423	F:structural constituent of eye lens; P:sensory organ development		IPR001436 (PRINTS); IPR001436 (PIRSF); IPR003090 (PFAM); IPR002068 (PFAM); IPR008978 (G3DSA:2.60.40.GENE3D); IPR012273 (PTHR11527:PANTHER); IPR031107 (PANTHER); IPR002068 (PROSITE_PROFILES); IPR008978 (SUPERFAMILY)
F6RCA8	peroxiredoxin- mitochondrial	161	20	8.63E-111	96.6%	2	F:GO:0016491; P:GO:0045454	F:oxidoreductase activity; P:cell redox homeostasis		IPR013740 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR10430:SF16 (PANTHER); PTHR10430 (PANTHER); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY)
F6YRC5	ras GTPase-activating IQGAP1	1639	20	0E0	98.35%	3	F:GO:0005515; P:GO:0007165; P:GO:0043087	F:protein binding; P:signal transduction; P:regulation of GTPase activity		IPR000048 (SMART); IPR001715 (SMART); IPR001936 (SMART); IPR001202 (SMART); IPR001715 (G3DSA:1.10.418.GENE3D); IPR000048 (PFAM); IPR027401 (G3DSA:4.10.270.GENE3D); IPR001715 (PFAM); IPR001936 (G3DSA:1.10.506.GENE3D); IPR000593 (PFAM); IPR001936 (PFAM); PTHR14149 (PANTHER); PTHR14149:SF15 (PANTHER); IPR001202 (PROSITE_PATTERNS); IPR023152 (PROSITE_PATTERNS); IPR001715 (PROSITE_PROFILES); IPR001202 (PROSITE_PROFILES); IPR001936 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); SSF143885 (SUPERFAMILY); IPR001715 (SUPERFAMILY); IPR008936 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
F6QYS3	extracellular matrix 1	544	20	0E0	89.55%	2	C:GO:0005615; P:GO:0007165	C:extracellular space; P:signal transduction		IPR008605 (PFAM); G3DSA:1.10.246.10 (GENE3D); PTHR16776 (PANTHER); PTHR16776:SF3 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); PS51257 (PROSITE_PROFILES); IPR020858 (SUPERFAMILY); IPR020858 (SUPERFAMILY)
F7BBJ0	rho GDP-dissociation inhibitor 2	200	20	1.1E-144	98.95%	2	C:GO:0005737; F:GO:0005094	C:cytoplasm; F:Rho GDP-dissociation inhibitor activity		IPR000406 (PRINTS); IPR000406 (PFAM); IPR024792 (G3DSA:2.70.50.GENE3D); IPR000406 (PANTHER); PTHR10980:SF15 (PANTHER); IPR014756 (SUPERFAMILY)
F7DIB3	SEC14 3	391	20	0E0	93%	4	C:GO:0016021; P:GO:0006810; C:GO:0005622; F:GO:0005215	C:integral component of membrane; P:transport; C:intracellular; F:transporter activity		IPR001071 (PRINTS); IPR011074 (SMART); IPR001251 (SMART); IPR011074 (PFAM); IPR001251 (G3DSA:3.40.525.GENE3D); IPR001251 (PFAM); PTHR23324:SF62 (PANTHER); PTHR23324 (PANTHER); IPR009038 (PROSITE_PROFILES); IPR001251 (PROSITE_PROFILES); IPR001251 (SUPERFAMILY); IPR009038 (SUPERFAMILY); IPR011074 (SUPERFAMILY)
F7CZS6	malate cytoplasmic	334	20	0E0	99.4%	6	P:GO:0005975; F:GO:0030060; P:GO:0006108; P:GO:0046487; P:GO:0019643; P:GO:0006090	P:carbohydrate metabolic process; F:L-malate dehydrogenase activity; P:malate metabolic process; P:glyoxylate metabolic process; P:reductive tricarboxylic acid cycle; P:pyruvate metabolic process	EC:1.1.1.37	IPR001557 (PIRSF); IPR016040 (G3DSA:3.40.50.GENE3D); IPR022383 (PFAM); IPR015955 (G3DSA:3.90.110.GENE3D); IPR011274 (TIGRFAM); IPR010945 (TIGRFAM); IPR001236 (PFAM); IPR010945 (PANTHER); IPR001252 (PROSITE_PATTERNS); IPR010945 (HAMAP); IPR016040 (SUPERFAMILY); IPR015955 (SUPERFAMILY)
F6ZMW3	immunoglobulin lambda light chain variable partial	115	20	1.37E-76	93.15%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); PTHR23267:SF198 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F7B821	disulfide-isomerase	459	20	0E0	98.5%	3	C:GO:0005783; P:GO:0045454; F:GO:0016853	C:endoplasmic reticulum; P:cell redox homeostasis; F:isomerase activity		PR00421 (PRINTS); IPR005792 (TIGRFAM); IPR013766 (PFAM); IPR005788 (TIGRFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR012336 (G3DSA:3.40.30.GENE3D); PF13848 (PFAM); PTHR18929:SF101 (PANTHER); PTHR18929 (PANTHER); IPR017937 (PROSITE_PATTERNS); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY)
F6V5H1	LChain Crystal Structures In An Anti-hiv Antibody Lineage From Immunization Of Rhesus Macaques	104	20	2.53E-67	78.7%	1	F:GO:0005515	F:protein binding		IPR003597 (SMART); IPR003597 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266:SF79 (PANTHER); PTHR23266 (PANTHER); IPR003006 (PROSITE_PATTERNS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F6Y0Q6	aldehyde dehydrogenase family 1 member A3	512	20	0E0	98.35%	2	P:GO:0055114; F:GO:0016620	P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor		IPR016163 (G3DSA:3.40.309.GENE3D); IPR015590 (PFAM); IPR016162 (G3DSA:3.40.605.GENE3D); PTHR11699 (PANTHER); PTHR11699:SF209 (PANTHER); IPR029510 (PROSITE_PATTERNS); IPR016160 (PROSITE_PATTERNS); IPR016161 (SUPERFAMILY)
F6UL68	transthyretin	147	20	8.18E-104	93.35%	3	F:GO:0070324; P:GO:0042572; P:GO:0070327	F:thyroid hormone binding; P:retinol metabolic process; P:thyroid hormone transport		IPR000895 (PRINTS); IPR023416 (SMART); IPR023416 (PFAM); IPR023416 (G3DSA:2.60.40.GENE3D); PTHR10395 (PANTHER); IPR030178 (PTHR10395:PANTHER); IPR023418 (PROSITE_PATTERNS); IPR023419 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR023416 (SUPERFAMILY)
F6VC90	immunoglobulin kappa light chain V-J partial	100	20	4.54E-53	89.1%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F6Q448	immunoglobulin lambda light chain V-J partial	77	20	6.7E-47	94.2%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF138 (PANTHER); PTHR23267 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F7AX54	myosin light polypeptide 6 isoform X2	151	20	1.2E-108	98.65%	1	F:GO:0005509	F:calcium ion binding		IPR002048 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR002048 (PFAM); PTHR23048 (PANTHER); PTHR23048:SF5 (PANTHER); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F7BA40	transaldolase	305	20	0E0	98.6%	4	P:GO:0005975; F:GO:0004801; C:GO:0005737; P:GO:0006098	P:carbohydrate metabolic process; F:sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity; C:cytoplasm; P:pentose-phosphate shunt	EC:2.2.1.2	IPR004730 (TIGRFAM); IPR001585 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); IPR001585 (PANTHER); PTHR10683:SF18 (PANTHER); IPR018225 (PROSITE_PATTERNS); IPR018225 (PROSITE_PATTERNS); SSF51569 (SUPERFAMILY)
F6YDZ0	serpin B5	375	20	0E0	97.05%	2	C:GO:0005615; F:GO:0004867	C:extracellular space; F:serine-type endopeptidase inhibitor activity		IPR000240 (PRINTS); IPR023796 (SMART); G3DSA:3.30.497.10 (GENE3D); G3DSA:2.30.39.10 (GENE3D); IPR023796 (PFAM); PTHR11461:SF55 (PANTHER); IPR000215 (PANTHER); IPR023795 (PROSITE_PATTERNS); IPR023796 (SUPERFAMILY)
F6UJ33	profilin-1	140	20	1.63E-100	99.45%	2	F:GO:0003779; P:GO:0030036	F:actin binding; P:actin cytoskeleton organization		IPR005455 (PRINTS); IPR005454 (PRINTS); IPR005455 (SMART); IPR005455 (PFAM); G3DSA:3.30.450.30 (GENE3D); PTHR13936 (PANTHER); IPR027310 (PROSITE_PATTERNS); IPR005455 (SUPERFAMILY)
F6ZND8	Keratin 6A	562	20	0E0	94.25%	2	C:GO:0045095; F:GO:0005198	C:keratin filament; F:structural molecule activity		IPR003054 (PRINTS); IPR001664 (SMART); IPR032444 (PFAM); G3DSA:1.20.5.170 (GENE3D); IPR001664 (PFAM); PTHR23239:SF141 (PANTHER); IPR001664 (PANTHER); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
F7AGY4	Keratin 6A	565	20	0E0	94.75%	2	C:GO:0045095; F:GO:0005198	C:keratin filament; F:structural molecule activity		IPR003054 (PRINTS); IPR001664 (SMART); G3DSA:1.20.5.170 (GENE3D); IPR001664 (PFAM); IPR032444 (PFAM); IPR001664 (PANTHER); PTHR23239:SF141 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
F6ZLH3	immunoglobulin kappa light chain V-J partial	115	20	1.89E-72	92.7%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); PS51257 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F6WBP0	glutathione S-transferase A2-like	221	20	4.61E-161	92.1%	4	P:GO:0006803; F:GO:0005515; P:GO:0006749; F:GO:0004364	P:obsolete glutathione conjugation reaction; F:protein binding; P:glutathione metabolic process; F:glutathione transferase activity	EC:2.5.1.18	IPR003080 (PRINTS); IPR010987 (G3DSA:1.20.1050.GENE3D); IPR004046 (PFAM); IPR004045 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR11571:SF107 (PANTHER); PTHR11571 (PANTHER); IPR004045 (PROSITE_PROFILES); IPR010987 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR010987 (SUPERFAMILY)
F6Z4J4	rab GDP dissociation inhibitor beta	431	20	0E0	93.7%	5	F:GO:0005093; F:GO:0016491; P:GO:0007264; P:GO:0015031; P:GO:0055114	F:Rab GDP-dissociation inhibitor activity; F:oxidoreductase activity; P:small GTPase mediated signal transduction; P:protein transport; P:oxidation-reduction process		IPR018203 (PRINTS); IPR000806 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); G3DSA:1.10.405.10 (GENE3D); IPR018203 (PFAM); G3DSA:3.30.519.10 (GENE3D); PTHR11787 (PANTHER); PTHR11787:SF1 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY)
F6Q6X3	coronin-1A	461	20	0E0	97.9%	3	F:GO:0051015; P:GO:0001845; P:GO:0030595	F:actin filament binding; P:phagolysosome assembly; P:leukocyte chemotaxis		IPR015048 (SMART); SM01167 (SMART); IPR001680 (SMART); IPR015049 (PFAM); IPR001680 (PFAM); PF16300 (PFAM); IPR015048 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015505 (PANTHER); IPR029508 (PTHR10856:PANTHER); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY)
F6VAS5	vascular non-inflammatory molecule 2	517	20	0E0	91.2%	2	F:GO:0016811; P:GO:0006807	F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; P:nitrogen compound metabolic process		IPR012101 (PIRSF); IPR003010 (G3DSA:3.60.110.GENE3D); IPR003010 (PFAM); IPR012101 (PANTHER); PTHR10609:SF15 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR003010 (PROSITE_PROFILES); IPR003010 (SUPERFAMILY)
F7DZ82	alpha-actinin-1 isoform X2	857	20	0E0	99%	4	F:GO:0051015; P:GO:0051764; F:GO:0005509; P:GO:0051017	F:actin filament binding; P:actin crosslink formation; F:calcium ion binding; P:actin filament bundle assembly		IPR002048 (SMART); IPR001715 (SMART); IPR018159 (SMART); SM01184 (SMART); G3DSA:1.20.58.60 (GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR002017 (PFAM); IPR001715 (PFAM); IPR014837 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); G3DSA:1.20.58.60 (GENE3D); PTHR11915 (PANTHER); IPR026921 (PTHR11915:PANTHER); IPR001589 (PROSITE_PATTERNS); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR001715 (PROSITE_PROFILES); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001715 (SUPERFAMILY); IPR011992 (SUPERFAMILY); SSF46966 (SUPERFAMILY)
F7DZI2	alpha-actinin-1 isoform X1	879	20	0E0	99%	4	F:GO:0051015; P:GO:0051764; F:GO:0005509; P:GO:0051017	F:actin filament binding; P:actin crosslink formation; F:calcium ion binding; P:actin filament bundle assembly		SM01184 (SMART); IPR001715 (SMART); IPR018159 (SMART); IPR002048 (SMART); IPR001715 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); IPR014837 (PFAM); G3DSA:1.20.58.60 (GENE3D); IPR002017 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); IPR002048 (PFAM); PTHR11915 (PANTHER); IPR026921 (PTHR11915:PANTHER); IPR018247 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR001715 (PROSITE_PROFILES); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR001715 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR011992 (SUPERFAMILY)
F6YRE7	leukotriene A-4 hydrolase isoform X1	612	20	0E0	98.1%	4	F:GO:0008270; P:GO:0006508; F:GO:0004463; F:GO:0008237	F:zinc ion binding; P:proteolysis; F:leukotriene-A4 hydrolase activity; F:metallopeptidase activity	EC:3.3.2.6	IPR014782 (PRINTS); IPR015211 (SMART); IPR012777 (TIGRFAM); G3DSA:1.10.390.10 (GENE3D); IPR014782 (PFAM); IPR015211 (PFAM); IPR001930 (PANTHER); SSF55486 (SUPERFAMILY); IPR016024 (SUPERFAMILY); SSF63737 (SUPERFAMILY)
F6PUX2	moesin	577	20	0E0	99.7%	4	C:GO:0005856; F:GO:0003779; C:GO:0005737; C:GO:0019898	C:cytoskeleton; F:actin binding; C:cytoplasm; C:extrinsic component of membrane		IPR000798 (PRINTS); IPR019749 (PRINTS); IPR018980 (SMART); IPR011174 (PIRSF); IPR019749 (SMART); IPR019748 (PFAM); IPR011259 (PFAM); G3DSA:1.20.5.450 (GENE3D); G3DSA:3.10.20.90 (GENE3D); IPR018980 (PFAM); IPR014352 (G3DSA:1.20.80.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR018979 (PFAM); PTHR23281:SF26 (PANTHER); PTHR23281 (PANTHER); IPR019747 (PROSITE_PATTERNS); IPR019747 (PROSITE_PATTERNS); IPR000299 (PROSITE_PROFILES); IPR008954 (SUPERFAMILY); IPR029071 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR019748 (SUPERFAMILY)
F6WGX6	type II cytoskeletal 1b isoform X1	586	20	0E0	88.55%	2	C:GO:0045095; F:GO:0005198	C:keratin filament; F:structural molecule activity		IPR003054 (PRINTS); IPR001664 (SMART); G3DSA:1.20.5.170 (GENE3D); IPR032444 (PFAM); IPR001664 (PFAM); PTHR23239:SF87 (PANTHER); IPR001664 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
F7DK11	periplakin	1737	20	0E0	96.5%	1	C:GO:0005856	C:cytoskeleton		IPR018159 (SMART); IPR001101 (SMART); G3DSA:1.20.58.60 (GENE3D); IPR001101 (G3DSA:3.90.1290.GENE3D); G3DSA:1.20.58.60 (GENE3D); PTHR23169 (PANTHER); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY)
F6YXD8	nucleobindin-2	420	20	0E0	96.8%	1	F:GO:0005509	F:calcium ion binding		IPR002048 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR002048 (PFAM); PTHR19237 (PANTHER); IPR028813 (PTHR19237:PANTHER); IPR018247 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F6Y426	nucleobindin-2	421	20	0E0	96.75%	1	F:GO:0005509	F:calcium ion binding		IPR002048 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR002048 (PFAM); PTHR19237 (PANTHER); IPR028813 (PTHR19237:PANTHER); IPR018247 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F6R3Z7	immunoglobulin lambda light chain variable partial	97	20	1.34E-62	84.9%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF174 (PANTHER); PTHR23267 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F6V3D5	T-complex 1 subunit gamma	545	20	0E0	98.75%	3	F:GO:0005524; F:GO:0051082; P:GO:0006457	F:ATP binding; F:unfolded protein binding; P:protein folding		IPR017998 (PRINTS); IPR012719 (TIGRFAM); IPR027409 (G3DSA:3.50.7.GENE3D); IPR027410 (G3DSA:3.30.260.GENE3D); IPR027413 (G3DSA:1.10.560.GENE3D); IPR002423 (PFAM); PTHR11353 (PANTHER); IPR012719 (PTHR11353:PANTHER); IPR002194 (PROSITE_PATTERNS); IPR002194 (PROSITE_PATTERNS); IPR002194 (PROSITE_PATTERNS); IPR027409 (SUPERFAMILY); SSF48592 (SUPERFAMILY); SSF54849 (SUPERFAMILY)
F6VFV9	Histone partial	103	20	1.92E-65	100%	6	C:GO:0005634; F:GO:0003677; F:GO:0046982; P:GO:0006352; C:GO:0000786; P:GO:0006334	C:nucleus; F:DNA binding; F:protein heterodimerization activity; P:DNA-templated transcription, initiation; C:nucleosome; P:nucleosome assembly		IPR001951 (PRINTS); IPR004823 (SMART); IPR001951 (SMART); PF15511 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); PTHR10484 (PANTHER); IPR019809 (PROSITE_PATTERNS); IPR009072 (SUPERFAMILY)
F7CVJ0	2-5A-dependent ribonuclease	722	20	0E0	88.1%	7	F:GO:0005524; F:GO:0005515; P:GO:0051252; F:GO:0004540; F:GO:0004672; P:GO:0006397; P:GO:0006468	F:ATP binding; F:protein binding; P:regulation of RNA metabolic process; F:ribonuclease activity; F:protein kinase activity; P:mRNA processing; P:protein phosphorylation	EC:3.1	IPR002110 (PRINTS); IPR000719 (SMART); IPR002110 (SMART); IPR018997 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); G3DSA:3.30.200.20 (GENE3D); IPR010513 (PFAM); PTHR24141 (PANTHER); IPR008266 (PROSITE_PATTERNS); IPR020683 (PROSITE_PROFILES); IPR010513 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR020683 (SUPERFAMILY)
F6TZS9	triosephosphate isomerase	249	20	0E0	98.35%	8	P:GO:0006094; P:GO:0006020; P:GO:0046486; P:GO:0006096; F:GO:0004807; P:GO:0006013; P:GO:0006000; P:GO:0015976	P:gluconeogenesis; P:inositol metabolic process; P:glycerolipid metabolic process; P:glycolytic process; F:triose-phosphate isomerase activity; P:mannose metabolic process; P:fructose metabolic process; P:carbon utilization	EC:5.3.1.1	IPR000652 (TIGRFAM); IPR013785 (G3DSA:3.20.20.GENE3D); IPR000652 (PFAM); IPR000652 (PANTHER); PTHR21139:SF8 (PANTHER); IPR020861 (PROSITE_PATTERNS); IPR000652 (PROSITE_PROFILES); IPR022896 (HAMAP); IPR000652 (SUPERFAMILY)
F6R7J2	Isocitrate dehydrogenase [NADP] cytoplasmic	420	20	0E0	98.65%	6	F:GO:0000287; F:GO:0051287; P:GO:0006749; F:GO:0004450; P:GO:0006102; P:GO:0019643	F:magnesium ion binding; F:NAD binding; P:glutathione metabolic process; F:isocitrate dehydrogenase (NADP+) activity; P:isocitrate metabolic process; P:reductive tricarboxylic acid cycle	EC:1.1.1.42; EC:1.1.1	IPR004790 (PIRSF); IPR024084 (SMART); IPR004790 (TIGRFAM); IPR024084 (G3DSA:3.40.718.GENE3D); IPR024084 (PFAM); IPR004790 (PANTHER); IPR019818 (PROSITE_PATTERNS); SSF53659 (SUPERFAMILY)
Q14ST5	S100-A7	101	20	7.51E-69	87.8%	1	F:GO:0005509	F:calcium ion binding		IPR013787 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR013787 (PFAM); IPR028477 (PTHR11639:PANTHER); PTHR11639 (PANTHER); IPR018247 (PROSITE_PATTERNS); IPR001751 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F6R6Z6	epithelial cell adhesion molecule	289	20	0E0	95.25%	20	C:GO:0016328; P:GO:0008284; P:GO:0023019; P:GO:0045944; C:GO:0005886; C:GO:0009986; F:GO:0098641; C:GO:0005887; C:GO:0005923; C:GO:0070062; P:GO:0048863; P:GO:0001657; P:GO:2000648; C:GO:0016020; C:GO:0016021; F:GO:0032403; P:GO:0098609; C:GO:0016323; C:GO:0016324; P:GO:2000048	C:lateral plasma membrane; P:positive regulation of cell proliferation; P:signal transduction involved in regulation of gene expression; P:positive regulation of transcription from RNA polymerase II promoter; C:plasma membrane; C:cell surface; F:cadherin binding involved in cell-cell adhesion; C:integral component of plasma membrane; C:bicellular tight junction; C:extracellular exosome; P:stem cell differentiation; P:ureteric bud development; P:positive regulation of stem cell proliferation; C:membrane; C:integral component of membrane; F:protein complex binding; P:cell-cell adhesion; C:basolateral plasma membrane; C:apical plasma membrane; P:negative regulation of cell-cell adhesion mediated by cadherin		IPR000716 (SMART); IPR000716 (PFAM); IPR000716 (G3DSA:4.10.800.GENE3D); PTHR14168:SF2 (PANTHER); PTHR14168 (PANTHER); IPR000716 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000716 (PROSITE_PROFILES); IPR000716 (SUPERFAMILY)
F6SK75	desmoglein-1	1035	20	0E0	89.9%	3	F:GO:0005509; P:GO:0007156; C:GO:0005886	F:calcium ion binding; P:homophilic cell adhesion via plasma membrane adhesion molecules; C:plasma membrane		IPR009123 (PRINTS); IPR009122 (PRINTS); IPR002126 (PRINTS); IPR002126 (SMART); IPR027397 (G3DSA:4.10.900.GENE3D); IPR002126 (PFAM); IPR002126 (G3DSA:2.60.40.GENE3D); IPR000233 (PFAM); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (G3DSA:2.60.40.GENE3D); IPR009122 (PANTHER); PTHR24025:SF9 (PANTHER); IPR020894 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR002126 (PROSITE_PROFILES); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY)
F7BU09	glutathione S-transferase P-like	210	20	1.88E-153	95.05%	4	P:GO:0006803; F:GO:0005515; P:GO:0006749; F:GO:0004364	P:obsolete glutathione conjugation reaction; F:protein binding; P:glutathione metabolic process; F:glutathione transferase activity	EC:2.5.1.18	IPR003082 (PRINTS); IPR004045 (PFAM); IPR004046 (PFAM); IPR010987 (G3DSA:1.20.1050.GENE3D); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR11571 (PANTHER); PTHR11571:SF113 (PANTHER); IPR010987 (PROSITE_PROFILES); IPR004045 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR010987 (SUPERFAMILY)
F7D144	macrophage-capping	349	20	0E0	98.4%	2	P:GO:0051016; F:GO:0003779	P:barbed-end actin filament capping; F:actin binding		IPR007122 (PRINTS); IPR007122 (SMART); IPR029006 (G3DSA:3.40.20.GENE3D); IPR007123 (PFAM); IPR029006 (G3DSA:3.40.20.GENE3D); IPR029006 (G3DSA:3.40.20.GENE3D); IPR007122 (PANTHER); IPR029917 (PTHR11977:PANTHER); SSF55753 (SUPERFAMILY); SSF55753 (SUPERFAMILY); SSF55753 (SUPERFAMILY)
F6ZW10	ladinin-1 isoform X1	509	20	0E0	81.95%	2	C:GO:0070062; F:GO:0005198	C:extracellular exosome; F:structural molecule activity		PTHR12392 (PANTHER)
F6T1M5	ladinin-1 isoform X1	509	20	0E0	82.45%	2	C:GO:0070062; F:GO:0005198	C:extracellular exosome; F:structural molecule activity		PTHR12392 (PANTHER)
F6YYI3	S100-A8	89	20	1.12E-57	94.7%	10	F:GO:0008270; F:GO:0035662; C:GO:0045298; P:GO:0007165; F:GO:0005509; P:GO:0045087; P:GO:0050727; F:GO:0050544; F:GO:0050786; F:GO:0008017	F:zinc ion binding; F:Toll-like receptor 4 binding; C:tubulin complex; P:signal transduction; F:calcium ion binding; P:innate immune response; P:regulation of inflammatory response; F:arachidonic acid binding; F:RAGE receptor binding; F:microtubule binding		IPR013787 (SMART); IPR013787 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); IPR028474 (PTHR11639:PANTHER); PTHR11639 (PANTHER); IPR018247 (PROSITE_PATTERNS); IPR001751 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F6SSG3	collagen alpha-1(I) chain	1424	20	0E0	94.6%	3	F:GO:0005515; F:GO:0005201; C:GO:0005578	F:protein binding; F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix		IPR001007 (SMART); IPR000885 (SMART); IPR001007 (PFAM); IPR008160 (PFAM); IPR000885 (PFAM); G3DSA:2.10.70.10 (GENE3D); PTHR24023 (PANTHER); PTHR24023:SF569 (PANTHER); IPR001007 (PROSITE_PATTERNS); IPR000885 (PRODOM); IPR000885 (PROSITE_PROFILES); IPR001007 (PROSITE_PROFILES); SSF57603 (SUPERFAMILY)
F6RVX8	collagen alpha-1(I) chain	1432	20	0E0	94.85%	3	F:GO:0005515; F:GO:0005201; C:GO:0005578	F:protein binding; F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix		IPR000885 (SMART); IPR001007 (SMART); IPR001007 (PFAM); IPR008160 (PFAM); IPR000885 (PFAM); G3DSA:2.10.70.10 (GENE3D); PTHR24023 (PANTHER); PTHR24023:SF569 (PANTHER); IPR001007 (PROSITE_PATTERNS); IPR000885 (PRODOM); IPR001007 (PROSITE_PROFILES); IPR000885 (PROSITE_PROFILES); SSF57603 (SUPERFAMILY)
F7D939	collagen alpha-1(I) chain	1448	20	0E0	97.65%	3	F:GO:0005515; F:GO:0005201; C:GO:0005578	F:protein binding; F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix		IPR001007 (SMART); IPR000885 (SMART); IPR008160 (PFAM); G3DSA:2.10.70.10 (GENE3D); IPR000885 (PFAM); IPR001007 (PFAM); PTHR24023:SF569 (PANTHER); PTHR24023 (PANTHER); IPR001007 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR000885 (PRODOM); IPR001007 (PROSITE_PROFILES); IPR000885 (PROSITE_PROFILES); SSF57603 (SUPERFAMILY)
F7D9C7	collagen alpha-1(I) chain	1448	20	0E0	97.8%	3	F:GO:0005515; F:GO:0005201; C:GO:0005578	F:protein binding; F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix		IPR001007 (SMART); IPR000885 (SMART); IPR008160 (PFAM); G3DSA:2.10.70.10 (GENE3D); IPR001007 (PFAM); IPR000885 (PFAM); PTHR24023:SF569 (PANTHER); PTHR24023 (PANTHER); IPR001007 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000885 (PRODOM); IPR001007 (PROSITE_PROFILES); IPR000885 (PROSITE_PROFILES); SSF57603 (SUPERFAMILY)
F6VUP8	collagen alpha-1(I) chain	1449	20	0E0	97.15%	3	F:GO:0005515; F:GO:0005201; C:GO:0005578	F:protein binding; F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix		IPR001007 (SMART); IPR000885 (SMART); IPR001007 (PFAM); G3DSA:2.10.70.10 (GENE3D); IPR008160 (PFAM); IPR000885 (PFAM); PTHR24023 (PANTHER); PTHR24023:SF569 (PANTHER); IPR001007 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR000885 (PRODOM); IPR000885 (PROSITE_PROFILES); IPR001007 (PROSITE_PROFILES); SSF57603 (SUPERFAMILY)
F7A3F7		1455				3	F:GO:0005515; F:GO:0005201; C:GO:0005578	F:protein binding; F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix		IPR001007 (SMART); IPR000885 (SMART); IPR008160 (PFAM); IPR001007 (PFAM); G3DSA:2.10.70.10 (GENE3D); IPR000885 (PFAM); PTHR24023 (PANTHER); PTHR24023:SF569 (PANTHER); IPR001007 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR000885 (PRODOM); IPR000885 (PROSITE_PROFILES); IPR001007 (PROSITE_PROFILES); SSF57603 (SUPERFAMILY)
F7AW05	tetranectin	202	20	2.69E-148	94.7%	17	P:GO:0030282; F:GO:0036143; F:GO:0008201; C:GO:0005576; C:GO:0001652; P:GO:0002576; P:GO:0071560; C:GO:0005615; C:GO:0070062; P:GO:0071310; C:GO:0005737; P:GO:0001503; F:GO:0005509; P:GO:0010756; C:GO:0031012; C:GO:0031089; F:GO:0030246	P:bone mineralization; F:kringle domain binding; F:heparin binding; C:extracellular region; C:granular component; P:platelet degranulation; P:cellular response to transforming growth factor beta stimulus; C:extracellular space; C:extracellular exosome; P:cellular response to organic substance; C:cytoplasm; P:ossification; F:calcium ion binding; P:positive regulation of plasminogen activation; C:extracellular matrix; C:platelet dense granule lumen; F:carbohydrate binding		IPR001304 (SMART); IPR016186 (G3DSA:3.10.100.GENE3D); IPR001304 (PFAM); PTHR22799 (PANTHER); IPR018378 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR001304 (PROSITE_PROFILES); SSF57944 (SUPERFAMILY); IPR016187 (SUPERFAMILY)
F6YY66	nucleoside diphosphate kinase B	227	20	7.36E-163	94.35%	7	P:GO:0006228; P:GO:0006206; P:GO:0006241; P:GO:0006183; P:GO:0006165; F:GO:0004550; P:GO:0006144	P:UTP biosynthetic process; P:pyrimidine nucleobase metabolic process; P:CTP biosynthetic process; P:GTP biosynthetic process; P:nucleoside diphosphate phosphorylation; F:nucleoside diphosphate kinase activity; P:purine nucleobase metabolic process	EC:2.7.4.6	IPR001564 (PRINTS); IPR001564 (SMART); IPR001564 (PFAM); G3DSA:3.30.70.141 (GENE3D); PTHR11349:SF57 (PANTHER); PTHR11349 (PANTHER); IPR023005 (PROSITE_PATTERNS); IPR001564 (HAMAP); SSF54919 (SUPERFAMILY); SSF54919 (SUPERFAMILY)
F6R3F4	inter-alpha-trypsin inhibitor heavy chain H4 isoform X1	941	20	0E0	80.7%	2	F:GO:0004867; P:GO:0030212	F:serine-type endopeptidase inhibitor activity; P:hyaluronan metabolic process		IPR002035 (SMART); IPR013694 (SMART); IPR010600 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); IPR013694 (PFAM); IPR002035 (PFAM); PTHR10338 (PANTHER); PTHR10338:SF119 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR013694 (PROSITE_PROFILES); IPR002035 (PROSITE_PROFILES); IPR002035 (SUPERFAMILY)
F7BXA6	puromycin-sensitive aminopeptidase	806	20	0E0	99.15%	3	F:GO:0008270; P:GO:0006508; F:GO:0008237	F:zinc ion binding; P:proteolysis; F:metallopeptidase activity		IPR014782 (PRINTS); IPR024571 (PFAM); G3DSA:1.10.390.10 (GENE3D); IPR014782 (PFAM); PTHR11533:SF187 (PANTHER); IPR001930 (PANTHER); SSF63737 (SUPERFAMILY); SSF55486 (SUPERFAMILY)
F7DZV9	14-3-3 beta alpha	246	20	0E0	99.75%	1	F:GO:0019904	F:protein domain specific binding		IPR000308 (PRINTS); IPR023410 (SMART); IPR000308 (PIRSF); IPR023410 (PFAM); G3DSA:1.20.190.20 (GENE3D); PTHR18860:SF28 (PANTHER); IPR000308 (PANTHER); IPR023409 (PROSITE_PATTERNS); IPR023409 (PROSITE_PATTERNS); IPR023410 (SUPERFAMILY)
F6XQQ9	glutathione S-transferase A1	222	20	9.44E-161	93.25%	4	P:GO:0006803; F:GO:0005515; P:GO:0006749; F:GO:0004364	P:obsolete glutathione conjugation reaction; F:protein binding; P:glutathione metabolic process; F:glutathione transferase activity	EC:2.5.1.18	IPR003080 (PRINTS); IPR004045 (PFAM); IPR010987 (G3DSA:1.20.1050.GENE3D); IPR004046 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR11571 (PANTHER); PTHR11571:SF107 (PANTHER); IPR010987 (PROSITE_PROFILES); IPR004045 (PROSITE_PROFILES); IPR010987 (SUPERFAMILY); IPR012336 (SUPERFAMILY)
F6ZUT4	anterior gradient 2 homolog	175	20	6.96E-126	97.9%	17	F:GO:0042803; P:GO:0060480; P:GO:0090004; F:GO:0005154; P:GO:0045742; P:GO:0060548; F:GO:0002162; P:GO:1903899; P:GO:1903896; C:GO:0005783; P:GO:0048546; P:GO:0048639; C:GO:0005615; P:GO:0070254; P:GO:0010628; C:GO:0005739; P:GO:0010811	F:protein homodimerization activity; P:lung goblet cell differentiation; P:positive regulation of establishment of protein localization to plasma membrane; F:epidermal growth factor receptor binding; P:positive regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of cell death; F:dystroglycan binding; P:positive regulation of PERK-mediated unfolded protein response; P:positive regulation of IRE1-mediated unfolded protein response; C:endoplasmic reticulum; P:digestive tract morphogenesis; P:positive regulation of developmental growth; C:extracellular space; P:mucus secretion; P:positive regulation of gene expression; C:mitochondrion; P:positive regulation of cell-substrate adhesion		PF13899 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR15337 (PANTHER); PTHR15337:SF1 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR012336 (SUPERFAMILY)
F7D5X8	type II cytoskeletal 4	604	20	0E0	90.75%	2	C:GO:0045095; F:GO:0005198	C:keratin filament; F:structural molecule activity		IPR003054 (PRINTS); IPR001664 (SMART); G3DSA:1.20.5.170 (GENE3D); IPR032444 (PFAM); IPR001664 (PFAM); PTHR23239:SF188 (PANTHER); IPR001664 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
P02561	tropomyosin alpha-4 chain isoform X3	248	20	7.49E-166	99.5%	21	C:GO:0005862; F:GO:0003674; C:GO:0002102; C:GO:0005856; F:GO:0005515; C:GO:0070062; F:GO:0008307; F:GO:0003779; C:GO:0005925; C:GO:0005737; F:GO:0046872; P:GO:0006928; P:GO:0006936; F:GO:0005509; C:GO:0016020; C:GO:0001725; P:GO:0001649; C:GO:0005829; C:GO:0031941; C:GO:0030863; P:GO:0030049	C:muscle thin filament tropomyosin; F:molecular_function; C:podosome; C:cytoskeleton; F:protein binding; C:extracellular exosome; F:structural constituent of muscle; F:actin binding; C:focal adhesion; C:cytoplasm; F:metal ion binding; P:movement of cell or subcellular component; P:muscle contraction; F:calcium ion binding; C:membrane; C:stress fiber; P:osteoblast differentiation; C:cytosol; C:filamentous actin; C:cortical cytoskeleton; P:muscle filament sliding		IPR000533 (PRINTS); G3DSA:1.20.5.340 (GENE3D); IPR000533 (PFAM); PTHR19269 (PANTHER); PTHR19269:SF40 (PANTHER); IPR000533 (PROSITE_PATTERNS); SSF57997 (SUPERFAMILY)
F7BXD8	CD5 antigen-like	330	20	0E0	82.25%	3	P:GO:0007165; C:GO:0016020; F:GO:0005044	P:signal transduction; C:membrane; F:scavenger receptor activity		IPR001190 (PRINTS); IPR017448 (SMART); IPR017448 (G3DSA:3.10.250.GENE3D); IPR001190 (PFAM); PTHR19331:SF246 (PANTHER); PTHR19331 (PANTHER); IPR001190 (PROSITE_PATTERNS); IPR001190 (PROSITE_PROFILES); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY)
P01958	hemoglobin subunit alpha	142	20	1.23E-97	98.65%	5	C:GO:0005833; F:GO:0019825; F:GO:0005506; P:GO:0015671; F:GO:0020037	C:hemoglobin complex; F:oxygen binding; F:iron ion binding; P:oxygen transport; F:heme binding		IPR002338 (PRINTS); IPR002339 (PRINTS); IPR000971 (PFAM); IPR012292 (G3DSA:1.10.490.GENE3D); PTHR11442:SF51 (PANTHER); PTHR11442 (PANTHER); IPR000971 (PROSITE_PROFILES); IPR009050 (SUPERFAMILY)
C6L1J5	lactate dehydrogenase B	333	20	0E0	99.1%	6	P:GO:0006094; F:GO:0004459; C:GO:0005737; P:GO:0006096; P:GO:0055114; P:GO:0006534	P:gluconeogenesis; F:L-lactate dehydrogenase activity; C:cytoplasm; P:glycolytic process; P:oxidation-reduction process; P:cysteine metabolic process	EC:1.1.1.27	IPR001557 (PRINTS); IPR001557 (PIRSF); IPR001236 (PFAM); IPR022383 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011304 (TIGRFAM); IPR015955 (G3DSA:3.90.110.GENE3D); IPR001557 (PANTHER); PTHR11540:SF12 (PANTHER); IPR018177 (PROSITE_PATTERNS); PS51257 (PROSITE_PROFILES); IPR011304 (HAMAP); IPR015955 (SUPERFAMILY); IPR016040 (SUPERFAMILY)
F7BWJ9	cysteine-rich secretory 2	245	20	0E0	90.7%	1	C:GO:0005576	C:extracellular region		IPR001283 (PRINTS); IPR014044 (SMART); IPR014044 (PFAM); IPR013871 (PFAM); IPR014044 (G3DSA:3.40.33.GENE3D); IPR001283 (PANTHER); PTHR10334:SF228 (PANTHER); IPR018244 (PROSITE_PATTERNS); IPR018244 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR003582 (PROSITE_PROFILES); IPR014044 (SUPERFAMILY); SSF57546 (SUPERFAMILY)
F6VE52	type II cytoskeletal 3	624	20	0E0	95.55%	2	C:GO:0045095; F:GO:0005198	C:keratin filament; F:structural molecule activity		IPR003054 (PRINTS); IPR001664 (SMART); IPR001664 (PFAM); IPR032444 (PFAM); G3DSA:1.20.5.170 (GENE3D); IPR001664 (PANTHER); PTHR23239:SF140 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
F6W8W3	type I cytoskeletal 24	506	20	0E0	94.3%	2	F:GO:0005198; C:GO:0005882	F:structural molecule activity; C:intermediate filament		IPR002957 (PRINTS); IPR001664 (SMART); G3DSA:1.20.5.170 (GENE3D); IPR001664 (PFAM); PTHR23239:SF207 (PANTHER); IPR001664 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
F7CAB1	epithelial chloride channel -like	904	20	0E0	92.4%	3	F:GO:0005229; P:GO:0006821; C:GO:0005622	F:intracellular calcium activated chloride channel activity; P:chloride transport; C:intracellular		IPR002035 (SMART); IPR013642 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); IPR004727 (TIGRFAM); IPR002035 (PFAM); PTHR10579:SF42 (PANTHER); PTHR10579 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR002035 (PROSITE_PROFILES); IPR002035 (SUPERFAMILY)
F6YKZ7	type II cytoskeletal 8	485	20	0E0	81.95%	2	C:GO:0045095; F:GO:0005198	C:keratin filament; F:structural molecule activity		IPR003054 (PRINTS); IPR001664 (SMART); IPR001664 (PFAM); G3DSA:1.20.5.170 (GENE3D); IPR032444 (PFAM); IPR001664 (PANTHER); PTHR23239:SF178 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
F6WKL7	type II cytoskeletal 8	492	20	0E0	82.65%	2	C:GO:0045095; F:GO:0005198	C:keratin filament; F:structural molecule activity		IPR003054 (PRINTS); IPR001664 (SMART); IPR001664 (PFAM); G3DSA:1.20.5.170 (GENE3D); IPR032444 (PFAM); IPR001664 (PANTHER); PTHR23239:SF178 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
F7BQW2	immunoglobulin kappa light chain V-J partial	124	20	4.3E-69	92.6%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F6ZSB4	tubulin alpha-1A chain	451	20	0E0	99.85%	5	F:GO:0005525; F:GO:0003924; F:GO:0005200; C:GO:0005874; P:GO:0007017	F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton; C:microtubule; P:microtubule-based process	EC:3.6.1; EC:3.6.1.15	IPR000217 (PRINTS); IPR002452 (PRINTS); IPR018316 (SMART); IPR003008 (SMART); IPR023123 (G3DSA:1.10.287.GENE3D); IPR003008 (G3DSA:3.40.50.GENE3D); IPR018316 (PFAM); IPR003008 (PFAM); IPR018316 (G3DSA:3.30.1330.GENE3D); PTHR11588:SF102 (PANTHER); IPR000217 (PANTHER); IPR017975 (PROSITE_PATTERNS); IPR008280 (SUPERFAMILY); IPR003008 (SUPERFAMILY)
F7ANC9	tubulin alpha-1A chain	454	20	0E0	99.7%	5	F:GO:0005525; F:GO:0003924; F:GO:0005200; C:GO:0005874; P:GO:0007017	F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton; C:microtubule; P:microtubule-based process	EC:3.6.1; EC:3.6.1.15	IPR002452 (PRINTS); IPR000217 (PRINTS); IPR018316 (SMART); IPR003008 (SMART); IPR003008 (PFAM); IPR003008 (G3DSA:3.40.50.GENE3D); IPR023123 (G3DSA:1.10.287.GENE3D); IPR018316 (PFAM); IPR018316 (G3DSA:3.30.1330.GENE3D); IPR000217 (PANTHER); PTHR11588:SF102 (PANTHER); IPR017975 (PROSITE_PATTERNS); IPR008280 (SUPERFAMILY); IPR003008 (SUPERFAMILY)
F6SAV5	Tubulin alpha-1D chain	455	20	0E0	99%	5	F:GO:0005525; F:GO:0003924; F:GO:0005200; C:GO:0005874; P:GO:0007017	F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton; C:microtubule; P:microtubule-based process	EC:3.6.1; EC:3.6.1.15	IPR002452 (PRINTS); IPR000217 (PRINTS); IPR003008 (SMART); IPR018316 (SMART); IPR023123 (G3DSA:1.10.287.GENE3D); IPR018316 (PFAM); IPR003008 (PFAM); IPR018316 (G3DSA:3.30.1330.GENE3D); IPR003008 (G3DSA:3.40.50.GENE3D); IPR000217 (PANTHER); PTHR11588:SF145 (PANTHER); IPR017975 (PROSITE_PATTERNS); IPR008280 (SUPERFAMILY); IPR003008 (SUPERFAMILY)
F6YRE0	tubulin alpha-1C chain	449	20	0E0	99.15%	5	F:GO:0005525; F:GO:0003924; F:GO:0005200; C:GO:0005874; P:GO:0007017	F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton; C:microtubule; P:microtubule-based process	EC:3.6.1; EC:3.6.1.15	IPR002452 (PRINTS); IPR000217 (PRINTS); IPR003008 (SMART); IPR018316 (SMART); IPR018316 (G3DSA:3.30.1330.GENE3D); IPR023123 (G3DSA:1.10.287.GENE3D); IPR018316 (PFAM); IPR003008 (PFAM); IPR003008 (G3DSA:3.40.50.GENE3D); IPR000217 (PANTHER); PTHR11588:SF102 (PANTHER); IPR017975 (PROSITE_PATTERNS); IPR003008 (SUPERFAMILY); IPR008280 (SUPERFAMILY)
F7B3I5	afamin	593	20	0E0	92.7%	2	C:GO:0005615; P:GO:0006810	C:extracellular space; P:transport		IPR021177 (PRINTS); IPR000264 (PRINTS); IPR021177 (PIRSF); IPR014760 (SMART); G3DSA:1.10.246.10 (GENE3D); G3DSA:1.10.246.10 (GENE3D); IPR014760 (PFAM); G3DSA:1.10.246.10 (GENE3D); G3DSA:1.10.246.10 (GENE3D); PTHR11385 (PANTHER); PTHR11385:SF14 (PANTHER); IPR020857 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); PD002486 (PRODOM); IPR014760 (PROSITE_PROFILES); IPR020858 (SUPERFAMILY); IPR020858 (SUPERFAMILY); IPR020858 (SUPERFAMILY)
F6VS95	disulfide-isomerase A6	440	20	0E0	98.6%	2	P:GO:0045454; F:GO:0016853	P:cell redox homeostasis; F:isomerase activity		PR00421 (PRINTS); IPR012336 (G3DSA:3.40.30.GENE3D); IPR013766 (PFAM); IPR005788 (TIGRFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR18929 (PANTHER); PTHR18929:SF38 (PANTHER); IPR017937 (PROSITE_PATTERNS); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY)
F6RVI6	mammaglobin-B-like	93	20	2.83E-61	81.7%	3	C:GO:0005615; F:GO:0046982; P:GO:0030521	C:extracellular space; F:protein heterodimerization activity; P:androgen receptor signaling pathway		IPR016126 (PFAM); G3DSA:1.10.210.10 (GENE3D); PTHR14037 (PANTHER); PTHR14037:SF4 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR016126 (PROSITE_PROFILES); PS51257 (PROSITE_PROFILES); IPR016126 (SUPERFAMILY)
F7CQT0	fatty acid synthase	620	20	0E0	94.45%	14	P:GO:0042967; F:GO:0004320; P:GO:0006633; F:GO:0004313; F:GO:0004315; F:GO:0004314; F:GO:0004317; C:GO:0005835; F:GO:0004316; F:GO:0004319; F:GO:0016295; F:GO:0016296; P:GO:0055114; F:GO:0031177	P:acyl-carrier-protein biosynthetic process; F:oleoyl-[acyl-carrier-protein] hydrolase activity; P:fatty acid biosynthetic process; F:[acyl-carrier-protein] S-acetyltransferase activity; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; F:[acyl-carrier-protein] S-malonyltransferase activity; F:3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity; C:fatty acid synthase complex; F:3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; F:enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity; F:myristoyl-[acyl-carrier-protein] hydrolase activity; F:palmitoyl-[acyl-carrier-protein] hydrolase activity; P:oxidation-reduction process; F:phosphopantetheine binding	EC:2.3.1.85; EC:2.3.1.41; EC:4.2.1.61; EC:3.1.2.14; EC:2.3.1.38; EC:4.2.1.59; EC:1.1.1.100; EC:2.3.1.39; EC:1.3.1.10; EC:2.3.1	IPR020843 (SMART); IPR020806 (SMART); SM00822 (SMART); IPR020841 (SMART); IPR020807 (SMART); IPR020801 (SMART); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR014043 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR014030 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR023102 (G3DSA:1.10.1470.GENE3D); G3DSA:3.30.70.250 (GENE3D); IPR013149 (PFAM); IPR001227 (G3DSA:3.40.366.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013968 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR014031 (PFAM); IPR009081 (PFAM); IPR001031 (PFAM); IPR020807 (PFAM); IPR032821 (PFAM); IPR013217 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); PTHR11712:SF280 (PANTHER); PTHR11712 (PANTHER); IPR006162 (PROSITE_PATTERNS); IPR018201 (PROSITE_PATTERNS); IPR009081 (PROSITE_PROFILES); IPR016039 (SUPERFAMILY); IPR029063 (SUPERFAMILY); IPR011032 (SUPERFAMILY); IPR016036 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR029058 (SUPERFAMILY); IPR016035 (SUPERFAMILY)
F7DDN1	fatty acid synthase	631	20	0E0	94.45%	14	P:GO:0042967; F:GO:0004320; P:GO:0006633; F:GO:0004313; F:GO:0004315; F:GO:0004314; F:GO:0004317; C:GO:0005835; F:GO:0004316; F:GO:0004319; F:GO:0016295; F:GO:0016296; P:GO:0055114; F:GO:0031177	P:acyl-carrier-protein biosynthetic process; F:oleoyl-[acyl-carrier-protein] hydrolase activity; P:fatty acid biosynthetic process; F:[acyl-carrier-protein] S-acetyltransferase activity; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; F:[acyl-carrier-protein] S-malonyltransferase activity; F:3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity; C:fatty acid synthase complex; F:3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; F:enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity; F:myristoyl-[acyl-carrier-protein] hydrolase activity; F:palmitoyl-[acyl-carrier-protein] hydrolase activity; P:oxidation-reduction process; F:phosphopantetheine binding	EC:2.3.1.85; EC:2.3.1.41; EC:4.2.1.61; EC:3.1.2.14; EC:2.3.1.38; EC:4.2.1.59; EC:1.1.1.100; EC:2.3.1.39; EC:1.3.1.10; EC:2.3.1	IPR020806 (SMART); IPR020841 (SMART); IPR020843 (SMART); SM00822 (SMART); IPR020807 (SMART); IPR020801 (SMART); IPR013968 (PFAM); IPR001227 (G3DSA:3.40.366.GENE3D); IPR014030 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR013217 (PFAM); IPR032821 (PFAM); IPR009081 (PFAM); IPR020807 (PFAM); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); G3DSA:3.30.70.250 (GENE3D); IPR013149 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR029063 (G3DSA:3.40.50.GENE3D); IPR023102 (G3DSA:1.10.1470.GENE3D); IPR001031 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR014031 (PFAM); IPR014043 (PFAM); PTHR11712:SF280 (PANTHER); PTHR11712 (PANTHER); IPR006162 (PROSITE_PATTERNS); IPR018201 (PROSITE_PATTERNS); IPR009081 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY); IPR016036 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR016035 (SUPERFAMILY); IPR029058 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR011032 (SUPERFAMILY)
F6Q3P2	trefoil factor 1	83	20	5.76E-52	80%	12	P:GO:0005975; F:GO:0008083; C:GO:0005615; F:GO:0005515; P:GO:0008285; P:GO:0030154; P:GO:0010039; P:GO:0007586; P:GO:0030277; P:GO:0035902; C:GO:0005576; P:GO:0043434	P:carbohydrate metabolic process; F:growth factor activity; C:extracellular space; F:protein binding; P:negative regulation of cell proliferation; P:cell differentiation; P:response to iron ion; P:digestion; P:maintenance of gastrointestinal epithelium; P:response to immobilization stress; C:extracellular region; P:response to peptide hormone		IPR017994 (PRINTS); IPR000519 (SMART); IPR000519 (PFAM); IPR000519 (G3DSA:4.10.110.GENE3D); PTHR13826 (PANTHER); IPR017957 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR000519 (PROSITE_PROFILES); IPR000519 (SUPERFAMILY)
F6ZBH0	signal transducer and activator of transcription 1-alpha beta	749	20	0E0	98.55%	8	C:GO:0005634; F:GO:0003677; C:GO:0005667; F:GO:0003700; P:GO:0007165; P:GO:0006355; P:GO:0006355; F:GO:0004871	C:nucleus; F:DNA binding; C:transcription factor complex; F:transcription factor activity, sequence-specific DNA binding; P:signal transduction; P:regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:signal transducer activity		IPR013799 (SMART); IPR012345 (G3DSA:2.60.40.GENE3D); IPR022752 (PFAM); IPR013801 (PFAM); IPR000980 (G3DSA:3.30.505.GENE3D); IPR013799 (G3DSA:1.10.532.GENE3D); IPR013800 (G3DSA:1.20.1050.GENE3D); IPR013800 (PFAM); IPR000980 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); IPR013799 (PFAM); PTHR11801:SF18 (PANTHER); IPR001217 (PANTHER); IPR000980 (PROSITE_PROFILES); IPR013799 (SUPERFAMILY); IPR000980 (SUPERFAMILY); IPR008967 (SUPERFAMILY); IPR015988 (SUPERFAMILY)
F6VUW2	cathepsin S isoform X1	330	20	0E0	94.8%	2	P:GO:0006508; F:GO:0008234	P:proteolysis; F:cysteine-type peptidase activity	EC:3.4	IPR000668 (PRINTS); IPR000668 (SMART); IPR013201 (SMART); IPR000668 (PFAM); G3DSA:3.90.70.10 (GENE3D); IPR013201 (PFAM); PTHR12411:SF54 (PANTHER); IPR013128 (PANTHER); IPR000169 (PROSITE_PATTERNS); IPR025661 (PROSITE_PATTERNS); IPR025660 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SSF54001 (SUPERFAMILY)
F6SG30	S100-A9-like isoform X2	155	20	9.76E-104	91.7%	10	F:GO:0008270; F:GO:0035662; C:GO:0045298; P:GO:0007165; F:GO:0005509; P:GO:0045087; P:GO:0050727; F:GO:0050544; F:GO:0050786; F:GO:0008017	F:zinc ion binding; F:Toll-like receptor 4 binding; C:tubulin complex; P:signal transduction; F:calcium ion binding; P:innate immune response; P:regulation of inflammatory response; F:arachidonic acid binding; F:RAGE receptor binding; F:microtubule binding		IPR013787 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR013787 (PFAM); IPR028475 (PTHR11639:PANTHER); PTHR11639 (PANTHER); IPR001751 (PROSITE_PATTERNS); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F6Q7J3	complement component C7	842	20	0E0	93.6%	3	C:GO:0005579; F:GO:0005515; P:GO:0006955	C:membrane attack complex; F:protein binding; P:immune response		IPR001862 (PRINTS); PR01705 (PRINTS); IPR002172 (SMART); IPR003884 (SMART); IPR000436 (SMART); IPR020864 (SMART); IPR000884 (SMART); G3DSA:2.10.70.10 (GENE3D); IPR020864 (PFAM); G3DSA:2.20.100.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR000884 (PFAM); IPR002172 (PFAM); IPR000436 (PFAM); G3DSA:2.10.25.10 (GENE3D); PTHR19325 (PANTHER); PTHR19325:SF389 (PANTHER); IPR023415 (PROSITE_PATTERNS); IPR020863 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR000436 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR002172 (PROSITE_PROFILES); IPR020864 (PROSITE_PROFILES); IPR000436 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000436 (SUPERFAMILY)
F6RLT8	calpain small subunit 1	265	20	0E0	97%	2	F:GO:0005509; P:GO:0006508	F:calcium ion binding; P:proteolysis		IPR002048 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); IPR002048 (PFAM); PTHR10183 (PANTHER); IPR029642 (PTHR10183:PANTHER); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
P83704	apolipo A-II	76	20	5.46E-48	88.45%	4	P:GO:0006869; F:GO:0008289; P:GO:0042157; C:GO:0005576	P:lipid transport; F:lipid binding; P:lipoprotein metabolic process; C:extracellular region		PF04711 (PFAM); IPR006801 (PANTHER); PTHR11027:SF0 (PANTHER); IPR006801 (PRODOM); IPR006801 (SUPERFAMILY)
F7BBP1	phospholipase membrane associated	144	20	2.42E-101	89.65%	5	F:GO:0004623; P:GO:0050482; F:GO:0005509; P:GO:0016042; P:GO:0009395	F:phospholipase A2 activity; P:arachidonic acid secretion; F:calcium ion binding; P:lipid catabolic process; P:phospholipid catabolic process	EC:3.1.1; EC:3.1.1.1; EC:3.1.1.4	IPR001211 (PRINTS); IPR016090 (SMART); IPR016090 (G3DSA:1.20.90.GENE3D); IPR016090 (PFAM); IPR001211 (PANTHER); PTHR11716:SF9 (PANTHER); IPR033113 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR016090 (SUPERFAMILY)
F7BKK5	glutathione S-transferase Mu 3	227	20	5.47E-169	96.55%	4	P:GO:0006803; F:GO:0005515; P:GO:0006749; F:GO:0004364	P:obsolete glutathione conjugation reaction; F:protein binding; P:glutathione metabolic process; F:glutathione transferase activity	EC:2.5.1.18	IPR003081 (PRINTS); IPR004046 (PFAM); IPR004045 (PFAM); IPR010987 (G3DSA:1.20.1050.GENE3D); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR11571 (PANTHER); PTHR11571:SF133 (PANTHER); IPR004045 (PROSITE_PROFILES); IPR010987 (PROSITE_PROFILES); IPR010987 (SUPERFAMILY); IPR012336 (SUPERFAMILY)
F6ZF46	calmodulin 5	149	20	2.48E-101	88.4%	1	F:GO:0005509	F:calcium ion binding		IPR002048 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR002048 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR23050 (PANTHER); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F6S8H1	S100-A8	89	20	4.27E-58	91.15%	10	F:GO:0008270; F:GO:0035662; C:GO:0045298; P:GO:0007165; F:GO:0005509; P:GO:0045087; P:GO:0050727; F:GO:0050544; F:GO:0050786; F:GO:0008017	F:zinc ion binding; F:Toll-like receptor 4 binding; C:tubulin complex; P:signal transduction; F:calcium ion binding; P:innate immune response; P:regulation of inflammatory response; F:arachidonic acid binding; F:RAGE receptor binding; F:microtubule binding		IPR013787 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR013787 (PFAM); IPR028474 (PTHR11639:PANTHER); PTHR11639 (PANTHER); IPR001751 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F6W039	rho GDP-dissociation inhibitor 1	204	20	3.69E-150	99.1%	2	C:GO:0005737; F:GO:0005094	C:cytoplasm; F:Rho GDP-dissociation inhibitor activity		IPR000406 (PRINTS); IPR024792 (G3DSA:2.70.50.GENE3D); IPR000406 (PFAM); IPR000406 (PANTHER); PTHR10980:SF9 (PANTHER); IPR014756 (SUPERFAMILY)
F6Z2I7	glutathione S-transferase Mu 1	228	20	4.59E-160	95.65%	4	P:GO:0006803; F:GO:0005515; P:GO:0006749; F:GO:0004364	P:obsolete glutathione conjugation reaction; F:protein binding; P:glutathione metabolic process; F:glutathione transferase activity	EC:2.5.1.18	IPR003081 (PRINTS); IPR010987 (G3DSA:1.20.1050.GENE3D); IPR004046 (PFAM); IPR004045 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR11571:SF137 (PANTHER); PTHR11571 (PANTHER); IPR010987 (PROSITE_PROFILES); IPR004045 (PROSITE_PROFILES); IPR010987 (SUPERFAMILY); IPR012336 (SUPERFAMILY)
O77691	S100-A6	92	20	6.79E-60	94.1%	1	F:GO:0005509	F:calcium ion binding		IPR002048 (SMART); IPR013787 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR013787 (PFAM); PTHR11639 (PANTHER); PTHR11639:SF80 (PANTHER); IPR001751 (PROSITE_PATTERNS); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F6SKV7	latent-transforming growth factor beta-binding 4 isoform X2	1560	20	0E0	70.05%	2	F:GO:0005515; F:GO:0005509	F:protein binding; F:calcium ion binding		IPR000742 (SMART); IPR001881 (SMART); IPR017878 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR001881 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR017878 (G3DSA:3.90.290.GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); PTHR24034 (PANTHER); PTHR24034:SF39 (PANTHER); IPR018097 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR017878 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR017878 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR017878 (SUPERFAMILY); IPR009030 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR009030 (SUPERFAMILY)
F6QP34	WAP four-disulfide core domain 2	123	20	8.02E-81	84%	2	F:GO:0030414; C:GO:0005576	F:peptidase inhibitor activity; C:extracellular region		IPR008197 (PRINTS); IPR008197 (SMART); IPR008197 (G3DSA:4.10.75.GENE3D); IPR008197 (G3DSA:4.10.75.GENE3D); IPR008197 (PFAM); PTHR19441 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR008197 (PROSITE_PROFILES); IPR008197 (SUPERFAMILY); IPR008197 (SUPERFAMILY)
F6RV94	glycogen liver form	830	20	0E0	97.7%	3	F:GO:0008184; P:GO:0005975; F:GO:0030170	F:glycogen phosphorylase activity; P:carbohydrate metabolic process; F:pyridoxal phosphate binding	EC:2.4.1.1	IPR000811 (PIRSF); IPR011833 (TIGRFAM); IPR000811 (PFAM); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); PTHR11468:SF12 (PANTHER); IPR000811 (PANTHER); IPR000811 (PROSITE_PATTERNS); SSF53756 (SUPERFAMILY)
P00443	superoxide dismutase [Cu-Zn]	154	20	2.21E-106	90.8%	4	P:GO:0006801; F:GO:0046872; P:GO:0055114; F:GO:0004784	P:superoxide metabolic process; F:metal ion binding; P:oxidation-reduction process; F:superoxide dismutase activity	EC:1.15.1.1	IPR001424 (PRINTS); IPR001424 (G3DSA:2.60.40.GENE3D); IPR001424 (PFAM); IPR024134 (PANTHER); IPR018152 (PROSITE_PATTERNS); IPR018152 (PROSITE_PATTERNS); IPR001424 (SUPERFAMILY)
F7A7E0	beta-microsemino	113	20	1.42E-78	84.55%	1	C:GO:0005576	C:extracellular region		IPR008735 (PFAM); IPR008735 (PANTHER); PTHR10500:SF0 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS)
F6ZI51	annexin A2	339	20	0E0	99.1%	4	F:GO:0005509; F:GO:0004859; F:GO:0008092; F:GO:0005544	F:calcium ion binding; F:phospholipase inhibitor activity; F:cytoskeletal protein binding; F:calcium-dependent phospholipid binding		IPR001464 (PRINTS); IPR002389 (PRINTS); IPR018502 (SMART); IPR018502 (G3DSA:1.10.220.GENE3D); IPR018502 (PFAM); IPR018502 (G3DSA:1.10.220.GENE3D); IPR018502 (G3DSA:1.10.220.GENE3D); IPR002389 (PTHR10502:PANTHER); PTHR10502 (PANTHER); IPR018252 (PROSITE_PATTERNS); SSF47874 (SUPERFAMILY)
F7BH02	filamin-A isoform X2	758	20	0E0	99%	1	F:GO:0051015	F:actin filament binding		IPR001715 (SMART); IPR001298 (SMART); IPR001715 (G3DSA:1.10.418.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR017868 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001715 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); PTHR11915 (PANTHER); IPR028559 (PTHR11915:PANTHER); IPR001589 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR017868 (PROSITE_PROFILES); IPR001715 (PROSITE_PROFILES); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR001715 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY)
F6VE62	beta-hexosaminidase subunit beta	486	20	0E0	89.65%	5	P:GO:0001575; P:GO:0005975; P:GO:0006040; F:GO:0004563; P:GO:0006027	P:globoside metabolic process; P:carbohydrate metabolic process; P:amino sugar metabolic process; F:beta-N-acetylhexosaminidase activity; P:glycosaminoglycan catabolic process	EC:3.2.1.52; EC:3.2.1	IPR025705 (PRINTS); IPR025705 (PIRSF); IPR029018 (G3DSA:3.30.379.GENE3D); IPR029019 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); IPR015883 (PFAM); PTHR22600:SF5 (PANTHER); PTHR22600 (PANTHER); IPR017853 (SUPERFAMILY); IPR029018 (SUPERFAMILY)
F6ZJE4	ras-related Rab-8A	207	20	3.31E-151	99.7%	2	F:GO:0005525; P:GO:0007264	F:GTP binding; P:small GTPase mediated signal transduction		PR00449 (PRINTS); SM00173 (SMART); SM00175 (SMART); SM00177 (SMART); SM00176 (SMART); SM00174 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001806 (PFAM); IPR005225 (TIGRFAM); PTHR24073 (PANTHER); PTHR24073:SF489 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F7BFF5	ras-related Rab-8B	207	20	3.46E-150	99.05%	2	F:GO:0005525; P:GO:0007264	F:GTP binding; P:small GTPase mediated signal transduction		PR00449 (PRINTS); SM00175 (SMART); SM00177 (SMART); SM00173 (SMART); SM00174 (SMART); SM00176 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); IPR001806 (PFAM); PTHR24073 (PANTHER); PTHR24073:SF22 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F6ZPC6	ras-related Rab-1A	202	20	1.22E-148	99.3%	2	F:GO:0005525; P:GO:0007264	F:GTP binding; P:small GTPase mediated signal transduction		PR00449 (PRINTS); SM00177 (SMART); SM00175 (SMART); SM00176 (SMART); SM00174 (SMART); SM00173 (SMART); IPR005225 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001806 (PFAM); PTHR24073:SF455 (PANTHER); PTHR24073 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F6TGA5	ras-related Rab-1B	201	20	1.06E-147	99.55%	2	F:GO:0005525; P:GO:0007264	F:GTP binding; P:small GTPase mediated signal transduction		PR00449 (PRINTS); SM00177 (SMART); SM00173 (SMART); SM00174 (SMART); SM00176 (SMART); SM00175 (SMART); IPR005225 (TIGRFAM); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24073 (PANTHER); PTHR24073:SF455 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F6YHD4	ras-related Rab-15	212	20	1.26E-157	99.4%	2	F:GO:0005525; P:GO:0007264	F:GTP binding; P:small GTPase mediated signal transduction		PR00449 (PRINTS); SM00176 (SMART); SM00173 (SMART); SM00174 (SMART); SM00175 (SMART); IPR005225 (TIGRFAM); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24073 (PANTHER); PTHR24073:SF567 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F6RM82	S100-A9-like isoform X2	131	20	2.13E-89	93.25%	10	F:GO:0008270; F:GO:0035662; C:GO:0045298; P:GO:0007165; F:GO:0005509; P:GO:0045087; P:GO:0050727; F:GO:0050544; F:GO:0050786; F:GO:0008017	F:zinc ion binding; F:Toll-like receptor 4 binding; C:tubulin complex; P:signal transduction; F:calcium ion binding; P:innate immune response; P:regulation of inflammatory response; F:arachidonic acid binding; F:RAGE receptor binding; F:microtubule binding		IPR013787 (SMART); IPR002048 (SMART); IPR013787 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR11639 (PANTHER); IPR028475 (PTHR11639:PANTHER); IPR001751 (PROSITE_PATTERNS); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F6SX07	galectin-7	136	20	2.45E-93	88.55%	3	C:GO:0005615; P:GO:0007157; F:GO:0030246	C:extracellular space; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; F:carbohydrate binding		IPR001079 (SMART); IPR001079 (SMART); IPR013320 (G3DSA:2.60.120.GENE3D); IPR001079 (PFAM); PTHR11346 (PANTHER); IPR030640 (PTHR11346:PANTHER); IPR001079 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY)
F6PNM1	45 kDa calcium-binding	361	20	0E0	94.9%	1	F:GO:0005509	F:calcium ion binding		IPR002048 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR002048 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR10827 (PANTHER); IPR027240 (PTHR10827:PANTHER); IPR018247 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY); IPR011992 (SUPERFAMILY)
F6Z5C4	calmodulin	148	20	2.12E-102	100%	1	F:GO:0005509	F:calcium ion binding		PR00450 (PRINTS); IPR002048 (SMART); IPR002048 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR23050 (PANTHER); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F7B812	serine protease HTRA1	323	20	0E0	99.1%	3	F:GO:0005515; P:GO:0006508; F:GO:0004252	F:protein binding; P:proteolysis; F:serine-type endopeptidase activity	EC:3.4.21	IPR001940 (PRINTS); IPR001478 (SMART); PF13365 (PFAM); IPR001478 (PFAM); G3DSA:2.40.10.10 (GENE3D); G3DSA:2.40.10.10 (GENE3D); IPR001478 (G3DSA:2.30.42.GENE3D); PTHR22939 (PANTHER); PTHR22939:SF13 (PANTHER); IPR001478 (PROSITE_PROFILES); IPR009003 (SUPERFAMILY); IPR001478 (SUPERFAMILY)
F6W683	GDP-mannose 4,6 dehydratase	343	20	0E0	98.6%	4	P:GO:0009298; P:GO:0006000; P:GO:0006012; F:GO:0008446	P:GDP-mannose biosynthetic process; P:fructose metabolic process; P:galactose metabolic process; F:GDP-mannose 4,6-dehydratase activity	EC:4.2.1.47	IPR016040 (G3DSA:3.40.50.GENE3D); G3DSA:3.90.25.10 (GENE3D); IPR006368 (TIGRFAM); IPR016040 (PFAM); PTHR10366 (PANTHER); PTHR10366:SF429 (PANTHER); IPR006368 (HAMAP); IPR016040 (SUPERFAMILY)
F6T0M8	EGF-containing fibulin-like extracellular matrix 1	490	20	0E0	95.95%	5	F:GO:0005515; F:GO:0005509; P:GO:0007173; C:GO:0031012; F:GO:0005006	F:protein binding; F:calcium ion binding; P:epidermal growth factor receptor signaling pathway; C:extracellular matrix; F:epidermal growth factor-activated receptor activity	EC:2.7.10; EC:2.7.10.1; EC:2.7.11	IPR001881 (SMART); IPR000742 (SMART); IPR026823 (PFAM); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR001881 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR032973 (PTHR24044:PANTHER); PTHR24044 (PANTHER); IPR013032 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR000742 (PROSITE_PROFILES); SSF57196 (SUPERFAMILY); IPR009030 (SUPERFAMILY)
F6PVG3	EGF-containing fibulin-like extracellular matrix 1	498	20	0E0	97%	5	F:GO:0005515; F:GO:0005509; P:GO:0007173; C:GO:0031012; F:GO:0005006	F:protein binding; F:calcium ion binding; P:epidermal growth factor receptor signaling pathway; C:extracellular matrix; F:epidermal growth factor-activated receptor activity	EC:2.7.10; EC:2.7.10.1; EC:2.7.11	IPR001881 (SMART); IPR000742 (SMART); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR001881 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR026823 (PFAM); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR032973 (PTHR24044:PANTHER); PTHR24044 (PANTHER); IPR000152 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000742 (PROSITE_PROFILES); SSF57196 (SUPERFAMILY); IPR009030 (SUPERFAMILY); SSF57196 (SUPERFAMILY)
F6QME0	purine nucleoside phosphorylase	230	20	1.98E-170	96.4%	6	P:GO:0006769; P:GO:0006206; P:GO:0046497; P:GO:0009116; P:GO:0006144; F:GO:0004731	P:nicotinamide metabolic process; P:pyrimidine nucleobase metabolic process; P:nicotinate nucleotide metabolic process; P:nucleoside metabolic process; P:purine nucleobase metabolic process; F:purine-nucleoside phosphorylase activity	EC:2.4.2.1	IPR011268 (PIRSF); IPR011270 (TIGRFAM); IPR000845 (G3DSA:3.40.50.GENE3D); IPR000845 (PFAM); IPR011268 (TIGRFAM); PTHR11904:SF12 (PANTHER); IPR001369 (PANTHER); IPR000845 (SUPERFAMILY)
F7DY67	purine nucleoside phosphorylase-like isoform X1	274	20	0E0	96.1%	6	P:GO:0006769; P:GO:0006206; P:GO:0046497; P:GO:0009116; P:GO:0006144; F:GO:0004731	P:nicotinamide metabolic process; P:pyrimidine nucleobase metabolic process; P:nicotinate nucleotide metabolic process; P:nucleoside metabolic process; P:purine nucleobase metabolic process; F:purine-nucleoside phosphorylase activity	EC:2.4.2.1	IPR011268 (PIRSF); IPR011268 (TIGRFAM); IPR000845 (PFAM); IPR000845 (G3DSA:3.40.50.GENE3D); IPR011270 (TIGRFAM); IPR001369 (PANTHER); PTHR11904:SF12 (PANTHER); IPR018099 (PROSITE_PATTERNS); IPR000845 (SUPERFAMILY)
F6PRI5	liver carboxylesterase-like isoform X1	565	20	0E0	92.35%	4	P:GO:0030855; C:GO:0005615; F:GO:0052689; F:GO:0016787	P:epithelial cell differentiation; C:extracellular space; F:carboxylic ester hydrolase activity; F:hydrolase activity		IPR002018 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR11559:SF179 (PANTHER); PTHR11559 (PANTHER); IPR019826 (PROSITE_PATTERNS); IPR019819 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR029058 (SUPERFAMILY)
F6PWL9	rab GDP dissociation inhibitor alpha	446	20	0E0	99.05%	5	F:GO:0005093; F:GO:0016491; P:GO:0007264; P:GO:0015031; P:GO:0055114	F:Rab GDP-dissociation inhibitor activity; F:oxidoreductase activity; P:small GTPase mediated signal transduction; P:protein transport; P:oxidation-reduction process		IPR000806 (PRINTS); IPR018203 (PRINTS); G3DSA:1.10.405.10 (GENE3D); G3DSA:3.30.519.10 (GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR018203 (PFAM); PTHR11787 (PANTHER); PTHR11787:SF3 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY)
F7BR00	peptidyl-glycine alpha-amidating monooxygenase isoform X1	974	20	0E0	95.85%	6	F:GO:0005515; F:GO:0005507; F:GO:0016715; P:GO:0006518; C:GO:0016020; P:GO:0055114	F:protein binding; F:copper ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen; P:peptide metabolic process; C:membrane; P:oxidation-reduction process	EC:1.14.17	IPR000720 (PRINTS); IPR001258 (PFAM); IPR014784 (G3DSA:2.60.120.GENE3D); IPR000323 (PFAM); IPR000323 (G3DSA:2.60.120.GENE3D); IPR011042 (G3DSA:2.120.10.GENE3D); IPR024548 (PFAM); PTHR10680:SF14 (PANTHER); PTHR10680 (PANTHER); IPR020611 (PROSITE_PATTERNS); IPR014783 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR013017 (PROSITE_PROFILES); IPR008977 (SUPERFAMILY); SSF63829 (SUPERFAMILY); IPR008977 (SUPERFAMILY)
F6ZCC8	peptidyl-glycine alpha-amidating monooxygenase isoform X1	976	20	0E0	95.4%	6	F:GO:0005515; F:GO:0005507; F:GO:0016715; P:GO:0006518; C:GO:0016020; P:GO:0055114	F:protein binding; F:copper ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen; P:peptide metabolic process; C:membrane; P:oxidation-reduction process	EC:1.14.17	IPR000720 (PRINTS); IPR000323 (PFAM); IPR001258 (PFAM); IPR011042 (G3DSA:2.120.10.GENE3D); IPR014784 (G3DSA:2.60.120.GENE3D); IPR000323 (G3DSA:2.60.120.GENE3D); IPR024548 (PFAM); PTHR10680 (PANTHER); PTHR10680:SF14 (PANTHER); IPR014783 (PROSITE_PATTERNS); IPR020611 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR013017 (PROSITE_PROFILES); IPR008977 (SUPERFAMILY); IPR008977 (SUPERFAMILY); SSF63829 (SUPERFAMILY)
F6V822	antileuko ase	131	20	2.36E-90	81.85%	3	F:GO:0004866; P:GO:0010951; C:GO:0005576	F:endopeptidase inhibitor activity; P:negative regulation of endopeptidase activity; C:extracellular region		IPR008197 (PRINTS); IPR008197 (SMART); IPR008197 (PFAM); IPR008197 (G3DSA:4.10.75.GENE3D); PTHR19441 (PANTHER); IPR029712 (PTHR19441:PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR008197 (PROSITE_PROFILES); IPR008197 (SUPERFAMILY); IPR008197 (SUPERFAMILY)
F6XLG0	purine nucleoside phosphorylase	289	20	0E0	96.15%	6	P:GO:0006769; P:GO:0006206; P:GO:0046497; P:GO:0009116; P:GO:0006144; F:GO:0004731	P:nicotinamide metabolic process; P:pyrimidine nucleobase metabolic process; P:nicotinate nucleotide metabolic process; P:nucleoside metabolic process; P:purine nucleobase metabolic process; F:purine-nucleoside phosphorylase activity	EC:2.4.2.1	IPR011268 (PIRSF); IPR000845 (PFAM); IPR000845 (G3DSA:3.40.50.GENE3D); IPR011268 (TIGRFAM); IPR011270 (TIGRFAM); PTHR11904:SF12 (PANTHER); IPR001369 (PANTHER); IPR018099 (PROSITE_PATTERNS); IPR000845 (SUPERFAMILY)
F7BHV8	tubulin beta-4A chain	425	20	0E0	99.7%	5	F:GO:0005525; F:GO:0003924; F:GO:0005200; C:GO:0005874; P:GO:0007017	F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton; C:microtubule; P:microtubule-based process	EC:3.6.1; EC:3.6.1.15	IPR000217 (PRINTS); IPR002453 (PRINTS); IPR018316 (SMART); IPR003008 (SMART); IPR003008 (G3DSA:3.40.50.GENE3D); IPR023123 (G3DSA:1.10.287.GENE3D); IPR018316 (PFAM); IPR018316 (G3DSA:3.30.1330.GENE3D); IPR003008 (PFAM); IPR000217 (PANTHER); PTHR11588:SF121 (PANTHER); IPR017975 (PROSITE_PATTERNS); IPR003008 (SUPERFAMILY); IPR008280 (SUPERFAMILY)
F6UF75	S100-A4	101	20	3.36E-68	99.35%	1	F:GO:0005509	F:calcium ion binding		IPR013787 (SMART); IPR002048 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR013787 (PFAM); PTHR11639:SF51 (PANTHER); PTHR11639 (PANTHER); IPR001751 (PROSITE_PATTERNS); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F7APR4	actin-related 2 3 complex subunit 2	298	20	0E0	99%	2	P:GO:0034314; C:GO:0005885	P:Arp2/3 complex-mediated actin nucleation; C:Arp2/3 protein complex		IPR007188 (PFAM); G3DSA:3.30.1460.20 (GENE3D); G3DSA:3.30.1460.20 (GENE3D); IPR007188 (PANTHER); SSF69645 (SUPERFAMILY); SSF69645 (SUPERFAMILY)
F6Z0A9	ras-related C3 botulinum toxin substrate 1 isoform X1	199	20	1.89E-145	99.85%	2	F:GO:0005525; P:GO:0007264	F:GTP binding; P:small GTPase mediated signal transduction		PR00449 (PRINTS); SM00173 (SMART); SM00174 (SMART); SM00175 (SMART); IPR005225 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001806 (PFAM); PTHR24072 (PANTHER); PTHR24072:SF169 (PANTHER); PS51420 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F7AX30	ras-related C3 botulinum toxin substrate 2	192	20	4.11E-140	98.75%	2	F:GO:0005525; P:GO:0007264	F:GTP binding; P:small GTPase mediated signal transduction		PR00449 (PRINTS); SM00176 (SMART); SM00174 (SMART); SM00173 (SMART); SM00175 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); IPR001806 (PFAM); PTHR24072 (PANTHER); PTHR24072:SF169 (PANTHER); PS51420 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F7AJD4	neuroblast differentiation-associated AHNAK isoform X4	1950	20	0E0	92.25%	23	P:GO:1901385; C:GO:0043034; C:GO:0005886; F:GO:0044548; C:GO:0005765; F:GO:0044822; F:GO:0097493; C:GO:0030315; C:GO:0044291; C:GO:0005634; F:GO:0005515; C:GO:0070062; C:GO:0005925; C:GO:0005737; C:GO:0042383; P:GO:0043484; C:GO:0016020; C:GO:0045121; C:GO:0015629; C:GO:0005829; C:GO:0019013; C:GO:0031982; P:GO:0051259	P:regulation of voltage-gated calcium channel activity; C:costamere; C:plasma membrane; F:S100 protein binding; C:lysosomal membrane; F:poly(A) RNA binding; F:structural molecule activity conferring elasticity; C:T-tubule; C:cell-cell contact zone; C:nucleus; F:protein binding; C:extracellular exosome; C:focal adhesion; C:cytoplasm; C:sarcolemma; P:regulation of RNA splicing; C:membrane; C:membrane raft; C:actin cytoskeleton; C:cytosol; C:viral nucleocapsid; C:vesicle; P:protein oligomerization		PTHR23348 (PANTHER); PTHR23348:SF41 (PANTHER)
F6R9A3	lipopolysaccharide-responsive and beige-like anchor isoform X1	978	20	0E0	97.9%	1	F:GO:0005515	F:protein binding		IPR000409 (SMART); IPR001680 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR010508 (PFAM); IPR001680 (PFAM); IPR023362 (G3DSA:2.30.29.GENE3D); IPR013320 (G3DSA:2.60.120.GENE3D); IPR000409 (PFAM); IPR000409 (G3DSA:1.10.1540.GENE3D); IPR023362 (PFAM); PF13385 (PFAM); IPR031570 (PFAM); PTHR13743 (PANTHER); PTHR13743:SF64 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); PD329443 (PRODOM); IPR001680 (PROSITE_PROFILES); IPR000409 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR017986 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR000409 (SUPERFAMILY); IPR013320 (SUPERFAMILY)
F6ZHQ5	chloride intracellular channel 1	241	20	5.29E-178	99.2%	4	F:GO:0005515; F:GO:0005254; P:GO:0051726; P:GO:0006821	F:protein binding; F:chloride channel activity; P:regulation of cell cycle; P:chloride transport		IPR002946 (PRINTS); IPR012336 (G3DSA:3.40.30.GENE3D); IPR004045 (PFAM); IPR010987 (G3DSA:1.20.1050.GENE3D); IPR002946 (TIGRFAM); PF13410 (PFAM); PTHR11260 (PANTHER); IPR030259 (PTHR11260:PANTHER); IPR010987 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR010987 (SUPERFAMILY)
F7CCI0	immunoglobulin lambda light chain variable partial	121	20	2.65E-58	83.6%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF187 (PANTHER); PTHR23267 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
P62327	TMSB4X partial	44	20	4.11E-22	100%	2	P:GO:0007015; F:GO:0003785	P:actin filament organization; F:actin monomer binding		IPR001152 (SMART); IPR001152 (PIRSF); IPR001152 (PFAM); IPR001152 (G3DSA:1.20.5.GENE3D); PTHR12021:SF13 (PANTHER); IPR001152 (PANTHER); IPR001152 (PROSITE_PATTERNS); IPR001152 (PRODOM)
F6VSN9	disulfide-isomerase A3	504	20	0E0	98.25%	3	C:GO:0005783; P:GO:0045454; F:GO:0016853	C:endoplasmic reticulum; P:cell redox homeostasis; F:isomerase activity		PR00421 (PRINTS); IPR013766 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PF13848 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR005792 (TIGRFAM); IPR005788 (TIGRFAM); PTHR18929 (PANTHER); PTHR18929:SF60 (PANTHER); IPR017937 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY)
F6WQF0	plectin isoform X16	492	20	0E0	99%	2	C:GO:0005856; F:GO:0008092	C:cytoskeleton; F:cytoskeletal protein binding		IPR018159 (SMART); IPR001101 (SMART); IPR001715 (SMART); IPR001715 (PFAM); G3DSA:1.20.58.60 (GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001101 (PFAM); IPR001101 (G3DSA:3.90.1290.GENE3D); IPR030269 (PTHR11915:PANTHER); PTHR11915 (PANTHER); IPR001589 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR001715 (PROSITE_PROFILES); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001715 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY)
F6WQ73	plectin isoform X5	498	20	0E0	99%	2	C:GO:0005856; F:GO:0008092	C:cytoskeleton; F:cytoskeletal protein binding		IPR001715 (SMART); IPR018159 (SMART); IPR001101 (SMART); IPR001715 (PFAM); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); IPR001101 (PFAM); IPR001101 (G3DSA:3.90.1290.GENE3D); IPR030269 (PTHR11915:PANTHER); PTHR11915 (PANTHER); IPR001589 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); IPR001715 (PROSITE_PROFILES); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001715 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY)
F6VG02	titin isoform X50	577	20	0E0	99.05%	4	F:GO:0005524; F:GO:0005515; F:GO:0004672; P:GO:0006468	F:ATP binding; F:protein binding; F:protein kinase activity; P:protein phosphorylation		PR00014 (PRINTS); IPR003961 (SMART); IPR003599 (SMART); IPR013106 (SMART); IPR003598 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR015129 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003961 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:1.20.5.510 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR000719 (PFAM); IPR004168 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR13817 (PANTHER); PTHR13817:SF10 (PANTHER); IPR008266 (PROSITE_PATTERNS); IPR003961 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY)
F6WPZ3	plectin isoform X16	492	20	0E0	99%	2	C:GO:0005856; F:GO:0008092	C:cytoskeleton; F:cytoskeletal protein binding		IPR018159 (SMART); IPR001101 (SMART); IPR001715 (SMART); IPR001715 (PFAM); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001101 (PFAM); IPR001101 (G3DSA:3.90.1290.GENE3D); IPR030269 (PTHR11915:PANTHER); PTHR11915 (PANTHER); IPR001589 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); IPR001715 (PROSITE_PROFILES); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001715 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY)
F6WXR4	plectin isoform X16	519	20	0E0	99%	2	C:GO:0005856; F:GO:0008092	C:cytoskeleton; F:cytoskeletal protein binding		IPR018159 (SMART); IPR001101 (SMART); IPR001715 (SMART); IPR001715 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); IPR001101 (G3DSA:3.90.1290.GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); IPR001101 (PFAM); G3DSA:1.20.58.60 (GENE3D); PTHR11915 (PANTHER); IPR030269 (PTHR11915:PANTHER); IPR001589 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); IPR001715 (PROSITE_PROFILES); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001715 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY)
F6WQW5	plectin isoform X17	634	20	0E0	99%	2	C:GO:0005856; F:GO:0008092	C:cytoskeleton; F:cytoskeletal protein binding		IPR001715 (SMART); IPR018159 (SMART); IPR001101 (SMART); IPR001101 (G3DSA:3.90.1290.GENE3D); IPR005326 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); IPR001101 (PFAM); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (PFAM); PTHR11915 (PANTHER); IPR030269 (PTHR11915:PANTHER); IPR001589 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); IPR001715 (PROSITE_PROFILES); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001715 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY)
F6WRA4	plectin isoform X17	638	20	0E0	99%	2	C:GO:0005856; F:GO:0008092	C:cytoskeleton; F:cytoskeletal protein binding		IPR001715 (SMART); IPR018159 (SMART); IPR001101 (SMART); IPR005326 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); IPR001101 (PFAM); G3DSA:1.20.58.60 (GENE3D); IPR001101 (G3DSA:3.90.1290.GENE3D); IPR001715 (PFAM); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); IPR030269 (PTHR11915:PANTHER); PTHR11915 (PANTHER); IPR001589 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); IPR001715 (PROSITE_PROFILES); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001715 (SUPERFAMILY)
F6UIC2	3 (2 ),5 -bisphosphate nucleotidase 1 isoform X1	308	20	0E0	97.85%	1	P:GO:0046854	P:phosphatidylinositol phosphorylation		IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); G3DSA:3.30.540.10 (GENE3D); IPR000760 (PANTHER); PTHR20854:SF5 (PANTHER); IPR020550 (PROSITE_PATTERNS); IPR020583 (PROSITE_PATTERNS); SSF56655 (SUPERFAMILY)
F6U5V3	transcobalamin-2	429	20	0E0	87.65%	2	F:GO:0031419; P:GO:0015889	F:cobalamin binding; P:cobalamin transport		IPR002157 (PFAM); IPR002157 (PANTHER); PTHR10559:SF14 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SSF81853 (SUPERFAMILY)
F6X8Q2	phosphoglucomutase-1 isoform X2	644	20	0E0	93.2%	4	F:GO:0000287; P:GO:0005975; F:GO:0016868; F:GO:0005509	F:magnesium ion binding; P:carbohydrate metabolic process; F:intramolecular transferase activity, phosphotransferases; F:calcium ion binding		IPR005841 (PRINTS); IPR011992 (G3DSA:1.10.238.GENE3D); IPR005846 (PFAM); IPR002048 (PFAM); IPR005843 (PFAM); IPR005844 (PFAM); IPR016055 (G3DSA:3.40.120.GENE3D); IPR016055 (G3DSA:3.40.120.GENE3D); IPR016055 (G3DSA:3.40.120.GENE3D); IPR005845 (PFAM); IPR005843 (G3DSA:3.30.310.GENE3D); PTHR22573:SF37 (PANTHER); PTHR22573 (PANTHER); IPR016066 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR005843 (SUPERFAMILY); IPR016055 (SUPERFAMILY); IPR016055 (SUPERFAMILY); IPR016055 (SUPERFAMILY); IPR011992 (SUPERFAMILY)
F7DVQ8	trefoil factor 3	80	20	4.87E-52	88.85%	5	P:GO:0010906; C:GO:0005737; C:GO:0030141; C:GO:0005576; C:GO:0005578	P:regulation of glucose metabolic process; C:cytoplasm; C:secretory granule; C:extracellular region; C:proteinaceous extracellular matrix		IPR017994 (PRINTS); IPR000519 (SMART); IPR000519 (G3DSA:4.10.110.GENE3D); IPR000519 (PFAM); PTHR13826 (PANTHER); IPR017957 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR000519 (PROSITE_PROFILES); IPR000519 (SUPERFAMILY)
F7BRA4	proteasome subunit alpha type-6	246	20	0E0	99.55%	3	C:GO:0019773; F:GO:0004298; P:GO:0006511	C:proteasome core complex, alpha-subunit complex; F:threonine-type endopeptidase activity; P:ubiquitin-dependent protein catabolic process	EC:3.4.25	IPR000426 (SMART); IPR000426 (PFAM); IPR029055 (G3DSA:3.60.20.GENE3D); IPR001353 (PFAM); PTHR11599:SF64 (PANTHER); PTHR11599 (PANTHER); IPR000426 (PROSITE_PATTERNS); IPR023332 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY)
F7C6F2	ubiquitin-like modifier-activating enzyme 1 isoform X2	1058	20	0E0	99.05%	2	P:GO:0006464; F:GO:0008641	P:cellular protein modification process; F:small protein activating enzyme activity		IPR000011 (PRINTS); IPR018965 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR032420 (PFAM); IPR019572 (PFAM); IPR018965 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR000594 (PFAM); IPR019572 (G3DSA:1.10.3240.GENE3D); IPR018075 (TIGRFAM); IPR032418 (PFAM); PTHR10953:SF144 (PANTHER); PTHR10953 (PANTHER); IPR018074 (PROSITE_PATTERNS); IPR033127 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000594 (SUPERFAMILY); IPR000594 (SUPERFAMILY)
F6X9U4	dystroglycan	894	20	0E0	97.4%	3	F:GO:0005509; C:GO:0016010; P:GO:0007016	F:calcium ion binding; C:dystrophin-associated glycoprotein complex; P:cytoskeletal anchoring at plasma membrane		IPR006644 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR008465 (PFAM); IPR027468 (G3DSA:3.30.70.GENE3D); PTHR21559:SF17 (PANTHER); PTHR21559 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR030398 (PROSITE_PROFILES); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR027468 (SUPERFAMILY)
F6ZNS0	pleckstrin homology domain-containing family S member 1 isoform X2	461	20	0E0	86.6%	1	F:GO:0005515	F:protein binding		IPR001849 (SMART); IPR001849 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); PTHR12156:SF19 (PANTHER); PTHR12156 (PANTHER); IPR001849 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY)
F6ZSZ5	vinculin isoform X1	1066	20	0E0	99.65%	4	F:GO:0051015; C:GO:0015629; F:GO:0005198; P:GO:0007155	F:actin filament binding; C:actin cytoskeleton; F:structural molecule activity; P:cell adhesion		PR00806 (PRINTS); G3DSA:1.20.1490.10 (GENE3D); G3DSA:1.20.120.230 (GENE3D); G3DSA:1.20.120.230 (GENE3D); G3DSA:1.20.120.230 (GENE3D); IPR006077 (PFAM); G3DSA:1.20.120.230 (GENE3D); IPR006077 (PANTHER); IPR000633 (PROSITE_PATTERNS); IPR000633 (PROSITE_PATTERNS); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY)
F6ZT22	vinculin isoform X1	1134	20	0E0	99.1%	4	F:GO:0051015; C:GO:0015629; F:GO:0005198; P:GO:0007155	F:actin filament binding; C:actin cytoskeleton; F:structural molecule activity; P:cell adhesion		PR00806 (PRINTS); G3DSA:1.20.1490.10 (GENE3D); G3DSA:1.20.120.230 (GENE3D); IPR006077 (PFAM); G3DSA:1.20.120.230 (GENE3D); G3DSA:1.20.120.230 (GENE3D); G3DSA:1.20.120.230 (GENE3D); IPR006077 (PANTHER); IPR000633 (PROSITE_PATTERNS); IPR000633 (PROSITE_PATTERNS); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY)
F6ZT60	vinculin isoform X1	1137	20	0E0	99%	4	F:GO:0051015; C:GO:0015629; F:GO:0005198; P:GO:0007155	F:actin filament binding; C:actin cytoskeleton; F:structural molecule activity; P:cell adhesion		PR00806 (PRINTS); G3DSA:1.20.120.230 (GENE3D); G3DSA:1.20.120.230 (GENE3D); G3DSA:1.20.120.230 (GENE3D); IPR006077 (PFAM); G3DSA:1.20.1490.10 (GENE3D); G3DSA:1.20.120.230 (GENE3D); IPR006077 (PANTHER); IPR000633 (PROSITE_PATTERNS); IPR000633 (PROSITE_PATTERNS); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY); IPR006077 (SUPERFAMILY)
F7CZH3	thioredoxin domain-containing 5	324	20	0E0	95.5%	2	P:GO:0045454; F:GO:0016853	P:cell redox homeostasis; F:isomerase activity		PR00421 (PRINTS); IPR013766 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR012336 (G3DSA:3.40.30.GENE3D); IPR005788 (TIGRFAM); PTHR18929:SF43 (PANTHER); PTHR18929 (PANTHER); IPR017937 (PROSITE_PATTERNS); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY)
F7DIE1	cornifin-A	73	20	3.22E-36	72.1%	9	P:GO:0030216; C:GO:0001533; C:GO:0070062; C:GO:0005737; F:GO:0005198; P:GO:0008544; P:GO:0018149; P:GO:0031424; F:GO:0030674	P:keratinocyte differentiation; C:cornified envelope; C:extracellular exosome; C:cytoplasm; F:structural molecule activity; P:epidermis development; P:peptide cross-linking; P:keratinization; F:protein binding, bridging		PR00021 (PRINTS); PF02389 (PFAM); PTHR23263:SF64 (PANTHER); IPR026075 (PANTHER)
F6YXX3	PDZ and LIM domain 5 isoform X1	596	20	0E0	95.3%	2	F:GO:0008270; F:GO:0005515	F:zinc ion binding; F:protein binding		IPR001478 (SMART); IPR001781 (SMART); IPR001781 (PFAM); IPR001478 (G3DSA:2.30.42.GENE3D); IPR031847 (PFAM); IPR001478 (PFAM); IPR001781 (G3DSA:2.10.110.GENE3D); IPR001781 (G3DSA:2.10.110.GENE3D); PTHR24214:SF32 (PANTHER); PTHR24214 (PANTHER); IPR001781 (PROSITE_PATTERNS); IPR001478 (PROSITE_PROFILES); IPR001781 (PROSITE_PROFILES); IPR001478 (SUPERFAMILY); SSF57716 (SUPERFAMILY); SSF57716 (SUPERFAMILY); SSF57716 (SUPERFAMILY)
F6R2K0		1222				2	F:GO:0005509; F:GO:0005198	F:calcium ion binding; F:structural molecule activity		IPR003303 (PRINTS); IPR013787 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR003303 (PFAM); IPR013787 (PFAM); PTHR22571 (PANTHER); PTHR22571:SF21 (PANTHER); IPR018247 (PROSITE_PATTERNS); IPR001751 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
Q8MIP0	ferritin heavy chain	182	20	4.17E-134	97.45%	3	P:GO:0006879; F:GO:0008199; P:GO:0006826	P:cellular iron ion homeostasis; F:ferric iron binding; P:iron ion transport		IPR012347 (G3DSA:1.20.1260.GENE3D); IPR008331 (PFAM); IPR001519 (PANTHER); PTHR11431:SF37 (PANTHER); IPR014034 (PROSITE_PATTERNS); IPR014034 (PROSITE_PATTERNS); IPR009040 (PROSITE_PROFILES); IPR009078 (SUPERFAMILY)
F6WXH5	ferritin heavy chain	186	20	3.9E-134	97.25%	3	P:GO:0006879; F:GO:0008199; P:GO:0006826	P:cellular iron ion homeostasis; F:ferric iron binding; P:iron ion transport		IPR012347 (G3DSA:1.20.1260.GENE3D); IPR008331 (PFAM); PTHR11431:SF37 (PANTHER); IPR001519 (PANTHER); IPR014034 (PROSITE_PATTERNS); IPR014034 (PROSITE_PATTERNS); IPR009040 (PROSITE_PROFILES); IPR009078 (SUPERFAMILY)
F7CBN0	alcohol dehydrogenase [NADP(+)]	324	20	0E0	98.55%	2	F:GO:0016491; P:GO:0055114	F:oxidoreductase activity; P:oxidation-reduction process		IPR020471 (PRINTS); IPR020471 (PIRSF); IPR023210 (PFAM); IPR023210 (G3DSA:3.20.20.GENE3D); PTHR11732:SF264 (PANTHER); IPR001395 (PANTHER); IPR018170 (PROSITE_PATTERNS); IPR018170 (PROSITE_PATTERNS); IPR018170 (PROSITE_PATTERNS); IPR023210 (SUPERFAMILY)
F7A103	nesprin-1 isoform X4	1693	20	0E0	97.55%	3	F:GO:0051015; P:GO:0090286; C:GO:0034993	F:actin filament binding; P:cytoskeletal anchoring at nuclear membrane; C:LINC complex		IPR001715 (SMART); IPR018159 (SMART); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (PFAM); IPR002017 (PFAM); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR030265 (PTHR11915:PANTHER); PTHR11915 (PANTHER); IPR001589 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); IPR001715 (PROSITE_PROFILES); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001715 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY)
F6RHE9	nesprin-1	768	20	0E0	96.05%	4	F:GO:0051015; C:GO:0016021; P:GO:0090286; C:GO:0034993	F:actin filament binding; C:integral component of membrane; P:cytoskeletal anchoring at nuclear membrane; C:LINC complex		IPR001715 (SMART); IPR018159 (SMART); IPR012315 (SMART); IPR001715 (G3DSA:1.10.418.GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR002017 (PFAM); IPR012315 (PFAM); IPR001715 (PFAM); G3DSA:1.20.58.60 (GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR030265 (PTHR11915:PANTHER); PTHR11915 (PANTHER); IPR001589 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR001715 (PROSITE_PROFILES); IPR012315 (PROSITE_PROFILES); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001715 (SUPERFAMILY); SSF46966 (SUPERFAMILY)
F6ZFH9	14-3-3 gamma	218	20	7.7E-161	100%	1	F:GO:0019904	F:protein domain specific binding		IPR000308 (PRINTS); IPR000308 (PIRSF); IPR023410 (SMART); G3DSA:1.20.190.20 (GENE3D); IPR023410 (PFAM); IPR000308 (PANTHER); PTHR18860:SF35 (PANTHER); IPR023409 (PROSITE_PATTERNS); IPR023409 (PROSITE_PATTERNS); IPR023410 (SUPERFAMILY)
F6ZE54	glucose-6-phosphate isomerase	558	20	0E0	97.35%	6	F:GO:0004347; P:GO:0006094; P:GO:0006098; P:GO:0006096; P:GO:0005982; P:GO:0005985	F:glucose-6-phosphate isomerase activity; P:gluconeogenesis; P:pentose-phosphate shunt; P:glycolytic process; P:starch metabolic process; P:sucrose metabolic process	EC:5.3.1.9	IPR001672 (PRINTS); IPR023096 (G3DSA:1.10.1390.GENE3D); G3DSA:3.40.50.10490 (GENE3D); IPR001672 (PFAM); IPR001672 (PANTHER); PTHR11469:SF4 (PANTHER); IPR018189 (PROSITE_PATTERNS); IPR018189 (PROSITE_PATTERNS); IPR001672 (HAMAP); IPR001672 (PROSITE_PROFILES); SSF53697 (SUPERFAMILY)
F6W4R2	angiotensinogen	485	20	0E0	88.8%	2	C:GO:0005615; P:GO:0003081	C:extracellular space; P:regulation of systemic arterial blood pressure by renin-angiotensin		IPR000227 (PRINTS); IPR023796 (SMART); IPR023796 (PFAM); G3DSA:2.30.39.10 (GENE3D); G3DSA:3.30.497.10 (GENE3D); PTHR11461:SF13 (PANTHER); IPR000215 (PANTHER); IPR023795 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR023796 (SUPERFAMILY)
F6V625	ubiquitin	77	20	2.12E-48	99.8%	1	F:GO:0005515	F:protein binding		IPR019956 (PRINTS); IPR000626 (SMART); IPR000626 (PFAM); G3DSA:3.10.20.90 (GENE3D); PTHR10666 (PANTHER); IPR019954 (PROSITE_PATTERNS); IPR000626 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY)
A0A0B4J1C5	Ubiquitin-60S ribosomal L40	128	20	9.68E-90	100%	5	F:GO:0005515; F:GO:0003735; P:GO:0042254; C:GO:0005840; P:GO:0006412	F:protein binding; F:structural constituent of ribosome; P:ribosome biogenesis; C:ribosome; P:translation		IPR019956 (PRINTS); IPR001975 (SMART); IPR000626 (SMART); IPR000626 (PFAM); G3DSA:3.10.20.90 (GENE3D); IPR001975 (PFAM); PTHR10666 (PANTHER); IPR019954 (PROSITE_PATTERNS); IPR000626 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY)
F7AUY9	ubiquitin-40S ribosomal S27a	172	20	2.54E-120	99.15%	5	F:GO:0005515; F:GO:0003735; P:GO:0042254; C:GO:0005840; P:GO:0006412	F:protein binding; F:structural constituent of ribosome; P:ribosome biogenesis; C:ribosome; P:translation		IPR019956 (PRINTS); IPR002906 (SMART); IPR000626 (SMART); IPR002906 (PFAM); IPR000626 (PFAM); G3DSA:3.10.20.90 (GENE3D); PTHR10666 (PANTHER); IPR019954 (PROSITE_PATTERNS); IPR000626 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY); IPR011332 (SUPERFAMILY)
F6YM88	polyubiquitin-B	229	20	1.5E-162	99.75%	1	F:GO:0005515	F:protein binding		IPR019956 (PRINTS); IPR000626 (SMART); G3DSA:3.10.20.90 (GENE3D); IPR000626 (PFAM); PTHR10666 (PANTHER); IPR019954 (PROSITE_PATTERNS); IPR000626 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY); IPR029071 (SUPERFAMILY); IPR029071 (SUPERFAMILY)
Q8MKD1	polyubiquitin-B	305	20	0E0	99.05%	1	F:GO:0005515	F:protein binding		IPR019956 (PRINTS); IPR000626 (SMART); G3DSA:3.10.20.90 (GENE3D); IPR000626 (PFAM); PTHR10666 (PANTHER); IPR019954 (PROSITE_PATTERNS); IPR000626 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY); IPR029071 (SUPERFAMILY); IPR029071 (SUPERFAMILY); IPR029071 (SUPERFAMILY)
F6S2F8	histone	213	20	5.3E-124	96.05%	4	C:GO:0005634; F:GO:0003677; C:GO:0000786; P:GO:0006334	C:nucleus; F:DNA binding; C:nucleosome; P:nucleosome assembly		IPR005819 (PRINTS); IPR005818 (SMART); IPR005818 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); PTHR11467 (PANTHER); PTHR11467:SF46 (PANTHER); IPR005818 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY)
F6ZVN2	nucleobindin-1 isoform X1	262	20	0E0	100%	1	F:GO:0005509	F:calcium ion binding		IPR011992 (G3DSA:1.10.238.GENE3D); PTHR19237 (PANTHER); PTHR19237:SF21 (PANTHER); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F6QXW2	phosphatidylethanolamine-binding 1	190	20	6.13E-133	95.75%	13	F:GO:0019901; F:GO:0008289; F:GO:0044822; F:GO:0000166; F:GO:0030414; C:GO:0005634; F:GO:0005524; F:GO:0004867; C:GO:0070062; C:GO:0005737; P:GO:0010951; P:GO:0010466; F:GO:0019899	F:protein kinase binding; F:lipid binding; F:poly(A) RNA binding; F:nucleotide binding; F:peptidase inhibitor activity; C:nucleus; F:ATP binding; F:serine-type endopeptidase inhibitor activity; C:extracellular exosome; C:cytoplasm; P:negative regulation of endopeptidase activity; P:negative regulation of peptidase activity; F:enzyme binding		IPR008914 (PFAM); IPR008914 (G3DSA:3.90.280.GENE3D); PTHR11362 (PANTHER); PTHR11362:SF8 (PANTHER); IPR008914 (SUPERFAMILY)
F7BXI0	retinol-binding 1	135	20	4.21E-97	99.5%	6	P:GO:0002138; C:GO:0005829; F:GO:0008289; P:GO:0006776; P:GO:0006810; F:GO:0005215	P:retinoic acid biosynthetic process; C:cytosol; F:lipid binding; P:vitamin A metabolic process; P:transport; F:transporter activity		IPR000463 (PRINTS); IPR000566 (PFAM); IPR012674 (G3DSA:2.40.128.GENE3D); IPR031259 (PANTHER); IPR031264 (PTHR11955:PANTHER); IPR000463 (PROSITE_PATTERNS); IPR011038 (SUPERFAMILY)
F6YZJ4	heat shock 70 kDa 4	840	20	0E0	98.2%	9	F:GO:0000166; F:GO:0005524; F:GO:0005515; P:GO:0045040; C:GO:0070062; C:GO:0005737; P:GO:0051131; C:GO:0005829; P:GO:0006986	F:nucleotide binding; F:ATP binding; F:protein binding; P:protein import into mitochondrial outer membrane; C:extracellular exosome; C:cytoplasm; P:chaperone-mediated protein complex assembly; C:cytosol; P:response to unfolded protein		IPR013126 (PRINTS); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.90.640.10 (GENE3D); IPR029047 (G3DSA:2.60.34.GENE3D); G3DSA:3.30.30.30 (GENE3D); IPR013126 (PFAM); IPR029048 (G3DSA:1.20.1270.GENE3D); G3DSA:3.30.420.40 (GENE3D); PTHR19375:SF136 (PANTHER); PTHR19375 (PANTHER); IPR018181 (PROSITE_PATTERNS); IPR018181 (PROSITE_PATTERNS); IPR029048 (SUPERFAMILY); SSF53067 (SUPERFAMILY); IPR029048 (SUPERFAMILY); IPR029047 (SUPERFAMILY); SSF53067 (SUPERFAMILY)
F6XTN1	eukaryotic initiation factor 4A-I	406	20	0E0	99.5%	4	F:GO:0003676; F:GO:0005524; P:GO:0006446; F:GO:0004004	F:nucleic acid binding; F:ATP binding; P:regulation of translational initiation; F:ATP-dependent RNA helicase activity	EC:3.6.1; EC:3.6.1.3; EC:2.7.7; EC:3.6.1.15	IPR014001 (SMART); IPR001650 (SMART); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR031258 (PTHR24031:PANTHER); PTHR24031 (PANTHER); IPR000629 (PROSITE_PATTERNS); IPR014001 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F6YYS2	eukaryotic initiation factor 4A-II isoform X1	407	20	0E0	99.05%	4	F:GO:0003676; F:GO:0005524; P:GO:0006446; F:GO:0004004	F:nucleic acid binding; F:ATP binding; P:regulation of translational initiation; F:ATP-dependent RNA helicase activity	EC:3.6.1; EC:3.6.1.3; EC:2.7.7; EC:3.6.1.15	IPR014001 (SMART); IPR001650 (SMART); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24031 (PANTHER); IPR031258 (PTHR24031:PANTHER); IPR000629 (PROSITE_PATTERNS); IPR001650 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F7D3D1	epidermal growth factor receptor kinase substrate 8 1	576	20	0E0	89.5%	1	F:GO:0005515	F:protein binding		IPR001452 (SMART); IPR001452 (PFAM); G3DSA:2.30.30.40 (GENE3D); PTHR12287:SF19 (PANTHER); PTHR12287 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY)
F6ZQX6	proteasome subunit alpha type-7	216	20	4.87E-157	100%	3	C:GO:0005839; F:GO:0004298; P:GO:0051603	C:proteasome core complex; F:threonine-type endopeptidase activity; P:proteolysis involved in cellular protein catabolic process	EC:3.4.25	IPR001353 (PFAM); IPR029055 (G3DSA:3.60.20.GENE3D); PTHR11599 (PANTHER); PTHR11599:SF40 (PANTHER); IPR023332 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY)
F7AMX0	glycerol-3-phosphate dehydrogenase 1	335	20	0E0	98.2%	8	P:GO:0005975; F:GO:0042803; P:GO:0046486; C:GO:0009331; F:GO:0051287; P:GO:0046168; P:GO:0055114; F:GO:0004367	P:carbohydrate metabolic process; F:protein homodimerization activity; P:glycerolipid metabolic process; C:glycerol-3-phosphate dehydrogenase complex; F:NAD binding; P:glycerol-3-phosphate catabolic process; P:oxidation-reduction process; F:glycerol-3-phosphate dehydrogenase [NAD+] activity	EC:1.1.1.8; EC:1.1.1.94	IPR006168 (PRINTS); IPR006168 (PIRSF); IPR017751 (TIGRFAM); IPR006109 (PFAM); IPR011128 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013328 (G3DSA:1.10.1040.GENE3D); PTHR11728:SF7 (PANTHER); PTHR11728 (PANTHER); IPR016040 (SUPERFAMILY); IPR008927 (SUPERFAMILY)
F6XLZ5	ADP-ribosylation factor 2	181	20	1.68E-131	99.45%	3	F:GO:0005525; P:GO:0007264; C:GO:0005622	F:GTP binding; P:small GTPase mediated signal transduction; C:intracellular		IPR006689 (PRINTS); SM00178 (SMART); SM00175 (SMART); SM00177 (SMART); IPR005225 (TIGRFAM); IPR006689 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11711:SF205 (PANTHER); PTHR11711 (PANTHER); IPR024156 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F6TD06	ADP-ribosylation factor 3	181	20	5.41E-132	100%	3	F:GO:0005525; P:GO:0007264; C:GO:0005622	F:GTP binding; P:small GTPase mediated signal transduction; C:intracellular		IPR006689 (PRINTS); SM00178 (SMART); SM00175 (SMART); SM00177 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); IPR006689 (PFAM); PTHR11711:SF205 (PANTHER); PTHR11711 (PANTHER); IPR024156 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F6YYB1	proteasome subunit beta type-1	241	20	7.76E-179	96.5%	3	C:GO:0005839; F:GO:0004298; P:GO:0051603	C:proteasome core complex; F:threonine-type endopeptidase activity; P:proteolysis involved in cellular protein catabolic process	EC:3.4.25	IPR001353 (PFAM); IPR029055 (G3DSA:3.60.20.GENE3D); PTHR11599 (PANTHER); PTHR11599:SF59 (PANTHER); IPR016050 (PROSITE_PATTERNS); IPR023333 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY)
F7D854	catalase	505	20	0E0	96.35%	7	P:GO:0006979; F:GO:0004096; P:GO:0006804; P:GO:0015947; P:GO:0055114; P:GO:0006568; F:GO:0020037	P:response to oxidative stress; F:catalase activity; P:obsolete peroxidase reaction; P:methane metabolic process; P:oxidation-reduction process; P:tryptophan metabolic process; F:heme binding	EC:1.11.1.7; EC:1.11.1.6	IPR018028 (PRINTS); IPR011614 (SMART); IPR024711 (PIRSF); IPR010582 (PFAM); IPR011614 (PFAM); IPR011614 (G3DSA:2.40.180.GENE3D); IPR018028 (PANTHER); IPR024708 (PROSITE_PATTERNS); IPR002226 (PROSITE_PATTERNS); IPR018028 (PROSITE_PROFILES); IPR020835 (SUPERFAMILY)
F6UNR3	elongation factor 1-delta isoform X1	642	20	0E0	92.8%	4	P:GO:0006448; F:GO:0003746; C:GO:0005840; C:GO:0005853	P:regulation of translational elongation; F:translation elongation factor activity; C:ribosome; C:eukaryotic translation elongation factor 1 complex		IPR018940 (SMART); IPR014038 (SMART); IPR014038 (PFAM); IPR018940 (PFAM); IPR014717 (G3DSA:3.30.70.GENE3D); PTHR11595 (PANTHER); PTHR11595:SF26 (PANTHER); IPR001326 (PROSITE_PATTERNS); IPR001326 (PROSITE_PATTERNS); IPR014038 (SUPERFAMILY)
F6YGC8	Proteasome activator complex subunit 1	120	20	2.8E-83	98.95%	1	C:GO:0008537	C:proteasome activator complex		IPR003186 (PFAM); IPR003186 (G3DSA:1.20.120.GENE3D); IPR009077 (PANTHER); PTHR10660:SF5 (PANTHER); IPR009077 (SUPERFAMILY)
F7A3N5	carbohydrate-binding AQN-1-like	138	20	1.13E-83	76.45%	1	P:GO:0007338	P:single fertilization		IPR000859 (SMART); IPR000859 (G3DSA:2.60.120.GENE3D); IPR000859 (PFAM); IPR000124 (PROSITE_PATTERNS); IPR000124 (PROSITE_PATTERNS); IPR000859 (PROSITE_PROFILES); IPR000859 (SUPERFAMILY)
F7DQG1	peptidoglycan recognition 1	193	20	2.7E-142	83.5%	4	F:GO:0008270; P:GO:0009253; P:GO:0009252; F:GO:0008745	F:zinc ion binding; P:peptidoglycan catabolic process; P:peptidoglycan biosynthetic process; F:N-acetylmuramoyl-L-alanine amidase activity	EC:3.5.1.28	IPR017331 (PIRSF); IPR006619 (SMART); IPR002502 (SMART); IPR002502 (PFAM); IPR002502 (G3DSA:3.40.80.GENE3D); PTHR11022:SF42 (PANTHER); IPR015510 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR002502 (SUPERFAMILY)
F7DMG5	glucose-6-phosphate 1-dehydrogenase	515	20	0E0	98.7%	6	F:GO:0050661; P:GO:0006098; P:GO:0006749; P:GO:0055114; P:GO:0006006; F:GO:0004345	F:NADP binding; P:pentose-phosphate shunt; P:glutathione metabolic process; P:oxidation-reduction process; P:glucose metabolic process; F:glucose-6-phosphate dehydrogenase activity	EC:1.1.1.49	IPR001282 (PRINTS); IPR001282 (PIRSF); IPR022674 (PFAM); G3DSA:3.30.360.10 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR022675 (PFAM); IPR001282 (TIGRFAM); IPR001282 (PANTHER); PTHR23429:SF0 (PANTHER); IPR019796 (PROSITE_PATTERNS); IPR001282 (HAMAP); IPR016040 (SUPERFAMILY); SSF55347 (SUPERFAMILY)
F6PH57	actin-related 2 3 complex subunit 4	168	20	6.23E-119	99.9%	2	P:GO:0034314; C:GO:0005885	P:Arp2/3 complex-mediated actin nucleation; C:Arp2/3 protein complex		IPR008384 (PIRSF); G3DSA:3.30.1460.20 (GENE3D); IPR008384 (PFAM); PTHR22629:SF0 (PANTHER); IPR008384 (PANTHER); SSF69645 (SUPERFAMILY)
F7ASE9	histone H2B type 1	126	20	1.06E-85	100%	3	F:GO:0003677; F:GO:0046982; C:GO:0000786	F:DNA binding; F:protein heterodimerization activity; C:nucleosome		IPR000558 (PRINTS); IPR000558 (SMART); IPR009072 (G3DSA:1.10.20.GENE3D); IPR007125 (PFAM); IPR000558 (PROSITE_PATTERNS); IPR009072 (SUPERFAMILY)
F6VUX0	histone H2B type 1	126	20	1.7E-85	99.05%	3	F:GO:0003677; F:GO:0046982; C:GO:0000786	F:DNA binding; F:protein heterodimerization activity; C:nucleosome		IPR000558 (PRINTS); IPR000558 (SMART); IPR007125 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); IPR000558 (PANTHER); IPR000558 (PROSITE_PATTERNS); IPR009072 (SUPERFAMILY)
F6TWM4	histone H2B type 1	126	20	8.58E-86	100%	3	F:GO:0003677; F:GO:0046982; C:GO:0000786	F:DNA binding; F:protein heterodimerization activity; C:nucleosome		IPR000558 (PRINTS); IPR000558 (SMART); IPR007125 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); IPR000558 (PANTHER); IPR000558 (PROSITE_PATTERNS); IPR009072 (SUPERFAMILY)
F6VYH8	histone H2B type 2-F	126	20	5.33E-86	100%	3	F:GO:0003677; F:GO:0046982; C:GO:0000786	F:DNA binding; F:protein heterodimerization activity; C:nucleosome		IPR000558 (PRINTS); IPR000558 (SMART); IPR009072 (G3DSA:1.10.20.GENE3D); IPR007125 (PFAM); IPR000558 (PANTHER); IPR000558 (PROSITE_PATTERNS); IPR009072 (SUPERFAMILY)
F7DLL0	histone H2B type 1	126	20	8.77E-86	98.45%	3	F:GO:0003677; F:GO:0046982; C:GO:0000786	F:DNA binding; F:protein heterodimerization activity; C:nucleosome		IPR000558 (PRINTS); IPR000558 (SMART); IPR007125 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); IPR000558 (PANTHER); IPR000558 (PROSITE_PATTERNS); IPR009072 (SUPERFAMILY)
F7E1X9	histone H2B type 1-M	126	20	5.87E-86	99.85%	3	F:GO:0003677; F:GO:0046982; C:GO:0000786	F:DNA binding; F:protein heterodimerization activity; C:nucleosome		IPR000558 (PRINTS); IPR000558 (SMART); IPR007125 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); IPR000558 (PANTHER); IPR000558 (PROSITE_PATTERNS); IPR009072 (SUPERFAMILY)
F6PWV1	histone H2B type 1	126	20	1.26E-85	100%	3	F:GO:0003677; F:GO:0046982; C:GO:0000786	F:DNA binding; F:protein heterodimerization activity; C:nucleosome		IPR000558 (PRINTS); IPR000558 (SMART); IPR007125 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); IPR000558 (PANTHER); IPR000558 (PROSITE_PATTERNS); IPR009072 (SUPERFAMILY)
F7CJ51	histone H2B type 1	126	20	1.18E-85	99.2%	3	F:GO:0003677; F:GO:0046982; C:GO:0000786	F:DNA binding; F:protein heterodimerization activity; C:nucleosome		IPR000558 (PRINTS); IPR000558 (SMART); IPR009072 (G3DSA:1.10.20.GENE3D); IPR007125 (PFAM); IPR000558 (PANTHER); IPR000558 (PROSITE_PATTERNS); IPR009072 (SUPERFAMILY)
F6SP02	14-3-3 theta	245	20	1.21E-180	99.65%	1	F:GO:0019904	F:protein domain specific binding		IPR000308 (PRINTS); IPR023410 (SMART); IPR000308 (PIRSF); IPR023410 (PFAM); G3DSA:1.20.190.20 (GENE3D); IPR000308 (PANTHER); PTHR18860:SF3 (PANTHER); IPR023409 (PROSITE_PATTERNS); IPR023409 (PROSITE_PATTERNS); IPR023410 (SUPERFAMILY)
F6WSA6	glutathione synthetase	474	20	0E0	97.2%	3	F:GO:0005524; P:GO:0006750; F:GO:0004363	F:ATP binding; P:glutathione biosynthetic process; F:glutathione synthase activity	EC:6.3.2.3	IPR005615 (PIRSF); IPR014049 (G3DSA:3.30.1490.GENE3D); IPR004887 (G3DSA:3.40.50.GENE3D); IPR005615 (PFAM); IPR014042 (G3DSA:1.10.1080.GENE3D); IPR004887 (PFAM); IPR014709 (G3DSA:3.30.1490.GENE3D); IPR005615 (TIGRFAM); IPR005615 (PANTHER); IPR016185 (SUPERFAMILY); SSF56059 (SUPERFAMILY)
F6QB61	peptidoglycan recognition 1	193	20	2.01E-141	84.1%	4	F:GO:0008270; P:GO:0009253; P:GO:0009252; F:GO:0008745	F:zinc ion binding; P:peptidoglycan catabolic process; P:peptidoglycan biosynthetic process; F:N-acetylmuramoyl-L-alanine amidase activity	EC:3.5.1.28	IPR002502 (SMART); IPR017331 (PIRSF); IPR006619 (SMART); IPR002502 (PFAM); IPR002502 (G3DSA:3.40.80.GENE3D); IPR015510 (PANTHER); PTHR11022:SF42 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR002502 (SUPERFAMILY)
F6RMM1	SH3 domain-binding glutamic acid-rich	114	20	3.75E-78	99.4%	7	C:GO:0005634; C:GO:0005615; F:GO:0005070; C:GO:0070062; C:GO:0005737; F:GO:0017124; P:GO:0009967	C:nucleus; C:extracellular space; F:SH3/SH2 adaptor activity; C:extracellular exosome; C:cytoplasm; F:SH3 domain binding; P:positive regulation of signal transduction		IPR006993 (PIRSF); IPR012336 (G3DSA:3.40.30.GENE3D); IPR006993 (PFAM); PTHR12232 (PANTHER); PTHR12232:SF5 (PANTHER); IPR012336 (SUPERFAMILY)
F6V0B8	cornifin-B	89	20	2.02E-45	83.2%	2	C:GO:0005737; P:GO:0018149	C:cytoplasm; P:peptide cross-linking		PR00021 (PRINTS); PF02389 (PFAM); IPR026075 (PANTHER); IPR003302 (PTHR23263:PANTHER)
F6XEJ7	unconventional myosin-VI isoform X2	1276	20	0E0	97.9%	3	C:GO:0016459; F:GO:0005524; F:GO:0003774	C:myosin complex; F:ATP binding; F:motor activity	EC:3.6.1; EC:3.6.1.15	IPR001609 (PRINTS); IPR001609 (SMART); IPR032412 (PFAM); IPR001609 (PFAM); PTHR13140 (PANTHER); PTHR13140:SF483 (PANTHER); IPR001609 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F6XF24	unconventional myosin-VI isoform X1	1285	20	0E0	98.25%	3	C:GO:0016459; F:GO:0005524; F:GO:0003774	C:myosin complex; F:ATP binding; F:motor activity	EC:3.6.1; EC:3.6.1.15	IPR001609 (PRINTS); IPR001609 (SMART); IPR032412 (PFAM); IPR001609 (PFAM); PTHR13140 (PANTHER); PTHR13140:SF483 (PANTHER); IPR001609 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F6XF44	unconventional myosin-VI isoform X1	1294	20	0E0	98.45%	3	C:GO:0016459; F:GO:0005524; F:GO:0003774	C:myosin complex; F:ATP binding; F:motor activity	EC:3.6.1; EC:3.6.1.15	IPR001609 (PRINTS); IPR001609 (SMART); IPR001609 (PFAM); IPR032412 (PFAM); PTHR13140 (PANTHER); PTHR13140:SF483 (PANTHER); IPR001609 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F6ZMG7	liver carboxylesterase-like isoform X1	567	20	0E0	91.85%	3	C:GO:0005615; F:GO:0052689; F:GO:0016787	C:extracellular space; F:carboxylic ester hydrolase activity; F:hydrolase activity		IPR002018 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR11559 (PANTHER); PTHR11559:SF179 (PANTHER); IPR019819 (PROSITE_PATTERNS); IPR019826 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR029058 (SUPERFAMILY)
F6XNT7	ribonuclease T2	175	20	2.83E-126	92%	2	F:GO:0003723; F:GO:0033897	F:RNA binding; F:ribonuclease T2 activity	EC:3.1.31; EC:3.1; EC:3.1.27; EC:3.1.27.1	IPR001568 (G3DSA:3.90.730.GENE3D); IPR001568 (PFAM); IPR001568 (PANTHER); IPR033130 (PROSITE_PATTERNS); IPR018188 (PROSITE_PATTERNS); IPR001568 (SUPERFAMILY)
F6T8J7	ly6 PLAUR domain-containing 3	351	20	0E0	86.9%	6	P:GO:0007160; C:GO:0005615; C:GO:0016020; C:GO:0016021; F:GO:0043236; C:GO:0005886	P:cell-matrix adhesion; C:extracellular space; C:membrane; C:integral component of membrane; F:laminin binding; C:plasma membrane		IPR016054 (SMART); G3DSA:2.10.60.10 (GENE3D); IPR016054 (PFAM); PTHR10624:SF8 (PANTHER); PTHR10624 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SSF57302 (SUPERFAMILY); SSF57302 (SUPERFAMILY)
F7BAB4	tumor D52 isoform X4	221	20	1E-153	95.85%	10	P:GO:0046903; F:GO:0005515; F:GO:0042803; C:GO:0048471; P:GO:0030183; C:GO:0005737; F:GO:0046982; F:GO:0005509; P:GO:0009653; C:GO:0005783	P:secretion; F:protein binding; F:protein homodimerization activity; C:perinuclear region of cytoplasm; P:B cell differentiation; C:cytoplasm; F:protein heterodimerization activity; F:calcium ion binding; P:anatomical structure morphogenesis; C:endoplasmic reticulum		IPR007327 (PFAM); PTHR19307:SF12 (PANTHER); IPR007327 (PANTHER)
F7CAG8	Ig kappa light chain variable partial	106	20	2.4E-53	84.45%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267 (PANTHER); PTHR23267:SF148 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F7A1W7	apolipo C-II	101	20	3.3E-65	84.25%	4	P:GO:0006869; C:GO:0042627; P:GO:0006629; F:GO:0008047	P:lipid transport; C:chylomicron; P:lipid metabolic process; F:enzyme activator activity		IPR023121 (G3DSA:1.10.1440.GENE3D); IPR008019 (PFAM); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS)
F6ZPY1	EF-hand domain-containing D2	138	20	1.96E-92	98.8%	1	F:GO:0005509	F:calcium ion binding		IPR011992 (G3DSA:1.10.238.GENE3D); PTHR13025:SF2 (PANTHER); PTHR13025 (PANTHER); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F7ALV0	thioredoxin	97	20	1.04E-64	95.9%	4	P:GO:0006118; F:GO:0015035; P:GO:0006662; P:GO:0045454	P:obsolete electron transport; F:protein disulfide oxidoreductase activity; P:glycerol ether metabolic process; P:cell redox homeostasis		PR00421 (PRINTS); IPR005746 (PIRSF); IPR012336 (G3DSA:3.40.30.GENE3D); IPR013766 (PFAM); PTHR10438:SF18 (PANTHER); IPR005746 (PANTHER); IPR017937 (PROSITE_PATTERNS); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY)
O97508	thioredoxin	105	20	2.46E-70	96.05%	4	P:GO:0006118; F:GO:0015035; P:GO:0006662; P:GO:0045454	P:obsolete electron transport; F:protein disulfide oxidoreductase activity; P:glycerol ether metabolic process; P:cell redox homeostasis		PR00421 (PRINTS); IPR005746 (PIRSF); IPR013766 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR10438:SF18 (PANTHER); IPR005746 (PANTHER); IPR017937 (PROSITE_PATTERNS); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY)
F7CL92	glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 isoform X1	699	20	0E0	98.3%	5	P:GO:0016051; F:GO:0004360; P:GO:0006040; P:GO:1901137; F:GO:0030246	P:carbohydrate biosynthetic process; F:glutamine-fructose-6-phosphate transaminase (isomerizing) activity; P:amino sugar metabolic process; P:carbohydrate derivative biosynthetic process; F:carbohydrate binding	EC:2.6.1.16	G3DSA:3.40.50.10490 (GENE3D); IPR005855 (TIGRFAM); G3DSA:3.40.50.10490 (GENE3D); PF13522 (PFAM); IPR001347 (PFAM); IPR029055 (G3DSA:3.60.20.GENE3D); PTHR10937 (PANTHER); PTHR10937:SF2 (PANTHER); IPR001347 (PROSITE_PROFILES); IPR017932 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY); SSF53697 (SUPERFAMILY)
F7CQ86	alpha-1-acid glyco 2-like	201	20	7.53E-150	81.65%	2	C:GO:0005615; P:GO:0002682	C:extracellular space; P:regulation of immune system process		IPR001500 (PRINTS); IPR012674 (G3DSA:2.40.128.GENE3D); IPR000566 (PFAM); IPR001500 (PANTHER); PTHR11967:SF2 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR011038 (SUPERFAMILY)
F6RTH0	thioredoxin domain-containing 17	123	20	8.22E-88	96.6%	9	F:GO:0004601; P:GO:0033209; F:GO:0005515; C:GO:0070062; C:GO:0005737; F:GO:0047134; P:GO:0098869; C:GO:0005829; P:GO:0055114	F:peroxidase activity; P:tumor necrosis factor-mediated signaling pathway; F:protein binding; C:extracellular exosome; C:cytoplasm; F:protein-disulfide reductase activity; P:cellular oxidant detoxification; C:cytosol; P:oxidation-reduction process		IPR010357 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR010357 (PANTHER); IPR012336 (SUPERFAMILY)
F7A4B1	F-box only 50	183	20	6.24E-132	92.25%	3	C:GO:0070062; C:GO:0005737; P:GO:0008284	C:extracellular exosome; C:cytoplasm; P:positive regulation of cell proliferation		IPR007397 (SMART); IPR008979 (G3DSA:2.60.120.GENE3D); IPR007397 (PFAM); PTHR12125 (PANTHER); PTHR12125:SF1 (PANTHER); IPR007397 (PROSITE_PROFILES); IPR008979 (SUPERFAMILY)
F6YMD9	microtubule-actin cross-linking factor 1 isoform X16	1296	20	0E0	99%	6	F:GO:0016887; F:GO:0003779; C:GO:0045298; F:GO:0005509; P:GO:0016055; F:GO:0008017	F:ATPase activity; F:actin binding; C:tubulin complex; F:calcium ion binding; P:Wnt signaling pathway; F:microtubule binding	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR002048 (SMART); IPR001101 (SMART); SM01129 (SMART); IPR003108 (SMART); IPR018159 (SMART); IPR001715 (SMART); IPR001715 (G3DSA:1.10.418.GENE3D); IPR003108 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); IPR002048 (PFAM); G3DSA:1.20.58.60 (GENE3D); IPR001101 (PFAM); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (PFAM); IPR002017 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001101 (G3DSA:3.90.1290.GENE3D); IPR003108 (G3DSA:3.30.920.GENE3D); IPR028408 (PTHR11915:PANTHER); PTHR11915 (PANTHER); IPR018247 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); IPR001589 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR001715 (PROSITE_PROFILES); IPR003108 (PROSITE_PROFILES); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR011992 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001715 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR003108 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); IPR001101 (SUPERFAMILY); IPR001101 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY); SSF46966 (SUPERFAMILY)
F6Z3G9	hexokinase-3 isoform X1	924	20	0E0	95.3%	14	P:GO:0006094; P:GO:0006040; P:GO:0006096; P:GO:0006013; P:GO:0006000; F:GO:0004396; P:GO:0006012; P:GO:0046835; P:GO:0005982; P:GO:0005985; F:GO:0005536; F:GO:0005524; P:GO:0001678; P:GO:0019872	P:gluconeogenesis; P:amino sugar metabolic process; P:glycolytic process; P:mannose metabolic process; P:fructose metabolic process; F:hexokinase activity; P:galactose metabolic process; P:carbohydrate phosphorylation; P:starch metabolic process; P:sucrose metabolic process; F:glucose binding; F:ATP binding; P:cellular glucose homeostasis; P:streptomycin biosynthetic process	EC:2.7.1.1	PR00475 (PRINTS); IPR022672 (PFAM); G3DSA:3.40.367.20 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR022673 (PFAM); PTHR19443:SF1 (PANTHER); IPR001312 (PANTHER); IPR019807 (PROSITE_PATTERNS); IPR001312 (PROSITE_PROFILES); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY)
F7BRS8	S100-A2	97	20	1.16E-64	97.45%	1	F:GO:0005509	F:calcium ion binding		IPR013787 (SMART); IPR013787 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR11639:SF59 (PANTHER); PTHR11639 (PANTHER); IPR018247 (PROSITE_PATTERNS); IPR001751 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F6X449	alpha-2-antiplasmin isoform X1	491	20	0E0	91.7%	33	P:GO:0048514; F:GO:0002020; P:GO:0042730; P:GO:0045944; C:GO:0005576; C:GO:0005577; P:GO:0002576; P:GO:0048661; P:GO:0032967; C:GO:0070062; P:GO:0010757; C:GO:0072562; P:GO:0010951; P:GO:0071636; C:GO:0031093; P:GO:0010033; F:GO:0042803; P:GO:0051918; P:GO:0045597; P:GO:0002034; P:GO:0006953; C:GO:0009986; F:GO:0030414; F:GO:0004867; C:GO:0005615; F:GO:0004866; F:GO:0005515; P:GO:0051496; P:GO:0046330; P:GO:0070374; P:GO:0030199; P:GO:2000049; P:GO:0010466	P:blood vessel morphogenesis; F:protease binding; P:fibrinolysis; P:positive regulation of transcription from RNA polymerase II promoter; C:extracellular region; C:fibrinogen complex; P:platelet degranulation; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of collagen biosynthetic process; C:extracellular exosome; P:negative regulation of plasminogen activation; C:blood microparticle; P:negative regulation of endopeptidase activity; P:positive regulation of transforming growth factor beta production; C:platelet alpha granule lumen; P:response to organic substance; F:protein homodimerization activity; P:negative regulation of fibrinolysis; P:positive regulation of cell differentiation; P:regulation of blood vessel size by renin-angiotensin; P:acute-phase response; C:cell surface; F:peptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity; C:extracellular space; F:endopeptidase inhibitor activity; F:protein binding; P:positive regulation of stress fiber assembly; P:positive regulation of JNK cascade; P:positive regulation of ERK1 and ERK2 cascade; P:collagen fibril organization; P:positive regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of peptidase activity		IPR023796 (SMART); G3DSA:2.30.39.10 (GENE3D); IPR023796 (PFAM); G3DSA:3.30.497.10 (GENE3D); IPR023795 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR023796 (SUPERFAMILY)
F7B5C4	vimentin	361	20	0E0	96.95%	2	F:GO:0005198; C:GO:0005882	F:structural molecule activity; C:intermediate filament		IPR001664 (SMART); G3DSA:1.20.5.170 (GENE3D); IPR001664 (PFAM); IPR027699 (PTHR23239:PANTHER); IPR001664 (PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY)
F7DQ79	peripherin isoform X2	467	20	0E0	98.25%	2	C:GO:0045098; F:GO:0005198	C:type III intermediate filament; F:structural molecule activity		IPR002957 (PRINTS); IPR001664 (SMART); G3DSA:1.20.5.170 (GENE3D); IPR006821 (PFAM); IPR001664 (PFAM); IPR001664 (PANTHER); IPR027700 (PTHR23239:PANTHER); IPR018039 (PROSITE_PATTERNS); SSF64593 (SUPERFAMILY); SSF64593 (SUPERFAMILY)
F7CVC4	AP-2 complex subunit alpha-2 isoform X1	912	20	0E0	98.2%	5	P:GO:0016192; C:GO:0030131; F:GO:0008565; F:GO:0005488; P:GO:0006886	P:vesicle-mediated transport; C:clathrin adaptor complex; F:protein transporter activity; F:binding; P:intracellular protein transport		IPR017104 (PIRSF); IPR008152 (SMART); IPR015873 (G3DSA:3.30.310.GENE3D); IPR013038 (G3DSA:2.60.40.GENE3D); IPR011989 (G3DSA:1.25.10.GENE3D); IPR003164 (PFAM); IPR002553 (PFAM); IPR008152 (PFAM); PTHR22780 (PANTHER); PTHR22780:SF24 (PANTHER); IPR009028 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR013041 (SUPERFAMILY)
F7BM69	immunoglobulin kappa light chain V-J partial	115	20	5.29E-76	95.9%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F6UH83	T-complex 1 subunit epsilon	541	20	0E0	99.1%	3	F:GO:0005524; F:GO:0051082; P:GO:0006457	F:ATP binding; F:unfolded protein binding; P:protein folding		IPR017998 (PRINTS); IPR027410 (G3DSA:3.30.260.GENE3D); IPR027413 (G3DSA:1.10.560.GENE3D); IPR012718 (TIGRFAM); IPR002423 (PFAM); IPR027409 (G3DSA:3.50.7.GENE3D); PTHR11353 (PANTHER); IPR002194 (PROSITE_PATTERNS); IPR002194 (PROSITE_PATTERNS); IPR002194 (PROSITE_PATTERNS); IPR027409 (SUPERFAMILY); SSF48592 (SUPERFAMILY); SSF54849 (SUPERFAMILY)
F7D3E3	UMP-CMP kinase	172	20	1.33E-122	99.9%	5	F:GO:0004127; F:GO:0005524; F:GO:0009041; P:GO:0006207; P:GO:0006221	F:cytidylate kinase activity; F:ATP binding; F:uridylate kinase activity; P:'de novo' pyrimidine nucleobase biosynthetic process; P:pyrimidine nucleotide biosynthetic process	EC:2.7.4; EC:2.7.4.14	IPR000850 (PRINTS); IPR027417 (G3DSA:3.40.50.GENE3D); IPR006266 (TIGRFAM); PF00406 (PFAM); IPR000850 (PANTHER); IPR033690 (PROSITE_PATTERNS); IPR000850 (HAMAP); IPR027417 (SUPERFAMILY)
F7CCF5	latexin	222	20	1.73E-166	95.4%	4	C:GO:0070062; P:GO:0010951; F:GO:0008191; P:GO:0050965	C:extracellular exosome; P:negative regulation of endopeptidase activity; F:metalloendopeptidase inhibitor activity; P:detection of temperature stimulus involved in sensory perception of pain		IPR009684 (PIRSF); G3DSA:3.10.450.10 (GENE3D); IPR009684 (PFAM); G3DSA:3.10.450.10 (GENE3D); PTHR28591 (PANTHER); IPR009684 (PRODOM); SSF54403 (SUPERFAMILY); SSF54403 (SUPERFAMILY)
F7C3F9	hemicentin- partial	364	20	1.34E-159	71.85%	1	F:GO:0005515	F:protein binding		IPR003599 (SMART); IPR003598 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PF13927 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR10489 (PANTHER); IPR032984 (PTHR10489:PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F7E481	Ig kappa chain V-II region RPMI 6410	122	20	1.1E-68	88.2%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF182 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F6Z563	S100-P	98	20	6.64E-65	92.6%	3	P:GO:0007165; F:GO:0005509; F:GO:0050786	P:signal transduction; F:calcium ion binding; F:RAGE receptor binding		IPR013787 (SMART); IPR002048 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR013787 (PFAM); IPR028494 (PTHR11639:PANTHER); PTHR11639 (PANTHER); IPR001751 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F7AS83	granulins	605	20	0E0	89.55%	3	C:GO:0070062; C:GO:0043231; F:GO:0044822	C:extracellular exosome; C:intracellular membrane-bounded organelle; F:poly(A) RNA binding		IPR000118 (SMART); IPR006150 (SMART); IPR000118 (PFAM); PTHR12274:SF5 (PANTHER); PTHR12274 (PANTHER); IPR000118 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SSF57277 (SUPERFAMILY); SSF57277 (SUPERFAMILY); SSF57277 (SUPERFAMILY); SSF57277 (SUPERFAMILY); SSF57277 (SUPERFAMILY); SSF57277 (SUPERFAMILY)
F7AB03	granulins	592	20	0E0	89.65%	17	F:GO:0008083; P:GO:0060179; P:GO:0007165; P:GO:0061351; P:GO:0060999; C:GO:0005576; F:GO:0005125; F:GO:0044822; C:GO:0005615; F:GO:0005515; C:GO:0070062; P:GO:0048488; C:GO:0043231; P:GO:0032355; C:GO:0005829; P:GO:0035988; P:GO:0010976	F:growth factor activity; P:male mating behavior; P:signal transduction; P:neural precursor cell proliferation; P:positive regulation of dendritic spine development; C:extracellular region; F:cytokine activity; F:poly(A) RNA binding; C:extracellular space; F:protein binding; C:extracellular exosome; P:synaptic vesicle endocytosis; C:intracellular membrane-bounded organelle; P:response to estradiol; C:cytosol; P:chondrocyte proliferation; P:positive regulation of neuron projection development		IPR000118 (SMART); IPR006150 (SMART); IPR000118 (PFAM); PTHR12274 (PANTHER); PTHR12274:SF5 (PANTHER); IPR000118 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SSF57277 (SUPERFAMILY); SSF57277 (SUPERFAMILY); SSF57277 (SUPERFAMILY); SSF57277 (SUPERFAMILY); SSF57277 (SUPERFAMILY); SSF57277 (SUPERFAMILY)
F6VZY5	vasodilator-stimulated phospho	213	20	2.94E-101	94.95%	5	C:GO:0005856; P:GO:0051289; F:GO:0003779; P:GO:0008154; F:GO:0017124	C:cytoskeleton; P:protein homotetramerization; F:actin binding; P:actin polymerization or depolymerization; F:SH3 domain binding		IPR014885 (PFAM); PTHR11202 (PANTHER); IPR017354 (PTHR11202:PANTHER); SSF118370 (SUPERFAMILY)
F7ALH5	tryptophan--tRNA cytoplasmic	466	20	0E0	94.05%	5	F:GO:0005524; C:GO:0005737; P:GO:0006436; P:GO:0006568; F:GO:0004830	F:ATP binding; C:cytoplasm; P:tryptophanyl-tRNA aminoacylation; P:tryptophan metabolic process; F:tryptophan-tRNA ligase activity	EC:6.1.1.2; EC:6.1.1	IPR002306 (PRINTS); IPR000738 (SMART); G3DSA:1.10.240.10 (GENE3D); IPR000738 (PFAM); IPR009068 (G3DSA:1.10.287.GENE3D); IPR014729 (G3DSA:3.40.50.GENE3D); IPR002306 (TIGRFAM); IPR002305 (PFAM); PTHR10055:SF1 (PANTHER); IPR002306 (PANTHER); IPR001412 (PROSITE_PATTERNS); IPR000738 (PROSITE_PROFILES); IPR009068 (SUPERFAMILY); SSF52374 (SUPERFAMILY)
Q3S4D6	ganglioside GM2 activator	193	20	1.32E-137	86.4%	2	F:GO:0008047; P:GO:0006689	F:enzyme activator activity; P:ganglioside catabolic process		IPR003172 (SMART); IPR003172 (PFAM); G3DSA:2.70.220.10 (GENE3D); IPR028996 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SSF63707 (SUPERFAMILY)
F6Y4I1	UTP--glucose-1-phosphate uridylyltransferase isoform X1	502	20	0E0	99.2%	6	P:GO:0006011; P:GO:0006012; P:GO:0005982; P:GO:0005985; F:GO:0003983; P:GO:0009117	P:UDP-glucose metabolic process; P:galactose metabolic process; P:starch metabolic process; P:sucrose metabolic process; F:UTP:glucose-1-phosphate uridylyltransferase activity; P:nucleotide metabolic process	EC:2.7.7.64; EC:2.7.7.9	IPR016267 (PIRSF); IPR029044 (G3DSA:3.90.550.GENE3D); IPR002618 (PFAM); IPR002618 (PANTHER); IPR029044 (SUPERFAMILY)
F7A676	cytosol aminopeptidase	519	20	0E0	95.45%	5	C:GO:0005737; P:GO:0006508; F:GO:0008235; F:GO:0004177; F:GO:0030145	C:cytoplasm; P:proteolysis; F:metalloexopeptidase activity; F:aminopeptidase activity; F:manganese ion binding	EC:3.4.11	IPR011356 (PRINTS); G3DSA:3.40.630.10 (GENE3D); IPR000819 (PFAM); G3DSA:3.40.220.10 (GENE3D); IPR008283 (PFAM); IPR011356 (PANTHER); PTHR11963:SF19 (PANTHER); IPR000819 (PROSITE_PATTERNS); IPR023042 (HAMAP); SSF52949 (SUPERFAMILY); SSF53187 (SUPERFAMILY)
F6Z6Q7	T-complex 1 subunit delta	497	20	0E0	99.15%	3	F:GO:0005524; F:GO:0051082; P:GO:0006457	F:ATP binding; F:unfolded protein binding; P:protein folding		IPR017998 (PRINTS); IPR027409 (G3DSA:3.50.7.GENE3D); IPR002423 (PFAM); IPR027410 (G3DSA:3.30.260.GENE3D); IPR012717 (TIGRFAM); IPR027413 (G3DSA:1.10.560.GENE3D); PTHR11353 (PANTHER); IPR002194 (PROSITE_PATTERNS); IPR002194 (PROSITE_PATTERNS); IPR002194 (PROSITE_PATTERNS); SSF48592 (SUPERFAMILY); IPR027409 (SUPERFAMILY); SSF54849 (SUPERFAMILY)
F7BMU5	cytidine deaminase	145	20	6.3E-104	94.65%	4	F:GO:0008270; P:GO:0006206; P:GO:0009972; F:GO:0004126	F:zinc ion binding; P:pyrimidine nucleobase metabolic process; P:cytidine deamination; F:cytidine deaminase activity	EC:3.5.4.5	IPR002125 (PFAM); IPR006262 (TIGRFAM); G3DSA:3.40.140.10 (GENE3D); PTHR11644 (PANTHER); IPR016192 (PROSITE_PATTERNS); IPR002125 (PROSITE_PROFILES); IPR016193 (SUPERFAMILY)
F6X0P8	kinesin-1 heavy chain	924	20	0E0	98.95%	6	F:GO:0005524; F:GO:0003777; C:GO:0045298; P:GO:0007018; F:GO:0008017; C:GO:0005874	F:ATP binding; F:microtubule motor activity; C:tubulin complex; P:microtubule-based movement; F:microtubule binding; C:microtubule	EC:3.6.1; EC:3.6.1.15	IPR001752 (PRINTS); IPR001752 (SMART); IPR001752 (PFAM); IPR001752 (G3DSA:3.40.850.GENE3D); IPR027640 (PANTHER); PTHR24115:SF513 (PANTHER); IPR019821 (PROSITE_PATTERNS); IPR001752 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F6SYQ8	secretoglobin family 1D member-like	90	20	3.45E-53	70.05%	3	C:GO:0005615; P:GO:0007165; C:GO:0005576	C:extracellular space; P:signal transduction; C:extracellular region		IPR016126 (PFAM); PTHR11332 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR016126 (PROSITE_PROFILES); IPR016126 (SUPERFAMILY)
P48770	complement component C9	547	20	0E0	89.95%	3	C:GO:0005579; F:GO:0005515; P:GO:0006955	C:membrane attack complex; F:protein binding; P:immune response		IPR001862 (PRINTS); IPR002172 (SMART); IPR020864 (SMART); IPR000884 (SMART); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR020864 (PFAM); IPR002172 (PFAM); G3DSA:2.20.100.10 (GENE3D); PTHR19325:SF362 (PANTHER); PTHR19325 (PANTHER); IPR023415 (PROSITE_PATTERNS); IPR020863 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR002172 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR020864 (PROSITE_PROFILES); IPR009030 (SUPERFAMILY); IPR002172 (SUPERFAMILY)
F6UFT2	complement component C9	547	20	0E0	90%	3	C:GO:0005579; F:GO:0005515; P:GO:0006955	C:membrane attack complex; F:protein binding; P:immune response		IPR001862 (PRINTS); IPR000884 (SMART); IPR020864 (SMART); IPR002172 (SMART); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.20.100.10 (GENE3D); IPR002172 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR020864 (PFAM); PTHR19325 (PANTHER); PTHR19325:SF362 (PANTHER); IPR020863 (PROSITE_PATTERNS); IPR023415 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR002172 (PROSITE_PROFILES); IPR020864 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR009030 (SUPERFAMILY); IPR002172 (SUPERFAMILY)
F7C0S3	ninein isoform X1	1347	20	0E0	97.25%	3	C:GO:0005813; F:GO:0005509; P:GO:0034454	C:centrosome; F:calcium ion binding; P:microtubule anchoring at centrosome		IPR011992 (G3DSA:1.10.238.GENE3D); PTHR18905 (PANTHER); IPR029664 (PTHR18905:PANTHER); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F6WG98	sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)	639	20	0E0	96.3%	4	P:GO:0006836; F:GO:0005328; P:GO:0006812; C:GO:0016021	P:neurotransmitter transport; F:neurotransmitter:sodium symporter activity; P:cation transport; C:integral component of membrane		IPR000175 (PRINTS); IPR000175 (PFAM); PTHR11616:SF160 (PANTHER); IPR000175 (PANTHER); IPR000175 (PROSITE_PATTERNS); IPR000175 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000175 (PROSITE_PROFILES); SSF161070 (SUPERFAMILY)
H9H007	cytosolic 10-formyltetrahydrofolate dehydrogenase isoform X1	896	20	0E0	95.4%	8	C:GO:0005737; P:GO:0009258; F:GO:0016155; P:GO:0055114; P:GO:0009058; F:GO:0016620; F:GO:0016742; P:GO:0006730	C:cytoplasm; P:10-formyltetrahydrofolate catabolic process; F:formyltetrahydrofolate dehydrogenase activity; P:oxidation-reduction process; P:biosynthetic process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; F:hydroxymethyl-, formyl- and related transferase activity; P:one-carbon metabolic process	EC:1.5.1.6	IPR011407 (PIRSF); IPR009081 (PFAM); IPR005793 (PFAM); IPR016162 (G3DSA:3.40.605.GENE3D); IPR015590 (PFAM); IPR016163 (G3DSA:3.40.309.GENE3D); IPR005793 (G3DSA:3.10.25.GENE3D); IPR002376 (G3DSA:3.40.50.GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR002376 (PFAM); PTHR11699 (PANTHER); PTHR11699:SF120 (PANTHER); IPR001555 (PROSITE_PATTERNS); IPR029510 (PROSITE_PATTERNS); IPR016160 (PROSITE_PATTERNS); IPR009081 (PROSITE_PROFILES); IPR002376 (SUPERFAMILY); IPR011034 (SUPERFAMILY); IPR016161 (SUPERFAMILY); IPR009081 (SUPERFAMILY)
F6XW20	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 isoform X1	776	20	0E0	96.65%	7	F:GO:0004435; F:GO:0005515; P:GO:0035556; F:GO:0005509; P:GO:0009395; P:GO:0035556; P:GO:0046339	F:phosphatidylinositol phospholipase C activity; F:protein binding; P:intracellular signal transduction; F:calcium ion binding; P:phospholipid catabolic process; P:intracellular signal transduction; P:diacylglycerol metabolic process	EC:3.1; EC:3.1.4.11; EC:3.1.1	IPR001192 (PRINTS); IPR001849 (SMART); IPR002048 (SMART); IPR001711 (SMART); IPR000909 (SMART); IPR000008 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR017946 (G3DSA:3.20.20.GENE3D); IPR001849 (PFAM); IPR000008 (PFAM); IPR001711 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR015359 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR000909 (PFAM); IPR028391 (PTHR10336:PANTHER); IPR001192 (PANTHER); IPR018247 (PROSITE_PATTERNS); IPR000008 (PROSITE_PROFILES); IPR001711 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR000909 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR017946 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR011993 (SUPERFAMILY)
F7C5G3	26S proteasome non-ATPase regulatory subunit 11	421	20	0E0	99%	1	F:GO:0005515	F:protein binding		IPR000717 (SMART); SM00753 (SMART); IPR011991 (G3DSA:1.10.10.GENE3D); IPR000717 (PFAM); PTHR10678 (PANTHER); PTHR10678:SF6 (PANTHER); IPR011991 (SUPERFAMILY)
F6PGW8	calpain-2 catalytic subunit	589	20	0E0	94.05%	5	F:GO:0005509; P:GO:0051493; P:GO:0006508; F:GO:0004198; C:GO:0005622	F:calcium ion binding; P:regulation of cytoskeleton organization; P:proteolysis; F:calcium-dependent cysteine-type endopeptidase activity; C:intracellular	EC:3.4.22; EC:3.4	IPR022684 (PRINTS); IPR022683 (SMART); IPR001300 (SMART); IPR001300 (PFAM); G3DSA:2.60.120.380 (GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR022682 (PFAM); G3DSA:3.90.70.10 (GENE3D); IPR002048 (PFAM); IPR029539 (PTHR10183:PANTHER); PTHR10183 (PANTHER); IPR018247 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR001300 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR022682 (SUPERFAMILY); SSF54001 (SUPERFAMILY); IPR011992 (SUPERFAMILY)
F7AAW3	condensin-2 complex subunit D3	1478	20	0E0	90.5%	3	P:GO:0007076; C:GO:0000799; F:GO:0005488	P:mitotic chromosome condensation; C:nuclear condensin complex; F:binding		IPR012371 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR032682 (PFAM); PTHR14222:SF1 (PANTHER); IPR026971 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR016024 (SUPERFAMILY)
F7BQE2	acyl-coenzyme A thioesterase 1	408	20	0E0	84.25%	2	P:GO:0006637; F:GO:0016790	P:acyl-CoA metabolic process; F:thiolester hydrolase activity		IPR016662 (PIRSF); IPR014940 (PFAM); IPR006862 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR10824 (PANTHER); PTHR10824:SF16 (PANTHER); IPR029058 (SUPERFAMILY)
F6ULK6	acyl-coenzyme A thioesterase 4	423	20	0E0	86.35%	2	P:GO:0006637; F:GO:0016790	P:acyl-CoA metabolic process; F:thiolester hydrolase activity		IPR016662 (PIRSF); IPR029058 (G3DSA:3.40.50.GENE3D); IPR014940 (PFAM); IPR006862 (PFAM); PTHR10824:SF6 (PANTHER); PTHR10824 (PANTHER); IPR029058 (SUPERFAMILY)
F7DUG2	acyl-coenzyme A thioesterase 6-like	423	20	0E0	92.6%	2	P:GO:0006637; F:GO:0016790	P:acyl-CoA metabolic process; F:thiolester hydrolase activity		IPR016662 (PIRSF); IPR029058 (G3DSA:3.40.50.GENE3D); IPR014940 (PFAM); IPR006862 (PFAM); PTHR10824:SF17 (PANTHER); PTHR10824 (PANTHER); IPR029058 (SUPERFAMILY)
H9GZM1	growth arrest-specific 6	485	20	0E0	93.1%	2	F:GO:0005515; F:GO:0005509	F:protein binding; F:calcium ion binding		IPR000742 (SMART); IPR001791 (SMART); IPR001881 (SMART); IPR001881 (PFAM); PF14670 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR001791 (PFAM); IPR001791 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); PTHR24035:SF104 (PANTHER); PTHR24035 (PANTHER); IPR018097 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000742 (PROSITE_PROFILES); IPR001791 (PROSITE_PROFILES); IPR009030 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR013320 (SUPERFAMILY)
F6XNR9	collagen alpha-1(XVIII) chain isoform X1	1704	20	0E0	79.2%	4	F:GO:0005515; F:GO:0005198; P:GO:0007155; C:GO:0031012	F:protein binding; F:structural molecule activity; P:cell adhesion; C:extracellular matrix		IPR020067 (SMART); IPR020067 (PFAM); IPR016186 (G3DSA:3.10.100.GENE3D); IPR010363 (PFAM); IPR010515 (PFAM); IPR020067 (G3DSA:1.10.2000.GENE3D); IPR008160 (PFAM); PTHR24023 (PANTHER); PTHR24023:SF587 (PANTHER); IPR020067 (PROSITE_PROFILES); IPR020067 (SUPERFAMILY); IPR016187 (SUPERFAMILY)
F6XHX6	collagen alpha-1(XVIII) chain	1110	20	0E0	91.1%	3	F:GO:0005198; P:GO:0007155; C:GO:0031012	F:structural molecule activity; P:cell adhesion; C:extracellular matrix		IPR016186 (G3DSA:3.10.100.GENE3D); IPR008160 (PFAM); IPR010515 (PFAM); PTHR24023 (PANTHER); PTHR24023:SF587 (PANTHER); IPR016187 (SUPERFAMILY)
F6XGY6	cytoplasmic dynein 1 heavy chain 1	525	20	0E0	98.25%	6	F:GO:0016887; F:GO:0005524; F:GO:0003777; C:GO:0030286; P:GO:0007018; C:GO:0005874	F:ATPase activity; F:ATP binding; F:microtubule motor activity; C:dynein complex; P:microtubule-based movement; C:microtubule	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR003593 (SMART); PF12781 (PFAM); IPR024743 (PFAM); IPR004273 (PFAM); IPR013602 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011704 (PFAM); PF12774 (PFAM); PF12775 (PFAM); IPR024317 (PFAM); IPR013594 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR026983 (PANTHER); PTHR10676:SF28 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
F6RHB3	cytoplasmic dynein 1 heavy chain 1	710	20	0E0	99.1%	6	F:GO:0016887; F:GO:0005524; F:GO:0003777; C:GO:0030286; P:GO:0007018; C:GO:0005874	F:ATPase activity; F:ATP binding; F:microtubule motor activity; C:dynein complex; P:microtubule-based movement; C:microtubule	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR004273 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PF12775 (PFAM); IPR013602 (PFAM); PF12781 (PFAM); IPR013594 (PFAM); IPR011704 (PFAM); IPR024317 (PFAM); PF12774 (PFAM); IPR024743 (PFAM); IPR026983 (PANTHER); PTHR10676:SF28 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
F7BAA0	glutathione S-transferase omega-1	241	20	2.06E-179	90.95%	5	P:GO:0006803; F:GO:0005515; C:GO:0005737; P:GO:0006749; F:GO:0004364	P:obsolete glutathione conjugation reaction; F:protein binding; C:cytoplasm; P:glutathione metabolic process; F:glutathione transferase activity	EC:2.5.1.18	IPR005442 (PRINTS); IPR004045 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR004046 (PFAM); IPR010987 (G3DSA:1.20.1050.GENE3D); PTHR11260 (PANTHER); PTHR11260:SF323 (PANTHER); IPR004045 (PROSITE_PROFILES); IPR010987 (PROSITE_PROFILES); IPR010987 (SUPERFAMILY); IPR012336 (SUPERFAMILY)
F6RLD7	glutathione S-transferase omega-2	216	20	4.46E-161	97.25%	5	P:GO:0006803; F:GO:0005515; C:GO:0005737; P:GO:0006749; F:GO:0004364	P:obsolete glutathione conjugation reaction; F:protein binding; C:cytoplasm; P:glutathione metabolic process; F:glutathione transferase activity	EC:2.5.1.18	IPR005442 (PRINTS); IPR012336 (G3DSA:3.40.30.GENE3D); IPR010987 (G3DSA:1.20.1050.GENE3D); IPR004045 (PFAM); PTHR11260 (PANTHER); PTHR11260:SF197 (PANTHER); IPR010987 (PROSITE_PROFILES); IPR004045 (PROSITE_PROFILES); IPR010987 (SUPERFAMILY); IPR012336 (SUPERFAMILY)
F6TZF2	pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16	1226	20	0E0	99.05%	3	F:GO:0003676; F:GO:0005524; F:GO:0008026	F:nucleic acid binding; F:ATP binding; F:ATP-dependent helicase activity	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR007502 (SMART); IPR014001 (SMART); IPR001650 (SMART); IPR011709 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR007502 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR011545 (PFAM); PTHR18934:SF91 (PANTHER); PTHR18934 (PANTHER); IPR002464 (PROSITE_PATTERNS); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F7BH96	cullin-associated NEDD8-dissociated 1	1229	20	0E0	99%	1	F:GO:0005488	F:binding		IPR011989 (G3DSA:1.25.10.GENE3D); IPR013932 (PFAM); PTHR12696 (PANTHER); PTHR12696:SF1 (PANTHER); IPR016024 (SUPERFAMILY)
F6WU92	arf-GAP with Rho-GAP ANK repeat and PH domain-containing 1 isoform X1	1214	20	0E0	93.55%	2	P:GO:0007165; F:GO:0005096	P:signal transduction; F:GTPase activator activity		IPR001849 (SMART); IPR000198 (SMART); IPR001164 (SMART); IPR000198 (G3DSA:1.10.555.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR000198 (PFAM); IPR001164 (PFAM); IPR001849 (PFAM); IPR000159 (PFAM); G3DSA:3.10.20.90 (GENE3D); PTHR23180:SF195 (PANTHER); PTHR23180 (PANTHER); IPR001164 (PROSITE_PROFILES); IPR000159 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR000198 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR008936 (SUPERFAMILY); SSF57863 (SUPERFAMILY); IPR011993 (SUPERFAMILY)
F6WUK1	arf-GAP with Rho-GAP ANK repeat and PH domain-containing 1 isoform X1	1455	20	0E0	92.55%	3	F:GO:0005515; P:GO:0007165; F:GO:0005096	F:protein binding; P:signal transduction; F:GTPase activator activity		IPR001660 (SMART); IPR001164 (SMART); IPR000198 (SMART); IPR001849 (SMART); IPR000198 (PFAM); IPR001849 (PFAM); IPR001164 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR001660 (PFAM); IPR000198 (G3DSA:1.10.555.GENE3D); G3DSA:3.10.20.90 (GENE3D); IPR000159 (PFAM); IPR013761 (G3DSA:1.10.150.GENE3D); PTHR23180:SF195 (PANTHER); PTHR23180 (PANTHER); IPR000159 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR000198 (PROSITE_PROFILES); IPR001164 (PROSITE_PROFILES); IPR001660 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR013761 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR008936 (SUPERFAMILY); IPR011993 (SUPERFAMILY); SSF57863 (SUPERFAMILY); IPR011993 (SUPERFAMILY)
F7DMQ3	aldose reductase	316	20	0E0	95.45%	2	F:GO:0016491; P:GO:0055114	F:oxidoreductase activity; P:oxidation-reduction process		IPR020471 (PRINTS); IPR020471 (PIRSF); IPR023210 (PFAM); IPR023210 (G3DSA:3.20.20.GENE3D); IPR001395 (PANTHER); PTHR11732:SF233 (PANTHER); IPR018170 (PROSITE_PATTERNS); IPR018170 (PROSITE_PATTERNS); IPR018170 (PROSITE_PATTERNS); IPR023210 (SUPERFAMILY)
F6VET1	3-oxo-5-beta-steroid 4-dehydrogenase	326	20	0E0	95.35%	2	F:GO:0016491; P:GO:0055114	F:oxidoreductase activity; P:oxidation-reduction process		IPR020471 (PRINTS); IPR020471 (PIRSF); IPR023210 (PFAM); IPR023210 (G3DSA:3.20.20.GENE3D); PTHR11732:SF211 (PANTHER); IPR001395 (PANTHER); IPR018170 (PROSITE_PATTERNS); IPR018170 (PROSITE_PATTERNS); IPR018170 (PROSITE_PATTERNS); IPR023210 (SUPERFAMILY)
F6TXZ9	40S ribosomal S25	137	20	3.06E-82	98.75%	24	C:GO:0022627; P:GO:0034198; P:GO:0006364; P:GO:0000028; C:GO:0005730; C:GO:0005840; P:GO:0006413; C:GO:0005654; F:GO:0044822; P:GO:0006412; C:GO:0005844; P:GO:0019083; C:GO:0005634; F:GO:0005515; C:GO:0070062; F:GO:0003723; P:GO:0006614; F:GO:0003735; C:GO:0030529; P:GO:0000184; C:GO:0005737; C:GO:0005829; C:GO:0015935; C:GO:0031012	C:cytosolic small ribosomal subunit; P:cellular response to amino acid starvation; P:rRNA processing; P:ribosomal small subunit assembly; C:nucleolus; C:ribosome; P:translational initiation; C:nucleoplasm; F:poly(A) RNA binding; P:translation; C:polysome; P:viral transcription; C:nucleus; F:protein binding; C:extracellular exosome; F:RNA binding; P:SRP-dependent cotranslational protein targeting to membrane; F:structural constituent of ribosome; C:intracellular ribonucleoprotein complex; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; C:cytoplasm; C:cytosol; C:small ribosomal subunit; C:extracellular matrix		IPR004977 (PFAM); IPR004977 (PANTHER); PTHR12850:SF12 (PANTHER); IPR004977 (PRODOM)
F6Z1U4	glyoxalase domain-containing 4	298	20	0E0	97.4%	2	C:GO:0070062; C:GO:0005739	C:extracellular exosome; C:mitochondrion		IPR029068 (G3DSA:3.10.180.GENE3D); PTHR10374 (PANTHER); PTHR10374:SF20 (PANTHER); IPR029068 (SUPERFAMILY); IPR029068 (SUPERFAMILY)
F7DEB1	insulin-like growth factor-binding 6	237	20	1.82E-166	93.3%	3	C:GO:0016942; P:GO:0001558; F:GO:0005520	C:insulin-like growth factor binding protein complex; P:regulation of cell growth; F:insulin-like growth factor binding		IPR022321 (PRINTS); IPR022326 (PRINTS); IPR000867 (SMART); IPR000716 (SMART); G3DSA:4.10.40.20 (GENE3D); IPR000716 (G3DSA:4.10.800.GENE3D); IPR000867 (PFAM); IPR000716 (PFAM); IPR009168 (PANTHER); PTHR11551:SF14 (PANTHER); IPR000716 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR000716 (PROSITE_PROFILES); IPR000867 (PROSITE_PROFILES); IPR009030 (SUPERFAMILY); IPR000716 (SUPERFAMILY)
F7ABF0	ATPase family AAA domain-containing 5	1857	20	0E0	91.2%	1	F:GO:0005524	F:ATP binding		IPR003593 (SMART); G3DSA:1.10.8.60 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003959 (PFAM); PTHR23389 (PANTHER); PTHR23389:SF6 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR027417 (SUPERFAMILY)
F7CPM7	DIS3-like exonuclease 1 isoform X2	971	20	0E0	97.65%	4	P:GO:0090503; F:GO:0000175; P:GO:0016075; P:GO:0051252	P:RNA phosphodiester bond hydrolysis, exonucleolytic; F:3'-5'-exoribonuclease activity; P:rRNA catabolic process; P:regulation of RNA metabolic process	EC:3.1; EC:3.1.13; EC:3.1.15	SM00955 (SMART); PF00773 (PFAM); IPR033770 (PFAM); IPR033771 (PFAM); IPR031192 (PTHR23355:PANTHER); PTHR23355 (PANTHER); IPR022966 (PROSITE_PATTERNS); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY)
F6UCT9	centrosomal of 83 kDa	304	20	0E0	96.9%	3	P:GO:0060271; C:GO:0005814; P:GO:0048278	P:cilium morphogenesis; C:centriole; P:vesicle docking		PTHR23170 (PANTHER); IPR029631 (PTHR23170:PANTHER)
F7E1H4	5 -nucleotidase domain-containing 1	450	20	0E0	94.5%	2	F:GO:0008253; P:GO:0016311	F:5'-nucleotidase activity; P:dephosphorylation		IPR023214 (G3DSA:3.40.50.GENE3D); IPR008380 (PFAM); PTHR12103:SF13 (PANTHER); IPR008380 (PANTHER); IPR023214 (SUPERFAMILY)
F6ZBL0	centrosomal of 83 kDa	701	20	0E0	96.85%	3	P:GO:0060271; C:GO:0005814; P:GO:0048278	P:cilium morphogenesis; C:centriole; P:vesicle docking		IPR029631 (PTHR23170:PANTHER); PTHR23170 (PANTHER)
F6WHM4	sal 2 isoform X1	1018	20	0E0	96.25%	2	F:GO:0003676; F:GO:0046872	F:nucleic acid binding; F:metal ion binding		IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); PF12874 (PFAM); PTHR23233:SF15 (PANTHER); PTHR23233 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
F7CFS8	ubiquitin-like modifier-activating enzyme 7 isoform X1	1011	20	0E0	91.35%	2	P:GO:0006464; F:GO:0008641	P:cellular protein modification process; F:small protein activating enzyme activity		IPR000011 (PRINTS); IPR018965 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR019572 (G3DSA:1.10.3240.GENE3D); IPR019572 (PFAM); IPR032418 (PFAM); IPR032420 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR018075 (TIGRFAM); IPR000594 (PFAM); IPR018965 (PFAM); PTHR10953:SF143 (PANTHER); PTHR10953 (PANTHER); IPR033127 (PROSITE_PATTERNS); IPR000594 (SUPERFAMILY); IPR000594 (SUPERFAMILY)
F6PYX5	CAP-Gly domain-containing linker 1 isoform X1	1429	20	0E0	96.3%	16	F:GO:0015631; C:GO:0015630; F:GO:0008270; C:GO:0035371; P:GO:0044861; C:GO:0044354; C:GO:0005881; F:GO:0008017; C:GO:0005874; C:GO:0005813; P:GO:0001578; C:GO:1990752; C:GO:0005737; C:GO:0016020; F:GO:0051010; P:GO:0031116	F:tubulin binding; C:microtubule cytoskeleton; F:zinc ion binding; C:microtubule plus-end; P:protein transport into plasma membrane raft; C:macropinosome; C:cytoplasmic microtubule; F:microtubule binding; C:microtubule; C:centrosome; P:microtubule bundle formation; C:microtubule end; C:cytoplasm; C:membrane; F:microtubule plus-end binding; P:positive regulation of microtubule polymerization		IPR000938 (SMART); IPR000938 (G3DSA:2.30.30.GENE3D); IPR000938 (PFAM); IPR032108 (PFAM); PTHR18916:SF44 (PANTHER); PTHR18916 (PANTHER); IPR000938 (PROSITE_PATTERNS); IPR000938 (PROSITE_PROFILES); IPR000938 (SUPERFAMILY); IPR000938 (SUPERFAMILY)
F7AX81	T-complex 1 subunit alpha	558	20	0E0	99.1%	3	F:GO:0005524; F:GO:0051082; P:GO:0006457	F:ATP binding; F:unfolded protein binding; P:protein folding		IPR017998 (PRINTS); IPR027413 (G3DSA:1.10.560.GENE3D); IPR012715 (TIGRFAM); IPR027409 (G3DSA:3.50.7.GENE3D); IPR027410 (G3DSA:3.30.260.GENE3D); IPR002423 (PFAM); PTHR11353 (PANTHER); IPR002194 (PROSITE_PATTERNS); IPR002194 (PROSITE_PATTERNS); IPR002194 (PROSITE_PATTERNS); SSF54849 (SUPERFAMILY); SSF48592 (SUPERFAMILY); IPR027409 (SUPERFAMILY)
F7C555	bifunctional purine biosynthesis PURH	591	20	0E0	96.85%	5	P:GO:0006164; F:GO:0003937; P:GO:0006144; C:GO:0042720; F:GO:0004643	P:purine nucleotide biosynthetic process; F:IMP cyclohydrolase activity; P:purine nucleobase metabolic process; C:mitochondrial inner membrane peptidase complex; F:phosphoribosylaminoimidazolecarboxamide formyltransferase activity	EC:3.5.4.10; EC:2.1.2.3	IPR002695 (SMART); IPR011607 (SMART); IPR002695 (PIRSF); IPR011607 (PFAM); IPR024050 (G3DSA:1.10.287.GENE3D); IPR024051 (G3DSA:3.40.140.GENE3D); IPR024051 (G3DSA:3.40.140.GENE3D); IPR002695 (TIGRFAM); IPR002695 (PFAM); IPR011607 (G3DSA:3.40.50.GENE3D); IPR002695 (PANTHER); PTHR11692:SF0 (PANTHER); IPR002695 (HAMAP); IPR011607 (SUPERFAMILY); IPR016193 (SUPERFAMILY)
F6U8R0	sciellin isoform X1	667	20	0E0	87.85%	1	F:GO:0008270	F:zinc ion binding		IPR001781 (SMART); IPR001781 (G3DSA:2.10.110.GENE3D); PTHR15468:SF7 (PANTHER); PTHR15468 (PANTHER); IPR001781 (PROSITE_PATTERNS); IPR001781 (PROSITE_PROFILES)
F6QDP0	ATP-citrate synthase isoform X1	1110	20	0E0	99.05%	6	F:GO:0005524; F:GO:0003878; F:GO:0048037; P:GO:0006085; P:GO:0006101; P:GO:0006099	F:ATP binding; F:ATP citrate synthase activity; F:cofactor binding; P:acetyl-CoA biosynthetic process; P:citrate metabolic process; P:tricarboxylic acid cycle	EC:2.3.3.8	PR01798 (PRINTS); IPR014608 (PIRSF); IPR003781 (SMART); IPR013816 (G3DSA:3.30.470.GENE3D); IPR016102 (G3DSA:3.40.50.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR016102 (G3DSA:3.40.50.GENE3D); IPR005811 (PFAM); IPR016143 (G3DSA:1.10.230.GENE3D); IPR002020 (PFAM); IPR032263 (PFAM); IPR003781 (PFAM); IPR016142 (G3DSA:1.10.580.GENE3D); PTHR23118 (PANTHER); IPR017440 (PROSITE_PATTERNS); IPR033847 (PROSITE_PATTERNS); IPR017866 (PROSITE_PATTERNS); IPR002020 (SUPERFAMILY); IPR016040 (SUPERFAMILY); SSF56059 (SUPERFAMILY); IPR016102 (SUPERFAMILY)
F6U3I9	interferon-induced very large GTPase 1-like	540	20	0E0	88.75%	1	F:GO:0005525	F:GTP binding		IPR022812 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR14819 (PANTHER); PTHR14819:SF3 (PANTHER); IPR030383 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F7DRS2	corticosteroid-binding globulin	404	20	0E0	81.7%	1	C:GO:0005615	C:extracellular space		IPR023796 (SMART); G3DSA:3.30.497.10 (GENE3D); G3DSA:2.30.39.10 (GENE3D); IPR023796 (PFAM); IPR000215 (PANTHER); PTHR11461:SF34 (PANTHER); IPR023795 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR023796 (SUPERFAMILY)
F6WKM3	src substrate cortactin isoform X2	511	20	0E0	95.15%	2	F:GO:0005515; P:GO:0030041	F:protein binding; P:actin filament polymerization		PR00499 (PRINTS); IPR001452 (PRINTS); IPR001452 (SMART); IPR001452 (PFAM); IPR003134 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR015503 (PTHR10829:PANTHER); PTHR10829 (PANTHER); IPR003134 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY)
F6X4S0	src substrate cortactin isoform X1	551	20	0E0	95.15%	2	F:GO:0005515; P:GO:0030041	F:protein binding; P:actin filament polymerization		PR00499 (PRINTS); IPR001452 (PRINTS); IPR001452 (SMART); IPR001452 (PFAM); IPR003134 (PFAM); G3DSA:2.30.30.40 (GENE3D); PTHR10829 (PANTHER); IPR015503 (PTHR10829:PANTHER); IPR001452 (PROSITE_PROFILES); IPR003134 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY)
F6QXE4	neural cell adhesion molecule L1 isoform X2	1209	20	0E0	96.65%	1	F:GO:0005515	F:protein binding		IPR003598 (SMART); IPR003599 (SMART); IPR003961 (SMART); IPR013151 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003961 (PFAM); IPR013098 (PFAM); PF13927 (PFAM); IPR026966 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR10489 (PANTHER); PTHR10489:SF653 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR003961 (SUPERFAMILY)
F7CSM4	calpastatin isoform X5	728	20	0E0	97.85%	6	C:GO:0005737; C:GO:0016020; P:GO:2000675; C:GO:0005829; C:GO:0005783; F:GO:0044822	C:cytoplasm; C:membrane; P:negative regulation of type B pancreatic cell apoptotic process; C:cytosol; C:endoplasmic reticulum; F:poly(A) RNA binding		IPR001259 (PFAM); IPR026998 (PANTHER); PTHR10077:SF0 (PANTHER)
F7C625	calpastatin isoform X4	771	20	0E0	95.35%	6	C:GO:0005737; C:GO:0016020; P:GO:2000675; C:GO:0005829; C:GO:0005783; F:GO:0044822	C:cytoplasm; C:membrane; P:negative regulation of type B pancreatic cell apoptotic process; C:cytosol; C:endoplasmic reticulum; F:poly(A) RNA binding		IPR001259 (PFAM); IPR026998 (PANTHER); PTHR10077:SF0 (PANTHER)
F6PZP5	carcinoembryonic antigen-related cell adhesion molecule 1-like isoform X1	521	20	0E0	88%	1	F:GO:0005515	F:protein binding		IPR003598 (SMART); IPR003599 (SMART); IPR007110 (PFAM); PF13927 (PFAM); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR12231 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F6V278	ubiquitin carboxyl-terminal hydrolase 14 isoform X1	494	20	0E0	99%	4	P:GO:0016579; F:GO:0005515; F:GO:0036459; P:GO:0006511	P:protein deubiquitination; F:protein binding; F:thiol-dependent ubiquitinyl hydrolase activity; P:ubiquitin-dependent protein catabolic process	EC:3.4; EC:3.4.19.12	IPR000626 (SMART); IPR001394 (PFAM); G3DSA:3.10.20.90 (GENE3D); PTHR24006 (PANTHER); IPR019954 (PROSITE_PATTERNS); IPR018200 (PROSITE_PATTERNS); IPR018200 (PROSITE_PATTERNS); IPR000626 (PROSITE_PROFILES); IPR028889 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY); SSF54001 (SUPERFAMILY)
F7C6E3	calpastatin isoform X5	699	20	0E0	97.85%	6	C:GO:0005737; C:GO:0016020; P:GO:2000675; C:GO:0005829; C:GO:0005783; F:GO:0044822	C:cytoplasm; C:membrane; P:negative regulation of type B pancreatic cell apoptotic process; C:cytosol; C:endoplasmic reticulum; F:poly(A) RNA binding		IPR001259 (PFAM); PTHR10077:SF0 (PANTHER); IPR026998 (PANTHER)
F6ZI08	tetraspanin-1	176	20	9.34E-122	85.5%	1	C:GO:0016021	C:integral component of membrane		IPR000301 (PRINTS); IPR000301 (PIRSF); IPR018499 (PFAM); PTHR19282 (PANTHER); PTHR19282:SF216 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR008952 (SUPERFAMILY)
F6V9C9	caspase-7	302	20	0E0	93.7%	2	P:GO:0006508; F:GO:0004197	P:proteolysis; F:cysteine-type endopeptidase activity	EC:3.4.22; EC:3.4	IPR015917 (PRINTS); IPR015917 (SMART); PF00656 (PFAM); IPR029030 (G3DSA:3.40.50.GENE3D); PTHR10454 (PANTHER); IPR016129 (PROSITE_PATTERNS); IPR033139 (PROSITE_PATTERNS); IPR002138 (PROSITE_PROFILES); IPR001309 (PROSITE_PROFILES); IPR029030 (SUPERFAMILY)
F7CFN5	complement component C8 alpha chain	548	20	0E0	90.95%	3	C:GO:0005579; F:GO:0005515; P:GO:0006955	C:membrane attack complex; F:protein binding; P:immune response		PR01705 (PRINTS); IPR001862 (PRINTS); IPR000884 (SMART); IPR002172 (SMART); IPR020864 (SMART); IPR002172 (PFAM); IPR000884 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); IPR020864 (PFAM); G3DSA:2.20.100.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); PTHR19325:SF385 (PANTHER); PTHR19325 (PANTHER); IPR013032 (PROSITE_PATTERNS); IPR020863 (PROSITE_PATTERNS); IPR023415 (PROSITE_PATTERNS); IPR020864 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR002172 (PROSITE_PROFILES); IPR009030 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY)
F6X756	elongation factor 1-beta	159	20	3.87E-109	100%	4	P:GO:0006448; F:GO:0003746; C:GO:0005840; C:GO:0005853	P:regulation of translational elongation; F:translation elongation factor activity; C:ribosome; C:eukaryotic translation elongation factor 1 complex		IPR014038 (SMART); IPR018940 (SMART); IPR018940 (PFAM); IPR014038 (PFAM); IPR014717 (G3DSA:3.30.70.GENE3D); PTHR11595 (PANTHER); PTHR11595:SF34 (PANTHER); IPR001326 (PROSITE_PATTERNS); IPR001326 (PROSITE_PATTERNS); IPR014038 (SUPERFAMILY)
F6ZPS6	breast carcinoma-amplified sequence 1 isoform X1	569	20	0E0	88.45%	1	C:GO:0070062	C:extracellular exosome		IPR026115 (PANTHER)
F7D7Q9	interferon-induced transmembrane 1-like	126	20	2.16E-89	90.45%	2	P:GO:0009607; C:GO:0016021	P:response to biotic stimulus; C:integral component of membrane		IPR007593 (PFAM); PTHR13999 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS)
F6RQE8	interferon-induced transmembrane 3-like	121	20	1.25E-73	89.45%	2	P:GO:0009607; C:GO:0016021	P:response to biotic stimulus; C:integral component of membrane		IPR007593 (PFAM); PTHR13999 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS)
F6WCY9	ribonuclease inhibitor isoform X2	456	20	0E0	92.1%	1	F:GO:0005515	F:protein binding		SM00368 (SMART); IPR006553 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); IPR001611 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR24112:SF30 (PANTHER); PTHR24112 (PANTHER); IPR001611 (PROSITE_PROFILES); SSF52047 (SUPERFAMILY); SSF52047 (SUPERFAMILY)
F7AJP3	chitotriosidase-1 isoform X3	600	20	0E0	92.1%	7	F:GO:0004568; P:GO:0005975; P:GO:0016998; C:GO:0005615; F:GO:0008061; P:GO:0006032; P:GO:0045766	F:chitinase activity; P:carbohydrate metabolic process; P:cell wall macromolecule catabolic process; C:extracellular space; F:chitin binding; P:chitin catabolic process; P:positive regulation of angiogenesis	EC:3.2.1.14	IPR011583 (SMART); IPR029070 (G3DSA:3.10.50.GENE3D); IPR001223 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR11177 (PANTHER); IPR028538 (PTHR11177:PANTHER); IPR001579 (PROSITE_PATTERNS); IPR017853 (SUPERFAMILY); IPR029070 (SUPERFAMILY); IPR017853 (SUPERFAMILY)
F6SUP2	secretoglobin family 1D member-like	82	20	5.97E-51	74.8%	2	P:GO:0007165; C:GO:0005576	P:signal transduction; C:extracellular region		G3DSA:1.10.210.10 (GENE3D); IPR016126 (PFAM); PTHR11332 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR016126 (PROSITE_PROFILES); IPR016126 (SUPERFAMILY)
F6YF95	cellular nucleic acid-binding isoform X3	170	20	1.35E-120	99.15%	2	F:GO:0003676; F:GO:0008270	F:nucleic acid binding; F:zinc ion binding		IPR001878 (SMART); IPR001878 (G3DSA:4.10.60.GENE3D); IPR001878 (G3DSA:4.10.60.GENE3D); IPR001878 (PFAM); IPR001878 (PROSITE_PROFILES); IPR001878 (SUPERFAMILY); IPR001878 (SUPERFAMILY); IPR001878 (SUPERFAMILY); IPR001878 (SUPERFAMILY)
P0DN28	apolipo C-III	97	20	8.48E-63	79.9%	4	P:GO:0006869; F:GO:0008289; P:GO:0042157; C:GO:0005576	P:lipid transport; F:lipid binding; P:lipoprotein metabolic process; C:extracellular region		IPR008403 (PFAM); IPR023121 (G3DSA:1.10.1440.GENE3D); PTHR14225:SF0 (PANTHER); IPR008403 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR008403 (PRODOM); SSF47162 (SUPERFAMILY)
O18999	interleukin-1 receptor antagonist isoform X1	177	20	1.17E-130	93.75%	8	P:GO:0008283; C:GO:0005615; P:GO:0006955; P:GO:0007165; F:GO:0005152; C:GO:0045323; F:GO:0005149; P:GO:0040007	P:cell proliferation; C:extracellular space; P:immune response; P:signal transduction; F:interleukin-1 receptor antagonist activity; C:interleukin-1 receptor complex; F:interleukin-1 receptor binding; P:growth		IPR003297 (PRINTS); IPR000975 (PRINTS); SM00125 (SMART); G3DSA:2.80.10.50 (GENE3D); IPR000975 (PFAM); PTHR10078 (PANTHER); IPR027166 (PTHR10078:PANTHER); IPR020877 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR008996 (SUPERFAMILY)
A0A140TAU8	interleukin-1 receptor antagonist isoform X1	177	20	1.37E-130	93.55%	8	P:GO:0008283; C:GO:0005615; P:GO:0006955; P:GO:0007165; F:GO:0005152; C:GO:0045323; F:GO:0005149; P:GO:0040007	P:cell proliferation; C:extracellular space; P:immune response; P:signal transduction; F:interleukin-1 receptor antagonist activity; C:interleukin-1 receptor complex; F:interleukin-1 receptor binding; P:growth		IPR000975 (PRINTS); IPR003297 (PRINTS); SM00125 (SMART); IPR000975 (PFAM); G3DSA:2.80.10.50 (GENE3D); PTHR10078 (PANTHER); IPR027166 (PTHR10078:PANTHER); IPR020877 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR008996 (SUPERFAMILY)
F6S4R4	S-phase kinase-associated 1	163	20	3.48E-115	99.95%	1	P:GO:0006511	P:ubiquitin-dependent protein catabolic process		IPR016897 (PIRSF); IPR001232 (SMART); IPR016073 (PFAM); G3DSA:3.30.710.10 (GENE3D); IPR016072 (PFAM); PTHR11165 (PANTHER); IPR016072 (SUPERFAMILY); IPR011333 (SUPERFAMILY)
F6UY34	-glutamate O-methyltransferase	441	20	0E0	94.3%	9	P:GO:2001020; F:GO:0008168; F:GO:0016740; F:GO:0008757; P:GO:0006479; P:GO:0006974; F:GO:0051998; F:GO:0019899; P:GO:0032259	P:regulation of response to DNA damage stimulus; F:methyltransferase activity; F:transferase activity; F:S-adenosylmethionine-dependent methyltransferase activity; P:protein methylation; P:cellular response to DNA damage stimulus; F:protein carboxyl O-methyltransferase activity; F:enzyme binding; P:methylation		IPR002791 (PFAM); PTHR12260 (PANTHER); PTHR12260:SF6 (PANTHER); IPR002791 (SUPERFAMILY)
Q9N0T3	calcitonin gene-related peptide 2 isoform X2	129	20	1.36E-87	92.3%	3	P:GO:0007165; C:GO:0005576; F:GO:0005179	P:signal transduction; C:extracellular region; F:hormone activity		IPR015476 (PRINTS); IPR001693 (SMART); IPR021116 (PFAM); PTHR10505:SF12 (PANTHER); IPR021117 (PANTHER); IPR018360 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS)
F6X3S7	UV excision repair RAD23 homolog B	386	20	0E0	97.45%	5	C:GO:0005634; P:GO:0043161; F:GO:0005515; P:GO:0006289; F:GO:0003684	C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; F:protein binding; P:nucleotide-excision repair; F:damaged DNA binding		IPR004806 (PRINTS); IPR015940 (SMART); IPR006636 (SMART); IPR015360 (G3DSA:1.10.10.GENE3D); IPR015940 (PFAM); IPR004806 (TIGRFAM); IPR015360 (PFAM); G3DSA:3.10.20.90 (GENE3D); G3DSA:1.10.8.10 (GENE3D); G3DSA:1.10.8.10 (GENE3D); IPR000626 (PFAM); PTHR10621 (PANTHER); PTHR10621:SF13 (PANTHER); IPR015940 (PROSITE_PROFILES); IPR000626 (PROSITE_PROFILES); IPR015360 (SUPERFAMILY); IPR029071 (SUPERFAMILY); IPR009060 (SUPERFAMILY); IPR009060 (SUPERFAMILY)
F6Q2E5	STE20-like serine threonine- kinase isoform X1	1242	20	0E0	95.4%	5	F:GO:0005524; F:GO:0005515; P:GO:0009069; F:GO:0004674; P:GO:0006468	F:ATP binding; F:protein binding; P:serine family amino acid metabolic process; F:protein serine/threonine kinase activity; P:protein phosphorylation	EC:2.7.11	IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); IPR022165 (PFAM); PTHR24361 (PANTHER); PTHR24361:SF418 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR001943 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)
F6YKL4	myotrophin	118	20	4.02E-81	99.25%	1	F:GO:0005515	F:protein binding		IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); PTHR24189 (PANTHER); PTHR24189:SF26 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY)
F6XWJ6	RUN and FYVE domain-containing 1	600	20	0E0	97.15%	1	F:GO:0046872	F:metal ion binding		IPR000306 (SMART); IPR004012 (SMART); IPR000306 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR004012 (PFAM); PTHR22835:SF84 (PANTHER); PTHR22835 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR004012 (PROSITE_PROFILES); IPR017455 (PROSITE_PROFILES); SSF140741 (SUPERFAMILY); IPR011011 (SUPERFAMILY)
F6W1S0	resistin	68	20	8.83E-42	92.4%	3	P:GO:0007165; C:GO:0005576; F:GO:0005179	P:signal transduction; C:extracellular region; F:hormone activity		IPR009714 (PFAM); PTHR21101:SF11 (PANTHER); IPR009714 (PANTHER); IPR009714 (SUPERFAMILY)
F6R3X8	brain acid soluble 1	233	20	5.54E-144	89.45%	14	F:GO:0019904; C:GO:0016607; F:GO:0044212; P:GO:0021762; C:GO:0005886; C:GO:0005634; C:GO:0070062; P:GO:0045892; C:GO:0005737; F:GO:0003714; P:GO:0072112; C:GO:0031982; C:GO:0030054; C:GO:0008180	F:protein domain specific binding; C:nuclear speck; F:transcription regulatory region DNA binding; P:substantia nigra development; C:plasma membrane; C:nucleus; C:extracellular exosome; P:negative regulation of transcription, DNA-templated; C:cytoplasm; F:transcription corepressor activity; P:glomerular visceral epithelial cell differentiation; C:vesicle; C:cell junction; C:COP9 signalosome		IPR008408 (PFAM); PTHR23212:SF0 (PANTHER); IPR008408 (PANTHER)
F6XX28	alanine--tRNA cytoplasmic	970	20	0E0	98.05%	7	F:GO:0003676; F:GO:0005524; C:GO:0005737; F:GO:0004813; P:GO:0006419; P:GO:0006531; P:GO:0006522	F:nucleic acid binding; F:ATP binding; C:cytoplasm; F:alanine-tRNA ligase activity; P:alanyl-tRNA aminoacylation; P:aspartate metabolic process; P:alanine metabolic process	EC:6.1.1.7; EC:6.1.1	IPR002318 (PRINTS); IPR012947 (SMART); IPR003156 (PFAM); IPR018164 (PFAM); IPR012947 (PFAM); IPR002318 (TIGRFAM); G3DSA:3.30.930.10 (GENE3D); PTHR11777 (PANTHER); PTHR11777:SF9 (PANTHER); IPR018165 (PROSITE_PROFILES); IPR023033 (HAMAP); IPR018163 (SUPERFAMILY); SSF55681 (SUPERFAMILY); IPR009000 (SUPERFAMILY); IPR018162 (SUPERFAMILY)
F6Y4Z6	proteasome subunit beta type-9	219	20	7.35E-159	98.5%	3	C:GO:0005839; F:GO:0004298; P:GO:0051603	C:proteasome core complex; F:threonine-type endopeptidase activity; P:proteolysis involved in cellular protein catabolic process	EC:3.4.25	IPR000243 (PRINTS); IPR001353 (PFAM); IPR029055 (G3DSA:3.60.20.GENE3D); PTHR11599:SF50 (PANTHER); PTHR11599 (PANTHER); IPR016050 (PROSITE_PATTERNS); IPR023333 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY)
F6UD63	cathelicidin antimicrobial peptide	157	20	5.74E-110	85.5%	2	C:GO:0005576; P:GO:0006952	C:extracellular region; P:defense response		PF00666 (PFAM); G3DSA:3.10.450.10 (GENE3D); IPR001894 (PANTHER); PTHR10206:SF2 (PANTHER); IPR018216 (PROSITE_PATTERNS); IPR018216 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); PD001838 (PRODOM); SSF54403 (SUPERFAMILY)
Q95LJ1	insulin-like growth factor-binding 7	117	20	5.06E-81	100%	3	C:GO:0016942; P:GO:0001558; F:GO:0005520	C:insulin-like growth factor binding protein complex; P:regulation of cell growth; F:insulin-like growth factor binding		IPR003599 (SMART); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR011390 (PANTHER); PTHR14186:SF15 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F6TIL8	AP-1 complex subunit mu-2 isoform X2	423	20	0E0	99.05%	3	P:GO:0016192; C:GO:0030131; P:GO:0006886	P:vesicle-mediated transport; C:clathrin adaptor complex; P:intracellular protein transport		IPR001392 (PRINTS); IPR001392 (PIRSF); G3DSA:3.30.450.60 (GENE3D); IPR028565 (PFAM); G3DSA:2.60.40.1170 (GENE3D); IPR022775 (PFAM); PTHR10529 (PANTHER); PTHR10529:SF234 (PANTHER); IPR018240 (PROSITE_PATTERNS); IPR018240 (PROSITE_PATTERNS); IPR028565 (PROSITE_PROFILES); IPR028565 (SUPERFAMILY); IPR011012 (SUPERFAMILY)
F6SZ35	proteasome subunit beta type-10	273	20	0E0	94.55%	3	C:GO:0005839; F:GO:0004298; P:GO:0051603	C:proteasome core complex; F:threonine-type endopeptidase activity; P:proteolysis involved in cellular protein catabolic process	EC:3.4.25	IPR000243 (PRINTS); IPR001353 (PFAM); IPR029055 (G3DSA:3.60.20.GENE3D); IPR024689 (PFAM); PTHR11599 (PANTHER); PTHR11599:SF41 (PANTHER); IPR016050 (PROSITE_PATTERNS); IPR023333 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY)
F6QYQ4	15 kDa seleno	95	20	1.55E-61	94.55%	5	C:GO:0005788; C:GO:0070062; F:GO:0008430; P:GO:0051084; C:GO:0005783	C:endoplasmic reticulum lumen; C:extracellular exosome; F:selenium binding; P:'de novo' posttranslational protein folding; C:endoplasmic reticulum		PTHR13077 (PANTHER); PTHR13077:SF6 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS)
F6XS05	S-formylglutathione hydrolase isoform X1	282	20	0E0	98.3%	3	F:GO:0018738; P:GO:0046294; P:GO:0015947	F:S-formylglutathione hydrolase activity; P:formaldehyde catabolic process; P:methane metabolic process	EC:3.1.2.12	IPR014186 (TIGRFAM); IPR000801 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR029058 (SUPERFAMILY)
F6RW00	myosin regulatory light chain skeletal muscle isoform	170	20	6.66E-122	99.6%	1	F:GO:0005509	F:calcium ion binding		IPR002048 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR002048 (PFAM); PTHR23049:SF10 (PANTHER); PTHR23049 (PANTHER); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F7DMY7	basement membrane-specific heparan sulfate proteoglycan core	421	20	0E0	95.4%	2	F:GO:0005515; F:GO:0005509	F:protein binding; F:calcium ion binding		IPR002172 (PRINTS); IPR003598 (SMART); IPR003599 (SMART); IPR001791 (SMART); IPR002049 (SMART); IPR013106 (SMART); IPR000082 (SMART); IPR000742 (SMART); IPR001881 (SMART); IPR002172 (SMART); IPR000034 (SMART); PF13927 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR013320 (G3DSA:2.60.120.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002049 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR013320 (G3DSA:2.60.120.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001791 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); IPR000742 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002172 (PFAM); G3DSA:2.170.300.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR000034 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013320 (G3DSA:2.60.120.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR10574:SF273 (PANTHER); PTHR10574 (PANTHER); IPR023415 (PROSITE_PATTERNS); IPR002049 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR000742 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); IPR001791 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR000034 (PROSITE_PROFILES); IPR000082 (PROSITE_PROFILES); IPR002172 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR013320 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR007110 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR007110 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F6QPI5	transportin-1 isoform X2	856	20	0E0	96%	1	F:GO:0005488	F:binding		IPR011989 (G3DSA:1.25.10.GENE3D); PF13513 (PFAM); PTHR10527 (PANTHER); PTHR10527:SF21 (PANTHER); IPR016024 (SUPERFAMILY)
F7DCH4	calponin-3	329	20	0E0	99.25%	2	F:GO:0003779; P:GO:0031032	F:actin binding; P:actomyosin structure organization		IPR001997 (PRINTS); IPR003096 (PRINTS); IPR001715 (SMART); IPR000557 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); IPR001715 (PFAM); PTHR18959:SF46 (PANTHER); PTHR18959 (PANTHER); IPR000557 (PROSITE_PATTERNS); IPR000557 (PROSITE_PROFILES); IPR001715 (PROSITE_PROFILES); IPR001715 (SUPERFAMILY)
F7DGE2	vesicle-fusing ATPase	738	20	0E0	99.05%	1	F:GO:0005524	F:ATP binding		PR00830 (PRINTS); IPR003338 (SMART); IPR003593 (SMART); IPR004201 (SMART); IPR003959 (PFAM); G3DSA:1.10.8.60 (GENE3D); IPR029067 (G3DSA:3.10.330.GENE3D); G3DSA:2.40.40.20 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003338 (PFAM); IPR004201 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.8.60 (GENE3D); PTHR23078:SF4 (PANTHER); PTHR23078 (PANTHER); IPR003960 (PROSITE_PATTERNS); IPR009010 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR029067 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
F7BYZ1	Niban	916	20	0E0	88.3%	8	C:GO:0070062; P:GO:0045727; C:GO:0005737; P:GO:0001933; C:GO:0016020; P:GO:0001934; C:GO:0005886; P:GO:0034976	C:extracellular exosome; P:positive regulation of translation; C:cytoplasm; P:negative regulation of protein phosphorylation; C:membrane; P:positive regulation of protein phosphorylation; C:plasma membrane; P:response to endoplasmic reticulum stress		IPR026088 (PANTHER); PTHR14392:SF3 (PANTHER)
F7BC37	prostasin	300	20	0E0	93.9%	2	P:GO:0006508; F:GO:0004252	P:proteolysis; F:serine-type endopeptidase activity	EC:3.4.21	IPR001314 (PRINTS); IPR001254 (SMART); G3DSA:2.40.10.10 (GENE3D); G3DSA:2.40.10.10 (GENE3D); IPR001254 (PFAM); PTHR24253:SF0 (PANTHER); PTHR24253 (PANTHER); IPR018114 (PROSITE_PATTERNS); IPR033116 (PROSITE_PATTERNS); IPR001254 (PROSITE_PROFILES); IPR009003 (SUPERFAMILY)
F7C0I7	Basement membrane-specific heparan sulfate proteoglycan core	434	20	0E0	96.25%	2	F:GO:0005515; F:GO:0005509	F:protein binding; F:calcium ion binding		IPR002172 (PRINTS); IPR003598 (SMART); IPR003599 (SMART); IPR002049 (SMART); IPR000082 (SMART); IPR001881 (SMART); IPR002172 (SMART); IPR001791 (SMART); IPR000034 (SMART); IPR013106 (SMART); IPR000742 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002049 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.170.300.10 (GENE3D); IPR013320 (G3DSA:2.60.120.GENE3D); IPR001791 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PF13927 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR000034 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR013320 (G3DSA:2.60.120.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR013320 (G3DSA:2.60.120.GENE3D); IPR000742 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (PFAM); PTHR10574:SF273 (PANTHER); PTHR10574 (PANTHER); IPR013032 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR002049 (PROSITE_PATTERNS); IPR023415 (PROSITE_PATTERNS); IPR007110 (PROSITE_PROFILES); IPR001791 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); IPR000034 (PROSITE_PROFILES); IPR000082 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR002172 (PROSITE_PROFILES); SSF57196 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR013320 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR013320 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F6UPK3	carbonic anhydrase 4	311	20	0E0	86.2%	6	F:GO:0008270; P:GO:0006807; F:GO:0004089; C:GO:0005886; P:GO:0006730; C:GO:0031225	F:zinc ion binding; P:nitrogen compound metabolic process; F:carbonate dehydratase activity; C:plasma membrane; P:one-carbon metabolic process; C:anchored component of membrane	EC:4.2.1.1	IPR001148 (SMART); IPR001148 (G3DSA:3.10.200.GENE3D); IPR001148 (PFAM); IPR018343 (PTHR18952:PANTHER); IPR023561 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR001148 (PROSITE_PROFILES); IPR001148 (SUPERFAMILY)
F7A0N8	serine threonine- phosphatase 2A 65 kDa regulatory subunit A alpha isoform	589	20	0E0	99.8%	2	F:GO:0005515; P:GO:0006461	F:protein binding; P:protein complex assembly		IPR011989 (G3DSA:1.25.10.GENE3D); IPR000357 (PFAM); PF13646 (PFAM); PTHR10648 (PANTHER); IPR031090 (PTHR10648:PANTHER); IPR021133 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)
F7AS57	proteasome activator complex subunit 2	239	20	7.54E-176	98.85%	1	C:GO:0008537	C:proteasome activator complex		IPR003185 (G3DSA:1.20.5.GENE3D); IPR003186 (PFAM); IPR003185 (PFAM); IPR003186 (G3DSA:1.20.120.GENE3D); IPR009077 (PANTHER); PTHR10660:SF6 (PANTHER); IPR009077 (SUPERFAMILY)
F7BSK7	dynactin subunit 2 isoform X2	403	20	0E0	97.55%	3	C:GO:0005869; P:GO:0007067; P:GO:0007017	C:dynactin complex; P:mitotic nuclear division; P:microtubule-based process		PF04912 (PFAM); IPR028133 (PTHR15346:PANTHER); PTHR15346 (PANTHER)
F6Z352	vitamin K-dependent S	649	20	0E0	94%	4	F:GO:0005515; F:GO:0005509; P:GO:0030195; C:GO:0005576	F:protein binding; F:calcium ion binding; P:negative regulation of blood coagulation; C:extracellular region		IPR000294 (PRINTS); IPR000742 (SMART); IPR000294 (SMART); IPR001791 (SMART); IPR001881 (SMART); IPR000742 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); IPR001791 (PFAM); IPR000294 (PFAM); IPR001791 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR017857 (G3DSA:4.10.740.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR001881 (PFAM); G3DSA:2.10.25.10 (GENE3D); PF14670 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); PTHR24040 (PANTHER); IPR033189 (PTHR24040:PANTHER); IPR018097 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000294 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR001791 (PROSITE_PROFILES); IPR000294 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR000294 (SUPERFAMILY)
F7DCZ5	60S ribosomal L29	161	20	5.3E-109	92.1%	4	F:GO:0003735; P:GO:0042254; C:GO:0005840; P:GO:0006412	F:structural constituent of ribosome; P:ribosome biogenesis; C:ribosome; P:translation		IPR002673 (PFAM); IPR002673 (PANTHER); IPR002673 (PRODOM)
F7DW15	40S ribosomal S8	191	20	1.41E-136	99.7%	4	F:GO:0003735; P:GO:0042254; C:GO:0005840; P:GO:0006412	F:structural constituent of ribosome; P:ribosome biogenesis; C:ribosome; P:translation		IPR001047 (TIGRFAM); IPR022309 (PFAM); IPR001047 (PANTHER)
F6T7J1	beta-hexosaminidase subunit alpha	529	20	0E0	93.15%	5	P:GO:0001575; P:GO:0005975; P:GO:0006040; F:GO:0004563; P:GO:0006027	P:globoside metabolic process; P:carbohydrate metabolic process; P:amino sugar metabolic process; F:beta-N-acetylhexosaminidase activity; P:glycosaminoglycan catabolic process	EC:3.2.1.52; EC:3.2.1	IPR025705 (PRINTS); IPR025705 (PIRSF); IPR013781 (G3DSA:3.20.20.GENE3D); IPR029018 (G3DSA:3.30.379.GENE3D); IPR015883 (PFAM); IPR029019 (PFAM); PTHR22600:SF20 (PANTHER); PTHR22600 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR017853 (SUPERFAMILY); IPR029018 (SUPERFAMILY)
A5YBL8	peptidyl-prolyl cis-trans isomerase B	216	20	2.35E-153	98.55%	3	F:GO:0003755; P:GO:0000413; P:GO:0006457	F:peptidyl-prolyl cis-trans isomerase activity; P:protein peptidyl-prolyl isomerization; P:protein folding	EC:5.2.1.8	IPR002130 (PRINTS); IPR002130 (PFAM); IPR029000 (G3DSA:2.40.100.GENE3D); PTHR11071:SF267 (PANTHER); IPR024936 (PANTHER); IPR020892 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR002130 (PROSITE_PROFILES); IPR029000 (SUPERFAMILY)
F7CH72	sortilin-related receptor	232	20	2.48E-168	98.55%	2	F:GO:0005515; C:GO:0016021	F:protein binding; C:integral component of membrane		IPR002172 (PRINTS); IPR002172 (SMART); IPR006581 (SMART); IPR000033 (SMART); IPR003961 (SMART); IPR031777 (PFAM); G3DSA:4.10.1220.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); IPR003961 (PFAM); G3DSA:2.130.10.140 (GENE3D); IPR000033 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR031778 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); IPR011042 (G3DSA:2.120.10.GENE3D); PTHR12106:SF20 (PANTHER); PTHR12106 (PANTHER); IPR023415 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR003961 (PROSITE_PROFILES); IPR000033 (PROSITE_PROFILES); IPR002172 (PROSITE_PROFILES); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF110296 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY)
F7CG82	sortilin-related receptor	232	20	2.48E-168	98.55%	2	F:GO:0005515; C:GO:0016021	F:protein binding; C:integral component of membrane		IPR002172 (PRINTS); IPR006581 (SMART); IPR002172 (SMART); IPR000033 (SMART); IPR003961 (SMART); IPR031777 (PFAM); G3DSA:4.10.1220.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:2.130.10.140 (GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR011042 (G3DSA:2.120.10.GENE3D); IPR002172 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); IPR003961 (PFAM); IPR000033 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR031778 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); PTHR12106:SF20 (PANTHER); PTHR12106 (PANTHER); IPR023415 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR003961 (PROSITE_PROFILES); IPR000033 (PROSITE_PROFILES); IPR002172 (PROSITE_PROFILES); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF110296 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY)
F6WB51	quinone oxidoreductase	328	20	0E0	93.3%	3	F:GO:0008270; F:GO:0016491; P:GO:0055114	F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process		IPR020843 (SMART); IPR013154 (PFAM); IPR013149 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); IPR002085 (PANTHER); PTHR11695:SF488 (PANTHER); IPR002364 (PROSITE_PATTERNS); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY)
F7ABC9	fibulin-1 isoform X1	684	20	0E0	97.1%	5	F:GO:0016504; F:GO:0005515; F:GO:0005509; P:GO:0030198; C:GO:0005576	F:peptidase activator activity; F:protein binding; F:calcium ion binding; P:extracellular matrix organization; C:extracellular region		IPR000020 (SMART); IPR000742 (SMART); IPR001881 (SMART); IPR017048 (PIRSF); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR001881 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR026823 (PFAM); PTHR24044:SF272 (PANTHER); PTHR24044 (PANTHER); IPR000020 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR000742 (PROSITE_PROFILES); IPR000020 (PROSITE_PROFILES); IPR009030 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR009030 (SUPERFAMILY)
F7A860	galectin-3	238	20	2.86E-171	86.15%	1	F:GO:0030246	F:carbohydrate binding		IPR001079 (SMART); IPR001079 (SMART); IPR013320 (G3DSA:2.60.120.GENE3D); IPR001079 (PFAM); PTHR11346 (PANTHER); IPR001079 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY)
F6V8I5	poly(rC)-binding 1	356	20	0E0	99.15%	1	F:GO:0003723	F:RNA binding		IPR004087 (SMART); IPR004088 (PFAM); IPR004088 (G3DSA:3.30.1370.GENE3D); IPR004088 (G3DSA:3.30.1370.GENE3D); PTHR10288:SF96 (PANTHER); PTHR10288 (PANTHER); IPR004088 (PROSITE_PROFILES); IPR004088 (SUPERFAMILY); IPR004088 (SUPERFAMILY); IPR004088 (SUPERFAMILY)
F6RKM7	60S ribosomal L22	128	20	1.44E-89	99.3%	4	F:GO:0003735; P:GO:0042254; C:GO:0005840; P:GO:0006412	F:structural constituent of ribosome; P:ribosome biogenesis; C:ribosome; P:translation		IPR002671 (PFAM); IPR002671 (PANTHER)
F6S0D9	catenin delta-1 isoform X1	932	20	0E0	99%	2	P:GO:0016337; F:GO:0045296	P:single organismal cell-cell adhesion; F:cadherin binding		IPR000225 (SMART); IPR000225 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR028439 (PTHR10372:PANTHER); IPR028435 (PANTHER); IPR000225 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)
F6Z230	S100-A12	94	20	4.41E-60	92.9%	1	F:GO:0005509	F:calcium ion binding		IPR002048 (SMART); IPR013787 (SMART); IPR013787 (PFAM); IPR002048 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR11639:SF77 (PANTHER); PTHR11639 (PANTHER); IPR001751 (PROSITE_PATTERNS); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F6U783	coatomer subunit beta	904	20	0E0	97.05%	5	C:GO:0030117; F:GO:0005515; P:GO:0016192; F:GO:0005198; P:GO:0006886	C:membrane coat; F:protein binding; P:vesicle-mediated transport; F:structural molecule activity; P:intracellular protein transport		IPR020472 (PRINTS); IPR016453 (PIRSF); IPR001680 (SMART); IPR001680 (PFAM); IPR006692 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR19876 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR011044 (SUPERFAMILY)
F6ZRU5	phospholipase D3	490	20	0E0	98.35%	1	F:GO:0003824	F:catalytic activity		IPR001736 (SMART); IPR032803 (PFAM); G3DSA:3.30.870.10 (GENE3D); IPR001736 (PFAM); PTHR10185:SF16 (PANTHER); PTHR10185 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR001736 (PROSITE_PROFILES); SSF56024 (SUPERFAMILY); SSF56024 (SUPERFAMILY)
F7BL38	mucin-1 isoform X5	174	20	1.5E-125	88.95%	2	C:GO:0016020; C:GO:0016021	C:membrane; C:integral component of membrane		PTHR10006 (PANTHER); IPR023217 (PTHR10006:PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000082 (PROSITE_PROFILES); IPR000082 (SUPERFAMILY)
F6YGW2	apoptosis regulator BAX	173	20	2.5E-96	86.4%	1	P:GO:0043065	P:positive regulation of apoptotic process		IPR026298 (PRINTS); SM00337 (SMART); G3DSA:1.10.437.10 (GENE3D); IPR026298 (PFAM); IPR026298 (PANTHER); IPR026304 (PTHR11256:PANTHER); IPR020717 (PROSITE_PATTERNS); IPR020728 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR002475 (PROSITE_PROFILES); SSF56854 (SUPERFAMILY)
A2Q127	elongation factor 1-gamma	437	20	0E0	99.25%	4	P:GO:0006448; F:GO:0005515; F:GO:0003746; C:GO:0005840	P:regulation of translational elongation; F:protein binding; F:translation elongation factor activity; C:ribosome		IPR001662 (SMART); IPR004045 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR001662 (PFAM); IPR001662 (G3DSA:3.30.70.GENE3D); IPR004046 (PFAM); IPR010987 (G3DSA:1.20.1050.GENE3D); PTHR11260:SF255 (PANTHER); PTHR11260 (PANTHER); IPR004045 (PROSITE_PROFILES); IPR010987 (PROSITE_PROFILES); IPR001662 (PROSITE_PROFILES); IPR001662 (SUPERFAMILY); IPR010987 (SUPERFAMILY); IPR012336 (SUPERFAMILY)
F7CSN0	ras-specific guanine nucleotide-releasing factor 1 isoform X2	1247	20	0E0	98.1%	4	P:GO:0035023; F:GO:0005515; P:GO:0043087; F:GO:0005089	P:regulation of Rho protein signal transduction; F:protein binding; P:regulation of GTPase activity; F:Rho guanyl-nucleotide exchange factor activity		IPR001895 (SMART); IPR000219 (SMART); IPR000651 (SMART); IPR001849 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); G3DSA:1.20.870.10 (GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR001895 (PFAM); IPR000219 (PFAM); IPR000651 (PFAM); IPR000219 (G3DSA:1.20.900.GENE3D); IPR001895 (G3DSA:1.10.840.GENE3D); IPR001849 (PFAM); IPR030745 (PTHR23113:PANTHER); PTHR23113 (PANTHER); IPR001331 (PROSITE_PATTERNS); IPR019804 (PROSITE_PATTERNS); IPR001895 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR000651 (PROSITE_PROFILES); IPR000219 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); IPR023578 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR000219 (SUPERFAMILY); IPR011993 (SUPERFAMILY)
F7D1U4	immmunoglobulin lambda light chain variable partial	42	20	4.21E-20	98.95%	1	F:GO:0005515	F:protein binding		IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23266 (PANTHER); IPR007110 (SUPERFAMILY)
F6XJF9	nucleo TPR	411	20	0E0	95.9%	1	P:GO:0006606	P:protein import into nucleus		IPR012929 (PFAM); IPR015866 (G3DSA:1.10.287.GENE3D); PTHR18898 (PANTHER)
F6Y257	nucleo TPR	425	20	0E0	99.35%	1	P:GO:0006606	P:protein import into nucleus		IPR012929 (PFAM); IPR015866 (G3DSA:1.10.287.GENE3D); PTHR18898 (PANTHER)
F6VAW6	collagen alpha-1(XI) chain isoform X4	1689	20	0E0	98.2%	2	F:GO:0005201; C:GO:0005578	F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix		IPR001791 (SMART); IPR001791 (SMART); IPR000885 (SMART); IPR001791 (PFAM); IPR008160 (PFAM); IPR000885 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); PTHR24023 (PANTHER); PTHR24023:SF42 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000885 (PRODOM); IPR000885 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY)
F6U661	collagen alpha-1(XI) chain isoform X2	1801	20	0E0	94.25%	2	F:GO:0005201; C:GO:0005578	F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix		IPR000885 (SMART); IPR001791 (SMART); IPR001791 (SMART); IPR001791 (PFAM); IPR000885 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); IPR008160 (PFAM); PTHR24023 (PANTHER); PTHR24023:SF42 (PANTHER); IPR000885 (PRODOM); IPR000885 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY)
F6VBF7	collagen alpha-1(XI) chain isoform X1	1805	20	0E0	98.5%	2	F:GO:0005201; C:GO:0005578	F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix		IPR001791 (SMART); IPR000885 (SMART); IPR001791 (SMART); IPR013320 (G3DSA:2.60.120.GENE3D); IPR001791 (PFAM); IPR008160 (PFAM); IPR000885 (PFAM); PTHR24023 (PANTHER); PTHR24023:SF42 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR000885 (PRODOM); IPR000885 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY)
F6RL09	glia maturation factor gamma isoform X1	142	20	1.36E-100	99.45%	5	F:GO:0003779; P:GO:2000249; C:GO:0005622; P:GO:0034316; F:GO:0071933	F:actin binding; P:regulation of actin cytoskeleton reorganization; C:intracellular; P:negative regulation of Arp2/3 complex-mediated actin nucleation; F:Arp2/3 complex binding		IPR011171 (PIRSF); IPR002108 (SMART); IPR029006 (G3DSA:3.40.20.GENE3D); IPR002108 (PFAM); IPR030076 (PTHR11249:PANTHER); IPR011171 (PANTHER); IPR002108 (PROSITE_PROFILES); SSF55753 (SUPERFAMILY)
F7BW76	glia maturation factor beta isoform X1	155	20	1.13E-99	95.1%	4	F:GO:0003779; C:GO:0005622; P:GO:0034316; F:GO:0071933	F:actin binding; C:intracellular; P:negative regulation of Arp2/3 complex-mediated actin nucleation; F:Arp2/3 complex binding		IPR002108 (SMART); IPR011171 (PIRSF); IPR029006 (G3DSA:3.40.20.GENE3D); IPR002108 (PFAM); PTHR11249:SF3 (PANTHER); IPR011171 (PANTHER); IPR002108 (PROSITE_PROFILES); SSF55753 (SUPERFAMILY)
F6YBT5	V-type proton ATPase catalytic subunit A	617	20	0E0	99.05%	5	F:GO:0005524; P:GO:0006119; P:GO:0015991; F:GO:0046961; C:GO:0033180	F:ATP binding; P:oxidative phosphorylation; P:ATP hydrolysis coupled proton transport; F:proton-transporting ATPase activity, rotational mechanism; C:proton-transporting V-type ATPase, V1 domain	EC:3.6.1; EC:3.6.1.3; EC:3.6.1.15	IPR024034 (G3DSA:1.10.1140.GENE3D); IPR004100 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000194 (PFAM); IPR031686 (PFAM); IPR005725 (TIGRFAM); PTHR15184:SF51 (PANTHER); PTHR15184 (PANTHER); IPR020003 (PROSITE_PATTERNS); PS51257 (PROSITE_PROFILES); IPR022878 (HAMAP); IPR027417 (SUPERFAMILY); SSF47917 (SUPERFAMILY); IPR004100 (SUPERFAMILY)
F6SP74	properdin	465	20	0E0	88.3%	1	C:GO:0031012	C:extracellular matrix		PR01705 (PRINTS); IPR000884 (SMART); G3DSA:2.20.100.10 (GENE3D); IPR000884 (PFAM); PTHR22906 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR000884 (PROSITE_PROFILES); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY)
F7AW38	ran-binding 6 isoform X1	1105	20	0E0	99.15%	1	F:GO:0005515	F:protein binding		PF13646 (PFAM); IPR000357 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR10527 (PANTHER); PTHR10527:SF16 (PANTHER); IPR016024 (SUPERFAMILY)
F7CDB4	aspartate cytoplasmic	413	20	0E0	96.95%	4	F:GO:0030170; F:GO:0008483; P:GO:0006520; P:GO:0009058	F:pyridoxal phosphate binding; F:transaminase activity; P:cellular amino acid metabolic process; P:biosynthetic process		IPR000796 (PRINTS); IPR015421 (G3DSA:3.40.640.GENE3D); IPR004839 (PFAM); IPR000796 (PANTHER); PTHR11879:SF3 (PANTHER); IPR004838 (PROSITE_PATTERNS); IPR015424 (SUPERFAMILY)
F6VCS1	carcinoembryonic antigen-related cell adhesion molecule 1-like isoform X1	522	20	0E0	89.65%	1	F:GO:0005515	F:protein binding		IPR003598 (SMART); IPR003599 (SMART); IPR007110 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PF13927 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR10489 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F6PLF6	2-phosphoxylose phosphatase 1 isoform X1	479	20	0E0	96.9%	3	P:GO:0019497; P:GO:0006771; F:GO:0003993	P:hexachlorocyclohexane metabolic process; P:riboflavin metabolic process; F:acid phosphatase activity	EC:3.1; EC:3.1.3.41; EC:3.1.3.2	IPR029033 (G3DSA:3.40.50.GENE3D); IPR000560 (PFAM); PTHR11567:SF125 (PANTHER); PTHR11567 (PANTHER); IPR033379 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR029033 (SUPERFAMILY)
F6V5D4	phosphatase and actin regulator 2 isoform X1	637	20	0E0	93.55%	3	F:GO:0004864; F:GO:0003779; P:GO:0043086	F:protein phosphatase inhibitor activity; F:actin binding; P:negative regulation of catalytic activity		IPR004018 (SMART); IPR004018 (PFAM); PTHR12751 (PANTHER); IPR029991 (PTHR12751:PANTHER); IPR004018 (PROSITE_PROFILES)
F6XH74	high mobility group B1	211	20	2.16E-143	98.85%	5	C:GO:0005634; F:GO:0003677; P:GO:0006954; P:GO:0007165; F:GO:0005125	C:nucleus; F:DNA binding; P:inflammatory response; P:signal transduction; F:cytokine activity		PR00886 (PRINTS); IPR009071 (SMART); IPR009071 (PFAM); IPR009071 (G3DSA:1.10.30.GENE3D); IPR009071 (G3DSA:1.10.30.GENE3D); IPR009071 (PFAM); PTHR13711 (PANTHER); IPR031076 (PTHR13711:PANTHER); IPR017967 (PROSITE_PATTERNS); IPR009071 (PROSITE_PROFILES); IPR009071 (SUPERFAMILY); IPR009071 (SUPERFAMILY)
Q08IE6	high mobility group B1	215	20	1.03E-148	99.8%	2	C:GO:0005634; F:GO:0003677	C:nucleus; F:DNA binding		PR00886 (PRINTS); IPR009071 (SMART); IPR009071 (G3DSA:1.10.30.GENE3D); IPR009071 (PFAM); IPR009071 (G3DSA:1.10.30.GENE3D); IPR009071 (PFAM); IPR017967 (PROSITE_PATTERNS); IPR009071 (PROSITE_PROFILES); IPR009071 (SUPERFAMILY); IPR009071 (SUPERFAMILY)
F6TZ46	small nuclear ribonucleo Sm D3	126	20	1.14E-87	99.6%	1	P:GO:0006396	P:RNA processing		IPR001163 (SMART); IPR001163 (PFAM); G3DSA:2.30.30.100 (GENE3D); IPR027141 (PANTHER); IPR010920 (SUPERFAMILY)
F6ZYA8	testis-expressed sequence 264	313	20	0E0	95.05%	1	C:GO:0070062	C:extracellular exosome		IPR011256 (G3DSA:3.20.80.GENE3D); PTHR15949:SF3 (PANTHER); PTHR15949 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR011256 (SUPERFAMILY)
F6X9D3	nucleophosmin isoform X1	294	20	0E0	99.3%	1	F:GO:0003676	F:nucleic acid binding		IPR024057 (PFAM); IPR024057 (G3DSA:2.60.120.GENE3D); IPR032569 (PFAM); IPR004301 (PANTHER); IPR024057 (SUPERFAMILY)
F6TGG7	PIP5K1A and PSMD4	863	20	0E0	95.8%	2	F:GO:0016307; P:GO:0046488	F:phosphatidylinositol phosphate kinase activity; P:phosphatidylinositol metabolic process	EC:2.7.1	IPR002035 (SMART); IPR002498 (SMART); IPR003903 (SMART); IPR027483 (G3DSA:3.30.810.GENE3D); IPR002498 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); IPR027484 (G3DSA:3.30.800.GENE3D); IPR003903 (PFAM); IPR002035 (PFAM); PTHR23086:SF54 (PANTHER); IPR023610 (PANTHER); IPR002498 (PROSITE_PROFILES); IPR002035 (PROSITE_PROFILES); IPR003903 (PROSITE_PROFILES); SSF56104 (SUPERFAMILY); IPR002035 (SUPERFAMILY)
F7D8L3	scavenger receptor class F member 2	805	20	0E0	91.4%	2	F:GO:0005515; P:GO:0007157	F:protein binding; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules		PR00011 (PRINTS); IPR002049 (SMART); IPR000742 (SMART); G3DSA:2.170.300.10 (GENE3D); IPR033327 (PTHR24043:PANTHER); PTHR24043 (PANTHER); IPR013032 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000742 (PROSITE_PROFILES); IPR009030 (SUPERFAMILY)
F7BDY5	tetraspanin-10	279	20	0E0	87.8%	1	C:GO:0016021	C:integral component of membrane		IPR000301 (PRINTS); IPR000301 (PIRSF); IPR018499 (PFAM); PTHR19282 (PANTHER); PTHR19282:SF190 (PANTHER); IPR018503 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR008952 (SUPERFAMILY)
F6VSS2	sodium hydrogen exchanger 2	814	20	0E0	95.85%	6	P:GO:0006814; P:GO:0055085; P:GO:0015992; F:GO:0015385; C:GO:0016021; P:GO:0006885	P:sodium ion transport; P:transmembrane transport; P:proton transport; F:sodium:proton antiporter activity; C:integral component of membrane; P:regulation of pH		IPR001953 (PRINTS); IPR004709 (PRINTS); IPR032103 (PFAM); IPR004709 (TIGRFAM); IPR006153 (PFAM); PTHR10110:SF89 (PANTHER); IPR018422 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS)
F6Y214	zinc transporter ZIP2	308	20	0E0	92.25%	4	P:GO:0055085; C:GO:0016020; F:GO:0046873; P:GO:0030001	P:transmembrane transport; C:membrane; F:metal ion transmembrane transporter activity; P:metal ion transport		IPR003689 (PFAM); PTHR11040 (PANTHER); PTHR11040:SF51 (PANTHER); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS)
F7A7A2	DNA dC-	208	20	3.4E-151	81.1%	3	F:GO:0008270; F:GO:0016814; P:GO:0006807	F:zinc ion binding; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines; P:nitrogen compound metabolic process		G3DSA:3.40.140.10 (GENE3D); IPR013158 (PFAM); PTHR13857 (PANTHER); PTHR13857:SF20 (PANTHER); IPR016192 (PROSITE_PATTERNS); IPR002125 (PROSITE_PROFILES); IPR016193 (SUPERFAMILY)
F7BZZ0	heterogeneous nuclear ribonucleo H3 isoform X1	346	20	0E0	99.6%	2	F:GO:0000166; F:GO:0003676	F:nucleotide binding; F:nucleic acid binding		IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR13976 (PANTHER); PTHR13976:SF36 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY)
F7CPZ3	calsyntenin-1 isoform X2	941	20	0E0	96.25%	3	F:GO:0005509; C:GO:0016020; P:GO:0007156	F:calcium ion binding; C:membrane; P:homophilic cell adhesion via plasma membrane adhesion molecules		IPR002126 (PRINTS); IPR002126 (SMART); IPR013320 (G3DSA:2.60.120.GENE3D); IPR002126 (G3DSA:2.60.40.GENE3D); PF13385 (PFAM); IPR002126 (PFAM); PTHR14139:SF4 (PANTHER); IPR026914 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR002126 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY)
F6QLC6	ras-related Rab-5C	216	20	1.86E-160	99.55%	2	F:GO:0005525; P:GO:0007264	F:GTP binding; P:small GTPase mediated signal transduction		PR00449 (PRINTS); SM00176 (SMART); SM00173 (SMART); SM00174 (SMART); SM00175 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001806 (PFAM); IPR005225 (TIGRFAM); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F6Z904	ras-related Rab-5A	215	20	7.99E-161	99.45%	2	F:GO:0005525; P:GO:0007264	F:GTP binding; P:small GTPase mediated signal transduction		PR00449 (PRINTS); SM00174 (SMART); SM00173 (SMART); SM00176 (SMART); SM00175 (SMART); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); PTHR24073:SF557 (PANTHER); PTHR24073 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F6WA92	ras-related Rab-5B	215	20	1.13E-160	99.1%	2	F:GO:0005525; P:GO:0007264	F:GTP binding; P:small GTPase mediated signal transduction		PR00449 (PRINTS); SM00173 (SMART); SM00174 (SMART); SM00176 (SMART); SM00175 (SMART); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); PTHR24073:SF555 (PANTHER); PTHR24073 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F6U7Q8	plexin-B3 isoform X1	1881	20	0E0	94.95%	4	F:GO:0005515; C:GO:0016020; F:GO:0017154; P:GO:0071526	F:protein binding; C:membrane; F:semaphorin receptor activity; P:semaphorin-plexin signaling pathway		IPR001627 (SMART); IPR002909 (SMART); IPR016201 (SMART); IPR002909 (PFAM); IPR002165 (PFAM); G3DSA:3.10.20.90 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001627 (PFAM); IPR013548 (PFAM); G3DSA:3.30.1680.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); G3DSA:3.30.1680.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR22625:SF33 (PANTHER); IPR031148 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR001627 (PROSITE_PROFILES); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR008936 (SUPERFAMILY); IPR001627 (SUPERFAMILY); IPR014756 (SUPERFAMILY); SSF103575 (SUPERFAMILY)
F6VNB1	myosin light chain 4	197	20	4.23E-142	96.35%	1	F:GO:0005509	F:calcium ion binding		IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR23048 (PANTHER); PTHR23048:SF1 (PANTHER); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY)
F6V7L0	eukaryotic translation initiation factor 5A-2	153	20	3.75E-110	99.85%	6	P:GO:0045905; F:GO:0003746; F:GO:0043022; P:GO:0006452; C:GO:0005840; P:GO:0045901	P:positive regulation of translational termination; F:translation elongation factor activity; F:ribosome binding; P:translational frameshifting; C:ribosome; P:positive regulation of translational elongation		IPR020189 (SMART); IPR001884 (PIRSF); IPR020189 (PFAM); IPR014722 (G3DSA:2.30.30.GENE3D); G3DSA:2.40.50.140 (GENE3D); IPR001884 (TIGRFAM); PTHR11673:SF13 (PANTHER); IPR001884 (PANTHER); IPR019769 (PROSITE_PATTERNS); IPR008991 (SUPERFAMILY); IPR012340 (SUPERFAMILY)
F7AAM8	---NA---	15				3	F:GO:0003677; C:GO:0090544; P:GO:0006338	F:DNA binding; C:BAF-type complex; P:chromatin remodeling		IPR001606 (SMART); SM01014 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR001606 (PFAM); IPR033388 (PFAM); IPR001606 (G3DSA:1.10.150.GENE3D); IPR030094 (PTHR12656:PANTHER); IPR021906 (PANTHER); IPR001606 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR001606 (SUPERFAMILY)
F7A5J4	AT-rich interactive domain-containing 1A isoform X2	1683	20	0E0	96.7%	3	F:GO:0003677; C:GO:0090544; P:GO:0006338	F:DNA binding; C:BAF-type complex; P:chromatin remodeling		IPR001606 (SMART); SM01014 (SMART); IPR001606 (PFAM); IPR001606 (G3DSA:1.10.150.GENE3D); IPR011989 (G3DSA:1.25.10.GENE3D); IPR033388 (PFAM); IPR021906 (PANTHER); IPR030094 (PTHR12656:PANTHER); IPR001606 (PROSITE_PROFILES); IPR001606 (SUPERFAMILY); IPR016024 (SUPERFAMILY)
F6TQR2	calreticulin	412	20	0E0	97.9%	4	F:GO:0005509; C:GO:0005783; F:GO:0051082; P:GO:0006457	F:calcium ion binding; C:endoplasmic reticulum; F:unfolded protein binding; P:protein folding		IPR001580 (PRINTS); IPR009169 (PIRSF); IPR013320 (G3DSA:2.60.120.GENE3D); IPR001580 (PFAM); IPR009033 (G3DSA:2.10.250.GENE3D); PTHR11073:SF16 (PANTHER); IPR001580 (PANTHER); IPR018124 (PROSITE_PATTERNS); IPR018124 (PROSITE_PATTERNS); IPR018124 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR009033 (SUPERFAMILY); IPR013320 (SUPERFAMILY)
F6SC92	helix-loop-helix 1	133	20	2.55E-91	96.6%	1	F:GO:0046983	F:protein dimerization activity		IPR011598 (SMART); IPR011598 (PFAM); IPR011598 (G3DSA:4.10.280.GENE3D); PTHR13864 (PANTHER); PTHR13864:SF20 (PANTHER); IPR011598 (PROSITE_PROFILES); IPR011598 (SUPERFAMILY)
F6VKF1	eukaryotic translation initiation factor 2-alpha kinase 4 isoform X1	1651	20	0E0	96.5%	4	F:GO:0005524; F:GO:0005515; F:GO:0004672; P:GO:0006468	F:ATP binding; F:protein binding; F:protein kinase activity; P:protein phosphorylation		IPR006575 (SMART); IPR000719 (SMART); IPR016135 (G3DSA:3.10.110.GENE3D); IPR006575 (PFAM); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PF13393 (PFAM); IPR004154 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.930.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR024435 (PFAM); PTHR11042 (PANTHER); PTHR11042:SF90 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR006575 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR011009 (SUPERFAMILY); SSF55681 (SUPERFAMILY); IPR016135 (SUPERFAMILY)
F6YTL9	plexin-D1	1529	20	0E0	96.45%	4	F:GO:0005515; C:GO:0016020; F:GO:0017154; P:GO:0071526	F:protein binding; C:membrane; F:semaphorin receptor activity; P:semaphorin-plexin signaling pathway		IPR016201 (SMART); IPR002909 (SMART); IPR013548 (PFAM); IPR001627 (PFAM); G3DSA:3.30.1680.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:3.30.1680.10 (GENE3D); IPR002165 (PFAM); IPR002909 (PFAM); G3DSA:3.10.20.90 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR031148 (PANTHER); PTHR22625:SF7 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR001627 (PROSITE_PROFILES); SSF103575 (SUPERFAMILY); IPR001627 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR008936 (SUPERFAMILY); IPR014756 (SUPERFAMILY)
F6YAV2	serpin B11 isoform X1	392	20	0E0	94.3%	3	C:GO:0005615; F:GO:0004867; P:GO:0010951	C:extracellular space; F:serine-type endopeptidase inhibitor activity; P:negative regulation of endopeptidase activity		IPR023796 (SMART); G3DSA:2.30.39.10 (GENE3D); G3DSA:3.30.497.10 (GENE3D); IPR023796 (PFAM); IPR023795 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR023796 (SUPERFAMILY)
F7D8G9	serine protease 27	295	20	0E0	94.5%	2	P:GO:0006508; F:GO:0004252	P:proteolysis; F:serine-type endopeptidase activity	EC:3.4.21	IPR001314 (PRINTS); IPR001254 (SMART); IPR001254 (PFAM); G3DSA:2.40.10.10 (GENE3D); G3DSA:2.40.10.10 (GENE3D); PTHR24253:SF6 (PANTHER); PTHR24253 (PANTHER); IPR018114 (PROSITE_PATTERNS); IPR033116 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR001254 (PROSITE_PROFILES); IPR009003 (SUPERFAMILY)
F6XGG1	immunoglobulin lambda light chain variable partial	116	20	9.49E-78	89.75%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF174 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F6V3P6	ATP-dependent RNA helicase DDX19A	478	20	0E0	99.05%	2	F:GO:0003676; F:GO:0005524	F:nucleic acid binding; F:ATP binding		IPR014001 (SMART); IPR001650 (SMART); IPR001650 (PFAM); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24031 (PANTHER); PTHR24031:SF323 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F7CR22	coatomer subunit delta	511	20	0E0	99.4%	2	P:GO:0006890; C:GO:0030126	P:retrograde vesicle-mediated transport, Golgi to ER; C:COPI vesicle coat		G3DSA:3.30.450.60 (GENE3D); IPR022775 (PFAM); IPR028565 (PFAM); IPR027059 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR028565 (PROSITE_PROFILES); IPR011012 (SUPERFAMILY); IPR028565 (SUPERFAMILY)
F7BWE6	DNA repair complementing XP-G cells isoform X3	1628	20	0E0	88.65%	4	C:GO:0005634; F:GO:0004519; P:GO:0006289; F:GO:0003697	C:nucleus; F:endonuclease activity; P:nucleotide-excision repair; F:single-stranded DNA binding	EC:3.1	IPR006084 (PRINTS); IPR001044 (PRINTS); IPR006085 (SMART); IPR008918 (SMART); IPR006086 (SMART); IPR001044 (TIGRFAM); IPR006085 (PFAM); IPR006086 (PFAM); G3DSA:1.10.150.20 (GENE3D); IPR029060 (G3DSA:3.40.50.GENE3D); PTHR16171:SF5 (PANTHER); PTHR16171 (PANTHER); IPR019974 (PROSITE_PATTERNS); IPR019974 (PROSITE_PATTERNS); IPR020045 (SUPERFAMILY); IPR029060 (SUPERFAMILY)
F6PVN3	OX-2 membrane glyco	274	20	0E0	93.9%	3	F:GO:0005515; P:GO:0043031; P:GO:0050776	F:protein binding; P:negative regulation of macrophage activation; P:regulation of immune response		IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013151 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23277 (PANTHER); IPR033321 (PTHR23277:PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F6X6A6	peptidyl-prolyl cis-trans isomerase A	104	20	3.5E-71	99.95%	3	F:GO:0003755; P:GO:0000413; P:GO:0006457	F:peptidyl-prolyl cis-trans isomerase activity; P:protein peptidyl-prolyl isomerization; P:protein folding	EC:5.2.1.8	IPR002130 (PRINTS); IPR002130 (PFAM); IPR029000 (G3DSA:2.40.100.GENE3D); PTHR11071:SF261 (PANTHER); IPR024936 (PANTHER); IPR002130 (PROSITE_PROFILES); IPR029000 (SUPERFAMILY)
F6PZR3	dnaJ homolog subfamily B member 5 isoform X1	382	20	0E0	99.2%	2	F:GO:0051082; P:GO:0006457	F:unfolded protein binding; P:protein folding		IPR001623 (PRINTS); IPR001623 (SMART); IPR001623 (PFAM); IPR001623 (G3DSA:1.10.287.GENE3D); G3DSA:2.60.260.20 (GENE3D); G3DSA:2.60.260.20 (GENE3D); IPR002939 (PFAM); PTHR24078:SF173 (PANTHER); PTHR24078 (PANTHER); IPR018253 (PROSITE_PATTERNS); IPR001623 (PROSITE_PROFILES); IPR008971 (SUPERFAMILY); IPR001623 (SUPERFAMILY); IPR008971 (SUPERFAMILY)
F7AU23	bifunctional UDP-N-acetylglucosamine 2-epimerase N-acetylmannosamine kinase isoform X2	722	20	0E0	99.1%	3	P:GO:0005975; P:GO:0006047; F:GO:0004553	P:carbohydrate metabolic process; P:UDP-N-acetylglucosamine metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds		PR00475 (PRINTS); G3DSA:3.30.420.40 (GENE3D); IPR020004 (TIGRFAM); IPR003331 (PFAM); G3DSA:3.30.420.40 (GENE3D); IPR000600 (PFAM); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); PTHR18964 (PANTHER); PTHR18964:SF10 (PANTHER); SSF53756 (SUPERFAMILY); SSF53067 (SUPERFAMILY)
F7B5P1	cytosolic non-specific dipeptidase	475	20	0E0	97%	3	F:GO:0016805; P:GO:0006508; F:GO:0008237	F:dipeptidase activity; P:proteolysis; F:metallopeptidase activity	EC:3.4.13	IPR017153 (PIRSF); IPR002933 (PFAM); G3DSA:3.40.630.10 (GENE3D); IPR011650 (PFAM); IPR011650 (G3DSA:3.30.70.GENE3D); PTHR11014:SF15 (PANTHER); PTHR11014 (PANTHER); IPR001261 (PROSITE_PATTERNS); SSF53187 (SUPERFAMILY)
F6XC16	synaptic vesicle membrane VAT-1 homolog	400	20	0E0	94.35%	3	F:GO:0008270; F:GO:0016491; P:GO:0055114	F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process		IPR020843 (SMART); IPR011032 (G3DSA:3.90.180.GENE3D); IPR013154 (PFAM); PF13602 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR11695:SF503 (PANTHER); IPR002085 (PANTHER); IPR002364 (PROSITE_PATTERNS); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY)
F6PX23	olfactory receptor 10J1	308	20	0E0	94.3%	5	F:GO:0004930; P:GO:0007187; P:GO:0007608; C:GO:0016021; F:GO:0004984	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:sensory perception of smell; C:integral component of membrane; F:olfactory receptor activity		IPR000725 (PRINTS); IPR000276 (PRINTS); PF13853 (PFAM); G3DSA:1.20.1070.10 (GENE3D); PTHR26451 (PANTHER); PTHR26451:SF417 (PANTHER); IPR000276 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR017452 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY)
F7BCE3	cell division cycle-associated 7 isoform X1	448	20	0E0	95.9%	2	P:GO:0008284; P:GO:0006355	P:positive regulation of cell proliferation; P:regulation of transcription, DNA-templated		IPR018866 (PFAM); IPR033578 (PTHR31169:PANTHER); PTHR31169 (PANTHER)
F7C2M4	leucine-rich repeat and death domain-containing 1	862	20	0E0	91.1%	1	F:GO:0005515	F:protein binding		PR00019 (PRINTS); IPR003591 (SMART); SM00365 (SMART); SM00364 (SMART); IPR001611 (PFAM); IPR011029 (G3DSA:1.10.533.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR23155 (PANTHER); PTHR23155:SF581 (PANTHER); IPR001611 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY); IPR032675 (SUPERFAMILY)
F6YNL9	integrin beta-2	770	20	0E0	90.8%	4	P:GO:0007160; P:GO:0007229; F:GO:0004872; C:GO:0008305	P:cell-matrix adhesion; P:integrin-mediated signaling pathway; F:receptor activity; C:integrin complex		IPR015812 (PRINTS); IPR012896 (SMART); IPR002369 (SMART); IPR014836 (SMART); IPR015812 (PIRSF); IPR016201 (SMART); IPR012896 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); IPR033760 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR002369 (PFAM); IPR014836 (PFAM); G3DSA:1.20.5.100 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR015439 (PTHR10082:PANTHER); IPR015812 (PANTHER); IPR015812 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR032695 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR012896 (SUPERFAMILY); IPR002035 (SUPERFAMILY); SSF103575 (SUPERFAMILY); SSF57196 (SUPERFAMILY)
F6PI70	immmunoglobulin lambda light chain variable partial	99	20	9.85E-64	90.55%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF161 (PANTHER); PTHR23267 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F6Z4A7	immunoglobulin lambda light chain V-J partial	106	20	2.64E-58	84.15%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF161 (PANTHER); PTHR23267 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F6WJI6	immunoglobulin lambda light chain V-J partial	118	20	3.25E-72	92.3%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013106 (PFAM); PTHR23267:SF161 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY)
F7DBG6	Ig kappa light chain variable partial	119	20	1.44E-53	80.4%	1	F:GO:0005515	F:protein binding		IPR013106 (SMART); IPR013106 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23267:SF148 (PANTHER); PTHR23267 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR007110 (SUPERFAMILY)
F6X256	platelet glyco V	553	20	0E0	85.25%	1	F:GO:0005515	F:protein binding		IPR003591 (SMART); IPR000483 (SMART); IPR001611 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR24373:SF144 (PANTHER); PTHR24373 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR001611 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY); IPR032675 (SUPERFAMILY)
F7DW74	39S ribosomal mitochondrial	93	20	1.08E-59	79.4%	4	F:GO:0003735; P:GO:0042254; C:GO:0005840; P:GO:0006412	F:structural constituent of ribosome; P:ribosome biogenesis; C:ribosome; P:translation		IPR000473 (TIGRFAM); IPR000473 (PFAM); IPR000473 (PANTHER); PTHR18804:SF13 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); PD002101 (PRODOM); IPR000473 (HAMAP); IPR000473 (SUPERFAMILY)
F6T1Y0	collagen alpha-1(XXVII) chain	1632	20	0E0	89.65%	6	C:GO:0005581; C:GO:0005583; P:GO:0030198; F:GO:0005201; P:GO:0003431; C:GO:0005578	C:collagen trimer; C:fibrillar collagen trimer; P:extracellular matrix organization; F:extracellular matrix structural constituent; P:growth plate cartilage chondrocyte development; C:proteinaceous extracellular matrix		IPR001791 (SMART); IPR008160 (PFAM); PTHR24023:SF546 (PANTHER); PTHR24023 (PANTHER); IPR013320 (SUPERFAMILY)
F6ULE3	mannosyl-oligosaccharide glucosidase	733	20	0E0	96.2%	2	F:GO:0004573; P:GO:0009311	F:mannosyl-oligosaccharide glucosidase activity; P:oligosaccharide metabolic process	EC:3.2.1.106; EC:3.2.1	IPR031631 (PFAM); IPR031335 (PFAM); PTHR10412:SF11 (PANTHER); IPR004888 (PANTHER); IPR008928 (SUPERFAMILY)
F7AGM1	ATP-dependent RNA helicase DDX54	832	20	0E0	92.35%	4	C:GO:0005634; F:GO:0005524; F:GO:0003723; F:GO:0004004	C:nucleus; F:ATP binding; F:RNA binding; F:ATP-dependent RNA helicase activity	EC:3.6.1; EC:3.6.1.3; EC:2.7.7; EC:3.6.1.15	IPR014001 (SMART); IPR012541 (SMART); IPR001650 (SMART); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR012541 (PFAM); IPR033517 (PTHR24031:PANTHER); PTHR24031 (PANTHER); IPR000629 (PROSITE_PATTERNS); IPR012541 (PRODOM); IPR014014 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
F6ZTQ7	kazal-type serine protease inhibitor domain-containing 1	302	20	0E0	96.55%	3	C:GO:0016942; P:GO:0001558; F:GO:0005520	C:insulin-like growth factor binding protein complex; P:regulation of cell growth; F:insulin-like growth factor binding		IPR011390 (PIRSF); IPR002350 (SMART); IPR003599 (SMART); IPR003598 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002350 (PFAM); IPR013098 (PFAM); IPR000867 (PFAM); G3DSA:3.30.60.30 (GENE3D); IPR011390 (PANTHER); PTHR14186:SF21 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR002350 (PROSITE_PROFILES); IPR000867 (PROSITE_PROFILES); IPR009030 (SUPERFAMILY); SSF100895 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F6ZAZ2	L-xylulose reductase	244	20	1.22E-163	91.85%	1	F:GO:0016491	F:oxidoreductase activity		IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); PTHR24322:SF396 (PANTHER); IPR002347 (PANTHER); IPR020904 (PROSITE_PATTERNS); IPR016040 (SUPERFAMILY)
F6VC27	proto-oncogene vav	828	20	0E0	96%	4	P:GO:0035023; F:GO:0005515; P:GO:0043087; F:GO:0005089	P:regulation of Rho protein signal transduction; F:protein binding; P:regulation of GTPase activity; F:Rho guanyl-nucleotide exchange factor activity		IPR000980 (PRINTS); IPR001452 (PRINTS); IPR000219 (SMART); IPR001849 (SMART); IPR001452 (SMART); IPR002219 (SMART); IPR000980 (SMART); IPR000980 (G3DSA:3.30.505.GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); G3DSA:2.30.30.40 (GENE3D); G3DSA:2.30.30.40 (GENE3D); IPR022613 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR001452 (PFAM); IPR011511 (PFAM); IPR000219 (G3DSA:1.20.900.GENE3D); G3DSA:3.30.60.20 (GENE3D); IPR002219 (PFAM); IPR000980 (PFAM); IPR000219 (PFAM); IPR001849 (PFAM); PTHR22826 (PANTHER); IPR028530 (PTHR22826:PANTHER); IPR002219 (PROSITE_PATTERNS); IPR001331 (PROSITE_PATTERNS); IPR000980 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR000219 (PROSITE_PROFILES); IPR002219 (PROSITE_PROFILES); IPR001715 (PROSITE_PROFILES); IPR001715 (SUPERFAMILY); IPR001452 (SUPERFAMILY); IPR000980 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR000219 (SUPERFAMILY)
F7DYA1	ala Mutant Of Liver Alcohol Dehydrogenase Complexed With Cofactor Nad And Inhibitor Trifluoroethanol Solved To Angstrom Resolution	327	20	0E0	96%	3	F:GO:0008270; F:GO:0016491; P:GO:0055114	F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process		IPR016040 (G3DSA:3.40.50.GENE3D); IPR013154 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR013149 (PFAM); IPR002085 (PANTHER); PTHR11695:SF517 (PANTHER); IPR002328 (PROSITE_PATTERNS); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY)
P00328	ala Mutant Of Liver Alcohol Dehydrogenase Complexed With Cofactor Nad And Inhibitor Trifluoroethanol Solved To Angstrom Resolution	374	20	0E0	97.9%	3	F:GO:0008270; F:GO:0016491; P:GO:0055114	F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process		IPR020843 (SMART); IPR013149 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013154 (PFAM); PTHR11695:SF517 (PANTHER); IPR002085 (PANTHER); IPR002328 (PROSITE_PATTERNS); IPR011032 (SUPERFAMILY); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY)
F6QGN5	FAM135A isoform X1	1523	20	0E0	93.9%	2	P:GO:0044255; F:GO:0052689	P:cellular lipid metabolic process; F:carboxylic ester hydrolase activity		IPR029058 (G3DSA:3.40.50.GENE3D); IPR022122 (PFAM); IPR007751 (PFAM); PTHR12482:SF12 (PANTHER); PTHR12482 (PANTHER); IPR029058 (SUPERFAMILY)
F7AGK7	collagen alpha-1(V) chain isoform X1	1775	20	0E0	94.85%	2	F:GO:0005201; C:GO:0005578	F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix		IPR001791 (SMART); IPR001791 (SMART); IPR000885 (SMART); IPR000885 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); IPR008160 (PFAM); PTHR24023:SF387 (PANTHER); PTHR24023 (PANTHER); IPR000885 (PRODOM); IPR000885 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY)
F7BG55	ephrin type-B receptor 4	977	20	0E0	98.25%	6	C:GO:0005887; F:GO:0005524; F:GO:0005515; P:GO:0048013; P:GO:0006468; F:GO:0005003	C:integral component of plasma membrane; F:ATP binding; F:protein binding; P:ephrin receptor signaling pathway; P:protein phosphorylation; F:ephrin receptor activity	EC:2.7.10; EC:2.7.10.1; EC:2.7.11	IPR001245 (PRINTS); PR00014 (PRINTS); IPR001660 (SMART); IPR020635 (SMART); IPR003961 (SMART); IPR011641 (SMART); IPR016257 (PIRSF); IPR001090 (SMART); IPR001245 (PFAM); IPR027936 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001090 (PFAM); IPR003961 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR011641 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001660 (PFAM); IPR013761 (G3DSA:1.10.150.GENE3D); IPR008979 (G3DSA:2.60.120.GENE3D); PTHR24416 (PANTHER); PTHR24416:SF296 (PANTHER); IPR001426 (PROSITE_PATTERNS); IPR008266 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); IPR001426 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000719 (PROSITE_PROFILES); IPR001660 (PROSITE_PROFILES); IPR001090 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR003961 (SUPERFAMILY); IPR008979 (SUPERFAMILY); IPR013761 (SUPERFAMILY)
F6VZ73	hyaluronan-binding 2	523	20	0E0	87.55%	4	F:GO:0005515; F:GO:0005509; P:GO:0006508; F:GO:0004252	F:protein binding; F:calcium ion binding; P:proteolysis; F:serine-type endopeptidase activity	EC:3.4.21	IPR001314 (PRINTS); PR00018 (PRINTS); IPR000001 (SMART); IPR001881 (SMART); IPR000742 (SMART); IPR001254 (SMART); IPR000742 (PFAM); G3DSA:2.40.10.10 (GENE3D); G3DSA:2.40.20.10 (GENE3D); G3DSA:2.40.10.10 (GENE3D); G3DSA:2.40.10.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR000001 (PFAM); IPR001254 (PFAM); PTHR24256 (PANTHER); PTHR24256:SF265 (PANTHER); IPR033116 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR018114 (PROSITE_PATTERNS); IPR000001 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR001254 (PROSITE_PROFILES); SSF57196 (SUPERFAMILY); IPR013806 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR009003 (SUPERFAMILY)
F6ZQE2	T-complex 1 subunit theta	550	20	0E0	98.4%	3	F:GO:0005524; F:GO:0051082; P:GO:0006457	F:ATP binding; F:unfolded protein binding; P:protein folding		IPR017998 (PRINTS); IPR027410 (G3DSA:3.30.260.GENE3D); IPR012721 (TIGRFAM); IPR027413 (G3DSA:1.10.560.GENE3D); IPR002423 (PFAM); IPR027409 (G3DSA:3.50.7.GENE3D); PTHR11353:SF78 (PANTHER); PTHR11353 (PANTHER); IPR002194 (PROSITE_PATTERNS); IPR002194 (PROSITE_PATTERNS); IPR002194 (PROSITE_PATTERNS); SSF48592 (SUPERFAMILY); SSF54849 (SUPERFAMILY); IPR027409 (SUPERFAMILY)
F7C3H1	low-density lipo receptor-related 4	17	20	8.42E-3	100%	5	F:GO:0005515; F:GO:0005509; P:GO:0030509; P:GO:0060828; P:GO:0048513	F:protein binding; F:calcium ion binding; P:BMP signaling pathway; P:regulation of canonical Wnt signaling pathway; P:animal organ development		IPR002172 (PRINTS); IPR000742 (SMART); IPR002172 (SMART); IPR001881 (SMART); IPR000033 (SMART); IPR002172 (PFAM); PF14670 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR026823 (PFAM); IPR011042 (G3DSA:2.120.10.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR000033 (PFAM); G3DSA:4.10.1220.10 (GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR030799 (PTHR10529:PANTHER); PTHR10529 (PANTHER); IPR000152 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR023415 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR002172 (PROSITE_PROFILES); IPR000033 (PROSITE_PROFILES); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); SSF63825 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR002172 (SUPERFAMILY)
F7DS15	sulfotransferase family cytosolic 2B member 1	273	20	0E0	92.45%	1	F:GO:0008146	F:sulfotransferase activity		IPR000863 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11783:SF9 (PANTHER); PTHR11783 (PANTHER); IPR027417 (SUPERFAMILY)
F6Q5M6	serine threonine- kinase NLK	527	20	0E0	99.25%	5	F:GO:0005524; F:GO:0004707; P:GO:0007178; P:GO:0009069; P:GO:0006468	F:ATP binding; F:MAP kinase activity; P:transmembrane receptor protein serine/threonine kinase signaling pathway; P:serine family amino acid metabolic process; P:protein phosphorylation	EC:2.7.11; EC:2.7.11.24	IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); PTHR24055:SF179 (PANTHER); PTHR24055 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)
F6YEX6	vascular endothelial growth factor receptor 1 isoform X1	1096	20	0E0	95.65%	6	C:GO:0005887; F:GO:0005524; P:GO:0048010; F:GO:0005515; F:GO:0005021; P:GO:0006468	C:integral component of plasma membrane; F:ATP binding; P:vascular endothelial growth factor receptor signaling pathway; F:protein binding; F:vascular endothelial growth factor-activated receptor activity; P:protein phosphorylation	EC:2.7.10; EC:2.7.10.1; EC:2.7.11	IPR009135 (PRINTS); PR01832 (PRINTS); IPR003599 (SMART); IPR003598 (SMART); IPR020635 (SMART); IPR001245 (PFAM); PF13927 (PFAM); IPR013151 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24416 (PANTHER); PTHR24416:SF259 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR008266 (PROSITE_PATTERNS); IPR001824 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F7CET7	vascular endothelial growth factor receptor 2	1343	20	0E0	95.2%	6	F:GO:0005524; F:GO:0019838; P:GO:0048010; C:GO:0016021; F:GO:0005021; P:GO:0006468	F:ATP binding; F:growth factor binding; P:vascular endothelial growth factor receptor signaling pathway; C:integral component of membrane; F:vascular endothelial growth factor-activated receptor activity; P:protein phosphorylation	EC:2.7.10; EC:2.7.10.1; EC:2.7.11	IPR009136 (PRINTS); PR01832 (PRINTS); IPR020635 (SMART); IPR003598 (SMART); IPR003599 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013151 (PFAM); G3DSA:1.10.510.10 (GENE3D); PF13927 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001245 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR009136 (PTHR24416:PANTHER); PTHR24416 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR008266 (PROSITE_PATTERNS); IPR001824 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F7DHE6	vascular endothelial growth factor receptor 2	1414	20	0E0	96.05%	6	F:GO:0005524; F:GO:0019838; P:GO:0048010; C:GO:0016021; F:GO:0005021; P:GO:0006468	F:ATP binding; F:growth factor binding; P:vascular endothelial growth factor receptor signaling pathway; C:integral component of membrane; F:vascular endothelial growth factor-activated receptor activity; P:protein phosphorylation	EC:2.7.10; EC:2.7.10.1; EC:2.7.11	IPR009136 (PRINTS); PR01832 (PRINTS); IPR000719 (SMART); IPR003599 (SMART); IPR003598 (SMART); IPR020635 (SMART); IPR013151 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001245 (PFAM); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:1.10.510.10 (GENE3D); PF13927 (PFAM); G3DSA:3.30.200.20 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR24416 (PANTHER); IPR009136 (PTHR24416:PANTHER); IPR017441 (PROSITE_PATTERNS); IPR001824 (PROSITE_PATTERNS); IPR008266 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F6T133	vascular endothelial growth factor receptor 1	1336	20	0E0	95.65%	6	C:GO:0005887; F:GO:0005524; P:GO:0048010; F:GO:0005515; F:GO:0005021; P:GO:0006468	C:integral component of plasma membrane; F:ATP binding; P:vascular endothelial growth factor receptor signaling pathway; F:protein binding; F:vascular endothelial growth factor-activated receptor activity; P:protein phosphorylation	EC:2.7.10; EC:2.7.10.1; EC:2.7.11	IPR009135 (PRINTS); PR01832 (PRINTS); IPR003599 (SMART); IPR003598 (SMART); IPR020635 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PF13927 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001245 (PFAM); IPR013151 (PFAM); IPR013098 (PFAM); G3DSA:3.30.200.20 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24416 (PANTHER); PTHR24416:SF259 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR001824 (PROSITE_PATTERNS); IPR008266 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR007110 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR007110 (SUPERFAMILY)
F6S634	serpin A12	414	20	0E0	87.05%	1	C:GO:0005615	C:extracellular space		PR00780 (PRINTS); IPR023796 (SMART); G3DSA:2.30.39.10 (GENE3D); IPR023796 (PFAM); G3DSA:3.30.497.10 (GENE3D); IPR000215 (PANTHER); PTHR11461:SF157 (PANTHER); IPR023795 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR023796 (SUPERFAMILY)
F6YZP7	coatomer subunit beta	953	20	0E0	99.05%	5	P:GO:0016192; F:GO:0005198; F:GO:0005488; P:GO:0006886; C:GO:0030126	P:vesicle-mediated transport; F:structural molecule activity; F:binding; P:intracellular protein transport; C:COPI vesicle coat		IPR016460 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR011710 (PFAM); IPR002553 (PFAM); IPR029446 (PFAM); IPR016460 (PANTHER); IPR016024 (SUPERFAMILY)
F6RTI8	collagen alpha-2(I) chain	1357	20	0E0	96.25%	2	F:GO:0005201; C:GO:0005578	F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix		IPR000885 (SMART); IPR000885 (PFAM); IPR008160 (PFAM); PTHR24023:SF568 (PANTHER); PTHR24023 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR000885 (PRODOM); IPR000885 (PROSITE_PROFILES)
F6RTH9	collagen alpha-2(I) chain	1357	20	0E0	96.25%	2	F:GO:0005201; C:GO:0005578	F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix		IPR000885 (SMART); IPR000885 (PFAM); IPR008160 (PFAM); PTHR24023:SF568 (PANTHER); PTHR24023 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000885 (PRODOM); IPR000885 (PROSITE_PROFILES)
F6RTJ6	collagen alpha-2(I) chain	1359	20	0E0	96.3%	2	F:GO:0005201; C:GO:0005578	F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix		IPR000885 (SMART); IPR000885 (PFAM); IPR008160 (PFAM); PTHR24023 (PANTHER); PTHR24023:SF568 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000885 (PRODOM); IPR000885 (PROSITE_PROFILES)
F6RTN7	collagen alpha-2(I) chain	1364	20	0E0	96.4%	2	F:GO:0005201; C:GO:0005578	F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix		IPR000885 (SMART); IPR008160 (PFAM); IPR000885 (PFAM); PTHR24023:SF568 (PANTHER); PTHR24023 (PANTHER); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR000885 (PRODOM); IPR000885 (PROSITE_PROFILES)
F6RUA6	collagen alpha-2(I) chain	1364	20	0E0	96.6%	2	F:GO:0005201; C:GO:0005578	F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix		IPR000885 (SMART); IPR008160 (PFAM); IPR000885 (PFAM); PTHR24023:SF568 (PANTHER); PTHR24023 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR000885 (PRODOM); IPR000885 (PROSITE_PROFILES)
F6RTL6	collagen alpha-2(I) chain	1364	20	0E0	96.4%	2	F:GO:0005201; C:GO:0005578	F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix		IPR000885 (SMART); IPR008160 (PFAM); IPR000885 (PFAM); PTHR24023:SF568 (PANTHER); PTHR24023 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR000885 (PRODOM); IPR000885 (PROSITE_PROFILES)
F6XRY7	cystatin-M	133	20	6.71E-65	76.4%	1	F:GO:0004869	F:cysteine-type endopeptidase inhibitor activity		IPR000010 (SMART); G3DSA:3.10.450.10 (GENE3D); IPR000010 (PFAM); IPR027214 (PANTHER); PTHR11413:SF60 (PANTHER); IPR018073 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SSF54403 (SUPERFAMILY)
F6VRK8	electrogenic sodium bicarbonate cotransporter 4	1136	20	0E0	94.9%	4	C:GO:0016021; F:GO:0005452; P:GO:0006821; P:GO:0015701	C:integral component of membrane; F:inorganic anion exchanger activity; P:chloride transport; P:bicarbonate transport		IPR003020 (PRINTS); IPR003024 (PRINTS); G3DSA:1.10.287.570 (GENE3D); IPR013769 (PFAM); IPR003020 (TIGRFAM); IPR011531 (PFAM); IPR013769 (G3DSA:3.40.1100.GENE3D); PTHR11453:SF20 (PANTHER); IPR003020 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); IPR016152 (SUPERFAMILY)
F6PYA8	T-cell surface glyco CD5	463	20	0E0	83.1%	3	P:GO:0007165; C:GO:0016020; F:GO:0005044	P:signal transduction; C:membrane; F:scavenger receptor activity		IPR003566 (PRINTS); IPR017448 (SMART); IPR017448 (G3DSA:3.10.250.GENE3D); PTHR19331:SF306 (PANTHER); PTHR19331 (PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR001190 (PROSITE_PROFILES); IPR017448 (SUPERFAMILY); IPR017448 (SUPERFAMILY)
F6ZPZ2	---NA---	2				7	P:GO:0035023; P:GO:0043087; F:GO:0004691; F:GO:0005089; P:GO:0009069; P:GO:0016310; C:GO:0005952	P:regulation of Rho protein signal transduction; P:regulation of GTPase activity; F:cAMP-dependent protein kinase activity; F:Rho guanyl-nucleotide exchange factor activity; P:serine family amino acid metabolic process; P:phosphorylation; C:cAMP-dependent protein kinase complex	EC:2.7.11; EC:2.7.11.11	IPR001849 (SMART); IPR000219 (SMART); IPR002219 (SMART); G3DSA:3.30.60.20 (GENE3D); IPR001849 (PFAM); IPR000219 (PFAM); IPR000219 (G3DSA:1.20.900.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); PTHR13944 (PANTHER); IPR028852 (PTHR13944:PANTHER); IPR002219 (PROSITE_PATTERNS); IPR000219 (PROSITE_PROFILES); IPR002219 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); SSF57889 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR000219 (SUPERFAMILY)
F7BR99	creatine kinase M-type	381	20	0E0	98.45%	1	F:GO:0016301	F:kinase activity		IPR022413 (PFAM); IPR022413 (G3DSA:1.10.135.GENE3D); IPR014746 (G3DSA:3.30.590.GENE3D); IPR022414 (PFAM); IPR000749 (PANTHER); PTHR11547:SF31 (PANTHER); IPR022415 (PROSITE_PATTERNS); IPR022414 (PROSITE_PROFILES); IPR022413 (PROSITE_PROFILES); IPR022413 (SUPERFAMILY); SSF55931 (SUPERFAMILY)
F6VRW6	solute carrier family 7 member 13-like	433	20	0E0	90.55%	3	C:GO:0016020; F:GO:0015171; P:GO:0003333	C:membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport		IPR002293 (PIRSF); IPR002293 (PFAM); IPR002293 (PANTHER); PTHR11785:SF306 (PANTHER); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS)
Q8HZI9	laminin subunit gamma-2	1190	20	0E0	94.3%	1	F:GO:0005515	F:protein binding		PR00011 (PRINTS); IPR002049 (SMART); IPR000742 (SMART); IPR000034 (SMART); G3DSA:2.10.25.10 (GENE3D); IPR000034 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR002049 (PFAM); G3DSA:2.10.25.10 (GENE3D); PTHR10574 (PANTHER); PTHR10574:SF270 (PANTHER); IPR002049 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000034 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY)
F6WZ08	laminin subunit gamma-2	1190	20	0E0	94.25%	1	F:GO:0005515	F:protein binding		PR00011 (PRINTS); IPR000742 (SMART); IPR000034 (SMART); IPR002049 (SMART); IPR002049 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR000034 (PFAM); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.170.300.10 (GENE3D); PTHR10574:SF270 (PANTHER); PTHR10574 (PANTHER); IPR002049 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR002049 (PROSITE_PROFILES); IPR000034 (PROSITE_PROFILES); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY)
F6ZVY1	synaptonemal complex 1 isoform X1	777	20	0E0	96.1%	2	P:GO:0007130; C:GO:0000795	P:synaptonemal complex assembly; C:synaptonemal complex		IPR008827 (PFAM); IPR024835 (PANTHER); PTHR15607:SF15 (PANTHER)
F6R5B2	high mobility group B2	210	20	1.55E-146	99.05%	5	C:GO:0005634; F:GO:0003677; P:GO:0045595; P:GO:0007283; P:GO:0006355	C:nucleus; F:DNA binding; P:regulation of cell differentiation; P:spermatogenesis; P:regulation of transcription, DNA-templated		PR00886 (PRINTS); IPR009071 (SMART); IPR009071 (G3DSA:1.10.30.GENE3D); IPR009071 (PFAM); IPR009071 (PFAM); IPR009071 (G3DSA:1.10.30.GENE3D); IPR031075 (PTHR13711:PANTHER); PTHR13711 (PANTHER); IPR017967 (PROSITE_PATTERNS); IPR009071 (PROSITE_PROFILES); IPR009071 (SUPERFAMILY); IPR009071 (SUPERFAMILY)
F6UCR9	centrosome-associated 350 isoform X2	1231	20	0E0	96.1%	4	C:GO:0005813; P:GO:0034453; C:GO:0045298; F:GO:0008017	C:centrosome; P:microtubule anchoring; C:tubulin complex; F:microtubule binding		IPR000938 (SMART); IPR000938 (G3DSA:2.30.30.GENE3D); IPR000938 (PFAM); IPR028750 (PANTHER); PTHR13958:SF4 (PANTHER); IPR000938 (PROSITE_PATTERNS); IPR000938 (PROSITE_PROFILES); IPR000938 (SUPERFAMILY)
F7BWP5	SPT2 homolog	680	20	0E0	93.4%	6	F:GO:0003677; F:GO:0042393; P:GO:0010847; P:GO:0043486; P:GO:0006355; P:GO:0006334	F:DNA binding; F:histone binding; P:regulation of chromatin assembly; P:histone exchange; P:regulation of transcription, DNA-templated; P:nucleosome assembly		IPR013256 (SMART); IPR013256 (PFAM); PTHR22691:SF8 (PANTHER); PTHR22691 (PANTHER)
F7B6Y9	olfactory receptor 9I1-like	311	20	0E0	93.1%	5	F:GO:0004930; P:GO:0007187; P:GO:0007608; C:GO:0016021; F:GO:0004984	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:sensory perception of smell; C:integral component of membrane; F:olfactory receptor activity		IPR000725 (PRINTS); IPR000276 (PRINTS); PF13853 (PFAM); G3DSA:1.20.1070.10 (GENE3D); PTHR26452 (PANTHER); PTHR26452:SF275 (PANTHER); IPR000276 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR017452 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY)
F6SZV7	semaphorin-6D isoform X3	1075	20	0E0	98.75%	2	F:GO:0005515; C:GO:0016020	F:protein binding; C:membrane		IPR001627 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR002165 (PFAM); G3DSA:3.30.1680.10 (GENE3D); IPR001627 (PFAM); IPR027231 (PANTHER); PTHR11036:SF65 (PANTHER); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR001627 (PROSITE_PROFILES); IPR001627 (SUPERFAMILY); SSF103575 (SUPERFAMILY)
F7DNZ3	sorting nexin-25 isoform X1	839	20	0E0	97.3%	1	F:GO:0035091	F:phosphatidylinositol binding		IPR001683 (SMART); IPR016137 (SMART); IPR003114 (SMART); IPR001683 (PFAM); IPR001683 (G3DSA:3.30.1520.GENE3D); IPR003114 (PFAM); G3DSA:1.10.167.10 (GENE3D); IPR013937 (PFAM); IPR016137 (PFAM); PTHR22775 (PANTHER); PTHR22775:SF29 (PANTHER); IPR001683 (PROSITE_PROFILES); IPR003114 (PROSITE_PROFILES); IPR016137 (PROSITE_PROFILES); IPR016137 (SUPERFAMILY); IPR001683 (SUPERFAMILY)
F7AGN4	zinc finger with UFM1-specific peptidase domain isoform X1	579	20	0E0	95.5%	1	F:GO:0046872	F:metal ion binding		IPR015880 (SMART); IPR012462 (PFAM); PTHR24375 (PANTHER); PTHR24375:SF140 (PANTHER); IPR007087 (PROSITE_PATTERNS)
F6ZU69	sodium-dependent phosphate transport 2B	693	20	0E0	94.35%	3	F:GO:0015321; P:GO:0044341; C:GO:0005886	F:sodium-dependent phosphate transmembrane transporter activity; P:sodium-dependent phosphate transport; C:plasma membrane		IPR003841 (TIGRFAM); IPR003841 (PFAM); PTHR10010 (PANTHER); IPR029852 (PTHR10010:PANTHER); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS)
F6XKF5	collagen alpha-3(V) chain isoform X1	1384	20	0E0	85.6%	2	F:GO:0005201; C:GO:0005578	F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix		IPR000885 (SMART); IPR008160 (PFAM); IPR000885 (PFAM); PTHR24023 (PANTHER); PTHR24023:SF516 (PANTHER); IPR000885 (PRODOM); IPR000885 (PROSITE_PROFILES)
F6WU55	deleted in malignant brain tumors 1	292	20	1.42E-161	82.1%	3	P:GO:0007165; C:GO:0016020; F:GO:0005044	P:signal transduction; C:membrane; F:scavenger receptor activity		IPR001190 (PRINTS); IPR017448 (SMART); IPR000859 (SMART); IPR001190 (PFAM); IPR000859 (G3DSA:2.60.120.GENE3D); IPR017448 (G3DSA:3.10.250.GENE3D); IPR000859 (PFAM); PTHR19331 (PANTHER); PTHR19331:SF22 (PANTHER); IPR001190 (PROSITE_PROFILES); IPR000859 (PROSITE_PROFILES); IPR017448 (SUPERFAMILY); IPR000859 (SUPERFAMILY); IPR000859 (SUPERFAMILY)
F6PMY4	prolow-density lipo receptor-related 1	598	20	0E0	98.35%	2	F:GO:0005515; F:GO:0005509	F:protein binding; F:calcium ion binding		IPR002172 (PRINTS); IPR000742 (SMART); IPR002172 (SMART); IPR000033 (SMART); IPR001881 (SMART); IPR000033 (PFAM); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR032485 (PFAM); IPR001881 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR026823 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:4.10.1220.10 (GENE3D); IPR011042 (G3DSA:2.120.10.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR011042 (G3DSA:2.120.10.GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); PF14670 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (PFAM); PTHR10529:SF100 (PANTHER); PTHR10529 (PANTHER); IPR018097 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR023415 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR000033 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR002172 (PROSITE_PROFILES); SSF57196 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR009030 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF63825 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY)
F6Q221	prolow-density lipo receptor-related 1	605	20	0E0	98.4%	2	F:GO:0005515; F:GO:0005509	F:protein binding; F:calcium ion binding		IPR002172 (PRINTS); IPR002172 (SMART); IPR000033 (SMART); IPR001881 (SMART); IPR000742 (SMART); IPR001881 (PFAM); IPR002172 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR032485 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.10.25.10 (GENE3D); PF14670 (PFAM); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:4.10.1220.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR026823 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); IPR000033 (PFAM); IPR011042 (G3DSA:2.120.10.GENE3D); IPR011042 (G3DSA:2.120.10.GENE3D); IPR002172 (G3DSA:4.10.400.GENE3D); PTHR10529:SF100 (PANTHER); PTHR10529 (PANTHER); IPR023415 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); IPR000033 (PROSITE_PROFILES); IPR002172 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); SSF57196 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR009030 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); SSF63825 (SUPERFAMILY); SSF63825 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); SSF63825 (SUPERFAMILY); SSF63825 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY); IPR002172 (SUPERFAMILY)
P49066	alpha-feto	609	20	0E0	92%	2	C:GO:0005615; P:GO:0006810	C:extracellular space; P:transport		IPR000264 (PRINTS); IPR021177 (PRINTS); IPR014760 (SMART); IPR021177 (PIRSF); G3DSA:1.10.246.10 (GENE3D); G3DSA:1.10.246.10 (GENE3D); G3DSA:1.10.246.10 (GENE3D); G3DSA:1.10.246.10 (GENE3D); IPR014760 (PFAM); G3DSA:1.10.246.10 (GENE3D); PTHR11385 (PANTHER); PTHR11385:SF7 (PANTHER); IPR020857 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); PD002486 (PRODOM); IPR014760 (PROSITE_PROFILES); IPR020858 (SUPERFAMILY); IPR020858 (SUPERFAMILY); IPR020858 (SUPERFAMILY)
F6U4X2	alpha-feto	614	20	0E0	92%	2	C:GO:0005615; P:GO:0006810	C:extracellular space; P:transport		IPR021177 (PRINTS); IPR000264 (PRINTS); IPR014760 (SMART); IPR021177 (PIRSF); G3DSA:1.10.246.10 (GENE3D); IPR014760 (PFAM); G3DSA:1.10.246.10 (GENE3D); G3DSA:1.10.246.10 (GENE3D); G3DSA:1.10.246.10 (GENE3D); G3DSA:1.10.246.10 (GENE3D); PTHR11385 (PANTHER); PTHR11385:SF7 (PANTHER); IPR020857 (PROSITE_PATTERNS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); PD002486 (PRODOM); IPR014760 (PROSITE_PROFILES); IPR020858 (SUPERFAMILY); IPR020858 (SUPERFAMILY); IPR020858 (SUPERFAMILY)
F6S8Z5	nicotinamide phosphoribosyltransferase	473	20	0E0	99.05%	3	F:GO:0004514; P:GO:0046497; P:GO:0009435	F:nicotinate-nucleotide diphosphorylase (carboxylating) activity; P:nicotinate nucleotide metabolic process; P:NAD biosynthetic process	EC:2.4.2.19	IPR016471 (PIRSF); IPR007229 (PFAM); G3DSA:3.20.140.10 (GENE3D); IPR016471 (PTHR11098:PANTHER); IPR007229 (PANTHER); IPR002638 (SUPERFAMILY)
F6PWM8	sushi domain-containing 1	713	20	0E0	92.05%	2	F:GO:0005515; F:GO:0005509	F:protein binding; F:calcium ion binding		IPR000742 (SMART); IPR000436 (SMART); IPR001881 (SMART); IPR001881 (PFAM); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.70.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR000436 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR023413 (G3DSA:2.40.155.GENE3D); PTHR24051 (PANTHER); PTHR24051:SF5 (PANTHER); IPR000152 (PROSITE_PATTERNS); IPR013032 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); IPR000436 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000436 (SUPERFAMILY); IPR009030 (SUPERFAMILY); IPR003961 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR000436 (SUPERFAMILY)
F7CPA2	anoctamin-8	1064	20	0E0	86.85%	8	F:GO:0005229; P:GO:1902476; P:GO:0034220; C:GO:0016020; C:GO:0016021; P:GO:0006821; C:GO:0005622; C:GO:0005886	F:intracellular calcium activated chloride channel activity; P:chloride transmembrane transport; P:ion transmembrane transport; C:membrane; C:integral component of membrane; P:chloride transport; C:intracellular; C:plasma membrane		IPR007632 (PFAM); IPR031289 (PTHR12308:PANTHER); IPR007632 (PANTHER); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS)
F6Z2E9	limb region 1 homolog	470	20	0E0	97.9%	3	C:GO:0016020; C:GO:0016021; P:GO:0042733	C:membrane; C:integral component of membrane; P:embryonic digit morphogenesis		IPR008075 (PRINTS); IPR006876 (PFAM); IPR008075 (PANTHER); PTHR12625:SF1 (PANTHER); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS)
F6XGW5	Hermansky-Pudlak syndrome 1 isoform X1	667	20	0E0	90.2%	10	P:GO:0007040; C:GO:0005887; F:GO:0005515; C:GO:0005737; C:GO:0031085; F:GO:0046983; C:GO:0016023; P:GO:0007601; P:GO:0050896; C:GO:0005764	P:lysosome organization; C:integral component of plasma membrane; F:protein binding; C:cytoplasm; C:BLOC-3 complex; F:protein dimerization activity; C:cytoplasmic, membrane-bounded vesicle; P:visual perception; P:response to stimulus; C:lysosome		IPR026053 (PANTHER)
F6WUZ3	Hermansky-Pudlak syndrome 1 isoform X1	711	20	0E0	91.2%	3	C:GO:0031085; F:GO:0046983; C:GO:0016023	C:BLOC-3 complex; F:protein dimerization activity; C:cytoplasmic, membrane-bounded vesicle		IPR026053 (PANTHER)
F7DKN8	POU class transcription factor 3	334	20	0E0	98.85%	7	P:GO:0007605; C:GO:0005667; F:GO:0003700; P:GO:0048839; P:GO:0006355; F:GO:0043565; P:GO:0006355	P:sensory perception of sound; C:transcription factor complex; F:transcription factor activity, sequence-specific DNA binding; P:inner ear development; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding; P:regulation of transcription, DNA-templated		IPR013847 (PRINTS); IPR001356 (SMART); IPR000327 (SMART); IPR000327 (PFAM); IPR001356 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); IPR010982 (G3DSA:1.10.260.GENE3D); PTHR11636 (PANTHER); IPR032961 (PTHR11636:PANTHER); IPR000327 (PROSITE_PATTERNS); IPR017970 (PROSITE_PATTERNS); IPR000327 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR000327 (PROSITE_PROFILES); IPR010982 (SUPERFAMILY); IPR009057 (SUPERFAMILY)
F7AIM2	acidic amino acid decarboxylase GADL1 isoform X1	502	20	0E0	98.5%	3	F:GO:0030170; P:GO:0019752; F:GO:0016831	F:pyridoxal phosphate binding; P:carboxylic acid metabolic process; F:carboxy-lyase activity		IPR015421 (G3DSA:3.40.640.GENE3D); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR002129 (PFAM); PTHR11999:SF95 (PANTHER); PTHR11999 (PANTHER); IPR021115 (PROSITE_PATTERNS); IPR015424 (SUPERFAMILY)
F6PHH1	serine threonine- kinase Nek4 isoform X1	787	20	0E0	92.25%	3	F:GO:0005524; F:GO:0004672; P:GO:0006468	F:ATP binding; F:protein kinase activity; P:protein phosphorylation		IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24361 (PANTHER); PTHR24361:SF361 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)
F6PHX3	serine threonine- kinase Nek4 isoform X1	838	20	0E0	86.45%	3	F:GO:0005524; F:GO:0004672; P:GO:0006468	F:ATP binding; F:protein kinase activity; P:protein phosphorylation		IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24361:SF361 (PANTHER); PTHR24361 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)
F6W627	tumor D54 isoform X1	206	20	2.36E-149	90.6%	5	F:GO:0042803; C:GO:0048471; C:GO:0005737; F:GO:0046982; F:GO:0044822	F:protein homodimerization activity; C:perinuclear region of cytoplasm; C:cytoplasm; F:protein heterodimerization activity; F:poly(A) RNA binding		IPR007327 (PFAM); PTHR19307:SF13 (PANTHER); IPR007327 (PANTHER)
F7BNH6	nck-associated 5-like isoform X1	1327	20	0E0	95.4%	9	C:GO:0005813; F:GO:0005515; C:GO:0005856; P:GO:0001578; C:GO:0005815; C:GO:0005737; C:GO:0035371; P:GO:0007019; C:GO:0005874	C:centrosome; F:protein binding; C:cytoskeleton; P:microtubule bundle formation; C:microtubule organizing center; C:cytoplasm; C:microtubule plus-end; P:microtubule depolymerization; C:microtubule		IPR032769 (PFAM); IPR026163 (PANTHER)
F6REQ2	nitric oxide endothelial	1213	20	0E0	96.4%	9	F:GO:0005516; F:GO:0050661; F:GO:0004517; F:GO:0010181; F:GO:0005506; F:GO:0050660; P:GO:0055114; P:GO:0006809; F:GO:0020037	F:calmodulin binding; F:NADP binding; F:nitric-oxide synthase activity; F:FMN binding; F:iron ion binding; F:flavin adenine dinucleotide binding; P:oxidation-reduction process; P:nitric oxide biosynthetic process; F:heme binding	EC:1.14.13.39; EC:1.14.13	IPR001094 (PRINTS); IPR001709 (PRINTS); IPR012144 (PIRSF); IPR023173 (G3DSA:1.20.990.GENE3D); G3DSA:2.40.30.10 (GENE3D); IPR004030 (PFAM); IPR008254 (PFAM); IPR029039 (G3DSA:3.40.50.GENE3D); G3DSA:3.40.50.80 (GENE3D); IPR001433 (PFAM); IPR004030 (G3DSA:3.90.340.GENE3D); IPR003097 (PFAM); G3DSA:3.90.1230.10 (GENE3D); PTHR19384 (PANTHER); PTHR19384:SF66 (PANTHER); IPR004030 (PROSITE_PATTERNS); IPR017927 (PROSITE_PROFILES); IPR008254 (PROSITE_PROFILES); IPR017938 (SUPERFAMILY); IPR029039 (SUPERFAMILY); IPR004030 (SUPERFAMILY); SSF52343 (SUPERFAMILY)
F6QGQ1	cadherin-22 isoform X1	604	20	0E0	84.9%	3	F:GO:0005509; P:GO:0007156; C:GO:0005886	F:calcium ion binding; P:homophilic cell adhesion via plasma membrane adhesion molecules; C:plasma membrane		IPR002126 (PRINTS); IPR002126 (SMART); IPR002126 (G3DSA:2.60.40.GENE3D); IPR000233 (PFAM); IPR002126 (G3DSA:2.60.40.GENE3D); IPR002126 (PFAM); IPR002126 (G3DSA:2.60.40.GENE3D); PTHR24027:SF311 (PANTHER); PTHR24027 (PANTHER); IPR020894 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR002126 (PROSITE_PROFILES); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY)
F6W6H9		1763				1	F:GO:0008289	F:lipid binding		IPR023393 (G3DSA:3.30.530.GENE3D); IPR002913 (PFAM); PTHR12136:SF48 (PANTHER); PTHR12136 (PANTHER); IPR002913 (PROSITE_PROFILES); SSF55961 (SUPERFAMILY)
F6WZW6	proteasome subunit alpha type-1	263	20	0E0	99.1%	3	C:GO:0019773; F:GO:0004298; P:GO:0006511	C:proteasome core complex, alpha-subunit complex; F:threonine-type endopeptidase activity; P:ubiquitin-dependent protein catabolic process	EC:3.4.25	IPR000426 (SMART); IPR029055 (G3DSA:3.60.20.GENE3D); IPR001353 (PFAM); IPR000426 (PFAM); PTHR11599:SF12 (PANTHER); PTHR11599 (PANTHER); IPR000426 (PROSITE_PATTERNS); IPR023332 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY)
F6ZN56	zinc finger 181 isoform X1	570	20	0E0	95.4%	4	F:GO:0003677; F:GO:0046872; P:GO:0006355; C:GO:0005622	F:DNA binding; F:metal ion binding; P:regulation of transcription, DNA-templated; C:intracellular		IPR001909 (SMART); IPR015880 (SMART); IPR003656 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR001909 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); PTHR24377 (PANTHER); IPR007087 (PROSITE_PATTERNS); IPR001909 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); IPR001909 (SUPERFAMILY); SSF57667 (SUPERFAMILY)
F7DUZ2	kinesin KIF18A	895	20	0E0	93.95%	6	F:GO:0005524; F:GO:0003777; C:GO:0045298; P:GO:0007018; F:GO:0008017; C:GO:0005874	F:ATP binding; F:microtubule motor activity; C:tubulin complex; P:microtubule-based movement; F:microtubule binding; C:microtubule	EC:3.6.1; EC:3.6.1.15	IPR001752 (PRINTS); IPR001752 (SMART); IPR001752 (G3DSA:3.40.850.GENE3D); IPR001752 (PFAM); IPR027640 (PANTHER); PTHR24115:SF399 (PANTHER); IPR019821 (PROSITE_PATTERNS); IPR001752 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY)
F7E1C0	olfactory receptor 11G2-like	306	20	0E0	93.35%	5	F:GO:0004930; P:GO:0007187; P:GO:0007608; C:GO:0016021; F:GO:0004984	F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:sensory perception of smell; C:integral component of membrane; F:olfactory receptor activity		IPR000725 (PRINTS); IPR000276 (PRINTS); G3DSA:1.20.1070.10 (GENE3D); PF13853 (PFAM); PTHR24242:SF183 (PANTHER); PTHR24242 (PANTHER); IPR000276 (PROSITE_PATTERNS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR017452 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY)
F6Y1Y3	msx2-interacting isoform X1	1738	20	0E0	92.15%	2	F:GO:0000166; F:GO:0003676	F:nucleotide binding; F:nucleic acid binding		IPR000504 (SMART); IPR016194 (G3DSA:2.40.290.GENE3D); IPR012921 (PFAM); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR23189 (PANTHER); PTHR23189:SF48 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR010912 (PROSITE_PROFILES); IPR016194 (SUPERFAMILY); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY)
F6RNK0	pre-mRNA-processing-splicing factor 8	447	20	0E0	99.65%	5	F:GO:0017070; F:GO:0030623; F:GO:0005515; C:GO:0005681; P:GO:0000398	F:U6 snRNA binding; F:U5 snRNA binding; F:protein binding; C:spliceosomal complex; P:mRNA splicing, via spliceosome		IPR000555 (SMART); IPR021983 (PFAM); IPR012591 (PFAM); IPR000555 (PFAM); IPR019581 (PFAM); IPR019580 (PFAM); IPR019582 (PFAM); IPR012984 (PFAM); IPR012592 (PFAM); IPR027652 (PANTHER); PTHR11140:SF0 (PANTHER); IPR012591 (PRODOM); IPR012337 (SUPERFAMILY); IPR012337 (SUPERFAMILY)
F6T7B9	gigaxonin	545	20	0E0	99.15%	2	F:GO:0005515; P:GO:0007010	F:protein binding; P:cytoskeleton organization		IPR011705 (SMART); IPR017096 (PIRSF); IPR006652 (SMART); G3DSA:3.30.710.10 (GENE3D); IPR011705 (PFAM); IPR006652 (PFAM); IPR015915 (G3DSA:2.120.10.GENE3D); IPR000210 (PFAM); PTHR24412 (PANTHER); IPR030579 (PTHR24412:PANTHER); IPR011333 (SUPERFAMILY); SSF117281 (SUPERFAMILY)
F6UN00	RNA-binding 28	761	20	0E0	93.05%	2	F:GO:0000166; F:GO:0003676	F:nucleotide binding; F:nucleic acid binding		IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR24012:SF442 (PANTHER); PTHR24012 (PANTHER); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY)
F6TR20	insulin-like growth factor 2 mRNA-binding 2 isoform X1	531	20	0E0	98.7%	2	F:GO:0000166; F:GO:0003729	F:nucleotide binding; F:mRNA binding		IPR000504 (SMART); IPR004087 (SMART); IPR004088 (G3DSA:3.30.1370.GENE3D); IPR004088 (PFAM); IPR004088 (G3DSA:3.30.1370.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR004088 (G3DSA:3.30.1370.GENE3D); IPR000504 (PFAM); PTHR10288 (PANTHER); IPR028743 (PTHR10288:PANTHER); IPR000504 (PROSITE_PROFILES); IPR004088 (PROSITE_PROFILES); IPR004088 (SUPERFAMILY); IPR004088 (SUPERFAMILY); IPR012677 (SUPERFAMILY); IPR004088 (SUPERFAMILY); IPR004088 (SUPERFAMILY)
F6XLH9	cytochrome P450 4A11-like	510	20	0E0	91.35%	4	F:GO:0005506; F:GO:0016705; P:GO:0055114; F:GO:0020037	F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:heme binding		IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24291 (PANTHER); PTHR24291:SF39 (PANTHER); IPR017972 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR001128 (SUPERFAMILY)
F6WWI9	ZBED8	594	20	0E0	98%	7	F:GO:0003676; F:GO:0003677; F:GO:0005515; C:GO:0005737; F:GO:0000981; C:GO:0005654; P:GO:0006357	F:nucleic acid binding; F:DNA binding; F:protein binding; C:cytoplasm; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; C:nucleoplasm; P:regulation of transcription from RNA polymerase II promoter		PTHR11697:SF102 (PANTHER); PTHR11697 (PANTHER)
F7AGL5	matrix metallo ase-9	714	20	0E0	89.3%	7	F:GO:0008270; P:GO:0001503; P:GO:0006508; P:GO:0030574; P:GO:0050900; C:GO:0031012; F:GO:0004222	F:zinc ion binding; P:ossification; P:proteolysis; P:collagen catabolic process; P:leukocyte migration; C:extracellular matrix; F:metalloendopeptidase activity	EC:3.4.24	IPR021190 (PRINTS); PR00013 (PRINTS); IPR006026 (SMART); IPR018487 (SMART); IPR000562 (SMART); IPR002477 (PFAM); IPR000562 (PFAM); IPR024079 (G3DSA:3.40.390.GENE3D); IPR000585 (G3DSA:2.110.10.GENE3D); IPR018487 (PFAM); IPR001818 (PFAM); IPR000562 (G3DSA:2.10.10.GENE3D); IPR028688 (PTHR10201:PANTHER); PTHR10201 (PANTHER); IPR021158 (PROSITE_PATTERNS); IPR000562 (PROSITE_PATTERNS); IPR018486 (PROSITE_PATTERNS); SIGNAL_PEPTIDE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); IPR000562 (PROSITE_PROFILES); IPR018487 (PROSITE_PROFILES); SSF55486 (SUPERFAMILY); IPR013806 (SUPERFAMILY); IPR013806 (SUPERFAMILY); IPR002477 (SUPERFAMILY); IPR013806 (SUPERFAMILY); IPR000585 (SUPERFAMILY)
F6VT48	papilin isoform X1	1255	20	0E0	89.2%	5	F:GO:0004867; F:GO:0008270; F:GO:0005515; F:GO:0004222; C:GO:0005578	F:serine-type endopeptidase inhibitor activity; F:zinc ion binding; F:protein binding; F:metalloendopeptidase activity; C:proteinaceous extracellular matrix	EC:3.4.24	IPR013273 (PRINTS); IPR002223 (PRINTS); IPR003599 (SMART); IPR003598 (SMART); IPR002223 (SMART); IPR000884 (SMART); PF16626 (PFAM); PF13927 (PFAM); IPR000884 (PFAM); IPR010294 (PFAM); IPR002223 (G3DSA:4.10.410.GENE3D); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR010909 (PFAM); G3DSA:2.20.100.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002223 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR13723:SF179 (PANTHER); PTHR13723 (PANTHER); IPR020901 (PROSITE_PATTERNS); IPR000884 (PROSITE_PROFILES); IPR002223 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR010909 (PROSITE_PROFILES); IPR007110 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR002223 (SUPERFAMILY); IPR007110 (SUPERFAMILY); IPR000884 (SUPERFAMILY); IPR000884 (SUPERFAMILY)
F6PJF0	chromobox homolog 3	183	20	2.73E-131	98.7%	1	C:GO:0005634	C:nucleus		IPR017984 (PRINTS); IPR008251 (SMART); IPR000953 (SMART); IPR008251 (PFAM); G3DSA:2.40.50.40 (GENE3D); IPR023780 (PFAM); G3DSA:2.40.50.40 (GENE3D); PTHR22812 (PANTHER); PTHR22812:SF93 (PANTHER); IPR023779 (PROSITE_PATTERNS); IPR000953 (PROSITE_PROFILES); IPR016197 (SUPERFAMILY); IPR016197 (SUPERFAMILY)
F7D8N7	strawberry notch homolog 1 isoform X1	1393	20	0E0	99.15%	1	P:GO:0006355	P:regulation of transcription, DNA-templated		IPR026937 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PF13872 (PFAM); IPR026741 (PANTHER); PTHR12706:SF8 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)
F7DE75	alpha-soluble NSF attachment	295	20	0E0	98.95%	2	F:GO:0005515; P:GO:0006886	F:protein binding; P:intracellular protein transport		IPR000744 (PRINTS); IPR011990 (G3DSA:1.25.40.GENE3D); PF14938 (PFAM); IPR000744 (PANTHER); PTHR13768:SF11 (PANTHER); IPR011990 (SUPERFAMILY)
F7DHH2	GON-4 isoform X3	344	20	0E0	94.15%	6	F:GO:0003677; C:GO:0005667; P:GO:0030183; P:GO:0045892; F:GO:0003714; P:GO:0045892	F:DNA binding; C:transcription factor complex; P:B cell differentiation; P:negative regulation of transcription, DNA-templated; F:transcription corepressor activity; P:negative regulation of transcription, DNA-templated		IPR003822 (PFAM); IPR003822 (G3DSA:1.20.1160.GENE3D); IPR009057 (G3DSA:1.10.10.GENE3D); IPR033277 (PTHR16088:PANTHER); PTHR16088 (PANTHER); IPR017877 (PROSITE_PROFILES); IPR003822 (PROSITE_PROFILES); IPR003822 (SUPERFAMILY); IPR009057 (SUPERFAMILY); IPR003822 (SUPERFAMILY)
Q2QLA8	F-actin-capping subunit alpha-2	286	20	0E0	99.05%	2	P:GO:0051016; C:GO:0008290	P:barbed-end actin filament capping; C:F-actin capping protein complex		IPR002189 (PRINTS); IPR002189 (PFAM); PTHR10653:SF2 (PANTHER); IPR002189 (PANTHER); IPR017865 (PROSITE_PATTERNS); IPR017865 (PROSITE_PATTERNS); SSF90096 (SUPERFAMILY)
F7D7V5	serine threonine- phosphatase 4 regulatory subunit 2 isoform X1	377	20	0E0	97.75%	1	C:GO:0030289	C:protein phosphatase 4 complex		IPR015267 (PFAM); IPR015267 (PANTHER)
F7C3L4	nuclear receptor subfamily 1 group D member 2	572	20	0E0	98.75%	9	C:GO:0005634; C:GO:0005667; F:GO:0003700; F:GO:0008270; F:GO:0003707; P:GO:0006355; F:GO:0043565; P:GO:0006355; P:GO:0043401	C:nucleus; C:transcription factor complex; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; F:steroid hormone receptor activity; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding; P:regulation of transcription, DNA-templated; P:steroid hormone mediated signaling pathway		IPR001723 (PRINTS); IPR001628 (PRINTS); IPR000536 (SMART); IPR001628 (SMART); IPR001628 (PFAM); IPR013088 (G3DSA:3.30.50.GENE3D); IPR000536 (PFAM); IPR000536 (G3DSA:1.10.565.GENE3D); PTHR24082 (PANTHER); PTHR24082:SF112 (PANTHER); IPR001628 (PROSITE_PATTERNS); IPR001628 (PROSITE_PROFILES); SSF57716 (SUPERFAMILY); IPR000536 (SUPERFAMILY)
F7AQJ9	band 2 isoform X4	994	20	0E0	90.05%	6	P:GO:0030866; C:GO:0005856; F:GO:0003779; C:GO:0005737; F:GO:0005198; C:GO:0019898	P:cortical actin cytoskeleton organization; C:cytoskeleton; F:actin binding; C:cytoplasm; F:structural molecule activity; C:extrinsic component of membrane		IPR019749 (PRINTS); IPR000798 (PRINTS); IPR019749 (SMART); PIRSF002304 (PIRSF); IPR014847 (SMART); IPR018980 (SMART); G3DSA:3.10.20.90 (GENE3D); IPR008379 (PFAM); IPR018979 (PFAM); IPR007477 (PFAM); IPR014352 (G3DSA:1.20.80.GENE3D); IPR019748 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR014847 (PFAM); IPR018980 (PFAM); PTHR23280 (PANTHER); IPR019747 (PROSITE_PATTERNS); IPR019747 (PROSITE_PATTERNS); IPR000299 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR029071 (SUPERFAMILY); IPR019748 (SUPERFAMILY)
F6SU72	opioid growth factor receptor	652	20	0E0	73.65%	3	P:GO:0007165; C:GO:0016020; F:GO:0004872	P:signal transduction; C:membrane; F:receptor activity		IPR006757 (PFAM); PTHR14015:SF1 (PANTHER); PTHR14015 (PANTHER)
F6S3W0	B-cell CLL lymphoma 9 isoform X1	1426	20	0E0	99.05%	10	C:GO:0005634; C:GO:0005801; P:GO:0014908; P:GO:0035914; C:GO:0005737; P:GO:0035019; P:GO:0060070; C:GO:0005794; F:GO:0008013; P:GO:0045944	C:nucleus; C:cis-Golgi network; P:myotube differentiation involved in skeletal muscle regeneration; P:skeletal muscle cell differentiation; C:cytoplasm; P:somatic stem cell population maintenance; P:canonical Wnt signaling pathway; C:Golgi apparatus; F:beta-catenin binding; P:positive regulation of transcription from RNA polymerase II promoter		IPR024670 (PFAM); IPR015668 (PANTHER); PTHR15185:SF5 (PANTHER)
F6TGN6	signal transducer and activator of transcription 5B isoform X1	788	20	0E0	99.1%	8	C:GO:0005634; F:GO:0003677; C:GO:0005667; F:GO:0003700; P:GO:0007165; P:GO:0006355; P:GO:0006355; F:GO:0004871	C:nucleus; F:DNA binding; C:transcription factor complex; F:transcription factor activity, sequence-specific DNA binding; P:signal transduction; P:regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:signal transducer activity		IPR013799 (SMART); IPR000980 (SMART); IPR013799 (G3DSA:1.10.532.GENE3D); IPR000980 (G3DSA:3.30.505.GENE3D); IPR012345 (G3DSA:2.60.40.GENE3D); IPR000980 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); IPR013800 (PFAM); IPR013801 (PFAM); IPR013800 (G3DSA:1.20.1050.GENE3D); IPR013799 (PFAM); PTHR11801:SF39 (PANTHER); IPR001217 (PANTHER); IPR000980 (PROSITE_PROFILES); IPR013799 (SUPERFAMILY); IPR000980 (SUPERFAMILY); IPR015988 (SUPERFAMILY); IPR008967 (SUPERFAMILY)
F7A6J6	ribonuclease UK114	137	20	4.6E-94	96.1%	27	F:GO:1904012; F:GO:0046914; P:GO:1902074; F:GO:1904013; F:GO:0043167; C:GO:0070062; P:GO:0001822; F:GO:0004519; F:GO:0004518; C:GO:0005829; P:GO:0033993; F:GO:0016892; P:GO:0017148; P:GO:0030324; P:GO:0090502; F:GO:0042803; F:GO:0036041; P:GO:0007420; F:GO:0044822; C:GO:0005777; C:GO:0005634; P:GO:0006449; C:GO:0005737; C:GO:0005739; P:GO:0050680; P:GO:0070314; F:GO:0016787	F:platinum binding; F:transition metal ion binding; P:response to salt; F:xenon atom binding; F:ion binding; C:extracellular exosome; P:kidney development; F:endonuclease activity; F:nuclease activity; C:cytosol; P:response to lipid; F:endoribonuclease activity, producing 3'-phosphomonoesters; P:negative regulation of translation; P:lung development; P:RNA phosphodiester bond hydrolysis, endonucleolytic; F:protein homodimerization activity; F:long-chain fatty acid binding; P:brain development; F:poly(A) RNA binding; C:peroxisome; C:nucleus; P:regulation of translational termination; C:cytoplasm; C:mitochondrion; P:negative regulation of epithelial cell proliferation; P:G1 to G0 transition; F:hydrolase activity		IPR006175 (PFAM); IPR006056 (TIGRFAM); IPR013813 (G3DSA:3.30.1330.GENE3D); IPR006175 (PANTHER); IPR013813 (SUPERFAMILY)
F6PT23	ubiquitin carboxyl-terminal hydrolase 11	910	20	0E0	96.6%	3	F:GO:0004843; P:GO:0016579; P:GO:0006511	F:thiol-dependent ubiquitin-specific protease activity; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process	EC:3.4; EC:3.4.19.12	IPR006615 (SMART); IPR028135 (PFAM); IPR006615 (PFAM); IPR001394 (PFAM); IPR006615 (G3DSA:3.30.2230.GENE3D); IPR029346 (PFAM); PTHR24006:SF403 (PANTHER); PTHR24006 (PANTHER); IPR018200 (PROSITE_PATTERNS); IPR018200 (PROSITE_PATTERNS); IPR006615 (PROSITE_PROFILES); IPR028889 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY); IPR006615 (SUPERFAMILY)
F6ZNZ4	microtubule-associated 1B isoform X2	584	20	0E0	95.75%	5	C:GO:0045298; P:GO:0007399; P:GO:0000226; C:GO:0005874; F:GO:0008017	C:tubulin complex; P:nervous system development; P:microtubule cytoskeleton organization; C:microtubule; F:microtubule binding		IPR001279 (G3DSA:3.60.15.GENE3D); IPR000102 (PFAM); IPR027321 (PTHR13843:PANTHER); IPR026074 (PANTHER); IPR000102 (PROSITE_PATTERNS)
AAF28866.1	E3 ubiquitin- ligase Mdm2 isoform X1	491	20	0E0	98.65%	7	P:GO:0000122; C:GO:0005634; F:GO:0008270; F:GO:0005515; P:GO:0071157; P:GO:0043066; P:GO:0016567	P:negative regulation of transcription from RNA polymerase II promoter; C:nucleus; F:zinc ion binding; F:protein binding; P:negative regulation of cell cycle arrest; P:negative regulation of apoptotic process; P:protein ubiquitination		IPR016495 (PIRSF); IPR028340 (PIRSF); PF13920 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR003121 (G3DSA:1.10.245.GENE3D); IPR001876 (PFAM); IPR003121 (PFAM); PTHR13844 (PANTHER); IPR015459 (PTHR13844:PANTHER); IPR001876 (PROSITE_PATTERNS); IPR001876 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR003121 (SUPERFAMILY); SSF57850 (SUPERFAMILY); IPR001876 (SUPERFAMILY); IPR003121 (SUPERFAMILY)
Q28388.1	alpha-2u globulin	180	20	3.44E-131	68.6%	3	F:GO:0005550; P:GO:0006810; F:GO:0005215	F:pheromone binding; P:transport; F:transporter activity		IPR002971 (PRINTS); IPR000566 (PFAM); IPR012674 (G3DSA:2.40.128.GENE3D); PTHR11430:SF70 (PANTHER); PTHR11430 (PANTHER); SIGNAL_PEPTIDE_C_REGION (PHOBIUS); SIGNAL_PEPTIDE_H_REGION (PHOBIUS); SIGNAL_PEPTIDE_N_REGION (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); SIGNAL_PEPTIDE (PHOBIUS); IPR011038 (SUPERFAMILY)
Q6SJP2.1	anion exchange 2 isoform X1	1237	20	0E0	97.4%	4	C:GO:0016021; F:GO:0005452; P:GO:0006821; P:GO:0015701	C:integral component of membrane; F:inorganic anion exchanger activity; P:chloride transport; P:bicarbonate transport		IPR002978 (PRINTS); IPR003020 (PRINTS); IPR001717 (PRINTS); IPR013769 (PFAM); IPR013769 (G3DSA:3.40.1100.GENE3D); IPR003020 (TIGRFAM); IPR011531 (PFAM); G3DSA:1.10.287.570 (GENE3D); IPR003020 (PANTHER); IPR002978 (PTHR11453:PANTHER); IPR018241 (PROSITE_PATTERNS); IPR018241 (PROSITE_PATTERNS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); NON_CYTOPLASMIC_DOMAIN (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); TRANSMEMBRANE (PHOBIUS); IPR016152 (SUPERFAMILY)
